<SEC-DOCUMENT>0001539497-25-002331.txt : 20250911
<SEC-HEADER>0001539497-25-002331.hdr.sgml : 20250911
<ACCEPTANCE-DATETIME>20250911160403
ACCESSION NUMBER:		0001539497-25-002331
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		144
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20250911
DATE AS OF CHANGE:		20250911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NIOCORP DEVELOPMENTS LTD
		CENTRAL INDEX KEY:			0001512228
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41655
		FILM NUMBER:		251308528

	BUSINESS ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		720-639-4647

	MAIL ADDRESS:	
		STREET 1:		7000 S. YOSEMITE STREET
		STREET 2:		STE. 115
		CITY:			CENTENNIAL
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUANTUM RARE EARTH DEVELOPMENTS CORP.
		DATE OF NAME CHANGE:	20110204
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>n2574_x280-10k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:niobf="http://niocorp.com/20250630">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2025%2D(with%2DECD%2Dand%2DCYD) -->
<!-- Field: Set; Name: xdx; ID: xdx_038_niobf_niocorp.com_20250630 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20240701_20250630 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DDocumentFiscalYearFocus_2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001512228 -->
<!-- Field: Set; Name: xdx; ID: xdx_073_XDX_Z%2D%2D\XBRL JOB\2025\Q3\08 AUGUST\Nuvo\iXBRL__NioCorp Developments LTD__n2574__x280__10%2DK\Out Bound\V18\Sams\NUH__n2574__x280%2D10k __ NioCorp Developments LTD __Form 10%2DK__V18\n2574__x280%2D10k.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_060_USDPShares_0_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_066_NUMBER_5_N -->
<!-- Field: Set; Name: xdx; ID: xdx_061_CADPShares_3_iso4217%2D%2DCAD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000004" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000005" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000006" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000007" name="dei:EntityCentralIndexKey">0001512228</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0021" name="dei:EntityIncorporationStateCountryCode">A1</ix:nonNumeric>
  <ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2024-12-31" id="xdx2ixbrl0045" decimals="0" unitRef="USD">62900000</ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2025-06-30" id="xdx2ixbrl0106" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2025-06-30" id="xdx2ixbrl0109" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2025-06-30" id="xdx2ixbrl0133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0149" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0151" name="us-gaap:CommonStockSharesAuthorizedUnlimited">Unlimited</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:InterestIncomeOperating" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquireOtherInvestments" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0303" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForDeposits" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0306" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0324" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0348" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0357" name="niobf:ValueOfWarrantsIssued" xs:nil="true"></ix:nonNumeric>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0369" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0383" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0385" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0386" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0420" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0421" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0464" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0481" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0491" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0500" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0501" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0506" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0507" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NumberOfReportableSegments" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0527" decimals="INF" unitRef="NUMBER">1</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0701" decimals="-3" scale="3" sign="-" unitRef="USD">17982</ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0703" decimals="-3" scale="3" sign="-" unitRef="USD">11898</ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30" id="xdx2ixbrl0777" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2025-06-30_custom_YorkvilleConvertibleDebenturesMember" id="xdx2ixbrl0786" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2025-06-30_custom_April2024ConvertibleSecurityMember" id="xdx2ixbrl0788" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2025-06-30" id="xdx2ixbrl0791" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2025-06-30_us-gaap_ConvertibleDebtSecuritiesMember" id="xdx2ixbrl0832" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueHedgeAssetsAtFairValue" contextRef="AsOf2025-06-30" id="xdx2ixbrl0903" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember" id="xdx2ixbrl1162" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P2Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember" id="xdx2ixbrl1190" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">P2Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl1277" decimals="-3" scale="3" unitRef="USD">2881</ix:nonFraction>
  <ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2025-06-30_custom_WarrantLiabilityMember" id="xdx2ixbrl1494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_DrillingMember" id="xdx2ixbrl1522" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="AsOf2025-06-30" id="xdx2ixbrl1532" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm">P1Y7M6D</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl1623" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="xdx2ixbrl1640" decimals="-3" scale="3" sign="-" unitRef="USD">139</ix:nonFraction>
  <ix:nonFraction name="niobf:DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" contextRef="AsOf2024-06-30" id="xdx2ixbrl1661" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2025-06-30" id="xdx2ixbrl1675" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2024-06-30" id="xdx2ixbrl1676" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1739" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1744" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1745" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1749" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1750" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1753" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1754" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1758" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1760" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1763" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1769" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1770" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1774" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1775" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1778" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="xdx2ixbrl1779" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1782" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1783" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1787" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="xdx2ixbrl1788" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1792" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="xdx2ixbrl1796" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2025-07-012025-07-18_us-gaap_SubsequentEventMember" id="xdx2ixbrl1804" name="us-gaap:SubsequentEventDescription">Maxim acted as sole placement agent for the July 2025 Offering. The Company intends to use the net proceeds from the July 2025 Offering for working capital and general corporate purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial operation.</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="niobf-20250630.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-07-01to2025-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-09-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-09-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_RedeemableNoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_Entity0896800BCLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_NioCorpTechnologiesLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_NioCorpTechnologiesLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_BuildingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_YorkvilleConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_April2024ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebenturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleDebenturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-17</xbrli:startDate>
        <xbrli:endDate>2024-07-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-17</xbrli:startDate>
        <xbrli:endDate>2024-07-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-11</xbrli:startDate>
        <xbrli:endDate>2024-04-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-132024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-13</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-12_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-132024-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-13</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_ClassBCommonStockECRCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:ClassBCommonStockECRCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_EarnoutMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-13_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-022025-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-02</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-022025-04-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-02</xbrli:startDate>
        <xbrli:endDate>2025-04-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-30</xbrli:startDate>
        <xbrli:endDate>2023-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-02_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-022024-06-24_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-02</xbrli:startDate>
        <xbrli:endDate>2024-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-24_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:YorkvilleEquityFacilityFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:YorkvilleEquityFacilityFinancingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_GXIIPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_GXIIPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_PublicWarrants2023Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:PublicWarrants2023Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_LindGlobalAssetManagementThreeLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:LindGlobalAssetManagementThreeLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-152024-09-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-15</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-15</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-05_custom_SeriesAPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-05_custom_SeriesBPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-13_custom_SeriesAPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-13_custom_SeriesBPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-01</xbrli:startDate>
        <xbrli:endDate>2024-11-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_SeriesAPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_SeriesBPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-13_custom_NovemberPrivateWarrantsliabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">niobf:NovemberPrivateWarrantsliabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-142025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">niobf:NovemberPrivateWarrantsliabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-14</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">niobf:NovemberPrivateWarrantsliabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-31_custom_SeriesAPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-31_custom_SeriesBPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice4.60Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice4.60Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice3.54Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.54Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice2.20Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.20Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice1.75Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice1.75Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice1.75OneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice1.75OneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice3.25Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.25Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice1.98Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice1.98Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice11.50Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice2.31Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.31Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice2.05Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.05Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice2.07Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.07Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice2.07OneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.07OneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_ExercisePrice2.60Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.60Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesValuationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesValuationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-15</xbrli:startDate>
        <xbrli:endDate>2024-09-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_custom_WarrantLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:WarrantLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-02</xbrli:startDate>
        <xbrli:endDate>2024-09-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-282024-10-30_us-gaap_BorrowingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-28</xbrli:startDate>
        <xbrli:endDate>2024-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-282024-10-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-28</xbrli:startDate>
        <xbrli:endDate>2024-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_FeasibilityStudyAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_FieldManagementAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_DrillingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:DrillingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_DrillingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:DrillingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_MetallurgicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_MetallurgicalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_custom_GeologistsAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012025-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012024-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_currency_CAD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_country_CA">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_country_US">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_country_GB">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-07-012025-07-18_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-01</xbrli:startDate>
        <xbrli:endDate>2025-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-08-26_us-gaap_WarrantMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-08-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-07-012025-08-26_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-01</xbrli:startDate>
        <xbrli:endDate>2025-08-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_PurchasesofLandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:PurchasesofLandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-01</xbrli:startDate>
        <xbrli:endDate>2025-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_DoDAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:DoDAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-07-01</xbrli:startDate>
        <xbrli:endDate>2025-07-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001512228</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="NUMBER">
      <xbrli:measure>niobf:N</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="CADPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:CAD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000539" toRefs="Footnote000550"/>
  <ix:relationship fromRefs="Fact000541" toRefs="Footnote000550"/>
  <ix:relationship fromRefs="Fact000543" toRefs="Footnote000550"/>
  <ix:relationship fromRefs="Fact000669" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact000671" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact000673" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact000675" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact000677" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact000679" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact000681" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact000683" toRefs="Footnote000692 Footnote000693"/>
  <ix:relationship fromRefs="Fact001216" toRefs="Footnote001219"/>
  <ix:relationship fromRefs="Fact001218" toRefs="Footnote001219"/>
  <ix:relationship fromRefs="Fact001375" toRefs="Footnote001404"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt; margin-right: 0"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%; margin-right: 0">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>UNITED
STATES&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Washington,
D. C. 20549 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>FORM
<span id="xdx_903_edei--DocumentType_c20240701__20250630_zkMfCIwQ2NDa"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000015" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">(Mark
One)&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 14%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--DocumentAnnualReport_c20240701__20250630_zvfRrbtVcJ87"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000016" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; width: 86%; padding-right: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="padding-right: 1in; text-align: center; text-indent: 76.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the fiscal year ended <span id="xdx_905_edei--DocumentPeriodEndDate_c20240701__20250630_zWbK7VPa1DAj"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:datemonthdayyearen" id="Fact000017" name="dei:DocumentPeriodEndDate">June 30, 2025</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="padding-right: 1in; text-align: center; text-indent: 63pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--DocumentTransitionReport_c20240701__20250630_zFAZSOI4JSfl"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: top; padding-right: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
</table>
<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b>For
the transition period from to</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 25%; margin-right: auto">
<tr style="vertical-align: top; text-align: left">
    <td style="border: Black 1pt solid; white-space: nowrap; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>&#160;&#160;Commission
    file number: <span id="xdx_90F_edei--EntityFileNumber_c20240701__20250630_zKUdC7ctUEJ5"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000019" name="dei:EntityFileNumber">001-41655</ix:nonNumeric></span>&#160;&#160;</b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 41%">&#160;</td>
    <td rowspan="2" style="width: 19%; font-size: 10pt; text-align: center"><img src="n257410kimg001.jpg" alt=""/></td>
    <td style="border-bottom: Black 1pt solid; width: 40%; font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span>&#160;</p>



<div style="border-bottom: Black 1pt solid; padding: 0in 0in 1pt; margin-right: 0; margin-left: 0.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b><span id="xdx_90E_edei--EntityRegistrantName_c20240701__20250630_zF2GFv8qVhpb"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000020" name="dei:EntityRegistrantName">NioCorp
                                         Developments Ltd.</ix:nonNumeric></span></b>&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 52%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_dxL_c20240701__20250630_zsAo9EGH6aic" title="::XDX::A1"><span style="-sec-ix-hidden: xdx2ixbrl0021">British
    Columbia, Canada</span></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: top; width: 27%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20240701__20250630_zh6vgQ9m7WVf"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000022" name="dei:EntityTaxIdentificationNumber">98-1262185</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction
    of incorporation or organization)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer
    Identification No.)</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20240701__20250630_zJ6DDMS1Ng21"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000023" name="dei:EntityAddressAddressLine1">7000
        South Yosemite Street</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20240701__20250630_zedz82g8Ij2c"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000024" name="dei:EntityAddressAddressLine2">Suite 115</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressCityOrTown_c20240701__20250630_zEyPnlk4fFv9"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000025" name="dei:EntityAddressCityOrTown">Centennial</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20240701__20250630_zegTRGvrY1Gf"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000026" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span>&#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Address
        of principal executive offices)&#160;</span></p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20240701__20250630_zXnLmNTSRW5j"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000027" name="dei:EntityAddressPostalZipCode">80112</ix:nonNumeric></span>&#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Zip
        Code)&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td colspan="4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
    telephone number, including area code: <span id="xdx_900_edei--CityAreaCode_c20240701__20250630_zuOJfbcLjdw1"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000028" name="dei:CityAreaCode">(720)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20240701__20250630_zCyJYC4julY8"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000029" name="dei:LocalPhoneNumber">334-7066</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border: Black 1pt solid; width: 37%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 25%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 38%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--Security12bTitle_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zOGfJMBbAp6l"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember" id="Fact000030" name="dei:Security12bTitle">Common
    Shares, without par value</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zLVpKkNbWO3"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember" id="Fact000031" name="dei:TradingSymbol">NB</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SecurityExchangeName_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--CommonSharesWithoutParValueMember_zYECSd8Dh4mf"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td id="xdx_98F_edei--Security12bTitle_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212Member_z3dCyxycViY2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member" id="Fact000033" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants,
    each exercisable for 1.11829212 </span><span style="font-family: Times New Roman, Times, Serif"><br/>
    <span style="font-size: 10pt">Common Shares</span></span></ix:nonNumeric></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212Member_zjw3eFkN8BTh"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member" id="Fact000034" name="dei:TradingSymbol">NIOBW</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SecurityExchangeName_c20240701__20250630__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachExercisableFor1.11829212Member_zCwbnKBPzcE3"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member" format="ixt-sec:exchnameen" id="Fact000035" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to section 12(g) of the Act: None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Yes
&#9744; <span id="xdx_903_edei--EntityWellKnownSeasonedIssuer_c20240701__20250630_z4qYbjqT7Sld"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000036" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> Yes
&#9744; <span id="xdx_900_edei--EntityVoluntaryFilers_c20240701__20250630_zTwZxfDijgYk"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000037" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntityCurrentReportingStatus_c20240701__20250630_zV6Z58MnUcA9"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000038" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--EntityInteractiveDataCurrent_c20240701__20250630_zZsBkiKGaJ3k"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000039" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>
&#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    Accelerated Filer </span></td>
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    Filer </span></td>
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntityFilerCategory_c20240701__20250630_zVNINM2y8pW8"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:entityfilercategoryen" id="Fact000040" name="dei:EntityFilerCategory">Non-Accelerated
    Filer</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Smaller Reporting
    Company </span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--EntitySmallBusiness_c20240701__20250630_zoJTx1KD5M14"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000041" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Emerging Growth
    Company </span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20240701__20250630_zeNku7TOjAW4"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000042" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the
registrant included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_900_edei--DocumentFinStmtErrorCorrectionFlag_c20240701__20250630_zA3qkVk3KSS2"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000043" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).
&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; No <span id="xdx_90B_edei--EntityShellCompany_dbF_c20240701__20250630_zzjwsEeYA5s7"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000044" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">At
December 31, 2024, the aggregate market value of the registrant&#8217;s voting and non-voting common equity held by non-affiliates
of the registrant was $<span id="xdx_901_edei--EntityPublicFloat_iI_dxL_c20241231_zsbjmFQPRxIi" title="::XDX::62900000"><span style="-sec-ix-hidden: xdx2ixbrl0045">62.9</span></span> million based on the
closing sale price as reported on the Nasdaq Stock Market. There were <span id="xdx_901_edei--EntityCommonStockSharesOutstanding_iI_pid_uShares_c20250911_z6GXuN7fezkd"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-09-11" id="Fact000046" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">77,757,089</ix:nonFraction></span> common
shares outstanding on September 11, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>DOCUMENTS
INCORPORATED BY REFERENCE </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->






<hr style="border-width: 0; background-color: black; height: 3px; width: 100%; color: black"/>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Table
of Contents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="width: 90%; text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a001"><span style="font-family: Times New Roman, Times, Serif">Select Mining Definitions</span></a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">i</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a002"><span style="font-family: Times New Roman, Times, Serif">Metric Equivalents</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">v</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a003"><span style="font-family: Times New Roman, Times, Serif">Mineral Reserves and Resources</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">v</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a004"><span style="font-family: Times New Roman, Times, Serif">Currency and Exchange Rates</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">vi</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a005"><span style="font-family: Times New Roman, Times, Serif">Risk Factors Summary</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">vi</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a006"><span style="font-family: Times New Roman, Times, Serif">PART I</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a007"><span style="font-family: Times New Roman, Times, Serif">ITEM 1.&#160;&#160;&#160; BUSINESS</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a008"><span style="font-family: Times New Roman, Times, Serif">Introduction</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a009"><span style="font-family: Times New Roman, Times, Serif">Business Operations</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a070">Corporate Structure</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">1</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a010"><span style="font-family: Times New Roman, Times, Serif">Historical Development of the Business</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a071">Recent Corporate Events</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">3</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a011"><span style="font-family: Times New Roman, Times, Serif">Competitive Business Conditions</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a012"><span style="font-family: Times New Roman, Times, Serif">Cycles</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a013"><span style="font-family: Times New Roman, Times, Serif">Economic Dependence</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a014"><span style="font-family: Times New Roman, Times, Serif">Government Regulation</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a015"><span style="font-family: Times New Roman, Times, Serif">Human Capital</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a016"><span style="font-family: Times New Roman, Times, Serif">Forward-Looking Statements</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a017"><span style="font-family: Times New Roman, Times, Serif">Available Information</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a018"><span style="font-family: Times New Roman, Times, Serif">ITEM 1A.&#160;&#160;&#160; RISK FACTORS</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a019"><span style="font-family: Times New Roman, Times, Serif">Risks Related to Our Business</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a020"><span style="font-family: Times New Roman, Times, Serif">Risks Related to Mining and Development</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">15</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a021"><span style="font-family: Times New Roman, Times, Serif">Risks Related to Government Regulation</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">19</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a022"><span style="font-family: Times New Roman, Times, Serif">Risks Related to Our Debt</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">21</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a023"><span style="font-family: Times New Roman, Times, Serif">Risks Related to the Common Shares</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">21</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a024"><span style="font-family: Times New Roman, Times, Serif">ITEM 1B.&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a025"><span style="font-family: Times New Roman, Times, Serif">ITEM 1C.&#160;&#160;&#160;CYBERSECURITY</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a026"><span style="font-family: Times New Roman, Times, Serif">ITEM 2.&#160;&#160;&#160; PROPERTIES</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a027"><span style="font-family: Times New Roman, Times, Serif">ITEM 3.&#160;&#160;&#160; LEGAL PROCEEDINGS</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">42</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a028"><span style="font-family: Times New Roman, Times, Serif">ITEM 4.&#160;&#160;&#160; MINE SAFETY DISCLOSURES</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">42</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a029"><span style="font-family: Times New Roman, Times, Serif">PART II</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a030"><span style="font-family: Times New Roman, Times, Serif">ITEM 5.&#160;&#160;&#160; MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a031"><span style="font-family: Times New Roman, Times, Serif">Market Information</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a032"><span style="font-family: Times New Roman, Times, Serif">Holders</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a033"><span style="font-family: Times New Roman, Times, Serif">Dividends</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a034"><span style="font-family: Times New Roman, Times, Serif">Securities Authorized for Issuance Under Equity Compensation Plans</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a035"><span style="font-family: Times New Roman, Times, Serif">Purchases of Equity Securities by the Company</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a036"><span style="font-family: Times New Roman, Times, Serif">Recent Sales of Unregistered Securities</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a037"><span style="font-family: Times New Roman, Times, Serif">Exchange Controls</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a038"><span style="font-family: Times New Roman, Times, Serif">Certain Canadian Federal Income Tax Considerations for U.S. Residents</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a039"><span style="font-family: Times New Roman, Times, Serif">ITEM 6.&#160;&#160;&#160;<i>RESERVED</i></span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a040"><span style="font-family: Times New Roman, Times, Serif">ITEM 7.&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a041"><span style="font-family: Times New Roman, Times, Serif">Summary of Consolidated Financial and Operating Performance</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a042"><span style="font-family: Times New Roman, Times, Serif">Results of Operations</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">45</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a043"><span style="font-family: Times New Roman, Times, Serif">Liquidity and Capital Resources</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a044"><span style="font-family: Times New Roman, Times, Serif">Cash Flow Considerations</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">50</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a045"><span style="font-family: Times New Roman, Times, Serif">Environmental</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">51</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a046"><span style="font-family: Times New Roman, Times, Serif">Forward-Looking Statements</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">51</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a047"><span style="font-family: Times New Roman, Times, Serif">Accounting Developments</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">51</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a048"><span style="font-family: Times New Roman, Times, Serif">Critical Accounting Estimates and Recent Accounting Pronouncements</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">51</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a049"><span style="font-family: Times New Roman, Times, Serif">Other</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">52</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a050"><span style="font-family: Times New Roman, Times, Serif">ITEM 7A.&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">52</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a051"><span style="font-family: Times New Roman, Times, Serif">Interest rate risk</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">52</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a052"><span style="font-family: Times New Roman, Times, Serif">Foreign currency exchange risk</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">53</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -4.5pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 67.5pt"><a href="#a053"><span style="font-family: Times New Roman, Times, Serif">Commodity price risk</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">53</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt; width: 90%"><a href="#a054"><span style="font-family: Times New Roman, Times, Serif">ITEM 8.&#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt; width: 10%"><span style="font-family: Times New Roman, Times, Serif">53</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a055"><span style="font-family: Times New Roman, Times, Serif">ITEM 9.&#160;&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">85</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a056"><span style="font-family: Times New Roman, Times, Serif">ITEM
    9A. &#160;CONTROLS AND PROCEDURES</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">85</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a057"><span style="font-family: Times New Roman, Times, Serif">ITEM
    9B. &#160;OTHER INFORMATION</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">87</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a058"><span style="font-family: Times New Roman, Times, Serif">ITEM 9C.&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">87</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a059"><span style="font-family: Times New Roman, Times, Serif">PART III</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">88</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a060"><span style="font-family: Times New Roman, Times, Serif">ITEM 10.&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">88</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a062"><span style="font-family: Times New Roman, Times, Serif">ITEM 11.&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">92</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a063"><span style="font-family: Times New Roman, Times, Serif">ITEM 12.&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">98</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a064"><span style="font-family: Times New Roman, Times, Serif">ITEM 13.&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">102</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a065"><span style="font-family: Times New Roman, Times, Serif">ITEM 14.&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">104</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a066"><span style="font-family: Times New Roman, Times, Serif">PART IV</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">105</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a067"><span style="font-family: Times New Roman, Times, Serif">ITEM 15.&#160;&#160;&#160;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">105</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; text-indent: -52.2pt; padding-top: 0in; padding-bottom: 0pt; padding-left: 63pt"><a href="#a068"><span style="font-family: Times New Roman, Times, Serif">ITEM 16.&#160;&#160;&#160;FORM 10&#8211;K SUMMARY</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">109</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#a069"><span style="font-family: Times New Roman, Times, Serif">SIGNATURES</span></a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">110</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0; margin-right: 0">&#160;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif"><span id="a001"></span>Select
Mining Definitions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24%; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>carbonatite</b></span></td>
    <td style="width: 76%; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
    type of intrusive or extrusive igneous rock defined by mineralogic composition consisting of greater than 50% carbonate minerals.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>cut-off
    grade</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    grade (i.e., the concentration of metal or mineral in rock) that determines the destination of the material during mining.
    For purposes of establishing &#8220;prospects of economic extraction,&#8221; the cut-off grade is the grade that distinguishes
    material deemed to have no economic value (it will not be mined in underground mining or if mined in surface mining, its destination
    will be the waste dump) from material deemed to have economic value (its ultimate destination during mining will be a processing
    facility). Other terms used in similar fashion as cut-off grade include net smelter return, pay limit, and break-even stripping
    ratio.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>deposit</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
    mineralized body which has been physically delineated by sufficient drilling, trenching, and/or underground work, and found
    to contain a sufficient average grade of metal or metals to warrant further exploration and/or development expenditures. Such
    a deposit does not qualify as a commercially mineable ore body or as containing reserves or ore, unless final legal, technical,
    and economic factors are resolved.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>development
    stage issuer</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">An
    issuer that is engaged in the preparation of mineral reserves for extraction on at least one material property</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>development
    stage property </b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
    property that has mineral reserves disclosed, pursuant to Regulation S-K 1300, but no material extraction</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>diamond
    drilling</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
    type of rotary drilling in which diamond bits are used as the rock-cutting tool to produce a recoverable drill core sample
    of rock for observation and analysis</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: -5.25pt; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>dysprosium
    or Dy</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element dysprosium (atomic number 66), a rare-earth element in the lanthanide series.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: -5.25pt; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>dysprosium
    oxide</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of dysprosium and oxygen with the formula Dy<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>economically
    viable</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When
    used in the context of mineral reserve determination, means that the qualified person has determined, using a discounted cash
    flow analysis, or has otherwise analytically determined, that extraction of the mineral reserve is economically viable under
    reasonable investment and market assumptions</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>feasibility
    study</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
        comprehensive technical and economic study of the selected development option for a mineral project, which includes detailed
        assessments of all applicable modifying factors, as defined under S-K 1300, together with any other relevant operational
        factors, and detailed financial analysis that are necessary to demonstrate, at the time of reporting, that extraction
        is economically viable. The results of the study may serve as the basis for a final decision by a proponent or financial
        institution to proceed with, or finance, the development of the project.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(1)
        A feasibility study is more comprehensive, and with a higher degree of accuracy, than a pre-feasibility study. It must
        contain mining, infrastructure, and process designs completed with sufficient rigor to serve as the basis for an investment
        decision or to support project financing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">(2)
The confidence level in the results of a feasibility study is higher than the confidence level in the results of a pre-feasibility
study. Terms such as <i>full</i>, <i>final</i>, <i>comprehensive</i>, <i>bankable</i>, or <i>definitive</i> feasibility study
are equivalent to feasibility study.&#160;</span></p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ferroniobium
    or FeNb</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif">An
    iron-niobium alloy, with a niobium content of 60-70%</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>indicated
    mineral resource</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of adequate geological evidence
    and sampling. The level of geological certainty associated with an indicated mineral resource is sufficient to allow a qualified
    person to apply modifying factors in sufficient detail to support mine planning and evaluation of the economic viability of
    the deposit. Because an indicated mineral resource has a lower level of confidence than the level of confidence of a measured
    mineral resource, an indicated mineral resource may only be converted to a probable mineral reserve.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>inferred
    mineral resource</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of limited geological evidence
    and sampling. The level of geological uncertainty associated with an inferred mineral resource is too high to apply relevant
    technical and economic factors likely to influence the prospects of economic extraction in a manner useful for evaluation
    of economic viability. Because an inferred mineral resource has the lowest level of geological confidence of all mineral resources,
    which prevents the application of the modifying factors in a manner useful for evaluation of economic viability, an inferred
    mineral resource may not be considered when assessing the economic viability of a mining project, and may not be converted
    to a mineral reserve.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LoM</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Life
    of Mine, the period from the beginning of construction to the end of mine life</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>measured
    mineral resource</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">That
    part of a mineral resource for which quantity and grade or quality are estimated on the basis of conclusive geological evidence
    and sampling. The level of geological certainty associated with a measured mineral resource is sufficient to allow a qualified
    person to apply modifying factors, as defined in this section, in sufficient detail to support detailed mine planning and
    final evaluation of the economic viability of the deposit. Because a measured mineral resource has a higher level of confidence
    than the level of confidence of either an indicated mineral resource or an inferred mineral resource, a measured mineral resource
    may be converted to a proven mineral reserve or to a probable mineral reserve.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>mineral
    reserve</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">An
    estimate of tonnage and grade or quality of indicated and measured mineral resources that, in the opinion of the qualified
    person, can be the basis of an economically viable project. More specifically, it is the economically mineable part of a measured
    or indicated mineral resource, which includes diluting materials and allowances for losses that may occur when the material
    is mined or extracted.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>mineral
    resource</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
    concentration or occurrence of material of economic interest in or on the Earth&#8217;s crust in such form, grade or quality,
    and quantity that there are reasonable prospects for economic extraction. A mineral resource is a reasonable estimate of mineralization,
    taking into account relevant factors such as cut-off grade, likely mining dimensions, location or continuity, that, with the
    assumed and justifiable technical and economic conditions, is likely to, in whole or in part, become economically extractable.
    It is not merely an inventory of all mineralization drilled or sampled.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>modifying
    factors</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    factors that a qualified person must apply to indicated and measured mineral resources and then evaluate in order to establish
    the economic viability of mineral reserves. A qualified person must apply and evaluate modifying factors to convert measured
    and indicated mineral resources to proven and probable mineral reserves. These factors include, but are not restricted to:
    mining; processing; metallurgical; infrastructure; economic; marketing; legal; environmental compliance; plans, negotiations,
    or agreements with local individuals or groups; and governmental factors. </span></td></tr>
</table>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify">The number, type and specific characteristics of
    the modifying factors applied will necessarily be a function of and depend upon the mineral, mine, property, or project.</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>niobium
    or Nb </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    element niobium (atomic number 41), a transition metal primarily used in the production of high-strength, low-alloy steel</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<sub>2</sub>O<sub>5</sub></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    pentoxide, a commercial form of refined niobium</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>neodymium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of neodymium and oxygen with the formula Nd<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Smelter Return, the net revenue that the owner of a mining property receives from the sale of the mine&#8217;s products less
    transportation and refining costs</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>praseodymium
    oxide</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    chemical compound composed of praseodymium and oxygen with the formula Pr<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>probable
    mineral reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    economically mineable part of an indicated and, in some cases, a measured mineral resource</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>production
    stage property</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    property with material extraction of mineral reserves</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>proven
    mineral reserve</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    economically mineable part of a measured mineral resource and can only result from conversion of a measured mineral resource</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>qualified
    person</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                         individual who is:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&#160;&#160;A
        mineral industry professional with at least five years of relevant experience in the type of mineralization and type of
        deposit under consideration and in the specific type of activity that person is undertaking on behalf of the registrant;
        and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&#160;&#160;An
        eligible member or licensee in good standing of a recognized professional organization at the time the technical report
        is prepared. For an organization to be a recognized professional organization, it must:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
        Be either:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
        An organization recognized within the mining industry as a reputable professional association; or</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
        A board authorized by Unites States federal, state, or foreign statute to regulate professionals in the mining, geoscience,
        or related field;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
        &#160;&#160;Admit eligible members primarily on the basis of their academic qualifications and experience;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
        &#160;&#160;Establish and require compliance with professional standards of competence and ethics;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)&#160;&#160;&#160;Require
        or encourage continuing professional development;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
        &#160;&#160;&#160;Have and apply disciplinary powers, including the power to suspend or expel
        a member regardless of where the member practices or resides; and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) &#160;&#160;Provide a public list of members in good standing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>rare
    earth elements, rare earths or REEs </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    group of 15 elements referred to as the lanthanide series in the periodic table of elements. Scandium and yttrium, while not
    true REEs, are also included in this categorization because they exhibit similar properties to the lanthanides and are found
    in the same ore bodies. Individual mineral deposits may not contain all REEs in economically
    recoverable quantities.</span></td></tr>
</table>
<p style="margin: 0">&#160;</p>


<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 24%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>rare
    earth products</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%"><span style="font-family: Times New Roman, Times, Serif">Commercial
    rare earth products currently being examined for production by the Company, including neodymium-praseodymium oxide (sometimes
    referred to as didymium oxide), dysprosium oxide, and terbium oxide. These are the primary rare earths compounds used to manufacture
    the world&#8217;s most powerful permanent magnets.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>relevant
    experience</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">For
        purposes of determining whether a party is a qualified person, that the party has experience in the specific type of activity
        that the person is undertaking on behalf of the registrant. If the qualified person is preparing or supervising the preparation
        of a technical report concerning exploration results, the relevant experience must be in exploration. If the qualified
        person is estimating, or supervising the estimation of mineral resources, the relevant experience must be in the estimation,
        assessment and evaluation of mineral resources and associated technical and economic factors likely to influence the prospect
        of economic extraction. If the qualified person is estimating, or supervising the estimation of mineral reserves, the
        relevant experience must be in engineering and other disciplines required for the estimation, assessment, evaluation,
        and economic extraction of mineral reserves.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif">(1)&#160;&#160;Relevant
        experience also means, for purposes of determining whether a party is a qualified person, that the party has experience
        evaluating the specific type of mineral deposit under consideration (e.g., coal, metal, base metal, industrial mineral,
        or mineral brine). The type of experience necessary to qualify as relevant is a facts and circumstances determination.
        For example, experience in a high-nugget, vein-type mineralization such as tin or tungsten would likely be relevant experience
        for estimating mineral resources for vein-gold mineralization, whereas experience in a low grade disseminated gold deposit
        likely would not be relevant.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>Note
        1 to Paragraph (1) of the Definition of Relevant Experience</i>: It is not always necessary for a person to have five
        years&#8217; experience in each and every type of deposit in order to be an eligible qualified person if that person has
        relevant experience in similar deposit types. For example, a person with 20 years&#8217; experience in estimating mineral
        resources for a variety of metalliferous hard-rock deposit types may not require as much as five years of specific experience
        in porphyry-copper deposits to act as a qualified person. Relevant experience in the other deposit types could count towards
        the experience in relation to porphyry-copper deposits.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif">(2)&#160;&#160;For
        a qualified person providing a technical report for exploration results or mineral resource estimates, relevant experience
        also requires, in addition to experience in the type of mineralization, sufficient experience with the sampling and analytical
        techniques, as well as extraction and processing techniques, relevant to the mineral deposit under consideration. Sufficient
        experience means that level of experience necessary to be able to identify, with substantial confidence, problems that
        could affect the reliability of data and issues associated with processing.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif">(3)&#160;&#160;For
        a qualified person applying the modifying factors, as defined by this section, to convert mineral resources to mineral
        reserves, relevant experience also requires:</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17pt; text-align: justify; text-indent: -17pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">(i)&#160;&#160;&#160;&#160;Sufficient
        knowledge and experience in the application of these factors to the mineral deposit under consideration; and</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">(ii)&#160;&#160;Experience
        with the geology, geostatistics, mining, extraction, and processing that is applicable to the type of mineral and mining
        under consideration.</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S-K
    1300</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subpart
    1300 of Regulation S-K promulgated by the SEC</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S-K
    1300 Elk Creek Technical Report Summary</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
    technical report summary for the Elk Creek Project that conforms to S-K 1300 reporting standards, with an effective date of
    June 30, 2022, originally filed as Exhibit </span></td></tr>
</table>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; width: 24%">&#160;</td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify; width: 76%">96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended
    June 30, 2022, and incorporated by reference into this Annual Report on Form 10-K</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>scandium
    or Sc</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    element scandium (atomic number 21), a transition metal used as an alloying agent with aluminum that provides high strength
    and lower weight for aerospace industry components and other applications that need lightweight metals. It also is used in
    the electrolyte layer of solid oxide fuel cells.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc<sub>2</sub>O<sub>3</sub></b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Scandium
    trioxide, the primary form of refined scandium</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>terbium
    oxide</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    chemical compound composed of terbium and oxygen with the formula Tb<sub>2</sub>O<sub>3</sub></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>titanium
    or Ti</b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 10pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
    element titanium (atomic number 22), a transition metal which in its oxide form is a common pigment in paper, paint, and plastic.
    In its metallic form, titanium is used in aerospace applications, armor, chemical processing applications, marine hardware
    applications, medical implants, power generation, and in sporting goods.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-bottom: 2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></td>
    <td style="padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Titanium
    dioxide, a commercial form of refined titanium</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif"><span id="a002"></span>Metric
Equivalents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.8in; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">For
ease of reference, the following factors for converting Imperial measurements into metric equivalents are provided:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>To
convert from Imperial</b>&#160;</span></p></td>
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>To
metric</b>&#160;</span></p></td>
    <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Multiply
by</b>&#160;</span></p></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Feet
    (&#8220;ft&#8221;)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Meters
    (&#8220;m&#8221;)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">0.3048</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Miles</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Kilometers
    (&#8220;km&#8221;)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">1.6093</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Tons</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Tonnes
    (&#8220;t&#8221;)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">0.9072</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0; margin-right: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
    mile = 1.6093 kilometers</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,204.62
    pounds = 1 metric tonne = 1 tonne</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2000
    pounds (1 short ton) = 0.9072 tonnes</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif"><span id="a003"></span>Mineral
Reserves and Resources</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.85pt; text-align: center; text-indent: -0.8in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Information
concerning our mining property in this Annual Report on Form 10-K has been prepared in accordance with the requirements of S-K
1300, which first became applicable to us for the fiscal year ended June 30, 2022. All mineral resource and mineral reserve estimates
included in this Annual Report on Form 10-K have been prepared in accordance with S-K 1300. Previously, we prepared our estimates
of mineral resources and mineral reserves following only National Instrument 43-101 of the Canadian Securities Administrators
entitled &#8220;Standards of Disclosure for Mineral Projects&#8221; (&#8220;NI 43-101&#8221;) and the Canadian Institute of Mining
and Metallurgy (&#8220;CIM&#8221;) &#8220;Definition Standards &#8211; For Mineral Resources and Mineral Reserves, May 10, 2014.&#8221;
The CIM-compliant NI 43-101 technical report (the &#8220;NI 43-101 Elk Creek Technical Report&#8221;) for the Company&#8217;s
niobium, scandium, and titanium project (the &#8220;Elk Creek Project&#8221;) and S-K 1300 Elk Creek Technical Report Summary,
filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022, and incorporated
by reference into this Annual Report on Form 10-K, are based on a feasibility study prepared by qualified persons (the &#8220;2022
Elk Creek Feasibility Study&#8221;) and are substantively identical to one another except for internal references to the regulations
under which the report is made, and certain organizational differences. In addition, S-K 1300 requires us to disclose our mineral
resources, in addition to our mineral reserves, as of the end of our most recently completed fiscal year. You are cautioned that
mineral resources are subject to further exploration and development and are subject to additional risks and no assurance can
be given that they will eventually convert to future reserves. Inferred resources, in particular, have a great amount of uncertainty
as to their existence and their economic and legal feasibility. Investors are cautioned not to assume that any part or all of
the inferred resource exists or is economically or legally mineable. See Item 1A., Risk Factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; margin-right: 0"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt; margin-right: 0"><p style="margin: 0pt 0 0pt 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif"><span id="a004"></span>Currency
and Exchange Rates</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.7pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">All
dollar amounts in this Annual Report on Form 10-K are expressed in United States (&#8220;U.S.&#8221;) dollars unless otherwise
indicated. The Company&#8217;s accounts are maintained in U.S. dollars and the Company&#8217;s consolidated financial statements
are prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Some of the Company&#8217;s
significant agreements, as well as certain vendors, use Canadian dollars. As used herein, &#8220;C$&#8221; represents Canadian
dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
following table sets forth the rate of exchange for the Canadian dollar, expressed in U.S. dollars in effect at the end of the
periods indicated, the average of exchange rates in effect during such periods, and the high and low exchange rates during such
periods based on the daily rate of exchange as reported by the Bank of Canada for conversion of Canadian dollars into U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr>
    <td rowspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Fiscal Year Ended June 30,</b>&#160;</span></p>

</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2025&#160;</b></span></p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>2024</b>&#160;</span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Canadian
    Dollars to U.S. Dollars</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate
    at end of period </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7330</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7306</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    rate for period </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7170</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7380</span></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High
    for period </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7429</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7617</span></td></tr>
<tr style="background-color: #CCECFF">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-indent: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low
    for period </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6848</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7207</span></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><span id="a005"></span>Risk
Factors Summary</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><i>Investing
in common shares, no par value, of the Company (&#8220;Common Shares&#8221;) involves numerous risks and uncertainties, as more
fully described below. You should read these risks before you invest in our Common Shares. In particular, risks associated with
our business include, but are not limited to, the following:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Risks
Related to Our Business </b>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Our
                                         ability to operate as a going concern is in doubt.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         will require significant additional capital to fund our business plan.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">We
                                         have a limited operating history on which to base an evaluation of our business and prospects.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         have a history of losses and expect to continue to incur losses in the future.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif">We
                                         may not recognize the full value of the Yorkville Equity Facility Financing Agreement
                                         (as defined herein) and may not receive any proceeds from the exercise our outstanding
                                         Common Share purchase warrants (&#8220;Warrants&#8221;), and the potential adverse effect
                                         on the prevailing market prices for our Common Shares as a result of sales, or the perception
                                         of future sales, of Common Shares could adversely affect our ability to raise additional
                                         capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">The
                                         Company has identified material weaknesses in its internal control over financial reporting.
                                         If not remediated, the Company&#8217;s failure to establish and maintain effective disclosure
                                         controls and procedures and internal control over financial reporting could result in
                                         material misstatements in its financial statements and a failure to meet its reporting
                                         and financial obligations, each of which could have a material adverse effect on the
                                         Company&#8217;s financial condition and the trading price of the Common Shares. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Risks
Related to Mining and Development</b>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         face numerous uncertainties in estimating our mineral reserves and resources and inaccuracies
                                         in our estimates could result in lower than expected revenues, higher than expected costs
                                         and decreased profitability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">The
                                         nature of mineral exploration and production activities involves a high degree of risk
                                         and the possibility of uninsured losses.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         have no history of producing commercial products from our current mining properties and
                                         there can be no assurance that we will successfully establish mining operations or profitably
                                         produce minerals.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin: 6pt 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div>
    <div style="margin: 6pt 0; page-break-before: always"><p style="margin: 0pt 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Any
                                         material changes in mineral resource/reserve estimates and grades of mineralization will
                                         affect the economic viability of placing a property into production and a property&#8217;s
                                         return on capital.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Our
                                         properties and operations may be subject to litigation or other claims.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         do not currently insure against all the risks and hazards of mineral exploration, development,
                                         and mining operations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Risks
Related to Government Regulation</b>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         may not be able to obtain or renew all required permits and licenses to place any of
                                         our properties into production.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         are subject to significant governmental regulations that affect our operations and costs
                                         of conducting our business.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">Land
                                         reclamation requirements for our properties may be burdensome and expensive.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Risks
Related to Our Debt </b>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">The
                                         level of our indebtedness from time to time could impair our ability to obtain additional
                                         financing.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b>Risks
Related to the Common Shares </b>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Future
                                         sales, or the perception of future sales, of Common Shares by existing shareholders or
                                         by us, or future dilutive issuances of Common Shares by us, could adversely affect prevailing
                                         market prices for the Common Shares and cause investors to suffer dilution in their net
                                         book value per Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: italic 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">We
                                         are subject to the continued listing criteria of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
                                         and our failure to satisfy these criteria may result in delisting of the Common Shares.
                                         </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin: 6pt 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div>
    <div style="margin: 6pt 0; page-break-before: always"><p style="margin: 0pt 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="a006"></span>PART
I</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif"><span id="a007"></span>ITEM 1.</span></td><td><span style="font-family: Times New Roman, Times, Serif">BUSINESS</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a008"></span>Introduction</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">NioCorp
Developments Ltd. (&#8220;NioCorp,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;)
was incorporated under the laws of the Province of British Columbia under the Business Corporations Act (British Columbia) on
February 27, 1987, under the name &#8220;IPC International Prospector Corp.&#8221; On May 22, 1991, we changed our name to &#8220;Kingston
Resources Ltd.&#8221; On June 29, 2001, we changed our name to &#8220;Butler Developments Corp.&#8221; On February 12, 2009, we
changed our name to &#8220;Butler Resource Corp.&#8221; On March 4, 2010, we changed our name to &#8220;Quantum Rare Earth Developments
Corp.&#8221; On March 4, 2013, we changed our name to &#8220;NioCorp Developments Ltd.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">NioCorp
is a United States Securities and Exchange Commission (&#8220;SEC&#8221;) reporting company, and we are also a Canadian reporting
issuer in British Columbia, Alberta, Saskatchewan, Ontario, and New Brunswick. Our registered and records office is located at
1133 Melville Street, Suite 3500, Vancouver, British Columbia V6E 4E5 (ATTN: Blake, Cassels &amp; Graydon LLP). Our principal
executive office is located at 7000 South Yosemite Street, Suite 115, Centennial, Colorado 80112.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a009"></span>Business
Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">NioCorp, through
ECRC (as defined below), is developing a critical minerals project that, if and when developed, will produce niobium, scandium,
titanium, and potentially, rare earth products. Known as the &#8220;Elk Creek Project,&#8221; it is located near Elk Creek, Nebraska,
in the southeast portion of the state.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">Niobium
                                         is used to produce various superalloys that are extensively used in high performance
                                         aircraft and jet turbines. It also is used in high-strength, low-alloy steel, a stronger
                                         steel used in automobiles, bridges, structural systems, buildings, pipelines, and other
                                         applications that generally enables those applications to be stronger and lighter in
                                         mass. This &#8220;lightweighting&#8221; benefit often results in environmental benefits,
                                         including reduced fuel consumption and material usage, which can result in fewer air
                                         emissions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">Scandium
                                         can be combined with aluminum to make super-high-performance alloys with increased strength
                                         and improved corrosion resistance. Scandium also is a critical component of advanced
                                         solid oxide fuel cells, an environmentally preferred technology for high-reliability,
                                         distributed electricity generation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">Titanium
                                         is a component of various superalloys and other applications that are used for aerospace
                                         applications, weapons systems, protective armor, medical implants and many others. It
                                         also is used in pigments for paper, paint, and plastics.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.75pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Rare
                                         earth elements are critical minerals that are needed in virtually all U.S. defense systems
                                         and across the electronics, manufacturing, high-technology, transportation, and energy
                                         sectors. Magnetic rare earths, such as neodymium, praseodymium, terbium, and dysprosium
                                         are critical to the making of neodymium-iron-boron magnets, which are used across a wide
                                         variety of defense and civilian applications.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
primary business strategy is to advance our Elk Creek Project to commercial production. Based on the success of our recent fund-raising
activities, as discussed below under Part II, Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition
and Results of Operations&#8212;Liquidity and Capital Resources,&#8221; we are focused on carrying out our near-term planned work
programs associated with securing the project financing necessary to complete detailed design, development, and construction of
the Elk Creek Project, as well as the commencement of early elements of project construction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.95pt"><span id="a070"></span><span style="font-family: Times New Roman, Times, Serif"><b>Corporate
Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s business operations are conducted primarily through ECRC. The table below provides an overview of the Company&#8217;s
current subsidiaries and their activities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 12; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin: 6pt 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="margin: 6pt 0; page-break-before: always"><p style="margin: 0pt 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Name&#160;</b></span></p></td>
    <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>State/Province
of <br/>
Formation</b>&#160;</span></p></td>
    <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Ownership&#160;</b></span></p></td>
    <td style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Business</b>&#160;</span></p></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    B.C. Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British
    Columbia</span></td>
    <td style="padding: 2pt 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span><span style="font-family: Times New Roman, Times, Serif"><br/>
    <br/></span></td>
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    only business of 0896800 is to hold the shares of Class A common stock of ECRC</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;)</span></td>
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</span></td>
    <td style="padding: 2pt 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.42%<sup>(1)</sup></span></td>
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    business of ECRC is the development of the Elk Creek Project</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
    Kingdom</span></td>
    <td style="padding: 2pt 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span><span style="font-family: Times New Roman, Times, Serif"><br/>
    <br/></span></td>
    <td style="padding: 2pt 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    business of NioCorp Technologies Limited is the research and development of aluminum-scandium alloys and other business opportunities</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify; padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif">Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 Vested Shares and 3,391,596
                                         Earnout Shares (each as defined below) held by third parties, and outstanding as of June
                                         30, 2025.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a010"></span>Historical
Development of the Business</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
acquisition of the carbonatite property located in Southeast Nebraska, USA (the &#8220;Elk Creek Property&#8221;) was closed in
December 2010 and involved the purchase by NioCorp of all of the issued and outstanding common shares of a private British Columbia
company, which in turn held 100% of the issued and outstanding shares of Elk Creek Resources Corp., a Nebraska corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Between
2011 and 2020, the Company advanced the Elk Creek Project through the completion of field exploration programs, feasibility study
development and reporting, updates to underground mine designs and supporting infrastructure, and the receipt of required permits
from the State of Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">During
fiscal year 2021, we obtained funding which allowed us to purchase land and mineral rights at the Elk Creek Property and continue
early project execution activities. During fiscal year 2022, we focused efforts towards refining our Elk Creek Project mineral
resource and mineral reserve estimates with respect to REEs. This work included additional assays of historical drill core to
fill data gaps in the existing resource database and re-modeling. Based on this re-interpretation of the geologic data, an update
to the mine plan was also completed. Based on this work, we issued the 2022 NI 43-101 Elk Creek Technical Report on June 28, 2022,
and filed the S-K 1300 Elk Creek Technical Report Summary as an exhibit to our Annual Report on Form 10-K for the year ended June
30, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
March 17, 2023 (the &#8220;Closing Date&#8221;), the Company closed  a series of transactions  (the
&#8220;GXII Transaction&#8221;), pursuant to the Business Combination Agreement, dated September 25, 2022 (the
&#8220;Business Combination Agreement&#8221;), among the Company, GX Acquisition Corp. II (&#8220;GXII&#8221;), and Big Red
Merger Sub Ltd (the &#8220;Closing&#8221;). At the Closing, the Company also closed convertible debt financings (the
&#8220;Yorkville Convertible Debt Financing&#8221;) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors
Global, LP (together with YA II PN, Ltd., &#8220;Yorkville&#8221;), and the standby equity purchase facility with Yorkville
(the &#8220;Yorkville Equity Facility Financing&#8221; and, together with the Yorkville Convertible Debt Financing, the
&#8220;Yorkville Financings&#8221;) became effective. The transactions contemplated by or related to the Business Combination
Agreement, including the GXII Transaction, the Yorkville Financings, and a 10-for-1 reverse stock split consummated in connection with the Closing, are referred to, collectively, as the &#8220;2023
Transactions.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
a result of the 2023 Transactions, among other matters, GXII became and indirect, majority-owned subsidiary of NioCorp and changed
its name to &#8220;Elk Creek Resources Corp.&#8221;, which we refer to as &#8220;ECRC,&#8221; and the Common Shares and the Warrants
that were assumed by NioCorp from GXII (the &#8220;NioCorp Assumed Warrants&#8221;) were listed for trading on Nasdaq under the
symbols &#8220;NB&#8221; and &#8220;NIOBW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Business Combination Agreement, the Sponsor Support Agreement, dated September 25, 2022, among GX Sponsor II LLC (the &#8220;Sponsor&#8221;),
GXII, the Company and the other persons party thereto, and the Exchange Agreement, dated as of March 17, 2023, by and among NioCorp,
ECRC and the Sponsor (the &#8220;Exchange Agreement&#8221;), after the Closing, the shares of Class B common stock of ECRC are
exchangeable into Common Shares on a one-for-one basis, subject to certain equitable adjustments, under certain conditions. Of
the issued and outstanding shares of Class B common stock of ECRC, 4,565,808 shares (the &#8220;Vested Shares&#8221;)&#8201;were
vested as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing
Date and 3,391,596 shares (the &#8220;Earnout Shares&#8221;) are exchangeable until the tenth anniversary of the Closing Date,
subject</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin: 6pt 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="margin: 6pt 0; page-break-before: always"><p style="margin: 0pt 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">to certain vesting conditions. See Note 9 to the consolidated financial statements included in Part II, Item 8 hereof
for additional information regarding the Class B common stock of ECRC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">During
fiscal year 2025, the Company initiated a drilling program at the Elk Creek Project to support the conversion of a portion of
its current indicated resources into measured resources and the subsequent conversion of a portion of its current probable mineral
reserves into proven mineral reserves. This drilling program is ongoing as of the date of this report. When completed, the results
of the drilling program, along with other technical and economic analyses undertaken by the Company, will be used to update the
feasibility study for the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.95pt"><span id="a071"></span><span style="font-family: Times New Roman, Times, Serif"><b>Recent
Corporate Events</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.95pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>EXIM
Bank Financing Process</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
previously disclosed, on March 6, 2023, the Company announced the receipt of a Letter of Interest from the Export-Import Bank
of the United States (&#8220;EXIM&#8221;) for potential debt financing through EXIM&#8217;s &#8220;Make More In America&#8221;
initiative to fund a portion of the project costs of the Elk Creek Project (the &#8220;EXIM Financing&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">NioCorp
submitted a formal application to EXIM for a loan under EXIM&#8217;s &#8220;Make More in America&#8221; initiative on June 6,
2023. The Company was informed that its application received approval by the first of three reviews by the EXIM Transaction Review
Committee on October 2, 2023. EXIM deployed additional resources to the processing of the Company&#8217;s application during the
quarter ended December 31, 2023, and has retained financial and legal consultants to support EXIM&#8217;s due diligence on the
Elk Creek Project. On April 15, 2024, the Company received a Preliminary Project Letter (the &#8220;PPL&#8221;) from EXIM. The
PPL is a summary of EXIM&#8217;s initial due diligence findings and also includes a preliminary Indicative Term Sheet. The PPL
identified additional project activities to be undertaken by the Company in conjunction with the EXIM evaluation process. These
include an updated mine plan and updated Elk Creek Project capital costs on a final or close-to-final basis reflecting updated
process flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Management
is working with EXIM to continue to advance the project through the next stages of EXIM&#8217;s due diligence and loan application
process. We are currently unable to estimate how long the application process, including the additional project activities identified
in the PPL, may take, and there can be no assurances that we will be able to successfully negotiate a final commitment of debt
financing from EXIM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 0; text-align: justify; text-indent: 0in"><i>April 2025
Offering</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
April 21, 2025, the Company closed an underwritten, registered public offering (the &#8220;April 2025 Offering&#8221;), pursuant
to the underwriting agreement, dated April 17, 2025, with Maxim Group LLC (&#8220;Maxim&#8221;), as underwriter, pursuant to which
the Company issued and sold (i) 6,628,846 Common Shares at a public offering price of $2.60 per Common Share and (ii) 1,063,462
pre-funded Warrants (the &#8220;April 2025 Pre-Funded Warrants&#8221;) to purchase up to an additional 1,063,462 Common Shares
at a public offering price of $2.5999. The April 2025 Pre-Funded Warrants have an exercise price of $0.0001 per underlying Common
Share, are exercisable immediately, and do not have an expiration date. On April 17, 2025, Maxim partially exercised its over-allotment
option to purchase 323,504 additional Common Shares at the closing. The net proceeds from the April 2025 Offering were approximately
$18.7 million, after deducting underwriting discounts and offering expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 2pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -1.75pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.75pt; text-align: justify; text-indent: -1.75pt"><i>July
2025 Offering</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt 0pt 1.75pt; text-align: justify; text-indent: -1.75pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -1.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
July 18, 2025, the Company closed a registered public offering (the &#8220;July 2025 Offering&#8221;), pursuant to a placement
agency agreement, dated July 17, 2025 (the &#8220;Placement Agency Agreement&#8221;) with Maxim, as sole placement agent, pursuant
to which the Company issued and sold 13,850,000 Common Shares at a public offering price of $3.25 per Common Share. The net proceeds
from the July 2025 Offering were approximately $41.2 million, after deducting underwriting discounts and offering expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -1.75pt"><span style="font-family: Times New Roman, Times, Serif"><i>DoD
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -1.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
August 4, 2025, ECRC entered into a Project Sub-Agreement (the &#8220;DoD Agreement&#8221;) with Advanced Technology International
(&#8220;ATI&#8221;), an entity acting on behalf of the Defense Industrial Base Consortium under the authority of the U.S. Department
of Defense (&#8220;DoD&#8221;). Subject to the terms and conditions of the DoD Agreement,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin: 6pt 0"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="margin: 6pt 0; page-break-before: always"><p style="margin: 0pt 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">ECRC is entitled to receive up to an
aggregate of approximately $10.0 million of reimbursement payments from the DoD upon the achievement of certain project milestones
related to feasibility study-level engineering and additional reserve drilling, as well as preparing updated cost estimates, for
the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a011"></span>Competitive
Business Conditions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">There
is significant competition within the minerals industry to discover, acquire and obtain project financing for mineral properties
considered to have commercial potential. We compete with others in efforts to obtain project financing and resources to advance
the Elk Creek Project to construction and commercial operation, acquire and utilize mining and processing equipment, and hire
qualified personnel. These other companies may be better capitalized than us and we may have difficulty in obtaining the financing
and resources necessary to advance the Elk Creek Project to construction and commercial operation. In addition, in competing for
qualified personnel, we may be required to pay compensation or benefits relatively higher than those paid in the past, and the
availability of qualified personnel may be limited in high-demand periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a012"></span>Cycles</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
mining business is subject to mineral price cycles. The marketability of minerals and mineral concentrates is also affected by
worldwide economic cycles. Demand has in the past, and may in the future, be subject to those same worldwide economic cycles.
Fluctuations in supply and demand in various regions throughout the world are common. In addition, the niobium, scandium, titanium,
and potentially, rare earth products, that we intend to produce at the Elk Creek Project are subject to additional commodity-specific
price cycles resulting from, among other factors, demand for specific products, export controls, taxes and other tariffs and fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
following table sets forth commodity prices for the last five calendar years for the ferroniobium, scandium trioxide, and titanium
dioxide products the Company anticipates extracting from its Elk Creek Project. These pricing surveys may not be representative
of the pricing that the Company anticipates achieving for its products if commercial production begins from its Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 21%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Year</b>&#160;</span></p></td>
    <td style="width: 27%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Ferroniobium</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>U.S. Price ($/kg-Nb)<sup>(</sup></b><sup>1)</sup>&#160;</span></p></td>
    <td style="width: 26%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>Sc<sub>2</sub>O<sub>3</sub></b></span><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>U.S. Price ($/kg)<sup>(</sup></b><sup>2)</sup>&#160;</span></p></td>
    <td style="width: 26%; padding-right: 5.75pt; padding-left: 5.75pt"><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>TiO<sub>2</sub></b></span><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>U.S. Price ($/kg)<sup>(</sup></b><sup>3)</sup>&#160;</span></p></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> $46</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,200</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1.31</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 51</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<sup>(4)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.46</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 46</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,100</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;1.47</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 44</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,200</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.30</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 37</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,800</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Source:
                                         Argus Metal Prices, average annual ending price, 2024. Ferroniobium 65% niobium content,
                                         FOB U.S. warehouse.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Source:
                                         United States Geological Service (&#8220;USGS&#8221;) Mineral Commodity Summary, 2024.
                                         Sc<sub>2</sub>O<sub>3</sub>, 99.99% purity, 5-kilogram (&#8220;kg&#8221;) lot size.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Source:
                                         USGS Mineral Commodity Summary, 2024. Rutile mineral concentrate, bulk, minimum 95% TiO<sub>2</sub>,
                                         f.o.b. Australia.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pricing
                                         information was not provided by the USGS for 2023.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
NioCorp is a development stage issuer and has not yet generated any revenue from the operation of the Elk Creek Project, it is
not currently significantly affected by changes in commodity demand and prices, except to the extent that these changes may impact the development
of the Elk Creek Project. As it does not carry on production activities, NioCorp&#8217;s ability to fund ongoing exploration is
affected by the availability of financing, which is, in turn, affected by the strength of the economy and other general economic
factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a013"></span>Economic
Dependence</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Other
than land and mineral right option agreements and agreements between NioCorp and third parties for the purchase and sale of products
to be produced from the Elk Creek Project (&#8220;offtake agreements&#8221;), NioCorp&#8217;s business is not substantially dependent
on any contract such as a contract to sell the major part of its product or services or to purchase the major part of its requirements
for goods, services or its raw materials, or any franchise or license or other agreement to use a patent, formula, trade secret,
process or trade name upon which its business depends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a014"></span>Government
Regulation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
exploration and development of a mining prospect is subject to regulation by a number of federal and state government authorities.
These include the United States Environmental Protection Agency (the &#8220;EPA&#8221;) and the United States Army Corps of Engineers
(the &#8220;USACE&#8221;) as well as the various state and local environmental protection agencies. The regulations address many
environmental issues relating to air, soil, and water contamination, and apply to many mining related activities including exploration,
mine construction, mineral extraction, ore milling, water use, waste disposal, and use of toxic substances. In addition, we are
subject to regulations relating to labor standards, occupational health and safety, mine safety, general land use, export of minerals,
taxation, data protection, and data security. Many of the regulations require permits or licenses to be obtained, the absence
of which and/or inability to obtain such permits or licenses will adversely affect our ability to conduct our exploration, development,
and operation activities. The failure to comply with the regulations and terms of permits and licenses may result in fines or
other penalties or in revocation of a permit or license or loss of a prospect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><i>General</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">While
none of the lands on which the Elk Creek Project is proposed to be built are owned by the U.S. Government, mining rights on public
lands are governed by the General Mining Law of 1872, as amended, which allows for the location of mining claims on certain federal
lands upon the discovery of a valuable mineral deposit and compliance with location requirements. The exploration of mining properties
and development and operation of mines is governed by both federal and state laws. Federal laws that govern mining claim location
and maintenance and mining operations on federal lands are generally administered by the Bureau of Land Management. Additional
federal laws, governing mine safety and health, also apply. State laws also require various permits and approvals before exploration,
development or production operations can begin. Among other things, a reclamation plan must typically be prepared and approved,
with financial assurance provided in the amount of projected reclamation costs. The financial assurance is used to ensure that
proper reclamation takes place and will not be released until that time. Local jurisdictions may also impose permitting requirements,
such as conditional use permits or zoning approvals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Environmental
Regulation</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
mineral projects are subject to various federal, state, and local laws and regulations governing protection of the environment.
These laws are continually changing and, in general, are becoming more restrictive. The development, operation, closure, and reclamation
of mining projects in the U.S. requires numerous notifications, permits, authorizations, and public agency decisions. Compliance
with environmental and related laws and regulations requires us to obtain permits issued by regulatory agencies and to file various
reports and keep records of our operations. Certain of these permits require periodic renewal or review of their conditions and
may be subject to a public review process during which opposition to our proposed operations may be encountered. We are currently
operating under various permits for activities connected to mineral exploration, reclamation, and environmental considerations.
Our policy is to conduct business in a way that safeguards public health and the environment. We believe that our operations are
conducted in material compliance with applicable laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Changes
to current local, state, or federal laws and regulations in the jurisdictions where we operate could require additional capital
expenditures and increased operating and/or reclamation costs. Although we are unable to predict what additional legislation,
if any, might be proposed or enacted, additional regulatory requirements could impact the economics of our projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Environmental
Regulation - U.S. Federal Laws</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Comprehensive Environmental, Response, Compensation, and Liability Act (&#8220;CERCLA&#8221;), and comparable state statutes,
impose strict, joint, and several liability on current and former owners and operators of sites and on persons who disposed of
or arranged for the disposal of hazardous substances found at such sites. It is not uncommon for the government to file claims
requiring clean-up actions and/or demands for reimbursement for government-incurred clean-up costs or natural resource damages.
It is also not uncommon for neighboring landowners and other third parties to file claims for personal injury and property damage
allegedly caused by hazardous substances released into the environment. The Resource Conservation and Recovery Act (&#8220;RCRA&#8221;),
and comparable state statutes, govern the disposal of solid waste and hazardous waste and authorize the imposition of substantial
fines and penalties for noncompliance, as well as requirements for corrective actions. CERCLA, RCRA, and comparable state statutes
can impose liability for clean-up of sites and disposal of substances found on exploration, mining and processing sites long after
activities on such sites have been completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Clean Air Act, as amended (&#8220;CAA&#8221;), restricts the emission of air pollutants from many sources, including mining and
processing activities. Any future mining operations by the Company may produce air emissions, including fugitive dust and other
air pollutants from stationary equipment, storage facilities, and the use of mobile sources such as trucks and heavy construction
equipment, which are subject to review, monitoring and/or control requirements under the CAA and state air quality laws. New facilities
may be required to obtain permits before work can begin, and existing facilities may be required to incur capital costs in order
to remain in compliance. In addition, permitting rules may impose limitations on our production levels or result in additional
capital expenditures in order to comply with the rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
National Environmental Policy Act (&#8220;NEPA&#8221;) requires federal agencies to integrate environmental considerations into
their decision-making processes by evaluating the environmental impacts of their proposed actions, including issuance of permits
to mining facilities and assessing alternatives to those actions. If a proposed action could significantly affect the environment,
the agency must prepare either a detailed statement known as an Environmental Impact Statement (&#8220;EIS&#8221;), or a less
detailed statement known as an Environmental Assessment (&#8220;EA&#8221;). The EPA, other federal agencies, and any interested
third parties can review and comment on the scope of the EIS or EA and the adequacy of any findings set forth in the draft and
final EIS or EA. This process can cause delays in issuance of required permits or result in changes to a project to mitigate its
potential environmental impacts, which can in turn impact the economic feasibility of a proposed project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Clean Water Act (&#8220;CWA&#8221;), and comparable state statutes, impose restrictions and controls on the discharge of pollutants
into waters of the U.S. The discharge of pollutants into regulated waters is prohibited, except in accordance with the terms of
a permit issued by the EPA or an analogous state agency. The CWA regulates storm water from mining facilities and requires a storm
water discharge permit or Stormwater Pollution Prevention Plan for certain activities. Such a permit requires the regulated facility
to monitor and sample storm water run-off from its operations. The CWA and regulations implemented thereunder also prohibit discharges
of dredged and fill material in wetlands and other waters of the U.S. unless authorized by an appropriately issued permit. The
CWA and comparable state statutes provide for civil, criminal, and administrative penalties for unauthorized discharges of pollutants,
and impose liability on parties responsible for those discharges for the costs of cleaning up any environmental damage caused
by the release and for natural resource damages resulting from the release.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Safe Drinking Water Act (&#8220;SDWA&#8221;) and the Underground Injection Control (&#8220;UIC&#8221;) program promulgated thereunder,
regulate the drilling and operation of subsurface injection wells. The EPA directly administers the UIC program in some states
and in others the responsibility for the program has been delegated to the state. The program requires that a permit be obtained
before drilling a disposal or injection well. Violation of these regulations and/or contamination of groundwater by mining-related
activities may result in fines, penalties, and remediation costs, among other sanctions and liabilities under the SDWA and state
laws. In addition, third-party claims may be filed by landowners and other parties claiming damages for alternative water supplies,
property damages, and bodily injury.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Environmental
Regulation &#8722; Nebraska</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Nebraska
has a well-developed set of environmental regulations and responsible agencies but does not have clearly defined regulations with
respect to permitting mines. As such, review of the project and the issuance of permits by Nebraska agencies and regulatory bodies
could potentially impact the total time to market for our Elk Creek Project. Other Nebraska regulations govern operating and design
standards for the construction and operation of any source of air emissions and landfill operations. Any changes to these laws
and regulations could have an adverse impact on our financial performance and results of operations by, for example, requiring
changes to operating conditions, technical criteria, fees, or surety requirements. The most stringent permit related to air quality
is known as a Prevention of Significant Deterioration (&#8220;PSD&#8221;) permit, which requires the applicant to demonstrate
compliance with NAAQS and Best Available Control Technology (&#8220;BACT&#8221;) for the control of air emissions. If the facility
exceeds the potential to emit thresholds for such a permit and is thus subject to PSD requirements, permanent construction at
the project site may not begin until the responsible agency issues the PSD permit. For facilities in Nebraska with potential emissions
below PSD thresholds, a state air construction permit is needed. The state permit also requires a demonstration of compliance
with NAAQS but does not require a BACT demonstration and further allows construction at a subject facility to proceed ahead of
permit issuance through an established variance process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a015"></span>Human
Capital</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s ability to continue to progress the Elk Creek Project will depend on its ability to attract and retain individuals
with (among other skills) financial, administrative, engineering, geological and mining skills, and knowledge of our industry
and targeted markets. Much of the necessary specialized skills and knowledge required by the Company as a mineral exploration
company are available from the Company&#8217;s current management team and Board of Directors (the &#8220;Board&#8221;). The Company
retains outside consultants if additional specialized skills and knowledge are required.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of June 30, 2025, we had seven full-time employees as well as one contract employee. In addition, we use consultants with specific
skills to assist with various aspects of our corporate affairs, project evaluation, due diligence, corporate governance, and property
management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
compensation programs are designed to align compensation of our employees with the Company&#8217;s performance and to provide
the proper incentives to attract, retain, and motivate employees to achieve superior results. The structure of our compensation
programs balances competitive wages and benefits and incentive earnings for both short-term and long-term performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
priority to maintain a culture of ethical performance as a core value is reflected in the Company&#8217;s Code of Business Conduct
and Ethics (the &#8220;Code of Conduct&#8221;) and other related policies. Oversight is provided by the Company&#8217;s Board
and, for specific areas of performance, by committees of the Board. Employees are required to review the Code of Conduct on a
periodic basis. Our compensation programs also include consideration of ethical performance in determining incentive awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company also provides a robust suite of benefits to our employees, including 401(k) participation, medical-insurance options,
and programs to encourage and support the whole person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a016"></span>Forward-Looking
Statements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">This
Annual Report on Form 10-K and the exhibits attached hereto contain &#8220;forward-looking statements&#8221; within the meaning
of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and &#8220;forward-looking information&#8221; within the meaning
of applicable Canadian securities legislation (collectively, &#8220;forward-looking statements&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in">Forward-looking
statements have been based upon our current business and operating plans, as approved by the Board, and may include statements
regarding, among other matters, the financial and business performance of NioCorp; NioCorp&#8217;s anticipated results and developments
in the operations of NioCorp in future periods; NioCorp&#8217;s planned exploration activities; the adequacy of NioCorp&#8217;s
financial resources; NioCorp&#8217;s ability to secure sufficient project financing to complete construction and commence operation
of the Elk Creek Project; NioCorp&#8217;s ability to receive a final commitment of financing from EXIM; the estimated total upfront
capital expenditure for the Elk Creek Project; NioCorp&#8217;s expectation and ability to produce niobium, scandium, and titanium
and the potential to produce rare earth elements at the Elk Creek Project; NioCorp&#8217;s plans to produce and supply specific
products and market demand for those products; NioCorp&#8217;s ability to access the full amount of the expected net proceeds
of the Yorkville Equity Facility Financing Agreement; NioCorp&#8217;s expectation that it will receive the full $10 million in
reimbursement under the DoD Agreement; the intended use of our cash balance as of June 30, 2025 as well as the proceeds from the
July 2025 Offering, the proceeds from Warrant exercise issuances, and the reimbursement payments pursuant to the DoD Agreement;
the expected results of the drilling program at the Elk Creek Project; the expectation that the results of the drilling program
will be used to update the feasibility study for the Elk Creek Project; the Elk Creek Project&#8217;s ability to produce multiple
critical metals; the Elk Creek Project&#8217;s projected ore production and mining operations over its expected mine life; the
completion of technical and economic analyses on the potential addition of magnetic rare earth oxides to NioCorp&#8217;s planned
product suite; statements with respect to the estimation of mineral resources and mineral reserves; the exercise of options to
purchase additional land parcels; the execution of contracts with engineering, procurement and construction companies; NioCorp&#8217;s
ongoing evaluation of the impact of inflation, supply chain issues, tariffs, and geopolitical unrest on the Elk Creek Project&#8217;s
economic model; and the creation of full time and contract construction jobs over the construction period of the Elk Creek Project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Forward-looking
statements are frequently, but not always, identified by words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221;
&#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; and similar expressions, or statements
that events, conditions, or results &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; or &#8220;should&#8221; (or the
negative and grammatical variations of any of these terms) occur or be achieved. Any statements that express or involve discussions
with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, or future events or performance
(often, but not always, using words or phrases such as &#8220;expects&#8221; or &#8220;does not expect,&#8221; &#8220;is expected,&#8221;
&#8220;anticipates&#8221; or &#8220;does not anticipate,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or &#8220;intends,&#8221;
or stating that certain actions, events, or results &#8220;may,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;might,&#8221;
or &#8220;will&#8221; be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements.
Forward-looking statements reflect material expectations and assumptions, including, without limitation, expectations and assumptions
relating to: NioCorp&#8217;s ability to receive sufficient project financing for the construction of the Elk Creek Project on
acceptable terms, or at all; the future price of metals; the stability of the financial and capital markets; and current estimates
and assumptions regarding the Yorkville Equity Facility Financing Agreement and its benefits. Such forward-looking statements
reflect the Company&#8217;s current views with respect to future events and are subject to certain known and unknown risks, uncertainties,
and assumptions. Many factors could cause actual results, performance, or achievements to be materially different from any future
results, performance, or achievements that may be expressed or implied by such forward-looking statements, including, among others,
risks related to the following: NioCorp&#8217;s ability to operate as a going concern; NioCorp&#8217;s requirement of significant
additional capital; NioCorp&#8217;s ability to receive sufficient project financing for the construction of the Elk Creek Project
on acceptable terms, or at all; NioCorp&#8217;s ability to achieve the required milestones and receive the full $10.0 million
in reimbursement under the DoD Agreement; NioCorp&#8217;s ability to receive a final commitment of financing from EXIM or other debt financing or financial support on acceptable timelines, on acceptable terms, or at all; NioCorp&#8217;s ability to access the
full amount of the expected net proceeds under the Yorkville Equity Facility Financing Agreement; NioCorp&#8217;s ability to continue
to meet Nasdaq listing standards; risks relating to the Common Shares, including price volatility, lack of dividend payments and
dilution or the perception of the likelihood of any of the foregoing; the extent to which NioCorp&#8217;s level of indebtedness
and/or the terms contained in agreements governing NioCorp&#8217;s indebtedness, if any, the Yorkville Equity Facility Financing
Agreement or other agreements may impair NioCorp&#8217;s ability to obtain additional financing, on acceptable terms, or at all;
covenants contained in agreements with NioCorp&#8217;s secured creditors that may affect its assets; NioCorp&#8217;s limited operating
history; NioCorp&#8217;s history of losses; the material weaknesses in NioCorp&#8217;s internal control over financial reporting,
NioCorp&#8217;s efforts to remediate such material weaknesses and the timing of remediation; the possibility that NioCorp may
qualify as a PFIC under the Code; the potential that the 2023 Transactions could result in NioCorp becoming subject to materially
adverse U.S. federal income tax consequences as a result of the application of Section 7874 and related sections of the Code;
cost increases for NioCorp&#8217;s exploration and, if warranted, development projects; a disruption in, or failure of, NioCorp&#8217;s
information technology systems, including those related to cybersecurity; equipment and supply shortages; variations in the market
demand for, and prices of, niobium, scandium, titanium and rare earth products; current and future offtake agreements, joint ventures,
and partnerships, including our ability to negotiate extensions to existing agreements or to enter into new agreements, on favorable
terms or at all; NioCorp&#8217;s ability to attract qualified management; estimates of mineral resources and reserves; mineral
exploration and production activities; feasibility study results; the results of metallurgical testing; the results of technological
research; changes in demand for and price of commodities (such as fuel and electricity) and currencies; competition in the mining
industry; changes or disruptions in the securities markets; legislative, political or economic developments, including changes
in federal and/or state laws that may significantly affect the mining industry; trade policies and tensions, including tariffs;
inflationary pressures; the impacts of climate change, as well as actions taken or required by governments related to strengthening
resilience in the face of potential impacts from climate change; the need to obtain permits and comply with laws and regulations
and other regulatory requirements; the timing and reliability of sampling and assay data; the possibility that actual results
of work may differ from projections/expectations or may not realize the perceived potential of NioCorp&#8217;s projects; risks
of accidents, equipment breakdowns, and labor disputes or other unanticipated difficulties or interruptions; the possibility of
cost overruns or unanticipated expenses in development programs; operating or technical difficulties in connection with exploration,
mining, or development activities; management of the water balance at the Elk Creek Project site; land reclamation requirements
related to the Elk Creek Project; the speculative nature of mineral exploration and development, including the risks of diminishing
quantities of grades of reserves and resources; claims on the title to NioCorp&#8217;s properties; potential future litigation;
and NioCorp&#8217;s lack of insurance covering all of NioCorp&#8217;s operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Should
one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may
vary materially from those described herein. This list is not exhaustive of the factors that may affect</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">any of the Company&#8217;s
forward-looking statements. Forward-looking statements are statements about the future and are inherently uncertain, and actual
achievements of the Company or other future events or conditions may differ materially from those reflected in the forward-looking
statements due to a variety of risks, uncertainties, and other factors, including without limitation those discussed under Item
1A., Risk Factors below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company&#8217;s forward-looking statements contained in this Annual Report on Form 10-K are based on the beliefs, expectations,
and opinions of management as of the date of this Annual Report on Form 10-K. The Company does not assume any obligation to update
forward-looking statements if circumstances or management&#8217;s beliefs, expectations, or opinions should change, except as
required by law. For the reasons set forth above, investors should not attribute undue certainty to, or place undue reliance on,
forward-looking statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a017"></span>Available
Information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
maintain a website at http://www.niocorp.com. Our Common Shares are currently registered under Section 12(b) of the Exchange Act,
and we are currently required to file reports on Forms 10-K, 10-Q, or 8-K. Our Annual Report on Form 10-K (which includes our
audited consolidated financial statements), Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to reports
filed or furnished pursuant to Sections 13(a) and 15(d) of the Exchange Act, are available on our website, free of charge, as
soon as reasonably practicable after we electronically file such reports with, or furnish those reports to, the SEC. The SEC maintains
an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically
with the SEC (http://www.sec.gov). We do not intend to send security holders a printed version of our Annual Report as it will
be available online.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
maintain a Code of Conduct, a copy of which may be found on our website in the &#8220;About Us&#8221; section under the main title
&#8220;Corporate Governance.&#8221; Our Code of Conduct contains information regarding whistleblower procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
are not including the information contained on or accessible through our website or the SEC&#8217;s website as a part of, or incorporating
it by reference into, this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif"><span id="a018"></span>ITEM 1A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">RISK
                                         FACTORS</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><i>Our
business activities are subject to significant risks, including those described below. You should carefully consider these risks.
If any of the described risks occur, our business, financial position, and results of operations could be materially adversely
affected. Such risks are not the only ones we face, and additional risks and uncertainties not presently known to us or that we
currently deem immaterial may also affect our business. This report contains forward-looking statements that involve risks and
uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result
of a number of factors, including the risks described below. See &#8220;Forward-Looking Statements&#8221; under Item 1., &#8220;Business.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a019"></span>Risks
Related to Our Business</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our
ability to operate as a going concern is in doubt.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The
notes that accompany our consolidated financial statements for the year ended June 30, 2025, disclose that substantial doubt exists
as to our ability to continue as a going concern. The consolidated
financial statements included in this Annual Report on Form 10-K have been prepared under the assumption that we will continue
as a going concern. We are a development stage issuer and we have incurred losses since our inception.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a development stage issuer, the Company has not yet commenced its mining operations and accordingly does not generate any
revenue. The Company does not have sufficient cash on hand to fund planned operations as well as the construction necessary
for mine development for the next twelve months. The Company is dependent on its ability to raise capital to fund future exploration
and working capital requirements.  Our plans for the long-term achievement of and continuation as a going concern include financing our future operations through
sales of our Common Shares and/or debt and the potential profitable exploitation of our Elk Creek Project. Additionally, capital
markets and general economic conditions in the U.S. and Canada may impose significant obstacles to raising the required funds.
As discussed further below, while we have been successful in doing so in the past, there can be no assurance we will be able to
raise funds in the future. These factors raise substantial doubt about our ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We
will require significant additional capital to fund our business plan.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
will be required to make substantial capital expenditures to advance the Elk Creek Project to construction and commercial operation.
We will also require funds for our ongoing capital needs and will be required to raise additional capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
expect that the Company will operate at a loss for the foreseeable future. The Company&#8217;s current planned cash needs are
approximately $40.0 million to $50.0 million for the next twelve months. In addition to outstanding accounts payable and short-term
liabilities, our planned expenditures over the next twelve months are expected to consist of expenditures relating to certain
advancements of the Elk Creek Project by NioCorp&#8217;s majority owned subsidiary, ECRC, corporate overhead costs, and estimated
costs related to securing financing necessary for advancement of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif">We
expect to use our cash balance as of June 30, 2025, as well as the proceeds from the July 2025 Offering, the proceeds from the
Warrant exercise issuances, and the reimbursement payments pursuant to the DoD Agreement, to fund our planned expenditures for
the next twelve months. However, additional work is required in order to advance the Elk Creek Project, which will require additional
financing. The S-K 1300 Elk Creek Technical Report Summary includes an estimated total upfront capital expenditure for the Elk
Creek Project of approximately $1,141.0 million. The actual amount of capital expenditure required to successfully achieve commercial
production at the Elk Creek Project is subject to, among other factors, the timing and actual cost of further exploration, preparing
feasibility studies, permitting, engineering and the construction of infrastructure, mining and processing facilities. If the
Company were able to obtain additional funding, the Company would be able to accelerate planned expenditures ahead of its current
schedule. In addition, to the extent that EXIM requests further project activities to be undertaken in connection with the diligence
process, the Company would require additional funding to complete such activities. The Company&#8217;s ability to continue operations
and fund our current work plan is dependent on management&#8217;s ability to secure additional financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif">Except
for the potential funding from advances under the Yorkville Equity Facility Financing Agreement, which is discussed below under
Part II, Item 7. &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity
and Capital Resources,&#8221; and the potential exercise of options to purchase Common Shares (&#8220;Options&#8221;) and Warrants,
we currently have no further funding commitments or arrangements for additional financing at this time. In addition, agreements
we enter into may contain restrictions on our ability to raise additional financing on reasonable terms or at all. For example,
pursuant to the Exchange Agreement, NioCorp is restricted from issuing equity or equity-linked securities (other than Common Shares)
or any preferred equity or non-voting equity if such issuance would adversely impact the rights of the holders of the shares of
Class B common stock of ECRC, without the consent of the holders of a majority of the shares of Class B common stock of ECRC.
Notwithstanding the restrictions set forth in the Exchange Agreement, there is significant uncertainty that we would be able to
secure any additional financing in the current equity or debt markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
ability to obtain necessary funding depends upon a number of factors, including the status of the national and worldwide economy
and the price of the products we intend to produce. We are actively pursuing additional sources of debt and equity financing,
and while we have been successful in doing so in the past, there can be no assurance we will be able to obtain any such additional
financing on acceptable terms, if at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
addition, the potential EXIM Financing is subject to, among other matters, the satisfactory completion of due diligence, including
the additional project activities identified in the PPL, the negotiation and settlement of final terms, and the negotiation of
definitive documentation. There can be no assurance that the EXIM Financing will be completed on the terms described herein or
at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
inability to access sufficient capital for our operations could have a material adverse effect on our financial condition, results
of operations, or prospects. Sales of substantial amounts of securities may have a highly dilutive effect on our ownership or
share structure. Sales of a large number of Common Shares in the public markets, or the potential for such sales, could decrease
the trading price of the Common Shares and could impair our ability to raise capital through future sales of Common Shares. We
have not yet commenced commercial production at any of our properties and, as such, have not generated positive cash flows to
date and have no reasonable prospects of doing so unless successful commercial production can be achieved at our Elk Creek Project.
We expect to continue to incur</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">negative investing and operating cash flows until such time as we enter into successful commercial
production. This will require us to deploy our working capital to fund such negative cash flow and to seek additional sources
of financing. There is no assurance that any such financing sources will be available or sufficient to meet our requirements.
There is no assurance that we will be able to continue to raise equity capital or to secure additional debt financing, or that
we will not continue to incur losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i>We
have a limited operating history on which to base an evaluation of our business and prospects.</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Since
our inception, we have had no revenue from operations. We have no history of producing products from any of our properties. Our
Elk Creek Project is a development stage property. Advancing our Elk Creek Project from a development stage property to a production
stage property will require significant capital and time, and successful commercial production from the Elk Creek Property will
be subject to permitting and construction of the mine, processing plants, roads, and other related works and infrastructure. As
a result, we are subject to all of the risks associated with developing and establishing new mining operations and business enterprises
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                         timing and cost, which can be considerable, of further exploration, preparing feasibility
                                         studies, permitting, engineering and construction of infrastructure, mining, and processing
                                         facilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                         availability and costs of drilling equipment, exploration personnel, skilled labor, and
                                         mining and processing equipment, if required;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                         availability and cost of appropriate smelting and/or refining arrangements, if required;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">compliance
                                         with environmental and other governmental approval and permit requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                         availability of funds to finance exploration, development, permitting, and construction
                                         activities, as warranted;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">potential
                                         opposition from non-governmental organizations, local groups, or local residents that
                                         may delay or prevent development activities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">potential
                                         increases in exploration, construction, and operating costs due to changes in the cost
                                         of fuel, power, materials, and supplies; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">potential
                                         shortages of mining, mineral processing, hydrometallurgical, pyrometallurgical, construction,
                                         and other facilities-related supplies.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
costs, timing, and complexities of exploration, development, engineering, and construction activities may be increased by the
location of our properties and competition from other mineral exploration and mining companies. It is common for exploration companies
to experience unexpected problems and delays during development, if commenced, including engineering, procurement, construction,
commissioning, and ramp-up. Accordingly, our activities may not result in profitable operations and we may not succeed in establishing
operations or profitably producing products at any of our current or future properties, including our Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We
have a history of losses and expect to continue to incur losses in the future.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
have incurred losses since inception, have negative cash flow from operating activities, and expect to continue to incur losses
in the future. We incurred a net loss attributable to the Company of $17.4 million for the year ended June 30, 2025, and $11.4
million for the year ended June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
expect to continue to incur losses unless and until such time as one of our properties enters into commercial production and generates
sufficient revenues to fund continuing operations. We recognize that if we are unable to generate significant revenues from operations
and dispositions of our properties, we will not be able to earn profits or continue operations. At this early stage of our operation,
we also expect to face the risks, uncertainties, expenses, and difficulties frequently encountered by companies at the start-up
stage of their business development. We cannot be sure that we will be successful in addressing these risks and uncertainties
and our failure to do so could have a materially adverse effect on our financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Increased
costs could affect our financial condition.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
anticipate that costs at our projects that we may explore or develop, including the Elk Creek Project, will frequently be subject
to variation from one year to the next due to a number of factors, such as changing ore grade, metallurgical performance, and
revisions to mine plans, if any, in response to the physical shape and location of the ore body. In addition, costs are affected
by the price of commodities such as fuel, steel, aluminum, iron, chemicals,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">natural gas, fresh water, and electricity, as well
as by government actions such as tariffs. Such commodities are at times subject to volatile price movements, including increases
that could make production at certain operations less profitable or not profitable at all. For example, the S-K 1300 Elk Creek
Technical Report Summary includes an estimated total upfront capital expenditure for the Elk Creek Project of approximately $1,141.0
million. The actual amount of capital expenditure required to successfully achieve commercial production at the Elk Creek Project
is subject to, among other factors, the timing and actual cost of further exploration, preparing feasibility studies, permitting,
engineering and the construction of infrastructure, mining, and processing facilities. A material increase in costs at any significant
location could have a significant effect on our profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
disruption in, or failure of our third-party service providers&#8217; IT systems, including those related to cybersecurity, could
adversely affect our business operations and financial performance.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
rely on the accuracy, capacity, and security of our third-party service providers&#8217; IT systems for the operations of many
of our business processes and to comply with regulatory, legal, and tax requirements. We are dependent on third parties to provide
important IT services relating to, among other things, operational technology at our facilities, human resources, electronic communications,
and certain finance functions. Despite the security measures that our third-party service providers have implemented, including
those related to cybersecurity, we have experienced, and may experience in the future, cybersecurity incidents. Cybersecurity
incidents and similar attacks vary in their form and can include the deployment of harmful malware or ransomware, denial-of-service
attacks, and other attacks, which may affect business continuity and threaten the availability, confidentiality and integrity
of our systems and information, and the systems and information of our third-party service providers. Cybersecurity incidents
can also include employee or personnel failures, fraud, phishing or other social engineering attempts or other methods to cause
confidential information, payments, account access or access credentials, or other data to be transmitted to an unintended recipient.
Cybersecurity threat actors also may attempt to exploit vulnerabilities in software that is commonly used by companies in cloud-based
services and bundled software. As previously disclosed, on February 14, 2025, we became aware of unauthorized third-party access
to our information systems, including portions of its email systems, that resulted in misdirected vendor payments (the &#8220;Cybersecurity
Incident&#8221;). To date, the Cybersecurity Incident has not had a material impact on our business operations or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.5pt; text-align: justify; text-indent: 0.25in">Though
our third-party service providers have controls in place, we cannot provide assurance that a cybersecurity incident will not occur
in the future. Furthermore, we may have little or no oversight with respect to security measures employed by third-party service
providers, which may ultimately prove to be ineffective at countering threats. Cybersecurity threats or incidents or disruptions
of our third-party service providers&#8217; IT systems could interrupt our ability to manage and operate our business, impact data,
and adversely affect our business operations and financial performance, including major disruptions to business operations, loss
of intellectual property, release of confidential information, alteration or corruption of data or systems, costs related to remediation
or the payment of ransom, and litigation including individual claims or consumer class actions, commercial litigation, administrative,
and civil or criminal investigations or actions, regulatory intervention and sanctions or fines, investigation and remediation
costs and possible prolonged negative publicity. In addition, we have incurred costs in connection with the remediation of the
Cybersecurity Incident and we may be required to incur significant costs to protect against and, if required, remediate the damage
caused by cybersecurity incidents, disruptions or system failures in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt 0pt 0.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">A
shortage of equipment and supplies could adversely affect our ability to operate our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
are dependent on various supplies and equipment to carry out our mining exploration and, if warranted, project development operations.
The shortage of such supplies, equipment, and parts could have a material adverse effect on our ability to carry out our operations
and could therefore limit, or increase the cost of, production. Ongoing disruptions to the world&#8217;s economy, including issues
related to supply chains, inflation, tariffs and trade tensions, and increased raw material and labor costs, may delay our ability
to secure supplies and equipment for the Elk Creek Project on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Joint
ventures and other partnerships, including offtake arrangements, may expose us to risks.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
have entered into offtake agreements related to our Elk Creek Project as well as agreements related to the supply of natural gas
and electricity to the project site, and may enter into joint ventures or partnership arrangements, including additional offtake
agreements, with other parties in relation to the exploration, development, and production of certain of the properties in which
we have an interest. Any failure of such other companies to meet their obligations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">to us or to third parties, or any disputes
with respect to the parties&#8217; respective rights and obligations, price fluctuations and termination provisions related to
such agreements, or our ability to negotiate extensions to existing agreements or to enter into new agreements, on favorable terms
or at all, could have a material adverse effect on us, the development and production at our properties, including the Elk Creek
Project, the joint ventures, if any, or their properties and therefore could have a material adverse effect on our results of
operations, financial performance, cash flows, and the price of our Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
may experience difficulty attracting and retaining qualified management to meet the needs of our anticipated growth, and the failure
to manage our growth effectively could have a material adverse effect on our business and financial condition.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
are dependent on a relatively small number of key employees, including our Chief Executive Officer. The loss of any officer could
have an adverse effect on us. We have no life insurance on any individual, and we may be unable to hire a suitable replacement
for them on favorable terms, should that become necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
effect on the capital markets and the economy of recent global events, including inflation, volatility in commodity prices, supply
chain uncertainty, tariffs and trade tensions, and increases in raw material and labor costs, could have an adverse effect on
NioCorp&#8217;s business plans, financial condition, and liquidity.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">Certain
events have effected, and continue to effect, the global and United States economies, including increased inflation, volatility
in commodity prices, supply chain uncertainty, tariffs and trade tensions, and increases in raw material and labor costs. We cannot
predict how this will affect our business, but the impact may be adverse.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">Although
it is not possible to predict the ultimate impact of these factors on NioCorp&#8217;s business plans, financial position, or liquidity,
such impacts that may be material include, but are not limited to: (i) delays in the completion of the mine and surface engineering
designs and uncertainty regarding our ability to finalize necessary Engineering, Procurement, and Construction (&#8220;EPC&#8221;)
agreements as a result of disruptions in the businesses of our engineering consultants and key contractors for the Elk Creek Project,
(ii) reduced availability and increased costs of employees, (iii) a negative impact on our liquidity position, and (iv) increased
costs and less ability to access funds in the capital markets. The full extent to which these factors may continue to impact our
business will depend on future developments, which continue to be highly uncertain and cannot be predicted at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">In
addition, we cannot predict the impact that recent global events, including inflation, volatility in commodity prices, supply
chain uncertainty, tariffs and trade tensions, and increases in raw material and labor costs will have on our customers, suppliers,
vendors, and other business partners, and each of their financial conditions; however, any material effect on these parties could
adversely impact us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">It
may be difficult to enforce judgments or bring actions outside the U.S. against us and certain of our directors.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
are a Canadian corporation and, as a result, it may be difficult or impossible for an investor to do the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">enforce
                                         in courts outside the U.S. judgments obtained in U.S. courts based upon the civil liability
                                         provisions of U.S. federal securities laws against these persons and the Company; or</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.75pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">bring
                                         in courts outside the U.S. an original action to enforce liabilities based upon U.S.
                                         federal securities laws against these persons and the Company.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
may not recognize the full value of the Yorkville Equity Facility Financing Agreement and may not receive any proceeds from the
exercise of our outstanding Warrants, and the potential adverse effect on the prevailing market prices for our Common Shares as
a result of sales, or the perception of future sales, of Common Shares could adversely affect our ability to raise additional
capital.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Although
we have entered into the Yorkville Equity Facility Financing Agreement, we may not recognize the full value thereof. Specifically,
our ability to sell Common Shares to Yorkville pursuant to the Yorkville Equity Facility Financing Agreement is subject to certain
restrictions and limitations, which may prevent us from selling the full commitment amount prior to the expiration of the commitment
period. Our ability to recognize the full value of the Yorkville Equity Facility Financing Agreement may be further impeded by
the potential negative pressure on the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">market price of our Common Shares as a result of sales, or the perception of future sales,
of Common Shares by us or by other security holders. As a result, there can be no assurance that we will receive all or even a
significant portion of the proceeds that we expect to receive in connection with the Yorkville Equity Facility Financing Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">In
addition, upon exercise, we will receive the cash exercise price of our outstanding Warrants (assuming, that they are not exercised
on a cashless basis, as applicable). We believe the likelihood that holders will exercise their Warrants, and therefore, the amount
of cash proceeds that we would receive, is, among other things, dependent upon the market price of our Common Shares. For so long
as the market price for our Common Shares is less than the applicable exercise price of the Warrants, we believe such holders
will be unlikely to exercise their Warrants. The potential adverse effect on the prevailing market price of our Common Shares
as a result of sales of Common Shares by us or by other security holders, or the perception that such sales may occur, could keep
the market price for our Common Shares below the applicable exercise price of the Warrants. Accordingly, the holders of the Warrants
may not exercise their Warrants before they expire, and we may not receive any proceeds from the exercise of the outstanding Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>We
may not recognize the full value of the DoD Agreement.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: justify; text-indent: 0.25in">Subject
to the terms and conditions of the DoD Agreement, the DoD will reimburse ECRC for a portion of the costs incurred by ECRC under
the DoD Agreement and ECRC is entitled to receive up to an aggregate of approximately $10.0 million of reimbursement payments from
the DoD upon the achievement of certain project milestones.&#160;If the Company is not successful in achieving the milestones required
under the DoD Agreement or if the reimbursements sought by the Company are rejected or the DoD Agreement is terminated prior to
completion of all milestones, the Company may not receive all or even a significant portion of the payments as reimbursements for
expenses incurred as expected under the DoD Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Company has identified material weaknesses in its internal control over financial reporting. If not remediated, the Company&#8217;s
failure to establish and maintain effective disclosure controls and procedures and internal control over financial reporting could
result in material misstatements in its financial statements and a failure to meet its reporting and financial obligations, each
of which could have a material adverse effect on the Company&#8217;s financial condition and the trading price of the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
management has identified material weaknesses in its internal control over financial reporting relating to deficiencies in the principles associated with the control environment, risk assessment, control activities, and monitoring components of internal control, based on the criteria established by the COSO Framework, that constitute material weaknesses, either individually or in the aggregate. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial
reporting, such that there is a reasonable possibility that a material misstatement of a company&#8217;s annual or interim financial
statements will not be prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
discussed in Item 9A, &#8220;Controls and Procedures,&#8221; of this Annual Report on Form 10-K, the Company&#8217;s management
has assessed the effectiveness of its internal control over financial reporting and its disclosure controls and procedures and
concluded that they were not effective as of June 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company is committed to remediating its material weaknesses as promptly as possible. Management is in the process of implementing
its remediation plan. However, there can be no assurance as to when the material weaknesses will be remediated or that additional
material weaknesses will not arise in the future. If the Company is unable to maintain effective internal control over financial
reporting, its ability to record, process and report financial information timely and accurately could be adversely affected,
which could subject the Company to litigation or investigations, require management resources, increase costs, negatively affect
investor confidence and adversely impact the trading price of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
may face litigation and other risks as a result of the material weaknesses in our internal control over financial reporting.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
identified material weaknesses in our internal control over financial reporting that exist as of June 30, 2025. As a result of
such material weaknesses and other matters raised or that may in the future be raised by the SEC or the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">Canadian securities regulators,
we face potential for litigation or other disputes, which may include, among others, claims invoking the federal and state securities
laws, contractual claims or other claims arising from the material weaknesses in our internal control over financial reporting
and the preparation of our financial statements. As of the date of this Annual Report on Form 10-K, we have no knowledge of any
such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future.
Any such litigation or dispute, whether successful or not, could adversely affect our business, financial condition and results
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a020"></span>Risks
Related to Mining and Development</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
face numerous uncertainties in estimating our mineral reserves and resources and inaccuracies in our estimates could result in
lower than expected revenues, higher than expected costs, and decreased profitability.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">A
mineral is economically recoverable when the price at which we may sell the mineral exceeds the costs and expenses of mining and
selling the mineral. Forecasts of our future performance are based on, among other things, estimates of our mineral reserves.
We base our reserve and resource information on engineering, economic, and geological data assembled and analyzed by qualified
persons, which include various engineers and geologists on our staff and with third parties. Our estimates are also subject to
SEC regulations regarding classification of reserves and resources, including S-K 1300. Our reserve and resource estimates as
to both quantity and quality are updated from time to time to reflect additional information received. There are numerous uncertainties
inherent in estimating quantities and qualities of mineral reserves and resources, including many factors beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">Estimates
of mineral reserves and resources necessarily depend upon a number of variable factors and assumptions, any one of which may,
if incorrect, result in an estimate that varies considerably from actual results. These factors and assumptions include, but are
not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">geologic
                                         and mining conditions, which may not be fully identified by available exploration data
                                         and may differ from our experience;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">demand
                                         for the minerals that we plan to produce;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">current
                                         and future market prices for minerals and contractual arrangements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">current
                                         and future operating costs and capital expenditures may exceed estimates, notwithstanding
                                         that, under S-K 1300, operating cost and capital expenditure estimates in feasibility
                                         studies must have an accuracy level of at least &#177;15% and a contingency range not
                                         exceeding 10%;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.75pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">additional
                                         capital expenditure related to the modification of the proposed surface plant related
                                         to the potential addition of rare earth elements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">severance
                                         and excise taxes, royalties and development and reclamation costs;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">future
                                         mining technology improvements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">the
                                         effects of regulation by governmental agencies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">the
                                         ability to obtain, maintain and renew all required permits;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">employee
                                         health and safety; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif">historical
                                         production from the area compared with production from other producing areas.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
conversion of reported mineral resources to mineral reserves should not be assumed, and the reclassification of reported mineral
resources from lower to higher levels of geological confidence should not be assumed. As such, actual mineral tonnage recovered
from identified reserves, and revenues and expenditures with respect to our reserves, may vary materially from estimates. Thus,
these estimates may not accurately reflect our actual reserves. Any material inaccuracy in our estimates related to our reserves
could result in lower than expected revenues, higher than expected costs, or decreased profitability, which could materially and
adversely affect our business, results of operations, financial position, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
nature of mineral exploration and production activities involves a high degree of risk and the possibility of uninsured losses.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Exploration
for and the production of minerals is highly speculative and involves much greater risk than many other businesses. Most exploration
programs do not result in the discovery of mineralization, and any mineralization discovered may not be of sufficient quantity
or quality to be profitably mined. Our operations are, and any future</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">development or mining operations we may conduct will be,
subject to all of the operating hazards and risks normally incident to exploring for and developing mineral properties, such as,
but not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">economically
                                         insufficient mineralized material;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">fluctuation
                                         in production costs that make production uneconomical;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">labor
                                         disputes;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">unanticipated
                                         variations in grade and other geologic problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">environmental
                                         hazards;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">water
                                         conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">difficult
                                         surface or underground conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">industrial
                                         accidents;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">metallurgical,
                                         pyrometallurgical, and other processing problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">mechanical
                                         and equipment performance problems;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">failure
                                         of dams, stockpiles, wastewater transportation systems, or impoundments;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">unusual
                                         or unexpected rock formations; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">personal
                                         injury, fire, flooding, cave-ins, and landslides.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Any
of these risks can materially and adversely affect, among other things, the development of properties, production quantities and
rates, costs and expenditures, potential revenues, and production dates. We currently have very limited insurance to guard against
some of these risks. If we determine that capitalized costs associated with any of our mineral interests are not likely to be
recovered, we would incur a write-down of our investment in these interests. All of these factors may result in losses in relation
to amounts spent that are not recoverable, or that result in additional expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
have no history of producing commercial products from our current mining properties and there can be no assurance that we will
successfully establish mining operations or profitably produce minerals.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
have no history of producing commercial products from our current mining properties. We do not produce commercial products and
do not currently generate operating earnings. While we seek to move our Elk Creek Project from a development stage property to
a production stage property, such efforts will be subject to all of the risks associated with establishing new mining operations
and business enterprises, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                         timing and cost, which are considerable, of the construction of mining and processing
                                         facilities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                         availability and costs of skilled labor and equipment;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">compliance
                                         with environmental and other governmental approval and permit requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                         availability of funds to finance construction and development activities;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">potential
                                         opposition from non-governmental organizations, local groups, or local residents that
                                         may delay or prevent development activities; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">potential
                                         increases in construction and operating costs due to changes in the cost and availability
                                         of labor, fuel, power, materials, and equipment and supplies, and the time elapsed since
                                         the most recent estimates of cost and availability were made.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">It
is common in new mining and processing operations to experience unexpected problems and delays during engineering, procurement,
construction, commissioning, and initial operations. In addition, our management and workforce will need to be expanded, and sufficient
housing and other support systems for our workforce will have to be established. This could result in delays in the commencement
of production and increased costs of production. Accordingly, we cannot assure you that our activities will result in profitable
operations or that we will successfully establish mining and processing operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Results
of metallurgical testing by us may not be favorable to, or as expected by, us.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
have completed significant bench, mini-pilot, and pilot scale metallurgical testing on material from the Elk Creek Project and
will continue to complete necessary metallurgical testing at the bench, mini-pilot, and pilot scale as the exploration and, if
warranted, development of the Elk Creek Project progresses. There can be no assurance that the results of such metallurgical testing
will be favorable to, or will be as expected by, us. Furthermore, there can be no certainty that metallurgical recoveries obtained
in bench or pilot scale tests will be achieved in either subsequent</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">testing or commercial operations. The development of a complete
metallurgical process to produce saleable final products from the Elk Creek Project is a complex and resource-intensive undertaking
that may result in overall schedule delays and increased project costs for us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Price
volatility could have dramatic effects on our results of operations and our ability to obtain financing for the Elk Creek Project
and execute our business plan.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
price of commodities varies on a daily basis. Niobium is a specialty metal and not a commonly traded commodity such as copper,
zinc, gold, or iron ore. The price of niobium tends to be set through a limited long-term offtake market, contracted between very
few suppliers and purchasers. The world&#8217;s largest supplier of niobium, Companhia Brasileira de Metalurgia e Minera&#231;&#227;o,
supplies approximately 85% of the world&#8217;s niobium. Any attempt to suppress the price of niobium by such supplier, or an
increase in production by any supplier in excess of any increased demand, would have negative consequences on the price of niobium
and, potentially, on our value. The price of niobium may also be reduced by the discovery of new niobium deposits, which could
not only increase the overall supply of niobium (causing downward pressure on its price) but could draw new firms into the niobium
industry that would compete with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Sc<sub>2</sub>O<sub>3
</sub>is used in solid oxide fuel cells and has the potential to become a valuable alloy with aluminum in the aerospace and automotive
industries. Supply of scandium has been sporadic in recent years, and there are no primary scandium mines in the world at present.
Production primarily occurs as a by-product from existing metallurgical plants, primarily in Russia, Canada, the Philippines,
and China. Our management believes the Elk Creek Project would significantly increase the world&#8217;s supply of scandium trioxide.
Although the Company&#8217;s market studies indicate a positive outlook for demand, there is no assurance at present that the
Company could sell all of its production. In addition, the sale of scandium represents a significant portion of the Elk Creek
Project revenue; achieving the revenue projected in the Company&#8217;s studies is subject to market growth in scandium, which
is a developing market with a risk of oversupply and/or undersupply disrupting pricing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Titanium
metal is used in various superalloys and other applications for aerospace applications, armor, and medical implants, and in oxide
form is a key component of pigments used in paper, paint, and plastics. The Elk Creek Project would produce a small quantity of
titanium dioxide relative to other producers. As a small producer, we would be subject to fluctuations in the price of TiO<sub>2
</sub>that would result from normal variations in supply and demand for this commodity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
addition, the niobium, scandium, titanium, and potentially, rare earth products, that we intend to produce at the Elk Creek Project
are also subject to additional commodity-specific price cycles resulting from, among other factors, export controls, taxes and
other tariffs and fees. Volatility in the demand for, and prices of, the niobium, scandium, titanium, and potentially, rare earth
products, that we intend to produce at the Elk Creek Project may adversely affect the overall value of the Elk Creek Project and
impact our ability to obtain financing for the Elk Creek Project on acceptable terms, or at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
may not be able to establish a viable recovery process for REEs<span style="font-style: normal">. </span></span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
market for rare earth products requires particular levels of purity and chemical form, which are achieved through the extraction
and separation of individual REEs from each other as well as from the other constituents in the rare earth ore. At present, the
Company has substantially completed the engineering and testing of a process for producing commercial rare earth products but
has not completed all work necessary to declare a REE reserve estimate for the Elk Creek deposit. The completion of the work necessary
to demonstrate an economically feasible rare earth recovery system will require additional expenditures of cash and time to complete.
There is no guarantee that the Company will be successful in demonstrating positive economics for a rare earth recovery system
tied to the Elk Creek Project, nor is there any guarantee that once constructed, the rare earth recovery system will operate as
designed and produce saleable commercial products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Estimates
of resources and reserves are subject to evaluation uncertainties that could result in project failure.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
exploration and future mining operations, if any, are and would be faced with risks associated with being able to accurately predict
the quantity and quality of resources/reserves within the earth using statistical sampling techniques. Estimates of any resources/reserves
on any of our properties would be made using samples obtained from</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">appropriately placed trenches, test pits, underground workings,
and intelligently designed drilling. There is an inherent variability of assays between check and duplicate samples taken adjacent
to each other and between sampling points that cannot be reasonably eliminated. Additionally, there also may be unknown geologic
details that have not been identified or correctly appreciated at the current level of accumulated knowledge about our properties.
This could result in uncertainties that cannot be reasonably eliminated from the process of estimating resources/reserves. If
these estimates were to prove to be unreliable, we could implement an exploitation plan that may not lead to commercially viable
operations in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Any
material changes in mineral resource/reserve estimates and grades of mineralization will affect the economic viability of placing
a property into production and a property&#8217;s return on capital.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Mineral
resource/reserve estimates may require adjustments or downward revisions. In addition, the grade of ore ultimately mined, if any,
may differ from that indicated by our feasibility studies and drill results. Minerals recovered in small scale tests may not be
duplicated in large scale tests under on-site conditions or at commercial production scale.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
mineral resource and mineral reserve estimates included in the S-K 1300 Elk Creek Technical Report Summary and contained in this
Annual Report on Form 10-K have been determined based on assumed future prices, cut-off grades, and operating costs that may prove
to be inaccurate. Extended declines in market prices for our products may render portions of our resource/reserve estimates uneconomic
and may result in reduced reported resources/reserves or may adversely affect any commercial viability determinations we may reach.
Any material reductions in estimates of resources/reserves could have a material adverse effect on our Common Share price and
on the value of our properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We
face intense competition in the mining industry.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
mining industry is intensely competitive in all of its phases, and we compete with other companies for capital. As a result of
this competition, some of which is with large established mining companies with substantial capabilities and with greater financial
and technical resources than ours, we may be unable to obtain financing for the Elk Creek Project on terms we consider acceptable,
or at all, or to acquire and develop additional properties in the future. In addition, we compete with others in efforts to obtain
resources to advance the Elk Creek Project to construction and commercial operation, including mining and processing equipment,
as well as qualified managerial and technical employees. If we are unable to successfully compete for required resources, including
qualified employees, we may have difficulty in advancing the Elk Creek Project to construction and commercial operation. In addition,
in competing for qualified personnel, we may be required to pay compensation or benefits relatively higher than those paid in
the past, and the availability of qualified personnel may be limited in high-demand periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Difficulties
in water balance management at our Elk Creek Project could negatively affect our potential production and economics at the project.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company has conducted three field investigations and two major technical studies into the hydrogeology of the Elk Creek carbonatite,
which is the geologic formation which hosts the mineralized material that would be extracted by the Company&#8217;s mining operations.
The Company expects to encounter significant amounts of water in the carbonatite, which will need to be pumped out of the formation
to facilitate a mining operation. Water quality analyses have demonstrated that this water will have elevated temperature and
salt content when compared to other water resources in the area. While the Company has developed plans to treat water produced
from the mine for use in its operations, there is no guarantee that the permits needed for the treatment of the water or the disposal
of the resultant waste products will be issued by the State of Nebraska, nor is there any guarantee that such permits will be
issued in a timely fashion. Further, based on such plans, the operations will rely on a water treatment system to achieve zero
discharge of wastewater, and there is no guarantee that this system will function as designed or achieve nameplate treatment capacity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Title
to our properties may be subject to other claims that could affect our property rights and claims.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">There
are risks that title to our properties may be challenged or impugned. Our Elk Creek Project is located in Nebraska and may be
subject to prior unrecorded agreements or transfers or native land claims, and title may be affected by undetected defects. Our
current land and/or mineral rights lease agreements between ECRC and individual</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">landowners give us an option to purchase additional
property (&#8220;OTP&#8221;), which, along with the property we already own, will allow us to construct the Elk Creek Project
once sufficient project financing is obtained. The rights of the current owners to sell the property subject to these options
may be subject to prior unrecorded or unknown claims to title. Further, our current OTP agreements, some of which are important
for our planned operations, are of fixed duration and expire between December 2029 and May 2040, and we may incur additional cost
and delays in securing renewals of such OTPs. We have investigated our rights to explore and exploit the Elk Creek Project resource/reserve
and, to the best of our knowledge, our rights in relation to lands covering the Elk Creek Project resource/reserve are in good
standing. However, there may be valid challenges to the title of our properties that, if successful, could impair development
and/or operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our
properties and operations may be subject to litigation or other claims.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">From
time to time our properties or operations may be subject to disputes that may result in litigation or other legal claims. We may
be required to assert or defend against these claims, which will divert resources and management time from operations. The costs
of these claims or adverse filings may have a material effect on our business and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
do not currently insure against all the risks and hazards of mineral exploration, development, and mining operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Exploration,
development, mining, and surface operations involve various hazards, including environmental hazards, industrial accidents, metallurgical
and other processing problems, unusual or unexpected rock formations, structural cave-ins or slides, flooding, fires, and periodic
interruptions due to inclement or hazardous weather conditions. These risks could result in damage to or destruction of mineral
properties, facilities, or other property, personal injury, environmental damage, delays in operations, increased cost of operations,
monetary losses, and possible legal liability. We may not be able to obtain insurance to cover these risks at economically feasible
premiums or at all. We may elect not to insure where premium costs are disproportionate to our perception of the relevant risks.
The payment of such insurance premiums and of such liabilities would reduce the funds available for exploration and production
activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a021"></span>Risks
Related to Government Regulation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
may not be able to obtain or renew all required permits and licenses to place any of our properties into production.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
current and future operations, including development activities and commencement of production, if warranted, on the Elk Creek
Project, require permits from governmental authorities and such operations are and will be governed by laws and regulations governing
prospecting, development, mining, production, exports, taxes, labor standards, occupational health, waste disposal, toxic substances,
land use, environmental protection, mine safety, and other matters. Companies engaged in mineral property exploration and the
development or operation of mines and related facilities generally experience increased costs, as well as delays in production
and other schedules as a result of the need to comply with applicable laws, regulations, and permits. We cannot predict if all
permits that we may require for continued exploration, development, or construction of mining facilities and conduct of mining
operations will be obtainable or renewable on reasonable terms, if at all. Costs related to applying for and obtaining permits
and licenses may be prohibitive and could delay our planned exploration and development activities. Failure to comply with applicable
laws, regulations, and permitting requirements may result in enforcement actions, including orders issued by regulatory or judicial
authorities causing operations to cease or be curtailed, and may include corrective measures requiring capital expenditures, installation
of additional equipment, or remedial actions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Facilities
associated with the Elk Creek Project, such as the mine, surface plant, tailings facilities, stockpiles and supporting infrastructure,
are likely to either temporarily or permanently impact waterbodies and wetlands that are subject to regulation by the USACE as
Waters of the United States (&#8220;WOUS&#8221;). We believe that we have obtained the necessary USACE permits to construct the
project, but changes to the design or layout of the facility may trigger the USACE to require us to obtain and maintain additional
permits for the Elk Creek Project. The duration of this permitting exercise is dictated by the USACE and would need to be completed
before facilities that would impact WOUS could be constructed. We may experience delays or additional costs in relation to obtaining
the necessary permits and these delays and additional costs could negatively affect the economics of the Elk Creek Project and
our results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Parties
engaged in mining operations may be required to compensate those suffering loss or damage by reason of the mining activities and
may have civil or criminal fines or penalties imposed for violations of applicable laws or regulations. Amendments to current
laws, regulations, and permits governing operations and activities of mining companies, or more stringent implementation thereof,
could have a material adverse impact on our operations and cause increases in capital expenditures or production costs or reduction
in levels of production at producing properties or require abandonment or delays in development of new mining properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
are subject to significant governmental regulations that affect our operations and costs of conducting our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
current and future operations, including development of the Elk Creek Project, are and will be governed by laws and regulations,
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">laws
                                         and regulations governing mineral concession acquisition, prospecting, development, mining,
                                         and production;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">laws
                                         and regulations related to exports, taxes, and fees;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">labor
                                         standards and regulations related to occupational health and mine safety; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">environmental
                                         standards and regulations related to waste disposal, toxic substances, land use reclamation,
                                         and environmental protection.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Companies
engaged in development activities often experience increased costs and delays in production and other schedules as a result of
the need to comply with applicable laws, regulations, and permits. Failure to comply with applicable laws, regulations, and permits
may result in enforcement actions, including the forfeiture of mineral claims or other mineral tenures and/or orders issued by
regulatory or judicial authorities requiring operations to cease or be curtailed, and may include corrective measures requiring
capital expenditures, installation of additional equipment, or costly remedial actions. We may be required to compensate those
suffering loss or damage by reason of our development activities and may have civil or criminal fines or penalties imposed for
violations of such laws, regulations, and permits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Existing
and possible future laws, regulations, and permits governing operations and activities of mineral development companies, or more
stringent implementation, could have a material adverse impact on our business and cause increases in capital expenditures or
require abandonment or delays in development. Our Elk Creek Project is located in Nebraska, and while the State does have a comprehensive
and modern set of environmental regulations, it does not have specific regulations with respect to permitting or reclaiming mines
which could potentially impact the total time to market for the project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our
activities are subject to environmental laws and regulations that may change, thereby increasing our costs of doing business and
restricting our operations.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">All
phases of our operations are subject to environmental regulation in the jurisdictions in which we operate. Environmental legislation
is evolving in a manner that may require stricter standards and enforcement, increased fines and penalties for non-compliance,
more stringent environmental assessments of proposed projects, and a heightened degree of responsibility for companies and their
officers, directors, and employees. These laws address emissions into the air, discharges into water, management of waste, management
of hazardous substances, protection of natural resources, antiquities and endangered species, and reclamation of lands disturbed
by mining operations. Compliance with environmental laws and regulations, and future changes in these laws and regulations, may
require significant capital outlays and may cause material changes or delays in our operations and future activities. It is possible
that future changes in these laws or regulations could have a significant adverse impact on our properties or some portion of
our business, causing us to re-evaluate those activities at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Regulations
and pending legislation governing issues involving climate change could result in increased operating costs, which could have
a material adverse effect on our business.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">A
number of governments or governmental bodies have introduced or are contemplating legislative and/or regulatory changes in response
to concerns about the potential impact of climate change. Legislation and increased regulation regarding climate change could
impose significant costs on us, on our future venture partners, if any, and on our suppliers, including costs related to increased
energy requirements, capital equipment, environmental monitoring and reporting, and other costs necessary to comply with such
regulations. Any adopted future climate change regulations could also negatively impact our ability to compete with companies
situated in areas not subject to such limitations. Given the emotion, political significance, and uncertainty surrounding the
impact of climate change and how it should be dealt with, we cannot predict how legislation and regulation will affect our financial
condition, operating performance, and ability to compete. Furthermore, even without such regulation, increased awareness and any
adverse publicity in the global marketplace about potential impacts on climate change by us or other companies in our industry
could harm our reputation. The potential physical impacts of climate change on our operations are highly uncertain and could be
particular to the geographic circumstances in areas in which we operate and may include changes in rainfall and storm patterns
and intensities, water shortages, changing sea levels, and changing temperatures. These impacts may adversely impact the cost,
production, and financial performance of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Land
reclamation requirements for our properties may be burdensome and expensive.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Although
variable depending on location and the governing authority, land reclamation requirements are generally imposed on mineral exploration
companies (as well as companies with mining operations) in order to minimize long-term effects of land disturbance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Reclamation
may include requirements to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">control
                                         dispersion of potentially deleterious effluents;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">treat
                                         ground and surface water to achieve water quality standards; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">reasonably
                                         re-establish pre-disturbance landforms and vegetation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
order to carry out reclamation obligations imposed on us in connection with our potential development activities, we must allocate
financial resources that might otherwise be spent on further exploration and development programs. We plan to set up a provision
for our reclamation obligations on our properties, as appropriate, but this provision may not be adequate. If we are required
to carry out unanticipated reclamation work, our financial position could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a022"></span>Risks
Related to Our Debt</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The
level of our indebtedness from time to time could impair our ability to obtain additional financing.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">From
time to time, we may enter into transactions to acquire assets or the shares of other companies or to fund development of the
Elk Creek Project. These transactions may be financed partially or wholly with debt, which may increase our debt levels above
industry standards. Our articles of incorporation do not limit the amount of indebtedness that we may incur. Our indebtedness
could impair our ability to obtain additional financing in the future on a timely basis to take advantage of business opportunities
that may arise. Our ability to service our debt obligations will depend on our future operations, which are subject to prevailing
industry conditions and other factors, many of which are beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><span id="a023"></span>Risks
Related to the Common Shares</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b><i>NioCorp
may be a &#8220;passive foreign investment company&#8221; for the current taxable year and for one or more future taxable years,
which may result in materially adverse U.S. federal income tax consequences for U.S. investors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">If
NioCorp is a passive foreign investment company (&#8220;PFIC&#8221;) for any taxable year, or portion thereof, that is included
in the holding period of a U.S. holder of Common Shares or other securities of NioCorp, such U.S. holder</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">may be subject to certain
adverse U.S. federal income tax consequences. These adverse tax consequences include requirements to treat any gain realized upon
a disposition of Common Shares or other securities, or any &#8220;excess distribution&#8221; received on Common Shares, as ordinary
income, to pay an interest charge on a portion of such gain or distribution, and certain additional reporting requirements. Such
consequences may be mitigated with respect to Common Shares (but not with respect to Warrants or other securities of NioCorp)
if the holder thereof makes a timely and effective &#8220;qualified electing fund&#8221; or &#8220;QEF&#8221; election or a &#8220;mark-to-market&#8221;
election. A U.S. holder of Common Shares that makes a QEF election generally must include in income on a current basis for U.S.
federal income tax purposes its share of NioCorp&#8217;s net capital gain and ordinary earnings for any taxable year in which
it is a PFIC, whether or not NioCorp distributes any amount to its shareholders. A U.S. holder of Common Shares that makes a mark-to-market
election generally must include as ordinary income each year the excess of the fair market value of the Common Shares over the
taxpayer&#8217;s basis therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">NioCorp
generally will be classified as a PFIC for a taxable year if (a) 75% or more of its gross income for such year is &#8220;passive
income&#8221; (generally, dividends, interest, rents, royalties, and gains from the disposition of assets producing passive income)
or (b) at least 50% or more of the value of its assets produce, or are held for the production of, passive income, based on the
quarterly average of the fair market value of such assets. NioCorp believes that it was classified as a PFIC for its taxable years
ended June 30, 2025 and 2024 and, based on the current composition of its income and assets, as well as current business plans
and financial expectations, may be classified as a PFIC for its current or future taxable years. Any conclusion regarding PFIC
status is a factual determination that must be made annually at the close of each taxable year and, thus, is subject to change.
In addition, even if NioCorp concluded it did not qualify as a PFIC, it is possible that the U.S. Internal Revenue Service (the
&#8220;IRS&#8221;) could assert, and that a court could sustain, a determination that NioCorp is a PFIC. Accordingly, there can
be no assurance that NioCorp will not be treated as a PFIC for any taxable year. The PFIC rules are complex and each holder of
Common Shares or other securities of NioCorp should consult its own tax advisors regarding these rules and the U.S. federal income
tax consequences of the acquisition, ownership, and disposition of such securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>The
2023 Transactions could result in NioCorp becoming subject to materially adverse U.S. federal income tax consequences.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Section
7874 and related sections of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), provide for certain
adverse tax consequences when the stock of a U.S. corporation is acquired by a non-U.S. corporation in certain transactions in
which former shareholders of the U.S. corporation come to own 60% or more of the stock of the non-U.S. corporation (by vote or
value, and applying certain specific counting and ownership rules). These adverse tax consequences include (i) potential additional
required gain recognition by the U.S. corporation, (ii) treatment of certain payments to the non-U.S. corporation that reduce
gross income as &#8220;base erosion payments,&#8221; (iii) an excise tax on certain options and stock-based compensation of the
U.S. corporation, (iv) disallowance of &#8220;qualified dividend&#8221; treatment for distributions by the non-U.S. corporation,
and (v) if former shareholders of the U.S. corporation come to own 80% or more of the stock of the non-U.S. corporation, treatment
of the non-U.S. corporation as a U.S. corporation subject to U.S. federal income tax on its worldwide income (in addition to any
tax imposed by non-U.S. jurisdictions). If the 2023 Transactions result in the application of any of these, or any other, adverse
tax consequences, NioCorp could incur significant additional tax costs. While NioCorp currently does not believe the 2023 Transactions
will cause such adverse tax consequences as a result of Section 7874 and related sections of the Code, this determination is subject
to significant legal and factual uncertainty. NioCorp has not sought and will not seek any rulings from the IRS as to the tax
treatment of any of the 2023 Transactions. Further, there can be no assurance that your tax advisor, the IRS, or a court, will
agree with the position that NioCorp is not subject to these adverse tax consequences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Our
Common Share price may be volatile and as a result you could lose all or part of your investment.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
addition to volatility associated with equity securities in general, the value of your investment could decline due to the impact
of any of the following factors upon the market price of the Common Shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">disappointing
                                         results from our exploration and/or, if warranted, project development efforts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">decline
                                         in demand for Common Shares;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">downward
                                         revisions in securities analysts&#8217; estimates or changes in general market conditions;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">technological
                                         innovations by competitors or in competing technologies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">investor
                                         perception of our industry or our prospects; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">general
                                         economic trends.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">From July 1, 2024, to the date of this report, the trading price of our stock on the Nasdaq has ranged from a low of $1.27 to a high of $5.19.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
addition, stock markets in general have experienced extreme price and volume fluctuations, and the market prices of securities
have been highly volatile. These fluctuations are often unrelated to operating performance and may adversely affect the market
price of the Common Shares. As a result, you may be unable to sell any Common Shares you acquire at a desired price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">We
have never paid dividends on the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
have not paid dividends on the Common Shares to date, and we may not be in a position to pay dividends for the foreseeable future.
Our ability to pay dividends with respect to the Common Shares will depend on our ability to successfully develop one or more
properties and generate earnings from operations. Further, our initial earnings, if any, will likely be retained to finance our
operations. Any future dividends on Common Shares will depend upon our earnings, our then-existing financial requirements, and
other factors, and will be at the discretion of our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Future
sales, or the perception of future sales, of Common Shares by existing shareholders or by us, or future dilutive issuances of
Common Shares by us, could adversely affect prevailing market prices for the Common Shares and cause investors to suffer dilution
in their net book value per Common Share.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Sales
of a substantial number of Common Shares in the public market could occur at any time, including issuances and sales of additional
Common Shares by us and sales by other security holders. These sales, or the market perception that the holders of a large number
of Common Shares or securities convertible, exercisable, or exchangeable into Common Shares intend to sell Common Shares, could
reduce the prevailing market price of the Common Shares. The effect, if any, that future public sales of these securities or the
availability of these securities for sale will have on the market price of the Common Shares is uncertain. If the market price
of the Common Shares were to drop as a result, this might impede our ability to raise additional capital and might cause remaining
shareholders to lose all or part of their investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Articles of NioCorp, as amended, permit us to issue an unlimited number of Common Shares. Subject to the requirements of the British
Columbia Business Corporations Act and Nasdaq, we will not be required to obtain the approval of the NioCorp shareholders for
the issuance of additional Common Shares. We have issued Common Shares in the past and will continue to issue Common Shares to
finance our activities in the future. In addition, outstanding Options and Warrants and securities convertible into or exchangeable
for Common Shares may be exercised, converted, or exchanged resulting in the issuance of additional Common Shares. If we issue
additional Common Shares or decide to enter into joint ventures with other parties in order to raise financing through the sale
of equity securities, investors&#8217; interests in the Company will be diluted and investors may suffer dilution in their net
book value per Common Share depending on the price at which such securities are sold.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Additionally,
pursuant to the Yorkville Equity Facility Financing Agreement, Yorkville has committed to purchase up to an additional $46.9 million
of our Common Shares, at our direction from time to time during the remaining seven months of the commitment period, subject to
certain limitations and the satisfaction of the conditions in the Yorkville Equity Facility Financing Agreement. We have filed
a registration statement under the Securities Act covering resales by Yorkville of the Common Shares issuable pursuant to the
Yorkville Equity Facility Financing Agreement. Accordingly, any Common Shares that we issue pursuant to the Yorkville Equity Facility
Financing Agreement will be available for sale into the public market, subject to applicable securities laws, which could reduce
the prevailing market price for the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
are subject to the continued listing criteria of the Nasdaq and our failure to satisfy these criteria may result in delisting
of the Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
Common Shares are currently listed on the Nasdaq Global Market under the symbol &#8220;NB&#8221;. The public NioCorp Assumed Warrants
are currently listed on Nasdaq under the symbol &#8220;NIOBW.&#8221; The Nasdaq Capital Market</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif">has rules for continued listing.
In order to maintain the listings, we must maintain certain financial and share distribution targets, including maintaining a
minimum number of public shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">If
Nasdaq delists the Common Shares, investors may face material adverse consequences, including, but not limited to, a lack of a
trading market for the Common Shares, reduced liquidity, a determination that our Common Shares are a &#8220;penny stock,&#8221;
decreased analyst coverage of the Company, and an inability for us to obtain additional financing to fund our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
our Common Shares are considered a penny stock and are subject to the penny stock rules, broker-dealers may be discouraged from
effecting transactions in Common Shares.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
Common Shares have in the past, and may in the future, be considered a &#8220;penny stock.&#8221; The SEC has adopted Rule 15g-9
which generally defines &#8220;penny stock&#8221; to be any equity security that has a market price (as defined) less than $5.00
per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Applicable penny stock rules impose
additional sales practice requirements on broker-dealers who sell to persons other than established customers and &#8220;accredited
investors.&#8221; The term &#8220;accredited investor&#8221; refers generally to institutions with assets in excess of $5.0 million
or individuals with a net worth in excess of $1.0 million or annual income exceeding $200,000 or $300,000, jointly with their
spouse. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules,
to deliver a standardized risk disclosure document in a form prepared by the SEC, which provides information about penny stocks
and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid
and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly
account statements showing the market value of each penny stock held in the customer&#8217;s account. The bid and offer quotations,
and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting
the transaction and must be given to the customer in writing before or with the customer&#8217;s confirmation. In addition, the
penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer
must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser&#8217;s
written agreement to the transaction. If and when applicable, these disclosure requirements may have the effect of reducing the
level of trading activity in the secondary market for the Common Shares. Consequently, these penny stock rules may affect the
ability of broker-dealers to trade in the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.0035in"/><td style="width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif">ITEM 1B.</span></td><td><span style="font-family: Times New Roman, Times, Serif"><span id="a024"></span>UNRESOLVED
                                         STAFF COMMENTS</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.0035in"/><td style="width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif">ITEM 1C.</span></td><td><span style="font-family: Times New Roman, Times, Serif"><span id="a025"></span>CYBERSECURITY</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<div id="xdx_981_ecyd--CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_iB_c20240701__20250630_zkeDKgwru80f" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000047" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Cybersecurity
risk management is <span id="xdx_906_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240701__20250630_zzvfcTvSgOPc" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000048" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag">integrated</ix:nonNumeric></span> into the Company&#8217;s enterprise-wide risk management. <span id="xdx_905_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240701__20250630_zzBvnsiCi2g3" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000049" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock">Our Board has overall oversight responsibility
for our risk management and management is responsible for identifying, considering, and assessing material risks to the Company.
Our Chief Financial Officer is responsible for assessing and managing cybersecurity risks</ix:nonNumeric></span>; however, as a smaller reporting company,
we currently do not have a dedicated cybersecurity team. Our Chief Financial Officer reports to the Board regarding financial
and operating risks, including cybersecurity risks. Our Chief Financial Officer has experience in managing public companies and
assessing financial and operating risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240701__20250630_zY1yw6Uqqc27" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000050" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">Our
cybersecurity risk management is designed to provide a framework for assessing, identifying, and managing material risks from
cybersecurity threats and to respond to cybersecurity incidents, including material risks associated with the use of services
provided by <span id="xdx_903_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240701__20250630_zaGSeNvtLRYe" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact000051" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag">third-party service providers</ix:nonNumeric></span>. We rely on the cybersecurity protections of many of our third-party service providers.
Our primary third-party service providers utilize two-factor authentication as well as login and password protections with email
verifications.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
are in the process of evaluating our cybersecurity needs and developing appropriate measures to enhance our cybersecurity posture.
Our goal is to establish a cybersecurity framework that is commensurate with our size, complexity, and nature of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_gIFCRMAORLTMA-EYWBMY_zwkZRvxSf94i" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" continuedAt="ConU000053-01" escape="true" id="Fact000053" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">For
the year ended June 30, 2025, the Company had <span id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240701__20250630_zyBQEttKdXC6" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact000054" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">no material cybersecurity incidents</ix:nonNumeric></span> or threats that have materially affected or
were reasonably likely to materially affect our business strategy, results of operations or</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<ix:exclude><!-- Field: Page; Sequence: 35; Value: 1 -->
    <div id="xdx_23C_zX7J1kj12Oea" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div id="xdx_23F_zRbmIiujuAM9" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zPBilWmQOt9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_C00_gIFCRMAORLTMA-EYWBMY_zFzSX3gs5OPk"><ix:continuation id="ConU000053-01">
financial condition. Despite our efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances that we
have not experienced an undetected cybersecurity incident.</ix:continuation></span> As previously disclosed, on February 14, 2025, we became aware of
unauthorized third-party access to our information systems, including portions of its email systems, that resulted in misdirected
vendor payments. To date, the Cybersecurity Incident has not had a material impact on our business operations or financial
condition.</span></p>

</ix:nonNumeric></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.0035in"/><td style="width: 0.7465in"><span style="font-family: Times New Roman, Times, Serif">ITEM 2.</span></td><td><span style="font-family: Times New Roman, Times, Serif"><span id="a026"></span>PROPERTIES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Elk
Creek Project, Nebraska </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
principal mineral property is the Elk Creek Property, a niobium, scandium and titanium development stage property. The Elk Creek
Project has established indicated and inferred resources along with probable reserves and the Company has completed a feasibility
study for the project. The below information is in part summarized or extracted from our S-K 1300 Elk Creek Technical Report Summary,
which was filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022, and
is incorporated by reference into this Annual Report on Form 10-K. The Company does not have any other material properties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in">The
qualified persons responsible for the S-K 1300 Elk Creek Technical Report Summary are Dahrouge Geological Consulting USA
Ltd.; Understood Mineral Resources Ltd.; Optimize Group; Tetra Tech; Adrian Brown Consultants Inc.; Metallurgy Concept
Solutions; Magemi Mining Inc.; L3 Process Development; A2GC; Scott Honan, M.Sc, SME-RM, NioCorp; Dumas Contracting Ltd.; Mahmood
Khwaja, P.E., CDM Smith; and Wynand Marx, M.Eng, BBE Consulting. A matrix of the sections for which each qualified person is
responsible is included in the S-K 1300 Elk Creek Technical Report Summary, except that Dumas Contracting Ltd., as evidenced by its
consent filed as Exhibit 23.14 to this Annual Report on Form 10-K has reviewed, approved, and taken responsibility for
Sections 13.7.1, 13.7.2, 13.7.3, 13.7.4, 13.7.9, 13.7.10, 13.7.11, 13.7.12, 13.7.13, 13.7.14, 15.1.3, 15.1.4 and 23.1.8 of
the S-K 1300 Elk Creek Technical Report Summary. Except for Scott Honan, none of the qualified persons is affiliated with the
Company. Mr. Honan is the Chief Operating Officer of the Company. The disclosure of scientific or technical information in
this Annual Report on Form 10-K was reviewed and approved by Mr. Honan who is a qualified person as defined in NI 43-101, and
Mr. Honan has verified the data disclosed herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Property
Description and Location</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Elk Creek Property is a carbonatite deposit located in Johnson County, southeast Nebraska, USA. The carbonatite contains elements
of economic significance, including niobium, titanium, and scandium, as well as potential economic significance for rare earth
products. The Elk Creek Property is situated as shown below and is located within the USGS Tecumseh Quadrangle Nebraska SE (7.5
minute series) mapsheet in Sections 1-6, 9-11; Township 3N; Range 11E and Sections 19-23, 25-36; Township 4N, Range 11E, at approximately
40&#176;16&#8217; north and 96&#176;11&#8217; west in the State of Nebraska, in central USA. The Elk Creek Property is approximately
45 miles southeast of Lincoln, Nebraska, the state capital of Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in; color: Red"><img src="n257410kimg002.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in; color: Red"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Title
and Ownership</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Land
in the project area is exclusively owned by private entities, and there is no federal or state land in the project area. The Company
has secured its rights to the project area by purchasing land from private landowners or by entering into agreements with the
landowners as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company currently owns approximately 227 acres of land and associated mineral rights, and an additional 80 acres of surface rights
and 40 acres of mineral rights, all within the carbonatite footprint. The Elk Creek Project&#8217;s mine infrastructure and a
portion of the supporting operations is planned to be located on this land. Ownership of the mineral rights discussed above includes
a 2% NSR royalty and grants us access to more than 90% of the Elk Creek Project&#8217;s mineral resources and mineral reserves.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of June 30, 2025, the total book value of the Elk Creek Property and associated buildings and equipment was $16.9 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
August 1, 2025, ECRC closed on its option to purchase three parcels of land in the project area, consisting of the property known
as Woltemath80S and approximately 1.66 acres of the property known as Woltemath002, for an aggregate purchase price of approximately
$2.7 million, pursuant to the terms of two OTPs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company currently holds six OTPs that are associated with the Elk Creek Project and one perpetual easement on a land parcel adjacent
to the Missouri River. The current optioned land package covers an area of 1,272 acres and is reflective of the land needed to
secure the remaining mineral resources and mineral reserves held under the OTPs along with the land needed for the development
and operations of the Elk Creek Project for its proposed 38-year operating life.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
general, exercise of an OTP is accomplished by paying the greater of a fixed amount per acre or a multiple of the appraised value
at the time of purchase. If the land is not purchased by the Company during the term of the OTP and the land in question is needed
for the project, the Company intends to negotiate a new OTP with the landowner. The OTP is accompanied by a negotiated payment
to the landowner that is paid upon execution of the OTP by the Company and the landowner. As of June 30, 2025, the Company was
obligated to make payments totaling approximately $101,000 over the next 15 years to maintain our rights under these OTPs. Details
on the current OTPs held by the Company are shown in the table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Active
Lease Agreements (OTPs) Covering the Elk Creek Project as of September 2025</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border: Black 1pt solid; width: 47%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreement
    Identifier</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Acres</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 33%; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agreement
    Expiry</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath002</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">375.15</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">04-Dec-29</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heidemann005</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">196.57</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16-Mar-30</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nielsen001</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249.32</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Jun-30</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath003J</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">220.00</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Mar-30</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beethe007</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163.75</span></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-Jan-31</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shuey001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-top: 0.75pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27-May-40</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
OTPs are between NioCorp&#8217;s subsidiary ECRC and the individual landowners. Land subject to the OTP agreements is currently
used for agricultural purposes, including growing row crops (corn and soybeans) and pasturing livestock. The land owned by ECRC
houses the Company&#8217;s drill core inventory and geological sample repository in two steel core shed buildings and the Company
maintains a cover crop (sorghum and rye) on portions of the property that were formerly used for growing row crops. The former
landowner maintains a residence and several outbuildings on the property subject to a life estate that accompanied the purchase
of the property by the Company in fiscal year 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
agreements that involve mineral rights include a 2% NSR royalty attached with the OTP. The OTPs grant the Company an exclusive
right to explore and evaluate the property for the term thereof, with an option to purchase the surface rights or a combination
of the mineral and surface rights at any time during the term. As the Woltemath80S agreement was limited to an option to purchase
the surface rights only, it does not contain an NSR provision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Land
Tenure Map as of September 2025</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><img src="n257410kimg003.jpg" alt=""/></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
current estimated mineral resource and reserve is wholly contained within land owned by the Company and parcel Woltemath003J.
The Company considers these two properties to be the only properties on which the Company&#8217;s development of the Elk Creek
Project is substantially dependent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
part of the OTPs, where required, the Company has also secured surface rights, which allow for access to the land for drilling
activities and associated mineral exploration and project development work.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accessibility,
Physiography, Climate and Infrastructure</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property is easily accessible year-round as it is situated approximately 45 miles southeast of Lincoln, Nebraska, the
state capital, and approximately 68 miles south of Omaha, Nebraska. Access to the site can be completed via road or from one of
the regional airports. There are several regular flights to both Lincoln and Omaha; however, the Elk Creek Property is most easily
accessible from Lincoln. From Lincoln Municipal Airport, the Elk Creek Property is accessed via paved roads on the main network
and a secondary network of gravel roads. The drive from the Lincoln Municipal Airport to the property is typically 1 hour and
15 minutes, and from Omaha&#8217;s Eppley Airport, the drive is approximately 1 hour and 45 minutes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property is immediately adjacent to paved Nebraska state highway 50, and the mineral resource and mineral reserve are
centered in Township 4N, Range 11E, Section 33. This section is immediately southwest of the junction of Nebraska state highways
50 and 62. Rail access is available in the town of Elk Creek, which is located 3 miles east of the project area. Water is available
at the project site from a well, as well as from Elk Creek, which crosses Section 33. Water is also available from the Johnson
County Rural Water system, which has distribution infrastructure on the north side of the Section 33 and from the Pawnee County
Rural Water system, which has distribution infrastructure on the south side of Section 33. Electricity is provided at the Company&#8217;s
Core Storage sheds located on the west side of Section 33 on land owned by the Company from the Omaha Public Power District (&#8220;OPPD&#8221;).
Personnel are available from the local surrounding towns, including Elk Creek (3 miles east), Tecumseh (6 miles north), Steinauer
(5 miles south), Pawnee City (10 miles south) and Syracuse (27 miles north). Due to the project&#8217;s location in Nebraska,
there are no ports nearby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Southeast
Nebraska is situated in a humid continental climate (Dfa) on the K&#246;ppen climate classification system. In eastern Nebraska,
this climate is generally characterized by hot humid summers and cold winters. Average winter temperatures vary between 13&#176;F
to 35&#176;F. Average summer temperatures vary between 64&#176;F to 90&#176;F. Exploration, construction and operational activities
may be conducted all year round.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
monthly precipitation (rain and snowfall) varies between 0.9 and 5.0 inches. Average yearly precipitation is between 31 and 33
inches with an average yearly snowfall of approximately 28 inches. Nebraska is located within an area known for tornadoes which
runs through the central U.S. where thunderstorms are common in the spring and summer months. Tornadoes primarily occur during
the spring and summer and may occur into the autumn months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are several local communities near the Elk Creek Property, including Elk Creek and Tecumseh, that will provide local housing for
the Elk Creek Project. There are a number of other communities within driving distance and the large cities of Lincoln and Omaha
are within reasonable driving distance. Mining activities currently taking place in the area are limited to limestone and aggregate
operations to support the local cement manufacturing and construction industries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is expected to incorporate surface and underground infrastructure, as well as tailings storage facilities. The
offsite infrastructure is expected to include a new high voltage transmission line constructed by the local utility company and
providing power to an on-site primary sub-station and a natural gas pipeline built by the owner of the interstate pipeline. Water
used for all on-site process needs and activities will be supplied from mine dewatering activities, local groundwater wells and
from a local water utility. See &#8220;<i>2022 Elk Creek Feasibility Study</i>&#8221; below for additional information regarding
proposed infrastructure related to the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
local topography of eastern Nebraska is relatively low-relief with shallow rolling hills intersected by shallow river valleys.
Elevation varies from about 1,066 to 1,280 ft above sea level. Bedrock outcrop exposure is nonexistent in the Elk Creek Project
area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
majority of the area around the Elk Creek Project is used for cultivation of corn and soybeans, along with uses as grazing land.
Native vegetation typical of eastern Nebraska is upland tall-grass, prairie and upland deciduous forests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Geology
and Mineralization</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Geology</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Property includes a carbonatite that has intruded older Precambrian granitic and low- to medium-grade metamorphic basement
rocks. The carbonatite is an elliptical magmatic body with a northwest-trending long axis perpendicular to the strike of the Midcontinent
Rift System, near the northern part of the Nemaha uplift. The carbonatite consists predominantly of dolomite, calcite and ankerite,
with lesser chlorite, barite, phlogopite, pyrochlore, serpentine, fluorite, sulfides, bastnasite, monazite, and quartz. It is,
however, believed from stratigraphic reconstruction based on drill core observation in the area that the carbonatite is unconformably
overlain by approximately 200 m of essentially flat-lying Palaeozoic marine sedimentary rocks, including carbonates, sandstones
and shales of Pennsylvanian age.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Mineralization</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
property hosts niobium, titanium, and scandium mineralization as well as REE mineralization that occurs within the Elk Creek carbonatite.
The current known extents of the carbonatite unit are approximately 950 m along strike, 300 m wide, and 750 m in dip extent, below
the unconformity. Niobium, titanium, scandium, and rare earths are considered the main elements of interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
deposit contains significant concentrations of niobium. Based on the metallurgical testwork completed to date at a number of laboratories
using QEMSCAN&#174; analysis, the niobium mineralization is known to be fine grained, and that 77% of the niobium occurs in the
mineral pyrochlore, while the balance occurs in an iron-titanium-niobium oxide mineral of varying composition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Within
the Elk Creek carbonatite, a host of other elements exist with varying degrees of concentration. The Company has completed both
whole rock analysis and multi-element analysis on all samples for the 2014 drilling program, described below, plus resampling
of selected historical core/pulps between 2011 and 2014.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Historical
Exploration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drilling
at the Elk Creek Property was conducted in three phases. The first was during the 1970&#8217;s and 1980&#8217;s by the Molybdenum
Company of America (&#8220;Molycorp&#8221;), the second in 2011 by Quantum Rare Earth Developments Corp (&#8220;Quantum&#8221;
- NioCorp under its former name), and the third and latest program from 2014 to 2016 by NioCorp. To date, 129 diamond core holes
have been completed for a total of 64,981 m over the entire geological complex. Of these, a total of 48 holes (33,909 m) have
been completed to date in the mineralized area and are used in the current mineral resource and reserve estimates. Five additional
holes, with a total length of 3,353.1 m, were drilled for hydrogeologic and geotechnical purposes in 2015. No sampling has been
completed of these five holes to date and therefore they have not been considered for the mineral resource or reserve estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
drilling has been completed using a combination of Tricone, Reverse Circulation (&#8220;RC&#8221;) or Diamond Drilling (&#8220;DDH&#8221;)
in the upper portion of the hole within the Pennsylvanian sediments. All drilling within the underlying carbonatite has been completed
using DDH methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
of Drilling Database within Elk Creek Deposit Area</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Company</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Holes</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Depth (m)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Sum Length (m)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1973-1986</span></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 17%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp</span></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 17%; text-align: right">27</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 17%; text-align: right">596.6</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 17%; text-align: right">16,108.2</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2011</td><td style="text-align: left">&#160;</td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quantum</span></td><td style="text-align: left">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">772.6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,317.7</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014 to present</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">845.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,482.8</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right">48</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right">700.9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2pt solid; text-align: left; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 2pt solid; text-align: right">33,908.7</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 2; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Molycorp,
1973-1986</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
1973 and 1974, Molycorp completed six drillholes: EC-1 to EC-4, targeting the Elk Creek anomaly, and two other holes outside the
Elk Creek anomaly area. Drillholes were typically carried out by RC drilling through the overlying sedimentary rocks and diamond
drilling through the Ordovician-Cambrian basement rocks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
continued their drill program from 1977 and, in May 1978, Molycorp made its discovery of the current mineral resource with drillhole
EC-11. EC-11 is located on Section 33, Township 4N, and Range 11. The carbonatite hosting the Elk Creek Project was intersected
at a vertical depth of 203.61 m (668 ft).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Molycorp
continued its drilling program through to 1984, which mainly centered on the Elk Creek Project within a radius of roughly 2 km.
By 1984, Molycorp had completed 57 drillholes within the Elk Creek gravity anomaly area, which included 25 drillholes over the
Elk Creek Project area.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1984 to 1986, drilling was focused on the Elk Creek gravity anomaly area. The anomaly area is roughly 7 km in diameter and drilling
was conducted on a grid pattern of approximately 610 m by 610 m (roughly 2,000 ft by 2,000 ft) with some closer spaced drillholes
in selected areas.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
1986, a total of 106 regional drillholes were completed for a total of approximately 46,797 m (153,532 ft). The deepest hole reached
a depth of 1,038 m (3,406 ft) and bottomed in carbonatite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Quantum, 2011</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2011, Quantum conducted a preliminary drill program (three holes) on the Elk Creek deposit and two REE exploration targets
(two holes), which have been excluded from the current mineral resource and reserve estimation, as they do not intersect the Nb<sub>2</sub>O<sub>5</sub>&#160;anomaly
and are located to the east. The objectives of the drill program over the Elk Creek Property were to verify the presence of higher-grade
niobium mineralization at depth, and to infill drill the known niobium deposit in order to upgrade the resource category of the
previous resource estimate and expand the known resource. The drill program was also established to collect sufficient sample
material for metallurgical characterization and process development studies of the niobium mineralization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2011 program consisted of five inclined drillholes, totaling 3,420 m of NQ size diameter core. Inclusive of this total, three
drillholes, totaling 2,318 m, were drilled into the known Elk Creek deposit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">NioCorp,
2014 to Present</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
commenced drilling on the Elk Creek Property using a three-phased program. The three-phased program was originally based on 14
drillholes for approximately 12,150 m (announced in a press release on April 29, 2014), but was subsequently expanded during the
program to 18 drillholes for approximately 15,482 m. Three of the 18 drillholes were drilled for the purpose of metallurgical
characterization and process development studies. Two of these drillholes, NEC14-MET-01 and NEC14-MET-02, were not assayed, while
NEC14-MET-03 was quarter cored with one quarter being assayed and the remainder used for metallurgical testwork. The drilling
has been orientated to intersect the geological model from the southwest and northeast (perpendicular to the strike), with the
exception of NEC14-011 and NEC14-012, which were oriented southeast and northwest, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, NioCorp collected a total of 1,095 samples originating from 18 diamond drill holes completed by MolyCorp, as
discussed above. These samples were collected, and subsequently assayed, in order to fill in gaps in our records regarding REE
grades and tonnage that may exist in the deposit. Assaying was conducted at Actlabs in Ancaster, Ontario. The assay results were
subjected to a Quality Assurance and Quality Control (&#8220;QA/QC&#8221;) program consistent with industry best practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Internal
Controls</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
integrated a series of routine QA/QC procedures throughout the sampling and analysis portion of the drilling programs to ensure
the highest level of quality was maintained throughout the process leading to the estimate of mineral reserves and mineral resources
for the Elk Creek Project. This included the insertion of duplicate samples taken from various stages of the process, insertion
of known control samples (standard reference materials, certified reference materials (&#8220;CRM&#8221;), and blanks) and sending
third-party pulps to a secondary lab (SGS Canada Inc.).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 3; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sample
tickets were assigned initially at the core shed using barcodes with duplicate tickets placed inside and on the outside of the
bag. Sample identification was confirmed using barcode labelling and visual sample type comparisons before sample shipment. The
use of barcoded samples ensured both shipment forms and analytical labs used accurate information. Multiple types of QC samples
were inserted at this stage of the process, which includes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field
                                         quartz blanks (1 in 20, or 5%) were inserted within or immediately after samples collected
                                         from mineralized intervals, targeting zones of elevated visual mineralization, where
                                         possible.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRMs
                                         (1 in 20, or 5%) were inserted in the field with the sample sequence.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field
                                         quarter-core duplicates (1 in 20, or 5%) were inserted to test mineralization and sampling
                                         variability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
details on the QA/QC program can be found in Section 8 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
deposits, including the Elk Creek deposit, are inherently uncertain because of variability at all scales and sparse sampling.
In addition to uncertainty associated with estimation, there are specific risks and sources of uncertainty associated with the
Elk Creek deposit. See Item 1A., Risk Factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-K
1300 and other similarly purposed International Codes (JORC, 2012; NI 43-101, 2014) are designed to require disclosure to the
public of risks relating to mineral resource and reserve estimation as identified and evaluated by a qualified person. The qualified
persons responsible for the S-K 1300 Elk Creek Technical Report Summary address the technical risks in various sections and consider
that no material technical risks are identified. Additional descriptions of the risks and uncertainty associated with reported
mineral reserves and resources can be found in Section 11 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022
Elk Creek Feasibility Study</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2022, the Company launched geological, metallurgical, engineering, and other analyses to assess the feasibility of
adding REE production to its plans once sufficient work has been completed. The Company and its consultants were required to complete
additional assays of historical drill core to fill data gaps in the existing resource database to establish an REE mineral resource.
The mine plan was also updated and the S-K 1300 Elk Creek Technical Report Summary was filed with the SEC as an exhibit to the
Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. The S-K 1300 Elk Creek Technical Report Summary
was based on the economic and process results of the feasibility study conducted by the qualified persons, which were also presented
in the 2022 NI 43-101 Elk Creek Technical Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is planned as an underground mining operation using a long-hole stoping mining method and paste backfill, operating
with a processing rate of 2,764 tonnes per day. Expected total production over the 38-year mine life includes 171,140 tonnes of
payable niobium, 3,676 tonnes of Sc<sub>2</sub>O<sub>3</sub>, and 431,793 tonnes of TiO<sub>2</sub>. Estimated up-front direct
capital costs are $760 million, in addition to indirect costs of $187 million, pre-production capital costs of $92 million, an
overall contingency of $102 million, and pre-production net revenue credit of $257 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Financial
Analysis Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
metrics reported in the S-K 1300 Elk Creek Technical Report Summary are based on the cash flow model results. The metrics are
on both a pre-tax and after-tax basis, on a 100% equity basis with no Elk Creek Project financing inputs and are in first quarter
2019 U.S. constant dollars. Foreign exchange impacts were deemed negligible as most, if not all, costs and revenues are denominated
in U.S. dollars. Key criteria used in the analysis are discussed in detail throughout this section.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 4; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Principal
Project Assumptions Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 35%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 75%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Production
    Period</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
    years</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Plant Life</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38
    years</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine
    Operating Days per Year</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mill
    Operating Days per Year</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">365</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount
    Rate, End of Period</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">@
    8%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    Production Year</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025
    </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Summary
of Key Evaluation Metrics Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ore
    Mined (kt)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,655</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ore
    Mining Rate (t/d)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,764</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Grade</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scandium
    Grade (parts per million, &#8220;ppm&#8221;)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Grade</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    Nb<sub>2</sub>O<sub>5</sub> (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    Sc (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contained
    TiO<sub>2</sub> (kt)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Ore Processed (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,655</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Rate (kt/y)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,009</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery, Nb<sub>2</sub>O<sub>5</sub></span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.4%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery Sc</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.1%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Average
    Recovery TiO<sub>2</sub></span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.3%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    Nb<sub>2</sub>O<sub>5</sub> (kt)</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">245</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    Sc (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,395</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recovered
    TiO<sub>2</sub> (kt)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">432</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized
    Market Prices</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb
    ($/kg)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$46.55</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>($/kg)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.99</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
    </sub>($/kg)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,674</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payable
    Metal</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb
    (t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,140</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc<sub>2</sub>O<sub>3
    </sub>(t)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,676</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>(t)</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 5; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Summary
Projected Economic Results Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Description </b></span></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 29%; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value ($000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Gross Revenue </span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$21,899,726</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Costs:</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,553,325)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,911,116)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    G&amp;A Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(300,400)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentrate
    Freight Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,472)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure Costs</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(200,407)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(609,195)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(73,822)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    Tax</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(217,540)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(300,503)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,500)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Operating Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,182,280)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Margin (EBITDA<sup>(1)</sup>)</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,717,445</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
    Tax Rate</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.42%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Taxes</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,246,186)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
    Capital</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt; padding-right: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Cash Flow</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12,471,258</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Totals
may not sum due to rounding.&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 2.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         term &#8220;EBITDA&#8221; refers to earnings before interest, taxes depreciation and
                                         amortization. See &#8220;Non-GAAP Financial Performance Measures&#8221; below for a discussion
                                         of the use of non-GAAP financial measures.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Capital
Cost Estimates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the breakout in LoM initial capital and sustaining capital cost estimates (excluding closure and reclamation
of $44 million), which total $1,562 million. This includes a total initial capital cost of $1,141 million, including a 10% contingency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.2pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 55%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000,000)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sustaining</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
    Preproduction Expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#160;&#160;&#160;77</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#160;&#160;&#160;-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&#160;&#160;&#160;&#160;77</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    Preparation and Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Plant</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">367</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">464</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management and Treatment</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">257</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">198</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">455</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    Wide Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commissioning</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owner&#8217;s
    Costs</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine
    Water Management Indirects</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingency</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Capital Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,141</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$422</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,562</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Totals
may not sum due to rounding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Operating
Cost Estimates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following LoM unit operating costs include the pre-production and first/last years of production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 279px; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LoM
    $/t ore </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$42.38</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Process
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.70</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.62</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Site
    G&amp;A Cost</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.20</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.47</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management Cost</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Expenses</span></td>
    <td style="border-right: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.22</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subtotal
    </span></td>
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187.59
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCECFF">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties/Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.35</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    LoM Operating Costs</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$195.94</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5in; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Totals
may not sum due to rounding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; text-indent: 85.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Planned
Mining Operations</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Elk Creek Project is planned as an underground mining operation using a long-hole stoping mining method and paste backfill, with
shaft access to minimize development through water bearing horizons. The mine will utilize jumbo drills for lateral development
and tophammer and down-the-hole drills for vertical development and production stoping. Rock bolters will be used for ground support
and probe holes will be used to support mine grouting where required. Ore will be remotely mucked from the bottom stope accesses
using 14 tonne Load-Haul-Dump units (&#8220;LHD&#8221;). The LHDs will transport the ore to an ore pass directly or to remuck
bays to maximize the efficiency of the stope mucking operations. When needed, a second LHD and a fleet of 40 tonne haul trucks
will be used to transport ore from the remuck bays to the grizzly feeding the underground material handling system. Multiple remuck
bays are used on each level to avoid interference between the LHD and the haul trucks. The ore is fed through the grizzlys with
rock breakers into an underground crusher (the &#8220;Primary Crusher&#8221;) and via a material handling system to the surface.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Planned
Processing Operations </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Planned
ore process operations include mineral processing, hydrometallurgical processing (&#8220;Hydromet&#8221;), and pyrometallurgical
processing (&#8220;Pyromet&#8221;) housed in separate buildings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mineral processing building will house all of its equipment within a single large building. Ore from the Primary Crusher (located
in the underground mine) will be fed to the secondary cone crusher system, operating in closed circuit with a double deck screen.
The screen undersize from the cone crusher system will be fed to a high-pressure grinding roll unit (&#8220;HPGR&#8221;), operating
in closed circuit with another double deck screen. The HPGR screen undersize is the comminution product that will report to the
Hydromet process.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Hydromet plant building will be a multi-level engineered steel structure, which will house equipment on two levels. Ore from mineral
processing will be fed through 15 individual processes required to separate the three recoverable products. The purpose of the
Hydromet processing steps is to leach the pay metals into solution using two separate acid leaches (Hydrochloric Acid Leach and
Sulfuric Acid Bake), remove impurities, separate the three pay metals, and perform precipitation/processing to final solid oxide
forms. Outputs from the Hydromet process include saleable TiO<sub>2</sub> and Sc<sub>2</sub>O<sub>3</sub>, with Nb<sub>2</sub>O<sub>5
</sub>reporting to the Pyromet plant for final processing. The Hydromet plant will be supported by a Hydrochloric Acid Regeneration
plant and a Sulfuric Acid Plant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pyromet building will house most of its equipment within a single building. The purpose of the Pyromet plant is to reduce the
Nb<sub>2</sub>O<sub>5</sub> coming from the Hydromet plant by converting it into a saleable FeNb metal. Aluminum shots and iron
oxide pellets will be introduced to an electric arc furnace on a continuous basis along with fluxing agents and Nb<sub>2</sub>O<sub>5
</sub>to produce a saleable ferroniobium metal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Production Plan and Schedule </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the 2022 Elk Creek Feasibility Study, the operating mine life is approximately 38 years with a nominal processing rate of 2,764
tonnes per day. The Elk Creek Project timeline is based on 39 months to mechanical </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 7; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">completion after Authorization to Proceed,
plus an additional six months of commissioning and ramp-up to 100% of production capacity for a total of 45&#160;months and assumes
no financing constraints. The Board must approve a construction program and budget before construction of the Elk Creek Project
can begin. This approval, along with the receipt of all required governmental permits and approvals and the completion of project
financings, will determine whether and when construction of the Elk Creek Project can begin.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Tailings Storage</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tailings produced by the process plant will consist of filtered water leach residue, calcined excess oxide, and slag. Four engineered
and lined tailings storage facilities (&#8220;TSFs&#8221;) will be constructed sequentially to contain the tailings over the life
of the Elk Creek Project and would contain approximately 14.5&#160;million tonnes of tailings. The tailings facilities have been
designed to incorporate two independent areas: a composite-lined tailings solids storage area; and an area with double lined containment,
including a leak collection and recovery system for management of stormwater runoff and drainage from the tailings solids. The
TSFs will store predominantly dry (i.e., not in a slurry consistency) tailings from the plant with embankment construction based
on a &#8220;downstream&#8221; construction method. Facility closure is considered in the design.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Salt Management</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
crystalline salt produced as a waste product of heating and evaporating brine from the reverse osmosis (&#8220;RO&#8221;) water
treatment plant will be transported by conveyor to the temporary salt staging area and then be transported by truck to the dedicated
salt management cells (&#8220;SMC&#8221;). Two SMCs will be constructed sequentially to contain the salt over the life of the
project and would contain approximately 1.63 million cubic meters of salt. The SMCs design will incorporate a composite-lined
storage area with double-lined containment including a leak collection and recovery system for management of stormwater runoff
and drainage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Water Management</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the first several years of construction, the advancement of the shaft and underground workings will require limited dewatering,
anticipated to be through lower-level sumping and pumping for surface collection and disposal. Initially, water will be stored
in the lined SMC #1 during construction or will be trucked off-site for treatment at a local publicly owned treatment works. Excess
water in the SMCs will be spray evaporated within the footprint of the SMC, to avoid the reintroduction of soluble salts into
the water treatment system. Temporary on-site storage or off-site shipment and disposal of the crystallizer solid waste may be
necessary until construction of SMC #1 is completed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
full operations commence, we anticipate a shortfall of approximately 3,700 gallons per minute of operational and processing water,
as the underground mine dewatering is only expected to produce 1,000 gallons per minute. To make up this shortfall, we would purchase
fresh water from a local utility and from local landowners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
tailings begin being deposited in the TSF, internal contact water (from residual moisture in the tailings and precipitation falling
within the impoundment footprint) will need to be actively managed. This water will be collected and treated using lime softening
to precipitate hydroxide and carbonate solid forms for many of the inorganic constituents. The treated water will be filtered
to remove the solids (which will be returned to the TSF for disposal), and the clean water will be pumped to the process plant
RO system for further treatment. The clean water from the process plant RO unit will be used in the process plant, and the reject
concentrate will be crystallized and deposited into the SMCs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Source of Power </span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
local power utility (Omaha Public Power District) will provide power from nearby transmission lines to the site. This will require
that an approximate 18-mile transmission line be installed by the utility to provide the site sub-station with the required site
power demand. The local power utility will also design and install the main substation that will be owned and maintained by the
utility. This infrastructure will be paid back through rate charges on the electrical usage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 8; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Proposed
Source of Natural Gas</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natural
gas, to be used throughout the Elk Creek Project during the construction and operation phases of the project, will be brought
to the site via pipeline from the local utility company. NioCorp has a natural gas transportation contract with Tallgrass Energy,
which operates the Rockies Express (&#8220;REX&#8221;) pipeline. Tallgrass will construct a 45 kilometer (28 mile) gas pipeline
lateral from the main REX pipeline system in Kansas to the project site. The lateral will be sized to provide a minimum of 27.5
dekatherms of gas per day. Natural gas will be distributed to all on-site facilities utilizing buried high-density polyethylene
natural gas distribution pipe. Natural gas piping above ground and located inside of facilities will consist predominately of
carbon steel pipe. Maximum on-site pipeline distribution pressure will be 100 pounds per square inch gauge. Natural gas will be
used for facility heating, water heating, and for gas-fired process equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Markets</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
studies for niobium, TiO<sub>2</sub>, and Sc<sub>2</sub>O<sub>3</sub> are an important part of the proposed Elk Creek operation.
These commodities, especially niobium and Sc<sub>2</sub>O<sub>3</sub>, are thinly traded without an established publicly available
price discovery mechanism. Hence, detailed third-party market studies provide the basis for assumptions used in the economic analysis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
economic analysis in the 2022 Elk Creek Feasibility Study used the 2019 U.S. dollar base price of $47/kg Nb as the forward-looking
price for steel grade (65%) ferroniobium based on published independent third-party reports. The base price is adjusted to a realized
price to account for the discount provisions contained in the two ferroniobium offtake agreements that the Company has concluded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
engaged OnG Commodities LLC (&#8220;OnG&#8221;) to produce a market assessment in April 2017. The study examines current scandium
production trends (approximately 20&#160;tons/year) from existing and emerging producers plus an outlook for supply to 2028. The
outlook then reviewed the current and emerging applications for scandium, including fuel cells, aerospace, industrial and other
uses, plus an outlook for demand to 2028. Based on these inputs, OnG provided pricing forecasts and global demand volumes by year
to 2028 based estimated production costs and supply-demand balances. The pricing for the OnG Commodities report was updated for
NioCorp in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
formal market study was done for TiO<sub>2</sub> as it only represents 2% of overall revenue in the economic analysis. All market
information for titanium and TiO<sub>2</sub> is derived from USGS Commodity Market Summaries (Bedinger, 2019).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Taxation
Rates Included in the 2022 Elk Creek Feasibility Study</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
that may be levied on the Elk Creek Project include corporate income tax rates of 21% for federal and 5.84% for Nebraska. The
Elk Creek Project is eligible for federal depletion allowances and credits, as well as various state incentives. The calculated
effective income tax rate for the Elk Creek Project is 16.42% for the 2022 Feasibility Study.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Design
Considerations for Environmental Performance</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current mine design incorporates the following strategies and technologies designed to minimize environmental impacts of operation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zero
                                         Process Liquid Discharge: The Elk Creek facility will now operate as a &#8220;Zero Process
                                         Liquid Discharge&#8221; facility, with no releases of process liquids. Instead, both
                                         naturally occurring, brackish (slightly salty) water produced during mining operations,
                                         and water used in ore processing, will be treated on site for use in operations. A solid
                                         salt will be produced from water treatment operations which will be stored on site.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
                                         Protection of Groundwater Resources Through Artificial Ground Freezing: The Elk Creek
                                         Project&#8217;s new mine design will utilize artificial ground freezing as part of the
                                         process of sinking the production and ventilation shafts. Artificial ground freezing
                                         creates a temporary frozen barrier that helps to protect groundwater resources in the
                                         area while shaft-sinking operations are underway.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avoidance
of Permanent Impacts to Federally Jurisdictional Waters: We designed the layout of the Elk Creek Project to minimize or avoid
permanent impacts to any federally jurisdictional waters and/or wetlands on the</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 9; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">property. This reduced the expected environmental impacts
                                         and allowed the Elk Creek Project to secure a Clean Water Act Section 404 permit from
                                         the USACE under the Nationwide Permit Program, a much more efficient and less expensive
                                         process than an individual Section 404 permit. No other NEPA-level federal permits are
                                         now expected to be required for the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recycling
                                         of Reagents Used in Mineral Processing: Metallurgical and process advances made in 2016
                                         and 2017 are expected to help reduce the volume of material planned for disposal in the
                                         Elk Creek Project&#8217;s tailings storage areas. As more of this material is recycled,
                                         the environmental footprint of the Elk Creek Project is reduced.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utilizing
                                         Tailings as Underground Mine Backfill: We plan to fill underground voids concurrently
                                         with mining operations using a paste backfill material that contains mine waste material
                                         that typically would be stored in above-ground tailings storage areas.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company has not identified any significant encumbrances to the property it owns or holds under OTP agreements. The Company has
not had any permit violations or fines since the filing of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permitting
requirements for the project have been identified. The Company holds an Air Construction Permit from the State of Nebraska and
a Special Use Permit from Johnson County, both of which are necessary to allow the start of project construction. In addition,
the Elk Creek Project will be required to obtain a series of permits for operations from federal, state, and local agencies. The
majority of these permits are ministerial in nature and present minimal risk to the Company and typically involve the completion
of an application and the payment of a nominal fee. Three permits from the state of Nebraska are discretionary in nature, where
an application and fee are provided to the state and the state must make a decision as to whether or not the permit will be granted.
While the risk involved in such permits is low, such discretionary permits require more processing time by the state and do require
the state agency to make a decision in favor of issuance of the permit. These three permits include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solid
                                         Waste Permit;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Air
                                         Operating Permit; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.25pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Radioactive
                                         Materials License.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cost and schedule for obtaining both the discretionary and ministerial permits is included in the overall execution plan for the
Elk Creek Project. Additional details on the project&#8217;s permitting requirements can be found in Section 17 of the S-K 1300
Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Mineral
Reserves and Resources</span></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mineral reserves and mineral resources disclosed below are based on the S-K 1300 Elk Creek Technical Report Summary, which was
originally filed as Exhibit 96.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June 30, 2022. Mineral
reserves and mineral resources at the Elk Creek Project as of June 30, 2025, are summarized in the tables below. Further discussion
and background regarding the approaches used to establish mineral reserves and mineral resources is contained in Chapters 11 and
12 of the S-K 1300 Elk Creek Technical Report Summary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek Project In Situ Mineral Resource Estimate (niobium, titanium, and scandium) Excluding Reserves</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as
of June 30, 2025</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR
    Cutoff</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage
    (Mt)</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Indicated</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">151.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.43</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">649.8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2.02</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">3,067</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (ppm)</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (t)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">56.42</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">8,558</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Inferred</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; background-color: White"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">108.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<span style="color: black"><sub>2</sub>O<sub>5
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.39</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">426.6</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<span style="color: black"><sub>2
    </sub>(kt)</span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2,082</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (ppm)</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc
    (t)</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">52.28</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">5,660</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 67.7pt; text-align: center; text-indent: -67.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
Creek Project In Situ Mineral Resource Estimate (rare earth oxides) Excluding Reserves</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 67.7pt; text-align: center; text-indent: -67.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as
of June 30, 2025</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 97%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NSR
    </b></span><span style="font-size: 10pt"><br/>
    <span style="font-family: Times New Roman, Times, Serif"><b>Cut-off</b></span></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage
    (Mt)</b></span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td rowspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Indicated</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">151.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0766</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">116.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1320</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">200.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0140</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">21.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0511</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">77.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0116</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">17.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0040</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">6.0</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0096</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">14.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0011</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0044</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">6.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3</sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0006</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0015</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">2.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0002</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0187</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">28.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (kt) </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2737</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">415.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0528</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">80.0</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3265</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">495.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">Inferred</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">$180</span></td>
    <td rowspan="12" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">108.3</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>La<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ce<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pr<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0943</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">102.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1576</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">170.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0163</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">17.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0575</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">62.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0116</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">12.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0038</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gd<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dy<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0090</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">9.8</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0042</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ho<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Er<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3</sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tm<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0006</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.7</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0014</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0002</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Yb<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lu<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(%)</span></b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Y<span style="color: black"><sub>2</sub>O<sub>3
    </sub>(kt)</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0010</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">1.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0001</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.1</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">19.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;LREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;HREO
    (kt) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (%) </b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;TREO
    (kt) </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3257</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">352.6</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.0512</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">55.5</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">0.3769</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: black">408.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Notes:</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
                                         of mineral resources in the above tables is in accordance with the S-K 1300 classification
                                         system. Mineral resources in this table are reported exclusive of mineral reserves.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         resources that are not mineral reserves do not have demonstrated economic viability.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral resources are reported at a Diluted Net Smelter Return (NSR) Cut-off of $180/tonne.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted NSR is defined as:</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: -4pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40.5pt; vertical-align: top"/><td style="font: 10pt Times New Roman, Times, Serif; padding-top: 4pt; text-align: left; width: 12.5pt; vertical-align: top"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">&#160;</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><img src="n257410kimg004.jpg" alt="" style="height: 29px; width: 525px"/></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: -5pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 40.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted revenue from Nb<sub>2</sub>O<sub>5</sub>, TiO<sub>2</sub>, and Sc per block used
                                         the following factors:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb<sub>2</sub>O<sub>5
                                         </sub>Revenue: a 94% grade recovery, a 0.696 factor to convert Nb<sub>2</sub>O<sub>5
                                         </sub>to Nb, 82.36% assumption for plant recovery, and a $39.60 selling price per kg
                                         of ferroniobium as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
                                         </sub>Revenue: a 94% grade recovery, a 40.31% assumption for plant recovery, and an $0.88
                                         kg selling price per kg of titanium oxide as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 11; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 58.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
                                         Revenue: a 94% grade recovery, a 1.534 factor to convert Sc to Sc<sub>2</sub>O<sub>3</sub>,
                                         93.14% assumption for plant recovery, and a $3,675 selling price per kg of scandium oxide
                                         as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 40.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         diluted tonnes are a 6% increase in the total tonnes of the block.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         assumptions for FeNb, Sc<sub>2</sub>O<sub>3</sub>, and TiO<sub>2</sub> as shown in note
                                         d, above, are based upon independent market analyses for each product.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numbers
                                         may not sum due to rounding. The rounding is not considered to be material.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rare
                                         Earth Oxides (REO) were evaluated as a potential by-product to the mining of niobium,
                                         titanium, and scandium; thus, the estimated values of the REOs are reported using the
                                         previously determined diluted NSR as derived from the Nb<sub>2</sub>O<sub>5</sub>, TiO<sub>2</sub>,
                                         and Sc mineral resources and are assigned a price of $0.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Light Rare Earth Oxides (LREO) grade (%) is the summation of La<sub>2</sub>O<sub>3
                                         </sub>(%), Ce<sub>2</sub>O<sub>3</sub> (%), Pr<sub>2</sub>O<sub>3</sub> (%), and Nd<sub>2</sub>O<sub>3
                                         </sub>(%) estimates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Heavy Rare Earth Oxides (HREO) grade (%) is the summation of Sm<sub>2</sub>O<sub>3
                                         </sub>(%), Eu<sub>2</sub>O<sub>3</sub> (%), Gd<sub>2</sub>O<sub>3</sub> (%), Tb<sub>2</sub>O<sub>3
                                         </sub>(%), Dy<sub>2</sub>O<sub>3</sub> (%), Ho<sub>2</sub>O<sub>3</sub> (%), Er<sub>2</sub>O<sub>3
                                         </sub>(%), Tm<sub>2</sub>O<sub>3</sub> (%), Yb<sub>2</sub>O<sub>3</sub> (%), Lu<sub>2</sub>O<sub>3
                                         </sub>(%), and Y<sub>2</sub>O<sub>3</sub> (%) estimates.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         stated Total Rare Earth Oxide (TREO) grade (%) is the summation of LREO (%) and HREO
                                         (%).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         effective date of the mineral resource, including by-products, is June 30, 2025.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: center; text-indent: -49.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elk
Creek Project Underground In Situ Mineral Reserves Estimate for Elk Creek</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: center; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as
of June 30, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75in; text-align: center; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tonnage</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(kt)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<sub>2</sub>O<sub>5
                                         </sub></b></span></p>
                                                                                                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grade&#160;</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained</b></span></p>
                                                                                                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb<sub>2</sub>O<sub>5
</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable</b></span></p>
                                                                                                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nb</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grade</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained</b></span></p>
                                                                                                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TiO<sub>2</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grade</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ppm)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contained</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payable</b></span></p>
                                                                                                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sc<sub>2</sub>O<sub>3</sub></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 0.125in; text-indent: -3.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proven</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 17.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 0.125in; text-indent: -3.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probable</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,656</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 0.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,278</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,409</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071,182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.75pt; padding-left: 17.85pt; text-indent: -17.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,656</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 0.45pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.81</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297,278</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,409</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.92</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,071,182</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,793</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.2</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,573</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,677</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
figures are rounded to reflect the relative accuracy of the estimates. Totals may not sum due to rounding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         qualified person for the mineral reserve estimate is Optimize Group Inc. The estimate
                                         has an effective date of June 30, 2025.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral reserve is based on the mine design, mine plan, and cash-flow model utilizing
                                         an average cut-off grade of 0.679% Nb<sub>2</sub>O<sub>5</sub> with an NSR of $180/mt.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         estimate of mineral reserves may be materially affected by metal prices, environmental,
                                         permitting, legal, title, taxation, socio-political, marketing, infrastructure development,
                                         or other relevant issues.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         economic assumptions used to define mineral reserve cut-off grade are as follows:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                         life of mine (LoM) production rate of ~7,450 tonnes of FeNb/annum during the years of
                                         full production.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
                                         elevated five-year production rate ~ 7,500 tonnes of FeNb/annum when full production
                                         is reached.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
                                         dilution of ~6% was applied to all stopes and development, based on 3% for the primary
                                         stopes, 9% for the secondary stopes, and 5% for ore development.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9675;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
                                         recoveries of 95% were applied in longhole stopes and 62.5% in sill pillar stopes.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 60%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Parameter</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unit</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mining
    Cost</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.38</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing
    </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.70</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Water
    Management and Infrastructure </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.62</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tailings
    Management</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Infrastructure</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.47</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and Administrative</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.91</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Royalties/Annual
    Bond Premium</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.34</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Costs </span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.29</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/t
    mined</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    Cost</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>196.72</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$/t
    mined</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nb<sub>2</sub>O<sub>5
    </sub>to Niobium Conversion</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69.60</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.36</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Niobium
    Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.60</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/kg</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.31</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TiO<sub>2
    </sub>Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.88</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/kg</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    Process Recovery</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.14</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    to Sc<sub>2</sub>O<sub>3</sub> Conversion</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">153.40</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sc
    Price</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,675.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$/kg</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         assumptions are as follows: FeNb $39.60/kg Nb, Sc<sub>2</sub>O<sub>3</sub> $3,675/kg,
                                         and TiO<sub>2</sub> $0.88/kg. Price assumptions are based upon independent market analyses
                                         for each product as of June 30, 2022.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 12; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         and cost assumptions are based on the pricing of products at the &#8220;mine-gate,&#8221;
                                         with no additional down-stream costs required. The assumed products are ferroniobium
                                         (metallic alloy shots consisting of 65%Nb and 35% Fe), a titanium dioxide product in
                                         powder form, and scandium trioxide in powder form.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         mineral reserve has an average LoM NSR of $563.06/tonne.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optimize
                                         Group has provided detailed estimates of the expected costs based on the knowledge of
                                         the style of mining (underground) and potential processing methods (by third-party qualified
                                         persons).</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         reserve effective date is June 30, 2025. The financial model was run after the estimate
                                         of the NSR above, which reflects a total cost per tonne of $196.72 versus $189.91. This
                                         is not considered a material change.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
                                         variances for commodities are based on independent market studies versus earlier projected
                                         pricing. The independent market studies do not have a negative effect on the reserve.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Comparison
of Mineral Resources and Mineral Reserves</span></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in the Elk Creek Project mineral resource or reserve estimates as of June 30, 2025, as compared to the Elk Creek
Project mineral resource and reserve estimates as of June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental
and Social</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of key permits and environmental management requirements have been identified for the Elk Creek Project, some of which
need to be implemented as soon as practicable in order to maintain the proposed Elk Creek Project schedule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
                                         not necessarily complex, the timing generally required to complete permitting through
                                         any federal regulatory agency requires that NioCorp engage key agencies (in this case
                                         the USACE and possibly the EPA) early on in Elk Creek Project development and consider
                                         the siting and orientation of facilities carefully to minimize the risk of a protracted
                                         National Environmental Policy Act analysis of the Elk Creek Project. At the present time,
                                         the Company believes that we have completed the major federal permitting actions needed
                                         for project construction, although changes to the design or location of project facilities
                                         may require that additional federal permits be obtained.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
                                         at the facility requires an Air Permit from the State of Nebraska, which was issued to
                                         the Company on June 2, 2020. The Air Permit describes all the prospective air emissions
                                         from the facility and required the completion of an air quality model that demonstrates
                                         compliance with the NAAQS. On April 15, 2022, the Company announced that the Nebraska
                                         Department of Environment and Energy advised the Company that periodic extensions to
                                         the Elk Creek Project&#8217;s Air Permit are no longer required because the Company has
                                         met the regulatory definition of &#8220;construction, reconstruction, or modification
                                         of the source&#8221; since the permit was issued.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         radioactive materials license will be needed from the Nebraska Department of Health and
                                         Human Services (&#8220;NDHHS&#8221;), Office of Radiological Health. Because of their
                                         limited experience with hard rock mining in the State of Nebraska, much less mining that
                                         includes Naturally Occurring Radioactive Material, the NDHHS may require additional information
                                         and more time to approve the Elk Creek Project under a Broad Scope License. The Company
                                         has been working with NDHHS on this aspect of project permitting since 2014.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documentation
                                         of existing baseline environmental conditions at the Elk Creek Project site was initiated
                                         in 2014 and will continue as needed throughout the permitting process.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surface
                                         water monitoring will continue throughout the permitting process and extend into construction
                                         and operations as part of the Environmental Management System and likely State of Nebraska
                                         permit requirements.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         wetland delineation and potential jurisdictional waters assessment was conducted in late
                                         2014 to identify wetland and drainage features within the proposed Elk Creek Project
                                         boundary which resulted in a formal JD being issued by the USACE on September 6, 2016.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.95pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         major land-use authorization for the project was received from Johnson County, Nebraska,
                                         on December 24, 2019, in the form of a Special Use Permit for the project. This land-use
                                         permit is a necessary precursor to any project-related construction activities. County
                                         zoning permits will be required for individual buildings constructed at the site, and
                                         the County requirement is that such applications must be submitted five days before construction
                                         commences.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 13; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closure
                                         costs for the Elk Creek Project have been estimated at just over $44 million, including
                                         approximately $13.5 million for reclamation and closure of the TSFs and $16.6 million
                                         for plant and building removal and reclamation.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 18.7pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Community
                                         engagement has occurred in parallel with Nebraska field operations and has included public
                                         meetings, presentations to public agencies, communications with local and state politicians,
                                         meetings with environmental groups, and one-on-one meetings with area landowners.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Elk Creek Project Activities</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 30, 2024, the Company announced that it had completed bench-scale testwork at a demonstration-scale processing plant located
in Trois-Rivieres, Quebec built by the Company and L3 Process Development (&#8220;L3&#8221;) and operated by L3 (the &#8220;Demonstration
Plant&#8221;), that successfully demonstrated that the process developed for extracting and recovering rare earth oxides found
in the ore at the Elk Creek Project can be used to recycle the rare earth content in rare earth permanent magnets. The L3 team
was able to demagnetize and grind up permanent rare earth magnets and then leach the contained rare earth elements from the magnet.
The successful outcome of this testing opens up the possibility of accepting mixed rare earth concentrate from other mines into
the planned Elk Creek plant once it is constructed and operating to supplement the ore expected to be produced from the Elk Creek
mine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 23, 2025,
the Company announced the launch of a drilling campaign (the &#8220;Campaign&#8221;) designed to support the conversion of a portion
of its current Indicated Resources into Measured Resources and the subsequent conversion of a portion of its current Probable Mineral
Reserves into Proven Mineral Reserves at the Elk Creek Project. On August 12, 2025, the Company announced the successful completion
of the Campaign. The Campaign was inclusive of nine HQ diamond drillholes, totaling 6,817 meters of drilling. Core processing is
currently underway with samples being sent to SGS USA for sample preparation and analysis. The Campaign supplemented previous exploratory
drilling and operated under existing permits issued by the State of Nebraska. The Campaign was designed to complement other technical
and economic analyses necessary to update the feasibility study for the Elk Creek Project. An updated feasibility study is necessary
as part of the due diligence process for up to $800 million in potential debt financing that NioCorp is seeking from EXIM, as further
discussed under &#8220;Part II, Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Liquidity
and Capital Resources<i>&#8221; </i>below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As
a result of favorable outcomes from the Campaign in terms of schedule and budget, the Company has elected to add up to an additional
six drillholes, totaling approximately 3,930 meters, which will form Phase II of the Campaign (&#8220;Phase II&#8221;). Phase
II is designed to support the conversion of additional indicated resources into measured resources and the subsequent conversion
of additional probable mineral reserves into proven mineral reserves, as well as capturing additional hydrogeologic and geomechanical
data that will be used to continue derisking the underground mine design.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed
Activities</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
present, the Company is maintaining the Elk Creek Property in anticipation of obtaining project financing that will facilitate
the construction, commissioning, and operation of the Elk Creek Project. The property is characterized as a development stage
property and is expected to move to a production stage property should financing be obtained.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
funds become available through the Company&#8217;s fundraising efforts, we expect to undertake the following activities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuation
    of the Company&#8217;s efforts to secure federal, state and local operating permits;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
    evaluation of the potential to produce rare earth products and sell such products under offtake agreements;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of offtake agreements for the remaining uncommitted production of Nb, Sc, and Ti from the project, including
    the potential sale of Ti as titanium tetrachloride, as well as potential REE production;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negotiation
    and completion of engineering, procurement, and construction agreements;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of the final detailed engineering for the underground portion of the Elk Creek Project;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    and completion of the final detailed engineering for surface project facilities;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 14; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construction
    of natural gas and electrical infrastructure under existing agreements to serve the Elk Creek Project site;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completion
    of water supply agreements and related infrastructure to deliver fresh water to the project site;</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation
    of revised mine groundwater investigation and control activities; </span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the results
    of the Company&#8217;s Demonstration Plant operations, update the characterization and testing of waste materials to support
    tailings impoundment and paste backfill plant designs;</span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation of long-lead
    equipment procurement activities; and </span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initiation of initial
    construction work at the project site.</span></td>
    </tr>
</table>
<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-GAAP
Financial Performance Measures</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-GAAP
financial performance measures are intended to provide additional information only and do not have any standard meaning prescribed
by U.S. GAAP. These measures should not be considered in isolation or as a substitute for performance measures prepared in accordance
with U.S. GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
S-K 1300 Elk Creek Technical Report Summary uses non-GAAP financial performance measures, such as EBITDA, Averaged Annual EBITDA,
and Averaged EBITDA Margin, for purposes of projecting the economic results of the Elk Creek Project. We are unable to provide
a reconciliation of these forward-looking non-GAAP measures to the most comparable U.S. GAAP financial performance measures because
certain information needed to reconcile those non-GAAP measures to the most comparable U.S. GAAP financial performance measures
is dependent on future events, some of which are outside the control of the Company, such as FeNb, Sc<sub>2</sub>O<sub>3,</sub>
and TiO<sub>2</sub> prices, interest rates, and exchange rates. Moreover, estimating such U.S. GAAP measures with the required
precision necessary to provide a meaningful reconciliation is extremely difficult and could not be accomplished without unreasonable
effort.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Headquarters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease our principal executive office space at 7000 South Yosemite Street, Suite 115, Centennial, Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                            3.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a027"></span>LEGAL
PROCEEDINGS</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 11, 2025, we are not a party to any legal proceedings that could
have a material adverse effect on the Company&#8217;s business, financial condition, or operating results. Further, to the Company&#8217;s
knowledge, no such proceedings have been threatened against the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                            4.</span></td><td style="text-align: justify"><span id="a028"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MINE
SAFETY DISCLOSURES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 1503(a) of the United States Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#8220;Dodd-Frank
Act&#8221;), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the U.S. are
required to disclose specified information about mine health and safety in their periodic reports. These reporting requirements
are based on the safety and health requirements applicable to mines under the Federal Mine Safety and Health Act of 1977 (the
&#8220;Mine Act&#8221;) which is administered by the U.S. Department of Labor&#8217;s Mine Safety and Health Administration (&#8220;MSHA&#8221;).
During the fiscal year ended June 30, 2025, the Company and its subsidiaries and their properties or operations were not subject
to regulation by MSHA under the Mine Act and thus no disclosure is required under Section 1503(a) of the Dodd-Frank Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 15; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span id="a029"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
II</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                            5.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a030"></span>MARKET
FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="a031"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
Information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">The Common Shares
are listed for trading on the Nasdaq under the trading symbol &#8220;NB.&#8221; The Company also trades on the Frankfurt Stock
Exchange as &#8220;BR3.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="a032"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Holders</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 11, 2025, we had 94 holders of record of the Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="a033"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any cash dividends on the Common Shares since our inception and do not anticipate paying any cash dividends in the
foreseeable future. We plan to retain our earnings, if any, to provide funds for the expansion of our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a034"></span>Securities
Authorized for Issuance Under Equity Compensation Plans</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See&#160;Equity
Compensation Plan Information&#160;under&#160;<i>Item 12</i>, &#8220;<i>Security Ownership of Certain Beneficial Owners and Management
and Related Stockholder Matters</i>,&#8221; for information on plans approved by our shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a035"></span>Purchases
of Equity Securities by the Company</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not make any repurchases in the quarter ended June 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a036"></span>Recent
Sales of Unregistered Securities</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued and sold the following Common Shares in reliance on Section 4(a)(2) of the Securities Act in connection with the
closing of advances under the Yorkville Equity Facility Financing Agreement and based upon representations and warranties of Yorkville
in connection therewith:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 31%; padding-right: 0.25pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross
    Proceeds ($000)</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    Issued</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price/Share</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    15, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,779</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,100,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.5261
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    29, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">385</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.3337
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    9, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">658</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.6257
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    20, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">169</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61,992</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.7200
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    24, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">197</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.6251
    </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    27, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,054</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,100,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2.4065
    </span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="a037"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
Controls</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no governmental laws, decrees, or regulations in Canada that restrict the export or import of capital, including foreign exchange
controls, or that affect the remittance of dividends, interest or other payments to non-resident holders of the securities of
NioCorp, other than Canadian withholding tax. See &#8220;Certain Canadian Federal Income Tax Considerations for U.S. Residents&#8221;
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a038"></span>Certain
Canadian Federal Income Tax Considerations for U.S. Residents</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following generally summarizes certain Canadian federal income tax consequences generally applicable under the Income Tax Act
(Canada) and the regulations enacted thereunder (collectively, the &#8220;Canadian Tax Act&#8221;) and the Canada-United States
Tax Convention (1980) (the &#8220;Convention&#8221;) to the holding and disposition of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 16; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Comment
is restricted to holders of Common Shares each of whom, at all material times for the purposes of the Canadian Tax Act and the
Convention, (i) is resident solely in the U.S. for tax purposes, (ii) is a &#8220;qualifying person&#8221; under and entitled
to the benefits of the Convention, (iii) holds all Common Shares as capital property, (iv) deals at arm&#8217;s length with and
is not affiliated with NioCorp, (v) does not and is not deemed to use or hold any Common Shares in a business carried on in Canada,
(vi) is not an insurer that carries on business in Canada and elsewhere, (vii) is not an &#8220;authorized foreign bank&#8221;
(as defined in the Canadian Tax Act), and (viii) has not entered into a &#8220;derivative forward agreement,&#8221; &#8220;synthetic
equity arrangement,&#8221; or &#8220;synthetic disposition arrangement&#8221; (each as defined in the Canadian Tax Act) with respect
to the Common Shares (each such holder, a &#8220;U.S. Resident Holder&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S.-resident entities that are fiscally transparent for U.S. federal income tax purposes (including limited liability companies)
may not in all circumstances be entitled to the benefits of the Convention. Members of or holders of an interest in such an entity
that holds Common Shares should consult their own tax advisers regarding the extent, if any, to which the benefits of the Convention
will apply to the entity in respect of its Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&#8217;s Common Shares will be considered to be capital property of such holder provided that the U.S. Resident
Holder is not a trader or dealer in securities, did not acquire, hold, or dispose of the Common Shares in one or more transactions
considered to be an adventure or concern in the nature of trade (i.e. speculation), and does not hold the Common Shares in the
course of carrying on a business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is based on the current provisions of the Canadian Tax Act and the Convention in effect as of the date prior to the date
hereof, all specific proposals to amend the Canadian Tax Act and Convention publicly announced by or on behalf of the Minister
of Finance (Canada) prior to the date hereof, and the current published administrative policies and assessing practices of the
Canada Revenue Agency (the &#8220;CRA&#8221;). It is assumed that all such amendments will be enacted as currently proposed, and
that there will be no other material change to any applicable law or administrative policy or assessing practice, whether by way
of judicial, legislative or governmental decision or action, although no assurance can be given in these respects. Except as otherwise
expressly provided, this summary does not take into account any provincial, territorial, or foreign tax considerations, which
may differ materially from those set out herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
summary is of a general nature only, is not exhaustive of all possible Canadian federal income tax considerations and is not intended
to be and should not be construed as legal or tax advice to any particular U.S. Resident Holder. U.S. Resident Holders are urged
to consult their own tax advisers for advice with respect to their particular circumstances. The discussion below is qualified
accordingly.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Disposition
of Common Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder who disposes or is deemed to dispose of one or more Common Shares generally should not incur any liability
for Canadian federal income tax in respect of any capital gain arising as a consequence of the disposition, unless the Common
Shares constitute &#8220;taxable Canadian property&#8221; (as defined in the Canadian Tax Act) of the U.S. Resident Holder at
the time of disposition and the U.S. Resident Holder is not entitled to relief under the Convention.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a U.S. Resident Holder&#8217;s Common Shares will not constitute &#8220;taxable Canadian property&#8221; of such holder at a particular
time at which the Common Shares are listed on a &#8220;designated stock exchange&#8221; (which currently includes Nasdaq) unless
at any time during the 60-month period that ends at the particular time both of the following conditions are concurrently met:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%
                                         or more of the issued shares of any class of the capital stock of NioCorp were owned
                                         by or belonged to one or any combination of:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         U.S. Resident Holder,</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
                                         with whom the U.S. Resident Holder did not deal at arm&#8217;s length, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
                                         in which the U.S. Resident Holder or a person referred to in clause (b) holds a membership
                                         interest directly or indirectly through one or more partnerships, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">more
than 50% of the fair market value of the Common Shares was derived directly or indirectly from, one or any combination of, real
or immovable property situated in Canada, &#8220;Canadian resource properties&#8221; (as defined</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 17; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">in
the Canadian Tax Act), &#8220;timber resource properties&#8221; (as defined in the Canadian Tax Act), or options in respect of,
or interests in any of the foregoing, whether or not the property exists.</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares may also be deemed to be &#8220;taxable Canadian property&#8221; in certain circumstances set out in the Canadian Tax Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends
on Common Shares</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Resident Holder to whom NioCorp pays or credits or is deemed to pay or credit a dividend on such holder&#8217;s Common Shares
will be subject to Canadian withholding tax, and NioCorp will be required to withhold the tax from the dividend and remit it to
the CRA for the holder&#8217;s account. The rate of withholding tax under the Canadian Tax Act is 25% of the gross amount of the
dividend, but should generally be reduced under the Convention to 15% (or, if the U.S. Resident Holder is a company which is the
beneficial owner of at least 10% of the voting stock of NioCorp, 5%) of the gross amount of the dividend. For this purpose, a
company that is a resident of the United States for purposes of the Canadian Tax Act and the Convention and is entitled to the
benefits of the Convention shall be considered to own the voting stock of NioCorp owned by an entity that is considered fiscally
transparent under the laws of the United States and that is not a resident of Canada, in proportion to such company&#8217;s ownership
interest in that entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0"><span id="a039"></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;6.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>RESERVED</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0"/><td style="width: 0.8in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a040"></span>ITEM
                          7.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following Management&#8217;s Discussion and Analysis (&#8220;MD&amp;A&#8221;) provides information that management believes is
relevant to an assessment and understanding of the consolidated financial condition and results of operations of NioCorp and subsidiaries.
This item should be read in conjunction with our consolidated financial statements and the notes thereto included in this Annual
Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a041"></span>Summary
of Consolidated Financial and Operating Performance</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no revenues from mining operations during the fiscal years presented below. Operating expenses incurred related primarily
to performing exploration and feasibility study related activities, as well as the activities necessary to support corporate and
shareholder duties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 65%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the year ended June 30,</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    </tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,958</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,757</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss attributable to the Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17,405</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,435</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss per share (basic and diluted)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.36</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">The
net loss attributable to the Company increased to $17.4 million for fiscal year 2025 from $11.4 million for fiscal year 2024.
This increased net loss in fiscal year 2025 as compared to fiscal year 2024 is primarily due to the fiscal year 2025 recognition
of non-cash losses related to the valuation of the Earnout Share and Warrant liabilities, partially offset by lower interest
expense, financial instrument fair values, and operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a042"></span>Results
of Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no revenues from mining operations during the fiscal years presented below. Operating expenses incurred related primarily
to performing exploration and feasibility study related activities, and the activities necessary to support corporate and shareholder
duties, as detailed in the following table:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 17.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 17.75pt"></p>

<!-- Field: Page; Sequence: 18; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 90%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the year ended June 30,</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($000)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 57%; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
    expenses:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 14%; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 1%; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 14%; padding-right: 0.7pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
    related costs</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,944</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,509</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
    fees</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,237</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,533</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exploration
    expenditures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,135</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,552</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    operating expenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,642</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,163</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    operating expenses</span></td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,958</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,757</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of earnout shares liability</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,063</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,704</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of warrant liabilities </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,093</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,875</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of convertible note</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,542</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expense</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,490</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange gain</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
    <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; text-indent: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest income</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(94</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>


<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt; padding-left: 8.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    gains</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(122</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(147</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on equity securities</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax benefit</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(139</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    attributable to noncontrolling interest</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(577</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(463</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
    loss attributable to the Company </b></span></td>
    <td style="border-bottom: Black 2.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(17,405</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 0.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td>
    <td style="border-bottom: Black 2.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(11,435</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Fiscal
Year 2025 as Compared to Fiscal Year 2024 </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
items affecting operating expenses are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employee-related
expenditures</i> decreased in fiscal year 2025 as compared to fiscal year 2024 primarily due to a reduction in the number of Options
issued to employees and the impact of a lower stock price on the Black-Scholes modeling results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Professional
fees</i> decreased for fiscal year 2025 as compared to fiscal year 2024, primarily due to higher costs incurred in 2024 related
to the timing of legal services associated with the Company&#8217;s SEC registration statements filed in October 2023, as well
as increased audit fees associated with the Company&#8217;s June 30, 2023 financial statements and increased review fees in connection
with the Company&#8217;s September 30, 2023 financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exploration
expenditures</i> increased for fiscal year 2025 as compared to 2024, as fiscal year 2025 costs include expenditures related to
a drilling program initiated by the Company in April 2025 designed to support the conversion of a portion of the Company&#8217;s
current Indicated Resources into Measured Resources and the subsequent conversion of a portion of current Probable Mineral Reserves
into Proven Mineral Reserves. Fiscal year 2024 costs included expenses associated with the third-party owned and operated Demonstration Plant, for which testwork was completed during the third quarter of fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
operating expenses</i> decreased for fiscal year 2025 as compared to fiscal year 2024 primarily due to a decrease in director
and officer insurance expense, the timing of fully vested Options issued to board members and advisors, and declines in scandium
development initiatives and financial-related services, partially offset by the expense incurred in 2025 associated with a cybersecurity
incident that resulted in misdirected vendor payments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
significant items impacting the change in the Company&#8217;s net loss are noted below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-indent: 17.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of Earnout Shares liability </i>represents the change in fair value related to the Earnout Shares based on the results
of Monte Carlo financial modeling. Overall, the increased expense in fiscal year 2025 corresponds to an overall increase in our
share value during fiscal year 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of Warrant liability </i>represents the change in fair value related to our liability-classified Warrant obligations.
The increase in expense during fiscal year 2025 is due primarily to the increase in the ending market value of our Common Shares
as of June 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 19; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change
in fair value of convertible notes </i>represents the impact of the initial allocation of fair value to the April 2024 Notes (as
defined below), which are carried at fair value, as well as the impact of fair value adjustments through final payoff.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<i>Interest
expense</i> decreased in fiscal year 2025 as compared to fiscal year 2024 due to the impacts of convertible debenture interest
expense incurred in fiscal year 2024. This convertible debt instrument was paid off in early fiscal year 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loss
attributable to noncontrolling interest</i> represents the portion of net loss in ECRC attributable to the Vested Shares, which
are not owned by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a043"></span>Liquidity
and Capital Resources</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no revenue generating operations from which we can internally generate funds. To date, our ongoing operations have been financed
by the sale of our equity securities by way of public and private offerings, convertible securities issuances, the exercise of
incentive Options and Warrants, and related party loans. With respect to currently outstanding Options and Warrants, we believe
that exercise of these instruments, and cash proceeds from such exercises, will not occur unless and until the market price for
our Common Shares equals or exceeds the related exercise price of each instrument.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II (&#8220;Lind II&#8221; and, together with Yorkville,
the &#8220;April 2024 Purchasers&#8221;), $8.0 million aggregate principal amount of unsecured notes (the &#8220;April 2024 Notes&#8221;),
pursuant to a securities purchase agreement, dated April 11, 2024, between the Company and each of the April 2024 Purchasers.
The Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of the April 2024 Notes
issued to each April 2024 Purchaser, Warrants to purchase up to 615,385 Common Shares. All remaining amounts due to Lind II ($176,000)
and Yorkville ($1.0 million) under the April 2024 Notes were repaid on January 6, 2025, and February 7, 2025, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, the Company and Mark Smith entered into the Loan Agreement, by and between the Company and Mark Smith (the
&#8220;Smith Loan Agreement&#8221;), which provides for a $2.0 million non-revolving credit facility (the &#8220;Smith Loan&#8221;).
A total of $504,000 was subsequently drawn down, and subsequently the Company repaid $508,000, representing the balance of the
interest and principal outstanding under the Smith Loan, plus $41,000 related to the loan origination fees payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 5, 2024, the Company closed an underwritten public offering (the &#8220;November 2024 Registered Offering&#8221;), pursuant
to the underwriting agreement, dated November 3, 2024, with Maxim, as underwriter, which consisted of 1,592,356 Common Shares,
1,672,090 Series A Warrants to purchase up to an additional 1,672,090 Common Shares and 836,045 Series B Warrants to purchase
up to 836,045 Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 13, 2024, the Company closed a non-brokered private placement (the &#8220;November 2024 Private Offering&#8221;) pursuant
to binding subscription agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602
units of the Company (the &#8220;November 2024 Units&#8221;). Each November 2024 Unit consists of one Common Share, one Series
A Warrant to purchase up to an additional Common Share and one-half of one Series B Warrant to purchase up to one-half of one
Common Share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 31, 2025, the Company closed an underwritten public offering (the &#8220;January 2025 Offering&#8221;), pursuant to the
underwriting agreement, dated January 29, 2025, with Maxim, as underwriter, which consisted of 2,577,320 Common Shares, 2,577,320
Series A Warrants to purchase up to an additional 2,577,320 Common Shares and 1,288,660 Series B Warrants to purchase up to 1,288,660
Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2025, the Company closed an underwritten public offering (the &#8220;April 2025 Offering&#8221;), pursuant to an underwriting
agreement dated April 17, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold an aggregate of 8,015,812
Common Shares (or pre-funded Warrants in lieu thereof), which includes 323,504 Common Shares issued and sold pursuant to Maxim&#8217;s
partial exercise of its over-allotment option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 20; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined gross proceeds from the November 2024 Registered Offering, the November 2024 Private Offering, the January 2025 Offering,
and the April 2025 Offering were approximately $31.8 million, before deducting underwriting discounts and offering expenses. In
addition, during fiscal year 2025, the Company issued an aggregate of 6,499,977 Common Shares under the Yorkville Equity Facility
Financing Agreement and through the exercise of Warrants by their holders, as a result of which, the Company received cash totaling
approximately $13.8 million. A portion of these proceeds were used for working capital and general corporate purposes, to repay
amounts outstanding on the Smith Loan, to repay the April 2024 Notes, and to advance efforts to launch construction of the Elk
Creek Project and move it to commercial operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2025, the Company had cash of $25.6 million and working capital of $24.8 million, compared to cash of $2.0 million
and a working capital deficit of $9.0 million on June 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the Company will operate at a loss for the foreseeable future. The Company&#8217;s current planned cash needs are
approximately $40.0 million to $50.0 million for the next twelve months. In addition to outstanding accounts payable and short-term
liabilities, our planned expenditures over the next twelve months are expected to consist of expenditures relating to certain
advancements of the Elk Creek Project by NioCorp&#8217;s majority owned subsidiary, ECRC, corporate overhead costs, and estimated
costs related to securing financing necessary for advancement of the Elk Creek Project. As discussed below, if the Company were
able to obtain additional funding, the Company would be in a position to accelerate planned expenditures ahead of its current
schedule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
planned expenditures relating to the advancement of the Elk Creek Project over the next twelve months include, but are not
limited to, an updated resource and reserve estimate and associated mine plan and an updated capital cost estimate in
connection with the EXIM application process. The planned corporate overhead costs over the next twelve months include Elk
Creek property lease commitments, which are $57,000 through June 30, 2026, and outstanding accounts payable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated financing costs associated with the Elk Creek Project over the next twelve months include, but are not limited to, costs
relating to the EXIM application process, the scope of which remains under discussion with EXIM. On June 6, 2023, the Company
announced that it had submitted an application to EXIM for up to $800 million in debt financing (the &#8220;EXIM Financing&#8221;)
to fund the project costs for the Elk Creek Project, under EXIM&#8217;s &#8220;Make More in America&#8221; initiative. The EXIM
Financing is subject to, among other matters, the satisfactory completion of due diligence, the negotiation and settlement of
final terms, and the negotiation of definitive documentation. There can be no assurance that the EXIM Financing will be completed
on the terms described herein or at all. The Company was informed that its application received approval by the first of three
reviews by the EXIM Transaction Review Committee (the &#8220;TRC&#8221;) on October 2, 2023. During the fourth quarter of fiscal
year 2025, EXIM continued to process the Company&#8217;s application for debt financing under EXIM&#8217;s Make More in America
Program. The Company&#8217;s application sits at the TRC in the second step in EXIM&#8217;s four-step approval process. The Company
continues to meet with EXIM as well as providing responses to requests for additional information from EXIM and to the consultants
that are conducting due diligence on the Company&#8217;s application on behalf of EXIM. As part of the diligence process, EXIM
has identified additional project activities to be undertaken, including, among other things, an updated mine plan and updated
Elk Creek Project capital costs on a final or close-to-final basis reflecting updated process flows. However, there can be no
assurance what further project activities or matters EXIM may request in connection with the application process. We are currently
unable to estimate how long the application process may take, and there can be no assurances that we will be able to successfully
negotiate a final commitment of debt financing from EXIM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 18, 2025, the Company closed a public offering (the &#8220;July 2025 Offering&#8221;), pursuant to which the Company issued
and sold 13,850,000 Common Shares at a public offering price of $3.25 per Common Share, for net proceeds of approximately $41.8
million after deducting placement agent fees discounts and prior to other offering expenses. Maxim acted as sole placement agent
for the July 2025 Offering. The Company intends to use the net proceeds from the July 2025 Offering for working capital and general
corporate purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial
operation. During the period from July 1, 2025 through September 11, 2025, the
Company also issued 5,000,312 Common Shares through the exercise of Warrants and Options by their
holders, and received cash totaling approximately $10.4 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 4, 2025, ECRC entered into the DoD Agreement with ATI, an entity acting on behalf of the Defense Industrial Base Consortium
under the authority of the DoD. Subject to the terms and conditions of the DoD</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 2pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 21; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">Agreement, ECRC is entitled to receive up to an
aggregate of approximately $10.0 million of reimbursement payments from the DoD upon the achievement of certain project milestones
related to feasibility study-level engineering and additional reserve drilling, as well as preparing updated cost estimates, for
the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">We
expect to use our cash balance as of June 30, 2025, as well as the proceeds from the July 2025 Offering, the proceeds from the
Warrant exercise issuances, and the reimbursement payments pursuant to the DoD Agreement, to fund our planned expenditures for
the next twelve months. However, additional work is required in order to advance the Elk Creek Project, requiring additional financing.
The S-K 1300 Elk Creek Technical Report Summary includes an estimated total upfront capital expenditure for the Elk Creek Project
of approximately $1,141.0 million. The actual amount of capital expenditure required to successfully achieve commercial production
at the Elk Creek Project is subject to, among other factors, the timing and actual cost of further exploration, preparing feasibility
studies, permitting, engineering and the construction of infrastructure, mining and processing facilities. If the Company were
able to obtain additional funding, the Company would be in a position to accelerate planned expenditures ahead of its current
schedule. In addition, to the extent that EXIM requests further project activities to be undertaken in connection with the diligence
process, the Company would require additional funding to complete such activities. The Company&#8217;s ability to continue operations
and fund our current work plan is dependent on management&#8217;s ability to secure additional financing.&#160;When available,
the Yorkville Equity Facility Financing Agreement provides an opportunity to actively manage the cash needs of the Company more
closely, and the Company may also utilize the Yorkville Equity Facility Financing Agreement to potentially generate funds at a
time when they are in need. Alternatively, the Company can also utilize the Yorkville Equity Facility Financing Agreement for
opportunistic share sales. However, the Yorkville Equity Facility Financing Agreement will expire by its terms on April 1, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 22.5pt">Except
for the potential funding from advances under the Yorkville Equity Facility Financing Agreement, as discussed above, and the potential
exercise of Options and Warrants, we currently have no further funding commitments or arrangements for additional financing at
this time. Management currently anticipates that it will fund the upfront capital expenditure amount for the Elk Creek Project
through a combination of debt and equity financing, with approximately two-thirds of such amount being funded from the net proceeds
of debt financing, including the amount of debt that would be represented by the EXIM Financing, if any. Management is actively
pursuing additional sources of debt and equity financing to meet its long-term funding requirements, and while it has been successful
in doing so in the past, there is no assurance that we will be able to obtain any such additional financing on acceptable terms,
if at all. Pursuant to the Exchange Agreement, NioCorp is restricted from issuing equity or equity-linked securities (other than
Common Shares) or any preferred equity or non-voting equity if such issuance would adversely impact the rights of the holders of
the shares of Class B common stock of ECRC, without the consent of the holders of a majority of the shares of Class B common stock
of ECRC. On July 17, 2025, we entered into the Placement Agency Agreement with Maxim, which also contains certain covenants that,
among other things, limit NioCorp&#8217;s ability to enter into any variable rate transaction on or before September 17, 2025, including
issuances of equity or debt securities that are convertible into Common Shares at variable rates and any equity line of credit,
ATM agreement, or other continuous offering of Common Shares, other than with Maxim, subject to certain exceptions. Notwithstanding
the restrictions set forth in the Exchange Agreement and the Placement Agency Agreement, there is significant uncertainty that
we would be able to secure any additional financing in the current equity or debt markets. The quantity of funds to be raised and
the terms of any proposed equity or debt financing that may be undertaken will be negotiated by management as opportunities to
raise funds arise. Management may pursue funding sources of both debt and equity financing, including but not limited to the issuance
of equity securities in the form of Common Shares, Warrants, subscription receipts, or any combination thereof in units of the
Company pursuant to private placements to accredited investors or pursuant to public offerings in the form of underwritten/brokered
offerings, registered direct offerings, or other forms of equity financing and public or private issuances of debt securities,
including secured and unsecured convertible debt instruments, or secured debt project financing. Management does not currently
know the terms pursuant to which such financings may be completed in the future, but any such financings will be negotiated at
arm&#8217;s-length. Future financings involving the issuance of equity securities or derivatives thereof will likely be completed
at a discount to the then-current market price of the Company&#8217;s securities and will likely be dilutive to current shareholders.
In addition, we could raise funds through the sale of interests in our mineral properties, although current market conditions and
other recent worldwide events have substantially reduced the number of potential buyers/acquirers of any such interests. However,
we cannot provide any assurances that we will be able to be successful in raising such funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 1pt; text-align: justify; text-indent: 22.5pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 22.5pt"></p>

<!-- Field: Page; Sequence: 22; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the conditions described within, management has concluded and the audit opinion and notes that accompany our consolidated financial
statements for the year ended June 30, 2025, disclose that substantial doubt exists as to our ability to continue as a going concern.
The consolidated financial statements included in this Annual Report on Form 10-K have been prepared under the assumption that
we will continue as a going concern. As defined under S-K 1300, we are a development stage issuer, and we have incurred losses
since our inception. The Company will require additional capital to meet its long-term operating requirements. Uncertainty in
capital markets, supply chain disruptions, increased interest rates and inflation, and the potential for geographic recessions
have contributed to general global economic uncertainty. During fiscal year 2025, these events continued to create uncertainty
with respect to overall project funding and timelines. We believe that the going concern uncertainty cannot be alleviated with
confidence until the Company has entered into a business climate where funding of its planned ongoing operating activities is
secured. Therefore, these factors raise substantial doubt as to our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no exposure to any asset-backed commercial paper. Other than cash held by our subsidiaries for their immediate operating
needs in Colorado and Nebraska, all of our cash reserves are on deposit with major U.S. and Canadian chartered banks. We do not
believe that the credit, liquidity, or market risks with respect thereto have increased as a result of the current market conditions.
However, in order to achieve greater security for the preservation of our capital, we have, of necessity, been required to accept
lower rates of interest, which has also lowered our potential interest income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2025, the Company&#8217;s operating activities consumed $10.7 million of cash (2024: $11.7 million). Overall,
operational outflows during fiscal year 2025 decreased from the corresponding period of 2024 primarily due to the timing of vendor
payments. Going forward, the Company&#8217;s working capital requirements are expected to increase substantially in connection
with the development of the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had minimal investing activities during the years ended June 30, 2025 and 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities was $34.2 million in fiscal year 2025 (2024: $11.4 million). This increase in financing
inflows primarily reflects the timing of cash inflows from the financing transactions disclosed above under &#8220;<i>Liquidity
and Capital Resources</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a044"></span>Cash
Flow Considerations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has historically relied upon debt and equity financing to finance its activities. Subject to the restrictions set forth
in the Exchange Agreement, the Company may pursue additional debt and/or equity financing in the medium term; however, there can
be no assurance the Company will be able to obtain any required financing in the future on acceptable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
Company has limited financial resources compared to its proposed expenditures, no source of operating income, and no assurance
that additional funding will be available to it for current or future projects, although the Company has been successful in the
past in financing its activities through the sale of equity securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the Company to arrange additional financing in the future will depend, in part, on the prevailing capital market conditions,
and its success in developing the Elk Creek Project. Any quoted market for the Common Shares may be subject to market trends generally,
notwithstanding any potential success of the Company in creating revenue, cash flows, or earnings, and any depression of the trading
price of the Common Shares could impact its ability to obtain equity financing on acceptable terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
the Company has used net proceeds from issuances of Common Shares to provide sufficient funds to meet its near-term exploration
and development plans and other contractual obligations when due. However, development and construction of the Elk Creek Project
will require substantial additional capital resources. This</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 23; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">includes near-term funding and, ultimately, funding for Elk Creek
Project construction and other costs. See &#8220;<i>Liquidity and Capital Resources&#8221; </i>above, for the Company&#8217;s
discussion of arrangements related to possible future financings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a045"></span>Environmental</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mining and exploration activities are subject to various federal and state laws and regulations governing the protection of the
environment. We have made, and expect to make in the future, expenditures to comply with such laws and regulations, but cannot
predict the full amount of such future expenditures. As of June 30, 2025 and 2024, we had accrued $48,000 and $48,000, respectively,
related to estimated environmental obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a046"></span>Forward-Looking
Statements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing discussion and analysis, as well as certain information contained elsewhere in this Annual Report on Form 10-K, contain
&#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act and Section&#160;21E of
the Exchange Act, and are intended to be covered by the safe harbor created thereby. See the discussion in &#8220;Forward-Looking
Statements&#8221; in Item&#160;1., &#8220;Business.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a047"></span>Accounting
Developments&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements, see Note&#160;3 to the
consolidated financial statements included in this Annual Report on Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a048"></span>Critical
Accounting Estimates and Recent Accounting Pronouncements</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
significant accounting policies are described in&#160;Note 3&#160;to the Consolidated Financial Statements included in this Annual
Report on Form 10-K.&#160;As described in Note 3, we are required to make estimates and assumptions that affect the reported amounts
and related disclosures of assets, liabilities, revenue, and expenses. Our estimates are based on our experience and our interpretation
of economic, political, regulatory, and other factors that affect our business prospects. Many of the inputs into our estimation
process are subjective and are subject to uncertainty over time and therefore, actual results may differ significantly from our
estimates. Note 3 also discloses recent accounting pronouncements applicable to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our most critical accounting estimates are related to the carrying value of our long term assets; accounting for
income taxes and the valuation of deferred tax assets; and the valuation of liabilities associated with Warrants, convertible
debt carried at fair value, and Earnout Shares, as they require us to make assumptions that are highly uncertain at the time the
accounting estimates are made and changes in them are reasonably likely to occur from period to period. Management has discussed
the development and selection of these critical accounting estimates with the Audit Committee of our Board (the &#8220;Audit Committee&#8221;),
and the Audit Committee has reviewed the disclosures presented below. In addition, there are other items within our financial
statements that require estimation, but are not deemed to be critical. However, changes in estimates used in these and other items
could have a material impact on our consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Carrying
Value of Long-Lived Assets </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. Key inputs include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Many of these inputs are subjective and are subject to uncertainty over time. Such evaluations compare estimated future
net cash flows with our carrying costs and future obligations on an undiscounted basis. If it is determined that the estimated
future undiscounted cash flows are less than the carrying value of the property, an impairment loss will be recorded, measured
by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Where</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 24; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"><span style="font: 10pt Times New Roman, Times, Serif">estimates of future net cash
flows are not determinable and where other conditions indicate the potential for impairment, management uses available market
information and/or third-party valuation experts to assess if the carrying value can be recovered and to estimate fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review and evaluate our long-lived assets, other than mineral properties, for impairment when events or changes in circumstances
indicate that the related carrying amounts may not be recoverable. An impairment loss is measured and recorded based on the estimated
fair value of the long-lived assets being tested for impairment and their carrying amounts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have assets, hold interests, and conduct activities in the U.S. and Canada and are subject to their tax regimes. Tax laws are
complex and continue to evolve. While we have a history of losses, our assumptions made in tax returns are subject to review and
interpretation by taxing authorities and could be modified. Management judgment is required in determining our provision for income
taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. We consider
factors such as the cumulative income or loss in recent years; reversal of deferred tax liabilities; projected future taxable
income exclusive of temporary differences; the character of the income tax asset, including income tax positions; tax planning
strategies and the period over which we expect the deferred tax assets to be recovered in the determination of the valuation allowance.
In the event that actual results differ from these estimates or we adjust our estimates in the future, we may need to adjust our
valuation allowance, which could materially impact our financial position and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financial
Instruments Carried at Fair Value</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair values of our Earnout Shares, private Warrants, Contingent Consent Warrants, and convertible debt carried at fair value
were determined using various significant unobservable inputs, including a discount rate and our best estimate of expected
volatility and expected holding periods. Changes in the estimated fair values of these liabilities may have material impacts
on our results of operations in any given period, as any increases in these liabilities have a corresponding negative impact
on our U.S. GAAP results of operations. See Notes 8, 9, and 10c to our consolidated financial statements included in this
Annual Report on Form 10-K for additional details.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a049"></span>Other</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one class of shares, being Common Shares. A summary of outstanding Common Shares, Vested Shares, Options, and Warrants
as of September 11, 2025, is set out below, on a fully diluted basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Shares Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(fully diluted)</b></span></p></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 72%; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Shares</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: right; padding-left: 5.4pt">77,757,089</td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested Shares<sup>(1)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right; padding-left: 5.4pt">3,518,450</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options<sup>(2)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right; padding-left: 5.4pt">4,900,000</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants<sup>(3)</sup></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right; padding-left: 5.4pt">24,787,533</td>
    <td>&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         exchangeable into one Common Share at any time, and from time to time, until the tenth
                                         anniversary of the Closing Date.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 23pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                         exercisable for one Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 27pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                         15,666,626 NioCorp Assumed Warrants that are each exercisable for 1.11829212 Common Shares,
                                         and 9,120,907 Warrants that are each exercisable
                                         into one Common Share.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                            7A.</span></td><td style="text-align: justify"><span id="a050"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a051"></span>Interest
rate risk</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s exposure to changes in market interest rates, relates primarily to the Company&#8217;s earned interest income
on cash deposits and short-term investments. The Company maintains a balance between the liquidity of cash assets and the interest
rate return thereon. The carrying amount of financial assets, net of any provisions for losses, represents the Company&#8217;s
maximum exposure to credit risk.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 25; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a052"></span>Foreign
currency exchange risk</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurs expenditures in both U.S. and Canadian dollars. Canadian dollar expenditures are primarily related to engineering
and metallurgical expenses, as well as certain professional services. As a result, currency exchange fluctuations may impact the
costs of our operating activities. To reduce this risk, we maintain sufficient cash balances in Canadian dollars to fund expected
near-term expenditures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a053"></span>Commodity
price risk</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is exposed to commodity price risk related to the elements associated with the Elk Creek Project. A significant decrease
in the global demand for these elements may have a material adverse effect on our business. The Elk Creek Project is not in production,
and the Company does not currently hold any commodity derivative positions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"><span id="a054"></span></td><td style="width: 0.75in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                            8.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 26; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the shareholders and the Board of Directors of NioCorp Developments Ltd.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_985_edei--AuditorOpinionTextBlock_c20240701__20250630_z0cPxgCiDQH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000056" name="dei:AuditorOpinionTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of NioCorp Developments Ltd. and subsidiaries (the &#8220;Company&#8221;)
as of June 30, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, cash flows, and shareholders&#8217;
equity and redeemable noncontrolling interest, for the each of the two years in the period ended June 30, 2025, the related notes
(collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and
its cash flows for each of the two years in the period ended June 30, 2025 in conformity with accounting principles generally
accepted in the United States of America.</span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As
discussed in Note 4 to the financial statements, the Company has an accumulated deficit and does not generate any revenue.
Further, the Company does not have sufficient cash on hand to fund normal operations as well as the construction necessary
for mine development for the next twelve months. These conditions raise substantial doubt about its ability to continue as a
going concern. Management&#8217;s plans in regard to these matters are also described in Note 4. The consolidated financial
statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly,
we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audit provides a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matter</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was
communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material
to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of
critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by
communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or
disclosures to which it relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 27; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants
issued in the current year and classified as equity&#8212; Refer to Notes 3 and 10 to the financial statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Critical
Audit Matter Description</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, November 5, 2024, January 31, 2025, and April 17, 2025, the Company issued warrants, which Management determined
would be classified as equity when issued to investors or lenders, collectively referred to as the &#8220;Warrants&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
warrants issued to investors or lenders in exchange for cash or other financial assets, Management follows guidance issued within
ASC 480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, <i>Derivatives and Hedging</i>, to assist in the determination
of whether the warrants should be classified as liabilities or equity. Warrants that are determined to require equity classification
are measured at fair value upon issuance and are not subsequently remeasured unless they are required to be reclassified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the significant assumptions made by management in determining the accounting classification for the Warrants, performing audit
procedures to evaluate the reasonableness of management's conclusions required a high degree of auditor judgment and an increased
extent of effort, including the need to involve professionals with expertise in accounting for complex financial instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>How
the Critical Audit Matter Was Addressed in the Audit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit procedures related to the Warrants included the following, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         evaluated management&#8217;s accounting position through the following procedures:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"/><td style="width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtained
                                         and evaluated the Company&#8217;s accounting memoranda regarding the application of the
                                         relevant accounting guidance for the Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.5pt"/><td style="width: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtained,
                                         read and compared the underlying terms and conditions of the relevant contracts to the
                                         Company&#8217;s accounting memoranda and evaluated management&#8217;s identification
                                         of significant terms and conditions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 22.3pt"/><td style="width: 13.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
                                         the Company&#8217;s conclusions regarding the accounting treatment applied to the transactions
                                         with the assistance of professionals with expertise in accounting for complex financial
                                         instruments.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
                                         the completeness and accuracy of the disclosures related to the Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <span style="text-transform: uppercase">Deloitte &amp; Touche</span> LLP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--AuditorLocation_c20240701__20250630_zwS1p2dxuPc6"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000057" name="dei:AuditorLocation">Denver,
Colorado</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 11, 2025<span id="xdx_903_edei--AuditorName_c20240701__20250630_zj6NjUXEq0Hd" style="display: none; visibility: hidden"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000058" name="dei:AuditorName">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="visibility: hidden"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_90B_edei--AuditorFirmId_c20240701__20250630_z1k1wDHXljl6" style="display: none"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000059" name="dei:AuditorFirmId">34</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="b002"></span>Consolidated Balance Sheets</b></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_pn3n3_zxVVpUpdWvUd" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom; background-color: white; visibility: hidden">
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_497_20250630_z45FoH9CGq1c" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_495_20240630_zsxgVOPY8szi" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zTkrxvcoTydh" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsCurrentAbstract_iB_ziGiA3d3M991" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maACz9aO_zkLwT6VPlZi4" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 70%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2025-06-30" id="Fact000067" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,554</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-06-30" id="Fact000068" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--PrepaidExpenseCurrent_i01I_maACz9aO_zZSNLhU15KF6" style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Prepaid expenses and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2025-06-30" id="Fact000070" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,183</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-06-30" id="Fact000071" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">916</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AssetsCurrent_i01TI_mtACz9aO_maAzj3U_zAc86IbOBaI4" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2025-06-30" id="Fact000073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,737</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-06-30" id="Fact000074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,928</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--AssetsNoncurrentAbstract_iB_zajNuBKDXHE8" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; padding-left: 0.7pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DepositsAssets_i01I_maAzj3U_ztEhLUGK6Ft7" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.125in">Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2025-06-30" id="Fact000079" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepositsAssets" contextRef="AsOf2024-06-30" id="Fact000080" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LongTermInvestmentsAndReceivablesNet_i01I_maAzj3U_z6q1z7xoktd3" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Investment in equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2025-06-30" id="Fact000082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermInvestmentsAndReceivablesNet" contextRef="AsOf2024-06-30" id="Fact000083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maAzj3U_zPogbZpoHBRf" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2025-06-30" id="Fact000085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">118</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2024-06-30" id="Fact000086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">181</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentGross_i01I_maAzj3U_zgjIaqHDUWZ6" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Land and buildings, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-06-30" id="Fact000088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-06-30" id="Fact000089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">837</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--CapitalizedCostsMineralInterestsInUnprovedProperties_i01I_maAzj3U_zqCHwHP1pNmj" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Mineral properties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2025-06-30" id="Fact000091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties" contextRef="AsOf2024-06-30" id="Fact000092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,085</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--Assets_i01TI_mtAzj3U_zAoJQGA9bAcf" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.7pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2025-06-30" id="Fact000094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,819</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-06-30" id="Fact000095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,070</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: right; padding-left: 0.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesAbstract_iB_zxc3hg4vrkS3" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; padding-left: 0.7pt">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsCurrentAbstract_iB_zxGewlvNWbo3" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.7pt">Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--AccountsPayableCurrent_i01I_maLCzg0y_zx6MtHqIN0Tc" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Accounts payable and accrued liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2025-06-30" id="Fact000103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,795</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-06-30" id="Fact000104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,843</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OtherLiabilitiesCurrent_i01I_maLCzg0y_zoadvRBYPuP" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Warrant liabilities, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0106">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000107" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ConvertibleDebtCurrent_i01I_maLCzg0y_zWYFOrwLYKU1" style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.125in">Convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0109">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-06-30" id="Fact000110" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,660</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maLCzg0y_zwWKV6l0S0O1" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2025-06-30" id="Fact000112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-06-30" id="Fact000113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzg0y_maLzZEE_zpqzfHyNt4B6" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact000115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,893</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,964</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--AssetsNoncurrentAbstract_iB_zEfvMY29wCJ" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.7pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzZEE_zf5bW02h0pTd" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Warrant liabilities, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2025-06-30" id="Fact000121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,852</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2024-06-30" id="Fact000122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--EarnoutLiabilityAtFairValue_i01I_maLzZEE_zjrutEsisoz9" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Earnout liability, at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2025-06-30" id="Fact000124" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutLiabilityAtFairValue" contextRef="AsOf2024-06-30" id="Fact000125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maLzZEE_zjpWrpAOnSVk" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2025-06-30" id="Fact000127" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-06-30" id="Fact000128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">104</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--Liabilities_i01TI_mtLzZEE_maLASEz2Vd_zGw1vNgnfaaa" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2025-06-30" id="Fact000130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,658</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-06-30" id="Fact000131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,536</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CommitmentsAndContingencies_i01I_zrNv1jsgrOE8" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.7pt">Commitments and contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="display: none; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0133">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--RedeemableNoncontrollingInterestEquityCarryingAmount_i01I_maLASEz2Vd_zwUMrDFDHIM" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.7pt">Redeemable noncontrolling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2025-06-30" id="Fact000136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">838</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" contextRef="AsOf2024-06-30" id="Fact000137" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_iB_zIlpDlC3tss3" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">SHAREHOLDERS&#8217; EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--CommonStockValue_i01I_maSEzGpR_zvPx6Lv8fPc1" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Common stock, <span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20240630_z9J9vqvn0MI7" title="Common stock, par value (in dollars per share)"><span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20250630_zm9RePyutM8f" title="Common stock, par value (in dollars per share)"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-06-30" id="Fact000145" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-06-30" id="Fact000147" format="ixt-sec:numwordsen" decimals="INF" unitRef="USDPShares">no</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_903_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20230701__20240630_zKhpUoam1Bd2" title="Common stock, authorized::XDX::Unlimited"><span id="xdx_908_eus-gaap--CommonStockSharesAuthorizedUnlimited_dxL_c20240701__20250630_zllHhkJOUBM7" title="Common stock, authorized::XDX::Unlimited"><span style="-sec-ix-hidden: xdx2ixbrl0149"><span style="-sec-ix-hidden: xdx2ixbrl0151">unlimited</span></span></span></span> shares authorized;&#160; <br/><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20250630_zsbHtSQk5jZi" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-06-30" id="Fact000153" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,491,196</ix:nonFraction></span> and <span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20240630_zVXpA87pmvTl" title="Common stock, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30" id="Fact000155" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,062,647</ix:nonFraction></span> shares outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2025-06-30" id="Fact000142" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">208,551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-06-30" id="Fact000143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163,823</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_maSEzGpR_z8Zh9yleH73e" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Accumulated deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2025-06-30" id="Fact000157" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">179,317</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-06-30" id="Fact000158" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">161,912</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_maSEzGpR_zs8xjZslo0L5" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Accumulated other comprehensive loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2025-06-30" id="Fact000160" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2024-06-30" id="Fact000161" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--StockholdersEquity_i01TI_mtSEzGpR_maLASEz2Vd_zJ7EW2mvkWGj" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 0.7pt">Total shareholders&#8217; equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30" id="Fact000163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,323</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEz2Vd_zx4KkWjAXWk6" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -17.25pt; padding-left: 17.25pt">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2025-06-30" id="Fact000166" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,819</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000167" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,070</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 29; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="b003"></span>Consolidated Statements of Operations and Comprehensive
Loss</b></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and per
share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_113_pn3n3_zEYYmuceYXk4" summary="xdx: Statement - Consolidated Statements of Operations and Comprehensive Loss" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom; background-color: white; visibility: hidden">
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_49A_20240701__20250630_zCngYCiCdrD7" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_492_20230701__20240630_zSmumAKzyv5d" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingExpensesAbstract_iB_z0Bun7TBWzUf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--LaborAndRelatedExpense_i01_maOEzH24_zgdJJ1y9uve" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Employee related costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000172" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,944</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-07-012024-06-30" id="Fact000173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,509</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--ProfessionalFees_i01_maOEzH24_zh9O9L7hHnCb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Professional fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-07-01to2025-06-30" id="Fact000175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-07-012024-06-30" id="Fact000176" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,533</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ExplorationExpense_i01_maOEzH24_z6LLppg3rvdd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Exploration expenditures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000178" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,135</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30" id="Fact000179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,552</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OtherGeneralExpense_i01_maOEzH24_zjkLRwiAXAIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0.7pt">Other operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,642</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-07-012024-06-30" id="Fact000182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,163</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--OperatingExpenses_i01T_mtOEzH24_msILFCOzBSr_zwtiuAE7yJFb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 1.5pt; padding-left: 0.7pt">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-07-01to2025-06-30" id="Fact000184" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,958</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-07-012024-06-30" id="Fact000185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,757</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--ChangeInFairValueOfEarnoutSharesLiabilityValue_msILFCOzBSr_zFM4n1jFObT2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Change in fair value of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutSharesLiabilityValue" contextRef="From2024-07-01to2025-06-30" id="Fact000187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,063</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutSharesLiabilityValue" contextRef="From2023-07-012024-06-30" id="Fact000188" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,704</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_409_ecustom--ChangeInFairValueOfWarrantLiabilityValue_msILFCOzBSr_z5laIsu3HCCg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiabilityValue" contextRef="From2024-07-01to2025-06-30" id="Fact000190" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,093</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfWarrantLiabilityValue" contextRef="From2023-07-012024-06-30" id="Fact000191" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,875</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_ecustom--ChangeInFairValueOfConvertibleNotesValue_msILFCOzBSr_ztSFsepFSboe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Change in fair value of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNotesValue" contextRef="From2024-07-01to2025-06-30" id="Fact000193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNotesValue" contextRef="From2023-07-012024-06-30" id="Fact000194" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--InterestExpenseNonoperating_msILFCOzBSr_zX5wi8GPV9Fk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-07-01to2025-06-30" id="Fact000196" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-07-012024-06-30" id="Fact000197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,490</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_iN_di_maILFCOzBSr_zlUoAAMTEYg1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Foreign exchange gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2024-07-01to2025-06-30" id="Fact000199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2023-07-012024-06-30" id="Fact000200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">)</td></tr>


    <tr id="xdx_40F_eus-gaap--InterestIncomeOperating_iN_di_maILFCOzBSr_zi0maanMX4Og" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeOperating" contextRef="From2024-07-01to2025-06-30" id="Fact000202" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0203">-</span></td><td style="text-align: left">&#160;</td></tr>

<tr id="xdx_40C_eus-gaap--OtherIncome_iN_di_maILFCOzBSr_z4OJmfJaTV0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 10.5pt; padding-left: 0.7pt">Other gains</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2024-07-01to2025-06-30" id="Fact000205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherIncome" contextRef="From2023-07-012024-06-30" id="Fact000206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_iN_di_maILFCOzBSr_zpLyqEicG0mg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0.7pt">Loss on equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2024-07-01to2025-06-30" id="Fact000208" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" contextRef="From2023-07-012024-06-30" id="Fact000209" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_maCINOTzPvY_mtILFCOzBSr_z96Uok0ppZU2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.7pt">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000211" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,982</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="Fact000212" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,037</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_d0_msCINOTzPvY_zcBGaeQMFMT7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0.7pt">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact000214" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-07-012024-06-30" id="Fact000215" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">139</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCINOTzPvY_maOEMIBznxO_zLFchENj1Fkj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.7pt">Net loss and comprehensive loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2024-07-01to2025-06-30" id="Fact000217" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,982</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2023-07-012024-06-30" id="Fact000218" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,898</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_msOEMIBznxO_zwMkWRlo1P5h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10.5pt; padding-left: 0.7pt">Net loss attributable to redeemable noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000220" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">577</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="Fact000221" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">463</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--OciEquityMethodInvestmentBeforeTaxParent_iT_mtOEMIBznxO_zVJdiNuINac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.7pt">Net loss and net comprehensive loss attributable to the Company</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2024-07-01to2025-06-30" id="Fact000223" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,405</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OciEquityMethodInvestmentBeforeTaxParent" contextRef="From2023-07-012024-06-30" id="Fact000224" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,435</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 0.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Loss per common share, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zQucXeET3pS6" title="Loss per common share, basic"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zQsaCdLhuk26" title="Loss per common share, diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000226" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-01to2025-06-30" id="Fact000228" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.36</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_z9DEAAsstTIj" title="Loss per common share, basic"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zHxidinHOVg6" title="Loss per common share, diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012024-06-30" id="Fact000230" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30" id="Fact000232" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.31</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right; padding-left: 0.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-left: 0.7pt">Weighted average common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zleb3YYHn7V4" title="Weighted average common shares outstanding, basic"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zFZYpYjoeGte" title="Weighted average common shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000234" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-01to2025-06-30" id="Fact000236" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,072,895</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_zYbkZF5xGfrh" title="Weighted average common shares outstanding, basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zflaSQmrw1Kd" title="Weighted average common shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012024-06-30" id="Fact000238" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012024-06-30" id="Fact000240" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,320,024</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>


<!-- Field: Page; Sequence: 30; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><b><span id="b004"></span>Consolidated Statements of
Cash Flows</b></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_300_112_pn3n3_zXE8sHWJnT97" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom; background-color: white; visibility: hidden">
    <td style="display: none; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_494_20240701__20250630_zz0UxX6ldMsi" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_49C_20230701__20240630_zjK50S95oTta" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zAebg48sql8b" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">CASH FLOWS FROM OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_i01_maNCPBUzBvj_zfsEJLtODZJe" style="vertical-align: bottom; background-color: white">
    <td style="width: 70%; text-align: left; padding-left: 0.125in">Net loss for the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000245" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,982</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30" id="Fact000246" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,898</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zKzQAjecDld8" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Adjustments for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--ChangeInFairValueOfEarnoutShareLiability_i01N_di_msNCPBUzBvj_z3e8vZA6LJ4d" style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.25in">Change in valuation of earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2024-07-01to2025-06-30" id="Fact000251" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,063</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValueOfEarnoutShareLiability" contextRef="From2023-07-012024-06-30" id="Fact000252" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,704</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--ChangeInValuationOfWarrantLiabilities_i01N_di_msNCPBUzBvj_zHCekR5XJFjl" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.25in">Change in valuation of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2024-07-01to2025-06-30" id="Fact000254" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,093</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ChangeInValuationOfWarrantLiabilities" contextRef="From2023-07-012024-06-30" id="Fact000255" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,875</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_ecustom--ChangeInFairValueOfConvertibleNoteValue_i01N_di_msNCPBUzBvj_z9je5MzP1FEi" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.25in">Change in fair value of convertible note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNoteValue" contextRef="From2024-07-01to2025-06-30" id="Fact000257" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ChangeInFairValueOfConvertibleNoteValue" contextRef="From2023-07-012024-06-30" id="Fact000258" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,542</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccretionExpense_i01_maNCPBUzBvj_zLHeNcpACtYa" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.25in">Accretion of convertible debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000260" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpense" contextRef="From2023-07-012024-06-30" id="Fact000261" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,490</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ShareBasedCompensation_i01_maNCPBUzBvj_znbwxiTzlez5" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.25in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-07-01to2025-06-30" id="Fact000263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">789</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-07-012024-06-30" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,881</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_ecustom--FairValueOfCommitmentSharesIssued_i01_maNCPBUzBvj_zgJoZTWCy1K5" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.25in">Yorkville share issuances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2024-07-01to2025-06-30" id="Fact000266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">589</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:FairValueOfCommitmentSharesIssued" contextRef="From2023-07-012024-06-30" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_maNCPBUzBvj_zAA9PzHSagh6" style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.25in">Fair value of insider warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-01to2025-06-30" id="Fact000269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">144</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0270">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--Depreciation_i01_maNCPBUzBvj_zEbpwoZyLjH1" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.25in">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-07-01to2025-06-30" id="Fact000272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-07-012024-06-30" id="Fact000273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--UnrealizedGainLossOnInvestments_i01N_di_msNCPBUzBvj_z9Rtbv4EP49j" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.25in">Unrealized loss on equity securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2024-07-01to2025-06-30" id="Fact000275" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnrealizedGainLossOnInvestments" contextRef="From2023-07-012024-06-30" id="Fact000276" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeaseImpairmentLoss_i01_maNCPBUzBvj_z2Y7hywDEIb3" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.25in">Noncash lease activity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000278" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseImpairmentLoss" contextRef="From2023-07-012024-06-30" id="Fact000279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--OtheroperatingGainsLosses_i01N_di_msNCPBUzBvj_zFW3AuEE0sL" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Other gains</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2024-07-01to2025-06-30" id="Fact000281" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:OtheroperatingGainsLosses" contextRef="From2023-07-012024-06-30" id="Fact000282" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_iT_mtNCPBUzBvj_maNCPBUz43m_zWH7jXskix26" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2024-07-01to2025-06-30" id="Fact000284" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,345</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-07-012024-06-30" id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,580</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_iB_zQaslVcKaLo3" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Change in working capital items:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msNCPBUz43m_zZnu1UA0MOAa" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.25in">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">267</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-07-012024-06-30" id="Fact000291" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">469</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i01_maNCPBUz43m_zLDToBWCAC8" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Accounts payable and accrued liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-07-01to2025-06-30" id="Fact000293" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">48</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-07-012024-06-30" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,621</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzHaa_mtNCPBUz43m_zGpxyg1U38zf" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Net cash used in operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-07-01to2025-06-30" id="Fact000296" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,660</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-07-012024-06-30" id="Fact000297" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,732</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 0.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zUTYV8lKAFuf" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">CASH FLOWS FROM INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--PaymentsToAcquireOtherInvestments_iN_di_msNCPBUznG2_zefE2tyC4Pxe" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Acquisition of fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireOtherInvestments" contextRef="From2024-07-01to2025-06-30" id="Fact000302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0303">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--PaymentsForDeposits_iN_di_msNCPBUznG2_zyCBxhEDwh67" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Deposits</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForDeposits" contextRef="From2024-07-01to2025-06-30" id="Fact000305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0306">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtNCPBUznG2_maCCERCzHaa_zfQIIGW7Pnug" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-07-01to2025-06-30" id="Fact000308" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zRYcl5kgKFLc" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">CASH FLOWS FROM FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfCommonStock_maNCPBUzKXD_zFBA35naPA82" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Proceeds from issuance of common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-07-01to2025-06-30" id="Fact000314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,666</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-07-012024-06-30" id="Fact000315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,185</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ProceedsFromConvertibleDebt_maNCPBUzKXD_zC0BPsK907ok" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Issuance of debt, net of costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-07-012024-06-30" id="Fact000318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,935</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ProceedsFromRelatedPartyDebt_maNCPBUzKXD_zfHUDMlw2Qvg" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Related party debt draws</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-07-01to2025-06-30" id="Fact000320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0321">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--RepaymentsOfRelatedPartyDebt_iN_di_msNCPBUzKXD_zYOjruoowFkk" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.125in">Related party debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2024-07-01to2025-06-30" id="Fact000323" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">504</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0324">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--RepaymentsOfDebt_iN_di_msNCPBUzKXD_zWXMBOojjZ1a" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.125in">Debt repayments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2024-07-01to2025-06-30" id="Fact000326" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,223</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfDebt" contextRef="From2023-07-012024-06-30" id="Fact000327" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,512</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_eus-gaap--PaymentsOfStockIssuanceCosts_iN_di_msNCPBUzKXD_za5rHYbPk7Mb" style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1pt; padding-left: 0.125in">Share issue costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2024-07-01to2025-06-30" id="Fact000329" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,234</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2023-07-012024-06-30" id="Fact000330" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtNCPBUzKXD_maCCERCzHaa_ztmBBCk6sjal" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="font-weight: bold; text-align: left; padding-left: 0.7pt">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-07-01to2025-06-30" id="Fact000332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,209</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-07-012024-06-30" id="Fact000333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,403</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzHaa_z3JdASsD7Gka" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.7pt">Change in cash and cash equivalents during period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-07-01to2025-06-30" id="Fact000335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,542</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-07-012024-06-30" id="Fact000336" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">329</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zDmbCB2Bclif" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.7pt">Cash and cash equivalents, beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000338" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-06-30" id="Fact000339" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,341</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zA0O3r6kQJc5" style="vertical-align: bottom; background-color: white">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.7pt">Cash and cash equivalents, end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2025-06-30" id="Fact000341" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,554</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2024-06-30" id="Fact000342" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-left: 0.7pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--SupplementalCashFlowInformationAbstract_iB_z4nX9b66Jgla" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.7pt">Supplemental cash flow information:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--InterestPaidNet_i01_zghFKRsfttlc" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.25in">Amounts paid for interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-07-01to2025-06-30" id="Fact000347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0348">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_znsKAn1RwQ96" style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-left: 0.25in">Non-cash investing and financing transactions:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--ConversionsOfDebtForCommonShares_i01_zTSeUWISsMHh" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; text-indent: 9.75pt; padding-left: 0.25in">Conversion of debt for common shares</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000353" name="niobf:ConversionsOfDebtForCommonShares">501</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="From2023-07-012024-06-30" id="Fact000354" name="niobf:ConversionsOfDebtForCommonShares">14,479</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--ValueOfWarrantsIssued_i01_zYmjtLuGuq75" style="vertical-align: bottom; background-color: white">
    <td style="text-indent: 9.75pt; padding-left: 0.25in">Value of Warrants issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact000356" name="niobf:ValueOfWarrantsIssued">2,262</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0357">-</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 31; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="b005"></span>Consolidated Statements of Shareholders&#8217; Equity and
Redeemable Noncontrolling Interest</b></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share data)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_303_114_pn3n3_zrbsvs2TAjzd" summary="xdx: Statement - Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: right; padding-left: 0.125in">&#160;</td><td style="border-right: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Common</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Shares</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Outstanding</p></td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zcykXKK4951g" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Common</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z4bpMckOQjQh" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Accumulated Deficit</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zsmlPr6MpTG9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Other Comprehensive</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Loss</p></td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_zOCaw7OgPeuc" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Total</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--RedeemableNoncontrollingInterestMember_z6XLgEHeHpCa" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">Redeemable Noncontrolling Interest</td><td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_437_c20230701__20240630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_z83NcED3o4Z" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; font-weight: bold; padding-bottom: 1pt; padding-left: 0.125in">Balance, June 30, 2023</td><td style="border-right: Black 1pt solid; width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"/><td id="xdx_982_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzd2n6JBtcjl" title="Beginning balance (in shares)" style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000365" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,202,131</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140,421</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000360" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">150,477</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000361" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30" id="Fact000362" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,967</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,100</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueEquityPlacement_zDRED7bWNOB4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Equity placements</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodValueSharesEquityPlacement_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcgCmtcwHWW5" title="Equity placements (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesEquityPlacement" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000373" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">978,432</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,995</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0369">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2023-07-012024-06-30" id="Fact000370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,995</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_zt1aKFVOEXJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Yorkville equity facility draws</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHLj7ettv3wc" title="Yorkville equity facility draws (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000381" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,358,000</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,398</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2023-07-012024-06-30" id="Fact000378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,398</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zdpJtKBsUrEd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Option exercises</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFCV6sFG7LLk" title="Option exercises (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000389" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,800</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0386">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0387">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueRedemptionsOfVestedShares_zJZKj9RmGopk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Redemption of vested shares</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr9ar1s8QYs2" title="Redemptions of vested shares (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000397" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">283,692</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2023-07-012024-06-30" id="Fact000394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000395" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">103</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zIOuoUJyVYBk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Debt conversions</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_pid_uShares_c20230701__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbMYGvD4DCyb" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000405" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,232,592</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,479</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2023-07-012024-06-30" id="Fact000402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,479</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockDividend_iN_di_zXoQAv2irYPk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Option liability valuations</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0408">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockDividend" contextRef="From2023-07-012024-06-30" id="Fact000410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zBswROUWFbOj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance costs</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000413" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0414">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0415">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-07-012024-06-30" id="Fact000416" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">204</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zLjv20YSA7x6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Share-based compensation</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember" id="Fact000419" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,779</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0421">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2023-07-012024-06-30" id="Fact000422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,779</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--ProfitLoss_zWU3yus1ih88" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Loss for the year</td><td style="border-right: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000426" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,435</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0427">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30" id="Fact000428" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,435</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000429" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">463</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_436_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zLjaON4X2Vk6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">Balance, June 30, 2024</td><td style="border-right: Black 1pt solid; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--CommonStockSharesOutstanding_iS_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfnoZ5vk48rc" title="Beginning balance (in shares)" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000437" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">38,062,647</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000431" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">163,823</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000432" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">161,912</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">)</td><td style="border-bottom: Black 2.5pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000433" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">)</td><td style="border-bottom: Black 2.5pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30" id="Fact000434" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueEquityPlacement_zDvZcKaxjHpe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Equity placements</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueSharesEquityPlacement_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zghYrb5AYz3d" title="Equity placements (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesEquityPlacement" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000445" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,321,628</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,059</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0441">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueEquityPlacement" contextRef="From2024-07-01to2025-06-30" id="Fact000442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,059</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_zJBViPxUpGA" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Yorkville equity facility draws</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmES9VfHCLC3" title="Yorkville equity facility draws (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000453" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,671,742</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,941</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0448">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0449">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" contextRef="From2024-07-01to2025-06-30" id="Fact000450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,941</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockWarrantsExercised_iP3custom--StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_z5LLhfFGxyAd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Warrant exercises</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueSharesStockWarrantsExercised_iP3custom--StockIssuedDuringPeriodValueStockWarrantsExercised_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3RPVkUTc614" title="Warrant exercises (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesStockWarrantsExercised" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000461" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">828,235</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000455" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,809</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueStockWarrantsExercised" contextRef="From2024-07-01to2025-06-30" id="Fact000458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,809</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0459">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zamX1gkvwqHa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Option exercises</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkhZpcfDz8gd" title="Option exercises (in shares)" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000469" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">512</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0463">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0464">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0466">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueRedemptionsOfVestedShares_zVVO7a3HQmJ8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Redemption of vested shares</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYDcpjJdEM3g" title="Redemptions of vested shares (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000477" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">348,085</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000471" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0473">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2024-07-01to2025-06-30" id="Fact000474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000475" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">119</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_zri69KJgcc5i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Debt conversions</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQQDur84twqb" title="Debt conversions (in shares)" style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000485" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">258,347</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000479" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0480">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0481">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" contextRef="From2024-07-01to2025-06-30" id="Fact000482" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">501</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_iP3custom--StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_ztXOL1Cce4g3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Issuance of Lind Consent warrants</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,262</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0488">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" contextRef="From2024-07-01to2025-06-30" id="Fact000490" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,262</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_iP3custom--StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_z00yN0E0r7I2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Conversion of private warrants</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000493" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">482</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-07-01to2025-06-30" id="Fact000496" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zmStBXjx0aZ6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance costs</td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000499" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,234</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0500">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0501">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-07-01to2025-06-30" id="Fact000502" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,234</ix:nonFraction></td><td style="text-align: left">)</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_zF4JOZUA2Rff" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in"><p style="margin-top: 0; margin-bottom: 0">Share-based compensation</p></td><td style="border-right: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact000505" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">789</ix:nonFraction></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0507">-</span></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="From2024-07-01to2025-06-30" id="Fact000508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">789</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="border-left: Black 1pt solid">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="border-right: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--ProfitLoss_z53b7sglFREe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Loss for the year</td><td style="border-right: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember" id="Fact000512" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,405</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000514" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,405</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td><td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000515" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">577</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_432_c20240701__20250630_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zsOL9JugkBV4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">Balance, June 30, 2025</td><td style="border-right: Black 1pt solid; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--CommonStockSharesOutstanding_iE_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhjIiyUGJMFd" title="Ending balance (in shares)" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000523" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">58,491,196</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">208,551</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember" id="Fact000518" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">179,317</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">)</td><td style="border-bottom: Black 2.5pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="Fact000519" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">911</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">)</td><td style="border-bottom: Black 2.5pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30" id="Fact000520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,323</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; border-left: Black 1pt solid">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2025-06-30_custom_RedeemableNoncontrollingInterestMember" id="Fact000521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">838</ix:nonFraction></td><td style="border-right: Black 1pt solid; border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">The accompanying notes are an integral part of these consolidated financial statements</p>

<p style="margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<!-- Field: Page; Sequence: 32; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="b006"></span>Notes to the Consolidated Financial Statements </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000525" name="us-gaap:NatureOfOperations"><p id="xdx_80F_eus-gaap--NatureOfOperations_z31rqZBDihfd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td id="xdx_825_zKgby0OEZ7Vg" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
OF BUSINESS</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (the &#8220;Company&#8221; or &#8220;NioCorp&#8221;) was incorporated on February 27, 1987, under the laws of
the Province of British Columbia and currently operates in <span id="xdx_908_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20240701__20250630_zUiL9VuznpU" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0527">one</span></span> reportable operating segment consisting of exploration and development
of mineral deposits in the United States, specifically, the Elk Creek Niobium/Scandium/Titanium property (the &#8220;Elk Creek
Project&#8221;) located in southeastern Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On March 17, 2023 (the &#8220;Closing Date&#8221;),
the Company closed a series of transactions (the &#8220;GXII Transaction&#8221;), pursuant to the Business
Combination Agreement, dated September 25, 2022 (the &#8220;Business Combination Agreement&#8221;), among the Company, GX Acquisition Corp. II (&#8220;GXII&#8221;), and
Big Red Merger Sub Ltd (the &#8220;Closing&#8221;). At the Closing, the Company also closed convertible debt financings (the &#8220;Yorkville
Convertible Debt Financing&#8221;) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with
YA II PN, Ltd., &#8220;Yorkville&#8221;), and the standby equity purchase facility with Yorkville (the &#8220;Yorkville Equity
Facility Financing&#8221; and, together with the Yorkville Convertible Debt Financing, the &#8220;Yorkville Financings&#8221;)
became effective. The transactions contemplated by the Business Combination Agreement, including the GXII Transaction, the Yorkville
Financings and a 10-for-1 reverse stock split consummated in connection with the Closing, are referred to, collectively, as the
&#8220;2023 Transactions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raise substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing, and maintaining continued support from its shareholders and creditors.</span></p>

</ix:nonNumeric><p id="xdx_818_z4Rgz0hGWOql" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000529" name="us-gaap:BasisOfAccounting"><p id="xdx_802_eus-gaap--BasisOfAccounting_z5XvER7iCjeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td id="xdx_82A_zWV72rtHBxva" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BASIS
OF PREPARATION</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                         of Preparation and Consolidation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United
States of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission. The
consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries with all
significant intercompany transactions eliminated. Certain transactions include reference to Canadian dollars (&#8220;C$&#8221;)
where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000531" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"><p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zGuk1eMn6nVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zqTB7GQb4nxg">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 87%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction
    of incorporation</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    at June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zcexJQlne0Xe" title="Jurisdiction of incorporation"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_Entity0896800BCLtdMember" id="Fact000533" name="niobf:IncorporationStateCountryName">British
    Columbia, Canada</ix:nonNumeric></span></span></td>
    <td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_znYdXXHzlZTe" title="Ownership at June 30, 2025" style="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2025-06-30_custom_Entity0896800BCLtdMember" id="Fact000535" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">100</ix:nonFraction>%</span></td>
    <td id="xdx_989_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z67aElvHa7u2" title="Ownership at June 30, 2024" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2024-06-30_custom_Entity0896800BCLtdMember" id="Fact000537" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">100</ix:nonFraction>%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;) <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zsaDnqiKPhAi" title="Jurisdiction of incorporation"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_ElkCreekResourcesCorpECRCMember" id="Fact000539" name="niobf:IncorporationStateCountryName">Delaware,
    USA</ix:nonNumeric></span></span></td>
    <td id="xdx_988_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zHKTM3jTQTR2" title="Ownership at June 30, 2025" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2025-06-30_custom_ElkCreekResourcesCorpECRCMember" id="Fact000541" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">80.42</ix:nonFraction>%</span></td>
    <td id="xdx_98F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zMnPBX90Jxp8" title="Ownership at June 30, 2024" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember" id="Fact000543" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">79.7</ix:nonFraction>%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zAzzIeOpxC7b" title="Jurisdiction of incorporation"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_NioCorpTechnologiesLimitedMember" id="Fact000545" name="niobf:IncorporationStateCountryName">United
    Kingdom</ix:nonNumeric></span></span></td>
    <td id="xdx_983_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zMpkBj4CXK3d" title="Ownership at June 30, 2025" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2025-06-30_custom_NioCorpTechnologiesLimitedMember" id="Fact000547" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">100</ix:nonFraction>%</span></td>
    <td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zraq8mZZDNY1" title="Ownership at June 30, 2024" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByParent" contextRef="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember" id="Fact000549" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">100</ix:nonFraction>%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_zsFFthMyjs42" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5in"><span id="xdx_F13_zump1IRpSDG9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000550" xml:lang="en-US">Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 and 4,282,116 Vested Shares
                                         and 3,391,596 and 3,391,596 Earnout Shares (each as defined below) held by third parties,
                                         and outstanding as of June 30, 2025 and 2024, respectively.</ix:footnote></span></td></tr></table>

</ix:nonNumeric><p id="xdx_8A7_zHuNeDHUudza" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                                         of Estimates</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the valuation of mineral properties, deferred income tax asset valuations, convertible
debt valuations, earnout valuation, derivative liabilities, warrant liabilities, and share-based compensation. The Company bases
its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable
under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results
experienced by the Company may differ materially and adversely from the Company&#8217;s</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 33; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_z0yn0t3yMSn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23F_z3yeifPfBK5c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zOalafuZQEsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zK8Z4GZFyDYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_znS7CB535cl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_23E_zGn83GOtdAd3" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_230_z6AEM9VutHk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">estimates. To the extent there are material
differences between estimates and the actual results, future results of operations will be affected.</span></p>

</ix:nonNumeric><p id="xdx_810_ziWTZybv2ucb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000559" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zP1oUJg4dpU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td id="xdx_823_zN0w7EFaP3zb" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNIFICANT
ACCOUNTING POLICIES</span></td>
</tr></table>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000561" name="niobf:DevelopmentStageIssuerPolicyTextBlock"><p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zc8c0al9Ze3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td id="xdx_868_z3ZweeecMiT3" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
                                         Stage Issuer</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

</ix:nonNumeric><p id="xdx_85C_z9ppAztdFu9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000563" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zwFw94J5Xv96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td id="xdx_86E_zp7AyUpFwzql" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                                         and Cash Equivalents</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) up
to C$100. At June 30, 2025, the Company had $24,711 and $22 in excess of the FDIC and CDIC insured limits, respectively.</span></p>

</ix:nonNumeric><p id="xdx_854_zwTIkYd4GfJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000565" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zVmA1NL8OM4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td id="xdx_86E_z1sTjiimVs8g" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
                                         Currency Translation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;). The functional currency for all entities is
the U.S. Dollar except for NioCorp Technologies Limited, which is measured in British Pounds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency, if any, are included as part of cumulative
currency translation adjustment, which is reported as a component of shareholders&#8217; equity under accumulated other comprehensive
loss.</span></p>

</ix:nonNumeric><p id="xdx_856_zzGc4b2EXj5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000567" name="niobf:MineralPropertiesPolicyTextBlock"><p id="xdx_842_ecustom--MineralPropertiesPolicyTextBlock_z7h7egP2AxVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td id="xdx_864_z9oOUv8PHS8h" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         Properties</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of common shares, no par value, of the Company (&#8220;Common Shares&#8221;) issued
as consideration. Properties acquired under option agreements, whereby payments are made at the sole discretion of the Company,
are capitalized as mineral property acquisition costs at such time as the payments are made. Exploration costs are expensed as
incurred. When it is determined that a mining deposit can be economically and legally extracted or produced based on established
proven and probable reserves under S-K 1300, and the Company&#8217;s board of directors (the &#8220;Board&#8221;) has approved
the commencement of formal development activities, development costs related to such reserves and incurred after such board approval
will be considered for capitalization. The establishment of proven and probable reserves is based on</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 34; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<ix:exclude><p id="xdx_233_znty1BeEBg28" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23E_zsbVHBDLAZc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_z1xvrfysKEZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_235_zqWM6c6IZJZb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zgJl5xiC68k6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_233_zUx5ZA8kBtXi" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_23C_zRVszu9sy2i4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">results of feasibility studies,
which indicate whether a property is economically feasible. Upon commencement of commercial production, capitalized costs will
be amortized over their estimated useful lives or units of production, whichever is a more reliable measure. Capitalized amounts
relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was <span id="xdx_904_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20250630_zBylhVoz8aX9" title="Impairment to mineral properties"><span id="xdx_90B_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20240630_zbzLtOSaCkP" title="Impairment to mineral properties"><ix:nonFraction name="us-gaap:MineralPropertiesAccumulatedImpairment" contextRef="AsOf2025-06-30" id="Fact000576" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:MineralPropertiesAccumulatedImpairment" contextRef="AsOf2024-06-30" id="Fact000578" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> impairment recorded to mineral properties as of
June 30, 2025 or 2024, respectively.</span></p>

</ix:nonNumeric><p id="xdx_856_zCiIZdKYt2Rl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000580" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zwVv4PIxVTJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td id="xdx_869_zmooaBqSCjB1" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long
                                         Lived Assets</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was <span id="xdx_90D_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20240701__20250630_zFeFBsrmvcn5" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20230701__20240630_zHjdsI6AnJMk" title="Impairment of long-lived assets"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2024-07-01to2025-06-30" id="Fact000582" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-07-012024-06-30" id="Fact000584" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> impairment recorded to long-lived assets as of June 30, 2025 or 2024, respectively.</span></p>

</ix:nonNumeric><p id="xdx_859_zBvAVsfqkApk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000586" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zdOOBvw5BJ7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td id="xdx_86C_zJ9OdHVnd3Wc" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, <i>Leases</i>, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

</ix:nonNumeric><p id="xdx_851_z5skVgBbhusd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000588" name="niobf:ConvertibleDebtCarriedatFairValuePolicyTextBlock"><p id="xdx_844_ecustom--ConvertibleDebtCarriedatFairValuePolicyTextBlock_z0JYCGUNEaFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td id="xdx_864_zCnFst6mSn9c" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
                                         Debt Carried at Fair Value</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to the Company&#8217;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in Note
8), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, <i>Derivatives and Hedging
</i>(&#8220;ASC 815&#8221;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument to account
for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter using a
Monte Carlo simulation methodology which</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 35; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zkVWQonkRHif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23A_zI8V3KfgDo3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_ztDCtWlWJM21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z1z1YbCanpn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zSyuRAOovXi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_23F_z2sY6V7xUD89" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_23E_z65CxEO24WE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">incorporates multiple conversion scenarios. All changes in fair value subsequent to the
initial recording, excluding the impact of the change in fair value related to the Company&#8217;s own credit risk, are recorded
as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#8217;s own credit risk, if any, are recorded through other comprehensive
loss.</span></p>

</ix:nonNumeric><p id="xdx_856_zAz6bkOdFVFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000597" name="niobf:WarrantsPolicyTextBlock"><p id="xdx_848_ecustom--WarrantsPolicyTextBlock_zh9de7G8fcsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td id="xdx_86A_zzBqJ858BRCf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We apply relevant accounting
guidance for warrants to purchase our Common Shares (&#8220;Warrants&#8221;) based on the nature of the relationship with the counterparty.
The Company has made an accounting policy election that the &#8220;greater of&#8221; Share-Price Input to the Black-Scholes Value
would not preclude equity classification. The Company has not had any historical transactions that include the &#8220;greater of&#8221;
Share-Price Input feature, and this is a new accounting policy election as of the current fiscal year. For Warrants issued to investors
or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC 480, <i>Distinguishing Liabilities
from Equity</i>, and ASC 815, to assist in the determination of whether the Warrants should be classified as liabilities or equity.
The fair value of Warrants is estimated using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features
embedded in the Warrant. Inputs under both models include inputs such as NioCorp&#8217;s Common Share price, the risk-free interest
rate, the expected term, the volatility, and the dividend rate. Warrants that are determined to require liability classifications
are measured at fair value upon issuance and are subsequently remeasured to their then fair value at each subsequent reporting
period with changes in fair value recorded in current earnings. Warrants that are determined to require equity classifications
measured at fair value upon issuance and are not subsequently remeasured unless they are required to be reclassified.</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000599" name="niobf:EarnoutSharesPolicyTextBlock"><p id="xdx_846_ecustom--EarnoutSharesPolicyTextBlock_zC8dRMo8Jo7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td id="xdx_865_zJVi2dEuUeTg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
                                         Shares</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#8217;s publicly traded Warrants,
the dividend rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective
and require significant judgment.</span></p>

</ix:nonNumeric><p id="xdx_852_zwUAMTbliwgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000601" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84D_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zGR01jbEI8O5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td id="xdx_86B_zmpv90UlaI9g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                         Instruments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, and accounts payable
and accrued liabilities. It is management&#8217;s opinion that the Company is not exposed to significant interest, currency or
credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying value unless
otherwise noted.</span></p>

</ix:nonNumeric><p id="xdx_852_znAwGZnSUxfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000603" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zqWAzZAReQ88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td id="xdx_867_zbgAPKWIgidd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration
                                         of Credit Risk</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Columbus, Ohio. As part
of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

</ix:nonNumeric><p id="xdx_85A_z6xVAby1KLR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000605" name="us-gaap:AssetRetirementObligationsPolicy"><p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z0YgSoWoFSXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td id="xdx_86D_zs7kZ0bx4kje" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
                                         Retirement Obligation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20250630_znG4zUDnMSV4" title="Accrued Exploration Stage Obligations"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2025-06-30" id="Fact000607" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zD2FSDHEwQKg" title="Accrued Exploration Stage Obligations"><ix:nonFraction name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" contextRef="AsOf2024-06-30" id="Fact000609" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></span> for estimated obligations as
of June 30, 2025 and June 30, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.</span></p>

</ix:nonNumeric><p id="xdx_85F_zK2ADdgdL6y" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><p id="xdx_23B_zxwcSqbUWkD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 36; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zCp3cdXXNW1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zF4NlNTenz29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_233_zKFNxSqd92xf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zWGMRP90zym3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zP7yG7XPLbgd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zUFZIifjM1le" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_234_z1X0e1GaoDV9" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000619" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zPJ5O1LrTg49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td id="xdx_860_zbbirz5EKLSl" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
                                         Taxes</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2025 and 2024, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

</ix:nonNumeric><p id="xdx_854_zvr8PDiV0zM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000621" name="niobf:RedeemableNoncontrollingInterestPolicyTextBlock"><p id="xdx_841_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zb2890q1vRkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td id="xdx_86D_z7Ncwdb9fCf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
                                         Noncontrolling Interest</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The Company&#8217;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;</span></p>

</ix:nonNumeric><p id="xdx_857_z1Sw9JbIsHDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000623" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zMwRJISFnjl8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td id="xdx_86C_zjipvAuSYPgf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
                                         and Diluted Per Share Disclosure</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 9), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000625" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWyAFxndIbw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B8_zwlyT1end3Ah">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify; background-color: white">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center; background-color: white">For the year ended June 30,</td><td style="background-color: white">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: justify; padding-left: 9pt">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_z4F4MXQKGrka" title="Net loss" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-01to2025-06-30" id="Fact000627" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,982</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zajpSponzKIc" title="Net loss" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012024-06-30" id="Fact000629" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,898</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Adjust: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20240701__20250630_zutq6Nkfe109" title="Adjust: Net loss attributable to noncontrolling interest" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000631" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">577</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zGc0Bl8WsSmh" title="Adjust: Net loss attributable to noncontrolling interest" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="Fact000633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">458</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20250630_zkkxBtYRUH46" title="Net loss available to participating securities" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000635" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,405</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zjlQucI0DBW3" title="Net loss available to participating securities" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-07-012024-06-30" id="Fact000637" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,440</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20240701__20250630_zx6g14PGNxV4" title="Net loss attributable to Vested Shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:NetLossAttributableToVestedShares" contextRef="From2024-07-01to2025-06-30" id="Fact000639" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,102</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20230701__20240630_zJhpLAyk3YXc" title="Net loss attributable to Vested Shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:NetLossAttributableToVestedShares" contextRef="From2023-07-012024-06-30" id="Fact000641" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">967</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 9pt">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20250630_zfcKqCWrkVkf" title="Net loss attributed to common shareholders - basic"><span id="xdx_90A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20240701__20250630_zd5eiOeCJ9Ne" title="Net loss attributed to common shareholders - diluted">(<ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000643" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD"><ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" contextRef="From2024-07-01to2025-06-30" id="Fact000645" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16,303</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zIPgAaR0Hkyi" title="Net loss attributed to common shareholders - basic"><span id="xdx_900_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20230701__20240630_z1pwClWsysZi" title="Net loss attributed to common shareholders - diluted">(<ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" contextRef="From2023-07-012024-06-30" id="Fact000647" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD"><ix:nonFraction name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" contextRef="From2023-07-012024-06-30" id="Fact000649" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,473</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zfo0ZGEwfa71" title="Weighted average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zwkZKVhJ7xgd" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000651" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-01to2025-06-30" id="Fact000653" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,072,895</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_z6kzP7KhBMEa" title="Weighted average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zJeMmTyr4gFa" title="Weighted average shares outstanding - diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012024-06-30" id="Fact000655" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012024-06-30" id="Fact000657" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,320,024</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 9pt">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zXjqFfBFYpM1" title="Loss per Common Share outstanding - basic"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zrCFblI8gIGi" title="Loss per Common Share outstanding - diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-01to2025-06-30" id="Fact000659" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-01to2025-06-30" id="Fact000661" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.36</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_zGSJbiYudYea" title="Loss per Common Share outstanding - basic"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zeZdYic62vO1" title="Loss per Common Share outstanding - diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012024-06-30" id="Fact000663" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012024-06-30" id="Fact000665" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.31</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zceKkRzdWzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following shares underlying options to purchase Common Shares (&#8220;Options&#8221;), Warrants, and outstanding convertible debt
were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation
for the periods indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000667" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zfnV3917EYcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span id="xdx_8B2_zIFTJ9XdJ09f" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.6in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup>(1)(2)</sup>:&#160;</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 66%; text-indent: 9pt">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20250630_fKDEpKDIp_zvHEtVOjsaJ6" title="Options" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2024-07-01to2025-06-30" id="Fact000669" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,020,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zSVC9VR5dap3" title="Options" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions" contextRef="From2023-07-012024-06-30" id="Fact000671" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,495,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: 9pt">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20250630_fKDEpKDIp_zfxzBVezte1f" title="Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2024-07-01to2025-06-30" id="Fact000673" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">31,839,152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_zO8ohOo3qU49" title="Warrants" style="text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2023-07-012024-06-30" id="Fact000675" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,563,561</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_d0_uShares_c20240701__20250630_fKDEpKDIp_zN7H7U4yxiug" title="Convertible debt" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2024-07-01to2025-06-30" id="Fact000677" format="ixt:zerodash" decimals="INF" sign="-" unitRef="Shares">-</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zIm3kG74jHG1" title="Convertible debt" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" contextRef="From2023-07-012024-06-30" id="Fact000679" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,849,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt">Total potentially dilutive securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DilutiveSecurities_c20240701__20250630_fKDEpKDIp_zqI5JkNsZ54j" title="Total potentially dilutive securities" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2024-07-01to2025-06-30" id="Fact000681" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,859,152</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_z68NfvevSWJ4" title="Total potentially dilutive securities" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2023-07-012024-06-30" id="Fact000683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,908,061</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 37; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_z8gmnKNUnMK7" style="margin-top: 0; margin-bottom: 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_zPVRy52XOCm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_231_zUn69pV7V0Qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zr7p7Wnmw883" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zGkG12canBC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_z0zhAx9DRZ6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_234_zmw91zs3TIa7" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_236_zomRtalRmk95" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F02_zcC7sWS9kIAl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; padding-bottom: 4pt; text-align: justify"><span id="xdx_F15_zdMfNW8gjA06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000692" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</ix:footnote></span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F0E_zZPpBNjaaE8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span id="xdx_F18_zw2zGyryrBC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000693" xml:lang="en-US">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</ix:footnote></span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A4_zIQT9463Qr8f" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_853_zrm9h2CqCqpa" style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000695" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zjNeX9w6d9k" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td id="xdx_86C_zf3D18XBiwh7" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                         Based Compensation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants Options to directors, officers, employees, and business advisors. Option terms and vesting conditions are at the
discretion of the Board. The Option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
on the day preceding the date of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of Options using the Black-Scholes option pricing model. The Company recognizes forfeitures as
they occur.&#160;</span></p>

</ix:nonNumeric><p id="xdx_85D_zOUEistcYy7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000697" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znH5E6LKdBDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></td><td id="xdx_86F_zYUklDvIs6re" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
                                         Accounting Standards</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recently
Adopted Accounting Standards</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
fiscal year 2025, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2023-07,&#160;<i>Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures</i>. Management has evaluated the Company&#8217;s operations and concluded it has&#160;one&#160;reportable
operating segment which will now require expanded disclosure. Adoption was made retroactively with segment disclosure included
for the fiscal years ended June 30, 2025 and 2024. This standard has not changed the processing, recording, or presentation of
financial data, other than providing additional disclosure regarding management oversight for the Company&#8217;s single operating
segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective<br/>
</span>In December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>,
which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of
rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#8217;s annual
periods beginning July 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively.
The Company is currently evaluating the ASU to determine its impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.&#160;</span></p>



</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000699" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_80D_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zHYF9w32aZOg" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td id="xdx_82C_zRkiL06WIOsl" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GOING
CONCERN ISSUES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred a net loss of $<span id="xdx_909_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20240701__20250630_ziNHsYhCtIN8" title="Net loss::XDX::-17982"><span style="-sec-ix-hidden: xdx2ixbrl0701">17,405</span></span> for the year ended June 30, 2025 (2024 - $<span id="xdx_90A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zoc82Euk4hE6" title="Net loss::XDX::-11898"><span style="-sec-ix-hidden: xdx2ixbrl0703">11,435</span></span>) and had an accumulated deficit of $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20250630_zww6tJrOqb0a" title="Accumulated Deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2025-06-30" id="Fact000705" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">179,317</ix:nonFraction></span>
as of June 30, 2025. As a development stage issuer, the Company has not yet commenced its mining operations and accordingly does
not generate any revenue. The Company does not have sufficient cash on hand to fund planned operations as well as the construction necessary for mine development for the next twelve months. The Company is dependent on its ability to raise capital to fund future exploration and working capital
requirements. These conditions and events raise substantial doubt about
the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to these conditions and events, the Company plans to obtain additional financing. As discussed in Note 17, on July 18,
2025, the Company closed a public offering which resulted in net proceeds of approximately $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240701__20250630_z6GELYMfwbnb" title="Net proceeds from public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfDebt" contextRef="From2024-07-01to2025-06-30" id="Fact000707" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,762</ix:nonFraction></span> after deducting placement agent
fees and discounts. Subject to the conditions discussed in Note 10a, NioCorp expects to have access to up to $<span id="xdx_906_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20240701__20250630_zWFVgYIjZO9h" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfDebt" contextRef="From2024-07-01to2025-06-30" id="Fact000709" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,917</ix:nonFraction></span> in net proceeds
from the Standby Equity Purchase Agreement, dated January 26, 2023 (the &#8220;Yorkville Equity Facility Financing Agreement&#8221;),
between the Company and YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;),
through April 1, 2026. In addition, the Company may pursue additional sources of financing, and while it has been successful in
doing so in the past, there can be no assurance it will be able to do so in the future. Other than the potential issuance of Common
Shares under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 38; Value: 28 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zTxpk8ChoN09" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23B_zsgHWOMUmSWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zBEr947yVSsb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zObBi6dAvWIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zWDW9Z6L3017" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_238_zOVSYxNmfVTf" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_23E_zDBtbl8A3Ud9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">for additional financing as of June 30, 2025. The Company&#8217;s plans to obtain additional financing have not been finalized,
are subject to market conditions, and are not within the Company&#8217;s control and therefore cannot be deemed probable. Further,
the Company will be required to raise additional funds for the construction and commencement of operations. As a result, the Company
has concluded that management&#8217;s plans do not alleviate substantial doubt about the Company&#8217;s ability to continue as
a going concern.</span></p>

</ix:nonNumeric><p id="xdx_810_z4yuwWbhFIx" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000718" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z9mO3FdLZrOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td id="xdx_82A_zdyMNiQljlqh" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAND
AND BUILDINGS, NET</span></td>
</tr></table>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000720" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zQQtDdjyGdN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zoch6eAZCja4" style="display: none; visibility: hidden">Schedule of properties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 22%; padding-left: 0.125in">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zRWGJDcz0Lq9" title="Cost" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2025-06-30_us-gaap_LandMember" id="Fact000722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zYKalscBZKYe" title="Accumulated depreciation" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2025-06-30_us-gaap_LandMember" id="Fact000724" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zeIWh5zJTjog" title="Net" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2025-06-30_us-gaap_LandMember" id="Fact000726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zmeqIhtJr691" title="Cost" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2024-06-30_us-gaap_LandMember" id="Fact000728" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zETTNUimlLt5" title="Accumulated depreciation" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30_us-gaap_LandMember" id="Fact000730" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zSKBeRBXnlcl" title="Net" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30_us-gaap_LandMember" id="Fact000732" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">807</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Buildings and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_znnUAw00thW8" title="Cost" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2025-06-30_us-gaap_BuildingMember" id="Fact000734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zlJdixZWBrd4" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2025-06-30_us-gaap_BuildingMember" id="Fact000736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIdiDMAiD3Z9" title="Net" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2025-06-30_us-gaap_BuildingMember" id="Fact000738" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zNDkoTkTGBd" title="Cost" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact000740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z2df0C6C6pad" title="Accumulated depreciation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact000742" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zQ8GF7ZWIEdh" title="Net" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30_us-gaap_BuildingMember" id="Fact000744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Land and buildings, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630_zK92fVwSsPx7" title="Cost" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2025-06-30" id="Fact000746" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">853</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630_z3UD99r1P9Oh" title="Accumulated depreciation" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2025-06-30" id="Fact000748" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630_znztPujhuZCj" title="Net" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2025-06-30" id="Fact000750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">839</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zF6KM3lSmfX6" title="Cost" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentOther" contextRef="AsOf2024-06-30" id="Fact000752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">848</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zshKFknmDq1a" title="Accumulated depreciation" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-06-30" id="Fact000754" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zh6AQC3kMxsc" title="Net" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-06-30" id="Fact000756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">837</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AB_ztvkqolwOdIl" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_81C_zQKYKhr3K0ek" style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000758" name="us-gaap:MineralIndustriesDisclosuresTextBlock"><p id="xdx_806_eus-gaap--MineralIndustriesDisclosuresTextBlock_zMhn8DA0T2L6" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td id="xdx_82A_zciq2pEl0F35" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MINERAL
PROPERTIES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
properties consist of original acquisition costs and purchased mineral rights related to the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include seven prepaid
mineral exploration option-to-purchase agreements which include a pre-determined buyout for permanent ownership of the mineral
and/or surface rights. Terms of the agreements require no further significant payments, and the Company may terminate the leases,
negotiate lease extensions, or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase
of mineral rights contain provisions whereby the landowners would retain a 2% net smelter return.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2025, the Company completed negotiations with landowners in Nebraska and entered into contract amendments
which extended the option periods by approximately five years for option to purchase agreements (&#8220;OTP&#8221;) covering six
parcels of land for project construction and operation which the Company does not already own. The Company recorded an exploration
expense for $<span id="xdx_904_ecustom--ExplorationExpenseForOTPExtensionPayments_pn3n3_uUSD_c20240701__20250630_zbLP80NxSF1c" title="Exploration expense for OTP extension payments"><ix:nonFraction name="niobf:ExplorationExpenseForOTPExtensionPayments" contextRef="From2024-07-01to2025-06-30" id="Fact000760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">310</ix:nonFraction></span> paid for OTP extension payments made and will make periodic payments totaling $<span id="xdx_904_ecustom--FutureOptionToPurchaseExtensionPaymentObligations_pn3n3_uUSD_c20240701__20250630_zIfWQXvUKYFk" title="Future Option to Purchase Extension Payment Obligations"><ix:nonFraction name="niobf:FutureOptionToPurchaseExtensionPaymentObligations" contextRef="From2024-07-01to2025-06-30" id="Fact000762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span> over the extension period.</span></p>

</ix:nonNumeric><p id="xdx_815_zopdJuEw7icg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000764" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zAI8fVjLJmDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td id="xdx_824_zpn90gdHi14g" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000766" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z0jnJnCG44Jh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_z89LVvJqnj45" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_492_20250630_zNf6tlgv6vva" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_498_20240630_z3RwxcXCvoG8" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zLUTTOdkfLlc" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 49%; text-align: left; padding-left: 0.2in">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2025-06-30" id="Fact000768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">692</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableTradeCurrent" contextRef="AsOf2024-06-30" id="Fact000769" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,417</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zugEg8xtDWVc" style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.2in">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact000771" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,055</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zy4RuEKI3tSk" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.2in">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2025-06-30" id="Fact000774" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-06-30" id="Fact000775" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zR7WW46OMhxd" style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.2in">Loan origination fees payable to related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact000778" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_znXImEMCEGR7" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2025-06-30" id="Fact000780" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,795</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-06-30" id="Fact000781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,843</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zLcsiORDuimf" style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><p id="xdx_818_zhmnD1PmXhI" style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000783" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_800_eus-gaap--LongTermDebtTextBlock_zX3rUZT8pD59" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_825_zspCXbtTW0l7">CONVERTIBLE
DEBT</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000785" name="niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_pn3n3_zNGRtBilwLCd" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span id="xdx_8BE_z5k4S4bzws22" style="display: none">Schedule of convertible debt&#160;</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 1pt; padding-left: 0.2in; width: 49%">Yorkville convertible debentures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zHfWyp91JNJg" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zMPkYj0bcnsc" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebenturesMember" id="Fact000787" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">571</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.2in">April 2024 notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zGqxeyKolCB8" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zS1SGXYvTrd6" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember" id="Fact000789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total convertible debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630_z8e6tbzXlJ85" title="Total convertible debt" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630_zWouEHdpqit9" title="Total convertible debt" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-06-30" id="Fact000793" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,660</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yorkville
Convertible Debentures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_980_eus-gaap--DebtInstrumentDescription_c20240701__20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_gBFDID-TLBFWD_zAy7XVAKng8b" title="Convertible debt, description" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebenturesMember" continuedAt="ConU000796-01" id="Fact000796" name="us-gaap:DebtInstrumentDescription">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zaCDDDZin4Kc" title="Aggregate principal amount" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,000</ix:nonFraction></span> aggregate principal</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_234_zUfIx15HVY98" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 39; Value: 28 -->
    <div id="xdx_23A_zVcFXvYlhoz3" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div>
    <div id="xdx_235_zPkDmpRJ66wg" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zY8HvsSLN633" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_233_zgGyqpC3ecva" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zTt4KCgFyUog" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_234_zDBLCAJt9Pt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_z5ZtuBoO8w1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_23B_zKVuL4LXyBee" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_238_zTWyueVH53I5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_C06_gBFDID-TLBFWD_zRVIdLKxWPUl"><ix:continuation id="ConU000796-01">
amount of unsecured convertible debentures (the &#8220;Convertible Debentures&#8221;) and (ii) Warrants exercisable for up to
<span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zM6PDy84pDrk" title="Number of shares purchase"><ix:nonFraction name="niobf:StockIssuedDuringPeriodSharesStockOptionsExercise" contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000808" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,789,267</ix:nonFraction></span> Common Shares for cash or, if at any time there is no effective registration statement registering, or no current
prospectus available for, the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price
per Common Share of approximately $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z3bacnZscts" title="Number of shares purchase"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000810" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.9422</ix:nonFraction></span>, subject to adjustment to give effect to any stock dividend, stock split, reverse stock
split or similar transaction.</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining outstanding principal and accrued interest of $<span id="xdx_907_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_uUSD_c20240717__20240719__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zr0N2VqeDCo9" title="Principal and accrued interest"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember" id="Fact000812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">554</ix:nonFraction></span> under the Convertible Debentures into Common Shares in exchange for
a $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_uUSD_c20240717__20240719__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z1ZrYMb6nuX6" title="Principal and accrued interest"><ix:nonFraction name="us-gaap:DebtInstrumentIncreaseAccruedInterest" contextRef="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000814" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></span> make-whole payment. The Company recorded a gain on extinguishment of $<span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_uUSD_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zFeCZGM23xej" title="Principal and accrued interest"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember" id="Fact000816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span> as part of other gains in the condensed consolidated
statements of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the Convertible Debentures are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000818" name="us-gaap:ConvertibleDebtTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ConvertibleDebtTableTextBlock_pn3n3_zD6ZVUqC1VQ8" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 1)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BE_zkBS6SAU7BFb" style="display: none">&#160;Schedule of changes
in the convertible debentures</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 67%">Balance, June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zzJXZFnRUtt7" title="Balance at June 30, 2024" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2023-06-30_us-gaap_ConvertibleDebtSecuritiesMember" id="Fact000820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,561</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; text-indent: 9pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zixJkcU1OtT8" title="Accretion expense" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpenseIncludingAssetRetirementObligations" contextRef="From2023-07-012024-06-30_us-gaap_ConvertibleDebtSecuritiesMember" id="Fact000822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,489</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Principal and accrued interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zyXxmmDgr9f1" title="Principal and interest converted" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:PrincipalAndAccruedInterestConverted" contextRef="From2023-07-012024-06-30_us-gaap_ConvertibleDebtSecuritiesMember" id="Fact000824" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,479</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>Balance, June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zo4bGElTgiO2" title="Balance at June 30, 2024" style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-06-30_us-gaap_ConvertibleDebtSecuritiesMember" id="Fact000826" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">571</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; text-indent: -4.5pt; padding-left: 13.5pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4A4eTyUvxWa" title="Accretion expense" style="text-align: right"><ix:nonFraction name="us-gaap:AccretionExpenseIncludingAssetRetirementObligations" contextRef="From2024-07-012025-06-30_us-gaap_ConvertibleDebtSecuritiesMember" id="Fact000828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -4.5pt; padding-left: 13.5pt">Principal and interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zW3rMxoUTXM5" title="Principal and interest converted" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:PrincipalAndAccruedInterestConverted" contextRef="From2024-07-012025-06-30_us-gaap_ConvertibleDebtSecuritiesMember" id="Fact000830" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">614</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Balance, June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z6flPImlVDK" title="Balance, December 31, 2024" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0832">-</span></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the components of interest expense associated with the Convertible Debentures:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000834" name="us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_pn3n3_z9G1SDXr4CU1" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 2)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B7_zDo4TJHqzSpg" style="display: none">Schedule of  components of interest expense    with convertible debenture</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_49B_20240701__20250630_zf24biSHMNn1" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_49C_20230701__20240630_zaF9W5nB7fog" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Component of Interest Expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCosts_z1X0V3sA5Mlj" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; text-align: justify; padding-left: 9pt">Amortization of discount and issuance costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2024-07-01to2025-06-30" id="Fact000836" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-07-012024-06-30" id="Fact000837" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,210</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--ContractualInterest_zzFMSyEgqT45" style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Contractual interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ContractualInterest" contextRef="From2024-07-01to2025-06-30" id="Fact000839" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ContractualInterest" contextRef="From2023-07-012024-06-30" id="Fact000840" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">279</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--InterestAndDebtExpense_zBGZLdbINUjl" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2024-07-01to2025-06-30" id="Fact000842" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestAndDebtExpense" contextRef="From2023-07-012024-06-30" id="Fact000843" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,489</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">April
2024 Notes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (together with Yorkville, the &#8220;April
2024 Purchasers&#8221;), $8,000 aggregate principal amount of unsecured notes (the &#8220;April 2024 Notes&#8221;), pursuant to
a securities purchase agreement, dated April 11, 2024 (the &#8220;April 2024 Purchase Agreement&#8221;), between the Company and
each of the April 2024 Purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of April 2024 Notes issued to
each April 2024 Purchaser, Warrants (the &#8220;April 2024 Warrants&#8221;) to purchase up to 615,385 Common Shares (the &#8220;April
2024 Warrants Shares&#8221;), which were equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April
2024 Purchasers divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock
split or recapitalization. The April 2024 Warrants expire on April 12, 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the April 2024 Purchase Agreement, the April 2024 Purchasers advanced an aggregate of $6,935 to the Company in consideration
of the issuance by the Company to the April 2024 Purchasers of $8,000 aggregate principal amount of the April 2024 Notes and April
2024 Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the April 2024 Notes, subject to certain exceptions, on the first day of each calendar month, beginning on June 1,
2024 (excluding August 2024) (the &#8220;Payment Date&#8221;), the Company was required to repay a portion of the outstanding
balance of all of the April 2024 Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1,400 of principal (or the
outstanding principal if less than such amount) in the aggregate among all of the outstanding Notes, plus (ii) 8.0% of the principal
amount being paid (the &#8220;Payment Premium&#8221;), and (iii) accrued and unpaid interest, if any, as of the Payment Date.
The Company was required to make payments on each Payment Date until the entire outstanding principal was repaid but did not have
an obligation to make a payment on a Payment Date if certain equity conditions were satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_23A_zoM2PhJls1Al" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 40; Value: 28 -->
    <div id="xdx_233_zkpZzWxCS4N2" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div>
    <div id="xdx_235_zxTAvY7rUy2c" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zToZ2AOKDE29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_234_z6FRuc1XAPB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zIDrGwx0uOM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zEuGATOsjaC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zrdZY8u66UE6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_237_zMOliL0fnvhi" style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_232_zUBXdtiLfUy1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the April 2024 Notes, holders of the April 2024 Notes were entitled to convert the principal
amount of, accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each April 2024 Note,
from time to time over their term, into a number of Common Shares equal to the quotient of the amount being converted divided
by a fixed conversion price of $2.75 per Common Share up to a maximum of 3,141,817 Common Shares (together with the April 2024
Warrant Shares, the &#8220;April 2024 Underlying Shares&#8221;). The terms of the April 2024 Notes restricted the conversion of
the April 2024 Notes by a holder if such a conversion would have caused such holder to exceed certain ownership thresholds in
the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes were the unsecured obligations of the Company and were originally scheduled to mature on December 31, 2024. The
April 2024 Notes incurred a simple interest rate obligation of 0.0% per annum (which would have increased to 18.0% per annum upon
the occurrence of an event of default).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes were also redeemable at the Company&#8217;s option at any time and from time to time over their term at a redemption
price equal to the principal amount being redeemed, plus the Payment Premium, plus accrued and unpaid interest, if any, as of
the redemption date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes contained events of default customary for instruments of their type (with customer grace periods, as applicable)
and provided that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to the Company, all outstanding April 2024 Notes would become due and payable immediately without further action or notice. If
any other type of event of default occurred and continued, then any holder could have declared all of its April 2024 Notes to
be due and payable immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement contained customary representations, warranties, conditions and indemnification obligations by each
party. The representations, warranties and covenants contained in the April 2024 Purchase Agreement were made only for purposes
of the April 2024 Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreement and
are subject to certain important limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement also contained certain covenants that, among other things, limited NioCorp&#8217;s ability to use
the proceeds from the April 2024 Purchase Agreement to repay related party debt or to enter into any variable rate transaction
other than with Yorkville, subject to certain exceptions, and to distribute proceeds from the April 2024 Purchase Agreement to
subsidiaries other than ECRC and 0896800 B.C. Ltd. (together with ECRC, the &#8220;Guarantors&#8221;), upon the entry by the Guarantors
into a global guaranty agreement, dated as of April 11, 2024, among the Guarantors in favor of the April 2024 Purchasers (the &#8220;Guaranty
Agreement&#8221;). Pursuant to the Guaranty Agreement, the Guarantors guaranteed the full, prompt and unconditional payment when
due (whether at maturity, by acceleration or otherwise), and the performance of all liabilities, agreements and other obligations
of NioCorp to the April 2024 Purchasers contained in the April 2024 Notes, the April 2024 Warrants, and the April 2024 Purchase
Agreement, to the extent such liabilities, agreements, and obligations are payable in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the Company&#8217;s analysis of the criteria contained in ASC 815, the Company determined that April 2024 Warrants met the
definition of a&#160;derivative liability, as any Warrant exercise that could cause the holder to exceed 19.9% ownership of NioCorp
Common Shares would require shareholder approval. As such, the April 2024 Warrants are recognized as Warrant liabilities on the
consolidated balance sheet and were measured at their inception date fair value and are subsequently remeasured at each reporting
period with changes being recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected to value the April 2024 Notes at fair value in accordance with ASC 815-15-25. The fair value of the April
2024 Notes was estimated using a Monte Carlo simulation pricing model and the April 2024 Notes were classified as Level 3
instruments. The Company incurred transaction costs totaling $<span id="xdx_90E_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z3wBvJIVyKM" title="Transaction loss"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000853" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">474</ix:nonFraction></span> in connection with the issuance of the April 2024 Notes and
due to the fair value election noted above, these costs were expensed at closing. Components and initial valuations
associated with the April 2024 Notes were comprised of the following amounts:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_236_z7LiOLReDKFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 41; Value: 28 -->
    <div id="xdx_231_zULFDzJe1PXj" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div>
    <div id="xdx_237_z0LyF2iZigL4" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zmjDa6eB7V9j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23E_zwVkxTjGPSrj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zR9TX0OeIFu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zVXgEvgFpZY9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zC3b5rGes5E9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-bottom: 1pt"><ix:exclude><div id="xdx_239_zWjys4OxWYj7" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_234_zfJSjj9WPtja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$902
    was recorded to Warrant liabilities, representing the initial fair value of the April 2024 Warrants based on the assumptions
    outlined below.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zbDHipFh34ra" title="Fair value" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000863" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,315</ix:nonFraction></span> was recorded
    to the April 2024 Notes, representing the fair value based on the assumptions outlined below. The Company also recognized
    an opening transaction loss of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zNCbxaDNDpP8" title="Transaction loss" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000865" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,256</ix:nonFraction></span>, representing the difference between the fair value of the April 2024 Notes, including
    the fair value of the variable conversion features embedded therein, and cash received in the transaction.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000867" name="us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_ztDoIMw7tf11" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 3)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B2_zgRQhqKlvPDe" style="display: none">Schedule of primary inputs for the Monte Carlo model</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 12,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iE_pid_uUSDPShares_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIppadkki5u8" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000869" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znp1SpRQvOId" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000871" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.11</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA5J2X6GyOm9" title="Term (expiry)"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact000873" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">December 31, 2024</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zObltUbYfQDe" title="Term (expiry)"><ix:nonNumeric contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact000875" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">December 31, 2024</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Weighted average of the equity volatility and implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z1M04SKpO8Sj" title="Equity volatility" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000877" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">80</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJ46VEBBxJV1" title="Equity volatility" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000879" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">66.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6PPiGHLGF8c" title="Risk-free rate" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000881" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.33</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zxGN43jf9Gk4" title="Risk-free rate" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000883" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.26</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify">Implied discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwpvRc52YOE2" title="Implied discount rate" style="text-align: right"><ix:nonFraction name="niobf:ImpliedDiscountRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000885" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">15.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA9ekh7Zmua7" title="Implied discount rate" style="text-align: right"><ix:nonFraction name="niobf:ImpliedDiscountRate" contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember" id="Fact000887" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">15.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 4, 2024 and October 3, 2024, the Company entered into (i) consents and waivers (the &#8220;2024 Yorkville Consents&#8221;)
to the April 2024 Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) consents and waivers
(together with the 2024 Yorkville Consents, the &#8220;2024 Note Consents&#8221;) to the April 2024 Notes issued and sold to Lind
II pursuant to the April 2024 Purchase Agreement. The 2024 Note Consents, among other things, extended and deferred certain monthly
payments and extended the maturity of the April 2024 Notes until January 31, 2025. On January 3, 2025, the Company entered into
a consent and waiver (the &#8220;January Yorkville Consent&#8221;) to the April 2024 Notes issued and sold to Yorkville pursuant
to the April 2024 Purchase Agreement. The January Yorkville Consent, among other things, deferred the due date for the amounts
that would otherwise have been due to Yorkville on January 1, 2025 to the maturity date and extended the maturity date to February
17, 2025, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of the Company
to pay to Yorkville the remainder of the amount due on January 1, 2025. All remaining amounts due to Lind II ($176) and Yorkville
($1,000) under the April 2024 Notes were repaid on January 6, 2025, and February 7, 2025, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000889" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_pn3n3_zBtEDD9oljXi" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 4)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8BC_zgV4vA9u1aHf" style="display: none">&#160;Schedule of changes in the fair value of  April 2024 Note</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 45%; text-align: justify">Fair value, April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240413__20240630_zteg0p1rgXqf" title="Fair value, April 12, 2024" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:FairValueHedgeAssetsAtFairValue" contextRef="AsOf2024-04-12" id="Fact000891" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,315</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; text-indent: 9pt">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240413__20240630_zPSp9A4MHFK9" title="Principal payments" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2024-04-132024-06-30" id="Fact000893" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,512</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangeInFairValue_c20240413__20240630_zlXYwaK7i5ng" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ChangeInFairValue" contextRef="From2024-04-132024-06-30" id="Fact000895" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,714</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">Balance, June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240701__20250630_zOBH3VzdRrU6" title="Fair value, April 12, 2024" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueHedgeAssetsAtFairValue" contextRef="AsOf2024-06-30" id="Fact000897" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; text-indent: 9pt">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240701__20250630_zhlBzptHc3q9" title="Principal payments" style="text-align: right">(<ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2024-07-01to2025-06-30" id="Fact000899" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,129</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ChangeInFairValue_c20240701__20250630_z9FPLejUwaBc" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ChangeInFairValue" contextRef="From2024-07-01to2025-06-30" id="Fact000901" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Balance, June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20240701__20250630_zXM39yVtExVl" title="Balance, June 30, 2024" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0903">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000905" name="niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_z2E1MfvZJxBg" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 5)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B0_zkcQeDw01o1a" style="display: none">Schedule of  Black-Scholes model used in April 2024 Warrants</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 39%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVwXQqnctCC6" title="Closing Common Share price" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact000907" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVLIh4QzKVre" title="Closing Common Share price" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact000909" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znZY2VpG4k8j" title="Term (years)" style="text-align: right"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" format="ixt-sec:duryear" id="Fact000911" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.78</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z2WyWNSC4HH1" title="Term (years)" style="text-align: right"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" format="ixt-sec:duryear" id="Fact000913" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.78</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJvm77hI83Rg" title="Expected volatility" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact000915" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">82.22</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzulsrUdhQbl" title="Expected volatility" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact000917" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">66.34</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhSO1cWiFxj2" title="Risk-free rate" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact000919" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.78</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zalp8dXUKLV3" title="Risk-free rate" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember" id="Fact000921" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.57</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_233_zxReWFOeiQUd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 42; Value: 28 -->
    <div id="xdx_23E_zHjdqr6wSePa" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div>
    <div id="xdx_230_zGW6aTR2uZz4" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zsEteINB1pn3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_236_zXloEenOc4O4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z6uL1GuyA8pe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zmbfithTuHQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zgpIEgJg0Rh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_235_zzPCFxAiaxDc" style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_230_zN46dmPMFwG1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000931" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zlZJY0yJbIZd" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 6)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B5_zMtaaIWMP1F2" style="display: none">&#160;Schedule of changes in fair value of April 2024 Warrant liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%; text-align: justify">Fair value as of April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0VrSHJRNjSj" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-04-12_custom_EarnoutMember" id="Fact000932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">902</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zktD7wgc3i07" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-04-132024-06-30_custom_EarnoutMember" id="Fact000933" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">604</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Fair value as of June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZNBMGPqUfpk" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_custom_EarnoutMember" id="Fact000934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">298</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhq95PR6iHj" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012025-06-30_custom_EarnoutMember" id="Fact000935" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">191</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqrYqwSOZr1" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30_custom_EarnoutMember" id="Fact000936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">489</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000938" name="niobf:DisclosureOfClassBCommonStockOfECRCTextBlock"><p id="xdx_803_ecustom--DisclosureOfClassBCommonStockOfECRCTextBlock_zpsT69BD9saf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_zTTqb5EHRhY9">CLASS
B COMMON STOCK OF ECRC</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Class B common stock of ECRC have the right to exchange such shares for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All <span style="color: #353535"><span id="xdx_90A_eus-gaap--SharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockECRCMember_zeqGQqKKeRl1" title="Common stock, shares, issued"><span id="xdx_900_eus-gaap--SharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockECRCMember_ziJrYfy2vq83" title="Common stock, shares, outstanding"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2023-06-30_custom_ClassBCommonStockECRCMember" id="Fact000940" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_ClassBCommonStockECRCMember" id="Fact000942" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,957,404</ix:nonFraction></ix:nonFraction></span></span> shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of June 30, 2023. </span>Of the issued
and outstanding shares of Class B common stock of ECRC, <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zmiPI88BrMGc" title="Earnout shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-012025-06-30_us-gaap_CommonClassBMember" id="Fact000944" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,565,808</ix:nonFraction></span> shares (the &#8220;Vested Shares&#8221;)&#8201;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#8220;Ten-Year Anniversary&#8221;) and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zo14V4C54JHa" title="Earnout shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-012025-06-30_custom_EarnoutMember" id="Fact000946" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,391,596</ix:nonFraction></span> shares (the &#8220;Earnout Shares&#8221;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement, dated as of March 17, 2023, by and among NioCorp, ECRC, and GX Sponsor II LLC (the &#8220;Sponsor&#8221;) in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2024 and May 16, 2024, 243,692 Vested Shares and 40,000 Vested Shares, respectively, were exchanged for an equivalent
number of Common Shares, and on December 12, 2024 and December 20, 2024, 25,000 Vested Shares and 323,085 Vested Shares, respectively,
were exchanged for an equivalent number of Common Shares. These exchanges resulted in a change in the Company&#8217;s ownership
interest in ECRC and were accounted for as an equity transaction in accordance with ASC 810-10-45-23, with no gain or loss recognized.
Accordingly, the carrying amount of the noncontrolling interest was adjusted to reflect the change in the Company&#8217;s ownership
interest with a corresponding offset to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
Vested Shares and Released Earnout Shares (as defined below) may be exchanged by the holders into Common Shares at any time. All
Vested Shares and Earnout Shares must be exchanged for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares
that have been vested for a period of fewer than twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares
will be forfeited if not exchanged for Common Shares by the date that is twenty-four months after the vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vested
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. Adjustments to the carrying value of the redeemable
noncontrolling interest associated with redemptions are recorded by reclassifying the proportionate amount of mezzanine equity
to permanent equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Earnout
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--DescriptionOfEarnOutShares_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zo6x7vKWDxlj" title="Description of earnout shares"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_EarnoutMember" id="Fact000948" name="niobf:DescriptionOfEarnOutShares">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement. These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_237_zeGdV4ISdZv8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 43; Value: 28 -->
    <div id="xdx_23F_zrPfG4jXueD8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div>
    <div id="xdx_233_zaeUH2u8sHsa" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_z3qg5q62ch53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23F_zAR6v18KGvMh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zoftjh7RpwWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_236_zIvcxY2m4dma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zvXnoZlNn0k2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_238_zZfvCxkDNRAj" style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_23F_zhSDO0uZGgh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model. The following table discloses the
primary inputs into the Monte Carlo models:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000958" name="niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zImukLpr4Dj" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8BF_zeToFecwANTk" style="display: none">Schedule of key valuation input</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 61%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zv8FWvKtsTTd" title="Closing common share price" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000960" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z5Ca5DGKWAdj" title="Closing common share price" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000962" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgSkDwnsuG48" title="Closing common share price" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000964" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.03</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIBGhBtzP3hf" title="Term (expiry)"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact000966" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zX2dmqp7K3l7" title="Term (expiry)"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact000968" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7b3nvFHTal" title="Term (expiry)"><ix:nonNumeric contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" format="ixt:datemonthdayyearen" id="Fact000970" name="niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">March 17, 2033</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJSH0hW5Vdwi" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000972" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">75.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQ4UrZXQYY5f" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000974" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">65.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zvccAD58q9Gb" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000976" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">33.5</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6pZ9A1pxrW3" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000978" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.04</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zsGkAgKaGOhi" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000980" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.35</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIg4xAqslFe4" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember" id="Fact000982" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.83</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000984" name="niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z2QdcGsXG1Rb" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8BE_z3gTaXUN9u4h" style="display: none">&#160;Schedule of  fair value of the Earnout Shares liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%; text-align: justify">Fair value as of June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3bKXXuUdipe" title="Fair value at beginning" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2023-06-30_custom_EarnoutMember" id="Fact000986" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,521</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZaCmd22F7Cd" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ServicingLiabilityAtFairValueAdditionsValue" contextRef="From2023-07-012024-06-30_custom_EarnoutMember" id="Fact000988" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,704</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Fair value as of June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLWAzjKE8Wll" title="Fair value at beginning" style="text-align: right"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2024-06-30_custom_EarnoutMember" id="Fact000990" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zV8E8YqOu4V5" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ServicingLiabilityAtFairValueAdditionsValue" contextRef="From2024-07-012025-06-30_custom_EarnoutMember" id="Fact000992" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,063</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zKDTEpC02DT9" title="Fair value at ending" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ServicingLiabilityAtFairValueAmount" contextRef="AsOf2025-06-30_custom_EarnoutMember" id="Fact000994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,880</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact000996" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock"><p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zILaMyMdXMU4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82B_zkeE3wk8hrE9">COMMON
SHARES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuances</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2025 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_983_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20241101__20241105_zoqYp4KVIdv9" title="Description of warrants" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-11-012024-11-05" id="Fact000998" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">On
November 5, 2024, the Company closed an underwritten public offering (the &#8220;November 2024 Registered Offering&#8221;),
pursuant to the underwriting agreement, dated November 3, 2024 (the &#8220;Underwriting Agreement&#8221;), with Maxim Group
LLC (&#8220;Maxim&#8221;), as underwriter, which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#8220;Series
A Public Warrants&#8221;) to purchase up to an additional 1,672,090 Common Shares and 836,045 Warrants (the &#8220;Series B
Public Warrants&#8221; and, together with the Series A Public Warrants, the &#8220;November 2024 Public Warrants&#8221;) to
purchase up to an additional 836,045 Common Shares. Each Common Share was sold together with one Series A Public Warrant and
one-half of one Series B Public Warrant at a combined public offering price of $1.57. The gross proceeds from the November
2024 Registered Offering were $2,501 before deducting underwriting discounts and offering expenses. The November 2024 Public
Warrants were classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair
values of the Common Shares and the November 2024 Public Warrants on the date of issuance, with $943 allocated to the fair
value of the November 2024 Public Warrants and the balance of the proceeds of $1,558 allocated to Common Shares. The Company
incurred total transaction costs related to the November 2024 Registered Offering $1,226, which were treated as share
issuance costs at closing. The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are
exercisable immediately, and will expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07
per underlying Common Share, are exercisable beginning six months and one day from the date of issuance and will expire on
November 5, 2029. In addition, pursuant to the Underwriting Agreement, the Company granted Maxim a 45-day over-allotment
option to purchase (i) 238,853 additional Common Shares and (ii) 358,280 Option Warrants (as defined below) to purchase up to
an aggregate of 358,280 Common Shares. &#8220;Option Warrant&#8221; means one Series A Public Warrant combined with one-half
of one Series B Public Warrant. On November 4, 2024, Maxim partially exercised its over-allotment option to purchase<span id="xdx_906_ecustom--DebtInstrumentIssuedPrincipalshars_c20241101__20241104__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesAMember_zPOftCEXUqIl">
<ix:nonFraction name="niobf:DebtInstrumentIssuedPrincipalshars" contextRef="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesAMember" id="Fact000999" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">79,734</ix:nonFraction></span> additional Series A Public Warrants and <span id="xdx_908_ecustom--DebtInstrumentIssuedPrincipalshars_c20241101__20241104__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesBMember_za0Rmru8M2p7"><ix:nonFraction name="niobf:DebtInstrumentIssuedPrincipalshars" contextRef="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesBMember" id="Fact001000" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">39,867</ix:nonFraction></span>
additional Series B Public Warrants, which amounts are included in the amounts discussed above and were issued at closing of
the November 2024 Registered Offering.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_238_z8w2gzW4SLP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 44; Value: 28 -->
    <div id="xdx_237_zUOOeRa09JK3" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div>
    <div id="xdx_23C_zdeDUKrOk2Lc" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zwVjB7vNsCV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23E_z8MYephHFHPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zinwgEZjQvC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_233_z3uMCu93mlwh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_z0QVCIhdquJ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23D_zr7jScG7xjbe" style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_23F_zsubJJTX0rij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the primary inputs for the Black-Scholes model used in valuing the November 2024 Public
Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_PublicWarrantsMember" escape="true" id="Fact001010" name="niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zjABPV9bQ4mg" summary="xdx: Disclosure - COMMON SHARES (Details)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_zWeeoFmduHP2" style="display: none">Schedule of Black-Scholes model used in public warrants</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">November 5, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Public Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series B</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zBwMFHnTn4K8" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-05_custom_SeriesAPublicWarrantsMember" id="Fact001012" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.455</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zoffagcetK24" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-05_custom_SeriesBPublicWarrantsMember" id="Fact001014" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.455</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zpK7A6WxWtri" title="Term (years)"><ix:nonNumeric contextRef="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember" format="ixt-sec:duryear" id="Fact001016" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zpuiUMuYHYG7" title="Term (years)"><ix:nonNumeric contextRef="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember" format="ixt-sec:duryear" id="Fact001018" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.0</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zTjDB5MmDIhk" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember" id="Fact001020" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">67.43</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zZEBZ0vBYNu2" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember" id="Fact001022" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">67.13</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zdWGujIdLif9" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember" id="Fact001024" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.14</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zyl3gVN7NXoa" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember" id="Fact001026" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.20</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zp1wETlPCxF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_98B_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20241101__20241113_z7UJcpV3rRR4" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2024-11-012024-11-13" id="Fact001027" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">On
November 13, 2024, the Company closed a non-brokered private placement (the &#8220;November 2024 Private Offering&#8221;),
pursuant to binding subscription agreements with certain accredited investors as part of a non-brokered private placement of <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20241101__20241113__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zTmdTlGXlD6j" title="Shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-11-012024-11-13_us-gaap_PrivatePlacementMember" id="Fact001029" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,199,602</ix:nonFraction></span>
units of the Company (the &#8220;November 2024 Units&#8221;). Each November 2024 Unit consisted of one Common Share, one
Warrant (a &#8220;Series A Private Warrant&#8221;) to purchase one Common Share, and one-half of one Warrant (each whole such
Warrant, a &#8220;Series B Private Warrant&#8221; and, together with the Series A Private Warrants, the &#8220;November 2024
Private Warrants&#8221;), with each Series B Private Warrant entitling the holder thereof to purchase one additional Common
Share. Each November 2024 Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company (the
&#8220;Insider Investors&#8221;) purchased November 2024 Units at a price of $1.7675 per November 2024 Unit, which price
includes $0.1975 per November 2024 Private Warrant and allowed such directors and officers to participate in the November
2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private Warrants have an exercise price of
$1.75 per underlying Common Share, are exercisable immediately, and will expire on November 13, 2026. The Series B Private
Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable beginning six months and one day from
the date of issuance and will expire on November 13, 2029. The Company recorded a non-cash expense of $34 and $110 to other
operating expenses and employee related costs, respectively, representing the excess of fair value of the November 2024 Units
over the purchase price paid by Insider Investors.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the Company&#8217;s analysis of the criteria contained in ASC 815, the Company determined that the November 2024
Private Warrants met the definition of a derivative liability, as any Warrant exercise that could cause the holder to exceed
19.9% ownership of NioCorp Common Shares would require shareholder approval. As such, the November 2024 Private Warrants were
recognized as warrant liabilities on the consolidated balance sheet and were measured at their issuance date fair value of
$<span id="xdx_905_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_pn3n3_c20240701__20250630_zYhr0CjxDyb" title="Fair value of non operating gain/loss"><ix:nonFraction name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" contextRef="From2024-07-01to2025-06-30" id="Fact001031" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,928</ix:nonFraction></span>
and subsequently remeasured at each reporting period with changes being recorded as a non-operating gain or loss in
the consolidated statement of operations and comprehensive loss. The remaining proceeds of the November 2024 Private Offering
of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdaOvSPTqX07" title="Remaining proceeds from private warrants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact001033" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,573</ix:nonFraction></span>
were allocated to Common Shares. The Company incurred total transaction costs related to the November 2024 Private
Offering of $<span id="xdx_909_ecustom--RegisteredOffering_iI_pn3n3_c20241130_zuKlEOkD3Mp" title="Registered Offering"><ix:nonFraction name="niobf:RegisteredOffering" contextRef="AsOf2024-11-30" id="Fact001035" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">161</ix:nonFraction></span>,
of which $<span id="xdx_90E_ecustom--PrivateOffering_iI_pn3n3_c20241130_zx99WNQVnrEd" title="Private Offering"><ix:nonFraction name="niobf:PrivateOffering" contextRef="AsOf2024-11-30" id="Fact001037" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span>
was allocated to the November 2024 Private Warrants and was expensed at closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables disclose the primary inputs for the Black-Scholes model used in valuing the November 2024 Private
Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_PrivateWarrantsMember" escape="true" id="Fact001039" name="niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zFjI4YyUrucg" summary="xdx: Disclosure - COMMON SHARES (Details 1)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_ztxowl6wpNnh" style="display: none">Schedule of Black-Scholes model used in Private warrants</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">November 13, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Private Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A Private</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series B Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z4s5mBECo834" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-13_custom_SeriesAPrivateWarrantsMember" id="Fact001041" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.49</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z36KZZtnDtQb" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-11-13_custom_SeriesBPrivateWarrantsMember" id="Fact001043" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.49</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zuirTne6rEEa" title="Term (years)"><ix:nonNumeric contextRef="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember" format="ixt-sec:duryear" id="Fact001045" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.0</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z40LzAZPI1Sa" title="Term (years)"><ix:nonNumeric contextRef="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember" format="ixt-sec:duryear" id="Fact001047" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zeBQfpiYG9U6" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember" id="Fact001049" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">67.26</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z5UfHhTX50H8" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember" id="Fact001051" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">67.52</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zvyh6atZ5Ek2" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember" id="Fact001053" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.20</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zFfLVlhe2DF1" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember" id="Fact001055" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.30</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 45; Value: 28 -->
    <div id="xdx_237_zg1fWyHnJIZ1" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div>
    <div id="xdx_23F_zOmQXUZd7Ne7" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zXGeFEJGWUL7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_238_zh59SBOuSTU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zaHElMUmduNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zGnoQqV3aeFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zq9evCSBqEpk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23D_zDUY4CvNG7We" style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_239_znrwyP3klGa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Private Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series A Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series B Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z5GQTy3h4J1k" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-06-30_custom_SeriesAPrivateWarrantsMember" id="Fact001064" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zNbYyKM4Cxzg" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-06-30_custom_SeriesBPrivateWarrantsMember" id="Fact001066" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zP0y9BLp3Rp4" title="Term (years)"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember" format="ixt-sec:duryear" id="Fact001068" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.37</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zANaPT946vLf" title="Term (years)"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember" format="ixt-sec:duryear" id="Fact001070" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.38</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zpYES54cGwCh" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember" id="Fact001072" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">86.14</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zwVEs7kpPGJ" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember" id="Fact001074" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">74.26</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z0QW52vdv1h6" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember" id="Fact001076" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.88</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zfzanleeOQ79" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember" id="Fact001078" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.77</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zhdErE0Nej5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth a summary of the changes in the fair value of the November 2024 Private Warrants
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001080" name="niobf:ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_pn3n3_zgJQ0aYt8XEb" summary="xdx: Disclosure - COMMON SHARES (Details 3)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8B9_zo6Yg9D0X9J4" style="display: none">Schedule of  changes in the fair value of  Private Warrants liabilities</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">November&#160;2024&#160;Private&#160;Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%; text-align: justify">Fair value at issuance (November 13, 2024)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_z9T2mvBFugIc" title="Beginning balance" style="width: 15%; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation1" contextRef="AsOf2024-11-13_custom_NovemberPrivateWarrantsliabilitiesMember" id="Fact001082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,929</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; text-indent: 9pt">Fair value of Warrants exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueOfWarrantsExercised_iN_pn3n3_di_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zNzQDvx8Cbl6" title="Fair value of Warrants exercised" style="text-align: right">(<ix:nonFraction name="niobf:FairValueOfWarrantsExercised" contextRef="From2024-11-142025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember" id="Fact001084" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">338</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zYu4P0N5b986" title="Change in fair value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" contextRef="From2024-11-142025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember" id="Fact001086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,240</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zL0EmStf7uLi" title="Ending balance" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation1" contextRef="AsOf2025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember" id="Fact001088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,831</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_982_ecustom--CommonShareDescription_c20250102__20250131_zW6NyPukfRp8" title="Common share, description" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2025-01-022025-01-31" id="Fact001090" name="niobf:CommonShareDescription">On
January 31, 2025, the Company closed an underwritten registered direct offering (the &#8220;January 2025 Offering&#8221;), pursuant
to an underwriting agreement, dated January 29, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold
2,577,320 Common Shares, 2,577,320 Series A Warrants to purchase up to 2,577,320 Common Shares (the &#8220;January 2025 Series
A Warrants&#8221;) and 1,288,660 Series B Warrants to purchase up to an additional 1,288,660 Common Shares (the &#8220;January
2025 Series B Warrants&#8221; and, together with the January 2025 Series A Warrants, the &#8220;January 2025 Warrants&#8221;).
Each Common Share was sold together with one January 2025 Series A Warrant and one-half of one January 2025 Series B Warrant at
a combined public offering price of $1.94. The gross proceeds from the January 2025 Offering were approximately $5,000 before
deducting underwriting discounts and offering expenses. The January 2025 Warrants were classified as equity instruments, and accordingly,
the net proceeds were allocated based on the relative fair values of the Common Shares and the January 2025 Warrants on the date
of issuance, with $2,200 allocated to the fair value of the January 2025 Warrants and the balance of the proceeds of $2,800 allocated
to Common Shares. The Company incurred total transaction costs related to the January 2025 Offering of $799, which were treated
as share issuance costs at closing. The January 2025 Series A Warrants have an exercise price of $1.98 per underlying Common Share,
are exercisable immediately, and will expire on August 2, 2027. The January 2025 Series B Warrants have an exercise price of $2.05
per underlying Common Share, are exercisable immediately, and will expire on January 31, 2029.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following primary inputs were used in the Black-Scholes model for valuing the January 2025 Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001092" name="niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_pn3n3_zxW275XyTNk7" summary="xdx: Disclosure - COMMON SHARES (Details 4)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-bottom: 1pt"><span id="xdx_8BA_zR1scRy2NAkj" style="display: none">Schedule of Black-Scholes model for warrants</span></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td><td style="text-align: right; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series B</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_ziqwvz8ifXng" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-01-31_custom_SeriesAPublicWarrantsMember" id="Fact001094" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zF3dBkIGi8p" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-01-31_custom_SeriesBPublicWarrantsMember" id="Fact001096" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zK3f3iIg1ugf" title="Term (years)"><ix:nonNumeric contextRef="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember" format="ixt-sec:duryear" id="Fact001098" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_z0BPucdjJLQi" title="Term (years)"><ix:nonNumeric contextRef="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember" format="ixt-sec:duryear" id="Fact001100" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.0</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zVxoQiJ3o6h1" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember" id="Fact001102" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">73.18</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zFYt7yuL6Myg" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember" id="Fact001104" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">73.36</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_z0P6pIedNQqb" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember" id="Fact001106" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.23</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zez53Gsgpcjh" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember" id="Fact001108" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.31</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
</table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p id="xdx_989_ecustom--CommonShareDescription_c20250402__20250421_gBFCSD-TT_z6OMmw6PC0O1" title="Common share, description" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2025-04-022025-04-21" continuedAt="ConU001111-01" id="Fact001111" name="niobf:CommonShareDescription">On
April 21, 2025, the Company closed an underwritten public offering (the &#8220;April 2025 Offering&#8221;), pursuant to an underwriting
agreement, dated April 17, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold (i) 6,628,846 Common
Shares at a public offering price of $2.60 per Common Share and (ii) 1,063,462 pre-funded Warrants (the
&#8220;April 2025 Pre-Funded Warrants&#8221;) to purchase up to an additional 1,063,462 Common Shares at a public offering price
of $2.5999. The April 2025 Pre-Funded Warrants have an exercise price of $0.0001 per underlying Common Share, are exercisable
immediately, and do not have an expiration date. On April 17, 2025, Maxim partially exercised its over-allotment option to purchase
323,504 additional Common Shares at closing. The gross proceeds from the April 2025 Offering were</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><p id="xdx_237_zhb9KvneHZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 46; Value: 28 -->
    <div id="xdx_230_zAHdRBusZ5P1" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div>
    <div id="xdx_23E_zSnsC7toXyFj" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zpjLtCr9h2T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23D_zznag9BmDHAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_236_z2jR0O3jc5O9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_23F_znuDE3q7zSA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_ztpqL7d8xlY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_235_zeV7ooeAOBTg" style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_23C_z7zHfbZMAJUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_C08_gBFCSD-TT_z7hcYMPlT25e"><ix:continuation id="ConU001111-01"><span style="font: 10pt Times New Roman, Times, Serif">
approximately $20,841 before deducting underwriting discounts and offering expenses. The April 2025 Pre-Funded Warrants were
classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair values of the Common
Shares and the April 2025 Pre-Funded Warrants on the date of issuance, with $2,765 allocated to the fair value of the April 2025
Pre-Funded Warrants (based on the value of the underlying Common Shares at closing) and the balance of the proceeds of $18,076
allocated to Common Shares. The Company incurred total transaction costs related to the April 2025 Offering of $2,102, which were
treated as share issuance costs at closing.</span></ix:continuation></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2024 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2023, the Company closed a non-brokered private placement of
units of the Company (the &#8220;September 2023 Units&#8221;). A total of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcnMzixEdHO7" title="Shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember" id="Fact001121" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span> September 2023 Units were issued at a price
per September 2023 Unit of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zOXAxDpdMxdl" title="Price per unit"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember" id="Fact001123" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span>, for total gross proceeds to the Company of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zN3hRBzc4Evd" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember" id="Fact001125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,000</ix:nonFraction></span>. Each September 2023 Unit consists of one
Common Share and one Warrant (&#8220;September 2023 Warrant&#8221;). Each September 2023 Warrant entitles the holder to acquire
one Common Share at a price of $<span id="xdx_900_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zi6PwD1M1g12" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember" id="Fact001127" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.60</ix:nonFraction></span> at any time prior to September 1, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
September 2023 Warrants were classified as an equity instrument and accordingly, the net proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930_z8SBiYPWUEtk"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-09-012023-09-30" id="Fact001128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">962</ix:nonFraction></span> were allocated based
on the relative fair values of the Common Shares and the September 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the September 2023 Warrants was $<span id="xdx_909_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxqBHTLMYjC6"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001129" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></span> and the balance of the proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z63p12ovCXbi"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2023-09-012023-09-30_us-gaap_CommonStockMember" id="Fact001130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">708</ix:nonFraction></span> was allocated to the Common
Shares. The fair value of the September 2023 Warrants issued was computed using the Black Scholes pricing model using the following
assumptions: an expected life of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTaxtwJfQoB1" title="Expected life"><ix:nonNumeric contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" format="ixt-sec:duryear" id="Fact001132" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.0</ix:nonNumeric></span> years, a risk-free interest rate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrWoP0LjBpbf" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001134" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.85</ix:nonFraction>%</span>, an expected volatility of <span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsWPARBBqCe5" title="Expected volatility"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001136" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">71.63</ix:nonFraction>%</span>, and an expected
dividend rate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl5CQm3kSkV6" title="Expected dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember" id="Fact001138" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0</ix:nonFraction>%</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2023, the Company closed a non-brokered private placement (the &#8220;December 2023 Private Placement&#8221;) of
<span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zX1ggqAg1NV7" title="Shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember" id="Fact001140" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">413,432</ix:nonFraction></span> units of the Company (the &#8220;December 2023 Units&#8221;). Each December 2023 Unit consists of one Common Share and
one Warrant (&#8220;December 2023 Warrant&#8221;). Each December 2023 Warrant entitles the holder to acquire one Common Share
at a price of $<span id="xdx_909_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgixaxJwteWh" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember" id="Fact001142" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.54</ix:nonFraction></span> at any time until December 22, 2025. <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zMtLNVXWum32" title="Units issue and sold"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember" id="Fact001144" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274,587</ix:nonFraction></span> of the December 2023 Units were issued and sold to certain accredited
investors, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, at a price of $<span id="xdx_90F_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zhiAQd1sj7Wh" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember" id="Fact001146" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.08</ix:nonFraction>
</span>per December 2023 Unit, and <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z32sSJmDDfuc" title="Units issue and sold"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_srt_DirectorMember" id="Fact001148" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">138,845</ix:nonFraction></span> of the December 2023 Units were issued and sold to certain officers and directors of the Company
(the &#8220;Insider Investors&#8221;), at a price of $<span id="xdx_90B_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zmNpsNmTa9Mb" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_srt_DirectorMember" id="Fact001150" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.205</ix:nonFraction></span> per December 2023 Unit. The price per December 2023 Unit paid by the
Insider Investors included $0.125 per December 2023 Warrant underlying each December 2023 Unit purchased by the Insider Investors
which allowed the Insider Investors to participate in the December 2023 Private Placement in accordance with the rules of Nasdaq.
The Company received aggregate gross proceeds from the December 2023 Private Placement of approximately $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zwVkOE7Lwlyh" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_currency_CAD" id="Fact001152" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,290</ix:nonFraction></span>. The Company recorded
a non-cash expense of $<span id="xdx_90D_eus-gaap--OtherCostAndExpenseOperating_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zT30JttLFDla" title="Other operating expenses"><ix:nonFraction name="us-gaap:OtherCostAndExpenseOperating" contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember" id="Fact001154" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--OperatingCostsAndExpenses_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlrsXDk921lk" title="Employee related costs"><ix:nonFraction name="us-gaap:OperatingCostsAndExpenses" contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember" id="Fact001156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span> to other operating expense and employee related costs, respectively, representing the excess
of fair value of the December 2023 Units over the purchase price paid by Insider Investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
December 2023 Warrants were classified as an equity instrument and accordingly, the estimated net proceeds of $1,241 were allocated
based on the relative fair values of the Common Shares and the December 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the December 2023 Warrants was $<span id="xdx_908_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zD6t4LldO1ke" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember" id="Fact001158" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">264</ix:nonFraction></span> and the balance of the proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2J60iSkglUa" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember" id="Fact001160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">977</ix:nonFraction></span> was allocated to the Common Shares.
The fair value of the December 2023 Warrants issued was computed using the Black Scholes pricing model using the following assumptions:
an expected life of <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpcB4YTFkPM6" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1162">2.0</span></span> years, a risk-free interest rate of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlHuOS8D7Huh" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember" id="Fact001164" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.33</ix:nonFraction>%</span>, an expected volatility of <span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRV8tIpNHQg4" title="Expected volatility"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember" id="Fact001166" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">54.8</ix:nonFraction>%</span>, and an expected dividend rate
of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zd1OEgMF963c" title="Expected dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember" id="Fact001168" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0</ix:nonFraction>%</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2024, the Company closed a non-brokered private placement of units of
the Company (the &#8220;June 2024 Units&#8221;). A total of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20240602__20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z6NWr6ZDZHze" title="Shares issue"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-06-022024-06-24_us-gaap_PrivatePlacementMember" id="Fact001170" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">315,000</ix:nonFraction></span> June 2024 Units were issued at a price per June 2024 Unit
of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNH8bFvFviml" title="Price per unit"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-06-24_us-gaap_PrivatePlacementMember" id="Fact001172" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.91</ix:nonFraction></span>, for total gross proceeds to the Company of $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20240602__20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcTtONtYf6el" title="Gross proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-06-022024-06-24_us-gaap_PrivatePlacementMember" id="Fact001174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">602</ix:nonFraction></span>. Each June 2024 Unit consists of one Common Share and one Warrant (&#8220;June
2024 Warrant&#8221;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $<span id="xdx_907_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zz6ahyejhmwj" title="Shares price"><ix:nonFraction name="niobf:SaleOfStockPricePerShare1" contextRef="AsOf2024-06-24_us-gaap_PrivatePlacementMember" id="Fact001176" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.20</ix:nonFraction></span> at any time prior
to June 24, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><p id="xdx_232_zm6rthspRVMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 47; Value: 28 -->
    <div id="xdx_232_zk8nfW8lEvLh" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div>
    <div id="xdx_232_zOpZX7tTdBo3" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zQ33bI2RhMvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>
<ix:exclude><p id="xdx_23F_zVfrc28mWC21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NioCorp Developments Ltd.&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_233_zz48HeEiGyb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Notes to the Consolidated Financial Statements </b></p></ix:exclude>

<ix:exclude><p id="xdx_231_zj4JRnStqtMa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>June 30, 2025</b>&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zyqjFOzLQNLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(expressed in thousands of U.S. dollars, except share and
per share data or as otherwise stated)</p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23E_zZ9q0259pr3l" style="text-align: left; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_237_zH4YHhsM65G2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 2024 Warrants were classified as an equity instrument and accordingly, the net proceeds of $602 were allocated based on the
relative fair values of the Common Shares and the June 2024 Warrants on the date of issuance. The amount allocated to the fair
value of the June 2024 Warrants was $<span id="xdx_90B_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7xA8nTm5Wma" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001186" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">161</ix:nonFraction></span> and the balance of the proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztsJxj98WuKf" title="Proceeds from equity"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="From2024-06-012024-06-30_us-gaap_CommonStockMember" id="Fact001188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">441</ix:nonFraction></span> was allocated to Common Shares. The fair value
of the June 2024 Warrants issued was computed using the Black Scholes pricing model using the following assumptions: an expected
life of <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zloz9QsTheUh" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1190">2.0</span></span> years, a risk-free interest rate of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0iRK4rJ8168" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001192" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.73</ix:nonFraction>%</span>, an expected volatility of <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4VE0pTv5uZg" title="Expected volatility"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001194" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">73.92</ix:nonFraction>%</span>, and an expected dividend rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRpIa9vIkxwh" title="Expected dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember" id="Fact001196" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0</ix:nonFraction>%</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Equity Facility Financing Agreement Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2025, the Company has access to up to $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zZjJ1nOuBIDc" title="Net proceeds"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember" id="Fact001198" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,917</ix:nonFraction></span> in net proceeds from the Yorkville Equity Facility Financing Agreement.
The Yorkville Equity Facility Financing Agreement expires on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20240701__20250630__us-gaap--ShortTermDebtTypeAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zzPa7ixBjDG1" title="Expires date"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember" format="ixt:datemonthdayyearen" id="Fact001200" name="us-gaap:DebtInstrumentMaturityDate">April 1, 2026</ix:nonNumeric></span>. The Company issued the following Common Shares under
the Yorkville Equity Facility Financing Agreement during the periods presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001202" name="niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_pn3n3_zC1q0aJQbfSk" summary="xdx: Disclosure - COMMON SHARES (Details 5)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span id="xdx_8B7_zTkJ5AOPBgLi" style="display: none">Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For The Year  <br/>Ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 74%; text-align: justify">Common Shares issued</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--CommonStockSharesIssued1_pid_uShares_c20240701__20250630_zmIiFOnitAKi" title="Common shares issued" style="width: 10%; text-align: right"><ix:nonFraction name="niobf:CommonStockSharesIssued1" contextRef="From2024-07-01to2025-06-30" id="Fact001204" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,671,742</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--CommonStockSharesIssued1_pid_uShares_c20230701__20240630_zIjUiwkfoof5" title="Common shares issued" style="width: 10%; text-align: right"><ix:nonFraction name="niobf:CommonStockSharesIssued1" contextRef="From2023-07-012024-06-30" id="Fact001206" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,358,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-left: 0.125in">Gross funds received</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zLMDNYNZVIq5" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-07-01to2025-06-30" id="Fact001208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230701__20240630_ztfSimaTqoz7" title="Gross funds received" style="text-align: right"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2023-07-012024-06-30" id="Fact001210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,293</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Market value of Common Shares issued<br/></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssued1_c20240701__20250630_zqnd5BCHOKPj" title="Market value of Common Shares issued" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2024-07-01to2025-06-30" id="Fact001212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,941</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssued1_c20230701__20240630_z74OWN2eV6E5" title="Market value of Common Shares issued" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2023-07-012024-06-30" id="Fact001214" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,398</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on issuance<sup>(1)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240701__20250630_fKDEp_zi38DeaHmkSd" title="(Gain)/Loss on Issuance" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2024-07-01to2025-06-30" id="Fact001216" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">589</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20230701__20240630_fKDEp_zPUTuQaIx7bh" title="(Gain)/Loss on Issuance" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" contextRef="From2023-07-012024-06-30" id="Fact001218" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">105</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_za1jIOPFlggi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 9pt"><span id="xdx_F1F_zVuOpfGNvd5k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001219" xml:lang="en-US">Loss
                                         on issuance represents a non-cash amount equal to the difference between the proceeds
                                         received and the fair value of the Common Shares issued based on the Nasdaq closing price
                                         per Common Share on the issuance date and is recorded in other operating expenses in
                                         the condensed consolidated statement of operations and comprehensive loss.</ix:footnote></span></td></tr></table>

</ix:nonNumeric><p id="xdx_8A0_zobZoM34NnW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                         Options</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, the Company&#8217;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#8220;2017 Amended Long-Term Incentive Plan&#8221;) and the granting of incentive securities thereunder until January 19,
2027. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant Options and share
units (in the form of restricted share units and performance share units), plus dividend equivalents, to non-employee directors,
employees and certain other service providers (as described in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated
entities selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any 1-year period, or issuable to insiders at any time, in the aggregate, under all security-based
compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding Common
Shares. The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved for issuance
to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation arrangements
of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment provisions
of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred by the Company
upon the exercise of Options will also be limited, as described in the 2017 Amended Long-Term Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has power over the granting, amendment, administration, or settlement of any award.</span></p>

<ix:exclude><p id="xdx_230_zMwX2ftDulQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zhqituqOLQvb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 48; Value: 28 -->
    <div id="xdx_23D_z0SFnuQgCUB8" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div>
    <div id="xdx_23E_zenre65RUj1e" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zyopXvrq4Yh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>


<ix:exclude><p id="xdx_23B_zAkmmMBAIBb1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zr4nezUMUXpg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zdbBILHgQzQh" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zyU1PwYtZF4a" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23B_ztRq8iix54Tc" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
transactions are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001229" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_pn3n3_zra9zMcF5HNh" summary="xdx: Disclosure - COMMON SHARES (Details 6)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BE_zqRO2c9yrHPf" style="display: none">Schedule of option</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number&#160;of&#160;Options</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate Intrinsic Value</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Remaining Contractual Life</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zo5FW6VaGGV4" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-06-30" id="Fact001231" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,541,500</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_z5aRZ0B4yIqc" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-06-30" id="Fact001233" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">7.19</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_z7UbXA2DKgPg" title="Granted, in shares" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-07-012024-06-30" id="Fact001235" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,625,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zq7dprEAdSfh" title="Granted, per share" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-07-012024-06-30" id="Fact001237" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.99</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zcpRxLZtHLe3" title="Cancelled/expired, in shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-07-012024-06-30" id="Fact001239" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,800</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zcua8iTgLMMi" title="Cancelled/expired, per share" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-07-012024-06-30" id="Fact001241" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">3.95</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_ztAKExeJEcdj" title="Cancelled/expired, in shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2023-07-012024-06-30" id="Fact001243" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">663,200</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zrSGke4oCfW2" title="Cancelled/expired, per share" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2023-07-012024-06-30" id="Fact001245" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">5.88</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20250630_zvDjJdNSlaTc" title="Beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-06-30" id="Fact001247" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,495,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20240701__20250630_zDTBdK33q3N6" title="Beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-06-30" id="Fact001249" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">4.78</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20250630_zy0nRSWy2s9i" title="Granted, in shares" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-07-01to2025-06-30" id="Fact001251" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">945,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zGNCkDvD8c12" title="Granted, per share" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-07-01to2025-06-30" id="Fact001253" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">1.41</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20250630_zQGeplrrOW5l" title="Cancelled/expired, in shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-07-01to2025-06-30" id="Fact001255" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">512</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zrSRhaFcDhab" title="Cancelled/expired, per share" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-07-01to2025-06-30" id="Fact001257" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">1.40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20250630_zYC8dMDLo6l8" title="Cancelled/expired, in shares" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2024-07-01to2025-06-30" id="Fact001259" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">419,988</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zMk0H7ryc6M3" title="Cancelled/expired, per share" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2024-07-01to2025-06-30" id="Fact001261" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">9.44</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2025</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20250630_z1qx7VjdF3m6" title="Ending balance" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2025-06-30" id="Fact001263" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,020,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20240701__20250630_zXM8lFwL92I" title="Ending balance" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-06-30" id="Fact001265" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">3.09</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20250630_zjwmjb5VjMmi" title="Aggregate intrinsic value" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2025-06-30" id="Fact001267" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">866</ix:nonFraction></td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630_zECCFukmRsF4" title="Weighted average remaining contractual life"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:duryear" id="Fact001269" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">3.5</ix:nonNumeric></span> years</span></td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2025,<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_uRatio_c20240701__20250630_zOh81uGwmVjb" title="Outstanding stock options vested"> <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" contextRef="From2024-07-01to2025-06-30" id="Fact001271" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">99.8</ix:nonFraction>%</span> of the outstanding Options were fully vested. The total intrinsic value of Options exercised during the
year ended June 30, 2025 <span style="background-color: white">was nil, and as of June 30, 2025, </span>there was $<span id="xdx_90F_ecustom--UnrecognizedCompensationCosts_iI_pn3n3_c20250630_zsjCKtzAezfd" title="Unrecognized compensation costs"><ix:nonFraction name="niobf:UnrecognizedCompensationCosts" contextRef="AsOf2025-06-30" id="Fact001273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span> of unrecognized
compensation costs related to unvested share-based compensation arrangements granted. The Company recognized share-based compensation
expense of $<span id="xdx_905_eus-gaap--ShareBasedCompensation_pn3n3_c20240701__20250630_zZYNEvzDISwc" title="Share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-07-01to2025-06-30" id="Fact001275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">789</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_pn3n3_dxL_c20230701__20240630_zklICT3YfVJ1" title="Share based compensation expense::XDX::2881"><span style="-sec-ix-hidden: xdx2ixbrl1277">2,779</span></span> for the years ended June 30, 2025 and 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the weighted average information and assumptions used to determine Option costs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001279" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zzeVpWSx38yc" summary="xdx: Disclosure - COMMON SHARES (Details 7)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; background-color: White; visibility: hidden">
    <td style="display: none; padding-left: 5pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_498_20240701__20250630_zr6u56GHJ8Ig" style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_49F_20230701__20240630_zFf2bGLFP1C8" style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; text-align: left; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt"><span id="xdx_8B9_znuoL3SnEEvc" style="display: none">Schedule of  weighted average  and assumptions used to option costs</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_zBGQgMDOCHP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 5pt">Fair value per option granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-07-01to2025-06-30" id="Fact001281" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.84</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-07-012024-06-30" id="Fact001282" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.71</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_zYkx8Fz5RPLk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2024-07-01to2025-06-30" id="Fact001284" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.44</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-07-012024-06-30" id="Fact001285" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.25</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zEFumOScew94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-07-01to2025-06-30" id="Fact001287" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-012024-06-30" id="Fact001288" format="ixt:numdotdecimal" decimals="INF" unitRef="Ratio">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_zWvBAbR5Epja" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Expected stock price volatility (historical basis)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-01to2025-06-30" id="Fact001290" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">67.3</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30" id="Fact001291" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">63.2</ix:nonFraction></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Expected option life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630_zbgAbYq8KEs5" style="text-align: right"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt-sec:duryear" id="Fact001292" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.0</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230701__20240630_zJpZ9V8HBIi5" style="text-align: right"><ix:nonNumeric contextRef="From2023-07-012024-06-30" format="ixt-sec:duryear" id="Fact001293" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.0</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to January 1, 2024, the Company concluded that under ASU 718, <i>Compensation &#8211; Stock Compensation (Topic 718)</i>, Options
previously issued on December 31, 2021, May 30, 2022, and March 27, 2023, which included a C$ strike price (the &#8220;CAD Options&#8221;)
should remain equity-classified as management determined that the Options qualified for an exemption from liability classification
as the CAD Options were denominated in a currency in which a substantial portion of the Company&#8217;s equity securities traded.
Effective January 1, 2024, the Company determined that due to historically decreasing trading volume on the TSX, this exemption
no longer applied and accordingly, these CAD Options were classified as a liability based on their fair values on that date. The
Company recorded a mark-to-market gain of $147 in other operating expenses related to these CAD Option liabilities for the year
ended June 30, 2024. The CAD Options expired at various dates during the year ended June 30, 2025, with no further gains or losses
recorded in other operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Board approved a modification to Options previously issued on March 27, 2023, with dual strike prices of $6.95
and C$9.52, under which the option to exercise in C$ was removed. No other terms or conditions were amended by the Board. Based
on this amendment, the Company re-classified these Options to equity on March 28, 2024, based on their fair value on that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
transactions are summarized as follows. Weighted average exercise prices related to Canadian dollar denominated Warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.</span></p>

<ix:exclude><p id="xdx_230_zYnwxamrewUb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zvebnwGmVlD9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 1; Options: NewSection; Value: 76 -->
    <div id="xdx_23B_zrD2CDhwd3i5" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div>
    <div id="xdx_23F_zCmQsmPTKAzc" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_ztMPHv6Ka2t9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zZ6PiuZnY3vg" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zGdTeGprjT9e" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zXw77rP7x95l" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zOFEDGYTmXe8" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_232_zl5mHtTotPl7" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001303" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zXuQE7ktV8p5" summary="xdx: Disclosure - COMMON SHARES (Details 8)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 3pt"><span id="xdx_8BC_zs9ZXhkeybme" style="display: none">Schedule of Weighted average exercise prices</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Warrants</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 59%; padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zUX6oVYEX5Ij" title="Beginning balance, Warrants" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-06-30" id="Fact001305" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,816,304</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zcGw2PVqxW6j" title="Beginning balance at Weighted Average Exercise Price" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2023-06-30" id="Fact001307" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.98</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_zFwo2AhJUFP" title="Beginning balance, Warrants" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightGranted" contextRef="From2023-07-012024-06-30" id="Fact001309" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,593,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zwNyIPwG4fFj" title="Beginning balance at Weighted Average Exercise Price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceGranted" contextRef="From2023-07-012024-06-30" id="Fact001311" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.33</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_zDIy7pizdv4e" title="Beginning balance, Warrants" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExpired" contextRef="From2023-07-012024-06-30" id="Fact001313" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,846,560</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_z4eGOlMMpZIa" title="Beginning balance at Weighted Average Exercise Price" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExpired" contextRef="From2023-07-012024-06-30" id="Fact001315" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.67</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20250630_zEJ1tK2Ezljd" title="Beginning balance, Warrants" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-30" id="Fact001317" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,563,561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20240701__20250630_zbSupISsCcpg" title="Beginning balance at Weighted Average Exercise Price" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2024-06-30" id="Fact001319" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.53</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20250630_ztbkMTkadHp7" title="Beginning balance, Warrants" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightGranted" contextRef="From2024-07-01to2025-06-30" id="Fact001321" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,553,714</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20250630_zWnCqbHapuc6" title="Beginning balance at Weighted Average Exercise Price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceGranted" contextRef="From2024-07-01to2025-06-30" id="Fact001323" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.05</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20250630_zwJk9Mhe7C3i" title="Beginning balance, Warrants" style="text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExercised" contextRef="From2024-07-01to2025-06-30" id="Fact001325" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">828,235</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20250630_zql4ZlYmrsZ4" title="Beginning balance at Weighted Average Exercise Price" style="text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExercised" contextRef="From2024-07-01to2025-06-30" id="Fact001327" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1.78</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20250630_zCdUca7tTTc7" title="Beginning balance, Warrants" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ClassOfWarrantOrRightExpired" contextRef="From2024-07-01to2025-06-30" id="Fact001329" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,303,118</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20250630_zlHjkOpjYvtl" title="Beginning balance at Weighted Average Exercise Price" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ClassOfWarrantOrRightExercisePriceExpired" contextRef="From2024-07-01to2025-06-30" id="Fact001331" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.72</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2025</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20250630_zIyW2AzEkrwj" title="Beginning balance, Warrants" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30" id="Fact001333" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,985,922</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20240701__20250630_zYae6k9rdGej" title="Beginning balance at Weighted Average Exercise Price" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="AsOf2025-06-30" id="Fact001335" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.06</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
June 30, 2025, the Company has outstanding exercisable Warrants, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001337" name="niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXHd4VtQMRbi" summary="xdx: Disclosure - COMMON SHARES (Details 9)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="display: none; vertical-align: bottom">
    <td colspan="2" style="display: none; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zdxmK0jNL4al" style="display: none">Schedule
of outstanding exercisable Warrants</span></span></td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; padding-left: 5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt">Expiry Date</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zd0IIseyj82k" title="Number of share outstanding" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice4.60Member" id="Fact001339" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zFL0jlRwAgLl" title="Exercise price" style="width: 18%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice4.60Member" id="Fact001341" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">4.60</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zyh0iohcDUw9" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice4.60Member" format="ixt:datemonthdayyearen" id="Fact001343" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">September 1, 2025</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zVGGTMFD7f5l" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice3.54Member" id="Fact001345" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">413,432</ix:nonFraction><br/>
</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_z8JIEsyEAb05" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice3.54Member" id="Fact001346" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">3.54</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zc5mDRVkN54h" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice3.54Member" format="ixt:datemonthdayyearen" id="Fact001348" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">December 22, 2025</ix:nonNumeric></span><br/>
</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_ztHLrjBYm4oh" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice2.20Member" id="Fact001350" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">315,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZSn1BkZxTe" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice2.20Member" id="Fact001351" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zvJmN7P2xkNe" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice2.20Member" format="ixt:datemonthdayyearen" id="Fact001353" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">June 24, 2026</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_z3XmybalTJr1" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice1.75Member" id="Fact001355" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,117,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zjsy76CW6Wqe" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice1.75Member" id="Fact001356" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">1.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zs8QG8ZZoO56" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice1.75Member" format="ixt:datemonthdayyearen" id="Fact001358" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">November 5, 2026</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zr7pf8oErYi8" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice1.75OneMember" id="Fact001360" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,992,214</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_z3syGfztzHT" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice1.75OneMember" id="Fact001361" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">1.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zwinatfKpBG2" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice1.75OneMember" format="ixt:datemonthdayyearen" id="Fact001363" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">November 13, 2026</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zzwRWNc2GOwg" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice3.25Member" id="Fact001365" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">615,385</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zyAIT8J6VI26" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice3.25Member" id="Fact001366" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">3.25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zEwwOexhFMvj" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice3.25Member" format="ixt:datemonthdayyearen" id="Fact001368" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">April 12, 2027</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_zypR2g71yvjd" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice1.98Member" id="Fact001370" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,577,320</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ziEZfIN2d1R3" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice1.98Member" id="Fact001371" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">1.98</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ztlSJK2yX35d" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice1.98Member" format="ixt:datemonthdayyearen" id="Fact001373" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">August 2, 2027</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_fKDEp_zxtFEcbnmEJk" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice11.50Member" id="Fact001375" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,666,626</ix:nonFraction></td><td style="white-space: nowrap; text-align: left"><sup>(1)</sup>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zArioAAX3led" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice11.50Member" id="Fact001376" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zo5kJ0xeoZ54" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice11.50Member" format="ixt:datemonthdayyearen" id="Fact001378" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">March 17, 2028</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zO4CBiwWlLue" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice2.31Member" id="Fact001380" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,816,742</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zwRG5lgseGJ8" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice2.31Member" id="Fact001381" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zrCEDZFZu0Ak" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice2.31Member" format="ixt:datemonthdayyearen" id="Fact001383" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">September 17, 2028</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_z1PzvW1Pp7xi" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice2.05Member" id="Fact001385" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,288,660</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zZ0hhfGF2R86" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice2.05Member" id="Fact001386" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.05</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zIpDLmRqiWWi" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice2.05Member" format="ixt:datemonthdayyearen" id="Fact001388" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">January 31, 2029</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYCi8ZTEpbxg" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice2.07Member" id="Fact001390" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">802,045</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zrClG3aAOJD" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice2.07Member" id="Fact001391" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.07</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYBjyllkmuij" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice2.07Member" format="ixt:datemonthdayyearen" id="Fact001393" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">November 5, 2029</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zJwsDpyLenOh" title="Number of share outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice2.07OneMember" id="Fact001395" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,067,946</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_ztkuA19O2YDg" style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice2.07OneMember" id="Fact001396" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.07</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zIfQP5YVrlgl" title="Expiry date"><ix:nonNumeric contextRef="AsOf2025-06-30_custom_ExercisePrice2.07OneMember" format="ixt:datemonthdayyearen" id="Fact001398" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate">November 13, 2029</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zHynswnRGWRl" title="Number of share outstanding" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30_custom_ExercisePrice2.60Member" id="Fact001400" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,063,462</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zEQauSMT7Hde" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-06-30_custom_ExercisePrice2.60Member" id="Fact001401" format="ixt:numdotdecimal" decimals="INF" unitRef="CADPShares">2.60</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">No expiry</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630_zkrTCT5o5nuk" title="Number of share outstanding" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2025-06-30" id="Fact001403" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,985,922</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="width: 6%; text-align: center"><span id="xdx_F08_zntRSXlTmEJl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 94%; text-align: justify"><span id="xdx_F10_zs4hJ7HULwAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001404" xml:lang="en-US">Includes
    11,165,324 and 4,501,302 2023 Public Warrants and 2023 Private Warrants, respectively, as defined below. Each 2023 Public
    Warrant and 2023 Private Warrant is exercisable into 1.11829212 Common Shares.</ix:footnote></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A0_zxuVg6mqYfR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed GXII&#8217;s obligations under
the agreement (the &#8220;GXII Warrant Agreement&#8221;) governing the GXII share purchase Warrants (the &#8220;GXII Warrants&#8221;)
and each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one
Warrant to purchase 1.11829212 Common Shares (the &#8220;NioCorp Assumed Warrants&#8221;) pursuant to the GXII Warrant Agreement,
as amended by an Assignment, Assumption and Amendment Agreement, dated March 17, 2023, among the Company, GXII, Continental Stock
Transfer &amp; Trust Company, as the existing warrant agent, and Computershare Inc. and its affiliate, Computershare Trust Company,
N.A, together as the successor warrant agent (the &#8220;NioCorp Assumed Warrant Agreement&#8221;). In connection with the Closing,
NioCorp issued (a)&#160;<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_zCEP1bCoIsnc" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-012025-06-30_custom_GXIIPublicWarrantsMember" id="Fact001406" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,999,959</ix:nonFraction></span>&#160;public NioCorp Assumed Warrants (the &#8220;2023 Public Warrants&#8221;) in respect of
the GXII Warrants that were publicly traded prior to the Closing and (b)&#160;<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zecvBiZgVyL3" title="Warrants traded prior to the closing"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-012025-06-30_custom_GXIIPrivateWarrantsMember" id="Fact001408" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,666,667</ix:nonFraction></span>&#160;NioCorp Assumed Warrants (the &#8220;2023
Private Warrants&#8221;) to the Sponsor in respect of the GXII Warrants that it held prior to
the Closing, which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the
Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like). No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.</span></p>

<ix:exclude><p id="xdx_23E_zvxTvtVkbma9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z0IkvQtY9uB4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 2; Value: 76 -->
    <div id="xdx_232_zZBLQDXrgMqf" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div>
    <div id="xdx_233_zOr6y1fDoVE6" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zUfYzpM2w921" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zCuPWHfAbOFk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; color: #212529"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zjHoQJPSGv2f" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zaA9HH43jfbf" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zZcaSnNr0v93" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><ix:exclude><div id="xdx_236_zvZhs4TsYHk3" style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></ix:exclude></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2023
Public Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may elect to redeem the 2023 Public Warrants subject to certain conditions, in whole and not in part, at a price of
$0.01 per 2023 Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrants2023Member_zYaRw4xQUQ4b" title="Description of warrants"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_PublicWarrants2023Member" id="Fact001418" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day
period ending on the third business day prior to the date on which the Company sends the notice of redemption to the Warrant
holders</ix:nonNumeric></span> and (iii) there is an effective registration statement covering the Common Shares issuable upon exercise of
the 2023 Public Warrants, and a current prospectus relating thereto, available through the redemption date. Upon issuance of
a redemption notice by the Company, the Warrant holders will have until the redemption date to exercise for cash, or, at the
Company&#8217;s election, on a cashless basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2023
Private Warrants </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii)
will not be redeemable by the Company, in either case as long as the 2023 Private Warrants are held by the initial purchasers
or their permitted transferees. Any 2023 Private Warrants that are held by someone other than the initial purchasers or their
permitted transferees are treated as 2023 Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the 2023 Private Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides
that because the 2023 Private Warrants do not meet the criteria for equity treatment thereunder, the 2023 Private Warrants must
be recorded as a liability. This liability is carried as a component of Warrant liabilities on the consolidated balance sheet
and is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted
to its current fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive
loss. The Company will reassess the classification at each balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
provided for in the <span id="xdx_905_ecustom--ExchangeOfWarrantsDescription_c20240701__20250630_zIn4ATDZqcKe" title="Exchange of warrants, description"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" id="Fact001420" name="niobf:ExchangeOfWarrantsDescription">NioCorp Assumed Warrant Agreement, through June 30, 2025, a total of 1,165,365 2023 Private Warrants were
exchanged for 2023 Public Warrants. Upon exchange, the Company recorded an additional fair value expense of $26 and transferred
the fair value of the exchanged 2023 Public Warrants from warrant liabilities to equity.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies the 2023 Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value
using a Black Scholes model with the following assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001422" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFk6Ox8K47Rd" summary="xdx: Disclosure - COMMON SHARES (Details 10)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: justify"><span id="xdx_8B1_zaWJlw2aMbae" style="display: none">Schedule of Company classifies the 2023 Private Warrants</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6oXgHKruWe6" title="Stock price on valuation date" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001424" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.33</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqekotrMP9Vi" title="Stock price on valuation date" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001426" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znCtEfbsXH08" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001428" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zF3USWMHviO5" title="Strike price" style="text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001430" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zokzvdR53Fk3" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001432" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">90.0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9U5QvrJpznl" title="Implied volatility of public warrants"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001434" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">69.0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znZARl9u7sBg" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001436" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.70</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0eYdPxiw4Vg" title="Risk free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001438" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.45</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgm51tujLyqh" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001440" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zg46M9I9XHcl" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001442" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected Warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlnRSv5Nal7c" title="Expected warrant life in years"><ix:nonNumeric contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt-sec:duryear" id="Fact001444" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.7</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtYp_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zh9w0dnN8xu9" title="Expected warrant life in years"><ix:nonNumeric contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member" format="ixt-sec:duryear" id="Fact001446" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3.7</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the 2023 Private Warrants liability is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001448" name="niobf:ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_z0wgS9c7yeFj" summary="xdx: Disclosure - COMMON SHARES (Details 11)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BA_zyhMrnzpsjGb" style="display: none">Schedule of change in the 2023 Private Warrants liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Valuation at June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zdA6r0J0esa4" title="Initial valuation, at begining" style="width: 12%; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2023-06-30_us-gaap_NoteWarrantMember" id="Fact001450" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,279</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu0bnuGHovO5" title="Change in valuation" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" contextRef="From2023-07-012024-06-30_us-gaap_NoteWarrantMember" id="Fact001452" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,926</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Valuation at June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zEgWZiuvZZk4" title="Initial valuation, at begining" style="text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2024-06-30_us-gaap_NoteWarrantMember" id="Fact001454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,353</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Exchange of 2023 Private Warrants for 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ExchangeOfPrivateWarrantsForPublicWarrants_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqxGr8R6Ic6" title="Exchange of 2023 Private Warrants for 2023 Public Warrants" style="text-align: right">(<ix:nonFraction name="niobf:ExchangeOfPrivateWarrantsForPublicWarrants" contextRef="From2024-07-012025-06-30_us-gaap_NoteWarrantMember" id="Fact001456" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">482</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zZz1REyuZhG6" title="Change in valuation" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" contextRef="From2024-07-012025-06-30_us-gaap_NoteWarrantMember" id="Fact001458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,661</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Valuation at June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zJRxXg73bqG3" title="Ending balance" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation1" contextRef="AsOf2025-06-30_us-gaap_NoteWarrantMember" id="Fact001460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,532</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"><p style="margin-top: 0; margin-bottom: 0">&#160;</p></td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 3; Value: 76 -->
    <div id="xdx_23C_zWFAJXK6Yn7i" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div>
    <div id="xdx_230_zgHB5QGhLJVg" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zz3BKDJ016Zi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zIsn2pAL9GG3" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zIxODa2Gvii5" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z7Pw3AFxeLI7" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zs6EAeScMnf9" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_232_zKmWE7N5ylcb" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<ix:exclude><p id="xdx_237_zvV6Y1oJxKAj" style="margin: 0"></p></ix:exclude>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingent
Consent Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20240701__20250630__us-gaap--BusinessAcquisitionAxis__custom--LindGlobalAssetManagementThreeLLCMember_zT3rn8cfB36" title="Contingent consideration description" class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-07-012025-06-30_custom_LindGlobalAssetManagementThreeLLCMember" id="Fact001469" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#8220;Lind Consent&#8221;), between the Company and Lind Global Asset Management III, LLC (&#8220;Lind III&#8221;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#8220;Contingent Consent Warrants&#8221;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance. Further, the number of Contingent Consent Warrants issued would be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Company&#8217;s Common Share price was below the threshold price set forth in the Lind Consent, and accordingly,
the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240915__20240917_zV7hAPsbKN5" title="Stock issued, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-09-152024-09-17" id="Fact001471" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,816,742</ix:nonFraction></span> Contingent Consent Warrants to Lind III. Each Contingent Consent Warrant is exercisable for one Common
Share at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zchsq8WjatB4" title="Common share exercise price, per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember" id="Fact001473" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.308</ix:nonFraction></span> and may be exercised at any time prior to their expiration on September 17, 2028. The number
of Contingent Consent Warrants issued was based on $<span id="xdx_904_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_c20240915__20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zo3BmPXABiDj"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember" id="Fact001474" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,000</ix:nonFraction></span> divided by the five-day volume weighted average price of the Common
Shares on September 16, 2024. The Company valued the Contingent Consent Warrants at $2,262 based on a Black-Scholes valuation
with the following inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001476" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zFUYIGd61og6" summary="xdx: Disclosure - COMMON SHARES (Details 12)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: justify"><span id="xdx_8B2_ziBCaZUdluGd" style="display: none">Schedule of  Black-Scholes valuation
</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 17,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zqGe67wsIuDc" title="Closing common share price" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember" id="Fact001478" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.74</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)<br/>
</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zV77JykhDcch" title="Term (years)"><ix:nonNumeric contextRef="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember" format="ixt-sec:duryear" id="Fact001480" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.0</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_z3nF9Ec9NROe" title="Historic equity volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember" id="Fact001482" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">67.14</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zo3NFj88A5Rb" title="Risk-free rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember" id="Fact001484" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.44</ix:nonFraction></span></td><td style="text-align: left">%</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the fair value of the Contingent Consent Warrants liability is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001486" name="niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcdwdb4ubHde" summary="xdx: Disclosure - COMMON SHARES (Details 13)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B2_zMGqK8zMF1m3" style="display: none">Schedule of change in fair value of Warrants liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Valuation at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zfJNBPrk2jef" title="Valuation, at begining" style="width: 12%; text-align: right"><ix:nonFraction name="niobf:ChangesInFairValueOfInitialValuation" contextRef="AsOf2024-06-30_custom_WarrantLiabilityMember" id="Fact001488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: 0.6pt; padding-left: 0.125in">Fair value of Warrants issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zydUoDS605P6" title="Fair value of Warrants issued" style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012025-06-30_custom_WarrantLiabilityMember" id="Fact001490" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,262</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Gain on issuance of Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--GainOnIssuanceOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zCu0szBFtWX7" title="Gain on issuance of Warrants" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:GainOnIssuanceOfWarrants" contextRef="From2024-07-012025-06-30_custom_WarrantLiabilityMember" id="Fact001492" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">103</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Ending balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_982_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zD6HKT2NGPWl" title="Valuation, at ending" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a gain of $<span id="xdx_90B_ecustom--GainOnIssuanceOfWarrants_iN_pn3n3_di_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zlDiKqF7j3Sd" title="Gain on issuance of Warrants"><ix:nonFraction name="niobf:GainOnIssuanceOfWarrants" contextRef="From2024-07-012025-06-30_custom_WarrantLiabilityMember" id="Fact001496" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">103</ix:nonFraction></span> on the issuance of the Contingent Consent Warrants. This gain was recorded as a part of other
gains in the condensed consolidated statements of operations and comprehensive loss.</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001498" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPJ2FHL92nq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_zgIbbwJJuj9f">RELATED
PARTY TRANSACTIONS AND BALANCES</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, the Company and Mark Smith, Chief Executive Officer, President, and Executive Chairman of NioCorp, entered
into a loan agreement (the &#8220;Smith Loan Agreement&#8221;), which provided for a $<span id="xdx_90B_eus-gaap--LongTermLineOfCredit_iI_c20240911__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zLYbG582apqi"><ix:nonFraction name="us-gaap:LongTermLineOfCredit" contextRef="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact001499" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000</ix:nonFraction></span> non-revolving, multi-draw credit facility
(the &#8220;Smith Loan&#8221;). The Smith Loan had an interest rate of <span id="xdx_90B_eus-gaap--RelatedPartyTransactionRate_pid_dp_uRatio_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzY88hw4WA8b"><ix:nonFraction name="us-gaap:RelatedPartyTransactionRate" contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact001500" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">10</ix:nonFraction>%</span> per annum, calculated monthly in arrears, through the
date of repayment of the Smith Loan. The Company could pre-pay the Smith Loan at any time without notice and without penalty,
but any amount of principal or interest repaid by the Company prior to the earlier of the date of expiration of the Smith Loan
Agreement, on June 30, 2025, and the occurrence of an event of default under the Smith Loan Agreement was subject to an early
payment fee of <span id="xdx_908_ecustom--LineOfCreditFacilityEstablishmentFee_pid_dp_uRatio_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zgbo0BEb6dRh"><ix:nonFraction name="niobf:LineOfCreditFacilityEstablishmentFee" contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember" id="Fact001501" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.5</ix:nonFraction>%</span> of the value of any such payment. The Smith Loan was secured by all of the Company&#8217;s assets pursuant
to a general security agreement between the Company and Mr. Smith dated September 11, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
October 30, 2024, the Company borrowed a total of $<span id="xdx_908_eus-gaap--OtherBorrowings_iI_c20241030_zA7nxAOPk56i"><ix:nonFraction name="us-gaap:OtherBorrowings" contextRef="AsOf2024-10-30" id="Fact001502" format="ixt:numdotdecimal" decimals="0" unitRef="USD">504</ix:nonFraction></span> under the Smith Loan and subsequently the Company repaid $508, representing
the balance of interest and principal outstanding under the Smith Loan, together with $<span id="xdx_90C_eus-gaap--LoanProcessingFee_c20241028__20241030__us-gaap--FairValueByLiabilityClassAxis__us-gaap--BorrowingsMember_zoY7mEff535b" title="Loan Origination fees"><ix:nonFraction name="us-gaap:LoanProcessingFee" contextRef="From2024-10-282024-10-30_us-gaap_BorrowingsMember" id="Fact001504" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41</ix:nonFraction></span> related to loan origination fees payable.
As of June 30, 2025, there were <span id="xdx_902_eus-gaap--InterestBearingLiabilitiesAverageAmountOutstanding_do_c20241028__20241030_zkXMFLfYLIS6"><ix:nonFraction name="us-gaap:InterestBearingLiabilitiesAverageAmountOutstanding" contextRef="From2024-10-282024-10-30" id="Fact001505" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> amounts outstanding under the Smith Loan.</span></p>

</ix:nonNumeric><p id="xdx_816_zhXMKCczNrP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_234_ziKTHMCD2WJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 4; Value: 76 -->
    <div id="xdx_234_zHuWWQgSMJ79" style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div>
    <div id="xdx_235_zuecJrGU4E9j" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p id="xdx_23D_zA5DPOriUaH" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p id="xdx_230_z9YSiiLlBg6h" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p>

<p id="xdx_238_zVc98l1wa3sj" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p>

<p id="xdx_23B_zLNoS3OILLui" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p>

<p id="xdx_23B_zCkwWFJq7JP5" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p>

<!-- Field: Rule-Page --><div id="xdx_234_zQNJ3OnZ2gz7" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p id="xdx_81F_zdeCgJljuWke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001514" name="niobf:ExplorationExpendituresDisclosuresTextBlock"><p id="xdx_808_ecustom--ExplorationExpendituresDisclosuresTextBlock_zXIYJ1SicAK5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_zzZjGz7dmPCc">EXPLORATION
EXPENDITURES</span></span></td>
</tr></table>



<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001516" name="niobf:ScheduleOfExplorationExpendituresTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zX9TSKCbmkQ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zvupSjrUFyr7" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left; padding-left: 0.25in">Feasibility study and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDpWpOYxdWYa" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012025-06-30_custom_FeasibilityStudyAndEngineeringMember" id="Fact001517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,112</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zXQAjsGpRnck" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember" id="Fact001518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_z5RYCZFNd7B3" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012025-06-30_custom_FieldManagementAndOtherMember" id="Fact001519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zBo3QRoaGHrk" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember" id="Fact001520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">503</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Drilling</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--DrillingMember_z8Fz75bOQNc4" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012025-06-30_custom_DrillingMember" id="Fact001521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--DrillingMember_zGXhEJ9phMh1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1522">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Metallurgical</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--MetallurgicalMember_z1xqNRpM3yB9" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012025-06-30_custom_MetallurgicalMember" id="Fact001523" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">214</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zuGpdFF7VYai" style="text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_MetallurgicalMember" id="Fact001524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,678</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Geologists and field staff</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z2Rw7VSemRwi" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-012025-06-30_custom_GeologistsAndFieldStaffMember" id="Fact001525" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">453</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z6NoXbEcfhRf" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember" id="Fact001526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.125in">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630_z6Z8yyA8jQ85" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2024-07-01to2025-06-30" id="Fact001527" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,135</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_zQC1S18XGML7" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ExplorationExpense" contextRef="From2023-07-012024-06-30" id="Fact001528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,552</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A7_znF8oZDbQW81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

</ix:nonNumeric><p id="xdx_81D_zbeol1br9ebh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001530" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_zv9Lk049ROtf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zvmCaQTA8wGl">LEASES</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2025 and 2024, the Company had one corporate office lease with a remaining lease term of <span id="xdx_908_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20250630_zznh92DLdroj" title="Remaining lease term::XDX::P1Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1532">1.6</span></span> years as of June 30,
2025. During the year ended June 30, 2025 and 2024, operating cash flows included cash payments of $<span id="xdx_902_eus-gaap--OperatingLeasePayments_pn3n3_c20240701__20250630_z6lXWIl8LRWf" title="Cash payment"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2024-07-01to2025-06-30" id="Fact001534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--OperatingLeasePayments_pn3n3_c20230701__20240630_zBoGch2L0Pe6" title="Cash payment"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-07-012024-06-30" id="Fact001536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">71</ix:nonFraction></span>, respectively related
to the measurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001538" name="us-gaap:LeaseCostTableTextBlock"><p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zExnnFSqKCr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zXg6SXALdpah">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; padding-left: 0.25in; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_492_20240701__20250630_zPGWeoLTBkT5" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20240630_zewXOxszxypd" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td></tr>
<tr id="xdx_404_ecustom--FixedRentExpense_pn3n3_zHftaIQeq4I9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left; padding-left: 0.25in">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2024-07-01to2025-06-30" id="Fact001540" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="niobf:FixedRentExpense" contextRef="From2023-07-012024-06-30" id="Fact001541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--VariableLeaseCost_pn3n3_zQBosEWhT6Fh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2024-07-01to2025-06-30" id="Fact001543" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:VariableLeaseCost" contextRef="From2023-07-012024-06-30" id="Fact001544" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_pn3n3_z3K5NHD26yt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2024-07-01to2025-06-30" id="Fact001546" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShortTermLeaseCost" contextRef="From2023-07-012024-06-30" id="Fact001547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--SubleaseIncome_iN_pn3n3_di_zLvRh6GJA36j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2024-07-01to2025-06-30" id="Fact001549" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:SubleaseIncome" contextRef="From2023-07-012024-06-30" id="Fact001550" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_z2a6AOMPC4wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0.125in">Net lease cost &#8211; other operating expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2024-07-01to2025-06-30" id="Fact001552" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-07-012024-06-30" id="Fact001553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">81</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zma3iv7OKjbk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001555" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmzjjIoA1uQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zXhhM714HkE8">The
maturity of lease liabilities is as follows at June 30, 2025:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 1in">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20250630_zjZPCCujtBoe" style="border-bottom: Black 1pt solid; text-align: center">Fiscal Year Lease Maturities</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zZGeTJaETxR4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 0.125in">2026</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2025-06-30" id="Fact001557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_zZQruMfEojNe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">2027</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2025-06-30" id="Fact001559" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zKDlzTqqRZ6d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:TotalLeasePayments" contextRef="AsOf2025-06-30" id="Fact001561" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zTNC2qafKZ8l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less amount of payments representing interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:LessAmountOfPaymentsRepresentingInterest" contextRef="AsOf2025-06-30" id="Fact001563" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zlaWoBnsjcab" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0in">Present value of lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2025-06-30" id="Fact001565" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">131</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zSp5xIOfexG7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:LessCurrentPortionOfOperatingLeaseLiability" contextRef="AsOf2025-06-30" id="Fact001567" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_zlkSIvHbAlQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0in">Noncurrent operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:OperatingLeasesLiabilityNoncurrent" contextRef="AsOf2025-06-30" id="Fact001569" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zkSCnuO7cMXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

</ix:nonNumeric><p id="xdx_814_zykpHBMCTGb4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001571" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zJFN0X4ylJ5b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_822_z7kxkFvJFG4g">INCOME
TAXES</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001573" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zckpTasrHiFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zpkvrK11UNG7">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; padding-left: 0.125in">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zaOhNaXNsYC6" title="Total" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-012025-06-30_country_CA" id="Fact001575" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,089</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zmNtALZ3bC8c" title="Total" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012024-06-30_country_CA" id="Fact001577" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,319</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zZUh6jHB9YUa" title="Total" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-012025-06-30_country_US" id="Fact001579" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,818</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zhf8OrpcQsKl" title="Total" style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012024-06-30_country_US" id="Fact001581" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,679</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zusJMQG2Neha" title="Total" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-012025-06-30_country_GB" id="Fact001583" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">75</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z5KneQklMtp1" title="Total" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012024-06-30_country_GB" id="Fact001585" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630_zl10EWO39HOa" title="Total" style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-07-01to2025-06-30" id="Fact001587" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,982</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630_zBsN06zrz9ne" title="Total" style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-07-012024-06-30" id="Fact001589" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,037</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A8_zuNlDp2zO4Zk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 5; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zx4PJYtIqBE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zq7WonJusBk3" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zWTiRSGsWvmc" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_233_z8BOExIb0o0i" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zcd67WaYrS3c" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_230_zKiqiyVKUa43" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001597" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs0kZpMl1m02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> <span style="font: 10pt Times New Roman, Times, Serif">The</span> <span style="font: 10pt Times New Roman, Times, Serif">following table is a reconciliation of income taxes at statutory rates:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zurgVWVYgAvd" style="display: none; visibility: hidden">The following table is a reconciliation of income taxes at statutory rates:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; padding-left: 5pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_497_20240701__20250630_zidKaOJrl8Of" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49C_20230701__20240630_z68QjPkVMzH3" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_pn3n3_zx3izuI5Rcf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5pt">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2024-07-01to2025-06-30" id="Fact001599" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,982</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" contextRef="From2023-07-012024-06-30" id="Fact001600" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,037</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_uUSD_zwDoic6nmFV8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Income tax benefit at Canadian federal rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2024-07-01to2025-06-30" id="Fact001602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,697</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="From2023-07-012024-06-30" id="Fact001603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,806</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_uUSD_zvP0cakAhIZ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Income tax benefit at Canadian provincial rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2024-07-01to2025-06-30" id="Fact001605" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,158</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-07-012024-06-30" id="Fact001606" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,444</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--WarrantLiability_pn3n3_zCJxMaapPwZk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:WarrantLiability" contextRef="From2024-07-01to2025-06-30" id="Fact001608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,105</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:WarrantLiability" contextRef="From2023-07-012024-06-30" id="Fact001609" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">506</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_ecustom--EarnoutSharesLiability_pn3n3_z92zcxpmYaRi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:EarnoutSharesLiability" contextRef="From2024-07-01to2025-06-30" id="Fact001611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">557</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:EarnoutSharesLiability" contextRef="From2023-07-012024-06-30" id="Fact001612" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,810</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_z2ZCuN46k7G5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2024-07-01to2025-06-30" id="Fact001614" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">239</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" contextRef="From2023-07-012024-06-30" id="Fact001615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">747</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_pn3n3_zOwlLdLRAK1b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2024-07-01to2025-06-30" id="Fact001617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" contextRef="From2023-07-012024-06-30" id="Fact001618" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AssetRetirementObligationAccretionExpense_pn3n3_zfyClHvGmsh6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetRetirementObligationAccretionExpense" contextRef="From2024-07-01to2025-06-30" id="Fact001620" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetRetirementObligationAccretionExpense" contextRef="From2023-07-012024-06-30" id="Fact001621" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,138</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_pn3n3_zwfH6057hQP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" contextRef="From2023-07-012024-06-30" id="Fact001624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--PaymentsOfStockIssuanceCost_pn3n3_zEdnnPmkiJha" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Stock issuance costs in equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:PaymentsOfStockIssuanceCost" contextRef="From2024-07-01to2025-06-30" id="Fact001626" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,143</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:PaymentsOfStockIssuanceCost" contextRef="From2023-07-012024-06-30" id="Fact001627" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_ecustom--ConvertibleNoteValuation_iN_pn3n3_di_zNv4wMsU3fO2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Convertible note valuation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="niobf:ConvertibleNoteValuation" contextRef="From2024-07-01to2025-06-30" id="Fact001629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:ConvertibleNoteValuation" contextRef="From2023-07-012024-06-30" id="Fact001630" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">607</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_zvwKqSBKbIv9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2024-07-01to2025-06-30" id="Fact001632" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="From2023-07-012024-06-30" id="Fact001633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_zjCO45iqQXyc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2024-07-01to2025-06-30" id="Fact001635" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,978</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-07-012024-06-30" id="Fact001636" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,718</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_d0_c20240701__20250630_zIzZEyXYrxol" title="Income tax benefit" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-07-01to2025-06-30" id="Fact001638" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">-</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zQQqTjLajXF1" title="Income tax benefit::XDX::-139" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1640">139</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A7_zP2YbN9YTIL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax benefit for the year ended June 30, 2024, was derived solely from our U.S. operations. The Company acquired a federal income tax payable of $<span id="xdx_90B_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_uUSD_c20230701__20240630_zWWWo1gTG0Zh"><ix:nonFraction name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2023-07-012024-06-30" id="Fact001641" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">443</ix:nonFraction></span> in connection with the GXII Transaction. As a result of a post-transaction loss at ECRC, a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $139 was recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for the year ended June 30, 2024. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001643" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z7CUHDhhOpI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zgyFopWNwKe6">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; padding-left: 5.4pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_491_20250630_zN8lA9GyijW4" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49F_20240630_zuYT51idjSr9" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzakr_zyQh7jWlY2v1" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.25in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2025-06-30" id="Fact001645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,125</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-06-30" id="Fact001646" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,177</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zlKDJJv2arNh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsMineralInterest" contextRef="AsOf2025-06-30" id="Fact001648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,438</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsMineralInterest" contextRef="AsOf2024-06-30" id="Fact001649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,438</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z0DV4YMNxnWc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsStartupAndOorganizationalCosts" contextRef="AsOf2025-06-30" id="Fact001651" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,842</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsStartupAndOorganizationalCosts" contextRef="AsOf2024-06-30" id="Fact001652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zJ7Q8LQevTic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsResearchAndDevelopmentCosts" contextRef="AsOf2025-06-30" id="Fact001654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,295</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsResearchAndDevelopmentCosts" contextRef="AsOf2024-06-30" id="Fact001655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,419</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zSHr7KpUMOH9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance/financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsShareIssuanceCosts" contextRef="AsOf2025-06-30" id="Fact001657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,357</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsShareIssuanceCosts" contextRef="AsOf2024-06-30" id="Fact001658" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">635</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>

    <tr id="xdx_406_ecustom--DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_iI_pn3n3_maDTAGzakr_zp1IvHCSliy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Canadian restricted interest and financing carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" contextRef="AsOf2025-06-30" id="Fact001660" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">605</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1661">-</span></td><td style="text-align: left">&#160;</td></tr>




<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zRloSVdyfijb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:CapitalLossesAvailableForFuturePeriods" contextRef="AsOf2025-06-30" id="Fact001663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="niobf:CapitalLossesAvailableForFuturePeriods" contextRef="AsOf2024-06-30" id="Fact001664" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">456</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzakr_zJpu2BYmt9N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2025-06-30" id="Fact001666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2024-06-30" id="Fact001667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">69</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_mtDTAGzakr_maDTALNz97R_zLdETNgphVsk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2025-06-30" id="Fact001669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,159</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2024-06-30" id="Fact001670" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTALNz97R_zIkydzzEBbQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2025-06-30" id="Fact001672" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,159</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-06-30" id="Fact001673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNz97R_zBeLq83o7uj9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1676">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A0_zHiBXJPKVbYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001678" name="us-gaap:SummaryOfValuationAllowanceTextBlock"><p id="xdx_891_eus-gaap--SummaryOfValuationAllowanceTextBlock_zGOanMTlNbRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zou3u5NwneBd">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20240701__20250630_zOyRK6RmI4zk" title="Valuation allowance, beginning of year" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-06-30" id="Fact001680" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20230701__20240630_z1g50xPtM5e4" title="Valuation allowance, beginning of year" style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-06-30" id="Fact001682" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,463</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Current year additions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20240701__20250630_zJzdRfZwDu9e" title="Current year additions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:DeferredTaxAssetsValuationAllowanceAdditions" contextRef="From2024-07-01to2025-06-30" id="Fact001684" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,978</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_zAdcqG6EKmY3" title="Current year additions" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="niobf:DeferredTaxAssetsValuationAllowanceAdditions" contextRef="From2023-07-012024-06-30" id="Fact001686" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,718</ix:nonFraction></td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20240701__20250630_zAOd9WUQqNvl" title="Valuation allowance, end of year" style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2025-06-30" id="Fact001688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,159</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20230701__20240630_zNRPWvKWj53f" title="Valuation allowance, end of year" style="border-bottom: Black 2.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-06-30" id="Fact001690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,181</ix:nonFraction></td><td style="text-align: left; padding-bottom: 2.5pt">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_zd9zz0TbUv3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company establishes a valuation allowance against future income tax assets if, based on available information, it is more likely
than not that all of the assets will not be realized. The valuation allowance of $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_uUSD_c20250630_zs5lRSZwwgtf" title="Valuation allowance"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2025-06-30" id="Fact001692" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,159</ix:nonFraction></span> at June 30, 2025, relates mainly to net
operating loss carryforwards in Canada and mineral interests due to deferred exploration expenditures in the United States, where
the utilization of such attributes is not more likely than not.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 6; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zymhHHoMZzsl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zpmp7j7MADli" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zMEz36Q738E9" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zaz7lr4GWZgd" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zQqkl02rwN25" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_23A_zCczT7ClENYg" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company has the following cumulative
net operating losses for Canadian and U.S. Federal income tax purposes. Canadian tax loss carryforwards will generally expire between
2028 and 2045. U.S. tax losses incurred through June 30, 2018, totaled $<span id="xdx_905_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_uUSD_c20180630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYBraYVX1Xb7" title="Tax losses incurred"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOtherLossCarryforwards" contextRef="AsOf2018-06-30_us-gaap_DomesticCountryMember" id="Fact001700" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">981</ix:nonFraction></span> and will generally expire between 2031 and 2038. As
a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for our tax years ending on and after June 30, 2019, totaling
$<span id="xdx_90B_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_uUSD_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zDaLhmgGiENg" title="Tax losses incurred"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOtherLossCarryforwards" contextRef="AsOf2019-06-30_us-gaap_DomesticCountryMember" id="Fact001702" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,645</ix:nonFraction></span>, have no expiration.</p>




<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001704" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock"><p id="xdx_89F_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zv2LGAJKYGFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_za9L87PEP262" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 3pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 3pt">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; padding-left: 0.125in">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--CA_zk6uhfxZdTS2" title="Total" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2025-06-30_country_CA" id="Fact001706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,194</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--CA_zPSxwRqTJFi6" title="Total" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30_country_CA" id="Fact001708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,623</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--US_zATr1iAW8bi2" title="Total" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2025-06-30_country_US" id="Fact001710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,627</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--US_zXhWEqe32mAg" title="Total" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30_country_US" id="Fact001712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,905</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--GB_z7scLv8mA3ig" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2025-06-30_country_GB" id="Fact001714" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--GB_zeOeeNPWj2rd" title="Total" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30_country_GB" id="Fact001716" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 3pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630_zHw7g5ZprTab" title="Total" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2025-06-30" id="Fact001718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59,933</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zYVKId8oc0D1" title="Total" style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-06-30" id="Fact001720" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,567</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zql5hxzXrpOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has a Canadian capital loss carryforward of $<span id="xdx_906_ecustom--CapitalLossCaryforward_iI_pn3n3_c20250630__srt--CurrencyAxis__currency--CAD_ziCF7dAU8hN5" title="Capital loss carryforward"><ix:nonFraction name="niobf:CapitalLossCaryforward" contextRef="AsOf2025-06-30_currency_CAD" id="Fact001722" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,378</ix:nonFraction></span> as of June 30, 2025, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $<span id="xdx_90B_ecustom--CapitalLossCaryforward_iI_pn3n3_c20250630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zQhrk4qe5Xac" title="Net operating loss carryforwards"><ix:nonFraction name="niobf:CapitalLossCaryforward" contextRef="AsOf2025-06-30_us-gaap_DomesticCountryMember" id="Fact001724" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,742</ix:nonFraction></span> as of June 30, 2025 which
generally expire between 2031 and 2045.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
June 30, 2025 and 2024, we had no undistributed earnings of foreign subsidiaries that would be subject to income tax upon distribution
to Canada from a foreign subsidiary. As such, as of June 30, 2025 and 2024, we did not provide for deferred taxes on any such
earnings of our foreign subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no unrecognized tax benefits as of June 30, 2025 or 2024. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction,
the United Kingdom, and Canada. Certain years remain subject to examination but there are currently no ongoing exams in any taxing
jurisdictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 4, 2025, the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;) was enacted in the U.S., which includes a broad range of tax
reform provisions affecting businesses. The OBBBA includes numerous changes to existing tax law including extending or making
permanent certain business and international tax measures initially established under the 2017 Tax Cuts and Jobs Act, which were
set to expire. The OBBBA contains several changes to corporate taxation including modifications to capitalization of research
and development expenses, modifications to deductions for interest expense, and accelerated depreciation on certain asset additions.
As the legislation was signed into law after June 30, 2025, our operating results for the year ended June 30, 2025, do not include
any adjustments related to the OBBBA, and the Company does not expect a material impact to our financial statements due to the
enactment of the OBBBA.</span></p>

</ix:nonNumeric><p id="xdx_819_zzoOAUejPA67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001726" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock"><p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zzzplemwOC37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15.</span></td><td id="xdx_826_zhBGYmXjvBT9"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span><span>Fair
Value Measurements</span></span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures the fair value of financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes
a framework for measuring fair value, and expands disclosures about fair value measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.<span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2025, and 2024, respectively, and indicate the fair value hierarchy of the valuation techniques the</span></p>

<ix:exclude><p id="xdx_236_z7iA6PwLUXPi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 7; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zdPfuFdqPnIe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zPRD7o7EEat8" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z3DfOPWOPdR3" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zeqgt5m37idc" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zQndok4PcdOl" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_237_z2jJJv6xdHkj" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Company utilized
to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted
prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the financial
instrument and include situations where there is little, if any, market activity for the instrument.</span></p>



<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001735" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock"><p id="xdx_89E_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zkm0AZ72Wp0a" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zL3QqlX7ONIh" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2025</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630_z6mIN1EWqmQa" title="Cash and cash equivalents" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2025-06-30" id="Fact001737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,554</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsaCEdpTEjp1" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001738" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,554</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZDR8Sk0mZQ" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1739">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLghj8V3Bfna" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630_zLzNssnTQApk" title="Investment in equity securities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2025-06-30" id="Fact001742" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKreZNu3ZKC2" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001743" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zubMPzpYQb77" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1744">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpyNxUhpo7i5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1745">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630_ziVisi7fFnKb" title="Total Assets" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2025-06-30" id="Fact001747" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,557</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvAigtjc9I83" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001748" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,557</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8eRQMAA8YPh" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1749">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCEpplm4a34h" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zV94tD9akeCb" title="Earnout Shares liability" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30" id="Fact001752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcKELJSdao4i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWAkDZGJHWae" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4VRaHm5Qtxk" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,880</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630_zSK4M2AspqKh" title="Warrant liabilities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2025-06-30" id="Fact001757" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,852</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHb62pLcaZEf" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1w8tlKZxfy4" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001759" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,852</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z024lwG5fGel" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1760">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zHWx22eO4NRe" title="Total Liabilities" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30" id="Fact001762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,732</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhR3Vs3vI85c" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1763">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgro6MDL5Kx6" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001764" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,852</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuIygyQ43me9" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,880</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630_z0erBTk3XG0l" title="Cash and cash equivalents" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyq88zENMvXk" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,012</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zX0voHd7R405" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1769">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrlcDnRt3Nak" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630_zU9m5yLbd0g7" title="Investment in equity securities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30" id="Fact001772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHKFXeuLB164" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="niobf:AvailableForSaleSecuritiesEquitySecuritiesOther" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001773" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9fdwIVI7mWj" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1774">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjzGmyfXylgh" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1775">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630_zegq5dSkYIt6" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001776" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,016</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpUVAXDALwEd" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member" id="Fact001777" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,016</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z17y5tejqWmb" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1778">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCxLR7QMzobh" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--NotesPayable_iIP3us-gaap--AssetsFairValueDisclosure_pn3n3_c20240630_zwANORIDx3hk" title="April 2024 notes" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30" id="Fact001781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4mbqnjCKIYb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9oC2C8Mx7Qj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1783">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zi4fNOdDNtR1" style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001784" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,089</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zxywbEgGaDUl" title="Earnout Shares liability" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6eGOd2iVj0d" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjSYPtYwgb31" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1788">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYkSQnVEP7Lc" style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001789" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,817</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630_zmbj6UEHzZi2" title="Warrant liabilities" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001791" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,016</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdQBpQoPOhkk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNJEi1Plqqh9" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001793" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkV1QiBPMW1g" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,365</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zsZt5ooqQSmc" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30" id="Fact001795" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,922</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQkW61lbASyb" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgXxIQyksy0b" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member" id="Fact001797" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zM5MdBbgAZZg" style="border-bottom: Black 2.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:FinancialLiabilitiesFairValueDisclosure" contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member" id="Fact001798" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,271</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zDO6FIHXgOi8" style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001800" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_zSwSSJGcaVTk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zXNMrwBcN7z1">SEGMENT
INFORMATION</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has&#160;one&#160;reportable segment: the United States. The United States segment conducts exploration, development,
and care and maintenance activities at the Elk Creek Project. This segment holds substantially all of the Company&#8217;s non-current assets and does not presently report any revenues from operations.
Through this segment, the Company seeks to position the Elk Creek Project as a development opportunity in the strategic minerals
sector. The Company&#8217;s chief operating decision maker is the Chief Executive Officer (&#8220;CODM&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
information and annual operating plans and forecasts are prepared and reviewed by the CODM at a consolidated level. The CODM
assesses performance for the single operating segment and decides how to better allocate resources based on total operating
expenses, net loss, changes in cash and cash equivalents, and cash and cash-equivalent balances that are reported on the
Consolidated Statement of Operations and Consolidated Statement of Cash Flows. The Company&#8217;s objective in making
resource allocation decisions is to optimize the Company&#8217;s ability to develop and operate the Elk Creek Project. In
addition, the CODM reviews the segment&#8217;s assets based on total assets reported on the consolidated balance sheet, and
the accounting policies of our single operating segment are the same as those described in the Summary of Significant
Accounting Policies herein. For additional reportable single operating segment level financial information, see the
Consolidated Financial Statements.</span></p>

</ix:nonNumeric><p id="xdx_81D_zNCv85K03pc9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001802" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zd9d4dEfE1T6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82B_z3cj66coW1fl">SUBSEQUENT
EVENTS</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
July 2025 Offering </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SubsequentEventDescription_dxL_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTWVuOwpA7Ri" title="Subsequent event description::XDX::Maxim%20acted%20as%20sole%20placement%20agent%20for%20the%20July%202025%20Offering.%20The%20Company%20intends%20to%20use%20the%20net%20proceeds%20from%20the%20July%202025%20Offering%20for%20working%20capital%20and%20general%20corporate%20purposes%2C%20including%20to%20advance%20its%20efforts%20to%20launch%20construction%20of%20the%20Elk%20Creek%20Project%20and%20move%20it%20to%20commercial%20operation."><span style="-sec-ix-hidden: xdx2ixbrl1804">On
July 18, 2025, the Company closed a public offering (the &#8220;July 2025 Offering&#8221;), pursuant to which the Company issued
and sold 13,850,000 Common Shares at a public offering price of $3.25 per Common Share, for net proceeds of approximately $41,762
after deducting placement agent fees discounts and prior to other offering expenses.</span></span> Maxim</span></p>

<ix:exclude><p id="xdx_239_zcUNdp3sOm9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zpYZwAWpZU9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 8; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div>
    <div id="xdx_23B_zl6qH1hM2hZh" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zH5V9SCJ0Kji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zDMlxcD3wpOj" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>NioCorp Developments Ltd.</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zAGTFwUJmih2" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Notes to the Consolidated Financial
Statements</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zga3p7ebRTj4" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2025</b></span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zDjjjaIzTmC4" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">(expressed in thousands of U.S.
dollars, except share and per share data or as otherwise stated)</span></p></ix:exclude>

<!-- Field: Rule-Page --><ix:exclude><div id="xdx_233_z6ROhZbcYxMf" style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div></ix:exclude><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">acted as sole placement agent for the
July 2025 Offering. The Company intends to use the net proceeds from the July 2025 Offering for working capital and general corporate
purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Common Share Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the period from July 1, 2025 through September 11, 2025, the Company issued <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20250826__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJRjaNoboB08" title="Issuance of shares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2025-08-26_us-gaap_WarrantMember_us-gaap_SubsequentEventMember" id="Fact001814" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,000,312</ix:nonFraction></span> Common Shares through the exercise
of Warrants and Options by their holders and received cash totaling approximately $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn3n3_uUSD_c20250701__20250826__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdKgm3eWted7" title="Cash received"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2025-07-012025-08-26_us-gaap_SubsequentEventMember" id="Fact001816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,401</ix:nonFraction></span>. In addition, <span id="xdx_906_ecustom--ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_pid_uShares_c20250701__20250826__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zImuPP2CRRl8" title="Exchnage for shares"><ix:nonFraction name="niobf:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="From2025-07-012025-08-26_us-gaap_SubsequentEventMember" id="Fact001818" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">415,581</ix:nonFraction></span> Vested Shares were exchanged
for an equivalent number of Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases
of Land </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2025, ECRC closed on its option to purchase three parcels of land in Johnson County, Nebraska (the &#8220;Property&#8221;),
pursuant to the terms of the Option to Purchase, dated as of December 4, 2009, as amended, and the Option to Purchase, dated December
4, 2014, as amended, each between Roger and Nancy Woltemath (the &#8220;Owners&#8221;) and ECRC (together, the &#8220;Option Agreements&#8221;).
Pursuant to the terms of the Option Agreements, the Owners sold, transferred, conveyed and assigned to ECRC all of their rights,
privileges, title and interest in and to the surface rights with respect to one of the parcels (consisting of the property known
as Woltemath80S) and to the surface rights and associated mineral rights with respect to the other two parcels (consisting of
approximately 1.66 acres of the property known as Woltemath002).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Option Agreements provided for a purchase price calculated based on the appraised value per acre of the parcels of land. The aggregate
purchase price was approximately $<span id="xdx_906_eus-gaap--PaymentsToAcquireLand_pn3n3_uUSD_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--PurchasesofLandMember_z0cIGTyQVEac" title="Agregate purchase price"><ix:nonFraction name="us-gaap:PaymentsToAcquireLand" contextRef="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_PurchasesofLandMember" id="Fact001820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,700</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>DoD
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 4, 2025, ECRC entered into a Project Sub-Agreement (the &#8220;DoD Agreement&#8221;) with Advanced Technology International
(&#8220;ATI&#8221;), an entity acting on behalf of the Defense Industrial Base Consortium under the authority of the U.S. Department
of Defense (&#8220;DoD&#8221;). Subject to the terms and conditions of the DoD Agreement, ECRC is entitled to receive up to an
aggregate of approximately $<span id="xdx_90D_eus-gaap--ProceedsFromCustomersForProgressPayments_pn3n3_dm_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--DoDAgreementMember_zFB10Q4DDlc7" title="Reimbursement Payments"><ix:nonFraction name="us-gaap:ProceedsFromCustomersForProgressPayments" contextRef="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_DoDAgreementMember" id="Fact001822" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">10.0</ix:nonFraction></span> million of reimbursement payments from the DoD upon the achievement of certain project milestones
related to feasibility study-level engineering and additional reserve drilling, as well as preparing updated cost estimates, for
the Elk Creek Project.</span></p>

</ix:nonNumeric><p id="xdx_815_zMhPG2qCprhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;9.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a055"></span>CHANGES
                                         IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;9A.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a056"></span>CONTROLS
                                         AND PROCEDURES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evaluation
of Disclosure Controls and Procedures</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of NioCorp Developments Ltd. has evaluated, under the supervision and with the participation of our Chief Executive
Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), the effectiveness of our disclosure controls and
procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2025. Based on that evaluation,
the CEO and the CFO have concluded that, as of June 30, 2025, our disclosure controls and procedures were not effective due to
the material weaknesses in internal control over financial reporting described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the material weaknesses in our internal control over financial reporting, our CEO and CFO have concluded that the audited consolidated
financial statements included in this Annual Report on Form 10-K fairly present, in all material respects, our financial position,
results of operations and cash flows for the periods presented in conformity with U.S. GAAP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s disclosure controls and procedures have been designed to ensure that: (i) information required to be disclosed
by us in reports that we file or submit to the SEC under the Exchange Act is recorded, processed, summarized, and reported within
the time periods specified in applicable rules and forms and (ii) material information required to be disclosed in our reports
filed under the Exchange Act is accumulated and communicated to management, including the CEO and the CFO, as appropriate, to
allow for accurate and timely decisions regarding required disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not expect that our disclosure controls and procedures will prevent all error and all fraud. The effectiveness of our or
any system of disclosure controls and procedures, however well designed and operated, can provide only reasonable assurance that
the objectives of the system will be met and is subject to certain limitations, including the exercise of judgment in designing,
implementing, and evaluating controls and procedures and the assumptions used in identifying the likelihood of future events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Management&#8217;s
Report on Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
management of NioCorp Developments Ltd. is responsible for establishing and maintaining adequate internal control over financial
reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act for the Company. Management assessed the effectiveness
of our internal control over financial reporting as of June 30, 2025. In making this assessment, our management used the criteria
set forth in the Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway
Commission (the &#8220;COSO Framework&#8221;). Based on that evaluation, the CEO and the CFO have concluded that, as of June 30,
2025, our internal control over financial reporting was not effective due to the material weaknesses in internal control over
financial reporting described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Material
Weaknesses</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be
prevented or detected on a timely basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
concluded that the material weaknesses disclosed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended June
30, 2023, continued to exist as of June 30, 2025. Specifically, management identified deficiencies in the principles associated
with the control environment, risk assessment, control activities, and monitoring components of internal control, based on the
criteria established by the COSO Framework, that constitute material weaknesses, either individually or in the aggregate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 10; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Environment:</span> The Company does not have sufficient personnel with the appropriate
                                         levels of knowledge, experience, and training in accounting and internal control over
                                         financial reporting commensurate with the complexity of the Company&#8217;s financing
                                         transactions and associated reporting requirements. This material weakness contributed
                                         to additional material weaknesses further described below.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Risk
                                         Assessment:</span> The Company does not have a formal process to identify, update, and assess
                                         financial reporting risks due to changes in the Company&#8217;s business practices, including
                                         entering into increasingly complex transactions that could significantly impact the design
                                         and operation of the Company&#8217;s control activities.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Control
                                         Activities:</span> Management did not maintain effective controls over:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
                                         and assessing the work of third-party specialists, including the evaluation of the appropriateness
                                         of accounting conclusions, </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         evaluation of certain inputs and assumptions used to estimate the fair value of instruments
                                         and features associated with complex debt and equity transactions, and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the design and
                                                                                                                                                     implementation of effective process-level control activities related to vendor banking information.</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Monitoring
                                         Activities:</span> Management did not appropriately:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">select, develop,
                                                                                                                                                    and perform ongoing evaluation to ascertain whether the components of internal controls are present and functioning,  and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 36.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluate
                                         and communicate internal control deficiencies in a timely manner to those parties responsible
                                         for taking corrective action.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, these material weaknesses resulted in errors that required the restatement of Company&#8217;s consolidated
financial statements as of and for the fiscal years ended June 30, 2022 and 2021, as well as the restatement of the Company&#8217;s
condensed consolidated financial statements as of and for the interim periods ended September 30, 2021, December 31, 2021, March
31, 2022, September 30, 2022 and December 31, 2022. Additionally, these material weaknesses could result in a misstatement of
the account balances or disclosures that would result in a material misstatement to the annual or interim consolidated financial
statements that would not be prevented or timely detected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remediation
Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
address our material weaknesses existing as of June 30, 2025, we have implemented a detailed plan to address each individual material
weakness identified, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         have, and will continue, to engage outside accounting and internal control consultants
                                         with subject matter expertise to supplement our level of knowledge, experience, and training
                                         in accounting and internal control over financial reporting.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.5pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         have developed a formal risk assessment process requiring periodic review and updates
                                         of current risks and internal controls, as well as a focus on potential future events
                                         that could result in additional risks and/or internal control lapses. This process is
                                         expected to enable us to effectively identify, develop, evolve, and implement controls
                                         and procedures to address risks, and results of this risk assessment process will be
                                         reviewed with the Audit Committee on a periodic basis.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.75pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                         have developed an initial training plan to provide incremental training to accounting
                                         and finance personnel responsible for overall technical accounting and valuation-related
                                         transactions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18.75pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
                                         is developing a monitoring program to periodically evaluate and assess whether those
                                         responsible for controls are conducting their activities in accordance with their design,
                                         such that there is contemporaneous evidence that the controls are present and functioning
                                         and will communicate internal control deficiencies in a timely manner to those parties
                                         responsible for taking corrective action.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 11; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;The
process of designing and maintaining effective internal control over financial reporting is a continuous effort that requires
management to anticipate and react to changes in our business, economic and regulatory environments and to expend significant
resources. As we continue to evaluate our internal control over financial reporting, we may take additional actions to remediate
the material weaknesses or modify the remediation actions described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we continue to devote significant time and attention to these remediation efforts, the material weaknesses will not be considered
remediated until management completes the design and implementation of the actions described above and the controls operate for
a sufficient period of time, and management has concluded, through testing, that these controls are effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes
in Internal Control over Financial Reporting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as discussed above, there has been no change in our internal control over financial reporting during the quarter ended June
30, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;9B.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a057"></span>OTHER
                                         INFORMATION</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended June 30, 2025, <span id="xdx_902_eecd--Rule10b51ArrAdoptedFlag_dbF_c20250401__20250630_z5OMqtCTU6Jh" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_900_eecd--NonRule10b51ArrAdoptedFlag_dbF_c20250401__20250630_zMhaHeKtVbFb" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_90B_eecd--Rule10b51ArrTrmntdFlag_dbF_c20250401__20250630_zwkKu3ZpXzLc" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_904_eecd--NonRule10b51ArrTrmntdFlag_dbF_c20250401__20250630_ze6bpxSbOqhd" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><ix:nonNumeric contextRef="From2025-04-012025-06-30" format="ixt:booleanfalse" id="Fact001823" name="ecd:Rule10b51ArrAdoptedFlag"><ix:nonNumeric contextRef="From2025-04-012025-06-30" format="ixt:booleanfalse" id="Fact001824" name="ecd:NonRule10b51ArrAdoptedFlag"><ix:nonNumeric contextRef="From2025-04-012025-06-30" format="ixt:booleanfalse" id="Fact001825" name="ecd:Rule10b51ArrTrmntdFlag"><ix:nonNumeric contextRef="From2025-04-012025-06-30" format="ixt:booleanfalse" id="Fact001826" name="ecd:NonRule10b51ArrTrmntdFlag">no</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span></span> director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the
Company adopted or terminated a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement&#8221;
(as each term is defined in Item 408 of Regulation S-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          9C.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a058"></span>DISCLOSURE
                                         REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a059"></span>PART
III&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          10.</span></td><td style="padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a060"></span>DIRECTORS,
                                         EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a061"></span>Directors
and Executive Officers</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth as of September 11, 2025, the names and ages of, and
position or positions held by, our executive officers and directors, the employment background of these persons, and any directorships
held by the current directors during the last five years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 83%; border-collapse: collapse; margin-right: auto">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Name</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Age</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position</span></td>
    <td style="vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    of Appointment</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, President, Executive
    Chairman, and Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer and Director:&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
23, 2013&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
and Executive Chairman:&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
31, 2015&#160;</span></p></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Corporate Secretary</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer:&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
1, 2016&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Secretary:&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.12in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
3, 2021</span></p></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Honan</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 6, 2014</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim Sims</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Communications Officer</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2, 2015</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ernest Cleave</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Vice President of Business Development</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David C. Beling</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 6, 2011</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony W. Fulton</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 9, 2025</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa Guerrero-Mahon</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 28, 2017</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean C. Kehler</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 17, 2023</span></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #353535; background-color: white">Michael
    G. Maselli&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 17, 2023</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Oliver</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 25, 2022</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth a brief description of the business experience of each executive officer and director of the Company, including
current directorships and directorships held in, at least, the past five years for each director:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
A. Smith &#8211; Executive Chairman, Director, President, and Chief Executive Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Smith has over 43 years of experience in operating, developing, and financing mining and strategic materials projects in the Americas
and abroad. In September 2013, he was appointed CEO and a Director of NioCorp. From April 2015 to September 2019, Mr. Smith served
as the President and Director for Largo Resources Ltd. (&#8220;Largo&#8221;), a mineral company with an operating property in
Brazil and projects in Brazil and Canada. In addition, from April 2015 to October 2018, Mr. Smith also served as the CEO of Largo.
Mr. Smith has also served on the board of directors of IBC Advanced Alloys Corp., a leading beryllium and copper advanced alloys
company (&#8220;IBC&#8221;), since May 2016 and as CEO of IBC since July 2020. From October 2008 through December 2012, Mr. Smith
served as President, CEO and Director of Molycorp, Inc., a rare earths producer (&#8220;Molycorp&#8221;), where he was instrumentally
involved in taking it from a private company to a publicly traded company with a producing mine. From November 2011 through May
2015, he served on the board of directors at Avanti Mining, a mining company (TSX-V: AVT; Avanti Mining changed its name to AlloyCorp
in early 2015). From December 2012 through September 2013, he served as the Managing Director of KMSmith LLC, a business strategy
and finance advisory firm, where he served as a consultant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to Molycorp, Mr. Smith held numerous engineering, environmental, and legal positions within Unocal Corporation, a former petroleum
explorer and marketer (&#8220;Unocal&#8221;), and later served as the President and CEO of Chevron Mining Inc., a coal and metal
mining company and wholly owned subsidiary of Chevron Corporation (&#8220;Chevron Mining&#8221;). Mr. Smith also served for over
seven years as the shareholder representative of Companhia Brasileira Metal&#250;rgica e Minera&#231;&#227;o (&#8220;CBMM&#8221;),
a private company that currently produces approximately 85% of the world supply of niobium. During his tenure with Chevron Mining,
Mr. Smith was responsible for Chevron Mining&#8217;s three coal mines, one molybdenum mine, a petroleum coke calcining operation
and Molycorp&#8217;s Mountain Pass mine. At Unocal, he served as the Vice-President from June 2000 to April 2006, and managed
the real estate,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 13; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">remediation, mining and carbon divisions. Mr. Smith is a Registered Professional Engineer and serves as an active
member of the State Bars of California and Colorado. He received his Bachelor of Science degree in Agricultural Engineering from
Colorado State University in 1981 and his Juris Doctor, cum laude, from Western State University, College of Law, in 1990.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
Shah &#8211; Chief Financial Officer and Corporate Secretary</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Shah joined NioCorp in September 2014 as Vice President of Finance, and now serves as the Company&#8217;s CFO and Corporate Secretary.
Mr. Shah served as Finance Manager at Covidien Ltd., a medical device company since acquired by Medtronic, from May 2014 through
September 2014. From April 2011 until May 2014, he held the positions of Senior Manager of Corporate Development and M&amp;A and
more recently the Director of Strategy and Business Planning at Molycorp. Mr. Shah graduated from the University of Colorado with
a BSc in Mechanical Engineering in 1996, and from Purdue University with an MBA in 2002. Since the completion of his MBA, Mr.
Shah also held key finance roles with Intel Corporation and IBM.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott
Honan &#8211; Chief Operating Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Honan joined NioCorp in May 2014 as Vice President, Business Development, and since July 2020, has served as the Company&#8217;s
Chief Operating Officer (&#8220;COO&#8221;). He also serves as President of Elk Creek Resources Corporation, the NioCorp subsidiary
that is developing the Elk Creek Project in Nebraska. Prior to his work at NioCorp, Mr. Honan served in several leadership capacities
at Molycorp from February 2001 until May 2014, including as Vice President/Director Health, Environment, Safety and Sustainability
and General Manager and Environmental Manager from July 2011 to May 2014. With over 32 years of experience in the gold and rare
earth industries, Mr. Honan is a graduate of Queen&#8217;s University in Mining Engineering in both Mineral Processing (B.Sc.
Honors) and Environmental Management (M.Sc.) disciplines.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jim
Sims &#8211; Chief Communications Officer</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Sims has more than 32 years of experience in devising and executing marketing, media relations, public affairs, and investor
relations operations for companies in the mining, chemical, manufacturing, utility, and renewable energy sectors. He joined
NioCorp in November 2015 as Vice President, External Affairs, and now serves as its Chief Communications Officer, effective
June 7, 2022. Prior to NioCorp, Mr. Sims served for more than five years as Director (and then Vice President) of Corporate
Communications for Molycorp from March 2010 through November 2015. Since May 2016, Mr. Sims has also served as Director of
Investor and Public Relations for IBC. Mr. Sims was President and CEO of Policy Communications, Inc. from 1998 until 2010 and
served as White House Director of Communications for the Energy Policy Development Group. A former U.S. Senate Chief of
Staff, he is the co-founder and former Executive Director of the Geothermal Energy Association, and he has served as Board
Chairman of the Rare Earth Technology Alliance. He is an honors graduate of Georgetown University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ernest
Cleave &#8211; Senior Vice President of Business Development</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 17.75pt"><span style="font-weight: normal; font-style: normal">Mr.
Cleave joined NioCorp in August 2025 as Senior Vice President of Business Development. Mr. Cleave has more than 20 years of experience
in the mining, mineral processing, and energy industries. Prior to his work at NioCorp, Mr. Cleave served as the President and
CEO of Tinova Resources Corp., a critical minerals exploration company, from June 2024 to August 2025. From September 2013 to June
2024, Mr. Cleave served as the Chief Financial Officer of Largo Inc., a supplier of vanadium and ilmenite products. Additionally,
Mr. Cleave served as the Interim President of Largo Clean Energy Corp. (a subsidiary of Largo Inc.) from November 2022 to June
2023. Mr. Cleave&#8217;s career has also spanned leadership positions in several other mining and energy companies, including as
Chief Financial Officer of Cline Mining, Chief Financial Officer of Petrolympic, Global Lead of Sarbanes-Oxley Compliance at Glencore
(previously Falconbridge), and Treasurer and Director of Financial Planning and Analysis at Goldcorp. Mr. Cleave is a Chartered
Accountant (AUS &amp; NZL) and is a registered CPA in both Canada and Australia. Mr. Cleave earned his M.B.A. from Deakin University
of Victoria, Australia and has undergraduate degrees in computational science and commerce, respectively. </span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 17.75pt">&#160;</p>



<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
C. Beling &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Beling is a Registered Professional Mining Engineer with 61 years of project and corporate experience. He has served as a director
on the boards of 14 mining companies starting in 1981, including NioCorp since 2011. Mr. Beling is the owner of D.C. Beling &amp;
Assoc., LLC, which provides strategic advisory, project, and corporate development services to the mining industry. His previous
employment and consulting included 14 years with five major mining companies and then 47 years with 30+ U.S. and Canadian junior
mining companies. He was the President, CEO, and Director of Bullfrog Gold Corp. from 2011 until October 2020; and the Executive
Vice President</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 14; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">and COO of Geovic Mining Corp. from 2004 through 2010. Mr. Beling has examined, significantly reviewed, or been
directly involved with 91 underground mines, 136 open pit mines, and 174 process plants in the global metal, energy, industrial
mineral, and critical minerals sectors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
W. Fulton &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 17.75pt"><span style="font-weight: normal; font-style: normal">A
former Nebraska State Senator and successful business entrepreneur, Mr. Fulton previously served on the Board from 2013 until
2016, when he left to serve as Nebraska Tax Commissioner and Director of the Nebraska Department of Revenue, a 400-employee, $9
billion enterprise from January 2016 to December 2022. A mechanical engineer by training, Mr. Fulton has been the President of
the Nevada-based Hallmark Homecare, LLC, an independent domestic caregiver referral agency since May 2023 and is the Founder and
Owner of Guardian Angels Homecare, Inc. of Lincoln, Nebraska, an in-home senior care company, where he has served as the President
and CEO since March 2003. In addition to his work in the senior care industry, Mr. Fulton serves as the Chairman of the Diocesan
Finance Council for the Catholic Diocese of Lincoln (Southern Nebraska) and is the recipient of numerous awards throughout his
professional career. He received his B.S. in Mechanical Engineering from the University of Nebraska-Lincoln, with studies in Philosophy
at Newman University in Wichita, Kansas and Theology at Mount Saint Mary&#8217;s University in Emmittsburg, Maryland.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0.25pt; text-align: justify; text-indent: 17.75pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa
Guerrero-Mahon &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt; text-align: justify; text-indent: 0.25in">A former CFO and
Controller for global corporations in the technology, energy, and government sectors, Ms. Guerrero-Mahon provides consulting services
to domestic and international corporations as the principal at NGM Business Consulting, LLC. In addition, Ms. Guerrero-Mahon was
appointed to the Board of FinGoal, Inc. in April 2022, a finance technology company building artificial intelligence tools for
the financial services industry and other financial technology developers. She also serves as the Chair of the Finance and Audit
Committee for the Financial Data Exchange (&#8220;FDX&#8221;). FDX unifies the financial industry around a common standard for secure and convenient
access of permissioned consumer and business financial data.&#160; From 2014 to 2019, she served as the Vice Chair of the Board
and Chaired the Strategy Committee for the Mountains &amp; North Denver Operating Group, the largest division in the Common Spirit
Health System (formerly Centura Health). From 2009 to 2025, Ms. Guerrero-Mahon served as a gubernatorial appointed Board Member of
the State of Colorado Securities Commission and the Financial Services Commission. Among other prior positions, from 2004 to 2007,
she was the Global Services Controller at Microsoft Corporation, overseeing internal controls, compliance and corporate finance
activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt; text-align: justify; text-indent: 0.25in">Ms. Guerrero-Mahon
stays current with the latest Corporate Governance practices serving as a member of the Nasdaq Center for Board Excellence. She
is an NACD Board Leadership Fellow and a member of the SASB Alliance. She holds a CERT Certificate in Cybersecurity Oversight from
Carnegie Mellon University. Ms. Guerrero-Mahon is a Certified Public Accountant and a Certified Fraud Examiner. She received an
Executive MBA from the Daniels College of Business at the University of Denver, a BS in Business Administration - Accounting from
the Interamerican University in San Juan, Puerto Rico, and an AS in Computer Science from the EDP University of Puerto Rico.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
Oliver &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a background in chemistry, Mr. Oliver began working at Greenbushes, Western Australia, for Sons of Gwalia, a mining company, in
May 2003. After Sons of Gwalia went into administration in 2004, Mr. Oliver was hired by Talison Lithium Limited (&#8220;Talison&#8221;),
a mining company, where he served as General Manager of Talison&#8217;s Greenbushes and Wodgina Mines and as Talison&#8217;s COO,
until Mr. Oliver was appointed as the CEO/Managing director. As Talison&#8217;s CEO/Managing director, Mr. Oliver led the listing
of Talison on the Toronto Stock Exchange in September 2010.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Oliver guided Talison through its acquisition in 2013 by Tianqi Lithium Corporation (&#8220;Tianqi&#8221;). He then served as
a corporate adviser to Tianqi, focusing on M&amp;A opportunities and global expansion, including advising on the sale of 49% of
Talison to Albermarle Corp. and the acquisition of 24% of Sociedad Quimica y Minera de Chile S.A., as well as significant expansions
of Talison&#8217;s Greenbushes lithium concentrate production.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Oliver also was a founding member of Tianqi Lithium Energy Australia Pty Ltd, a wholly owned subsidiary of Tianqi, which was established
to build a major Lithium Hydroxide manufacturing facility in Western Australia. Until June 2021, Mr. Oliver remained as a director
of Talison, a joint venture between Tianqi and Albemarle Corp. In September 2022, Mr. Oliver was appointed to the Board of Latin
Resources, a lithium exploration company in Australia. Mr. Oliver was appointed to the role of Executive Director of Latin Resources in 2024 and helped lead the successful acquisition
of Latin Resources by Pilbara Minerals LTD (ASX: PLS) in March 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 15; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
C. Kehler &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify; text-indent: 0.25in">Mr.
Kehler co-founded Trimaran Fund Management, L.L.C. (&#8220;Trimaran Fund&#8221;) in 1998, where he is a Managing Partner, and serves
as a Manager of Trimaran Fund II. Mr. Kehler was also the Co-Chairman and Chief Executive Officer of GX Acquisition Corp. II,
a position he held from August 2018 to March 2023. From 1995 to 2000, Mr. Kehler held senior positions at Canadian Imperial Bank
of Commerce (&#8220;CIBC&#8221;), including Vice Chairman of CIBC World Markets Corp. Mr. Kehler currently serves on the Board of
Directors of BCP Investment Corporation (formerly Portman Ridge Finance Corporation). Within the last five years, he has served
a director of Celularity Inc. and El Pollo Loco Holdings, Inc. He holds a bachelor&#8217;s degree from the Wharton School of the University
of Pennsylvania.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
G. Maselli &#8211; Director</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Maselli is a managing director of Trimaran Fund, a position he has held since 2006, and was the President of Acquisitions of GX
Acquisition Corp. II from August 2018 to March 2023. Before joining Trimaran Fund in February 2006, Mr. Maselli worked in the
Corporate and Leverage Finance Groups of CIBC World Markets. Prior to joining CIBC in 1997, Mr. Maselli served as a Managing Director
in Bear Stearns&#8217; corporate finance group and, prior to that, as a Vice President at Kidder Peabody &amp; Co. Incorporated.
Mr. Maselli served on the board of directors of El Pollo Loco Holdings from 2010 to 2024, and he served as their Chairman of the
Board from 2011 to 2023.&#160; He served on the board of ChanceLight, Inc. (f/k/a Educational Services of America, Inc.) until
2018. From 2013 to 2015, he served on the board of directors of Norcraft Companies, Inc., and also served on the board of managers
of its predecessor company beginning in 2003. Additionally, Mr. Maselli served on the board of directors of Standard Steel, LLC,
and was director as well as Chairman of the Board of CB Holding Corp. Mr. Maselli received an MBA with distinction from The A.B.
Freeman School at Tulane University and a bachelor&#8217;s degree in economics from the University of Colorado.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Directorships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a list of directorships held over the past five years by our directors. Except as listed below, no directors of the
Company are also directors of reporting issuers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 80%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Director</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 51%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Reporting Issuer (or equivalent)</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David C. Beling</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bullfrog Gold</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CSE</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IBC Advanced Alloys Corp.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TSX-V</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Oliver</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Latin Resources</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASX</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean C. Kehler</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">El
Pollo Loco Holdings, Inc.&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BCP Investment Corporation</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Celularity
        Inc.&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GX
Acquisition Corp. II&#160;</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq&#160;</span></p></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael G. Maselli</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">El Pollo Loco Holdings, Inc.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
director or executive officer of the Company is a party adverse to the Company or any of its subsidiaries or has a material interest
adverse to the Company or any of its subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past ten years, none of the persons serving as executive officers and/or directors of the Company and, with respect to promoters
or control persons, for the past five years, none have been the subject matter of any of the legal proceedings that are required
to be disclosed pursuant to Item 401(f) of Regulation S-K. Further, no such legal proceedings are believed to be contemplated
by governmental authorities against any director or executive officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ethical
Business Conduct</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board expects management to operate the business of the Company in a manner that enhances shareholder value and is consistent
with the highest level of integrity. Management is expected to execute the Company&#8217;s business plan and to meet performance
goals and objectives according to the highest ethical standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 16; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, directors and senior officers are bound by the provisions of the Company&#8217;s Articles and the British Columbia Business
Corporations Act (&#8220;BCBCA&#8221;), which set forth how any conflicts of interest are to be dealt with. In particular, any
director who has a material interest in a particular transaction is required to disclose such interest and to refrain from voting
with respect to the approval of any such transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Insider
Trading Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have insider trading policies and procedures, as described below, applicable to our directors, officers, and employees, and have
implemented processes for the Company, that we believe are reasonably designed to promote compliance with insider trading laws,
rules, and regulations, and the Nasdaq listing standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has adopted an <span id="xdx_907_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20240701__20250630_z8pNwgy6NwI8"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact001827" name="ecd:InsiderTrdPoliciesProcAdoptedFlag">insider trading policy</ix:nonNumeric></span> (the &#8220;Insider Trading Policy&#8221;) to help ensure, among other things: (i)
that persons to whom the policy applies understand their obligations to preserve the confidentiality of &#8220;Material Nonpublic
Information&#8221; (as defined in the Insider Trading Policy); (ii) strict compliance by all insiders with all requirements relating
to the reporting of insider trading and with respect to trading when in possession of &#8220;Material Nonpublic Information&#8221;;
and (iii) that individuals subject to scheduled and unscheduled blackout periods adhere to the restrictions on trading as set
out in the Insider Trading Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted a written Code of Business Conduct and Ethics applicable to our employees, officers, and directors, including
those officers responsible for financial reporting. The Code of Business Conduct and Ethics is available on our website at www.niocorp.com.
If the Board amends the Code of Business Conduct and Ethics or grants a waiver, including an implicit waiver, from the Code of
Business Conduct and Ethics, the Company will disclose the information on its internet website. The waiver information will remain
on the website for at least 12 months after the initial disclosure of such waiver. Given the current size of the Company workforce,
and the lack of significant operations, the Board monitors compliance through periodic discussions with executive management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee and Audit Committee Financial Experts</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee is currently comprised of Anthony W. Fulton, Nilsa Guerrero-Mahon, Dean Kehler, and Michael Maselli, all of whom
are independent directors. Our Board has determined that each of Ms. Guerrero-Mahon and Messrs. Kehler and Maselli are audit committee
financial experts, as defined by the rules of the SEC. Further, all Audit Committee members are financially literate as defined
in NI 52-110. The Audit Committee was established in accordance with Section 3(a)(58)(A) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          11.</span></td><td style="padding-right: 0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a062"></span>EXECUTIVE
                                         COMPENSATION</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets out the compensation for the fiscal years ended June 30, 2025 and 2024 for the individual who served as the
Company&#8217;s CEO during fiscal year 2025, as well as the Company&#8217;s two other most highly compensated executive officers
other than the CEO who were serving at the end of the last fiscal year (collectively, the &#8220;named executive officers&#8221;):&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.25pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
2025 Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center">Name and Principal Position</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Fiscal  <br/>Year</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Salary  <br/>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Bonus &#160; <br/>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Option &#160; <br/>Awards (1) &#160; <br/>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total &#160; <br/>($)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: left">Mark A. Smith, Chief Executive Officer, President (2)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 12%; text-align: center">$325,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: center">$&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 12%; text-align: center">$126,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 12%; text-align: center">$451,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">325,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">641,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">966,250</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Scott Honan, Chief Operating Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">84,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">364,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">280,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">427,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">707,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Neal Shah, Chief Financial Officer and Corporate Secretary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">84,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">334,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">427,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">677,500</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 17; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 7px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 23px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects the grant
    date fair value of the Options granted during the reported fiscal years. Fiscal year 2025 grants consisted of 150,000 Options
    for Mr. Smith and 100,000 Options for each of Messrs. Honan and Shah, in each case at an exercise price of $1.40 per share.
    Grant date fair values were computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts
    are described in Note 10b in the Company&#8217;s consolidated financial statements included in this Annual Report on Form
    10-K. These Options were fully vested on the grant date (December 23, 2024) and generally remain exercisable for a period
    of five years after the grant date.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed amounts
    were paid to 76 Resources, LLC, an entity controlled by Mr. Smith, as further described below under &#8220;Employment Agreements
    and Severance Arrangements.&#8221;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Narrative
Disclosure to Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Governance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Compensation and Organization Committee of the Board (the &#8220;Compensation Committee&#8221;) generally determines
the amount of compensation for the Company&#8217;s executives, which is designed to reflect the need to provide incentives and
compensation for the time and effort expended by the executives while taking into account the financial and other resources of
the Company. The Compensation Committee has the authority to engage and compensate, at the expense of the Company, any outside
advisor that it determines to be necessary to permit it to carry out its duties (including compensation consultants and advisors).
For fiscal year 2025, however, the Compensation Committee did not engage any such advisors in connection with its activities.
The Company has also determined that none of its compensation policies and practices creates any risks that are reasonably likely
to have a material adverse effect on the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Program Design</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board, in conjunction with the Compensation Committee, determines compensation and rewards to senior management on the basis of
individual and corporate performance, both in the short term and the long term, while at the same time being mindful of the responsibility
that the Company has to its shareholders. In general, the Compensation Committee considers that its compensation program should
be relatively simple in concept, given the current stage of the Company&#8217;s development, and that its focus should be balanced
between reasonable current compensation and longer-term compensation tied to performance of the Company as a whole.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
fiscal year 2025, the Compensation Committee did not establish a formal set of benchmarks or performance criteria to be met by
the Company&#8217;s named executive officers; rather, the members of the Compensation Committee used their own subjective assessments
of the level of success of the Company to determine, collectively, whether or not the named executive officers had successfully
achieved the Company&#8217;s business plan and strategy and the degree to which they performed in that regard. The Compensation
Committee also has not established any pre-determined formula for determining named executive officer compensation, either as
to the amount thereof or the specific mix of compensation elements. Instead, compensation (and adjustments from time to time)
is set through discussions and subjective assessments at the Compensation Committee level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Key
Elements of Named Executive Officer Compensation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Base
Salaries</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Compensation Committee use their own experience and familiarity with the industry, and consider the factors described
above, to determine what they believe to be reasonable base salaries for our named executive officers. The base salaries of the
named executive officers are set at levels which are considered by the members of the Compensation Committee to be competitive,
thereby enabling the Company to compete for and retain executives critical to the long-term success of the Company. Initially,
base salaries (or, for Mr. Smith, base consulting fees) are set through negotiation when executive officers join the Company (with
direct input from the Compensation Committee) and are subsequently reviewed each fiscal year to determine if adjustments are required.
For fiscal year 2025, no changes were made to the named executive officers&#8217; base salary or consulting fees levels from those
in effect for fiscal year 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bonus
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has discretion, where deemed appropriate and financially affordable for the Company, to grant a cash bonus to a named executive
officer based on the performance of both the individual named executive officer and the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 18; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Company. No cash bonuses were contemplated,
approved, or paid for the named executive officers for fiscal year 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Option-Based
Awards</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
incentive portion of each named executive officer&#8217;s compensation package consists primarily of Options awarded under the
2017 Amended Long-Term Incentive Plan. Share ownership opportunities through the grant of Options are provided to align the interests
of senior management of the Company with the longer-term interests of the shareholders of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amended Long-Term Incentive Plan is administered by the Board or Compensation Committee, and is intended to advance the interests
of the Company through the attraction, motivation, and retention of officers and other key employees, directors and consultants
of the Company and affiliates of the Company and to secure for the Company and its shareholders the benefits inherent in the ownership
of Common Shares of the Company by officers and other key employees, directors and consultants of the Company and affiliates of
the Company. Grants of Options under the 2017 Amended Long-Term Incentive Plan are proposed and recommended by the CEO and reviewed
by the Board or Compensation Committee, or are proposed by the Board or Compensation Committee. The Board or Compensation Committee
can approve, modify, or reject any proposed grants, in whole or in part. In general, the allocation of available Options among
the eligible participants in the 2017 Amended Long-Term Incentive Plan is on an ad hoc basis, and there is no set formula for
allocating available Options, nor is there any fixed benchmark or performance criteria to be achieved in order to receive an award
of or vest in Options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board or Compensation Committee does not consider the accounting value of any such Option grants in determining the number of
Options to award to any individual, as any such &#8220;value&#8221; is an accounting measure that is not relevant to incentivizing
the individual. The timing of the grants of Options is determined by the Board or Compensation Committee, and there is no regular
interval for the awarding of Option grants. In general, a higher level of responsibility will result in a larger grant of Options.
Because the number of Options available is limited, in general, the Board or Compensation Committee aims to have individuals at
what it subjectively considers to be the same levels of responsibility holding equivalent numbers of Options, with additional
grants being allocated for individuals who the Board or Compensation Committee believes are in a position to more directly affect
the success of the Company through their efforts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board or Compensation Committee looks at the overall number of Options held by an individual (plus the exercise prices and remaining
terms of existing Options and whether any previously granted Options have expired out of the money or were exercised) and takes
such information into consideration when reviewing proposed new grants. After considering the CEO&#8217;s recommendations, if
any, and the foregoing factors, the resulting proposed Option grant is then submitted to the Board for final approval.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended June 30, 2025, the Board or Compensation Committee approved all recommendations for the grant of Options
proposed by management, and the named executive officers were granted the following number of Options effective December 23, 2024,
each with an exercise price per share of $1.40 per share: Mr. Smith, 150,000 Options; Mr. Honan, 100,000 Options; and Mr. Shah,
100,000 Options. These Options were fully vested and exercisable on the grant date and generally remain exercisable until five
years after the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreements and Severance Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Agreement
Regarding Mr. Smith</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is currently a party to a Consulting Agreement with 76 Resources, LLC (an entity controlled by Mr. Smith) under which
(as currently in effect, the &#8220;Smith Agreement&#8221;) 76 Resources, LLC, through Mr. Smith, performs the duties and responsibilities
of the CEO of the Company and related services, for an indefinite term at a base rate of $325,000 per year as of June 30, 2025, generally payable in equal semi-monthly installments of $13,542. Any bonuses and incentive payments are payable at the discretion of the Board. Mr. Smith is eligible
to receive Options under the 2017 Amended Long-Term Incentive Plan, as determined by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may terminate the Smith Agreement at any time without notice or payment if (1) 76 Resources, LLC commits a material breach
of the Smith Agreement (subject to a cure period in certain circumstances), (2) Mr. Smith dies or becomes permanently disabled,
or (3) certain other &#8220;for cause&#8221; scenarios occur (as further described in the Smith Agreement). In the event the Smith
Agreement is terminated by the Company for any other reason or if 76</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 19; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Resources, LLC terminates the Smith Agreement on the occurrence
of a Triggering Event, the Company shall pay 76 Resources, LLC a lump sum termination fee equal to the base fee in effect at the
termination date as well as the average of any annual bonuses or other cash incentive payments for two calendar years immediately
preceding the year the termination occurs. A Triggering Event is defined as: a substantial change in the nature of services to
be performed by 76 Resources, LLC; a material breach by the Company of the Smith Agreement that is not remedied within 30 days
of notice; the cessation of the Company as a going concern; the failure of the Company to pay a material amount due pursuant to
the Smith Agreement within 30 days of the due date; or a material reduction in base fee or any other form of compensation payable
by the Company to 76 Resources, LLC, except where all senior executives or consultants of the Company are subject to relatively
similar reductions in such values. 76 Resources, LLC may terminate the Smith Agreement for a reason other than a Triggering Event
on 90 days&#8217; written notice and, should the Company immediately accept such termination notice, it shall pay 76 Resources,
LLC the sum of $69,904. Should a change of control of the Company occur (as that term is defined in the Smith Agreement) and,
within one year, either a Triggering Event occurs and 76 Resources, LLC terminates the Smith Agreement or 76 Resources, LLC&#8217;s
engagement is terminated by the Company under circumstances that would give rise to a termination payment in the absence of a
change of control, then 76 Resources, LLC shall be entitled to receive an amount equal to the base fee in effect at the termination
date as well as the average of any annual bonuses or other cash payments for two calendar years immediately preceding the year
the termination occurs. In the event 76 Resources, LLC is entitled to a termination payment with respect to a change of control,
any Options previously granted to Mr. Smith shall become fully vested and shall remain exercisable for the original term of grant
despite a termination of the services of 76 Resources, LLC. Termination payments under the Smith Agreement are generally contingent
on a release of claims by 76 Resources, LLC. The Smith Agreement also includes customary confidentiality and six-month employee
non-solicitation provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Smith Agreement had been terminated by the Company for any reason other than as set out in the Smith Agreement, if 76 Resources,
LLC terminated the Smith Agreement on the occurrence of a Triggering Event, or had a change of control of the Company occurred
and within one year, either a Triggering Event occurred and 76 Resources, LLC terminated the Smith Agreement or 76 Resources,
LLC&#8217;s engagement was terminated by the Company without the occurrence of a Triggering Event for any reason other than as
set out in the Smith Agreement, effective as of June 30, 2025, 76 Resources, LLC (as ultimate successor in interest to KMSmith)
would have been entitled to a payment of $375,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Agreements
Regarding Messrs. Shah and Honan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, on September 25, 2022, in connection with our entry into the Business Combination Agreement, Messrs. Shah
and Honan (the &#8220;Covered Officers&#8221;) entered into employment agreements with a United States affiliate (the &#8220;U.S.
Affiliate&#8221;) of the Company (the &#8220;Employment Agreements&#8221;). The Employment Agreements became effective upon the
closing of the GXII Transaction, and will continue until either the Covered Officer or the U.S. Affiliate terminates the Covered
Officer&#8217;s employment for any reason. Pursuant to the Employment Agreements, Mr. Shah continues to serve as Chief Financial
Officer of the Company, and Mr. Honan continues to serve as the COO of the Company and serves as President of the U.S. Affiliate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Employment Agreement for Mr. Shah provided for an initial annual base salary of $220,000 per year, and Mr. Honan&#8217;s Employment
Agreement provided for an initial annual base salary of $260,000 per year. The annual base salary rates for the Covered Officers
are reviewed at least annually for potential increases. The base salary rates of Messrs. Shah and Honan were increased in fiscal
2023 to $250,000 for Mr. Shah and $280,000 for Mr. Honan. There were no increases in base salary rates for fiscal 2024 or 2025. The Employment Agreements also provide each of the Covered Officers with eligibility to participate in (1) any annual cash bonus
plan and/or any long-term incentive compensation plan as may be established by the U.S. Affiliate or its affiliates, and (2) any
employee benefit plan, program, or policy of the U.S. Affiliate or its affiliates as may be in effect for senior executives of
the U.S. Affiliate or its affiliates generally. The Employment Agreements also include the following additional features: (1)
severance benefits upon certain qualifying terminations of employment, consisting of: (a) for a qualifying termination of the
Covered Officer&#8217;s employment by the U.S. Affiliate without Cause (as such term is defined in the Employment Agreements)
that does not occur within two years after a Change in Control of the U.S. Affiliate (as defined in the Employment Agreements),
certain accrued obligations, plus 12 months of salary continuation, and (b) for a qualifying termination of the Covered Officer&#8217;s
employment by the U.S. Affiliate without Cause or by the Covered Officer for Good Reason (as such term is defined in the Employment
Agreements) that occurs within two years after a Change in Control (a &#8220;Change in Control Termination&#8221;), certain accrued
obligations, and a lump sum cash amount equal to two times the Covered Officer&#8217;s annual base salary as in effect at the
time of such termination; and (2) a</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 20; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">requirement that each Covered Executive execute a customary release of claims in favor of
the U.S. Affiliate to receive severance compensation. In connection with the Covered Officers entering into the Employment Agreements
each Covered Officer also entered into a restrictive covenant agreement (a &#8220;Restrictive Covenant Agreement&#8221;). The
Restrictive Covenant Agreements include customary restrictive covenants, including non-competition and non-solicitation obligations
that remain in effect both during the employment term and for one year following termination of the Covered Officer&#8217;s employment
other than a Change in Control Termination (in which case the period will be two years following such Change in Control Termination),
as well as other customary restrictive covenants, such as confidentiality provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Options Under the 2017 Amended Long-Term Incentive Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the 2017 Amended Long-Term Incentive Plan, the Company granted Options to its named executive officers during
the Company&#8217;s 2025 fiscal year; no other equity-based awards were granted to the named executive officers during the 2025
fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the outstanding equity awards for each named executive officer at June 30, 2025. The Company has not
granted full value stock-based awards to any of its named executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2025 Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="15" style="text-align: center">Option Awards</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Grant Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexercised&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(#)&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexercised&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(#)&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unexercisable&#160;</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price
($)</span></p></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Option  <br/>Expiration &#160; <br/>Date </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; text-align: left; padding-left: 5pt">Mark A. Smith</td><td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: center">03/27/2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: center">70,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: center">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: center">$6.95</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: center">03/27/2026</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">02/15/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">375,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">02/15/2029</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/21/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">1.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/21/2029</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Scott Honan</td><td>&#160;</td>
    <td style="text-align: center">03/27/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">6.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">03/27/2026</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">02/15/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">02/15/2029</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/21/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">1.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/21/2029</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Neal Shah</td><td>&#160;</td>
    <td style="text-align: center">03/27/2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">40,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">6.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">03/27/2026</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">02/15/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">02/15/2029</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/21/2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">100,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">1.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">12/21/2029</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Retirement
Plan Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Messrs.
Honan and Shah are each eligible to participate in the Company&#8217;s 401(k) savings plan, which is designed to reward continued
employment with the Company and assist participants with financial preparation for retirement. All amounts credited under the
401(k) savings plan relate to participant contributions. The Company does not currently make matching or other contributions to
the 401(k) savings plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination
and Change of Control Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described above, the Company is not a party to any plans or arrangements regarding the named executive officers under which
they may receive enhanced or incremental compensation or benefits in the event of a change of control, termination of employment
(as a result of resignation, retirement, change of control, etc.) or a change in responsibilities following a change of control.
Options are generally subject to clawback provisions, and provide for post-employment exercise periods, pursuant to the terms
of such awards and the 2017 Amended Long-Term Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 21; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Practices
Related to the Grant of Equity Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div id="xdx_982_eecd--AwardTmgMnpiDiscTextBlock_c20240701__20250630_zsa1JeN8PeS6" title="Award Timing MNPI Disclosure"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001829" name="ecd:AwardTmgMnpiDiscTextBlock">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eecd--AwardTmgMethodTextBlock_c20240701__20250630_zUCn0D2oxEt" title="Award Timing Method" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001831" name="ecd:AwardTmgMethodTextBlock">Under
our policies and practices, the approval of Options (including any Option grants to our named executive officers and
directors) is typically provided at a Board or Compensation Committee meeting or via unanimous written action on the part of the  Board or Compensation
Committee, but such grants are not generally made on any kind of predetermined, regular schedule. Instead, as noted above, our
award recipients (including the named executive officers and directors) generally receive annual grants of fully-vested and exercisable
Options at various times each year, including as recommended by the CEO to the Board or Compensation Committee.</ix:nonNumeric></span>  Board or Compensation Committee
meetings or written actions to approve such grants are scheduled on an ad hoc, as-needed basis, generally prompted by a determination
by the Board or Compensation Committee that such grants should be made (or a request by management or the Board that such grants be made).
<span id="xdx_900_eecd--AwardTmgPredtrmndFlag_dbT_c20240701__20250630_zqSmXRRTVSi" title="Award Timing Predetermined" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleantrue" id="Fact001833" name="ecd:AwardTmgPredtrmndFlag">These grants are then made effective at the meeting at which the grants are so approved.</ix:nonNumeric></span> The  Board or Compensation Committee typically
fixes the grant schedule for such awards when they are approved at such meetings or through written action. Generally, award values
to be utilized for such awards are determined shortly before or as of the grant date based upon the closing share price on the
business day preceding the grant. These values and other information are then used in determining the number of Options to be
awarded to recipients, but values are not modified to reflect any subsequent increase or decrease in value of our stock between
the end of the preceding business day and the effective date of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
equity grant approach is used by the Board or Compensation Committee in order to best help ensure the grants are made only during an open
window, and after the release of the Company&#8217;s <span id="xdx_903_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zbGP1hraM7O9" title="Award Timing MNPI Considered" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" format="ixt:booleanfalse" id="Fact001835" name="ecd:AwardTmgMnpiCnsdrdFlag">material non-public information</ix:nonNumeric></span> regarding its most recently-completed fiscal
year. Including for grants made during fiscal year 2025, <span id="xdx_90B_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240701__20250630_z312nmHTEpF7" title="Award Timing, How MNPI Considered" class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-07-01to2025-06-30" escape="true" id="Fact001837" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock">we do not time the disclosure of material non-public information for
purposes of affecting the value of executive compensation, and we do not make any grants while in the possession of material non-public
information.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2025, we did not grant Options (or similar awards) to any of our named executive officers during the period beginning
four business days before and ending one business day after the filing of any Company periodic report on Form 10-Q or Form 10-K,
or the filing or furnishing of any Company Form 8-K, that disclosed any material non-public information.</span></p>

</ix:nonNumeric></div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
2025 Director Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the directors serving on the Board (Mr. Smith) is also a named executive officer. For a description of the compensation paid
to Mr. Smith, see &#8220;Fiscal 2025 Summary Compensation Table&#8221; and the accompanying narrative provided above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all compensation the Company granted to our directors, other than Mr. Smith, for the fiscal year ended
June 30, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 5pt">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Fees Earned or Paid in Cash  <br/>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Option Awards<br/> ($)(1)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">All Other Compensation  <br/>($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total<br/> ($)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 5pt">Michael J. Morris</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 12%; text-align: center">$&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 12%; text-align: center">$63,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 12%; text-align: center">$&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 12%; text-align: center">$63,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Nilsa Guerrero-Mahon</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">63,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">63,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">David C. Beling</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Dean C. Kehler</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Michael G. Maselli</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Peter Oliver</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">42,000</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 98%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
    the grant date fair value of Options granted during the 2025 fiscal year, consisting of 75,000 Options each for Mr. Morris
    and Ms. Guerrero-Mahon, and 50,000 Options each for Messrs. Beling, Oliver, Kehler, and Maselli, in each case at an exercise
    price of $1.40 per share, computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of these amounts
    are described in Note 10b in the Company&#8217;s consolidated financial statements included in this Annual Report on Form
    10-K. These Options were fully vested on the grant date (December 23, 2024) and generally remain exercisable until five years
    after the grant date.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended June 30, 2025, the directors of the Company did not receive any cash fees for serving on the Board. The
directors of the Company have no standard compensation arrangements, or any other arrangements, with the Company, except as herein
disclosed. Option grants are determined by the  Board or Compensation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 22; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Committee on a discretionary basis each year. Executive officers of
the Company who also act as directors of the Company do not receive any additional compensation for services rendered in such
capacity. See &#8220;Fiscal 2025 Summary Compensation Table&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of Option awards outstanding at the end of fiscal year 2025 for each non-employee director who served during
fiscal 2025 was as follows: Mr. Morris, 200,000 Options; Ms. Guerrero-Mahon 195,000 Options; Mr. Beling, 140,000 Options; Mr.
Kehler, 100,000 Options; Mr. Maselli, 100,000 Options; and Mr. Oliver, 140,000 Options. As of June 30, 2025, all the above Options
were 100% vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the 2017 Amended Long-Term Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, NioCorp&#8217;s shareholders approved the adoption of the 2017 Amended Long-Term Incentive Plan. Under the 2017
Amended Long-Term Incentive Plan, the Board may in its discretion from time-to-time grant Options, share units (in the form of
restricted share units (&#8220;RSUs&#8221;) and performance share units (&#8220;PSUs&#8221;)) and dividend equivalents to non-employee
directors, employees and certain other service providers (as further described in the 2017 Amended Long-Term Incentive Plan) of
the Company and affiliated entities selected by the Board. Subject to adjustment as provided in the 2017 Amended Long-Term Incentive
Plan, the aggregate number of Common Shares that may be reserved for issuance to participants under the 2017 Amended Long-Term
Incentive Plan, together with all other security-based compensation arrangements of the Company, may not exceed 10% of the issued
and outstanding Common Shares from time to time, and the Common Shares reserved for issuance upon settlement of share units shall
not exceed 5% of the issued and outstanding Common Shares from time to time. Further, the aggregate number of Common Shares reserved
for issuance to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, must not exceed 5% of the then issued and outstanding Common Shares (on a non-diluted basis). The
maximum number of Common Shares (1) issued to insiders (for purposes of the Toronto Stock Exchange Company Manual) within any
one-year period and (2) issuable to insiders at any time, under the 2017 Amended Long-Term Incentive Plan, or when combined with
the Company&#8217;s other security-based compensation arrangements, will not exceed 10% of the number of the then issued and outstanding
Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the burn rates for the 2017 Amended Long-Term Incentive Plan for the three most recent fiscal years:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Fiscal Year<br/> Ending June 30,</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number of awards granted</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighted average number of Common Shares outstanding</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Burn rate</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 23%; text-align: center">2025</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: center">945,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: center">45,072,895</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 22%; text-align: center">2.1%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: center">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">1,625,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">34,320,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">4.7%</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">578,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">28,705,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2.0%</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 96%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
    fiscal year 2023, the Company completed a 10-for-1 reverse stock split (the &#8220;Reverse Stock Split&#8221;). For purposes
    of comparability across fiscal years in this table, amounts in these columns with respect to fiscal years prior to 2023 represent
    the original amounts adjusted to reflect the Reverse Stock Split. With respect to the number of awards granted in fiscal 2023,
    any actual grants made prior to the Reverse Stock Split have also been adjusted.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          12.</span></td><td style="padding-right: 0.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a063"></span>SECURITY
                                         OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the beneficial ownership of Common Shares of NioCorp as of

September 11, 2025 (except where otherwise indicated), for the following:
(1) each person who is known by NioCorp to beneficially own more than 5% of the outstanding shares of NioCorp&#8217;s Common Shares;
(2) each of the named executive officers (as defined in the &#8220;Fiscal 2025 Summary Compensation Table,&#8221; above); (3)
each of NioCorp&#8217;s directors; and (4) all directors and executive officers of NioCorp as a group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership of Common Shares in the table below is determined in accordance with the rules of the SEC and includes voting or investment
power with respect to the Common Shares. Common Shares that may be acquired by an individual or group within 60 days of September
11, 2025, pursuant to the exercise of Options, the exercise of Warrants, or the exchange of shares of Class B common stock
of ECRC (formerly known as GXII), are deemed to be outstanding for the purpose of computing the percentage ownership of such individual
or group but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown
in the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 23; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">table. Percentage of ownership is based on 77,757,089 Common Shares outstanding
as of September 11, 2025. Unless otherwise noted in the table below, Options
vested at the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as indicated in footnotes to this table, we believe that the shareholders named in this table have sole voting and investment
power with respect to all Common Shares shown to be beneficially owned by them, based on information provided to us by such shareholders.
Unless otherwise indicated, the address for each director and executive officer listed is: c/o NioCorp Developments Ltd., 7000
South Yosemite Street, Suite 115, Centennial, CO 80112.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Address of<br/> Beneficial Owner</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    and Nature of Beneficial Ownership<br/> (1)</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percent
    of Common Shares</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mark
                                         A. Smith, PE, Esq.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Highlands
                                  Ranch, Colorado, USA</span></p></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 35%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive
    Officer, President, Executive Chairman and Director</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,316,452</span></td>
    <td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neal
                                 Shah</b>&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Superior,
                          Colorado, USA&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer
    and Corporate Secretary</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">550,032</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scott
                                 Honan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Centennial,
                     Colorado, USA&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">530,762</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>David
                                 C. Beling</b>&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand
                               Junction, Colorado, USA&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">229,013</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anthony
                                 W. Fulton</b>&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lincoln,
                               Nebraska, USA&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,209</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nilsa
                                 Guerrero-Mahon</b>&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brighton,
                                    Colorado, USA&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">259,768</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean
    Kehler<br/> New York, New York, USA</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,708,811</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Michael
                                 Maselli</b>&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pelham,
                             New York, USA&#160;</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655,235</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Peter
                                 Oliver</b>&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bunbury,
                            Western Australia, Australia</span></p></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lead Director</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,400</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All current directors,
    executive officers and named executive officers as a group (11 persons)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,228,610</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.06</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Kenneth Griffin
    </b><br/>Miami, Florida, USA</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,903,395</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.02</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Represents ownership of less than 1%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated
                                         in accordance with Rule 13d-3 of the Exchange Act.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Smith beneficially owns 2,272,018 outstanding Common Shares. In addition, he beneficially
                                         owns 321,934 Common Shares issuable upon exercise of: (i) 46,801 Warrants each exercisable
                                         for one Common Share at a price of $3.54 until December 22, 2025; (ii) 183,422 Warrants
                                         each exercisable for one Common Share at a price of $1.75 until November 13, 2026; and
                                         (iii) 91,711 Warrants each exercisable for one Common Share at a price of $2.07 until
                                         November 13, 2029. He also beneficially owns 722,500 Common Shares issuable upon exercise
                                         of vested Options comprised of the following: (i) on March 27, 2023, Mr. Smith was granted
                                         70,000 Options each exercisable for one Common Share for a period of three years at a
                                         price of $6.95 per Common Share; (ii) on February 15, 2024, Mr. Smith was granted 375,000
                                         Options each exercisable for one Common Share for a period of five years at a price of
                                         $2.99; (iii) on December 23, 2024, Mr. Smith was granted 150,000 Options each exercisable
                                         for one Common Shares for a period of five years at a price of $1.40; and (iv) on August
                                         18, 2025, Mr. Smith was granted 375,000 Options each exercisable for One Common Share
                                         for a period of five years at a price of $4.35 which will vest over a period of two years
                                         with 34% having vested at this time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Shah beneficially owns 65,671 outstanding Common Shares. He beneficially owns 9,361 Common Shares issuable upon exercise of 9,361
Warrants each exercisable for one Common Share at a price of $3.54 until December 22, 2025. In addition, he beneficially owns
475,000 Common Shares issuable upon exercise of vested Options comprised of the following: (i) on March 27, 2023, Mr. Shah was
granted 40,000 Options each exercisable for one Common Share for a period of three years at a price of $6.95 per Common Share;
(ii) on February 15, 2024, Mr. Shah was granted 250,000 Options each exercisable for one Common Share for a period of five years
at a price of
$2.99; (iii) on December 23, 2024, Mr. Shah was granted 100,000 Options each exercisable for one Common Share for a period of
five years at a price </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 24; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of $1.40; and (iv) on August 18, 2025, Mr. Shah was granted 250,000 Options each exercisable for One Common
Share for a period of five years at a price of $4.35 which will vest over a period of two years with 34% having vested at this
time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Honan beneficially owns 55,762 outstanding Common Shares. In addition, he beneficially
                                         owns 475,000 Common Shares issuable upon exercise of vested Options comprised of the
                                         following: (i) on March 27, 2023, Mr. Honan was granted 40,000 Options each exercisable
                                         for one Common Share for a period of three years at a price of $6.95 per Common Share;
                                         (ii) on February 15, 2024, Mr. Honan was granted 250,000 Options each exercisable for
                                         one Common Share for a period of five years at a price of $2.99; (iii) on December 23,
                                         2024, Mr. Honan was granted 100,000 Options each exercisable for one Common Share for
                                         a period of five years at a price of $1.40; and (iv) on August 18, 2025, Mr. Honan was
                                         granted 250,000 Options each exercisable for One Common Share for a period of five years
                                         at a price of $4.35 which will vest over a period of two years with 34% having vested
                                         at this time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Beling beneficially owns 72,013 outstanding Common Shares. In addition, he beneficially
                                         owns 157,000 Common Shares issuable upon exercise of vested Options comprised of the
                                         following: (i) on March 27, 2023, Mr. Beling was granted 40,000 Options each exercisable
                                         for one Common Share for a period of three years at a price of $6.95 per Common Share;
                                         (ii) on February 15, 2024, Mr. Beling was granted 50,000 Options each exercisable for
                                         one Common Share for a period of five years at a price of $2.99; (iii) on December 23,
                                         2024, Mr. Beling was granted 50,000 Options each exercisable for one Common Share for
                                         a period of five years at a price of $1.40; and (iv) on August 18, 2025, Mr. Beling was
                                         granted 50,000 Options each exercisable for One Common Share for a period of five years
                                         at a price of $4.35 which will vest over a period of two years with 34% having vested
                                         at this time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Fulton beneficially owns 179,350 Common Shares. He shares both voting and investment
                                         power with respect to 2,276 of such Common Shares with members of his family. In addition,
                                         he beneficially owns 54,859 Common Shares issuable upon exercise of 49,058 NioCorp Assumed
                                         Warrants each exercisable for 1.11829212 Common Shares at a price of $11.50 until March
                                         17, 2028. He also beneficially owns 17,000 Common Shares issuable upon exercise of vested
                                         Options comprised of: (i) on August 18, 2025, Mr. Fulton was granted 50,000 Options each
                                         exercisable for One Common Share for a period of five years at a price of $4.35 which
                                         will vest over a period of two years with 34% having vested at this time. He shares both
                                         voting and investment power with respect to 12,335 Common Shares issuable upon exercise
                                         of 11,032 of such NioCorp Assumed Warrants with members of his family.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
                                         Guerrero-Mahon beneficially owns 46,068 Common Shares. In addition, she beneficially
                                         owns 213,700 Common Shares issuable upon exercise of vested Options comprised of the
                                         following: (i) on March 27, 2023, Ms. Guerrero-Mahon was granted 45,000 Options each
                                         exercisable for one Common Share for a period of three years at a price of $6.95 per
                                         Common Share; (ii) on February 15, 2024, Ms. Guerrero-Mahon was granted 75,000 Options
                                         each exercisable for one Common Share for a period of five years at a price of $2.99;
                                         (iii) on December 23, 2024, Ms. Guerrero-Mahon was granted 75,000 Options each exercisable
                                         for one Common Share for a period of five years at a price of $1.40; and (iv) on August
                                         18, 2025, Ms. Guerrero-Mahon was granted 55,000 Options each exercisable for One Common
                                         Share for a period of five years at a price of $4.35 which will vest over a period of
                                         two years with 34% having vested at this time.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td><td style="text-align: justify; padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Kehler beneficially owns 134,580 Common Shares, and 1,441,290 Common Shares issuable
                                         upon the exchange of Vested Shares (as defined herein). He shares both voting and investment
                                         power with respect to 318,470 of such Vested Shares with U.S. Trust Company of Delaware,
                                         as co-trustee of the Elizabeth Kehler 2012 Family Trust under Declaration of Trust dated
                                         December 12, 2012 (the &#8220;Elizabeth Kehler Trust&#8221;). In addition, he beneficially
                                         owns 2,015,941 Common Shares issuable upon exercise of the following: (i) 1,657,057 Private
                                         Warrants (as defined herein) exercisable for an aggregate of up to 1,853,073 Common Shares
                                         held by Mr. Kehler; (ii) 78,003 Warrants each exercisable for one Common Share at a price
                                         of $3.54 until December 22, 2025; (iii) 56,577 Warrants each exercisable for one Common
                                         Share at a price of $1.75 until November 13, 2026; and (iv) 28,288 Warrants each exercisable
                                         for one Common Share at a price of $2.07 until November 13, 2029. He also beneficially
                                         owns 117,000 Common Shares issuable upon exercise of vested Options comprised of the
                                         following: (i) on February 15, 2024, Mr. Kehler was granted 50,000 Options each exercisable
                                         for one Common Share for a period of five years at a price of $2.99; (ii) on December
                                         23, 2024, Mr. Kehler was granted 50,000 Options each exercisable for one Common Share
                                         for a period of five years at a price of $1.40; and (iii) on August 18, 2025, Mr. Kehler
                                         was granted 50,000 Options each exercisable for One Common Share for a period of five
                                         years at a price of $4.35 which will vest over a period of two years with 34% having
                                         vested at this time. The total does not include Common Shares that may be issuable upon
                                         exchange of (i) 417,030 Tranche I Earnout Shares (as defined herein) held by Mr. Kehler,
                                         (ii) 417,030 Tranche II Earnout Shares (as defined herein) held by Mr. Kehler, (iii)
                                         118,284 Tranche I Earnout Shares held by the Elizabeth Kehler Trust; and (iv) 118,284
                                         Tranche II Earnout Shares held by the Elizabeth Kehler Trust.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Maselli beneficially owns 323,085 Common Shares. In addition, Mr. Maselli beneficially owns 215,150 Common Shares issuable upon
exercise of 192,392 Private Warrants held by Mr. Maselli. He also beneficially owns 117,000 Common Shares issuable upon exercise
of vested Options comprised of the following: (i) on February 15, 2024, Mr. Maselli was granted 50,000 Options each exercisable
for one Common Share for a period of five years at a price of $2.99; (ii) on December 23, 2024, Mr. Maselli was granted 50,000
Options each exercisable for one Common Share for a period of five years at a price of $1.40 and (iii) on August 18, 2025, Mr.
Maselli was granted 50,000 Options each exercisable for One Common Share for a period of five years at a price of $4.35 which
will vest over a period of two years with 34%</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 25; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-align: justify">having vested at this time. The total does not include
                                         Common Shares that may be issuable upon exchange of (i) 119,998 Tranche I Earnout Shares
                                         held by Mr. Maselli and (ii) 119,998 Tranche II Earnout Shares held by Mr. Maselli.</p>

<p style="margin-top: 0; margin-bottom: 0; margin-left: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Oliver beneficially owns 160,400 Common Shares issuable upon exercise of vested Options
                                         comprised of the following: (i) on March 27, 2023, Mr. Oliver was granted 40,000 Options
                                         each exercisable for one Common Share for a period of three years at a price of $6.95
                                         per Common Share; (ii) on February 15, 2024, Mr. Oliver was granted 50,000 Options each
                                         exercisable for one Common Share for a period of five years at a price of $2.99; (iii)
                                         on December 23, 2024, Mr. Oliver was granted 50,000 Options each exercisable for one
                                         Common Share for a period of five years at a price of $1.40 and (iv) on August 18, 2025,
                                         Mr. Oliver was granted 60,000 Options each exercisable for One Common Share for a period
                                         of five years at a price of $4.35 which will vest over a period of two years with 34%
                                         having vested at this time.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                         reported by Kenneth Griffin on a Schedule 13G jointly filed with the SEC on July 25,
                                         2025 by Mr. Griffin, Citadel Advisors LLC (&#8220;Citadel Advisors&#8221;), Citadel Advisors Holdings
                                         LP (&#8220;CAH&#8221;), Citadel GP LLC (&#8220;CGP&#8221;), Citadel Securities LLC (&#8220;Citadel Securities&#8221;), Citadel
                                         Securities Group LP (&#8220;CALC4&#8221;) and Citadel Securities GP LLC (&#8220;CSGP&#8221;) with respect to
                                         Common Shares owned by Citadel Multi-Strategy Equities (Ireland) Designated Activity
                                         Company, an Ireland company (&#8220;CSMI&#8221;) and Citadel Securities. Citadel Advisors is the
                                         portfolio manager for CMSI. CAH is the sole member of Citadel Advisors. CGP is the general
                                         partner of CAH. CALC4 is the non-member manager of Citadel Securities. CSGP is the general
                                         partner of CALC4. Mr. Griffin is the President and Chief Executive Officer of CGP, and
                                         owns a controlling interest in CGP and CSGP.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EQUITY
COMPENSATION PLANS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has maintained equity compensation plans under which Options have been granted. Option grants have been determined by
the Company&#8217;s directors and are only provided in compliance with applicable laws and regulatory policy. The following information
is provided with respect to compensation plans (including individual compensation arrangements) under which equity securities
were authorized for issuance as of June 30, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="13" style="text-align: center">Equity Compensation Plan Information</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="13" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; padding-left: 0.125in; text-indent: -0.125in">Plan Category </td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: left"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Number of Securities</span><br/> <span style="font: 10pt Times New Roman, Times, Serif">to be Issued Upon</span><br/> <span style="font: 10pt Times New Roman, Times, Serif">Exercise of</span><br/> <span style="font: 10pt Times New Roman, Times, Serif">Outstanding Options,</span><br/> <span style="font: 10pt Times New Roman, Times, Serif">Warrants, and Rights</span></p>

</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: left"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Weighted-Average Exercise Price of Outstanding</span><br/> <span style="font: 10pt Times New Roman, Times, Serif">Options, Warrants,</span><br/> <span style="font: 10pt Times New Roman, Times, Serif">and Rights</span></p>

</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: left"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Second Column)</span></p>

</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Compensation Plans Approved by Security Holders&#160;<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: center">3,020,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"/><td style="width: 15%; text-align: center">$3.09</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: center">2,829,119<sup>(2)</sup></td><td style="width: 1%; text-align: left"/></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in">Equity Compensation Plans Not Approved by Security Holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">3,020,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: center">$3.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2,829,119</td><td style="text-align: left"/></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents Options
    granted pursuant to the 2017 Amended Long-Term Incentive Plan.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><p style="margin-top: 0; margin-bottom: 0"></p>
        <p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally, the aggregate
    number of Common Shares reserved for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with
    all other security-based compensation arrangements of the Company may not exceed 10% of the issued and outstanding Common
    Shares from time to time, and the Common Shares reserved for issuance upon settlement of share units shall not exceed 5% of
    the issued and outstanding Common Shares from time to time. Common Shares subject to any grant (or any portion thereof) that
    are issued upon exercise or settlement, forfeited, surrendered, cancelled, unearned, or otherwise terminated will again be
    available for grant under the 2017 Amended Long-Term Incentive Plan.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2025, there were: (i) 3,020,000 outstanding securities awarded under the 2017
    Amended Long-Term Incentive Plan representing 5.16% of the Company&#8217;s
    currently issued and outstanding Common Shares; and (ii) 2,829,119 remaining securities
    available for grant representing 4.84% of the Company&#8217;s currently issued
    and outstanding Common Shares.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Performance
Graph</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following graph compares total cumulative shareholder return for $100 invested in Common Shares from July 1, 2020, to June 30,
2025, with cumulative total returns for the S&amp;P/TSX Composite Index and S&amp;P/TSX Mining Index:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 26; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: center; text-indent: -2.5pt; color: Red"><img src="n257410kimg005.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: center; text-indent: -2.5pt; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
the Company&#8217;s cumulative return for the five-year period ended below the range of returns for the two selected indices.
As an exploration stage company, executive officer compensation has not historically been adjusted to reflect share performance
trends. Compensation to executive officers remained flat from 2013 through February 2023, except for increases supported by additional
job responsibilities and/or job promotions. Effective September 1, 2019, the Board approved a 10% base rate increase for all NioCorp
employees and effective April 1, 2023, the Compensation Committee approved a base rate average increase of 12% for all NioCorp
employees. There were no salary increases granted during fiscal years 2025 or 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          13.</span></td><td style="padding-right: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a064"></span>CERTAIN
                                         RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following sets forth certain information regarding transactions between the Company (and its subsidiaries) and its officers, directors,
and significant shareholders. There have been no other transactions since the end of the Company&#8217;s most recently completed
fiscal year and there are no currently proposed transactions in which the Company was or is to be a participant and the amount
involved exceeds $120,000, and in which any related person (for purposes of Item 404 of Regulation S-K) had or will have a direct
or indirect material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Transactions: </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Smith is our Chief Executive Officer, President, Executive Chairman, and Director. On September 11, 2024, the Company and Mr.
Smith entered into the Smith Loan Agreement pursuant to which Mr. Smith agreed to make available to the Company a non-revolving,
multiple draw credit facility of up to $2,000,000. The Smith Loan expired on June 30, 2025, was non-revolving, and amounts paid
back under the terms of the Smith Loan Agreement did not again become available for drawdowns at the request of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company paid interest to Mr. Smith on amounts outstanding under the Smith Loan at a rate equal to 10% per annum, calculated monthly
in arrears, through to the date of repayment of the Loan. Mr. Smith also received an establishment fee equal to 2.5% of the amount
of each drawdown payable at the time of the drawdown as consideration of the advancement of such drawdown. Any outstanding balance
on the Loan, including accrued interest, were immediately due and payable by the Company on the earlier of the date of expiration
of the Smith Loan Agreement and the occurrence of an event of default thereunder (the &#8220;Due Date&#8221;). The Company could
repay the Smith Loan at any time without notice and without penalty, but any amount of principal or interest repaid by the Company prior
to the Due Date will be subject to an early payment fee of 2.5% of the value of any such payment. Amounts outstanding under the
Smith Loan Agreement were secured by all of the Company&#8217;s assets pursuant to a general security agreement between the Company
and Mr. Smith, dated September 11, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
October 30, 2024, the Company borrowed a total of $504,000 under the Smith Loan and the largest aggregate amount of principal
outstanding under the Smith Loan Agreement during the period ended June 30, 2025, was $504,000. The Company subsequently repaid
$508,200, representing the balance of the principal outstanding</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 27; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">under the Smith Loan plus accrued interest, and also repaid $40,850
related to loan origination fees payable. As of June 30, 2025, there was no principal amount or accounts payable outstanding under
the Smith Loan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>December
2023 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2023, the Company closed a non-brokered private placement (the &#8220;December 2023 Private Placement&#8221;) and
issued an aggregate of 413,432 units of the Company (the &#8220;December 2023 Units&#8221;). Each December 2023 Unit consisted
of one Common Share and one Warrant (the &#8220;December 2023 Warrants&#8221;). Each December 2023 Warrant is exercisable for
one Common Share at a price of $3.54 until December 22, 2025. Certain of the Company&#8217;s officers and directors, including
Messrs. Kehler, Smith and Shah, subscribed to purchase an aggregate of 138,845 December 2023 Units in the December 2023 Private
Placement. Each officer and director of the Company who subscribed to purchase December 2023 Units in the December 2023 Private
Placement paid a purchase price of $3.205 per unit (the &#8220;December 2023 Insider Unit Price&#8221;) upon the closing of the
December 2023 Private Placement. The December 2023 Insider Unit Price included $0.125 per December 2023 Warrant underlying each
December 2023 Unit purchased by officers and directors of the Company. Messrs. Kehler, Smith and Shah purchased 78,003 December
2023 Units, 46,801 December 2023 Units, and 9,361 December 2023 Units, respectively, for aggregate purchase prices of $249,999.62,
$149,997.21, and $30,002.01, respectively. The remaining investors in the December 2023 Private Placement, who are not affiliated
with the Company but with whom the Company had a pre-existing relationship, subscribed to purchase an aggregate of 274,587 December
2023 Units at a purchase price per December 2023 Unit of $3.08, which is equal to the consolidated closing bid price for the Common
Shares as reported by Nasdaq on December 13, 2023. Gross proceeds to the Company from the December 2023 Private Placement were
approximately $1.29 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.25pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>November
2024 Private Placement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 13, 2024, the Company closed a non-brokered private placement (the &#8220;November 2024 Private Placement&#8221;) and
issued an aggregate of 2,199,602 units of the Company (the &#8220;November 2024 Units&#8221;). Each November 2024 Unit consists
of one Common Share, one Warrant (collectively, the &#8220;Series A Private Warrants&#8221;) to purchase one Common Share and
one-half of one Warrant to purchase one-half of one Common Share (the &#8220;Series B Private Warrants&#8221; and, together with
the Series A Private Warrants, the &#8220;November 2024 Private Warrants&#8221;). Each Series A Private Warrant is exercisable
into one Common Share (a &#8220;Series A Warrant Share&#8221;) at an exercise price of $1.75 per Series A Warrant Share at any
time on or after the date of issuance until November 13, 2026. Each Series B Private Warrant is exercisable into one Common Share
(a &#8220;Series B Warrant Share&#8221;) at an exercise price of $2.07 per Series B Warrant Share at any time beginning six months
and one day from the date of issuance until November 13, 2029. Messrs. Kehler and Smith subscribed to purchase an aggregate of
239,999 November 2024 Units in the November 2024 Private Placement and paid a purchase price of $1.7675 per November 2024 Unit
(the &#8220;November 2024 Insider Unit Price&#8221;) upon the closing of the November 2024 Private Placement. The November 2024
Insider Unit Price included $0.125 per November 2024 Private Warrant underlying each November 2024 Unit purchased by directors
of the Company. Messrs. Kehler and Smith purchased 56,577 November 2024 Units and 183,422 November 2024 Units, respectively, for
aggregate purchase prices of approximately $100,000 and $324,198, respectively. The remaining investors in the November 2024 Private
Placement, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, subscribed to purchase
an aggregate of 1,959,603 November 2024 Units at a purchase price per November 2024 Unit of $1.57. Gross proceeds to the Company
from the November 2024 Private Placement were approximately $3.5 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 22.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Review,
Approval or Ratification of Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as described below, the Company does not currently have in place any specific policy or procedure in respect of the review,
approval or ratification of any transaction required to be reported under Item 404(a) of Regulation S-K. Sections 147-153 of the
BCBCA set out rules and procedures applicable to all British Columbia corporations, pursuant to which a director presented with
a resolution in respect of any matter (including an equity issuance) in respect of which he/she has an interest must disclose
that interest in writing to the corporation&#8217;s board of directors prior to the approval of such matter. This procedure ensures
that each equity issuance to a director or officer of the Company is approved by all directors of the Company not involved in
such sale. All loan transactions from directors and officers are typically subject to review and approval by the Board prior to
acceptance and are documented in the meeting minutes or resolutions related to same. Under its charter, the Audit Committee is
responsible for reviewing and approving any related party transaction in advance of such transaction, unless the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 28; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Chief Financial
Officer or General Counsel determines that it is not practicable to wait until the next Audit Committee meeting, in which case
the related party transaction will be submitted to the Chair of the Audit Committee, who will have delegated authority to act
between Audit Committee meetings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #212529">The
Company&#8217;s Board consists of Messrs. Smith, Beling, Fulton, Oliver, Kehler, and Maselli and Ms. Guerrero-Mahon. The </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
<span style="color: #212529">utilizes the definition of &#8220;independent&#8221; as it is set forth in Nasdaq Listing Rule 5605(a)(2)
(&#8220;Rule 5605(a)(2)&#8221;) and National Instrument 52-110&#160;<i>Audit Committees</i>&#160;(&#8220;NI 52-110&#8221;). Further,
the Board considers all relevant facts and circumstances in its determination of independence of all members of the Board (including
any relationships). Currently, Messrs. Beling, Fulton, Oliver, Kehler, and Maselli and Ms. Guerrero-Mahon are considered independent
directors. Mr. Michael J. Morris, who served as a director of the Company during fiscal 2025, was previously determined by the
Board to be an independent director.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          14.</span></td><td style="padding-right: 1.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a065"></span>PRINCIPAL
                                         ACCOUNTANT FEES AND SERVICES</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in">The following
table presents fees for professional services rendered by Deloitte &amp; Touche LLP for the fiscal year ended June 30, 2025 and
Deloitte &amp; Touche LLP and BDO USA, P.C. for the fiscal year ended June 30, 2024 for the audit of the Company&#8217;s annual
consolidated financial statements and review of consolidated financial statements included in the Company&#8217;s filings and fees
billed for other services rendered by the firms during those periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Fiscal Year Ending June 30,</span></td>
    <td style="vertical-align: top; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Audit Fees<sup>(1)</sup> ($)</span></td>
    <td style="vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Audit-Related Fees<sup>(2)</sup> ($)</span></td>
    <td style="vertical-align: top; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Tax Fees<sup>(3)</sup> ($)</span></td>
    <td style="vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">All Other Fees<sup>(4)</sup> ($)</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span style="text-decoration: underline">2025</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Deloitte</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">601,274</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">601,309</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">94,016</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#8212;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span style="text-decoration: underline">2024</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">Deloitte</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">1,092,834</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">34,125</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#8212;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#8212;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCECFF">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">BDO</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">132,500</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">95,599</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">48,263</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt">&#8212;</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.5pt; text-align: justify; text-indent: 0.25in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 31.5pt">(1)</td><td style="text-align: justify">&#8220;Audit Fees&#8221; consist of fees billed, or to be billed, for professional services
rendered for the audit of our annual consolidated financial statements and reviews of our interim financial statements included
in quarterly reports and services normally provided by our independent registered public accounting firm in connection with statutory
filings.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 31.5pt">(2)</td><td style="text-align: justify">&#8220;Audit-Related Fees&#8221; consist of fees billed, or to be billed, related to agreed-upon
procedures and services, including for comfort letters, normally provided by our independent registered public accounting firm
in connection with debt offerings or regulatory filings.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 31.5pt">(3)</td><td style="text-align: justify">&#8220;Tax Fees&#8221; include fees for all tax services other than those included in &#8220;Audit
Fees&#8221; and &#8220;Audit-Related Fees.&#8221; This category includes fees for tax compliance, tax planning, and tax advice.
Tax planning and tax advice include assistance with tax audits and appeals, tax advice related to mergers and acquisitions, and
requests for rulings or technical advice from tax authorities. For the financial year ended June 30, 2025, these tax services included
the preparation of Canadian and U.S. federal and state tax returns and tax planning and tax advice services.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;All
                                         Other Fees&#8221; includes all other non-audit services.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-approval
Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
policy of the Audit Committee has been to pre-approve all audit, audit-related and non-audit services performed by our independent
auditors and to subsequently review the actual fees and expenses paid to our independent auditors. Accordingly, the Audit Committee
pre-approved all audit, audit-related and non-audit services performed by Deloitte &amp; Touche LLP and BDO USA, P.C. and subsequently reviewed
the actual fees and expenses paid for these services. The Audit Committee has determined that the fees paid to Deloitte &amp;
Touche LLP for services are compatible with maintaining Deloitte &amp; Touche LLP&#8217;s independence as our auditor. All of
the services provided during the years ended June 30, 2025 and 2024, were approved by the Audit Committee pursuant to paragraph
(c)(7)(i)(C) of Rule 2-01 of Regulation S-X.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a066"></span>PART
IV&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
                          15.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a067"></span>EXHIBITS
                                         AND FINANCIAL STATEMENT SCHEDULES&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are filed as a part of this report:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;
<b><i>Financial Statements</i>&#160;&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-indent: -24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 24.45pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Consolidated Financial Statements, together with the report thereon of Deloitte &amp;
                                         Touche LLP, dated September 11, 2025
                                         are included as part of Item&#160;8, &#8220;Financial Statements and Supplementary Data,&#8221;
                                         commencing on page 59 above.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 80%; background-color: white; border-collapse: collapse; margin-left: 0.6in">
<tr style="vertical-align: bottom">
    <td style="width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.1in; text-indent: -0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b001">Report of Independent Registered Public Accounting Firms</a><br/>
    &#160;<a href="#b001">(Deloitte &amp; Touche LLP; Denver, Colorado; PCAOB ID#34)</a>&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b002">Consolidated Balance Sheets</a>&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b003">Consolidated Statements of Operations and Comprehensive Loss</a>&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b004">Consolidated Statements of Cash Flows</a>&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b005">Consolidated Statements of Shareholders&#8217; (Deficit) Equity and Redeemable Noncontrolling Interest</a>&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-left: 12pt; text-indent: -12pt">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 12pt; text-indent: -12pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b006">Notes to Consolidated Financial Statements</a>&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></td><td style="padding-right: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exhibits</i></b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
No.</b>&#160;</span></p></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 83%"><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b>&#160;</span></p></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh2-1.htm"><span style="color: #0000EE">2.1(1)**</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh2-1.htm">Business
    Combination Agreement, dated September 25, 2022, by and among NioCorp Developments Ltd., GX Acquisition Corp. II and Big Red
    Merger Sub Ltd</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename2.htm"><span style="color: #0000EE">3.1(2)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename2.htm"><span style="color: #0000EE">Notice
    of Articles of NioCorp Developments Ltd., dated April 5, 2016</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename3.htm"><span style="color: #0000EE">3.2(2)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename3.htm"><span style="color: #0000EE">Articles
    of NioCorp Developments Ltd., as amended, effective as of January 27, 2015</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh3-1.htm"><span style="color: #0000EE">3.3(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh3-1.htm"><span style="color: #0000EE">Amendment
    to Articles, effective March 17, 2023</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-1.htm">4.1(4)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598221000044/sf0095h_ex4-1.htm">Convertible
    Security Funding Agreement, dated February 16, 2021, between the Company and Lind Global Asset Management III, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722000259/n2574_x23exh10-2.htm">4.2(5)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722000259/n2574_x23exh10-2.htm">Amendment
    #1 to Convertible Security Funding Agreement, dated December 2, 2021, between the Company and Lind Global Asset Management
    III, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001757/n2574s4_ex4-17waiveconsent.htm">4.3(6)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001757/n2574s4_ex4-17waiveconsent.htm">Waiver
    and Consent Agreement, dated September 25, 2022, between NioCorp Developments Ltd. and Lind Global Asset Management III, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex4-5.htm">4.4(7)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex4-5.htm">Form of Lind Contingent Consent Warrants</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-1.htm"><span style="color: #0000EE">4.5(1)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-1.htm"><span style="color: #0000EE">Sponsor
    Support Agreement, dated as of September 25, 2022, by and among GX Acquisition Corp. II, NioCorp Developments Ltd., GX Sponsor
    II LLC, in its capacity as a shareholder of GX Acquisition Corp. II, and certain other shareholders of GX Acquisition Corp.
    II</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-5.htm">4.6(8)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-5.htm"><span style="color: #0000EE">Joinder
    to Sponsor Support Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd. and each of the Holders party
    thereto</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-1.htm"><span style="color: #0000EE">4.7(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-1.htm">Amended
    and Restated Registration Rights Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., GX Acquisition
    Corp. II, GX Sponsor II LLC, certain holders of the common shares of the NioCorp Developments Ltd. listed on Schedule 1 thereto,
    certain current and former stockholders of GX Acquisition Corp. II, and other persons and entities listed on Schedule 2 thereto</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-2.htm"><span style="color: #0000EE">4.8(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-2.htm"><span style="color: #0000EE">Registration
    Rights Agreement Joinder, dated as of March 17, 2023, by and among NioCorp Developments Ltd. and each of the parties listed
    on Schedule A thereto</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-3.htm"><span style="color: #0000EE">4.9(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh10-3.htm"><span style="color: #0000EE">Exchange
    Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., GX Acquisition Corp. II and GX Sponsor II LLC</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-9.htm">4.10(8)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000670/exh4-9.htm"><span style="color: #0000EE">Joinder
    to Exchange Agreement, dated as of March 17, 2023, by and among NioCorp Developments Ltd., Elk Creek Resources Corp (f/k/a
    GX Acquisition Corp. II) and each of the Holders party thereto</span></a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 30; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1826669/000121390021017023/ea138188ex4-1gxacquisit2.htm"><span style="color: #0000EE">4.11(9)</span></a></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 83%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1826669/000121390021017023/ea138188ex4-1gxacquisit2.htm"><span style="color: #0000EE">Warrant
    Agreement, dated March 17, 2021, by and between GX Acquisition Corp. II and Continental Stock Transfer &amp; Trust Company</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">4.12(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">Assignment,
    Assumption and Amendment Agreement, dated as of March 17, 2023, by and among GX Acquisition Corp. II, NioCorp Developments
    Ltd., Continental Stock Transfer &amp; Trust Company, as the existing Warrant Agent, and Computershare Inc. and its affiliate
    Computershare Trust Company, N.A., as the successor Warrant Agent</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">4.13(3)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000458/exh4-2.htm"><span style="color: #0000EE">Form
    of Warrant (included in Exhibit 4.12)</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-4.htm"><span style="background-color: white">4.14(10)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh4-4.htm">Registration
    Rights Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="background-color: white">4.15(11)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-2subscription.htm"><span style="background-color: white">Form
    of Subscription Agreement in respect of units issued in September 2023</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="background-color: white">4.16(11)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001523/n2574x155_exh4-1warrant.htm"><span style="background-color: white">Form
    of Warrants issued in September 2023</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723002204/n2574_x184exh4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.17(12)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue">&#160;</span></td>

    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723002204/n2574_x184exh4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">Form of Subscription Agreement in respect of units issued in December 2023</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723002204/n2574_x184exh4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.18(12)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723002204/n2574_x184exh4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">Form of Warrants issued in December 2023</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.19(13)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">Securities Purchase Agreement, dated as of April 11, 2024, by and between NioCorp Developments Ltd. and each of YA II PN, Ltd. and Lind Global Fund II LP</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-1.htm#st-a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.20(13)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-1.htm#st-a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">Form of Common Stock Purchase Warrant (included in Exhibit 4.19)</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.21(13)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">Global Guaranty Agreement, dated as of April 11, 2024, by Elk Creek Resources Corporation and 0896800 B.C. Ltd.</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.22(13)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000818/exh10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">Registration Rights Agreement, dated as of April 11, 2024, by and between NioCorp Developments Ltd. and each of YA II PN, Ltd. and Lind Global Fund II LP</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001294/exh4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.23(14)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001294/exh4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">Form of Subscription Agreement in respect of units issued in June 2024</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001294/exh4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">4.24(14)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001294/exh4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">Form of Warrants issued in June 2024</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh1_1-underwriting.htm">4.25(15)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh1_1-underwriting.htm">Underwriting Agreement, dated as of November 3, 2024, by and between NioCorp Developments Ltd. and Maxim Group LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_1-warrantagency.htm">4.26(15)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_1-warrantagency.htm">Warrant Agency Agreement, dated as of November 5, 2024, by and between NioCorp Developments Ltd., Computershare Inc. and Computershare Trust Company, N.A.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_2-seriesawarrant.htm">4.27(15)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_2-seriesawarrant.htm">Form of November 2024 Series A Public Warrant</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_3-seriesbwarrant.htm">4.28(15)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002341/exh4_3-seriesbwarrant.htm">Form of November 2024 Series B Public Warrant</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002408/n2574_x224exh4-8.htm">4.29(16)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002408/n2574_x224exh4-8.htm">Form of Subscription Agreement in respect of units issued in November 2024</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002408/n2574_x224exh4-9.htm">4.30(16)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002408/n2574_x224exh4-9.htm">Form of November 2024 Series A Private Warrant</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002408/n2574_x224exh4-10.htm">4.31(16)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724002408/n2574_x224exh4-10.htm">Form of November 2024 Series B Private Warrant</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725000227/exh_1-1.htm">4.32(17)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725000227/exh_1-1.htm">Underwriting Agreement, dated as of January 29, 2025, by and between NioCorp Developments Ltd. and Maxim Group LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725000227/exh_4-1.htm">4.33(17)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725000227/exh_4-1.htm">Form of January 2025 Series A Warrant</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725000227/exh_4-2.htm">4.34(17)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725000227/exh_4-2.htm">Form of January 2025 Series B Warrant</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725001179/exh1-1_ua.htm">4.35(18)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725001179/exh1-1_ua.htm">Underwriting Agreement, dated as of April 17, 2025, by and between NioCorp Developments Ltd. and Maxim Group LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725001179/exh4-1_prefundedwarrant.htm">4.36(18)</a></span></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725001179/exh4-1_prefundedwarrant.htm">Form of April 2025 Pre-Funded Warrant</a></span></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex4-37.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">4.37</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex4-37.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">Description
    of Securities</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename9.htm">10.1(2)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416114498/filename9.htm">Consulting
    Agreement, dated May 13, 2014, between the Company and KMSmith, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-3.htm">10.2(19)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-3.htm">Amendment
    to Contract, dated September 1, 2019, between the Company and KMSmith, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-4.htm">10.3(19)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-4.htm">Contract
    Assignment and Novation Agreement, dated as of August 31, 2020, among the Company, KMSmith, LLC and 76 Resources, Inc.</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949721001306/exh10-5agreement.htm">10.4(20)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949721001306/exh10-5agreement.htm">Contract
    Assignment and Novation Agreement, dated as of August 1, 2021, among the Company, 76 Resources, Inc. and 76 Resources, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001504/exh10-6_amndtmnt.htm">10.5(21)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723001504/exh10-6_amndtmnt.htm">Amendment
    to Contract, dated April 1, 2023, between the Company and 76 Resources, LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416122587/v448164_ex10-3.htm">10.6(22)*</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000114420416122587/v448164_ex10-3.htm">Offtake
    agreement, dated June 13, 2016, between the Company and CMC Cometals, a division of Commercial Metals Company</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001717/n2574_x60ex10-7.htm">10.7(23)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001717/n2574_x60ex10-7.htm">Amendment
    No. 1 to Offtake Agreement, dated April 13, 2020, between the Company and Traxys North America LLC, as assignee</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417004839/s107345_ex10-4.htm">10.8(24)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000161577417004839/s107345_ex10-4.htm">Offtake
    agreement with ThyssenKrupp Metallurgical Products GmbH</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-8.htm">10.9(19)*,
    **</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-8.htm">Woltemath
    003J Amended and Restated Option to Purchase, dated January 4, 2017, among ECRC and Victor L. and Juanita E. Woltemath</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-9.htm">10.10(19)*,
    **</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000178598220000846/sf0013h_ex10-9.htm">Woltemath
    003J Extension to Option to Purchase, dated December 23, 2019, among ECRC and Victor L. and Juanita E. Woltemath</a></span></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex10-11.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11*, **</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex10-11.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woltemath 003J Second Extension to Option to
    Purchase, dated December 9, 2024, between ECRC and Juanita E. Woltemath</span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh10-1.htm"><span style="color: #0000EE">10.12(10)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949723000085/n2574_x77exh10-1.htm"><span style="color: #0000EE">Standby
    Equity Purchase Agreement, dated as of January 26, 2023, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000948/exh10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="color: #0000EE">10.13(25)</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000948/exh10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment #1 to Standby Equity Purchase Agreement, dated as of May 3, 2024, by and between NioCorp Developments Ltd. and YA II PN, Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000458/exh10-4.htm">10.14(3)#</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/0001512228/000153949723000458/exh10-4.htm"><span style="background-color: white">Form
    of Director and Officer Indemnification Agreement</span></a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 31; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-3.htm"><span style="background-color: white">10.15(1)#</span></a></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 83%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-3.htm"><span style="background-color: white">Employment
    Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Neal Shah</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-4.htm"><span style="background-color: white">10.16(1)#</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-4.htm"><span style="background-color: white">Employment
    Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Scott Honan</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-5.htm"><span style="background-color: white">10.17(1)#</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-5.htm"><span style="background-color: white">Employment
    Agreement, dated as of September 25, 2022, by and between Elk Creek Resources Corporation and Jim Sims</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-6.htm"><span style="background-color: white">10.18(1)#</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001611/n2574_x43exh10-6.htm"><span style="background-color: white">Form
    of Restrictive Covenant Agreement</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000066/n2574_x188exh10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="background-color: white">10.19(26)#</span></span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724000066/n2574_x188exh10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: blue"><span style="text-decoration: underline">NioCorp Developments Ltd. Long-Term Incentive Plan, as amended</span></span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-1.htm">10.20(27)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-1.htm">Loan
    Agreement, dated as of September 11, 2024, between the Company and Mark Smith</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-2.htm">10.21(27)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001909/n2574_x218exh10-2.htm">Security
    Agreement, dated as of September 11, 2024, between the Company and Mark Smith</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725001918/exh1-1_paa.htm">10.22(28)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949725001918/exh1-1_paa.htm">Placement Agency Agreement, dated as of July 17, 2025, by and between NioCorp Developments Ltd. and Maxim Group LLC</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex19-1.htm">19.1(7)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex19-1.htm">NioCorp Developments Ltd. Insider Trading Policy</a></span></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex21-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex21-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries
    of NioCorp Developments Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Deloitte &amp; Touche LLP</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Dahrouge Geological Consulting USA Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.4</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Understood Mineral Resources Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.5</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Optimize Group Inc.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.6</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Tetra Tech</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-7.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.7</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-7.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Adrian Brown Consultants Inc.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-8.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.8</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-8.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Magemi Mining Inc.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-9.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.9</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-9.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of L3 Process Development</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-10.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.10</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-10.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Olsson</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-11.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.11</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-11.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of A2GC</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-12.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.12</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-12.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Metallurgy Concept Solutions</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-13.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.13</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-13.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Scott Honan, M.Sc., SME-RM, NioCorp</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-14.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.14</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-14.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Dumas Contracting Ltd.</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-15.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.15</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-15.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Mahmood Khwaja, P.E., CDM Smith</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex23-16.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.16</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex23-16.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Wynand Marx, M.Eng., BBE Consulting</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex31-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex31-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex31-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex31-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex32-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex32-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
<tr style="vertical-align: top">
    <td><a href="n2574_x280ex32-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></a></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><a href="n2574_x280ex32-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh96-1.htm"><span style="color: #0000EE">96.1(29)</span></a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949722001510/n2574_x36exh96-1.htm"><span style="color: #0000EE">S-K
    1300 Elk Creek Technical Report Summary</span></a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex97-1.htm">97.1(7)</a></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1512228/000153949724001980/n2574_x219ex97-1.htm">Compensation Clawback Policy</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS(30)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Instance Document</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH(30)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Schema</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL(30)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Calculations</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF(30)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Definitions</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB(30)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Labels</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE(30)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL Taxonomy Extension &#8211; Presentations</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted
    as Inline XBRL and contained in Exhibit 101)</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management compensation
    plan, arrangement or agreement.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.3in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions
    of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, which portions will be furnished to the
    Securities and Exchange Commission upon request.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.3in; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted exhibit will
    be furnished to the Securities and Exchange Commission upon request.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on September
    29, 2022 and incorporated herein by reference. </span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Draft Registration Statement on Form S-1 (Registration No. 377-01354) submitted to the
    SEC on July 26, 2016 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on March 17,
    2023 and incorporated herein by reference. </span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 32; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.3in; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on February
    17, 2021 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 10-Q (File No. 000-55710) filed with the SEC on February
    4, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Registration Statement on Form S-4 (Registration No. 333-268227) filed with the SEC on
    November 7, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 001-41655) filed with the SEC on September 23, 2024
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Registration Statement on Form S-3 (File No. 333-271268) filed with the SEC on April
    14, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to Elk Creek Resources Corp.&#8217;s (f/k/a GX Acquisition Corp. II) Current Report on Form 8-K (File No. 001-40226)
    filed with the SEC on March 22, 2021 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 000-55710) filed with the SEC on January 27, 2023
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on September 1, 2023
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on December 20, 2023
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on April 12, 2024
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on June 24, 2024 and
    incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on November 5, 2024
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q (File No. 001-41655) filed with the SEC on November 13,
    2024 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on January 31, 2025
    and incorporated herein by reference</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on April 21, 2025
    and incorporated herein by reference</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(19)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September 16, 2020
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September 8, 2021
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 on Form S-1
    (File No. 333-271268) filed with the SEC on August 22, 2023 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Registration Statement on Form S-1 (Registration No. 333-213451) filed with the
    SEC on September 2, 2016 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to Amendment No. 1 to the Company&#8217;s Annual Report on Form 10-K/A (File No. 000-55710) filed with the SEC
    on October 31, 2022 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on August 29,
    2017 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on May 3, 2024
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on January 22,
    2024 and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(27)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on September 11, 2024
    and incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(28)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed
    as an exhibit to the Company&#8217;s Current Report on Form 8-K (File No. 001-41655) filed with the SEC on July 18, 2025 and
    incorporated herein by reference.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29)</span></td>
    <td style="text-align: justify; padding-bottom: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously
    filed as an exhibit to the Company&#8217;s Annual Report on Form 10-K (File No. 000-55710) filed with the SEC on September
    6, 2022 and incorporated herein by reference.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 33; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submitted
    Electronically Herewith. Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting
    Language): (i) the Consolidated Balance Sheets at June 30, 2025 and June 30, 2024, (ii) the Consolidated Statements of Operations
    and Comprehensive Loss for the years ended June 30, 2025 and 2024, (iii) the Consolidated Statements of Cash Flows for the
    years ended June 30, 2025 and 2024, (iv) the Consolidated Statements of Shareholders&#8217; Equity (Deficit) and Redeemable
    Noncontrolling Interest for the years ended June 30, 2025 and 2024, (v) the Notes to the Consolidated Financial Statements.</span></td></tr>
<tr>
    <td style="width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.8in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;16.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a068"></span>FORM
                                         10&#8211;K SUMMARY&#160;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a069"></span>SIGNATURES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NIOCORP DEVELOPMENTS LTD.</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Neal
    Shah</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal
Shah&#160;&#160;</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer&#160;</span></p></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 11, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the registrant and in the capacities indicated on September 11, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.75pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mark
    A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer
    (Principal</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark A. Smith</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Officer and Authorized
    U.S. Representative)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and Chairman of the Board of Directors</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Neal
    Shah</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer (Principal
    Financial and</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neal Shah</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Officer)</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
David C. Beling&#160;</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David C. Beling</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><p style="border-bottom: black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Anthony W. Fulton&#160;</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony W. Fulton</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Nilsa
    Guerrero-Mahon</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nilsa Guerrero-Mahon</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Dean
    C. Kehler</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dean C. Kehler</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Michael G. Maselli</span></td>
    <td style="vertical-align: top; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael G. Maselli</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Peter
    Oliver</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Oliver</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 35; Value: 76 -->
    <div style="border-bottom: Black 2pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt">&#160;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->

<p style="margin: 0"></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.37
<SEQUENCE>2
<FILENAME>n2574_x280ex4-37.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.37</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>DESCRIPTION
OF Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Common Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The authorized capital of NioCorp Developments
Ltd., a British Columbia corporation (the &ldquo;Company&rdquo;), consists of an unlimited number of common shares, without par
value, of the Company (the &ldquo;Common Shares&rdquo;). The holders of Common Shares are entitled to receive notice of and attend
all meetings of shareholders, with each Common Share held entitling the holder to one (1) vote on any resolution to be passed at
such shareholder meetings. The holders of Common Shares are entitled to dividends if, as and when declared by the Company&rsquo;s
Board of Directors. The Common Shares are entitled, upon liquidation, dissolution, or winding up of the Company, to receive the
remaining assets of the Company available for distribution to shareholders. There are no pre-emptive, conversion, or redemption
rights attached to the Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Exchange Controls</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">There are no governmental laws, decrees,
or regulations in Canada that restrict the export or import of capital, including foreign exchange controls, or that affect the
remittance of dividends, interest or other payments to non-resident holders of the securities of the Company, other than as discussed
below and Canadian withholding tax. See &ldquo;&mdash;<I>Certain Canadian Federal Income Tax Considerations for U.S. Residents</I>&rdquo;
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Competition Act</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Limitations on the ability to acquire and
hold Common Shares may be imposed by the Competition Act (Canada). This legislation permits the Commissioner of Competition of
Canada (the &ldquo;Commissioner&rdquo;) to review any acquisition of a significant interest in the Company. This legislation grants
the Commissioner jurisdiction to challenge such an acquisition before the Canadian Competition Tribunal if the Commissioner believes
that it would, or would be likely to, result in a substantial lessening or prevention of competition in any market in Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Investment Canada Act</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Investment Canada Act subjects an acquisition
of control of a Canadian business by a non-Canadian to government notification or review depending on whether the relevant financial
threshold (based on enterprise value or asset value of the company), as calculated pursuant to the legislation, exceeds a threshold
amount. A reviewable acquisition may not proceed unless the relevant minister is satisfied that the investment is likely to result
in a net benefit to Canada. Under the national-security-review regime in the Investment Canada Act, review on a discretionary basis
may also be undertaken by the federal government in respect of a broad range of investments by a non-Canadian. No financial threshold
applies to a national security review. The relevant test is whether such investment by a non-Canadian could be &ldquo;injurious
to national security.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Certain Canadian Federal Income Tax Considerations for
U.S. Residents</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following generally summarizes certain Canadian federal income tax consequences generally applicable under the Income Tax Act (Canada)
and the regulations enacted thereunder (collectively, the &ldquo;Canadian Tax Act&rdquo;) and the <I>Canada-United States Tax Convention
(1980)</I> (the &ldquo;Convention&rdquo;) to the holding and disposition of Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Comment is restricted
to holders of Common Shares each of whom, at all material times for the purposes of the Canadian Tax Act and the Convention, (i)
is resident solely in the U.S. for tax purposes, (ii) is a &ldquo;qualifying person&rdquo; under and entitled to the benefits of
the Convention, (iii) holds all Common Shares as capital property, (iv) deals at arm&rsquo;s length with and is not affiliated
with the Company, (v) does not and is not deemed to use or hold any Common Shares in a business carried on in Canada, (vi) is not
an insurer that carries on business in Canada and elsewhere, (vii) is not an &ldquo;authorized foreign bank&rdquo; (as defined
in the Canadian Tax Act), and (viii) has not entered into a &ldquo;derivative forward agreement&rdquo;, &ldquo;synthetic equity
arrangement&rdquo; or &ldquo;synthetic disposition arrangement&rdquo; (each as defined in the Canadian Tax Act) with respect to
the Common Shares (each such holder, a &ldquo;U.S. Resident Holder&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Certain U.S.-resident
entities that are fiscally transparent for U.S. federal income tax purposes (including limited liability companies) may not in
all circumstances be entitled to the benefits of the Convention. Members of or holders of an interest in such an entity that holds
Common Shares should consult their own tax advisers regarding the extent, if any, to which the benefits of the Convention will
apply to the entity in respect of its Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Generally, a
U.S. Resident Holder&rsquo;s Common Shares will be considered to be capital property of such holder provided that the U.S. Resident
Holder is not a trader or dealer in securities, did not acquire, hold, or dispose of the Common Shares in one or more transactions
considered to be an adventure or concern in the nature of trade (i.e. speculation), and does not hold the Common Shares in the
course of carrying on a business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">This summary
is based on the current provisions of the Canadian Tax Act and the Convention in effect as of the date prior to the date hereof,
all specific proposals to amend the Canadian Tax Act and Convention publicly announced by or on behalf of the Minister of Finance
(Canada) prior to the date hereof, and the current published administrative policies and assessing practices of the Canada Revenue
Agency (the &ldquo;CRA&rdquo;). It is assumed that all such amendments will be enacted as currently proposed, and that there will
be no other material change to any applicable law or administrative policy or assessing practice, whether by way of judicial, legislative
or governmental decision or action, although no assurance can be given in these respects. Except as otherwise expressly provided,
this summary does not take into account any provincial, territorial, or foreign tax considerations, which may differ materially
from those set out herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.25pt; text-align: justify; text-indent: 0.25in"><B>This
summary is of a general nature only, is not exhaustive of all possible Canadian federal income tax considerations and is not intended
to be and should not be construed as legal or tax advice to any particular U.S. Resident Holder. U.S. Resident Holders are urged
to consult their own tax advisers for advice with respect to their particular circumstances. The discussion below is qualified
accordingly.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1.25pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">A U.S. Resident
Holder who disposes or is deemed to dispose of one or more Common Shares generally should not incur any liability for Canadian
federal income tax in respect of any capital gain arising as a consequence of the disposition, unless the Common Shares constitute
&ldquo;taxable Canadian property&rdquo; (as defined in the Canadian Tax Act) of the U.S. Resident Holder at the time of disposition
and the U.S. Resident Holder is not entitled to relief under the Convention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">Generally, a
U.S. Resident Holder&rsquo;s Common Shares will not constitute &ldquo;taxable Canadian property&rdquo; of such holder at a particular
time at which the Common Shares are listed on a &ldquo;designated stock exchange&rdquo; (which currently includes Nasdaq) unless
at any time during the 60-month period that ends at the particular time both of the following conditions are concurrently met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 13.5pt">1.</TD><TD STYLE="text-align: justify; padding-right: 1.45pt">25% or more of the issued shares of any class of the capital stock of the
Company were owned by or belonged to one or any combination of:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.5pt"></TD><TD STYLE="width: 13.5pt">(a)</TD><TD STYLE="text-align: justify; padding-right: 1.25pt">the U.S. Resident Holder,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.5pt"></TD><TD STYLE="width: 13.5pt">(b)</TD><TD STYLE="text-align: justify; padding-right: 1.5pt">persons with whom the U.S. Resident Holder did not deal at arm&rsquo;s length,
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 31.5pt"></TD><TD STYLE="width: 13.5pt">(c)</TD><TD STYLE="text-align: justify; padding-right: 1.45pt">partnerships in which the U.S. Resident Holder or a person referred to in
clause (b) holds a membership interest directly or indirectly through one or more partnerships, and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 13.5pt"></TD><TD STYLE="width: 13.5pt">2.</TD><TD STYLE="text-align: justify; padding-right: 1.5pt">more than 50% of the fair market value of the Common Shares was derived directly
or indirectly from, one or any combination of, real or immovable property situated in Canada, &ldquo;Canadian resource properties&rdquo;
(as defined in the Canadian Tax Act), &ldquo;timber resource properties&rdquo; (as defined in the Canadian Tax Act), or options
in respect of, or interests in any of the foregoing, whether or not the property exists.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify; text-indent: 0.25in">Common Shares
may also be deemed to be &ldquo;taxable Canadian property&rdquo; in certain circumstances set out in the Canadian Tax Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in">A U.S. Resident
Holder to whom the Company pays or credits or is deemed to pay or credit a dividend on such holder&rsquo;s Common Shares will be
subject to Canadian withholding tax, and the Company will be required to withhold the tax from the dividend and remit it to the
CRA for the holder&rsquo;s account. The rate of withholding tax under the Canadian Tax Act is 25% of the gross amount of the dividend,
but should generally be reduced under the Convention to 15% (or, if the U.S. Resident Holder is a company which is the beneficial
owner of at least 10% of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0">the voting stock of the Company, 5%) of the gross amount of the dividend. For this purpose, a company
that is a resident of the U.S. for purposes of the Canadian Tax Act and the Convention and is entitled to the benefits of the Convention
shall be considered to own the voting stock of the Company owned by an entity that is considered fiscally transparent under the
laws of the U.S. and that is not a resident of Canada, in proportion to such company&rsquo;s ownership interest in that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">From time to time, the Company has outstanding
Common Share purchase warrants (&ldquo;Warrants&rdquo;), with each Warrant exercisable for one Common Share. The exercise price
per Common Share and the number of Common Shares issuable upon exercise of Warrants is subject to adjustment upon the occurrence
of certain events, including, but not limited to, the following:<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the subdivision or re-division of the outstanding Common Shares into a greater number of Common Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the reduction, combination or consolidation of the outstanding Common Shares into a lesser number of Common Shares;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the issuance of Common Shares or securities exchangeable for, or convertible into, Common Shares to all or substantially all
of the holders of Common Shares by way of stock dividend or other distribution (other than a distribution of Common Shares upon
the exercise of Warrants or any outstanding options);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>the reorganization of the Company or the consolidation or merger or amalgamation of the Company with or into another corporate
body; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>a reclassification or other similar change to the outstanding Common Shares.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company generally will issue the Common
Shares issuable upon exercise of Warrants within five business days following its receipt of notice of exercise and payment of
the exercise price, subject to surrender of the Warrants. Prior to the exercise of any Warrants, holders of the Warrants will not
have any of the rights of holders of the Common Shares issuable upon exercise, including the right to vote or to receive any payments
of dividends on the Common Shares issuable upon exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NioCorp Assumed Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On March 17, 2023 (the &ldquo;Closing Date&rdquo;),
the Company closed a series of transactions (the &ldquo;GXII Transaction&rdquo;) pursuant to the Business Combination Agreement,
dated as of September 25, 2022 (the &ldquo;Business Combination Agreement&rdquo;), by and among the Company, GX Acquisition Corp.
II, a Delaware corporation (&ldquo;GXII&rdquo;), and Big Red Merger Sub Ltd., a Delaware corporation and a direct, wholly owned
subsidiary of the Company. In connection with the closing of the GXII Transaction (the &ldquo;Closing&rdquo;), pursuant to the
Business Combination Agreement, the Company assumed GXII&rsquo;s obligations under the Warrant Agreement, dated March 17, 2021
(the &ldquo;GXII Warrant Agreement&rdquo;), by and between GXII and Continental Stock Transfer &amp; Trust Company (&ldquo;CST&rdquo;),
as warrant agent, and each share purchase warrant of GXII thereunder (the &ldquo;GXII Warrants&rdquo;) that was issued and outstanding
immediately prior to the Closing Date was converted into one Warrant (the &ldquo;NioCorp Assumed Warrants&rdquo;) pursuant to the
GXII Warrant Agreement, as amended by an Assignment, Assumption and Amendment Agreement, dated the Closing Date (the GXII Warrant
Agreement, as so amended, the &ldquo;NioCorp Assumed Warrant Agreement&rdquo;), among the Company, GXII, CST, as existing warrant
agent, and Computershare Inc. and its affiliate Computershare Trust Company, N.A, together as successor warrant agent (the &ldquo;NioCorp
Assumed Warrant Agent&rdquo;). In connection with the Closing, NioCorp issued (a) 9,999,959 public NioCorp Assumed Warrants in
respect of the GXII Warrants that were publicly traded prior to the Closing and (b) 5,666,667 NioCorp Assumed Warrants to GX Sponsor
II LLC (the &ldquo;Sponsor&rdquo;) in respect of the GXII Warrants that it held prior to the Closing, which NioCorp Assumed Warrants
were subsequently distributed by the Sponsor to its members in connection with the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Both the public NioCorp Assumed Warrants
and the NioCorp Assumed Warrants issued to the Sponsor are subject to the terms of the NioCorp Assumed Warrant Agreement and are
identical, with certain exceptions applicable to the NioCorp Assumed Warrants issued to the Sponsor for so long as such NioCorp
Assumed Warrants are held by the Sponsor, its members, or their respective affiliates and other permitted transferees. In accordance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">with the NioCorp Assumed Warrant Agreement, any NioCorp Assumed Warrants issued to the Sponsor that are held by someone other than
the Sponsor, its members, or their respective affiliates and other permitted transferees, are treated as public NioCorp Assumed
Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each NioCorp Assumed Warrant is exercisable
on and after April 16, 2023 until its expiration for 1.11829212 Common Shares at a price of $11.50 per 1.11829212 Common Shares
(subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the like). Under the terms of
NioCorp Assumed Warrant Agreement, for so long as the NioCorp Assumed Warrants issued to the Sponsor are held by the Sponsor, its
members, or their respective affiliates and other permitted transferees, such holders have the right to elect to exercise those
NioCorp Assumed Warrants on a cashless basis. For such NioCorp Assumed Warrants exercised on a cashless basis after the Closing,
the holder will be entitled to pay the exercise price for those NioCorp Assumed Warrants by surrendering all or portion of the
cash and/or Common Shares (valued at their fair market value) into which those NioCorp Assumed Warrants are exercisable as shall
be elected by the holder. For this purpose, Common Shares so surrendered will be deemed to have a &ldquo;fair market value&rdquo;
equal to the average reported last sale price of the Common Shares for the 10 trading days ending on the third trading day prior
to the date of exercise of the applicable NioCorp Assumed Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants will expire
at 5:00 p.m., New York City time, on March 17, 2028 or earlier upon redemption or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will not be obligated to deliver
any Common Shares pursuant to the exercise of a NioCorp Assumed Warrant and will have no obligation to settle such exercise unless
a registration statement under the Securities Act with respect to the Common Shares underlying the NioCorp Assumed Warrants is
then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below
with respect to registration. No NioCorp Assumed Warrant will be exercisable and the Company will not be obligated to issue Common
Shares upon exercise of a NioCorp Assumed Warrant unless Common Shares issuable upon such exercise have been registered, qualified
or deemed to be exempt under the securities laws of the state of residence of the registered holder of the NioCorp Assumed Warrants.
In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a NioCorp Assumed
Warrant, the holder of such NioCorp Assumed Warrant will not be entitled to exercise such NioCorp Assumed Warrant and such NioCorp
Assumed Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any NioCorp
Assumed Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants, and the underlying
Common Shares issuable upon the exercise thereof, were registered under the Securities Act pursuant to the Company&rsquo;s registration
statement on Form S-4, originally filed on November 7, 2022, as subsequently amended, which was declared effective by the SEC on
February 8, 2023. The ongoing registered offering of the Common Shares underlying the NioCorp Assumed Warrants is being conducted
pursuant to the Company&rsquo;s registration statement on Form S-3, originally filed on April 14, 2023, as subsequently post-effectively
amended to convert such registration statement to Form S-1, which was declared effective on October 30, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company will have the right to call
the public NioCorp Assumed Warrants for redemption at any time following the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>in whole and not in part;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>at a price of $0.01 per NioCorp Assumed Warrant;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>upon not less than 30 days&rsquo; prior written notice of redemption (the &ldquo;30-day redemption period&rdquo;) to each public
NioCorp Assumed Warrant holder;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>if, and only if, the reported last sale price of the Common Shares equals or exceeds approximately $16.10 per share (subject
to certain adjustments) for any 20 trading days within a 30-trading day period commencing once the NioCorp Assumed Warrants become
exercisable and ending three business days before the Company sends the notice of redemption to the public NioCorp Assumed Warrant
holders; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD>if there is an effective registration statement covering the Common Shares issuable upon exercise of the NioCorp Assumed Warrants,
and a current prospectus relating thereto, available throughout the 30-day redemption period.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants issued to
the Sponsor are not redeemable by the Company for so long as such NioCorp Assumed Warrants are held by the Sponsor, its members,
or their respective affiliates or other permitted transferees. In addition, the Company may not exercise its redemption right if
the issuance of Common Shares upon exercise of the NioCorp Assumed Warrants is not exempt from registration or qualification under
applicable state blue sky laws or the Company is unable to effect such registration or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Company calls the public NioCorp
Assumed Warrants for redemption as described above, the Company will have the option to require any holder that wishes to exercise
its public NioCorp Assumed Warrant to do so on a &ldquo;cashless basis.&rdquo; In determining whether to require all holders to
exercise their public NioCorp Assumed Warrants on a &ldquo;cashless basis,&rdquo; the Company will consider, among other factors,
its cash position, the number of NioCorp Assumed Warrants that are outstanding and the dilutive effect on the Company&rsquo;s shareholders
of issuing the maximum number of Common Shares issuable upon the exercise of the NioCorp Assumed Warrants. If the Company takes
advantage of this option, all holders of public NioCorp Assumed Warrants would pay the exercise price by surrendering their NioCorp
Assumed Warrants for that number of Common Shares equal to the quotient obtained by dividing (x) the product of the number of Common
Shares underlying the public NioCorp Assumed Warrants, multiplied by the difference between the exercise price of the NioCorp Assumed
Warrants and the &ldquo;fair market value&rdquo; (defined below) by (y) the fair market value. The &ldquo;fair market value&rdquo;
shall mean the average reported last sale price of the Common Shares for the 10 trading days ending on the third trading day prior
to the date on which the notice of redemption is sent to the holders of public NioCorp Assumed Warrants. If the Company takes advantage
of this option, the notice of redemption will contain the information necessary to calculate the number of Common Shares to be
received upon exercise of the NioCorp Assumed Warrants, including the &ldquo;fair market value&rdquo; in such case. Requiring a
cashless exercise in this manner will reduce the number of Common Shares to be issued and thereby lessen the dilutive effect of
a redemption of the public NioCorp Assumed Warrants. If the Company calls the public NioCorp Assumed Warrants for redemption and
does not take advantage of this option, the Sponsor, its members, and their respective affiliates and other permitted transferees
would still be entitled to exercise their NioCorp Assumed Warrants for cash or on a cashless basis using the same formula described
above that other NioCorp Assumed Warrant holders would have been required to use had all NioCorp Assumed Warrant holders been required
to exercise their NioCorp Assumed Warrants on a cashless basis, as described in more detail below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A holder of a NioCorp Assumed Warrant may
notify the Company in writing in the event it elects to be subject to a requirement that such holder will not have the right to
exercise such NioCorp Assumed Warrant, to the extent that after giving effect to such exercise, such holder (together with such
holder&rsquo;s affiliates), to the NioCorp Assumed Warrant Agent&rsquo;s actual knowledge, would beneficially own in excess of
4.9% or 9.8% (or such other amount as a holder may specify) of the Common Shares outstanding immediately after giving effect to
such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants have certain
anti-dilution and adjustments rights upon certain events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants may be exercised
upon surrender of the certificate representing such NioCorp Assumed Warrants on or prior to the expiration date at the offices
of the NioCorp Assumed Warrant Agent, with the exercise form on the reverse side of such certificate completed and executed as
indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official
bank check payable to the order of the NioCorp Assumed Warrant Agent or by wire transfer, for the number of NioCorp Assumed Warrants
being exercised. The NioCorp Assumed Warrant holders will not have the rights or privileges of holders of Common Shares or any
attendant voting rights until they exercise their NioCorp Assumed Warrants and receive Common Shares. After the issuance of Common
Shares upon exercise of the NioCorp Assumed Warrants, each holder will be entitled to one (1) vote for each Common Share held of
record on all matters to be voted on by NioCorp shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If, upon exercise of the NioCorp Assumed
Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to
the nearest whole number of Common Shares to be issued to the NioCorp Assumed Warrant holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The NioCorp Assumed Warrants were issued
in registered form under the NioCorp Assumed Warrant Agreement. The NioCorp Assumed Warrant Agreement may be amended by the parties
thereto without the consent of any registered holder (i) for the purpose of curing any ambiguity, or curing, correcting or supplementing
any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">mistake, or adding or changing any other provisions with respect to matters or questions arising under NioCorp Assumed Warrant
Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the
registered holders of the NioCorp Assumed Warrants, and (ii) to provide for the delivery of such kind and amount of Common Shares
or other securities or property (including cash) receivable upon a reclassification, reorganization, merger or consolidation, or
upon a dissolution following any such sale or transfer, that the holder of NioCorp Assumed Warrants would have received if such
holder had exercised his, her or its NioCorp Assumed Warrants immediately prior to such event. All other modifications or amendments,
including any amendment to increase the warrant price or shorten the exercise period, shall require the vote or written consent
of the registered holders of a majority of the then outstanding public NioCorp Assumed Warrants. Any amendment solely to the NioCorp
Assumed Warrants issued to the Sponsor and that are held by the Sponsor, its members, or their respective affiliates or other permitted
transferees, shall require the vote or written consent of a majority of the holders of the then outstanding NioCorp Assumed Warrants
issued to the Sponsor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>3
<FILENAME>n2574_x280ex10-11.htm
<DESCRIPTION>WOLTEMATH 003J SECOND EXTENSION TO OPTION TO PURCHASE, DATED DECEMBER 9, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Exhibit 10.11</B></FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">CERTAIN INFORMATION HAS BEEN EXCLUDED FROM
THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND <BR>
WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE
OMITTED PORTIONS <BR>
OF THIS DOCUMENT ARE INDICATED BY [**].</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 16pt">Elk Creek
Resources Corp.</FONT><BR>
(the &ldquo;<B>Company</B>&rdquo;)&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">7000 South Yosemite, Suite 115&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Centennial, CO 80112</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">December 9, 2024 (&ldquo;<B>Effective Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Juanita E. Woltemath <BR>
62044 720 Rd.<BR>
Elk Creek, Nebraska 68348</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD><U>Second Extension of Option Period for Option to Purchase (&ldquo;<B>Second Extension Agreement</B>&rdquo;) </U></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Dear Mrs. Woltemath:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to
the Amended and Restated Option to Purchase dated January 4, 2017, including each exhibit, schedule and addendum thereto, together
with that certain Extension of Option Period for Option to Purchase dated December 23, 2019, each of which was executed among you
and your husband Victor (now deceased) and the Company (collectively, the &ldquo;<B>Original Option</B>&rdquo;, which is incorporated
and made a part of this Second Extension Agreement by this reference). Whenever used in this Second Extension Agreement, any reference
to &ldquo;you&rdquo; or &ldquo;Owner(s)&rdquo; shall mean and refer to Juanita E. Woltemath and Victor L. Woltemath, both individually
and collectively, as may be required to give effect to this Second Extension Agreement. Unless otherwise defined in this Second
Extension Agreement, all capitalized terms used herein shall be ascribed the meanings set forth in the Original Option.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Among its other terms,
the Original Option provides that the Option must be exercised during the Option Period (as defined in the Option), which, unless
extended, expires as of 11:59 p.m. (Central) on March 25, 2025. The Company and you wish to extend the Original Option and such
Option Period and to otherwise amend the Original Option as set forth herein. Please execute this letter in the space provided
below, understanding that in doing so, you and the Company&nbsp;are agreeing to be bound by the Original Option as amended by the
terms and provisions of this Second Extension Agreement as of the Effective Date. For avoidance of doubt, any reference in this
Second Extension Agreement to &ldquo;Option&rdquo; shall mean and refer to the Original Option as amended by this Second Extension
Agreement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">1.&nbsp;&nbsp;&nbsp;In
partial consideration of your execution of this Second Extension Agreement, the Company agrees to pay you, and you agree to accept,
the following payments (collectively &ldquo;<B>Second Extension Payment(s)</B>&rdquo;):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
aggregate payment in the amount of [**] payable as follows: (i) [**] to be paid to you contemporaneously with the execution of
this Second Extension Agreement by you and the</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0">Company, the receipt of which is hereby acknowledged, and (ii) [**] to be paid to
you after December 31, 2024, but on or before January 15, 2025.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise provided in paragraph 1(a) of this Second Extension Agreement, the Company may pay any Second Extension Payment identified
in paragraph 1(a) at any time on or prior to its due date. All the Second Extension Payments shall be made by check representing
good funds, wire transfer or transfer by ACH, as determined by Company. None of the Second Extension Payments shall be deducted
from the Purchase Price; provided, however, if the Option is exercised in respect of the Real Estate (as defined in the Original
Option) or if the Option is terminated by the Company prior to the due date for any Second Extension Payment(s) identified in Paragraph
1(b) above, the Company shall not be obligated to pay any such Second Extension Payment that becomes due after the date of any
termination of the Option by the Company or the date of Company&rsquo;s exercise and closing of the Option in respect of the entirety
of the Real Property.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">2.&nbsp;&nbsp;&nbsp;The
Original Option is hereby amended as necessary to effect the following:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Option Period is hereby extended through 11:59 p.m. (Central) on March 25, 2030 (the &ldquo;<B>Second Extended Option Period</B>&rdquo;),
and any reference in the Original Option to the expiration of any of: (i) the Option, (ii) the Option Period, (iii) the Option
Term, (iv) the term of the Option, (v) the Extended Option Period, or (vi) any similar reference shall mean and refer to the expiration
of the Second Extended Option Period.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Written
Harlow Lease:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Optionee
and you acknowledge that, there exists a written cash farming lease between Owners and Adam Harlow (&ldquo;Harlow&rdquo;), dated
December 16, 2019, permitting Harlow to farm crops on a certain portion of the Real Property consisting of approximately 183.9
acres (the &ldquo;Written Harlow Lease&rdquo;) for a term expiring March 28, 2025, subject in all cases to the terms and conditions
of this Option, including without limitation, the rights of Optionee and the obligations of Owners under and respect of Section
8 of the Original Option.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delete
Section 8(iii) of the Original Option in its entirety and insert in lieu thereof, the following:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><U>&ldquo;Written
Farm Leases</U>. For the duration of the Option Period, [other than the Written Harlow Lease], Owners agree not to enter into any
lease in respect of any portion of the Real Property other than a written farm lease on terms reasonably acceptable to Optionee
that is for a term no longer than one year, but will contain terms that such lease will immediately terminate upon notice of exercise
of the Option by Optionee.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delete
Section 8(iv) of the Original Option in its entirety and insert in lieu thereof, the following:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;If Optionee
exercises its Option during the term of any written farm lease with respect to the Real Property, then Owner agrees that as a result
of such termination,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0">Optionee shall, as Optionee&rsquo;s sole obligation and liability to Owner, tenant of Owner or to any other
person, be obligated to pay the following alternative amounts: (a) if, as of the date of the Notice of Exercise of Option, crops
have not been planted for the next ensuing crop season (i.e. on or after March 1 falling in any calendar year), Owner shall be
obligated to directly pay to Owner or any tenant of Owner, as applicable, the actual amounts expended thereby prior to the date
of the Notice of Exercise of Option by Owner or any tenant of Owner in preparation of the land for such ensuing crop season, but
without duplication of any payment of any type or amounts among them, or (b) if, as of the date of the Notice of Exercise of Option,
crops have been planted for the next ensuing crop season, Owner shall be obligated to directly pay to Owner or any tenant of Owner,
as applicable, an amount equal to the value of the growing or unharvested crops on the Real Property for such ensuing crop season,
plus the actual amounts, if any, expended by Owner or any tenant of Owner prior to the date of the Notice of Exercise of Option
in preparation of the land for the ensuing crop season immediately commencing thereafter, but, in all cases, without duplication
of any payment of any type or amounts among them.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company desires to update its address for notice purposes. The Original Option is hereby amended by deleting the Company&rsquo;s
address in Paragraph 14 and replacing it with the following:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Company: 7000
South Yosemite, Suite 115, Centennial, CO 80112&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You agree this is effective notice from
the Company of its change of address.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">To the extent the provisions set forth in
this Paragraph 2 conflict with any of the terms and conditions set forth in the Original Option, the provisions set forth in this
Paragraph 2 shall control.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delete
the verbiage in Paragraph 15(xi) in its entirety and insert in lieu thereof the word &ldquo;Reserved&rdquo;.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">3.&nbsp;&nbsp;&nbsp;All
dollar amounts expressed in the Option and in this Extension Agreement are to be paid in United States currency. All Second Extension
Payments will be considered to have been timely made if personally received by you on or before the due date or if, on or before
the due date, the Company sends the required payment to you at the address identified for you by application of paragraph 14 of
the Option by prepaid certified or registered mail, return receipt requested, or by Federal Express or other overnight courier,
as evidenced by a receipt for certified or registered mail, or Federal Express or other overnight courier date stamp.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">4.&nbsp;&nbsp;&nbsp;Without
limitation to any provisions in this Second Extension Agreement, you hereby reaffirm, covenant and represent that all representations
and warranties made by you in the Original Option and in this Second Extension are to the best of your knowledge true, accurate
and complete as of the Effective Date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">5.&nbsp;&nbsp;&nbsp;Contemporaneously
with the execution of this Second Extension Agreement by you and the Company, you and the Company also agree to execute the Second
Amendment to Memorandum of Option to Purchase substantially in the form of that attached to this Second Extension Agreement as</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0">Exhibit &ldquo;A&rdquo; and incorporated into this Second Extension Agreement by this reference. The Second Amendment to Memorandum
of Option to Purchase shall be recorded by the Company at the Company&rsquo;s expense in the appropriate records of the officials
of Johnson County, Nebraska. If the Option expires or is terminated, the Company shall record a release of the Second Amendment
to Memorandum of Option to Purchase.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">6.&nbsp;&nbsp;&nbsp;This
Second Extension Agreement, together with the Original Option, will be binding upon, and will inure to the benefit of and be enforceable
by, the parties hereto and each of their respective permitted assigns, grantees (and other transferees), successors, heirs, executors,
personal representatives and administrators. No assignment of this Second Extension Agreement by either party will be permitted
except to the extent that the Option is so assignable by such party and is duly assigned; provided, however, that upon any assignment
of the Option to any permitted assignee, this Third Extension Agreement shall be assigned together with the Original Option to
such assignee, in all cases in accordance with, and as permitted by, the terms set forth in the Option.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">7.&nbsp;&nbsp;&nbsp;This
Second Extension Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.&nbsp; Any executed signature page of any such counterpart, or any
facsimile or electronic PDF copy thereof, may be attached or appended by either party to any other counterpart to complete a fully
executed and original Second Extension Agreement.&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">8.&nbsp;&nbsp;&nbsp;All
provisions of this Second Extension Agreement shall be in full force and effect, commencing on the Effective Date and during the
Second Extended Option Period and thereafter to the extent necessary to give effect to terms and conditions set forth in this Second
Extension Agreement. Except to the extent expressly modified or amended by application of any provision of this Second Extension
Agreement, all covenants, terms, conditions and other provisions of the Original Option will continue and remain in full force
and effect during the Second Extended Option Period. In the event of any conflict between any provision of this Second Extension
Agreement and the Original Option, the provisions of this Second Extension Agreement shall control.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Best regards,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">ELK CREEK RESOURCES CORP., the Company</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 3%">By:</TD>
    <TD STYLE="width: 22%; border-bottom: Black 1pt solid">/s/ Scott Honan</TD>
    <TD STYLE="width: 75%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Name: Scott Honan&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Title: President</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">AGREED AND ACCEPTED:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Juanita E. Woltemath hereby execute this
Extension Agreement and approve the terms and conditions set forth herein, to be effective as of the Effective Date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid">/s/ Juanita E. Woltenmath</TD>
    <TD STYLE="width: 75%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Juanita E. Woltemath</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Acknowledgements and Exhibits to Follow</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">STATE OF</FONT></TD>
    <TD STYLE="width: 78%; border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Nebraska</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 73%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">) ss:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">COUNTY OF</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Johnson</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;)</FONT></TD></TR>
</TABLE>

</div><DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><IMG SRC="n2574ex1011img001.jpg" ALT=""></P>

</div><DIV STYLE='CLEAR:BOTH'></DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Before me, a Notary public qualified for
said County, personally came Juanita E. Woltemath, known to me to be the identical person(s) who signed the foregoing instrument,
and acknowledged the execution thereof by her to be her voluntary act and deed.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 90%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 27%">Witness my hand and notarial seal on </TD>
    <TD STYLE="width: 73%; padding-left: 0.125in; border-bottom: Black 1pt solid">December 9, 2024 </TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 90%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 18%">My Commission Expires: </TD>
    <TD STYLE="width: 44%; padding-left: 0.125in; border-bottom: Black 1pt solid">September 16, 2026</TD>
    <TD STYLE="width: 38%; padding-left: 0.125in; border-bottom: Black 1pt solid; text-align: center">/s/ Nicole
Wellensiek</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.125in; text-align: center">Notary Public</TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 15%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">STATE OF</FONT></TD>
    <TD STYLE="width: 78%; border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Nebraska</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 73%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;) ss:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">COUNTY OF</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Johnson</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;)</FONT></TD></TR>
</TABLE>

</div><DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 4.5in">&nbsp;</P>

</div><DIV STYLE='CLEAR:BOTH'></DIV>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Before me, a Notary public qualified for
said County, personally came Scott Honan, known to me to be the President of Elk Creek Resources Corp., a Nebraska corporation,
the identical person who signed the foregoing instrument, and acknowledged the execution thereof by him to be his voluntary act
and deed on behalf of the corporation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 90%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 27%">Witness my hand and notarial seal on </TD>
    <TD STYLE="width: 73%; padding-left: 0.125in; border-bottom: Black 1pt solid">December 9, 2024 </TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 90%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 18%">My Commission Expires: </TD>
    <TD STYLE="width: 44%; padding-left: 0.125in; border-bottom: Black 1pt solid">September 16, 2026</TD>
    <TD STYLE="width: 38%; padding-left: 0.125in; border-bottom: Black 1pt solid; text-align: center">/s/ Nicole
Wellensiek</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.125in; text-align: center">Notary Public</TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 56%">&nbsp;</TD>
    <TD STYLE="width: 44%"><IMG SRC="n2574ex1011img002.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>n2574_x280ex21-1.htm
<DESCRIPTION>SUBSIDIARIES OF NIOCORP DEVELOPMENTS LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
of Subsidiaries of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: #D9D9D9">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State/Province
    of </B><BR>
    <B>Formation</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800 B.C. Ltd.
    (&ldquo;0896800&rdquo;)</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Columbia</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk Creek Resources
    Corp.</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="padding-bottom: 8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.42%<SUP>(1)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp Technologies
    Limited</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United Kingdom</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 100%
    of Class A common stock owned by 0896800, and 3,934,031 Vested Shares and 3,391,596 Earnout Shares (each as defined in the
    Company&rsquo;s Annual Report on Form 10-K for the year ended June 30, 2025) held by third parties, and outstanding as of
    June 30, 2025.</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>n2574_x280ex23-1.htm
<DESCRIPTION>CONSENT OF DELOITTE & TOUCHE LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Exhibit 23.1</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">We
consent to the incorporation by reference in Registration Statement Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511,
333-270541, and 333-271266 on Form S-1, No. 333-280176 on Form S-3 and No. 333-222313 on Form S-8 of our report dated September 11,
2025, relating to the financial statements of NioCorp Developments Ltd. appearing in this Annual Report on Form 10-K for the year
ended June 30, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>/s/
DELOITTE &amp; TOUCHE LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Denver,
Colorado</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">September 11, 2025</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>6
<FILENAME>n2574_x280ex23-3.htm
<DESCRIPTION>CONSENT OF DAHROUGE GEOLOGICAL CONSULTING USA LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 23.3</FONT></P>





<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="n2574ex2303img001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. hereby consents to the public filing of Sections 1.1 to 1.5, 1.9 to 1.11, 2 to 6, 7.1 to 7.2, 8,
9.2, 9.3, 16, 18 to 21, 22.1, 22.3, 22.9 to 22.12, 23.1.1, and 23.1.9 (the &ldquo;Covered Sections&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2025
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s
Registration Statement on Form S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and
333-271266), Registration Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration
No. 333-222313) (collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge
Geological Consulting USA Ltd. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025
at Centennial, Colorado.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Trevor Mills</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trevor Mills, P.G., SME-RM</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Geologist / US Operations Manager</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dahrouge Geological Consulting USA Ltd.</FONT></TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>7
<FILENAME>n2574_x280ex23-4.htm
<DESCRIPTION>CONSENT OF UNDERSTOOD MINERAL RESOURCES LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.4</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2304img001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CONSENT
OF QUALIFIED PERSON</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Understood Mineral
Resources Ltd. hereby consents to the public filing of Sections 1.6, 9.1, 11 and 22.2 (the &ldquo;Covered Sections&rdquo;) of the
Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June
30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended
June 30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Understood Mineral
Resources Ltd. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement
on Form S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration
Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Understood Mineral
Resources Ltd. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the
Form 10-K, the Registration Statements and the Technical Report Summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Understood Mineral
Resources Ltd. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference
in the Registration Statements (the &ldquo;Disclosure&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Understood Mineral
Resources Ltd. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Signed and dated this 11th day of September, 2025 at 22 Middleton Crescent, Saskatoon, Saskatchewan, Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>/s/ Matt Batty</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid">Matt Batty, P.Geo</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Owner and Geostatistican</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Understood Mineral Resources Ltd.</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.5
<SEQUENCE>8
<FILENAME>n2574_x280ex23-5.htm
<DESCRIPTION>CONSENT OF OPTIMIZE GROUP INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.5</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2305img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CONSENT
OF QUALIFIED PERSON</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Optimize Group Inc.
hereby consents to the public filing of Sections 1.7, 12, 13.3 to 13.5, 15.7, 22.5 and 23.1.4 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Optimize Group Inc.
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-1
(Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the
&ldquo;Registration Statements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Optimize Group Inc.
also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as
defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form
10-K, the Registration Statements and the Technical Report Summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Optimize Group Inc.
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Optimize Group Inc.
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Signed and dated this 11th day of September, 2025 at Toronto, Ontario, Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>/s/ Tara Gilfillan</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid">Tara Gilfillan</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Founder and Executive Chair</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Optimize Group Inc.</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.6
<SEQUENCE>9
<FILENAME>n2574_x280ex23-6.htm
<DESCRIPTION>CONSENT OF TETRA TECH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.6</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2306img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CONSENT
OF QUALIFIED PERSON</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tetra Tech hereby consents
to the public filing of Sections 14.5, 15.1.1, 15.1.2, 15.2 to 15.4, 22.7 and 23.1.6 (the &ldquo;Covered Sections&rdquo;) of the
Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June
30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended
June 30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tetra Tech also consents
to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-1 (Registration
Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form S-3
(Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration
Statements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tetra Tech also consents
to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as defined in Subpart
1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K, the Registration
Statements and the Technical Report Summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tetra Tech also consents
to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration Statements
(the &ldquo;Disclosure&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tetra Tech certifies
that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information in the
Covered Sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Signed and dated this 11th day of September, 2025 at Salt Lake City, Utah.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">/s/ David R. Winters</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt; border-top: Black 1pt solid">David R. Winters, SE, PE</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Project Manager and Senior Principal Engineer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Tetra Tech</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.7
<SEQUENCE>10
<FILENAME>n2574_x280ex23-7.htm
<DESCRIPTION>CONSENT OF ADRIAN BROWN CONSULTANTS INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 5pt; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 23.7</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="n2574ex2307img001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. hereby consents to the public filing of Sections 7.4 and 13.2 (the &ldquo;Covered Sections&rdquo;) of the
Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of
June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June&nbsp;30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266),
Registration Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313)
(collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Brown Consultants Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025
at Denver, Colorado, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Adrian Brown</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian Brown, PE</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian Brown Consultants Inc.</FONT></TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.8
<SEQUENCE>11
<FILENAME>n2574_x280ex23-8.htm
<DESCRIPTION>CONSENT OF MAGEMI MINING INC.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 23.8</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-size: 10pt"><IMG SRC="n2574ex2308img001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. hereby consents to the public filing of Sections 10.1, 14.1.1, 14.2.1, 14.3.1, and 14.4.1 (the &ldquo;Covered Sections&rdquo;)
of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date
of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year
ended June 30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement
on Form S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration
Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference
in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi
Mining Inc. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025
at North York, Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Georgi Doundarov</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Georgi Doundarov, M.SC,
    P.Eng., PMP, CCP</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Magemi Mining Inc.</FONT></TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.9
<SEQUENCE>12
<FILENAME>n2574_x280ex23-9.htm
<DESCRIPTION>CONSENT OF L3 PROCESS DEVELOPMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 23.9</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left"><IMG SRC="n2574ex2309img001.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development hereby consents to the public filing of Sections 10.2, 10.2.1 to 10.2.3, 14.1.2, 14.1.4, 14.2.2, 14.2.4, 14.3.2,
14.3.4, 14.4.2, 14.4.4, 22.4, 22.6, 23.1.2, and 23.1.5 (the &ldquo;Covered Sections&rdquo;) of the Technical Report Summary titled
&ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical
Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2025 (the &ldquo;Form
10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266),
Registration Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313)
(collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3
Process Development certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents
the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025
at Salt Lake City.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eric Larochelle</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric Larochelle Ing.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Co-Owner - CEO</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L3 Process Development</FONT></TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.10
<SEQUENCE>13
<FILENAME>n2574_x280ex23-10.htm
<DESCRIPTION>CONSENT OF OLSSON
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; "><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
23.10</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="n2574ex2310img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Olsson
hereby consents to the public filing of Sections 1.8, 17, 22.8 and 23.1.7 (the &ldquo;Covered Sections&rdquo;) of the Technical
Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022
(the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30,
2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Olsson
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form
S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Olsson
also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as
defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the
Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Olsson
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the
Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Olsson
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Signed
and dated this 11th day of September, 2025 at Omaha, Nebraska.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">/s/ Brian Osborn</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; text-align: left; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Brian
    Osborn</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vice President</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Olsson</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.11
<SEQUENCE>14
<FILENAME>n2574_x280ex23-11.htm
<DESCRIPTION>CONSENT OF A2GC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 23.11</FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><IMG SRC="n2574ex2311img001.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
hereby consents to the public filing of Sections 7.3, 13.1 and 23.1.3 (the &ldquo;Covered Sections&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2025
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statements on Form
S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo; (as
defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the
Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the
Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC
certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025
in Montreal, Quebec, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Patrick Andrieux</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrick Andrieux, Ph.D.,
    P.Eng., Eng.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2GC</FONT></TD></TR>
</TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.12
<SEQUENCE>15
<FILENAME>n2574_x280ex23-12.htm
<DESCRIPTION>CONSENT OF METALLURGY CONCEPT SOLUTIONS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><B>Exhibit 23.12</B></P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: left; margin-bottom: 0"><IMG SRC="n2574ex2312img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC hereby consents to the public filing of Sections 10.3, 14.1.3, 14.2.3, 14.3.3, and 14.4.3 (the &ldquo;Covered
Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with
an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K
for the fiscal year ended June 30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration
Statement on Form S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266),
Registration Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313)
(collectively, the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified
person&rdquo; (as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection
with the Form 10-K, the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated
by reference in the Registration Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy
Concept Solutions LLC certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately
represents the information in the Covered Sections.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September, 2025 at 50 St-Louis #103, Valleyfield, QC, Canada J6T 1M6.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sylvain Harton </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sylvain Harton, P.
    Eng.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior Metallurgist
    Engineer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Metallurgy Concept
    Solutions LLC</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.13
<SEQUENCE>16
<FILENAME>n2574_x280ex23-13.htm
<DESCRIPTION>CONSENT OF SCOTT HONAN, M.SC., SME-RM, NIOCORP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.13</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"><IMG SRC="n2574ex2313img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CONSENT
OF QUALIFIED PERSON</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I, Scott Honan, M.Sc.,
SME-RM, consent to the public filing of Sections 13.7.5, 13.7.6, 13.7.7, 13.7.8, 13.7.15, 15.5, 15.6 and 22.7.1 (the &ldquo;Covered
Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with
an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K
for the fiscal year ended June 30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I also consent to the
incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statement on Form S-1 (Registration Nos.
333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement on Form S-3 (Registration
No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively, the &ldquo;Registration Statements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I also consent to the
use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined in Subpart 1300
of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K, the Registration
Statements and the Technical Report Summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I also consent to any
extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in the Registration Statements
(the &ldquo;Disclosure&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I certify that I have
read the Disclosure being filed by the Company and that it fairly and accurately represents the information in the Covered Sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Signed and dated this 11th day of September 2025 at Centennial, Colorado, USA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">/s/ Scott Honan</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: left; border-top: Black 1pt solid">Scott Honan, M.Sc., SME-RM</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Chief Operating Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">NioCorp Developments Ltd.</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.14
<SEQUENCE>17
<FILENAME>n2574_x280ex23-14.htm
<DESCRIPTION>CONSENT OF DUMAS CONTRACTING LTD.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: left; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit 23.14</FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><IMG SRC="n2574ex2314img001a.jpg" ALT="">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF QUALIFIED PERSON</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dumas Contracting Ltd. has reviewed, approved and taken responsibility for Sections 13.7.1, 13.7.2, 13.7.3, 13.7.4, 13.7.9, 13.7.10, 13.7.11, 13.7.12,
13.7.13, 13.7.14, 15.1.3, 15.1.4 and 23.1.8 (the &ldquo;Covered Sections&rdquo;) of the Technical Report Summary titled &ldquo;Technical
Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the &ldquo;Technical Report Summary&rdquo;).
Dumas Contracting Ltd. hereby consents to the public filing of the Covered Sections as an exhibit to the Annual Report on Form 10-K for the fiscal
year ended June 30, 2025 (the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dumas Contracting
Ltd. also consents to the incorporation by reference of the Covered Sections in the Company&rsquo;s Registration Statements on
Form S-1 (Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration
Statement on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dumas Contracting
Ltd. also consents to the use of and references to our name, including our status as an expert or &ldquo;qualified person&rdquo;
(as defined in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with
the Form 10-K, the Registration Statements and the Technical Report Summary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dumas Contracting
Ltd. also consents to any extracts from or a summary of the Covered Sections in the Form 10-K and incorporated by reference in
the Registration Statements (the &ldquo;Disclosure&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Dumas Contracting
Ltd. certifies that we have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025 at Timmins, Ontario, Canada.<SUP></SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>/s/ Tony Linton</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid">Tony Linton, FEC, P.Eng.<BR>
    Director, Engineering &amp; Technical Services<BR>
    Dumas Contracting Ltd.</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.15
<SEQUENCE>18
<FILENAME>n2574_x280ex23-15.htm
<DESCRIPTION>CONSENT OF MAHMOOD KHWAJA, P.E., CDM SMITH
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; "><B>Exhibit 23.15</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="n2574ex2315img001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Mahmood Khwaja, P.E., consent to the public filing of Section 15.8 (the &ldquo;Covered Section&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2025
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Section in the Company&rsquo;s Registration Statement on Form S-1
(Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Section in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025 at Boston, Massachusetts, USA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>/s/ Mahmood Khwaja</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mahmood
Khwaja, PE&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
President / Senior Geotechnical Engineer&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technical
Services Unit &#9474; ISG&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CDM
Smith</FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.16
<SEQUENCE>19
<FILENAME>n2574_x280ex23-16.htm
<DESCRIPTION>CONSENT OF WYNAND MARX, M.ENG., BBE CONSULTING
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.16</B></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><IMG SRC="n2574ex2316img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF QUALIFIED PERSON</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Wynand Marx, M.Eng., consent to the public filing of Section 13.6 (the &ldquo;Covered Section&rdquo;) of the Technical Report
Summary titled &ldquo;Technical Report Summary, Elk Creek Project, Nebraska&rdquo; with an Effective Date of June 30, 2022 (the
&ldquo;Technical Report Summary&rdquo;) as an exhibit to the Annual Report on Form 10-K for the fiscal year ended June 30, 2025
(the &ldquo;Form 10-K&rdquo;) of NioCorp Developments Ltd. (the &ldquo;Company&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the incorporation by reference of the Covered Section in the Company&rsquo;s Registration Statement on Form S-1
(Registration Nos. 333-285066, 333-279429, 333-270542, 333-271268, 333-254511, 333-270541 and 333-271266), Registration Statement
on Form S-3 (Registration No. 333-280176) and Registration Statement on Form S-8 (Registration No. 333-222313) (collectively,
the &ldquo;Registration Statements&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to the use of and references to my name, including my status as an expert or &ldquo;qualified person&rdquo; (as defined
in Subpart 1300 of Regulation S-K promulgated by the U.S. Securities and Exchange Commission), in connection with the Form 10-K,
the Registration Statements and the Technical Report Summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
also consent to any extracts from or a summary of the Covered Section in the Form 10-K and incorporated by reference in the Registration
Statements (the &ldquo;Disclosure&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
certify that I have read the Disclosure being filed by the Company and that it fairly and accurately represents the information
in the Covered Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signed
and dated this 11th day of September 2025 at Johannesburg, South Africa.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">/s/ Wynand Marx</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; text-align: left; border-top: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wynand
    Marx, M.Eng.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BBE Consulting</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>20
<FILENAME>n2574_x280ex31-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Mark A. Smith, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1. I have reviewed this Annual Report
on Form 10-K of NioCorp Developments Ltd.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">2. Based on my knowledge, this report does not contain
any untrue statement of a material fact or omit to state a material fact necessary to make&nbsp;the&nbsp;statements made, in light
of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading with respect to&nbsp;the&nbsp;period covered
by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">3. Based on my knowledge,&nbsp;the&nbsp;financial
statements, and other financial information included in this report, fairly present in all material respects the&nbsp;financial
condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of, and for,&nbsp;the&nbsp;periods presented in
this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">4.&nbsp;The&nbsp;registrant's other&nbsp;certifying&nbsp;officer(s)
and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant
and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(a) Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during&nbsp;the&nbsp;period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(b) Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance
regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation of financial statements for external purposes
in accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(c) Evaluated&nbsp;the&nbsp;effectiveness of&nbsp;the&nbsp;registrant's
disclosure controls and procedures and presented in this report our conclusions about&nbsp;the effectiveness of&nbsp;the&nbsp;disclosure
controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(d) Disclosed in this report any change in&nbsp;the&nbsp;registrant's
internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant's most recent fiscal quarter (the&nbsp;registrant's
fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially affected, or is reasonably likely to materially
affect,&nbsp;the&nbsp;registrant's internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">5.&nbsp;The&nbsp;registrant's other&nbsp;certifying&nbsp;officer(s)
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to&nbsp;the&nbsp;registrant's
auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant's board of directors (or persons performing&nbsp;the&nbsp;equivalent
functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(a) All significant deficiencies and material weaknesses
in&nbsp;the&nbsp;design or operation of internal control over financial reporting which are reasonably likely to adversely affect&nbsp;the&nbsp;registrant's
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(b) Any fraud, whether or not material, that involves
management or other employees who have a significant role in&nbsp;the&nbsp;registrant's internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: September 11,
2025&nbsp;</P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Principal Executive Officer)&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>
<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>21
<FILENAME>n2574_x280ex31-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>EXHIBIT
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CERTIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">I, Neal Shah, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1. I have
reviewed this Annual Report on Form 10-K of NioCorp Developments Ltd.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">2. Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make&nbsp;the&nbsp;statements
made, in light of&nbsp;the&nbsp;circumstances under which such statements were made, not misleading with respect to&nbsp;the&nbsp;period
covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">3. Based on my knowledge,&nbsp;the&nbsp;financial
statements, and other financial information included in this report, fairly present in all material respects the&nbsp;financial
condition, results of operations and cash flows of&nbsp;the&nbsp;registrant as of, and for,&nbsp;the&nbsp;periods presented in
this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">4.&nbsp;The&nbsp;registrant's
other&nbsp;certifying&nbsp;officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for&nbsp;the&nbsp;registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">(a) Designed such disclosure
controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to&nbsp;the&nbsp;registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during&nbsp;the&nbsp;period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">(b) Designed such internal
control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding&nbsp;the&nbsp;reliability of financial reporting and&nbsp;the&nbsp;preparation of financial
statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">(c) Evaluated&nbsp;the&nbsp;effectiveness
of&nbsp;the&nbsp;registrant's disclosure controls and procedures and presented in this report our conclusions about&nbsp;the effectiveness
of&nbsp;the&nbsp;disclosure controls and procedures, as of&nbsp;the&nbsp;end of&nbsp;the&nbsp;period covered by this report based
on such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">(d) Disclosed in this
report any change in&nbsp;the&nbsp;registrant's internal control over financial reporting that occurred during&nbsp;the&nbsp;registrant's
most recent fiscal quarter (the&nbsp;registrant's fourth fiscal quarter in&nbsp;the&nbsp;case of an annual report) that has materially
affected, or is reasonably likely to materially affect,&nbsp;the&nbsp;registrant's internal control over financial reporting;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">5.&nbsp;The&nbsp;registrant's
other&nbsp;certifying&nbsp;officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to&nbsp;the&nbsp;registrant's auditors and&nbsp;the&nbsp;audit committee of&nbsp;the&nbsp;registrant's board of directors
(or persons performing&nbsp;the&nbsp;equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">(a) All significant deficiencies
and material weaknesses in&nbsp;the&nbsp;design or operation of internal control over financial reporting which are reasonably
likely to adversely affect&nbsp;the&nbsp;registrant's ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">(b) Any fraud, whether
or not material, that involves management or other employees who have a significant role in&nbsp;the&nbsp;registrant's internal
control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Date: September 11,
        2025</FONT></P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Chief Financial Officer&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">(Principal Financial
        and Accounting Officer)</FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>22
<FILENAME>n2574_x280ex32-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the Annual Report on
Form 10-K of NioCorp Developments Ltd. (the &quot;Company&quot;), for the period ended June 30, 2025, as filed with the Securities
and Exchange Commission on the date hereof (the &quot;Report&quot;), I, Mark A. Smith, Chief Executive Officer of the Company,
hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that,
to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">1. The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">2. The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: September 11,
2025&nbsp;</P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Mark A. Smith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Principal Executive Officer)&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>23
<FILENAME>n2574_x280ex32-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt"><B>EXHIBIT
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>AS ADOPTED
PURSUANT TO</B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">In connection
with the Annual Report on Form 10-K of NioCorp Developments Ltd. (the &quot;Company&quot;), for the year ended June 30, 2025,
as filed with the Securities and Exchange Commission on the date hereof (the &quot;Report&quot;), I, Neal Shah, Chief Financial
Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to my knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-size: 10pt">1. The Report
fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-size: 10pt">2. The information contained
in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 54%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Date:
September 11, 2025&nbsp;</FONT></P></TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 43%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Neal Shah</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Chief Financial Officer&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">(Principal Financial
and Accounting Officer)&nbsp;</FONT></P></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>24
<FILENAME>niobf-20250630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9aM5s7xRiXhun8uCaHNMOaiNKbPtxpd9KelBvm1ybekKDyosST7NXSqdGM02wTwD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:niobf="http://niocorp.com/20250630" elementFormDefault="qualified" targetNamespace="http://niocorp.com/20250630">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://niocorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" id="StatementsOfOperationsAndComprehensiveLoss">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical" id="StatementsOfOperationsAndComprehensiveLossParenthetical">
          <link:definition>00000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" id="StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest">
          <link:definition>00000007 - Statement - Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
          <link:definition>999015 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPreparation" id="BasisOfPreparation">
          <link:definition>999016 - Disclosure - BASIS OF PREPARATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
          <link:definition>999017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcernIssues" id="GoingConcernIssues">
          <link:definition>999018 - Disclosure - GOING CONCERN ISSUES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LandAndBuildingsNet" id="LandAndBuildingsNet">
          <link:definition>999019 - Disclosure - LAND AND BUILDINGS, NET</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MineralProperties" id="MineralProperties">
          <link:definition>999020 - Disclosure - MINERAL PROPERTIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
          <link:definition>999021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebt" id="ConvertibleDebt">
          <link:definition>999022 - Disclosure - CONVERTIBLE DEBT</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" id="ClassBCommonStockOfEcrc">
          <link:definition>999023 - Disclosure - CLASS B COMMON STOCK OF ECRC</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonShares" id="CommonShares">
          <link:definition>999024 - Disclosure - COMMON SHARES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" id="RelatedPartyTransactionsAndBalances">
          <link:definition>999025 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpenditures" id="ExplorationExpenditures">
          <link:definition>999026 - Disclosure - EXPLORATION EXPENDITURES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/Leases" id="Leases">
          <link:definition>999027 - Disclosure - LEASES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>999028 - Disclosure - INCOME TAXES</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>999029 - Disclosure - Fair Value Measurements</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SegmentInformation" id="SegmentInformation">
          <link:definition>999030 - Disclosure - SEGMENT INFORMATION</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>999031 - Disclosure - SUBSEQUENT EVENTS</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
          <link:definition>999032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/BasisOfPreparationTables" id="BasisOfPreparationTables">
          <link:definition>999033 - Disclosure - BASIS OF PREPARATION (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
          <link:definition>999034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" id="LandAndBuildingsNetTables">
          <link:definition>999035 - Disclosure - LAND AND BUILDINGS, NET (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
          <link:definition>999036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtTables" id="ConvertibleDebtTables">
          <link:definition>999037 - Disclosure - CONVERTIBLE DEBT (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" id="ClassBCommonStockOfEcrcTables">
          <link:definition>999038 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesTables" id="CommonSharesTables">
          <link:definition>999039 - Disclosure - COMMON SHARES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ExplorationExpendituresTables" id="ExplorationExpendituresTables">
          <link:definition>999040 - Disclosure - EXPLORATION EXPENDITURES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LeasesTables" id="LeasesTables">
          <link:definition>999041 - Disclosure - LEASES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>999042 - Disclosure - INCOME TAXES (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>999043 - Disclosure - Fair Value Measurements (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" id="TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details">
          <link:definition>999044 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" id="DescriptionOfBusinessDetailsNarrative">
          <link:definition>999045 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" id="FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails">
          <link:definition>999046 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" id="ScheduleOfExcludedFromDilutiveSecuritiesDetails">
          <link:definition>999047 - Disclosure - Schedule of excluded from the dilutive securities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
          <link:definition>999048 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" id="GoingConcernIssuesDetailsNarrative">
          <link:definition>999049 - Disclosure - GOING CONCERN ISSUES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" id="ScheduleOfPropertiesDetails">
          <link:definition>999050 - Disclosure - Schedule of properties (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" id="MineralPropertiesDetailsNarrative">
          <link:definition>999051 - Disclosure - MINERAL PROPERTIES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" id="ScheduleOfAccountPayableAndAccruedLiabilitiesDetails">
          <link:definition>999052 - Disclosure - Schedule of account payable and accrued liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetails" id="ConvertibleDebtDetails">
          <link:definition>999053 - Disclosure - CONVERTIBLE DEBT (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetails1" id="ConvertibleDebtDetails1">
          <link:definition>999054 - Disclosure - CONVERTIBLE DEBT (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetails2" id="ConvertibleDebtDetails2">
          <link:definition>999055 - Disclosure - CONVERTIBLE DEBT (Details 2)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetails3" id="ConvertibleDebtDetails3">
          <link:definition>999056 - Disclosure - CONVERTIBLE DEBT (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetails4" id="ConvertibleDebtDetails4">
          <link:definition>999057 - Disclosure - CONVERTIBLE DEBT (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetails5" id="ConvertibleDebtDetails5">
          <link:definition>999058 - Disclosure - CONVERTIBLE DEBT (Details 5)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetails6" id="ConvertibleDebtDetails6">
          <link:definition>999059 - Disclosure - CONVERTIBLE DEBT (Details 6)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" id="ConvertibleDebtDetailsNarrative">
          <link:definition>999060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails" id="ClassBCommonStockOfEcrcDetails">
          <link:definition>999061 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1" id="ClassBCommonStockOfEcrcDetails1">
          <link:definition>999062 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" id="ClassBCommonStockOfEcrcDetailsNarrative">
          <link:definition>999063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails" id="CommonSharesDetails">
          <link:definition>999064 - Disclosure - COMMON SHARES (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails1" id="CommonSharesDetails1">
          <link:definition>999065 - Disclosure - COMMON SHARES (Details 1)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails3" id="CommonSharesDetails3">
          <link:definition>999066 - Disclosure - COMMON SHARES (Details 3)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails4" id="CommonSharesDetails4">
          <link:definition>999067 - Disclosure - COMMON SHARES (Details 4)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails5" id="CommonSharesDetails5">
          <link:definition>999068 - Disclosure - COMMON SHARES (Details 5)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails6" id="CommonSharesDetails6">
          <link:definition>999069 - Disclosure - COMMON SHARES (Details 6)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails7" id="CommonSharesDetails7">
          <link:definition>999070 - Disclosure - COMMON SHARES (Details 7)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails8" id="CommonSharesDetails8">
          <link:definition>999071 - Disclosure - COMMON SHARES (Details 8)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails9" id="CommonSharesDetails9">
          <link:definition>999072 - Disclosure - COMMON SHARES (Details 9)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails10" id="CommonSharesDetails10">
          <link:definition>999073 - Disclosure - COMMON SHARES (Details 10)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails11" id="CommonSharesDetails11">
          <link:definition>999074 - Disclosure - COMMON SHARES (Details 11)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails12" id="CommonSharesDetails12">
          <link:definition>999075 - Disclosure - COMMON SHARES (Details 12)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetails13" id="CommonSharesDetails13">
          <link:definition>999076 - Disclosure - COMMON SHARES (Details 13)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" id="CommonSharesDetailsNarrative">
          <link:definition>999077 - Disclosure - COMMON SHARES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" id="RelatedPartyTransactionsAndBalancesDetailsNarrative">
          <link:definition>999078 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" id="ScheduleOfExplorationExpendituresDetails">
          <link:definition>999079 - Disclosure - Schedule of exploration expenditures (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" id="CompanyIncurredLeaseCostsAsFollowsDetails">
          <link:definition>999080 - Disclosure - The Company incurred lease costs as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" id="MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details">
          <link:definition>999081 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2025: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
          <link:definition>999082 - Disclosure - LEASES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" id="DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails">
          <link:definition>999083 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" id="FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails">
          <link:definition>999084 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" id="DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails">
          <link:definition>999085 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" id="ChangesInValuationAllowanceAreAsFollowsDetails">
          <link:definition>999086 - Disclosure - Changes in the valuation allowance are as follows: (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" id="ScheduleOfCumulativeNetOperatingLossesDetails">
          <link:definition>999087 - Disclosure - Schedule of cumulative net operating losses (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>999088 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" id="ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails">
          <link:definition>999089 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>999090 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20250630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20250630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20250630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="niobf-20250630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/cyd/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <element id="niobf_CommonSharesWithoutParValueMember" name="CommonSharesWithoutParValueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantsEachExercisableFor1.11829212Member" name="WarrantsEachExercisableFor1.11829212Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterestMember" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_Entity0896800BCLtdMember" name="Entity0896800BCLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ElkCreekResourcesCorpECRCMember" name="ElkCreekResourcesCorpECRCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NioCorpTechnologiesLimitedMember" name="NioCorpTechnologiesLimitedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleDebenturesMember" name="YorkvilleConvertibleDebenturesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_April2024ConvertibleSecurityMember" name="April2024ConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" name="YorkvilleConvertibleDebtFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutMember" name="EarnoutMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_BlackScholesMember" name="BlackScholesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassBCommonStockECRCMember" name="ClassBCommonStockECRCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PurchaseAgreementSeriesAMember" name="PurchaseAgreementSeriesAMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PurchaseAgreementSeriesBMember" name="PurchaseAgreementSeriesBMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleEquityFacilityFinancingAgreementMember" name="YorkvilleEquityFacilityFinancingAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIPublicWarrantsMember" name="GXIIPublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GXIIPrivateWarrantsMember" name="GXIIPrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PublicWarrants2023Member" name="PublicWarrants2023Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LindGlobalAssetManagementThreeLLCMember" name="LindGlobalAssetManagementThreeLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LindConsentWarrantIssuanceMember" name="LindConsentWarrantIssuanceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantLiabilityMember" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PublicWarrantsMember" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivateWarrantsMember" name="PrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SeriesAPublicWarrantsMember" name="SeriesAPublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SeriesBPublicWarrantsMember" name="SeriesBPublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SeriesAPrivateWarrantsMember" name="SeriesAPrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SeriesBPrivateWarrantsMember" name="SeriesBPrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NovemberPrivateWarrantsliabilitiesMember" name="NovemberPrivateWarrantsliabilitiesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice4.60Member" name="ExercisePrice4.60Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice3.54Member" name="ExercisePrice3.54Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.20Member" name="ExercisePrice2.20Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice1.75Member" name="ExercisePrice1.75Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice1.75OneMember" name="ExercisePrice1.75OneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice3.25Member" name="ExercisePrice3.25Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice1.98Member" name="ExercisePrice1.98Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice11.50Member" name="ExercisePrice11.50Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.31Member" name="ExercisePrice2.31Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.05Member" name="ExercisePrice2.05Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.07Member" name="ExercisePrice2.07Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.07OneMember" name="ExercisePrice2.07OneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice2.60Member" name="ExercisePrice2.60Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_BlackScholesValuationMember" name="BlackScholesValuationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NonRevolvingCreditFacilityAgreementMember" name="NonRevolvingCreditFacilityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeneralSecurityAgreementMember" name="GeneralSecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FeasibilityStudyAndEngineeringMember" name="FeasibilityStudyAndEngineeringMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FieldManagementAndOtherMember" name="FieldManagementAndOtherMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DrillingMember" name="DrillingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MetallurgicalMember" name="MetallurgicalMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GeologistsAndFieldStaffMember" name="GeologistsAndFieldStaffMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PurchasesofLandMember" name="PurchasesofLandMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DoDAgreementMember" name="DoDAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutLiabilityAtFairValue" name="EarnoutLiabilityAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue" name="ChangeInFairValueOfEarnoutSharesLiabilityValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfWarrantLiabilityValue" name="ChangeInFairValueOfWarrantLiabilityValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNotesValue" name="ChangeInFairValueOfConvertibleNotesValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutShareLiability" name="ChangeInFairValueOfEarnoutShareLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInValuationOfWarrantLiabilities" name="ChangeInValuationOfWarrantLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNoteValue" name="ChangeInFairValueOfConvertibleNoteValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueOfCommitmentSharesIssued" name="FairValueOfCommitmentSharesIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OtheroperatingGainsLosses" name="OtheroperatingGainsLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConversionsOfDebtForCommonShares" name="ConversionsOfDebtForCommonShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ValueOfWarrantsIssued" name="ValueOfWarrantsIssued" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueEquityPlacement" name="StockIssuedDuringPeriodValueEquityPlacement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement" name="StockIssuedDuringPeriodValueSharesEquityPlacement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" name="StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" name="StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised" name="StockIssuedDuringPeriodValueStockWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised" name="StockIssuedDuringPeriodValueSharesStockWarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares" name="StockIssuedDuringPeriodValueRedemptionsOfVestedShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" name="StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" name="StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" name="StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureClassBCommonStockOfEcrcAbstract" name="DisclosureClassBCommonStockOfEcrcAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock" name="DisclosureOfClassBCommonStockOfECRCTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureExplorationExpendituresAbstract" name="DisclosureExplorationExpendituresAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpendituresDisclosuresTextBlock" name="ExplorationExpendituresDisclosuresTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DevelopmentStageIssuerPolicyTextBlock" name="DevelopmentStageIssuerPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MineralPropertiesPolicyTextBlock" name="MineralPropertiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock" name="ConvertibleDebtCarriedatFairValuePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantsPolicyTextBlock" name="WarrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesPolicyTextBlock" name="EarnoutSharesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" name="RedeemableNoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" name="ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" name="ShareholdersEquityAndShareBasedWarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" name="ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" name="ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" name="FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" name="ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" name="FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" name="ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" name="ScheduleOfOutstandingExercisableWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" name="ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" name="ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ScheduleOfExplorationExpendituresTableTextBlock" name="ScheduleOfExplorationExpendituresTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncorporationStateCountryName" name="IncorporationStateCountryName" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_NetLossAttributableToVestedShares" name="NetLossAttributableToVestedShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpenseForOTPExtensionPayments" name="ExplorationExpenseForOTPExtensionPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FutureOptionToPurchaseExtensionPaymentObligations" name="FutureOptionToPurchaseExtensionPaymentObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrincipalAndAccruedInterestConverted" name="PrincipalAndAccruedInterestConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ContractualInterest" name="ContractualInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ImpliedDiscountRate" name="ImpliedDiscountRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValue" name="ChangeInFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" name="StockIssuedDuringPeriodSharesStockOptionsExercise" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ServicingLiabilityAtFairValueAdditionsValue" name="ServicingLiabilityAtFairValueAdditionsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DescriptionOfEarnOutShares" name="DescriptionOfEarnOutShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangesInFairValueOfInitialValuation1" name="ChangesInFairValueOfInitialValuation1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FairValueOfWarrantsExercised" name="FairValueOfWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" name="ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CommonStockSharesIssued1" name="CommonStockSharesIssued1" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightGranted" name="ClassOfWarrantOrRightGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceGranted" name="ClassOfWarrantOrRightExercisePriceGranted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExpired" name="ClassOfWarrantOrRightExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ClassOfWarrantOrRightExercisePriceExercised" name="ClassOfWarrantOrRightExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangesInFairValueOfInitialValuation" name="ChangesInFairValueOfInitialValuation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExchangeOfPrivateWarrantsForPublicWarrants" name="ExchangeOfPrivateWarrantsForPublicWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_GainOnIssuanceOfWarrants" name="GainOnIssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DebtInstrumentIssuedPrincipalshars" name="DebtInstrumentIssuedPrincipalshars" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_RegisteredOffering" name="RegisteredOffering" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PrivateOffering" name="PrivateOffering" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CommonShareDescription" name="CommonShareDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_SaleOfStockPricePerShare1" name="SaleOfStockPricePerShare1" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_UnrecognizedCompensationCosts" name="UnrecognizedCompensationCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExchangeOfWarrantsDescription" name="ExchangeOfWarrantsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LineOfCreditFacilityEstablishmentFee" name="LineOfCreditFacilityEstablishmentFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CostCentreAxis" name="CostCentreAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="niobf_CostCentreDomain" name="CostCentreDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_FixedRentExpense" name="FixedRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TotalLeasePayments" name="TotalLeasePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LessAmountOfPaymentsRepresentingInterest" name="LessAmountOfPaymentsRepresentingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LessCurrentPortionOfOperatingLeaseLiability" name="LessCurrentPortionOfOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_OperatingLeasesLiabilityNoncurrent" name="OperatingLeasesLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WarrantLiability" name="WarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarnoutSharesLiability" name="EarnoutSharesLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_PaymentsOfStockIssuanceCost" name="PaymentsOfStockIssuanceCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConvertibleNoteValuation" name="ConvertibleNoteValuation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsMineralInterest" name="DeferredTaxAssetsMineralInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" name="DeferredTaxAssetsStartupAndOorganizationalCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" name="DeferredTaxAssetsResearchAndDevelopmentCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsShareIssuanceCosts" name="DeferredTaxAssetsShareIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" name="DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CapitalLossesAvailableForFuturePeriods" name="CapitalLossesAvailableForFuturePeriods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DeferredTaxAssetsValuationAllowanceAdditions" name="DeferredTaxAssetsValuationAllowanceAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CapitalLossCaryforward" name="CapitalLossCaryforward" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" name="AvailableForSaleSecuritiesEquitySecuritiesOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" name="ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExplorationExpenditures" name="ExplorationExpenditures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfEarnoutSharesLiability" name="ChangeInFairValueOfEarnoutSharesLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfWarrantLiability" name="ChangeInFairValueOfWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNotes" name="ChangeInFairValueOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EarningsLossPerShareBasicAndDiluted" name="EarningsLossPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" name="TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ChangeInFairValueOfConvertibleNote" name="ChangeInFairValueOfConvertibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AdjustmentsToReconcileNetIncomeLossesToCashProvidedByUsedInOperatingActivities" name="AdjustmentsToReconcileNetIncomeLossesToCashProvidedByUsedInOperatingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_CashAndCashEquivalentsAtCarryingValue1" name="CashAndCashEquivalentsAtCarryingValue1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_AdgMember" name="AdgMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice970Member" name="ExercisePrice970Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice894Member" name="ExercisePrice894Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice260Member" name="ExercisePrice260Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice270Member" name="ExercisePrice270Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice207Member" name="ExercisePrice207Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice207OneMember" name="ExercisePrice207OneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice205Member" name="ExercisePrice205Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice231Member" name="ExercisePrice231Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice1150Member" name="ExercisePrice1150Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice198Member" name="ExercisePrice198Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice325Member" name="ExercisePrice325Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice175Member" name="ExercisePrice175Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice175OneMember" name="ExercisePrice175OneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice220Member" name="ExercisePrice220Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice354Member" name="ExercisePrice354Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ExercisePrice460Member" name="ExercisePrice460Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_YorkvilleConvertibleSecurityMember" name="YorkvilleConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ConvertibleSecurityMember" name="ConvertibleSecurityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_DoDAgreementMaximumReimbursementAmount" name="DoDAgreementMaximumReimbursementAmount" nillable="true" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRate" name="IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRate" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EffectiveIncomeTaxRateReconciliationAtProvincialStatutoryIncomeTaxRate" name="EffectiveIncomeTaxRateReconciliationAtProvincialStatutoryIncomeTaxRate" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_LineOfCreditFacilityPrepaymentFee" name="LineOfCreditFacilityPrepaymentFee" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_MarkSmithMember" name="MarkSmithMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EstablishmentFeesPayable" name="EstablishmentFeesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_EstablishmentFeePayable" name="EstablishmentFeePayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ReimbursementAmount" name="ReimbursementAmount" nillable="true" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="niobf_ReimbursementPayments" name="ReimbursementPayments" nillable="true" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>25
<FILENAME>niobf-20250630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#Cover" roleURI="http://niocorp.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BalanceSheets" roleURI="http://niocorp.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BalanceSheetsParenthetical" roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfOperationsAndComprehensiveLoss" roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfOperationsAndComprehensiveLossParenthetical" roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfCashFlows" roleURI="http://niocorp.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DescriptionOfBusiness" roleURI="http://niocorp.com/role/DescriptionOfBusiness" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BasisOfPreparation" roleURI="http://niocorp.com/role/BasisOfPreparation" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPolicies" roleURI="http://niocorp.com/role/SignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#GoingConcernIssues" roleURI="http://niocorp.com/role/GoingConcernIssues" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LandAndBuildingsNet" roleURI="http://niocorp.com/role/LandAndBuildingsNet" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MineralProperties" roleURI="http://niocorp.com/role/MineralProperties" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#AccountsPayableAndAccruedLiabilities" roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebt" roleURI="http://niocorp.com/role/ConvertibleDebt" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrc" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonShares" roleURI="http://niocorp.com/role/CommonShares" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#RelatedPartyTransactionsAndBalances" roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ExplorationExpenditures" roleURI="http://niocorp.com/role/ExplorationExpenditures" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#Leases" roleURI="http://niocorp.com/role/Leases" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxes" roleURI="http://niocorp.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FairValueMeasurements" roleURI="http://niocorp.com/role/FairValueMeasurements" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SegmentInformation" roleURI="http://niocorp.com/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SubsequentEvents" roleURI="http://niocorp.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BasisOfPreparationTables" roleURI="http://niocorp.com/role/BasisOfPreparationTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesTables" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LandAndBuildingsNetTables" roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#AccountsPayableAndAccruedLiabilitiesTables" roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtTables" roleURI="http://niocorp.com/role/ConvertibleDebtTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcTables" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesTables" roleURI="http://niocorp.com/role/CommonSharesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ExplorationExpendituresTables" roleURI="http://niocorp.com/role/ExplorationExpendituresTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LeasesTables" roleURI="http://niocorp.com/role/LeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxesTables" roleURI="http://niocorp.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FairValueMeasurementsTables" roleURI="http://niocorp.com/role/FairValueMeasurementsTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DescriptionOfBusinessDetailsNarrative" roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesDetailsNarrative" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#GoingConcernIssuesDetailsNarrative" roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfPropertiesDetails" roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MineralPropertiesDetailsNarrative" roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails" roleURI="http://niocorp.com/role/ConvertibleDebtDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails1" roleURI="http://niocorp.com/role/ConvertibleDebtDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails2" roleURI="http://niocorp.com/role/ConvertibleDebtDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails3" roleURI="http://niocorp.com/role/ConvertibleDebtDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails4" roleURI="http://niocorp.com/role/ConvertibleDebtDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails5" roleURI="http://niocorp.com/role/ConvertibleDebtDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails6" roleURI="http://niocorp.com/role/ConvertibleDebtDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetailsNarrative" roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetails" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetails1" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails" roleURI="http://niocorp.com/role/CommonSharesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails1" roleURI="http://niocorp.com/role/CommonSharesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails3" roleURI="http://niocorp.com/role/CommonSharesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails4" roleURI="http://niocorp.com/role/CommonSharesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails5" roleURI="http://niocorp.com/role/CommonSharesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails6" roleURI="http://niocorp.com/role/CommonSharesDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails7" roleURI="http://niocorp.com/role/CommonSharesDetails7" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails8" roleURI="http://niocorp.com/role/CommonSharesDetails8" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails9" roleURI="http://niocorp.com/role/CommonSharesDetails9" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails10" roleURI="http://niocorp.com/role/CommonSharesDetails10" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails11" roleURI="http://niocorp.com/role/CommonSharesDetails11" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails12" roleURI="http://niocorp.com/role/CommonSharesDetails12" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails13" roleURI="http://niocorp.com/role/CommonSharesDetails13" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetailsNarrative" roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfExplorationExpendituresDetails" roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LeasesDetailsNarrative" roleURI="http://niocorp.com/role/LeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxesDetailsNarrative" roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SubsequentEventsDetailsNarrative" roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapExplorationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue" xlink:label="loc_niobfChangeInFairValueOfEarnoutSharesLiabilityValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_niobfChangeInFairValueOfEarnoutSharesLiabilityValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfWarrantLiabilityValue" xlink:label="loc_niobfChangeInFairValueOfWarrantLiabilityValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_niobfChangeInFairValueOfWarrantLiabilityValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNotesValue" xlink:label="loc_niobfChangeInFairValueOfConvertibleNotesValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_niobfChangeInFairValueOfConvertibleNotesValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaapInterestIncomeOperating" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestIncomeOperating" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNoteValue" xlink:label="loc_niobfChangeInFairValueOfConvertibleNoteValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_niobfChangeInFairValueOfConvertibleNoteValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaapPaymentsToAcquireOtherInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireOtherInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForDeposits" xlink:label="loc_us-gaapPaymentsForDeposits" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForDeposits" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" xlink:title="00000007 - Statement - Consolidated Statements of Shareholders&apos; Equity and Redeemable Noncontrolling Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000013 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000014 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="999015 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="999016 - Disclosure - BASIS OF PREPARATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="999017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="999018 - Disclosure - GOING CONCERN ISSUES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="999019 - Disclosure - LAND AND BUILDINGS, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="999020 - Disclosure - MINERAL PROPERTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="999021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="999022 - Disclosure - CONVERTIBLE DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="999023 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="999024 - Disclosure - COMMON SHARES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="999025 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="999026 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="999027 - Disclosure - LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="999028 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="999029 - Disclosure - Fair Value Measurements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SegmentInformation" xlink:title="999030 - Disclosure - SEGMENT INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="999031 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="999032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="999033 - Disclosure - BASIS OF PREPARATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="999034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="999035 - Disclosure - LAND AND BUILDINGS, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="999036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="999037 - Disclosure - CONVERTIBLE DEBT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="999038 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="999039 - Disclosure - COMMON SHARES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="999040 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="999041 - Disclosure - LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="999042 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="999043 - Disclosure - Fair Value Measurements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:title="999044 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="999045 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="999046 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="999047 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="999048 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="999049 - Disclosure - GOING CONCERN ISSUES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="999050 - Disclosure - Schedule of properties (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:title="999051 - Disclosure - MINERAL PROPERTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="999052 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails" xlink:title="999053 - Disclosure - CONVERTIBLE DEBT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails1" xlink:title="999054 - Disclosure - CONVERTIBLE DEBT (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails2" xlink:title="999055 - Disclosure - CONVERTIBLE DEBT (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails3" xlink:title="999056 - Disclosure - CONVERTIBLE DEBT (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails4" xlink:title="999057 - Disclosure - CONVERTIBLE DEBT (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails5" xlink:title="999058 - Disclosure - CONVERTIBLE DEBT (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails6" xlink:title="999059 - Disclosure - CONVERTIBLE DEBT (Details 6)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="999060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails" xlink:title="999061 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1" xlink:title="999062 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="999063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails" xlink:title="999064 - Disclosure - COMMON SHARES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails1" xlink:title="999065 - Disclosure - COMMON SHARES (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails3" xlink:title="999066 - Disclosure - COMMON SHARES (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails4" xlink:title="999067 - Disclosure - COMMON SHARES (Details 4)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails5" xlink:title="999068 - Disclosure - COMMON SHARES (Details 5)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails6" xlink:title="999069 - Disclosure - COMMON SHARES (Details 6)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails7" xlink:title="999070 - Disclosure - COMMON SHARES (Details 7)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails8" xlink:title="999071 - Disclosure - COMMON SHARES (Details 8)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails9" xlink:title="999072 - Disclosure - COMMON SHARES (Details 9)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails10" xlink:title="999073 - Disclosure - COMMON SHARES (Details 10)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails11" xlink:title="999074 - Disclosure - COMMON SHARES (Details 11)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails12" xlink:title="999075 - Disclosure - COMMON SHARES (Details 12)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails13" xlink:title="999076 - Disclosure - COMMON SHARES (Details 13)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="999077 - Disclosure - COMMON SHARES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="999078 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="999079 - Disclosure - Schedule of exploration expenditures (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="999080 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" xlink:title="999081 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2025: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_TotalLeasePayments" xlink:label="loc_niobfTotalLeasePayments" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfTotalLeasePayments" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_niobfTotalLeasePayments" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="999082 - Disclosure - LEASES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" xlink:title="999083 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="999084 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="999085 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="loc_niobfDeferredTaxAssetsMineralInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsMineralInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="loc_niobfDeferredTaxAssetsShareIssuanceCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsShareIssuanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" xlink:label="loc_niobfDeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfDeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfCapitalLossesAvailableForFuturePeriods" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_niobfCapitalLossesAvailableForFuturePeriods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="999086 - Disclosure - Changes in the valuation allowance are as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="999087 - Disclosure - Schedule of cumulative net operating losses (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="999088 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="999089 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="999090 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>26
<FILENAME>niobf-20250630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#Cover" roleURI="http://niocorp.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BalanceSheets" roleURI="http://niocorp.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BalanceSheetsParenthetical" roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfOperationsAndComprehensiveLoss" roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfOperationsAndComprehensiveLossParenthetical" roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfCashFlows" roleURI="http://niocorp.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DescriptionOfBusiness" roleURI="http://niocorp.com/role/DescriptionOfBusiness" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BasisOfPreparation" roleURI="http://niocorp.com/role/BasisOfPreparation" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPolicies" roleURI="http://niocorp.com/role/SignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#GoingConcernIssues" roleURI="http://niocorp.com/role/GoingConcernIssues" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LandAndBuildingsNet" roleURI="http://niocorp.com/role/LandAndBuildingsNet" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MineralProperties" roleURI="http://niocorp.com/role/MineralProperties" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#AccountsPayableAndAccruedLiabilities" roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebt" roleURI="http://niocorp.com/role/ConvertibleDebt" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrc" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonShares" roleURI="http://niocorp.com/role/CommonShares" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#RelatedPartyTransactionsAndBalances" roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ExplorationExpenditures" roleURI="http://niocorp.com/role/ExplorationExpenditures" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#Leases" roleURI="http://niocorp.com/role/Leases" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxes" roleURI="http://niocorp.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FairValueMeasurements" roleURI="http://niocorp.com/role/FairValueMeasurements" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SegmentInformation" roleURI="http://niocorp.com/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SubsequentEvents" roleURI="http://niocorp.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BasisOfPreparationTables" roleURI="http://niocorp.com/role/BasisOfPreparationTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesTables" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LandAndBuildingsNetTables" roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#AccountsPayableAndAccruedLiabilitiesTables" roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtTables" roleURI="http://niocorp.com/role/ConvertibleDebtTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcTables" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesTables" roleURI="http://niocorp.com/role/CommonSharesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ExplorationExpendituresTables" roleURI="http://niocorp.com/role/ExplorationExpendituresTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LeasesTables" roleURI="http://niocorp.com/role/LeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxesTables" roleURI="http://niocorp.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FairValueMeasurementsTables" roleURI="http://niocorp.com/role/FairValueMeasurementsTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DescriptionOfBusinessDetailsNarrative" roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesDetailsNarrative" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#GoingConcernIssuesDetailsNarrative" roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfPropertiesDetails" roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MineralPropertiesDetailsNarrative" roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails" roleURI="http://niocorp.com/role/ConvertibleDebtDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails1" roleURI="http://niocorp.com/role/ConvertibleDebtDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails2" roleURI="http://niocorp.com/role/ConvertibleDebtDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails3" roleURI="http://niocorp.com/role/ConvertibleDebtDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails4" roleURI="http://niocorp.com/role/ConvertibleDebtDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails5" roleURI="http://niocorp.com/role/ConvertibleDebtDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails6" roleURI="http://niocorp.com/role/ConvertibleDebtDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetailsNarrative" roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetails" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetails1" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails" roleURI="http://niocorp.com/role/CommonSharesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails1" roleURI="http://niocorp.com/role/CommonSharesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails3" roleURI="http://niocorp.com/role/CommonSharesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails4" roleURI="http://niocorp.com/role/CommonSharesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails5" roleURI="http://niocorp.com/role/CommonSharesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails6" roleURI="http://niocorp.com/role/CommonSharesDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails7" roleURI="http://niocorp.com/role/CommonSharesDetails7" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails8" roleURI="http://niocorp.com/role/CommonSharesDetails8" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails9" roleURI="http://niocorp.com/role/CommonSharesDetails9" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails10" roleURI="http://niocorp.com/role/CommonSharesDetails10" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails11" roleURI="http://niocorp.com/role/CommonSharesDetails11" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails12" roleURI="http://niocorp.com/role/CommonSharesDetails12" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails13" roleURI="http://niocorp.com/role/CommonSharesDetails13" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetailsNarrative" roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfExplorationExpendituresDetails" roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LeasesDetailsNarrative" roleURI="http://niocorp.com/role/LeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxesDetailsNarrative" roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SubsequentEventsDetailsNarrative" roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantsEachExercisableFor1.11829212Member" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag_60" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="loc_deiAuditorOpinionTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorOpinionTextBlock_60" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation_60" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId_60" xlink:type="arc" order="62" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" xlink:title="00000007 - Statement - Consolidated Statements of Shareholders&apos; Equity and Redeemable Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueEquityPlacement" xlink:label="loc_niobfStockIssuedDuringPeriodValueEquityPlacement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueEquityPlacement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesEquityPlacement" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesEquityPlacement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesEquityPlacement_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" xlink:label="loc_niobfStockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="loc_niobfStockIssuedDuringPeriodValueStockWarrantsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueStockWarrantsExercised_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesStockWarrantsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesStockWarrantsExercised_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares" xlink:label="loc_niobfStockIssuedDuringPeriodValueRedemptionsOfVestedShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueRedemptionsOfVestedShares_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" xlink:label="loc_niobfStockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_60" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000013 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000014 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="999015 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="999016 - Disclosure - BASIS OF PREPARATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="999017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="999018 - Disclosure - GOING CONCERN ISSUES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="999019 - Disclosure - LAND AND BUILDINGS, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="999020 - Disclosure - MINERAL PROPERTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="999021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="999022 - Disclosure - CONVERTIBLE DEBT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="999023 - Disclosure - CLASS B COMMON STOCK OF ECRC" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="999024 - Disclosure - COMMON SHARES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="999025 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="999026 - Disclosure - EXPLORATION EXPENDITURES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="999027 - Disclosure - LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="999028 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="999029 - Disclosure - Fair Value Measurements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SegmentInformation" xlink:title="999030 - Disclosure - SEGMENT INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="999031 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="999032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="999033 - Disclosure - BASIS OF PREPARATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="999034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="999035 - Disclosure - LAND AND BUILDINGS, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="999036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="999037 - Disclosure - CONVERTIBLE DEBT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="999038 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="999039 - Disclosure - COMMON SHARES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PublicWarrantsMember" xlink:label="loc_niobfPublicWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfPublicWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrivateWarrantsMember" xlink:label="loc_niobfPrivateWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfPrivateWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" xlink:label="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:label="loc_niobfScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_40" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="999040 - Disclosure - EXPLORATION EXPENDITURES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="999041 - Disclosure - LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="999042 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="999043 - Disclosure - Fair Value Measurements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:title="999044 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfEntity0896800BCLtdMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="loc_niobfElkCreekResourcesCorpECRCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpECRCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NioCorpTechnologiesLimitedMember" xlink:label="loc_niobfNioCorpTechnologiesLimitedMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfNioCorpTechnologiesLimitedMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_IncorporationStateCountryName" xlink:label="loc_niobfIncorporationStateCountryName_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_niobfIncorporationStateCountryName_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_100" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="999045 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="999046 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="999047 - Disclosure - Schedule of excluded from the dilutive securities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="999048 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="999049 - Disclosure - GOING CONCERN ISSUES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="999050 - Disclosure - Schedule of properties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapLandMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapBuildingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:title="999051 - Disclosure - MINERAL PROPERTIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="999052 - Disclosure - Schedule of account payable and accrued liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails" xlink:title="999053 - Disclosure - CONVERTIBLE DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebenturesMember" xlink:label="loc_niobfYorkvilleConvertibleDebenturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfYorkvilleConvertibleDebenturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_April2024ConvertibleSecurityMember" xlink:label="loc_niobfApril2024ConvertibleSecurityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfApril2024ConvertibleSecurityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebt_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails1" xlink:title="999054 - Disclosure - CONVERTIBLE DEBT (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaapConvertibleDebtSecuritiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapConvertibleDebtSecuritiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapConvertibleDebt_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="loc_niobfPrincipalAndAccruedInterestConverted_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_niobfPrincipalAndAccruedInterestConverted_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails2" xlink:title="999055 - Disclosure - CONVERTIBLE DEBT (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails3" xlink:title="999056 - Disclosure - CONVERTIBLE DEBT (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MonteCarloModelMember" xlink:label="loc_us-gaapMonteCarloModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapMonteCarloModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ImpliedDiscountRate" xlink:label="loc_niobfImpliedDiscountRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_niobfImpliedDiscountRate_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails4" xlink:title="999057 - Disclosure - CONVERTIBLE DEBT (Details 4)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails5" xlink:title="999058 - Disclosure - CONVERTIBLE DEBT (Details 5)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_BlackScholesMember" xlink:label="loc_niobfBlackScholesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfBlackScholesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails6" xlink:title="999059 - Disclosure - CONVERTIBLE DEBT (Details 6)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="999060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebenturesMember" xlink:label="loc_niobfYorkvilleConvertibleDebenturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfYorkvilleConvertibleDebenturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_100" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails" xlink:title="999061 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1" xlink:title="999062 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingLiabilityAtFairValueAdditionsValue" xlink:label="loc_niobfServicingLiabilityAtFairValueAdditionsValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_niobfServicingLiabilityAtFairValueAdditionsValue_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="999063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassBCommonStockECRCMember" xlink:label="loc_niobfClassBCommonStockECRCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfClassBCommonStockECRCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="loc_niobfDescriptionOfEarnOutShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfDescriptionOfEarnOutShares_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails" xlink:title="999064 - Disclosure - COMMON SHARES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPublicWarrantsMember" xlink:label="loc_niobfSeriesAPublicWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesAPublicWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPublicWarrantsMember" xlink:label="loc_niobfSeriesBPublicWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesBPublicWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails1" xlink:title="999065 - Disclosure - COMMON SHARES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPrivateWarrantsMember" xlink:label="loc_niobfSeriesAPrivateWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesAPrivateWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPrivateWarrantsMember" xlink:label="loc_niobfSeriesBPrivateWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesBPrivateWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails3" xlink:title="999066 - Disclosure - COMMON SHARES (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NovemberPrivateWarrantsliabilitiesMember" xlink:label="loc_niobfNovemberPrivateWarrantsliabilitiesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_niobfNovemberPrivateWarrantsliabilitiesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueOfWarrantsExercised" xlink:label="loc_niobfFairValueOfWarrantsExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueOfWarrantsExercised_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails4" xlink:title="999067 - Disclosure - COMMON SHARES (Details 4)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPublicWarrantsMember" xlink:label="loc_niobfSeriesAPublicWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesAPublicWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPublicWarrantsMember" xlink:label="loc_niobfSeriesBPublicWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesBPublicWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails5" xlink:title="999068 - Disclosure - COMMON SHARES (Details 5)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails6" xlink:title="999069 - Disclosure - COMMON SHARES (Details 6)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails7" xlink:title="999070 - Disclosure - COMMON SHARES (Details 7)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails8" xlink:title="999071 - Disclosure - COMMON SHARES (Details 8)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails9" xlink:title="999072 - Disclosure - COMMON SHARES (Details 9)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice4.60Member" xlink:label="loc_niobfExercisePrice4.60Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice4.60Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice3.54Member" xlink:label="loc_niobfExercisePrice3.54Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.54Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.20Member" xlink:label="loc_niobfExercisePrice2.20Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.20Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.75Member" xlink:label="loc_niobfExercisePrice1.75Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice1.75Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.75OneMember" xlink:label="loc_niobfExercisePrice1.75OneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice1.75OneMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice3.25Member" xlink:label="loc_niobfExercisePrice3.25Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.25Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.98Member" xlink:label="loc_niobfExercisePrice1.98Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice1.98Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.31Member" xlink:label="loc_niobfExercisePrice2.31Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.31Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.05Member" xlink:label="loc_niobfExercisePrice2.05Member_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.05Member_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.07Member" xlink:label="loc_niobfExercisePrice2.07Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.07Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.07OneMember" xlink:label="loc_niobfExercisePrice2.07OneMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.07OneMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.60Member" xlink:label="loc_niobfExercisePrice2.60Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.60Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate_150" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails10" xlink:title="999073 - Disclosure - COMMON SHARES (Details 10)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails11" xlink:title="999074 - Disclosure - COMMON SHARES (Details 11)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExchangeOfPrivateWarrantsForPublicWarrants" xlink:label="loc_niobfExchangeOfPrivateWarrantsForPublicWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfExchangeOfPrivateWarrantsForPublicWarrants_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails12" xlink:title="999075 - Disclosure - COMMON SHARES (Details 12)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_BlackScholesValuationMember" xlink:label="loc_niobfBlackScholesValuationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfBlackScholesValuationMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails13" xlink:title="999076 - Disclosure - COMMON SHARES (Details 13)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantLiabilityMember" xlink:label="loc_niobfWarrantLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfWarrantLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GainOnIssuanceOfWarrants" xlink:label="loc_niobfGainOnIssuanceOfWarrants_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfGainOnIssuanceOfWarrants_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="999077 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchaseAgreementSeriesAMember" xlink:label="loc_niobfPurchaseAgreementSeriesAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchaseAgreementSeriesBMember" xlink:label="loc_niobfPurchaseAgreementSeriesBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PublicWarrants2023Member" xlink:label="loc_niobfPublicWarrants2023Member_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfPublicWarrants2023Member_330" xlink:type="arc" order="331" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantLiabilityMember" xlink:label="loc_niobfWarrantLiabilityMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfWarrantLiabilityMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CAD" xlink:label="loc_currencyCAD_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:label="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="loc_niobfGXIIPublicWarrantsMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPublicWarrantsMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="loc_niobfLindConsentWarrantIssuanceMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLindConsentWarrantIssuanceMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LindGlobalAssetManagementThreeLLCMember" xlink:label="loc_niobfLindGlobalAssetManagementThreeLLCMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfLindGlobalAssetManagementThreeLLCMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_400" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DebtInstrumentIssuedPrincipalshars" xlink:label="loc_niobfDebtInstrumentIssuedPrincipalshars_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfDebtInstrumentIssuedPrincipalshars_400" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_400" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1_400" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_400" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RegisteredOffering" xlink:label="loc_niobfRegisteredOffering_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfRegisteredOffering_400" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrivateOffering" xlink:label="loc_niobfPrivateOffering_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfPrivateOffering_400" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonShareDescription" xlink:label="loc_niobfCommonShareDescription_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfCommonShareDescription_400" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_400" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_400" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="loc_niobfSaleOfStockPricePerShare1_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfSaleOfStockPricePerShare1_400" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaapProceedsFromOtherEquity_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromOtherEquity_400" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_400" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_400" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:label="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_400" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_400" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_400" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating_400" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses_400" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_400" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_400" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_400" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_UnrecognizedCompensationCosts" xlink:label="loc_niobfUnrecognizedCompensationCosts_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfUnrecognizedCompensationCosts_400" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation_400" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_400" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExchangeOfWarrantsDescription" xlink:label="loc_niobfExchangeOfWarrantsDescription_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfExchangeOfWarrantsDescription_400" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription_400" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_400" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_400" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_400" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GainOnIssuanceOfWarrants" xlink:label="loc_niobfGainOnIssuanceOfWarrants_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfGainOnIssuanceOfWarrants_400" xlink:type="arc" order="30" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="999078 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BorrowingsMember" xlink:label="loc_us-gaapBorrowingsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="loc_us-gaapBorrowingsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LineOfCreditFacilityEstablishmentFee" xlink:label="loc_niobfLineOfCreditFacilityEstablishmentFee_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityEstablishmentFee_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaapOtherBorrowings_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherBorrowings_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoanProcessingFee" xlink:label="loc_us-gaapLoanProcessingFee_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLoanProcessingFee_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding" xlink:label="loc_us-gaapInterestBearingLiabilitiesAverageAmountOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapInterestBearingLiabilitiesAverageAmountOutstanding_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="999079 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="loc_niobfFeasibilityStudyAndEngineeringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFeasibilityStudyAndEngineeringMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="loc_niobfFieldManagementAndOtherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldManagementAndOtherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DrillingMember" xlink:label="loc_niobfDrillingMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfDrillingMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_MetallurgicalMember" xlink:label="loc_niobfMetallurgicalMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfMetallurgicalMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="loc_niobfGeologistsAndFieldStaffMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistsAndFieldStaffMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="999080 - Disclosure - The Company incurred lease costs as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" xlink:title="999081 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2025: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="999082 - Disclosure - LEASES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" xlink:title="999083 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_countryUS_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_countryGB_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="999084 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="999085 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="999086 - Disclosure - Changes in the valuation allowance are as follows: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="999087 - Disclosure - Schedule of cumulative net operating losses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_countryUS_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_countryGB_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="999088 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CAD" xlink:label="loc_currencyCAD_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CapitalLossCaryforward" xlink:label="loc_niobfCapitalLossCaryforward_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_niobfCapitalLossCaryforward_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="999089 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapNotesPayable_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="999090 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTransactionTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchasesofLandMember" xlink:label="loc_niobfPurchasesofLandMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfPurchasesofLandMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DoDAgreementMember" xlink:label="loc_niobfDoDAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfDoDAgreementMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_niobfShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireLand" xlink:label="loc_us-gaapPaymentsToAcquireLand_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsToAcquireLand_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromCustomersForProgressPayments" xlink:label="loc_us-gaapProceedsFromCustomersForProgressPayments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromCustomersForProgressPayments_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>27
<FILENAME>niobf-20250630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="niobf_CommonSharesWithoutParValueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonSharesWithoutParValueMember_lbl" xml:lang="en-US">Common Shares Without Par Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantsEachExercisableFor1.11829212Member" xlink:label="niobf_WarrantsEachExercisableFor1.11829212Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212Member" xlink:to="niobf_WarrantsEachExercisableFor1.11829212Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantsEachExercisableFor1.11829212Member_lbl" xml:lang="en-US">Warrants Each Exercisable For111829212 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="niobf_RedeemableNoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestMember" xlink:to="niobf_RedeemableNoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterestMember_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="niobf_Entity0896800BCLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_Entity0896800BCLtdMember" xlink:to="niobf_Entity0896800BCLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_Entity0896800BCLtdMember_lbl" xml:lang="en-US">Entity0896800 B C Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="niobf_ElkCreekResourcesCorpECRCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpECRCMember" xlink:to="niobf_ElkCreekResourcesCorpECRCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ElkCreekResourcesCorpECRCMember_lbl" xml:lang="en-US">Elk Creek Resources Corp E C R C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NioCorpTechnologiesLimitedMember" xlink:label="niobf_NioCorpTechnologiesLimitedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NioCorpTechnologiesLimitedMember" xlink:to="niobf_NioCorpTechnologiesLimitedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NioCorpTechnologiesLimitedMember_lbl" xml:lang="en-US">Nio Corp Technologies Limited [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebenturesMember" xlink:label="niobf_YorkvilleConvertibleDebenturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebenturesMember" xlink:to="niobf_YorkvilleConvertibleDebenturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleConvertibleDebenturesMember_lbl" xml:lang="en-US">Yorkville Convertible Debentures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_April2024ConvertibleSecurityMember" xlink:label="niobf_April2024ConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_April2024ConvertibleSecurityMember" xlink:to="niobf_April2024ConvertibleSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_April2024ConvertibleSecurityMember_lbl" xml:lang="en-US">April2024 Convertible Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember" xlink:label="us-gaap_UnsecuredDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtMember" xlink:to="us-gaap_UnsecuredDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebtMember_lbl" xml:lang="en-US">Unsecured Debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Combination [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_lbl" xml:lang="en-US">Yorkville Convertible Debt Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MonteCarloModelMember" xlink:label="us-gaap_MonteCarloModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MonteCarloModelMember" xlink:to="us-gaap_MonteCarloModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MonteCarloModelMember_lbl" xml:lang="en-US">Valuation Technique, Monte Carlo Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="niobf_EarnoutMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutMember_lbl" xml:lang="en-US">Earnout [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_BlackScholesMember" xlink:label="niobf_BlackScholesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BlackScholesMember" xlink:to="niobf_BlackScholesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_BlackScholesMember_lbl" xml:lang="en-US">Black Scholes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassBCommonStockECRCMember" xlink:label="niobf_ClassBCommonStockECRCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassBCommonStockECRCMember" xlink:to="niobf_ClassBCommonStockECRCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassBCommonStockECRCMember_lbl" xml:lang="en-US">Class B Common Stock E C R C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchaseAgreementSeriesAMember" xlink:label="niobf_PurchaseAgreementSeriesAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesAMember" xlink:to="niobf_PurchaseAgreementSeriesAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PurchaseAgreementSeriesAMember_lbl" xml:lang="en-US">Purchase Agreement Series A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchaseAgreementSeriesBMember" xlink:label="niobf_PurchaseAgreementSeriesBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesBMember" xlink:to="niobf_PurchaseAgreementSeriesBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PurchaseAgreementSeriesBMember_lbl" xml:lang="en-US">Purchase Agreement Series B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CAD" xlink:label="currency_CAD" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_CAD" xlink:to="currency_CAD_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_CAD_lbl" xml:lang="en-US">Canada, Dollars</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:label="niobf_YorkvilleEquityFacilityFinancingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:to="niobf_YorkvilleEquityFacilityFinancingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_YorkvilleEquityFacilityFinancingAgreementMember_lbl" xml:lang="en-US">Yorkville Equity Facility Financing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="us-gaap_TransactionTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransactionTypeAxis" xlink:to="us-gaap_TransactionTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransactionTypeAxis_lbl" xml:lang="en-US">Transaction Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="niobf_GXIIPublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPublicWarrantsMember" xlink:to="niobf_GXIIPublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIPublicWarrantsMember_lbl" xml:lang="en-US">G X I I Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="niobf_GXIIPrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GXIIPrivateWarrantsMember_lbl" xml:lang="en-US">G X I I Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PublicWarrants2023Member" xlink:label="niobf_PublicWarrants2023Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PublicWarrants2023Member" xlink:to="niobf_PublicWarrants2023Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PublicWarrants2023Member_lbl" xml:lang="en-US">Public Warrants2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LindGlobalAssetManagementThreeLLCMember" xlink:label="niobf_LindGlobalAssetManagementThreeLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindGlobalAssetManagementThreeLLCMember" xlink:to="niobf_LindGlobalAssetManagementThreeLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LindGlobalAssetManagementThreeLLCMember_lbl" xml:lang="en-US">Lind Global Asset Management Three L L C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="niobf_LindConsentWarrantIssuanceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindConsentWarrantIssuanceMember" xlink:to="niobf_LindConsentWarrantIssuanceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LindConsentWarrantIssuanceMember_lbl" xml:lang="en-US">Lind Consent Warrant Issuance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantLiabilityMember" xlink:label="niobf_WarrantLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiabilityMember" xlink:to="niobf_WarrantLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantLiabilityMember_lbl" xml:lang="en-US">Warrant Liability [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PublicWarrantsMember" xlink:label="niobf_PublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PublicWarrantsMember" xlink:to="niobf_PublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrivateWarrantsMember" xlink:label="niobf_PrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivateWarrantsMember" xlink:to="niobf_PrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivateWarrantsMember_lbl" xml:lang="en-US">Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPublicWarrantsMember" xlink:label="niobf_SeriesAPublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesAPublicWarrantsMember" xlink:to="niobf_SeriesAPublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SeriesAPublicWarrantsMember_lbl" xml:lang="en-US">Series A Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPublicWarrantsMember" xlink:label="niobf_SeriesBPublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesBPublicWarrantsMember" xlink:to="niobf_SeriesBPublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SeriesBPublicWarrantsMember_lbl" xml:lang="en-US">Series B Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPrivateWarrantsMember" xlink:label="niobf_SeriesAPrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesAPrivateWarrantsMember" xlink:to="niobf_SeriesAPrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SeriesAPrivateWarrantsMember_lbl" xml:lang="en-US">Series A Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPrivateWarrantsMember" xlink:label="niobf_SeriesBPrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesBPrivateWarrantsMember" xlink:to="niobf_SeriesBPrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SeriesBPrivateWarrantsMember_lbl" xml:lang="en-US">Series B Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NovemberPrivateWarrantsliabilitiesMember" xlink:label="niobf_NovemberPrivateWarrantsliabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NovemberPrivateWarrantsliabilitiesMember" xlink:to="niobf_NovemberPrivateWarrantsliabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NovemberPrivateWarrantsliabilitiesMember_lbl" xml:lang="en-US">November Private Warrantsliabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice4.60Member" xlink:label="niobf_ExercisePrice4.60Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice4.60Member" xlink:to="niobf_ExercisePrice4.60Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice4.60Member_lbl" xml:lang="en-US">Exercise Price 4. 60 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice3.54Member" xlink:label="niobf_ExercisePrice3.54Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.54Member" xlink:to="niobf_ExercisePrice3.54Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice3.54Member_lbl" xml:lang="en-US">Exercise Price 3. 54 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.20Member" xlink:label="niobf_ExercisePrice2.20Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.20Member" xlink:to="niobf_ExercisePrice2.20Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.20Member_lbl" xml:lang="en-US">Exercise Price 2. 20 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.75Member" xlink:label="niobf_ExercisePrice1.75Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice1.75Member" xlink:to="niobf_ExercisePrice1.75Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice1.75Member_lbl" xml:lang="en-US">Exercise Price 1. 75 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.75OneMember" xlink:label="niobf_ExercisePrice1.75OneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice1.75OneMember" xlink:to="niobf_ExercisePrice1.75OneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice1.75OneMember_lbl" xml:lang="en-US">Exercise Price 1. 75 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice3.25Member" xlink:label="niobf_ExercisePrice3.25Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice3.25Member" xlink:to="niobf_ExercisePrice3.25Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice3.25Member_lbl" xml:lang="en-US">Exercise Price 3. 25 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.98Member" xlink:label="niobf_ExercisePrice1.98Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice1.98Member" xlink:to="niobf_ExercisePrice1.98Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice1.98Member_lbl" xml:lang="en-US">Exercise Price 1. 98 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice11.50Member" xlink:label="niobf_ExercisePrice11.50Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice11.50Member" xlink:to="niobf_ExercisePrice11.50Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice11.50Member_lbl" xml:lang="en-US">Exercise Price 11. 50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.31Member" xlink:label="niobf_ExercisePrice2.31Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.31Member" xlink:to="niobf_ExercisePrice2.31Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.31Member_lbl" xml:lang="en-US">Exercise Price 2. 31 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.05Member" xlink:label="niobf_ExercisePrice2.05Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.05Member" xlink:to="niobf_ExercisePrice2.05Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.05Member_lbl" xml:lang="en-US">Exercise Price 2. 05 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.07Member" xlink:label="niobf_ExercisePrice2.07Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.07Member" xlink:to="niobf_ExercisePrice2.07Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.07Member_lbl" xml:lang="en-US">Exercise Price 2. 07 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.07OneMember" xlink:label="niobf_ExercisePrice2.07OneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.07OneMember" xlink:to="niobf_ExercisePrice2.07OneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.07OneMember_lbl" xml:lang="en-US">Exercise Price 2. 07 One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.60Member" xlink:label="niobf_ExercisePrice2.60Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice2.60Member" xlink:to="niobf_ExercisePrice2.60Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExercisePrice2.60Member_lbl" xml:lang="en-US">Exercise Price 2. 60 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoteWarrantMember" xlink:label="us-gaap_NoteWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoteWarrantMember" xlink:to="us-gaap_NoteWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoteWarrantMember_lbl" xml:lang="en-US">Note Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_BlackScholesValuationMember" xlink:label="niobf_BlackScholesValuationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BlackScholesValuationMember" xlink:to="niobf_BlackScholesValuationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_BlackScholesValuationMember_lbl" xml:lang="en-US">Black Scholes Valuation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_lbl" xml:lang="en-US">Non Revolving Credit Facility Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="niobf_GeneralSecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeneralSecurityAgreementMember_lbl" xml:lang="en-US">General Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US">Liability Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BorrowingsMember" xlink:label="us-gaap_BorrowingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BorrowingsMember" xlink:to="us-gaap_BorrowingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BorrowingsMember_lbl" xml:lang="en-US">Borrowings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CostCentreAxis" xlink:label="niobf_CostCentreAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CostCentreAxis_lbl" xml:lang="en-US">Cost Centre [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="niobf_FeasibilityStudyAndEngineeringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FeasibilityStudyAndEngineeringMember" xlink:to="niobf_FeasibilityStudyAndEngineeringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FeasibilityStudyAndEngineeringMember_lbl" xml:lang="en-US">Feasibility Study And Engineering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="niobf_FieldManagementAndOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldManagementAndOtherMember" xlink:to="niobf_FieldManagementAndOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FieldManagementAndOtherMember_lbl" xml:lang="en-US">Field Management And Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DrillingMember" xlink:label="niobf_DrillingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DrillingMember" xlink:to="niobf_DrillingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DrillingMember_lbl" xml:lang="en-US">Drilling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_MetallurgicalMember" xlink:label="niobf_MetallurgicalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MetallurgicalMember" xlink:to="niobf_MetallurgicalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MetallurgicalMember_lbl" xml:lang="en-US">Metallurgical [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="niobf_GeologistsAndFieldStaffMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistsAndFieldStaffMember" xlink:to="niobf_GeologistsAndFieldStaffMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GeologistsAndFieldStaffMember_lbl" xml:lang="en-US">Geologists And Field Staff [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="country_CA" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_CA_lbl" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="country_US" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="country_GB" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl" xml:lang="en-US">UNITED KINGDOM</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchasesofLandMember" xlink:label="niobf_PurchasesofLandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchasesofLandMember" xlink:to="niobf_PurchasesofLandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PurchasesofLandMember_lbl" xml:lang="en-US">Purchasesof Land [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DoDAgreementMember" xlink:label="niobf_DoDAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DoDAgreementMember" xlink:to="niobf_DoDAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DoDAgreementMember_lbl" xml:lang="en-US">Do D Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorOpinionTextBlock_lbl" xml:lang="en-US">Auditor Opinion [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssets" xlink:label="us-gaap_DepositsAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssets" xlink:to="us-gaap_DepositsAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssets_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:to="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermInvestmentsAndReceivablesNet_lbl" xml:lang="en-US">Investment in equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Land and buildings, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:to="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties_lbl" xml:lang="en-US">Mineral properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Warrant liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Warrant liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="niobf_EarnoutLiabilityAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutLiabilityAtFairValue_lbl" xml:lang="en-US">Earnout liability, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_lbl" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, no par value, unlimited shares authorized;&#160; 58,491,196 and 38,062,647 shares outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:to="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorizedUnlimited_lbl" xml:lang="en-US">Common stock, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Employee related costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExplorationExpense" xlink:label="us-gaap_ExplorationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExplorationExpense_lbl" xml:lang="en-US">Exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralExpense" xlink:label="us-gaap_OtherGeneralExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralExpense_lbl" xml:lang="en-US">Other operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue" xlink:label="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue" xlink:to="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue_lbl" xml:lang="en-US">Change in fair value of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfWarrantLiabilityValue" xlink:label="niobf_ChangeInFairValueOfWarrantLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiabilityValue" xlink:to="niobf_ChangeInFairValueOfWarrantLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfWarrantLiabilityValue_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNotesValue" xlink:label="niobf_ChangeInFairValueOfConvertibleNotesValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotesValue" xlink:to="niobf_ChangeInFairValueOfConvertibleNotesValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfConvertibleNotesValue_lbl" xml:lang="en-US">Change in fair value of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange gain</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOperating" xlink:label="us-gaap_InterestIncomeOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOperating" xlink:to="us-gaap_InterestIncomeOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestIncomeOperating_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Other gains</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xml:lang="en-US">Loss on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Net loss and comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss attributable to redeemable noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_lbl" xml:lang="en-US">Net loss and net comprehensive loss attributable to the Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Loss per common share, basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Loss per common share, diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average common shares outstanding, basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average common shares outstanding, diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments for:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_lbl" xml:lang="en-US">Change in valuation of earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_lbl" xml:lang="en-US">Change in valuation of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNoteValue" xlink:label="niobf_ChangeInFairValueOfConvertibleNoteValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNoteValue" xlink:to="niobf_ChangeInFairValueOfConvertibleNoteValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ChangeInFairValueOfConvertibleNoteValue_lbl" xml:lang="en-US">Change in fair value of convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionExpense" xlink:label="us-gaap_AccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpense" xlink:to="us-gaap_AccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpense_lbl" xml:lang="en-US">Accretion of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="niobf_FairValueOfCommitmentSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueOfCommitmentSharesIssued_lbl" xml:lang="en-US">Yorkville share issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of insider warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Unrealized loss on equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US">Noncash lease activity</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="niobf_OtheroperatingGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_OtheroperatingGainsLosses_lbl" xml:lang="en-US">Other gains</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in working capital items:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="us-gaap_PaymentsToAcquireOtherInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_lbl" xml:lang="en-US">Acquisition of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForDeposits" xlink:label="us-gaap_PaymentsForDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForDeposits" xlink:to="us-gaap_PaymentsForDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForDeposits_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Issuance of debt, net of costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Related party debt draws</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Related party debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Debt repayments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Share issue costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Change in cash and cash equivalents during period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Amounts paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash investing and financing transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="niobf_ConversionsOfDebtForCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConversionsOfDebtForCommonShares_lbl" xml:lang="en-US">Conversion of debt for common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ValueOfWarrantsIssued" xlink:label="niobf_ValueOfWarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ValueOfWarrantsIssued_lbl" xml:lang="en-US">Value of Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Beginning balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueEquityPlacement" xlink:label="niobf_StockIssuedDuringPeriodValueEquityPlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueEquityPlacement" xlink:to="niobf_StockIssuedDuringPeriodValueEquityPlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueEquityPlacement_lbl" xml:lang="en-US">Equity placements</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesEquityPlacement" xlink:label="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement" xlink:to="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement_lbl" xml:lang="en-US">Equity placements (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" xlink:label="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" xlink:to="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_lbl" xml:lang="en-US">Yorkville equity facility draws</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" xlink:label="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" xlink:to="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_lbl" xml:lang="en-US">Yorkville equity facility draws (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:to="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised_lbl" xml:lang="en-US">Warrant exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised" xlink:label="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised" xlink:to="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised_lbl" xml:lang="en-US">Warrant exercises (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Option exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Option exercises (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares" xlink:label="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares" xlink:to="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares_lbl" xml:lang="en-US">Redemption of vested shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" xlink:label="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" xlink:to="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_lbl" xml:lang="en-US">Redemptions of vested shares (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xml:lang="en-US">Debt conversions</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_lbl" xml:lang="en-US">Debt conversions (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" xlink:label="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" xlink:to="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_lbl" xml:lang="en-US">Issuance of Lind Consent warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of private warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_lbl" xml:lang="en-US">Option liability valuations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Loss for the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Ending balance (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="ecd_AwardTmgDiscLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgDiscLineItems" xlink:to="ecd_AwardTmgDiscLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgDiscLineItems_lbl" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="cyd_MaterialCybersecurityIncidentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentAbstract" xlink:to="cyd_MaterialCybersecurityIncidentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentAbstract_lbl" xml:lang="en-US">Material Cybersecurity Incident [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Nature [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Scope [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Timing [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US">BASIS OF PREPARATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">GOING CONCERN ISSUES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">LAND AND BUILDINGS, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="srt_ExtractiveIndustriesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ExtractiveIndustriesAbstract" xlink:to="srt_ExtractiveIndustriesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ExtractiveIndustriesAbstract_lbl" xml:lang="en-US">Extractive Industries [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="us-gaap_MineralIndustriesDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:to="us-gaap_MineralIndustriesDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MineralIndustriesDisclosuresTextBlock_lbl" xml:lang="en-US">MINERAL PROPERTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">CONVERTIBLE DEBT</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:to="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureClassBCommonStockOfEcrcAbstract_lbl" xml:lang="en-US">Class B Common Stock Of Ecrc</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureOfClassBCommonStockOfECRCTextBlock" xlink:label="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock" xlink:to="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock_lbl" xml:lang="en-US">CLASS B COMMON STOCK OF ECRC</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">COMMON SHARES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS AND BALANCES</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="niobf_DisclosureExplorationExpendituresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureExplorationExpendituresAbstract" xlink:to="niobf_DisclosureExplorationExpendituresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureExplorationExpendituresAbstract_lbl" xml:lang="en-US">Exploration Expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_lbl" xml:lang="en-US">EXPLORATION EXPENDITURES</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="niobf_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementInputsDisclosureTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:to="niobf_DevelopmentStageIssuerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock_lbl" xml:lang="en-US">Development Stage Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_MineralPropertiesPolicyTextBlock" xlink:label="niobf_MineralPropertiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MineralPropertiesPolicyTextBlock" xlink:to="niobf_MineralPropertiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_MineralPropertiesPolicyTextBlock_lbl" xml:lang="en-US">Mineral Properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock" xlink:label="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock" xlink:to="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock_lbl" xml:lang="en-US">Convertible Debt Carried at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantsPolicyTextBlock" xlink:label="niobf_WarrantsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsPolicyTextBlock" xlink:to="niobf_WarrantsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantsPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutSharesPolicyTextBlock" xlink:label="niobf_EarnoutSharesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesPolicyTextBlock" xlink:to="niobf_EarnoutSharesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesPolicyTextBlock_lbl" xml:lang="en-US">Earnout Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="us-gaap_AssetRetirementObligationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationsPolicy" xlink:to="us-gaap_AssetRetirementObligationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationsPolicy_lbl" xml:lang="en-US">Asset Retirement Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_lbl" xml:lang="en-US">Redeemable Noncontrolling Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Per Share Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_lbl" xml:lang="en-US">These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_lbl" xml:lang="en-US">Schedule of excluded from the dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of account payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_lbl" xml:lang="en-US">Schedule of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of changes in the convertible debentures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_lbl" xml:lang="en-US">Schedule of components of interest expense with convertible debenture</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:label="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:to="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock_lbl" xml:lang="en-US">Schedule of primary inputs for the Monte Carlo model</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of changes in the fair value of April 2024 Note</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:label="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:to="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_lbl" xml:lang="en-US">Schedule of Black-Scholes model used in April 2024 Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_lbl" xml:lang="en-US">Schedule of changes in fair value of April 2024 Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_lbl" xml:lang="en-US">Schedule of key valuation input</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value of the Earnout Shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Black-Scholes model used in Private warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_lbl" xml:lang="en-US">Schedule of changes in the fair value of Private Warrants liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" xlink:label="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_lbl" xml:lang="en-US">Schedule of Black-Scholes model for warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:label="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:to="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_lbl" xml:lang="en-US">Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of option</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted average and assumptions used to option costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Weighted average exercise prices</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_lbl" xml:lang="en-US">Schedule of outstanding exercisable Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Company classifies the 2023 Private Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_lbl" xml:lang="en-US">Schedule of change in the 2023 Private Warrants liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Black-Scholes valuation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_lbl" xml:lang="en-US">Schedule of change in fair value of Warrants liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_lbl" xml:lang="en-US">Schedule of exploration expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">The Company incurred lease costs as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">The maturity of lease liabilities is as follows at June 30, 2025:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">The following table is a reconciliation of income taxes at statutory rates:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock_lbl" xml:lang="en-US">Changes in the valuation allowance are as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_lbl" xml:lang="en-US">Schedule of cumulative net operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xml:lang="en-US">Schedule of fair values determined by level 3 inputs are unobservable data</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_lbl" xml:lang="en-US">Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_lbl" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_IncorporationStateCountryName" xlink:label="niobf_IncorporationStateCountryName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncorporationStateCountryName" xlink:to="niobf_IncorporationStateCountryName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_IncorporationStateCountryName_lbl" xml:lang="en-US">Jurisdiction of incorporation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Ownership at June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xml:lang="en-US">Number of reportable segments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Adjust: Net loss attributable to noncontrolling interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss available to participating securities</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NetLossAttributableToVestedShares" xlink:label="niobf_NetLossAttributableToVestedShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NetLossAttributableToVestedShares" xlink:to="niobf_NetLossAttributableToVestedShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_NetLossAttributableToVestedShares_lbl" xml:lang="en-US">Net loss attributable to Vested Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_lbl" xml:lang="en-US">Net loss attributed to common shareholders - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:to="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_lbl" xml:lang="en-US">Net loss attributed to common shareholders - diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average shares outstanding - basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted average shares outstanding - diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Loss per Common Share outstanding - basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Loss per Common Share outstanding - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:to="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions_lbl" xml:lang="en-US">Options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecurities" xlink:label="us-gaap_DilutiveSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecurities" xlink:to="us-gaap_DilutiveSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecurities_lbl" xml:lang="en-US">Total potentially dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MineralPropertiesAccumulatedImpairment" xlink:label="us-gaap_MineralPropertiesAccumulatedImpairment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MineralPropertiesAccumulatedImpairment" xlink:to="us-gaap_MineralPropertiesAccumulatedImpairment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MineralPropertiesAccumulatedImpairment_lbl" xml:lang="en-US">Impairment to mineral properties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xml:lang="en-US">Accrued Exploration Stage Obligations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Net proceeds from public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfDebt_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl" xml:lang="en-US">Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Net</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExplorationExpenseForOTPExtensionPayments" xlink:label="niobf_ExplorationExpenseForOTPExtensionPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenseForOTPExtensionPayments" xlink:to="niobf_ExplorationExpenseForOTPExtensionPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExplorationExpenseForOTPExtensionPayments_lbl" xml:lang="en-US">Exploration expense for OTP extension payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FutureOptionToPurchaseExtensionPaymentObligations" xlink:label="niobf_FutureOptionToPurchaseExtensionPaymentObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FutureOptionToPurchaseExtensionPaymentObligations" xlink:to="niobf_FutureOptionToPurchaseExtensionPaymentObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FutureOptionToPurchaseExtensionPaymentObligations_lbl" xml:lang="en-US">Future Option to Purchase Extension Payment Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="us-gaap_AccountsPayableTradeCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Accounts payable, trade</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Trade payable accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Environmental accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Loan origination fees payable to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Total convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ConvertibleDebt_2_lbl" xml:lang="en-US">Balance at June 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:to="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionExpenseIncludingAssetRetirementObligations_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="niobf_PrincipalAndAccruedInterestConverted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrincipalAndAccruedInterestConverted_lbl" xml:lang="en-US">Principal and interest converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ConvertibleDebt_3_lbl" xml:lang="en-US">Balance, December 31, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of discount and issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ContractualInterest" xlink:label="niobf_ContractualInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ContractualInterest" xlink:to="niobf_ContractualInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ContractualInterest_lbl" xml:lang="en-US">Contractual interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestAndDebtExpense" xlink:label="us-gaap_InterestAndDebtExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDebtExpense_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Business Combination [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Combination [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Closing common share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Closing common share price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_lbl" xml:lang="en-US">Term (expiry)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Equity volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ImpliedDiscountRate" xlink:label="niobf_ImpliedDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ImpliedDiscountRate" xlink:to="niobf_ImpliedDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ImpliedDiscountRate_lbl" xml:lang="en-US">Implied discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_lbl" xml:lang="en-US">Fair value, April 12, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Principal payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValue" xlink:label="niobf_ChangeInFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValue" xlink:to="niobf_ChangeInFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValue_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_2_lbl" xml:lang="en-US">Balance, June 30, 2024</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_3_lbl" xml:lang="en-US">Closing Common Share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Term (years)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_2_lbl" xml:lang="en-US">Other Liabilities, Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Convertible debt, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Aggregate principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_lbl" xml:lang="en-US">Number of shares purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Number of shares purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Principal and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Principal and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Transaction loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_lbl" xml:lang="en-US">Fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Transaction loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_lbl" xml:lang="en-US">Implied volatility of public warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_lbl" xml:lang="en-US">Fair value at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingLiabilityAtFairValueAdditionsValue" xlink:label="niobf_ServicingLiabilityAtFairValueAdditionsValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ServicingLiabilityAtFairValueAdditionsValue" xlink:to="niobf_ServicingLiabilityAtFairValueAdditionsValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ServicingLiabilityAtFairValueAdditionsValue_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_2_lbl" xml:lang="en-US">Fair value at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Common stock, shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Common stock, shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Earnout shares</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="niobf_DescriptionOfEarnOutShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfEarnOutShares" xlink:to="niobf_DescriptionOfEarnOutShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DescriptionOfEarnOutShares_lbl" xml:lang="en-US">Description of earnout shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Term (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="niobf_ChangesInFairValueOfInitialValuation1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueOfWarrantsExercised" xlink:label="niobf_FairValueOfWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfWarrantsExercised" xlink:to="niobf_FairValueOfWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_FairValueOfWarrantsExercised_lbl" xml:lang="en-US">Fair value of Warrants exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_lbl" xml:lang="en-US">Change in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonStockSharesIssued1" xlink:label="niobf_CommonStockSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonStockSharesIssued1" xlink:to="niobf_CommonStockSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonStockSharesIssued1_lbl" xml:lang="en-US">Common shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Gross funds received</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Market value of Common Shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:label="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:to="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_lbl" xml:lang="en-US">(Gain)/Loss on Issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted, in shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted, per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Cancelled/expired, in shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled/expired, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Cancelled/expired, in shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Cancelled/expired, per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Fair value per option granted during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Beginning balance, Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Beginning balance at Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightGranted" xlink:label="niobf_ClassOfWarrantOrRightGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightGranted" xlink:to="niobf_ClassOfWarrantOrRightGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightGranted_lbl" xml:lang="en-US">Beginning balance, Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_lbl" xml:lang="en-US">Beginning balance at Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="niobf_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Beginning balance, Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_lbl" xml:lang="en-US">Beginning balance at Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercised" xlink:label="niobf_ClassOfWarrantOrRightExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US">Beginning balance, Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_lbl" xml:lang="en-US">Beginning balance at Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Beginning balance, Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xml:lang="en-US">Beginning balance at Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Number of share outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xml:lang="en-US">Expiry date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="srt_PlatformOperatorCryptoAssetTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetTable" xlink:to="srt_PlatformOperatorCryptoAssetTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetTable_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="srt_PlatformOperatorCryptoAssetLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetLineItems" xlink:to="srt_PlatformOperatorCryptoAssetLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetLineItems_lbl" xml:lang="en-US">Platform Operator, Crypto Asset [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Stock price on valuation date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_4_lbl" xml:lang="en-US">Strike price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_lbl" xml:lang="en-US">Risk free rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3_lbl" xml:lang="en-US">Expected warrant life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="niobf_ChangesInFairValueOfInitialValuation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation_lbl" xml:lang="en-US">Initial valuation, at begining</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_2_lbl" xml:lang="en-US">Change in valuation</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExchangeOfPrivateWarrantsForPublicWarrants" xlink:label="niobf_ExchangeOfPrivateWarrantsForPublicWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExchangeOfPrivateWarrantsForPublicWarrants" xlink:to="niobf_ExchangeOfPrivateWarrantsForPublicWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExchangeOfPrivateWarrantsForPublicWarrants_lbl" xml:lang="en-US">Exchange of 2023 Private Warrants for 2023 Public Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_3_lbl" xml:lang="en-US">Fair value of Warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GainOnIssuanceOfWarrants" xlink:label="niobf_GainOnIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GainOnIssuanceOfWarrants" xlink:to="niobf_GainOnIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_GainOnIssuanceOfWarrants_lbl" xml:lang="en-US">Gain on issuance of Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="niobf_ChangesInFairValueOfInitialValuation_2_lbl" xml:lang="en-US">Valuation, at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xml:lang="en-US">Description of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DebtInstrumentIssuedPrincipalshars" xlink:label="niobf_DebtInstrumentIssuedPrincipalshars" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtInstrumentIssuedPrincipalshars" xlink:to="niobf_DebtInstrumentIssuedPrincipalshars_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DebtInstrumentIssuedPrincipalshars_lbl" xml:lang="en-US">Debt Instrument Issued Principalshars</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Shares issue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xml:lang="en-US">Fair value of non operating gain/loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Remaining proceeds from private warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RegisteredOffering" xlink:label="niobf_RegisteredOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RegisteredOffering" xlink:to="niobf_RegisteredOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_RegisteredOffering_lbl" xml:lang="en-US">Registered Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrivateOffering" xlink:label="niobf_PrivateOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivateOffering" xlink:to="niobf_PrivateOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PrivateOffering_lbl" xml:lang="en-US">Private Offering</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonShareDescription" xlink:label="niobf_CommonShareDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonShareDescription" xlink:to="niobf_CommonShareDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CommonShareDescription_lbl" xml:lang="en-US">Common share, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="niobf_SaleOfStockPricePerShare1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SaleOfStockPricePerShare1" xlink:to="niobf_SaleOfStockPricePerShare1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_SaleOfStockPricePerShare1_lbl" xml:lang="en-US">Shares price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xml:lang="en-US">Proceeds from equity</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:to="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_lbl" xml:lang="en-US">Expected dividend rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Units issue and sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="us-gaap_OtherCostAndExpenseOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherCostAndExpenseOperating_lbl" xml:lang="en-US">Other operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xml:lang="en-US">Employee related costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Expires date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xml:lang="en-US">Outstanding stock options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_UnrecognizedCompensationCosts" xlink:label="niobf_UnrecognizedCompensationCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_UnrecognizedCompensationCosts" xlink:to="niobf_UnrecognizedCompensationCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_UnrecognizedCompensationCosts_lbl" xml:lang="en-US">Unrecognized compensation costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Warrants traded prior to the closing</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExchangeOfWarrantsDescription" xlink:label="niobf_ExchangeOfWarrantsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExchangeOfWarrantsDescription" xlink:to="niobf_ExchangeOfWarrantsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ExchangeOfWarrantsDescription_lbl" xml:lang="en-US">Exchange of warrants, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription_lbl" xml:lang="en-US">Contingent consideration description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Stock issued, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Common share exercise price, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GainOnIssuanceOfWarrants" xlink:to="niobf_GainOnIssuanceOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_GainOnIssuanceOfWarrants_2_lbl" xml:lang="en-US">Gain on issuance of Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xml:lang="en-US">Long-Term Line of Credit, Noncurrent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="us-gaap_RelatedPartyTransactionRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionRate" xlink:to="us-gaap_RelatedPartyTransactionRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionRate_lbl" xml:lang="en-US">Related Party Transaction, Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LineOfCreditFacilityEstablishmentFee" xlink:label="niobf_LineOfCreditFacilityEstablishmentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityEstablishmentFee" xlink:to="niobf_LineOfCreditFacilityEstablishmentFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LineOfCreditFacilityEstablishmentFee_lbl" xml:lang="en-US">Line Of Credit Facility Establishment Fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherBorrowings" xlink:label="us-gaap_OtherBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherBorrowings" xlink:to="us-gaap_OtherBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherBorrowings_lbl" xml:lang="en-US">Other Borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoanProcessingFee" xlink:label="us-gaap_LoanProcessingFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanProcessingFee" xlink:to="us-gaap_LoanProcessingFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanProcessingFee_lbl" xml:lang="en-US">Loan Origination fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding" xlink:label="us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding" xlink:to="us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding_lbl" xml:lang="en-US">Interest-Bearing Liabilities, Average Amount Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExplorationExpense" xlink:to="us-gaap_ExplorationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExplorationExpense_2_lbl" xml:lang="en-US">Exploration Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_DisclosureLeasesAbstract_2_lbl" xml:lang="en-US">Company Incurred Lease Costs As Follows</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FixedRentExpense" xlink:label="niobf_FixedRentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FixedRentExpense_lbl" xml:lang="en-US">Fixed rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableLeaseCost_lbl" xml:lang="en-US">Variable rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short term lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SubleaseIncome_lbl" xml:lang="en-US">Sublease income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Net lease cost &#8211; other operating expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureLeasesAbstract" xlink:to="niobf_DisclosureLeasesAbstract_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="niobf_DisclosureLeasesAbstract_3_lbl" xml:lang="en-US">Maturity Of Lease Liabilities Is As Follows At June 30 2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_TotalLeasePayments" xlink:label="niobf_TotalLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalLeasePayments" xlink:to="niobf_TotalLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_TotalLeasePayments_lbl" xml:lang="en-US">Total lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_lbl" xml:lang="en-US">Less amount of payments representing interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:to="niobf_LessCurrentPortionOfOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability_lbl" xml:lang="en-US">Less current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_OperatingLeasesLiabilityNoncurrent" xlink:label="niobf_OperatingLeasesLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OperatingLeasesLiabilityNoncurrent" xlink:to="niobf_OperatingLeasesLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OperatingLeasesLiabilityNoncurrent_lbl" xml:lang="en-US">Noncurrent operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xml:lang="en-US">Remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax benefit at Canadian federal rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">Income tax benefit at Canadian provincial rate</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantLiability" xlink:label="niobf_WarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiability" xlink:to="niobf_WarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_WarrantLiability_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutSharesLiability" xlink:label="niobf_EarnoutSharesLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesLiability" xlink:to="niobf_EarnoutSharesLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_EarnoutSharesLiability_lbl" xml:lang="en-US">Earnout shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign rate differential</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense_lbl" xml:lang="en-US">Accretion expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Change in estimates related to prior years</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PaymentsOfStockIssuanceCost" xlink:label="niobf_PaymentsOfStockIssuanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PaymentsOfStockIssuanceCost" xlink:to="niobf_PaymentsOfStockIssuanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_PaymentsOfStockIssuanceCost_lbl" xml:lang="en-US">Stock issuance costs in equity</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ConvertibleNoteValuation" xlink:label="niobf_ConvertibleNoteValuation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleNoteValuation" xlink:to="niobf_ConvertibleNoteValuation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_ConvertibleNoteValuation_lbl" xml:lang="en-US">Convertible note valuation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating losses available for future periods</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="niobf_DeferredTaxAssetsMineralInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsMineralInterest" xlink:to="niobf_DeferredTaxAssetsMineralInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsMineralInterest_lbl" xml:lang="en-US">Mineral interests</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:to="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_lbl" xml:lang="en-US">Startup and organizational costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:to="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:to="niobf_DeferredTaxAssetsShareIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts_lbl" xml:lang="en-US">Share issuance/financing costs</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" xlink:label="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" xlink:to="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_lbl" xml:lang="en-US">Canadian restricted interest and financing carryforward</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossesAvailableForFuturePeriods" xlink:to="niobf_CapitalLossesAvailableForFuturePeriods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods_lbl" xml:lang="en-US">Capital losses available for future periods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Valuation allowance, beginning of year</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_lbl" xml:lang="en-US">Current year additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Valuation allowance, end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOtherLossCarryforwards_lbl" xml:lang="en-US">Tax losses incurred</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CapitalLossCaryforward" xlink:label="niobf_CapitalLossCaryforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossCaryforward" xlink:to="niobf_CapitalLossCaryforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_CapitalLossCaryforward_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xml:lang="en-US">Fair Value, off-Balance-Sheet Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xml:lang="en-US">Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_lbl" xml:lang="en-US">Investment in equity securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">April 2024 notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:to="us-gaap_OtherLiabilitiesFairValueDisclosure_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesFairValueDisclosure_3_lbl" xml:lang="en-US">Earnout Shares liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xml:lang="en-US">Warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventDescription" xlink:label="us-gaap_SubsequentEventDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventDescription" xlink:to="us-gaap_SubsequentEventDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventDescription_lbl" xml:lang="en-US">Subsequent event description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Issuance of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Cash received</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Exchnage for shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireLand" xlink:label="us-gaap_PaymentsToAcquireLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireLand" xlink:to="us-gaap_PaymentsToAcquireLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireLand_lbl" xml:lang="en-US">Agregate purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromCustomersForProgressPayments" xlink:label="us-gaap_ProceedsFromCustomersForProgressPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCustomersForProgressPayments" xlink:to="us-gaap_ProceedsFromCustomersForProgressPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromCustomersForProgressPayments_lbl" xml:lang="en-US">Reimbursement Payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsEachExercisableFor1.11829212Member" xlink:to="niobf_WarrantsEachExercisableFor1.11829212Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantsEachExercisableFor1.11829212Member_doc" xml:lang="en-US">The element represents warrants each exercisable for1.11829212 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonSharesWithoutParValueMember" xlink:to="niobf_CommonSharesWithoutParValueMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonSharesWithoutParValueMember_doc" xml:lang="en-US">The element represents common shares without par value member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutLiabilityAtFairValue" xlink:to="niobf_EarnoutLiabilityAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutLiabilityAtFairValue_doc" xml:lang="en-US">The element represents earnout liability at fair value.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExplorationExpenditures" xlink:label="niobf_ExplorationExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenditures" xlink:to="niobf_ExplorationExpenditures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpenditures_doc" xml:lang="en-US">The element represents exploration expenditures.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfEarnoutSharesLiability" xlink:label="niobf_ChangeInFairValueOfEarnoutSharesLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutSharesLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutSharesLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutSharesLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout shares liability.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfWarrantLiability" xlink:label="niobf_ChangeInFairValueOfWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiability" xlink:to="niobf_ChangeInFairValueOfWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfWarrantLiability_doc" xml:lang="en-US">The element represents change in fair value of warrant liability.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNotes" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotes" xlink:to="niobf_ChangeInFairValueOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNotes_doc" xml:lang="en-US">The element represents change in fair value of convertible notes.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1" xlink:to="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1_doc" xml:lang="en-US">The element represents income loss from continuing operations before income taxes extraordinary items noncontrolling interest1.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarningsLossPerShareBasicAndDiluted" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarningsLossPerShareBasicAndDiluted" xlink:to="niobf_EarningsLossPerShareBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarningsLossPerShareBasicAndDiluted_doc" xml:lang="en-US">The element represents earnings loss per share basic and diluted.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted_doc" xml:lang="en-US">The element represents total weighted average number of share outstanding basic and diluted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_doc" xml:lang="en-US">The element represents change in fair value of earnout share liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_doc" xml:lang="en-US">The element represents change in valuation of warrant liabilities.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNote" xlink:label="niobf_ChangeInFairValueOfConvertibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNote" xlink:to="niobf_ChangeInFairValueOfConvertibleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNote_doc" xml:lang="en-US">The element represents change in fair value of convertible note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfCommitmentSharesIssued" xlink:to="niobf_FairValueOfCommitmentSharesIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueOfCommitmentSharesIssued_doc" xml:lang="en-US">The element represents fair value of commitment shares issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OtheroperatingGainsLosses_doc" xml:lang="en-US">The element represents otheroperating gains losses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConversionsOfDebtForCommonShares" xlink:to="niobf_ConversionsOfDebtForCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConversionsOfDebtForCommonShares_doc" xml:lang="en-US">The element represents conversions of debt for common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ValueOfWarrantsIssued" xlink:to="niobf_ValueOfWarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ValueOfWarrantsIssued_doc" xml:lang="en-US">The element represents value of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PaymentsOfStockIssuanceCost" xlink:to="niobf_PaymentsOfStockIssuanceCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PaymentsOfStockIssuanceCost_doc" xml:lang="en-US">The element represents payments of stock issuance cost.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_AdjustmentsToReconcileNetIncomeLossesToCashProvidedByUsedInOperatingActivities" xlink:label="niobf_AdjustmentsToReconcileNetIncomeLossesToCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AdjustmentsToReconcileNetIncomeLossesToCashProvidedByUsedInOperatingActivities" xlink:to="niobf_AdjustmentsToReconcileNetIncomeLossesToCashProvidedByUsedInOperatingActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AdjustmentsToReconcileNetIncomeLossesToCashProvidedByUsedInOperatingActivities_doc" xml:lang="en-US">The element represents adjustments to reconcile net income losses to cash provided by used in operating activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestMember" xlink:to="niobf_RedeemableNoncontrollingInterestMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RedeemableNoncontrollingInterestMember_doc" xml:lang="en-US">The element represents redeemable noncontrolling interest member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueEquityPlacement" xlink:to="niobf_StockIssuedDuringPeriodValueEquityPlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueEquityPlacement_doc" xml:lang="en-US">The element represents stock issued during period value equity placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" xlink:to="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws_doc" xml:lang="en-US">The element represents stock issued during period value yorkville equity facility draws.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:to="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueStockWarrantsExercised_doc" xml:lang="en-US">The element represents stock issued during period value stock warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" xlink:to="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants_doc" xml:lang="en-US">The element represents stock issued during period value issuance of lind consent warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement" xlink:to="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueSharesEquityPlacement_doc" xml:lang="en-US">The element represents stock issued during period value shares equity placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" xlink:to="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws_doc" xml:lang="en-US">The element represents stock issued during period value shares yorkville equity facility draws.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised" xlink:to="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised_doc" xml:lang="en-US">The element represents stock issued during period value shares stock warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" xlink:to="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares_doc" xml:lang="en-US">The element represents stock issued during period value shares redemptions of vested shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares" xlink:to="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares_doc" xml:lang="en-US">The element represents stock issued during period value redemptions of vested shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments_doc" xml:lang="en-US">The element represents stock issued during period value shares conversion of convertible securities net of adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncorporationStateCountryName" xlink:to="niobf_IncorporationStateCountryName_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncorporationStateCountryName_doc" xml:lang="en-US">The element represents incorporation state country name.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_Entity0896800BCLtdMember" xlink:to="niobf_Entity0896800BCLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_Entity0896800BCLtdMember_doc" xml:lang="en-US">The element represents entity0896800 b c ltd member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ElkCreekResourcesCorpECRCMember" xlink:to="niobf_ElkCreekResourcesCorpECRCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ElkCreekResourcesCorpECRCMember_doc" xml:lang="en-US">The element represents elk creek resources corp e c r c member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NioCorpTechnologiesLimitedMember" xlink:to="niobf_NioCorpTechnologiesLimitedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NioCorpTechnologiesLimitedMember_doc" xml:lang="en-US">The element represents nio corp technologies limited member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:to="niobf_DevelopmentStageIssuerPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DevelopmentStageIssuerPolicyTextBlock_doc" xml:lang="en-US">The element represents development stage issuer policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MineralPropertiesPolicyTextBlock" xlink:to="niobf_MineralPropertiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MineralPropertiesPolicyTextBlock_doc" xml:lang="en-US">The element represents mineral properties policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock" xlink:to="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock_doc" xml:lang="en-US">The element represents convertible debt carriedat fair value policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantsPolicyTextBlock" xlink:to="niobf_WarrantsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantsPolicyTextBlock_doc" xml:lang="en-US">The element represents warrants policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesPolicyTextBlock" xlink:to="niobf_EarnoutSharesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesPolicyTextBlock_doc" xml:lang="en-US">The element represents earnout shares policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:to="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RedeemableNoncontrollingInterestPolicyTextBlock_doc" xml:lang="en-US">The element represents redeemable noncontrolling interest policy text block.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WorkingCapitalDeficit" xlink:label="niobf_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WorkingCapitalDeficit" xlink:to="niobf_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WorkingCapitalDeficit_doc" xml:lang="en-US">The element represents working capital deficit.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CashAndCashEquivalentsAtCarryingValue1" xlink:to="niobf_CashAndCashEquivalentsAtCarryingValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CashAndCashEquivalentsAtCarryingValue1_doc" xml:lang="en-US">The element represents cash and cash equivalents at carrying value1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FutureOptionToPurchaseExtensionPaymentObligations" xlink:to="niobf_FutureOptionToPurchaseExtensionPaymentObligations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FutureOptionToPurchaseExtensionPaymentObligations_doc" xml:lang="en-US">The element represents future option to purchase extension payment obligations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpenseForOTPExtensionPayments" xlink:to="niobf_ExplorationExpenseForOTPExtensionPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpenseForOTPExtensionPayments_doc" xml:lang="en-US">The element represents exploration expense for o t p extension payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NetLossAttributableToVestedShares" xlink:to="niobf_NetLossAttributableToVestedShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NetLossAttributableToVestedShares_doc" xml:lang="en-US">The element represents net loss attributable to vested shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DebtInstrumentIssuedPrincipalshars" xlink:to="niobf_DebtInstrumentIssuedPrincipalshars_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DebtInstrumentIssuedPrincipalshars_doc" xml:lang="en-US">The element represents debt instrument issued principalshars.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesAMember" xlink:to="niobf_PurchaseAgreementSeriesAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PurchaseAgreementSeriesAMember_doc" xml:lang="en-US">The element represents purchase agreement series a member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchaseAgreementSeriesBMember" xlink:to="niobf_PurchaseAgreementSeriesBMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PurchaseAgreementSeriesBMember_doc" xml:lang="en-US">The element represents purchase agreement series b member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_doc" xml:lang="en-US">The element represents fair value assets and liability measured on recurring and nonrecurring basis table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesAPublicWarrantsMember" xlink:to="niobf_SeriesAPublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SeriesAPublicWarrantsMember_doc" xml:lang="en-US">The element represents series a public warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesBPublicWarrantsMember" xlink:to="niobf_SeriesBPublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SeriesBPublicWarrantsMember_doc" xml:lang="en-US">The element represents series b public warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_RegisteredOffering" xlink:to="niobf_RegisteredOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_RegisteredOffering_doc" xml:lang="en-US">The element represents registered offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivateOffering" xlink:to="niobf_PrivateOffering_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivateOffering_doc" xml:lang="en-US">The element represents private offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesAPrivateWarrantsMember" xlink:to="niobf_SeriesAPrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SeriesAPrivateWarrantsMember_doc" xml:lang="en-US">The element represents series a private warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PublicWarrantsMember" xlink:to="niobf_PublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PublicWarrantsMember_doc" xml:lang="en-US">The element represents public warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrivateWarrantsMember" xlink:to="niobf_PrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrivateWarrantsMember_doc" xml:lang="en-US">The element represents private warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SeriesBPrivateWarrantsMember" xlink:to="niobf_SeriesBPrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SeriesBPrivateWarrantsMember_doc" xml:lang="en-US">The element represents series b private warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonShareDescription" xlink:to="niobf_CommonShareDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonShareDescription_doc" xml:lang="en-US">The element represents common share description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in the fair value of private warrants table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_doc" xml:lang="en-US">The element represents changes in fair value of initial valuation1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NovemberPrivateWarrantsliabilitiesMember" xlink:to="niobf_NovemberPrivateWarrantsliabilitiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NovemberPrivateWarrantsliabilitiesMember_doc" xml:lang="en-US">The element represents november private warrantsliabilities member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfWarrantsExercised" xlink:to="niobf_FairValueOfWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueOfWarrantsExercised_doc" xml:lang="en-US">The element represents fair value of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" xlink:to="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents fair value assets and liability measured on recurring and nonrecurring basis of warrants table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SaleOfStockPricePerShare1" xlink:to="niobf_SaleOfStockPricePerShare1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SaleOfStockPricePerShare1_doc" xml:lang="en-US">The element represents sale of stock price per share1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:to="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_doc" xml:lang="en-US">The element represents share based compensation arrangement by share based payment award fair value assumptions expected volatility rate1.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_AdgMember" xlink:label="niobf_AdgMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AdgMember" xlink:to="niobf_AdgMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AdgMember_doc" xml:lang="en-US">The element represents adg member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:to="niobf_YorkvilleEquityFacilityFinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleEquityFacilityFinancingAgreementMember_doc" xml:lang="en-US">The element represents yorkville equity facility financing agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:to="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_doc" xml:lang="en-US">The element represents schedule common shares under facility financing agreement table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CommonStockSharesIssued1" xlink:to="niobf_CommonStockSharesIssued1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CommonStockSharesIssued1_doc" xml:lang="en-US">The element represents common stock shares issued1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_UnrecognizedCompensationCosts" xlink:to="niobf_UnrecognizedCompensationCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_UnrecognizedCompensationCosts_doc" xml:lang="en-US">The element represents unrecognized compensation costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightGranted" xlink:to="niobf_ClassOfWarrantOrRightGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightGranted_doc" xml:lang="en-US">The element represents class of warrant or right granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">The element represents class of warrant or right expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercised_doc" xml:lang="en-US">The element represents class of warrant or right exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_doc" xml:lang="en-US">The element represents class of warrant or right exercise price expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_doc" xml:lang="en-US">The element represents class of warrant or right exercise price exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceGranted_doc" xml:lang="en-US">The element represents class of warrant or right exercise price granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of outstanding exercisable warrants table text block.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice970Member" xlink:label="niobf_ExercisePrice970Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice970Member" xlink:to="niobf_ExercisePrice970Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice970Member_doc" xml:lang="en-US">The element represents exercise price9.70 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice894Member" xlink:label="niobf_ExercisePrice894Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice894Member" xlink:to="niobf_ExercisePrice894Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice894Member_doc" xml:lang="en-US">The element represents exercise price8.94 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice260Member" xlink:label="niobf_ExercisePrice260Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice260Member" xlink:to="niobf_ExercisePrice260Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice260Member_doc" xml:lang="en-US">The element represents exercise price2.60 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice270Member" xlink:label="niobf_ExercisePrice270Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice270Member" xlink:to="niobf_ExercisePrice270Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice270Member_doc" xml:lang="en-US">The element represents exercise price2.70 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice207Member" xlink:label="niobf_ExercisePrice207Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice207Member" xlink:to="niobf_ExercisePrice207Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice207Member_doc" xml:lang="en-US">The element represents exercise price2.07 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice207OneMember" xlink:label="niobf_ExercisePrice207OneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice207OneMember" xlink:to="niobf_ExercisePrice207OneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice207OneMember_doc" xml:lang="en-US">The element represents exercise price2.07 one member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice205Member" xlink:label="niobf_ExercisePrice205Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice205Member" xlink:to="niobf_ExercisePrice205Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice205Member_doc" xml:lang="en-US">The element represents exercise price2.05 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice231Member" xlink:label="niobf_ExercisePrice231Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice231Member" xlink:to="niobf_ExercisePrice231Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice231Member_doc" xml:lang="en-US">The element represents exercise price2.31 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1150Member" xlink:label="niobf_ExercisePrice1150Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice1150Member" xlink:to="niobf_ExercisePrice1150Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice1150Member_doc" xml:lang="en-US">The element represents exercise price11.50 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice198Member" xlink:label="niobf_ExercisePrice198Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice198Member" xlink:to="niobf_ExercisePrice198Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice198Member_doc" xml:lang="en-US">The element represents exercise price1.98 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice325Member" xlink:label="niobf_ExercisePrice325Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice325Member" xlink:to="niobf_ExercisePrice325Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice325Member_doc" xml:lang="en-US">The element represents exercise price3.25 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice175Member" xlink:label="niobf_ExercisePrice175Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice175Member" xlink:to="niobf_ExercisePrice175Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice175Member_doc" xml:lang="en-US">The element represents exercise price1.75 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice175OneMember" xlink:label="niobf_ExercisePrice175OneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice175OneMember" xlink:to="niobf_ExercisePrice175OneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice175OneMember_doc" xml:lang="en-US">The element represents exercise price1.75 one member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice220Member" xlink:label="niobf_ExercisePrice220Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice220Member" xlink:to="niobf_ExercisePrice220Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice220Member_doc" xml:lang="en-US">The element represents exercise price2.20 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice354Member" xlink:label="niobf_ExercisePrice354Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice354Member" xlink:to="niobf_ExercisePrice354Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice354Member_doc" xml:lang="en-US">The element represents exercise price3.54 member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice460Member" xlink:label="niobf_ExercisePrice460Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExercisePrice460Member" xlink:to="niobf_ExercisePrice460Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExercisePrice460Member_doc" xml:lang="en-US">The element represents exercise price4.60 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPublicWarrantsMember" xlink:to="niobf_GXIIPublicWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIPublicWarrantsMember_doc" xml:lang="en-US">The element represents g x i i public warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GXIIPrivateWarrantsMember" xlink:to="niobf_GXIIPrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GXIIPrivateWarrantsMember_doc" xml:lang="en-US">The element represents g x i i private warrants member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PublicWarrants2023Member" xlink:to="niobf_PublicWarrants2023Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PublicWarrants2023Member_doc" xml:lang="en-US">The element represents public warrants2023 member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExchangeOfWarrantsDescription" xlink:to="niobf_ExchangeOfWarrantsDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExchangeOfWarrantsDescription_doc" xml:lang="en-US">The element represents exchange of warrants description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in the fair value of the private warrants table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangesInFairValueOfInitialValuation_doc" xml:lang="en-US">The element represents changes in fair value of initial valuation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindGlobalAssetManagementThreeLLCMember" xlink:to="niobf_LindGlobalAssetManagementThreeLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LindGlobalAssetManagementThreeLLCMember_doc" xml:lang="en-US">The element represents lind global asset management three l l c member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LindConsentWarrantIssuanceMember" xlink:to="niobf_LindConsentWarrantIssuanceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LindConsentWarrantIssuanceMember_doc" xml:lang="en-US">The element represents lind consent warrant issuance member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BlackScholesValuationMember" xlink:to="niobf_BlackScholesValuationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_BlackScholesValuationMember_doc" xml:lang="en-US">The element represents black scholes valuation member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiabilityMember" xlink:to="niobf_WarrantLiabilityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantLiabilityMember_doc" xml:lang="en-US">The element represents warrant liability member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GainOnIssuanceOfWarrants" xlink:to="niobf_GainOnIssuanceOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GainOnIssuanceOfWarrants_doc" xml:lang="en-US">The element represents gain on issuance of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in the fair value of the2023 private warrants liability table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock" xlink:to="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DisclosureOfClassBCommonStockOfECRCTextBlock_doc" xml:lang="en-US">The element represents disclosure of class b common stock of e c r c text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutMember" xlink:to="niobf_EarnoutMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutMember_doc" xml:lang="en-US">The element represents earnout member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DescriptionOfEarnOutShares" xlink:to="niobf_DescriptionOfEarnOutShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DescriptionOfEarnOutShares_doc" xml:lang="en-US">The element represents description of earn out shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:to="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_doc" xml:lang="en-US">The element represents schedule of primary inputs into the monte carlo models table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:to="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_doc" xml:lang="en-US">The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:to="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_doc" xml:lang="en-US">The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:to="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_doc" xml:lang="en-US">The element represents schedule of changes in lind iii convertible security text block.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleSecurityMember" xlink:label="niobf_YorkvilleConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleSecurityMember" xlink:to="niobf_YorkvilleConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleSecurityMember_doc" xml:lang="en-US">The element represents yorkville convertible security member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_April2024ConvertibleSecurityMember" xlink:to="niobf_April2024ConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_April2024ConvertibleSecurityMember_doc" xml:lang="en-US">The element represents april2024 convertible security member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ConvertibleSecurityMember" xlink:label="niobf_ConvertibleSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleSecurityMember" xlink:to="niobf_ConvertibleSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConvertibleSecurityMember_doc" xml:lang="en-US">The element represents convertible security member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebenturesMember" xlink:to="niobf_YorkvilleConvertibleDebenturesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleDebenturesMember_doc" xml:lang="en-US">The element represents yorkville convertible debentures member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:to="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_YorkvilleConvertibleDebtFinancingAgreementMember_doc" xml:lang="en-US">The element represents yorkville convertible debt financing agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PrincipalAndAccruedInterestConverted" xlink:to="niobf_PrincipalAndAccruedInterestConverted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PrincipalAndAccruedInterestConverted_doc" xml:lang="en-US">The element represents principal and accrued interest converted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ContractualInterest" xlink:to="niobf_ContractualInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ContractualInterest_doc" xml:lang="en-US">The element represents contractual interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:to="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_StockIssuedDuringPeriodSharesStockOptionsExercise_doc" xml:lang="en-US">The element represents stock issued during period shares stock options exercise.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ImpliedDiscountRate" xlink:to="niobf_ImpliedDiscountRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ImpliedDiscountRate_doc" xml:lang="en-US">The element represents implied discount rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValue" xlink:to="niobf_ChangeInFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValue_doc" xml:lang="en-US">The element represents change in fair value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:to="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock_doc" xml:lang="en-US">The element represents shareholders equity and share based warrants text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_BlackScholesMember" xlink:to="niobf_BlackScholesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_BlackScholesMember_doc" xml:lang="en-US">The element represents black scholes member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_NonRevolvingCreditFacilityAgreementMember" xlink:to="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_NonRevolvingCreditFacilityAgreementMember_doc" xml:lang="en-US">The element represents non revolving credit facility agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeneralSecurityAgreementMember" xlink:to="niobf_GeneralSecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeneralSecurityAgreementMember_doc" xml:lang="en-US">The element represents general security agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityEstablishmentFee" xlink:to="niobf_LineOfCreditFacilityEstablishmentFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LineOfCreditFacilityEstablishmentFee_doc" xml:lang="en-US">The element represents line of credit facility establishment fee.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DoDAgreementMaximumReimbursementAmount" xlink:label="niobf_DoDAgreementMaximumReimbursementAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DoDAgreementMaximumReimbursementAmount" xlink:to="niobf_DoDAgreementMaximumReimbursementAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DoDAgreementMaximumReimbursementAmount_doc" xml:lang="en-US">The element represents do d agreement maximum reimbursement amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DoDAgreementMember" xlink:to="niobf_DoDAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DoDAgreementMember_doc" xml:lang="en-US">The element represents do d agreement member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_PurchasesofLandMember" xlink:to="niobf_PurchasesofLandMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_PurchasesofLandMember_doc" xml:lang="en-US">The element represents purchasesof land member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_doc" xml:lang="en-US">The element represents available for sale securities equity securities other.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleNoteValuation" xlink:to="niobf_ConvertibleNoteValuation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ConvertibleNoteValuation_doc" xml:lang="en-US">The element represents convertible note valuation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EarnoutSharesLiability" xlink:to="niobf_EarnoutSharesLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EarnoutSharesLiability_doc" xml:lang="en-US">The element represents earnout shares liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_WarrantLiability" xlink:to="niobf_WarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_WarrantLiability_doc" xml:lang="en-US">The element represents warrant liability.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="niobf_IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="niobf_IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_IncomeTaxReconciliationAtFederalStatutoryIncomeTaxRate_doc" xml:lang="en-US">The element represents income tax reconciliation at federal statutory income tax rate.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EffectiveIncomeTaxRateReconciliationAtProvincialStatutoryIncomeTaxRate" xlink:label="niobf_EffectiveIncomeTaxRateReconciliationAtProvincialStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EffectiveIncomeTaxRateReconciliationAtProvincialStatutoryIncomeTaxRate" xlink:to="niobf_EffectiveIncomeTaxRateReconciliationAtProvincialStatutoryIncomeTaxRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EffectiveIncomeTaxRateReconciliationAtProvincialStatutoryIncomeTaxRate_doc" xml:lang="en-US">The element represents effective income tax rate reconciliation at provincial statutory income tax rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsMineralInterest" xlink:to="niobf_DeferredTaxAssetsMineralInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsMineralInterest_doc" xml:lang="en-US">The element represents deferred tax assets mineral interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:to="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsStartupAndOorganizationalCosts_doc" xml:lang="en-US">The element represents deferred tax assets startup and oorganizational costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:to="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsResearchAndDevelopmentCosts_doc" xml:lang="en-US">The element represents deferred tax assets research and development costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:to="niobf_DeferredTaxAssetsShareIssuanceCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsShareIssuanceCosts_doc" xml:lang="en-US">The element represents deferred tax assets share issuance costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossesAvailableForFuturePeriods" xlink:to="niobf_CapitalLossesAvailableForFuturePeriods_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CapitalLossesAvailableForFuturePeriods_doc" xml:lang="en-US">The element represents capital losses available for future periods.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_doc" xml:lang="en-US">The element represents deferred tax assets valuation allowance additions.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CapitalLossCaryforward" xlink:to="niobf_CapitalLossCaryforward_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CapitalLossCaryforward_doc" xml:lang="en-US">The element represents capital loss caryforward.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FixedRentExpense" xlink:to="niobf_FixedRentExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FixedRentExpense_doc" xml:lang="en-US">The element represents fixed rent expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_TotalLeasePayments" xlink:to="niobf_TotalLeasePayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_TotalLeasePayments_doc" xml:lang="en-US">The element represents total lease payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_doc" xml:lang="en-US">The element represents less amount of payments representing interest.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:to="niobf_LessCurrentPortionOfOperatingLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability_doc" xml:lang="en-US">The element represents less current portion of operating lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OperatingLeasesLiabilityNoncurrent" xlink:to="niobf_OperatingLeasesLiabilityNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_OperatingLeasesLiabilityNoncurrent_doc" xml:lang="en-US">The element represents operating leases liability noncurrent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:to="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExplorationExpendituresDisclosuresTextBlock_doc" xml:lang="en-US">The element represents exploration expenditures disclosures text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:to="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ScheduleOfExplorationExpendituresTableTextBlock_doc" xml:lang="en-US">The element represents schedule of exploration expenditures table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_CostCentreAxis" xlink:to="niobf_CostCentreAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_CostCentreAxis_doc" xml:lang="en-US">The element represents cost centre axis.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FeasibilityStudyAndEngineeringMember" xlink:to="niobf_FeasibilityStudyAndEngineeringMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FeasibilityStudyAndEngineeringMember_doc" xml:lang="en-US">The element represents feasibility study and engineering member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FieldManagementAndOtherMember" xlink:to="niobf_FieldManagementAndOtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_FieldManagementAndOtherMember_doc" xml:lang="en-US">The element represents field management and other member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MetallurgicalMember" xlink:to="niobf_MetallurgicalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MetallurgicalMember_doc" xml:lang="en-US">The element represents metallurgical member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_GeologistsAndFieldStaffMember" xlink:to="niobf_GeologistsAndFieldStaffMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_GeologistsAndFieldStaffMember_doc" xml:lang="en-US">The element represents geologists and field staff member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DrillingMember" xlink:to="niobf_DrillingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DrillingMember_doc" xml:lang="en-US">The element represents drilling member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LineOfCreditFacilityPrepaymentFee" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LineOfCreditFacilityPrepaymentFee" xlink:to="niobf_LineOfCreditFacilityPrepaymentFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_LineOfCreditFacilityPrepaymentFee_doc" xml:lang="en-US">The element represents line of credit facility prepayment fee.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_MarkSmithMember" xlink:label="niobf_MarkSmithMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_MarkSmithMember" xlink:to="niobf_MarkSmithMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_MarkSmithMember_doc" xml:lang="en-US">The element represents mark smith member.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EstablishmentFeesPayable" xlink:label="niobf_EstablishmentFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EstablishmentFeesPayable" xlink:to="niobf_EstablishmentFeesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EstablishmentFeesPayable_doc" xml:lang="en-US">The element represents establishment fees payable.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EstablishmentFeePayable" xlink:label="niobf_EstablishmentFeePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_EstablishmentFeePayable" xlink:to="niobf_EstablishmentFeePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_EstablishmentFeePayable_doc" xml:lang="en-US">The element represents establishment fee payable.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ReimbursementAmount" xlink:label="niobf_ReimbursementAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ReimbursementAmount" xlink:to="niobf_ReimbursementAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ReimbursementAmount_doc" xml:lang="en-US">The element represents reimbursement amount.</link:label>
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ReimbursementPayments" xlink:label="niobf_ReimbursementPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ReimbursementPayments" xlink:to="niobf_ReimbursementPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ReimbursementPayments_doc" xml:lang="en-US">The element represents reimbursement payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassBCommonStockECRCMember" xlink:to="niobf_ClassBCommonStockECRCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ClassBCommonStockECRCMember_doc" xml:lang="en-US">The element represents class b common stock e c r c member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_doc" xml:lang="en-US">The element represents share based compensation arrangement by shares based payment award options vested and expected to vest outstanding number.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:to="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_doc" xml:lang="en-US">The element represents servicing assets at fair value changes in fair value resulting from changes in valuation inputs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ServicingLiabilityAtFairValueAdditionsValue" xlink:to="niobf_ServicingLiabilityAtFairValueAdditionsValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ServicingLiabilityAtFairValueAdditionsValue_doc" xml:lang="en-US">The element represents servicing liability at fair value additions value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ExchangeOfPrivateWarrantsForPublicWarrants" xlink:to="niobf_ExchangeOfPrivateWarrantsForPublicWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ExchangeOfPrivateWarrantsForPublicWarrants_doc" xml:lang="en-US">The element represents exchange of private warrants for public warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNoteValue" xlink:to="niobf_ChangeInFairValueOfConvertibleNoteValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNoteValue_doc" xml:lang="en-US">The element represents change in fair value of convertible note value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" xlink:to="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_doc" xml:lang="en-US">The element represents restricted interest and financing carryforward.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue" xlink:to="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue_doc" xml:lang="en-US">The element represents change in fair value of earn out shares liability value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfWarrantLiabilityValue" xlink:to="niobf_ChangeInFairValueOfWarrantLiabilityValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfWarrantLiabilityValue_doc" xml:lang="en-US">The element represents change in fair value of warrant liability value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNotesValue" xlink:to="niobf_ChangeInFairValueOfConvertibleNotesValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="niobf_ChangeInFairValueOfConvertibleNotesValue_doc" xml:lang="en-US">The element represents change in fair value of convertible notes value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2_lbl" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOperating" xlink:to="us-gaap_InterestIncomeOperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOperating_2_lbl" xml:lang="en-US">Interest Income, Operating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_2_lbl" xml:lang="en-US">Other Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_2_lbl" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:to="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciEquityMethodInvestmentBeforeTaxParent_2_lbl" xml:lang="en-US">OCI, Equity Method Investment, before Tax, Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:to="niobf_ChangeInFairValueOfEarnoutShareLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfEarnoutShareLiability_3_lbl" xml:lang="en-US">Change In Fair Value Of Earnout Share Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInValuationOfWarrantLiabilities" xlink:to="niobf_ChangeInValuationOfWarrantLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInValuationOfWarrantLiabilities_3_lbl" xml:lang="en-US">Change In Valuation Of Warrant Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangeInFairValueOfConvertibleNoteValue" xlink:to="niobf_ChangeInFairValueOfConvertibleNoteValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangeInFairValueOfConvertibleNoteValue_3_lbl" xml:lang="en-US">Change in fair value of convertible note value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_2_lbl" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_OtheroperatingGainsLosses" xlink:to="niobf_OtheroperatingGainsLosses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_OtheroperatingGainsLosses_3_lbl" xml:lang="en-US">Otheroperating Gains Losses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Continuing Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="us-gaap_PaymentsToAcquireOtherInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForDeposits" xlink:to="us-gaap_PaymentsForDeposits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForDeposits_2_lbl" xml:lang="en-US">Payments for Deposits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayments of Related Party Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_2_lbl" xml:lang="en-US">Repayments of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockDividend_2_lbl" xml:lang="en-US">Stock Issued During Period, Value, Stock Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_2_lbl" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_lbl" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="us-gaap_FairValueHedgeAssetsAtFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueHedgeAssetsAtFairValue_3_lbl" xml:lang="en-US">Fair Value Hedge Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_2_lbl" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServicingLiabilityAtFairValueAmount" xlink:to="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServicingLiabilityAtFairValueAmount_3_lbl" xml:lang="en-US">Servicing Liability at Fair Value, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ServicingLiabilityAtFairValueAdditionsValue" xlink:to="niobf_ServicingLiabilityAtFairValueAdditionsValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ServicingLiabilityAtFairValueAdditionsValue_3_lbl" xml:lang="en-US">Servicing liability at fair value additions value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation1" xlink:to="niobf_ChangesInFairValueOfInitialValuation1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangesInFairValueOfInitialValuation1_4_lbl" xml:lang="en-US">Changes In Fair Value Of Initial Valuation1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_FairValueOfWarrantsExercised" xlink:to="niobf_FairValueOfWarrantsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_FairValueOfWarrantsExercised_3_lbl" xml:lang="en-US">Fair Value Of Warrants Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_3_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExpired" xlink:to="niobf_ClassOfWarrantOrRightExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExpired_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExpired_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Exercise Price Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercised" xlink:to="niobf_ClassOfWarrantOrRightExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercised_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:to="niobf_ClassOfWarrantOrRightExercisePriceExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ClassOfWarrantOrRightExercisePriceExercised_3_lbl" xml:lang="en-US">Class Of Warrant Or Right Exercise Price Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ChangesInFairValueOfInitialValuation" xlink:to="niobf_ChangesInFairValueOfInitialValuation_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ChangesInFairValueOfInitialValuation_4_lbl" xml:lang="en-US">Changes In Fair Value Of Initial Valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostAndExpenseOperating" xlink:to="us-gaap_OtherCostAndExpenseOperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostAndExpenseOperating_2_lbl" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_2_lbl" xml:lang="en-US">Operating Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubleaseIncome_2_lbl" xml:lang="en-US">Sublease Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessAmountOfPaymentsRepresentingInterest" xlink:to="niobf_LessAmountOfPaymentsRepresentingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LessAmountOfPaymentsRepresentingInterest_3_lbl" xml:lang="en-US">Less Amount Of Payments Representing Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:to="niobf_LessCurrentPortionOfOperatingLeaseLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_LessCurrentPortionOfOperatingLeaseLiability_3_lbl" xml:lang="en-US">Less Current Portion Of Operating Lease Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="us-gaap_AssetRetirementObligationAccretionExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetRetirementObligationAccretionExpense_2_lbl" xml:lang="en-US">Asset Retirement Obligation, Accretion Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_ConvertibleNoteValuation" xlink:to="niobf_ConvertibleNoteValuation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_ConvertibleNoteValuation_3_lbl" xml:lang="en-US">Convertible Note Valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_2_lbl" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_3_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:to="niobf_DeferredTaxAssetsValuationAllowanceAdditions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_DeferredTaxAssetsValuationAllowanceAdditions_3_lbl" xml:lang="en-US">Deferred Tax Assets Valuation Allowance Additions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_2_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:to="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="niobf_AvailableForSaleSecuritiesEquitySecuritiesOther_3_lbl" xml:lang="en-US">Available For Sale Securities Equity Securities Other</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>28
<FILENAME>niobf-20250630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#Cover" roleURI="http://niocorp.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BalanceSheets" roleURI="http://niocorp.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BalanceSheetsParenthetical" roleURI="http://niocorp.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfOperationsAndComprehensiveLoss" roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfOperationsAndComprehensiveLossParenthetical" roleURI="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfCashFlows" roleURI="http://niocorp.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" roleURI="http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DescriptionOfBusiness" roleURI="http://niocorp.com/role/DescriptionOfBusiness" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BasisOfPreparation" roleURI="http://niocorp.com/role/BasisOfPreparation" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPolicies" roleURI="http://niocorp.com/role/SignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#GoingConcernIssues" roleURI="http://niocorp.com/role/GoingConcernIssues" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LandAndBuildingsNet" roleURI="http://niocorp.com/role/LandAndBuildingsNet" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MineralProperties" roleURI="http://niocorp.com/role/MineralProperties" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#AccountsPayableAndAccruedLiabilities" roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebt" roleURI="http://niocorp.com/role/ConvertibleDebt" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrc" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrc" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonShares" roleURI="http://niocorp.com/role/CommonShares" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#RelatedPartyTransactionsAndBalances" roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ExplorationExpenditures" roleURI="http://niocorp.com/role/ExplorationExpenditures" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#Leases" roleURI="http://niocorp.com/role/Leases" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxes" roleURI="http://niocorp.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FairValueMeasurements" roleURI="http://niocorp.com/role/FairValueMeasurements" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SegmentInformation" roleURI="http://niocorp.com/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SubsequentEvents" roleURI="http://niocorp.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#BasisOfPreparationTables" roleURI="http://niocorp.com/role/BasisOfPreparationTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesTables" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LandAndBuildingsNetTables" roleURI="http://niocorp.com/role/LandAndBuildingsNetTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#AccountsPayableAndAccruedLiabilitiesTables" roleURI="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtTables" roleURI="http://niocorp.com/role/ConvertibleDebtTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcTables" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesTables" roleURI="http://niocorp.com/role/CommonSharesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ExplorationExpendituresTables" roleURI="http://niocorp.com/role/ExplorationExpendituresTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LeasesTables" roleURI="http://niocorp.com/role/LeasesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxesTables" roleURI="http://niocorp.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FairValueMeasurementsTables" roleURI="http://niocorp.com/role/FairValueMeasurementsTables" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" roleURI="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DescriptionOfBusinessDetailsNarrative" roleURI="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" roleURI="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfExcludedFromDilutiveSecuritiesDetails" roleURI="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SignificantAccountingPoliciesDetailsNarrative" roleURI="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#GoingConcernIssuesDetailsNarrative" roleURI="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfPropertiesDetails" roleURI="http://niocorp.com/role/ScheduleOfPropertiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MineralPropertiesDetailsNarrative" roleURI="http://niocorp.com/role/MineralPropertiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" roleURI="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails" roleURI="http://niocorp.com/role/ConvertibleDebtDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails1" roleURI="http://niocorp.com/role/ConvertibleDebtDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails2" roleURI="http://niocorp.com/role/ConvertibleDebtDetails2" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails3" roleURI="http://niocorp.com/role/ConvertibleDebtDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails4" roleURI="http://niocorp.com/role/ConvertibleDebtDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails5" roleURI="http://niocorp.com/role/ConvertibleDebtDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetails6" roleURI="http://niocorp.com/role/ConvertibleDebtDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ConvertibleDebtDetailsNarrative" roleURI="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetails" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetails1" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ClassBCommonStockOfEcrcDetailsNarrative" roleURI="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails" roleURI="http://niocorp.com/role/CommonSharesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails1" roleURI="http://niocorp.com/role/CommonSharesDetails1" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails3" roleURI="http://niocorp.com/role/CommonSharesDetails3" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails4" roleURI="http://niocorp.com/role/CommonSharesDetails4" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails5" roleURI="http://niocorp.com/role/CommonSharesDetails5" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails6" roleURI="http://niocorp.com/role/CommonSharesDetails6" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails7" roleURI="http://niocorp.com/role/CommonSharesDetails7" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails8" roleURI="http://niocorp.com/role/CommonSharesDetails8" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails9" roleURI="http://niocorp.com/role/CommonSharesDetails9" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails10" roleURI="http://niocorp.com/role/CommonSharesDetails10" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails11" roleURI="http://niocorp.com/role/CommonSharesDetails11" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails12" roleURI="http://niocorp.com/role/CommonSharesDetails12" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetails13" roleURI="http://niocorp.com/role/CommonSharesDetails13" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CommonSharesDetailsNarrative" roleURI="http://niocorp.com/role/CommonSharesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#RelatedPartyTransactionsAndBalancesDetailsNarrative" roleURI="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfExplorationExpendituresDetails" roleURI="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#CompanyIncurredLeaseCostsAsFollowsDetails" roleURI="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" roleURI="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#LeasesDetailsNarrative" roleURI="http://niocorp.com/role/LeasesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" roleURI="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" roleURI="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" roleURI="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ChangesInValuationAllowanceAreAsFollowsDetails" roleURI="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfCumulativeNetOperatingLossesDetails" roleURI="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#IncomeTaxesDetailsNarrative" roleURI="http://niocorp.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" roleURI="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" />
    <link:roleRef xlink:type="simple" xlink:href="niobf-20250630.xsd#SubsequentEventsDetailsNarrative" roleURI="http://niocorp.com/role/SubsequentEventsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonSharesWithoutParValueMember" xlink:label="loc_niobfCommonSharesWithoutParValueMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfCommonSharesWithoutParValueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantsEachExercisableFor1.11829212Member" xlink:label="loc_niobfWarrantsEachExercisableFor1.11829212Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfWarrantsEachExercisableFor1.11829212Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="loc_deiAuditorOpinionTextBlock" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorOpinionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssets" xlink:label="loc_us-gaapDepositsAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDepositsAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermInvestmentsAndReceivablesNet" xlink:label="loc_us-gaapLongTermInvestmentsAndReceivablesNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapLongTermInvestmentsAndReceivablesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties" xlink:label="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapCapitalizedCostsMineralInterestsInUnprovedProperties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutLiabilityAtFairValue" xlink:label="loc_niobfEarnoutLiabilityAtFairValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_niobfEarnoutLiabilityAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapRedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorizedUnlimited" xlink:label="loc_us-gaapCommonStockSharesAuthorizedUnlimited" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorizedUnlimited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapExplorationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue" xlink:label="loc_niobfChangeInFairValueOfEarnoutSharesLiabilityValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutSharesLiabilityValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfWarrantLiabilityValue" xlink:label="loc_niobfChangeInFairValueOfWarrantLiabilityValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfWarrantLiabilityValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNotesValue" xlink:label="loc_niobfChangeInFairValueOfConvertibleNotesValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_niobfChangeInFairValueOfConvertibleNotesValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaapInterestIncomeOperating" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestIncomeOperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncome" xlink:label="loc_us-gaapOtherIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OciEquityMethodInvestmentBeforeTaxParent" xlink:label="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOciEquityMethodInvestmentBeforeTaxParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfEarnoutShareLiability" xlink:label="loc_niobfChangeInFairValueOfEarnoutShareLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInFairValueOfEarnoutShareLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInValuationOfWarrantLiabilities" xlink:label="loc_niobfChangeInValuationOfWarrantLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInValuationOfWarrantLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValueOfConvertibleNoteValue" xlink:label="loc_niobfChangeInFairValueOfConvertibleNoteValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfChangeInFairValueOfConvertibleNoteValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionExpense" xlink:label="loc_us-gaapAccretionExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAccretionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueOfCommitmentSharesIssued" xlink:label="loc_niobfFairValueOfCommitmentSharesIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfFairValueOfCommitmentSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="loc_us-gaapUnrealizedGainLossOnInvestments" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapUnrealizedGainLossOnInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseImpairmentLoss" xlink:label="loc_us-gaapOperatingLeaseImpairmentLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_OtheroperatingGainsLosses" xlink:label="loc_niobfOtheroperatingGainsLosses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_niobfOtheroperatingGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="loc_us-gaapPaymentsToAcquireOtherInvestments" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsToAcquireOtherInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForDeposits" xlink:label="loc_us-gaapPaymentsForDeposits" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsForDeposits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ConversionsOfDebtForCommonShares" xlink:label="loc_niobfConversionsOfDebtForCommonShares" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_niobfConversionsOfDebtForCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ValueOfWarrantsIssued" xlink:label="loc_niobfValueOfWarrantsIssued" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_niobfValueOfWarrantsIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest" xlink:title="00000007 - Statement - Consolidated Statements of Shareholders&apos; Equity and Redeemable Noncontrolling Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RedeemableNoncontrollingInterestMember" xlink:label="loc_niobfRedeemableNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_niobfRedeemableNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueEquityPlacement" xlink:label="loc_niobfStockIssuedDuringPeriodValueEquityPlacement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueEquityPlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesEquityPlacement" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesEquityPlacement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesEquityPlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" xlink:label="loc_niobfStockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:label="loc_niobfStockIssuedDuringPeriodValueStockWarrantsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesStockWarrantsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesStockWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares" xlink:label="loc_niobfStockIssuedDuringPeriodValueRedemptionsOfVestedShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueRedemptionsOfVestedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:label="loc_niobfStockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" xlink:label="loc_niobfStockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockDividend" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockDividend" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000013 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="loc_cydCybersecurityRiskRoleOfManagementTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskRoleOfManagementTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000014 - Disclosure - Material Cybersecurity Incident Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="loc_cydMaterialCybersecurityIncidentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentNatureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentNatureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentScopeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentScopeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentTimingTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentTimingTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusiness" xlink:title="999015 - Disclosure - DESCRIPTION OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparation" xlink:title="999016 - Disclosure - BASIS OF PREPARATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccounting" xlink:label="loc_us-gaapBasisOfAccounting" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccounting" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPolicies" xlink:title="999017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssues" xlink:title="999018 - Disclosure - GOING CONCERN ISSUES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNet" xlink:title="999019 - Disclosure - LAND AND BUILDINGS, NET">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralProperties" xlink:title="999020 - Disclosure - MINERAL PROPERTIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="loc_srtExtractiveIndustriesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="loc_us-gaapMineralIndustriesDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtExtractiveIndustriesAbstract" xlink:to="loc_us-gaapMineralIndustriesDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="999021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebt" xlink:title="999022 - Disclosure - CONVERTIBLE DEBT">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrc" xlink:title="999023 - Disclosure - CLASS B COMMON STOCK OF ECRC">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureOfClassBCommonStockOfECRCTextBlock" xlink:label="loc_niobfDisclosureOfClassBCommonStockOfECRCTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfDisclosureOfClassBCommonStockOfECRCTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonShares" xlink:title="999024 - Disclosure - COMMON SHARES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalances" xlink:title="999025 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpenditures" xlink:title="999026 - Disclosure - EXPLORATION EXPENDITURES">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExplorationExpendituresDisclosuresTextBlock" xlink:label="loc_niobfExplorationExpendituresDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfExplorationExpendituresDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/Leases" xlink:title="999027 - Disclosure - LEASES">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxes" xlink:title="999028 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurements" xlink:title="999029 - Disclosure - Fair Value Measurements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SegmentInformation" xlink:title="999030 - Disclosure - SEGMENT INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEvents" xlink:title="999031 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesPolicies" xlink:title="999032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DevelopmentStageIssuerPolicyTextBlock" xlink:label="loc_niobfDevelopmentStageIssuerPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfDevelopmentStageIssuerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_MineralPropertiesPolicyTextBlock" xlink:label="loc_niobfMineralPropertiesPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfMineralPropertiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock" xlink:label="loc_niobfConvertibleDebtCarriedatFairValuePolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfConvertibleDebtCarriedatFairValuePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantsPolicyTextBlock" xlink:label="loc_niobfWarrantsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfWarrantsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutSharesPolicyTextBlock" xlink:label="loc_niobfEarnoutSharesPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfEarnoutSharesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationsPolicy" xlink:label="loc_us-gaapAssetRetirementObligationsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAssetRetirementObligationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RedeemableNoncontrollingInterestPolicyTextBlock" xlink:label="loc_niobfRedeemableNoncontrollingInterestPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfRedeemableNoncontrollingInterestPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/BasisOfPreparationTables" xlink:title="999033 - Disclosure - BASIS OF PREPARATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesTables" xlink:title="999034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LandAndBuildingsNetTables" xlink:title="999035 - Disclosure - LAND AND BUILDINGS, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="999036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtTables" xlink:title="999037 - Disclosure - CONVERTIBLE DEBT (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:label="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfScheduleOfChangesInLindIiiConvertibleSecurityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaapConvertibleDebtTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebtTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="loc_us-gaapScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock" xlink:label="loc_us-gaapScheduleOfInterestRateDerivativesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInterestRateDerivativesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:label="loc_niobfShareholdersEquityAndShareBasedWarrantsTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfShareholdersEquityAndShareBasedWarrantsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcTables" xlink:title="999038 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:label="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:label="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_niobfScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesTables" xlink:title="999039 - Disclosure - COMMON SHARES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PublicWarrantsMember" xlink:label="loc_niobfPublicWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrivateWarrantsMember" xlink:label="loc_niobfPrivateWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" xlink:label="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfFairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:label="loc_niobfScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfOutstandingExercisableWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:label="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ExplorationExpendituresTables" xlink:title="999040 - Disclosure - EXPLORATION EXPENDITURES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ScheduleOfExplorationExpendituresTableTextBlock" xlink:label="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_niobfScheduleOfExplorationExpendituresTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesTables" xlink:title="999041 - Disclosure - LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesTables" xlink:title="999042 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="loc_us-gaapSummaryOfValuationAllowanceTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfValuationAllowanceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:label="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapSummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FairValueMeasurementsTables" xlink:title="999043 - Disclosure - Fair Value Measurements (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details" xlink:title="999044 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:label="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="loc_srtOwnershipAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_Entity0896800BCLtdMember" xlink:label="loc_niobfEntity0896800BCLtdMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfEntity0896800BCLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ElkCreekResourcesCorpECRCMember" xlink:label="loc_niobfElkCreekResourcesCorpECRCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfElkCreekResourcesCorpECRCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NioCorpTechnologiesLimitedMember" xlink:label="loc_niobfNioCorpTechnologiesLimitedMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_niobfNioCorpTechnologiesLimitedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_IncorporationStateCountryName" xlink:label="loc_niobfIncorporationStateCountryName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_niobfIncorporationStateCountryName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="999045 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaapNumberOfReportableSegments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNumberOfReportableSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails" xlink:title="999046 - Disclosure - The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NetLossAttributableToVestedShares" xlink:label="loc_niobfNetLossAttributableToVestedShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_niobfNetLossAttributableToVestedShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:label="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:label="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails" xlink:title="999047 - Disclosure - Schedule of excluded from the dilutive securities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToWrittenPutOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaapDilutiveSecurities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDilutiveSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="999048 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MineralPropertiesAccumulatedImpairment" xlink:label="loc_us-gaapMineralPropertiesAccumulatedImpairment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMineralPropertiesAccumulatedImpairment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/GoingConcernIssuesDetailsNarrative" xlink:title="999049 - Disclosure - GOING CONCERN ISSUES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRepaymentsOfDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfPropertiesDetails" xlink:title="999050 - Disclosure - Schedule of properties (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LandMember" xlink:label="loc_us-gaapLandMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaapBuildingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapBuildingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:label="loc_us-gaapPropertyPlantAndEquipmentOther" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MineralPropertiesDetailsNarrative" xlink:title="999051 - Disclosure - MINERAL PROPERTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ExtractiveIndustriesAbstract" xlink:label="loc_srtExtractiveIndustriesAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExplorationExpenseForOTPExtensionPayments" xlink:label="loc_niobfExplorationExpenseForOTPExtensionPayments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtExtractiveIndustriesAbstract" xlink:to="loc_niobfExplorationExpenseForOTPExtensionPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FutureOptionToPurchaseExtensionPaymentObligations" xlink:label="loc_niobfFutureOptionToPurchaseExtensionPaymentObligations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtExtractiveIndustriesAbstract" xlink:to="loc_niobfFutureOptionToPurchaseExtensionPaymentObligations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails" xlink:title="999052 - Disclosure - Schedule of account payable and accrued liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableTradeCurrent" xlink:label="loc_us-gaapAccountsPayableTradeCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableTradeCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails" xlink:title="999053 - Disclosure - CONVERTIBLE DEBT (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebenturesMember" xlink:label="loc_niobfYorkvilleConvertibleDebenturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfYorkvilleConvertibleDebenturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_April2024ConvertibleSecurityMember" xlink:label="loc_niobfApril2024ConvertibleSecurityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfApril2024ConvertibleSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails1" xlink:title="999054 - Disclosure - CONVERTIBLE DEBT (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="loc_us-gaapConvertibleDebtSecuritiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapConvertibleDebtSecuritiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionExpenseIncludingAssetRetirementObligations" xlink:label="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapAccretionExpenseIncludingAssetRetirementObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrincipalAndAccruedInterestConverted" xlink:label="loc_niobfPrincipalAndAccruedInterestConverted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_niobfPrincipalAndAccruedInterestConverted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapConvertibleDebt_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails2" xlink:title="999055 - Disclosure - CONVERTIBLE DEBT (Details 2)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ContractualInterest" xlink:label="loc_niobfContractualInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfContractualInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapInterestAndDebtExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails3" xlink:title="999056 - Disclosure - CONVERTIBLE DEBT (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MonteCarloModelMember" xlink:label="loc_us-gaapMonteCarloModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapMonteCarloModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ImpliedDiscountRate" xlink:label="loc_niobfImpliedDiscountRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_niobfImpliedDiscountRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails4" xlink:title="999057 - Disclosure - CONVERTIBLE DEBT (Details 4)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="loc_us-gaapFairValueHedgeAssetsAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueHedgeAssetsAtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangeInFairValue" xlink:label="loc_niobfChangeInFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_niobfChangeInFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueHedgeAssetsAtFairValue" xlink:label="loc_us-gaapFairValueHedgeAssetsAtFairValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapFairValueHedgeAssetsAtFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails5" xlink:title="999058 - Disclosure - CONVERTIBLE DEBT (Details 5)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_BlackScholesMember" xlink:label="loc_niobfBlackScholesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfBlackScholesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetails6" xlink:title="999059 - Disclosure - CONVERTIBLE DEBT (Details 6)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ConvertibleDebtDetailsNarrative" xlink:title="999060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebenturesMember" xlink:label="loc_niobfYorkvilleConvertibleDebenturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_niobfYorkvilleConvertibleDebenturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebtMember" xlink:label="loc_us-gaapUnsecuredDebtMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapUnsecuredDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleConvertibleDebtFinancingAgreementMember" xlink:label="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfYorkvilleConvertibleDebtFinancingAgreementMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_StockIssuedDuringPeriodSharesStockOptionsExercise" xlink:label="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_niobfStockIssuedDuringPeriodSharesStockOptionsExercise" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails" xlink:title="999061 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:label="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_niobfSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1" xlink:title="999062 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingLiabilityAtFairValueAdditionsValue" xlink:label="loc_niobfServicingLiabilityAtFairValueAdditionsValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_niobfServicingLiabilityAtFairValueAdditionsValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ServicingLiabilityAtFairValueAmount" xlink:label="loc_us-gaapServicingLiabilityAtFairValueAmount_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapServicingLiabilityAtFairValueAmount_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative" xlink:title="999063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureClassBCommonStockOfEcrcAbstract" xlink:label="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureClassBCommonStockOfEcrcAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassBCommonStockECRCMember" xlink:label="loc_niobfClassBCommonStockECRCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_niobfClassBCommonStockECRCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutMember" xlink:label="loc_niobfEarnoutMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_niobfEarnoutMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DescriptionOfEarnOutShares" xlink:label="loc_niobfDescriptionOfEarnOutShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_niobfDescriptionOfEarnOutShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails" xlink:title="999064 - Disclosure - COMMON SHARES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPublicWarrantsMember" xlink:label="loc_niobfSeriesAPublicWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesAPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPublicWarrantsMember" xlink:label="loc_niobfSeriesBPublicWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesBPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails1" xlink:title="999065 - Disclosure - COMMON SHARES (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPrivateWarrantsMember" xlink:label="loc_niobfSeriesAPrivateWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesAPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPrivateWarrantsMember" xlink:label="loc_niobfSeriesBPrivateWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesBPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails3" xlink:title="999066 - Disclosure - COMMON SHARES (Details 3)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NovemberPrivateWarrantsliabilitiesMember" xlink:label="loc_niobfNovemberPrivateWarrantsliabilitiesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_niobfNovemberPrivateWarrantsliabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FairValueOfWarrantsExercised" xlink:label="loc_niobfFairValueOfWarrantsExercised" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfFairValueOfWarrantsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails4" xlink:title="999067 - Disclosure - COMMON SHARES (Details 4)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesAPublicWarrantsMember" xlink:label="loc_niobfSeriesAPublicWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesAPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SeriesBPublicWarrantsMember" xlink:label="loc_niobfSeriesBPublicWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfSeriesBPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails5" xlink:title="999068 - Disclosure - COMMON SHARES (Details 5)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonStockSharesIssued1" xlink:label="loc_niobfCommonStockSharesIssued1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfCommonStockSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:label="loc_us-gaapNonmonetaryTransactionGainLossRecognizedOnTransfer" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapNonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails6" xlink:title="999069 - Disclosure - COMMON SHARES (Details 6)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails7" xlink:title="999070 - Disclosure - COMMON SHARES (Details 7)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails8" xlink:title="999071 - Disclosure - COMMON SHARES (Details 8)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightGranted" xlink:label="loc_niobfClassOfWarrantOrRightGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercisePriceGranted" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExpired" xlink:label="loc_niobfClassOfWarrantOrRightExpired" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExpired" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceExpired" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercised" xlink:label="loc_niobfClassOfWarrantOrRightExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ClassOfWarrantOrRightExercisePriceExercised" xlink:label="loc_niobfClassOfWarrantOrRightExercisePriceExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_niobfClassOfWarrantOrRightExercisePriceExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails9" xlink:title="999072 - Disclosure - COMMON SHARES (Details 9)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice4.60Member" xlink:label="loc_niobfExercisePrice4.60Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice4.60Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice3.54Member" xlink:label="loc_niobfExercisePrice3.54Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.54Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.20Member" xlink:label="loc_niobfExercisePrice2.20Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.20Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.75Member" xlink:label="loc_niobfExercisePrice1.75Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice1.75Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.75OneMember" xlink:label="loc_niobfExercisePrice1.75OneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice1.75OneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice3.25Member" xlink:label="loc_niobfExercisePrice3.25Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice3.25Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice1.98Member" xlink:label="loc_niobfExercisePrice1.98Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice1.98Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice11.50Member" xlink:label="loc_niobfExercisePrice11.50Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice11.50Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.31Member" xlink:label="loc_niobfExercisePrice2.31Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.31Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.05Member" xlink:label="loc_niobfExercisePrice2.05Member" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.05Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.07Member" xlink:label="loc_niobfExercisePrice2.07Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.07Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.07OneMember" xlink:label="loc_niobfExercisePrice2.07OneMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.07OneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExercisePrice2.60Member" xlink:label="loc_niobfExercisePrice2.60Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_niobfExercisePrice2.60Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails10" xlink:title="999073 - Disclosure - COMMON SHARES (Details 10)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_PlatformOperatorCryptoAssetTable" xlink:label="loc_srtPlatformOperatorCryptoAssetTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_PlatformOperatorCryptoAssetLineItems" xlink:label="loc_srtPlatformOperatorCryptoAssetLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_srtPlatformOperatorCryptoAssetLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtPlatformOperatorCryptoAssetLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails11" xlink:title="999074 - Disclosure - COMMON SHARES (Details 11)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoteWarrantMember" xlink:label="loc_us-gaapNoteWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapNoteWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:label="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExchangeOfPrivateWarrantsForPublicWarrants" xlink:label="loc_niobfExchangeOfPrivateWarrantsForPublicWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfExchangeOfPrivateWarrantsForPublicWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation1" xlink:label="loc_niobfChangesInFairValueOfInitialValuation1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails12" xlink:title="999075 - Disclosure - COMMON SHARES (Details 12)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_BlackScholesValuationMember" xlink:label="loc_niobfBlackScholesValuationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_niobfBlackScholesValuationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetails13" xlink:title="999076 - Disclosure - COMMON SHARES (Details 13)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantLiabilityMember" xlink:label="loc_niobfWarrantLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfWarrantLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GainOnIssuanceOfWarrants" xlink:label="loc_niobfGainOnIssuanceOfWarrants" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfGainOnIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ChangesInFairValueOfInitialValuation" xlink:label="loc_niobfChangesInFairValueOfInitialValuation_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_niobfChangesInFairValueOfInitialValuation_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CommonSharesDetailsNarrative" xlink:title="999077 - Disclosure - COMMON SHARES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchaseAgreementSeriesAMember" xlink:label="loc_niobfPurchaseAgreementSeriesAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchaseAgreementSeriesBMember" xlink:label="loc_niobfPurchaseAgreementSeriesBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfPurchaseAgreementSeriesBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PublicWarrants2023Member" xlink:label="loc_niobfPublicWarrants2023Member" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfPublicWarrants2023Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantLiabilityMember" xlink:label="loc_niobfWarrantLiabilityMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_niobfWarrantLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtCurrencyAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_YorkvilleEquityFacilityFinancingAgreementMember" xlink:label="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_niobfYorkvilleEquityFacilityFinancingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GXIIPublicWarrantsMember" xlink:label="loc_niobfGXIIPublicWarrantsMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GXIIPrivateWarrantsMember" xlink:label="loc_niobfGXIIPrivateWarrantsMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfGXIIPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LindConsentWarrantIssuanceMember" xlink:label="loc_niobfLindConsentWarrantIssuanceMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfLindConsentWarrantIssuanceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LindGlobalAssetManagementThreeLLCMember" xlink:label="loc_niobfLindGlobalAssetManagementThreeLLCMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_niobfLindGlobalAssetManagementThreeLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DebtInstrumentIssuedPrincipalshars" xlink:label="loc_niobfDebtInstrumentIssuedPrincipalshars" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfDebtInstrumentIssuedPrincipalshars" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:label="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapFairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_RegisteredOffering" xlink:label="loc_niobfRegisteredOffering" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfRegisteredOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PrivateOffering" xlink:label="loc_niobfPrivateOffering" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfPrivateOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CommonShareDescription" xlink:label="loc_niobfCommonShareDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfCommonShareDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_SaleOfStockPricePerShare1" xlink:label="loc_niobfSaleOfStockPricePerShare1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfSaleOfStockPricePerShare1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaapProceedsFromOtherEquity" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromOtherEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:label="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_UnrecognizedCompensationCosts" xlink:label="loc_niobfUnrecognizedCompensationCosts" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfUnrecognizedCompensationCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ExchangeOfWarrantsDescription" xlink:label="loc_niobfExchangeOfWarrantsDescription" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfExchangeOfWarrantsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GainOnIssuanceOfWarrants" xlink:label="loc_niobfGainOnIssuanceOfWarrants" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_niobfGainOnIssuanceOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" xlink:title="999078 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_NonRevolvingCreditFacilityAgreementMember" xlink:label="loc_niobfNonRevolvingCreditFacilityAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfNonRevolvingCreditFacilityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GeneralSecurityAgreementMember" xlink:label="loc_niobfGeneralSecurityAgreementMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_niobfGeneralSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BorrowingsMember" xlink:label="loc_us-gaapBorrowingsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="loc_us-gaapBorrowingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermLineOfCredit" xlink:label="loc_us-gaapLongTermLineOfCredit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLongTermLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionRate" xlink:label="loc_us-gaapRelatedPartyTransactionRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapRelatedPartyTransactionRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LineOfCreditFacilityEstablishmentFee" xlink:label="loc_niobfLineOfCreditFacilityEstablishmentFee" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_niobfLineOfCreditFacilityEstablishmentFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherBorrowings" xlink:label="loc_us-gaapOtherBorrowings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LoanProcessingFee" xlink:label="loc_us-gaapLoanProcessingFee" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLoanProcessingFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding" xlink:label="loc_us-gaapInterestBearingLiabilitiesAverageAmountOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapInterestBearingLiabilitiesAverageAmountOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails" xlink:title="999079 - Disclosure - Schedule of exploration expenditures (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureExplorationExpendituresAbstract" xlink:label="loc_niobfDisclosureExplorationExpendituresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureExplorationExpendituresAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CostCentreAxis" xlink:label="loc_niobfCostCentreAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_niobfCostCentreAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CostCentreDomain" xlink:label="loc_niobfCostCentreDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreAxis" xlink:to="loc_niobfCostCentreDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FeasibilityStudyAndEngineeringMember" xlink:label="loc_niobfFeasibilityStudyAndEngineeringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFeasibilityStudyAndEngineeringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FieldManagementAndOtherMember" xlink:label="loc_niobfFieldManagementAndOtherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfFieldManagementAndOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DrillingMember" xlink:label="loc_niobfDrillingMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfDrillingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_MetallurgicalMember" xlink:label="loc_niobfMetallurgicalMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfMetallurgicalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_GeologistsAndFieldStaffMember" xlink:label="loc_niobfGeologistsAndFieldStaffMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfCostCentreDomain" xlink:to="loc_niobfGeologistsAndFieldStaffMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ExplorationExpense" xlink:label="loc_us-gaapExplorationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapExplorationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails" xlink:title="999080 - Disclosure - The Company incurred lease costs as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_FixedRentExpense" xlink:label="loc_niobfFixedRentExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfFixedRentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_VariableLeaseCost" xlink:label="loc_us-gaapVariableLeaseCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapVariableLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermLeaseCost" xlink:label="loc_us-gaapShortTermLeaseCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapShortTermLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubleaseIncome" xlink:label="loc_us-gaapSubleaseIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapSubleaseIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details" xlink:title="999081 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2025: (Details)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_TotalLeasePayments" xlink:label="loc_niobfTotalLeasePayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfTotalLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LessAmountOfPaymentsRepresentingInterest" xlink:label="loc_niobfLessAmountOfPaymentsRepresentingInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfLessAmountOfPaymentsRepresentingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_LessCurrentPortionOfOperatingLeaseLiability" xlink:label="loc_niobfLessCurrentPortionOfOperatingLeaseLiability" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfLessCurrentPortionOfOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_OperatingLeasesLiabilityNoncurrent" xlink:label="loc_niobfOperatingLeasesLiabilityNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_niobfOperatingLeasesLiabilityNoncurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/LeasesDetailsNarrative" xlink:title="999082 - Disclosure - LEASES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DisclosureLeasesAbstract" xlink:label="loc_niobfDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_niobfDisclosureLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails" xlink:title="999083 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_countryGB" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails" xlink:title="999084 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_WarrantLiability" xlink:label="loc_niobfWarrantLiability" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfWarrantLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_EarnoutSharesLiability" xlink:label="loc_niobfEarnoutSharesLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfEarnoutSharesLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetRetirementObligationAccretionExpense" xlink:label="loc_us-gaapAssetRetirementObligationAccretionExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapAssetRetirementObligationAccretionExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PaymentsOfStockIssuanceCost" xlink:label="loc_niobfPaymentsOfStockIssuanceCost" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfPaymentsOfStockIssuanceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ConvertibleNoteValuation" xlink:label="loc_niobfConvertibleNoteValuation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfConvertibleNoteValuation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationOtherAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails" xlink:title="999085 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsMineralInterest" xlink:label="loc_niobfDeferredTaxAssetsMineralInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsMineralInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsStartupAndOorganizationalCosts" xlink:label="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsStartupAndOorganizationalCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsResearchAndDevelopmentCosts" xlink:label="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsResearchAndDevelopmentCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsShareIssuanceCosts" xlink:label="loc_niobfDeferredTaxAssetsShareIssuanceCosts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsShareIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" xlink:label="loc_niobfDeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsRestrictedInterestAndFinancingCarryforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CapitalLossesAvailableForFuturePeriods" xlink:label="loc_niobfCapitalLossesAvailableForFuturePeriods" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfCapitalLossesAvailableForFuturePeriods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails" xlink:title="999086 - Disclosure - Changes in the valuation allowance are as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DeferredTaxAssetsValuationAllowanceAdditions" xlink:label="loc_niobfDeferredTaxAssetsValuationAllowanceAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_niobfDeferredTaxAssetsValuationAllowanceAdditions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails" xlink:title="999087 - Disclosure - Schedule of cumulative net operating losses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CA" xlink:label="loc_countryCA" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryCA" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_countryUS" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryUS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_countryGB" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_countryGB" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="999088 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_CAD" xlink:label="loc_currencyCAD" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyCAD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapFederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOtherLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_us-gaapDeferredTaxAssetsOtherLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_CapitalLossCaryforward" xlink:label="loc_niobfCapitalLossCaryforward" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEffectiveIncomeTaxRateReconciliationLineItems" xlink:to="loc_niobfCapitalLossCaryforward" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails" xlink:title="999089 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_AvailableForSaleSecuritiesEquitySecuritiesOther" xlink:label="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_niobfAvailableForSaleSecuritiesEquitySecuritiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapOtherLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapOtherLiabilitiesFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://niocorp.com/role/SubsequentEventsDetailsNarrative" xlink:title="999090 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionTypeAxis" xlink:label="loc_us-gaapTransactionTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTransactionTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TransactionDomain" xlink:label="loc_us-gaapTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionTypeAxis" xlink:to="loc_us-gaapTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_PurchasesofLandMember" xlink:label="loc_niobfPurchasesofLandMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfPurchasesofLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_DoDAgreementMember" xlink:label="loc_niobfDoDAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransactionDomain" xlink:to="loc_niobfDoDAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventDescription" xlink:label="loc_us-gaapSubsequentEventDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="niobf-20250630.xsd#niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_niobfShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_niobfShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireLand" xlink:label="loc_us-gaapPaymentsToAcquireLand" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsToAcquireLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromCustomersForProgressPayments" xlink:label="loc_us-gaapProceedsFromCustomersForProgressPayments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromCustomersForProgressPayments" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>n257410kimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1@"< P$1  (1 0,1 ?_$ -H   $#!0$!
M      D'" H  P0%!@$" 0 !! ,! 0              !@<("0(#!00!$
M!@$"! (%!P8)" L    ! @,$!08' !$A$@@),1,4%187"D%182*V=SAQ@2.U
M-SF1H;-T)G88>!FQ,C,D-K<H.L%2177%1H8G1U>G$0 ! @0#!@$%"@D'"0D
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M5.H5SE->Q49>!FI6-RD7(#*13@+6%29U]$N.T"'8N((905!*U5*!0-YIRCR
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M8]#F*/F*<1!>6.HU>*C5%37,MF^*IBBH99%/D2^0K(]Q _E#J3Q,R&@MQ6.
MAH]7473KD]#4-OJG?JLFOXE'4O<WQ%4V'%IPSRV<LE/#RN/%MH>4F"_<.._#
BC\GS_FX;[:C:-O\ IR$_<B;..4^3^2+FLH(K1!%:((__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>n257410kimg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!K (F P$1  (1 0,1 ?_$ /4   $#!0$! 0
M       '" D! @,%!@0*"P$!  (# 0$!              $# @0%!@<($
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M!4?QI/TY0\:%S1#ZO%^ZA_[70%O\J6]./_ 3F?\ P8+I_2Z J/XTKZ<0!O\
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M0%OWM5_]8X7]B6']@T ?>U7_ -8X7]B6']@T ?>U7_UCA?V)8?V#0!][5?\
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MS]<86$Y)Q4V:$D$*55GUA@H_%3]&ZUR%&:%R*<K&PKYT;SU'A3&>CL0=BAN
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M-@NM\IT7=VG"(VW,C3-N7++#XGKB#E T@_)7R6DCF1EG[5,R;8"E,4HB)C;
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M-.QC:5C7B6Q@=-G"0*D(80'M*Y2#<JA-]R'*(#H#L@'< 'Y0WZ_/H"H].H^
M: Q><F'\]]8IA#ZX (: J50#!OVG /E,78!^<.H]- 5$X>SK^5_,T!<4>X-_
M#KH"N@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0
M!H T!"]ZWC*W2/&'#L;0311+JKRZP(2L*3OQ(0@RQ;&X,V3E!:?VR1JX.?RQ
M$FX@)@UE"65U!#(2Q^O!R&MEXKU!XY8<XMU>HS3Z&6MV7GKYPC=RMGRK(TQC
MY*/4=KN6*CA/S2BY(0P[[=NK?&[ .6IGIN^H+D:C5ZK<J^>Z[47\RE:KPK@>
MIM:]:H>3BG"GT17*=:7*/>M$.VQ@4<%7;B)C>S3QNP'?YIXG>I:-4A\8<<.1
M.-(*.8.E%U,WY#C'RV41@F2 FC:X_BFS<T))/'3LA4UG1@#<IS"!0U'C=@.[
MQ5PYY43BC*VYOFN-U9R.E%1T-(R=/QVE;36N1:MA(I-R4W*H)N(X7KP"B=-!
M/M3'P'3QNP'/T!IR4S1BBR)V/!N+LB4]Y9+KCF:JT+;R0YY^"K\JM#3KAY$/
M$5&3<LD=#N*CYA3& =@'54G5M]0?/QR-]-?DOB?D#?,W0-5SOC# JT4YB*;^
MU]8\:X]0P+&D(1:7?SESGW7P#"K"DCY2#CO\PPB  7?8!@#>>._('C#8;A96
M&7/5XYK<2K%CJ318IO+3<H6]1=S4%4&KR,:+5IC*IO95BBD4X.! R0I+%$!Z
M] )N<7>KGP6HU@C;%=.=.2<_)X0@+!!0(V[&D91TK+*O(K[L^-87 QQG\L^C
MVX!WG*1-4Y@^7;0'9X\_&$L=<F[?$5WB;Q]R!EUHR:S;VYPUAFF5:N!64(B=
MVX:T6-6>+1\@_8L$O.[153%8HAV (ZRA++*H&'\H.<M.YL5MAG_A?0IF"SU'
MV)O5KGBW(;A;&MV.ZBVCY$)J3E(^?BI.37CS("5NFX24(OV;$-VZM\;L Q[C
M1R\SQB/->+,N\]8'+^2LSVN%G8C#F(JC/,XN#QG0FBSXL^]RX:2DDX*35F/@
M3'C$''G*&*;<3@.P:M6K48I9?:#L\P^JK-<L,%YE=U2RX+Q[AEO-/(1Q0+92
MK\@ZBI.-,C*U/XK)58A7M;^^67=M!(  *92]P% P@.^HGJ5*-%&GI O]+];'
MD_C;BCA"MFX>XQR16LO55_6I>F4XE@^C*>1R?Z*=6"\P\9])2SYG.M]EC*B0
MH"8-QV,(%&OQNP"3HY/YO^GSA5GRZQ_F>'YD\)9[)[2-M6-8VMV^+LF(G;X3
MELM-@FE@C3/'U-K:*QVW<H)40,0-S;".H\;L)%=J=8]-WELO$6^ASS[ASD?)
M%3E,H5VTU0T$N:OPX/2N)V1FA=QI_O:D';E0Y5D7'W/WO=V#42NYEEH0/&XT
MTODO*9QO-<P+E.N0&$,3XT;5C&O/&2PUCR9K4BNHS:O[A3;;?4G#>2=/%)9S
MYHBW R(E*(@;<-M5 CBXZ<YO69LG.#)7">-Y00F4"5@L\E'9LAL6JR>.8-H*
M3YU 666>.F+%5Q3I,H BBX;F7(BL4"]P[: (G%?JK$YTGP,7GCD=3-#+$4YG
MC)^074A(LL-/GARN&-0IE3@U$OHELQ5=D(5TY<>65)$1/UT!H&'K:\^N*]3<
M-^8&&XK,$J:UNJ:YM<RQ-;L>KV%BJX;MI2EL%&I(Z+B8V$*=5T[3\TSTFY4]
M@W'0$W,7P?\ 3O\ 6(XOX7R*^#&#ES&GCK586W&M;Z!KL9*O5BOI. FZVU30
M,W=O1*= YW27Q'F@)0-L :MC<RQ4:< ?/UZA'IB>H1Z;^9$<K<)I_D3E_!4P
M>8FH:M8G=W"23Q.SK:B$DQA[Q'K&D/CF()=X FBB4@H)F*([B :GQL> )D?2
MM]3JF\C./\,RY'YMQ)6^25=DCPUPJ4U,)T*R'(MV?1:KZL691BLSD%=Q*8J?
M=WF*([CTU/C=@J39-ER.44ETW!%$5MA;JH$4<H.4C!N15NZ1 S90AR]2CW;"
M'4-6QEFBF'4]1%$SD,HF<#@4!Z!\_3Q^;64(9I)$U&FUC(U!QSZJ&&IK(-UJ
MM$C'/%K*+)E(V^Q15=CGSU2VQ?;'-'4NY:(.9!4-NQ$INXX;@'76-[X*\QVF
MHSG X/7]26!R+5>1C>TYDA<D4<Z] ^]Y5].5%M,Q3$'V/JA<7[<M&=Q=AB3$
M='9&<&D2E4W;[ZU&\SJ0*9^,E'%3T=^11NWL ;'A\?+Z[DWRK5_<'?80$F^P
M]/9J 2U?Y*'^KD7][530$(_XKT)@]-2XB0H&.',CE*)"[@!C&"]B( 03 8 4
M$0]WY] )S%.<2S7K:E5C<N4B>9)6^:0L..9JDOH>8K.4&-0<LHUG&+,'18BQ
MR$LJ\6*F^41%P4 .4YC (  $N% PSB'$7/!]^U3C.DXZ&R\9I%[8S4^O1]?-
M//BY$9G!Y,IQR#<CM\!C^\H<HG$?$1'KH!"O6I]2&.]-CAO;LCQ#9W-9GOY%
MJ!A"!CXN1E3A;9AJ"#NT2#9FV4*A'5)JL9T4%#E\Y0I2%[A$ T U7\7HY)<.
M<J</+Q!<:GN0;;;,:V$+ARLR1DFJKPUGREG"[Q)[%<;(HX>*G7=A\6@=JR;K
M]I6[,A2@4 $= 2%\3K]=%LB7BNQ>'\E5# EC;+Y"H4W=6<:SBJ].NWAT)JLQ
MH-7J[I>'EW*QG#4H$ $^[M+TT!)4F<W8(F#P[=@VVV ?9T#?IH#"Z7$J)MA$
MFX '<!1.8 $Q2B()AL8X  B([: @ZSERWY54'D7E:EHRS>+Q:Q.T2K,Y7\>2
M=B_:\:L(MPX;/+B ,3&>.<ES@(,H_P I14J(*F$Q0,&@%HR!S Y+T"?C8J,P
M9(VCZ<PKBVX,A4CY)*+89-M (H62FNGS))PHF+-1?X@_FE+Y:9! -AT [?B]
ME_*N5:W+/\N4-C09UBM%F9L(T[Y5J\82+950QU%'K9$0>-7*(D.4@[  ATZZ
M =D7;;IT^;Y!^0=_;H"N@#0!H T : - &@#0!H T : - &@#0!H T : - &@
M#0!H T : - &@#0!H T!"QZX<=:YCB]B&-H<RE7;T^Y;8&3I\XX;I.FL?9 G
MG:L6L\05(<IFAG2)2J;!N4H[^P= >WC!R9NV3LAW[ &9*0C3LY83J]*E;J,?
M88^9@+*YL*"R3><BB()IF00DET3+@WZB03== /H*JD9/8"]X"&X>84/, YB
M0QMQ+W)J&[=M]]]O;H#7NW#M(OW%(@" E$"F,)0$0W'??J(B _D: 3*>M4Q$
M%*1LW*#@Y1*W^#;J+'3#8R0[F*42D(;N'NZ;B/70#78[CM ?3EAM%096?&<_
M87@R4PYQ_9GT%$OI=X8WGRKFNK&4B/BEE%!45,"0>8?J;<= =%9,&9L<P4K6
M']ZJ.<:).I(!.8USQ4HZ7BI-!(2BHQ5?,RD17:J"4#D!9)1,A@WVWT RY;A%
MZ?\ 69YV_P O^F/CV&F'8B<MAI-%"]UYT\ YA*[BT8E9-:)<.@.(B/E%.)?;
ML : W]OXS>E)FZCO,!WOC?0J+7[*1RVB%;CC5QCN51?R;4T>G)UBYRZ38P3"
M( (D,9R $$ V#IH#A?2D]+>L>FQ:<W0M*Y"P67\%6]^A/8TILY'TM6RXYFU7
M %EU92S,CNWS\5XY,B2!P.0AP 1$NXF$0)0IGB]QLN$_9+;/8:QC8)BWP\?!
M3LFYKM>57>,(H7!HP$%F[=,S=TU^*4V52$JAP'8QAV#0"(8X],3@?B]G.M:S
MQHH3HD^9VI*KV=!S9Y$4Y$YQ79,59A\^<QJ!3'$P>48@DWZ;!H#J9'T_.(BF
M#<A<=*_@NDTK$.3R&&[5&C1Y*VE+K',85)$7+4#KIR1>\3 J7WQ-H"_B'P=X
M_<(,:(X?PA7%2U9K)2TBQ?6\&]IM"+655(J:-^^*4:'E31Z!R^XD8_:0?M=M
M +-E)TI1\>3CFH8B;9/,S9G41Q3"-:Y&EM0NCF4=)%:2"",4(J'#N.!R&,J8
M>HCOH"!'D1F[@5R+KCUGFW!^?^)N1<<1,]5RU=3$,C0X>]N9](\<EC5W8:K#
MDB+1'2,B8H@"*@&\LVY1T!$9DSF_ZLN*(+"W[0?%]I0L&0%'>,8?$].IJ5HP
M%9\>TNQ_1LPC:078NGR60IQ-'M!58X&(7O$W</4 )O>*\+D/DHIC#E3EZP4*
MJ3;&&=N*KA[#,%$UUA1JO-,S,V5/OLI%*(2L^A$*&$Y6[E+R4EC"(% 0WUOV
M;*G;BWS0'BYJM6+:)2;5.Y-5CHJNR,2YK4LY;1IW5CG4)%D=HI78(8Y(TS(.
M'[9P(HMDS&[CCT+N&K/IX\<"2-?*N2>(-&@&=?N+3(^4[-5*JU<8GP!F2MR+
M:N@Y79)Q\ 4&<O#L&C)PX0=IH)"N?S.XWVPB81T^GCV$,?UZ>_&*&JL$GR5B
MHA+%UFR+3QK@X1J5=;43'U,;-9-)ZNE8JY'*N4YNTL'8" /U#;F3$-A H[:T
M+T5&ZXK@@/\ ,KS^1Z1AW)5II%>0NV0X"DV*<J%60-]RL]DC8ARM%0O;ML<\
MDX*5+MV$5-]NN^JP?%?+\Y2Y]Q%:;AS;],3CAE7,!K#.TO(-+QNQ1QGR8Q6S
M(5=&/M<I5UV3*R31]P(9LLQ!<QC)F$ T D]:L')1EG/'&"/2"S]R3L]:+)4]
MYE^+S/%2<]B+ K:8:-72C89>[-RS<M$L0.H1PCN54AQ$I0#H(;-NN14%3[(J
M*ULK*LP#.Z/HR4M243&IV23A43LX>4F>P$G[Z):*_=6S!PX2.8J0^\3</8&M
MBW\Z](Z#=8O$^+LM>J1A:OY3Q[3\BPC/BODV4CXFZ0L?/QS*9+=(Q)M(MF4F
MDNF1X7?M*J4 %/?<-AV'56I_$EB)9N>8I=>M9C.%BLMT!I 5^0JL=DW%,_1W
MT:K7;O#5U)GCL(%VP<,XJ?/,/%4D$'JR9UV:J8E$_8&VM,@=;^,GE%/T>N1)
M-A*/WR8> Q1'<=_VTZP(@(_+W!H"6C_)0_U<B_O:J: A+_%>2B'IKW$H[E$O
M,GE&)A*<"F(7[_>IBFV,'< > >T= ..ON+N14MZA^.VJ?&;#B.)E9AYDAKRX
MI,,U99"@F;",,E]ZET*Z3$SB?DGIBD*X((@=,3=IR[#H!\Y2B7GBQ P!W?@O
M/Q$ $1 1'([#<0[MS%[O'81$0'VCH!S,Y2ZK9A34M%6K]D!FFJ=C]\,1%S/P
M1S$,!Q:H/VKDK8Q@Z")!W$/'0'R'_BRK9JTM/K;-F:22#5#EY>$&[=% C9%!
M!%.XE323;HE(@DF0H[% I0  #0'U@80*DXQ!CD%3@</O7C"J$,?80$"F O<4
MP]P>'30'YMO.K\9H]5K W,OD_AC'^3L<LZ-C'-N0*=3VKS',;(.&L# SCF.C
M$5WQW93O>QH@ B)@#<P[_)H!J1?QL3UC"]1RIB\P#TW'%,7MOX[;@] -]M 7
M_P K"]88W=ODS%2AE-@.'[4\,8QNS[7N SHPG[/$/'8?DT!9_*P?6,\ ROBX
M0_\ I61@[ (;]1^.T !^-A>L64>\<K8O[@*<"]V*XT2;F*8OO)_'=IC==R[^
M AH#]'?TC>1>2.6/IP\2.1N9I:+E\IY:QG]\UUD8EB6+8NI8LY*L3*H1R9CI
MM/[49I"8A1$ $>@[: D@3<(*" D6(;J(" "(B!BC[Q!  Z'+[0'KH#V (" "
M'@.@*Z - &@#0!H T : - 8E#D[>N_Y&_P FE:8F,KBM4;YL\7Q2:.P&4*7N
M$PE =Q$0*&YS"  .Q2^T1Z:JGJM-;PN22+8NY>Q42H+MU">:19,Y=NX#$.!M
M^F^P;#U^IXZB%Z<*N;3B\5W/@,]Q892XJY#!L(=GO !0. E'<W0/MMAV';ZF
MIB[TIN54H4(4YUK1E/B4PWV$  I2G-W;E[>_[0#=VVQC>P/$=6Y+CQS(ARD\
M:5* \3-N "!NWN P%W,<.T2@<>P/>V()@W^36K=5S3NKDJ2Q(4I?E9>!TC]0
M$3!OMN&^P^Z!O=-X&#8P>&HI<45=;33)E?E;^9<2GQ1"=P%'N[=Q,':<Q@V\
M=@*&X_D:K>LTMO\ =DDR8Y[O!%B;M%3[0Y#%.(!W (]O7V;FVZAOX:O\6=QQ
MN6FO!2]:#E<3HXNJ+A722 H]X!YANPA3;@8Q^H]H%^V$P^SY=8WKTW*-Q-*V
MF'.;XQ+"/6JAA*"R?>4=A)U P;=!Z" #T'I]4-8RL7-5<5ZW)94%*=.#+Q=)
MAW=P]I2"0IC& 0+LI]H8!'Q*(>(^ >W6YEN)_,B,T^46 .$!WV.4=MM]MQV
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MZV[GF/=H[6M3:J[B?#LIU_H5K3Z=W'#"B2?K_L:Q7.MIDN.EYR\S:LV+^/\
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M)*L55(PA>NV:RBW23KQIQQ/2TB$(YN@T:((M6C9,B+9LW3*FD@FF7M(1(A0
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M.3>?*#,<>HFJH.+?C7C=AFJ.%U\TSEV9+B^BI%:XM"MFZ;Q,4GXO$T42F/U
M!P_IJ<T,N\QH7E0CDQ->,G:;=XF3HT')TV5HLK6,97Z!=R57KT@QEDD74J^B
MD4 %5\7N(X,IT\- 2$\0T0)@&A)'< [6!.PF<>^)ONZ=AD>OF";<1+Y@_7T
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M 0#;;M$=@V^7N'?0%3%$1$0#\SY- 9-@^30%-@^0/K: KH T : - &@#0!H
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MN #!MH#OEZO7UY+Z;<5^*5FCM$FRLTK#L_IQ=F1,[0[4TH+857 '8'\@"'V
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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MQ _/-F8![B_@O/O>#PZY&8#^1N Z >*4P[@&_3_>T!ET : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T!3</E#_=U_,T!7?V^S0!H T
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MH'[^(%Y]'RU87,Y;2+5YL0P()@NV33==Q3[E,0QN[0"S(B)BG$0$!-UV$-A
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M2 ??8NX]- +$D<HD%0Q@*)AW.4QQ$"#T)L 'V$@#MX?*.@,_S^S0% , ^ Z
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M^WV"L9*%(0]G9G=$\XHF-Y@^\ CN.JZ*."X(KG%1FXK@F<!S!XCU#DKFKC=
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M[S'QS-0Z.-,B<!,;,K5)-86BX]R?;G-F=.SNOBB6ZFN9!ZRA:+&^:Z/V$CT
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MXZ UTI3_ %9:_+0TO 9IXN9 B&:2:LS5YRC6BFKS#CRA(NT:3+=R_*Q#S=C
M<Y!  Z![= 62T9ZJ67"MX<)O!/%EK"E!TXM==5D\NR-WEB]ATF32-?HLD8&#
M* "1P97<_<.Y $ #0&["[^J0I&C3V6)..#*RQ((I/,MS=_L#JH65  $4I"'J
M$:S-,,'+HI!\Q)80*01Z#TT!R4MR3]07 TNK9>1?'2F9)P0QAFXS]NXP34K8
M+_6WAEP^,GW-$G!:OY2!9-NXRI&AE'!0(.R8[Z \G-#D%B3DOZ9W+BRX3R#"
MW>,'$E@92C=FZ73GJVZ3=1Q)"/ME<>D1FZ^LU;&/\6FZ03%(I3[;EWT!)/B>
M9AYG'-$=UV;AYZ%5IM8!A+0+Q%]$O6Q(-DD5U%N4#J)N&QE"B ;&W)T >O30
M"CD*.VWF'';Q$?'K]41\- )#G*32@\0Y.>KJ*?#MZ=.*JK";O4*91DH4 ,!@
M .S8VP 0!';0'3XR5,MCZC"8WF I3X _<<H;F'Z,:")Q\/ZH50.GLT!W!D2C
MT]TH=>XH$)VG ?8<! =P#0'B=1S-PB9%VT:.VQO=,@Y:MUDC@/\ .J)J)"D8
MH>SH _/H")FF14+$>K]G1C,UZ-81=LX@XK/1BOX=DG'6)] VB;4L80!5$/*<
MNXM!=/XH2;&(00 >@Z E42JU:42 1KL"7</YV%C?DZ@("V,&V@,(4:F]W>:I
MU<PB.XC][L0 B/RB;X01WT!52DTWL-M4*N8>G0T!%" [" ]0^$Z[;;Z 1&W5
M?!W[8V+VMFJ-32O"ZUH7QP!JU&F+YJ$<F>P.  C$0!4&AR@ GZ%WW^V'?0"R
MHTBD&( C4*F7Y_O=A@$PB &$P@#0  PF,._0.N@-7*PF-H-N=W,0U&BV9!V^
M)D8BOLD#&_K9%G"*:0GV]F^@.'R'-XKQS2I&_P S38"4KL2DP<N%(*I1LR[.
MA).$6J"\>W:-!*_3*HL J&2,8"% 1T!L[7A_$>7,>2U3M>.J?-4S(%:5CYB(
M<UR.2^D(F7;=P)G &J:S=<$%"J%$!*=%4H" [@&@&A>G/6(=3BE!1$C'15F^
M\^Z9+HD#(3L/#OY(:U5+C+QM;CGCT[/O?&C8Q B)5#;F$I  =Q#0&VY5<+X3
MEWQ?ON#[^C5:M=9EVC8\?Y"I<&PC)7'M]JTJA/X\M,>X(W06+(0,HS3\XQ!'
MS$3' >@CJRW;\266M,.\# :+ZDV5.*43"0GJF<3[;B.3B'C.GV'F30:RTO."
M+4Y9*DCHVY6&6ADW5DI83C<J:RYG"8(I*&-[Q2AK8^D3X3]A.!.)C'+>-<P4
MR&R%B>[U?(]%L#9-Y$6RG3C&P03ML<I! R<@P673%8"G 13-LH7?W@WU1X36
M#>* F?*6VP]1P??)":;.'3*9CVU0.S;I X65-;W[>! FX$601*8CT1%10-DP
M#<.NVJKJ=N.;CC0ABT52"9P-:A*\P*8L? P,-!MF;KN7*1M&L&R"15P4,('5
M%-/[8/'<!U3XKZ$T-=;:53;U%#6[M6:W;H4ZA7BD'/PS&69+KI*%!)T1D\07
M JC940[3E @$'^>U:G55($!SKPYP3R#/%25XJ4A'7.MM2L*M?:;-RM,O=99)
M=GPC6'L4,\1,+!#L+NBJ51(0* =O3?4@9=-2F:N V7J2%GR=R,Y/\8;52[,P
M-7%J&VR1>J+=XMZU>02KFS5]NTEI&*>-#G3*#@!,(AU$=NH"B*>JCC-N*:"?
M&GFLMW <">3QTM F*FGXJJ=RA!3+MUZ^ :RC',Z 97FOGSA_)',G@B:0IF3L
M.(TBVY"L=DGL[4EQCV*BZ^_J1V#=X=Z_743(NL[+]S*?M$X;CTVU?/3.$,Z=
M<>@)FYC.^-V;:'L3/)F*EJ@_'XF5L;K(57:,$(DY04:/DUE) R:R2FX[AN40
M$-M4^'/HP;"C<D,#Y-MSJB8ZS%CB_6YA$)S[Z$IUMA+"[9PZBWD$?.213MWY
M"*BO0FX]0#6O*XXR<: 7(GB/U/YH:F$\SI2@,FK  ]0$/ET!#EZT/7CM@DWY
M[F1QY-M\G_G0N7;5MGY_02C<NOZN?Z@?FFU>PC!J"1+\T1#"5Q5DF+E(]>9C
MY"C69-S%M2"9R[ (ERHF1N  ?=8BQ2F+T'J724<T:&)#I@W%$[;<54N:-R"R
MT=5S"H%739R4:F@Q7;F,W/& BK%@= 6!$RIB3<1+V]=5>#V@\M+QQ<9K)N8*
MW+<ALI1]<HSVGM8EP^FX*/135L<>+APDL]78>6==\[,4J!-NY4X[ &^JI+*Z
M [=KQT:5:2M\^XY#Y(AW4J[2?7UXK;:Z5"*DT&31NV^^ ZC$J42Y39 F()'$
MG=N >W;4 3_#V.KQ=%LER3_D3E.1@(S)-ACJ7+1LW"*UV2HT.S;+)RC6938'
M9/V:2P.?,6*;M0*D;S.W;0'-1:N8N*N)KS-Q$?5LSU.7R0_OL#=5[J+E[8H?
M)%C:-(ETJZC6@L';9)=02B9$3$]S< T XQI8.397&[[%>/BLO)[P5;7:0<*F
M%0IB F=(6!0(8.H[>W;V:NL3C"YFE',J/#\3&5IW:03HZI^HBUYS<%N3'+;*
M,-D5M'8KJT96*.:N)LI.=D'SM4R#I1\5^EO'*(-NXYNP -UW#Y]]?9/^.=\V
MS;]9&>JLJ23X9J?@?7/)&^:+0SC;U%M2:YYJ?@0!?>B^0,\;*4"277C'<E'.
M7#"HRJ\>L]BG2C1R=JN6+,"K959(3 <!'<.NOVGL'FWR#K-';6JA;MWG!53D
MGCZEV'Z;V?S1Y2U6CM6+UN,;R@E+XD\<>PT:<<[83A#UZJ2\=:*VY:6%BY85
M:4*_BGC1RBZCI!9!%B#QHW763VV. %/TVWUY7SM=\GZC0W?I,E*IUPY<BCS+
MJ?*=[:[D++@YN47RY,^MGC1SEF<TXKJ\U#X=R]:)Z+AXN$N8LVT6R=-;.R;
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M@" ]- (7R>?O8S .8)2-6.C)1]'E'3!0FQA*Z(D()[$$IBCYIO<V$!#V[;Z
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M JH1RRI0:K.=AW\LQ@/V]0#;KK$"K)G.8J8F$-Q O=MV[;B ;@&PF#IO\HZ
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MI'1.19YMD[-'+B(I^2XPB\53J]AFW)(T2D1J_EKOR+!*-536IVN)!%0SD *
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M\?GT!Y2JH]PJ 80#S 3Z"($ QM]NXVW3?P^8= >9S*HMC@"QO( O88XG /)
MAS@F'>Y,)4$S&..P%$V^^@/<@Y\\GF>69,OO[ 82B803,)##[@F+MW!TZ]=
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MLPA;^K6G,<11U'R<@6UL#LTEVC^/5;.E/HA0O?V=W8"?40WZZX)SQ&K3%P&
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M%3?H(CXZ ?OB^-N$/4XR.OSB =V=DBM'/%JTBY;Q1V""IPB^U)VNY6!R5CV
MH/>/<;K[= >V*QY6JU/V>RP$0E'S=V>-'UG?)G,89EVQ1(U8N'29S&*4S9L4
M2!V=HF ?>WT!!QZDBSP,"-VKZ7?RX1WJ8X<8,1DG1W:L3'.)2-?(0[4Z@CY,
M4S4.;R4B@ %$PCK*$'.<4NI*AGJJTP'%2JH 9\4 [NUN_P"N^V_]JG]FVO2:
M!^'K[?/%&SMOZ=_J0M^GQR8A>(_IN9=S3/Q!YQ%ES+RY78R +(MH?Z8G+3?
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MKORV=2L-C.7N=0A_O^I5;B8)Y.OI><(\:JN@8J-4RE22$QQV6]PP .GAW/\
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MK<KZ;21EHU9^HX<Q,/2CJT7,O/4"-()K*J#SAOH  +J%)NG#1/8<Z91$#.
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M?6LJU_%#&4L4##1E4R!ZB?'J[UD5I0YYYO$.A8MU&\JP(F+=N^*_2, E(H<
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MK&9A)IBYB)>&E&I)"+EHE^@HU?QT@P<=S1=LZ04$I@,40$!][?0$%N+J!?\
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MGTDXNVC)%3JUC<1D9=Z])0DR_K\S V.MIO7#AA*Q\M&K)&3 3%$  P"(" B
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M1_.G-VB &UK7%^HZNKKQZFQ'3_IJ:>#1B=I+*ME2 FLF(@41.5#O$I0,'=L
M 8Q=P'[8.I=5RDHJM#7:HQI%D/:V%CFGD32XN7EWLP#4Y'V/R'0BHZ.*/T;.
MO;'LHX>B'>.YQ3,(#[OMU7XW80=E$Y'R%!TYBV=T:0G'4LG--)!$U=;DB)"3
M8AW,#+M&C0ZJ3232,)2+B4O:4-A#KOJF3S2;Z@Z+%V7L@2DE!5N4X_UBCU_X
M6.;R3AS&*I1P1CQ559ZL#=./[UDF8IEZ"<!$Q@';IJ =8KF*^%GYB%A>,T:^
M20&P)MGSJ+5<++E(D9)@X56/%'8(+L4DP57.8_<*9R@GN(#H!O,K+9FDE'))
M' =0F5X=NA+G.==V+>0.V16<L6$"O]'(.3/&I4^P4Q[2B(_-MJV-W+'+3@#&
M_P B9,=L6\M$8&!X1=Y&QCYK.LCEE"O'HD*)S)"P4*:MPX'[55BB!B@&Q0U;
M;FKD\G"H%UIDE,S1Y@\W5F<7*1#TU?!0&AU@>D2:IE=IL'2K1-XM'-BG*FF!
MA[0 =O#6SX*I\PP.Q;T<ATE)!.OQK)JS3!([AU#MD !,1W400[F8^8<V^Y3#
MX".G@KJ#&K4TFS-!+[W6YF1UQ<I$-%)E1,).X4W!$O((1)^0IQ#S=]]AZ;:G
MP5^;V SIPC8ZQ)%.*1;R)4Q2*[^C6B[H$@*)4B"X73.ML3?J&_74>"J_,#S&
MKC!,5")PC1--1R1VLDG&(>2X<I@8$UUB&(('4(!QZ_*.GA+G) ]Q(@$E3+),
M0165'9PY39-TUE$2]>Q59(I5ERI[;E PCUU#2LQ=SC3E[!SJ,K?\A,4<=?4Z
MPA:\PVC[S(":XRY,KD?(*Q4O+&4F'-PBU$6JK:'9/ED4SHIB83F* %^4-:EV
M]XO*@-5G]?CC*>H1"6_'\5F"KY@?YEQ<ZDWLU*1<%B+*D^_AHU6.?,E4&S_+
MS&(4@C)E$S,A(-95,4W7E^.J . _&3A<AZ/7(T7)2)JGL6'P,D78Q0,.4ZOW
M%*8.FP#X#\@: EIW_P"R?M_]3D'[VIOL: A%_%?! /32N8F\L2_AC\I>X%0W
M1[?O\Z^>'M1 .IOFT C4,QGS^N.TDWK[D9&QL5=)I@PC+#26KFN':V*$>G*Y
M@[N+02K8SG0: 98ICF49"1(I!*!Q 0)UT&3-ISN:D;L&+05>+[U1;X5HV;&,
MH7(K+85#MTDA5,7O$ $V_3PT ] $R$)[I>WVCMX&$?'NW^V\?;H#FK5"!9(-
M_!F=/HY.10.@>1BG0LI%COV]J[19,AE"*!\I=A#0'KKL6I$QC-BH]>R!6+5%
MH1Y(*^<\<E0+V?$.5 *GYJJFVXF$O</B(B.@&:SE*L-BYZ5>VGEK/'5Z@<>I
M$C-FT7<(5V=FK/<G#1TVD%O)(D]=,F#<BA4@-L0=C!UT ]TC8AT"D6%102AU
M$ZJAA[@V,!A'NZF*(=!T U_F)DJJXXXX9ND+3<X6D*2>)LDQ-<?3\I'1*$C9
M7=+F BXV+7EED&KB8=+E*1!+<>]00#M$1V$#><272<AQ8XVN$^\IW&!\5*&\
MTFR_=]Y4(#@%#;  *F6W$^W3N#ITT X(S<0 /:(F />V$-AW P" >(& >N^X
M: :[QCC?(<\B5S)I=KWDOD,Z(>4GN0$&-?*< ]WHGYG=VE\"@([>.@'1'9)'
M,!S(I&. ; <4DQ$ V -MAW+X!MOMOMH#"G%Q[=3SDHY@BM[VRJ3)LFJ'=T/L
M<J?=[X=!Z]= 45B(YQVBK',%@*(]@+,VZP$W^V @*D-V 8?$ VT!SMK@H,*S
M80&%APVK\R;<8QD8"C]'..NPHB&WYN@$HXRQ,8IQ_P 3)@PCS)K4F)%PE\"U
M\I?8BA2G63\H"*F#;;<P".@&D<T\.S&/['7.;N"JFUE<MX4C%8W)%"CHA P9
MMP0HLBK9JPHW31,B[M51:F4DH502>:*J1D '80#0#UL2Y!QGFG'=2R5CEY7[
M31[?&)3==E(U-BNS.1P!"O&CQHDEY;&9C5]T7*0E!1)8AB&V$!#0";<O8*.5
MP-:DFD"P754EJ.!DFT8S%<Z(W&$%;M J'</:3??YMP\!T Z%"&AC((B$3&[>
M2EL QS0H@'878HD!$ )L'L]F@,OT+#?K3&?_  !K_8M 4&%AP ?^*8SP'_W@
MU_L6@&ZY-A8HV8>/@A%1G;],W(3E^ : 4VU=/U,7R=C"4/M=_M1ZAUT @G,;
MCGDFTV3%?(SCFI7T<Y\>@L0P5'L3-L6FY/I5F\E&Y4)^N1%$T3*RC1KWQ[P2
MF(BZVWZ"(B M'&_/6,^1U2<S\!7D:U;:T\^@,BXULD*SCKSC&W-R@+^MV6-4
M:D5(0##W-71 \ETB(')[= .93AV!$2HDCV)4"F%0B!6;<$"'-N/>F@)/*(<=
M_$"@.@&V0;%DVY;W15JDV;BKA:N(G!L@B@90R=E=]@*F1(03@3V=V^P=/#0#
MH5C^2  0ACB)1\L@> J="D QAZ% 1'Q'IH#CJ_;:K<B/W%9F(V?28OY&$=O(
MYXD]19R\>H+26C5C(CV(/6ZI>Q4O0P!MOH!E$YZ6?!J8>RLRTP1'U"SS,D[F
M7ELQ_9;13+&68?O#/W3]N]@IIH5HL=\H943$)]N(B(=1T UG"'$7D[B]WF>.
MXQ\Q[(PAX;,4^9*E9YJL=E"%=J.8Z.<'24LPKL;.7RS[!WB=0QBAU$1 - +<
MY_C;ZNP<*%D>%=_122.^<OEV63*TLFBBD<RS5K%L?CR.0.5+[D/F 8QS" @&
MP;@(KBJ=]43E'#/[K!YUPGQZ;PD^_JKJD/\  =FFUE744<Y'$BVDK9(Q,DLT
M=AVB02$$@D\!T!#WS6XD>L#B3GQQNS)B3D)BCD)E/+Q<B4F#CK3775!I-$0/
M6O*L15(E>:?(%C7L4MV[(AW=X@;;QT!.?Q88>I9CC"%%Q?><1\9(V;I->0A%
M79,K6>5/*+@NY67>"2/AS$9MSG5^YI 8PE( !O[- =C)O_5=4$XPE3X6HH%4
M.9%23L^2G!U2 8>P55&T:7=3M^V$.F^@$QS0GZHDIBR_Q-IC>'\?7)+']G&Q
M2<%-9&&8A"IQ:RA3Q*:K- [A18Y0* B;<-^@[[: YVZ\O>5'!^B4C(_)_%M?
MRWQWFXVAU]6[<;8^PO+#B!>5CXV-2F<EUJ;(X?RM, 5S*NI)MN1B)!,J %V'
M0$O53LU;MU?@[35IR+L58L$8TEH&PPTDTDX>;CG229FSUD]:&4173434#8Q#
M&#V;]- (!RMXG8PYBXN;8FRU]\R-8:6N%ND=(4^Q/:Q8H>R5=RHYA92/EV7<
MNDHT74$>T.AM@#?;<-91DX.J!$GRB]*['-&JE35HN>>7<6ZG+[5*Q)SSS.]B
MF#1;27?(LS+M8HZ!4%UW'<(&*8Y=@'N -^NK?'F!O]H](IW'\O,1X3?\Z>8"
M-7N^&LC7%R,/D-PQD%+!4)N&:M 165^*(1N$?(F$4Q'<1WWZAOJ/'F!VT;Z%
MU&C9%@_?<WN=4XQ:K)K/(<^9%&9)- #%!1J9T@V(J@*A3=! =9V[T,U+Z3AV
MO"O+K@206YA],7U'6?(+D?6>.7*'+]WD< 7"O7JJ81N&7YED7,>%;>3OBX-I
M9A(B,;8FI45416*( "P;&'?7=T]W::)R5/[$?<2$<$>&.%N?=&4S%&Y<Y[88
M<X[L=@Q!EW"EES?)N5Z[F"E2(-K$E#VQNFJA/U_S"G(!DAW -O;OKF:F5OZF
M?A?MYG3N&))LGZ.7'SRQ%3-O,0ZF_P!L'(:T%V 1WV OPXAMK5E=E'A]XQ,#
MOT<^/Q&RJJ>;.8@&3*)R@/(:S?=#E 1(B)OAC"4BQ]BF$ $0#P$/'6'CS E%
M/](VEKXYFI3).4N5-?OK8+(#:,J_)&V2L=\*W!R>NN$?/;IBL^=-RD,HD C[
M^X!UT\>8K4]>&_28PQ8\5T.=MN:N9I+--5N/D9Q)7/MC9.2R:W=YZ16QF9?@
MA*)>J0AN(#J5>N2PC2O:91@[CRH3KD-P3X;\>*^RD[3G7FP]G9Y^E!U"E5_/
MMFF;=9[ Z$I&4>SAVS4RX('7,4%5Q*!$R&$1'<-<O6Z]V,;C:?9B=[;]FN:E
MK"JZUP:[,,?81T\O.&-OXL5[!O(.XYIY3-<87^>B\2Y!Q=!9SGI2?H%]R'.M
MT,=VSZ1.D8TM%L6I5&D@@4 #SC=P![HCK.SJO$L1NIMJ2YX/THKUEI:>[/31
M^6#I7DR:-CZ.G'UTW07-FWF)VK,VQE$QY#602F.JU154-N#??WA5WV\ ]FKU
M<S/*^AQ9<7WGK#T:>/)0  S7S$#8GE@/X0]F$>S??MW%J(B&^LS$J?T;./)M
MQ'-/,+[42FVY"V8NY1VW >UL7Y.GR: J;T<N/1P$ILU\Q!*/;W%_"&LVP]@"
M!-P^'_G>X=M >MOZ/^"&Y>QMG7F6@7X<&H@3D5:0[FX%[2IF^X>]V@&X".X[
M]= >,OHU\>B@ !FSF*/O=W<;D/9S'W]X1V.+;< ,)A$?E$= 9 ]'#C\ B(9N
MYB]0[1_[0UF$.S<!%,H?#>ZD)@W$H=!'KK*,G"69<040]&_C\V."B&;>8::@
M&$WF!R$L@G,8=MS',9J(F-T]NK/'EP)-BOZ0V$7*94G&>N9*J)#@<J)N0MC\
MKO#VBF#3M-^3IX\R"JWI#X1<MRM5\\\R%6Y=NU(W(.Q;!MX;#\'W=-3X\P:L
M/1MX^%WVS=S%ZCO_ (P]F]O_ -[:>/,DH/HU\?!'?]N[F-_"'LW]RZ>/(&0?
M1RX_;#W9MYBB78=P#D+9 ';;V;-=^FL979R65\ <%AC@7AWC5Z@U1G:S8\LW
MZ1D.-MQ)YV8+VYR(VC45[HR*NLP3F$ &,$X% ISD#N$-@W !'>H@CWSO%SX^
MM#1IE-7D#!QU?O\ 5R_1SRC(3L(LC8XYHV"0QU9"M3I)T6<.W!O+-A-NQ*43
M@!0-OH!XOXRGO_$_<C@-MTLF'AV =P*(Y6JX"!1'V!X: EC_ ,E#_5R+^]JI
MH"$K\5Z(;^+4N0" [CS%Y3;;;>!KV)=Q\=@'?KX]- /OM?'+ES9N859L4QG=
MG<^&'TLK=W>*9.%1@;;1+5$QYDH&#B)^".RDIB!5E-ERBLH=,O:(*%$-M .&
M HDYWL0$QC"/%U^81.)3'W-D=B.QC%V*80^4/'0#S@\ ^H'YF@*Z - -X4RK
M)!R:3PA]  :(4PV.3CV@7*AET9'[[5:Z2%^% OE)M#-DA4WWZG]N_B X,! "
M=?: [?EZ B3]:6A0&0."5RKCZOL[%=);)F!HW$31[&-9($<HO<ST4M:\L7A3
M)-F3@4%2OM]@.V[@]O4"52%:"T:,T"I-VIFS9)NY:QZ?E123A)%,BR<>B)2B
MBU(J003+L %)L&P: W"JGEEWV$P[]"AXC\P?/N.@&J<6)=*8B,T2#4BA6Y^1
M^44@!1)1$^[5W%HK&%-8I% ^Z$V =MC '30#KMPZ?/X: KH T!P.3#*I4.\N
M$1[5$*5:EB'W^T.G!O3%-T'?H8- )AQ-!57C9A)=8W>X4QU73.#[ '>N=KWK
M"/AU!01T O[AL*P;=A!,"9R^^(@10IP$ATE>WJ)3$,/U- 168;J#+CIZD&2<
M%8YF A\-9MXY+\H'6'R,BI5VEY?892"D6VTT'X<I$X6-NC5VBO),=O+,\)YI
M #O,  .^Y:+.D\(SRK!RJT<#-TI,CI$YDU4P5MD.FH!-@'N%4H]O7IH!S""0
MD12*'>;9,FYE#B=0YNPNYE#&ZB<1\= >O0%!\!^H/YF@&Z9._P#HO\>@]H3=
MS$?J?>Z?KH!P)R@)#%,)@W((&$H@!@V#V#\H"&@(W,'MFB7J3\XSM$D4%G>,
M>-RSTB $)\0N$3-D(Y<$+L(N12#M$QNH@'CH"2D_0JGSE$ ^KVCH!C.0LDQ.
M)^2<C.2%:N5E4E\00;0C2D0*T_(D42LKH %P@V IR)& >AC=-] =O$<GF4Z]
M9L&^(<\,3.W+<A'DG0'39FB(JEV.X45<) 1(IMA./4>T!Z: ]3V7KV FK]E1
M<*W"71GY66N<G&XU@2KMGUAEG'Q4F^5,X=( E)/ES=ZI#>'30%]*Y!66Y6&.
M@C\=LTTYLY.4KFQ6F&CX^(C$C&!05'*B<FJL<.X?>$I3;=1T!BX\N1=V_D<@
MH(;,LS.@)U 3=BT'&J%Z;=.XH@/AOMH!T_ED';M$0 /#MZ!OX[[;>/70%O:D
M01,)0$=Q,8P@4-A]IA\ W /;MOMH"-SEBFP<<Q?3X;/5O*.K;,RBQ$#F(H5V
M7'1P!5+M*;[JB17N* [ (Z <SQ=?2<Q@''TO-2SV7FG<9)E=RT@H*K]X=O.R
MC9,7*H=#&321*0!#IV@&@,-,QQE&$RQ?+Q9,P2MJI5J08LZWBQ6":,86DBT4
M-YCUG+I&%T]<NBB'?W!L;;KH!5<C1U?>TFT1]J7*VK#ZO2+2Q.3J%2!K$*MC
ME>.14VV*#=(!,(]=@#0'HA8N"D*BPB8XT?-UIU7&40@1ZDF_8RE>-'E:BV=I
MF 4'3-^P4 !#82G*;80$!T!&I;^'67N+\TTR#Z?=J3@*@UFG=AR'PRN$@"^)
MLE,SME_BH_%DQ($<N\16==R<JB'D')'+*$*0Y"$$0T ZWC#RHHG)2O33N!1F
M*CD&AOT:[EW#MR2*QR)BFU)HG5=0=IBR',F=(YB"HT?( 9N];B4Y3" Z 43-
M%.<Y!KL;#MG3-H=E:ZY84W#D.Y,#PCY)Z4J8@(_=%2;[?+X>.@&'93B1;>KE
MPYGT9R; )WC+R.8O80\@!H 4XU_57;=XWC# 'P[]518>]0HB)@#KMH"58I3@
MCN/LV]T1#8P@(^[\GB.@(UI&LS;KU*K',5F5"+?_ (%JT0+1<1&.E+$M=W9H
M.7?))AW@C".3 7<FY]C].@".@(__ $1<N8RQ!Q>R+@G+>1&%/S_B'DSFM+.M
M5MCLK*0"V6>[RTTRL#(3E^*=05C8+E<,US[^:F.V^X;:Z*KX4,,,O$(G)?<A
M<*Q*H,Y+*-.9.O*0="@K+(E5^%<E Z+GM'<105(8! P=.NN>^+[P(S*<D./<
MED.L&9<@&)I-!-RS1I$6[76CK"K*J$3;NI0I&1E/-8B0?* #EV'Q#4 ZBY\H
M<+Q49.0YKPDWG$V$LW:I)0\PY,C)%9N2-#E,1BJ '(Y$H@(F\?;MJ97%"/H*
MKU)I1(_K;ZA<+BWB1BAW,69P&>LCJQ>.JV6QP$M'@]NL@Z?).YLK=1D15\6O
MQ*'QRB:/<<03*&WO:X>MGXUO)%NN9'K=@VJQ?G_O:+3J+=>U+#VU%JQ!B;!.
M.HNG<A91&\9JR?<HL/A\L3,5-66Q.U'@F<.U(N"5W2K$:NN83( DD4R9-@WZ
M#K'3V,%U-C=-^O0KH-)3PEAAQPZO\*>EC)O4BN]+DL8QDK6L4YS=2=PY3\8U
M+:ZM-<F&]6(PB;XP8.5HEH[<_"Q)C,E1*91-,H&'<?$>O:MQRVXQ?)'D9NXY
MMW?W*X]Y]!3#X<A$T$">6F@1-%%$2F*= B:)2)IJE-[Z8D1 I?>\1#69B;/0
M!H T : - &@#0!H T : - 4'P'Z@_F: 9A8P_P"W/01]T=^-MO((" BINI<V
M0%[1\-A,'7?0#=,Z\<N:5YY?8[GZYGR+D>$CE9E/Y,PU,P:3&SUNTU9J08?[
MT+9$*,9MW$6.2$%U4U53 V4*;N Z8@70#8_QDM,J/HZ\D #?M&?P[MN(CL'[
M:]2V#?H)MOE]N@):O\D\WS\<B;?D8V4W_-T!"?\ BNAQ-Z;5NV#;?F/RD)UZ
M^%\$=]NGR: ^C@4TP PB0HB.W<.P (]>G7QZ;Z 9NH)"\\F(!T_[+K_IU]T/
MVQ6(^/MZ!H!XY#F'M#LVZ>/=\WU-] 9>OR!]<?L: .OR!]<?L: ;4C5)P.5D
MED S-3[V5<$,*8@_[P A;"C>'\NO'F3$!'M%@H10#_+TT Y H"8I? -M_;OX
M_4#0$;OJT0EF<\"\[7"E*/4KCAIE4<^5TC!L9XXD'F$[C#9$<19&Y=U!+(1D
M(X0,8H )04WZ@ Z ?)BN^,\G8VQ[DB+:JM(_(M)JE\9,W([+LF5M@V4VBW6-
MML=9$KWM\ WV'0'=N#@0"=X&ZFV 2 (B [#M[VWN!O[= -BXQ.6;QAG!=DN1
M9J7DAE5!,Q1*8 %NYB2*)[EZ")50, _/XZ 5F0MK]K=X.I$KDVZ9R\4^D%+<
M@FF>OQ;ID8H)Q#Y4#><1X^((BD.W:.PZ 49$^Z9.X?>V#?\ W!H#()_D#?Y_
M]P: X?)O_P!#C()A$ #[Q+;O\W_$3X=_J &@$OXEF$O&O"1#!M_U>0([[[[_
M '#8.FWM+L.@'%;B/4-A#ZHA_,T!'5:*^P:^J%B*XE^(/+S/#+*]-.;?L:EC
M(7+%2GT!.CU[E!<OQ#?IT /ET X/E&S?26&9EBS*59T:>I"A2F$J113);X91
M7<QS;!VD+N'7<1Z: <2#@"D-W?;)>6!^[IL!P  /[H'#M$=_J: ]._3?YM^G
MV= 6"?<!#;Q#_=[-8R;2P50-7S2[<LLV<8"-U  CZUV]FX()=^Y,:X=3?QZ?
M)K'//\HYCGO.(<PIE P;]Q1,/: %-X   (]RGC_.@(:L!&9@&'C(;U,>=RK!
M-4J\QC/C?)R G<*K$.X^CIY !2*L9040[2]2EV+N/AH"3TVQNXNX!MU'Z@@/
M40Z;: 1E ]3+FB5!#XK[_5*1&&>'^Z$:!3QEUP9D Q1[#+#) (CML;;VZ 5\
M4/- H@H<@=0,43&4 VX=.BAC 42B.X"'7Y] 5!+LV 3F'[4?=V)N(;[B.V^X
MF#Q^IH"I@*(E$P )2B!A ^YP 0ZB8.X=RB'LT UGCY%.XS)7*47*8IED<MLY
M!GN;H9HO6H\A!*'AU%(1_)VT ZT $H;=!]OCM_,'0&)0H]IO>[>X#>\&VY=P
M'J & 0$0T!#:QE;CR&]6&2K\O7E6>*^%6+59*"FVSK9)?)^46IV:JD@!DB^8
MLW@2&$H 80[=^@: DJP-4V]'QE4J8UGX^R-J\VD6Q)B,6*X9/S+2[]XJ9,Y3
MG!,R:C@2&()C"4P#H!;/<'H&W7H'30"+<C2]^",RE+L8QL7W<@)^[[X_0#XP
M%$3"!0*.WO?(&^@,G']P9?">'W @03KXRI0F(02 1(35]@/ED[-RF3)ML4>N
MX== *ZN1-8!*<NY@W HE-[Y1Z_:_/OH"%',>-+K#^LCQAR/CNXL:O&Y#XZY#
MB<C5Q*/,5*[Q-&?1RK<L\\0$A9"58E>%29JK@8R"0&* [#H"0/E[-2U?PT>8
MKJRS!\RNU"!$[0!!4$U+)'H+D5 O_O4$U#=^PB!@';0#4[&>WY-]6?&L?5GT
M,TIW%WC/9YG)R_P/FRJL]F^4:MJW!1SE0IR%(Y80:CI0"_:IE#H B B!(NRR
M%6G]TF<<MWBXVVOQ49-RL>9FN1%".EE#)-%$G@E^&7.?MW[2F$P!X@&@([,@
M9+B,=>K7A.ES\\W8CG[BS?J_3HA(/,6D;#2;8VGGRKHQ0 [(I(E4Q4C;B!U.
MGCH!HWJ0X\F>'')#'WJ?XNAJ-)0$F-/P7RJQ!/-XU%7*]?M4XR@J-:*P#E%1
MN_O]5DY H;&#SSM"GZCK?C1V(QQX?;[<P3)T6"?V:K(2U[QA1JO:GJ"@!'1S
M>)FD6#02",0[,LLP WQ)4%B&4;B/:F< ^36B^+!TU+QK%5J%BXYXQB)F5C4A
M*K9G->@D)-ZY\]5=-T?X=D3M,B"@$* &W "^.H!T<R,/7V#R3>-8M!K&MG3M
M\_<-FJ1$VC5 7+MTX.=,$TT2$[A,8>@  ZT]9^G#/6M3:T>@EJK\4I4J^A'1
MBRI%Y17&Z\H[Y QCJF0\)9ZEQAB)&+;KJ1<-\&]9S&4TVKA,"LY^R2*9D6S@
MJ8&(S(':;WM]<W2PEJ+GQ8*C/3[K<AM6F6@M/-/,FY<,.-*.O'OP0[WB\Q,S
MX\XL;F4,9=I54FI3D<'64$[9V](/:J<^Q 5$@@ ;]!Z:[-JTK?:>1N2\2;G'
M!OTD??JCV)EE7@Q;Y@8RYU5S1,_X1=?!2J3F#=+R]?RG6D 4(<JAU'%??).]
MP,'NG'K[-6LK5?\ +B3$,"&(DB4PF-VMD $QC=QA/Y*?<)CC]T4$=_$PCH2;
M'0!H T : - &@#0!H T : - 4'P'Z@_F: 9I/J%)SHH "7N[N.%L'QVV\NZ,
MU/D]NVV@'BD3*)2B&WO !O !^VZ_S= 0+?C+A0+Z/W(\ Z 2P8;$0_/!^VI5
M0V^OH"6(?\4\/]',/WM3Z A-_%<?^[;MO^F5RE_Y]&T!]'Q_M1_(_-#0$>60
M&&3'W.Z'_:YFZM!N"<9'QGZMEB7LN5RA^V"S "-B-7#<K;W]MQ,([C\V@%;9
MQO,=!=0SNRX->M@6$$4R5^Q-E?+V'M(LH5X8I!-L ;@ COH#T22G,-NLU-&-
M,%2*!E"_%D75M3!1(H_^YHG#SP4,(^.^VV@/:A*\JB$5%W3,2J*"82D%"S31
M4B[=-P*=KWC\X#H!*6DKSJ1R3+S#W'>(Y'&SB"8L8RNHW=RVED)M!TLHZL(O
MC,^Q5.1:B0A6QOM!#V: Z?\ ;DSRVR#7\=26'JLVD)Z"E+&5XVR 59%G$PSU
MDTD#+=S$0^- 77N$\!'0%N4G6>+G3[_0U,!U>UP5RJUFIQDG&2HYB62AK+"O
MXAP@](Y8[>2HB[$50#;H/00';8!EOI2Y5STMP]Q=C*SXA7?.,#*6;CW,W9MD
M*&EVLY*8;F)2KB]8F40!PX8^6T0:HB8V^Z9AWV#;0$AQ,EYL* ?]G>6VV XF
M/D&L'$QB*AV" )@ %*<O78>H!XZ :AQ4O&5*7:,N8GD<'SCMR7D!;;99[)$6
MRN/(6KQV2D4;)%)N=E2N'2[1KV J4@>Z8- .^G<EW&%G7C!C@N^61FS%(B-@
MB'==(PDR=GBF@XD$71/*,/3<!#?PT![JODRX6*:3BY+#EWI;$Z"RRD]/.H0[
M!$Z91%)OV-G:ZQE%C= [2CMH#4J9DO:#MRU+Q^R4[2;N54$WS=S7OA7B:9M@
M=-^]\13R%@ZE[MAT!K)VZ7F^8^RG#CBFVU*76I-F803>?=12AIF4D(=VU8,V
M)V3E5N555RH3;S#;>P= (%A7,63\88>QQ1I_BOG-S-5"GP\%)&C&< Z;+NV3
M8H.E4#&E 5%#S0'J!=]AT Z6QY6DJ]5Z[9?VMK[.N+"L@"U:K[!LXGJXDJCW
MJ'F6QUR(D!!78G0W41WT!&?>\Z69+U0^+QRXORHV@9KB7R"9*P;FM- EPE&E
MZH;LTH41D=OH]%#8#&'W0#KMH!W_ #.O<C#8>D6[6EW"Q$5>U6;=/:XQ16:1
M;*%M,0ZD&S]P=V@H@]42**8$ ! 3=-] 6RF4+]*7VH7")H^=8ZDQC%V,C26M
M(B3)V9=VF8L>^<R9I/SFZ: ["*9 * @'41WT K(<@9;M #X)S47H &$*VP';
MIUV_XS !T!8;D"_(&XX.S6._0 ^]EA_,D]4W]1'3Q4I<W0#:<R9EGI#*?'2P
MEP?F9&,KEXFDGZBM7;G'SI:"6;-$P%!^?R^]0/%3M)\^M9[E;2[ =_2LE6Z,
MR38%5,=<C9AAD&:9G(I9V,$2J8X:HD!$&K+R71W*3-TL83G O>82[!UUO1>:
M*EU5?6!N;&V73%/J-<J[&SPQDS(L%>,18%+$RU,9,%XU)2#2F6SY!RO(.6A0
M7*X6Z@43" >S;J$@?A1LQ6ZZ3?T;)X/R50&!DC"K.VOZ#;,B]I=RH@1N]<JB
MH;?Q /\ > XB(FI!3EW8V#RNRC!D;#D<G%33D[?X"6&.LBQG7D 583_<?. >
MA=Q\= .Q!R )@(?*'7QZ;?[V@/.=T83@ #ON ;  !_2CH"\7 "42B.VX=HCV
M[[;]!Z;[;AJ: 8+$9.S+&9KY&P-!Q,AD..B[33U"OQM475RL3/*PBJ+=8L@4
MZS@QB%,8-OMA#8/'4 7&<R1F5*8/%5O%U?L"B<='.')7&0V$7(1SAP03.T5X
MPS,ZID&RHB0%=P ^W3PT!D1M_(]R\8IK8CIC6.%TV3?.AR 59=NR,H0'*[=+
MX0B;A=% 3&*41 #"'LT!'/QEM&?U^=OJ,QU<J&/'\<VMF*#('E+$]2%TT-5%
M4V2P&:-E"'6%N4QER";M()@ /'J Z?!W[>E2Q^ZK5(0PK<VM:M%N0?OXZTS!
MACY)><=RTO!+%^$$/C(U5R*&P^!0#0'3X_RKR7RMCJ,NE3K^'8Z3D;"\8FC9
M"7FGK1I$Q;QS'R +*-BIK#,D71[O*W .T/9H#L;%&\G)FN24<^#"#UM)QCM@
M_8.HZR*-W97#=1-9BH19T!#MWB1A3ZB(]Q@]F^@&TP>4.7[+CM-Y*:4W%>*P
MQU 6XW[7-G@)XDHG&T3XELV!HDV?E0182;%H11H'< B!@#P'0"M<4LHY\R[B
M?]L_,,3$TQ29:.%:Y7TJ[(Q;XC?R4EV<\\ [MV9:,=E5 R?;L)B_/H!G/(&$
MY%1'.KA-/)Y2QW&RMEJF<*%%/U:H];P!$7\5%3";=VR<R!#OIJ3%F!42$,41
M[3[%T!(8CBO(MQQU)4K,UWA[(\>SK&0;S%4K_P![B;%I&R35^E'$8N'#P'0I
MK-A QMP-VC\O70$9&-)W,%$Y.<[\CRM_J$>S#EC@FA2;;Z";@(8_"@11(!DM
M,R+Q%2+!FWD5#J"4034.<3;;Z F6"TT5HU/:"2]9%@HH9FI9$7D8BS4!JH(I
MMU985#I*>0(CVE\P1-[-] 1%\EKO@V1]3OTY\@C=\=NG%?JG)2#<6'Z?B5S1
MQ7E78JLF+E4J_:@HY7 XIB.P@H41\!WT VOUG95#.'(#TP^+]&5DK].V/DO5
MLXVS'=?*JY2>8IQZY;R;BZ3CA$_P@P\:\ BA/$1 NNC%4L*O1?;[=H)[J);+
MG8)Z^,;12EZE%UZUN(FKOA=I.4[C">4@+>P())!NW*90_E]INH]N^N>^(,AL
MGP1<AJ8M5^DSV8:T%K(=&(?)0ZT8H[.T(@TEQ(JV-)%$@B9(P[B7J&H U'U"
M;*^0X_SN/JS.KQ5^RU(1=%HD8S;+/)6Q.7K]F:6AT6Q *X1:GA?.^(<=/*#Q
M';7%U]YRD[;Y.GJ/7^7--XC=VF$(-^GW\>Y#LZA6$JWCZ#JS1BWBOHNE-8=)
MBW(046RC.(^$%J@9( 0!% R>^P!L)A[O$==#1VE&RI\Z'%W2^[]^<FZK-A]O
MQZ4$LX>M%6W'*@1SY0RKAD>R-%#KB*@G%K:IGR^X3>()@( 'U-;1RAIWJ[1U
MGC>%&9+I$R[4T%2&E$M=FA9!J)B*PM6O\%,RDFW=A]U4=M6J(]B0"*8D 1'J
M&@)),?6V#O=4K-QK4BA+0-E@8Z7B7[8_W)PS>M4E2F\L_P!T 4^A?J^.@.YT
M : - &@#0!H T : - &@#0%!\!^H/YF@&7V/_'IQ]_HW7'_G@UT \Y/^II_\
M O\ X(: @6_&6PW](#DB _K]AO\ ?5JN@)7?\E#_ %<B_O:J: A._%<?^[;M
MO^F5RE_Y]&T!]'IP$=MOG_F: 9RL/_;T:![!XO/_ -\=CH!Y !T#Z@?F: KH
M VW\= >=0G<004 .S<!'< $ V$! P!UV$!#IH!&W=$C'F6XG(ZL^Y)+PM,FZ
M>V@.]/X%6-EIAO).YA=#<%S/?B6X)E, "3IXZ 6%,H@3?8 ,*H>9MX[%/ON/
ML[Q#;NVZ".@(U_36@S8_J?)/")Y9K)$PSS#SK#Q:9 43?,JO>I=KDZ#;R?<0
MIWS@ N"OEN#!L9,-@$>T= 22K;)@42]0[RF4  '?RBB GV$1VZ]-P]H: ;WB
M+&DS2,C<@+9.NFBK;*U[A++!M6Q1[VL;#5EC"&0>"8.IS.$#''?PW^30#C 2
M+T$!^H(;_E;#H %$H^([_5W'\T= 5\H/E'\O[.@*"@40V'<0WW_)^7J(AOH"
MOE  [@=3?PZF$>GUPT!A,U3,<3B!NXP !C .W< > #[P"(!\^@(C>9MF-#>H
MOZ4;2OMY)&<G[[R2K-DFV; QF#C'[O#4I).JS)2@]Q-G%BA6;@J(["/E=P?+
MH!]G*-5!GQUR<X\K<A8!J)TP#<3[RT=M^3[= +C!F!S%PZR9S 12)CCE* F#
MM*9FD;MV^7WM ;5THF@0%#B8  Q0 1,;MW$>T-^NP;B/MZ:FN $6S=<5Z?BZ
M[V5JHJFX8P<@FP6:'\Q0)%P7X)L")DN\05375[N@#L!=>(\YWM78V:<]&F[F
M->ZAT=KA&YK(QG3+A]XP;CO;,C)Y/I>*\CV*8<N\<13V5DI)1159G;#6EJBM
M %.Y6(0JRJ/Q1R=A1$2B37Y]\H[MYCO:V=J]"?AYGU/I&^[?HK6U*Y8<'=:Y
M4Q%28<C<DRF?5,?M(J.:5)I:G%8<QKCO),"W:M2N'=@*H8 4%J)!$"E$ #Y!
MUZBUYNW:>X?3RA/+&3CSY8?@>7N;9I7H?$JLSBCC.0.7;O2\W3KFEV%JV)1Z
M)"D3J4FB=5&XR<_*$3(S8$33%59ZS:#T$-^W?KL&^J-SWS=[.Y*YI(S<F\>/
M V]NT-B&V9G2K?# <)DO(V06LSA^ET1LR;3N0DW;Z>/--EWS2%BVC%LO('62
M$NZ;LCI84TB_*'R:]S#>-\W#0J&669Q])QXVK/CR<J8/N$CY4Y;E,.R]9L=;
M18/,D,JFX:K*R,>X.U=P3B1;)BQ(V34(DS5</S&,"@%.8H#OL(:X_F+S5NFT
MZC3VHQDY*$$^/&B3]IM:':=->S335')\^T4W/.9+GCW%%8LT&G#(6V;"+7<H
M/S"9)LW,P4>2BK!J!B?%K-3F'L(8=C"'MUAO/F;>9;=:UFGA+QLR;6/"C_$S
MT>UZ66MFFUEC\.)R^0LK6=UQ%6OC-952UW*M,6$*M&-',>N\E)]TC'-"MFA^
MY=DX63,.Y@#W3&WZ!K6N^9/,%[8);BHR^HBG1=Q<MNTKW96TU@U]O<;C#66+
M(. );(=[6!N>KLGS%2)0;*.9&$/6VQ(YTUDS]'#IT+E,%%3@ B;N$0U&P[YN
M=_:);I>C-:A1JUC6M*O QUVWZ;^44%3CCTX_>:CB/?93(T]EN=E8:(1=/I&O
MN).98,G+ DFX^CQ*R26144435^$;@7L-]L'7?7H/)/F/7;]K[RUD914;;I6J
MX22.9OFCLZ7*[3QP7HH/10JT*684L1&+8LZ\:IM)"13[@</&R)SG;MSB81#R
MDSJ"/L\=?6]/P/.FM5K;]6TH6 )R1;-FT0XB1K9"I'@W+EP?S"S"B8^^+Y$!
M\O8?=$FM@'&8?P;4,*Q\\QJ2#@[JT626M-@G9,Q7DS*R4N^.^$7T@8?,708J
M'$J"0^ZFGT#IH!18FL0T B_2AXIC'HOUWL@\1CVA&H.W[I,_Q3UR4G]5=NE!
MZGWW'IOH!%N+%4;U7$$,Q"%-!N'E@MLJ\:+I*)+++R%DDU_BUB*@!P5<E,!@
M$.G7Y- .-5:HJ% JI0.7N =A#<.X-]AV$=NF@$XRQ66-JQS>ZN[62:M;+3K%
M"+N' [))@_BUVQ7+A0=P(@Q,8JAA$?M0'0&7&,:,?CNE01G+=X6&I];A2/6A
MP59O$XV):LR.6J@"(*M5BI 8H]0$!T CO*GC+5.3F,9*B6B4EJK+MI%I8J!D
M>L+"VN.,KI%K%<05KKCDIR@5Q&O"@<Y!$2+)"9,P;&'0#/H;F7DSB/!25,YX
M4N\S"E!9^1$<F\84:0MM)RE74%"H,K!88>!2.ZIMJ,W]^00,GY J#WE-L.@&
MVX"S)C?*-D]1#*5%:U;,V.\@\H..R*#2:36=1!6$MC.MQ;I9=BH1)PREHOQ%
M,P )3@&@)MFV+:'] H5<M3@RU)N<%6U=4CDS1::@]JGGD:G$Z??N<=A'J'70
M$:7J8<:<>1G'%UG7&N(ZZ.5.+%KKF=:$2KU1E]*21*_+LVMU@';5LBH>8BYF
MF/'OFH& =S)%, ;AH!H>1+5&Y!]9OT^\FU26@JOC*Q\-<@R=3NYUFS2%O1)9
MS&G6H4&[*8&I96-2V[V@"51,P"38# (:ZMJZHZ6,7Q5:^EU^X05ASK)/,3HU
MV_R,O=+54U:;8HEA6$F9T;9(I$+7; *P[&)!*@<1$6IAV5$P%#?PW'6FYVY3
M>:B5'B="4+62MM5DW@CC\_YC@L+8UL>07PIR+IHF5C P[7M/(3MB?&^#B(*/
M\L#.#.7\DHF0Q  >TO4=@WUP-QO^&JP.EM6VN5_-<5$L<>'=[OZ#9>)'%.\5
M5W'YJS_DNSY>S),LG[N+1M1D1AL3P]DD3RX5BIM$]MG\6V<?"J.CAYARD$/#
M7/TNEN3DM3*M9XF]NFLA'-IH?)%TPYTXU73M_ D8.3R4%")%,IN50"D* ]Y]
MRB':41V[3#KTT?VU'N/$NKU+ERH1[X)M$[CN<J./KWBV^UB>G9*_0</8'+\J
MU+=LX^8F;+'?!LO/$GQ[YBJ!@$2";KM\VA<)5S]N5NRYPSM=2CZ:^BELQ5;+
M=2G:K.D*9VE&PM,LKKS7B?N#Y#EPP1=)&#M /=WVWT \'@O)/YKASQ9EY804
MEGV \8J22Q4RH=[_ .]**(\5,BF $**ZZ8B/SAH!V6@#0%O>7Y?RA^QH"H"
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MIH)C  ["7<1WVT!NI%'XANHAL!O,(=,2B8Q.XJI#IF #D$#IF IA$#!U =M
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MFIA6/:G;L"O5[D@W!NV34*"W:#5NGW'/T[P';0$HZYS=@CMW@7WA+X;]0#M
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M7.+8;N;5ZRMEB7KS)G'FG6ZAW*"K9FZ476 Q?M=A';0"RM;!RO4('Q6-<+-
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MW$-]]@WT OILQ8R)<?VN4\A4X]]3$$AIGWP1B=C[RI$4[0B55BO#'%(X&[0
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M]"Y\HU4U6<?Q[JM<D%W#8I)QUE**DXUH5R<I9":=1[)DU<RBC5(PB!>X%%0
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MYWA,%<UL8S%CI^6+@WG<"6B*9,\3T"5R%),5ANK,RDC+L(C[O'1Z".XBN8!
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MM[Q!3<X=W:8^P^]U 1W^769)L.XWR_E!]C0&-43&(/RE#N ?D$IB]=MMAZ:
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M.7W<2/XF,+7S'N\K \EK8YJ+%*&8VNE<=*NZ*9W4H%XN"<;8\L/4#)MI*;F
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M'2)1*;[50H"7VZ VE@4D$F+M>);$=R2#196/;K'.FW7?$25.T2<G3W4*T5<
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M(UT*\K'*+3[Z9?UI0[&?))G#X1-$J91 $^WNZ>/MT!*6) 3\GO.;;HF(&[A
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MD<7Q[)_#@[^&_P#UJU;ZNV@)7_\ )0_U<B_O:J: A._%<?\ NV[;_IE<I?\
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M^P; 0H_:ATZ@'30"6$B<AHWJ\R\K885YC9W6V[>K5AM&K$FHF718N@F7K^6
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M#I0L</6S)J=TH(H-$ $ZZIR@DDFF0=U%U%E=DTTBEZB8P@4 UE7-\77$KI3
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MY -6L3QPQ=*5&K2>Z+O->6V*]?;1K%4137?U&G&*$G,N@3,!FX+ DGW^\81
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M2Q#?0"CHP+.A ZIS&=.E1 3&-OVCN ;] T Q[B]QZPWC/U:N7PTS&$#45(_
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MR;QUX-8%<M<NY3@H?_B..A(*@H3+I\[6BHVF1LFTAJ]28MMVJ.7$$SDUQ;E
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M^BU 63>S>?(X1 KM/RQ1<I' VX]HB $ZO<0>>+$";@ \7'W02]H[_MBL1W$
M "B(A[0Z: >6)@$@ '41 OL'YOFT!K%IB,9KMFKF18MG;U?X5FT<NDD'3MP
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M;V:8 Y^LY<Y4R!\7Y.=>EW-2E[J%(90%>MBF><>(232#E6#7XQ%LF5+M!J[
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MH'?]%IR%M:H2)FVXCY!'P& AA />,70$BZCA),!]\@@EY93@80#N+N&X !C
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M)O[3?(SXU>DIGB$CG9JHN$PDVX)@= Q@$- +)^,ED,7T>>1H'4!8Q+'AXPJ
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MB0R0C2;C;)6Z8IO$<]F7B$(]QI*0RLJT-,1A$E(Y5X:=:?VJ<!,KYGAH"1V
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M@$ZY$XVJ,)@S*3^JXCHDQ86=*DU(UJK!Q,<@JJ=(R"ZHR!V7>DX0;G,<FX@
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M_>N:9.[58<ZG.U*X^@44/#7I+=,BH:SX@/A^2'Y0@.LR!F-B,?\ #IH/:41
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MY?'0'F3]++$.5IUCE7F98+=RBSN@5X$?<I&QV*B5O&K*4(4TK2\1UFGRD.2
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M(NK\894$C&Z;@&O06+&U;9!2<8.BQX)^EG=6BV_268NJP7"E!2.*OXON/)&
MA\A\I#4W!]#?.714,)8*DI.]Y"ETV$FX3D&V3,\W)P]E#NEUTA%0L40A.XQM
MAZAJC</.UC2679VS3NWJTU6>94RNM4E3%O#N.=?\P0T-?H(9-0L,U>3XH^E[
MC/P&XJ<0ZDG4^.N%J;B]%.-49*3L5%HN[@\%1/L.\>6I\#B85>F-[QE/, 3&
M]FOG.Z>8MSU\G*]-UKPY<.G-=C;1P]5OVMU<D[\FXUX5HO2EQKT=5V",4:EM
M\7\YD:^VFK1/LYO!K]=*0M,\M/R[MT2RG=+@[<NA!9%L@=7L02*;L(7P -?/
MM=J-7J-PBI77EKS1V+]_ZW9(2<5&Y&.-.>/WTX]HJ.1(O.<WA3DQ%9P2QPVJ
MKNJ60*2ICP\H::-#H('<(*6PTF4K9&1[$R@/D;D 0'KKU,Y*D84>:G'^AX!1
M=7.N%:4.UK%VS TO&'J1#XT;O\(26'X1]9<K.95-N\A+0G%-@B8=I$F45^DV
M\@W,!CJE#[FITW]FL"1@DCRUJ7&GU+^4V(KKC7+5J>YHP_@S+>.V>(,2V')K
MZRQ=;CK#4+?(2YH)NNWADXR5000(+TR1%3G]T=P#<!8VOJ;1SVP'@V/!CU%!
M049?&#-FXU2S.)^X[D!F19W-)J)@)2 8!*4 $1$/#0#C,$<J\>\A+[D2A1E"
MR1CG)^'8^KR-LJV5:6C5;'%Q>0&*[ZNO&9TW;T56LDBT,"I .4Q3!L(: CVY
MT4'.'#[DPT]4GCC59/+<0ZI<#B?G+A)DW6DK&\X\U>27ED,J89BVHFEWM^H:
MQS++1J8B$BT VVPE -1-7HY?#CF4NVA9&VFJN20X+"> /3WY82D7STPFP3ND
MQF.9@K_'9;K=JND X<3=6;DBBHK0!9%FU:/XX4A:2;1VV!0JA#)G#IJR_;N:
M:GBI)/M7/A@43E*+I%9O22AII DD)3"4YC")S"4H$+WFV[Q*F7<"E,(?5W\=
M8)QEP=2R$92XX&F<P#!ZX*Z<,(Y=7=$!4<,&ZZPI)&%0$O.4*)]O,'<!]FN1
MN&S:3<YQGJ8IT?-5J7*[.UA9;C/KU+C0,?Y -08MC,0,;>.%!$[-0IC>:('0
M,44S#YOO"(A[-0]FTT5&.G481CV5"OS;SS;=SJ8'5:CI $0?QS!QY)TU" Z9
MH.B)F*.YSM2.2*%;'$H 4.W8 +K/4;1I]3*,KBC\/9Q+X:^[#KZZ?<7NZW&2
M*!6LFP92+9,2G2;NVZ3E!!8I@V4026*8B8 0-@   /R-5/8M!.]*Y=@G;?"/
M0H^HNJ]*ZF\>OO,[B$9.FYV:[1LHS4*4BC8R"(H&33 H)$,V,4[8Q2;> EVU
M7<\NZ"Y/"*5K\M/40M1>C>5V+=57V]I08*/%I]'@Q9%C@2%(L>1JW2:%*<1\
MTH-TR%1[%M]Q+V[=W4-;#V/:W:\/PD5QO:I7/$S_ &[ZEB->CFR"C9LP8-&Z
MOF>8W;,FR:"@*  '\Y$" FX$X%#<3@(ZBULVFL14+.517# V'J[LG63;EWF1
M2$9*) V,T9_! 9(WP0MDU&IP2)V^6+=0!133WV$ (4-A#5ZV^,O@NR4K'.-*
M<.'M(6JGSKPZFQ;-P;D*F4"%(F0A$RD 2E A0VV[=Q*4 'P /9K;=BRK?AVH
MY2N[<\3E0V!?M0_W>W4VH.W;4&ZM<RMNK*CX#]0?S-6$#,K ;LYTT#IOW<;;
M<'R;=ET9*;_D]NV@'F$ZD(/RD+^8&@(%?QEGIZ/_ "/+\D_AX=_JY2JWV- 2
MNC_BH!_HY?\ _-1T!"=^*X_]VW;?],KE+_SZ-H#Z/3CX!\OC^5H"-G+G'G!^
M=>>=06S-BRC92+3^-DG(5=E?(%G98V%?K9!9IJ.T(J3(XC55!*(["JD<2B(B
M78>N@) *[3:S3HYO$U*"A:Q$--@0BJ[$Q\)')E HID3*RC6[=L!$BCL3W-RA
MTWT!N56I5PV-YA@W$1 5E-A[BB780$1 0 !$0#P >N@/8F0"$*40#< VW'81
M';H&X[=1V]N@&I<P91&(Q5%JN#&$'F5,91Z?:.VQW5L8B4-NH;=I.N@.TY&8
MZ+F7 F9<6&0^)^__ !I<:HDW*0QB*/Y2NO08 <B8E/[[WL -AZB.V@$6]/S)
MJ>1N(^%WS]T@>UT^KM,8WR&*V*B^KEPQ^0]6EH*08  '9.FGT4"AP#H("&V@
M'P HF(!V[^ " E*.^VV^X>T.F@+BB0^^PF';;Q^?_P!30#<KU_C*8'__ +:R
ME_\ TJ/T X90>Y(0.(=HE#NW 1#;H/4">\.@$==5:^%O%LLCN[BICY[1"Q4-
M04(E!)>,LQ$US25C&:*<ZC@CQ 03*W  !,0W\>F@&-\"X V0N-O'.V5/(4[#
M5FB3F2TYZOQ!$DFUXD$;E/L1:3RA2 <[9@MW&$/ ^_70$HRH?<E"@ #LD8 #
MH!?=)[NW=[H  AOUT C4= 5X]SMLC6Y15M8G+^&7R-'$.D]!THTBB(QB"A#%
M$&A19['W)MW;COH!L'++B+DO*=PI.;N,^7(SCQR6I;0:JMDN0JJ-SKUUQC)N
MDG$U1;S5!6:!.@U6("\8J=0#M5^I3  [: CKRY?N2'&WU'>*%@RHVLW,J5#B
MYGZ.- <;L.LX"V55"4M=$*%RL<,ZMKA$\%-.XP6H& Q02> ( &V^X#OYSU/Y
M>N,"RUBX#<[XE@=\SBDU#8JC%Q5>R#@$6:0),;$LMVF5^V,.P$)\OAH!(>-'
MJ*/(G'<;5"\,N7\C/)35XD2,XZ@0CA<S%>XRI0<H-1GTERH(K'!-0#)_<S /
M4V@%*8^J^SEY.[PL5P?YM/I3'*XM[FW1Q4Q L.H#4'O:"QIP0=G.W-W 1,!,
M.VP!H#HX7U<N,4A%M9%W3>3$2NJV36>1DCQXR"F^BE5#=HLI $HTZ)7*9RB'
M<0PI& -P'0')9G]6'B0E29VK6!?+5,?7:L2;"M+6[#MZAF$H\>-%P09D>+19
MD"J*D()MMP$  = *G4?4GX;U_'U.2D<OD(Z:U^#9.6R%0N#URFX*U;HB*B#6
M%$P$*<!#IU /ET Q[U$O4(XGV%3@ZE"911D :<XL.SS]8E:M21(R*B&5H%T_
M=F5ADQ3(D1R =@;J=P^&P: =LT]3STX*Q8K1*P^06\589V3.>U2\5BN]$=SS
MYH)D4W$D_0JY1DQ33V\LYA,(%$-AT!%KZKOJ)</>26%<3XEPUE8+KD)ES$XT
MN7U?3JMHC7$:V:Y 8'(I**R\4T9M!%$=B@<_>?;H77J_+$'<G.;ID2IV\3U>
MR6)6XRN.F5I->VOK)IC@ .%Q'J8%.SO,.YQ( F'8QAW$PAOXC[.FN;O&XW'K
M'IH/&./X' W._&>KE"ZZ11F.4-NWIVB&X].NX^W?;?7*^IU'5G/S:;\Q%!ZM
M')G-'%W&& I3!<TI7;-E;D;2L33,@SH9\DS9*K8F<FN[7K-027;A)S@J,P*4
M@GW';H ;ZW(ZK494JO@;<7I<J>9\!I=TYI\KL45C 1G]^D;3)92EN0/TLYRK
M@<<36AJTQAC5]:(%H2H%?+A\,G,-R&5<@(&40$0$/#6,[[N*FH;R\N\RKI?S
M,=3Z4/J()^H+@UM:PB7;^QT&+@XK*]X;,6L?59W(SM 7,S!5:#2<#*-V;!,R
M9"JF+VF,([#TU773<')T'^U_,Q ,$\F>>_*:2N7(W'67>/&.,!T;DQ-X2)@O
M(E<<M9"<JE0L U^>F9/)!Y%-6+O,LJD=2-CRH>6H % =]52U-^+RQ;R<NXU)
M/39G\7,W4UZW5$81UUGH_C3F16O0^:I+CS0)^0>5J/B,I9:A)%9G-P4"[<+E
M,R9QJ2 KF<K$[/*, >(AJ87G<>6^WD_$LM/2YL9<CQV3UV\"Q,5CM]&XARW8
MI&Q5V4N61JNV^B64[BBMU^U&ILXM(MU2$&S+%F0[VJ;+<[EOL8H[[ZS_ -KP
MJ_67_P"U_,_6>_BOZJ*65^;69^'LTT=W*UHWI:7Q<WA(UG!I4?"J53BYU2<O
MSA\MYDK(*.Y(")-VX?$E'J;W0VU>M3>BE&#>1<.X9[O^#>3E^!.(R%)<!W*!
MS 'VP% -PWVW -M@WU7=U6IRX-\2N[.^XXOF>I5!("B($V$2[#X!T^H ;:UW
MJM3U9K.=[JQE7+FB<*IV!K=XYGP>)7]9QN_=R50E,N&9IQD1)*)"#L\<DZ[C
M/%C$+_4BE-YI@  *([!KUVV[AN?@PAM^,U%5_$])H-1*486Y8TBD-#I?+C)N
M841H?I7\+%;! )JG8IYYO5=:X9X\PY2F,1%]& U9Q5AN"3<3F4,5!(A3@7MW
M'?7I;FJOZ.Q]1K<JU#=*-TJN=.=>Q'H;JAIK"OSIBTO6<O ^GIDO+'-BKX?]
M4#/UEY'0]SQ!)Y3QUBO%;J2QG@9A+UF3396:#N->;+)2-G:M0>)F9*K*@*XE
MV.40WUP=7YG\..:-(RKS55@\>:?#^IR+V^JQA&B=>?VZ$_\ 1J7BK"^)+#7^
M+V-\?)L*5#RC*)H6.6L-"QKN=BV0)E@GSF,1021D55 V/\0)E-QZCKS%[<[^
MKGGE)M.55TXX8<*\CSU_=+^IN-IUBY51J.#]ED+3QXJ<M+PRM=ESR]N;2L L
MJFX-#2B5@?*/61'!0'SRHJ*"7N(/:.M:;G*59]"F'B2G6;JAW.XAOM^=_FCK
M5OX)E]$_61?YBQ?'9$]0###R0FK/#!5<7S5D1;UF85APG7+6:;IIQD\9$0%Q
M%CW=X)CN4X!L.O+WU_\ HP3X5/7:9N.QN6&$7][^W>/"Y$2$4AA7)U?=2C%K
M+3N/KM%PC%R]9LWTP^2K[QS\%')+]BCM<" .P$+VB ==>IG^Y'_I/$+Y9=,Q
MV&$4E!P]BHRY3E<DQY306 #"(%4^]]B84Q$-RG%)01[@#H!OJ:$#0LJ_0]>]
M23B*_:LRM;!?,)<@Z8_DT!,1Q)5^LIUZV,HE\8O1PT828_$) ??RU#"(;;CH
M!T=2=9U/D*]EN[>AABQ,&/[6CFO.);[[G1SE$) ;21<YF"*:0[BD*0>\&@(B
M[3R S=Q\]5GD%6:SQ&R-G2)S#Q_P]9H"P8ZD*XP*'WDOY*#DWDVXLDBQ2^&:
M.9,J8%2$QMP\/9H!?L^<T>5%#Q!=+]$\ \JMG4-#RJYW4K?,?2 PJ9FJ[?[X
M'L-&OG+N68Q7<"QFY $PI%'IUUW/+NP6M[W6UI[FHR.<DE&M,7R6*JSSOF7<
MI[3H?JXIN"572M%RQIP/GL]*SU-E.-%CPU@2XT>WM<622%QC[C-,;!!+5E]E
M3(5[>6>0R3*11RL%X$AGTD9N9N7JBB0.F^OL_F/_ (7N:70K6V;SE-)43QX^
MG[5/G.V?\F6IZE69T?$^UN*E&\@T:O6[I!\U=I)N&KMON*#ILL0JJ*Z1P$Q#
MIJ)G#82B("&OSWK-)/0:GPYIQ:;33XIKBF?8M'K[>MTBOV^:.B(("4!#P$-3
M5/%<"R$L\5+J7:&0: - &@#0!H T!00 ?'0%0#;H&@*#X#]0?S- ,OL?^/3C
M[_1NN/\ SP:Z ><G_4T_^ 7_ ,$- 0*_C+@[>C_R1$/$)[#?Y>5:L'Y@Z E>
M$/\ LGA\OX.0!O\ ^C0WLT!"=^*X_P#=MVW_ $RN4O\ SZ-H#Z0!';J.@(AN
M5.2^3.-.;E3?<:>.D/R)EGW&B70L\/*9.C<:*03$E]:':KM7DDQ=HOO/5  $
M-NX!'8-O'0">K\WO5A;*NFZ7I#'<E05[$EV_*+'Q4'* ?;G3[XXI^[\[OXC\
MGCH#MS\[>?49&,W$GZ3&8'#XY4C/&D!FS&<GY"P]5>P_F)G733]F_C[- <8M
MZF'.-!19(/1HY6+"FH<H*HWK&PI+;".RB8BX$>T_SZ X7D'S<Y#Y(QS4H^3]
M+WFI&OFF0Z1<):,CXZFRYT6U;DTGRS5%PREBG=&!4/ 2!T 1Z]- *&[]6G)S
M-46CCTJ?4-*H02'$6N-Z^X*5,"B9-0BB<V('.!PV*4VWU= -BXI\O<D8XY%\
MV<GW+@#SBJ% SU=\;VW&M:88>&0%)Y#4=.&NTK*,&DJ#:*E)6<#S3')OYQ@$
MQMQ'?0"X94]6-&;81D?3N-/J'T&3A;1$OYM^3BC8I@9JO1ZQAEZ_N9T8K,\F
M  4BI $-@]F^@%+CO64Q<Z<=A^'_ *@S AP*<RKGBU;BIE$?= IB)N!$IB@'
M7;PW]N@.<D/4OQS:\QXNNP<=N9T+#U",O3"4-*\:;RD\ \Y',T8TQ$B)*[MG
M*B8@(AN(;==O'0"JVOU@^,U*!J-HQ=R]C0>F[&Z@\7<E+]QMAW OPK!14H!L
M/42Z X1_ZV_#E:/?IEHW+PQE&3I(I2\5LM]YA51.F!$Q"&$"G-W=!'8-] ,Z
M]-GU2./.%N,54Q5DK'O*:LW&+M&19)ZVD.,V3CHE:V"[3LQ&*G=-H4R!E%HY
MXD8P!N(=VPCX[ 2!CZQ7$ P=@1O(T!'M#<.-^5NG4-^GWOB&VWU>F@$>H_JS
M<48C)V8K"^@N1Z+"U/:@ZAG"O&O*B8.4XJ!".> F<(,=P2<AML8"B/CUT N[
M;U>>'#A(%CR.:F)A,8/AG_'_ "N@Y(!1Z&,G][!O</\ SH[COH!EEK]2'C5_
M&"X8S! LLJKT<.,.5<<9!N88&RQ\1&KFN]8L]$K0G"ME.F+QTF_7#M(8/<#N
M,41#8!Z:OJX<-=A$LUF$P@DH8.[!.63)[E+N!3%-60*)C;^[T'J'B&@$AH'J
M:\$W#UIDAY4\H4^]_#2E;!<N!<JFE$('Z266!$R[6OBU^%E%"@Y'8!.!E W$
M!T KJ/JM\+&JSM=N^RPV7?*IK/7#? .5TCO%"%[2**G+5Q,H<A.@F-UT![ ]
M6[AN'_RWE\=_SV!<LF_*"J;Z 3;+?JG<.+'0+8Q;+Y2DY=2ORR,&1?CODMTL
ME)+L%DFXLC/:I_:JYU3 'F#L >S0'MI'JG<*HVGUAI(J9*1DVE>B$7Q5..>3
MO/!ZDQ0!R4YD*H<AU?. VX@.PCU]N@&-<ZO4<XR9:)Q7;X_HN>IQ'&_+_$N3
M+J+7C/DDC=G1JTA84YR5[SU]$JJ2:CU !(41,<#?:CMH!XTIZS_"2.>+,C4#
MDZY41,'<NPXEY-<MC"8.\.Q8U?*!Q* @ C\N@(D_4DYU<-,XXYQ[7,*XLS+4
M\F9#YA\:IZR66Z<=;MC>.GE(*],R">8LL[%MFA'*+;8$$P,4%!Z[#KTVPY_B
M?^%/34[FQMUEQH3-Y'Y)X Q9<$J?DK,6-,?VV0*@LRK=PM\/ S#IN[<"U:N$
M&4@Z0540<N?N:9P#M.?H ZT=?3ZMG-U__P!Q]PLZ#\KE%-PB '0.FDJ19( 5
M0.@L0JB#DJQ ,F+9=-0HD4 >PP"&P]=:E$:K0R3G#QJPGRAJ&-:/G"]7#&:=
M=RU7;AC.V4FV!3K4ADV,1>EA6=<DE *9R^<INS""*93' 2CL'36G*N9]X$OC
M/3'PZ$74F-ZRYR%RNM2W][?P-@R??E9^PLC9'K"]2L3!-^NW$/AEHIV8R*6W
M=YA2[[  Z@'=<:."O'CA3.&G,,N)6G*3E%JV+I&'EIMNI"VI[4W*JU=GEX,X
M-R*WAPFH=-11(!.LF4-]^W?0")3WIM<&W7(UG;7;VRQ-PMUP)F4./K+)TM'X
MSNF0H1TFJIDMQBTKLH.'T.XV$ZY?N7F"(B7;0"A2_I<\:K%B)UB/ON\?#?MY
M63D5"66*GP97*EY3LKH[N3FH*042<-8]F ;IIIJD, I^S?;04.2GO21XLV)K
MC!3X[*<%+8WJJE1/98&Z*_?'D*JOI[[XW\7?GSA JDD@ZEA,;9+90!$0*< V
M  .J+Z;'&"I95/G>/&QU+(Z&5H[*ZEQ:SJ$5(HR1:XUIAJZO(OB]ZU4FXE%-
M-6.6.8#G 3 ;NT _6OW.MV"1L457IZ,FWU3E @;0SC':#MS7IE%(JPQ4TFW,
M?X*1!!4I_+-U[! =6VOF] ^X[4BH+ <H" J  I]G\]W=HJ &WRB7P^7P\=;&
M!-?40N>H\WE7?+'T]4*]QTCN64RWL&8Y2*P9*3D9!PMIEHRG$<LW\@^L";BN
M)*PA^Y8HKI&[13WZCKUVW7HQVN:;RTCQPP[<:KUGK=!>C'1Q3:C2WQPPPXXI
MKUU75#R:_P Q/5,8)1T-'^CNA7HQ-))BDBUY.X\81,:U2#9$B;&-B?*32(4-
MO=( _D:\;?N9Z_$V\W-_;V'!UUR,I4C-S5>+:?W(Y*WV?U;+AFS'6>*]Z=>&
MHIWCVG76GI5FU\I8 KB3^_#X4Q'BKIE7^U-LR,V]XOVVX[AK6[SGG7XSO'JY
M4I1_#5OTS^(^.H2=DW<W..6G+%=RB[EGIQ4>O7;9G6%%G;UV<PCW[]1\>F@-
MG3G'K+T*H2%;J/&O@^FJO9)Z<9GF\Z7UP9!&>D#R2Z!B1U3(EWHJJ=NX=.GM
MZ: ZROV_UQ'<D5O8\,^GO6X\R?W269Y/RM+K=_;V@!F?WOM3"&_CMH!)+1@_
MUJ9O+,3F> MW :N66'K<E4F;%2/RG,1Q85^X*Y,*AE443^> DZ"7P$?9KG1T
M<UJI7^3E7D=KZRR]#'3.N$<>/&M3V9(XG^K/G:,J;V_9WX)U^Y55:6<PDE$8
M=R#835U26CE8QTXC%WTZS*LY5;+F[O, 2![-=B32LY*.M4<22_4S+@;6F<8_
M6RK<? 5UQS]XKHU^"9L8AN$=QJ>*/B1D:T29M1*5Y-@BHH*26YN\1$3>W5!(
MGV4/34]4+*V5,8YDE/5,K-;N>''MH=X^<5?C%6&[5@VNL0E"VF)DVRTX;Z4C
M9-D@38A^J9B@(;Z 6E3@KZD\[ N(JQ>KK>XN2<N45OIBB\<L8Q:Z":)0,*28
MOG+H"(+F#M. ==MMA#0'%P/I/<H29)C\M73U:.4MCO<75Y&DL9B*H&*($R%5
MEGJ$@XC@3&*>H]X.TO,\WM$Y?9H#KV'I2Y=2?K.Y_P!4OGG963@KCXR'6L%!
M:L')%^_=(Q25<VY"@;J4=P$-=#:]VN[;J,^GH[D7[?4:FNV[1[C8\*_1-\<:
M^RF @$E^+J\0)22?3DEECDG)S+PSMVN\D;M&G:?'O"F46DCQS2):(&="^,"W
M\Z "&P=-?4[?_+>_0T3T5^$)::BXR?+A_BSY_J/^,=M^H6LLR:N)]%S])V>&
M^565/3>L<!Q3]1"20=89\]I \<>;L3%.$J/.0B;@6\+1<[$:( TH-SBF?:D5
M^H<&CL-CF.'CKY;NNO6YZ^6I2IGE5]Y]$T&VK0Z%68NM$3H0T_%S,:SE8N1C
MY2)DFA)"+E(MVWD&$@Q<"!F[MF\9*+-G+=0AP$IR&$I@$!UH366;70M@FHI/
MB;4JXF\!*/B(#W% ! H;F$!$-A[/;\@]!UB9%Q3^:)@ Q3"0=C=IBCVB(;[#
MM[=M 9R]  !^?\W0%V@#0!H T : - 4'P'Z@_F: 9?8_\>G'W^C=<?\ G@UT
M \Y/^II_\ O_ ((: @6_&6_^Z Y(_P#+V&_WU:KH"5W_ "4/]7(O[VJF@(4/
MQ70O9Z;5M'??;F1RD-\G0;X)?K]= ?1R)]PVV_+_ -[0#.%R_P#;R9E >T0X
MO/\ WR[;C_UB,B;]0'PWW#0#QRIF]T15./M, ]GO=.FX@4!#;0!Y0"(B(B(#
M_N\?9H"XI (4"AOL&_\ /&'Q$1]HB/MT!C%(PF >\2?+V"/O=-@W[A$!VT!>
M1,2=!4.</Z(>OUPZZ N$!]GA\XF^SH#S[G+ML8PCL(" B4=QWZ#U+TU5>NNT
MTHQS-^@P<U6BQ+RBJ(#N( .W3P'\P"ZSS4BI3P;Y"$L[:I2A9W+%+L(@<W7J
M4-@V'P\1$=PUBKMENDI)=Y<H)\71%OOB)1$>[8>[8Q2; /RE]T1*.WSZ9^PU
MW=QX%X& ?MB%W#[4?=W#Y1#<NLXMRY$>+V%0-UW'J/R^YN'Y/;[-9Y6/%?Y6
M6CVB']2(/_K2]?RA#5.=]!XO87E#NZ!T -M@,4@@'U  I1#6495Y4,XSS<@%
MNB<>Y1-(YMMNX4DQ'8/ .I3#L&LC,Q S2 ! 4T# *G>(>2F4H]>AC 4H 90H
M= $>GS: N,T0$/=1;@;<-C"@F.WR[ !0ZB&@ 6J8B(B">V_NAY"/NE]A0W((
MB : R@BEMMY28]-OZF3K^1MMH \A#^LI?_<R?8T!C,U1$P""* ?GA\A,3&#\
M[N)>@: !:-Q =D42C[!!%(=OG#<GLT!>*/N=@'$ \!#M3[#!X=HD[!+MM\FV
M@*'*)"AMVB !L'<4O3;<=@[2@ !^1H"$GUUU"_@I8C'W"'_#+XT;;)IF[C_M
MA,2@H)P[3 80'M#KU'QWUZ3R]&4KL\'3*OO9VM@4IW)JC6/O(7^=W"C*G,OU
M.^0U I<!AJ'K5RX/46G3.2<Y8^E;@%5))6F10DI7#<@T71;Q&1X5FIYZ:YE/
MN)Q ?$-:>Y1E:U;<T\O TMSMRM:IRG\K.&FH?G_B:9Y^Q^&LZ9ZM5?X48EP'
MC3CE1'D:C(URX-I2B0E<R-D<J;AD+NUV.N,4UWL:T(L8/BB@ E$=AUH>+'E4
MY_B0[1*6&?>0"%TQO5JQE;*V=^.H<L>*S+$F5.2-::1^3)C*5AK4Z]RGC2(+
M(QL<LXK$5(H(*>8FB4[0RIDQ4$.NJ6E5X^P>)$YC#/*/U991SROE$[=D*Q9*
MC\?YGD;-C.<K4A(L\9V..N;AA6GN-6IX:/A(=U&TX#K(MDG+L71B <! >FHI
M'K[#*,[;XNALLBRMKO1.$-HB>3?-K*.+L><W,4.[K<KY475?=UA>Q4<Z]D;)
MO8R+2?3E>BK$7X<HK(BDV\TVYA\=*1Z^PRK:_.B2?FEE2LX%]6#B%G/(L=;$
ML80O'#,D+*6:OU.>LC2,EYQ[&&B4'XPS5TJ5T^;E,8P'#<!,/33)=Y1;0K;_
M #(:ARZY;<DK1G6Z6_#V6>0U!@BU7$4MP;H%!QS(*47/DY.V!JSOD?E4)"(7
M6!)G'**>85<[7R2]>[3)-8S32%;7YT=!4.1_).(Y&9NF,UY/Y:1.::E<LGH1
M7%?'.,F%GP2&'X2B)R%/G(N3>, 9-Y=^\5.<CQ-TJ<STW9Y7N]5(]?8*VOS(
MBV?Y/YI<@,(\BX:^Y&Y7JXX@KAQ<R]5AD5GTG=H!L\R2NTO[<9%K7(@=H-F4
MASQB"2R;8Z>VYP#JI'K["?TOSH?5;<L\AJUDK(\(MDK-V'>)EQYP2\/E+D5B
MND;Y?98YCL&0;K'+IG*! N'BC"=MQ#IOY%1F<PJ !#"4-90<8.M?81^E^='.
M,\C>IKEZD11+)FWD5BM2K<'.0^9X&3I]281%@RC;,:7IV?!CZ\HN(]ZBRG;?
M6&R!W+!$$U7*2F^Q3&'5OBQ[16UQSHEZQE;KG?>1GH<WC(P.T,AV_$F0;%?4
MG#$8U4EOE,)-'%A0=L=B'9NB2:J@G(<.AMPVUV[,YQVRY2+<)0?JH=U0=K09
MDTXRM?>CZ9$2F#RP PAN01ZCW= VZ;#MKR]N4[CE.2IB<2]*MWL/3Y?M[C!O
MX]H]NX_*/CUU88%>PNW@ C\I@ 1'YQ'VZ IY9?:4OUA^R.@#RR^PI?K#]D-
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M82]_.K'P;[?]F^V!\O\ 5+FT3_*$=] /**;M*4NV_:4 WW\=@VT! Q^,M?\
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MW(''<3&1+]'B5#S-O?[ +W>W62>VR?ZSBX]Z'T&U_F7K1<3(WJ?G[#_Q<--
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M/7H T : - &@#0%!\!^H/YF@&664#&YU8^ @"<2\;K:(E* B)?\ SV8%$W>
M[I=P")0.&X@(Z @NS22!FO6'B7BMIK"DS3,IT-L,E<(%]$4>,6?0S, QZK6&
M[ R-TR$N@)5XVPB<Q4SG\L3AV[  ['\91.53T?>1YRB/::R8@^VWWZ97K F
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M!X"[4JPE,JEL8 V\ )I$R&(0I3J]PAOU,0B0;?SI2$( % A Z!XC\^@,H&
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M/_QIV I]%]@,BG4DA*._DE 3C[ T!N4>-V9%/>_#+S*8NWZPT@O7P$-OH@#
M8# .X>(#TT!D#C9F,P[#S)S/M[?^(J07PZ_;!%=- ;#''&26I65OVX+CF_(.
M6I]O3G=)B$+2W@V#.'BGDFG+NCMTX=HV\]V9PCN!U? O3PT!%%G/C!:83G,Y
MY5ST?QOF:\\SKC:%8QHH.T\B,X1!HR23L[U]'OEWT9.,E2G!1(6IBNDO*[C>
M68- =-^,H*)J^CWR042W$AK%AXVX_P \4<K540'YM]]] 2S?Y*'^KD7][530
M$)_XKYL'IL7,G@8O,7E&4X?SQ#C?!$ $0$.P_P @CX#H"1YSZ;/'Y'FO#<Z:
MZRF*[E!)A.$N<%&2;@E2R#/RD4$2VMLS"'7%FE8F+8PE\PI>Q7H)R[AOH"15
M$H@F #Y8^\80$G0H@(]#" [!WC_/; !=_#0'KW#Y0^N&@#</E#ZX: -P^4/K
MAH W#Y0^N&@#</E#ZX: -P^4/KAH#"X.4J*AA$-B@!A][;H!BB(?/OX;>WPT
M!!GSPX%<O>2W(AEE:D9XK:6)*UC=]6:U@J7/8H*)=S,HX9DLK>;?Q3CR'C6T
MQR)TU'1RB=%,?+( >.@$?P?Z<_+K ^5)RW!?(2V_2V,'>&:;/1MDG(X]<J=E
MKK1LA'R4>Z%4J%=Q-+-5BQH-]UG"CKSC;B&P (7'^CMS(/*(O'N7:C#1K1E(
M6"N56L6RU-65(LQP70G:=!N0[?,BLMH['G'ZG<HGWB1, [A$ )X.#N"[/QSX
M_4S%=N?L7D_#J2\A)MHEP]=0D(>6D#.T8*"=R"JCMU%1R9NTAU/?$V_LT \;
M</E#ZX: -P^4/KAH W#Y0^N&@#</E#ZX: H(AL/4/ ?:&@/&X#W>INWH;;82
M=PCT'M 3#_/;;"'M\- 0"\S/39Y)9VY)Y+S9CJT5J'B;A$T>IV&M6*^VI>*R
MICV#7\QQ3U8-L4C6@$C72P/#.&RACR!VY4S]I1Z@<CCOT[.9^%6^9JU6,BP5
MEDLH8HD</PV77]ML3>?3@T64:M"R%@8N 43:+,BM5HE@1N4?AVRXG$=^N@$*
M_B<.8D;$JLJQF:JPRC>!4=Q206RU*%;,[ J0;A@1HX,(GCJ!) !U5'P=SAR9
M40]T- ?0!PSPO(\<N..*L)35B=VB8H5<-&R$T\>N7XK.W;YW)*,FCMX)G*D9
M%"[^&;"?KY*1=^N@'4@(;!U#P#VAH"NX?*'UPT ;A\H?7#0!N'RA]<- &X?*
M'UPT!Y71M@*8#=H%[NX>[8!#;[3Q\3: ^:[.'I4<OLHYTY+Y!1RK3Y2GYPRH
MSE6S&>L$^1X2@$:II01&S1FBFG$H8YZJ-8A,WEO7Z8+F/[PAH#H:/Z=W-K'>
M/<_X^89 K]EL.<(J(AY;)D];;"+BQ1=,F2+QSJS--R_ SUYK9OHQT#4 (S;I
M>Z.YA'0"0,/1ZY=U6&E8Z*RE3Y_>)BHU:-F+7:31E\JLA*A(/,6RBH&\Z J%
M 5,*K$4A%1VJ3<YMC;: ^BCCOC5UA["^+<6/K"\M+['U-AJT^L;LQA7FG,>T
M$BZZ@JB*HMDW"ABH]P]W84N_7?0"X[A\H?7#0!N'RA]<- &X?*'UPT ;A\H?
M7#0!N'RA]<- :Q\<"I@(&$!(H)Q$@AWE*40$3%WZ"8-NF@(!L^>EGDO(M\OM
M_P >VFLU27RSG5Y<+00LY8F,;7:=$QS-M0[+&,$%E".[K!2"3AXHE[J!UW&X
M@(%VT!R=']//F#5</YFQ'(2-0M+O+T_5[=8I)U=;"$%:7E3D'+9=*>5,)GOT
MQ>6SDKV1\H$TB%;D2*.@$17]&SF,I)2TG8<TUNWKE<QM63:*V:T1$;=*0<S5
MW%R%O:M@*F@IB Z -X9FE[KDJ93*".XZ ^FK'$ K5:;5*PN]5DU*S6H. 4E7
M(@#B37BXQNS<2"H  ?\ E*R(B7?J!?KZ [S</E#ZX: -P^4/KAH W#Y0^N&@
M#</E#ZX: -P^4/KAH#620KBU<F9G(1R*"I6JBHF\E-T9(Y4#J@02J&2(H("8
M"B!A -@'0'RT0WHU<RW5AEW\[GR%CV-KRA:,BN7;.V69:>HUF4DQE(2[5Q1L
M1JV=OY!-$&9&B@&)'-UC?;#H!9UO3HYCSW'N0XWNGM&@8"1RRTR;9%6]RM3V
M"G"RT:Y@Y&.16*J$I(/*](%2LAO-$B;N1$"B(D+VZ X$WH[<MW4FP/)YM@)5
MC]],-'VE=]8K260NL/77*:\#F&8<(G3\S($"U)\*R9E[&Y"#[X&T!],T(Q/'
M1;"/.N=T+!BS8 [5'M5=E9-DFP.EB"(]BZ_E]Q]AVW'0&Y#;8-Q#</E$!T!7
M<N^_N[AX#TW#0%=P^4/KAH W#Y0^N&@*"<A0W,8H!\HB&@."OK%]-56R0L8M
MY3V7KL[&LU"*F;JIO7T6Z9M3H/"B)61P6<!]U[3"F'O  B&@/F"J?HS\W&$/
M Q4_R,KJ:L6M9+97UX2=L4:[QM9W<LLLA7(-9$@HR2=WB021FY0Y!4-U$A0$
M1T NUH]./F'=>.V-^-,?;*?0JU1LBVFWSSQO8[,L@HYNT:*\5-UEV)C.BJ8A
MG??8-%1!-^X546/[ T!RV-?2*Y2P5MQ^_M67X1U6V5Y8V6UMD;;9W,C%3%<E
MVCU+*D:NH) D[O=HYD+9TD< 00(L)0 /'0'TQM3BH451[2E.)Q* >[T\PVPB
M43"(&$ W'Y1T!Z]P^4/KAH# X 3E A%!)N;WC$V$_;[0 ! 0V'V[Z CER+Z:
MV L@<R<8\V%"6"MY3Q^E)(3S&!EW+:NY/[XM**KKZX,_B_)^D*LFD!D1(F +
ME*4AO#?0#*?QE4GE^CUR.$XE[_OBPX([; !C#E6K>!2_+W;Z EJ_R3N[V?@Y
MAU_]&AO9X^W0'RB>F5ESU8O30P-=^-9/1RS/FYD?D#F7)D9D2&RG1ZVQF([(
M-I5E&1$XUVB\44!NBF =XG*!@'?M#PT!(L7U8/5A'??T&L]%^KF['G7_ / =
M 7?QL'JQAX>@QGP0^4,X8[ /K? Z /XV#U9/]@OGW]W#'?\ <.@#^-@]63_8
M+Y]_=PQW_<.@#^-@]63_ &"^??W<,=_W#H _C8/5D_V"^??W<,=_W#H _C8/
M5D_V"^??W<,=_P!PZ /XV#U9/]@OGW]W#'?]PZ H/JP>K((;?Q"^?/R<X8[$
M/K? Z L'U7?5D_G?07SP'R]V;<>#];9EH"P?5:]6,?MO09SL&X;#OF['X#M[
M.W9E[N@+@]5WU90VW]!C.X@'R9MQ[W?7%D/70&7^-@]6,/#T%\^A_P"G#'7]
MPZ /XV#U9/\ 8+Y]_=PQW_<.@#^-@]63_8+Y]_=PQW_<.@#^-@]63_8+Y]_=
MPQW_ '#H _C8/5D_V"^??W<,=_W#H _C8/5D_P!@OGW]W#'?]PZ H/JP>K(/
M_P!@7SY^3F_'8_\ XB&@+?XU[U8Q\?06SU^[=CK^XM 8_P"-;]6$3 8_H,YW
M,(> !F_'_=X] #=D)=^N@,@^J[ZL7L]!C/!/G/FW'8@/S!VL0T !ZKWJR!]K
MZ#.>1'\\7-N/ #;Y-O@P'0%_\;!ZLG^P8S[^[ACO^X= '\;!ZLG^P7S[^[AC
MO^X= '\;!ZLG^P7S[^[ACO\ N'0!_&P>K)_L%\^_NX8[_N'0!_&P>K)_L%\^
M_NX8[_N'0%!]6#U91_\ L#&?.WV@.;\=C^7\%M^5H#&'JP>K%W;?Q"N>@#NV
MW_;OQT&P;^.X,>FV@*CZKGJPB?N'T&L[[?/F_'PF_P#Y$"Z J;U7?5C$?<]!
MG.X@ ;>]FW'@]?FV9>&@*AZK_JR!MMZ"^>P_/;9NQV&X^W;^T@V_+T!=_&P>
MK)_L%\^_NX8[_N'0!_&P>K)_L%\^_NX8[_N'0!_&P>K)_L%\^_NX8[_N'0!_
M&P>K)_L%\^_NX8[_ +AT ?QL'JR?[!?/O[N&._[AT!:/JO\ JQC_ /8%\]_/
MOF_'0[__ ("&V@#^->]6'_8*Y[_=OQU_<&@*#ZKGJQ;]P>@MGH# '01SACP-
MOT+#0%O\:[ZL^^X^@QG@0WZ_]=^/MQ#?KXL=M]M 9?XV#U8P\/07SZ ?_3PQ
MU_,8Z /XV#U9/]@OGW]W#'?]PZ /XV#U9/\ 8+Y]_=PQW_<.@#^-@]63_8+Y
M]_=PQW_<.@#^-@]63_8+Y]_=PQW_ '#H _C8/5D_V"^??W<,=_W#H _C8/5C
M'Q]!?/O[N&.O[AT!C#U7/5C 1'^(6SSU^3-N._R_[2\= 4-ZKOJR;>YZ"V>2
MC[1-G''NPA\P%8 )?KZ  ]5SU8PZAZ"^>M__ *>&/C?E"R - 9/XV#U9/]@O
MGS]W#'?]PZ K_&P>K)_L%\^_NX8[_N'0!_&P>K)_L%\^_NX8[_N'0!_&P>K)
M_L%\^_NX8[_N'0!_&P>K)_L%\^_NX8[_ +AT!0?5@]60?_L"^?/R<X8['_\
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MS0%/=_3/U70![OZ9^JZ /=_3/U70![OZ9^JZ /=_3/U70![OZ9^JZ I[F_\
M[KOO^G[?8VT!?T_HO_9Z H/;_1_D>9_,T!3W?TS]5T >[^F?JN@#W?TS]5T
M>[^F?JN@#W?TS]5T >[^F?JN@#W?TS]5T >[^F?JN@#W?TS]5T >[^F?JN@#
MW?TS]5T >[^F?JN@#W?TS]5T >[^F?JN@#W?TS]5T >[^F?JN@#W?TS]5T >
M[^F?JN@#W?TS]5T >[^F?JN@#W?TS]5T >[^F?JN@#W?TS]5T >[^F?JN@#W
M?TS]5T >[^F?JN@#W?TS]5T >[^F?JN@*!V?IWY/G_S>F@*^[^F?JN@#W?TS
M]5T >[^F?JN@+#[=-O-]OAYWS: RD^U#[;V_;=V_B/CW== >=3S.T=O,WW#;
B;?;Y]]NNVWR]- :\/*^"'?\ \GW]S[3NV\T.[YM^[0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>n257410kimg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!NP*\ P$1  (1 0,1 ?_$ /H   (# 0$! 0$!
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M/B;R71ZT0I53Y+92:=V==5,:_P!V@+IK]?IP0WFOBLM!-W8?>7?3+6;<^"7
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MQG\74#"_#WX4WI,_A,MX:\QX7>.#QT><BQDWR-MMB<I@GL15VN19-O'RBK+
M)"S+)H#TZ#U'$V<X\6.> ;NPI^LN^F3R<]\,1QN>.4W[G#9ZY&/_ '=6\_PI
M^$M6.2Q8\4>7%KQF(.8_D7?>2-94#1R$?W>=,B3 ]2E?IPTO.?%C!V;OE_WE
MWTR$_I/X<K_N2_\ X;'_ !=<IOA/\,DD@6+Q!Y6EAGA:Q'-_[R5\2&-?S P+
MXY8JR_T\#-Y[XO)H;SE_WEWTRJ/BSPLU^E_*+UIPP]<8?_=T,9?XA_$2DO\
M[.\&^3;[">* ]WY07ZP#S$= 8#QM(1R//TX.9S7Q6X5-W8?>7?3(EOB;PH6U
M;RF_+M@]<CQZ/VN@:3X\_#FC<:'*^"/)M>M6OBC<L5_E!DIA'TRB.:= ?&HZ
MT0MIRU.O$OK3Q5^&6'WEWTR'E\5^'& TY%S#^&Q_Q9%+_%7X<Q92WC9/"'E4
MB**&S2LI\E<J@R%>=>XI@BE\:J[2QQD=0&H_#BJ3F_BQIH+SE^7W%WTRLM_$
MWAJ>/B/Y-?,-:4-XPY;?VN,U=5/B1\(IR@;Q#Y>C+]()?Y%Y *C'_;(\=E@
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MCFGNH^ =J/L?)4,)N.:S+7H9'(X\WJ$*6+[))[BE"ZNX4'74$D\9URMJX'R
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MINQ5$0>L;,GN"KR"-@IZ->?IRXA)@PJ+FZNRN]G9V;P]59<GB;51[)?LBW-
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MN")M?(BA2X+12:&(Z]" :*K/S*C30D$_CKQ#AQ]*BV5SI=%!2J_8\$Z1LXA
M1@6FT+<FTY!.?V@C3\>!"ZDI8.Z#@IR1,,A.*H,QA&OVXIXJ"1-#4A$H24AW
MZ".DL0>9)_-^(X*$;7-KBK+:)G&%<L?0J/V<ABL4W5HW9E,?3)U,@ZNI^@@?
M:.0_'A^"VNU$RNC9BT!?0BEB40FPX0,Q,;LI&K'J(.HUTU/+A<%O2@R]CCJ-
M$Q?&5649V6K#;7OW,%N2%4B[4;O5&&MSN%<+R=BNA/X#B+XVAI(K5#7;1+;/
MC9@XC9UA+RME9H6B<8N=5Z%,S&;221M.G0E2!VOMU T]>*5A>HRG:59?N8;1
MY:$D;!M!#U$\GYK+KJ0RJ#SXM8QKFUQJICB0#A5Q&/G4J++I$HC:MD%^[[1'
M%JKDG_8>0JRM].6G#NC:&DXU3.EDH<5.VRL5S!RR3R-'*<M=6.&:32S$K.0)
M'CTT2 '\#Q3TK?M'N=;4.Y<KV-M2Q7,:D?<J6HNS8E"ZPRL3JLT1.ICEB/Y6
M',<5/<\&C<J(%T$CFEC,65\M5'AADQERM-:RMFK0APQBF]W)WD66 B"*1!TA
MG9@O\23Q R2=%$T5O)$"/L#GU("W=N:&T!B<9B:=_-V5;IIV2L$TM, ]VY-8
M0Z4JZ(>ON:AQR&G/B^+6_,!52Z&"K4EWLU\<RTK&XLC+;K!E=<0M?V"([EU@
MCLV6,MKM Z%S^8\&"'"F*I;>,8W2ZF)7\^:CC/5^^[E*%EDB@<X\Q5BJF/I@
MZ64A2OKS/%9M036IJJG7%LXU)QZU'@L8OHL=67W(#9.K2B:KW(R2".T3)H-=
M/J#Q+U??52]:MNA=I?VO(S+%+EMR2I(BI,#)77N%%[<9>2/J"]3%01RUX)@B
M+&NT[T/+<QE[>%2E/A1!D-MXN'9L^%IV;29/)5+EN'&SPI,!9PZ_KFO*K Q+
M,9.0U)Y'BJ6:9IH *(^"<$4-,?A1GMBBL.U\,SR/U+C(8XI8/U!'=A^YF?K8
M:1(H.IU^T<^? \3&OSJL^\MN [3!4MZ50[DW]5KX]\/M*_B,ONZ*J[PU>Y9E
MHVL9('BAQZ7H59VSN/O/W NFCK]O\>+I8^"6\*N._H15I! Z-SI2[7ADDYCY
M[#55ALLE^R]])LQ8OUJTMNU=4?>LK*&:..O)KT)J&70!N>O%\41>,<UG7=PZ
M%U(J$=*>OC_<U>U_RZW@L<WC_=N1CAL552&O)M7<%M7K8W>V(1=4H6IV=(;,
M495)HB25)&O!LC P8(J"=Y&G"BZ[>\#_ /M&YB-S79\:F&L3X,VX,?8L"E;(
MDC3*&71DDJV"5==->D<B?KQG27,C<@$5!RRWF>7O+P[#(_D(_P#'/B^[LW,H
MU9\KD*%9+V S$N2Q56.QD*$\C!,C$T+%9L?<1NJ(,20OJ!P(]Y?WEMV\;+?"
M/'K5-E*>9V?D9ZE2&8[5@RG[16N1U>6W<A8<O!3L](42XV^& [Q&D1/KPG/<
MX4*'(<2>M'E)II,=,;,#074*PR]9U7N(X$CH?22NVOV..3#@5UO&\]JJKD#L
M!L)2ZWA9KU\_M.A+0CFO9B[8PU2&W*8()X)(6DL6C)U*O1!IZ>I;3BQC&L[M
M4)?1.BCUMK5$>RHYL9@TH7S#+)6L7X#[M"TTU869&K=9ZEZI$70 _AQ-7174
MW#;E72/0K5Y46P9"B1PL.E>A0/N)U ^XGZ#ADTDKY&Z74I5=&M00W,6\2-),
MV1J0QZ:?IFRSQ=\](U$<0/W_ -7"5-,%R..Q^'J_M>)8O5I7KD*M98/+)D)K
M)GEKD($*"+4D,>3<+:C(9I:!H T@4"^U4/*&TZBH82 ^@?Z::>FA'"<W4*&M
M$> XMJK6F=+,#= 'ZD</Z0T?IFZD8ZG7D!PX.AO9W):7+Q)[*_RG[?5NC_-F
M[.NHZNG]MZ-==-.K3CTFI^I]6WU;] BJ'ATVT7H)\?Z$%[$_*#NC5H?G[\C3
M'RU^]X]K](77^VVG])TX\[YZYP]H6EN->1#\8E76WS [V=V9_P#V&;\2B1GN
MS;6*S5:'W]2*^V,NK9@IO+81Q,YZ5E60GI$RKRT]-.7#\O?(+!@>" :Y^1<$
MZ$:#7[I)\"#\3'E=H9 %\M7QU+(W.P]BPBO'K&"R0(K_ &U?9)R?33774\7H
M5L&ON]I-2O:O2"&U9[5NC(&FAEBC'3+J>E9X^D:-&X'YAZ\)$1:[>4-<" <<
M?,C[9RSY7=VRJ\D"!!N_!6JZQQAH^U%<-@=: <W+PDZ?5AP[>\.L>E$7;8Y@
M.T":A)'=%V;^>MYY6LT23W=V[CMR3V%>6K=(REAXI%*@]#E">LCT4\:KHF#
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M2PEEN7'H64YP8_4J'M;PS-J2S4PVX4DJPOW\<U&S##=5= +,BLG1,6 Y<P>
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MC <*T]XH$F\N^9<!OF^]KR/^XKA?96KM')U8?96.CL,U6QV2@)EJ+H>KUU/
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MO#BX:=?+>YBM,T[S^_L]I0G>,<@!;F.7 -I\_BK#@,<%XP=Z?^5/<=N/W/\
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MNW\5,*\:N$:+W,7H^G,Z\8HL.'(Y],"XGSFJIDOVRC2,EGX/&E#[HNT_;T"
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M0,B55P1O2[Q>R<_0S%>M^]V,.J6LI>M7;6(UJYS(W6836&=7!6/I]"H_-P7
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ME#JAE>"]9:]-^O?:W([/&HD6&.JC>VC6-_L[;$ GB3FB-C:8U"A+W%1PY/\
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MI5?C8HED,?;ZF5>]W!H0(_4Q _4R?4<"R=]7#(44U]"ZRUT A4]4L*_F=/\
M8"^K'G_JX@G/O+M01K&0]K%--$TL0=C7T62LJMJ760_8LZ:<D/,Z\)%VV:O]
MN'%+1K7*U>>G'WK):ED:\<%D213,%LK%"-.N20&0.>;$\)'.[M%0^0;=?';7
MW->FG2&6UC)UDN6IU"B68O*']Q."L$I#:@KKTGAV4U"N]9$^U8ZVK&,C8QD!
MEN9(YK]TJ_N#VDR%F&O!4EG*EGC1+<4PC_2<'30$<&(!1Y:KR8^.!G>N_6RP
M&PB0-6A@7_=Z+]H,J@G3^/"RR0\W>'4HV(G0XR^\"R1IW"T,$DH*,9]4,B1@
MZQJ/4 ^G"56Q'^R)X+^$L8F)52/'3)8C .C6))G*2M&IYR%&&IT]!SX&N#@B
M+>E>E6^1,L"2UNX$^QN74-' Y=2$?G4_0CUX%AR/6M)W=0!%"G2BL=6(9M6)
M&OW-KKJ.1XN67/WE'GK,YZHZS:#_ +T =M?Z7]!U?3\>%AL5/H4.:)XHF,D/
M7J5TT(+>OT U/ \V82S4E1JJG01Z@?8Q"LO+T(^G%. P3@BBMXLHM>M-7E7O
MUV32-2-!"VOYE'U.O!NS%-15<3:\^X91U%NH@@A6_*HU]>D<$0G22-X5T.U6
MU:Y'WA5?M:="N.MP"0Q(8A=-2(]"6/HHYG@]MFZ85 5Z^YLYT"2E3D @ZE1I
MX06%@R!2D:#0:J_6.ECH#].&-N1AN4YKJ8-H%88W*B"QC[#4X+BPV._2:P%D
ML-,G<CDFAD8=35EZ&27I&H&NGX\3B#X#J;M5%C?RQRNKM;\*<LOFW>J[6\/;
M5V59VQ2W+X5R>X,WX5FR&QZ]K<6USG,KE<UN? ;?W9/(<?E<=E;&1G)AFC,\
M75JI/&G#S>2 4.Q:1YG+3%+G=WR5\O>8MA;#\4^0]W19[9OBX5H=C[8LXFEC
MLGL6#$UK52QB]MY(1QY"G3RZWFGR9'.>:.,^J\6>O3.[>../G0W,+N6;2[<
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MP7*U9WEM35(5F,:1RVQ&H=8DZBH=5T2=3U'4.#KRU]!QT5M;RPB@**;S-\&
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MOY("/%O&;22-#CHY>I777IA=CT@:GC(LI[AMR\5.#B%K\LOGO=I21\G^"J>
ML3VL%C5K8?,(F4A4*R):B?KD6>"17[RJXD.JA@-#IIP;--.^734THK.91E[:
ML[U0L^>S@2:G#-7K0PTW$,,*5XE2.-.B$HBA1TJD0Z-/]GEP; 9J9E8QAEWE
M>;/;A_NB[70OM_\ -![?1T_9V?Y8Z>CI_P!GM\M/PX]#J?JROV7 _0+=H?5=
M.WA_ MV^*[%"&]YCBR&#MY.*Y_B&?*&N,G3M35CA]:NSB8YQ'-$)8[VF@Y$@
MK_$<<'S?'QX[=]2#\8E7<74@9[.;0';XBF_$HEK;*0+[K'4H3K"$?M]3DE5'
M)5<R-U=:CD=3KKP'9'_,F=9^!<7'."X#]6?Z0A7R%7QV4Q25+5>":A6NM?NV
M9_<"*&+'Q&8D=CID:8NH$:?]X>0!/%Z;F&1!7YX/OX3?'E7:5"@F4:\F3Q]V
M.YD:EO$8^6*L5G=89;9UD>&.N/M==#Z<.N=%=?E3TR*ELIEKD)E66WE,G,+?
M:&NDEVPVI2%0@ZA^  TX6U:L/=0G:662PI?1*R?>\ T8O,G/W&JG[>HZ\N&5
MBX7(ZUN(SQ<I5Z>I2I'(?AKIRY?T<.G'>"_H*2RPQS-KJR_C]02/Q_ <,5J0
MC"BZ)50NJ&(QEN0.I!U.NG+EZG@-7>=<A2@ZY!KIHW01H1]P]1_'37A45T.3
ME+AJ)')7!^U3JRLWVJVC<^ECRU_AZ\)!3]]=)*LBZ]+DDD].BZCUY<_3A+,Q
MK13J54S,L<[ZJ!JVH/VD?A^.O\.$EDJ?+UX.N1#&6,0!B/2PZN6NFGXCAEI0
M(.:"0RMI&T*NO21R(;7U!(U"?U\.JSF>LJRJI'6KEC&9948F./ES+#I)ZC]G
M)3^/"5L-=1ZE)HV8.AXHD,/;E:0.>?ZC!>H$#7\IX6SH0MQD=U4-VGFNWW1U
MZNMV4::#N=9(Y^GYM?KP6WNCJ0NRB),M0B3!B(((YZN,2*CJ>=9P6>>('T8O
M_#BJX;KCH,ZJ$A<UM6XFJ ]JY.3'W<1D!_P_8DUF:0$&-&D,3H1IJW<8D\OQ
MX"X#MBIXTIV%&6%BDN>0/)&4K-7@H5,EB<152-?U9;0H)<O7;<A&DU=D<= &
MNA/\.+FB@IN1#"7-!=F5G_S+E3C,MG*$(M7+5T0W<G/0K):MX_'*$B4UTF*Q
M/:E<@*%)=?4#3BV+O^=0F[AZPKFK3[M6I2L]4%I:=+].1.FSH(%,0L1IJ#;>
M-@64:D\$X*^VPPZ%%W!'F:?[/%C8H9C?NFODII)Y(IUIJG.1%(Z%CT!4CUX2
MMENGQC0,@N5R>.I@<D17]I2I8ZS-)7H@H3 8RK.-0/MT.K?PUXG'WQN64ZY?
M(_01@4+82^T52"Y.*TB,1CZT,8!FLX*2%&"2./M*AY P.O/I/!2/M:U5F^M*
M<P]8DC"AXI!S#Q$:@Z<R.D'30\^$M:/N"BDUK)TUY:>NOIR]?PX2=W=*[[DH
MPY';.5J91'6A-42::2)6]P8D+,B4Y5U5))9  P)'+A57.<QJK78%!:^TL%3F
MHW*C15!>&/ZE+R26G98$<JQ3N15P"S>G/C,NOGCU!80Z40;OP^=K8K 0;<!J
M35,C/:R^XXL=&X_;9%).-!UZGE<Z#[?4CBEN+@G*7/C&KNOR-EL5BK.YL15$
MWD:'(M0RE):=;*1&[7AMP7Y>V[Q=,-;J51H_6 >.AA_:_D15NG?E=@0#=FY*
ME>Y:K18;=.9DHQX^11%(4M%37D6R)180-U$2%AJI T&G&%-WR%J"(R,U*OL/
M=Q>[:F)BNK9KSXU;<,/2/=1-';6":%@H"A)$Y:#E^'%2RYH2"2EUYNS>V6QU
M;!NWN\O4NB]8]FDDK51+8$<-6S+&C)"9V5@%+:CIUTX)M\2A@M._&N:*WN-K
M]%8Q'-MOV=:HH*/C94-=)&G[@4ZR2 \_0C@B?9U+<Y+74=VKX%M/.6J=3%J;
MQ2NK_HS2S:*I520LBG^V';TT]?IQCR]_RA=?<=P(/WE=-7 S25XUM223QI7@
M]>\\==&B!7U 9#KSTTXO0F:7]/<21W8HY\#D(F>M";%B'I-&O)TZ. JGJ51]
M3PDDS<)?=%2P)8[&*R5>2J%=@^(O469ER-6T_,-),!H">6HX22R7\A/%>$\9
MR5/+.QXXJ6R\DCXG<&UJL\26*N;L,TV.R*&1U$BLD?00@/"39=*5N,R\>2QL
M5RNO5%+%#(K3*5L0NW475.H MJ?734<+:KX3@[%39YI))#&"\LOM3TM)HKP@
M^G4#IKR]/X<:<'=04]=2Z80S09"E;>-H[:V(AVXUTBU+!%%A?JCZ\P1SUX.G
M[M!N6-/0 H0S4U&'#9T4:\D6.L[TM1XU98G5J=P?9F(ZY91_P+6#JO\ VN,L
MYK,.=$N*QDBNXN(1L1'?I$D@@%%O0?J,3^77^//A=";"BUO\U<YD,?YG2O%9
M@[T6V-HVH[;58A-$DNWJ B[,BZE6 .@/X<*F*-DG&@5W+,.)\D;VQ[&K0SUR
MK!,'#P5)S!"Q8'[UZ.?=/UU '"]" 9.*NZE=83=-_.Y? XG<;[VW9A#F(YMP
M;:P-NS9S.2J0@O[>JL(;IC>?IZG/VJFNO"]"NY=<#C5JMA[PGR%X^,[)Q$>W
M9K%/,P)MLRQRR;<PE:(^WIO)&QC>ZT!61BI.C$@\^ W=X]:WYL655,R0QK(]
MB(2V.V88NCDK(2#UR?C(-!SX;H6>SYP]15;$K(I##3F2%UUT'X:_7ABKBI-,
M"2ZB?3J0-_ $J#_JX<&BIN16,)'>2K=C'7X)*;@5ERUIWL3@O,D72%/M].HH
MK$:<]#Q9%W_(N4E^<JE9E+<MNC[A5DDA68DSN&U;J8,&8GDW+TTUTX)4>I<Z
M,[V#K .Z"HYIS(Y:$D?3IX2'N<@M+>$,?/:J9>C))1DFR5:4L9?NLBC!U.TT
M:C5NH]/+BN7N+>Y0,!U? ONY.%FMU>W9$T(E#-UJ67H;H ;GH/L4$#UX&VK1
MN.A=X:KV*JWDL=3"JR1];#NR7:J]RO5C4$M+8E;DJ+JS<6>KLF8*]XJ%J-)#
MD69/Y&XF]MK#4+_C+?KYQ*E6GEK(P=FO4GOQRB%G"M"LL70"#KH.H#EP&.4B
M&47(^Q_N?"ND]<:ZU=!M(5%O9I!NS/\ :>6*&Q:K6-+ 99ZXDHUSV)HG^]64
M?33@A<5=_MBIWJBQF)Q]C+T[-6K##EFBDC-Z0=3-!Z.I U+=8]->%CD**^WI
MZUY BC-Y4PY"IA(*K2VFCBED-3FF/IG]-FLC^SW2-=/S<^(O'8/4MF6O$;UJ
M96J1&?HK1&.(1A4 T+22$AG;I]0=0?7@3).H62D:+(4:;9&A# 8+?>Q4C_\
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M(L"TQZRS(.04'3GQ=&W1CFL-:)^(<\7<AG(R$D[X9\?DFLRR6YY)JEN.)G)
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MF IX/&W8,/67&PUXVDE%76$RS+]@N:#\LLZ@%B.9UXOB=J.K>A[^Q;;6  V
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M[VZM>.I$DNU\.JQ1]$%63)Y&:_*Y.OZC.M,ZMZ\N$:K2L=7#.H8ZO@5>W2)
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MIULBGHZ5(TKC0@L#ZZ\M>*H>YT50MS7BX5I0(6IO*K^V),T)^TIRZUKCDT;
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M)&6T*A>DC^'XZ<M. MN"NJ5>54UB$C2=5AF+,5U"A3Z J>>H/]7!%LPO)&5
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M_I)(Y(Z[:D!; BE;0_<"#H>7/D3Z<)0<[2*YT4SN2QLT5!!-8C<*78B..-=
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M-W<D0DD#4)!@'-)[8+L@:X9'I42,M7EY??%JQ?11')(220K]'Z94#EZ:\'<
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MKSFI_P#M*_S^YO\ HO?VYJ$_M$]@ K_MKQ'G_P#CUS[WRWFZ%9UO#N5A8?\
M,+P\   B-OF J3SU^V*K(2?Z=.*)O;KSB@KX1O\ [V_Z)8=S[2/8#&6GZZ\2
M U/_ /;US],K&'Q+DU;5O(WAJ&!M263?*H5,,D<LK:B@3]_<"#\">*![=.<$
MT_HC?_>G_1(BW]IGL!/\M>)/_P#7;GZ9?OR;W+5PGD)L?OK#XG'Y&'"[;:'&
MT\XF<@I5\=@:L-2ZT\:Q:F[#I*.H'DW,<>B<A\;>-?%WAV+G-GR%K87S%A'K
M@:1I+FT(X6!&FA!R."ZWEW,/8=XH\._7MGXBYF(HY2T_[.E!%"X4(XW9.&(.
M1P6:8?*VP)(KF,HR)';BECO3)5A:8TZRP$2R3I%J>U:_-&3R'TX[2:Z\?3.$
MD')HH0UNFKKUM#MH*QC':MIUO[$A.V3^D?,M!B'\G2YU_7E5Q^0=N6$BEAR4
ML;D%TG-!@I!8]L=$FFHTT_@>*>+[1?YNM:_OYGZ13X7L0_\ R/F(_P#ETOTR
M5GG3=^U)-OXRF^Y:\^9SMNK?:7'4KN4$<6-5H)ZF3&/BE3'V((Y%<(_T&AX7
M)N7^)[SQ39<QOH]+F"5I .H"A:" [[(#[89YJ7B/Q'[.+3V?7G(?#-Y-<27-
M]:$E\99J+7/Q(+CI)U9')*C!;)IY@[@PPW)0LRX*KC<U<RE>IV(Q3L(TDRQR
MVA7[L:1-HW/[&TY<>JOK;MB:[YQS9#_WB^:#812Z;H1PM=)KQ:YI<0UQ;B *
MTPQ*AIX\PG1UMOS&]+:DMVZKOZ\NE([)&@737^/#>L)?5[3L7Q)XPP_3':B\
MD862;KT@@:DWOT24].J%2U=8Q_$ZC@*[X-JSUJ[?PX7=JI-,T3=<H^5M8[!I
MDNI6M)'2=FU:BV5BY=G8.$KB[5[,@U[C9JM7'7;BKJ%I/615Z20@Y@Z]7')3
M>.O!$,WJMQS>&*;/MO:!AUO'D7J=M[)_:7=6[)['DTTUNYN!8QQQIO##EM53
MN3%SY^._E;]:]!)8MODI<G-5D:Y<O2D?\-%0A01B)%&A( Z>(#QUX#_GRT_/
ML_3JBX]CWM7_ )@O/O<GZ15=7&Y7&Q1QU+7LDG0=<EJGH7E*]3)UR:-T=)_*
M1R/!?+_$WA;G<SK7EURRX<TTXC2"';:@@D=&:YGG'@OQEX68U_B/E4D$+A7M
M,<#2M*FK05#A:K5R=7)6,I++'5;JZ)T)B>=%YJZ( 6!/H!Z'C5E>V.860^R^
M#%9<=XUM&6[=,#L_(C2KNS%R@B'&UX86ZF)F]S#$SZEF(4KI)U%N7X<+U< K
MK+><^K5"@R^2<?M^&;*V-OTI*\;20)8[UAUKRRJ$]P4C!D$03Z$>O/@<VX$Q
MWH&Z)=#JZ5&I;D67%]$"U6I!7_XI9;'5.)%+"402*)(XP6TY \:L$.BC@JX9
M#%;.E&S^XB/R5M[;N6H;)AMT*F3FL[4Q]NCFJ-B<VXX?O2S1:/H/=[++J/\
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MQ_\ !A^,2KO[N81^S"V;]D?$DWXC$FQM7&V)CDLC?L-:RV1D%=9TQZT[-6&
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MJP_4K])(YAP0&_'F.+2,$?#<=FG0I4=I.T D)0=1)C504/<_,&5E8=(/I^'
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M/ANA"2M,A[.]8?S5.H^9S Q\=Q(!F;%.MT%(Y9Q"SUNOKF=1&NHU9AJ .?!
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M _:0NM2[!G,)D<K2LU[5<K>Q[21OKVGIPM(4FB($T,YTT/4 I^AXYWQ/"_\
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MYO([.I;$VSM_9S;SES^\]P;>K8^XD.5Q.%L8I8J.7M6<7NR*;,1324;PKS+
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M@/UYGB'K!;@-BRW9D]*A)1*AKBT[[&W&$IFY7L3>X60R(LTTB1.T<@C0#1=
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MZ:#WDX]C?AU[J?TRY;4D?XA_TRS9\C/D7C?.U_;5C&[8RN#Q^ WWYDW?<KV
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M2J$^G'1&.-M&M.H:&X[S05]]>8RM:V0@%[AAB\U=EM.'DZ%QHRTH;E4&'O\
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M$AWQN<ZHI11LE'%8QLU4PI*)56-XG4"-Q+(J:-R/H&_U<57$@BMI930TB?F
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MKUNQIT(Y\5Y?!7]Y;(AWY1ZMLU-X[0GW-# %EK3;<&=QS9=3^JDAKOCA(&Y
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MT=HQ_1T\N/.?9S_R3R_\P[_ "]G]JG]JW/=WUG-Z&JLF9))"T8Z8U)$*^FB
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MQMC,P/G/+3;QRWD[R/@*7ECR9CJ&W\F^XXY<7M*""K5KUZ-14M-(\Z=K0O\
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MU^O$2RV=F,=XS\G2B(BV(]E\8;MI7)7^*WI<EFBM9#&PP8RO'VI_;RK[M3U
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MW24Q>YW>-5U-RNU<UFKHU@_:LO1JP!&@(.G\>" ]]!4XT1,+V8!VQ#.3QIL
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M0.6OIQ+A/V(2<=I$]69JW9%*.&S(]5UBJ6R6,LA.B1L5^Z->K33\."<554Y
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M7#@7,8X:'AK0&Z7 EM,'5Q42'/9:"?\ 1GS$]!K0AIU?;CLU8Z2-')*)9QU
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MSLLK%NE'AE)A@223\J@D <9OK+-BGJ_+.\ZA2Q:O4@2"]=AE[HM*$T>"=QT
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M,++/>*)Z,\%^(-H8;"-V+D4C F"TB]3J[>BKTZ:'TUXE5-5=R%9/7]-E//\
M[!'KI_\ 2\-%V=6K:FJKG:^8AQ]^*.S$\M+K(<#4<M-(W<?55;34<9,UN\3&
M5P^3.&:=6>2S%V2]+7LQP2JH,L=J)@1VRQ[:GIY,RKIQ3I9Y$E5/GK:+JO)Q
M^G$?^QZ*W\-!].(&WE)JT"AZ50)"V0[JJ10R^3J68;#.EB&!@XCETZ7+_P"]
M^WZ,/0'^/$X[>4.J0*4WA'"[8!0D^9?>5RE:UE(KN)H+34LBM2+KVTE:1&EF
M1C]HZFU.G%QB?0X)&\CH<3YEYM=<G]S_ '-?U?\ ,_Z]=>7<_E?JUU_^FX[N
MA^JJ;?5_T"Z[6/J_7LX-?[U>@/B>KC[N(^2E:_%'*D_SY^3$2=3K!/&[0[6(
MEJ6'9>F=2/RKJQX\\YO_ &D?_(1^,2KK>=R<'V:6<N[Q'-^)1(UAVWMZ*S%E
M#1MSW:*!$R6;REJV*O6 "J&S*ZQ.=/RA5 XOB%;",;23\"\_O;KUOEM<Z/D^
M!.O%XU[VP]N/(8Y*EGR!D;@K2,7>XF-Q+5I)()(7""*.1QKJ==3Z'AO5D9X>
M^9"N-P5+>8Q40HSP8O+T%JPXVQ>IID*@CD8ZK8K$I,NGY>L/R'TX;U;!=$[-
M*W)5MST(N[N+&U7IEP)<KM@S6<55D5NGNY""1%LQ12$:AM&Y\OIP_J^W<F49
M2L8MQ1O-UB%9A-V>F"6&4\C%ULLC]0]>7+B*'G*LI(EC@2Q*ZB%*ZR2$#G&B
MC0Z '[V)/IRX=!P[4+/+%=M33R RPI''7KQ]10)6!ZW7D#J92W,_3^/"R%0K
M]JO(2)81"P^Q$D$0UYH>DZ$GEUZ<!!,I6(@KW6F[\7?D6M[>Q'TAHY$+!D:1
M/Z5Y#BZ&N*NAD,8/2HJB"L/OC,<:7)%5%70JKOU!0GT"#D/Q'%Z#GN<<$:[?
MITOY2S&:MPM:R,5KM5WD+Q=($BE2%0.QT'T'".*NSHJ3M9;,6,9)W\A-/CYI
M.JJ8; KRU9G))+R'I4P@<M >K^'%,VRN])5>YO?E.T<?!%8G:1/;,O/VBG21
MV)4$22KS TX+M\DE58K'/47JG_1#*%$:@/VXM!TGU&I51Z<$(P8 *SD12"B:
MR))]O41TE?KU=/,<(*$N+$14EC2&+I5W>)64#IUAE+#3H8:_:PXSKG.JY3F&
M97Y'6L31QQS0V I=Y2C)%[>**.3I+*5"MH&&@!_T\%'YEOYD>A!_:]05K6C9
MXI"ZZK"WZ:@G[A^.O]'TX"C^<\BZZW_:8ZPJS,',U4AR5*WC(Z-*.2QFJF15
MQW,7&29Y89$5R)8M?M &I/%Z2HZNY\;DYJ$&*R5+(TLG0M-)!7FC>9HA*&4R
M 'OUC&/HR@\0E[J2G.%1EKUX^FJK=2)&>@:G\[3::]UF^A/IQBW&73561?.>
M0I?^6;MA,-M_;V+@=9MR9I*]^Y%(%FHXC'Q&_<-9F*@3V&C"#^'^CBRV*JG&
M:U_\1:%ZMMW/9>42OB,UG(Y*Q?HCU@K5>B36).J/KU14;3U/,\^++G()09-7
M7RYD!4\@9!(8XQ4LTL>;$2KTB0+%U*&;G(=&T^O&O8_M=:QQA*7J6J$=2:O#
M41._(90XEF0QD_F70']3J_CZ<%*BA\JI>B%\@SN3#7: 5NZCRLZSN!TN>N0J
M0-?PY</Z$[GP-;VP=75@BS%[?QN46TMW)C%?MJ1V,I8*RY$4L6'2*7*"* ZM
M$DCKJ'Z/M).O+A#-9\U[#I+&N;4Y"N/F0]@,8HWA#@9*]?(EMQXYL9,&22A?
MA-M6K9.DC?JE)80&5B-%;D-> [A9,5S_ )R%LO![\VCN&KO/!XS+TKV?V;4O
M09NLCK&U0]=J,&0MH]F6)NGN= +:'@$0:OE5N2/XD@=T!%6WL15Q>TL!%:$@
M:O0KM,8"Q[@C0N\B<NI0QDU'X <,;CA]A:MKWF]:S]Y^W;->VS0V[XWN5,W-
MG\OCL#F;5.VEF7$]=J:2?]:LT@$SUV8%6*Z::<%6]QBLZ]_;%.E=MF8JGM_#
MU,(D4<%6O6AKU"Y'>>=!^K++H@UZY2?7@F5W$=JV45@R"*[U^E@\=8O9J44<
M?"@FFO32".KTF4))]YT"(HYZGEQ6WO#K25='/AK*^XQMV&X9.W8J2U+,=F"2
M)P3U-)$64'I;T^O#7?\ NF<?Z-+_ (036Q[3O=M"%\U%D7G@>E!7/M;0%*?H
MUGKS3+I9F1/RL8TYZ\>>>SFG]#;/=1_[(]>L^V+^TKF?YJ'\6A5%4L3T^[A)
M[7N#,\D*S69.Q*TN0F$LP5V7IEZPO5U*?IH/7CMEYIT+FN'RNEJ"A5GMP7)'
MAE<P#5*3MVUD:;4M'+-(NFFG(<]>$EZM3!&.S-NY7&[OV.UJ&>-8]V;?7MR0
M_:D37X(8Q):UU;J(]=./*O;9_9ES7][N79^ [?\ VO=_\+F_PF+KYHCBI^7/
M) KQI#W=_P"X;4K5W_/,UQP29&!#E?37I'IQYSX+_P"3[+]Z#]D*^'O#-O\
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MR<N#ZGW\0O)RYKJ:37 #R@4/F*'I:=%FCB@RL%PLZ:R^X[<Z6"RGW*N/]RQ
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MY5F3R'GLE'C,MN^AC+]RGA:QIXM"E"HM.O4@61F2.I7C6-"Y8E5&I)UX\?\
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MM@GE>]TC^3<,U<2-'R^%-^)QS0'A*<Q>VBV>QSB1R;AXFHT#CX4.W$XYIW?
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M>3WM%<.$_EK'0UWF-JO)/[K0+ I) XPX;2Y?+H=33YE='<21=RE.H%;)Q?\
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MAS>X<Q2GJ5Z7[=[N*1 73HU/$7<N?""^+"0;\1C_ '4\Y>8B(](?OHCW:O\
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M)>==LW=U8K';DGCGA%2:M)6FKM S=(*D()\OYA%;V?!>0'-%,\_>-%&.> ,
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M.HT].*97EI%,EF;>E2Z53(T<E7ARF0JT;S5%L2&45[,C20NSU<?&6#?\04(
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MIQ"YMS6=VH'+H7K[8W'MW"4ZQOYS#8FM7>*%&MWZL,D==V[8LV(7F[[&U*=
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M'5MLV/,7AW>_C*GNVW=H[9N;HBQ\<.<N8RM%9RM6F^-OWD:3&Q3*TG41H&'
M-Y8,FL722%Y=)/QCC]EV<!N;V1AUXK @Y9;%PJW21]K@D_DL54IXC*6#B/W>
M][+M01SR, 9ICU+,&!7[8"FK#Z\/ 83'K=&QCG$DZ!2M=_P+>E#&QL8TX"O2
ME%@]KY3<\I_<[=>&"'NS6P*B-65XFB5:]5F#E7 <C4D\^+M4/2J$U;E+$8#"
M9"I5I4XX*5&:Y%#9421W%IPO(G[C(J@2JT@Y@C3Z<"MMHV&K:^=!ESJYE9>>
M_E;U6ME<W8J6E:P,C^U8B UHZ3%7]@%,01HU@ZPR\SHW/@N*5\7<ICO5,U7
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M'"ZK.6QM:1;/9+<,P>UIJYKA@00-QP-*BO6%1S"LC*Q@E8SO?"_Y=XG9.?\
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M1)60N9C%'&O:BC5B25,2C3I_L^G%T;B^J%G:YA'#!(IC16F,TZAUJ$(/5TL
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M>V+MRKB-O;1;%FTT;21QQQW*A)LE+'VK(W-J7&KA3?\  ?1T)B;5SC5VS/T
M^CHP7EK\MO%7P[\,X3P9L_X[_*>W\K?*^.Q&YI_,VXMF%9?C?LS#YBPTV'P_
MC+'69YUP.XLEDZ2>\IT7G:2N._:=" AR;XQ.?JC=7?AAT4VDYUPHL[FDL;(
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M;'E7I!N;'WFNF]T5W.7G:6%J]B.>.%@D:BM.5)99_0!=-6/IQS8^%=S:S:(
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M%Q]R1+-J[/H)X(+=@,I20D:#EPD+7:B"Y.TT;6J_9D6.PDW17= O:=V:R"H
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M#L5:9RO->YTZZ$?<1PEF36FEVK4/.KVO,_04,CA0P8*ITT<?E.@'(C7A;%=
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M2.F:%F0$N2.;,#]#RXVK("%H Q6%S%XC;K8XDG8L_;W-JGN.W70%85CB9N;
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M?*M#'/:^\O7D7]150'\I/UTY<:T!%,QYPL&?/!+;>]!UV3@P0)8:V[!<ED*
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M75CR^XC^/H"?X::\5VP-5OVU>">I,#Q]8EK7KC1(\G>@E7JC*GI:)5E)ZFU
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ME^PQK /<=0>.,YMK#>6[27:3IIG2G]W/K)WA2$S"*Y)V_('_ !&-C^1OC?\
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MK8L5XZ-7+X,Y"C!!D*M6!Y:5YC)9^W(T 9570:=!_'C+Q5N.Q7U+8&=Q%?\
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MB@1G *IX]D;KR-@T\=A+=S(1J+%O&U8#<NQ53IVK<U>J9)*]0J=>ZX5-".?
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M5C^+'7B'!.\(SU.WW!6%W<^1H4;"TLI9K"GC["]N-8(HY)>UT(K21P@QC7T
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MA2'[[4SF60ECPUSS&YN&T%6D^;S#(*\6=,-0\R^$VSCY(7JI6KR0R1Q13=R
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MQ4731M?HKBHFP?#MV>#.YZ"OD,CM&KA<+!<O[HS^01\CER8I%J[?[EM(V2V
MXD>(&50>8].+R.,=0P49FMX@H006A$^U\?B,;!=VM;L/BH(Y+V0IKB[MJ[BD
M#R2"%#D[LAO))%/I&4.NA&O"X/2/,K&VI<*Z@!U)1;K\@87:N0&,S]3-XF\!
M(JNUJ.Y8S%D2HD<&.KUK+LP$+]9+=.H'TX7!.\55<D;8_LP5"K^4MIK.E7]Z
MN4YYX9AVKL5A+BS$"-L=/#$EBPCS1NK+I]HX7!_+!4 M=B,4.;0ST]ZC<CK7
MB]^">[!6QL\TJ:K#,TH$ZRE;2@*NA8@-H=>$8J"M5(!M10;5:%LIDKM;/&];
MQ<55I9LOMJO9<UI+P01QSPVTD%EH)4_*OH#S;7BGI1E!50BM3*-&DE20-+)+
M(@EN7))$#2:LI8S:>OX<N%L4'N:W"B+\!M>O'DJ\XQK3- Y>)#;MD :<@1WM
M&8'TX14.*T;"FME,;N+$X:QFZ[1I+#!U+C[BR:.TY[,*RR!Q.%>210=#Z'C0
MLB''$+8@A,[-7=]]:=^>N)3X\-LOXF[#O9G;M7;GB[QIY1\U[IQC6<5N+R]Y
MB\CX"'=#0;BW)6D7*1;+V1AK*TJ6,K/'!(-6<$\:EX&L8U]-Z&=&7Z]@9[]5
MB3$?)/S1L_PWY)\(OY&R-WP=Y7KXZSNC ;XI4]W)B9<1:-Y,QL#(Y];V4V'D
MKLL(BLRU)5>6,CI'&;#.)G:0TA8YC,KRVM%TW)X,V;X?G\<)\BM\[L\4YKRE
ML;;WDJA@=D[$B\A[FV!XKW;.\.T]\^3:&5RF(@I#<$""_%0J&2[[!&E_, .#
MV,A>:%E%48'#,K0N_O@'YPV)/E?$N4SNT-SX#:&&Q7RPI?(&"WE%\6Y?XNY+
M;AO6_*@$\#96M9EF6.C!B%3NRY.5(0^C!N+)[ :*L(;05.WT+0L(@QSM5#@%
M(\<?'##>>?''DO=7@#R)F-U[T\-[*/DS?7A+R'M6'9VZ=Q^)X4UN[_\ %&2H
MW<C6S];;D0[UW&W.S:A4=(ZB.>0WEDET\M;(T$=!^/'XJE:.EIR"%=H_'NCD
M/)7@/QUYG\PX?X_97Y&[4VAOSQ_<R&U[6[LC@=B>0+\V-\;;Q\GUJERE5VEB
M?(-VN8JJAI'K!E:=D4Z\'?4KY7#Y5HIAD5<)(\M*U#C-I/X:^,_^//\ ';.W
M<]D=P^$=C?'[:^Z+F5PD>W%R5^+RCCIXK^'QL-W(5Y\9F8^S+4D9E>Q#*K$=
M)XTY;*>TMVL8\%Q-#04RQ]*&NRV2/0!0UQ2 \$_%JEC?(6QO 'ECR'E/%GEK
MREM;;6ZXQC=C?S7LWQG#O_$MD]EVO.&Y_?5)MGXS*U(Q)8FJ0LN/@E1G)!/%
M#;!DQ^6>T>1#1V'%%0X#R)>P;,W1:\D2^)</-3W+Y*3R;<\:T\?MHU\KL+*3
M5)6@CW?M[?;L(,MMR:1'?NE0L<"&1B1QANMCQG,:X:0XC+8"BPQK1IIB,%8Y
MOQGCWV]OG>.QO*_C3S%C_&6XL7MGR*?'-;-5+6V,CG<G)@L/F*[[CK5DW-L^
MWN"(T6RM'2ND_JH4:\6'E\H;4/!\A5<K06]@8K]W%X@KV*/D/;F%\K^)][;^
MV+L3.[NW3L/:TFY))+./VM2BRF[*>UM]O3_E;=&<VO2D+V(:[(K%"JMJ.(^I
M3#"OO*C0[[5<,AX2DPN+^/V1WOY0V!BY?-E?P_O+;NTL<^X,MNBKXJWMF$J3
M;EWJU2J,?@85CKF!JC2233B;5#H#P7H$3&AV+J!$ML]30ZH%1EN3(W7\8=AT
M/DO_ (DNQ=D[R\1-LO#_ !_\F93;F9S:9/$;/\,+BMY[.EE@ARNXJ4MJME\5
MC&G[+4E9YS+VX]"=>-"&T!9Q@X4RHH36S8X];R*5&Q9L\483S9\9<7M#Y(?%
MKRQL[RWM[<.Z,[L+)V8-E79<1@L]C*,&9DVWN[:.^\=(V._=,2RVJ=Z,%9E(
M/)N7%<NB,8XX(7AM=W&U7D!_>#N[^7_[U>S4_GW_ #;_ .\'V_M*_L?YO]C_
M #'V?8]OVOL_WK[>UT=OH^W33EQU-1]7:MG!_0K7I_F^FF.C+R9+;WA@S?MW
MR66%E73YZ_)EWU&K=';VH#H3Z CUXX#FG]HA_P"!#\8E7=3?V=6G_J*;\2B3
M??N8Z$/7/VR]([,A#,[R*65E,>I9F ) ;0G3BC]R15^V^)<^RHA<=H?(N=?+
MS0*'E4]IW ?31577T;ER '%E0@Q.Y2\G''8P^7E1-8[%&QTJ&+--T()#)%&/
M70#34<5E@EE#-M%&=SGVKB1D4A)-S8_'9NCGUR/1D*MFJU2EVIHK4,F.C05Y
MH;4?2E26#I)ZNH.#S]>"W3NY:6F,Z7ZA0UH0:X$'80<0=AQ7&MH9B-A/O+1%
M;=>];5;%3+Y&W;/3LP13I''N;.'I6R6:M5-M<B'FBKNY^XGEZ\=*_G'BJX:9
M7<TY@3^^I/TRT#8<O_!\.K\A%[;BWA7ZH)=X[K#="J?;[QS\P"MS'WMD6T8Z
M<9,?B;Q*QSF.YK?8$?NJ3],EZC8?@_O?D(&S^Z]V4LC3F&_]Y/)DWO8PTQN;
M<C"/NUT%9I E[H>>!E+JXY\6_P!*/$6->:7V7X5)^F2]1Y?^#^]^0IM#=T_E
M;:6.VY<W;N;>6[O'U>_2M2Y5LG%4WC@8^X#E*0LV)*KY7"V9>TT@4R&/4ZZC
MC.EYOS^]M/4[F\,C=U?R2NDC?:<*D0&2&MJY2C;Q\%?KK3;E@BLP^WA4*V0]
MA(6L148WUE:XM?I4)I][ GZ\56L,D,>AYJ5SSR3*^N2S[F<%E<GNS*V63.W*
M>.<9_P!G;KM#D:E/(]2M5$(024)E>)0CMU'0:CUX)67<8''-:'P$HLU]GUXD
MR2218O,V)XLIVHYYS&8HH[$0_P!X_;1NDD>OKQFS@@+HN1@D*PN),K](#1H)
M%+\^90G[P#Z@Z?7Z< 1#MD="V9GF-V&U#*P.,GD9I)0D?;05#_W@4*>GJ;U?
M0_CP0J/674Z4445$58/'S9^GK)/5J#IUZ?@2NO\ 1P$[O$%:$'<KO0]-[2;,
MYV1Y3VH*.!Q\R(@>2.1C;L+, 3H#&.DC7EKP39_.&FY<W>_.GK5--GX_)$%6
MQ1@O8!4MG;\LV7JP*[14) MNQ"T9"R#(4P_3K]VIUXT$#EFM5>%MN;;S&^L9
MC,YD=OX#;N=AW5A(+&?RR;:I05\=M2_+@63<%DK7HW[V;@K1PP!-96;HZON)
MX)MKJ%S^&:5!IYEU$< 9;QR;2P>A:A\=[<V/5V_\?"^[L#@+6<K[BW#YBVKN
M_=6+P^8S>)PFWWM0X+"YV9!C*6Y\GG(S6I16UB>20$1EH^?&M=VD4EJ"P8ZA
M\*A%='B:,,E*M5L!-LS8EJYN7%4LUNS+;FO[AKKD8L@^Q,'M[=U>+;F6W-C>
MVKX6RNVKC%>MGCMM'U$ :<9?U=45H47ZP3M1#D;6S);=2396\LAN*O/DLS!D
M%S5&C2R%3'8[&U;]3-J:3&O-2O2R&-3RUZAISX'FMM(+:8!5#BM>9?L#BE2/
M/'CVO^[3-9R=K]GLFO:BK8>><3NK]#"N&Z>X-#KKKRXR'VXU(Z/FL49T_9(2
M3Y ;!HV+"/'N;(XMK,UE<[5Q12/&1J.X:=Z-I>I.V&TY?0<&V]N-R%N.=1K%
MNX,C4S6X,CEZ<;^TR5VU;JN T1>"61FCE*$L5D9=-3J3QI-;I:&[EQ-_><6\
MDD;D3\ 7]C;\\$JRJZ]2JP5M%ZAJC+HI].I_0_CQ)502E\H:>E!]9[(2LCV+
MJRPI>FEFMR%[ N"=G*G55:,2(P"?@!PD]S55F0$&3B%2U2BL%89I/N&D\;6.
M4DPE4JP0:Z$>FNIX72@V#3\H5(2*7:BUBEJ[E/<VX+-;!U:O?FO,D1CLM' .
M<XKJ1UCZZ:GTXG'WP%HVE^>.R(G,_&CUY<=<QLF<9JV/K55D-PW':NV.:% T
MJVXOS0NJG[!_;;EP5CY5M^L;DOMT[SJX_;GNL1=@R7\Q8Z]!B;L9>*>)%1H9
MK8@E =5B)]?3ZCA*I[N([5T('VY>PLWCW>*YW)VYF39L,M:S3G(O+([I76I)
M"I18Z]J2,EBVH?77Z\,3I&K<H/%6D;"%8XVED;>)I7*V.BMB.Y#VUJ*-*6'C
MH1+22VDFC'1T8N .EAP!<7!WJ=O $]-E[>3&K@('M4I;D$T]S(WJT7;>66TQ
M>*B&;7MQQ1N!T+HO&>)RM6)NB8-V45KY'[";7R^-1*YJ-<Q1Z3'/(?=OD(M4
M&HT:3K0:#7B3)ZO WD*ZZ^=;UH0\G9YL'!CK-]&D;)9/"8VJ(@&2-)4CB:1Q
MZ(%4:=/XGC163?FE2N#T:8$-VY+"R@I7B0?<[E_O!.AY$:Z:<)8MOF>M*CS=
MTWK?C+9*W(ZD5W(7-RS00&7W%F##H9*P8)I!HDH_M'7ACD?*MR+N40#=L68X
M7:!76JUIIW(,=F_5@L:02R/!"3+8[K:].HT7@,>^J_5V;"H%6A7&3K9B.)#<
MBL28BJ6A]Q"N/0=^:2O$@=(K;+J9"1UAN$*UP5$UNVHIDJW*U\7/-%%8GD[/
M=;*58L;&T%FU9'<K*9H6Z(KDT4.NC%25]1SXU800VO0J> ,T>^,,)N#*YZIN
MC:F<GPUK!RR6J&-S%2%J):LK4?8QUYU*68[]5R3WEUYZC0C@+U@JKH6CA#O#
M<VW*HV_1&R]U4MRU&S4+-'54T7FDZ,IB\A)$\LLGN6U2.,J!KH/7A>L;5? -
M56;T:>1=P2WO'&QL%6VMMW'Y7;^2W'F<QO'$P21YO>T^::O#9?<K2F6"2?'>
MV81F)05#ZG[B>%ZP=ZQ>:VHM?E,BH>!HSY[P]N"M##,'QNXX<C%+&ID=HI*S
M)+&B$?J(%4<O3EKQEP7!+D(T-NN6%QV)88X^\Q< ]M(@25XI9G!71(!(\NJ$
M:*2J>O!TUQV0@N6NUMX0R"MLCMK<&VLKBJF2H%);T=&[1M%-$LTKB+;A14].
MM8V&K?7BCCE;$UHVW9Q-JT#YKD>GYCS5F)W6&IA\'1@<DLO<DP&-C,6A_,ZJ
M2-?77C+.9ZRM%N+0=[1Z$H,A&;D*O6!9*ZE2H;0CJ;4NY]6)/U/$<5";NCK5
M"N-:PT7:[L9C(>1HUZY6Y^AD]>CER7TXTK=#+:/B?%X39?C0Y',[XPUB_OG$
M9C(XNAAL(F7RFVX([S5HL3N6],0V,MW)JI&AY+'(&'+@FB?!9'\WY>"'!T<!
M6NY'%Y?/3IWVIPQR0FJ96$A]RA+16;$)_-]0/X<53=P4WI^DH>H;>Q&(@J3H
M+ L68%KV+\5F2*6?'Z=LXN9ETUJV4'5*AY2$ZG@<)JK3NSJ.$PVSL9#@JAA]
MZ]FS)3FE=XJ'MV,44$0D+:)-&Q=!KIRY<9\DY;(1TKK^5?,L_,A0]X]B;;EN
M6ZP/9-?L.8U;HD+Z(H4 :=?$X)M<FGH/O(?F>1ZPJC"^5LIB:$.(@AK".FLD
M4"2!FF9#H>[U1CJ"J>1UX,PVKE[FI7S=R,V4H)G;JE9\C=[,MB*29(98A]HZ
M$#+HVHTZO4GA5"RKCNA!3Y2I7&5GR,\]3'8JQ6JWK,M?JCK>_L+##-,#_8C#
M@D^H]>'6K:X6I2=K/BZ?NMO3RX/*FSDFQN0RF.KE9<E5NW#82U);D(LF:K'*
MO2PZ2NO+A8!98KZPG]OT>--F?'W:&#SN][N,\M[0WUDLECL4,18NG,;.W#AG
MJ5I!D^OM34ADD(EKR:N-"PY'A U"WJ'@A"WCVO8QGC[;HFFK6K!BR%N+VE6.
M2NT3RB2+K71BWVAAZ\(5\BSO\<*J5A[BT<OD,$+$DBVIDW#A(C%J5KR=(OU7
MD&I=8I3U*/[(.G#=2)IO3?S-R>'$;&9)TD$.UK7N($*LHF_=YA'TC^R0LAU'
MX\/2J8FG6ACMNBK)*25DDZ(QKR!U.@/^UT@<*A475IV3BH&4@$]F(*42RZM%
M7ZP.R"PT/=4_;H4^I^O#T6#*V;UC [5<1;CS,.,H[?,S2T*-EG-6Y*9(#8.@
M>6JAT$3D#177GIQ6Z0QFFQ:)E?$\-=G0+XR>3R,%&T^VJU-]S.DE7!+D705Z
M<\RE9GD$NJ7DB#:HCCDPUXCZPZBTX9B]N@9G#SI,[6\5+@?W"[GVJ9;<>0FF
ML6;[DRRU\DW69Q75V?T>0?:O2 !PN.51<6LM,\5<[?P-J/?F?W#-4QU:C7PL
M&VZ,EJ.(SY*U+")K&7BA8:K[65P&(Y\M->%QW*JW88FEKSB35"&+\?9[9M_-
MYL+1R^/M4K-E[S6.W;KRQREI^D=3-(A1CU:G[APXG=6FQ$MH2*;TV,3B:K86
MG=5HY#D('M=?KVHEC+M&?P'IH/IQ8C"0$+0QI)#6MUVC+L#KTJ-"W6?R_0#0
M<*JHFI4=(1WC<E=Q1BN1PPN@5>X'<%UY^I!]"!S X95 X@]**]U;JL;FQ]O'
M4YEKF[C(Z\EH@*]=U8/#+%)_W4J.@(_'3@^P[PHK)N?0VS^'4+T%\X;BV+\]
M/&WBSR)@=Z[%V/\ ,+QAXUVUXK\Q^(?).=K;0H^9MN[1K>PVIY*\>[RRW3A;
M^?&,18;%!G220NH4@ \=%<QF6 5!U 4^+WOCVK3M[EEW;OD9F*56//$&PO#.
MW-C?*[$_+/:OBJKNS&^&\['\<[>3W+-:WS;^0LE]!M[&4J.T,S?I6<+6K*&,
ML\(@[:Z-KS/&796WRIP63#C,5>_.C<VR_F#CO!?R6\9;BVC1\I)\??'OA;Y+
M^%-W;HP^TMS[,WUXMQ$6 PV^L*V1[6.W!L/<V.>3IFI_J540!D5FX(8=;P0,
M: $=(P]\ 'KJI2.UD$9T \PIZ /+@MP^)OF;X1W%LNK\6-][GBE\'X;_  ^<
M#\/=R?(R+'Y')8RKY=SNX)-RU<\D$,1R=CQ7MO/I!C[5ABS(5[@7HY@BZ>60
MBM:4/N\Z)LZDN!K0 >DK''Q.\@#X7>2O(WD/?&3VGG;V'\$>3_$NRMH;%W;C
MMV5_)VY]_P"%DVOC+U*Y2C,./V?BJ$S9::>\$D$0$>G6>,2SN7,G+ATCSX?"
MC@2W%'G@S!1_XDV^_CALKS#MW.>'O(/QN\,T]E;,^1E+,8;8VQ?F;B?$V2CW
M+X<\'Y"ONN;&VMO7)<[$*BY>B\RSUV=5ZB0HV()ZNI4#/?[JG(>_O3+E-Y#W
M%F]I?XTN(^4&6V]XH^8'R<Q_B*ID_&^\IK.V7R>^-F[PHWY-G[95X'C.+PNV
M\7%'0L$D6H$[JG1N#;F]$# 9>\21CO54]:"N=4R?D->V5\O,'LSY-^(_*^P\
M7G\IX4\<;#^4'QNWMO:IXUW?M?=/C;!U]IT]T82KD8H(=_;5SE6HI$$4K$!1
MH-3IQER.DN?F:X^[W9(JW(TK*7QT\EX_PYYF\3^4K^+K)MW9.XK4-V..DU],
M?A,YCLCM_(9Z/$,-;<&(6^+8@(UL*HX C:0\@YUQ4'=X]:-]Q^0LAA]I^2-J
M;_\ .W@O-;4W+F-N8$^/_"&V/'>/W1Y@V54WK6W!N;(;FO8;'T<CL7;.+V]4
M]XT,\J9":\>V@^X\:T<@B&I_=2:X1G4[),.UY1Q6)RGG&Q8\^_'S;O@W<W@C
MSKM/Q!M;:YVX3N#$[DVG/0\?;;P.W:>'CW/M+<?ZBI<N6[1DFLA]2P.O%GK4
M.[!2%S%DLC[G\C;0S];XZWL)FX,T=D_'3XT8/=9HI)9DQ&9\>R6Y]QXFW$J(
M)IL:E8LR$MJRZ\SQ@WUP.*:=VJ'-R=1IDCGS5O\ \;9GR+\Y[];>&S]T8'SG
MXEW,?%N[-MSSYZGO"7>^[=I7H-M6,=7KI+BMZ8>QCI4GJN2$6/7TXU()SZIT
M5"JE:^\;P&G&H/F_NHLV?@]O>/\ XO;+\1U\E)+O'>WF?%[MW&HJ6Y9KN)BV
MI6A2_9EF/MBLQB[$@4@AET_AQG74YH:[EHV43;?YW&B_S]>RJ^X_;O;I[+_.
M.]E[7I;H]KU]CL='YNGM?;IZ\=MJ_P!CZO\ 1OT"(U-XFK["M?(MK> Y(TQO
MR<,D?6/_ '^?DGJQ ("]K:^JG77U/TXX'G/]H)_X&/QB5=C-_9S:'_\ 8IOQ
M&)/79O9O2^3-%C*UOCSYBL1]:J1!:@EV<:]F,L"(KE=93VY5TDC#GI(U.MG+
M:>H1DXXGX%Q8)TYFG%D](0T(HTFE!"2'MZBN.DF4%5?H1.8)*?=_1P:)C]J*
M=00]Q72*9(;W8!)A'I+-' ]HT:O[B+)A!AO78P:$(5U*B=%(D90"J\/QG'$-
M'F"!:U[P:%U*[REWF\5B<?72.:(M@[N8A_<*,ZK8@MTL?(#?AEMJ5L4ZDY0!
M) P=@>?#.E+FD%H.!S%4C!T8IS[06I/&JX&2.3"39 Y'%1.$-?&T;B!?VZF&
M4GV^+E557J9BVG]/ -O%)E4TZRH5=L)]]76,N8_)QVIZ4TCI7R60Q-A["HCR
MW\1.:5Z:,*2.S+/&2H^@^G&AZN*=T>8*Z(NH<4,;R.3HSX._C*;9"*'(GWE=
M+,55YD%290D$D@*]WK(]-#PO5A]J/,%=4TJ@[!9G<.&%6W8HW=O9'%S6<IC(
M_<13]V*U,)152.,:10R/RE237K74>O ? (Q 2&& P7';#=_>M7<66R].KNC)
M9"T^W<;CX"AQ>/=!)DK45V$>WAMQ]1Z4D4L"W(\0=$_B,Q/G0ERPN+2WI37\
M@6\96V]MS>V%:S);W/OOR+M6XV2F!LS5]DU-MOB^[.NDC2&QEIBZ_E'(#D.-
MN2 \$&F*$,!S*7$6ZZ$>>AL6HK36X,6_197&V6HU&M,&F6&9=5ZDT^X<@2>,
M$V<A.-??1UO4'##JP]")'W-B+]1IH+W=9?S"&I,A#/\ :%8NO/4\M/QXHELG
M@"E<UMQ8DUW*CHY"I=FE-B6S"*\@1BT##1G_ -TA^WF7^GTXH]3DWE7T&5$1
M9+,UL3B[=ZUU=C'1I+:5!I,L4LL<$1Z1_:=YE _B>#K*Q<0=05T$S=!"!*MF
M"6UNF6!#.MS<<D4MF-F)(JU(D2$CT58PQU'H#Q4Z!\$[G 8$47,\P/%FTC84
M44([=J;!PT(XXHL?<MW)D:) )6>F84!CTZ69RV@)'KQ*LNY*WA<1CN6BL(D,
M$>VYIJ<31XK)5KE^6T.]&S=^..%@DP>,F!?O ^FG+B;Y7-8*-%>H574QBD36
MG8T+6&[:5+)XC<*38ZE=KW,=D#9:6O7#"1<?W8G&L?3',@'4K@@H/0C@**XF
M?.&.<ZE=Y^-3HW, 5Z@OP8'"6-S[QE6&U5LR;LMH+U.S8CAECBPV([<) 4UK
M$3Q-H P9=>6G#\TDD;<LTN<.HD?"E0;AYEEOS!:WGX>L96KMK)W<WL#>U=VG
MLY=#<RFU<K"")(,?>C4)#5L G])RJ@#D.0XKU/,QJYV>\H&[F>UI:!@,EE6I
MG;LD:I7O320V'1K$;.2LLH/VN&5B&()YG4_QX,?015VU"Y<SO?/I-0,5_9:W
M)CJ&8GMZ+5%"[+,>\(U66.!T;K@Y>XTZP6//B^WR0EP7;RN.&,]7#X0JZ3"?
M%T)8_P!+MF0)7CE0)&^I4R]PC_M:<&(/-=X<TURK/:Q&.DR@6]-CYX5>.K-2
MDC)0O&SC0F"3FVH]!PDL0<,T/6O?S14R(J68--9#FK$5T/8FR*2,42/L,%=8
M8] VG('UX2<N)VU"KLQN<8?#29*5Z'ODU$.,6L\]Q^Y($2 ",%YM68#0:^O"
M48XW/FJ#@F)L>ID;-RMO'+06\?F#4]E1HN\;X[&K(O\ Q=ZE#IW8I)P=/N/K
MKPEUEA;L!:XM;4= 2OW9MFSML/C:S6+FS+^<CW'NO*9;(&2WG,I?L215MNUX
M6;JKU$>,2.0VBIZ#A5Z45<-&. R2WG S>0BH"]!C\D(\C=K35@##9IUHW5\=
M5:8=E%D4!(PBC4CBYDH:VA61(3JVJ]VCMJ[7V=E:MRO*URYM(6LAE?;J52B+
M[M#3LAE$8>)&52?H1RX=\S=)ZE.W-;A@V:@G3LF!?Y;1JS3/,V6G4RNBA):D
M<$:#H;75XUD!&GH.?&1<3-IL6_0#*B;VW*ZB]#+)T+/V92"RKVPB!0&*Z%=5
M8\SZ\9A=J>",DS*>L#J0]Y'F6? U\==2:*#*;NP-%KM35IH62\DJK.JZ="6V
M!"M^'&C%0-KT*V[[[=]0J'<<"LLONR;D\=FSW4DBC=:B5YFCJS(D@8"55(TT
MY\'6^)H<D%< '-+?<%.[8PF*C:X].%<G%USQ)U6Y!/*J$2IZ(BH!SUY:\$S"
MA!&Y9$E!( !A1&N\<%6S%7&1.\=6;$\DR31QSR/'9C6*Q$I4"2!VCU)7737U
MXI.1ZEH0TTUZ53T=M8K#4)ABH*\72BJ<EHL]N4]:]+'K5CT#GJNO3P$$9QF[
MDI+Z?M6^,U6QDDM:*K@*!LX^J8FJ17\EWR^09V#:2S5SU,1S'(<!W1(>VE<C
MT*J1P>1ADAK-4VH[DQDU:M'-K4JUZ]@2>X9(I"S9"274=".V@T*\P/Z^"(7.
MTYG+>JZ#WEI_P[&EZ3,N]35JT,*B4Q(L$+2 = 1R )6=#R)UXI@F!-"LO@E/
MB&EU1,L\<LB1@F0#4]M$U<NVA/3VP-1^'TX/>X/ HK(V%A*"]Z4:^$FP=:@'
MBA7N6W>37HA:=^Z58'DHFZ@?^UKQ6K' .[P!Z\?2CWQ*<;0@S6,$B4VS=ZO+
M7A#B6G+9D@ECEAZY3TQ$*Y;30<^,^\H'C3AU?D)N7B."!S'AN-=@6?\ <.!G
MP&\,CMHRN>O)(8(=6ZYFNS@0F- ='CU)].1'+C1MZ&W-<31<P_E[KKF.MG9:
MTUPP&/51;6WGMNAG]I5:]Y-,E@,=4:MD$725)Z-1&FCA.@+=E0.I"=!QCLKQ
MRN\?;1.LQ&:$^1*SSF*/]XVXWM]-N2=< XCF<UC $PE0%950CMO*P# ^O$3F
M>M<FX4<1C@?0ESC\[CX*7L/;PQV*ZCW8 612\G.(]QEYAH^?KPRG#BXCH4.>
M[>EQN3LXVK/K5J3S1I5KH\]FS&4"UH5(7N2,IU X52-I1&%<@HNV9H<AB\IB
MY,;EL3C<Y4KR9R[9R<;W8LM7D4P"&N.@PS9-I"LT(8F)(QIS/&NSN-Z@JI0
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MG_I0]/[?^8!V_IZ_PX22YM_<KR_Z3/I^;_, _#Z<)2/E74_W*]'_ (4?Z_\
M, Z.$F7,?W*])_Z3?7Z?Y@'3_7_'A)E^#^Y77_PF?U?Y@&O#)+\_Y*Z#_I+]
M6_\ M@&G]7\?QX<^5)?:_P!RN@_Z3O\ T?\ , T_JX7G2VKY;^Y7I/\ TF?F
M_M?Y@'3]?7_M<,DN?_)73_PD>J__ &P#3U_\OX<.F*UA_P CO_</_P#"'[K_
> -[[_P"Z(?[C^Y[_ /I'?Z__ .9T_P"SPMJ=?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>n257410kimg004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0+R17AI9@  34T *@    @ ! $[  (
M   -   !2H=I  0    !   !6)R=  $    :   "T.H<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1&%N(%1R869F;W)D    !9 #  (    4   "II $  (    4   "NI*1  (
M   #-CD  )*2  (    #-CD  .H<  <   $,   !F@     <Z@    $
M
M
M
M
M
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M?A5?)BM6.//A*JI')&>%Y&1D$XYQ0K+XMK_I^5[?B4]?AWL_^!\]_P #HI=
M\2:'X]TBX\-7=U=>'[GS$U>WU#4)+@Q'&4DC\UBPYXPIQ[=QR'B[Q!IOA?\
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M_2+YA;W0!&]# 3Y*Y&<84'ISWK$^.\CKX7\)R7>V)QX@M&EPWRJ<-GGTK/\
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M0Q#&N_;&@\PY?"CYC[^M>-?!C1M.;XE^/]<TFSAM;)+X:?:QP(%10G,FT#@
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MPWJ46HM&@Y>)3B0?ES^%2G:46^Z_,=KQ:75/\CT6218HFDD.U$!9B>P%>?\
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M?\-OY^95\'VUYXV\+VGB?5]4U"WN;\-<6D-E=O#%9QDX1=BD+*< $F0-R3@
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MRW+7[.V?^%*Z9GKY]Q_Z-:HH+M]'_:BN;"'Y;?7-$2XE0=&EC8J&^NU2*D^
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M3;73-=TP[;I(H!$]RH.!(W&2P/RMGOCUK=ZUG)[Q=[&$=**2V:L>TJ,* 3G
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M/R%>A^*O'W_"+:G'9?\ ")^*-9\R(2^?I&F_:(ER2-I;<,-QG'H17FNJ'?\
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M?^ART3_OS%_\CT?\([^T3_T.6B?]^8O_ )'H ]SHKPS_ (1W]HG_ *'+1/\
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M<YB;[R+D_=Y'H!705X9_PCO[1/\ T.6B?]^8O_D>C_A'?VB?^ART3_OS%_\
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MX9_PCO[1/_0Y:)_WYB_^1Z/^$=_:)_Z'+1/^_,7_ ,CT >YT5X9_PCO[1/\
MT.6B?]^8O_D>C_A'?VB?^ART3_OS%_\ (] 'N=%>&?\ "._M$_\ 0Y:)_P!^
M8O\ Y'H_X1W]HG_H<M$_[\Q?_(] 'N=%>&?\([^T3_T.6B?]^8O_ )'H_P"$
M=_:)_P"ART3_ +\Q?_(] 'N=%>&?\([^T3_T.6B?]^8O_D>C_A'?VB?^ART3
M_OS%_P#(] &S?6/BMOCU:^*H/!U_)I-OIS:>S_;+02,2['S%4S?=Y'!(..V>
M*]:KPS_A'?VB?^ART3_OS%_\CT?\([^T3_T.6B?]^8O_ )'HZ)=O^'!ZN_\
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ML70-!D\.%[&QG#Z. 6MK=_OVIS_JU/>/T!Y7IDC 'D__  CO[1/_ $.6B?\
M?F+_ .1Z/^$=_:)_Z'+1/^_,7_R/0![G17AG_"._M$_]#EHG_?F+_P"1Z/\
MA'?VB?\ H<M$_P"_,7_R/0![G17AG_"._M$_]#EHG_?F+_Y'H_X1W]HG_H<M
M$_[\Q?\ R/0![G17AG_"._M$_P#0Y:)_WYB_^1Z/^$=_:)_Z'+1/^_,7_P C
MT >YT5X9_P ([^T3_P!#EHG_ 'YB_P#D>C_A'?VB?^ART3_OS%_\CT >YT5X
M9_PCO[1/_0Y:)_WYB_\ D>C_ (1W]HG_ *'+1/\ OS%_\CT >TZBE])9-'I<
ML,-PW EF0N(QW;:,;C[9%0:'HEKH&G?9;/>Y=VEGFD.9)Y6.6=CW)/X#H,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTZ+X:Z38^,_ ]M#I,EE>1I?6EHOE0WD3G!$B+\I.<88C(SUZ4GQ&M[Z;XB>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5YY\7/"7B?QQH<&C^'ETF&!+B.Y:YOKJ57W(2=H18F
M&.G.[U&.]>AT4=4P*FE-J+Z;$=9@M;>]QB1+2=I8Q[AF1#SUZ<=.>M6Z**;U
M$M HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>n257410kimg005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n257410kimg005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!0P+N P$1  (1 0,1 ?_$ /@  0 !! ,! 0
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MQ$ $QE= '907-U/1$=%*3\E+QK&!2:>/+3#MXU;1:+%0 51>*2*BP,P;&2.
M@??W# (" T%OG;XM"V(QO-W'=-M6_"N^:\4F)R>BHF,= X(11L+=\_>-VRP+
M$4 Q=TP[Q1 0H(5XFLLRN/.%K..8L=2D'(3%EXDO>\[2EB<Q-P2LI"0#Q_&+
MF!LX,VDF0.T"B8I50WB[-0H,AP#D.3OGAWP[E*]7\6UF+OQ38UXW,^T2BH=*
M2GK<CY6263*LMS;)IXTZ-N%,H($*( (CRT$BVU?5H7FFY6L^[;6NM%JIS+A2
MVYV+G2-%0,)#)NU(IZ[*@<IRB [VFV@\DMDJP8!K(OIR^;.AF$9)C#OGLK<D
M+'M&,L4J8FB':[I^F1&4 %"B9N<2K% Y?!VA07IW<T$RAR3[J;AVT$IXN8DX
MZDF3>&.F\.FDT4+**+@S%-TNL0B1@,.^<P%#:-!;V5^6=(3SVTX^[[5D;IBT
M^<D[=9S\4XGF! U RCZ';NU9%H4NZ(B)TP  #:(4%4#?5H72O(M;9NRV+B<P
MZ_B\NA S\5+KQ:P&W>:?H1SMTHT4,;P=U4"#K[.R@XN2^K0L\S$MUW;:]L=)
M*E08!<4]%0AGRQC:<VT"4>M/&3A_>DWC:]^@N3Z?BHQB63D9>+8QBJC-)"2>
M/&S9@NK)+I-8Y%)XJJ5N=5ZY<$(B4IA%0Y@*&T0H+:PORS92=?6O&W=:DE<L
M9O#)V^PN&*=SL<!>Z]AV[E60;@&NW?(4 H->5N,C$S7B=?\ "X]DV;&Z8W%J
M>47ETO)^VV]J()#=*5KJ6BLNM+)NT;M376*L+8Q -S([VFE!/]Q9$L6T#1R=
MUWO:%LJRYBIQ2=P7#$PII(YMI"QY9)ZW,[%0/R=S4!H.B_;Q5M''UYWLP;MI
M0;7LV>NEHB=4Q&DB:)B7,F@D9T@"NXBY\7W1,0#;!U#N4$/<'^?)/B4X9<2Y
M\N"!C[0D,BVL>XI&!8OE'D?"BG(2#(Z:+]V5!59N!&0'WU"D$"B.O)06K#'&
M-B;-N1,U8UMR4:,9O"U^1>/W3F0G+=,SOB1D[>;7"5_8Y6LLLXEH]%)SS)Q
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MA?\ @LB?-Y&@N>"OJKM/]7,_.&4H)<H% H% H% H% H% H% H% H% H% H%
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M\MX[M2\W1&BC>V[BNJ)B)8Z<B!ACU!9OG2*H)O +^C,.Z4V@Z#02\FJ"A2F
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M!K[BVUL\,@W*[S'(3"$G$)J05VFUM5O'6U.H*'50(<X\ZHAJL0E!X9_+N5+
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MAEW3DZ:*0'4.!0U$-1'2@N1%4U2$42.51-0I#IJ)B!TU"*!J0Y#EU*<ABCJ
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MES;)QD;=UU6*%L7Q(8Z:-6,;'KJ  )GMUF[158(BU;HI$$A4P0W]_FR%)N@
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M=0VT%SH% H% H% H% H% H% H,;N:[+>LR$?7%=<NP@(2-1,N\D9-<K5LBF
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MU1(8$U#% X$/IX)A)J4#:#W-0H,1Z-O0  >L\<(B&@E- %,4N@[-#%>%,(B
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M/[,N:&2:O/&$PW5BQ:JKA$KO54/\6("L!=1W>[0;4!'7H Z=9XPP[!'6  =
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MH% H%!"%Y_7-A?\ @LB?-Y&@N>"OJKM/]7,_.&4H)<H% H% H% H% H% H%
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M<//.WT*;8G"8EP*@ -98IF8Q637$3AC3YY<B< T[X\@<E8ZJ[=$X5U1'BO\
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M:JL8KC"J)P=M71.,8KRJA0*"$+S^N;"_\%D3YO(T%SP5]5=I_JYGYPRE!+E
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M/J^GZ98C?\2OBF/=Q69QQ,\=M[I&#'G"R2VFSGPFTG=RS@JR:8\@J(O7<>F
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MB48X8[?0I5[,8SN\FWU..=)WQ_"4P?VJOJF*:>*9C#TL47J)JX=N/A/X%0&
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M &WE'5KE/EF*?UJ(;5?RW\MY*G#4^=]&M8=T<?TTW)=/_%MQCS @$!P7W"W
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MZT8XJLN\VS5UOP*O<,TL8""=1T^#11-+? 1*D00(&NHZB(C03J4! H (B80
M $P\H^R.FS4:#F@4% GTU 2F[NFP1 =FO*&NE!YBK!RF 2@ ;=XV@AWN796.
MJJJB,<Q-NFGRS'UL=,43]CXDSX2Q:?OVR+72%:Y;NMNWTRE,;69N"*BQ, <N
MZ#QXB)M/8Y*BL_S!R_I=/'GL]DK$3C]N[;IQPWX8U1CAY$MIO+7,&NU\&DY+
M.YF8W_"MW*L,=V/#3.'GP:W79QY\*EFJ&0?Y9B9%R4#:-[>2>3ZAS$_*(F,:
MBNDJ8!#3P3#MKS76>O73'0JIISFI6*YC_5\-?ZLR]/T+Y>NK&O1CDM)S=%/?
M=BJC]:$!O/69V)+N#,,5X?RWDI8YM$5(NW7+-NMJ(@!BE\7=.MH]SF]:X&_\
MR&E7:/A\L:-JVL7)G9A9O83W83\*O8[[*?*MK&6N8\V:YHND9:-^.9LS7[LW
M*-O?M6U7B+X\[]<@7'G"\UL]L)]U-[?3A= 4TS@(%663>+QI!W==1 "&'V*U
MZ.I'7'7L;6@<L59#B_&S.-,1'DBY;HVX_0W*^FGR\\NW8_Q%S9_>%=N?L96G
MBF9[<:K55?LX=_:U[XCA]85!VFFI>%SBNRNY9:#<6KB& =2KI%HNT4,^6DG,
M3'.3,V8)&YL!,H)E#B!0#6O->ID_,!E- KN:O=S&9HS$31\#*17,^ULP_9<7
M?W/2^EUKY7<WS-1;T.S1EKN6FFY]XSE=,4<5,S,;+W#M]G''Z6MW#'C'B-&^
M(S'41*YGP9#W.JZ63G4;2NF,A2RS-D5= LH5PV:((INDDA*"QQ#:70=HUY1T
MNY9ZI9W6;7+^7KUK1LG73''571F:(BOMXL?AQOWS+V'K%SGTDR6@UZ[>HT37
ML[;JX:+=-66KJ^'CAA3A\2=E/9'=L?2 _"KQJ1ZHJQ?&9*KA^24LHR>'W@[H
MF 5%0UU#9LKZDHZ1]9\OC39YJS%VW&Z*YN3$>F[.Y\J5]8>A6<R\3=Y&LV[L
MSMKMU6XF?)LM1L\Z@^#/6'L=.C^)FTY0 UTZ3BSCO"&P $W1BV@"'?&MNWR/
MU_R<89?7K=<?G1/UW$=7SI\NN=VYGE3,43/==P]5+L2M#UG$6'-)9*Q),E1\
M$IEV22?. &W4PGC4!VCLVUCKT[YG\M5P6,[I-VU&Z:Z;?%/CC5CCXL]G5OE5
MO[+VEZUEZ^VFBN[-%/DIPIPP\'J%UZT./$%1C\&392?WJC)NJ<!T+H4>=0.&
MFNW9R52+_P T.7]N]&D7J(WTTQ:BJ?#"J=V^?(VYH^4S,1PQ5K%C'\:KX\Q'
MC$T]NYYU,B^LSC]>?P[BR5U[K.1(8QMW8.G-2J92ZZ]VJ_XB^9*S]K2\E7X3
M1]37KY>^5?-;;6L:E:_\NY/KATDX@O6#1@<W*<*L)*')^6I&R:@@?4=0W2HO
M7(AH4=.[MJD\^==LI&&>Y;MWKD;ZJ*MD]V&%$[F".0?EYS57#I_-=ZS;[*;E
MJ8JCOQQF.W;'D"\77&"R$.E."V[% *([XQKQ\H.@;!W"<PJ)MO>"K/\ G'U6
MRM4?>N3\S-,;^"*YGS86I;%KHIT:SU446>>+%'%VUQ3$1XXW8>P..G-D<&L_
MP69C1 ?!WVB#U4N\&TVZ!HE03!N^U62>OG.=J,,UR=JD1Y+=Z?58;7_3AR!<
MVZ=SYI57Z5RS'KS,.K_]1J49C_I?A9SA%[OY7.0SHN@?WVBD:B @.W;W:NH^
M8G5+4\.;Y5U>U3_4WO["&K<^673+L<63YQT.[5NC',68]5^58>M!QXV$"S.(
MLQ1!A$"CSUN&6T[AM13 .0>_I6Y3\R6C1&&:TC5K=SNFQ>P\\_#B$?7\K_,%
M4X9+7M"NQ.[#-VL9\(XYVKJW]:+P]'$"R,?D2''E$7-HO%1 ?[TQ4MXW=[VE
M9J/F8Y,HVY[+9ZS'EM5_T865?*GU*N1_ YK2[T^3,6Y^M[WOK%^#BZX]S#W)
M-OW<6]3YEXQGK,D%6JA-!\%1!9%4# &]L'34!Y*V*/F<Z553A7FLW:G^JN0P
MW?E-ZP41Q7,ODKL]G#>MSL[FE-P92X<+ N!6_>$_B$"PIE511Q(8\GXZ=2M:
M=WCBJH@B9RS%!$##X)"*E%/0="G >23R_P P?1S-1PW]4O1,[-L5QO[)B>SO
M0]_Y;.LV5JX:-+MU4_FS1/HF/H;F80]89C.^8TD=DQ=G9,\FF&]-D/XY:,L"
M>PRZ#M#GC1BA% $#)+@&[_?5Z7I_,?*VJZ73G]'S%J]I\1MBUPS.Z.RB9GZ'
ME.N\G<V\LZM5IFIY2[EL[,X15<B<-\]M44Q]+T6+ZP_$<YE[)MEW%=%LVY9-
ML(0XVG=;B01(2<4.D9*0\<#G!5:>/N WV'.$3Y]$AS%W@#6O+\OU@T_(<P9S
M+\T<>FZ+;FB,K<S%,TQ>IPGXLTS7%.RF<-V.&,;GI^9Z-9[.\K9#4>5;M.K\
MQWXJG-V,K--RO+SC'PHKBW57,353C.V(W3ABF!UQW<)[+7G<U6FKH/(U4=.#
M!WP 46Q@$?PZ@/+MJ<O=<>EUJ/B_WSE)MX;HKIG^<B['0CJWF9BS9T//4SV\
M5%4>N&)N/6.<(;?77*/C!@UT*VMZ?<;VWN&*PYO\8A7/7/F1Z16(F?[QN58=
MU%<IVQ\LO62_,4U:;33C^571$1XXRQI]ZSCA21$"M;GN1Z.HZ>(VE*F$WX#$
M3'3O5H5?,YTJO3P6[^>N3'Y%B[/IX8E+4?*=U?F.*+.G6>_XF8M4^CBF/H6!
MQZT3 )!TCH;)4OL 0%M:3L@FUY="JG VSVJQU?,?R95/\%D]6O1_47OZ$LD?
M*OU&M_[YG=$M3Y<W9_I+<7UG]D/-XL/A+-<F("($$ELG*53:(%$HD*L8 /W-
M=NVM>Y\R&GS&&3T/6+M7=]WO>OX4MFU\LFLTS_'Z_H%F.W^+LS_/A3_^HK/R
M!@+#\*.<)+>'P/\ 0KY,I@Y-[48DY VCWZT+GS#Z[7_NG*.L5^7X5[^P;\?+
M9HUB(KS/.6B6ZNV(OV9]>8AW*\;^>7.A87@GR\83EU)XZW>)E-WA$21I-T*M
MCKWS[=V9?DW5)\;=Z/\ T&3_ *?.GUO;GN>]+I_1KLSZLQ+PDXLN,Z1,H$9P
M8W V 1'F^DW[M$P /Y/.%431 !#NA2.L75;-U89;D_,TX_EQ7$^?&U#7N]&N
MB.1VYOG>W5,;YHIIJB?#"Y.SN=2F>/6(RB>[&<,=N1JAC%TZ1E@()0 ?"WMZ
M40.&P>]MK8CGOKQF8_@>6K=FN=U5R=D=\;:(VRU_\#?+7:GX6=YKS=VF.RS:
MJXMF["8F=G>]+>]?6;R(@*.*<416]IJ+^41$":_\^4.!@#N\M4GF3YDKL>SI
MF1MSXT?6V;?+_P J>3VUZOK5[#_9WH]4/4!O6AOCG+_\#H-/74.;,P<B79R"
M &74Y>_5)O?-%F9X[?\ <]FBK\6N+4U1X^UY]S8J_P"DZS3C$:W?P[8F_'%_
MHO"K8?K.)4>;<Y7Q5#)J#H;Q5@10Q0UWM2F+%J% 0T[]5ITSYGLU/!F,_I5B
MU.^JBBWQ1X85Q._9X2T;NM_*OEZL+.DZQF:NRFNY7%$_I8T^>/+@J# ?K!WY
M='_%%!1@B(@(1<0<NZ \H@9)DD(Z=ZJU<A]?<Y'\1S);H_1IF/5=64]0/ETR
M$_PW*5^O#\JYCZZ'G5X5>,GFEWLWQG7,"2"*BQTXIA(;XI)$.JL1) JA><5%
M,G@ 'Y1ME:4](.L<WZLYG>;LU5EXHF:K5$W8CV8V887M\^#?L=9NB%%49?*\
MDV(O5U1337<FU.&.R<>*ULC=M?(J]K<XDKCO->Z'D+GBZ)R$D'*-OW=(6I>A
M9<&D:LY38N&SLL?SL:8XF$Y2I'UT, [:^.^8]#ZK5<QW-2S&6US,YG+YC@MY
MFBG,S-%,3/MTS%,S&'#$QA5'B^[N6]6Z.Z;R[:TW)9GE[+Y/4,O$WLK<KRD6
MZJJHC&BY%55-.&V8GBIP\CZ@XPX$C96L6V;TN_./$!'R,Y&I/G\!-OW\9(1C
MM7P';-9K(J"Z*0%B"!=0 1+H/=KZPY<Z'9GF[ERSJ6MZ[S'9SM5,353-[,VY
MB=N,<-5<2^+^=_F$HY9YDS&@\O<N<IU9&U7,4W+.7RM<54[XF*K=.$SA.W"=
MD[$F-?5>X*..].W/E"?, ^$9Y=CA(JA0 -0,4I3AM'4?PUT-OY;.2LYPSJ><
MUC-7J(X>*]=NS5AOPCCQG#;,]V+CJ/FIZBY3&C2]/T?*VIG'"C+VXC'OV88?
MR,I8>K/X3V9=%[2N*3#9J9]=<J<!#N[P)"B4V\'+4WE_EHZ56Z?VUC,W,(VQ
M7<G"?&)IW3VX]C7O_-?UINQPVKF3LQ/;;MTQ/C&W?'9AMQ9U%^K]X2(X"@AB
M.*<E+M*+]U(O U[X\Z[,)JE\C\O_ $>RTQ-G1LE<G\ZBW5_-<YGOF.ZS9R)I
MN:YG[<_F5UT^JI($?PE\-<,) :X<L(FYM(+N 9N]A?\ ">)+!W>37;4_1T8Z
M8VYCX.B9"C#\FS;B)\<*/6Y3.=:^J>:G^+Y@U*9[.*]<W3W>TRE'%^#;:\)&
MP<70Y0T #A;MK,@V=\YVR8B/MU-Y/ICR?:GAR6AY.9CNLVYGZ*,7,YSJ;S;?
MB8SNOYV8G?%68N?VF#L6N? MM!_E%PXDMXI=I@6EK/C!+IL_).NCW:[/*<@Y
MVU$59/2+]4=F%BJ8]/ YG-\^92[MSFKT3_69B)_6K8R^XH^&:W]XCS-F,&I2
MZ@)&USQ"H%W=HZ%8JK=P:Z+*\C\VW8FG+:1G*<-_!8K\V.%,.>S/.?*-O"K-
MZKD)GL_;VL?+^/,H_E./WA!B=[QC.5J.0+KX3 7S\!'N@46S,^H@.SV*E+/2
MKGO-^U1D,]1^E173]2)S'4_D++^S.?RM<]\5T3_.1U)^LZX/V &!/($K,;!T
M+%VM,N=_;L N^@EO:]SOU,V^AO4"K"J[9RM,3^551CY]N./?CMQWH6YUBY)I
M_<U9JN<>RBO"?#R=V'F8>X]:OP]@(DA[5RG<!/\ HQCK/< *G>$"*JE. ".S
MDK<HZ&\RX_Q=W3K48;Z[UNF/-C.]KQUDT&N<+&7SU?Z-NY,_13.QX1]9LC(:
M]4N%[/=P%$ $AT[<7;D/O;":"FV< &]^.I"ST;RMC9J.MZ3EY[HNVJO_ %*5
MM?5+/WMNG:-J-Z/ZN['_ *<J#<<W$E+@)[5X&,LJ\YX133/CK4NAQU*)A"/1
M#33ETK-<Z6<G9>.+,\S9;_-JMS'F_:SYF&.I?--RKX=KE[,4UQ^537$^?&UO
M[U)N)7U@LN05(+@X8QIE T2"?FUD13$=H'4\8?,N0/PB-:-?)O2W*?[YS%.$
M=L48X^3V:IWLESG'J7FJ>#):--NN9WU8X1XXTP^>/&GG/C,:R=LP^86:^'6;
MJ/<24?'6-(NV$5.*;P@9>1FV+LZCEVPV%!(RP<V(:Z&KV#IAR=TRS?Q9Y4C*
MZAF)_>57Z:,=G=%R,?/#R?J#K_4:W\.US-5FLMEXVT1EZJXB?'@V=_E;$<,D
M'ZP#/N*8F?AL^IV-9>KB(AY*X84RUU32+(O-%E3/U& O))$3&W$W!E1%0"<N
MRN+YWN=(N3->NV+&DT7=7JKQNQ:F(MQ5A&R(IIX<,(C=$NNY7L=3N;]%M7;F
M<O6LC33A15755QS&,[:L:HJG;,[9;!%X"<UW3N?27QG9:E!./^5-8!P^C&RI
M1 0.4H^/)E* AW!((5"W>JW*=FW3&C<N9:UF:(]FNN*)P[-WPMN,>5T&2Z7<
MY<55>K:]=G+U;Z8FK;W;?B=Z^Q7JJ\!&,"MX75E2^U , F&:NYPBFH'*8JB;
M<OAE/W=NM1-SK5S;EXG^[+64RT_F6XC\"8HZ2Z/=_P#<,UF,QWXUS^&4P6[Z
MO'@_MDX&0PW!R2I1 W/3:SZ64W@_)-JX7$F\ >Q4!G^L'4#4:YG,YV]17NGX
M6-,8>:4KE.EO).4PF,M17,?ZSAJGSXQBGVW,#X7M$I MG%F/XCF@T3.TM*$3
M7  #3:X%F*QC#WQ&N<S7-W-&HTS1F\_G*[-6^FJY7A/C&.'I=+EN6.5\G-,Y
M?(Y2FY3NJBW;XHGOB<,82:UCF;),$6+-HQ3*  0C1L@@0F@[0(1%,A2ZA4-7
M7<N[;E54SXRF+>7RMG]S3;CPB'I,34VTQNYILWAV=P3#KJ7V*P?#N8^Q5,4K
MJZ['%A73%5??AV.XA"EY VCM[O\ 8$1 *NPG\?;*Z)C\2,(=M%Q0*!0*!0*!
M0*!0*!0*"$+S^N;"_P#!9$^;R-!<\%?57:?ZN9^<,I02Y0*!0*!0*!0*!0<#
ML"F\AT**F*)=THB.HZAWP#3738(B.W95T4LD6^+MP:KYTXKK-P^9.VHM-:_,
MGR1P;0]B6^4'CXCI70B)IE1MSI8Y,QS )2&T5/R '=JRNJNBK"+5<T]\1.'I
M8:YMT5315=HBN.R9B)]&]!ME\-N0\Y7&SRAQ82"JJ2!B.+8Q$S5,A%0C910%
M2$F$45!1$PB4-Y+PEC:#SANY2;]BF/:X:9\LK<:HG'VJHQ[(?0V,C(V'8-HN
M(9(1T<R1*@T9,D"-VK9$@ 4J:**90(0I0#^D:MBY%>VU--4>*LU^2J/,.Y!G
M%('6?.VD>U3#>%9XX1:(D -IM5'!TDREV:\M:V8SEC*4\><NVK-.'XU41L[\
M9P9LO:NWYX+<55US.R(B<?1&*%[KXH>'RRDU%+CS%8+ R8'$S8EQ1S]X!B:[
MQ :QRSM8R@"&@%W=HUQ.J=5^G&D35:S^LZ?;OQ$^S-ZWQ8]T1Q;9QW0[[1^D
MW4W7XB[H^AZIF+$S'M49:Y-&$]LU<.$1WSNB&L]Q^LYX:HLZC6VG]UWX^*;=
M*A;=M/3I',(>"0KET1$@"<=@:AK7F6I_,SR%D;GW?3:KVH9KLILTQ5C/FJF?
MH>K:7\J?5//9?[SJ-O+:;E^VK,7)HP\<:</I863CJSW?"2OT1<(.0Y9,1 J$
MG<:+]DR #_XI8PH1P( F(#J.JOX:@JNO//\ JU<4<M<H:E=LS_XE5N[A'=CA
M1,1WIVQ\N_(NCV*KO.G.ND9?,4SLMVKMJJJJ,-N$37$SMV;EN5N+UE5Y)F.Y
M#$>$X]P!C'&9=1)Y% AN0Q>>Z16WP+W1 *R?>?FBYBPKTJQD].LU=EVBF:HB
M=_VK,[8[/*U+?_2CRQ-5O5[NH:M?IC'&BJNW1.'EIN41A]3 9'"E[S6\IG+U
MA4;'(Z#X]%V]>43&(E1TVE3!238BGJ/^!4OD_EUZU<QQ%.NZSJ=VU/91EYH^
MFB:4'>^93H7H%<_X2Y?TZS<[*KN9IN;?"N*V#I8F]679[E9S?O$"WR.[3W3.
M@D[[=2)3B F$RBB$ 194PF-WCCKIRUW.B_(I>SM<W]2RNN:G>IPF..]?IIHF
M=^R+LQA5Y<-SDM4^>C5M+B;.FYK0].RMS'"+.6RMRNJ(W15551C'#CLF-^.U
MG,1Q(>JQQB<A;3MR#E7I1#F58S'LQ<3E82Z;@).9AF8#F4#V:]VY<^4.O3;/
MP;>BZ;:C##^+IMUU>FY17./G>*:[\W.JZK=F]=UW4JYG'99N56J=O=%JNF/!
MGR/K-\+-@,TQ[A/+DWS)=UNA!6$E&ME V 42E1*84R![!:[7*_+]?TS[6:T7
M)41^3511$>BFEYSGNM]&I53<IR^JYR_/;7%=<SYYJJEVAQ^9MN$1ZB\$.9),
M1'1)66:/6)#ZAH50X)11@*F.O*8VGLU.6NE?+&4HBO4N9<AMV3%NY;KP[>VN
M,$-3U%YOS4UQI?+F9F8C&9KHKIV8]_!.,^1#N>>*7CT2Q?=\NMP_+X;MH(TI
M)6\T7:LA<-O,'"Y&ZKQLD0QW#94H*[HK @(H%$3@("&H3O+7(G2RG6[%B-4I
MS]R*XFFBN:(HJJC;&V*IQW8X=KF^9.>NH=&EW;MG3;F5N5483,453,1Y,:([
MYVM/N#SB)XQCWI-1&)S3.:G2\,YDI:V;VG7<I&LDB.DE4Y)"5?R! 8NUP4W$
MR"H7GC&'97H?4WE7IY5E:+NI3ELE73,<-=FFB*MNS#V8CB\LSCW^5YUT_P";
M>H<YJJC*T9C-5S,XT5\54>6-L588/I$7BHX\8</E!P1OY8R8?I%;>FCK[VFT
M>;3:F>&'4 [^E>.VN2.F69IQL\R4T7?R:HM[O+C<CU/8XYXZEV:OA9CEZY<L
M;\::KD;?-;<CZP;,,, =;.";-484@?Y0=DT=.@2$!T-N%/%AO_CJR]TNY8S$
M8Y#F')US^=513^K<EECJ;S-EMF;T#-4>'Q)]=$.TGK2;%8D(-UX)SM;(CIS@
MN;4,J!#".A@'4$!#3V:UK?174[W^X:EI5ZB=TQ?VSYL)F&Q_SFTRW3AG]/U&
MU=C[41:F8B?).,8K\W]:CPL*$+TLOD"WE!, &))66_$A==-IU$E#@&W9R5FJ
MZ&<YTT\=FK(W/)1=F:O-A1CX^1?8ZU<DU78IS%.=M[_MV\*8\<:\/#RLYB_6
M1\'4ES9 RXRC5%=-PDG#33(PB([=\18J)EW>[J;NU"9WI+U"RLX6LA5>_1F9
M^I*1U8Y!S$84YNFUXQ1'\Y)D-QH<*LP( USQCHJI@UW'<XV8'Y=F\#P4#%U#
MO@%0M?3SGVU/\1I>;BKMIBBJJ(\^"7RG/_(UZW%5&HY29G';5713/HQ2;'9W
MPK, 7HO+F-GF\(;H)7E B81$-@%*+\!-J'<TK1S/*7,^4C',Z=G:*.^;5?KP
MV).SS9RKF;E-%C4,I775.RF+M$S/FXL69M;MMB2 AHRZK=?@80VL9J,< 8H\
M@@*#H=0$?;J&NY/.9?\ >V+U,^6BKZTO1J&1N?N;EB?"N/Y5^(*3@NH* J!N
M0Q-%4Q#_ )P 8HU'U6Z*ZIB[1A/=51$3]/8WK%V9HXZ>'#'?3./TAV+(Q=T[
M9N?>#00.D0P&U#0=0, AH-:]S):=<B::[-C;';11/U+HS&8HKBNBNN,)[)G\
M*UN+5MET ^.6] .->45XB/5$1Y-O.-QUK3_P_H-R,+N3R=R?+9M3_-E(V];U
MJULR^<SEO]&]<I]52Q.<9XW>%,1S8-E.2&UW@5M>%4UUY=3"R$=M:=SD[E>[
M.->F:=_^+9G'S\#=M\X\WY:.&C5=4B/)F;_]-BSSA]P?(?YYB/'ZX:B/AVO$
M]T-!Y&H;.\'(%:5WI_R->B8NZ3D9F8G=E[<;_"F&Y3U$YZM83;UG5(F/_J+L
M^NM .>^#RP[BQ+?D-A2P,9V3E67@GC6S+KDH@R$; 3RB0E92SU%@!3N$F:NA
MMS00,/* UGT?DW2.7[55CE_+6[-JK?3$S,3YIQP\S4SW.6M:W5$\P9Z_>F(V
M3=GCJQ\:IQ^E^"OU;WJR_7&M/6O9M0R,UD6*-@3I97B&O;([==YBC,,(_%1U
M:<5;)G90BID\PR,!H\&_^KD=XIMS:%26I\N:%JV2HT_6]/L7\O5$X3<IBK#O
MX:JHF8Q[>'?.&.Z#0^8M6Y7SM>I:-G[^5S%>&VW5-/'ANF8B8B9CLF8G#'8_
M9 TLF_<:_H[UX#L=7>Q0$V_+V-&(/3'3*83"MS""DH<H#KLYQ,@_V:Y^ST<Z
M:Y:S--.F9":)[)HIF?IC%T%75KJ%G*YF-=U.B9WS\6N,?15#/+:XD>$.),5G
M>G#V;%KX@E(X1F,:LU6Z2P:@8@G2CB'T#3NDK?HZ?\GVX_9Z-DJ?+]UM3ZZ$
M37U#YTKQBK6]5J_\^['JK;665E7A&NI-L-IS.'B*+ 4$V:L? 0CT#"/@I'0?
MM&:I5 'N;=M;%'*O+63JXHTW(TS/Y.4LT^JAIWN;N:,Y3$9C4M4JICOS%^8_
M7P;#,(ZV%DRKQ,7;ZB @ D7CFD<HF)1#4#$5:IF((#W-!K>HTG1:(]C)6:?"
MS1'JA$W=7U&Y$Q=S>:JG\ZNNKUU2O1&3=,H;C5 I1VZ$3*74.7:!2@%;/W/)
M6X]BS;CPMT_@1_'F;D\54U3._&;E6+N$=T- 3.0"[>Z0H![8:;*6:K=-S"BB
MN)P_(V+ZOBTQQ8T>><?J6M:=B&8&%Y+QC8"\OC,DS;Z!WQ%5R'].E;]-O,5_
M9M7)G]"6"K,VZ/WMVS'GCZV)R&6L71.\64R18<<8IA!0'MXP3<Q1+KO 8%'X
M::#R[*D\OH/,6:B)R^0S5=,QLF+5<Q,=\3$(NOF3EC+W*K>9U#*4W:9]JF;E
MN,)[8F)J1],\4W#9":FDLYXM;F*(:E"\H9<=O)N@@Y5$QO:J6M\B<]WJL,KI
M>=JK[IMUTQAV[X:%[G?DJS3-4:ADJ:N^FNW-7T3Z4;R?K ^$"(U*YSC:RAB%
M-H6.))26_NCMW!9QZQ##KR;=M;EOIAU&OSA5I=^C'MF)^M&W>I?)5J,9SE-R
M?)A_21_)>M X.F!@(G?LS+*''0@Q=H3;O?TY1*06R)M/;KI,GT/Y\S%F+MVU
ME[=,_P"LN<,^>.&9A%7>KO)=JN8HNWIF.R(_[S$'GK4^'_?%.$M3+=Q"8=TG
MB-D.T0.&GY9?&%0'=&MN>A?,FZ[F-.HGRWO^ZP5=9N7,.'+VLS77V<-&,SX1
MCM6X?6:MWH@G:_#!GVX=\-$3DM=PBD;7\G>,1HXW0-^&L?\ R=N6*N'/ZUI&
M7B-_[:F9^G!@JZKYC,1/W#2<_?Q_V54>K$_XY^(V5UZK<"V5W(''0IY(KYH4
MN]M 3B,6B4 UV[#5MV.EW(UJ[-.?YJRD7YB,8IFU-.'9A/Q(V[\=BRKJ%SC-
MKXECE[,<,8X<<7(J]'PY\VU\R,U\=7%8OEJ4?O+BGL1.;5?)-#8U8FYEK#*M
MB Z.VG63A(@3"RY0U.934%"#ND'6O9^6.E?3^C1Z[%/P<_DZZ)XLQ&$S3$[Z
MXX9F-G=C$/&N8^H_.]S5Z;EF;F4S_'$46*HV5U=E'M1LQ[^&9?1>V,G>L^O^
MW8*Y;:QQB:'CIR/:/VKJ:>MTG+ABZ;IF;/E6+E[SC11R4.<%,2 8H#II7CVI
M:9T9T74+F3S.9SMZBW5-/LTS$1,3MC&FJ/#^5ZUI6L=6]6TZB[\#*6K\QOG#
MZ[;(E;7]:K/: ?(6$K4()=%"L&#-TJF.N]J(A$NP$V@Z?E=RM6=5Z)6_]WT_
M-YBG'[55V]3,>3"*YCR^=N5:5UAOQ%5[4,O8G#=3;MU1AWXS3$X@\._K%9PH
M#-<74!" ?\LD# *)F3WMAR@=!@U((D[@@ ![%:U?,W2>Q7$V-#KN3$QLJOW,
M)\FVJ=[#/+G5:]C1<UBBFBJ,)F+5$81.^8PC8Z/^!OB;ES@>Z..'(RAQ =\(
M=!XW((:<A1(^:Z5)1U3Y,R5&&0Y7RM'GBK]:B6&CI?S9?_WO7LQ51Y)F/57
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M#1-R[7-Z_57-4SNJB/3_ "RFJZ(BW%&7HHIB.S&7L+<UNZ:#.PH>U*Q^@_\
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MSJP_;T#K+;G:"$\ZL/V] ZRVYV@A.]_K5AW?_IZ"[IJIJE*=)0BI#E Q3IF
MY#%'D$IRB)3![0T'90*!0*!00A>?US87_@LB?-Y&@N>"OJKM/]7,_.&4H)<H
M% H% H,=N:*E):!F(R$E4H.3D&2[9G*JL4Y,D>LOX)G L5E$DG([AC:%,8
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M6X<G8^M.6B8&YKP@(*;GB"I#1,G(H-9&3(#A)H)V;)0P.%TP<KD3W@+NB<X
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MR)<I;4M.>Q[/@IB[)V5\IO;^@9J%8K7[T^A*'L>)@I-1R9^N[=2TNW.\2D4
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MT' VS,'+NJ7C+G)W2^*192FU'4=\ :Z"'L<E!#E^\+&-,F$5ZY,F\BY4$?\
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MC)R!7"8J.'Y@(4O-I[PAOF Z@ ]\ &@YH% H% H% H% H*3B(%$0UV;=FW8
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M;Y1$V\(&W=W^Z >4HB'M"- %$@]TW* Z[-0$IA, [0$-0$1]C;0=U H% H%
MH% H% H.!#4!#40U[H<O].M!UE1(4- UTV#M'NAR#[8!LH*A( B(ZF#7O&'3
M8&@!IR:!WN2@X%(HB ZFT#:!=?!UV[>377;0.:)J Z"(AR"(B/?[_+R]V@K
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'#56+M[7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>n2574ex1011img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex1011img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 70%> P$1  (1 0,1 ?_$ (X   $% 0$! 0$!
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M9&B7^)K<C4Y!:W*<_  ]R1XP!R]!A^T07*S7OG/9C!XRUH?L;Z*NJ0KR"@Y
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MA7UWLV_-:7PS:W>QY70-]BK=3"F!T@MJV;H)&\A;S&5(X6=:TI'[&D0!5(7
MD)(AJD?<L!@.W8:S[^U<W(^S+=U)4S8%FV\^Z[<7,>H2'QR!O<J<IB\V+64T
MI4N>1Z/I41Q\TB=9RER/4N_HP'E RV'D&B!D!O@!GW/QRNG'5J/Q&;(P .ST
MVNK3^]=6"'ZK9 4.^XM0\,N5K&AW*3M$,K:#.$S%&",NCD8/"5R6D(% "QHA
M8SX/&$55;I.[ZW<4>CVP:[31X<-J-.^5A'=$MC;%42HG96?UN9NC:$6*; 2=
MD8%$G>&8VNI^V/ #EX5S28U-Y0OW6"R3R N-GFI1CG]B2C-IV:D#G".-''39
M*"Q+F5L1RJ.M=B!M-KB]<(TST[B,9T4]#$%3DF* U8 Z9:33LGXRESD6 LFW
M4T6UKY!JE24AM-"W.>5R@E;3-4K&WS"5Q$.)&RE+$[>L5CB[PU8=2B4[@<'!
M"P*@@(C/," )H0&! =(!Q6:]:HZ1[3ZEZ',*G795L) +81IYHFD\S>GUILV<
MURO@\=F^7M1(0/Z,^+8RC$FP@4HQ$X38&7D)N<F9#-I7.N/+_NKKKHIH'MOH
M&M@\JU[M.JI=,^2;8FP*WL*7-->4]9;O8+G'8\EC:IUGJM^E# UQN.I,978$
MZ!1&&.1PLC$L) E=^^(C?V4W9R\IM+JLHQ)4'*/%-33%DZ=[ZD%>S&(6+1TL
M9IM9JY\C (P^E.\,N41SZTOK<G4D86$N!8\=B3%9)@2#&>,#D N/7SE]IFW*
M!TQU,6;TU+3C113/K-*"CJ<ASW332N:$<0DT4;(+%74EQE9@L*5DDQA1X<*
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M-;W*TPP$VD2=Z:'W$0BR)3'5<L:F22S<EO,CC1+G^/IBU"!J,/\ 6*L+$@
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MIU>6E&SN[ UJ\)D@U/F8*\@H8&3O/1-BW;<'UUJ$Y.V2H[ZLR7W%M,V[*,;
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M$K!X %O42%?8ETIT&JW2RFM'M.#)%3\&7Q.'75+=JTCW@*U?,G:5&/3M6Y#
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MA[I;4,;W1 3E*:B!&6\@\AN++<!(!@=%PZ3[/SNKE3%,.#C3*UF]7"8/K89
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M5$I@%2PN7'9OFMCUV:8<0FMMPP*'2 $+@%K<B%OR4FGV:A8G-'%6.9.D=@2
M\,R>I2Y1!NR!G*;78;SDE>)0<@2 +P=T!*BX[7[B-X^;.JS0JF]BMS[WV(D-
M@#O39"'7%2U6[9QELFL,5&/UMPV862VJD+P;%548;B6B/(0JEISHJ"KR,U5D
MPX05ZZ\\=?*C6^MM38J>S.3. UJ3%&99"];2]]=3X-9\58Y@\&*TJ9V+<]95
ML>9'9J&]">W)&I<S5(2 ')#,!68$G"$\4[KIRY0V S99M&?M++W:'M\GL=%9
MK;S'H:>)45_YL@>VROIU$6*EY- F^XJP86DE/(W%#ENA:K"Q(<2K,_CAD@5W
M$M&]]M>TM)U<MTKUZIO1:Y(Y9%P6"]$[GNVP.P=96]/SE$X#*)Q)G LZ(3MC
MN<]Q3Y;F^.&.8$GG'+%+J6#!:4T =W,XXKFXI-Q*9W^X1H6;(T=L31)6NQ_'
M/&Y#Y4!M1F"R.+BY2V$-BN0IRFLQ&THCC3A9 >&/.9I3@G_A3U:(P"$0_83V
MV<ZMS=*#AZDHZ]_EUE^W&/4\@NJB"P\:UP%6H;YG;1E-K$Y-KE,4;7I1IE1.
M6CU9:G&"?+\P00Y"0.-;[)VKFX=?6!96T3Y1>CS0=>S15-%1^PMA84[3"=-+
MO&TR\]VED;SEL?8:W1]Z).)52-P1H(R,"D@&%)9A1OC XI#SO<2S-4=BW&V[
MQT)+6:M6,;VX1!AL*+(+.E/9F*?2F:NZ]F3M%)%/9$I0G8"6B;2CSLJL"39Q
MA0$16 9L:^Q)PLRM&C7M>_E3I2%SXXQ\DN2,-FPU8!>UQ!=-E)ZQNE\$8W!O
M9#&=N,(3N9Y1;:L=Q%-1!YCF>2C,!DE_9DX/32RS0[VQS 3 !,#@RF=D"3,!
M&' L8,).IP!I0\8S^H1!P(.?TSC&>@KSK3F/^O\ 4_MIN!R"9WGGEG77;\:8
M8&Q1635;<CEB$5U6K(D4'5]KRB45LW-K/'[4EB4#H?AS7H_4.N,9-$F*P(0@
M+Z/_ &I^%=Z#),KMDI7%S&)$-4WE2"EK2&*7'A52%/AMC9D>C3^F*6F%,11^
M!.@VU/Y3FDQDW!F5!:<!]B_W$^(Z0KB4C@T[:0].<W.RSW224M&5+>6N;6=4
MZ)6 08C9\J<1N[XJ( @2>6G&D"K4%B4'D)O,4%A&;9]S'CK<+&<&?\#;:8J<
MJ&MKDU6,DAT*7RA;/#G0\EVA:^N29J!$VM3:S^0I*=RY J$I/,&1E&4$ #S0
M;DV^Y)JLU5\OG\!TJVQF+8HE4_A\+>I DCT)@$L?8LLBJM@913Q.&7)6V2/,
M+?5+NZ-Q*1<H8@$)BQ85 6A/)#J5_P#;CA%R"DPZ1XRMSK>35XJC,GM,<"1@
ME*FN:,-C"=;85NR0B,Q-]):P0R8A5MB-$M.1('5$G"M-=$ QB1%! %J_<7EC
M,PVJB@G%E>#)+8B]!@3*]V=+W/$;C=ARLER.K!JM",-5;,SNTN<H1(,K L1;
MH0O5%E&E)5 \ ]1@##@_/=RD607&F&+?7^V]23.-LF9K<)\Z,E-9Q9SA\/C:
MEPLE-6"NQJZB9&)LK<L%"CK,8M>'5R!XDJ=&L5"#V" -@>>?GDA4S9%E=\$E
MBM59V#!8Q8->MDEA%W7)/$<>>4HB#<6&ZTX2B9X5*CW5(>9F-.S:TO[6E$5A
M6F[C"8,/-4_+A]@&])U6CK(> N+2(Y&PVK,:_<Y<PRZHY)$7..-"N)K')!,;
MTDK>@KAT4O3FE!EO580.\H9O4%MF#0"]04$CP[E+^T#-@%^T<)53%#%%XK+1
M#D<R604L;7+P.(FHH(9K>3)D#Z5[4=[@SY$)V9O$5A>G3Y/)\P'T];M_:L<X
M_$I,S\4NK4:/)L4UID$'Q;C"Z2ATCA,8/,"YN1JR\#8^TPY4[O) @*D3@8\8
M6-0RA)@IC/&:'(0SG[=BF/VX_*:OT?2+5Z@%.0.('.\>*D<7>8TUI0+=H84:
M4E<([(X5.5C8H&2V21QPK*4.)6 LJ4@D78)4:D'VT7"OW=*J>>+]JE4L@58)
M61]7N$U+DE921G)"OFKR>S(JU=8<]2R9A5>B=TQN7!B0*$V1M(2R\^8:#<;*
MC^W,>PR9<Z[5\<K=(FT+-F*L"6!A<F^4"6.&4[X!S?A5&A,C6&1NQA25G"19
MZP>?*_=?Z?0"A;G'I]MF5+?''.2JDR$KVYF62[AB\\D%; CDOE[&T$22MF E
M#3CV:IKJ%+FS)304(XE*(1IJD"<@P\8< Z,\*GV&;$5ND*M+G*DS37:N"U](
M</C*WRMV=5EGE.3>\R:#B:$#S$EZ"-PYU;@C1OQ;ED;V6  36U($PTL 2E,>
M''[ SZXL*(OGTD2^/O:==')TI+JQSBPV2.$158C0.3.Q-$B4)I,]O#F I,KR
M)0U'%!.&M]2<<#!0P@VN_K:<M=3PQ^KVON=F?QR'R:0QV5O3.3!+(785/\47
MMCDPN!:]TN!<YH<HUC,E$(I.<42>$D(#@& [AR#QB'U?-K9$LLR1;&\P5\SN
M;V5/8O('*6PQKE#*YH6 Z0GO]GG1TQ^L)X#$IY*,EIDB%P0AP@3(,J4QZ%04
M> )(2,[_ %,JY?T>&Y\Y2.1UZ;@KVQT @=[)8G)&%R97!.ZLSAA,L;#2,+VE
MT2%*4QV X,(4% ,!D(PXS@(AF_TV*/D;^;+T?(-M^Y3"6OS4CM24S=7$9 _S
M.M5(/1S:/&O)32E=%C\]-:=.0E4.)RY 2$GL>C4@\(0!.ZOZDNK,LC$'AUN;
ML;U7!&HE.@25<QS6TDBYE>HPC8&]C9H4D9#D"AEC 67TRD1#FA3@7A(6F)_%
M@L!7@#A0SZ:O&.PQ1,RRJ>[$SN2$BL3SIDMF#8P*U897'"&:%X.98^U(V0L5
M6NY0G9%DLH&'-88(IQPI1X F"$ZMOU'.&A*VMB1?65SNB]&VMZ-<[&7M.4AS
MNN2(R$ZQV4)$BHM&E4NBDL2@PH@!:<LPS(2@ +P$& D.!_5:X8H&X/;@7KW+
M9;[Y$9)$!HIY;,VD[>UER5!EO-D3(F5.!?MDN9RAB&VN ,^:A/SYI?8P(!!
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MT0VRP.OLV#L+]J4QLPKF^60N*Z;U^3@:,-IO^9T7)C:NWK4+RBC9AA=AM&[
M&(MFR1EJ"-GPDQD/Z,9JY#;;9E/8_P!M\VUR=>K91/X(I2LV(F[DS*['5#K6
M21TU-?BA[9:1CTNP L+($#@S/#N).8I=6Q4$\H0<ZOB.+],5K\7)G7[2KQ.<
MQ*Y3-/U;7'WF-.X:%,;E([22ZVMS9)96(=9I(%GRY6HCRH*%0WA&8O)(*%Y8
M0Y\4(X:QR764^*.GV0TU/D1DP-0-9S#)ET/=$1SY),:^F4<_0N1MSPPHF^Z
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M*_CU-[#\D_(?]AO>?BWE^L][_K;WK_QW^N/%T!9Y_P -]WSW_N1>_?\ 7O\
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M[C]/Z/OX/WGD^3W\'Z_Z?E_ZG_'^G0?X/V_L9X_1]O-!YOC\GMYW;]UYG?\
M\+X?]'O^O;^CH/9T"Z!= N@70+H%T"Z!= N@70+H%T"Z!= N@70+H%T"Z!=
$N@__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>n2574ex1011img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex1011img002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 8@%> P$1  (1 0,1 ?_$ )    $% 0 # 0$
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MNTU(.=G&2H^0:O5!3U!%WG;4+?OB;4K85:^*.O)])K@0GL'NN1SV25M7.*Y
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M^^@PJ\ V;9?_ %FOG\L+^6\&_F#_ (S_ !I,_P"7_P#.>-?M+\/_ !P XO\
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M+:62>(!_P6ZJ.<K;;/==\8SCVZ[Y_AZ!@NT?-GP_P\Y#P^Q"]EV-><CJIC<
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M>)K.0A?4Y^(40;H,]W?H$-;?Q=H$9=5"6J2RX?'6IR6\?C;NAHOJ>E)46I:
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MMI8'(O& MY%R09!J8)YSHH/RR126V2_&TR"(KK@"];#X%\)5$6US??#!&O\
MS 7-9EW17$1E$=E%95BO<G3TMC\\F:F&.7T0A[O)48ZU(K?:0<-W2?VEOJNE
MML$Y?&1U4RYQZM[^I*3T+TU,2?8/G1[-B\"G=<U,H>K&%*1FMZ3+DCEJRHF;
M J1>-;A/R7Z#QLV(ZKL6#I;3&=$=LY",_GBJ7CZ)>8[QI].^0D(E/N,ICS=T
M335FQ9>K+2L,=%9'5R1R4UX?--ZI%R"2%,2^9W@Q:L6R#/ZM%A*JZN=D=\[)
M!!GRGQ'A7R(<Q\3\N^%6CJGM!C0$9ZC\B6J3G6=U.!@_,=92G]A7/7B,>L<?
M&Y43>]*7ONP;:-4E4'&CJ+)[[;MFB^':8/' >_\ DJ2^6*N9E(@E5\LUF%^.
M[B&42B5?Q5O6\>D$Z'!N@?P(4;%_EQ:M6T0KE8]'TMTW^ZSA-DNQ^YA=UEGD
M+>?CB] 4TSX.Y?XP5OTY8'3D+YDA/0DJJ^8BB# [7=36T3=/H&(CS_\ 06 0
MG# PQVS_  ]$WCU\@S(-5%_MIN4-< F.YZ%YB\FG>?1/.DO*71QUT]PYS=4,
ML@';5+7LC6DXE]87*_.V(=AW[4<XC[&0U[ RL&7W=.7CY=JR>/%U,+CU/ZR@
M40<-VIY/>P?(17Y>>!87,S 7Q W2G0$G[T'F+!H?H"-;V1'*_FM[1EM56ZH^
ML9#=FKM!B;5T_7'C0!E9JY_4&SMGJH#P^(""5#%K*Y)-7/><(DT*IWP0=&V<
M$A5O0%0ZWAD#EW1<G#6W9KFP98 ',XI2+F."\O@B)AFV<ZQF2.6?TV;[N/NA
M'3DI@WAW/'(=O-8ZQ%V54_QI_*#=$'L%W#Q+^:02<5G?1\W55F1LA(!CE=B=
MA2[O5>.O_K[6R;O_ %;?"3C/O!)N.=.CH!!>!BT/J'F;FF-K^ WO"9VGI05B
M8,ROJBFBO.*DR>OK$A3ZNPLR0GDCDT[BY-\B1>E!BYW0C^$4UU;Z([!,:H_%
M_P  V=V#XE>/[?Y?K07)I5X.RDPZGK4>U(0:TP=T%8_63A"P9^WCY :6"VPV
ME1R3[-2+[3=[JZV7]WOPW;?9!LO#_P ?T#Y3!7"E)]@YWNJN><O$U:#\'7;P
M@2U)Q627+V5:]>C#RLV9[LI(,?QJ$05GI&&J)!X@(U:?W2++5--%0*]J0E9#
MKH%QYS]V14?D;[PYMAWBD7'PVJ>*H\K8\EHN>9Z.NRG:XNM6NVQ*,1]X2@D&
MK<2$&D"*B^FN&B*3I!XCNJED+'>'>0NK_(GV)Q_1W<O076W/8WG#Q/UG)[$I
MZ#S:PJ8G=FC(UTE?M.4^I,W(Z49R(DA2NF  J>.;).R)S9'&-=T?O_?1#0#\
MD+FVI;5\-W2CF>"#AI]SC!Q=HU.2TE9]D^#S>,.1L;&EC&[=[AM+$E@Y=RBZ
M0)I.DUOO;*Z_;<ZI+IAGAZ!)="RZ _$GHZBX]65IN9/SL&L ;2U^-31'GF43
M^%4_500))+691H%(3>HF,1R6E]<.4FKC\3#C;;.F,9VSZ"[[X[-DU/(2_DNK
M-#DMGR-UU6?7)!QVA#(-.R$WHHQ8DH?3=@#=THBX+/!\,C0Q2'E4% K-+9LV
MURBJDZ6060:L0DQY;N;N'5["Y\\C'D2E\&_PV<%UUT,V5IR>0P1,@UN3R]6$
M%!1MEL&-+.4I.8#:Q-38*%;,573PVX;+_>12:J8W#-AXY>>I5TO;?BP\8W2'
M*10'R)6-2]]>1.UN<+D8'X.;W"6W>]U55S/+[!@9HHP)N/V,WD QM'L,U5W/
MMDCY9;&[=+[V _?&9RQ9?D0H*&U===H1H/XK_&7Y&>XMK[HTP?D8W6:U3#HI
M [7HN&E&J3$JG.(17TP,2!)S^I%&&XH$^]C75=9)#=N',*W#5 #B^DN8*XN3
ML!]X_NS_ "N]'2;D2"<U"+9GMNV7P-S3#6[.3\7P 6_<Q&THF2OKI.4-D8LV
M<*X8-6WW795XU236T5"X'Q^'N2:1\5/DPN>B>ANPI+S2##6J9(TY9I8L([8X
M:?5E1C*+3KGQPXEDF,MHU+XT[ _J,?\ ;A!LS;/$--E'GV<NE0H\JO\ [D7T
MI_SU@?\ X^J!]!J#F?QG_#%-YD5FC_D(8'<%A \8L!BT^L2.19L[9$S9)Q(6
M08;)TM$#Q?\ 6<(.U,[[(;H,V^-$D]M=]U C9CXB7AIQC&,P&^=LXQC&=LWQ
M)?KMG&/Z<^UGKK]<_P";&,>@=RK_ (R7C@H_!K6E9;VI3^LDRPS(]:N[ M>
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?Y_06Q_\ ^>__ /(?_P#+Q_\ Z'?\FW_L;_Z7]!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>n2574ex2303img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2303img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !1 +,# 2(  A$! Q$!_\0
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MG?$KQ!;ZBPD+_;[C[;IK>?S]W*%1M' V\=:^O/VBC_QM,_X*8?\ 9*KS_P!
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M^&+V6*:6WMK^:R<M'(DJ'S(F5A\R*>O:OD#_ (A6/V+_ /H0/$G_ (5^I_\
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MR,H+,Q).*7M8A9GPU\5'#_LJ_'(@@@_M:Z600<@_\3C2^]?-W[2/AFY\*?\
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0 !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>n2574ex2304img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2304img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 3@$X P$1  (1 0,1 ?_$ *H   $$ P$
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M4S)X1P/NK[>K';#A:6RNB"@* H"@* H"@* H"@* H"@* H"@* H"@* H"@*
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MV3K>O9]5>XLV/^JL>SYAK_Q5KW:+8CYN?CSS)W3V"OJZ.:0X3U9]U=811_K
M0M?2,E"2H(R$<K([A98N?OUTIU25@=)Y,:3TTUEUAQ+K?V?'3SI-^*$!*A]P
MBL;,Y6)4GZH'VW^I_3Z$R0Y*2^VHLIXJLN2D)X>^U=:=&9.7K3_L3@/^H$?^
MB::^I(ZR=)9V5U/![]JO,SMN#@Q7G%,\%OM--)4%#]-ON]HX5,\JJG=.J,?J
M%F^G$YT>7FX+R8^89 (2'0^W9:;]RP+^ZND:^$6UZT0?W&PONR/^K-<:JO#5
M?[,8@=_R;'^C36;1.5<V^K>7&S.Y:CK.-5YV:2YXT-^)3?GN)2V#;C?AS5UK
M'"3U/7K#:6SH&M-+-UMSDH4KWI8()J4GDEHQ/IIW&9BH4MOJ'.:;D,-.H; <
MLE*T!02/K!V7JVOR0MOI1T_R^D8>5C\CG7L\[)D^>F2^""A/($\@YBKAX;US
MFRN9M9_O1_OHWC^[OR/M/YA_YSYGEY?)\_AR\_?S5VF(PRV[-L?6S8]L8Z7[
MQFH^"3D5H2\YY:4,N(6+H'F(^,+(L![>%2L02ZCU#0\#JNDL:HR@/XQEE;<I
M3X'UWF7\U:^[Q7KC-IRUA3F?])49N8YE-#V-_#.+NXS'4HEL7X@)=;(5R^SM
MK?=*8)^EG4/JCJ_5-GIIOL@9,2DGY:6H\ZTDI*VU)<'Q(5:W&I(Z#V?^S>5_
MV-__ $2JD=5E17HP_L9GQ_\ H_ZL5;$&_P!:$&8(6K94-ER#%DN-O@=@4KE4
MF_ZP216M:2Z!U7,X[,Z]CLICG4O0I4=M;*T$$6*1X>'84]AK%HG)$J\]4.;Q
MN.Z/Y:/+<2'\D6XT-LVYE.<X62!^BE/&M:^I*O8.LYD>CA^+Y*C(<:7D$M<>
M8,?,>=>WZ@YK5K^PG7I6SN+R'22!#BK0)6,<<8F-"P4%*45I4H?I!7;6-A"S
M]@RD#%X6=D9[R6845AQQYU9 2 $GV^VLUB27.GHU@2G9FVYQ*2C'2'4,L\"
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MB.UVA"$A(^\*S:9EPV[;WZR)N-A3FRS,C-R&OS'4A:;CW&E;S!%YB."0:CK
M_P"%1?\ ,H_%5_-9)O,G%B,TPREEE ;:; 2VA( 2D#V =E8M/=U2))W$8U,E
MOS$M)D.'ZH*L%*([;=YKSQX5+3W82_D3'TY+!W=YKT5C"8;*K1NV/-Q,%@9^
M9EA:HN/87(>2V+K*&T\QY1WGA019KJYI;TG6(T60N2]M?BQK;:;E"0FZE/?F
M65X?IJX$BF[#!B;#CL$X%F9DVWWF"!X F-R\_,??SBU3 02=[U^+NK&G25J9
MS$J*9D3F'U;J4J(4A*OS^%[58'D'>L/+TV1MK:'1C(K<AYU"D_6<L8J"[)]O
M@X4P-.G;RO9O+<1A9\"&^PF3'ERPV&UI78I Y%*5S$&_$4M4(L]U5QV&RN2A
MN8G(2HN&#2LMD8S25L1TNH\P%7B"B$IXJL.%,"6JR,/[,^T_.3\EY/S(?[O*
MY>?F_9J8#5HV[8?<< C,XKS$,+<6TIE]/(ZA:#:RDGLN+*'N-61OQ&SX_*YC
M+XR.AP2,(\VQ+4L625.MAQ/(>_PFH'&;,:AP9,QVY:BMK><Y>)Y6TE1M[["A
M*&ZSU:P^=F8V(O'3L6<TVI[#/3&PEN4E">=7EJ25<>7C8]U:PD%6P=1F,3L?
M[OQ\1.RN13%$YQ,-+?*EI2N07*U([Z1"G+8=NQN UE6P91IUIA(;_HP2%/>8
M\H(0U8&W,5* [;5F(&W6-@=S<);[N-EXMUM?EKBS4I2OVW24E25)]X-68$9D
M]9==8?D."'.>P,.1\G,V)MKFA-/!7(H<U^8H2K@I8%A3 DNQ;3C<%%@RI06X
MSD)3$*.61S?6239"CQ^'WU!E$V.%+V7(X!I*Q,Q;3#[ZU"S93(!* D]Y%N-!
M&<AU>P\"?.9E8S()QF-F)@3LT&@J*V\OE/B(/-R_6)N;=]7 D.T[;C-;QK<V
M8''W'W$L0H<9/F/R7U_"VTCO-N-3 ]U?9'<ZP^MS%S,0_&<\IV-.0$*N1<%!
M22E0MW@T#/@>I*<YDA'@X+(F$9#L5636&TLA3"BA:OBY[<R?95P%>T[_  <!
MDX^*;@RLKE)#*Y?R<)*5+3&;4$J</,4@BZK6'&I$"1Q) DQ6I"4J0'DI6E#@
MY5IYA?E4.XB@;L%L<',.9-F(E87BI:X,CG%@7&P#X?:/%5P(_M74Y&NYMC$.
MX#)S7IAY8+T5M"FGUA/.I*"5#BE/$TP'/;=UB:QA8F3F1)+_ ,X^Q%8AL)"G
MR](X(002!V\#3 -5WC%[$_,AML2,?E,>4B;C9K?E/MAR_(OEXA2#;M%,"2@B
MUN\5D5YU8QDIJ' V3'H*YV ?$DI'Q*9['1][C7?7.>'T_;=L6S2W283+!9F'
ME\3%R4-P.,24!:%#W]WW*Q>,2\6_3-+S$G 6/NO6,N$/?PT4)33+,0+@5,X:
MCEX7$@$GNJQ&6;6B$%QZCL6\N9%-EXW" L1U=QD*^,IM[.RO9:>VG;ZOD:;V
MV;<_"$Y"?'>U>+#[$PV55,VYX63G-4RV(BK0W(GQG&&EN7Y I:; JMQM5@0Y
M71['PLKB<IA6VHTMK),9#,*456<#+);*&0/@!4>:W9>KE,)+E-:F2]WP>>;6
MVF+C(\MEYM5^=2I/)R\O=8<G&LACV?I>=BVC(9.4^&6'\<Q'Q[[5Q)C3([I=
M;D-GNM?L[ZN1G@M!S4'I-(T^7+9>RST27'5-0"&E.2>?QD$7%RNYID(>E'3W
M-:F0U,QV.C)$1##DR%(DNN.N(L+EMX!"0;7X59D)=OZ.Y+.Y38<HSD2Q(R#L
M-V%%\UQ,5U$5 #C,QM'!:'>SAQM3(E.\:OF,_JB=?@/-X]N866,BXBX\N(+>
M<ACA\1 Y4WJ9"/3=!RNK[)D9+.35/PV49:4^U)"0^W+8'EI4CD2E'(6@ >^]
M)E26#K6_8?=L[D\:C&R,/G9+#[HD./)D-I;:2TH)"4%![+]M!-,M">F8>=#;
ML'9,=UE!5\(+B"D7MW<:@KG1ND&0U?,X#(*EIR"86.,.:U)=<<2P]8?6P0K@
M@+^%0/=6IE(AAU Z79O.;N-@C0\=DHOR"88BSGI$<I<2X5^8%, W]EC2)$RV
M'!9;):><6U&@.3%M-H=AS$K<AJY;<R+CQVL/"KMJ!MZ8Z;G-8AY!K(/MAB4^
MEV%BV'77V(;:4\JD-N/^,\ZO%;L%)D1]73;?&,%.TJ#.@#4ISSMIKB7/GFHD
ME9<=9" /*4JZB$K)ID2G=M,F9C5HN,Q+Z(T[%OQ96.<D J;+D-0*$N<O'E4!
M8VID:M.UC9(V>S&R;$N*,GEDQV$Q()66&F8R2!XG %*4HD]U!%\GT9RDK)3L
MLB:E<A[-HR:<:XZZ(+T8)0DM/LIX>9X2H*'?:F3"7[SJN7S+>+GX>0U&S6#E
M"9 $@%4=PE!;<:="?$ I*N"AV4R'+6!N"F'E[/\ )(D*7>.U +BD(; [%*<
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D0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4!0% 4'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>n2574ex2305img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2305img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 4P#G P$1  (1 0,1 ?_$ *L   $% 0$!
M       ! @4&!P0#" $!  (# 0$               $$ P4& @<0  $# P,"
M P4#!0D*#P    $" P0 $04A$@8Q!T%1$V$B,A0(<8%"D:%2(Q7!T4-STW15
M=19B<N(S@[,D-)0V\.'QLF-DA+0E)E87)S<8$0$  @(! P0" @(#
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MN29.-(=4Y\;+"U$I;%^A4.M!H7?W3'=M?ZSC?\UN@W9:FT!2UD)2D;E*4;
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M^'Y[TEC]3T]?WJE[.J$B@*!JK;O#I0>2MNW\/AYT'H+6'3I[:!BK7'P^'6]
M(M;\/CY^= Y%O9^>@--PZ=#YT"FUC]OMH&BVP_#^>W6@!;<?A^Z_MH'&U_"@
M:NUOP_?>U IMO'_'>@737IUH%'W>% P6W'IU]MZ!1:_AX^?G0!MITZ^V@73>
,>G3VT!I<=.AH/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>n2574ex2306img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2306img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ /0#6 P$1  (1 0,1 ?_$ *4  0 " @,!
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ME493]FEHD$CPT'P6GV4GQ%5\#H6US22)!U+I%1=!]
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M6TMR-/9T$E;GZQ1F[^W[%N'LDO1/(<^IT#(]
(       __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>n2574ex2307img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2307img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !> *$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBF7"[[=Q@'*D8(R#^% #1>1D]>?0@@CZTY+A)%!4Y!Z$
M=Z^6/V]OCU\8?@)I(\1>#])T=O!FC)YVJ7T\JSW$Q/&T19RJ#N0"17HO[&W[
M2]I^TU\#_#OB0M80ZM>0N+ZQMY@YLIXY#$X*@DC)!(/0CD''-:+#UG1^L6]V
M]K^8-I'LN<44P3*QQGGT[T^LP"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHI';:A/H,T (7"C.:BO)0\#QAAO=2!E2V,^H&#C\1]:25]R$!EW8[]J\
MC_:__:/\'?L]_"B]OO&%S<_9-05[6&RM)C'>7_RD.L90A\ $[F4C8/F)4#-5
M2IU*LU"DKM] NEN?%_\ P4JUSQIX.U#4/$VE_%&+Q1X>UV[;0KW1;&\$46G(
M48M!*B.XPP+*6P2O>O,M;U'PY\)OCYX%\;?!:?5]6T738HM2UO3O+FDGL<.5
M,,HPH*-&0H?!Y&:ZOXT?"?P_^R?^WC\,+JRM9M1\#^*_(E==0;[0DK3NT,S%
MG#EF'G)+R1]W&0:Z3X::'9_LK_\ !7Z[\.P6\5KX=\8VIM+>V09AA@N(4>.(
M _>Q- 0<]-YQ7Z-EV72A@HI)-J$I^J6C7JCDE51]C?L??MG:%^U[X;U&]TNU
MO-.NM$N$M;ZRN"C&-V4,"K*3D$'/_P"HU[6'!K\X/^">N?V<O^"DWQ+^',LK
MQV>MFXEM P&US'()X,>G^CRNO_ :_1B-LN/K7Q^?Y?'!8A0IZQ<5)>C1TQ;:
M+%%%%>.4%%%% !1110 4444 %%%% !1110 4444 %,D?$9QR<<#UIS'"GZ5G
MZ[?R6>C7;VR":Z2!VAB)P9'"Y4?B<?G3BN9V \Q_:P_:S\-_LF_#B36M9G\V
MYN"T>FZ=%S/?RA2VU1U[<DX ZG%?"_PL^#^J_MP>);SXW_'G4H]'^&VE[I;2
MRD/EVMW!&=ZB/)W+",?,0,R\KR#6;\&_!EK^U]\7O&/Q7^.NO6$7AWP#,LEU
MI!D=;6,GS%2%00/W6(R0!\\C?+C!&;NK>(?&7_!5SXJ#0-&6?P?\'_"S(;B9
MALC54Y5V!PLLY095" L?!.:_2\HRVA0PS5"6J5ZE1_93^S#NV<U25V;O_!1C
MQ3H/[3'[&G@SXG>#X)+.R\*:X^G0I+$J7%C&?W(!7=E1O2+@C>-XXK _X*#>
M*Y9(OV?_ (YV:LK2V%I->2J-H6:)H9RC'ZO*N>GRFJ_QP^)-K\9K;3OV;OV?
M]&6[\*V<N-4U&-1)'?%!EYGD8$+%Y@YF?EI -@<"I? 7Q#_:,_8?\ P>$M;^
M&5IXM\'6$38@>P^V0LDKL[XEM]^0-\B_-'C##(P*]G X2I0P])PE'G3G:$I*
M,G"7?L^IE97UV.@_;.UJ'X1_\%!_@[\5;)]ND>*X;*2:;:0LB<QR-TSCR;E&
M/'\/J,5^D=G=_:4!'W2$.WNI.,U^9OCK]O;X#?M@^'K+0/BMX0\0^&)=%8I;
M26;;QI1VJO'ED.%&Q>&3MR*^POV4_P!K70?CQXXU_P .^'EO[G3/"=I9B'5;
MB-E.J[T"LX! (QM Y ZU\7Q50Q$:&'I8BFX3IKE;W3735:,Z8R1[]14:W*,<
M;N?3N/PJ2OCC4**** "BBB@ HHHH **** "BBB@ HHHH :[;%)]J\8_;N\5Z
MMX-_96\9:AH&LKH6JV=B6BO'4;D4L Z1D_\ +0J&V@<YQZBO9Y5W(>,^WK7R
M)_P5G_9Y\4_''X3:$_AF'4=271[Y[B_T^VG6,7*>7E9<,PW,C*"!R2>U;8-I
M5E*6R8'P5XQ\+^!?"'[(^@7O_"17VI>-/$NM7$E[8BZ+/';0%D *C*G#&-P[
M]=YV;MIQZ]XT^*?B#X[>'O#W[/\ \$_#<OAG1;;3X$UJ:.UE@5B,QW ;< \<
M0).[J\N<#A@:^@+C_@FO:2>)_A5XL\&:=H^CV/A:WL3>Z#J<!9[M(SO?>^#F
M8;G S\I(7)Q7LGAK]C'2?!7[1NJ?$72M0U&WNM?CGCU:P=A);WWF*O//W<-&
MC  >M?51XBHX>JJT(\S6JOM?H[+33H<\H7U/$?A7\*OAY^SI\-M?^$_@+XH>
M%-"^*<\*_P!J:M.(GO59Q\S)'O7RU&3L5&.Q@&.#7E:_"7]KG]FE3)H>MK\1
M='7$HB-PNHI*-VXDQ3L)!D?\\B<=CFO=/C5_P1R^%OQ5NKF\T\:SX8O;N8W$
MGV.Y\RV>4\[FAD#)NSW %>/3?\$Z_P!HG]F23S/A;\3&UBQ@;,=A-</;JZ^A
MMY2\#'\4S[5Z^!Q^$K.5:5>,JD_B56.GRDMA<C:L<1XJ_;UT'QC%)I'QL^ 6
MG3Z[&C107+VIL6,F,*,3*749Q\RR'V!KEO"FN?&?X)_"IM$T_P .:3X(\$^/
M94AM=;D2.S>%9\E(I;HR;E7:?XPI[#DXKT+QCXY_:4^.@M?A?XQ\ 6]KJFKR
M 1ZX='V!(P<,QN,R11C'.4PPZKS76_#_ /X)7_$KX@>,8M.^+_CB;7O">E6[
M)92VNH22W$A/RF-5<!84/WN%8D+C*DU685\)3A*G5Y8J7V5)S7K'L3&FTSZL
M^$/[0_AJY\1>%OA^/$-IX@\2-HB7,L]@WVBU?R416/FCJ6.Y^3_#ZD9]CW5\
MX_LB_P#!-[PE^R9XFNM:L;O4M=U5U,5I=:DX>2QA)^:-<8'3O7T9T_.OSG$<
MBJ\M+8ZQ]%%%0 4444 %%%% #3( ,TAN$!'/7VJ.1@D)/HI/?^E?*?[=?_!0
M>_\ V6?'FAZ+HF@0>(6-JNK:](S.?[(L1,(FDRHQDDD#\">.:Z,'A*N*JJC0
M5V$FD?6#3J@Y/?'2E\P%<YK%\+>)K;Q9X?LM2LY!-:ZC"ES"PY_=L@;/ZUC_
M !>^(9\"_#3Q-JEFMO=7^C:1<W\5M*3B5XXF=58#D D#/<"L(4ZDJGLN74-+
M7.R\P ]_RIHN4.>>@SG''Y]*\M_9.^.%S\?OV=/"OC/4+:WT^[\0VANI(8"?
M+B;<5"C=[#O4_P"TIXT\8>"OAI+>^ ?#UEXG\2^?%'%875P((WC)RS$L54''
M0$Y/;-7*C4C4=)K78GF/3#,I'7KZCK3=@!ST..QZUE:%JK2:%:37RPVEUY2/
M<Q*^Y8)&4;ES[&KL&JV]VJ^7()!)PK*"5;()X/3L:S<915[%71*F(OQZG<23
M3C(H/6JLFI6\6UC*GSML7+<,V,X!KAOVFOB_=?!'X(>(O%-C;VUY<Z';+/'%
M*3M<[P,-CD#!K-OE=I?D&AZ$S@C *Y]B*:,LIZ[NP(P:^ -#_P""JGQ:\4^&
M;W6-/^&6DWVD:>2MW>0QW<EO;X&27<$@* <D] *^E_V+_P!L33_VN/!%S>)I
MDVCZII#0B]LY'RJ^;N*.AZ[3M; //&".:?LU>X'M M,/G8N1_%@9_"I/(^:D
M.H0APOFIN8E0,\DCJ/J._I3+C5[:T2,RS)%YN-HD.TG/L>:K7N!8(P.*15IO
MVN//WN>> #G@XZ4GVR/(Y)R<9"DCIGK_ %_#K3 EHJ'[?%G[W<C.#C((4C/K
MD].]'VZ( G>, 9SVXZ\^V.?2@":BHOML0G\KS$\P\!,\GOTIRSJ[[0><$]/3
MB@!]%%% &5KFM0:-I%S=7$ZV\%M$TDDC-M"*!R<GTK\N? 7[4W@?XC^*OC%X
MF\>:/XMU&3XEQMH^F-IVCO<0V>F)NCB4, >2<2$@$_)TS@5^BW[1GPDO/C?\
M&=:\'Z=K<WA^77[8V<EY&F]DA)Q(!R""RDC(-2?!?X4:7\'_ (4:%X;TH$66
MCV<=E&Y&'8HIW.>2#GG@UZV79A1P=&<JB<I-JUM+(SW/D?\ 87_:RO=#_P""
M?/C2WF^V3^*?A78WD<<%W;DW+1!9)+9Y(S@D= 0>R=LBL;P-^QGH'CW]@JX^
M)&L:MK=U\1-5T6[UB7Q ^L2\R$.3$.=@A9?D\O!],U]&P_L2Z;:?M)^+?&MM
MJ;1Z9XYTD:?KV@26JR6U\Q!C67?D,I&WH!WKSS2?^">GB7PS\.-0\ V?Q:U>
M#X97-O*+?25TN+[;;0RD[8/M6[<T(8\IMY7(S7K1QV'G6]M2]V\E+Y=5]X^E
MCPSXGZK>#_@D5\&+BSU&[TN[NM6TZ..[M#LD@=Y)5^]D D') /4K7H_[:/[-
M&E?LM_L#^-X_#VI>(YKW7[W3KF^NK_5)II)I1<Q*"ISE5);!53R*]5\1_P#!
M/B+7_P!EOP7\-#XJFA'@W4;2\74ET]"]TL$K2)$4SM /F8+=:[S]KG]GQ/VI
M?V?M1\&G5/['_M%[>3[6MHLIC\J5)3\A.#G9TK.>8TG7C+ISR;^;(L>$?MUW
MWASQ1!\*?#FM7/C77;N>-;R+P;H/#^(D6%1NN"2NQ5;N&[\URW_!/75+KP)^
MV'X\\'Z=X<U_P-X7?PW!J47AS4[W[5)ITQ:'E7#NH+"4'9NSSR*]L_: _8LO
M?'?COP;XT\->,I?"7BOPAITEA!=G34OX+FW=1YBM"[*!D*1@-WZTW]GW]AB^
M^$?[1>M_$;6/'%[XMUO6]+%AJ+75BD.Z93'\\>UB$3:@&S]:TCB\)'#RAW3^
M^]RSYL_8S_8^\-_M*?LZ>+O$GBZYUK5+^RUO58-.DCU:X6/1_++%6@*MDGD$
M[AQV%=G\-?B'K'Q)_P""->K:AK5_+J%_;V5Q8O=2D.S+#=;$!89W8 ZD'/H:
M^B/V7_V6T_9F^%.L>$!K3ZO_ &SJ=[?I=-:K&81,$RFT'!QZ^]<]\/?V%T\'
M_L7WOP<_X2225;]9U_M-K)<Q+).92-@8;NN.H^M<F,Q].K3FNO,FO2P'Q/\
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0,%RORYP..U %RBBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>n2574ex2308img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2308img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !1 *(# 2(  A$! Q$!_\0
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M[-RS.I>QA>4]WT3/F\1I)<X#<8R 3P!Z"K5K"9+I(]A/G+@J1D]>G&>#GGV
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MT*'Q#I\UI=0PW%M<)LDCE7(<=\UGI\/-,6XLIA860FTZ,PVK^4"8$Z84XXX
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M?[-MK;3+(6MK!&75V.T#J2HKUZ^^'5AK6J"]OK.RNKO[*;0S21[G,;??7/\
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,% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>n2574ex2309img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2309img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !3 04# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]VOBK\5M
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M#]-_^(H7X7_]$Z\=?]_+;_XJG-_P=!_"Y%R?AYXZ '))DMN/_'J_-S_ATO\
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M#SC_ ()A^ O^N]]_Z525]FU_,?$/_(SQ'^.7YG[%EW^ZT_1!1117C'8%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YI?\'/G_)GO
M@C_L;$_])IJ_$$]:_;[_ (.?/^3/?!'_ &-B?^DTU?B">M?T1X=_\B6'J_\
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M2OA/\0/"FJ>)O#&H^-=(CAFT#Q7H]G')!=$3(LL;(5V.K(QVOL!!'-=)J?\
MP0"^*T'P5^'GB'1[;PBOQ'\.I+;:WX>U6=+G3]1C$SM"X?!1CL<!E;'0<\5K
M6W_!%'XS:Y^S+\2_[>\)?"J'QOXEELCH%CH\,5K)I CD3SPLZXC2)HU/R#)+
M'.:I?ZJQC[BBX\W7>_-OZ6^5B>3.&];['E7@O_@MS^U7\+].\'>.O%WV'6O
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>n2574ex2310img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2310img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ .@#" P$1  (1 0,1 ?_$ )@   $% 0$!
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M'\,E<RP=9RI\SA)?WV21@OD!6_VUWOLJ<H18V#&.D\.'*S'>2S''56$9[V+
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M$:3'R',JS $Z;F]F/9;LKF<MIVPL\EV++9SXOJ%U+BP^&LJ3 <GE74W\P/\
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MJ0CV$42?IJPUCL.(F=M>W9RJ,O'CG"?#XBAK>:]07:T+?V0!@;5MV C+AP)
MKF["-0MR**=:%?ZH"95A/(',W'IW9=RE67-PXIY%&E6=02!YZJVZ<)]6(T/X
M&VX6!CKCXD*00+?3%& JB_FJ6FA00)$VI10I0$'*A@!IJ 2GL!>VF@ I0%IH
M!2L!*$ @I)"BTU"!VTX I11:400TB 4TD@/)H0H"HP/0J1"!V4J !2@!IK \
-M48HHJ8 I$(+2@?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>n2574ex2311img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2311img001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" "$ &P# 2(  A$! Q$!_\0
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M/3DXKZ3 X18:@J,7=(_(N(,\JYOC98^O%*<][*ROW/9J*:I!-.KK/$"BBB@
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*]%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>n2574ex2312img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2312img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ < "2 P$1  (1 0,1 ?_$ )8   $$ P$
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MO.:7#'<-$"S*_P"X\C>3:[0!YDK>X..C_;1V]AIH )CN,P;UEL7'(X]7$<#
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M@;L9\A0IP([=0#7);=;\4S=,I]H'#,X!M]^BC]VU*6/ \D?=)KN^>NFM!/\
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MTGQ5T&3)-4FZ2T\5"O#=N/,]@]XUL=6L,-,,H990EMEI(0TV@42E*10) '(
M:HST"T#4J+'E1W(\EM+T=Y)0ZTL!25I4*%*@>8.@YOS_ *0W'"$3W[#;59)T
MZGDO7?%353\)1XJ?A'S<.?#B/=J45#&L@NV.VT3[ ^YF. )\[*?_ -2V<.*'
M&^)VI^7NUFP$7'LDQS)X?U=CFHEI'[QD>%YL]RVCXAK%F!NN,4/+4'B6S75J
MGY,+ZRW28G)3[:DH/<JE4_;KGM,QK2XH7S;)#O#"5/@HD-U1O1X7$D&A2:\%
M>(=NOF?=UN'T?F;>3%KMEZL48LPELO[IB9:E/!;>]"6BTM@@!:2%A5=VO5S[
MQQWY6LGI.6/E)D1X<A"G9:I3:WU)#S$L)3Z H@;/3"*)4/EK=_9U9G"O;5 3
M;Y:9,2PQ8;S":1W4W&4LJJ"*24[=KJ17@*#4O[$7\%1\7#HS!4_-DF2KQK7'
M83L0=U2H%2C7;QY:X7KY=YS\-[&L@LD:_LW*\26;38+$V9 84:J<> ]..A*1
MXEJ'$@"O+7IXZ6W+S]MI)A(W_*,AS*W.RE/*PKITFHE7B7X)TY/YD='.BO9_
MX:]DUP\EIW", N74.#'L]CANXMTFCKW/R%#9.NZDGG4\=JJ<3R'M/ :PCIRP
MV"T6"U1K3:(R(=NB(#;$=L42!WGO)YDGGJB0T"T"T"T"H- *,YZ"VNZW)>1X
MC-7BF5\5*EQ1_P"WD'ND,BB37M(^-= #<PQV=9+C]3GM@E8W=$&C6<8R"8KA
M_/?910"O;R/LU+!*V/*.H3; <MLBV]0K6D#\6$ZF/<4I_P!1D[25?JZF!*1^
ML6)-NAB^QI^/2^2FKA&6$@_[B!3[-9NHM-JS7"I^TPK] >)Y)]="5?$*VG6?
MD5_)XT.)>E2&7FG(-P'JDMK0H)6*!P52H\_,->#]CCE[N/3!@O,! 5Z[>P\:
ME:1P^)UY9RV=_P D1\O(L=A@F3<XC5.=7D'[ 3K<X;?\2]9$'*ZA8_(>2Q:4
M2KU)' ,0(ZW 3V>*@&NVOZ=OMB_LR,YEOSZ5#4]<TP,(LZQ14R\O)5*V'CX&
M1XJ_#7JT_4UGORX;?L6^FIB=FL+MRVX'89?4'(TJ 5D%U06K7'4#3>E"J)-/
MTCKU:S#S;7(T8O\ T_OSKDQD/4^Y?S)=FJ*C6I *;;&IR2EKAOV^ZGOUI!G:
M::;:0VVA*&T )0A( 2D 4  ' #09Z!:!:!:!:!:!:#!YEIYM33J$N-+%%MK
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7S8HVPR@-H2/8E( U1L:!:!:!:!:#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>n2574ex2313img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2313img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 50"Z P$1  (1 0,1 ?_$ +\   $% 0$!
M      < ! 4&" $" P$!  (# 0                ,& @0% 1   0($ @4#
M#0@/! L!     0(# !$$!1(&(3$3% =!471A<8&Q(C*RPA46-C<(D5)RTC-S
MLR2AP4*2(U.3-%2T-55UUA=B0Y3$T>'Q@F.#HT2$I"8G$0 " 0(#!04' P0#
M 0       0(1 Q($!2$Q07$343)R,S1A@2)2(Q05P4+2\(*B))&A8K+_V@ ,
M P$  A$#$0 _ +MGC,V8:+.-Q;I;@^TTRZDMM)<(0))2>]U2@ PY<O+-YLM+
M<6S\N@%Q/O5C0M/85 $D8 "V>;_?*;/;]+3U[[-,'&0&4.*"9*2F>@<\ %#-
M.8&K#:';BXVIW9D)0V#*:E&0F>:(KUW JFOFLQTH8BL<.,T7:_W"Z/UR_P &
M@-AEA.A" 2J<N<]6(,M><VVS2T_-2NMME_')&X=4[ "@#YO+2VA2U:$H25*/
M4&F/&J[#R4J*IF:^<7\^W6\."V5CE(PIQ2*2CID J*9R3,R4I2C%JLZ99C"L
MRH7M3O2F\!\QFOC0?[ZZ_D5?$CW[?*>S_D?<YSMD?)SB3Q4M52V:RX533A[I
M+-6V E8!]ZI(F.M&:T[+7(U@8//YB#^)LT3DC,"LPY7M]X4@-N53<W4#4'$D
MI7*?)B&B*QF+/3FXEJRE_JVU(G8A-D4 * % "@!0 H 4 * % &>^(*%KSO<T
M(25*4ZD)2-9)0D0!9^#682S5U-B?5)+\WJ8'D<2/PB>R-/8@ NP !^(/K$J/
MG6/!3 !:SI;[76V)UNZ56Z4#:TN/O:C)!GA$^4Q'=MJ:HR&_95R.%D-P_OUG
MKWZVW66C%+;:%"-FX1)QU2B05*]SETQE""BJ(RM6HVU1(L-XS38+*4IN58AA
MQ8FELS4LCGPI!,HR)"*_JCDC]XC\FY\6 /;7$S)+BP@7)(*M14AQ(]TI@"=J
MW6WK:\\TL+;6RLH6DS!!2=((C*&]&%SNOD96X9>L:Q]+\546_/+_ %WR*9D'
M_L+F:S$4TNH%^/>6[_=[E:5VNWOUJ&F74N*905A"BM) ,N>.YI&8A;3QLX&L
MV)SDG%5+MPGHJZUY MU+<:==)4,ATNM.C"I,W%'2#U(T,_=5R\VN)T=/@[=E
M)\!5G&#A[2/J8=N[:G$$A6R2MQ((,N^2DB/8:?>DJI">IV8NE3X_ULX;_O7_
M *3OQ8R_&W_E,?RECM)6P\1<G7ZIW6UW-I^I()#!"D+(&N25A,^Q$%W*7+>V
M2)K6>M3=$Q_?<T6&PH:<O%:W1MODI94Y/NE)$R!(&,+5F5SNJI+=OPM]YT(L
M\3\@BG34&^4NR6HH2<1F2-?<RQ?8B59&]6F%D/W]FG>0\L^=\K7NJ52VBXM5
ME0A!<6TW.80" 5:0.4QA=RURVJR5"2WFK=QTBZB7GK)S:U-N7JB0X@E*TE]
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M/XS_ )@1<(^F7A*3<]0_$%#VDOV58^D.^ (Y>B=Z7([&N]R)*>SQZ$U/3G?
M1$6L^;[B;1/)]X4#'(1V'N,DVGUF4W\9'ZQ%TN^F?A*1:]2O$:WBELO!G/VA
MO3:FZ"CZ1<6?1/+?,J>N>;[B!_EF-W^9I_P+CFSUF/\ 3&?$BEEX#U  YXQY
M>WJU-7AE/X:A."H/.RLZS\%7;@ 4,5+U1<*13RL2FU--)/\ 900$CW( -O%?
MT*K/G&?#$ 57@?\ G5V^ UVU0!5,^>G%RZ0.T( T$S\BCX([4 "OCA\I:>L]
MXL 3G#+U>JZ]3]N,H;T87.Z^0!^&7K%L?2_%5%OS[_UWR*9D/4+F:Q!BFEU
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M](N+/HOE/F537/-1!?RS&[7_ .S4_@7C--!7+XCONHIG5-;XR=H&U%,AATS
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*&J % "@!0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>n2574ex2314img001a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2314img001a.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ -@#Z P$1  (1 0,1 ?_$ +D   $$ P$!
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M'O=\V\Y9QU^6LZ=G]4AP_'N^YX*Y;S&W:->WEZ(;/N&1YZZ#ES;<L^)BJ$W
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M>%S,;SD/3"^X+;KD-OR*U 9V6:Z/-1MB2JJA;:\>4[N]&X>"]F@'O..GO4;
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M$:]4JEW;D3N#ZM4KILV1W*/C<*"MN@K='GQAL!(CFR9@ZS000A=:)M4X+Z-
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*YBG3O302O0?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>n2574ex2315img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2315img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 'P!% P$1  (1 0,1 ?_$ (4   (" P$
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AOM.Z_5J]^W4^ZZT_4X'6G>_[Z:]OPV/T,6]?RW'UG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>n2574ex2316img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 n2574ex2316img001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ,P#+ P$1  (1 0,1 ?_$ *<   $$ P$
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M[LJL>:DPA0!0!0!0!0!0!0!0!0!0!0!0'"N3_P"4?_BK^\:U#Z78U6OD=?\
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MD./]M *30,S0@2=]"0H!.R_'\M +H /S4(,<!NH /"A()^;YJ * .-2 ^BH
4<: * QPH#(X4!GB=U"#'T4!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Sep. 11, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NioCorp
                                         Developments Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001512228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1262185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">A1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000
        South Yosemite Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Centennial<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(720)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">334-7066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,757,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of NioCorp Developments Ltd. and subsidiaries (the &#8220;Company&#8221;)
as of June 30, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, cash flows, and shareholders&#8217;
equity and redeemable noncontrolling interest, for the each of the two years in the period ended June 30, 2025, the related notes
(collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and
its cash flows for each of the two years in the period ended June 30, 2025 in conformity with accounting principles generally
accepted in the United States of America.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Denver,
Colorado<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember', window );">Common Shares Without Par Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Shares, without par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212Member', window );">Warrants Each Exercisable For111829212 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    each exercisable for 1.11829212
    Common Shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NIOBW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_CommonSharesWithoutParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_WarrantsEachExercisableFor1.11829212Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 25,554<span></span>
</td>
<td class="nump">$ 2,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,183<span></span>
</td>
<td class="nump">916<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">26,737<span></span>
</td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestmentsAndReceivablesNet', window );">Investment in equity securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">118<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Land and buildings, net</a></td>
<td class="nump">839<span></span>
</td>
<td class="nump">837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties', window );">Mineral properties</a></td>
<td class="nump">16,085<span></span>
</td>
<td class="nump">16,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">43,819<span></span>
</td>
<td class="nump">20,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,795<span></span>
</td>
<td class="nump">1,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,893<span></span>
</td>
<td class="nump">11,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Warrant liabilities, at fair value</a></td>
<td class="nump">6,852<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutLiabilityAtFairValue', window );">Earnout liability, at fair value</a></td>
<td class="nump">5,880<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,658<span></span>
</td>
<td class="nump">17,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value, unlimited shares authorized;&#160; 58,491,196 and 38,062,647 shares outstanding, respectively</a></td>
<td class="nump">208,551<span></span>
</td>
<td class="nump">163,823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(179,317)<span></span>
</td>
<td class="num">(161,912)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(911)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">28,323<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interest, and shareholders&#8217; equity</a></td>
<td class="nump">$ 43,819<span></span>
</td>
<td class="nump">$ 20,070<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout liability at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation, depletion, amortization, and valuation allowance, of capitalized cost for mineral interest in unproved property in oil- and gas-producing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-15<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-13<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestmentsAndReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestmentsAndReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorizedUnlimited', window );">Common stock, authorized</a></td>
<td class="text">Unlimited<span></span>
</td>
<td class="text">Unlimited<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding</a></td>
<td class="nump">58,491,196<span></span>
</td>
<td class="nump">38,062,647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorizedUnlimited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether number of common shares permitted to be issued is unlimited. Acceptable value is "Unlimited".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorizedUnlimited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>us-types:authorizedUnlimitedItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Employee related costs</a></td>
<td class="nump">$ 1,944<span></span>
</td>
<td class="nump">$ 3,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">2,237<span></span>
</td>
<td class="nump">3,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration expenditures</a></td>
<td class="nump">4,135<span></span>
</td>
<td class="nump">2,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Other operating expenses</a></td>
<td class="nump">3,642<span></span>
</td>
<td class="nump">4,163<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">11,958<span></span>
</td>
<td class="nump">13,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue', window );">Change in fair value of earnout shares liability</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="num">(6,704)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfWarrantLiabilityValue', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">4,093<span></span>
</td>
<td class="num">(1,875)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfConvertibleNotesValue', window );">Change in fair value of convertible notes</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">2,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">4,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange gain</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="num">(94)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other gains</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Loss on equity securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(17,982)<span></span>
</td>
<td class="num">(12,037)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net loss and comprehensive loss</a></td>
<td class="num">(17,982)<span></span>
</td>
<td class="num">(11,898)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Net loss attributable to redeemable noncontrolling interest</a></td>
<td class="num">(577)<span></span>
</td>
<td class="num">(463)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent', window );">Net loss and net comprehensive loss attributable to the Company</a></td>
<td class="num">$ (17,405)<span></span>
</td>
<td class="num">$ (11,435)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfConvertibleNotesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of convertible notes value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfConvertibleNotesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earn out shares liability value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfWarrantLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of warrant liability value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfWarrantLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExplorationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&amp;G" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExplorationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479255/942-310-S50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.H.2.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478116/942-310-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-39<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentBeforeTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481725/323-10-35-18<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentBeforeTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per common share, basic</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per common share, diluted</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic</a></td>
<td class="nump">45,072,895<span></span>
</td>
<td class="nump">34,320,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted</a></td>
<td class="nump">45,072,895<span></span>
</td>
<td class="nump">34,320,024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss for the period</a></td>
<td class="num">$ (17,982)<span></span>
</td>
<td class="num">$ (11,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfEarnoutShareLiability', window );">Change in valuation of earnout shares liability</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="num">(6,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInValuationOfWarrantLiabilities', window );">Change in valuation of warrant liabilities</a></td>
<td class="nump">4,093<span></span>
</td>
<td class="num">(1,875)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValueOfConvertibleNoteValue', window );">Change in fair value of convertible note</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">2,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpense', window );">Accretion of convertible debt</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">4,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">789<span></span>
</td>
<td class="nump">2,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueOfCommitmentSharesIssued', window );">Yorkville share issuances</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of insider warrants</a></td>
<td class="nump">144<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on equity securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Noncash lease activity</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_OtheroperatingGainsLosses', window );">Other gains</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">&#160;</a></td>
<td class="num">(10,345)<span></span>
</td>
<td class="num">(10,580)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in working capital items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="num">(267)<span></span>
</td>
<td class="nump">469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(48)<span></span>
</td>
<td class="num">(1,621)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(10,660)<span></span>
</td>
<td class="num">(11,732)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Acquisition of fixed assets</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForDeposits', window );">Deposits</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">45,666<span></span>
</td>
<td class="nump">6,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of debt, net of costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Related party debt draws</a></td>
<td class="nump">504<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Related party debt repayments</a></td>
<td class="num">(504)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Debt repayments</a></td>
<td class="num">(7,223)<span></span>
</td>
<td class="num">(1,512)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
<td class="num">(4,234)<span></span>
</td>
<td class="num">(205)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">34,209<span></span>
</td>
<td class="nump">11,403<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents during period</a></td>
<td class="nump">23,542<span></span>
</td>
<td class="num">(329)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,012<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">25,554<span></span>
</td>
<td class="nump">2,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Amounts paid for interest</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConversionsOfDebtForCommonShares', window );">Conversion of debt for common shares</a></td>
<td class="text">501<span></span>
</td>
<td class="text">14,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ValueOfWarrantsIssued', window );">Value of Warrants issued</a></td>
<td class="text">2,262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfConvertibleNoteValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of convertible note value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfConvertibleNoteValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValueOfEarnoutShareLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value of earnout share liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValueOfEarnoutShareLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInValuationOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in valuation of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInValuationOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConversionsOfDebtForCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents conversions of debt for common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConversionsOfDebtForCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueOfCommitmentSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value of commitment shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueOfCommitmentSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_OtheroperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents otheroperating gains losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_OtheroperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ValueOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ValueOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481639/420-10-35-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity attributable to continuing operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Redeemable Noncontrolling Interest [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Jun. 30, 2023</a></td>
<td class="nump">$ 140,421<span></span>
</td>
<td class="num">$ (150,477)<span></span>
</td>
<td class="num">$ (911)<span></span>
</td>
<td class="num">$ (10,967)<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2023</a></td>
<td class="nump">31,202,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueEquityPlacement', window );">Equity placements</a></td>
<td class="nump">$ 2,995<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,995<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesEquityPlacement', window );">Equity placements (in shares)</a></td>
<td class="nump">978,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws', window );">Yorkville equity facility draws</a></td>
<td class="nump">$ 3,398<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,398<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws', window );">Yorkville equity facility draws (in shares)</a></td>
<td class="nump">1,358,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Option exercises</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option exercises (in shares)</a></td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares', window );">Redemption of vested shares</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares', window );">Redemptions of vested shares (in shares)</a></td>
<td class="nump">283,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 14,479<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">14,479<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions (in shares)</a></td>
<td class="nump">4,232,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockDividend', window );">Option liability valuations</a></td>
<td class="num">$ (148)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(148)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">(204)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share-based compensation</a></td>
<td class="nump">2,779<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,779<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(11,435)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,435)<span></span>
</td>
<td class="num">(463)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2024</a></td>
<td class="nump">$ 163,823<span></span>
</td>
<td class="num">(161,912)<span></span>
</td>
<td class="num">(911)<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">1,534<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2024</a></td>
<td class="nump">38,062,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,062,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueEquityPlacement', window );">Equity placements</a></td>
<td class="nump">$ 30,059<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 30,059<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesEquityPlacement', window );">Equity placements (in shares)</a></td>
<td class="nump">13,321,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws', window );">Yorkville equity facility draws</a></td>
<td class="nump">$ 12,941<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,941<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws', window );">Yorkville equity facility draws (in shares)</a></td>
<td class="nump">5,671,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueStockWarrantsExercised', window );">Warrant exercises</a></td>
<td class="nump">$ 1,809<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,809<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised', window );">Warrant exercises (in shares)</a></td>
<td class="nump">828,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Option exercises</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option exercises (in shares)</a></td>
<td class="nump">512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares', window );">Redemption of vested shares</a></td>
<td class="nump">$ 119<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares', window );">Redemptions of vested shares (in shares)</a></td>
<td class="nump">348,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions</a></td>
<td class="nump">$ 501<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Debt conversions (in shares)</a></td>
<td class="nump">258,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants', window );">Issuance of Lind Consent warrants</a></td>
<td class="nump">$ 2,262<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of private warrants</a></td>
<td class="nump">482<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Share issuance costs</a></td>
<td class="num">(4,234)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,234)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Share-based compensation</a></td>
<td class="nump">789<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">789<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(17,405)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(17,405)<span></span>
</td>
<td class="num">(577)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Jun. 30, 2025</a></td>
<td class="nump">$ 208,551<span></span>
</td>
<td class="num">$ (179,317)<span></span>
</td>
<td class="num">$ (911)<span></span>
</td>
<td class="nump">$ 28,323<span></span>
</td>
<td class="nump">$ 838<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="nump">58,491,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,491,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueEquityPlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value equity placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueEquityPlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value issuance of lind consent warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value redemptions of vested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value shares conversion of convertible securities net of adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueSharesEquityPlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value shares equity placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueSharesEquityPlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value shares redemptions of vested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value shares stock warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value shares yorkville equity facility draws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueStockWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value stock warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueStockWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period value yorkville equity facility draws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 37: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 38: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued to shareholders as a dividend during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 42: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 47: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 51: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 52: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 54: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 55: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (17,982)<span></span>
</td>
<td class="num">$ (11,898)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90F_eecd--AwardTmgMethodTextBlock_c20240701__20250630_zUCn0D2oxEt" title="Award Timing Method">Under
our policies and practices, the approval of Options (including any Option grants to our named executive officers and
directors) is typically provided at a Board or Compensation Committee meeting or via unanimous written action on the part of the  Board or Compensation
Committee, but such grants are not generally made on any kind of predetermined, regular schedule. Instead, as noted above, our
award recipients (including the named executive officers and directors) generally receive annual grants of fully-vested and exercisable
Options at various times each year, including as recommended by the CEO to the Board or Compensation Committee.</span>  Board or Compensation Committee
meetings or written actions to approve such grants are scheduled on an ad hoc, as-needed basis, generally prompted by a determination
by the Board or Compensation Committee that such grants should be made (or a request by management or the Board that such grants be made).
<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_900_eecd--AwardTmgPredtrmndFlag_dbT_c20240701__20250630_zqSmXRRTVSi" title="Award Timing Predetermined">These grants are then made effective at the meeting at which the grants are so approved.</span> The  Board or Compensation Committee typically
fixes the grant schedule for such awards when they are approved at such meetings or through written action. Generally, award values
to be utilized for such awards are determined shortly before or as of the grant date based upon the closing share price on the
business day preceding the grant. These values and other information are then used in determining the number of Options to be
awarded to recipients, but values are not modified to reflect any subsequent increase or decrease in value of our stock between
the end of the preceding business day and the effective date of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
equity grant approach is used by the Board or Compensation Committee in order to best help ensure the grants are made only during an open
window, and after the release of the Company&#8217;s <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_903_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zbGP1hraM7O9" title="Award Timing MNPI Considered">material non-public information</span> regarding its most recently-completed fiscal
year. Including for grants made during fiscal year 2025, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240701__20250630_z312nmHTEpF7" title="Award Timing, How MNPI Considered">we do not time the disclosure of material non-public information for
purposes of affecting the value of executive compensation, and we do not make any grants while in the possession of material non-public
information.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2025, we did not grant Options (or similar awards) to any of our named executive officers during the period beginning
four business days before and ending one business day after the filing of any Company periodic report on Form 10-Q or Form 10-K,
or the filing or furnishing of any Company Form 8-K, that disclosed any material non-public information.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">Under
our policies and practices, the approval of Options (including any Option grants to our named executive officers and
directors) is typically provided at a Board or Compensation Committee meeting or via unanimous written action on the part of the  Board or Compensation
Committee, but such grants are not generally made on any kind of predetermined, regular schedule. Instead, as noted above, our
award recipients (including the named executive officers and directors) generally receive annual grants of fully-vested and exercisable
Options at various times each year, including as recommended by the CEO to the Board or Compensation Committee.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">we do not time the disclosure of material non-public information for
purposes of affecting the value of executive compensation, and we do not make any grants while in the possession of material non-public
information.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Cybersecurity
risk management is <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240701__20250630_zzvfcTvSgOPc">integrated</span> into the Company&#8217;s enterprise-wide risk management. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240701__20250630_zzBvnsiCi2g3">Our Board has overall oversight responsibility
for our risk management and management is responsible for identifying, considering, and assessing material risks to the Company.
Our Chief Financial Officer is responsible for assessing and managing cybersecurity risks</span>; however, as a smaller reporting company,
we currently do not have a dedicated cybersecurity team. Our Chief Financial Officer reports to the Board regarding financial
and operating risks, including cybersecurity risks. Our Chief Financial Officer has experience in managing public companies and
assessing financial and operating risks.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240701__20250630_zY1yw6Uqqc27">Our
cybersecurity risk management is designed to provide a framework for assessing, identifying, and managing material risks from
cybersecurity threats and to respond to cybersecurity incidents, including material risks associated with the use of services
provided by <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240701__20250630_zaGSeNvtLRYe">third-party service providers</span>. We rely on the cybersecurity protections of many of our third-party service providers.
Our primary third-party service providers utilize two-factor authentication as well as login and password protections with email
verifications.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
are in the process of evaluating our cybersecurity needs and developing appropriate measures to enhance our cybersecurity posture.
Our goal is to establish a cybersecurity framework that is commensurate with our size, complexity, and nature of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_gIFCRMAORLTMA-EYWBMY_zwkZRvxSf94i">For
the year ended June 30, 2025, the Company had <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240701__20250630_zyBQEttKdXC6">no material cybersecurity incidents</span> or threats that have materially affected or
were reasonably likely to materially affect our business strategy, results of operations or</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_C00_gIFCRMAORLTMA-EYWBMY_zFzSX3gs5OPk">
financial condition. Despite our efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances that we
have not experienced an undetected cybersecurity incident.</span> As previously disclosed, on February 14, 2025, we became aware of
unauthorized third-party access to our information systems, including portions of its email systems, that resulted in misdirected
vendor payments. To date, the Cybersecurity Incident has not had a material impact on our business operations or financial
condition.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">Our Board has overall oversight responsibility
for our risk management and management is responsible for identifying, considering, and assessing material risks to the Company.
Our Chief Financial Officer is responsible for assessing and managing cybersecurity risks<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">For
the year ended June 30, 2025, the Company had <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240701__20250630_zyBQEttKdXC6">no material cybersecurity incidents</span> or threats that have materially affected or
were reasonably likely to materially affect our business strategy, results of operations or
financial condition. Despite our efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances that we
have not experienced an undetected cybersecurity incident.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--NatureOfOperations_z31rqZBDihfd" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td id="xdx_825_zKgby0OEZ7Vg" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
OF BUSINESS</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
Developments Ltd. (the &#8220;Company&#8221; or &#8220;NioCorp&#8221;) was incorporated on February 27, 1987, under the laws of
the Province of British Columbia and currently operates in <span id="xdx_908_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20240701__20250630_zUiL9VuznpU" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0527">one</span></span> reportable operating segment consisting of exploration and development
of mineral deposits in the United States, specifically, the Elk Creek Niobium/Scandium/Titanium property (the &#8220;Elk Creek
Project&#8221;) located in southeastern Nebraska.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On March 17, 2023 (the &#8220;Closing Date&#8221;),
the Company closed a series of transactions (the &#8220;GXII Transaction&#8221;), pursuant to the Business
Combination Agreement, dated September 25, 2022 (the &#8220;Business Combination Agreement&#8221;), among the Company, GX Acquisition Corp. II (&#8220;GXII&#8221;), and
Big Red Merger Sub Ltd (the &#8220;Closing&#8221;). At the Closing, the Company also closed convertible debt financings (the &#8220;Yorkville
Convertible Debt Financing&#8221;) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with
YA II PN, Ltd., &#8220;Yorkville&#8221;), and the standby equity purchase facility with Yorkville (the &#8220;Yorkville Equity
Facility Financing&#8221; and, together with the Yorkville Convertible Debt Financing, the &#8220;Yorkville Financings&#8221;)
became effective. The transactions contemplated by the Business Combination Agreement, including the GXII Transaction, the Yorkville
Financings and a 10-for-1 reverse stock split consummated in connection with the Closing, are referred to, collectively, as the
&#8220;2023 Transactions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raise substantial doubt about the Company&#8217;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing, and maintaining continued support from its shareholders and creditors.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">BASIS OF PREPARATION</a></td>
<td class="text"><p id="xdx_802_eus-gaap--BasisOfAccounting_z5XvER7iCjeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td id="xdx_82A_zWV72rtHBxva" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BASIS
OF PREPARATION</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
                                         of Preparation and Consolidation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United
States of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the U.S. Securities and Exchange Commission. The
consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries with all
significant intercompany transactions eliminated. Certain transactions include reference to Canadian dollars (&#8220;C$&#8221;)
where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zGuk1eMn6nVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zqTB7GQb4nxg">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 87%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction
    of incorporation</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    at June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zcexJQlne0Xe" title="Jurisdiction of incorporation">British
    Columbia, Canada</span></span></td>
    <td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_znYdXXHzlZTe" style="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td id="xdx_989_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z67aElvHa7u2" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;) <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zsaDnqiKPhAi" title="Jurisdiction of incorporation">Delaware,
    USA</span></span></td>
    <td id="xdx_988_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zHKTM3jTQTR2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.42%</span></td>
    <td id="xdx_98F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zMnPBX90Jxp8" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.7%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zAzzIeOpxC7b" title="Jurisdiction of incorporation">United
    Kingdom</span></span></td>
    <td id="xdx_983_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zMpkBj4CXK3d" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zraq8mZZDNY1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_zsFFthMyjs42" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5in"><span id="xdx_F13_zump1IRpSDG9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 and 4,282,116 Vested Shares
                                         and 3,391,596 and 3,391,596 Earnout Shares (each as defined below) held by third parties,
                                         and outstanding as of June 30, 2025 and 2024, respectively.</span></td></tr></table>

<p id="xdx_8A7_zHuNeDHUudza" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
                                         of Estimates</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the valuation of mineral properties, deferred income tax asset valuations, convertible
debt valuations, earnout valuation, derivative liabilities, warrant liabilities, and share-based compensation. The Company bases
its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable
under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results
experienced by the Company may differ materially and adversely from the Company&#8217;s</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>












<div style="text-align: left; margin-bottom: 1pt"></div>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">estimates. To the extent there are material
differences between estimates and the actual results, future results of operations will be affected.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zP1oUJg4dpU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td id="xdx_823_zN0w7EFaP3zb" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNIFICANT
ACCOUNTING POLICIES</span></td>
</tr></table>

<p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zc8c0al9Ze3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td id="xdx_868_z3ZweeecMiT3" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
                                         Stage Issuer</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

<p id="xdx_85C_z9ppAztdFu9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zwFw94J5Xv96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td id="xdx_86E_zp7AyUpFwzql" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                                         and Cash Equivalents</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) up
to C$100. At June 30, 2025, the Company had $24,711 and $22 in excess of the FDIC and CDIC insured limits, respectively.</span></p>

<p id="xdx_854_zwTIkYd4GfJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zVmA1NL8OM4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td id="xdx_86E_z1sTjiimVs8g" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
                                         Currency Translation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;). The functional currency for all entities is
the U.S. Dollar except for NioCorp Technologies Limited, which is measured in British Pounds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency, if any, are included as part of cumulative
currency translation adjustment, which is reported as a component of shareholders&#8217; equity under accumulated other comprehensive
loss.</span></p>

<p id="xdx_856_zzGc4b2EXj5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_842_ecustom--MineralPropertiesPolicyTextBlock_z7h7egP2AxVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td id="xdx_864_z9oOUv8PHS8h" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         Properties</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of common shares, no par value, of the Company (&#8220;Common Shares&#8221;) issued
as consideration. Properties acquired under option agreements, whereby payments are made at the sole discretion of the Company,
are capitalized as mineral property acquisition costs at such time as the payments are made. Exploration costs are expensed as
incurred. When it is determined that a mining deposit can be economically and legally extracted or produced based on established
proven and probable reserves under S-K 1300, and the Company&#8217;s board of directors (the &#8220;Board&#8221;) has approved
the commencement of formal development activities, development costs related to such reserves and incurred after such board approval
will be considered for capitalization. The establishment of proven and probable reserves is based on</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>











<div style="text-align: left; margin-bottom: 1pt"></div>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">results of feasibility studies,
which indicate whether a property is economically feasible. Upon commencement of commercial production, capitalized costs will
be amortized over their estimated useful lives or units of production, whichever is a more reliable measure. Capitalized amounts
relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was <span id="xdx_904_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20250630_zBylhVoz8aX9" title="Impairment to mineral properties"><span id="xdx_90B_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20240630_zbzLtOSaCkP" title="Impairment to mineral properties">no</span></span> impairment recorded to mineral properties as of
June 30, 2025 or 2024, respectively.</span></p>

<p id="xdx_856_zCiIZdKYt2Rl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zwVv4PIxVTJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td id="xdx_869_zmooaBqSCjB1" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long
                                         Lived Assets</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was <span id="xdx_90D_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20240701__20250630_zFeFBsrmvcn5" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20230701__20240630_zHjdsI6AnJMk" title="Impairment of long-lived assets">no</span></span> impairment recorded to long-lived assets as of June 30, 2025 or 2024, respectively.</span></p>

<p id="xdx_859_zBvAVsfqkApk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zdOOBvw5BJ7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td id="xdx_86C_zJ9OdHVnd3Wc" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, <i>Leases</i>, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

<p id="xdx_851_z5skVgBbhusd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_844_ecustom--ConvertibleDebtCarriedatFairValuePolicyTextBlock_z0JYCGUNEaFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td id="xdx_864_zCnFst6mSn9c" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
                                         Debt Carried at Fair Value</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to the Company&#8217;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in Note
8), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, <i>Derivatives and Hedging
</i>(&#8220;ASC 815&#8221;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument to account
for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter using a
Monte Carlo simulation methodology which</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>












<div style="text-align: left; margin-bottom: 1pt"></div>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">incorporates multiple conversion scenarios. All changes in fair value subsequent to the
initial recording, excluding the impact of the change in fair value related to the Company&#8217;s own credit risk, are recorded
as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#8217;s own credit risk, if any, are recorded through other comprehensive
loss.</span></p>

<p id="xdx_856_zAz6bkOdFVFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_848_ecustom--WarrantsPolicyTextBlock_zh9de7G8fcsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td id="xdx_86A_zzBqJ858BRCf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We apply relevant accounting
guidance for warrants to purchase our Common Shares (&#8220;Warrants&#8221;) based on the nature of the relationship with the counterparty.
The Company has made an accounting policy election that the &#8220;greater of&#8221; Share-Price Input to the Black-Scholes Value
would not preclude equity classification. The Company has not had any historical transactions that include the &#8220;greater of&#8221;
Share-Price Input feature, and this is a new accounting policy election as of the current fiscal year. For Warrants issued to investors
or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC 480, <i>Distinguishing Liabilities
from Equity</i>, and ASC 815, to assist in the determination of whether the Warrants should be classified as liabilities or equity.
The fair value of Warrants is estimated using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features
embedded in the Warrant. Inputs under both models include inputs such as NioCorp&#8217;s Common Share price, the risk-free interest
rate, the expected term, the volatility, and the dividend rate. Warrants that are determined to require liability classifications
are measured at fair value upon issuance and are subsequently remeasured to their then fair value at each subsequent reporting
period with changes in fair value recorded in current earnings. Warrants that are determined to require equity classifications
measured at fair value upon issuance and are not subsequently remeasured unless they are required to be reclassified.</p>

<p id="xdx_846_ecustom--EarnoutSharesPolicyTextBlock_zC8dRMo8Jo7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td id="xdx_865_zJVi2dEuUeTg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
                                         Shares</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#8217;s publicly traded Warrants,
the dividend rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective
and require significant judgment.</span></p>

<p id="xdx_852_zwUAMTbliwgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_84D_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zGR01jbEI8O5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td id="xdx_86B_zmpv90UlaI9g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                         Instruments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, and accounts payable
and accrued liabilities. It is management&#8217;s opinion that the Company is not exposed to significant interest, currency or
credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying value unless
otherwise noted.</span></p>

<p id="xdx_852_znAwGZnSUxfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zqWAzZAReQ88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td id="xdx_867_zbgAPKWIgidd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration
                                         of Credit Risk</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Columbus, Ohio. As part
of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

<p id="xdx_85A_z6xVAby1KLR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z0YgSoWoFSXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td id="xdx_86D_zs7kZ0bx4kje" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
                                         Retirement Obligation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20250630_znG4zUDnMSV4" title="Accrued Exploration Stage Obligations">48</span> and $<span id="xdx_904_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zD2FSDHEwQKg" title="Accrued Exploration Stage Obligations">48</span> for estimated obligations as
of June 30, 2025 and June 30, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.</span></p>

<p id="xdx_85F_zK2ADdgdL6y" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>














<div style="text-align: left; margin-bottom: 1pt"></div>

<p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zPJ5O1LrTg49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td id="xdx_860_zbbirz5EKLSl" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
                                         Taxes</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2025 and 2024, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

<p id="xdx_854_zvr8PDiV0zM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p id="xdx_841_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zb2890q1vRkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td id="xdx_86D_z7Ncwdb9fCf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
                                         Noncontrolling Interest</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The Company&#8217;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;</span></p>

<p id="xdx_857_z1Sw9JbIsHDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zMwRJISFnjl8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td id="xdx_86C_zjipvAuSYPgf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
                                         and Diluted Per Share Disclosure</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 9), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWyAFxndIbw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B8_zwlyT1end3Ah">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify; background-color: white">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center; background-color: white">For the year ended June 30,</td><td style="background-color: white">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: justify; padding-left: 9pt">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_z4F4MXQKGrka" style="width: 10%; text-align: right" title="Net loss">(17,982</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zajpSponzKIc" style="width: 10%; text-align: right" title="Net loss">(11,898</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Adjust: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20240701__20250630_zutq6Nkfe109" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">577</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zGc0Bl8WsSmh" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">458</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20250630_zkkxBtYRUH46" style="text-align: right" title="Net loss available to participating securities">(17,405</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zjlQucI0DBW3" style="text-align: right" title="Net loss available to participating securities">(11,440</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20240701__20250630_zx6g14PGNxV4" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">1,102</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20230701__20240630_zJhpLAyk3YXc" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">967</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 9pt">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20250630_zfcKqCWrkVkf" title="Net loss attributed to common shareholders - basic"><span id="xdx_90A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20240701__20250630_zd5eiOeCJ9Ne" title="Net loss attributed to common shareholders - diluted">(16,303</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zIPgAaR0Hkyi" title="Net loss attributed to common shareholders - basic"><span id="xdx_900_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20230701__20240630_z1pwClWsysZi" title="Net loss attributed to common shareholders - diluted">(10,473</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zfo0ZGEwfa71" title="Weighted average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zwkZKVhJ7xgd" title="Weighted average shares outstanding - diluted">45,072,895</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_z6kzP7KhBMEa" title="Weighted average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zJeMmTyr4gFa" title="Weighted average shares outstanding - diluted">34,320,024</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 9pt">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zXjqFfBFYpM1" title="Loss per Common Share outstanding - basic"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zrCFblI8gIGi" title="Loss per Common Share outstanding - diluted">(0.36</span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_zGSJbiYudYea" title="Loss per Common Share outstanding - basic"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zeZdYic62vO1" title="Loss per Common Share outstanding - diluted">(0.31</span></span></td><td style="text-align: left">)</td></tr>
</table>

<p id="xdx_8AF_zceKkRzdWzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following shares underlying options to purchase Common Shares (&#8220;Options&#8221;), Warrants, and outstanding convertible debt
were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation
for the periods indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zfnV3917EYcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span id="xdx_8B2_zIFTJ9XdJ09f" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.6in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup>(1)(2)</sup>:&#160;</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 66%; text-indent: 9pt">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20250630_fKDEpKDIp_zvHEtVOjsaJ6" style="width: 10%; text-align: right" title="Options">3,020,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zSVC9VR5dap3" style="width: 10%; text-align: right" title="Options">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: 9pt">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20250630_fKDEpKDIp_zfxzBVezte1f" style="text-align: right" title="Warrants">31,839,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_zO8ohOo3qU49" style="text-align: right" title="Warrants">18,563,561</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_d0_uShares_c20240701__20250630_fKDEpKDIp_zN7H7U4yxiug" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zIm3kG74jHG1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,849,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt">Total potentially dilutive securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DilutiveSecurities_c20240701__20250630_fKDEpKDIp_zqI5JkNsZ54j" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities">34,859,152</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_z68NfvevSWJ4" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities">23,908,061</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>














<div style="text-align: left; margin-bottom: 1pt"></div>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F02_zcC7sWS9kIAl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; padding-bottom: 4pt; text-align: justify"><span id="xdx_F15_zdMfNW8gjA06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F0E_zZPpBNjaaE8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span id="xdx_F18_zw2zGyryrBC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</span></td></tr>
</table>

<p id="xdx_8A4_zIQT9463Qr8f" style="margin-top: 0; margin-bottom: 0"></p>

<p id="xdx_853_zrm9h2CqCqpa" style="margin-top: 0; margin-bottom: 0"></p>

<p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zjNeX9w6d9k" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td id="xdx_86C_zf3D18XBiwh7" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                         Based Compensation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants Options to directors, officers, employees, and business advisors. Option terms and vesting conditions are at the
discretion of the Board. The Option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
on the day preceding the date of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of Options using the Black-Scholes option pricing model. The Company recognizes forfeitures as
they occur.&#160;</span></p>

<p id="xdx_85D_zOUEistcYy7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

<p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znH5E6LKdBDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></td><td id="xdx_86F_zYUklDvIs6re" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
                                         Accounting Standards</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recently
Adopted Accounting Standards</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
fiscal year 2025, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2023-07,&#160;<i>Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures</i>. Management has evaluated the Company&#8217;s operations and concluded it has&#160;one&#160;reportable
operating segment which will now require expanded disclosure. Adoption was made retroactively with segment disclosure included
for the fiscal years ended June 30, 2025 and 2024. This standard has not changed the processing, recording, or presentation of
financial data, other than providing additional disclosure regarding management oversight for the Company&#8217;s single operating
segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective<br/>
</span>In December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>,
which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of
rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#8217;s annual
periods beginning July 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively.
The Company is currently evaluating the ASU to determine its impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.&#160;</span></p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN ISSUES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">GOING CONCERN ISSUES</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zHYF9w32aZOg" style="margin-top: 0; margin-bottom: 0"><span style="font-size: 1pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td id="xdx_82C_zRkiL06WIOsl" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GOING
CONCERN ISSUES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred a net loss of $<span id="xdx_909_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20240701__20250630_ziNHsYhCtIN8" title="Net loss::XDX::-17982"><span style="-sec-ix-hidden: xdx2ixbrl0701">17,405</span></span> for the year ended June 30, 2025 (2024 - $<span id="xdx_90A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zoc82Euk4hE6" title="Net loss::XDX::-11898"><span style="-sec-ix-hidden: xdx2ixbrl0703">11,435</span></span>) and had an accumulated deficit of $<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20250630_zww6tJrOqb0a" title="Accumulated Deficit">179,317</span>
as of June 30, 2025. As a development stage issuer, the Company has not yet commenced its mining operations and accordingly does
not generate any revenue. The Company does not have sufficient cash on hand to fund planned operations as well as the construction necessary for mine development for the next twelve months. The Company is dependent on its ability to raise capital to fund future exploration and working capital
requirements. These conditions and events raise substantial doubt about
the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to these conditions and events, the Company plans to obtain additional financing. As discussed in Note 17, on July 18,
2025, the Company closed a public offering which resulted in net proceeds of approximately $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240701__20250630_z6GELYMfwbnb" title="Net proceeds from public offering">41,762</span> after deducting placement agent
fees and discounts. Subject to the conditions discussed in Note 10a, NioCorp expects to have access to up to $<span id="xdx_906_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20240701__20250630_zWFVgYIjZO9h" title="Net proceeds">46,917</span> in net proceeds
from the Standby Equity Purchase Agreement, dated January 26, 2023 (the &#8220;Yorkville Equity Facility Financing Agreement&#8221;),
between the Company and YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;),
through April 1, 2026. In addition, the Company may pursue additional sources of financing, and while it has been successful in
doing so in the past, there can be no assurance it will be able to do so in the future. Other than the potential issuance of Common
Shares under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>












<div style="text-align: left; margin-bottom: 1pt"></div>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">for additional financing as of June 30, 2025. The Company&#8217;s plans to obtain additional financing have not been finalized,
are subject to market conditions, and are not within the Company&#8217;s control and therefore cannot be deemed probable. Further,
the Company will be required to raise additional funds for the construction and commencement of operations. As a result, the Company
has concluded that management&#8217;s plans do not alleviate substantial doubt about the Company&#8217;s ability to continue as
a going concern.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAND AND BUILDINGS, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">LAND AND BUILDINGS, NET</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z9mO3FdLZrOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td id="xdx_82A_zdyMNiQljlqh" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LAND
AND BUILDINGS, NET</span></td>
</tr></table>

<p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zQQtDdjyGdN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zoch6eAZCja4" style="display: none; visibility: hidden">Schedule of properties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 22%; padding-left: 0.125in">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zRWGJDcz0Lq9" style="width: 10%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zYKalscBZKYe" style="width: 10%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zeIWh5zJTjog" style="width: 10%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zmeqIhtJr691" style="width: 10%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zETTNUimlLt5" style="width: 10%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zSKBeRBXnlcl" style="width: 10%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Buildings and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_znnUAw00thW8" style="border-bottom: Black 1pt solid; text-align: right" title="Cost">46</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zlJdixZWBrd4" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">14</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIdiDMAiD3Z9" style="border-bottom: Black 1pt solid; text-align: right" title="Net">32</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zNDkoTkTGBd" style="border-bottom: Black 1pt solid; text-align: right" title="Cost">41</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z2df0C6C6pad" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zQ8GF7ZWIEdh" style="border-bottom: Black 1pt solid; text-align: right" title="Net">30</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Land and buildings, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630_zK92fVwSsPx7" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost">853</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630_z3UD99r1P9Oh" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation">14</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630_znztPujhuZCj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net">839</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zF6KM3lSmfX6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost">848</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zshKFknmDq1a" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation">11</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zh6AQC3kMxsc" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net">837</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AB_ztvkqolwOdIl" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MINERAL PROPERTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ExtractiveIndustriesAbstract', window );"><strong>Extractive Industries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MineralIndustriesDisclosuresTextBlock', window );">MINERAL PROPERTIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--MineralIndustriesDisclosuresTextBlock_zMhn8DA0T2L6" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td id="xdx_82A_zciq2pEl0F35" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MINERAL
PROPERTIES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
properties consist of original acquisition costs and purchased mineral rights related to the Elk Creek Project.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include seven prepaid
mineral exploration option-to-purchase agreements which include a pre-determined buyout for permanent ownership of the mineral
and/or surface rights. Terms of the agreements require no further significant payments, and the Company may terminate the leases,
negotiate lease extensions, or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase
of mineral rights contain provisions whereby the landowners would retain a 2% net smelter return.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended June 30, 2025, the Company completed negotiations with landowners in Nebraska and entered into contract amendments
which extended the option periods by approximately five years for option to purchase agreements (&#8220;OTP&#8221;) covering six
parcels of land for project construction and operation which the Company does not already own. The Company recorded an exploration
expense for $<span id="xdx_904_ecustom--ExplorationExpenseForOTPExtensionPayments_pn3n3_uUSD_c20240701__20250630_zbLP80NxSF1c" title="Exploration expense for OTP extension payments">310</span> paid for OTP extension payments made and will make periodic payments totaling $<span id="xdx_904_ecustom--FutureOptionToPurchaseExtensionPaymentObligations_pn3n3_uUSD_c20240701__20250630_zIfWQXvUKYFk" title="Future Option to Purchase Extension Payment Obligations">93</span> over the extension period.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ExtractiveIndustriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ExtractiveIndustriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MineralIndustriesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for mineral industries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 930<br> -SubTopic 715<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477692/930-715-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 930<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/930/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MineralIndustriesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</a></td>
<td class="text"><p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zAI8fVjLJmDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td id="xdx_824_zpn90gdHi14g" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z0jnJnCG44Jh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_z89LVvJqnj45" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_492_20250630_zNf6tlgv6vva" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_498_20240630_z3RwxcXCvoG8" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zLUTTOdkfLlc" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 49%; text-align: left; padding-left: 0.2in">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">692</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,417</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zugEg8xtDWVc" style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.2in">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zy4RuEKI3tSk" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.2in">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zR7WW46OMhxd" style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.2in">Loan origination fees payable to related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_znXImEMCEGR7" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">1,795</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">1,843</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zLcsiORDuimf" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">CONVERTIBLE DEBT</a></td>
<td class="text"><p id="xdx_800_eus-gaap--LongTermDebtTextBlock_zX3rUZT8pD59" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_825_zspCXbtTW0l7">CONVERTIBLE
DEBT</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_pn3n3_zNGRtBilwLCd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details)">
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span id="xdx_8BE_z5k4S4bzws22" style="display: none">Schedule of convertible debt&#160;</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 1pt; padding-left: 0.2in; width: 49%">Yorkville convertible debentures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zHfWyp91JNJg" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zMPkYj0bcnsc" style="width: 10%; text-align: right">571</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.2in">April 2024 notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zGqxeyKolCB8" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zS1SGXYvTrd6" style="border-bottom: Black 1pt solid; text-align: right">7,089</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total convertible debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630_z8e6tbzXlJ85" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt"><span style="-sec-ix-hidden: xdx2ixbrl0791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630_zWouEHdpqit9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt">7,660</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yorkville
Convertible Debentures</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_980_eus-gaap--DebtInstrumentDescription_c20240701__20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_gBFDID-TLBFWD_zAy7XVAKng8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify" title="Convertible debt, description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zaCDDDZin4Kc" title="Aggregate principal amount">16,000</span> aggregate principal</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>














<div style="text-align: left; margin-bottom: 1pt"></div>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_C06_gBFDID-TLBFWD_zRVIdLKxWPUl">
amount of unsecured convertible debentures (the &#8220;Convertible Debentures&#8221;) and (ii) Warrants exercisable for up to
<span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zM6PDy84pDrk" title="Number of shares purchase">1,789,267</span> Common Shares for cash or, if at any time there is no effective registration statement registering, or no current
prospectus available for, the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price
per Common Share of approximately $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z3bacnZscts" title="Number of shares purchase">8.9422</span>, subject to adjustment to give effect to any stock dividend, stock split, reverse stock
split or similar transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining outstanding principal and accrued interest of $<span id="xdx_907_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_uUSD_c20240717__20240719__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zr0N2VqeDCo9" title="Principal and accrued interest">554</span> under the Convertible Debentures into Common Shares in exchange for
a $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_uUSD_c20240717__20240719__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z1ZrYMb6nuX6" title="Principal and accrued interest">95</span> make-whole payment. The Company recorded a gain on extinguishment of $<span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_uUSD_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zFeCZGM23xej" title="Principal and accrued interest">19</span> as part of other gains in the condensed consolidated
statements of operations and comprehensive loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
in the Convertible Debentures are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ConvertibleDebtTableTextBlock_pn3n3_zD6ZVUqC1VQ8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 1)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BE_zkBS6SAU7BFb" style="display: none">&#160;Schedule of changes
in the convertible debentures</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 67%">Balance, June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zzJXZFnRUtt7" style="width: 10%; text-align: right" title="Balance at June 30, 2024">10,561</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; text-indent: 9pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zixJkcU1OtT8" style="text-align: right" title="Accretion expense">4,489</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Principal and accrued interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zyXxmmDgr9f1" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted">(14,479</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>Balance, June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zo4bGElTgiO2" style="text-align: right" title="Balance at June 30, 2024">571</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; text-indent: -4.5pt; padding-left: 13.5pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4A4eTyUvxWa" style="text-align: right" title="Accretion expense">43</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -4.5pt; padding-left: 13.5pt">Principal and interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zW3rMxoUTXM5" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted">(614</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Balance, June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z6flPImlVDK" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, December 31, 2024"><span style="-sec-ix-hidden: xdx2ixbrl0832">-</span></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the components of interest expense associated with the Convertible Debentures:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_pn3n3_z9G1SDXr4CU1" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 2)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B7_zDo4TJHqzSpg" style="display: none">Schedule of  components of interest expense    with convertible debenture</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_49B_20240701__20250630_zf24biSHMNn1" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_49C_20230701__20240630_zaF9W5nB7fog" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Component of Interest Expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCosts_z1X0V3sA5Mlj" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; text-align: justify; padding-left: 9pt">Amortization of discount and issuance costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">42</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">4,210</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--ContractualInterest_zzFMSyEgqT45" style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Contractual interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">279</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--InterestAndDebtExpense_zBGZLdbINUjl" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">43</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">4,489</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">April
2024 Notes</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (together with Yorkville, the &#8220;April
2024 Purchasers&#8221;), $8,000 aggregate principal amount of unsecured notes (the &#8220;April 2024 Notes&#8221;), pursuant to
a securities purchase agreement, dated April 11, 2024 (the &#8220;April 2024 Purchase Agreement&#8221;), between the Company and
each of the April 2024 Purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of April 2024 Notes issued to
each April 2024 Purchaser, Warrants (the &#8220;April 2024 Warrants&#8221;) to purchase up to 615,385 Common Shares (the &#8220;April
2024 Warrants Shares&#8221;), which were equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April
2024 Purchasers divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock
split or recapitalization. The April 2024 Warrants expire on April 12, 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the April 2024 Purchase Agreement, the April 2024 Purchasers advanced an aggregate of $6,935 to the Company in consideration
of the issuance by the Company to the April 2024 Purchasers of $8,000 aggregate principal amount of the April 2024 Notes and April
2024 Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the April 2024 Notes, subject to certain exceptions, on the first day of each calendar month, beginning on June 1,
2024 (excluding August 2024) (the &#8220;Payment Date&#8221;), the Company was required to repay a portion of the outstanding
balance of all of the April 2024 Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1,400 of principal (or the
outstanding principal if less than such amount) in the aggregate among all of the outstanding Notes, plus (ii) 8.0% of the principal
amount being paid (the &#8220;Payment Premium&#8221;), and (iii) accrued and unpaid interest, if any, as of the Payment Date.
The Company was required to make payments on each Payment Date until the entire outstanding principal was repaid but did not have
an obligation to make a payment on a Payment Date if certain equity conditions were satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain limitations contained within the April 2024 Notes, holders of the April 2024 Notes were entitled to convert the principal
amount of, accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each April 2024 Note,
from time to time over their term, into a number of Common Shares equal to the quotient of the amount being converted divided
by a fixed conversion price of $2.75 per Common Share up to a maximum of 3,141,817 Common Shares (together with the April 2024
Warrant Shares, the &#8220;April 2024 Underlying Shares&#8221;). The terms of the April 2024 Notes restricted the conversion of
the April 2024 Notes by a holder if such a conversion would have caused such holder to exceed certain ownership thresholds in
the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes were the unsecured obligations of the Company and were originally scheduled to mature on December 31, 2024. The
April 2024 Notes incurred a simple interest rate obligation of 0.0% per annum (which would have increased to 18.0% per annum upon
the occurrence of an event of default).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes were also redeemable at the Company&#8217;s option at any time and from time to time over their term at a redemption
price equal to the principal amount being redeemed, plus the Payment Premium, plus accrued and unpaid interest, if any, as of
the redemption date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Notes contained events of default customary for instruments of their type (with customer grace periods, as applicable)
and provided that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to the Company, all outstanding April 2024 Notes would become due and payable immediately without further action or notice. If
any other type of event of default occurred and continued, then any holder could have declared all of its April 2024 Notes to
be due and payable immediately.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement contained customary representations, warranties, conditions and indemnification obligations by each
party. The representations, warranties and covenants contained in the April 2024 Purchase Agreement were made only for purposes
of the April 2024 Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreement and
are subject to certain important limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
April 2024 Purchase Agreement also contained certain covenants that, among other things, limited NioCorp&#8217;s ability to use
the proceeds from the April 2024 Purchase Agreement to repay related party debt or to enter into any variable rate transaction
other than with Yorkville, subject to certain exceptions, and to distribute proceeds from the April 2024 Purchase Agreement to
subsidiaries other than ECRC and 0896800 B.C. Ltd. (together with ECRC, the &#8220;Guarantors&#8221;), upon the entry by the Guarantors
into a global guaranty agreement, dated as of April 11, 2024, among the Guarantors in favor of the April 2024 Purchasers (the &#8220;Guaranty
Agreement&#8221;). Pursuant to the Guaranty Agreement, the Guarantors guaranteed the full, prompt and unconditional payment when
due (whether at maturity, by acceleration or otherwise), and the performance of all liabilities, agreements and other obligations
of NioCorp to the April 2024 Purchasers contained in the April 2024 Notes, the April 2024 Warrants, and the April 2024 Purchase
Agreement, to the extent such liabilities, agreements, and obligations are payable in cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the Company&#8217;s analysis of the criteria contained in ASC 815, the Company determined that April 2024 Warrants met the
definition of a&#160;derivative liability, as any Warrant exercise that could cause the holder to exceed 19.9% ownership of NioCorp
Common Shares would require shareholder approval. As such, the April 2024 Warrants are recognized as Warrant liabilities on the
consolidated balance sheet and were measured at their inception date fair value and are subsequently remeasured at each reporting
period with changes being recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected to value the April 2024 Notes at fair value in accordance with ASC 815-15-25. The fair value of the April
2024 Notes was estimated using a Monte Carlo simulation pricing model and the April 2024 Notes were classified as Level 3
instruments. The Company incurred transaction costs totaling $<span id="xdx_90E_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z3wBvJIVyKM" title="Transaction loss">474</span> in connection with the issuance of the April 2024 Notes and
due to the fair value election noted above, these costs were expensed at closing. Components and initial valuations
associated with the April 2024 Notes were comprised of the following amounts:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>














<div style="text-align: left; margin-bottom: 1pt"></div>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$902
    was recorded to Warrant liabilities, representing the initial fair value of the April 2024 Warrants based on the assumptions
    outlined below.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zbDHipFh34ra" title="Fair value">10,315</span> was recorded
    to the April 2024 Notes, representing the fair value based on the assumptions outlined below. The Company also recognized
    an opening transaction loss of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zNCbxaDNDpP8" title="Transaction loss">4,256</span>, representing the difference between the fair value of the April 2024 Notes, including
    the fair value of the variable conversion features embedded therein, and cash received in the transaction.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_ztDoIMw7tf11" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 3)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B2_zgRQhqKlvPDe" style="display: none">Schedule of primary inputs for the Monte Carlo model</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 12,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iE_pid_uUSDPShares_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIppadkki5u8" style="width: 12%; text-align: right" title="Closing common share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znp1SpRQvOId" style="width: 12%; text-align: right" title="Closing common share price">3.11</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA5J2X6GyOm9" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zObltUbYfQDe" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Weighted average of the equity volatility and implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z1M04SKpO8Sj" style="text-align: right" title="Equity volatility">80</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJ46VEBBxJV1" style="text-align: right" title="Equity volatility">66.0</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6PPiGHLGF8c" style="text-align: right" title="Risk-free rate">5.33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zxGN43jf9Gk4" style="text-align: right" title="Risk-free rate">5.26</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify">Implied discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwpvRc52YOE2" style="text-align: right" title="Implied discount rate">15.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA9ekh7Zmua7" style="text-align: right" title="Implied discount rate">15.0</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
September 4, 2024 and October 3, 2024, the Company entered into (i) consents and waivers (the &#8220;2024 Yorkville Consents&#8221;)
to the April 2024 Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) consents and waivers
(together with the 2024 Yorkville Consents, the &#8220;2024 Note Consents&#8221;) to the April 2024 Notes issued and sold to Lind
II pursuant to the April 2024 Purchase Agreement. The 2024 Note Consents, among other things, extended and deferred certain monthly
payments and extended the maturity of the April 2024 Notes until January 31, 2025. On January 3, 2025, the Company entered into
a consent and waiver (the &#8220;January Yorkville Consent&#8221;) to the April 2024 Notes issued and sold to Yorkville pursuant
to the April 2024 Purchase Agreement. The January Yorkville Consent, among other things, deferred the due date for the amounts
that would otherwise have been due to Yorkville on January 1, 2025 to the maturity date and extended the maturity date to February
17, 2025, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of the Company
to pay to Yorkville the remainder of the amount due on January 1, 2025. All remaining amounts due to Lind II ($176) and Yorkville
($1,000) under the April 2024 Notes were repaid on January 6, 2025, and February 7, 2025, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_pn3n3_zBtEDD9oljXi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 4)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8BC_zgV4vA9u1aHf" style="display: none">&#160;Schedule of changes in the fair value of  April 2024 Note</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 45%; text-align: justify">Fair value, April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240413__20240630_zteg0p1rgXqf" style="width: 12%; text-align: right" title="Fair value, April 12, 2024">10,315</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; text-indent: 9pt">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240413__20240630_zPSp9A4MHFK9" style="text-align: right" title="Principal payments">(1,512</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangeInFairValue_c20240413__20240630_zlXYwaK7i5ng" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(1,714</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">Balance, June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240701__20250630_zOBH3VzdRrU6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value, April 12, 2024">7,089</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; text-indent: 9pt">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240701__20250630_zhlBzptHc3q9" style="text-align: right" title="Principal payments">(7,129</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ChangeInFairValue_c20240701__20250630_z9FPLejUwaBc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">40</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Balance, June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20240701__20250630_zXM39yVtExVl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, June 30, 2024"><span style="-sec-ix-hidden: xdx2ixbrl0903">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_z2E1MfvZJxBg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 5)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B0_zkcQeDw01o1a" style="display: none">Schedule of  Black-Scholes model used in April 2024 Warrants</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 39%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVwXQqnctCC6" style="width: 10%; text-align: right" title="Closing Common Share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVLIh4QzKVre" style="width: 10%; text-align: right" title="Closing Common Share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znZY2VpG4k8j" style="text-align: right" title="Term (years)">1.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z2WyWNSC4HH1" style="text-align: right" title="Term (years)">2.78</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJvm77hI83Rg" style="text-align: right" title="Expected volatility">82.22</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzulsrUdhQbl" style="text-align: right" title="Expected volatility">66.34</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhSO1cWiFxj2" style="text-align: right" title="Risk-free rate">3.78</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zalp8dXUKLV3" style="text-align: right" title="Risk-free rate">4.57</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zlZJY0yJbIZd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 6)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B5_zMtaaIWMP1F2" style="display: none">&#160;Schedule of changes in fair value of April 2024 Warrant liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%; text-align: justify">Fair value as of April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0VrSHJRNjSj" style="width: 12%; text-align: right">902</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zktD7wgc3i07" style="border-bottom: Black 1pt solid; text-align: right">(604</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Fair value as of June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZNBMGPqUfpk" style="text-align: right">298</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhq95PR6iHj" style="border-bottom: Black 1pt solid; text-align: right">191</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqrYqwSOZr1" style="border-bottom: Black 2.5pt solid; text-align: right">489</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureOfClassBCommonStockOfECRCTextBlock', window );">CLASS B COMMON STOCK OF ECRC</a></td>
<td class="text"><p id="xdx_803_ecustom--DisclosureOfClassBCommonStockOfECRCTextBlock_zpsT69BD9saf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_824_zTTqb5EHRhY9">CLASS
B COMMON STOCK OF ECRC</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Class B common stock of ECRC have the right to exchange such shares for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All <span style="color: #353535"><span id="xdx_90A_eus-gaap--SharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockECRCMember_zeqGQqKKeRl1" title="Common stock, shares, issued"><span id="xdx_900_eus-gaap--SharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockECRCMember_ziJrYfy2vq83" title="Common stock, shares, outstanding">7,957,404</span></span> shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of June 30, 2023. </span>Of the issued
and outstanding shares of Class B common stock of ECRC, <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zmiPI88BrMGc" title="Earnout shares">4,565,808</span> shares (the &#8220;Vested Shares&#8221;)&#8201;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#8220;Ten-Year Anniversary&#8221;) and <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zo14V4C54JHa" title="Earnout shares">3,391,596</span> shares (the &#8220;Earnout Shares&#8221;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement, dated as of March 17, 2023, by and among NioCorp, ECRC, and GX Sponsor II LLC (the &#8220;Sponsor&#8221;) in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2024 and May 16, 2024, 243,692 Vested Shares and 40,000 Vested Shares, respectively, were exchanged for an equivalent
number of Common Shares, and on December 12, 2024 and December 20, 2024, 25,000 Vested Shares and 323,085 Vested Shares, respectively,
were exchanged for an equivalent number of Common Shares. These exchanges resulted in a change in the Company&#8217;s ownership
interest in ECRC and were accounted for as an equity transaction in accordance with ASC 810-10-45-23, with no gain or loss recognized.
Accordingly, the carrying amount of the noncontrolling interest was adjusted to reflect the change in the Company&#8217;s ownership
interest with a corresponding offset to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
Vested Shares and Released Earnout Shares (as defined below) may be exchanged by the holders into Common Shares at any time. All
Vested Shares and Earnout Shares must be exchanged for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares
that have been vested for a period of fewer than twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares
will be forfeited if not exchanged for Common Shares by the date that is twenty-four months after the vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Vested
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. Adjustments to the carrying value of the redeemable
noncontrolling interest associated with redemptions are recorded by reclassifying the proportionate amount of mezzanine equity
to permanent equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Earnout
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--DescriptionOfEarnOutShares_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zo6x7vKWDxlj" title="Description of earnout shares">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement. These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model. The following table discloses the
primary inputs into the Monte Carlo models:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zImukLpr4Dj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8BF_zeToFecwANTk" style="display: none">Schedule of key valuation input</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 61%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zv8FWvKtsTTd" style="width: 10%; text-align: right" title="Closing common share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z5Ca5DGKWAdj" style="width: 10%; text-align: right" title="Closing common share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgSkDwnsuG48" style="width: 10%; text-align: right" title="Closing common share price">5.03</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIBGhBtzP3hf" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zX2dmqp7K3l7" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7b3nvFHTal" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJSH0hW5Vdwi" title="Implied volatility of public warrants">75.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQ4UrZXQYY5f" title="Implied volatility of public warrants">65.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zvccAD58q9Gb" title="Implied volatility of public warrants">33.5</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6pZ9A1pxrW3" title="Risk-free rate">4.04</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zsGkAgKaGOhi" title="Risk-free rate">4.35</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIg4xAqslFe4" title="Risk-free rate">3.83</span></td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z2QdcGsXG1Rb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8BE_z3gTaXUN9u4h" style="display: none">&#160;Schedule of  fair value of the Earnout Shares liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%; text-align: justify">Fair value as of June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3bKXXuUdipe" style="width: 12%; text-align: right" title="Fair value at beginning">10,521</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZaCmd22F7Cd" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(6,704</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Fair value as of June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLWAzjKE8Wll" style="text-align: right" title="Fair value at beginning">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zV8E8YqOu4V5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">2,063</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zKDTEpC02DT9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Fair value at ending">5,880</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureOfClassBCommonStockOfECRCTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents disclosure of class b common stock of e c r c text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureOfClassBCommonStockOfECRCTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">COMMON SHARES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zILaMyMdXMU4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_82B_zkeE3wk8hrE9">COMMON
SHARES</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuances</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2025 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_983_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20241101__20241105_zoqYp4KVIdv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify" title="Description of warrants"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 5, 2024, the Company closed an underwritten public offering (the &#8220;November 2024 Registered Offering&#8221;),
pursuant to the underwriting agreement, dated November 3, 2024 (the &#8220;Underwriting Agreement&#8221;), with Maxim Group
LLC (&#8220;Maxim&#8221;), as underwriter, which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#8220;Series
A Public Warrants&#8221;) to purchase up to an additional 1,672,090 Common Shares and 836,045 Warrants (the &#8220;Series B
Public Warrants&#8221; and, together with the Series A Public Warrants, the &#8220;November 2024 Public Warrants&#8221;) to
purchase up to an additional 836,045 Common Shares. Each Common Share was sold together with one Series A Public Warrant and
one-half of one Series B Public Warrant at a combined public offering price of $1.57. The gross proceeds from the November
2024 Registered Offering were $2,501 before deducting underwriting discounts and offering expenses. The November 2024 Public
Warrants were classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair
values of the Common Shares and the November 2024 Public Warrants on the date of issuance, with $943 allocated to the fair
value of the November 2024 Public Warrants and the balance of the proceeds of $1,558 allocated to Common Shares. The Company
incurred total transaction costs related to the November 2024 Registered Offering $1,226, which were treated as share
issuance costs at closing. The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are
exercisable immediately, and will expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07
per underlying Common Share, are exercisable beginning six months and one day from the date of issuance and will expire on
November 5, 2029. In addition, pursuant to the Underwriting Agreement, the Company granted Maxim a 45-day over-allotment
option to purchase (i) 238,853 additional Common Shares and (ii) 358,280 Option Warrants (as defined below) to purchase up to
an aggregate of 358,280 Common Shares. &#8220;Option Warrant&#8221; means one Series A Public Warrant combined with one-half
of one Series B Public Warrant. On November 4, 2024, Maxim partially exercised its over-allotment option to purchase<span id="xdx_906_ecustom--DebtInstrumentIssuedPrincipalshars_c20241101__20241104__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesAMember_zPOftCEXUqIl">
79,734</span> additional Series A Public Warrants and <span id="xdx_908_ecustom--DebtInstrumentIssuedPrincipalshars_c20241101__20241104__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesBMember_za0Rmru8M2p7">39,867</span>
additional Series B Public Warrants, which amounts are included in the amounts discussed above and were issued at closing of
the November 2024 Registered Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table discloses the primary inputs for the Black-Scholes model used in valuing the November 2024 Public
Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zjABPV9bQ4mg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_zWeeoFmduHP2" style="display: none">Schedule of Black-Scholes model used in public warrants</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">November 5, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Public Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series B</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zBwMFHnTn4K8" style="width: 12%; text-align: right" title="Closing common share price">1.455</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zoffagcetK24" style="width: 12%; text-align: right" title="Closing common share price">1.455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zpK7A6WxWtri" title="Term (years)">4.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zpuiUMuYHYG7" title="Term (years)">2.0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zTjDB5MmDIhk" title="Historic equity volatility">67.43</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zZEBZ0vBYNu2" title="Historic equity volatility">67.13</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zdWGujIdLif9" title="Risk-free rate">4.14</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zyl3gVN7NXoa" title="Risk-free rate">4.20</span></td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A3_zp1wETlPCxF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_98B_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20241101__20241113_z7UJcpV3rRR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On
November 13, 2024, the Company closed a non-brokered private placement (the &#8220;November 2024 Private Offering&#8221;),
pursuant to binding subscription agreements with certain accredited investors as part of a non-brokered private placement of <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20241101__20241113__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zTmdTlGXlD6j" title="Shares issue">2,199,602</span>
units of the Company (the &#8220;November 2024 Units&#8221;). Each November 2024 Unit consisted of one Common Share, one
Warrant (a &#8220;Series A Private Warrant&#8221;) to purchase one Common Share, and one-half of one Warrant (each whole such
Warrant, a &#8220;Series B Private Warrant&#8221; and, together with the Series A Private Warrants, the &#8220;November 2024
Private Warrants&#8221;), with each Series B Private Warrant entitling the holder thereof to purchase one additional Common
Share. Each November 2024 Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company (the
&#8220;Insider Investors&#8221;) purchased November 2024 Units at a price of $1.7675 per November 2024 Unit, which price
includes $0.1975 per November 2024 Private Warrant and allowed such directors and officers to participate in the November
2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private Warrants have an exercise price of
$1.75 per underlying Common Share, are exercisable immediately, and will expire on November 13, 2026. The Series B Private
Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable beginning six months and one day from
the date of issuance and will expire on November 13, 2029. The Company recorded a non-cash expense of $34 and $110 to other
operating expenses and employee related costs, respectively, representing the excess of fair value of the November 2024 Units
over the purchase price paid by Insider Investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the Company&#8217;s analysis of the criteria contained in ASC 815, the Company determined that the November 2024
Private Warrants met the definition of a derivative liability, as any Warrant exercise that could cause the holder to exceed
19.9% ownership of NioCorp Common Shares would require shareholder approval. As such, the November 2024 Private Warrants were
recognized as warrant liabilities on the consolidated balance sheet and were measured at their issuance date fair value of
$<span id="xdx_905_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_pn3n3_c20240701__20250630_zYhr0CjxDyb" title="Fair value of non operating gain/loss">1,928</span>
and subsequently remeasured at each reporting period with changes being recorded as a non-operating gain or loss in
the consolidated statement of operations and comprehensive loss. The remaining proceeds of the November 2024 Private Offering
of $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdaOvSPTqX07" title="Remaining proceeds from private warrants">1,573</span>
were allocated to Common Shares. The Company incurred total transaction costs related to the November 2024 Private
Offering of $<span id="xdx_909_ecustom--RegisteredOffering_iI_pn3n3_c20241130_zuKlEOkD3Mp" title="Registered Offering">161</span>,
of which $<span id="xdx_90E_ecustom--PrivateOffering_iI_pn3n3_c20241130_zx99WNQVnrEd" title="Private Offering">60</span>
was allocated to the November 2024 Private Warrants and was expensed at closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables disclose the primary inputs for the Black-Scholes model used in valuing the November 2024 Private
Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zFjI4YyUrucg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 1)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_ztxowl6wpNnh" style="display: none">Schedule of Black-Scholes model used in Private warrants</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">November 13, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Private Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A Private</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series B Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z4s5mBECo834" style="width: 12%; text-align: right" title="Closing common share price">1.49</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z36KZZtnDtQb" style="width: 12%; text-align: right" title="Closing common share price">1.49</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zuirTne6rEEa" title="Term (years)">2.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z40LzAZPI1Sa" title="Term (years)">4.5</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zeBQfpiYG9U6" title="Historic equity volatility">67.26</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z5UfHhTX50H8" title="Historic equity volatility">67.52</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zvyh6atZ5Ek2" title="Risk-free rate">4.20</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zFfLVlhe2DF1" title="Risk-free rate">4.30</span></td><td style="text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

















<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Private Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series A Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series B Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z5GQTy3h4J1k" style="width: 12%; text-align: right" title="Closing common share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zNbYyKM4Cxzg" style="width: 12%; text-align: right" title="Closing common share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zP0y9BLp3Rp4" title="Term (years)">1.37</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zANaPT946vLf" title="Term (years)">4.38</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zpYES54cGwCh" title="Historic equity volatility">86.14</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zwVEs7kpPGJ" title="Historic equity volatility">74.26</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z0QW52vdv1h6" title="Risk-free rate">3.88</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zfzanleeOQ79" title="Risk-free rate">3.77</span></td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A7_zhdErE0Nej5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth a summary of the changes in the fair value of the November 2024 Private Warrants
liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_pn3n3_zgJQ0aYt8XEb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 3)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8B9_zo6Yg9D0X9J4" style="display: none">Schedule of  changes in the fair value of  Private Warrants liabilities</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">November&#160;2024&#160;Private&#160;Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%; text-align: justify">Fair value at issuance (November 13, 2024)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_z9T2mvBFugIc" style="width: 15%; text-align: right" title="Beginning balance">1,929</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; text-indent: 9pt">Fair value of Warrants exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueOfWarrantsExercised_iN_pn3n3_di_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zNzQDvx8Cbl6" style="text-align: right" title="Fair value of Warrants exercised">(338</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zYu4P0N5b986" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">2,240</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zL0EmStf7uLi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">3,831</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_982_ecustom--CommonShareDescription_c20250102__20250131_zW6NyPukfRp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify" title="Common share, description"><span style="font: 10pt Times New Roman, Times, Serif">On
January 31, 2025, the Company closed an underwritten registered direct offering (the &#8220;January 2025 Offering&#8221;), pursuant
to an underwriting agreement, dated January 29, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold
2,577,320 Common Shares, 2,577,320 Series A Warrants to purchase up to 2,577,320 Common Shares (the &#8220;January 2025 Series
A Warrants&#8221;) and 1,288,660 Series B Warrants to purchase up to an additional 1,288,660 Common Shares (the &#8220;January
2025 Series B Warrants&#8221; and, together with the January 2025 Series A Warrants, the &#8220;January 2025 Warrants&#8221;).
Each Common Share was sold together with one January 2025 Series A Warrant and one-half of one January 2025 Series B Warrant at
a combined public offering price of $1.94. The gross proceeds from the January 2025 Offering were approximately $5,000 before
deducting underwriting discounts and offering expenses. The January 2025 Warrants were classified as equity instruments, and accordingly,
the net proceeds were allocated based on the relative fair values of the Common Shares and the January 2025 Warrants on the date
of issuance, with $2,200 allocated to the fair value of the January 2025 Warrants and the balance of the proceeds of $2,800 allocated
to Common Shares. The Company incurred total transaction costs related to the January 2025 Offering of $799, which were treated
as share issuance costs at closing. The January 2025 Series A Warrants have an exercise price of $1.98 per underlying Common Share,
are exercisable immediately, and will expire on August 2, 2027. The January 2025 Series B Warrants have an exercise price of $2.05
per underlying Common Share, are exercisable immediately, and will expire on January 31, 2029.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following primary inputs were used in the Black-Scholes model for valuing the January 2025 Warrants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_pn3n3_zxW275XyTNk7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 4)">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-bottom: 1pt"><span id="xdx_8BA_zR1scRy2NAkj" style="display: none">Schedule of Black-Scholes model for warrants</span></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td><td style="text-align: right; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series B</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_ziqwvz8ifXng" style="width: 12%; text-align: right" title="Closing common share price">2.25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zF3dBkIGi8p" style="width: 12%; text-align: right" title="Closing common share price">2.25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zK3f3iIg1ugf" title="Term (years)">2.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_z0BPucdjJLQi" title="Term (years)">4.0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zVxoQiJ3o6h1" title="Historic equity volatility">73.18</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zFYt7yuL6Myg" title="Historic equity volatility">73.36</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_z0P6pIedNQqb" title="Risk-free rate">4.23</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zez53Gsgpcjh" title="Risk-free rate">4.31</span></td><td style="text-align: left">%</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_989_ecustom--CommonShareDescription_c20250402__20250421_gBFCSD-TT_z6OMmw6PC0O1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify" title="Common share, description"><span style="font: 10pt Times New Roman, Times, Serif">On
April 21, 2025, the Company closed an underwritten public offering (the &#8220;April 2025 Offering&#8221;), pursuant to an underwriting
agreement, dated April 17, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold (i) 6,628,846 Common
Shares at a public offering price of $2.60 per Common Share and (ii) 1,063,462 pre-funded Warrants (the
&#8220;April 2025 Pre-Funded Warrants&#8221;) to purchase up to an additional 1,063,462 Common Shares at a public offering price
of $2.5999. The April 2025 Pre-Funded Warrants have an exercise price of $0.0001 per underlying Common Share, are exercisable
immediately, and do not have an expiration date. On April 17, 2025, Maxim partially exercised its over-allotment option to purchase
323,504 additional Common Shares at closing. The gross proceeds from the April 2025 Offering were</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_C08_gBFCSD-TT_z7hcYMPlT25e"><span style="font: 10pt Times New Roman, Times, Serif">
approximately $20,841 before deducting underwriting discounts and offering expenses. The April 2025 Pre-Funded Warrants were
classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair values of the Common
Shares and the April 2025 Pre-Funded Warrants on the date of issuance, with $2,765 allocated to the fair value of the April 2025
Pre-Funded Warrants (based on the value of the underlying Common Shares at closing) and the balance of the proceeds of $18,076
allocated to Common Shares. The Company incurred total transaction costs related to the April 2025 Offering of $2,102, which were
treated as share issuance costs at closing.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal
Year 2024 Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 1, 2023, the Company closed a non-brokered private placement of
units of the Company (the &#8220;September 2023 Units&#8221;). A total of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcnMzixEdHO7" title="Shares issue">250,000</span> September 2023 Units were issued at a price
per September 2023 Unit of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zOXAxDpdMxdl" title="Price per unit">4.00</span>, for total gross proceeds to the Company of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zN3hRBzc4Evd" title="Gross proceeds">1,000</span>. Each September 2023 Unit consists of one
Common Share and one Warrant (&#8220;September 2023 Warrant&#8221;). Each September 2023 Warrant entitles the holder to acquire
one Common Share at a price of $<span id="xdx_900_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zi6PwD1M1g12" title="Shares price">4.60</span> at any time prior to September 1, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
September 2023 Warrants were classified as an equity instrument and accordingly, the net proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930_z8SBiYPWUEtk">962</span> were allocated based
on the relative fair values of the Common Shares and the September 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the September 2023 Warrants was $<span id="xdx_909_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxqBHTLMYjC6">254</span> and the balance of the proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z63p12ovCXbi">708</span> was allocated to the Common
Shares. The fair value of the September 2023 Warrants issued was computed using the Black Scholes pricing model using the following
assumptions: an expected life of <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTaxtwJfQoB1" title="Expected life">2.0</span> years, a risk-free interest rate of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrWoP0LjBpbf" title="Risk-free rate">4.85%</span>, an expected volatility of <span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsWPARBBqCe5" title="Expected volatility">71.63%</span>, and an expected
dividend rate of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl5CQm3kSkV6" title="Expected dividend rate">0%</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2023, the Company closed a non-brokered private placement (the &#8220;December 2023 Private Placement&#8221;) of
<span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zX1ggqAg1NV7" title="Shares issue">413,432</span> units of the Company (the &#8220;December 2023 Units&#8221;). Each December 2023 Unit consists of one Common Share and
one Warrant (&#8220;December 2023 Warrant&#8221;). Each December 2023 Warrant entitles the holder to acquire one Common Share
at a price of $<span id="xdx_909_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgixaxJwteWh" title="Shares price">3.54</span> at any time until December 22, 2025. <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zMtLNVXWum32" title="Units issue and sold">274,587</span> of the December 2023 Units were issued and sold to certain accredited
investors, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, at a price of $<span id="xdx_90F_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zhiAQd1sj7Wh" title="Shares price">3.08
</span>per December 2023 Unit, and <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z32sSJmDDfuc" title="Units issue and sold">138,845</span> of the December 2023 Units were issued and sold to certain officers and directors of the Company
(the &#8220;Insider Investors&#8221;), at a price of $<span id="xdx_90B_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zmNpsNmTa9Mb" title="Shares price">3.205</span> per December 2023 Unit. The price per December 2023 Unit paid by the
Insider Investors included $0.125 per December 2023 Warrant underlying each December 2023 Unit purchased by the Insider Investors
which allowed the Insider Investors to participate in the December 2023 Private Placement in accordance with the rules of Nasdaq.
The Company received aggregate gross proceeds from the December 2023 Private Placement of approximately $<span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zwVkOE7Lwlyh" title="Gross proceeds">1,290</span>. The Company recorded
a non-cash expense of $<span id="xdx_90D_eus-gaap--OtherCostAndExpenseOperating_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zT30JttLFDla" title="Other operating expenses">92</span> and $<span id="xdx_90E_eus-gaap--OperatingCostsAndExpenses_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlrsXDk921lk" title="Employee related costs">10</span> to other operating expense and employee related costs, respectively, representing the excess
of fair value of the December 2023 Units over the purchase price paid by Insider Investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
December 2023 Warrants were classified as an equity instrument and accordingly, the estimated net proceeds of $1,241 were allocated
based on the relative fair values of the Common Shares and the December 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the December 2023 Warrants was $<span id="xdx_908_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zD6t4LldO1ke" title="Proceeds from equity">264</span> and the balance of the proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2J60iSkglUa" title="Proceeds from equity">977</span> was allocated to the Common Shares.
The fair value of the December 2023 Warrants issued was computed using the Black Scholes pricing model using the following assumptions:
an expected life of <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpcB4YTFkPM6" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1162">2.0</span></span> years, a risk-free interest rate of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlHuOS8D7Huh" title="Risk-free rate">4.33%</span>, an expected volatility of <span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRV8tIpNHQg4" title="Expected volatility">54.8%</span>, and an expected dividend rate
of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zd1OEgMF963c" title="Expected dividend rate">0%</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2024, the Company closed a non-brokered private placement of units of
the Company (the &#8220;June 2024 Units&#8221;). A total of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20240602__20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z6NWr6ZDZHze" title="Shares issue">315,000</span> June 2024 Units were issued at a price per June 2024 Unit
of $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNH8bFvFviml" title="Price per unit">1.91</span>, for total gross proceeds to the Company of $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20240602__20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcTtONtYf6el" title="Gross proceeds">602</span>. Each June 2024 Unit consists of one Common Share and one Warrant (&#8220;June
2024 Warrant&#8221;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $<span id="xdx_907_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zz6ahyejhmwj" title="Shares price">2.20</span> at any time prior
to June 24, 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



















<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
June 2024 Warrants were classified as an equity instrument and accordingly, the net proceeds of $602 were allocated based on the
relative fair values of the Common Shares and the June 2024 Warrants on the date of issuance. The amount allocated to the fair
value of the June 2024 Warrants was $<span id="xdx_90B_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7xA8nTm5Wma" title="Proceeds from equity">161</span> and the balance of the proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztsJxj98WuKf" title="Proceeds from equity">441</span> was allocated to Common Shares. The fair value
of the June 2024 Warrants issued was computed using the Black Scholes pricing model using the following assumptions: an expected
life of <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zloz9QsTheUh" title="Expected life::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl1190">2.0</span></span> years, a risk-free interest rate of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0iRK4rJ8168" title="Risk-free rate">4.73%</span>, an expected volatility of <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4VE0pTv5uZg" title="Expected volatility">73.92%</span>, and an expected dividend rate of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRpIa9vIkxwh" title="Expected dividend rate">0%</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Equity Facility Financing Agreement Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2025, the Company has access to up to $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zZjJ1nOuBIDc" title="Net proceeds">46,917</span> in net proceeds from the Yorkville Equity Facility Financing Agreement.
The Yorkville Equity Facility Financing Agreement expires on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20240701__20250630__us-gaap--ShortTermDebtTypeAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zzPa7ixBjDG1" title="Expires date">April 1, 2026</span>. The Company issued the following Common Shares under
the Yorkville Equity Facility Financing Agreement during the periods presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_pn3n3_zC1q0aJQbfSk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - COMMON SHARES (Details 5)">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span id="xdx_8B7_zTkJ5AOPBgLi" style="display: none">Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For The Year  <br/>Ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 74%; text-align: justify">Common Shares issued</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--CommonStockSharesIssued1_pid_uShares_c20240701__20250630_zmIiFOnitAKi" style="width: 10%; text-align: right" title="Common shares issued">5,671,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--CommonStockSharesIssued1_pid_uShares_c20230701__20240630_zIjUiwkfoof5" style="width: 10%; text-align: right" title="Common shares issued">1,358,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-left: 0.125in">Gross funds received</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zLMDNYNZVIq5" style="text-align: right" title="Gross funds received">12,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230701__20240630_ztfSimaTqoz7" style="text-align: right" title="Gross funds received">3,293</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Market value of Common Shares issued<br/></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssued1_c20240701__20250630_zqnd5BCHOKPj" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued">12,941</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssued1_c20230701__20240630_z74OWN2eV6E5" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued">3,398</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on issuance<sup>(1)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240701__20250630_fKDEp_zi38DeaHmkSd" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance">589</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20230701__20240630_fKDEp_zPUTuQaIx7bh" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance">105</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_za1jIOPFlggi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 9pt"><span id="xdx_F1F_zVuOpfGNvd5k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
                                         on issuance represents a non-cash amount equal to the difference between the proceeds
                                         received and the fair value of the Common Shares issued based on the Nasdaq closing price
                                         per Common Share on the issuance date and is recorded in other operating expenses in
                                         the condensed consolidated statement of operations and comprehensive loss.</span></td></tr></table>

<p id="xdx_8A0_zobZoM34NnW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                         Options</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 19, 2024, the Company&#8217;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#8220;2017 Amended Long-Term Incentive Plan&#8221;) and the granting of incentive securities thereunder until January 19,
2027. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant Options and share
units (in the form of restricted share units and performance share units), plus dividend equivalents, to non-employee directors,
employees and certain other service providers (as described in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated
entities selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any 1-year period, or issuable to insiders at any time, in the aggregate, under all security-based
compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding Common
Shares. The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved for issuance
to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation arrangements
of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment provisions
of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred by the Company
upon the exercise of Options will also be limited, as described in the 2017 Amended Long-Term Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has power over the granting, amendment, administration, or settlement of any award.</span></p>




















<p style="margin: 0"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
transactions are summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_pn3n3_zra9zMcF5HNh" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 6)">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BE_zqRO2c9yrHPf" style="display: none">Schedule of option</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number&#160;of&#160;Options</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate Intrinsic Value</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Remaining Contractual Life</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zo5FW6VaGGV4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">1,541,500</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_z5aRZ0B4yIqc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">7.19</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_z7UbXA2DKgPg" style="text-align: right" title="Granted, in shares">1,625,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zq7dprEAdSfh" style="text-align: right" title="Granted, per share">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zcpRxLZtHLe3" style="text-align: right" title="Cancelled/expired, in shares">(7,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zcua8iTgLMMi" style="text-align: right" title="Cancelled/expired, per share">3.95</td><td style="text-align: left">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_ztAKExeJEcdj" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares">(663,200</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zrSGke4oCfW2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share">5.88</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20250630_zvDjJdNSlaTc" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">2,495,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20240701__20250630_zDTBdK33q3N6" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">4.78</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20250630_zy0nRSWy2s9i" style="text-align: right" title="Granted, in shares">945,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zGNCkDvD8c12" style="text-align: right" title="Granted, per share">1.41</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20250630_zQGeplrrOW5l" style="text-align: right" title="Cancelled/expired, in shares">(512</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zrSRhaFcDhab" style="text-align: right" title="Cancelled/expired, per share">1.40</td><td style="text-align: left">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20250630_zYC8dMDLo6l8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares">(419,988</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zMk0H7ryc6M3" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share">9.44</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2025</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20250630_z1qx7VjdF3m6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">3,020,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20240701__20250630_zXM8lFwL92I" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">3.09</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20250630_zjwmjb5VjMmi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Aggregate intrinsic value">866</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630_zECCFukmRsF4" title="Weighted average remaining contractual life">3.5</span> years</span></td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2025,<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_uRatio_c20240701__20250630_zOh81uGwmVjb" title="Outstanding stock options vested"> 99.8%</span> of the outstanding Options were fully vested. The total intrinsic value of Options exercised during the
year ended June 30, 2025 <span style="background-color: white">was nil, and as of June 30, 2025, </span>there was $<span id="xdx_90F_ecustom--UnrecognizedCompensationCosts_iI_pn3n3_c20250630_zsjCKtzAezfd" title="Unrecognized compensation costs">4</span> of unrecognized
compensation costs related to unvested share-based compensation arrangements granted. The Company recognized share-based compensation
expense of $<span id="xdx_905_eus-gaap--ShareBasedCompensation_pn3n3_c20240701__20250630_zZYNEvzDISwc" title="Share based compensation expense">789</span> and $<span id="xdx_902_eus-gaap--ShareBasedCompensation_pn3n3_dxL_c20230701__20240630_zklICT3YfVJ1" title="Share based compensation expense::XDX::2881"><span style="-sec-ix-hidden: xdx2ixbrl1277">2,779</span></span> for the years ended June 30, 2025 and 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the weighted average information and assumptions used to determine Option costs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zzeVpWSx38yc" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 7)">
<tr style="display: none; vertical-align: bottom; background-color: White; visibility: hidden">
    <td style="display: none; padding-left: 5pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_498_20240701__20250630_zr6u56GHJ8Ig" style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_49F_20230701__20240630_zFf2bGLFP1C8" style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; text-align: left; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt"><span id="xdx_8B9_znuoL3SnEEvc" style="display: none">Schedule of  weighted average  and assumptions used to option costs</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_zBGQgMDOCHP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 5pt">Fair value per option granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.84</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1.71</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_zYkx8Fz5RPLk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.44</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.25</td><td style="text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zEFumOScew94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_zWvBAbR5Epja" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Expected stock price volatility (historical basis)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63.2</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Expected option life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630_zbgAbYq8KEs5" style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230701__20240630_zJpZ9V8HBIi5" style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to January 1, 2024, the Company concluded that under ASU 718, <i>Compensation &#8211; Stock Compensation (Topic 718)</i>, Options
previously issued on December 31, 2021, May 30, 2022, and March 27, 2023, which included a C$ strike price (the &#8220;CAD Options&#8221;)
should remain equity-classified as management determined that the Options qualified for an exemption from liability classification
as the CAD Options were denominated in a currency in which a substantial portion of the Company&#8217;s equity securities traded.
Effective January 1, 2024, the Company determined that due to historically decreasing trading volume on the TSX, this exemption
no longer applied and accordingly, these CAD Options were classified as a liability based on their fair values on that date. The
Company recorded a mark-to-market gain of $147 in other operating expenses related to these CAD Option liabilities for the year
ended June 30, 2024. The CAD Options expired at various dates during the year ended June 30, 2025, with no further gains or losses
recorded in other operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Board approved a modification to Options previously issued on March 27, 2023, with dual strike prices of $6.95
and C$9.52, under which the option to exercise in C$ was removed. No other terms or conditions were amended by the Board. Based
on this amendment, the Company re-classified these Options to equity on March 28, 2024, based on their fair value on that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
transactions are summarized as follows. Weighted average exercise prices related to Canadian dollar denominated Warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.</span></p>



















<p style="margin: 0"></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zXuQE7ktV8p5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 8)">
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 3pt"><span id="xdx_8BC_zs9ZXhkeybme" style="display: none">Schedule of Weighted average exercise prices</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Warrants</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 59%; padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zUX6oVYEX5Ij" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance, Warrants">18,816,304</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zcGw2PVqxW6j" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance at Weighted Average Exercise Price">10.98</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_zFwo2AhJUFP" style="text-align: right" title="Beginning balance, Warrants">1,593,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zwNyIPwG4fFj" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price">3.33</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_zDIy7pizdv4e" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants">(1,846,560</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_z4eGOlMMpZIa" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">8.67</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20250630_zEJ1tK2Ezljd" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants">18,563,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20240701__20250630_zbSupISsCcpg" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">10.53</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20250630_ztbkMTkadHp7" style="text-align: right" title="Beginning balance, Warrants">13,553,714</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20250630_zWnCqbHapuc6" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price">2.05</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20250630_zwJk9Mhe7C3i" style="text-align: right" title="Beginning balance, Warrants">(828,235</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20250630_zql4ZlYmrsZ4" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price">1.78</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20250630_zCdUca7tTTc7" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants">(1,303,118</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20250630_zlHjkOpjYvtl" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">7.72</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2025</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20250630_zIyW2AzEkrwj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance, Warrants">29,985,922</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20240701__20250630_zYae6k9rdGej" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">7.06</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
June 30, 2025, the Company has outstanding exercisable Warrants, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXHd4VtQMRbi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 9)">
<tr style="display: none; vertical-align: bottom">
    <td colspan="2" style="display: none; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zdxmK0jNL4al" style="display: none">Schedule
of outstanding exercisable Warrants</span></span></td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; padding-left: 5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt">Expiry Date</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zd0IIseyj82k" style="width: 18%; text-align: right" title="Number of share outstanding">250,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zFL0jlRwAgLl" style="width: 18%; text-align: right" title="Exercise price">4.60</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zyh0iohcDUw9" title="Expiry date">September 1, 2025</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zVGGTMFD7f5l" style="text-align: right" title="Number of share outstanding">413,432<br/>
</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_z8JIEsyEAb05" style="text-align: right">3.54</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zc5mDRVkN54h" title="Expiry date">December 22, 2025</span><br/>
</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_ztHLrjBYm4oh" style="text-align: right" title="Number of share outstanding">315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZSn1BkZxTe" style="text-align: right">2.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zvJmN7P2xkNe" title="Expiry date">June 24, 2026</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_z3XmybalTJr1" style="text-align: right" title="Number of share outstanding">1,117,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zjsy76CW6Wqe" style="text-align: right">1.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zs8QG8ZZoO56" title="Expiry date">November 5, 2026</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zr7pf8oErYi8" style="text-align: right" title="Number of share outstanding">1,992,214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_z3syGfztzHT" style="text-align: right">1.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zwinatfKpBG2" title="Expiry date">November 13, 2026</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zzwRWNc2GOwg" style="text-align: right" title="Number of share outstanding">615,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zyAIT8J6VI26" style="text-align: right">3.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zEwwOexhFMvj" title="Expiry date">April 12, 2027</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_zypR2g71yvjd" style="text-align: right" title="Number of share outstanding">2,577,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ziEZfIN2d1R3" style="text-align: right">1.98</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ztlSJK2yX35d" title="Expiry date">August 2, 2027</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_fKDEp_zxtFEcbnmEJk" style="text-align: right" title="Number of share outstanding">15,666,626</td><td style="white-space: nowrap; text-align: left"><sup>(1)</sup>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zArioAAX3led" style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zo5kJ0xeoZ54" title="Expiry date">March 17, 2028</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zO4CBiwWlLue" style="text-align: right" title="Number of share outstanding">2,816,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zwRG5lgseGJ8" style="text-align: right">2.31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zrCEDZFZu0Ak" title="Expiry date">September 17, 2028</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_z1PzvW1Pp7xi" style="text-align: right" title="Number of share outstanding">1,288,660</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zZ0hhfGF2R86" style="text-align: right">2.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zIpDLmRqiWWi" title="Expiry date">January 31, 2029</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYCi8ZTEpbxg" style="text-align: right" title="Number of share outstanding">802,045</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zrClG3aAOJD" style="text-align: right">2.07</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYBjyllkmuij" title="Expiry date">November 5, 2029</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zJwsDpyLenOh" style="text-align: right" title="Number of share outstanding">1,067,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_ztkuA19O2YDg" style="text-align: right">2.07</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zIfQP5YVrlgl" title="Expiry date">November 13, 2029</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zHynswnRGWRl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share outstanding">1,063,462</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zEQauSMT7Hde" style="padding-bottom: 1pt; text-align: right">2.60</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">No expiry</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630_zkrTCT5o5nuk" style="border-bottom: Black 2.5pt solid; text-align: right" title="Number of share outstanding">29,985,922</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="width: 6%; text-align: center"><span id="xdx_F08_zntRSXlTmEJl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 94%; text-align: justify"><span id="xdx_F10_zs4hJ7HULwAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    11,165,324 and 4,501,302 2023 Public Warrants and 2023 Private Warrants, respectively, as defined below. Each 2023 Public
    Warrant and 2023 Private Warrant is exercisable into 1.11829212 Common Shares.</span></td></tr>
</table>
<p id="xdx_8A0_zxuVg6mqYfR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed GXII&#8217;s obligations under
the agreement (the &#8220;GXII Warrant Agreement&#8221;) governing the GXII share purchase Warrants (the &#8220;GXII Warrants&#8221;)
and each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one
Warrant to purchase 1.11829212 Common Shares (the &#8220;NioCorp Assumed Warrants&#8221;) pursuant to the GXII Warrant Agreement,
as amended by an Assignment, Assumption and Amendment Agreement, dated March 17, 2023, among the Company, GXII, Continental Stock
Transfer &amp; Trust Company, as the existing warrant agent, and Computershare Inc. and its affiliate, Computershare Trust Company,
N.A, together as the successor warrant agent (the &#8220;NioCorp Assumed Warrant Agreement&#8221;). In connection with the Closing,
NioCorp issued (a)&#160;<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_zCEP1bCoIsnc" title="Warrants traded prior to the closing">9,999,959</span>&#160;public NioCorp Assumed Warrants (the &#8220;2023 Public Warrants&#8221;) in respect of
the GXII Warrants that were publicly traded prior to the Closing and (b)&#160;<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zecvBiZgVyL3" title="Warrants traded prior to the closing">5,666,667</span>&#160;NioCorp Assumed Warrants (the &#8220;2023
Private Warrants&#8221;) to the Sponsor in respect of the GXII Warrants that it held prior to
the Closing, which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the
Closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like). No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.</span></p>

















<div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"></div>

<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2023
Public Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may elect to redeem the 2023 Public Warrants subject to certain conditions, in whole and not in part, at a price of
$0.01 per 2023 Public Warrant if (i) 30 days&#8217; prior written notice of redemption is provided to the holders, <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrants2023Member_zYaRw4xQUQ4b" title="Description of warrants">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day
period ending on the third business day prior to the date on which the Company sends the notice of redemption to the Warrant
holders</span> and (iii) there is an effective registration statement covering the Common Shares issuable upon exercise of
the 2023 Public Warrants, and a current prospectus relating thereto, available through the redemption date. Upon issuance of
a redemption notice by the Company, the Warrant holders will have until the redemption date to exercise for cash, or, at the
Company&#8217;s election, on a cashless basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2023
Private Warrants </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#8217;s option and (ii)
will not be redeemable by the Company, in either case as long as the 2023 Private Warrants are held by the initial purchasers
or their permitted transferees. Any 2023 Private Warrants that are held by someone other than the initial purchasers or their
permitted transferees are treated as 2023 Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the 2023 Private Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides
that because the 2023 Private Warrants do not meet the criteria for equity treatment thereunder, the 2023 Private Warrants must
be recorded as a liability. This liability is carried as a component of Warrant liabilities on the consolidated balance sheet
and is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted
to its current fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive
loss. The Company will reassess the classification at each balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
provided for in the <span id="xdx_905_ecustom--ExchangeOfWarrantsDescription_c20240701__20250630_zIn4ATDZqcKe" title="Exchange of warrants, description">NioCorp Assumed Warrant Agreement, through June 30, 2025, a total of 1,165,365 2023 Private Warrants were
exchanged for 2023 Public Warrants. Upon exchange, the Company recorded an additional fair value expense of $26 and transferred
the fair value of the exchanged 2023 Public Warrants from warrant liabilities to equity.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies the 2023 Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value
using a Black Scholes model with the following assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFk6Ox8K47Rd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 10)">
<tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: justify"><span id="xdx_8B1_zaWJlw2aMbae" style="display: none">Schedule of Company classifies the 2023 Private Warrants</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6oXgHKruWe6" style="width: 12%; text-align: right" title="Stock price on valuation date">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqekotrMP9Vi" style="width: 12%; text-align: right" title="Stock price on valuation date">1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znCtEfbsXH08" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zF3USWMHviO5" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zokzvdR53Fk3" title="Implied volatility of public warrants">90.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9U5QvrJpznl" title="Implied volatility of public warrants">69.0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znZARl9u7sBg" title="Risk free rate">3.70</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0eYdPxiw4Vg" title="Risk free rate">4.45</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgm51tujLyqh" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zg46M9I9XHcl" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected Warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlnRSv5Nal7c" title="Expected warrant life in years">2.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtYp_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zh9w0dnN8xu9" title="Expected warrant life in years">3.7</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the 2023 Private Warrants liability is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_z0wgS9c7yeFj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 11)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BA_zyhMrnzpsjGb" style="display: none">Schedule of change in the 2023 Private Warrants liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Valuation at June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zdA6r0J0esa4" style="width: 12%; text-align: right" title="Initial valuation, at begining">3,279</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu0bnuGHovO5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">(1,926</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Valuation at June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zEgWZiuvZZk4" style="text-align: right" title="Initial valuation, at begining">1,353</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Exchange of 2023 Private Warrants for 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ExchangeOfPrivateWarrantsForPublicWarrants_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqxGr8R6Ic6" style="text-align: right" title="Exchange of 2023 Private Warrants for 2023 Public Warrants">(482</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zZz1REyuZhG6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">1,661</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Valuation at June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zJRxXg73bqG3" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">2,532</td><td style="padding-bottom: 1pt; text-align: left"><p style="margin-top: 0; margin-bottom: 0">&#160;</p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p>

















<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contingent
Consent Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20240701__20250630__us-gaap--BusinessAcquisitionAxis__custom--LindGlobalAssetManagementThreeLLCMember_zT3rn8cfB36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify" title="Contingent consideration description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#8220;Lind Consent&#8221;), between the Company and Lind Global Asset Management III, LLC (&#8220;Lind III&#8221;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#8220;Contingent Consent Warrants&#8221;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance. Further, the number of Contingent Consent Warrants issued would be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2024, the Company&#8217;s Common Share price was below the threshold price set forth in the Lind Consent, and accordingly,
the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240915__20240917_zV7hAPsbKN5" title="Stock issued, shares">2,816,742</span> Contingent Consent Warrants to Lind III. Each Contingent Consent Warrant is exercisable for one Common
Share at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zchsq8WjatB4" title="Common share exercise price, per share">2.308</span> and may be exercised at any time prior to their expiration on September 17, 2028. The number
of Contingent Consent Warrants issued was based on $<span id="xdx_904_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_c20240915__20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zo3BmPXABiDj">5,000</span> divided by the five-day volume weighted average price of the Common
Shares on September 16, 2024. The Company valued the Contingent Consent Warrants at $2,262 based on a Black-Scholes valuation
with the following inputs:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zFUYIGd61og6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 12)">
<tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: justify"><span id="xdx_8B2_ziBCaZUdluGd" style="display: none">Schedule of  Black-Scholes valuation
</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 17,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zqGe67wsIuDc" style="width: 12%; text-align: right" title="Closing common share price">1.74</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)<br/>
</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zV77JykhDcch" title="Term (years)">4.0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_z3nF9Ec9NROe" title="Historic equity volatility">67.14</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zo3NFj88A5Rb" title="Risk-free rate">3.44</span></td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in the fair value of the Contingent Consent Warrants liability is presented below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcdwdb4ubHde" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 13)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B2_zMGqK8zMF1m3" style="display: none">Schedule of change in fair value of Warrants liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Valuation at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zfJNBPrk2jef" style="width: 12%; text-align: right" title="Valuation, at begining">2,365</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: 0.6pt; padding-left: 0.125in">Fair value of Warrants issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zydUoDS605P6" style="text-align: right" title="Fair value of Warrants issued">(2,262</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Gain on issuance of Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--GainOnIssuanceOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zCu0szBFtWX7" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on issuance of Warrants">(103</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Ending balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_982_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zD6HKT2NGPWl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation, at ending"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized a gain of $<span id="xdx_90B_ecustom--GainOnIssuanceOfWarrants_iN_pn3n3_di_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zlDiKqF7j3Sd" title="Gain on issuance of Warrants">103</span> on the issuance of the Contingent Consent Warrants. This gain was recorded as a part of other
gains in the condensed consolidated statements of operations and comprehensive loss.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS AND BALANCES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPJ2FHL92nq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_zgIbbwJJuj9f">RELATED
PARTY TRANSACTIONS AND BALANCES</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, the Company and Mark Smith, Chief Executive Officer, President, and Executive Chairman of NioCorp, entered
into a loan agreement (the &#8220;Smith Loan Agreement&#8221;), which provided for a $<span id="xdx_90B_eus-gaap--LongTermLineOfCredit_iI_c20240911__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zLYbG582apqi">2,000</span> non-revolving, multi-draw credit facility
(the &#8220;Smith Loan&#8221;). The Smith Loan had an interest rate of <span id="xdx_90B_eus-gaap--RelatedPartyTransactionRate_pid_dp_uRatio_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzY88hw4WA8b">10%</span> per annum, calculated monthly in arrears, through the
date of repayment of the Smith Loan. The Company could pre-pay the Smith Loan at any time without notice and without penalty,
but any amount of principal or interest repaid by the Company prior to the earlier of the date of expiration of the Smith Loan
Agreement, on June 30, 2025, and the occurrence of an event of default under the Smith Loan Agreement was subject to an early
payment fee of <span id="xdx_908_ecustom--LineOfCreditFacilityEstablishmentFee_pid_dp_uRatio_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zgbo0BEb6dRh">2.5%</span> of the value of any such payment. The Smith Loan was secured by all of the Company&#8217;s assets pursuant
to a general security agreement between the Company and Mr. Smith dated September 11, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
October 30, 2024, the Company borrowed a total of $<span id="xdx_908_eus-gaap--OtherBorrowings_iI_c20241030_zA7nxAOPk56i">504</span> under the Smith Loan and subsequently the Company repaid $508, representing
the balance of interest and principal outstanding under the Smith Loan, together with $<span id="xdx_90C_eus-gaap--LoanProcessingFee_c20241028__20241030__us-gaap--FairValueByLiabilityClassAxis__us-gaap--BorrowingsMember_zoY7mEff535b" title="Loan Origination fees">41</span> related to loan origination fees payable.
As of June 30, 2025, there were <span id="xdx_902_eus-gaap--InterestBearingLiabilitiesAverageAmountOutstanding_do_c20241028__20241030_zkXMFLfYLIS6">no</span> amounts outstanding under the Smith Loan.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpendituresDisclosuresTextBlock', window );">EXPLORATION EXPENDITURES</a></td>
<td class="text"><p id="xdx_808_ecustom--ExplorationExpendituresDisclosuresTextBlock_zXIYJ1SicAK5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_821_zzZjGz7dmPCc">EXPLORATION
EXPENDITURES</span></span></td>
</tr></table>



<p id="xdx_89B_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zX9TSKCbmkQ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zvupSjrUFyr7" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left; padding-left: 0.25in">Feasibility study and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDpWpOYxdWYa" style="width: 10%; text-align: right">1,112</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zXQAjsGpRnck" style="width: 10%; text-align: right">353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_z5RYCZFNd7B3" style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zBo3QRoaGHrk" style="text-align: right">503</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Drilling</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--DrillingMember_z8Fz75bOQNc4" style="text-align: right">1,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--DrillingMember_zGXhEJ9phMh1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1522">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Metallurgical</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--MetallurgicalMember_z1xqNRpM3yB9" style="text-align: right">214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zuGpdFF7VYai" style="text-align: right">1,678</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Geologists and field staff</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z2Rw7VSemRwi" style="border-bottom: Black 1pt solid; text-align: right">453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z6NoXbEcfhRf" style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.125in">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630_z6Z8yyA8jQ85" style="border-bottom: Black 2.5pt solid; text-align: right">4,135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_zQC1S18XGML7" style="border-bottom: Black 2.5pt solid; text-align: right">2,552</td><td style="text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A7_znF8oZDbQW81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpendituresDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exploration expenditures disclosures text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpendituresDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_zv9Lk049ROtf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zvmCaQTA8wGl">LEASES</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2025 and 2024, the Company had one corporate office lease with a remaining lease term of <span id="xdx_908_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20250630_zznh92DLdroj" title="Remaining lease term::XDX::P1Y7M6D"><span style="-sec-ix-hidden: xdx2ixbrl1532">1.6</span></span> years as of June 30,
2025. During the year ended June 30, 2025 and 2024, operating cash flows included cash payments of $<span id="xdx_902_eus-gaap--OperatingLeasePayments_pn3n3_c20240701__20250630_z6lXWIl8LRWf" title="Cash payment">96</span> and $<span id="xdx_908_eus-gaap--OperatingLeasePayments_pn3n3_c20230701__20240630_zBoGch2L0Pe6" title="Cash payment">71</span>, respectively related
to the measurement of lease liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zExnnFSqKCr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zXg6SXALdpah">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; padding-left: 0.25in; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_492_20240701__20250630_zPGWeoLTBkT5" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20240630_zewXOxszxypd" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td></tr>
<tr id="xdx_404_ecustom--FixedRentExpense_pn3n3_zHftaIQeq4I9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left; padding-left: 0.25in">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">94</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--VariableLeaseCost_pn3n3_zQBosEWhT6Fh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_pn3n3_z3K5NHD26yt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--SubleaseIncome_iN_pn3n3_di_zLvRh6GJA36j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(41</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(32</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_z2a6AOMPC4wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0.125in">Net lease cost &#8211; other operating expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">81</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zma3iv7OKjbk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmzjjIoA1uQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zXhhM714HkE8">The
maturity of lease liabilities is as follows at June 30, 2025:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 1in">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20250630_zjZPCCujtBoe" style="border-bottom: Black 1pt solid; text-align: center">Fiscal Year Lease Maturities</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zZGeTJaETxR4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 0.125in">2026</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">98</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_zZQruMfEojNe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">2027</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">50</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zKDlzTqqRZ6d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zTNC2qafKZ8l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less amount of payments representing interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(17</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zlaWoBnsjcab" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0in">Present value of lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">131</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zSp5xIOfexG7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(98</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_zlkSIvHbAlQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0in">Noncurrent operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">33</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A1_zkSCnuO7cMXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zJFN0X4ylJ5b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_822_z7kxkFvJFG4g">INCOME
TAXES</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zckpTasrHiFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zpkvrK11UNG7">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; padding-left: 0.125in">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zaOhNaXNsYC6" style="width: 10%; text-align: right" title="Total">(13,089</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zmNtALZ3bC8c" style="width: 10%; text-align: right" title="Total">(8,319</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zZUh6jHB9YUa" style="text-align: right" title="Total">(4,818</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zhf8OrpcQsKl" style="text-align: right" title="Total">(3,679</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zusJMQG2Neha" style="border-bottom: Black 1pt solid; text-align: right" title="Total">(75</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z5KneQklMtp1" style="border-bottom: Black 1pt solid; text-align: right" title="Total">(39</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630_zl10EWO39HOa" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total">(17,982</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630_zBsN06zrz9ne" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total">(12,037</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
</table>


<p id="xdx_8A8_zuNlDp2zO4Zk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>















<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs0kZpMl1m02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> <span style="font: 10pt Times New Roman, Times, Serif">The</span> <span style="font: 10pt Times New Roman, Times, Serif">following table is a reconciliation of income taxes at statutory rates:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zurgVWVYgAvd" style="display: none; visibility: hidden">The following table is a reconciliation of income taxes at statutory rates:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; padding-left: 5pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_497_20240701__20250630_zidKaOJrl8Of" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49C_20230701__20240630_z68QjPkVMzH3" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_pn3n3_zx3izuI5Rcf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5pt">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(17,982</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(12,037</td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_uUSD_zwDoic6nmFV8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Income tax benefit at Canadian federal rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,697</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,806</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_uUSD_zvP0cakAhIZ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Income tax benefit at Canadian provincial rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,158</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,444</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--WarrantLiability_pn3n3_zCJxMaapPwZk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,105</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(506</td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_ecustom--EarnoutSharesLiability_pn3n3_z92zcxpmYaRi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,810</td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_z2ZCuN46k7G5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">747</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_pn3n3_zOwlLdLRAK1b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AssetRetirementObligationAccretionExpense_pn3n3_zfyClHvGmsh6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,138</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_pn3n3_zwfH6057hQP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--PaymentsOfStockIssuanceCost_pn3n3_zEdnnPmkiJha" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Stock issuance costs in equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,143</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_ecustom--ConvertibleNoteValuation_iN_pn3n3_di_zNv4wMsU3fO2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Convertible note valuation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(137</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_zvwKqSBKbIv9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_zjCO45iqQXyc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,978</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,718</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_d0_c20240701__20250630_zIzZEyXYrxol" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zQQqTjLajXF1" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit::XDX::-139"><span style="-sec-ix-hidden: xdx2ixbrl1640">139</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A7_zP2YbN9YTIL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax benefit for the year ended June 30, 2024, was derived solely from our U.S. operations. The Company acquired a federal income tax payable of $<span id="xdx_90B_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_uUSD_c20230701__20240630_zWWWo1gTG0Zh">443</span> in connection with the GXII Transaction. As a result of a post-transaction loss at ECRC, a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $139 was recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for the year ended June 30, 2024. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z7CUHDhhOpI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zgyFopWNwKe6">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; padding-left: 5.4pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_491_20250630_zN8lA9GyijW4" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49F_20240630_zuYT51idjSr9" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzakr_zyQh7jWlY2v1" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.25in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">16,125</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">14,177</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zlKDJJv2arNh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,438</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,438</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z0DV4YMNxnWc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,842</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,987</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zJ7Q8LQevTic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,295</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,419</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zSHr7KpUMOH9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance/financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">635</td><td style="text-align: left">&#160;</td></tr>

    <tr id="xdx_406_ecustom--DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_iI_pn3n3_maDTAGzakr_zp1IvHCSliy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Canadian restricted interest and financing carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1661">-</span></td><td style="text-align: left">&#160;</td></tr>




<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zRloSVdyfijb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">456</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzakr_zJpu2BYmt9N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">69</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_mtDTAGzakr_maDTALNz97R_zLdETNgphVsk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,181</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTALNz97R_zIkydzzEBbQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(32,159</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(28,181</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNz97R_zBeLq83o7uj9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1676">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A0_zHiBXJPKVbYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_891_eus-gaap--SummaryOfValuationAllowanceTextBlock_zGOanMTlNbRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zou3u5NwneBd">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20240701__20250630_zOyRK6RmI4zk" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(28,181</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20230701__20240630_z1g50xPtM5e4" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(25,463</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Current year additions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20240701__20250630_zJzdRfZwDu9e" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions">(3,978</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_zAdcqG6EKmY3" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions">(2,718</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20240701__20250630_zAOd9WUQqNvl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year">(32,159</td><td style="text-align: left; padding-bottom: 2.5pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20230701__20240630_zNRPWvKWj53f" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year">(28,181</td><td style="text-align: left; padding-bottom: 2.5pt">)</td></tr>
</table>

<p id="xdx_8A1_zd9zz0TbUv3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company establishes a valuation allowance against future income tax assets if, based on available information, it is more likely
than not that all of the assets will not be realized. The valuation allowance of $<span id="xdx_90F_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_uUSD_c20250630_zs5lRSZwwgtf" title="Valuation allowance">32,159</span> at June 30, 2025, relates mainly to net
operating loss carryforwards in Canada and mineral interests due to deferred exploration expenditures in the United States, where
the utilization of such attributes is not more likely than not.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>















<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company has the following cumulative
net operating losses for Canadian and U.S. Federal income tax purposes. Canadian tax loss carryforwards will generally expire between
2028 and 2045. U.S. tax losses incurred through June 30, 2018, totaled $<span id="xdx_905_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_uUSD_c20180630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYBraYVX1Xb7" title="Tax losses incurred">981</span> and will generally expire between 2031 and 2038. As
a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for our tax years ending on and after June 30, 2019, totaling
$<span id="xdx_90B_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_uUSD_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zDaLhmgGiENg" title="Tax losses incurred">5,645</span>, have no expiration.</p>




<p id="xdx_89F_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zv2LGAJKYGFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_za9L87PEP262" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 3pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 3pt">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; padding-left: 0.125in">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--CA_zk6uhfxZdTS2" style="width: 10%; text-align: right" title="Total">53,194</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--CA_zPSxwRqTJFi6" style="width: 10%; text-align: right" title="Total">47,623</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--US_zATr1iAW8bi2" style="text-align: right" title="Total">6,627</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--US_zXhWEqe32mAg" style="text-align: right" title="Total">4,905</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--GB_z7scLv8mA3ig" style="border-bottom: Black 1pt solid; text-align: right" title="Total">112</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--GB_zeOeeNPWj2rd" style="border-bottom: Black 1pt solid; text-align: right" title="Total">39</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 3pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630_zHw7g5ZprTab" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total">59,933</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zYVKId8oc0D1" style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: right" title="Total">52,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zql5hxzXrpOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has a Canadian capital loss carryforward of $<span id="xdx_906_ecustom--CapitalLossCaryforward_iI_pn3n3_c20250630__srt--CurrencyAxis__currency--CAD_ziCF7dAU8hN5" title="Capital loss carryforward">3,378</span> as of June 30, 2025, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $<span id="xdx_90B_ecustom--CapitalLossCaryforward_iI_pn3n3_c20250630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zQhrk4qe5Xac" title="Net operating loss carryforwards">8,742</span> as of June 30, 2025 which
generally expire between 2031 and 2045.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
June 30, 2025 and 2024, we had no undistributed earnings of foreign subsidiaries that would be subject to income tax upon distribution
to Canada from a foreign subsidiary. As such, as of June 30, 2025 and 2024, we did not provide for deferred taxes on any such
earnings of our foreign subsidiaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no unrecognized tax benefits as of June 30, 2025 or 2024. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction,
the United Kingdom, and Canada. Certain years remain subject to examination but there are currently no ongoing exams in any taxing
jurisdictions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 4, 2025, the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;) was enacted in the U.S., which includes a broad range of tax
reform provisions affecting businesses. The OBBBA includes numerous changes to existing tax law including extending or making
permanent certain business and international tax measures initially established under the 2017 Tax Cuts and Jobs Act, which were
set to expire. The OBBBA contains several changes to corporate taxation including modifications to capitalization of research
and development expenses, modifications to deductions for interest expense, and accelerated depreciation on certain asset additions.
As the legislation was signed into law after June 30, 2025, our operating results for the year ended June 30, 2025, do not include
any adjustments related to the OBBBA, and the Company does not expect a material impact to our financial statements due to the
enactment of the OBBBA.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zzzplemwOC37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15.</span></td><td id="xdx_826_zhBGYmXjvBT9"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span><span>Fair
Value Measurements</span></span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures the fair value of financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes
a framework for measuring fair value, and expands disclosures about fair value measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.<span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2025, and 2024, respectively, and indicate the fair value hierarchy of the valuation techniques the</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>















<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Company utilized
to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted
prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the financial
instrument and include situations where there is little, if any, market activity for the instrument.</span></p>



<p id="xdx_89E_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zkm0AZ72Wp0a" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zL3QqlX7ONIh" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2025</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630_z6mIN1EWqmQa" style="width: 10%; text-align: right" title="Cash and cash equivalents">25,554</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsaCEdpTEjp1" style="width: 10%; text-align: right">25,554</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZDR8Sk0mZQ" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1739">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLghj8V3Bfna" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630_zLzNssnTQApk" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities">3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKreZNu3ZKC2" style="border-bottom: Black 1pt solid; text-align: right">3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zubMPzpYQb77" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1744">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpyNxUhpo7i5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1745">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630_ziVisi7fFnKb" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Assets">25,557</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvAigtjc9I83" style="border-bottom: Black 2.5pt solid; text-align: right">25,557</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8eRQMAA8YPh" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1749">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCEpplm4a34h" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zV94tD9akeCb" style="text-align: right" title="Earnout Shares liability">5,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcKELJSdao4i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWAkDZGJHWae" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4VRaHm5Qtxk" style="text-align: right">5,880</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630_zSK4M2AspqKh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities">6,852</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHb62pLcaZEf" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1w8tlKZxfy4" style="border-bottom: Black 1pt solid; text-align: right">6,852</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z024lwG5fGel" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1760">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zHWx22eO4NRe" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Liabilities">12,732</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhR3Vs3vI85c" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1763">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgro6MDL5Kx6" style="border-bottom: Black 2.5pt solid; text-align: right">6,852</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuIygyQ43me9" style="border-bottom: Black 2.5pt solid; text-align: right">5,880</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630_z0erBTk3XG0l" style="width: 10%; text-align: right" title="Cash and cash equivalents">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyq88zENMvXk" style="width: 10%; text-align: right">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zX0voHd7R405" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1769">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrlcDnRt3Nak" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630_zU9m5yLbd0g7" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHKFXeuLB164" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9fdwIVI7mWj" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1774">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjzGmyfXylgh" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1775">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630_zegq5dSkYIt6" style="border-bottom: Black 2.5pt solid; text-align: right">2,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpUVAXDALwEd" style="border-bottom: Black 2.5pt solid; text-align: right">2,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z17y5tejqWmb" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1778">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCxLR7QMzobh" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--NotesPayable_iIP3us-gaap--AssetsFairValueDisclosure_pn3n3_c20240630_zwANORIDx3hk" style="text-align: right" title="April 2024 notes">7,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4mbqnjCKIYb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9oC2C8Mx7Qj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1783">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zi4fNOdDNtR1" style="text-align: right">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zxywbEgGaDUl" style="text-align: right" title="Earnout Shares liability">3,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6eGOd2iVj0d" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjSYPtYwgb31" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1788">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYkSQnVEP7Lc" style="text-align: right">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630_zmbj6UEHzZi2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities">4,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdQBpQoPOhkk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNJEi1Plqqh9" style="border-bottom: Black 1pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkV1QiBPMW1g" style="border-bottom: Black 1pt solid; text-align: right">2,365</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zsZt5ooqQSmc" style="border-bottom: Black 2.5pt solid; text-align: right">14,922</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQkW61lbASyb" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgXxIQyksy0b" style="border-bottom: Black 2.5pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zM5MdBbgAZZg" style="border-bottom: Black 2.5pt solid; text-align: right">13,271</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zDO6FIHXgOi8" style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_zSwSSJGcaVTk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_820_zXNMrwBcN7z1">SEGMENT
INFORMATION</span></span></td>
</tr></table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has&#160;one&#160;reportable segment: the United States. The United States segment conducts exploration, development,
and care and maintenance activities at the Elk Creek Project. This segment holds substantially all of the Company&#8217;s non-current assets and does not presently report any revenues from operations.
Through this segment, the Company seeks to position the Elk Creek Project as a development opportunity in the strategic minerals
sector. The Company&#8217;s chief operating decision maker is the Chief Executive Officer (&#8220;CODM&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
information and annual operating plans and forecasts are prepared and reviewed by the CODM at a consolidated level. The CODM
assesses performance for the single operating segment and decides how to better allocate resources based on total operating
expenses, net loss, changes in cash and cash equivalents, and cash and cash-equivalent balances that are reported on the
Consolidated Statement of Operations and Consolidated Statement of Cash Flows. The Company&#8217;s objective in making
resource allocation decisions is to optimize the Company&#8217;s ability to develop and operate the Elk Creek Project. In
addition, the CODM reviews the segment&#8217;s assets based on total assets reported on the consolidated balance sheet, and
the accounting policies of our single operating segment are the same as those described in the Summary of Significant
Accounting Policies herein. For additional reportable single operating segment level financial information, see the
Consolidated Financial Statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zd9d4dEfE1T6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_82B_z3cj66coW1fl">SUBSEQUENT
EVENTS</span></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
July 2025 Offering </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--SubsequentEventDescription_dxL_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTWVuOwpA7Ri" title="Subsequent event description::XDX::Maxim%20acted%20as%20sole%20placement%20agent%20for%20the%20July%202025%20Offering.%20The%20Company%20intends%20to%20use%20the%20net%20proceeds%20from%20the%20July%202025%20Offering%20for%20working%20capital%20and%20general%20corporate%20purposes%2C%20including%20to%20advance%20its%20efforts%20to%20launch%20construction%20of%20the%20Elk%20Creek%20Project%20and%20move%20it%20to%20commercial%20operation."><span style="-sec-ix-hidden: xdx2ixbrl1804">On
July 18, 2025, the Company closed a public offering (the &#8220;July 2025 Offering&#8221;), pursuant to which the Company issued
and sold 13,850,000 Common Shares at a public offering price of $3.25 per Common Share, for net proceeds of approximately $41,762
after deducting placement agent fees discounts and prior to other offering expenses.</span></span> Maxim</span></p>



















<p style="margin: 0"></p>

<p style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">acted as sole placement agent for the
July 2025 Offering. The Company intends to use the net proceeds from the July 2025 Offering for working capital and general corporate
purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial operation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Common Share Issuances</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the period from July 1, 2025 through September 11, 2025, the Company issued <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20250826__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJRjaNoboB08" title="Issuance of shares">5,000,312</span> Common Shares through the exercise
of Warrants and Options by their holders and received cash totaling approximately $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn3n3_uUSD_c20250701__20250826__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdKgm3eWted7" title="Cash received">10,401</span>. In addition, <span id="xdx_906_ecustom--ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_pid_uShares_c20250701__20250826__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zImuPP2CRRl8" title="Exchnage for shares">415,581</span> Vested Shares were exchanged
for an equivalent number of Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases
of Land </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2025, ECRC closed on its option to purchase three parcels of land in Johnson County, Nebraska (the &#8220;Property&#8221;),
pursuant to the terms of the Option to Purchase, dated as of December 4, 2009, as amended, and the Option to Purchase, dated December
4, 2014, as amended, each between Roger and Nancy Woltemath (the &#8220;Owners&#8221;) and ECRC (together, the &#8220;Option Agreements&#8221;).
Pursuant to the terms of the Option Agreements, the Owners sold, transferred, conveyed and assigned to ECRC all of their rights,
privileges, title and interest in and to the surface rights with respect to one of the parcels (consisting of the property known
as Woltemath80S) and to the surface rights and associated mineral rights with respect to the other two parcels (consisting of
approximately 1.66 acres of the property known as Woltemath002).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Option Agreements provided for a purchase price calculated based on the appraised value per acre of the parcels of land. The aggregate
purchase price was approximately $<span id="xdx_906_eus-gaap--PaymentsToAcquireLand_pn3n3_uUSD_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--PurchasesofLandMember_z0cIGTyQVEac" title="Agregate purchase price">2,700</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>DoD
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0; margin-left: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 4, 2025, ECRC entered into a Project Sub-Agreement (the &#8220;DoD Agreement&#8221;) with Advanced Technology International
(&#8220;ATI&#8221;), an entity acting on behalf of the Defense Industrial Base Consortium under the authority of the U.S. Department
of Defense (&#8220;DoD&#8221;). Subject to the terms and conditions of the DoD Agreement, ECRC is entitled to receive up to an
aggregate of approximately $<span id="xdx_90D_eus-gaap--ProceedsFromCustomersForProgressPayments_pn3n3_dm_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--DoDAgreementMember_zFB10Q4DDlc7" title="Reimbursement Payments">10.0</span> million of reimbursement payments from the DoD upon the achievement of certain project milestones
related to feasibility study-level engineering and additional reserve drilling, as well as preparing updated cost estimates, for
the Elk Creek Project.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DevelopmentStageIssuerPolicyTextBlock', window );">Development Stage Issuer</a></td>
<td class="text"><p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zc8c0al9Ze3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td><td id="xdx_868_z3ZweeecMiT3" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
                                         Stage Issuer</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#8220;S-K 1300&#8221;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#8217;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#8217;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zwFw94J5Xv96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td><td id="xdx_86E_zp7AyUpFwzql" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
                                         and Cash Equivalents</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#8220;U.S.&#8221;) are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) up
to C$100. At June 30, 2025, the Company had $24,711 and $22 in excess of the FDIC and CDIC insured limits, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zVmA1NL8OM4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td><td id="xdx_86E_z1sTjiimVs8g" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
                                         Currency Translation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Functional
and reporting currency</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
included in the financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#8220;the functional currency&#8221;). The functional currency for all entities is
the U.S. Dollar except for NioCorp Technologies Limited, which is measured in British Pounds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reporting currency for these consolidated financial statements is U.S. dollars.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transactions
in foreign currency</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Translation
to reporting currency</i>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Translation
gains and losses from the application of the U.S. dollar as the reporting currency, if any, are included as part of cumulative
currency translation adjustment, which is reported as a component of shareholders&#8217; equity under accumulated other comprehensive
loss.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_MineralPropertiesPolicyTextBlock', window );">Mineral Properties</a></td>
<td class="text"><p id="xdx_842_ecustom--MineralPropertiesPolicyTextBlock_z7h7egP2AxVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td><td id="xdx_864_z9oOUv8PHS8h" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
                                         Properties</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of common shares, no par value, of the Company (&#8220;Common Shares&#8221;) issued
as consideration. Properties acquired under option agreements, whereby payments are made at the sole discretion of the Company,
are capitalized as mineral property acquisition costs at such time as the payments are made. Exploration costs are expensed as
incurred. When it is determined that a mining deposit can be economically and legally extracted or produced based on established
proven and probable reserves under S-K 1300, and the Company&#8217;s board of directors (the &#8220;Board&#8221;) has approved
the commencement of formal development activities, development costs related to such reserves and incurred after such board approval
will be considered for capitalization. The establishment of proven and probable reserves is based on</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>











<div style="text-align: left; margin-bottom: 1pt"></div>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">results of feasibility studies,
which indicate whether a property is economically feasible. Upon commencement of commercial production, capitalized costs will
be amortized over their estimated useful lives or units of production, whichever is a more reliable measure. Capitalized amounts
relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are written off.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#8217;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was <span id="xdx_904_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20250630_zBylhVoz8aX9" title="Impairment to mineral properties"><span id="xdx_90B_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20240630_zbzLtOSaCkP" title="Impairment to mineral properties">no</span></span> impairment recorded to mineral properties as of
June 30, 2025 or 2024, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long Lived Assets</a></td>
<td class="text"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zwVv4PIxVTJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td><td id="xdx_869_zmooaBqSCjB1" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long
                                         Lived Assets</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was <span id="xdx_90D_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20240701__20250630_zFeFBsrmvcn5" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20230701__20240630_zHjdsI6AnJMk" title="Impairment of long-lived assets">no</span></span> impairment recorded to long-lived assets as of June 30, 2025 or 2024, respectively.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zdOOBvw5BJ7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td><td id="xdx_86C_zJ9OdHVnd3Wc" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Accounting Standards Codification (&#8220;ASC&#8221;) 842, <i>Leases</i>, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#8220;ROU&#8221;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock', window );">Convertible Debt Carried at Fair Value</a></td>
<td class="text"><p id="xdx_844_ecustom--ConvertibleDebtCarriedatFairValuePolicyTextBlock_z0JYCGUNEaFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td><td id="xdx_864_zCnFst6mSn9c" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
                                         Debt Carried at Fair Value</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to the Company&#8217;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in Note
8), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, <i>Derivatives and Hedging
</i>(&#8220;ASC 815&#8221;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument to account
for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter using a
Monte Carlo simulation methodology which</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>












<div style="text-align: left; margin-bottom: 1pt"></div>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">incorporates multiple conversion scenarios. All changes in fair value subsequent to the
initial recording, excluding the impact of the change in fair value related to the Company&#8217;s own credit risk, are recorded
as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#8217;s own credit risk, if any, are recorded through other comprehensive
loss.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_WarrantsPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><p id="xdx_848_ecustom--WarrantsPolicyTextBlock_zh9de7G8fcsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</span></td><td id="xdx_86A_zzBqJ858BRCf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">We apply relevant accounting
guidance for warrants to purchase our Common Shares (&#8220;Warrants&#8221;) based on the nature of the relationship with the counterparty.
The Company has made an accounting policy election that the &#8220;greater of&#8221; Share-Price Input to the Black-Scholes Value
would not preclude equity classification. The Company has not had any historical transactions that include the &#8220;greater of&#8221;
Share-Price Input feature, and this is a new accounting policy election as of the current fiscal year. For Warrants issued to investors
or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC 480, <i>Distinguishing Liabilities
from Equity</i>, and ASC 815, to assist in the determination of whether the Warrants should be classified as liabilities or equity.
The fair value of Warrants is estimated using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features
embedded in the Warrant. Inputs under both models include inputs such as NioCorp&#8217;s Common Share price, the risk-free interest
rate, the expected term, the volatility, and the dividend rate. Warrants that are determined to require liability classifications
are measured at fair value upon issuance and are subsequently remeasured to their then fair value at each subsequent reporting
period with changes in fair value recorded in current earnings. Warrants that are determined to require equity classifications
measured at fair value upon issuance and are not subsequently remeasured unless they are required to be reclassified.</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesPolicyTextBlock', window );">Earnout Shares</a></td>
<td class="text"><p id="xdx_846_ecustom--EarnoutSharesPolicyTextBlock_zC8dRMo8Jo7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td id="xdx_865_zJVi2dEuUeTg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
                                         Shares</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#8217;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#8217;s publicly traded Warrants,
the dividend rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective
and require significant judgment.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zGR01jbEI8O5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</span></td><td id="xdx_86B_zmpv90UlaI9g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
                                         Instruments</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, receivables, equity securities, and accounts payable
and accrued liabilities. It is management&#8217;s opinion that the Company is not exposed to significant interest, currency or
credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying value unless
otherwise noted.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zqWAzZAReQ88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</span></td><td id="xdx_867_zbgAPKWIgidd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentration
                                         of Credit Risk</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Columbus, Ohio. As part
of its cash management process, the Company regularly monitors the relative credit standing of these institutions.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsPolicy', window );">Asset Retirement Obligation</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z0YgSoWoFSXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</span></td><td id="xdx_86D_zs7kZ0bx4kje" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset
                                         Retirement Obligation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20250630_znG4zUDnMSV4" title="Accrued Exploration Stage Obligations">48</span> and $<span id="xdx_904_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zD2FSDHEwQKg" title="Accrued Exploration Stage Obligations">48</span> for estimated obligations as
of June 30, 2025 and June 30, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zPJ5O1LrTg49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</span></td><td id="xdx_860_zbbirz5EKLSl" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
                                         Taxes</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, <i>&#8220;Income Taxes &#8211; Recognition.&#8221;
</i>Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#8220;more likely than not&#8221; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#8220;Income Taxes &#8211; Disclosure,&#8221;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2025 and 2024, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RedeemableNoncontrollingInterestPolicyTextBlock', window );">Redeemable Noncontrolling Interest</a></td>
<td class="text"><p id="xdx_841_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zb2890q1vRkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</span></td><td id="xdx_86D_z7Ncwdb9fCf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
                                         Noncontrolling Interest</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#8217;s control and is reported in the mezzanine section between total liabilities
and shareholders&#8217; deficit, as temporary equity in the Company&#8217;s consolidated balance sheets. The Company&#8217;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Per Share Disclosure</a></td>
<td class="text"><p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zMwRJISFnjl8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</span></td><td id="xdx_86C_zjipvAuSYPgf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
                                         and Diluted Per Share Disclosure</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 9), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWyAFxndIbw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B8_zwlyT1end3Ah">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify; background-color: white">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center; background-color: white">For the year ended June 30,</td><td style="background-color: white">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: justify; padding-left: 9pt">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_z4F4MXQKGrka" style="width: 10%; text-align: right" title="Net loss">(17,982</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zajpSponzKIc" style="width: 10%; text-align: right" title="Net loss">(11,898</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Adjust: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20240701__20250630_zutq6Nkfe109" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">577</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zGc0Bl8WsSmh" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">458</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20250630_zkkxBtYRUH46" style="text-align: right" title="Net loss available to participating securities">(17,405</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zjlQucI0DBW3" style="text-align: right" title="Net loss available to participating securities">(11,440</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20240701__20250630_zx6g14PGNxV4" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">1,102</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20230701__20240630_zJhpLAyk3YXc" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">967</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 9pt">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20250630_zfcKqCWrkVkf" title="Net loss attributed to common shareholders - basic"><span id="xdx_90A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20240701__20250630_zd5eiOeCJ9Ne" title="Net loss attributed to common shareholders - diluted">(16,303</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zIPgAaR0Hkyi" title="Net loss attributed to common shareholders - basic"><span id="xdx_900_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20230701__20240630_z1pwClWsysZi" title="Net loss attributed to common shareholders - diluted">(10,473</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zfo0ZGEwfa71" title="Weighted average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zwkZKVhJ7xgd" title="Weighted average shares outstanding - diluted">45,072,895</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_z6kzP7KhBMEa" title="Weighted average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zJeMmTyr4gFa" title="Weighted average shares outstanding - diluted">34,320,024</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 9pt">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zXjqFfBFYpM1" title="Loss per Common Share outstanding - basic"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zrCFblI8gIGi" title="Loss per Common Share outstanding - diluted">(0.36</span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_zGSJbiYudYea" title="Loss per Common Share outstanding - basic"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zeZdYic62vO1" title="Loss per Common Share outstanding - diluted">(0.31</span></span></td><td style="text-align: left">)</td></tr>
</table>

<p id="xdx_8AF_zceKkRzdWzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The
following shares underlying options to purchase Common Shares (&#8220;Options&#8221;), Warrants, and outstanding convertible debt
were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation
for the periods indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zfnV3917EYcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span id="xdx_8B2_zIFTJ9XdJ09f" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.6in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup>(1)(2)</sup>:&#160;</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 66%; text-indent: 9pt">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20250630_fKDEpKDIp_zvHEtVOjsaJ6" style="width: 10%; text-align: right" title="Options">3,020,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zSVC9VR5dap3" style="width: 10%; text-align: right" title="Options">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: 9pt">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20250630_fKDEpKDIp_zfxzBVezte1f" style="text-align: right" title="Warrants">31,839,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_zO8ohOo3qU49" style="text-align: right" title="Warrants">18,563,561</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_d0_uShares_c20240701__20250630_fKDEpKDIp_zN7H7U4yxiug" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zIm3kG74jHG1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,849,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt">Total potentially dilutive securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DilutiveSecurities_c20240701__20250630_fKDEpKDIp_zqI5JkNsZ54j" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities">34,859,152</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_z68NfvevSWJ4" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities">23,908,061</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>














<div style="text-align: left; margin-bottom: 1pt"></div>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F02_zcC7sWS9kIAl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; padding-bottom: 4pt; text-align: justify"><span id="xdx_F15_zdMfNW8gjA06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F0E_zZPpBNjaaE8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span id="xdx_F18_zw2zGyryrBC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</span></td></tr>
</table>

<p id="xdx_8A4_zIQT9463Qr8f" style="margin-top: 0; margin-bottom: 0"></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share Based Compensation</a></td>
<td class="text"><p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zjNeX9w6d9k" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)</span></td><td id="xdx_86C_zf3D18XBiwh7" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                         Based Compensation</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company grants Options to directors, officers, employees, and business advisors. Option terms and vesting conditions are at the
discretion of the Board. The Option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
on the day preceding the date of the grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates the fair value of Options using the Black-Scholes option pricing model. The Company recognizes forfeitures as
they occur.&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znH5E6LKdBDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)</span></td><td id="xdx_86F_zYUklDvIs6re" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
                                         Accounting Standards</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Recently
Adopted Accounting Standards</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
fiscal year 2025, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2023-07,&#160;<i>Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures</i>. Management has evaluated the Company&#8217;s operations and concluded it has&#160;one&#160;reportable
operating segment which will now require expanded disclosure. Adoption was made retroactively with segment disclosure included
for the fiscal years ended June 30, 2025 and 2024. This standard has not changed the processing, recording, or presentation of
financial data, other than providing additional disclosure regarding management oversight for the Company&#8217;s single operating
segment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Issued
and Not Effective<br/>
</span>In December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>,
which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of
rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#8217;s annual
periods beginning July 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively.
The Company is currently evaluating the ASU to determine its impact on the Company&#8217;s disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#8217;s consolidated financial statements upon adoption.&#160;</span></p>



<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents convertible debt carriedat fair value policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DevelopmentStageIssuerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents development stage issuer policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DevelopmentStageIssuerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout shares policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_MineralPropertiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents mineral properties policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_MineralPropertiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RedeemableNoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents redeemable noncontrolling interest policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RedeemableNoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_WarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents warrants policy text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_WarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/410-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PREPARATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated.</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zGuk1eMn6nVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B9_zqTB7GQb4nxg">These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 87%; border-collapse: collapse; margin-right: auto">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction
    of incorporation</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
    at June 30,</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0896800
    BC Ltd. (&#8220;0896800&#8221;)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zcexJQlne0Xe" title="Jurisdiction of incorporation">British
    Columbia, Canada</span></span></td>
    <td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_znYdXXHzlZTe" style="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td id="xdx_989_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z67aElvHa7u2" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elk
    Creek Resources Corp. (&#8220;ECRC&#8221;) <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zsaDnqiKPhAi" title="Jurisdiction of incorporation">Delaware,
    USA</span></span></td>
    <td id="xdx_988_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zHKTM3jTQTR2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.42%</span></td>
    <td id="xdx_98F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zMnPBX90Jxp8" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.7%</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NioCorp
    Technologies Limited</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zAzzIeOpxC7b" title="Jurisdiction of incorporation">United
    Kingdom</span></span></td>
    <td id="xdx_983_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zMpkBj4CXK3d" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td>
    <td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zraq8mZZDNY1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_zsFFthMyjs42" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5in"><span id="xdx_F13_zump1IRpSDG9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 and 4,282,116 Vested Shares
                                         and 3,391,596 and 3,391,596 Earnout Shares (each as defined below) held by third parties,
                                         and outstanding as of June 30, 2025 and 2024, respectively.</span></td></tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4M<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders:</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWyAFxndIbw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. <span id="xdx_8B8_zwlyT1end3Ah">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share
attributable to common shareholders:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: justify; background-color: white">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center; background-color: white">For the year ended June 30,</td><td style="background-color: white">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 74%; text-align: justify; padding-left: 9pt">Net loss</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_z4F4MXQKGrka" style="width: 10%; text-align: right" title="Net loss">(17,982</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zajpSponzKIc" style="width: 10%; text-align: right" title="Net loss">(11,898</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Adjust: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20240701__20250630_zutq6Nkfe109" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">577</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zGc0Bl8WsSmh" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest">458</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Net loss available to participating securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20250630_zkkxBtYRUH46" style="text-align: right" title="Net loss available to participating securities">(17,405</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zjlQucI0DBW3" style="text-align: right" title="Net loss available to participating securities">(11,440</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Net loss attributable to Vested Shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20240701__20250630_zx6g14PGNxV4" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">1,102</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20230701__20240630_zJhpLAyk3YXc" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares">967</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 9pt">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_905_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20250630_zfcKqCWrkVkf" title="Net loss attributed to common shareholders - basic"><span id="xdx_90A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20240701__20250630_zd5eiOeCJ9Ne" title="Net loss attributed to common shareholders - diluted">(16,303</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span id="xdx_908_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zIPgAaR0Hkyi" title="Net loss attributed to common shareholders - basic"><span id="xdx_900_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20230701__20240630_z1pwClWsysZi" title="Net loss attributed to common shareholders - diluted">(10,473</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 9pt">Weighted average shares outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zfo0ZGEwfa71" title="Weighted average shares outstanding - basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zwkZKVhJ7xgd" title="Weighted average shares outstanding - diluted">45,072,895</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_z6kzP7KhBMEa" title="Weighted average shares outstanding - basic"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zJeMmTyr4gFa" title="Weighted average shares outstanding - diluted">34,320,024</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 9pt">Loss per Common Share outstanding &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zXjqFfBFYpM1" title="Loss per Common Share outstanding - basic"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zrCFblI8gIGi" title="Loss per Common Share outstanding - diluted">(0.36</span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_zGSJbiYudYea" title="Loss per Common Share outstanding - basic"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zeZdYic62vO1" title="Loss per Common Share outstanding - diluted">(0.31</span></span></td><td style="text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of excluded from the dilutive securities</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zfnV3917EYcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span id="xdx_8B2_zIFTJ9XdJ09f" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.6in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded potentially dilutive securities <sup>(1)(2)</sup>:&#160;</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 66%; text-indent: 9pt">Options</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20250630_fKDEpKDIp_zvHEtVOjsaJ6" style="width: 10%; text-align: right" title="Options">3,020,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"></td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zSVC9VR5dap3" style="width: 10%; text-align: right" title="Options">2,495,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-indent: 9pt">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20250630_fKDEpKDIp_zfxzBVezte1f" style="text-align: right" title="Warrants">31,839,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_zO8ohOo3qU49" style="text-align: right" title="Warrants">18,563,561</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Convertible debt</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_d0_uShares_c20240701__20250630_fKDEpKDIp_zN7H7U4yxiug" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zIm3kG74jHG1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,849,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 2.5pt">Total potentially dilutive securities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--DilutiveSecurities_c20240701__20250630_fKDEpKDIp_zqI5JkNsZ54j" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities">34,859,152</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_z68NfvevSWJ4" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities">23,908,061</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>














<div style="text-align: left; margin-bottom: 1pt"></div>




<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F02_zcC7sWS9kIAl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; padding-bottom: 4pt; text-align: justify"><span id="xdx_F15_zdMfNW8gjA06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</span></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span id="xdx_F0E_zZPpBNjaaE8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span id="xdx_F18_zw2zGyryrBC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</span></td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LAND AND BUILDINGS, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of properties</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zQQtDdjyGdN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8B2_zoch6eAZCja4" style="display: none; visibility: hidden">Schedule of properties</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="22" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Cost</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated Depreciation</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Net</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 22%; padding-left: 0.125in">Land</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zRWGJDcz0Lq9" style="width: 10%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zYKalscBZKYe" style="width: 10%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zeIWh5zJTjog" style="width: 10%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zmeqIhtJr691" style="width: 10%; text-align: right" title="Cost">807</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zETTNUimlLt5" style="width: 10%; text-align: right" title="Accumulated depreciation">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zSKBeRBXnlcl" style="width: 10%; text-align: right" title="Net">807</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Buildings and other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_znnUAw00thW8" style="border-bottom: Black 1pt solid; text-align: right" title="Cost">46</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zlJdixZWBrd4" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">14</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIdiDMAiD3Z9" style="border-bottom: Black 1pt solid; text-align: right" title="Net">32</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zNDkoTkTGBd" style="border-bottom: Black 1pt solid; text-align: right" title="Cost">41</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z2df0C6C6pad" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zQ8GF7ZWIEdh" style="border-bottom: Black 1pt solid; text-align: right" title="Net">30</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Land and buildings, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630_zK92fVwSsPx7" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost">853</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630_z3UD99r1P9Oh" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation">14</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630_znztPujhuZCj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net">839</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zF6KM3lSmfX6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost">848</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zshKFknmDq1a" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation">11</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zh6AQC3kMxsc" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net">837</td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of account payable and accrued liabilities</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z0jnJnCG44Jh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_8BE_z89LVvJqnj45" style="display: none; visibility: hidden">Schedule of account payable and accrued liabilities</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_492_20250630_zNf6tlgv6vva" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_498_20240630_z3RwxcXCvoG8" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zLUTTOdkfLlc" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 49%; text-align: left; padding-left: 0.2in">Accounts payable, trade</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">692</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,417</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zugEg8xtDWVc" style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 0.2in">Trade payable accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">350</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zy4RuEKI3tSk" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-left: 0.2in">Environmental accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zR7WW46OMhxd" style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.2in">Loan origination fees payable to related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0777">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">28</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_znXImEMCEGR7" style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total accounts payable and accrued liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">1,795</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">1,843</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock', window );">Schedule of convertible debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_pn3n3_zNGRtBilwLCd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details)">
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span id="xdx_8BE_z5k4S4bzws22" style="display: none">Schedule of convertible debt&#160;</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 1pt; padding-left: 0.2in; width: 49%">Yorkville convertible debentures</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zHfWyp91JNJg" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0786">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zMPkYj0bcnsc" style="width: 10%; text-align: right">571</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.2in">April 2024 notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zGqxeyKolCB8" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zS1SGXYvTrd6" style="border-bottom: Black 1pt solid; text-align: right">7,089</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt">Total convertible debt</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630_z8e6tbzXlJ85" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt"><span style="-sec-ix-hidden: xdx2ixbrl0791">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630_zWouEHdpqit9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt">7,660</td><td style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of changes in the convertible debentures</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ConvertibleDebtTableTextBlock_pn3n3_zD6ZVUqC1VQ8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 1)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BE_zkBS6SAU7BFb" style="display: none">&#160;Schedule of changes
in the convertible debentures</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="width: 67%">Balance, June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zzJXZFnRUtt7" style="width: 10%; text-align: right" title="Balance at June 30, 2024">10,561</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; text-indent: 9pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zixJkcU1OtT8" style="text-align: right" title="Accretion expense">4,489</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt">Principal and accrued interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zyXxmmDgr9f1" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted">(14,479</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>Balance, June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zo4bGElTgiO2" style="text-align: right" title="Balance at June 30, 2024">571</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; text-indent: -4.5pt; padding-left: 13.5pt">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4A4eTyUvxWa" style="text-align: right" title="Accretion expense">43</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -4.5pt; padding-left: 13.5pt">Principal and interest converted</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zW3rMxoUTXM5" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted">(614</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Balance, June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z6flPImlVDK" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, December 31, 2024"><span style="-sec-ix-hidden: xdx2ixbrl0832">-</span></td><td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock', window );">Schedule of components of interest expense with convertible debenture</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_pn3n3_z9G1SDXr4CU1" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 2)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B7_zDo4TJHqzSpg" style="display: none">Schedule of  components of interest expense    with convertible debenture</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_49B_20240701__20250630_zf24biSHMNn1" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td id="xdx_49C_20230701__20240630_zaF9W5nB7fog" style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Component of Interest Expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCosts_z1X0V3sA5Mlj" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; text-align: justify; padding-left: 9pt">Amortization of discount and issuance costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">42</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">4,210</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_401_ecustom--ContractualInterest_zzFMSyEgqT45" style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt">Contractual interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">279</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--InterestAndDebtExpense_zBGZLdbINUjl" style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">43</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">4,489</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock', window );">Schedule of primary inputs for the Monte Carlo model</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_ztDoIMw7tf11" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 3)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B2_zgRQhqKlvPDe" style="display: none">Schedule of primary inputs for the Monte Carlo model</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">April 12,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iE_pid_uUSDPShares_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIppadkki5u8" style="width: 12%; text-align: right" title="Closing common share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znp1SpRQvOId" style="width: 12%; text-align: right" title="Closing common share price">3.11</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA5J2X6GyOm9" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zObltUbYfQDe" title="Term (expiry)">December 31, 2024</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Weighted average of the equity volatility and implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z1M04SKpO8Sj" style="text-align: right" title="Equity volatility">80</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJ46VEBBxJV1" style="text-align: right" title="Equity volatility">66.0</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6PPiGHLGF8c" style="text-align: right" title="Risk-free rate">5.33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zxGN43jf9Gk4" style="text-align: right" title="Risk-free rate">5.26</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify">Implied discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwpvRc52YOE2" style="text-align: right" title="Implied discount rate">15.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA9ekh7Zmua7" style="text-align: right" title="Implied discount rate">15.0</td><td style="text-align: left">%</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of changes in the fair value of April 2024 Note</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_pn3n3_zBtEDD9oljXi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 4)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8BC_zgV4vA9u1aHf" style="display: none">&#160;Schedule of changes in the fair value of  April 2024 Note</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 45%; text-align: justify">Fair value, April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240413__20240630_zteg0p1rgXqf" style="width: 12%; text-align: right" title="Fair value, April 12, 2024">10,315</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left; text-indent: 9pt">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240413__20240630_zPSp9A4MHFK9" style="text-align: right" title="Principal payments">(1,512</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangeInFairValue_c20240413__20240630_zlXYwaK7i5ng" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(1,714</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">Balance, June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240701__20250630_zOBH3VzdRrU6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value, April 12, 2024">7,089</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: left; text-indent: 9pt">Principal payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240701__20250630_zhlBzptHc3q9" style="text-align: right" title="Principal payments">(7,129</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_ecustom--ChangeInFairValue_c20240701__20250630_z9FPLejUwaBc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">40</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="padding-bottom: 2.5pt">Balance, June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20240701__20250630_zXM39yVtExVl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, June 30, 2024"><span style="-sec-ix-hidden: xdx2ixbrl0903">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock', window );">Schedule of Black-Scholes model used in April 2024 Warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_z2E1MfvZJxBg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 5)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8B0_zkcQeDw01o1a" style="display: none">Schedule of  Black-Scholes model used in April 2024 Warrants</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 39%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVwXQqnctCC6" style="width: 10%; text-align: right" title="Closing Common Share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVLIh4QzKVre" style="width: 10%; text-align: right" title="Closing Common Share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znZY2VpG4k8j" style="text-align: right" title="Term (years)">1.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z2WyWNSC4HH1" style="text-align: right" title="Term (years)">2.78</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJvm77hI83Rg" style="text-align: right" title="Expected volatility">82.22</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzulsrUdhQbl" style="text-align: right" title="Expected volatility">66.34</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhSO1cWiFxj2" style="text-align: right" title="Risk-free rate">3.78</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zalp8dXUKLV3" style="text-align: right" title="Risk-free rate">4.57</td><td style="text-align: left">%</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of changes in fair value of April 2024 Warrant liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zlZJY0yJbIZd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 6)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B5_zMtaaIWMP1F2" style="display: none">&#160;Schedule of changes in fair value of April 2024 Warrant liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%; text-align: justify">Fair value as of April 12, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0VrSHJRNjSj" style="width: 12%; text-align: right">902</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zktD7wgc3i07" style="border-bottom: Black 1pt solid; text-align: right">(604</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Fair value as of June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZNBMGPqUfpk" style="text-align: right">298</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhq95PR6iHj" style="border-bottom: Black 1pt solid; text-align: right">191</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqrYqwSOZr1" style="border-bottom: Black 2.5pt solid; text-align: right">489</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in lind iii convertible security text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents shareholders equity and share based warrants text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Subparagraph (b)<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the detailed components of other nonoperating expenses. This disclosure may include methodology, assumptions and amounts for : (a) losses on securities (net of profits) and (b) miscellaneous income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract', window );"><strong>Class B Common Stock Of Ecrc</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock', window );">Schedule of key valuation input</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zImukLpr4Dj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details)">
<tr style="display: none; vertical-align: bottom; background-color: white">
    <td style="display: none; text-align: justify"><span id="xdx_8BF_zeToFecwANTk" style="display: none">Schedule of key valuation input</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30,  <br/>2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 61%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zv8FWvKtsTTd" style="width: 10%; text-align: right" title="Closing common share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z5Ca5DGKWAdj" style="width: 10%; text-align: right" title="Closing common share price">1.73</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgSkDwnsuG48" style="width: 10%; text-align: right" title="Closing common share price">5.03</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (expiry)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIBGhBtzP3hf" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zX2dmqp7K3l7" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7b3nvFHTal" title="Term (expiry)">March 17, 2033</span></span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJSH0hW5Vdwi" title="Implied volatility of public warrants">75.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQ4UrZXQYY5f" title="Implied volatility of public warrants">65.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zvccAD58q9Gb" title="Implied volatility of public warrants">33.5</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6pZ9A1pxrW3" title="Risk-free rate">4.04</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zsGkAgKaGOhi" title="Risk-free rate">4.35</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIg4xAqslFe4" title="Risk-free rate">3.83</span></td><td style="text-align: left">%</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock', window );">Schedule of fair value of the Earnout Shares liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z2QdcGsXG1Rb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8BE_z3gTaXUN9u4h" style="display: none">&#160;Schedule of  fair value of the Earnout Shares liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%; text-align: justify">Fair value as of June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3bKXXuUdipe" style="width: 12%; text-align: right" title="Fair value at beginning">10,521</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZaCmd22F7Cd" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">(6,704</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Fair value as of June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLWAzjKE8Wll" style="text-align: right" title="Fair value at beginning">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zV8E8YqOu4V5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">2,063</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 2.5pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zKDTEpC02DT9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Fair value at ending">5,880</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureClassBCommonStockOfEcrcAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureClassBCommonStockOfEcrcAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of primary inputs into the monte carlo models table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock', window );">Schedule of changes in the fair value of Private Warrants liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_pn3n3_zgJQ0aYt8XEb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 3)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8B9_zo6Yg9D0X9J4" style="display: none">Schedule of  changes in the fair value of  Private Warrants liabilities</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">November&#160;2024&#160;Private&#160;Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%; text-align: justify">Fair value at issuance (November 13, 2024)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_z9T2mvBFugIc" style="width: 15%; text-align: right" title="Beginning balance">1,929</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; text-indent: 9pt">Fair value of Warrants exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--FairValueOfWarrantsExercised_iN_pn3n3_di_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zNzQDvx8Cbl6" style="text-align: right" title="Fair value of Warrants exercised">(338</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCECFF">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt">Change in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zYu4P0N5b986" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value">2,240</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">Fair value as of June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zL0EmStf7uLi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">3,831</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock', window );">Schedule of Black-Scholes model for warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_pn3n3_zxW275XyTNk7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 4)">
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-bottom: 1pt"><span id="xdx_8BA_zR1scRy2NAkj" style="display: none">Schedule of Black-Scholes model for warrants</span></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td><td style="text-align: right; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series B</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_ziqwvz8ifXng" style="width: 12%; text-align: right" title="Closing common share price">2.25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zF3dBkIGi8p" style="width: 12%; text-align: right" title="Closing common share price">2.25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zK3f3iIg1ugf" title="Term (years)">2.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_z0BPucdjJLQi" title="Term (years)">4.0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zVxoQiJ3o6h1" title="Historic equity volatility">73.18</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zFYt7yuL6Myg" title="Historic equity volatility">73.36</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_z0P6pIedNQqb" title="Risk-free rate">4.23</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zez53Gsgpcjh" title="Risk-free rate">4.31</span></td><td style="text-align: left">%</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock', window );">Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_pn3n3_zC1q0aJQbfSk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - COMMON SHARES (Details 5)">
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span id="xdx_8B7_zTkJ5AOPBgLi" style="display: none">Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For The Year  <br/>Ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 74%; text-align: justify">Common Shares issued</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--CommonStockSharesIssued1_pid_uShares_c20240701__20250630_zmIiFOnitAKi" style="width: 10%; text-align: right" title="Common shares issued">5,671,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--CommonStockSharesIssued1_pid_uShares_c20230701__20240630_zIjUiwkfoof5" style="width: 10%; text-align: right" title="Common shares issued">1,358,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-left: 0.125in">Gross funds received</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zLMDNYNZVIq5" style="text-align: right" title="Gross funds received">12,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230701__20240630_ztfSimaTqoz7" style="text-align: right" title="Gross funds received">3,293</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Market value of Common Shares issued<br/></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssued1_c20240701__20250630_zqnd5BCHOKPj" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued">12,941</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssued1_c20230701__20240630_z74OWN2eV6E5" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued">3,398</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on issuance<sup>(1)</sup></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240701__20250630_fKDEp_zi38DeaHmkSd" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance">589</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20230701__20240630_fKDEp_zPUTuQaIx7bh" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance">105</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0E_za1jIOPFlggi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 9pt"><span id="xdx_F1F_zVuOpfGNvd5k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
                                         on issuance represents a non-cash amount equal to the difference between the proceeds
                                         received and the fair value of the Common Shares issued based on the Nasdaq closing price
                                         per Common Share on the issuance date and is recorded in other operating expenses in
                                         the condensed consolidated statement of operations and comprehensive loss.</span></td></tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule of option</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_pn3n3_zra9zMcF5HNh" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 6)">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BE_zqRO2c9yrHPf" style="display: none">Schedule of option</span></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Number&#160;of&#160;Options</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Aggregate Intrinsic Value</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Remaining Contractual Life</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 39%; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zo5FW6VaGGV4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">1,541,500</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_z5aRZ0B4yIqc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance">7.19</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_z7UbXA2DKgPg" style="text-align: right" title="Granted, in shares">1,625,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zq7dprEAdSfh" style="text-align: right" title="Granted, per share">2.99</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zcpRxLZtHLe3" style="text-align: right" title="Cancelled/expired, in shares">(7,800</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zcua8iTgLMMi" style="text-align: right" title="Cancelled/expired, per share">3.95</td><td style="text-align: left">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_ztAKExeJEcdj" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares">(663,200</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zrSGke4oCfW2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share">5.88</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20250630_zvDjJdNSlaTc" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">2,495,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20240701__20250630_zDTBdK33q3N6" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance">4.78</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; background-color: White">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: right; background-color: White">&#160;</td><td style="padding-bottom: 1pt; text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20250630_zy0nRSWy2s9i" style="text-align: right" title="Granted, in shares">945,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zGNCkDvD8c12" style="text-align: right" title="Granted, per share">1.41</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20250630_zQGeplrrOW5l" style="text-align: right" title="Cancelled/expired, in shares">(512</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zrSRhaFcDhab" style="text-align: right" title="Cancelled/expired, per share">1.40</td><td style="text-align: left">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td><td style="background-color: White">&#160;</td>
    <td style="text-align: left; background-color: White">&#160;</td><td style="text-align: right; background-color: White">&#160;</td><td style="text-align: left; background-color: White">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/expired</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20250630_zYC8dMDLo6l8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares">(419,988</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zMk0H7ryc6M3" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share">9.44</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2025</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20250630_z1qx7VjdF3m6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">3,020,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20240701__20250630_zXM8lFwL92I" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">3.09</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20250630_zjwmjb5VjMmi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Aggregate intrinsic value">866</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630_zECCFukmRsF4" title="Weighted average remaining contractual life">3.5</span> years</span></td><td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted average and assumptions used to option costs</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zzeVpWSx38yc" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 7)">
<tr style="display: none; vertical-align: bottom; background-color: White; visibility: hidden">
    <td style="display: none; padding-left: 5pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_498_20240701__20250630_zr6u56GHJ8Ig" style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; text-align: left; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: left; visibility: hidden">&#160;</td><td id="xdx_49F_20230701__20240630_zFf2bGLFP1C8" style="display: none; text-align: right; visibility: hidden">&#160;</td><td style="display: none; text-align: left; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt"><span id="xdx_8B9_znuoL3SnEEvc" style="display: none">Schedule of  weighted average  and assumptions used to option costs</span></td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="border-bottom: Black 1pt solid; padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_zBGQgMDOCHP3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; text-align: left; padding-left: 5pt">Fair value per option granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.84</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1.71</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_zYkx8Fz5RPLk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.44</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.25</td><td style="text-align: left">%</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zEFumOScew94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
<tr id="xdx_401_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_zWvBAbR5Epja" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5pt">Expected stock price volatility (historical basis)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63.2</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5pt">Expected option life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630_zbgAbYq8KEs5" style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230701__20240630_zJpZ9V8HBIi5" style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Weighted average exercise prices</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zXuQE7ktV8p5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 8)">
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-left: 3pt"><span id="xdx_8BC_zs9ZXhkeybme" style="display: none">Schedule of Weighted average exercise prices</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Warrants</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Weighted Average Exercise Price</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 59%; padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2023</span></td><td style="width: 1%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zUX6oVYEX5Ij" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance, Warrants">18,816,304</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zcGw2PVqxW6j" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance at Weighted Average Exercise Price">10.98</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_zFwo2AhJUFP" style="text-align: right" title="Beginning balance, Warrants">1,593,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zwNyIPwG4fFj" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price">3.33</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_zDIy7pizdv4e" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants">(1,846,560</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_z4eGOlMMpZIa" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">8.67</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2024</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20250630_zEJ1tK2Ezljd" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants">18,563,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20240701__20250630_zbSupISsCcpg" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">10.53</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20250630_ztbkMTkadHp7" style="text-align: right" title="Beginning balance, Warrants">13,553,714</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20250630_zWnCqbHapuc6" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price">2.05</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20250630_zwJk9Mhe7C3i" style="text-align: right" title="Beginning balance, Warrants">(828,235</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20250630_zql4ZlYmrsZ4" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price">1.78</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.145in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20250630_zCdUca7tTTc7" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants">(1,303,118</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20250630_zlHjkOpjYvtl" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">7.72</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, June 30, 2025</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20250630_zIyW2AzEkrwj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance, Warrants">29,985,922</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20240701__20250630_zYae6k9rdGej" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price">7.06</td><td style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock', window );">Schedule of outstanding exercisable Warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXHd4VtQMRbi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 9)">
<tr style="display: none; vertical-align: bottom">
    <td colspan="2" style="display: none; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BE_zdxmK0jNL4al" style="display: none">Schedule
of outstanding exercisable Warrants</span></span></td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; padding-left: 5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Number</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Exercise Price</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-left: 5pt">Expiry Date</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zd0IIseyj82k" style="width: 18%; text-align: right" title="Number of share outstanding">250,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zFL0jlRwAgLl" style="width: 18%; text-align: right" title="Exercise price">4.60</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zyh0iohcDUw9" title="Expiry date">September 1, 2025</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zVGGTMFD7f5l" style="text-align: right" title="Number of share outstanding">413,432<br/>
</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_z8JIEsyEAb05" style="text-align: right">3.54</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zc5mDRVkN54h" title="Expiry date">December 22, 2025</span><br/>
</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_ztHLrjBYm4oh" style="text-align: right" title="Number of share outstanding">315,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZSn1BkZxTe" style="text-align: right">2.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zvJmN7P2xkNe" title="Expiry date">June 24, 2026</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_z3XmybalTJr1" style="text-align: right" title="Number of share outstanding">1,117,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zjsy76CW6Wqe" style="text-align: right">1.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zs8QG8ZZoO56" title="Expiry date">November 5, 2026</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zr7pf8oErYi8" style="text-align: right" title="Number of share outstanding">1,992,214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_z3syGfztzHT" style="text-align: right">1.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zwinatfKpBG2" title="Expiry date">November 13, 2026</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zzwRWNc2GOwg" style="text-align: right" title="Number of share outstanding">615,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zyAIT8J6VI26" style="text-align: right">3.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zEwwOexhFMvj" title="Expiry date">April 12, 2027</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_zypR2g71yvjd" style="text-align: right" title="Number of share outstanding">2,577,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ziEZfIN2d1R3" style="text-align: right">1.98</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ztlSJK2yX35d" title="Expiry date">August 2, 2027</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_fKDEp_zxtFEcbnmEJk" style="text-align: right" title="Number of share outstanding">15,666,626</td><td style="white-space: nowrap; text-align: left"><sup>(1)</sup>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zArioAAX3led" style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zo5kJ0xeoZ54" title="Expiry date">March 17, 2028</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zO4CBiwWlLue" style="text-align: right" title="Number of share outstanding">2,816,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zwRG5lgseGJ8" style="text-align: right">2.31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zrCEDZFZu0Ak" title="Expiry date">September 17, 2028</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_z1PzvW1Pp7xi" style="text-align: right" title="Number of share outstanding">1,288,660</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zZ0hhfGF2R86" style="text-align: right">2.05</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zIpDLmRqiWWi" title="Expiry date">January 31, 2029</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYCi8ZTEpbxg" style="text-align: right" title="Number of share outstanding">802,045</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zrClG3aAOJD" style="text-align: right">2.07</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYBjyllkmuij" title="Expiry date">November 5, 2029</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zJwsDpyLenOh" style="text-align: right" title="Number of share outstanding">1,067,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_ztkuA19O2YDg" style="text-align: right">2.07</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zIfQP5YVrlgl" title="Expiry date">November 13, 2029</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zHynswnRGWRl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share outstanding">1,063,462</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zEQauSMT7Hde" style="padding-bottom: 1pt; text-align: right">2.60</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">No expiry</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630_zkrTCT5o5nuk" style="border-bottom: Black 2.5pt solid; text-align: right" title="Number of share outstanding">29,985,922</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1pt">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: top">
    <td style="width: 6%; text-align: center"><span id="xdx_F08_zntRSXlTmEJl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="width: 94%; text-align: justify"><span id="xdx_F10_zs4hJ7HULwAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    11,165,324 and 4,501,302 2023 Public Warrants and 2023 Private Warrants, respectively, as defined below. Each 2023 Public
    Warrant and 2023 Private Warrant is exercisable into 1.11829212 Common Shares.</span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Company classifies the 2023 Private Warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFk6Ox8K47Rd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 10)">
<tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: justify"><span id="xdx_8B1_zaWJlw2aMbae" style="display: none">Schedule of Company classifies the 2023 Private Warrants</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: justify">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 25%; text-align: justify">Stock price on valuation date</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6oXgHKruWe6" style="width: 12%; text-align: right" title="Stock price on valuation date">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqekotrMP9Vi" style="width: 12%; text-align: right" title="Stock price on valuation date">1.73</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Strike price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znCtEfbsXH08" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zF3USWMHviO5" style="text-align: right" title="Strike price">11.50</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Implied volatility of the 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zokzvdR53Fk3" title="Implied volatility of public warrants">90.0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9U5QvrJpznl" title="Implied volatility of public warrants">69.0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znZARl9u7sBg" title="Risk free rate">3.70</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0eYdPxiw4Vg" title="Risk free rate">4.45</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgm51tujLyqh" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zg46M9I9XHcl" title="Dividend yield">0</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected Warrant life in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlnRSv5Nal7c" title="Expected warrant life in years">2.7</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtYp_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zh9w0dnN8xu9" title="Expected warrant life in years">3.7</span></td><td style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock', window );">Schedule of change in the 2023 Private Warrants liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_z0wgS9c7yeFj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 11)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BA_zyhMrnzpsjGb" style="display: none">Schedule of change in the 2023 Private Warrants liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%">Valuation at June 30, 2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zdA6r0J0esa4" style="width: 12%; text-align: right" title="Initial valuation, at begining">3,279</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu0bnuGHovO5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">(1,926</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Valuation at June 30, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zEgWZiuvZZk4" style="text-align: right" title="Initial valuation, at begining">1,353</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">Exchange of 2023 Private Warrants for 2023 Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--ExchangeOfPrivateWarrantsForPublicWarrants_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqxGr8R6Ic6" style="text-align: right" title="Exchange of 2023 Private Warrants for 2023 Public Warrants">(482</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Change in valuation</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zZz1REyuZhG6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation">1,661</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Valuation at June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zJRxXg73bqG3" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance">2,532</td><td style="padding-bottom: 1pt; text-align: left"><p style="margin-top: 0; margin-bottom: 0">&#160;</p></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Black-Scholes valuation</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zFUYIGd61og6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 12)">
<tr style="display: none; vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: justify"><span id="xdx_8B2_ziBCaZUdluGd" style="display: none">Schedule of  Black-Scholes valuation
</span></td><td style="display: none">&#160;</td>
    <td style="display: none; text-align: left">&#160;</td><td style="display: none; text-align: right">&#160;</td><td style="display: none; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Key Valuation Input</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">September 17,  <br/>2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zqGe67wsIuDc" style="width: 12%; text-align: right" title="Closing common share price">1.74</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Term (years)<br/>
</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zV77JykhDcch" title="Term (years)">4.0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_z3nF9Ec9NROe" title="Historic equity volatility">67.14</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zo3NFj88A5Rb" title="Risk-free rate">3.44</span></td><td style="text-align: left">%</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock', window );">Schedule of change in fair value of Warrants liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcdwdb4ubHde" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 13)">
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span id="xdx_8B2_zMGqK8zMF1m3" style="display: none">Schedule of change in fair value of Warrants liability</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Valuation at June 30, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zfJNBPrk2jef" style="width: 12%; text-align: right" title="Valuation, at begining">2,365</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: 0.6pt; padding-left: 0.125in">Fair value of Warrants issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zydUoDS605P6" style="text-align: right" title="Fair value of Warrants issued">(2,262</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in">Gain on issuance of Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--GainOnIssuanceOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zCu0szBFtWX7" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on issuance of Warrants">(103</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Ending balance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_982_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zD6HKT2NGPWl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation, at ending"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Black-Scholes model used in Private warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zjABPV9bQ4mg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_zWeeoFmduHP2" style="display: none">Schedule of Black-Scholes model used in public warrants</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">November 5, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Public Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series B</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Public</p>
                                                                   <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zBwMFHnTn4K8" style="width: 12%; text-align: right" title="Closing common share price">1.455</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zoffagcetK24" style="width: 12%; text-align: right" title="Closing common share price">1.455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zpK7A6WxWtri" title="Term (years)">4.5</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zpuiUMuYHYG7" title="Term (years)">2.0</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zTjDB5MmDIhk" title="Historic equity volatility">67.43</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zZEBZ0vBYNu2" title="Historic equity volatility">67.13</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zdWGujIdLif9" title="Risk-free rate">4.14</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zyl3gVN7NXoa" title="Risk-free rate">4.20</span></td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_PrivateWarrantsMember', window );">Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Black-Scholes model used in Private warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zFjI4YyUrucg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 1)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8BB_ztxowl6wpNnh" style="display: none">Schedule of Black-Scholes model used in Private warrants</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">November 13, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Private Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><p style="margin-top: 0; margin-bottom: 0">Series A Private</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series B Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z4s5mBECo834" style="width: 12%; text-align: right" title="Closing common share price">1.49</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z36KZZtnDtQb" style="width: 12%; text-align: right" title="Closing common share price">1.49</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zuirTne6rEEa" title="Term (years)">2.0</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z40LzAZPI1Sa" title="Term (years)">4.5</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zeBQfpiYG9U6" title="Historic equity volatility">67.26</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z5UfHhTX50H8" title="Historic equity volatility">67.52</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zvyh6atZ5Ek2" title="Risk-free rate">4.20</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zFfLVlhe2DF1" title="Risk-free rate">4.30</span></td><td style="text-align: left">%</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

















<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2025</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">November 2024 Private Warrants:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series A Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">Series B Private Warrants</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 35%; text-align: justify">Closing Common Share price</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z5GQTy3h4J1k" style="width: 12%; text-align: right" title="Closing common share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zNbYyKM4Cxzg" style="width: 12%; text-align: right" title="Closing common share price">2.33</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Term (years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zP0y9BLp3Rp4" title="Term (years)">1.37</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zANaPT946vLf" title="Term (years)">4.38</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify">Historic equity volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zpYES54cGwCh" title="Historic equity volatility">86.14</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zwVEs7kpPGJ" title="Historic equity volatility">74.26</span></td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify">Risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z0QW52vdv1h6" title="Risk-free rate">3.88</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zfzanleeOQ79" title="Risk-free rate">3.77</span></td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value assets and liability measured on recurring and nonrecurring basis of warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value assets and liability measured on recurring and nonrecurring basis table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule common shares under facility financing agreement table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in the fair value of private warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in the fair value of the2023 private warrants liability table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of changes in the fair value of the private warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of outstanding exercisable warrants table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EXPLORATION EXPENDITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureExplorationExpendituresAbstract', window );"><strong>Exploration Expenditures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock', window );">Schedule of exploration expenditures</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zX9TSKCbmkQ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zvupSjrUFyr7" style="display: none; visibility: hidden">Schedule of exploration expenditures</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left; padding-left: 0.25in">Feasibility study and engineering</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDpWpOYxdWYa" style="width: 10%; text-align: right">1,112</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zXQAjsGpRnck" style="width: 10%; text-align: right">353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Field management and other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_z5RYCZFNd7B3" style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zBo3QRoaGHrk" style="text-align: right">503</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Drilling</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--DrillingMember_z8Fz75bOQNc4" style="text-align: right">1,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--DrillingMember_zGXhEJ9phMh1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1522">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Metallurgical</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--MetallurgicalMember_z1xqNRpM3yB9" style="text-align: right">214</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zuGpdFF7VYai" style="text-align: right">1,678</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Geologists and field staff</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z2Rw7VSemRwi" style="border-bottom: Black 1pt solid; text-align: right">453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z6NoXbEcfhRf" style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; padding-left: 0.125in">Total</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_987_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630_z6Z8yyA8jQ85" style="border-bottom: Black 2.5pt solid; text-align: right">4,135</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_zQC1S18XGML7" style="border-bottom: Black 2.5pt solid; text-align: right">2,552</td><td style="text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureExplorationExpendituresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureExplorationExpendituresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ScheduleOfExplorationExpendituresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents schedule of exploration expenditures table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ScheduleOfExplorationExpendituresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">The Company incurred lease costs as follows:</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zExnnFSqKCr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zXg6SXALdpah">The
Company incurred lease costs as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; padding-left: 0.25in; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_492_20240701__20250630_zPGWeoLTBkT5" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49A_20230701__20240630_zewXOxszxypd" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td></tr>
<tr id="xdx_404_ecustom--FixedRentExpense_pn3n3_zHftaIQeq4I9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; text-align: left; padding-left: 0.25in">Fixed rent expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">94</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--VariableLeaseCost_pn3n3_zQBosEWhT6Fh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Variable rent expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_pn3n3_z3K5NHD26yt9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Short term lease cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--SubleaseIncome_iN_pn3n3_di_zLvRh6GJA36j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Sublease income</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(41</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(32</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_z2a6AOMPC4wf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0.125in">Net lease cost &#8211; other operating expense</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right">81</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">The maturity of lease liabilities is as follows at June 30, 2025:</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmzjjIoA1uQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zXhhM714HkE8">The
maturity of lease liabilities is as follows at June 30, 2025:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 1in">
<tr style="vertical-align: bottom">
    <td style="text-align: center; padding-left: 0.125in">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20250630_zjZPCCujtBoe" style="border-bottom: Black 1pt solid; text-align: center">Fiscal Year Lease Maturities</td><td style="border-bottom: Black 1pt solid">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zZGeTJaETxR4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; padding-left: 0.125in">2026</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">98</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_zZQruMfEojNe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">2027</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">50</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
<tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zKDlzTqqRZ6d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0in">Total lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">148</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zTNC2qafKZ8l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less amount of payments representing interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(17</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zlaWoBnsjcab" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0in">Present value of lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">131</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zSp5xIOfexG7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Less current portion of operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(98</td><td style="border-bottom: Black 1pt solid; text-align: left">)</td></tr>
<tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_zlkSIvHbAlQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0in">Noncurrent operating lease liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">33</td><td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zckpTasrHiFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zpkvrK11UNG7">Domestic
and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:</span>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; padding-left: 0.125in">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zaOhNaXNsYC6" style="width: 10%; text-align: right" title="Total">(13,089</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zmNtALZ3bC8c" style="width: 10%; text-align: right" title="Total">(8,319</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zZUh6jHB9YUa" style="text-align: right" title="Total">(4,818</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zhf8OrpcQsKl" style="text-align: right" title="Total">(3,679</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zusJMQG2Neha" style="border-bottom: Black 1pt solid; text-align: right" title="Total">(75</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z5KneQklMtp1" style="border-bottom: Black 1pt solid; text-align: right" title="Total">(39</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630_zl10EWO39HOa" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total">(17,982</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630_zBsN06zrz9ne" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total">(12,037</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">The following table is a reconciliation of income taxes at statutory rates:</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs0kZpMl1m02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> <span style="font: 10pt Times New Roman, Times, Serif">The</span> <span style="font: 10pt Times New Roman, Times, Serif">following table is a reconciliation of income taxes at statutory rates:</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zurgVWVYgAvd" style="display: none; visibility: hidden">The following table is a reconciliation of income taxes at statutory rates:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; padding-left: 5pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_497_20240701__20250630_zidKaOJrl8Of" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49C_20230701__20240630_z68QjPkVMzH3" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_pn3n3_zx3izuI5Rcf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left; padding-left: 5pt">Loss before income taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(17,982</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(12,037</td><td style="width: 1%; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_uUSD_zwDoic6nmFV8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Income tax benefit at Canadian federal rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,697</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,806</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_uUSD_zvP0cakAhIZ" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Income tax benefit at Canadian provincial rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,158</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,444</td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_ecustom--WarrantLiability_pn3n3_zCJxMaapPwZk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,105</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(506</td><td style="text-align: left">)</td></tr>
<tr id="xdx_405_ecustom--EarnoutSharesLiability_pn3n3_z92zcxpmYaRi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Earnout shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,810</td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_z2ZCuN46k7G5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Share based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">747</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_pn3n3_zOwlLdLRAK1b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Foreign rate differential</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">102</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--AssetRetirementObligationAccretionExpense_pn3n3_zfyClHvGmsh6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Accretion expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,138</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_pn3n3_zwfH6057hQP5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Change in estimates related to prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--PaymentsOfStockIssuanceCost_pn3n3_zEdnnPmkiJha" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Stock issuance costs in equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,143</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(55</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_ecustom--ConvertibleNoteValuation_iN_pn3n3_di_zNv4wMsU3fO2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Convertible note valuation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(137</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">607</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_zvwKqSBKbIv9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.2in">Other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_zjCO45iqQXyc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.2in">Change in valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,978</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,718</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt">Income tax benefit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_d0_c20240701__20250630_zIzZEyXYrxol" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zQQqTjLajXF1" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit::XDX::-139"><span style="-sec-ix-hidden: xdx2ixbrl1640">139</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z7CUHDhhOpI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zgyFopWNwKe6">Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="display: none; vertical-align: bottom; visibility: hidden">
    <td style="display: none; text-align: right; padding-left: 5.4pt; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td id="xdx_491_20250630_zN8lA9GyijW4" style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td style="display: none; text-align: center; visibility: hidden">&#160;</td>
    <td colspan="2" id="xdx_49F_20240630_zuYT51idjSr9" style="display: none; text-align: center; visibility: hidden">&#160;</td><td style="display: none; visibility: hidden">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right; padding-left: 5.4pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzakr_zyQh7jWlY2v1" style="vertical-align: bottom; background-color: White">
    <td style="width: 44%; text-align: left; padding-left: 0.25in">Net operating losses available for future periods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">16,125</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">14,177</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zlKDJJv2arNh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Mineral interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,438</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,438</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z0DV4YMNxnWc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Startup and organizational costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,842</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,987</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zJ7Q8LQevTic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.25in">Research and development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,295</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,419</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zSHr7KpUMOH9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.25in">Share issuance/financing costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">635</td><td style="text-align: left">&#160;</td></tr>

    <tr id="xdx_406_ecustom--DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_iI_pn3n3_maDTAGzakr_zp1IvHCSliy8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in">Canadian restricted interest and financing carryforward</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1661">-</span></td><td style="text-align: left">&#160;</td></tr>




<tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zRloSVdyfijb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.25in">Capital losses available for future periods</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">456</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzakr_zJpu2BYmt9N7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 0.25in">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">41</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">69</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_mtDTAGzakr_maDTALNz97R_zLdETNgphVsk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 5.4pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,159</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,181</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTALNz97R_zIkydzzEBbQa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in">Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(32,159</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(28,181</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNz97R_zBeLq83o7uj9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1676">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Changes in the valuation allowance are as follows:</a></td>
<td class="text"><p id="xdx_891_eus-gaap--SummaryOfValuationAllowanceTextBlock_zGOanMTlNbRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zou3u5NwneBd">Changes
in the valuation allowance are as follows:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">For the year ended June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left">Valuation allowance, beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20240701__20250630_zOyRK6RmI4zk" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(28,181</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20230701__20240630_z1g50xPtM5e4" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year">(25,463</td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Current year additions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20240701__20250630_zJzdRfZwDu9e" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions">(3,978</td><td style="text-align: left; padding-bottom: 1pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_zAdcqG6EKmY3" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions">(2,718</td><td style="text-align: left; padding-bottom: 1pt">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Valuation allowance, end of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20240701__20250630_zAOd9WUQqNvl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year">(32,159</td><td style="text-align: left; padding-bottom: 2.5pt">)</td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20230701__20240630_zNRPWvKWj53f" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year">(28,181</td><td style="text-align: left; padding-bottom: 2.5pt">)</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of cumulative net operating losses</a></td>
<td class="text"><p id="xdx_89F_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zv2LGAJKYGFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_za9L87PEP262" style="display: none; visibility: hidden">Schedule of cumulative net operating losses</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="padding-left: 3pt">&#160;</td><td>&#160;</td>
    <td colspan="6" style="text-align: center">As of June 30,</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-left: 3pt">Jurisdiction</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2025</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 24%; padding-left: 0.125in">Canada</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--CA_zk6uhfxZdTS2" style="width: 10%; text-align: right" title="Total">53,194</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--CA_zPSxwRqTJFi6" style="width: 10%; text-align: right" title="Total">47,623</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 0.125in">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--US_zATr1iAW8bi2" style="text-align: right" title="Total">6,627</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--US_zXhWEqe32mAg" style="text-align: right" title="Total">4,905</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">United Kingdom</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--GB_z7scLv8mA3ig" style="border-bottom: Black 1pt solid; text-align: right" title="Total">112</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--GB_zeOeeNPWj2rd" style="border-bottom: Black 1pt solid; text-align: right" title="Total">39</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 3pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630_zHw7g5ZprTab" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total">59,933</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zYVKId8oc0D1" style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: right" title="Total">52,567</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of fair values determined by level 3 inputs are unobservable data</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zkm0AZ72Wp0a" style="margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;<span id="xdx_8B9_zL3QqlX7ONIh" style="display: none; visibility: hidden">Schedule of fair values determined by level 3 inputs are unobservable data</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2025</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630_z6mIN1EWqmQa" style="width: 10%; text-align: right" title="Cash and cash equivalents">25,554</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsaCEdpTEjp1" style="width: 10%; text-align: right">25,554</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZDR8Sk0mZQ" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1739">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLghj8V3Bfna" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630_zLzNssnTQApk" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities">3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKreZNu3ZKC2" style="border-bottom: Black 1pt solid; text-align: right">3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zubMPzpYQb77" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1744">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpyNxUhpo7i5" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1745">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630_ziVisi7fFnKb" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Assets">25,557</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvAigtjc9I83" style="border-bottom: Black 2.5pt solid; text-align: right">25,557</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8eRQMAA8YPh" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1749">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCEpplm4a34h" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1750">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zV94tD9akeCb" style="text-align: right" title="Earnout Shares liability">5,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcKELJSdao4i" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWAkDZGJHWae" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4VRaHm5Qtxk" style="text-align: right">5,880</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630_zSK4M2AspqKh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities">6,852</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHb62pLcaZEf" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1758">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1w8tlKZxfy4" style="border-bottom: Black 1pt solid; text-align: right">6,852</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z024lwG5fGel" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1760">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zHWx22eO4NRe" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Liabilities">12,732</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhR3Vs3vI85c" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1763">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgro6MDL5Kx6" style="border-bottom: Black 2.5pt solid; text-align: right">6,852</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98D_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuIygyQ43me9" style="border-bottom: Black 2.5pt solid; text-align: right">5,880</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in">
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="14" style="text-align: center">As of June 30, 2024</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 1</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 2</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Level 3</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Assets:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 48%; text-align: left; padding-left: 0.125in">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630_z0erBTk3XG0l" style="width: 10%; text-align: right" title="Cash and cash equivalents">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyq88zENMvXk" style="width: 10%; text-align: right">2,012</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zX0voHd7R405" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1769">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrlcDnRt3Nak" style="width: 10%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Investment in equity securities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630_zU9m5yLbd0g7" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHKFXeuLB164" style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9fdwIVI7mWj" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1774">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjzGmyfXylgh" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1775">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630_zegq5dSkYIt6" style="border-bottom: Black 2.5pt solid; text-align: right">2,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpUVAXDALwEd" style="border-bottom: Black 2.5pt solid; text-align: right">2,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z17y5tejqWmb" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1778">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCxLR7QMzobh" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1779">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in">April 2024 notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--NotesPayable_iIP3us-gaap--AssetsFairValueDisclosure_pn3n3_c20240630_zwANORIDx3hk" style="text-align: right" title="April 2024 notes">7,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4mbqnjCKIYb" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1782">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9oC2C8Mx7Qj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1783">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zi4fNOdDNtR1" style="text-align: right">7,089</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">Earnout Shares liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zxywbEgGaDUl" style="text-align: right" title="Earnout Shares liability">3,817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6eGOd2iVj0d" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjSYPtYwgb31" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1788">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYkSQnVEP7Lc" style="text-align: right">3,817</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in">Warrant liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630_zmbj6UEHzZi2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities">4,016</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdQBpQoPOhkk" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1792">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNJEi1Plqqh9" style="border-bottom: Black 1pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkV1QiBPMW1g" style="border-bottom: Black 1pt solid; text-align: right">2,365</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zsZt5ooqQSmc" style="border-bottom: Black 2.5pt solid; text-align: right">14,922</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQkW61lbASyb" style="border-bottom: Black 2.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgXxIQyksy0b" style="border-bottom: Black 2.5pt solid; text-align: right">1,651</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zM5MdBbgAZZg" style="border-bottom: Black 2.5pt solid; text-align: right">13,271</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_Entity0896800BCLtdMember', window );">Entity0896800 B C Ltd [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Jurisdiction of incorporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">British
    Columbia, Canada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership at June 30, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember', window );">Elk Creek Resources Corp E C R C [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Jurisdiction of incorporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">Delaware,
    USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership at June 30, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">80.42%<span></span>
</td>
<td class="nump">79.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=niobf_NioCorpTechnologiesLimitedMember', window );">Nio Corp Technologies Limited [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_IncorporationStateCountryName', window );">Jurisdiction of incorporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United
    Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership at June 30, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 and 4,282,116 Vested Shares
                                         and 3,391,596 and 3,391,596 Earnout Shares (each as defined below) held by third parties,
                                         and outstanding as of June 30, 2025 and 2024, respectively.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_IncorporationStateCountryName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents incorporation state country name.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_IncorporationStateCountryName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_Entity0896800BCLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_Entity0896800BCLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_ElkCreekResourcesCorpECRCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=niobf_NioCorpTechnologiesLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=niobf_NioCorpTechnologiesLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>N</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common shareholders: (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (17,982)<span></span>
</td>
<td class="num">$ (11,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Adjust: Net loss attributable to noncontrolling interest</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss available to participating securities</a></td>
<td class="num">(17,405)<span></span>
</td>
<td class="num">(11,440)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_NetLossAttributableToVestedShares', window );">Net loss attributable to Vested Shares</a></td>
<td class="nump">1,102<span></span>
</td>
<td class="nump">967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net loss attributed to common shareholders - basic</a></td>
<td class="num">(16,303)<span></span>
</td>
<td class="num">(10,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted', window );">Net loss attributed to common shareholders - diluted</a></td>
<td class="num">$ (16,303)<span></span>
</td>
<td class="num">$ (10,473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding - basic</a></td>
<td class="nump">45,072,895<span></span>
</td>
<td class="nump">34,320,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding - diluted</a></td>
<td class="nump">45,072,895<span></span>
</td>
<td class="nump">34,320,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per Common Share outstanding - basic</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per Common Share outstanding - diluted</a></td>
<td class="num">$ (0.36)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_NetLossAttributableToVestedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents net loss attributable to vested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_NetLossAttributableToVestedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of excluded from the dilutive securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions', window );">Options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">3,020,000<span></span>
</td>
<td class="nump">2,495,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">31,839,152<span></span>
</td>
<td class="nump">18,563,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">2,849,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Total potentially dilutive securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">$ 34,859,152<span></span>
</td>
<td class="nump">$ 23,908,061<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 35<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-35<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-36<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MineralPropertiesAccumulatedImpairment', window );">Impairment to mineral properties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued Exploration Stage Obligations</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480095/942-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480035/942-10-S99-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MineralPropertiesAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The accumulated decrease in the carrying value of the mineral properties as a result of adjustments in estimates of future income generating potential of the mineral property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MineralPropertiesAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOING CONCERN ISSUES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (17,982)<span></span>
</td>
<td class="num">$ (11,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="nump">179,317<span></span>
</td>
<td class="nump">$ 161,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Net proceeds from public offering</a></td>
<td class="nump">41,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfDebt', window );">Net proceeds</a></td>
<td class="nump">$ 46,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of properties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">$ 853<span></span>
</td>
<td class="nump">$ 848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">839<span></span>
</td>
<td class="nump">837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_BuildingMember', window );">Building [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Cost</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MINERAL PROPERTIES (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ExtractiveIndustriesAbstract', window );"><strong>Extractive Industries [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExplorationExpenseForOTPExtensionPayments', window );">Exploration expense for OTP extension payments</a></td>
<td class="nump">$ 310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FutureOptionToPurchaseExtensionPaymentObligations', window );">Future Option to Purchase Extension Payment Obligations</a></td>
<td class="nump">$ 93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExplorationExpenseForOTPExtensionPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exploration expense for o t p extension payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExplorationExpenseForOTPExtensionPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FutureOptionToPurchaseExtensionPaymentObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents future option to purchase extension payment obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FutureOptionToPurchaseExtensionPaymentObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ExtractiveIndustriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ExtractiveIndustriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of account payable and accrued liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable, trade</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 1,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Trade payable accruals</a></td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Environmental accruals</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure', window );">Loan origination fees payable to related party</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,795<span></span>
</td>
<td class="nump">$ 1,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of trade and related party payables and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total convertible debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 7,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleDebenturesMember', window );">Yorkville Convertible Debentures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total convertible debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_April2024ConvertibleSecurityMember', window );">April2024 Convertible Security [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Total convertible debt</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 7,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleDebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleDebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_April2024ConvertibleSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_April2024ConvertibleSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance at June 30, 2024</a></td>
<td class="nump">$ 7,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance, December 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 7,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Convertible Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance at June 30, 2024</a></td>
<td class="nump">571<span></span>
</td>
<td class="nump">10,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations', window );">Accretion expense</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">4,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrincipalAndAccruedInterestConverted', window );">Principal and interest converted</a></td>
<td class="num">(614)<span></span>
</td>
<td class="num">(14,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Balance, December 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 571<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrincipalAndAccruedInterestConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents principal and accrued interest converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrincipalAndAccruedInterestConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionExpenseIncludingAssetRetirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481879/410-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionExpenseIncludingAssetRetirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of discount and issuance costs</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 4,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ContractualInterest', window );">Contractual interest</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Total</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 4,489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ContractualInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents contractual interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ContractualInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details 3) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 12, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Valuation Technique, Monte Carlo Pricing Model [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">Term (expiry)</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">66.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">5.26%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.33%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ImpliedDiscountRate', window );">Implied discount rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ImpliedDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents implied discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ImpliedDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_MonteCarloModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_MonteCarloModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details 4) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair value, April 12, 2024</a></td>
<td class="nump">$ 10,315<span></span>
</td>
<td class="nump">$ 7,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Principal payments</a></td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(7,129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangeInFairValue', window );">Change in fair value</a></td>
<td class="num">(1,714)<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Balance, June 30, 2024</a></td>
<td class="nump">$ 7,089<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents change in fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative assets designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details 5) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Term (years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Black Scholes [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing Common Share price</a></td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Term (years)</a></td>
<td class="text">1 year 9 months 10 days<span></span>
</td>
<td class="text">2 years 9 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">82.22%<span></span>
</td>
<td class="nump">66.34%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">3.78%<span></span>
</td>
<td class="nump">4.57%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=niobf_BlackScholesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=niobf_BlackScholesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details 6) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="nump">$ 3,817<span></span>
</td>
<td class="nump">5,880<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember', window );">Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="nump">902<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair Value Adjustment of Warrants</a></td>
<td class="num">(604)<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Other Liabilities, Fair Value Disclosure</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 489<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE DEBT (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 19, 2024</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Transaction loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Principal and accrued interest</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Principal and accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember', window );">Yorkville Convertible Debt Financing Agreement [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise', window );">Number of shares purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,789,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Number of shares purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Principal and accrued interest</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt [Member] | Yorkville Convertible Debt Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleDebenturesMember', window );">Yorkville Convertible Debentures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Convertible debt, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $16,000 aggregate principal
amount of unsecured convertible debentures (the &#8220;Convertible Debentures&#8221;) and (ii) Warrants exercisable for up to
1,789,267 Common Shares for cash or, if at any time there is no effective registration statement registering, or no current
prospectus available for, the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price
per Common Share of approximately $8.9422, subject to adjustment to give effect to any stock dividend, stock split, reverse stock
split or similar transaction.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_StockIssuedDuringPeriodSharesStockOptionsExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents stock issued during period shares stock options exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_StockIssuedDuringPeriodSharesStockOptionsExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_YorkvilleConvertibleDebtFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleDebenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=niobf_YorkvilleConvertibleDebenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Valuation Technique, Option Pricing Model [Member] | Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
<td class="nump">$ 5.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2', window );">Term (expiry)</a></td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">Mar. 17,  2033<span></span>
</td>
<td class="text">Mar. 17,  2033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">33.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.04%<span></span>
</td>
<td class="nump">4.35%<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Details 1) - Earnout [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at beginning</a></td>
<td class="nump">$ 3,817<span></span>
</td>
<td class="nump">$ 10,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ServicingLiabilityAtFairValueAdditionsValue', window );">Change in fair value</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="num">(6,704)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ServicingLiabilityAtFairValueAmount', window );">Fair value at ending</a></td>
<td class="nump">$ 5,880<span></span>
</td>
<td class="nump">$ 3,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ServicingLiabilityAtFairValueAdditionsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents servicing liability at fair value additions value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ServicingLiabilityAtFairValueAdditionsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServicingLiabilityAtFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481229/860-50-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481260/860-50-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481260/860-50-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481260/860-50-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServicingLiabilityAtFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CLASS B COMMON STOCK OF ECRC (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember', window );">Earnout [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Earnout shares</a></td>
<td class="nump">3,391,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DescriptionOfEarnOutShares', window );">Description of earnout shares</a></td>
<td class="text">The
Earnout Shares vest (the &#8220;Released Earnout Shares&#8221;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement. These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=niobf_ClassBCommonStockECRCMember', window );">Class B Common Stock E C R C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Common stock, shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,957,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,957,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Earnout shares</a></td>
<td class="nump">4,565,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DescriptionOfEarnOutShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents description of earn out shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DescriptionOfEarnOutShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=niobf_EarnoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=niobf_ClassBCommonStockECRCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=niobf_ClassBCommonStockECRCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 05, 2024</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPublicWarrantsMember', window );">Series A Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.455<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.43%<span></span>
</td>
<td class="nump">73.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">4.14%<span></span>
</td>
<td class="nump">4.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPublicWarrantsMember', window );">Series B Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.455<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.13%<span></span>
</td>
<td class="nump">73.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 13, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPrivateWarrantsMember', window );">Series A Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.49<span></span>
</td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">1 year 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.26%<span></span>
</td>
<td class="nump">86.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">3.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPrivateWarrantsMember', window );">Series B Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.49<span></span>
</td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">4 years 4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.52%<span></span>
</td>
<td class="nump">74.26%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">3.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 3) - November Private Warrantsliabilities [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation1', window );">Beginning balance</a></td>
<td class="nump">$ 1,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FairValueOfWarrantsExercised', window );">Fair value of Warrants exercised</a></td>
<td class="num">(338)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs', window );">Change in fair value</a></td>
<td class="nump">2,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation1', window );">Ending balance</a></td>
<td class="nump">$ 3,831<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangesInFairValueOfInitialValuation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents changes in fair value of initial valuation1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangesInFairValueOfInitialValuation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FairValueOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fair value of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FairValueOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents servicing assets at fair value changes in fair value resulting from changes in valuation inputs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=niobf_NovemberPrivateWarrantsliabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=niobf_NovemberPrivateWarrantsliabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 4) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 05, 2024</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPublicWarrantsMember', window );">Series A Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.455<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.43%<span></span>
</td>
<td class="nump">73.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">4.14%<span></span>
</td>
<td class="nump">4.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPublicWarrantsMember', window );">Series B Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.455<span></span>
</td>
<td class="nump">$ 2.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.13%<span></span>
</td>
<td class="nump">73.36%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_SeriesAPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_SeriesBPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 5) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CommonStockSharesIssued1', window );">Common shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,671,742<span></span>
</td>
<td class="nump">1,358,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross funds received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 12,352<span></span>
</td>
<td class="nump">$ 3,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Market value of Common Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,941<span></span>
</td>
<td class="nump">3,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer', window );">(Gain)/Loss on Issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 589<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Loss
                                         on issuance represents a non-cash amount equal to the difference between the proceeds
                                         received and the fair value of the Common Shares issued based on the Nasdaq closing price
                                         per Common Share on the issuance date and is recorded in other operating expenses in
                                         the condensed consolidated statement of operations and comprehensive loss.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CommonStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents common stock shares issued1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CommonStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the difference in values (gain (loss)) between the nonmonetary assets or liabilities exchanged with another entity inclusive of boot (small monetary consideration).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 845<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482864/845-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 845<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482864/845-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (t)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 6)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance | shares</a></td>
<td class="nump">2,495,500<span></span>
</td>
<td class="nump">1,541,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance | $ / shares</a></td>
<td class="nump">$ 4.78<span></span>
</td>
<td class="nump">$ 7.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted, in shares | shares</a></td>
<td class="nump">945,000<span></span>
</td>
<td class="nump">1,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted, per share | $ / shares</a></td>
<td class="nump">$ 1.41<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Cancelled/expired, in shares | shares</a></td>
<td class="num">(512)<span></span>
</td>
<td class="num">(7,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Cancelled/expired, per share | $ / shares</a></td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="nump">$ 3.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/expired, in shares | shares</a></td>
<td class="num">(419,988)<span></span>
</td>
<td class="num">(663,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/expired, per share | $ / shares</a></td>
<td class="nump">$ 9.44<span></span>
</td>
<td class="nump">$ 5.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance | shares</a></td>
<td class="nump">3,020,000<span></span>
</td>
<td class="nump">2,495,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance | $ / shares</a></td>
<td class="nump">$ 3.09<span></span>
</td>
<td class="nump">$ 4.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value | $</a></td>
<td class="nump">$ 866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 7) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value per option granted during the period</a></td>
<td class="nump">$ 0.84<span></span>
</td>
<td class="nump">$ 1.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 8) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance, Warrants</a></td>
<td class="nump">18,563,561<span></span>
</td>
<td class="nump">18,816,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Beginning balance at Weighted Average Exercise Price</a></td>
<td class="nump">$ 10.53<span></span>
</td>
<td class="nump">$ 10.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightGranted', window );">Beginning balance, Warrants</a></td>
<td class="nump">13,553,714<span></span>
</td>
<td class="nump">1,593,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceGranted', window );">Beginning balance at Weighted Average Exercise Price</a></td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExpired', window );">Beginning balance, Warrants</a></td>
<td class="num">(1,303,118)<span></span>
</td>
<td class="num">(1,846,560)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceExpired', window );">Beginning balance at Weighted Average Exercise Price</a></td>
<td class="nump">$ 7.72<span></span>
</td>
<td class="nump">$ 8.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercised', window );">Beginning balance, Warrants</a></td>
<td class="num">(828,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ClassOfWarrantOrRightExercisePriceExercised', window );">Beginning balance at Weighted Average Exercise Price</a></td>
<td class="nump">1.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Beginning balance, Warrants</a></td>
<td class="nump">29,985,922<span></span>
</td>
<td class="nump">18,563,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Beginning balance at Weighted Average Exercise Price</a></td>
<td class="nump">$ 7.06<span></span>
</td>
<td class="nump">$ 10.53<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercisePriceGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercise price granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercisePriceGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ClassOfWarrantOrRightGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents class of warrant or right granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ClassOfWarrantOrRightGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>COMMON SHARES (Details 9) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,985,922<span></span>
</td>
<td class="nump">18,563,561<span></span>
</td>
<td class="nump">18,816,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member', window );">Exercise Price 4. 60 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Sep.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member', window );">Exercise Price 3. 54 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">413,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Dec. 22,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member', window );">Exercise Price 2. 20 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Jun. 24,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.75Member', window );">Exercise Price 1. 75 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,117,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nov.  05,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.75OneMember', window );">Exercise Price 1. 75 One [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,992,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nov. 13,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member', window );">Exercise Price 3. 25 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">615,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Apr. 12,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.98Member', window );">Exercise Price 1. 98 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,577,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Aug.  02,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member', window );">Exercise Price 11. 50 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,666,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Mar. 17,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.31Member', window );">Exercise Price 2. 31 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,816,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Sep. 17,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.05Member', window );">Exercise Price 2. 05 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,288,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Jan. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.07Member', window );">Exercise Price 2. 07 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">802,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nov.  05,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.07OneMember', window );">Exercise Price 2. 07 One [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,067,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Expiry date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nov. 13,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.60Member', window );">Exercise Price 2. 60 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,063,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes
    11,165,324 and 4,501,302 2023 Public Warrants and 2023 Private Warrants, respectively, as defined below. Each 2023 Public
    Warrant and 2023 Private Warrant is exercisable into 1.11829212 Common Shares.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice4.60Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.54Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.75Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.75Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.75OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.75OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice3.25Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.98Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice1.98Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice11.50Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.31Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.31Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.05Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.05Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.07Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.07Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.07OneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.07OneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.60Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=niobf_ExercisePrice2.60Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 10) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected warrant life in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetLineItems', window );"><strong>Platform Operator, Crypto Asset [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Stock price on valuation date</a></td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="nump">$ 1.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Strike price</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Implied volatility of public warrants</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="nump">69.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected warrant life in years</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.FF.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476188/405-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 11) - Note Warrant [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation', window );">Initial valuation, at begining</a></td>
<td class="nump">$ 1,353<span></span>
</td>
<td class="nump">$ 3,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs', window );">Change in valuation</a></td>
<td class="nump">1,661<span></span>
</td>
<td class="num">$ (1,926)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExchangeOfPrivateWarrantsForPublicWarrants', window );">Exchange of 2023 Private Warrants for 2023 Public Warrants</a></td>
<td class="num">(482)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation1', window );">Ending balance</a></td>
<td class="nump">$ 2,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangesInFairValueOfInitialValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents changes in fair value of initial valuation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangesInFairValueOfInitialValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangesInFairValueOfInitialValuation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents changes in fair value of initial valuation1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangesInFairValueOfInitialValuation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExchangeOfPrivateWarrantsForPublicWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exchange of private warrants for public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExchangeOfPrivateWarrantsForPublicWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents servicing assets at fair value changes in fair value resulting from changes in valuation inputs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_NoteWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 12) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 17, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.30%<span></span>
</td>
<td class="nump">63.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember', window );">Measurement Input, Exercise Price [Member] | Black Scholes Valuation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Combination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing common share price</a></td>
<td class="nump">$ 1.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Equity volatility</a></td>
<td class="nump">67.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate</a></td>
<td class="nump">3.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-47<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br><br>Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=niobf_BlackScholesValuationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=niobf_BlackScholesValuationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details 13) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of Warrants issued</a></td>
<td class="nump">$ 144<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_WarrantLiabilityMember', window );">Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation', window );">Initial valuation, at begining</a></td>
<td class="nump">2,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of Warrants issued</a></td>
<td class="num">(2,262)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_GainOnIssuanceOfWarrants', window );">Gain on issuance of Warrants</a></td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ChangesInFairValueOfInitialValuation', window );">Valuation, at ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,365<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ChangesInFairValueOfInitialValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents changes in fair value of initial valuation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ChangesInFairValueOfInitialValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_GainOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents gain on issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_GainOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON SHARES (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 13, 2024</div></th>
<th class="th"><div>Nov. 05, 2024</div></th>
<th class="th"><div>Nov. 04, 2024</div></th>
<th class="th"><div>Sep. 17, 2024</div></th>
<th class="th"><div>Sep. 02, 2023</div></th>
<th class="th"><div>Apr. 21, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 24, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants</a></td>
<td class="text">On
November 13, 2024, the Company closed a non-brokered private placement (the &#8220;November 2024 Private Offering&#8221;),
pursuant to binding subscription agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602
units of the Company (the &#8220;November 2024 Units&#8221;). Each November 2024 Unit consisted of one Common Share, one
Warrant (a &#8220;Series A Private Warrant&#8221;) to purchase one Common Share, and one-half of one Warrant (each whole such
Warrant, a &#8220;Series B Private Warrant&#8221; and, together with the Series A Private Warrants, the &#8220;November 2024
Private Warrants&#8221;), with each Series B Private Warrant entitling the holder thereof to purchase one additional Common
Share. Each November 2024 Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company (the
&#8220;Insider Investors&#8221;) purchased November 2024 Units at a price of $1.7675 per November 2024 Unit, which price
includes $0.1975 per November 2024 Private Warrant and allowed such directors and officers to participate in the November
2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private Warrants have an exercise price of
$1.75 per underlying Common Share, are exercisable immediately, and will expire on November 13, 2026. The Series B Private
Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable beginning six months and one day from
the date of issuance and will expire on November 13, 2029. The Company recorded a non-cash expense of $34 and $110 to other
operating expenses and employee related costs, respectively, representing the excess of fair value of the November 2024 Units
over the purchase price paid by Insider Investors.<span></span>
</td>
<td class="text">On
November 5, 2024, the Company closed an underwritten public offering (the &#8220;November 2024 Registered Offering&#8221;),
pursuant to the underwriting agreement, dated November 3, 2024 (the &#8220;Underwriting Agreement&#8221;), with Maxim Group
LLC (&#8220;Maxim&#8221;), as underwriter, which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#8220;Series
A Public Warrants&#8221;) to purchase up to an additional 1,672,090 Common Shares and 836,045 Warrants (the &#8220;Series B
Public Warrants&#8221; and, together with the Series A Public Warrants, the &#8220;November 2024 Public Warrants&#8221;) to
purchase up to an additional 836,045 Common Shares. Each Common Share was sold together with one Series A Public Warrant and
one-half of one Series B Public Warrant at a combined public offering price of $1.57. The gross proceeds from the November
2024 Registered Offering were $2,501 before deducting underwriting discounts and offering expenses. The November 2024 Public
Warrants were classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair
values of the Common Shares and the November 2024 Public Warrants on the date of issuance, with $943 allocated to the fair
value of the November 2024 Public Warrants and the balance of the proceeds of $1,558 allocated to Common Shares. The Company
incurred total transaction costs related to the November 2024 Registered Offering $1,226, which were treated as share
issuance costs at closing. The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are
exercisable immediately, and will expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07
per underlying Common Share, are exercisable beginning six months and one day from the date of issuance and will expire on
November 5, 2029. In addition, pursuant to the Underwriting Agreement, the Company granted Maxim a 45-day over-allotment
option to purchase (i) 238,853 additional Common Shares and (ii) 358,280 Option Warrants (as defined below) to purchase up to
an aggregate of 358,280 Common Shares. &#8220;Option Warrant&#8221; means one Series A Public Warrant combined with one-half
of one Series B Public Warrant. On November 4, 2024, Maxim partially exercised its over-allotment option to purchase
79,734 additional Series A Public Warrants and 39,867
additional Series B Public Warrants, which amounts are included in the amounts discussed above and were issued at closing of
the November 2024 Registered Offering.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Fair value of non operating gain/loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_RegisteredOffering', window );">Registered Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PrivateOffering', window );">Private Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CommonShareDescription', window );">Common share, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On
April 21, 2025, the Company closed an underwritten public offering (the &#8220;April 2025 Offering&#8221;), pursuant to an underwriting
agreement, dated April 17, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold (i) 6,628,846 Common
Shares at a public offering price of $2.60 per Common Share and (ii) 1,063,462 pre-funded Warrants (the
&#8220;April 2025 Pre-Funded Warrants&#8221;) to purchase up to an additional 1,063,462 Common Shares at a public offering price
of $2.5999. The April 2025 Pre-Funded Warrants have an exercise price of $0.0001 per underlying Common Share, are exercisable
immediately, and do not have an expiration date. On April 17, 2025, Maxim partially exercised its over-allotment option to purchase
323,504 additional Common Shares at closing. The gross proceeds from the April 2025 Offering were
approximately $20,841 before deducting underwriting discounts and offering expenses. The April 2025 Pre-Funded Warrants were
classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair values of the Common
Shares and the April 2025 Pre-Funded Warrants on the date of issuance, with $2,765 allocated to the fair value of the April 2025
Pre-Funded Warrants (based on the value of the underlying Common Shares at closing) and the balance of the proceeds of $18,076
allocated to Common Shares. The Company incurred total transaction costs related to the April 2025 Offering of $2,102, which were
treated as share issuance costs at closing.<span></span>
</td>
<td class="text">On
January 31, 2025, the Company closed an underwritten registered direct offering (the &#8220;January 2025 Offering&#8221;), pursuant
to an underwriting agreement, dated January 29, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold
2,577,320 Common Shares, 2,577,320 Series A Warrants to purchase up to 2,577,320 Common Shares (the &#8220;January 2025 Series
A Warrants&#8221;) and 1,288,660 Series B Warrants to purchase up to an additional 1,288,660 Common Shares (the &#8220;January
2025 Series B Warrants&#8221; and, together with the January 2025 Series A Warrants, the &#8220;January 2025 Warrants&#8221;).
Each Common Share was sold together with one January 2025 Series A Warrant and one-half of one January 2025 Series B Warrant at
a combined public offering price of $1.94. The gross proceeds from the January 2025 Offering were approximately $5,000 before
deducting underwriting discounts and offering expenses. The January 2025 Warrants were classified as equity instruments, and accordingly,
the net proceeds were allocated based on the relative fair values of the Common Shares and the January 2025 Warrants on the date
of issuance, with $2,200 allocated to the fair value of the January 2025 Warrants and the balance of the proceeds of $2,800 allocated
to Common Shares. The Company incurred total transaction costs related to the January 2025 Offering of $799, which were treated
as share issuance costs at closing. The January 2025 Series A Warrants have an exercise price of $1.98 per underlying Common Share,
are exercisable immediately, and will expire on August 2, 2027. The January 2025 Series B Warrants have an exercise price of $2.05
per underlying Common Share, are exercisable immediately, and will expire on January 31, 2029.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.44%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Outstanding stock options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_UnrecognizedCompensationCosts', window );">Unrecognized compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 789<span></span>
</td>
<td class="nump">$ 2,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ExchangeOfWarrantsDescription', window );">Exchange of warrants, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">NioCorp Assumed Warrant Agreement, through June 30, 2025, a total of 1,165,365 2023 Private Warrants were
exchanged for 2023 Public Warrants. Upon exchange, the Company recorded an additional fair value expense of $26 and transferred
the fair value of the exchanged 2023 Public Warrants from warrant liabilities to equity.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,816,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=niobf_LindGlobalAssetManagementThreeLLCMember', window );">Lind Global Asset Management Three L L C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription', window );">Contingent consideration description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#8220;Lind Consent&#8221;), between the Company and Lind Global Asset Management III, LLC (&#8220;Lind III&#8221;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#8220;Contingent Consent Warrants&#8221;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance. Further, the number of Contingent Consent Warrants issued would be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember', window );">G X I I Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,999,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember', window );">G X I I Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Warrants traded prior to the closing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember', window );">Lind Consent Warrant Issuance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Common share exercise price, per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=niobf_YorkvilleEquityFacilityFinancingAgreementMember', window );">Yorkville Equity Facility Financing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Expires date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  01,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Remaining proceeds from private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">708<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.85%<span></span>
</td>
<td class="nump">4.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71.63%<span></span>
</td>
<td class="nump">54.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_PublicWarrants2023Member', window );">Public Warrants2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Description of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day
period ending on the third business day prior to the date on which the Company sends the notice of redemption to the Warrant
holders<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=niobf_WarrantLiabilityMember', window );">Warrant Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_GainOnIssuanceOfWarrants', window );">Gain on issuance of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issue</a></td>
<td class="nump">2,199,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SaleOfStockPricePerShare1', window );">Shares price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Employee related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SaleOfStockPricePerShare1', window );">Shares price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Units issue and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_SaleOfStockPricePerShare1', window );">Shares price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Units issue and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesAMember', window );">Purchase Agreement Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DebtInstrumentIssuedPrincipalshars', window );">Debt Instrument Issued Principalshars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesBMember', window );">Purchase Agreement Series B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DebtInstrumentIssuedPrincipalshars', window );">Debt Instrument Issued Principalshars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CommonShareDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents common share description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CommonShareDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DebtInstrumentIssuedPrincipalshars">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents debt instrument issued principalshars.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DebtInstrumentIssuedPrincipalshars</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ExchangeOfWarrantsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents exchange of warrants description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ExchangeOfWarrantsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_GainOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents gain on issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_GainOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PrivateOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents private offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PrivateOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_RegisteredOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents registered offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_RegisteredOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_SaleOfStockPricePerShare1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents sale of stock price per share1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_SaleOfStockPricePerShare1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents share based compensation arrangement by share based payment award fair value assumptions expected volatility rate1.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_UnrecognizedCompensationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents unrecognized compensation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_UnrecognizedCompensationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of contingent consideration arrangement in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482881/825-10-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=niobf_LindGlobalAssetManagementThreeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=niobf_LindGlobalAssetManagementThreeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIPublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_GXIIPrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_LindConsentWarrantIssuanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=niobf_YorkvilleEquityFacilityFinancingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=niobf_YorkvilleEquityFacilityFinancingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_PublicWarrants2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_PublicWarrants2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=niobf_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=niobf_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_PurchaseAgreementSeriesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 30, 2024</div></th>
<th class="th"><div>Sep. 11, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherBorrowings', window );">Other Borrowings</a></td>
<td class="nump">$ 504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding', window );">Interest-Bearing Liabilities, Average Amount Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_BorrowingsMember', window );">Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoanProcessingFee', window );">Loan Origination fees</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember', window );">Non Revolving Credit Facility Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Long-Term Line of Credit, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember', window );">General Security Agreement [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related Party Transaction, Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LineOfCreditFacilityEstablishmentFee', window );">Line Of Credit Facility Establishment Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LineOfCreditFacilityEstablishmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents line of credit facility establishment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LineOfCreditFacilityEstablishmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average amount outstanding of interest-bearing liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph b<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanProcessingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses paid for obtaining loans which includes expenses such as application and origination fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanProcessingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_BorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_BorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_NonRevolvingCreditFacilityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=niobf_GeneralSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of exploration expenditures (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration Expense</a></td>
<td class="nump">$ 4,135<span></span>
</td>
<td class="nump">$ 2,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember', window );">Feasibility Study And Engineering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration Expense</a></td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember', window );">Field Management And Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration Expense</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_DrillingMember', window );">Drilling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration Expense</a></td>
<td class="nump">1,456<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_MetallurgicalMember', window );">Metallurgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration Expense</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">1,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember', window );">Geologists And Field Staff [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExplorationExpense', window );">Exploration Expense</a></td>
<td class="nump">$ 453<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExplorationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&amp;G" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 932<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477215/932-235-50-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExplorationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_FeasibilityStudyAndEngineeringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_FieldManagementAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_DrillingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_DrillingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_MetallurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_MetallurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CostCentreAxis=niobf_GeologistsAndFieldStaffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company incurred lease costs as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_FixedRentExpense', window );">Fixed rent expense</a></td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable rent expense</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost &#8211; other operating expense</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_FixedRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents fixed rent expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_FixedRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The maturity of lease liabilities is as follows at June 30, 2025: (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">$ 98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_TotalLeasePayments', window );">Total lease payments</a></td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LessAmountOfPaymentsRepresentingInterest', window );">Less amount of payments representing interest</a></td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease payments</a></td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_LessCurrentPortionOfOperatingLeaseLiability', window );">Less current portion of operating lease liability</a></td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_OperatingLeasesLiabilityNoncurrent', window );">Noncurrent operating lease liability</a></td>
<td class="nump">$ 33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LessAmountOfPaymentsRepresentingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents less amount of payments representing interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LessAmountOfPaymentsRepresentingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_LessCurrentPortionOfOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents less current portion of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_LessCurrentPortionOfOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_OperatingLeasesLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents operating leases liability noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_OperatingLeasesLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_TotalLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents total lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_TotalLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash payment</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="num">$ (17,982)<span></span>
</td>
<td class="num">$ (12,037)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="num">(13,089)<span></span>
</td>
<td class="num">(8,319)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="num">(4,818)<span></span>
</td>
<td class="num">(3,679)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total</a></td>
<td class="num">$ (75)<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The following table is a reconciliation of income taxes at statutory rates: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax', window );">Loss before income taxes</a></td>
<td class="num">$ (17,982)<span></span>
</td>
<td class="num">$ (12,037)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at Canadian federal rate</a></td>
<td class="num">(2,697)<span></span>
</td>
<td class="num">(1,806)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Income tax benefit at Canadian provincial rate</a></td>
<td class="num">(2,158)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_WarrantLiability', window );">Warrant liability</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="num">(506)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_EarnoutSharesLiability', window );">Earnout shares liability</a></td>
<td class="nump">557<span></span>
</td>
<td class="num">(1,810)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Share based compensation</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion expense</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">1,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Change in estimates related to prior years</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_PaymentsOfStockIssuanceCost', window );">Stock issuance costs in equity</a></td>
<td class="num">(1,143)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ConvertibleNoteValuation', window );">Convertible note valuation</a></td>
<td class="num">(137)<span></span>
</td>
<td class="nump">607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">3,978<span></span>
</td>
<td class="nump">2,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ (0)<span></span>
</td>
<td class="num">$ (139)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ConvertibleNoteValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents convertible note valuation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ConvertibleNoteValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_EarnoutSharesLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents earnout shares liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_EarnoutSharesLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_PaymentsOfStockIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents payments of stock issuance cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_PaymentsOfStockIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481879/410-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479176/718-740-35-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses available for future periods</a></td>
<td class="nump">$ 16,125<span></span>
</td>
<td class="nump">$ 14,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsMineralInterest', window );">Mineral interests</a></td>
<td class="nump">10,438<span></span>
</td>
<td class="nump">9,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsStartupAndOorganizationalCosts', window );">Startup and organizational costs</a></td>
<td class="nump">1,842<span></span>
</td>
<td class="nump">1,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsResearchAndDevelopmentCosts', window );">Research and development costs</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsShareIssuanceCosts', window );">Share issuance/financing costs</a></td>
<td class="nump">1,357<span></span>
</td>
<td class="nump">635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward', window );">Canadian restricted interest and financing carryforward</a></td>
<td class="nump">605<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossesAvailableForFuturePeriods', window );">Capital losses available for future periods</a></td>
<td class="nump">456<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">32,159<span></span>
</td>
<td class="nump">28,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(32,159)<span></span>
</td>
<td class="num">(28,181)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CapitalLossesAvailableForFuturePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents capital losses available for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CapitalLossesAvailableForFuturePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsMineralInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets mineral interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsMineralInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents restricted interest and financing carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsShareIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets share issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsShareIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsStartupAndOorganizationalCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets startup and oorganizational costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsStartupAndOorganizationalCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in the valuation allowance are as follows: (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Valuation allowance, beginning of year</a></td>
<td class="num">$ (28,181)<span></span>
</td>
<td class="num">$ (25,463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_DeferredTaxAssetsValuationAllowanceAdditions', window );">Current year additions</a></td>
<td class="num">(3,978)<span></span>
</td>
<td class="num">(2,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Valuation allowance, end of year</a></td>
<td class="num">$ (32,159)<span></span>
</td>
<td class="num">$ (28,181)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_DeferredTaxAssetsValuationAllowanceAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents deferred tax assets valuation allowance additions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_DeferredTaxAssetsValuationAllowanceAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of cumulative net operating losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">$ 59,933<span></span>
</td>
<td class="nump">$ 52,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">CANADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">53,194<span></span>
</td>
<td class="nump">47,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">6,627<span></span>
</td>
<td class="nump">4,905<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_GB', window );">UNITED KINGDOM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Total</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal Income Tax Expense (Benefit), Continuing Operations</a></td>
<td class="nump">$ 443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 28,181<span></span>
</td>
<td class="nump">$ 32,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CAD', window );">Canada, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossCaryforward', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards', window );">Tax losses incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,645<span></span>
</td>
<td class="nump">$ 981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_CapitalLossCaryforward', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_CapitalLossCaryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents capital loss caryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_CapitalLossCaryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOtherLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOtherLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of fair values determined by level 3 inputs are unobservable data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 25,554<span></span>
</td>
<td class="nump">$ 2,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Investment in equity securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="nump">25,557<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">April 2024 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Earnout Shares liability</a></td>
<td class="nump">5,880<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">6,852<span></span>
</td>
<td class="nump">4,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">12,732<span></span>
</td>
<td class="nump">14,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">25,554<span></span>
</td>
<td class="nump">2,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Investment in equity securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="nump">25,557<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">April 2024 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Earnout Shares liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Investment in equity securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">April 2024 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Earnout Shares liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">6,852<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">6,852<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther', window );">Investment in equity securities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">April 2024 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesFairValueDisclosure', window );">Earnout Shares liability</a></td>
<td class="nump">5,880<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total Liabilities</a></td>
<td class="nump">$ 5,880<span></span>
</td>
<td class="nump">$ 13,271<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_AvailableForSaleSecuritiesEquitySecuritiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents available for sale securities equity securities other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_AvailableForSaleSecuritiesEquitySecuritiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 825<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 18, 2025</div></th>
<th class="th"><div>Aug. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventDescription', window );">Subsequent event description</a></td>
<td class="text">Maxim acted as sole placement agent for the July 2025 Offering. The Company intends to use the net proceeds from the July 2025 Offering for working capital and general corporate purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial operation.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Cash received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Exchnage for shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Purchasesof Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLand', window );">Agregate purchase price</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Do D Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomersForProgressPayments', window );">Reimbursement Payments</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,312<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The element represents share based compensation arrangement by shares based payment award options vested and expected to vest outstanding number.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>niobf_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomersForProgressPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from customers as progress payments on projects that have been partially completed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomersForProgressPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_PurchasesofLandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_PurchasesofLandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=niobf_DoDAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=niobf_DoDAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>208</ContextCount>
  <ElementCount>398</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>80</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>999015 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusiness</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>999016 - Disclosure - BASIS OF PREPARATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPreparation</Role>
      <ShortName>BASIS OF PREPARATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>999017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>999018 - Disclosure - GOING CONCERN ISSUES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcernIssues</Role>
      <ShortName>GOING CONCERN ISSUES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>999019 - Disclosure - LAND AND BUILDINGS, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LandAndBuildingsNet</Role>
      <ShortName>LAND AND BUILDINGS, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>999020 - Disclosure - MINERAL PROPERTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MineralProperties</Role>
      <ShortName>MINERAL PROPERTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>999021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>999022 - Disclosure - CONVERTIBLE DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebt</Role>
      <ShortName>CONVERTIBLE DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>999023 - Disclosure - CLASS B COMMON STOCK OF ECRC</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrc</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>999024 - Disclosure - COMMON SHARES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonShares</Role>
      <ShortName>COMMON SHARES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>999025 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalances</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>999026 - Disclosure - EXPLORATION EXPENDITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpenditures</Role>
      <ShortName>EXPLORATION EXPENDITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>999027 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/Leases</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>999028 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>999029 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>999030 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SegmentInformation</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>999031 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>999032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>999033 - Disclosure - BASIS OF PREPARATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/BasisOfPreparationTables</Role>
      <ShortName>BASIS OF PREPARATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/BasisOfPreparation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>999034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>999035 - Disclosure - LAND AND BUILDINGS, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LandAndBuildingsNetTables</Role>
      <ShortName>LAND AND BUILDINGS, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/LandAndBuildingsNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>999036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>999037 - Disclosure - CONVERTIBLE DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtTables</Role>
      <ShortName>CONVERTIBLE DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebt</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>999038 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrc</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>999039 - Disclosure - COMMON SHARES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesTables</Role>
      <ShortName>COMMON SHARES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonShares</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>999040 - Disclosure - EXPLORATION EXPENDITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ExplorationExpendituresTables</Role>
      <ShortName>EXPLORATION EXPENDITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/ExplorationExpenditures</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>999041 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LeasesTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/Leases</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>999042 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/IncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>999043 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://niocorp.com/role/FairValueMeasurements</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>999044 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details</Role>
      <ShortName>These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>999045 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/DescriptionOfBusiness</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>999046 - Disclosure - The following table sets forth the computation of the Company???s basic and diluted net loss per share attributable to common shareholders: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails</Role>
      <ShortName>The following table sets forth the computation of the Company???s basic and diluted net loss per share attributable to common shareholders: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>999047 - Disclosure - Schedule of excluded from the dilutive securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails</Role>
      <ShortName>Schedule of excluded from the dilutive securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>999048 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>999049 - Disclosure - GOING CONCERN ISSUES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/GoingConcernIssuesDetailsNarrative</Role>
      <ShortName>GOING CONCERN ISSUES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/GoingConcernIssues</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>999050 - Disclosure - Schedule of properties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfPropertiesDetails</Role>
      <ShortName>Schedule of properties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>999051 - Disclosure - MINERAL PROPERTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MineralPropertiesDetailsNarrative</Role>
      <ShortName>MINERAL PROPERTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/MineralProperties</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>999052 - Disclosure - Schedule of account payable and accrued liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Schedule of account payable and accrued liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>999053 - Disclosure - CONVERTIBLE DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetails</Role>
      <ShortName>CONVERTIBLE DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>999054 - Disclosure - CONVERTIBLE DEBT (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetails1</Role>
      <ShortName>CONVERTIBLE DEBT (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>999055 - Disclosure - CONVERTIBLE DEBT (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetails2</Role>
      <ShortName>CONVERTIBLE DEBT (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>999056 - Disclosure - CONVERTIBLE DEBT (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetails3</Role>
      <ShortName>CONVERTIBLE DEBT (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>999057 - Disclosure - CONVERTIBLE DEBT (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetails4</Role>
      <ShortName>CONVERTIBLE DEBT (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>999058 - Disclosure - CONVERTIBLE DEBT (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetails5</Role>
      <ShortName>CONVERTIBLE DEBT (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>999059 - Disclosure - CONVERTIBLE DEBT (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetails6</Role>
      <ShortName>CONVERTIBLE DEBT (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>999060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ConvertibleDebtDetailsNarrative</Role>
      <ShortName>CONVERTIBLE DEBT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ConvertibleDebtTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>999061 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcDetails</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>999062 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>999063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative</Role>
      <ShortName>CLASS B COMMON STOCK OF ECRC (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/ClassBCommonStockOfEcrcTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>999064 - Disclosure - COMMON SHARES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails</Role>
      <ShortName>COMMON SHARES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>999065 - Disclosure - COMMON SHARES (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails1</Role>
      <ShortName>COMMON SHARES (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>999066 - Disclosure - COMMON SHARES (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails3</Role>
      <ShortName>COMMON SHARES (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>999067 - Disclosure - COMMON SHARES (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails4</Role>
      <ShortName>COMMON SHARES (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>999068 - Disclosure - COMMON SHARES (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails5</Role>
      <ShortName>COMMON SHARES (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>999069 - Disclosure - COMMON SHARES (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails6</Role>
      <ShortName>COMMON SHARES (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>999070 - Disclosure - COMMON SHARES (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails7</Role>
      <ShortName>COMMON SHARES (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>999071 - Disclosure - COMMON SHARES (Details 8)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails8</Role>
      <ShortName>COMMON SHARES (Details 8)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>999072 - Disclosure - COMMON SHARES (Details 9)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails9</Role>
      <ShortName>COMMON SHARES (Details 9)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>999073 - Disclosure - COMMON SHARES (Details 10)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails10</Role>
      <ShortName>COMMON SHARES (Details 10)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>999074 - Disclosure - COMMON SHARES (Details 11)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails11</Role>
      <ShortName>COMMON SHARES (Details 11)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>999075 - Disclosure - COMMON SHARES (Details 12)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails12</Role>
      <ShortName>COMMON SHARES (Details 12)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>999076 - Disclosure - COMMON SHARES (Details 13)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetails13</Role>
      <ShortName>COMMON SHARES (Details 13)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>999077 - Disclosure - COMMON SHARES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CommonSharesDetailsNarrative</Role>
      <ShortName>COMMON SHARES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/CommonSharesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>999078 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/RelatedPartyTransactionsAndBalances</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>999079 - Disclosure - Schedule of exploration expenditures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails</Role>
      <ShortName>Schedule of exploration expenditures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>999080 - Disclosure - The Company incurred lease costs as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails</Role>
      <ShortName>The Company incurred lease costs as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>999081 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2025: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details</Role>
      <ShortName>The maturity of lease liabilities is as follows at June 30, 2025: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>999082 - Disclosure - LEASES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/LeasesDetailsNarrative</Role>
      <ShortName>LEASES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/LeasesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>999083 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails</Role>
      <ShortName>Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>999084 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails</Role>
      <ShortName>The following table is a reconciliation of income taxes at statutory rates: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>999085 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails</Role>
      <ShortName>Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>999086 - Disclosure - Changes in the valuation allowance are as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails</Role>
      <ShortName>Changes in the valuation allowance are as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>999087 - Disclosure - Schedule of cumulative net operating losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails</Role>
      <ShortName>Schedule of cumulative net operating losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>999088 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/IncomeTaxesTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>999089 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails</Role>
      <ShortName>Schedule of fair values determined by level 3 inputs are unobservable data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="n2574_x280-10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>999090 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://niocorp.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://niocorp.com/role/SubsequentEvents</ParentRole>
      <Position>88</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="n2574_x280-10k.htm">n2574_x280-10k.htm</File>
    <File>niobf-20250630.xsd</File>
    <File>niobf-20250630_cal.xml</File>
    <File>niobf-20250630_def.xml</File>
    <File>niobf-20250630_lab.xml</File>
    <File>niobf-20250630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>n257410kimg001.jpg</File>
    <File>n257410kimg002.jpg</File>
    <File>n257410kimg003.jpg</File>
    <File>n257410kimg004.jpg</File>
    <File>n257410kimg005.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="715">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>145
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "n2574_x280-10k.htm": {
   "nsprefix": "niobf",
   "nsuri": "http://niocorp.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "n2574_x280-10k.htm"
     ]
    },
    "schema": {
     "local": [
      "niobf-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "niobf-20250630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "niobf-20250630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "niobf-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "niobf-20250630_pre.xml"
     ]
    }
   },
   "keyStandard": 304,
   "keyCustom": 94,
   "axisStandard": 24,
   "axisCustom": 1,
   "memberStandard": 28,
   "memberCustom": 51,
   "hidden": {
    "total": 126,
    "http://fasb.org/us-gaap/2025": 90,
    "http://xbrl.sec.gov/dei/2025": 7,
    "http://niocorp.com/20250630": 29
   },
   "contextCount": 208,
   "entityCount": 1,
   "segmentCount": 80,
   "elementCount": 701,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 715,
    "http://xbrl.sec.gov/dei/2025": 41,
    "http://xbrl.sec.gov/ecd/2025": 10,
    "http://xbrl.sec.gov/cyd/2025": 7
   },
   "report": {
    "R1": {
     "role": "http://niocorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://niocorp.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://niocorp.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss",
     "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical",
     "longName": "00000005 - Statement - Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:EarningsPerShareBasic",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://niocorp.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ChangeInFairValueOfEarnoutShareLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ChangeInFairValueOfEarnoutShareLiability",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest",
     "longName": "00000007 - Statement - Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest",
     "shortName": "Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2025-04-012025-06-30",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-04-012025-06-30",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://niocorp.com/role/DescriptionOfBusiness",
     "longName": "999015 - Disclosure - DESCRIPTION OF BUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://niocorp.com/role/BasisOfPreparation",
     "longName": "999016 - Disclosure - BASIS OF PREPARATION",
     "shortName": "BASIS OF PREPARATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:BasisOfAccounting",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://niocorp.com/role/SignificantAccountingPolicies",
     "longName": "999017 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://niocorp.com/role/GoingConcernIssues",
     "longName": "999018 - Disclosure - GOING CONCERN ISSUES",
     "shortName": "GOING CONCERN ISSUES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://niocorp.com/role/LandAndBuildingsNet",
     "longName": "999019 - Disclosure - LAND AND BUILDINGS, NET",
     "shortName": "LAND AND BUILDINGS, NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://niocorp.com/role/MineralProperties",
     "longName": "999020 - Disclosure - MINERAL PROPERTIES",
     "shortName": "MINERAL PROPERTIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:MineralIndustriesDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:MineralIndustriesDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "999021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://niocorp.com/role/ConvertibleDebt",
     "longName": "999022 - Disclosure - CONVERTIBLE DEBT",
     "shortName": "CONVERTIBLE DEBT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrc",
     "longName": "999023 - Disclosure - CLASS B COMMON STOCK OF ECRC",
     "shortName": "CLASS B COMMON STOCK OF ECRC",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://niocorp.com/role/CommonShares",
     "longName": "999024 - Disclosure - COMMON SHARES",
     "shortName": "COMMON SHARES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalances",
     "longName": "999025 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://niocorp.com/role/ExplorationExpenditures",
     "longName": "999026 - Disclosure - EXPLORATION EXPENDITURES",
     "shortName": "EXPLORATION EXPENDITURES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ExplorationExpendituresDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://niocorp.com/role/Leases",
     "longName": "999027 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://niocorp.com/role/IncomeTaxes",
     "longName": "999028 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://niocorp.com/role/FairValueMeasurements",
     "longName": "999029 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://niocorp.com/role/SegmentInformation",
     "longName": "999030 - Disclosure - SEGMENT INFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://niocorp.com/role/SubsequentEvents",
     "longName": "999031 - Disclosure - SUBSEQUENT EVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesPolicies",
     "longName": "999032 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:DevelopmentStageIssuerPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:DevelopmentStageIssuerPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://niocorp.com/role/BasisOfPreparationTables",
     "longName": "999033 - Disclosure - BASIS OF PREPARATION (Tables)",
     "shortName": "BASIS OF PREPARATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesTables",
     "longName": "999034 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://niocorp.com/role/LandAndBuildingsNetTables",
     "longName": "999035 - Disclosure - LAND AND BUILDINGS, NET (Tables)",
     "shortName": "LAND AND BUILDINGS, NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables",
     "longName": "999036 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://niocorp.com/role/ConvertibleDebtTables",
     "longName": "999037 - Disclosure - CONVERTIBLE DEBT (Tables)",
     "shortName": "CONVERTIBLE DEBT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcTables",
     "longName": "999038 - Disclosure - CLASS B COMMON STOCK OF ECRC (Tables)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://niocorp.com/role/CommonSharesTables",
     "longName": "999039 - Disclosure - COMMON SHARES (Tables)",
     "shortName": "COMMON SHARES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://niocorp.com/role/ExplorationExpendituresTables",
     "longName": "999040 - Disclosure - EXPLORATION EXPENDITURES (Tables)",
     "shortName": "EXPLORATION EXPENDITURES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://niocorp.com/role/LeasesTables",
     "longName": "999041 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://niocorp.com/role/IncomeTaxesTables",
     "longName": "999042 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://niocorp.com/role/FairValueMeasurementsTables",
     "longName": "999043 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details",
     "longName": "999044 - Disclosure - These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)",
     "shortName": "These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated. (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2024-07-012025-06-30_custom_Entity0896800BCLtdMember",
      "name": "niobf:IncorporationStateCountryName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_custom_Entity0896800BCLtdMember",
      "name": "niobf:IncorporationStateCountryName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "us-gaap:BasisOfAccounting",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative",
     "longName": "999045 - Disclosure - DESCRIPTION OF BUSINESS (Details Narrative)",
     "shortName": "DESCRIPTION OF BUSINESS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R44": {
     "role": "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
     "longName": "999046 - Disclosure - The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders: (Details)",
     "shortName": "The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails",
     "longName": "999047 - Disclosure - Schedule of excluded from the dilutive securities (Details)",
     "shortName": "Schedule of excluded from the dilutive securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative",
     "longName": "999048 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:MineralPropertiesAccumulatedImpairment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "niobf:MineralPropertiesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:MineralPropertiesAccumulatedImpairment",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "niobf:MineralPropertiesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative",
     "longName": "999049 - Disclosure - GOING CONCERN ISSUES (Details Narrative)",
     "shortName": "GOING CONCERN ISSUES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ProceedsFromIssuanceOfDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://niocorp.com/role/ScheduleOfPropertiesDetails",
     "longName": "999050 - Disclosure - Schedule of properties (Details)",
     "shortName": "Schedule of properties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:PropertyPlantAndEquipmentOther",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://niocorp.com/role/MineralPropertiesDetailsNarrative",
     "longName": "999051 - Disclosure - MINERAL PROPERTIES (Details Narrative)",
     "shortName": "MINERAL PROPERTIES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ExplorationExpenseForOTPExtensionPayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:MineralIndustriesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:ExplorationExpenseForOTPExtensionPayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:MineralIndustriesDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails",
     "longName": "999052 - Disclosure - Schedule of account payable and accrued liabilities (Details)",
     "shortName": "Schedule of account payable and accrued liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetails",
     "longName": "999053 - Disclosure - CONVERTIBLE DEBT (Details)",
     "shortName": "CONVERTIBLE DEBT (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_custom_YorkvilleConvertibleDebenturesMember",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetails1",
     "longName": "999054 - Disclosure - CONVERTIBLE DEBT (Details 1)",
     "shortName": "CONVERTIBLE DEBT (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_us-gaap_ConvertibleDebtSecuritiesMember",
      "name": "us-gaap:ConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetails2",
     "longName": "999055 - Disclosure - CONVERTIBLE DEBT (Details 2)",
     "shortName": "CONVERTIBLE DEBT (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetails3",
     "longName": "999056 - Disclosure - CONVERTIBLE DEBT (Details 3)",
     "shortName": "CONVERTIBLE DEBT (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember",
      "name": "niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetails4",
     "longName": "999057 - Disclosure - CONVERTIBLE DEBT (Details 4)",
     "shortName": "CONVERTIBLE DEBT (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-12",
      "name": "us-gaap:FairValueHedgeAssetsAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-12",
      "name": "us-gaap:FairValueHedgeAssetsAtFairValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetails5",
     "longName": "999058 - Disclosure - CONVERTIBLE DEBT (Details 5)",
     "shortName": "CONVERTIBLE DEBT (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetails6",
     "longName": "999059 - Disclosure - CONVERTIBLE DEBT (Details 6)",
     "shortName": "CONVERTIBLE DEBT (Details 6)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OtherLiabilitiesFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-12_custom_EarnoutMember",
      "name": "us-gaap:OtherLiabilitiesFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
     "longName": "999060 - Disclosure - CONVERTIBLE DEBT (Details Narrative)",
     "shortName": "CONVERTIBLE DEBT (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember",
      "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
     "longName": "999061 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
       "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1",
     "longName": "999062 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30_custom_EarnoutMember",
      "name": "us-gaap:ServicingLiabilityAtFairValueAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
       "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
     "longName": "999063 - Disclosure - CLASS B COMMON STOCK OF ECRC (Details Narrative)",
     "shortName": "CLASS B COMMON STOCK OF ECRC (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2024-07-012025-06-30_custom_EarnoutMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_custom_EarnoutMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "niobf:DisclosureOfClassBCommonStockOfECRCTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://niocorp.com/role/CommonSharesDetails",
     "longName": "999064 - Disclosure - COMMON SHARES (Details)",
     "shortName": "COMMON SHARES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R63": {
     "role": "http://niocorp.com/role/CommonSharesDetails1",
     "longName": "999065 - Disclosure - COMMON SHARES (Details 1)",
     "shortName": "COMMON SHARES (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-13_custom_SeriesAPrivateWarrantsMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://niocorp.com/role/CommonSharesDetails3",
     "longName": "999066 - Disclosure - COMMON SHARES (Details 3)",
     "shortName": "COMMON SHARES (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-13_custom_NovemberPrivateWarrantsliabilitiesMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-13_custom_NovemberPrivateWarrantsliabilitiesMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://niocorp.com/role/CommonSharesDetails4",
     "longName": "999067 - Disclosure - COMMON SHARES (Details 4)",
     "shortName": "COMMON SHARES (Details 4)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R66": {
     "role": "http://niocorp.com/role/CommonSharesDetails5",
     "longName": "999068 - Disclosure - COMMON SHARES (Details 5)",
     "shortName": "COMMON SHARES (Details 5)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:CommonStockSharesIssued1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:CommonStockSharesIssued1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://niocorp.com/role/CommonSharesDetails6",
     "longName": "999069 - Disclosure - COMMON SHARES (Details 6)",
     "shortName": "COMMON SHARES (Details 6)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://niocorp.com/role/CommonSharesDetails7",
     "longName": "999070 - Disclosure - COMMON SHARES (Details 7)",
     "shortName": "COMMON SHARES (Details 7)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://niocorp.com/role/CommonSharesDetails8",
     "longName": "999071 - Disclosure - COMMON SHARES (Details 8)",
     "shortName": "COMMON SHARES (Details 8)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://niocorp.com/role/CommonSharesDetails9",
     "longName": "999072 - Disclosure - COMMON SHARES (Details 9)",
     "shortName": "COMMON SHARES (Details 9)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30_custom_ExercisePrice4.60Member",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://niocorp.com/role/CommonSharesDetails10",
     "longName": "999073 - Disclosure - COMMON SHARES (Details 10)",
     "shortName": "COMMON SHARES (Details 10)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "Ratio",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://niocorp.com/role/CommonSharesDetails11",
     "longName": "999074 - Disclosure - COMMON SHARES (Details 11)",
     "shortName": "COMMON SHARES (Details 11)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30_us-gaap_NoteWarrantMember",
      "name": "niobf:ChangesInFairValueOfInitialValuation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://niocorp.com/role/CommonSharesDetails12",
     "longName": "999075 - Disclosure - COMMON SHARES (Details 12)",
     "shortName": "COMMON SHARES (Details 12)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://niocorp.com/role/CommonSharesDetails13",
     "longName": "999076 - Disclosure - COMMON SHARES (Details 13)",
     "shortName": "COMMON SHARES (Details 13)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_custom_WarrantLiabilityMember",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://niocorp.com/role/CommonSharesDetailsNarrative",
     "longName": "999077 - Disclosure - COMMON SHARES (Details Narrative)",
     "shortName": "COMMON SHARES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2024-11-012024-11-13",
      "name": "us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-11-012024-11-13",
      "name": "us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative",
     "longName": "999078 - Disclosure - RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "shortName": "RELATED PARTY TRANSACTIONS AND BALANCES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "AsOf2024-10-30",
      "name": "us-gaap:OtherBorrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-10-30",
      "name": "us-gaap:OtherBorrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
     "longName": "999079 - Disclosure - Schedule of exploration expenditures (Details)",
     "shortName": "Schedule of exploration expenditures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_custom_FeasibilityStudyAndEngineeringMember",
      "name": "us-gaap:ExplorationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "niobf:ScheduleOfExplorationExpendituresTableTextBlock",
       "niobf:ExplorationExpendituresDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails",
     "longName": "999080 - Disclosure - The Company incurred lease costs as follows: (Details)",
     "shortName": "The Company incurred lease costs as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "niobf:FixedRentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details",
     "longName": "999081 - Disclosure - The maturity of lease liabilities is as follows at June 30, 2025: (Details)",
     "shortName": "The maturity of lease liabilities is as follows at June 30, 2025: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://niocorp.com/role/LeasesDetailsNarrative",
     "longName": "999082 - Disclosure - LEASES (Details Narrative)",
     "shortName": "LEASES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
     "longName": "999083 - Disclosure - Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)",
     "shortName": "Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012025-06-30_country_CA",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails",
     "longName": "999084 - Disclosure - The following table is a reconciliation of income taxes at statutory rates: (Details)",
     "shortName": "The following table is a reconciliation of income taxes at statutory rates: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-01to2025-06-30",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails",
     "longName": "999085 - Disclosure - Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)",
     "shortName": "Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes a (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails",
     "longName": "999086 - Disclosure - Changes in the valuation allowance are as follows: (Details)",
     "shortName": "Changes in the valuation allowance are as follows: (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:DeferredTaxAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-06-30",
      "name": "us-gaap:DeferredTaxAssetsNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails",
     "longName": "999087 - Disclosure - Schedule of cumulative net operating losses (Details)",
     "shortName": "Schedule of cumulative net operating losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://niocorp.com/role/IncomeTaxesDetailsNarrative",
     "longName": "999088 - Disclosure - INCOME TAXES (Details Narrative)",
     "shortName": "INCOME TAXES (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "From2023-07-012024-06-30",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012024-06-30",
      "name": "us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails",
     "longName": "999089 - Disclosure - Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "shortName": "Schedule of fair values determined by level 3 inputs are unobservable data (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-30",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://niocorp.com/role/SubsequentEventsDetailsNarrative",
     "longName": "999090 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "From2025-07-012025-08-26_us-gaap_SubsequentEventMember",
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-07-012025-08-26_us-gaap_SubsequentEventMember",
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "n2574_x280-10k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r55",
      "r58",
      "r1132"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan origination fees payable to related party",
        "documentation": "Fair value portion of trade and related party payables and accrued expenses."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1163",
      "r1167",
      "r1171",
      "r1172",
      "r1173",
      "r1175"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued liabilities",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r854"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable, trade",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r53"
     ]
    },
    "us-gaap_AccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccretionExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of convertible debt",
        "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations."
       }
      }
     },
     "auth_ref": [
      "r819",
      "r1111"
     ]
    },
    "us-gaap_AccretionExpenseIncludingAssetRetirementObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccretionExpenseIncludingAssetRetirementObligations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion expense",
        "documentation": "Amount of accretion expense, which includes, but is not limited to, accretion expense from asset retirement obligations, environmental remediation obligations, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Exploration Stage Obligations",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Environmental accruals",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r118",
      "r643"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails13",
      "http://niocorp.com/role/CommonSharesDetails4",
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r472",
      "r473",
      "r474",
      "r475",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r67",
      "r124",
      "r639",
      "r669",
      "r670",
      "r1158"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails13",
      "http://niocorp.com/role/CommonSharesDetails4",
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136",
      "r472",
      "r473",
      "r474",
      "r475",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r8",
      "r14",
      "r467",
      "r470",
      "r540",
      "r665",
      "r666",
      "r1025",
      "r1026",
      "r1027",
      "r1087",
      "r1088",
      "r1089",
      "r1090"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1120",
      "r1127"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r915",
      "r926",
      "r940",
      "r967"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r918",
      "r929",
      "r943",
      "r970"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r955"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2025",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r919",
      "r930",
      "r944",
      "r962",
      "r971",
      "r975",
      "r983"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of discount and issuance costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r307",
      "r1077",
      "r1179"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "niobf_April2024ConvertibleSecurityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "April2024ConvertibleSecurityMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April2024 Convertible Security [Member]",
        "documentation": "The element represents april2024 convertible security member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of long-lived assets",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r28",
      "r864",
      "r865"
     ]
    },
    "us-gaap_AssetRetirementObligationAccretionExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligationAccretionExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accretion expense",
        "label": "Asset Retirement Obligation, Accretion Expense",
        "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r281",
      "r282"
     ]
    },
    "us-gaap_AssetRetirementObligationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetRetirementObligationsPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Retirement Obligation",
        "documentation": "Disclosure of accounting policy for legal obligation associated with retirement of long-lived asset that results from acquisition, construction, or development or from normal operation of long-lived asset. Excludes environmental remediation liability from improper or other-than-normal operation of long-lived asset, obligation arising in connection with leased property that meets definition of lease payments or variable lease payments and from plan to sell or otherwise dispose of a long-lived asset."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r101",
      "r119",
      "r155",
      "r156",
      "r157",
      "r199",
      "r209",
      "r216",
      "r219",
      "r259",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r458",
      "r463",
      "r505",
      "r626",
      "r627",
      "r635",
      "r722",
      "r813",
      "r814",
      "r825",
      "r854",
      "r871",
      "r872",
      "r885",
      "r1114",
      "r1115",
      "r1190"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r126",
      "r155",
      "r156",
      "r157",
      "r259",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r458",
      "r463",
      "r505",
      "r854",
      "r1114",
      "r1115",
      "r1190"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Assets",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r842"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r899",
      "r922"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r899",
      "r922"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r899",
      "r922"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "niobf_AvailableForSaleSecuritiesEquitySecuritiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "AvailableForSaleSecuritiesEquitySecuritiesOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment in equity securities",
        "documentation": "The element represents available for sale securities equity securities other.",
        "label": "Available For Sale Securities Equity Securities Other"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "us-gaap_BasisOfAccounting": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccounting",
     "presentation": [
      "http://niocorp.com/role/BasisOfPreparation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BASIS OF PREPARATION",
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "niobf_BlackScholesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "BlackScholesMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Black Scholes [Member]",
        "documentation": "The element represents black scholes member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_BlackScholesValuationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "BlackScholesValuationMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Black Scholes Valuation [Member]",
        "documentation": "The element represents black scholes valuation member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BorrowingsMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings [Member]",
        "documentation": "Obligations to pay to another in accordance with an expressed or implied agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BuildingMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r672",
      "r834",
      "r835",
      "r1141",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r672",
      "r834",
      "r835",
      "r1141",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction loss",
        "documentation": "Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost."
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r401",
      "r402",
      "r403",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r448",
      "r449",
      "r450",
      "r453",
      "r837",
      "r839",
      "r1141",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationContingentConsiderationArrangementsDescription",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration description",
        "documentation": "Description of contingent consideration arrangement in business combination."
       }
      }
     },
     "auth_ref": [
      "r444",
      "r450",
      "r837",
      "r838"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value",
        "documentation": "The expenses and losses recorded for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination."
       }
      }
     },
     "auth_ref": [
      "r1140",
      "r1142"
     ]
    },
    "country_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CA",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA"
       }
      }
     },
     "auth_ref": []
    },
    "currency_CAD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2025",
     "localname": "CAD",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CapitalLossCaryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "CapitalLossCaryforward",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "The element represents capital loss caryforward."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CapitalLossesAvailableForFuturePeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "CapitalLossesAvailableForFuturePeriods",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital losses available for future periods",
        "documentation": "The element represents capital losses available for future periods."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedCostsMineralInterestsInUnprovedProperties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalizedCostsMineralInterestsInUnprovedProperties",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral properties",
        "documentation": "Amount, before accumulated depreciation, depletion, amortization, and valuation allowance, of capitalized cost for mineral interest in unproved property in oil- and gas-producing activities."
       }
      }
     },
     "auth_ref": [
      "r1192",
      "r1193",
      "r1194",
      "r1195"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r116",
      "r792"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r499",
      "r500",
      "r1162",
      "r1163"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r77",
      "r152"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Change in cash and cash equivalents during period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r77"
     ]
    },
    "niobf_ChangeInFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangeInFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value",
        "documentation": "The element represents change in fair value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfConvertibleNoteValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangeInFairValueOfConvertibleNoteValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of convertible note",
        "documentation": "The element represents change in fair value of convertible note value.",
        "label": "Change in fair value of convertible note value"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfConvertibleNotesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangeInFairValueOfConvertibleNotesValue",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of convertible notes",
        "documentation": "The element represents change in fair value of convertible notes value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfEarnoutShareLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangeInFairValueOfEarnoutShareLiability",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in valuation of earnout shares liability",
        "documentation": "The element represents change in fair value of earnout share liability.",
        "label": "Change In Fair Value Of Earnout Share Liability"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfEarnoutSharesLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangeInFairValueOfEarnoutSharesLiabilityValue",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of earnout shares liability",
        "documentation": "The element represents change in fair value of earn out shares liability value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInFairValueOfWarrantLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangeInFairValueOfWarrantLiabilityValue",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of warrant liabilities",
        "documentation": "The element represents change in fair value of warrant liability value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangeInValuationOfWarrantLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangeInValuationOfWarrantLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in valuation of warrant liabilities",
        "documentation": "The element represents change in valuation of warrant liabilities.",
        "label": "Change In Valuation Of Warrant Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "niobf_ChangesInFairValueOfInitialValuation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangesInFairValueOfInitialValuation",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11",
      "http://niocorp.com/role/CommonSharesDetails13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Initial valuation, at begining",
        "periodEndLabel": "Valuation, at ending",
        "documentation": "The element represents changes in fair value of initial valuation.",
        "label": "Changes In Fair Value Of Initial Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ChangesInFairValueOfInitialValuation1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ChangesInFairValueOfInitialValuation1",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11",
      "http://niocorp.com/role/CommonSharesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "documentation": "The element represents changes in fair value of initial valuation1.",
        "label": "Changes In Fair Value Of Initial Valuation1"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassBCommonStockECRCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ClassBCommonStockECRCMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock E C R C [Member]",
        "documentation": "The element represents class b common stock e c r c member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r121",
      "r122",
      "r123",
      "r155",
      "r157",
      "r182",
      "r186",
      "r194",
      "r196",
      "r201",
      "r202",
      "r259",
      "r283",
      "r285",
      "r286",
      "r287",
      "r290",
      "r291",
      "r311",
      "r312",
      "r314",
      "r315",
      "r317",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r505",
      "r675",
      "r676",
      "r677",
      "r678",
      "r686",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r710",
      "r730",
      "r755",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r1004",
      "r1081",
      "r1083",
      "r1092"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercisePriceExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ClassOfWarrantOrRightExercisePriceExercised",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Beginning balance at Weighted Average Exercise Price",
        "documentation": "The element represents class of warrant or right exercise price exercised.",
        "label": "Class Of Warrant Or Right Exercise Price Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceExpired": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ClassOfWarrantOrRightExercisePriceExpired",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Beginning balance at Weighted Average Exercise Price",
        "documentation": "The element represents class of warrant or right exercise price expired.",
        "label": "Class Of Warrant Or Right Exercise Price Expired"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExercisePriceGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ClassOfWarrantOrRightExercisePriceGranted",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Beginning balance at Weighted Average Exercise Price",
        "documentation": "The element represents class of warrant or right exercise price granted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of shares purchase",
        "label": "Exercise price",
        "terseLabel": "Common share exercise price, per share",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r160",
      "r328"
     ]
    },
    "niobf_ClassOfWarrantOrRightExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ClassOfWarrantOrRightExercised",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Beginning balance, Warrants",
        "documentation": "The element represents class of warrant or right exercised.",
        "label": "Class Of Warrant Or Right Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ClassOfWarrantOrRightExpired",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Beginning balance, Warrants",
        "documentation": "The element represents class of warrant or right expired.",
        "label": "Class Of Warrant Or Right Expired"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ClassOfWarrantOrRightGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ClassOfWarrantOrRightGranted",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Beginning balance, Warrants",
        "documentation": "The element represents class of warrant or right granted."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8",
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, Warrants",
        "periodEndLabel": "Beginning balance, Warrants",
        "label": "Number of share outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of warrants",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r96",
      "r637",
      "r709"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "niobf_CommonShareDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "CommonShareDescription",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common share, description",
        "documentation": "The element represents common share description."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CommonSharesWithoutParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "CommonSharesWithoutParValueMember",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Without Par Value [Member]",
        "documentation": "The element represents common shares without par value member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r875",
      "r876",
      "r878",
      "r879",
      "r880",
      "r881",
      "r1087",
      "r1088",
      "r1090",
      "r1159",
      "r1228",
      "r1233"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_CommonStockSharesAuthorizedUnlimited": {
     "xbrltype": "authorizedUnlimitedItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorizedUnlimited",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, authorized",
        "documentation": "Indicates whether number of common shares permitted to be issued is unlimited. Acceptable value is \"Unlimited\"."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "niobf_CommonStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "CommonStockSharesIssued1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares issued",
        "documentation": "The element represents common stock shares issued1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/BalanceSheetsParenthetical",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, outstanding",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r62",
      "r710",
      "r728",
      "r1233",
      "r1234"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, no par value, unlimited shares authorized;\u00a0 58,491,196 and 38,062,647 shares outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r312",
      "r319",
      "r638",
      "r854"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OciEquityMethodInvestmentBeforeTaxParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss and comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r131",
      "r133",
      "r139",
      "r624",
      "r651",
      "r653"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OciEquityMethodInvestmentBeforeTaxParent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributable to redeemable noncontrolling interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r42",
      "r45",
      "r131",
      "r133",
      "r138",
      "r623",
      "r651",
      "r652"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r502",
      "r503"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]",
        "documentation": "Disclosure of information about effect of change in parent's ownership interest in subsidiary on equity attributable to parent. Excludes change from deconsolidation of subsidiary."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r46"
     ]
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "presentation": [
      "http://niocorp.com/role/BasisOfPreparationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "These consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All intercompany transactions and balances have been eliminated.",
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r46"
     ]
    },
    "niobf_ContractualInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ContractualInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contractual interest",
        "documentation": "The element represents contractual interest."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ConversionsOfDebtForCommonShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ConversionsOfDebtForCommonShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of debt for common shares",
        "documentation": "The element represents conversions of debt for common shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails",
      "http://niocorp.com/role/ConvertibleDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total convertible debt",
        "periodStartLabel": "Balance at June 30, 2024",
        "periodEndLabel": "Balance, December 31, 2024",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r95",
      "r1197"
     ]
    },
    "niobf_ConvertibleDebtCarriedatFairValuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ConvertibleDebtCarriedatFairValuePolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt Carried at Fair Value",
        "documentation": "The element represents convertible debt carriedat fair value policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtSecuritiesMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt Securities [Member]",
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r1124",
      "r1125"
     ]
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in the convertible debentures",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ConvertibleNoteValuation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ConvertibleNoteValuation",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Convertible note valuation",
        "documentation": "The element represents convertible note valuation.",
        "label": "Convertible Note Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CostCentreAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "CostCentreAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Centre [Axis]",
        "documentation": "The element represents cost centre axis."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_CostCentreDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "CostCentreDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1177"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r907",
      "r994"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r907",
      "r994"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r996"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r996"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r911",
      "r998"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r996"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r989"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r903",
      "r990"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r903",
      "r990"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r901",
      "r988"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r991"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r906",
      "r993"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r906",
      "r993"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r907",
      "r994"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r910",
      "r997"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r908",
      "r995"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r905",
      "r992"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r54",
      "r55",
      "r93",
      "r95",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r852",
      "r1079",
      "r1080",
      "r1082",
      "r1086",
      "r1107",
      "r1108",
      "r1109",
      "r1178",
      "r1180",
      "r1196"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt, description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r36",
      "r47",
      "r54",
      "r93",
      "r95",
      "r520"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate principal amount",
        "verboseLabel": "Net proceeds",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r520",
      "r521",
      "r821",
      "r822",
      "r852"
     ]
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal and accrued interest",
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period."
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1082"
     ]
    },
    "niobf_DebtInstrumentIssuedPrincipalshars": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DebtInstrumentIssuedPrincipalshars",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument Issued Principalshars",
        "documentation": "The element represents debt instrument issued principalshars."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expires date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r820",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r852",
      "r1079",
      "r1080",
      "r1082",
      "r1086",
      "r1107",
      "r1108",
      "r1109",
      "r1178",
      "r1180",
      "r1196"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Principal payments",
        "label": "Debt Instrument, Periodic Payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r48"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1",
      "http://niocorp.com/role/ConvertibleDebtDetails1",
      "http://niocorp.com/role/ConvertibleDebtDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r1106"
     ]
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1",
      "http://niocorp.com/role/ConvertibleDebtDetails1",
      "http://niocorp.com/role/ConvertibleDebtDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1106"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total deferred tax assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "niobf_DeferredTaxAssetsMineralInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DeferredTaxAssetsMineralInterest",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral interests",
        "documentation": "The element represents deferred tax assets mineral interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Valuation allowance, beginning of year",
        "negatedPeriodEndLabel": "Valuation allowance, end of year",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating losses available for future periods",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsOtherLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOtherLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax losses incurred",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "niobf_DeferredTaxAssetsResearchAndDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DeferredTaxAssetsResearchAndDevelopmentCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development costs",
        "documentation": "The element represents deferred tax assets research and development costs."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canadian restricted interest and financing carryforward",
        "documentation": "The element represents restricted interest and financing carryforward."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsShareIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DeferredTaxAssetsShareIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issuance/financing costs",
        "documentation": "The element represents deferred tax assets share issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DeferredTaxAssetsStartupAndOorganizationalCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DeferredTaxAssetsStartupAndOorganizationalCosts",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Startup and organizational costs",
        "documentation": "The element represents deferred tax assets startup and oorganizational costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DeferredIncomeTaxesReflectNetTaxEffectsOfTemporaryDifferencesBetweenCarryingAmountsOfAssetsAndLiabilitiesForFinancialReportingPurposesAndAmountsUsedForIncomeTaxPurposes.SignificantComponentsOfDeferredTaxesDetails",
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "niobf_DeferredTaxAssetsValuationAllowanceAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DeferredTaxAssetsValuationAllowanceAdditions",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ChangesInValuationAllowanceAreAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current year additions",
        "documentation": "The element represents deferred tax assets valuation allowance additions.",
        "label": "Deferred Tax Assets Valuation Allowance Additions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepositsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepositsAssets",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future."
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r29",
      "r145",
      "r795",
      "r796",
      "r798",
      "r800"
     ]
    },
    "niobf_DescriptionOfEarnOutShares": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DescriptionOfEarnOutShares",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of earnout shares",
        "documentation": "The element represents description of earn out shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DevelopmentStageIssuerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DevelopmentStageIssuerPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Development Stage Issuer",
        "documentation": "The element represents development stage issuer policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DilutiveSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DilutiveSecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total potentially dilutive securities",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "DirectorMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r1100",
      "r1229"
     ]
    },
    "niobf_DisclosureClassBCommonStockOfEcrcAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DisclosureClassBCommonStockOfEcrcAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock Of Ecrc"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DisclosureExplorationExpendituresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DisclosureExplorationExpendituresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration Expenditures"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DisclosureLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DisclosureLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "verboseLabel": "Company Incurred Lease Costs As Follows",
        "terseLabel": "Maturity Of Lease Liabilities Is As Follows At June 30 2025"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_DisclosureOfClassBCommonStockOfECRCTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DisclosureOfClassBCommonStockOfECRCTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CLASS B COMMON STOCK OF ECRC",
        "documentation": "The element represents disclosure of class b common stock of e c r c text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss before income taxes",
        "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r51"
     ]
    },
    "niobf_DoDAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DoDAgreementMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Do D Agreement [Member]",
        "documentation": "The element represents do d agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r899",
      "r922"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r899",
      "r922",
      "r963"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "niobf_DrillingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "DrillingMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Drilling [Member]",
        "documentation": "The element represents drilling member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share, basic",
        "verboseLabel": "Loss per Common Share outstanding - basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r140",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r179",
      "r182",
      "r194",
      "r195",
      "r196",
      "r198",
      "r310",
      "r356",
      "r399",
      "r455",
      "r478",
      "r479",
      "r625",
      "r654",
      "r804"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share, diluted",
        "verboseLabel": "Loss per Common Share outstanding - diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r140",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r182",
      "r194",
      "r195",
      "r196",
      "r198",
      "r310",
      "r356",
      "r399",
      "r455",
      "r478",
      "r479",
      "r625",
      "r654",
      "r804"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic and Diluted Per Share Disclosure",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r197"
     ]
    },
    "niobf_EarnoutLiabilityAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "EarnoutLiabilityAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout liability, at fair value",
        "documentation": "The element represents earnout liability at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "EarnoutMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5",
      "http://niocorp.com/role/ConvertibleDebtDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout [Member]",
        "documentation": "The element represents earnout member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutSharesLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "EarnoutSharesLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout shares liability",
        "documentation": "The element represents earnout shares liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_EarnoutSharesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "EarnoutSharesPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout Shares",
        "documentation": "The element represents earnout shares policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationLineItems",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r836"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1131",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTable",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Table]",
        "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r836"
     ]
    },
    "niobf_ElkCreekResourcesCorpECRCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ElkCreekResourcesCorpECRCMember",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elk Creek Resources Corp E C R C [Member]",
        "documentation": "The element represents elk creek resources corp e c r c member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_Entity0896800BCLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "Entity0896800BCLtdMember",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity0896800 B C Ltd [Member]",
        "documentation": "The element represents entity0896800 b c ltd member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails13",
      "http://niocorp.com/role/CommonSharesDetails4",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/CommonSharesTables",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r109",
      "r111",
      "r112",
      "r135",
      "r136",
      "r137",
      "r163",
      "r164",
      "r165",
      "r167",
      "r174",
      "r176",
      "r178",
      "r200",
      "r260",
      "r261",
      "r278",
      "r309",
      "r329",
      "r356",
      "r389",
      "r390",
      "r396",
      "r397",
      "r398",
      "r400",
      "r454",
      "r455",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r522",
      "r525",
      "r540",
      "r649",
      "r665",
      "r666",
      "r667",
      "r686",
      "r755"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r915",
      "r926",
      "r940",
      "r967"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r912",
      "r923",
      "r937",
      "r964"
     ]
    },
    "niobf_ExchangeOfPrivateWarrantsForPublicWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExchangeOfPrivateWarrantsForPublicWarrants",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange of 2023 Private Warrants for 2023 Public Warrants",
        "documentation": "The element represents exchange of private warrants for public warrants."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExchangeOfWarrantsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExchangeOfWarrantsDescription",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange of warrants, description",
        "documentation": "The element represents exchange of warrants description."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "niobf_ExercisePrice1.75Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice1.75Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 1. 75 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice1.75OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice1.75OneMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 1. 75 One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice1.98Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice1.98Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 1. 98 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice11.50Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice11.50Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 11. 50 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.05Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice2.05Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 2. 05 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.07Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice2.07Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 2. 07 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.07OneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice2.07OneMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 2. 07 One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.20Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice2.20Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 2. 20 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.31Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice2.31Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 2. 31 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice2.60Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice2.60Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 2. 60 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice3.25Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice3.25Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 3. 25 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice3.54Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice3.54Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 3. 54 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExercisePrice4.60Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExercisePrice4.60Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price 4. 60 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ExplorationExpendituresDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExplorationExpendituresDisclosuresTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpenditures"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EXPLORATION EXPENDITURES",
        "documentation": "The element represents exploration expenditures disclosures text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExplorationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ExplorationExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration expenditures",
        "verboseLabel": "Exploration Expense",
        "documentation": "Exploration expenses (including prospecting) related to oil and gas producing entities and would be included in operating expenses of that entity. Costs incurred in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: (i) Costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or \"G&amp;G\" costs. (ii) Costs of carrying and retaining undeveloped properties, such as delay rentals, ad valorem taxes on properties, legal costs for title defense, and the maintenance of land and lease records. (iii) Dry hole contributions and bottom hole contributions. (iv) Costs of drilling and equipping exploratory wells. (v) Costs of drilling exploratory-type stratigraphic test wells."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r601",
      "r602"
     ]
    },
    "niobf_ExplorationExpenseForOTPExtensionPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ExplorationExpenseForOTPExtensionPayments",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exploration expense for OTP extension payments",
        "documentation": "The element represents exploration expense for o t p extension payments."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ExtractiveIndustriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ExtractiveIndustriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Extractive Industries [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails13",
      "http://niocorp.com/role/ConvertibleDebtDetails6",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of insider warrants",
        "verboseLabel": "Fair Value Adjustment of Warrants",
        "terseLabel": "Fair value of Warrants issued",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Black-Scholes valuation",
        "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r1162",
      "r1163",
      "r1168"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Company classifies the 2023 Private Warrants",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r844"
     ]
    },
    "niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Black-Scholes model for warrants",
        "documentation": "The element represents fair value assets and liability measured on recurring and nonrecurring basis of warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Black-Scholes model used in Private warrants",
        "documentation": "The element represents fair value assets and liability measured on recurring and nonrecurring basis table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair values determined by level 3 inputs are unobservable data",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r501",
      "r788",
      "r851",
      "r1174"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r337",
      "r338",
      "r480",
      "r482",
      "r483",
      "r484",
      "r485",
      "r492",
      "r493",
      "r495",
      "r497",
      "r554",
      "r555",
      "r556",
      "r788",
      "r821",
      "r822",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r842",
      "r844",
      "r851"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r494"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r485",
      "r842",
      "r1165",
      "r1169"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueHedgeAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueHedgeAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value, April 12, 2024",
        "periodEndLabel": "Balance, June 30, 2024",
        "label": "Fair Value Hedge Assets",
        "documentation": "Fair value of all derivative assets designated as fair value hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r1148",
      "r1149",
      "r1150"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r330",
      "r335",
      "r337",
      "r482",
      "r493",
      "r497",
      "r554",
      "r788",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r842",
      "r851"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r330",
      "r335",
      "r337",
      "r339",
      "r482",
      "r483",
      "r493",
      "r497",
      "r555",
      "r788",
      "r821",
      "r822",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r842",
      "r851"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r337",
      "r338",
      "r482",
      "r483",
      "r484",
      "r485",
      "r493",
      "r497",
      "r556",
      "r788",
      "r821",
      "r822",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r842",
      "r844",
      "r851"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r494"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r485",
      "r842",
      "r1165",
      "r1169"
     ]
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r1160"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r337",
      "r338",
      "r480",
      "r482",
      "r483",
      "r484",
      "r485",
      "r492",
      "r493",
      "r495",
      "r497",
      "r554",
      "r555",
      "r556",
      "r788",
      "r821",
      "r822",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r842",
      "r844",
      "r851"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1169"
     ]
    },
    "niobf_FairValueOfCommitmentSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FairValueOfCommitmentSharesIssued",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville share issuances",
        "documentation": "The element represents fair value of commitment shares issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r1170"
     ]
    },
    "niobf_FairValueOfWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FairValueOfWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Fair value of Warrants exercised",
        "documentation": "The element represents fair value of warrants exercised.",
        "label": "Fair Value Of Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r634"
     ]
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of non operating gain/loss",
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r507",
      "r788",
      "r851"
     ]
    },
    "niobf_FeasibilityStudyAndEngineeringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FeasibilityStudyAndEngineeringMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Feasibility Study And Engineering [Member]",
        "documentation": "The element represents feasibility study and engineering member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r158",
      "r368",
      "r369"
     ]
    },
    "niobf_FieldManagementAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FieldManagementAndOtherMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Field Management And Other [Member]",
        "documentation": "The element represents field management and other member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetails1",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5",
      "http://niocorp.com/role/ConvertibleDebtDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r308",
      "r326",
      "r465",
      "r476",
      "r496",
      "r504",
      "r507",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r634",
      "r650",
      "r818",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r855",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1161",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1169",
      "r1171",
      "r1172"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Liabilities",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1163",
      "r1167",
      "r1171",
      "r1172",
      "r1173",
      "r1175"
     ]
    },
    "niobf_FixedRentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FixedRentExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed rent expense",
        "documentation": "The element represents fixed rent expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign exchange gain",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r509",
      "r510",
      "r511",
      "r512",
      "r752"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Translation",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r508"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r930",
      "r944",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r930",
      "r944",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r930",
      "r944",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r930",
      "r944",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r930",
      "r944",
      "r971"
     ]
    },
    "niobf_FutureOptionToPurchaseExtensionPaymentObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "FutureOptionToPurchaseExtensionPaymentObligations",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/MineralPropertiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Future Option to Purchase Extension Payment Obligations",
        "documentation": "The element represents future option to purchase extension payment obligations."
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "GB",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GXIIPrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "GXIIPrivateWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "G X I I Private Warrants [Member]",
        "documentation": "The element represents g x i i private warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GXIIPublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "GXIIPublicWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "G X I I Public Warrants [Member]",
        "documentation": "The element represents g x i i public warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GainOnIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "GainOnIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails13",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on issuance of Warrants",
        "negatedLabel": "Gain on issuance of Warrants",
        "documentation": "The element represents gain on issuance of warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal and accrued interest",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r34",
      "r35"
     ]
    },
    "niobf_GeneralSecurityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "GeneralSecurityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Security Agreement [Member]",
        "documentation": "The element represents general security agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_GeologistsAndFieldStaffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "GeologistsAndFieldStaffMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geologists And Field Staff [Member]",
        "documentation": "The element represents geologists and field staff member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r84"
     ]
    },
    "niobf_ImpliedDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ImpliedDiscountRate",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Implied discount rate",
        "documentation": "The element represents implied discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "verboseLabel": "Total",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r98",
      "r100",
      "r626",
      "r628",
      "r645",
      "r797",
      "r799",
      "r801",
      "r809",
      "r813",
      "r1094",
      "r1096",
      "r1097",
      "r1098",
      "r1099"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r370",
      "r371",
      "r379",
      "r386",
      "r836",
      "r1137"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r370",
      "r371",
      "r379",
      "r386",
      "r836",
      "r1137"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INCOME TAXES",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r159",
      "r365",
      "r370",
      "r376",
      "r377",
      "r378",
      "r380",
      "r385",
      "r391",
      "r393",
      "r394",
      "r395",
      "r633",
      "r671",
      "r680",
      "r836"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107",
      "r155",
      "r177",
      "r178",
      "r199",
      "r212",
      "r219",
      "r368",
      "r370",
      "r392",
      "r657",
      "r797",
      "r799",
      "r801",
      "r836"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r366",
      "r367",
      "r380",
      "r381",
      "r384",
      "r388",
      "r674"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r836",
      "r1133"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign rate differential",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r374",
      "r836",
      "r1133"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax benefit at Canadian federal rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r836"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r836",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in estimates related to prior years",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax benefit at Canadian provincial rate",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r836",
      "r1133"
     ]
    },
    "niobf_IncorporationStateCountryName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "IncorporationStateCountryName",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jurisdiction of incorporation",
        "documentation": "The element represents incorporation state country name."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in working capital items:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r184",
      "r185",
      "r196"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible debt",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r191",
      "r196"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToWrittenPutOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncrementalCommonSharesAttributableToWrittenPutOptions",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExcludedFromDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r196",
      "r802",
      "r803"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r919",
      "r930",
      "r944",
      "r962",
      "r971",
      "r975",
      "r983"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r987"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r987"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r987"
     ]
    },
    "us-gaap_InterestAndDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestAndDebtExpense",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_InterestBearingLiabilitiesAverageAmountOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestBearingLiabilitiesAverageAmountOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest-Bearing Liabilities, Average Amount Outstanding",
        "documentation": "Average amount outstanding of interest-bearing liabilities."
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r797",
      "r801",
      "r1031"
     ]
    },
    "us-gaap_InterestIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeOperating",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest income",
        "label": "Interest Income, Operating",
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r630",
      "r631",
      "r731",
      "r764",
      "r766",
      "r813",
      "r882",
      "r883",
      "r1028",
      "r1235"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r149",
      "r150"
     ]
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestorMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r1186",
      "r1187"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee related costs",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r799",
      "r1029"
     ]
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LandMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r1122",
      "r1123"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net lease cost \u2013 other operating expense",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r853"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Company incurred lease costs as follows:",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1183"
     ]
    },
    "niobf_LessAmountOfPaymentsRepresentingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "LessAmountOfPaymentsRepresentingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less amount of payments representing interest",
        "documentation": "The element represents less amount of payments representing interest.",
        "label": "Less Amount Of Payments Representing Interest"
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LessCurrentPortionOfOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "LessCurrentPortionOfOperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less current portion of operating lease liability",
        "documentation": "The element represents less current portion of operating lease liability.",
        "label": "Less Current Portion Of Operating Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r529"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The maturity of lease liabilities is as follows at June 30, 2025:",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1184"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details": {
       "parentTag": "niobf_TotalLeasePayments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r1080",
      "r1086",
      "r1196"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details": {
       "parentTag": "niobf_TotalLeasePayments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r1080",
      "r1086",
      "r1196"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining lease term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r537",
      "r1182"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://niocorp.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LEASES",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r155",
      "r156",
      "r157",
      "r259",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r459",
      "r463",
      "r464",
      "r505",
      "r708",
      "r808",
      "r825",
      "r885",
      "r1114",
      "r1190",
      "r1191"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, redeemable noncontrolling interest, and shareholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r97",
      "r641",
      "r854",
      "r871",
      "r872",
      "r1079",
      "r1084",
      "r1105",
      "r1176"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r115",
      "r155",
      "r156",
      "r157",
      "r259",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r459",
      "r463",
      "r464",
      "r505",
      "r854",
      "r1114",
      "r1190",
      "r1191"
     ]
    },
    "niobf_LindConsentWarrantIssuanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "LindConsentWarrantIssuanceMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind Consent Warrant Issuance [Member]",
        "documentation": "The element represents lind consent warrant issuance member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LindGlobalAssetManagementThreeLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "LindGlobalAssetManagementThreeLLCMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lind Global Asset Management Three L L C [Member]",
        "documentation": "The element represents lind global asset management three l l c member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_LineOfCreditFacilityEstablishmentFee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "LineOfCreditFacilityEstablishmentFee",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line Of Credit Facility Establishment Fee",
        "documentation": "The element represents line of credit facility establishment fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoanProcessingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LoanProcessingFee",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Origination fees",
        "documentation": "Expenses paid for obtaining loans which includes expenses such as application and origination fees."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONVERTIBLE DEBT",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_LongTermInvestmentsAndReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermInvestmentsAndReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in equity securities",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle) and amount due to the Entity from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such investments and receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Line of Credit, Noncurrent",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r31",
      "r32"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r33",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r934"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r935"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r936"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r936"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r936"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r933",
      "r936"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r1129",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r483",
      "r484",
      "r485",
      "r837",
      "r838",
      "r839",
      "r844"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r485",
      "r837",
      "r838",
      "r839",
      "r844"
     ]
    },
    "niobf_MetallurgicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "MetallurgicalMember",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Metallurgical [Member]",
        "documentation": "The element represents metallurgical member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MineralIndustriesDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MineralIndustriesDisclosuresTextBlock",
     "presentation": [
      "http://niocorp.com/role/MineralProperties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MINERAL PROPERTIES",
        "documentation": "The entire disclosure for mineral industries."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587"
     ]
    },
    "us-gaap_MineralPropertiesAccumulatedImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MineralPropertiesAccumulatedImpairment",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment to mineral properties",
        "documentation": "The accumulated decrease in the carrying value of the mineral properties as a result of adjustments in estimates of future income generating potential of the mineral property."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_MineralPropertiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "MineralPropertiesPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mineral Properties",
        "documentation": "The element represents mineral properties policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership at June 30, 2024",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_MonteCarloModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MonteCarloModelMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Technique, Monte Carlo Pricing Model [Member]",
        "documentation": "Valuation technique estimating price of option using Monte Carlo pricing model."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r1005",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DESCRIPTION OF BUSINESS",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r203",
      "r806",
      "r807"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r80"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "",
        "label": "Cash Provided by (Used in) Operating Activity, Continuing Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity attributable to continuing operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r80"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfCashFlows",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss for the period",
        "verboseLabel": "Net Income (Loss)",
        "terseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r80",
      "r99",
      "r112",
      "r113",
      "r130",
      "r132",
      "r137",
      "r155",
      "r156",
      "r157",
      "r162",
      "r166",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r192",
      "r259",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r310",
      "r313",
      "r316",
      "r321",
      "r356",
      "r399",
      "r455",
      "r479",
      "r505",
      "r648",
      "r729",
      "r753",
      "r754",
      "r797",
      "r799",
      "r801",
      "r883",
      "r1114"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjust: Net loss attributable to noncontrolling interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r91",
      "r130",
      "r132",
      "r174",
      "r177",
      "r178",
      "r647",
      "r1027"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss available to participating securities",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r141",
      "r170",
      "r171",
      "r172",
      "r173",
      "r179",
      "r180",
      "r193",
      "r196",
      "r313",
      "r316",
      "r321",
      "r455"
     ]
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributed to common shareholders - basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r196"
     ]
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributed to common shareholders - diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r187",
      "r188",
      "r189",
      "r196"
     ]
    },
    "niobf_NetLossAttributableToVestedShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "NetLossAttributableToVestedShares",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss attributable to Vested Shares",
        "documentation": "The element represents net loss attributable to vested shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Standards",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_NioCorpTechnologiesLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "NioCorpTechnologiesLimitedMember",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nio Corp Technologies Limited [Member]",
        "documentation": "The element represents nio corp technologies limited member."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "niobf_NonRevolvingCreditFacilityAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "NonRevolvingCreditFacilityAgreementMember",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Revolving Credit Facility Agreement [Member]",
        "documentation": "The element represents non revolving credit facility agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash investing and financing transactions:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonmonetaryTransactionGainLossRecognizedOnTransfer",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Gain)/Loss on Issuance",
        "documentation": "Disclosure of the difference in values (gain (loss)) between the nonmonetary assets or liabilities exchanged with another entity inclusive of boot (small monetary consideration)."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r538",
      "r539"
     ]
    },
    "us-gaap_NoteWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoteWarrantMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Warrant [Member]",
        "documentation": "A note that entitles the holder to buy stock of the company at a specified price, which is much higher than the stock price at the time of issue."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "April 2024 notes",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r95",
      "r1197",
      "r1198"
     ]
    },
    "niobf_NovemberPrivateWarrantsliabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "NovemberPrivateWarrantsliabilitiesMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "November Private Warrantsliabilities [Member]",
        "documentation": "The element represents november private warrantsliabilities member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://niocorp.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r817",
      "r1095"
     ]
    },
    "us-gaap_OciEquityMethodInvestmentBeforeTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OciEquityMethodInvestmentBeforeTaxParent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss and net comprehensive loss attributable to the Company",
        "label": "OCI, Equity Method Investment, before Tax, Parent",
        "documentation": "Amount, before tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r457",
      "r462"
     ]
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Employee related costs",
        "label": "Operating Costs and Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash lease activity",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1181"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Present value of lease payments",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r527"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash payment",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r528",
      "r534"
     ]
    },
    "niobf_OperatingLeasesLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "OperatingLeasesLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncurrent operating lease liability",
        "documentation": "The element represents operating leases liability noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r387"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfAccountPayableAndAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade payable accruals",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Borrowings",
        "documentation": "The carrying amount as of the balance sheet date for the aggregate of other miscellaneous borrowings owed by the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r95"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on equity securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r649"
     ]
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCostAndExpenseOperating",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other operating expenses",
        "label": "Other Cost and Expense, Operating",
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r656",
      "r813"
     ]
    },
    "us-gaap_OtherGeneralExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherGeneralExpense",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other operating expenses",
        "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r813"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncome",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other gains",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r732",
      "r765",
      "r766",
      "r767",
      "r871",
      "r872"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities, at fair value",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r854"
     ]
    },
    "us-gaap_OtherLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails6",
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Other Liabilities, Fair Value Disclosure",
        "periodEndLabel": "Other Liabilities, Fair Value Disclosure",
        "label": "Earnout Shares liability",
        "documentation": "Fair value portion of other liabilities."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1163",
      "r1167"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrant liabilities, at fair value",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "niobf_OtheroperatingGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "OtheroperatingGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other gains",
        "documentation": "The element represents otheroperating gains losses.",
        "label": "Otheroperating Gains Losses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r917",
      "r928",
      "r942",
      "r969"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r920",
      "r931",
      "r945",
      "r972"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r920",
      "r931",
      "r945",
      "r972"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://niocorp.com/role/TheseConsolidatedFinancialStatementsIncludeAccountsOfCompanyAndSubsidiariesListedInFollowingTable.AllIntercompanyTransactionsAndBalancesHaveBeenEliminated.Details"
     ],
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r949"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForDeposits",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deposits",
        "label": "Payments for Deposits",
        "documentation": "The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities."
       }
      }
     },
     "auth_ref": [
      "r1075",
      "r1076"
     ]
    },
    "niobf_PaymentsOfStockIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PaymentsOfStockIssuanceCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issuance costs in equity",
        "documentation": "The element represents payments of stock issuance cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share issue costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_PaymentsToAcquireLand": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireLand",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Agregate purchase price",
        "documentation": "The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireOtherInvestments",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of fixed assets",
        "label": "Payments to Acquire Other Investments",
        "documentation": "Amount of cash outflow to acquire investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "srt_PlatformOperatorCryptoAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "PlatformOperatorCryptoAssetLineItems",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "srt_PlatformOperatorCryptoAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "PlatformOperatorCryptoAssetTable",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Platform Operator, Crypto Asset [Table]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r270",
      "r271",
      "r793"
     ]
    },
    "niobf_PrincipalAndAccruedInterestConverted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PrincipalAndAccruedInterestConverted",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal and interest converted",
        "documentation": "The element represents principal and accrued interest converted."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivateOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PrivateOffering",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Offering",
        "documentation": "The element represents private offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PrivateWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Warrants [Member]",
        "documentation": "The element represents private warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of debt, net of costs",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ProceedsFromCustomersForProgressPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromCustomersForProgressPayments",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reimbursement Payments",
        "documentation": "Cash received from customers as progress payments on projects that have been partially completed."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r584"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from public offering",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash received",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r675"
     ]
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromOtherEquity",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from equity",
        "documentation": "Amount of cash inflow from the issuance of equity classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party debt draws",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromRepaymentsOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds",
        "documentation": "The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r222",
      "r585",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r789",
      "r796",
      "r799",
      "r801",
      "r826",
      "r827",
      "r866",
      "r867",
      "r868",
      "r870",
      "r873",
      "r1006",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1112",
      "r1113",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "auth_ref": [
      "r222",
      "r585",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r789",
      "r796",
      "r799",
      "r801",
      "r826",
      "r827",
      "r866",
      "r867",
      "r868",
      "r870",
      "r873",
      "r1006",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1112",
      "r1113",
      "r1199",
      "r1200",
      "r1201",
      "r1202",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r799",
      "r813",
      "r883",
      "r1231",
      "r1232"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss for the year",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r130",
      "r132",
      "r147",
      "r155",
      "r156",
      "r157",
      "r162",
      "r166",
      "r174",
      "r177",
      "r178",
      "r259",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r310",
      "r356",
      "r399",
      "r455",
      "r457",
      "r460",
      "r461",
      "r479",
      "r505",
      "r626",
      "r628",
      "r646",
      "r685",
      "r729",
      "r753",
      "r754",
      "r840",
      "r841",
      "r884",
      "r1027",
      "r1114"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LAND AND BUILDINGS, NET",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r104",
      "r105",
      "r106"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Land and buildings, net",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r117",
      "r644"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r536",
      "r632",
      "r644",
      "r854"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentOther",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfPropertiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://niocorp.com/role/LandAndBuildingsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of properties",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "niobf_PublicWarrants2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PublicWarrants2023Member",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Warrants2023 [Member]",
        "documentation": "The element represents public warrants2023 member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PublicWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Warrants [Member]",
        "documentation": "The element represents public warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PurchaseAgreementSeriesAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PurchaseAgreementSeriesAMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement Series A [Member]",
        "documentation": "The element represents purchase agreement series a member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PurchaseAgreementSeriesBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PurchaseAgreementSeriesBMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement Series B [Member]",
        "documentation": "The element represents purchase agreement series b member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_PurchasesofLandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "PurchasesofLandMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchasesof Land [Member]",
        "documentation": "The element represents purchasesof land member."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r912",
      "r923",
      "r937",
      "r964"
     ]
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable noncontrolling interest",
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r318",
      "r1116",
      "r1117",
      "r1118"
     ]
    },
    "niobf_RedeemableNoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "RedeemableNoncontrollingInterestMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest [Member]",
        "documentation": "The element represents redeemable noncontrolling interest member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_RedeemableNoncontrollingInterestPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "RedeemableNoncontrollingInterestPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redeemable Noncontrolling Interest",
        "documentation": "The element represents redeemable noncontrolling interest policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_RegisteredOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "RegisteredOffering",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Offering",
        "documentation": "The element represents registered offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161",
      "r162",
      "r227",
      "r336",
      "r340",
      "r544",
      "r545",
      "r636",
      "r642",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r727",
      "r760",
      "r1230"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161",
      "r162",
      "r227",
      "r544",
      "r545",
      "r546",
      "r735",
      "r736",
      "r739"
     ]
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionRate",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction, Rate",
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties."
       }
      }
     },
     "auth_ref": [
      "r1185"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161",
      "r162",
      "r227",
      "r336",
      "r340",
      "r544",
      "r545",
      "r636",
      "r642",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r727",
      "r760",
      "r1189",
      "r1230"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalances"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTY TRANSACTIONS AND BALANCES",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r541",
      "r542",
      "r543",
      "r545",
      "r547",
      "r681",
      "r682",
      "r683",
      "r737",
      "r738",
      "r739",
      "r758",
      "r759"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt repayments",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Related party debt repayments",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r913",
      "r924",
      "r938",
      "r965"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r914",
      "r925",
      "r939",
      "r966"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r921",
      "r932",
      "r946",
      "r973"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets",
      "http://niocorp.com/role/GoingConcernIssuesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated Deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r86",
      "r640",
      "r668",
      "r670",
      "r679",
      "r711",
      "r854"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r111",
      "r112",
      "r163",
      "r164",
      "r165",
      "r167",
      "r174",
      "r176",
      "r178",
      "r260",
      "r261",
      "r278",
      "r309",
      "r356",
      "r389",
      "r390",
      "r396",
      "r397",
      "r398",
      "r400",
      "r454",
      "r455",
      "r466",
      "r468",
      "r469",
      "r471",
      "r477",
      "r522",
      "r525",
      "r665",
      "r667",
      "r686",
      "r1233"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross funds received",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11",
      "http://niocorp.com/role/CommonSharesDetails3",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issue",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Price per unit",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SaleOfStockPricePerShare1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "SaleOfStockPricePerShare1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares price",
        "documentation": "The element represents sale of stock price per share1."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement",
        "documentation": "The element represents schedule common shares under facility financing agreement table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/AccountsPayableAndAccruedLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of account payable and accrued liabilities",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r401",
      "r402",
      "r403",
      "r404",
      "r410",
      "r411",
      "r412",
      "r413",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r448",
      "r449",
      "r450",
      "r453",
      "r837",
      "r839",
      "r1141",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in the fair value of April 2024 Note",
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "niobf_ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of convertible debt",
        "documentation": "The element represents schedule of changes in lind iii convertible security text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in the fair value of Private Warrants liabilities",
        "documentation": "The element represents schedule of changes in the fair value of private warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of change in the 2023 Private Warrants liability",
        "documentation": "The element represents schedule of changes in the fair value of the2023 private warrants liability table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of change in fair value of Warrants liability",
        "documentation": "The element represents schedule of changes in the fair value of the private warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1139"
     ]
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in fair value of April 2024 Warrant liability",
        "documentation": "Tabular disclosure of derivative liabilities at fair value."
       }
      }
     },
     "auth_ref": [
      "r1146",
      "r1147",
      "r1152"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table sets forth the computation of the Company\u2019s basic and diluted net loss per share attributable to common shareholders:",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of excluded from the dilutive securities",
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r27",
      "r1091"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The following table is a reconciliation of income taxes at statutory rates:",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r836",
      "r1133"
     ]
    },
    "niobf_ScheduleOfExplorationExpendituresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfExplorationExpendituresTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ExplorationExpendituresTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of exploration expenditures",
        "documentation": "The element represents schedule of exploration expenditures table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, off-Balance-Sheet Risk [Table]",
        "documentation": "Disclosure of information about fair value of financial asset and liability not recognized in financial statement because of failure to meet criterion for recognition."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r634",
      "r1171"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1085"
     ]
    },
    "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfInterestRateDerivativesTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of primary inputs for the Monte Carlo model",
        "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments."
       }
      }
     },
     "auth_ref": [
      "r1146",
      "r1147",
      "r1151",
      "r1152"
     ]
    },
    "us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherNonoperatingExpenseByComponentTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of components of interest expense with convertible debenture",
        "documentation": "Tabular disclosure of the detailed components of other nonoperating expenses. This disclosure may include methodology, assumptions and amounts for : (a) losses on securities (net of profits) and (b) miscellaneous income deductions."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfOutstandingExercisableWarrantsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of outstanding exercisable Warrants",
        "documentation": "The element represents schedule of outstanding exercisable warrants table text block."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of key valuation input",
        "documentation": "The element represents schedule of primary inputs into the monte carlo models table text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r161",
      "r162",
      "r544",
      "r545",
      "r546",
      "r735",
      "r736",
      "r739"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of weighted average and assumptions used to option costs",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of option",
        "documentation": "Tabular disclosure of the change in stock options."
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonSharesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted average exercise prices",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "niobf_ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value of the Earnout Shares liability",
        "documentation": "The element represents schedule ofsummary of the changes in the fair value of the earnout share liability table text block."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "auth_ref": [
      "r204",
      "r224",
      "r225",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r626",
      "r627",
      "r628",
      "r629",
      "r699",
      "r700",
      "r701",
      "r761",
      "r762",
      "r763",
      "r768",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r790",
      "r805",
      "r826",
      "r828",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r869",
      "r876",
      "r1199",
      "r1200",
      "r1201",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://niocorp.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEGMENT INFORMATION",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r199",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r213",
      "r214",
      "r215",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r226",
      "r810",
      "r811",
      "r812",
      "r813",
      "r815",
      "r816",
      "r817"
     ]
    },
    "niobf_SeriesAPrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "SeriesAPrivateWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Private Warrants [Member]",
        "documentation": "The element represents series a private warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SeriesAPublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "SeriesAPublicWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Public Warrants [Member]",
        "documentation": "The element represents series a public warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SeriesBPrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "SeriesBPrivateWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Private Warrants [Member]",
        "documentation": "The element represents series b private warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_SeriesBPublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "SeriesBPublicWarrantsMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Public Warrants [Member]",
        "documentation": "The element represents series b public warrants member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11",
      "http://niocorp.com/role/CommonSharesDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value",
        "label": "Change in valuation",
        "documentation": "The element represents servicing assets at fair value changes in fair value resulting from changes in valuation inputs."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_ServicingLiabilityAtFairValueAdditionsValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ServicingLiabilityAtFairValueAdditionsValue",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value",
        "documentation": "The element represents servicing liability at fair value additions value.",
        "label": "Servicing liability at fair value additions value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ServicingLiabilityAtFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ServicingLiabilityAtFairValueAmount",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Fair value at beginning",
        "periodEndLabel": "Fair value at ending",
        "label": "Servicing Liability at Fair Value, Amount",
        "documentation": "Fair value of a liability representing servicing arrangements under which the estimated future revenue from contractually specified servicing fees, late charges, and other ancillary revenues are not expected to adequately compensate the servicer."
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482",
      "r497",
      "r566",
      "r567",
      "r568",
      "r569",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "verboseLabel": "Share based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock price on valuation date",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/CommonSharesDetails7",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected dividend yield",
        "verboseLabel": "Dividend yield",
        "terseLabel": "Expected dividend rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r353"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/CommonSharesDetails4",
      "http://niocorp.com/role/CommonSharesDetails7",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity volatility",
        "verboseLabel": "Expected volatility",
        "terseLabel": "Implied volatility of public warrants",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "niobf_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The element represents share based compensation arrangement by share based payment award fair value assumptions expected volatility rate1."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails7",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free rate",
        "verboseLabel": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/CommonSharesDetails4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Risk-free rate",
        "label": "Risk free rate",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancelled/expired, in shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted, in shares",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value per option granted during the period",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate intrinsic value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding stock options vested",
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "niobf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchnage for shares",
        "documentation": "The element represents share based compensation arrangement by shares based payment award options vested and expected to vest outstanding number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancelled/expired, per share",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cancelled/expired, per share",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted, per share",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r342",
      "r349",
      "r350",
      "r351",
      "r352",
      "r355",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/CommonSharesDetails4",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Closing common share price",
        "label": "Closing common share price",
        "verboseLabel": "Closing Common Share price",
        "terseLabel": "Strike price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails10",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/CommonSharesDetails4",
      "http://niocorp.com/role/CommonSharesDetails7",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected warrant life in years",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "niobf_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2": {
     "xbrltype": "dateItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/ConvertibleDebtDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term (expiry)",
        "documentation": "The element represents sharebased compensation arrangement by sharebased payment award fair value assumptions expected term2."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term (years)",
        "verboseLabel": "Weighted average remaining contractual life",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance at Weighted Average Exercise Price",
        "periodEndLabel": "Beginning balance at Weighted Average Exercise Price",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://niocorp.com/role/CommonShares"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMON SHARES",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r1119",
      "r1126"
     ]
    },
    "niobf_ShareholdersEquityAndShareBasedWarrantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ShareholdersEquityAndShareBasedWarrantsTextBlock",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Black-Scholes model used in April 2024 Warrants",
        "documentation": "The element represents shareholders equity and share based warrants text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssued",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares, issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares, outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short term lease cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r853"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r121",
      "r122",
      "r123",
      "r155",
      "r157",
      "r182",
      "r186",
      "r194",
      "r196",
      "r201",
      "r202",
      "r259",
      "r283",
      "r285",
      "r286",
      "r287",
      "r290",
      "r291",
      "r311",
      "r312",
      "r314",
      "r315",
      "r317",
      "r320",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r505",
      "r675",
      "r676",
      "r677",
      "r678",
      "r686",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r710",
      "r730",
      "r755",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r1004",
      "r1081",
      "r1083",
      "r1092"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails",
      "http://niocorp.com/role/CommonSharesDetails1",
      "http://niocorp.com/role/CommonSharesDetails13",
      "http://niocorp.com/role/CommonSharesDetails4",
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/CommonSharesTables",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r62",
      "r64",
      "r65",
      "r109",
      "r111",
      "r112",
      "r135",
      "r136",
      "r137",
      "r163",
      "r164",
      "r165",
      "r167",
      "r174",
      "r176",
      "r178",
      "r200",
      "r260",
      "r261",
      "r278",
      "r309",
      "r329",
      "r356",
      "r389",
      "r390",
      "r396",
      "r397",
      "r398",
      "r400",
      "r454",
      "r455",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r477",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r522",
      "r525",
      "r540",
      "r649",
      "r665",
      "r666",
      "r667",
      "r686",
      "r755"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r204",
      "r224",
      "r225",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r626",
      "r627",
      "r628",
      "r629",
      "r699",
      "r700",
      "r701",
      "r761",
      "r762",
      "r763",
      "r768",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r790",
      "r805",
      "r826",
      "r828",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r869",
      "r876",
      "r1199",
      "r1200",
      "r1201",
      "r1203",
      "r1204",
      "r1205",
      "r1206",
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/ScheduleOfPropertiesDetails",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r200",
      "r311",
      "r312",
      "r314",
      "r317",
      "r525",
      "r585",
      "r673",
      "r687",
      "r698",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r710",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r733",
      "r734",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r755",
      "r799",
      "r801",
      "r877",
      "r1230"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/Cover",
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails",
      "http://niocorp.com/role/ScheduleOfExplorationExpendituresDetails",
      "http://niocorp.com/role/ScheduleOfPropertiesDetails",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r200",
      "r227",
      "r311",
      "r312",
      "r314",
      "r317",
      "r525",
      "r585",
      "r673",
      "r687",
      "r698",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r710",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r733",
      "r734",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r755",
      "r799",
      "r801",
      "r877",
      "r1230"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r916",
      "r927",
      "r941",
      "r968"
     ]
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market value of Common Shares issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r22"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnout shares",
        "verboseLabel": "Warrants traded prior to the closing",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued, shares",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r61",
      "r62",
      "r86",
      "r675",
      "r755",
      "r770"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units issue and sold",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodSharesStockOptionsExercise": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercise",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares purchase",
        "documentation": "The element represents stock issued during period shares stock options exercise."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails6",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option exercises (in shares)",
        "negatedLabel": "Cancelled/expired, in shares",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r61",
      "r62",
      "r86",
      "r346"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of private warrants",
        "verboseLabel": "Transaction loss",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r62",
      "r64",
      "r65",
      "r86"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions",
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueEquityPlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueEquityPlacement",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity placements",
        "documentation": "The element represents stock issued during period value equity placement."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Lind Consent warrants",
        "documentation": "The element represents stock issued during period value issuance of lind consent warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share issuance costs",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r61",
      "r62",
      "r86",
      "r686",
      "r755",
      "r770",
      "r884"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining proceeds from private warrants",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueRedemptionsOfVestedShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueRedemptionsOfVestedShares",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemption of vested shares",
        "documentation": "The element represents stock issued during period value redemptions of vested shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversions (in shares)",
        "documentation": "The element represents stock issued during period value shares conversion of convertible securities net of adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueSharesEquityPlacement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueSharesEquityPlacement",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity placements (in shares)",
        "documentation": "The element represents stock issued during period value shares equity placement."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemptions of vested shares (in shares)",
        "documentation": "The element represents stock issued during period value shares redemptions of vested shares."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueSharesStockWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueSharesStockWarrantsExercised",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exercises (in shares)",
        "documentation": "The element represents stock issued during period value shares stock warrants exercised."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville equity facility draws (in shares)",
        "documentation": "The element represents stock issued during period value shares yorkville equity facility draws."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockDividend",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Option liability valuations",
        "label": "Stock Issued During Period, Value, Stock Dividend",
        "documentation": "Value of stock issued to shareholders as a dividend during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r62",
      "r64",
      "r65",
      "r86"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option exercises",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r62",
      "r64",
      "r65",
      "r86"
     ]
    },
    "niobf_StockIssuedDuringPeriodValueStockWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueStockWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exercises",
        "documentation": "The element represents stock issued during period value stock warrants exercised."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville equity facility draws",
        "documentation": "The element represents stock issued during period value yorkville equity facility draws."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r81",
      "r712",
      "r728",
      "r756",
      "r757",
      "r854",
      "r885",
      "r1079",
      "r1083",
      "r1084",
      "r1105",
      "r1176",
      "r1233"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://niocorp.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/StatementsOfShareholdersEquityAndRedeemableNoncontrollingInterest"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, value",
        "periodEndLabel": "Ending balance, value",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r41",
      "r43",
      "r109",
      "r110",
      "r111",
      "r112",
      "r136",
      "r163",
      "r164",
      "r165",
      "r167",
      "r174",
      "r176",
      "r260",
      "r261",
      "r278",
      "r309",
      "r329",
      "r356",
      "r389",
      "r390",
      "r396",
      "r397",
      "r398",
      "r400",
      "r454",
      "r455",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r477",
      "r513",
      "r514",
      "r518",
      "r523",
      "r540",
      "r666",
      "r667",
      "r684",
      "r712",
      "r728",
      "r756",
      "r757",
      "r774",
      "r871",
      "r872",
      "r884",
      "r1079",
      "r1083",
      "r1084",
      "r1105",
      "r1176",
      "r1233"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r853"
     ]
    },
    "us-gaap_SubsequentEventDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventDescription",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent event description",
        "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r549"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r549"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r549"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r549"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r549"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://niocorp.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUBSEQUENT EVENTS",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r550"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11",
      "http://niocorp.com/role/CommonSharesDetails3",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11",
      "http://niocorp.com/role/CommonSharesDetails3",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails11",
      "http://niocorp.com/role/CommonSharesDetails3",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://niocorp.com/role/GoingConcernIssues"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GOING CONCERN ISSUES",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cumulative net operating losses",
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r1137"
     ]
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "presentation": [
      "http://niocorp.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in the valuation allowance are as follows:",
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance."
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1100",
      "r1188"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "auth_ref": []
    },
    "niobf_TotalLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "TotalLeasePayments",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://niocorp.com/role/MaturityOfLeaseLiabilitiesIsAsFollowsAtJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total lease payments",
        "documentation": "The element represents total lease payments."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransactionDomain",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r794",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1153",
      "r1155",
      "r1156",
      "r1157"
     ]
    },
    "us-gaap_TransactionTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransactionTypeAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Type [Axis]",
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r794",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1154",
      "r1155",
      "r1156",
      "r1157"
     ]
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails1",
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetails1",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5",
      "http://niocorp.com/role/ConvertibleDebtDetails6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r308",
      "r326",
      "r465",
      "r476",
      "r496",
      "r504",
      "r507",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r634",
      "r650",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r855",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1101",
      "r1102",
      "r1103",
      "r1104",
      "r1161",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1169",
      "r1171",
      "r1172"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://niocorp.com/role/DomesticAndForeignComponentsOfLossBeforeIncomeTaxesForYearsEndedJune302025And2024AreAsFollowsDetails",
      "http://niocorp.com/role/ScheduleOfCumulativeNetOperatingLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://niocorp.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized loss on equity securities",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "niobf_UnrecognizedCompensationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "UnrecognizedCompensationCosts",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation costs",
        "documentation": "The element represents unrecognized compensation costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r837",
      "r839",
      "r844",
      "r1166"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails",
      "http://niocorp.com/role/CommonSharesDetails12",
      "http://niocorp.com/role/ConvertibleDebtDetails3",
      "http://niocorp.com/role/ConvertibleDebtDetails5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r484",
      "r837",
      "r839",
      "r844",
      "r1166"
     ]
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "presentation": [
      "http://niocorp.com/role/ClassBCommonStockOfEcrcDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "documentation": "Valuation technique calculating price of option."
       }
      }
     },
     "auth_ref": [
      "r844",
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "niobf_ValueOfWarrantsIssued": {
     "xbrltype": "stringItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "ValueOfWarrantsIssued",
     "presentation": [
      "http://niocorp.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Warrants issued",
        "documentation": "The element represents value of warrants issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://niocorp.com/role/CompanyIncurredLeaseCostsAsFollowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable rent expense",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r853"
     ]
    },
    "niobf_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/FollowingTableIsReconciliationOfIncomeTaxesAtStatutoryRatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liability",
        "documentation": "The element represents warrant liability."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails13",
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant Liability [Member]",
        "documentation": "The element represents warrant liability member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative",
      "http://niocorp.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r875",
      "r878",
      "r879",
      "r880",
      "r881"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetails9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiry date",
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r1164",
      "r1165",
      "r1166"
     ]
    },
    "niobf_WarrantsEachExercisableFor1.11829212Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "WarrantsEachExercisableFor1.11829212Member",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Each Exercisable For111829212 [Member]",
        "documentation": "The element represents warrants each exercisable for1.11829212 member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsNotSettleableInCashFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://niocorp.com/role/ScheduleOfFairValuesDeterminedByLevel3InputsAreUnobservableDataDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities",
        "documentation": "Fair value portion of warrants not settleable in cash classified as equity."
       }
      }
     },
     "auth_ref": [
      "r1162",
      "r1163",
      "r1167"
     ]
    },
    "niobf_WarrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "WarrantsPolicyTextBlock",
     "presentation": [
      "http://niocorp.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "The element represents warrants policy text block."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding, diluted",
        "verboseLabel": "Weighted average shares outstanding - diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r196"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://niocorp.com/role/FollowingTableSetsForthComputationOfCompanysBasicAndDilutedNetLossPerShareAttributableToCommonShareholdersDetails",
      "http://niocorp.com/role/StatementsOfOperationsAndComprehensiveLossParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average common shares outstanding, basic",
        "verboseLabel": "Weighted average shares outstanding - basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r196"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://niocorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "niobf_YorkvilleConvertibleDebenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "YorkvilleConvertibleDebenturesMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetails",
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Convertible Debentures [Member]",
        "documentation": "The element represents yorkville convertible debentures member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleConvertibleDebtFinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "YorkvilleConvertibleDebtFinancingAgreementMember",
     "presentation": [
      "http://niocorp.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Convertible Debt Financing Agreement [Member]",
        "documentation": "The element represents yorkville convertible debt financing agreement member."
       }
      }
     },
     "auth_ref": []
    },
    "niobf_YorkvilleEquityFacilityFinancingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://niocorp.com/20250630",
     "localname": "YorkvilleEquityFacilityFinancingAgreementMember",
     "presentation": [
      "http://niocorp.com/role/CommonSharesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Equity Facility Financing Agreement [Member]",
        "documentation": "The element represents yorkville equity facility financing agreement member."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-13"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-14"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-21"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4M"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-40/tableOfContent"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-42"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481725/323-10-35-18"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.FF.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/410-20/tableOfContent"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481879/410-20-45-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482864/845-10-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "845",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482864/845-10-50-3"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481260/860-50-45-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481260/860-50-45-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481260/860-50-45-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "930",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/930/tableOfContent"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "930",
   "SubTopic": "715",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477692/930-715-50-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479255/942-310-S50-4"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.H.2.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478116/942-310-S99-2"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480397/718-10-55-16"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "35",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-35"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-36"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-4"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481639/420-10-35-4"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "942",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480095/942-10-S50-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "942",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480035/942-10-S99-6"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477346/946-830-45-39"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481879/410-20-45-1"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479176/718-740-35-2"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/820/tableOfContent"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479424/830-30-S99-1"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479365/842-20-25-6"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-13"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-14"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-15"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-15"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>146
<FILENAME>0001539497-25-002331-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001539497-25-002331-xbrl.zip
M4$L#!!0    ( 'J *UL>!Y.Q&C   'DP   2    ;C(U-S0Q,&MI;6<P,#$N
M:G!GC7IE4!Q D.[BDN 0W-W='3;(XN[.0B X+!:"N\OB$ B^BP6WX.[!'8(L
M&B"0  $"7.ZNWKW[>=_\F>JNGIFN:OFZ:EY67[X#\$%*JDH )&0 P/[? KS\
M !  (7;O P!( %0 X+]$%P!<>7MW6S# ON^?!.EE Q )0/J_ _G_ ^5_\/]T
M_Z5&^M^:_R->^@ $F  E0 $*$@$ F0 )A0#I90BP_N]]*&A(2(#_ 18&)C8
M!14-_=]= "14E/^M Z!C8&(AHZ"A(N'_VR,AHR*C8:!C8;[Z3R^1_],& T!
M3XB)Q4]$3/*&%%M>QX:AU4_,,XRQ150\[7.3#XLOF3]Y@X @DT@;FT2_[EO(
ML%(TJ[)1)<$_<U04="0T;"P,+*S_/@U @(I&3XC.+T]$C(')H&,CT$3B&:;;
MR.@#>2,BFO:Y04'06YB4K'\N7%$O0NSGKJV772FPF3ECD$E(O\P S/JR#GB-
M@O3/410"@"P@Q,1,RO)+B%6N(GW_K"9/$F.5V0>$=0H_P[LU,H%5&GI!=%^%
MH[FPYD1=> D:\G6J.C)2.WHL@^GOKB"2AW*3+D,:0H5NE_#$+X/2ZL-\O-0<
M<ZQ)B6YZ9-@P/7T 8L>+"K5T2$@>Y:A+\.BJF\K$8J3W ]6/;&<R@@4,-_(.
M>@W!":\TWPDFF%S_'D JV )?F7/#=H<=:^-I>&V^CM7^+-GKQT-P:^#)^#8G
M>M/1](:8;\.RA[XFMUPXG22T=-#2>2530^5< :"7U%H.\"6$IF/L)4/V6GS/
M- P^V FLV0R'(=A4M3&FP"EYA,^;'5:PGC)O!_F9#B?V@7U18N:SY@&&M7=Y
MJ"Z-MV25\!$#QDQM9-5YESPRJIXUR&MFA([%%-J"^,+[D:K%;.?\FP/>U%W$
M>RRAUU<@]&OTA>9[6SX?3MWW3Q^K.6[<*G#S"2JX&W;'!E2M2KYMVTN!A@H/
M<>A%OU,&%0!E)^]_WQ(EWI%ECG- H?QDRMNQ$U*T2'\C2C#C0X*?&YMNA:;^
MG*'8?LUT']$?:HCWVS"%!E2V='R0^KKXN]G;\%J0'R2<)62OAJDQ[_(V/FW)
M^%"[DC CR^.V8>$C>] 70^</YXPD2PYES:L0))OF5FA5:L9N7M,Y](!9++1P
M[4;0T$28FR6MP5!667&2>>EGEG8E\1X4'8Q%!9ND8^52A8K&C[K27/N>+OFN
M$!6ROB)W#(_[,I*VH]\6:?E&QBDB@$7NA$%,/TX,?49M1K>@3\\-P%ANX6CT
MZ%Y<ZQNVH1BD9*Y+PH'^Q,16-CG-WTJP:$%PH=F3!+]UT_2P=.54O\#&X)@G
M9DTFHTY="DQ0Z\AVX[R5,6.!$*4QG(NHC+\RT/\6 )\,#@V:07KTK<^=&9[J
ME/I0)DWO,U'MB+/XU@>ZD8*/-I.B#.SL>E<KHO:6EZ-_M]U /5H_DTN#0R&T
M8#1GB@"3VUIB:RY_";]GRUE']P4P(9I5J\6$T :%1Q[(_\$F9/2,&[3F"OW%
M^?V';,:!6=F\,KV=A/3,6SB 6;XY*KF-DNL)%9N!09_(]_B[W/VKUFHS/=,,
MNT6#97M"'37],^O",GHP0_!/@G</H)^'Q?.WCPO%&' 8A:?N6JXJFF[V)W^W
M*&]S,9VW[\(Y@02F=/%SJ(:Q#,WR)"68,3R.P_/W,;4SE4Z9O\@<57UFLG*R
M(K6FI:KA3LPU,7'J7X?7G-#33M/X<8:($;NC0'S31Q$(R;FO<*//O4T0A)4_
M/?K+@LKW_2/QDAE)6G7K-'77(<ZFLQ3 "T"8%18#X(FE][\X^L/7] *P.):M
MBP 23/A.^P['N!L1$J;%3H_P>>98C@V*$V9^[6))&!.#D+47Q.,3!(<[J PP
M\R%I2F$,&G,W2X1OA+*CXLNORO?%+CYRZPM4T*J8J:&R,ZGC>] E??_!%W;[
M_724[49PB>1K5A1C-=ES6PQ-5EP\7 45S%'\S>6FF0!]BH##^ED]241])@O7
MF@>A#JN0RONSP,TW;VS#KLA.B*4"0#H 6*,&E5=6EE2\969\YYS[!5D[E! :
M]@7 !*"1I^QID*S>^MGCU&13()M\^BM^OJ IMN#+AGY>4$WBPSGE5Z^!-Q0D
M4P$9\JE='%2G'+ EXPH$O:+KK4N?2]*WU8BOI,94*)O#*"$XW4EC&Y>_7,]2
MJ'_+XW:5])RT<5WF%O\<,2\V.+OD'LIP-V_07\I^I\^R3]:1@0F+#8CA7224
M=IG6)0 NT6<8%^OARVU PY&SAY3_+,&>J*4-6Q]DR^XL3#"<K/Q(6$.:+6]<
MA^WN(E5.HSB42\>:KE:(,/OI: [X5@!/4+O91KZ'^H^JM]'?:__N;[=XVDD8
M:ZEOR*^-Z3V4R3U<,*XO-VW2+"1S$]U'#R=FCAI4H[EVB8&:#:+8=;7&&E,E
MAY=2TVU])X0%->7HY?JL1?;H*XW*I5T[?> [)FYM<_SZ6V8PCVSB,BAQ61E(
M;M;E:=5)8O!;E[L19U4=2<NLKCAP/345BA:%QL7A8*]F7RI:W5-I]VCHHY>@
M&Q=[5^M0UU"Z2Q4T8=&WLJ8Y-F (95B6),@A69\V;HD+,X"8M1%(Q!?$01%(
M1-FX1>\FZCIO".L3C]@U3WSK/JN20R,S4["1R[ XM %%/A&-N)_/XBU#?\\G
M<;7-&#13EE6"_K*;IH>#5K+)P:I]^(X]2(HAL91UX]:2JT'D,=2C58WE;XT?
M-+6@+O+TK8(AZJXN.L*X*6'M86U7@,5B*^=N[@HC],9STX5^07HWOO2@>R\;
M IM/%Q(PPV1I:GC<1,"YFA8!+].?M/25/;(SD6Z6_@]UZ(-P8%5Q_%RU@KUI
MQ@DJ$7_0]>CXF#$M 0FVSD:!&8\N9@R_<A^$L_FBR-QIY<?[6N=MPO3P-6-5
M2>QT(@'IJXN1V;T70-7M:23'N5.)&IH>.W=GN-Y7ILSO0=<R!S14EYLD@59N
ML=M=5P82$AZ.U?X/_20:[=+^^8;1;<:VWYGW#BP'<]&6O-%/UD\R@1T@V!S2
M*K9K"ZE//2C#YW3B >Q;90:NM'35$D%=&D!3U<;.N0K%E43:(*PW@ 3XSJ2T
M+%&2"%#IU38V-U['8?%P<LR7A&<(D2>UIR%1!3-)G?++F$B\'[;LOBEF<XQP
M;G_-;Q/6(&?Z ""V3/R\&99T]"#'A/6#1CO?VQG$V8S#D5</[5ZJ*.(JT_YF
M&+#G8%_0N)5E_^Q[G'!^5UIM::MAPK:DE^=/&N]UST0B/AOLI.9#0)/XH>V@
MI_0A\(Q1;/,*AP5G19WX]DV.Z9:#VT<F[FA/)'"NQXBFDH7HJ7*,%*$]0QQ3
ML+8V$"2)GGM1_)MEH>S&(D/#U U/BN<R:W$_#".&(143,WM@E/K;K]]G[907
M-?/9YZJ!;7S]S7K,BZW)#-X/>FAJ.M=NUX\_1V/V#%N@D1*%K,MCZ !1JC8F
M6CK,4'<EG*&NJX7B#R*:YM,[Z1ZTBW@A#U-@'%W)E3J.R1\LXT2KURD=]PV_
MM>),I\"8.B=*[5XY(&0L\ F2>$1H+-$#KJR9>Y$5GL,TOGQOG%NFU/@=P,OS
M[L]*K>J4"UO6_=?/T4\PQLV8\F?I',5'CL?G.R.WNXA+QBW'CB++T8!//;<?
MUE.L/E@=6R;]2('UM!4=!V><R!9?^ST\N/5&;1G<')U6"NTT!@3+B@\:FN<V
M(G9G@E1WLT5F2?.H9O=F53\"'Y8FQ,_='",F'(D**O-EK!0?9-XI2'Q<_3!B
M(:?H(6(RRXQ/0T?W+I\,$]-S$[4K])1WJ"F9EF]X_/;X@IPV,.Q=5Q!$4.@]
M]+T2@E T)*FN+M,14LN$TD$L';"V28*<O"<OWW&+2T$77KOE9BKQX3-,?"SF
MW1APVN2JIL;L]O!(_D=08KH6N21PMV]<S*5!4^=>SD>>JM(M9*O-^MFQ("0]
M:PX5[]/X"R!V\FBSJZA%N!9?&<N%76/K>Q0_R"L?#A_EU]0MJ$"DQ^&C$/?1
M62/A91_.H8(6K.\C1D, 5U<[UY?_R OZ*W:UK; .D"ZT_%2+-0RD&P;21N/N
M ^A" >4 O'P@_FHP@^Q(B]YC]W+/PA;$GKKL:6/QB>ZNVHV3]"MM-[953L._
MTHG1+_OEK_"=3HK,V.!I]PWO^JN869J;Z@3*^5X'UUX^NR4&$FTVU[^!^U1*
M_#O;ZLIJ>W($O!KM*#;X+X =4L7!X^+5V\6O/V[8#5LZ'(A> )5XYK'1U*=/
M<<U)(X>P%\ JG'K%KBS]!8#+)25C^B&O/V/*$YD8]? N3(9JE+I-_!Z$U'XA
M"0A:=Y?,\K2K]GNM=9RS\SS,0J6YO.[TD;(MDYGIZE04[UQ?-E7NYD_&6(Y^
MI[HVT;\,*>(@FD(=GQWC)R$X.$(<'FR*;GQLVZ]\WP3FW,C.$(R2I/Q;;7GL
M^+CJVFSJTD&(,=G]1>V7WIMK][_M4#Q<$@F Q[\6?K%WIEE$>#%3IT?X<3_F
ME-&A1$>Z:'[VNY#L'79RT^Y<K1'K%U(=;$VC[X?ZBH**!"3,MG8'Q"K1)4 R
M/?6+C1HOUBD&J6))-P89!HFEK2<(1*:V)<^OT%VX&XC036<=9O!"Q4E/>LK9
MJ+U9E_D!7R8/4&VG0VYFML<E/L .&_"?>'5D23+Q%T^QVPR5BEB*3;SOGM@\
M4MV.[9L'NZ$]$KTY>7%*'GM8#%2CEV>_+;GT!:#N#(<_I-D+:XH=FD7HSI3
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MO=_O5?_3<\ZN6J/&'+5JUEK]O/2\#F#*OY5["X!@ ,#BY0,\'P)84I[F]KX
M"( #@+^YC@%T<0MG,TO HN?% WJ& J$ Z%]O,/_58/]W^\_8W\*@OX_\B^VY
M!\!" E7!T,&"L  8+! L%NAY +AZP0<+_S(P\+\;(A(R" 86'@$.!?7%#0/[
M#T$0+ P</ (B$B8 (+Q\?QD7"0,+!1Z%X*7+7X&7:U!B<^ @BU/AJIGBN29-
M<U+C$Z($%]2K)YL7::41?&S-('K=*V$VPZ4Q2S,WK\TOJ^L3J7>ZX4;KV;)
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MFAOT[YCP06FL^P.BN.^LGP$$XK++#N!)L[6,X!9YXAGX.U+)4>BYGH$0^!<
M(.,=^7NW((C_U!/JC<J^!^B?\.<_<;>6$?I,"^22Z\02@)^!Y;_R8#P;\0=A
MU_O4M/TQ#O@?39!+('=M&>:MFF^^F$;,C?B3%40LC7%_] ET(7G+MBI6,H7W
MI)E7QG8+_W<,Y>8$;TGN1IP:=SP#_Y%GL5.<++$72"]S%$MC_J?^967D+5%_
M]?=X .6SD@]]O-P 04\(,I^!E"'4#(P%Z%^#/N6(K?-Q?0U!^WYH _N/)FK_
M64D ?RC?P\!NPK9KX![EU?44[E_#4MRJ_DT[7U_4]PPP:<PF"MOX3V-<_2]@
MK/],KLY_D]R4/[!_F\E_:D/DZY_0W807A^/+1?#_'2K_F5GCE_7CBA%&D+GU
M5,7WOU+GK,QVBO,R[=X/?^6N_"_J">-[)7<A"2,D)AU(3VH>\#)GQ8\"DB^"
MQ+SO,NZ(>%K\2W#.?_'[7_V>_DH9PC/@DS.%43GXD(_X_Y;EB]*8]X<HV]0$
M<BG/GUX1*'T]]4",NME2][,>IDMN:.XVDN Q.J #48L,*TAQJ[\A%Y0N<O&E
MNM/,;E$<?Z.*A;56"\8B;4*<VGBC*&:_TX 5UDL9>(7L10VA#-NL,Y;$]]'$
M7WT<\- &:,]O?IM P?[W@<R'+ :URL3)\5M%G]K0S=U"<]^77\?C,MFNO4(N
MEM:2'8^6P^V#A\U9S:=N@>YA%(%KQ-^;%@P_ UD9$4_T8%@#"%D1(@KU>:P&
MZ!D8L$$).-)Y!G0W@LQT@TRF$'_.!UW%$US31ERC ?\?(B#;@RD+ANP]W1#'
M=8F!NI4^ZCK<+Z. $Y60)RD0MKVR,1S+W?7>L,BV0-UP0F:)=B/K>WYO8SM#
M1P6M?M]=)2>/4!KQ4.+&B@M#*C3")G(/380KV5!O1$.QTF/\B;U>Y6L)S\B(
ME,PKU]4XHM%7Y7JQ6J]+U3F4L*,F-)!8U!W,,5$7P:Z'[25]MO"F28Z9IZ>,
M)B*0>N0V3Y)Y'5,=6#('X3(6;%QM&ZD)&JI/A5NMQT;W()\A/F&EC-^NK3EV
MUY]=RL>)^EPOSEX1,8WV56NK(3+BXME\V%;#T\!D)PQ>[ <SK+U/#*HZ?0;J
M6<3J]E >C\&1#NQU6^?/P*"BWY-,2C[C3;/QHWG88Y3I8PB8_+W6,[# ;[R4
M3K[$#;II!L@P7?)%>^]I(U3FN!'@U_,3V5P+-GJ^>/,/U!\R7,($MX"5V@>\
MT"#>I,#B25?-IC9[FP''XS- M27_929*W=*G36<'4W(?Y<I,?,Q1=W2D>$%D
M.%EFK!Q>7+22Q12341 =\G/>EWAPO/- T5.'TER@++6B2&&P!.%MK.Y4FLP$
M*MVRY6:H@]7ZTD1$UVH9>ZD0;@_"BP)1B28#<10X$Y+,,^MQTM6;?U0:T#.6
MCX^J(W05)*7[T]\+@[B:=;_DBD-(2'KK905!_>:5VF_&/9$,KOD]5=LT6*K4
MDFOU3+)E1*,^FM7'@HT:/[32K490I&ZS@T9,,#%!:$!^P']P=666<?4H"3;X
MGXCZ/T00/PV\0O68< D.XW/J7\92E'3!^BUT1]8SA1:^-O9$-55V@A?C)3\X
MI=$V=;J_9IX;0NFNJ]WC,1MA\XAPN*A*0YKIAI1/7)YE=<(.\MM#FY"AOOW"
MOTCU-6J$L'V+1':2D23YJ&+:ODC99+].R&Q72S.;B ?I3J27 ZP%X@?!NB<X
M0;:B)I6QF28//^BEX+#,B!;_/#^34NPU;ZD2<#V-&F5(=I@H2#BC@L??@15@
M0-\$+WG IGT6+?AI/Y7>4>&9.784+=)5Q3U@3WB#=>YZ@GV1+6BR-<+ +[M_
MA;4$U[T*FGL\ZL6 2O03BHI'F?XE*[5_=>FIUH C0FG8 V1+7VJ9R"DR&=6Z
MN%F.47CLSZV83!;1)@CLQZ2H';!M5_OY1%M/SJ?I3+..Q6.6AY9$]H4_S!BO
MVP00Q)".J0:%ZPWZAU@L"W' VOX%'82O:"C!BJ8PX?>P;?1T;57-YI0KF=N&
M5D^-T33C6(F[/Q[)-D7;*=PBZ>8.:"8"1:33,5C%(N!!&@'Y\?WY G)D=J>E
M]/L?1G<5)29UD>1WXK7:%TT:0RE9"S/MCV><0JA9+K9B.TQHI- ]'B*Z4%L@
MGNS5%8UGT^=G#A3D;^6YG*E)'JOL:0U$$[RB".R.V@?;9<;UN""')J I8L@_
MWMHT3NRZ1=ZBX\H\R?W/DC*Z:8<AA<$G@7V2-W\Q?75"0A0<"\Q>B0RB)[D.
M_G8]8M,H!K6ZA#\#O!!;\8EC?-@=:NT)_JC.N5KY+>K2#9_M2(,M-4QOF,(A
M,TTU000 @WT(!CG"\1+ARDGCC)7$4B!C?F2IE\76H)ZL2,!%BS<8NV\JI9!+
M'7>7F=)E8^I-@51ALC7E+-EY9"J<!T*Z9&8.:XRRDDQF"#8F%;U)I?-[_ 1-
M&+,Q56YF[5VES.!I(\B5ENBV+'5]+.PL6' AB><F$FM,]718V@Q+$U^95T!3
M1UP=3^JCM#KMLL<<)402_/Y#)\R+"@;JMIZ!2<4@KM$IW(?EVJ?ZOJ>!NJ?>
M?(PO%<_  0G;H0+&X6O@_QB![:?$TXMUJ!QF/[5I<8K^1E)3; !3&N*UGVF9
MP^0JA93%0*/&,6$*P(1#[&(%TOI&.7O+O[.9X119IN>$A>A)$[90WZ'\D)JU
M!>4TRA)CY=E<?U*C)( >FSF"V@W22)2<XRG=[ML)B%J&\(4H&4_YPC0L=/68
MQ7\RC$R5YVT(S_VDJ'A[(2Z1B*)ZO-9: UDLFT GKKH*]1/PQA;VI'>FA8]6
M7(@WV&2MH-/"BE9<G]/ -.XJ87JX(^T#Z%<\8,N=X1'6(:8?PA7[8%>,"S,R
MY"E,&5)E1@#>/C+*J8!/W(CE]HG44Z:4H:+BT69BMW$@YW]<:;T^<-SLB*.7
M"FA?'^,AP;5#FB&1SON((X.8L7'2QMW"@J9:2+LV#$([3.VPEAI2N)31:FBQ
ML*NSSFC]8(7T9^!:%?KC5B"XNSR>F]WY*B:?4N;L72S<Y8^V<KJC9Z"%C2%T
M"!KT#(BUK#F"+FVTQN!/. 8&2%OX<<%?"X$E[RE 0!9ZG2-C"KV;.FB%>'MB
M31$)]SRU?=P+.=R#G< XB J,%/T&^==<%Q7N#)*8%;1M1W6I@^R7F&1AG&&@
M/7(&&Z2X'9GB;X+;UX&^HXP3JZF5! E=0[A+A%2Q\+D)NDHQ"\?ZHV]U2M26
M"M<G!RH*-2 L]"N/4$\0BO-^;:Q/I4=L;N0DG_?11>SGN@ZT78J#6B/M^5&>
M\T%#L@%Y'CU8WP7-#5E6I'*B)E=< 20 88I0:8\G2CO7TR+K.Q&,TUNE4/UD
M6Z&:N>EX5_<JS'V-JNDC)!=E)E&LML,N.V-W/]IC5:6-?-K6.$(F\KC;0E3<
M7J6V7 FB\7V"1C>Y1JO?9E:6IN]9:3BJ@&IS3+?#348*%9?0/0"43R*3>?Z)
M]1G8"$B:0LP@7\1^Q SX!/@&/[JR32/^^.]<A"2$98J]NZ4:7ADH)AHFE+'$
MH.&?#!@VD8YS@O&0B'BY>WGU.\J<PZ[@Q F-.?O4OBOSX8!C#:9A+HN#@*-Q
M C<C3RV1:T9N='<.N35M=%P\R4XP[]V:\HK2D,#]MU>ADZWE^K_8D1UZFY=F
MM.QK+9@.\:(D)NI%LZ7-!#PL=ZA0UO%=S'$55J* 8BPTT+3H)=$@AAEI@W,N
M)PX>2;NYC1X4Y5&M F5[MP9;<[%$KQ6[<).Q7WDSE]ZME>/+.H85).,-SWI6
M[6OV$AQ$#5QX>VXDTWB'LSX&+E^FL_&2[1VZ=[PVI@Z3MHQ\=A6,=")1J3VJ
M2[ F(#]XR?M-X\)G( A,9A)DJ' I?NT!VD6\&O@J16[]W[E\<[QR2C$U\TWH
MP? :C%YK/3TN9.'0\CTDF:]^#)L'W]Y-"B1FME(NTKD[R:L_FL3&)]0*.FC2
MZJ7%Q:/-1I2ZV%JS;0V,<'C14-6/7E\#1_G8FW[F4V>X]3Y?]+\O$NHJRPTJ
M96&+HVCI786CB.&)O3TP#",J<&,<&^KK]G 6D0GCR(T?((TFAI#BB$E,Z*!B
MGJ5IB&XS( ;)-S0L6GYH5O'KDO[RNU1]BY4[>O#6 )59;<Q$/.OET'8&?9Q
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MX'4,B[GN>.]<YR 26!9?2%"&TMZT>6;T'?+=U32UK3*QMR["N@M0Y4>6<??
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M"<@\2[J*=VYU9V[C*;E#E1B6FN<NB?L#A1VHPBX8X3S9Z30"KRKH-?M7,A+
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M^S=TGGOIGJFB!J_,:&\7 &9\[W&RPOH-#/4SY13T8]($7]2(F;J?&1P; ]\
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M+PYQ9Z$B"&_.L83Y)@\SG^\S@.@8:': H+W$KG\ ;PRFL),KX9>+56_4QG^
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M5!(0IXIW)")/]*JE*OQE+_Q&:?RLJOQFI3/K/!;HJ=.ESN7[)HGJO*JGL:)
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MD5>\*.@](1?W\3Q1 !#HGA"=T<'2BJ;._GD/IY8#WI!/4 R=UL&/=61VC._
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M<T#9?!N'ANH,KXWV>??9[L0Y07ZL/52ARRM@LI-%C\/9^82<;@VNLLGTY1]
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MMJ!\*7)45/3B@OT[\GPYOK8Y?^!=KKPR">"+.>!J P$@0/5=!$OQZ<Y87?#
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M[8'.9ED[MPZV&9A.%EPX.:]Q&[VJTL8CZ.%(Y9P66+ISN-L1@%J7+QC2I^1
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ML97!UW%4;-6Y1J85VDS+TO@H5S.;.1*$TP)3/SY/^02'D_"X%%,K=;V5,")
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M/A!+C. C)EVM<[L2N"1)BN@NS/YJWN K[7E^5+7LZ>7N'CO@SSDM6W'+? /
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M%AVH>(<CA,0Z,1:O$'+&L<Y&W"4NM& #9L< SLLKGOWX?71\+)>U(Y*FZ8)
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M-WZ)^D.JWC6>ZH5:<A:C6=)2N\0!Z=MCXI$=PFXL'L=%3>$00'([\&%V>TB
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MJZ!SFE65YD/IVH"+2G]6-9@<,]5FV#F!.Z/CD:K.JEQ$'<QF+:G@KM .\!?
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MW9Q_N\M9)/P#,#H7D5SA*A=>T&ABXX*^QC8'%CF9#LRPNH#(8+?(  <M_]-
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MS-,7_0@/!P[%,PKD1_\?_V.2=]X3?_T'*$:_W<2X^JM>.$UR\ 5WWT359Y]
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M.^$GEI >M!V%57Z]5*<A7VM"$\IQ]K=T;E5B]+DDH[!,PU5W6X6347_S=:\
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MZK/DD6&OB^W+4]N J_,I:ZTZ+G0%<HOO_0\P #[6!;H2&O(S>[MM_@,,-MM
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MDRH2JBS2(DDXKUH"N\4ZFU8NF7T2NV\M (;JNN?*(K&!W<J02)SHRRQ<%TT
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M;?GEZ]T F-L-3!CVH"DNCI&0G>RH.RZ.+(+L_!K@0<5N.YD/$C!%L<1/NB2
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M1^;^J^4N_?M>9J%'X=L^YLSES7.I/I2 >K1PSM4X(*6CN^<TU^^)SYY5ZPW
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MJJ#FZU4E<?[FO*H2U;= P@\8_>&789\"7QFYPRD-V$38_)&^V5.7@@F3:_1
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M=$5 "7P,_0^!,A;? $.EE%^*/8=>??BFL(4DCFS? -T<KZ@VJ.!GR^Z-Z3=
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MM.*W8 7C*4.W!BJ: I)JB8"WZ?CG6?P3:44 ]0V??2H!3W.P@;?.?WJ:K(#
M,;TR@O']Q/S%-VOUM@W3R<U=!)1>:7T+?=F2I'?3W (6F3A2/US^TYO\E3ID
M>LD5EDFQM@*AI96U;J^N*K-]3AU!S5>>J8;?#B7YDG2B\BU3!P:YAD^B1" !
M@1XR7%BEH&JC)*:8P"(-X"TF#.J'^BI;-<9@B?I7RQ!+X"N6Z+KXE@ K6HRG
M:R =%CJQ8JF;R_MA<R;7(_/,3PM!;4<!0LDG1N/;:>J$5Q4:9&[ES4J1:R!
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MK;YW"3SH1;)FS;=/@V4EY=*E)T>!CXX+T/>?,_20FM2N'[<Q3T)8!4S->F[
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MX3S7^V:,)#EHI#3Z[O_=)G4"XS^W>UKJ^\NR@(F]-),9/MQ>>EQGD$S&PX@
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M7\28+E2]C%:3'B6 6XLEF_G#D(BSUJ]Y*28-L33VSC89Y6XS!FK;XL8,<+=
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M\&26#J64A2N"< 96U*8U[>NKWC"*-=U2%GG,$]VKF-%_Y$E.*64N?DJX[@Z
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M0"SO1[_#:+B2H-$2SI=?5>::$E-$%.5, ]R"!SEC/@47*DBWIM>X'A8TG_<
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M?.0("?:_]$H_8^-Y+$LL/:2.%0S**IL[VS _,;,WN<6*?F&CWS(H-$2#?%"
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M"2'NU.C*$JTH'67L"J/DY'0\E$GAP;749$PT.XGV0E1PF@5VN232SX3 D3(
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MAWFQ)&@T^M^@<"<? \ M71+TUP/)/<Z_8RO<7UZP)4,$4=]?_LHG3+?JM3-
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ML8*H4#EA\A7GOKG6\DHC:3[%,NR1PVGZ."Y4QHU2:[,*X,*B?%/* YX[A.5
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MG#@+&!')-PT;6*N@0OB:)3HCM&,L'!;:V8O9B(JM:YP!7=8,XIY0/T,$OJ.
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M$;8^,"5NG&-M:8DN'1^7,RS_PF8SQ7\?E_>@=?XKHM'HN"2:%M-^>EH8FOC
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MQA2:1V%1Z*3[_PB+.E VSR_90UWZ+;RW*!"4#?W3[%PI0S.XN?,?0+O/;].
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MK._^SACPUJ&M^'>ZEKKKA=FJZ7-,;'QO)D-??1Z*[R[TSY,7;2L+\:E;Q_L
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M-B=GI]-%TQ[UO#AUHL6^MYE]X'DU4+$[W4>PE^RU [J9_%]02P,$%     @
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M4_(2E0 BE$[R!)36^;FGBQQH_C/]++LYY&C6.I[&D8CW!=FLKP"B#IYJ"%/
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M/EJ.+&\U/,FHPE;^.:0:\YW?N,#T(WYO/ )_3.'SJFSD0Z+0FK@<'+?9 9Q
M%Y7E*X#,;E2@!%K_U!C/'C4M#F=XBU%+>AF&N$(1S\95@C)6;%I:\%I0A.B&
M]GE-O()XOM4EG2RVS<N^5U_.U<4CG<3,Y$#]7:'=!N =2%C[Z*C7L>:^6 ,\
M6<760U3:*B]\FA1T*912%#\XCELFZ"G;H&4VF_YYJH=4 EZ_AL!>]:";37[Q
MOMC\=#&(7>)*1R>@]V"MSDT5C?Z4.%LN.&'N:"E9*9RHCCRE78,_R7I:BC_@
MAI"4:<NO<,2[%=M52AYF:TTY?_0E+Y0TD-ZRG"\.K<E6DLOX#ANH3Q3]\ ]P
M)M,\UM:R#G[04)N,K[#JK'3=%6ZU\- UO*/V;@\+^_R@.&JK47_8CZ(\LC\D
M X_FR9!CJ@CBVG!TZ/DG7D.LR:?6IZ1TS0)&"NK9+IE2M1NJ1=KK6:\+<F"6
M-^O/7'=1M%0R=]$%FZ44_!V9WW),C ER2C@)#>Y(/RN<A(8C#PL.X1$GO%E=
MF'#6G_OE.G\2,PAC[ZOL$V&O#I*&U+?B'N[^B8-*,CXHG0EYBVKL>05#6>HV
M9N[77>)@7Y.)#D&E([-A&Y2V)7).QBZB"D\,^^"Q&?&$0D8.2X:D *VF+UB&
M/)59*+T\"Q>7^'NZ30%EQ\YXA(R&6K#5UM%GZT',2[7#4[:O?&2JOQQ;QJN;
MM=_=V4E/@3GX+.<Q54=NV7DK4V-.MXJ[U/EX4)<H+:S=M](6!R?(U-*)$M2#
MT0I)=77ZGV5$W..Y:%9$\I2G<.A-*D=.L">X^%W_6 !36R^90<"Q#G$CM;T)
M!9CYL^8Z\+;NH*#ME-!B)^0L7-V3;[.F$2!U W7#=E=*WD!I6< <JL=W82,H
MV6X9'0T-;G'60,N."X3T!H"<),F$I>'#@\V&C:S&O*WN:2G?O0*8:[H.2N%3
M14H(4YF\\Z=G,(3\XTIW9J3[:()I]L 7("7!Q<=$OF8G'. 0/IVZ+I4%Z6R=
M$!O\<;+RPDKH*6*!BF@="5Q[BV/V$2H^_E;IG9W>5B9E%*$'Y:1AGZO3X3@]
M[8FBK42]IVLHT(E6.V';2O2"I=:5?;;4F+*457Q"B0OUYH]U$[<;5SOO.1>$
MAUS'DM>1/:2A#=G$?9M<=L772/HBWC4I)#XAH0O,]ZQR1EJB8O81D4;/11"!
M<;2MAO.Q-<%%.8KXP3_)Z02&TTI:'RX&&6OY1*19FG\>1C\GR?1:XDERZU>=
M),+Q0:32KXAMGU'Y&/+ > EQ#G8!TJS&W<[B04VYH"+I'54^*/-JF&IHRQDB
M$K]QO]"# 0]SQ(>"\!AWR3ML ^_#Z,T88LJ-4MZ,:Z7H<G:;Q*QA_*9(83'T
M&.CEDX-'B8Y'E.YX4)WK,(KU:!H_UD 4'CM/![($Z4EDY.X+>3O,>0E(I>BR
MF@>Q_E9!Y<2WJ>G/R$CB;/\X"5UQ$THUN.O.UU0KA>.V,^O;PDPTM]0>IT#@
M",;I8FE]9V=S=()(B"MW XL#3:4JK&)M'JMMNYYLW#B]N )G'6J)67)P(=H\
MM  ;6^*P2"@SD!)D;=UM:GVZV&! &16I\YT9!]^19&\8.\WHVW<04#K_.J%
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MJW*]?G#P8=SD4#UW59 =$Y3%;0O5JV\!3</"NZ-%[P#4RTZZT4%?PM[S&KG
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M1!#Q>_44=VW+%02U#\^XZ4,SU;*P7@U/Z"6$;&+ZI]X:K/<YBNBH]*2\0PM
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M'5E]R V3JTHFJ]R,D@CM$R:#73Z@\2]7WU4O6K;H7:7]KR,RQ2Y;<DJ2(J3
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MI-%#@SU2F)*L>YL??K5HT-B[,TL%9"->[8I&4]^T8?JK<F^G!%O)GQ,,LU?
MYL==+@:]*F+DLS9BEFKUL3?PJ*MB7/2Y&.K1,(753/49Q85F3\RIZ\$\2+[8
M>=$<>II4*)5R^6[=JS#1CF0!(;%BF]=<*U:4CLRQ).Z7IK+-H!S!(U^G N-4
M)K?7(T4B7)S4H9)XXHG< FY%=M/CF#@!F,$)KR 11!M2Q8+I]>$2!FG]9DAQ
MH<5>4J.=J5_W7.VXZ&W[7MWCS%>6,24>_H$KM%"0EJO,3H9#Z?7B.IN\>=+Z
MRD^U/F7;(3S4;<U5<E4L+W#9AM1+#&J4Q$I2P68&,P#70L05ZC^/$E'C..._
M%-W8U#)[ZPV+V-#BANBQ0O9+<]5*>=K4,MCY\Q&8HZ(>>$1VJK"+J 770D<M
M.)LD;$27;0B[.5W$=^9^%$<GQSWT]6&Q>\:[]BL$/[R2'+82_6QU97/7(L"M
M7ED:5!RC^I'%OK3.A:0=*<@3Y%1-X;@K)8LU[>_,-64RQS1Y78.7J/9G@ZI$
MJ005K3QW3UK]S* &]>%ZTS/!$!D@ ):ZO4JJ^\> \4[CV?27*127=UXO=63S
M&2P$^'BFC]H:&-QU:"V&EEE!ZV8]1Z-.!+V7C1!C1CK!PZ$/<%S8\!C5))BH
M55AF9^EG60AC]LID(5=-?L)'H.#&N;ZO2O:]]8-PZ7.A17@LM+[*UBWACF]U
M2ORI.\X,I2NP#!8-=91$>6HUZ>!D3:N!:W5G15].Q-3$4L=IBQ9).WU=P*HT
M) CY_0?APJ$Y+;B))'#Q=38FM'F\%DJAFR1#9%HPL;R$UG#$@&4LVB2,I TZ
MN>GIQ+2[<?,K#(]O?PZU>MC^Q8IUHX&R8FA2=YYNGM,N@<2-&FL:! /IZZ?B
M>&+2,Q@A XNF+ZUJ5MGXQW(AM?=V0[D.M[<\JPP4H9DA'LJL47='= 8)JW,_
MQX&G-8BT8NP]*TH@7-TC,IL[YVU2WAMRWB\D$8V()01TJ_;1EZ(YH@0>EH2^
MH(].,X-=N*%GY>Z;->8N\-H939 EPV7KS1TJ-IH:N26)V@R$$QZ*!A;0)-81
MB#)IJ0O/B]CFM;I<0"N9O>720S$4(CPQV(;6II46X>F1[/V'D#VRGJP_V0>G
M_7Q(ECNS48H1L#@-8Q 5E@<C%+DJT?>L,T7Z2:NYAZG!"(.?3TAAS'X'AN"U
M:=M>SM'# .E#OD/;[8: [LK59K,5R</DI$DD<8I96$+31P+U!*0;0,0 NIT/
M$AI;A4*GFL$DMH92UU-]$()+/*5#*&4D*9.D#0'^T.7VG3Z?3B6DYC)>;\ B
M:NDX'<KRL8XHY)"W=*0OH%/6RGEST!^WERX95,8_U@8'-:FV/B*DN/V1= /9
MAV[>FK"(#I6Q+F)%ZQIR4JOU_#APO3^1M=ZG4@TUG9U)0[\VBN#LY>QDZ_N<
M+=>;)1B2(/5LSQ2/*4'<4Q2"-^1'/3A :CI=@#@ND<X,MWG:&N]"OML^<MD8
MG#X>-C?CLQBQ2GEP.W[3UZ4@A>.*F"\/;:>0$:B/^G@":&1DNEA)9T9)K#F
M$-'4!2DVON'(9VYEIGP]LU1;LG&W+1LR2*&L.W;O6+&K"<KS":_8.7!PB$0
M!K45*BZX;*\EQ Q1D]RF6FY@$)'T+U=?2ZM]P4_4@^O#]:T8I8])[0I3>N]&
M2(7=;445R"S!/TI8FECAC<IK'*&A/47C(U5?0_7A*G4W>%]X_(/'&SO" ZO+
M%615(4JIZ0_;;[X^9Y$^O"5L?#<#J< >M5[V+"S@NJ>Y#:Q  :E->H@C3FVF
MN@^O+A*9$-.\W+>NE?,&%+"TI;:5+32R-7E>2& -KT3R"F6$;3*>6NFH;A+
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MG?T+;?B'(Y/$X/Y.Y/%9*M!/COGO\E;%C$W44P96HT>UED$$K:""]&5TC/\
M'CS_ )O_ &D#_@(_&95TO,90SV>68_\ V&;\2B1=E?*]YZ)L0[-GED=87G@P
MN3A>Y4*@,YLK.!UOIS'(ACQ?%^T(^L_ N!XP>TMWRR#T($R&^+++)C)L'))=
MME):%C.8[_ZWPWF&MEXX;#P6LFJ]2G[0 #Q'T)1R<#%0XLCF[MF.)LY<Q%3'
MR%<%##.:U26[!H'>.K.JFX95'--2BCA*<MP+HAP^Q%/A3#V-Y&S^,WW@;XR=
M&[=VV<GF[,$%?W%8P4J=B-'GGC;L&PDLI<1@Z\N'&8ZPJ@=)!V#'S)>[?Q&[
M?).7R=K)9RV<3&':.D(I,36EMV79[$D+P?K21CJ!4DC730C@FYN&XJ^2]%QE
MM6@=C;"Q&QJM>&I"TN0F ?(WK+/9FRLB*W1_OW;VD,4C !$^WZZ<8=S.\-/#
MR5EHV-H<9,*D40GY#)Q\^5S.;BE[2G'PX^-(W>2U:G/*K3$8+V75O73D!Q+E
M=Q/KPJC*P;TC4EFBM6[=DRMF+--NBM-6E>.GJ"%K/U)T+'_#C=7(<T^<485H
MDJO#/C(+\EE()KC0UNIDL:OT-'&B:!(-3R')M>>FG%,U<-RE:]S#-</Y1VY-
M/:S4]4U;$->$B*6S+9QDS4M+#M+C:\A"R3@=+)T\ARXHHB%?8?!8ZS85[*37
MH3*V9>OCII*)CC"&21148?J5:T:_9]?X<6"X1PJN>Z-ST:DN*J68<%C:=ET:
MVDJ29.YD4FF)H4LC"J]=6N\'W,S%=/X\1=('X;DSH]8HF3M^$Y;!2RRT*0Q;
MNT.,QJVEGQ<U",G_ (M89"LD3S2?E0^@7B)41;DX)>;IQM>>W*+\T#/!2@K1
MXV)TBGKQU9A8I301(RK:K69/TW4L-5'UX+&0ZD,:@T13#^X8#*P9S;[8[&YI
MX:E[W$;3B)4C5;$E2J(VZ?<*D?2%.@YZ<0F[HZU; _AO)Z%ZA>.?.&U]R[>I
M6<MG<;BK\-.LF9BR=^*A)3G9%2&U-%8D566:0^@) TX'I48K;M[A,+<'E';^
MU\4NZ]S^2L3CL)!*CULC)=JRPSQ5D$79P=>/N"]8T&IZ!IISUX9:4EQV!U+S
MY\R^;I?+N-:ICHL1A]J?NV7OXB]D;0AO6L#BAT19>QW(P@AM6)"RC4D#T'%L
M7?\ (L>>X'DJL>V<C/DNG'X&?#74O]$*2V;:TW,Y 99T(4EH9.95QKK_ *N"
M5BW%QLJF;1Q%/9\T5Z6M5G:KM\4;$!TL7JO=!EO"O8[G3TR:'F1S'J>&5$5P
M"4.8^K2STYJX.WVK+&2S4H6?TY9HI!U.B-]W<[2^G22/X\6Q=_'<MNUO!$X/
MZ"/.J2U'9BF"6PS25YG1(3(RN'C;I<.--"BM]>"40^87!Z49T<_E\3CVJUK(
ML5\@JQEY96:6+5]6 E()BB521R_#B$G=30C2[2O5CXZ8/]M\.[:MV8&BNY09
M*S;4Z%G:U<=:\RZ'[H6@C74\N,E_>6S;G).:Q C=,:J0XA6)_H"NGW]/J>&1
MF*Q;\E]KWK>/PV0K*3)C;SB&NS,L%B-SJ'8 ']6,<AR^G%K88GMU.[RYGF_&
MFG="SN@#T+(=."ZA]MV+$O0S%0JEH@S:@ZGUZ1J?IPGPQ-:7-/:"P(VS12<!
M^3L$5;;VGE,C&]RM!%TXFW%;N]N9.Z\/459(81^I+)_V=!Q55;-O 1U+YWOE
M*LNSMX8S#3-F;$E9MOVZV/LP228F6Y)%.LEN'4O6,+*"Q/IPW!UOU)7YE,9M
M&5I2OG28J5)*-"N\<DER"HJ5LA.OZG5891I)&?61%Y]1Y<_IQI-MSPCOHN!N
M["YM]3B#D5,H.)H;+P$O&JE9)%21HUZSTA"ZJ1U]1YCU XH]7*P&>L>L5QS6
MUMC5I,?M3:!?&SV9(]H2= 3JZ'9LI-* C#[6^T<^>NIXHD9H=3H7JOA_7]7]
MO/B'T!=9L(^XK60H9WJR,(QK)%@$@D6&AW"9#+[AHUU*J?NTUU/X\5[5LENH
M$;*)74LYO7QIELWMS#[&PE[ 1X(9*;=>4Q=C(6):]^:.-XX<9VY*L=JI*459
M$_4TU/U/""PKV.6 5B%:($QHR6*R63RUG$Q0P9"[7O)6@AFB4L-#>6S1* 5Q
M,C=49]3KSTX2&Y>^:5KC<"C@Z@ZJ)TT_%>R\C9GW%%?RM:A?KQV5PP<A89Y1
MW)NV-"ZH@)Z5',GEPZZ*&FA!_P"S>/\ (8"YN/9DV8F->S9JB*Z+(EFLT[!@
MM(]*9%=.VRZ_;J-#KPE<J&U6S<TD1BV]#6C>M')),^*NUQU$<M6=-9'8>A T
MX2;#RJ+7IY::5:LNWGD 93[F.&RCG1M25':^T<N?/TX22&[&,F1K52O1M0+4
MO7)I6"3V $L,6:,.J.RJ)#]O5IJ>&2"UOL/$W9-A8VC#0O1W#1'1))5F2998
MIP\D<Q*:*3"W(:\]>'3XJTW#CV3"S2R4IH>W,TH6:K.A>G"O5.5;M]LN@YD=
M0 X5$R6M;)1R=\U:[W%D@ZXS6@-F.:$D*VA752I4Z-KZ<0]7*Y^Z''!"#*>P
M-L8J[<SJ4+,UN<SV?9VZC&"NY^[LUXV;I5%9M>0/]'%4L7# .]8K;$Q.U?;?
M I\/\RYR]7K4\9EC%0"K*\.*D>.VCC6&I7D[:J%C7[1Z<5+5M[?!>@&4V_N&
MAO\ SRV-OYBF(\3M\R12TW9^F/ 47<L)"LD2*K EB !^/%?JYS75\H^1[2!\
M]>W2D[U<7BKF0ZG,06 1N@5T.CDB310/IK]>)-B,>*-O>9 @MW*@Q.Q=^SVC
M-D\#DJE11W8KDCUBTK'F8W*3LHTU]-=1Q(5J@>7<P'&K45JHWDK9.Z\OCL*,
M;@<M=EQLUY[<5.N)852S%''"SD2<VD9#KRTY\*JC>W(F>YOY8^E9TW!L7R##
M6EJXOQSNN?K7_B&7%Z1+)IIS;N_0GA;%S,]J:Z]E5'VAXS\C=4=:WL3.XYX,
MC#*EJ3%LZ,MRO+69XRO4)6B)U4'3I))'"1%O;E6#^(MY8VK4EP7CO)8[/,YQ
MT-R''7KEF;W-J037)YY8FCCOW#($C (9NK0<*. N?7>47ZLX[,%I>C\8?E72
MQ^-K2_&/S97:&M"R?_8%E!#&G0'83.?RV78AM #J&'/C2=#(V/4QFMU1A[MR
MDR,P'B$89>=2K?QS^0DJB:YX#\NUI4$B.)-BYD,S/&5!'3">I0>1/TXITW/X
M./-^0K?6!T(=RW@KS?1Q%_&OX@\MXYLECAC7M+X^W!(];N#62>LWM"%G0<D(
M_'AV0/+]3FZ7;MRIF<'#5O62\YM[?VQ\HU'<7CSRK@J=>K!C\?E\ULC<M& ]
MM_TQ:R&0I5X$MV)QJJ!F9EU/!TL)9;EQZ%E.<&/U*A[6\,S:DLU,-N%)*L+]
M_'-1LPPW570"S(K)T3%@.7,'@'!/ZP%!?:F[K3O'+1SU6M9@$T-?'U,K#6AD
M;^THAA($ZGUTUY\"R=\H)\?%G,@V_$CWQ+XVS@\A8[(S5,Y9E%?/0QV)</?B
M583A+,1-^W*G08=0=>0]>*T;ZO\ (E#&9\58+*25\G=H5(9H_P!?MX]VIBU'
MT1JD,XA9@80Z$^@Y\.A_5S5?DFW<)8IPTIJ20UJLK2&G7L^WCDC<ZR0/)$4E
M[<GU+$ \)2#2P:5>5EP&#56JB7%M9@B2.">S):K5X*[-W+4,G6TBQ1KRU UX
M7H4D,YG+8+/4LM34YBOD,?>V[BI<A[<-2DKV9)9O;8E@1-6:RC _>6##7TX2
M2 HZ<5?(NEN6$4YN]5QTT%>2W5NU6O(9\;:[+$UKX,88R$J-1H#PDNM,W"[1
M.#L9?<>!LKN.+!)$]B,#V\\1R*D&K;KS$QVL;3F^Y0I+=(UUUX0-*.W*<3@R
M0.W$(>W5?M[@V9?S-JHU&W5S%2GFL76#SUX&=G.-R&.8*G35E9?O! T_CQ/U
MC>IWDGK HE?F)8LG6CR59>GH<5;L!1DD2S H22<1Z<Z\N@Z7Y:_AQ?"_B8C>
MN?FM2VH5"LR12+(I$S*NCHW,HP'-=/30<;,.2QI;?M@[B%+BLK.W4(^@_P"R
MH&GIZCBQ&%6CR],1"J_<4)*.0T*%^V0"3S8'GI^' \U/>3C.@3 VW5CS?[/<
M*1M<P.319F'*5:,JL9)/NT!'4!Z\N,:;O+4@P "76]+=.,3T[^0S<^;J7P^%
M5:=**I1J269)GD$E?HF9T:34#337UXM@N,47/D@VMF&@LR5K\#VR2'KR1ZFQ
M8@TU>>:./5(^AC]VIUY_7C0=)Q *;%E.CUG#8BFCFJ+E>\U,=3=4*SF7NH%^
MWLQH"A0DCJ[A/4OTY<-054?5CG1:^\=;X\>[\VOC_'_E2H<-N2E;A.Q_+5*4
M^^1XI5[&!WB9 K7Z5N4*8IF+,BC\->$NB@]7KF%K??&R9TLU[^-LIE\+D,=4
ME]_0FAN5HKZ1I%<@DGK/(FMFPAD74ZJ#STX!OF&0-Z"?0M!\D4;1H.)2^>O^
MSD16Q(H;_?&.*283Q$:QJK*NJ*HY=0Y'Z$\9YMU7ZP%^R:R(TU:.9Q$O6J)!
M,[D @J %0ZL!P8+<T'4G]8"[3;A[7143J>T]?N>U>-T+@$!HW)7JB8:Z^GIQ
M-L1C-2B+:6.0N#\M*'=PY*GM7&Y+,WZ6?FL2UUIV&P=%+]WV4[H\D-:+MR/-
M'"Q!.NGKQ)4W'J]<"%!S..VS.:\N)CW%8CGHT;ALW*=N/M6;$2R7Q<K0P%WG
MA3I/;4:D#3EP,X7&JHK2J"X%N<=I7YF-M9;%0X&V,3EIJ]ZG+(DM?'7GK3H'
M'3*(/;]Y)0/JP&G/BF87&@8'-3$4;*EG>HAFUA,I<F5JNW\XTC?I(/VBZG<F
ME=1'"O7"-99".0^O W^<; 5G0CY=-7-4-U6<>&BKR27L'#BUKP7:EB%!2JRB
M:YB8HJ\"--;:/4]<FK@C3BX0.<T..:Z=DC&1BA!=08*TDOY?.8>2? UY,9E&
M6) ]W'6,A2QSUY%:Q#<J1*Q#O!J4!T(UXF(BRKNA66W,#'+4@AM#BJO)U[VY
M+W[;B,5G!7KV:5>Y8A@DA[L\A2<S0V6)<59>VVD14=(.FO%5IA/@AKR87%5_
MG[_;Y?Y>_:NU^O\ YMW[?V.@_P"]]C[;M=OU_/RZ?ZN/5?Y._P A^A5U/\VT
M_E/@6K-DQ))0\]B&C8O9>7Y__*"'$%9"*%1V@VE[B?)US^G:0IR0-^5AJ./-
M^>.+/:,PC,\D _\ ,2KI^:QAWL]LR3__ '!-^)1)JXKQWC:T$$N0QUFM<O3/
M(<E'E"<@\\1ZPD@((CQY?\L1&G3R/!0&F)D/V(:7>6B\_$8:-0)J)9#[X4FY
MLK<-BY<MUFJ9JG/-%!W9)H*QQW5&4$L#E-2:W3Z?B>!!*\Y *J5[IACAU(/W
M1BX]N0$[D2A)2AHS]XK:>>>)(D_X?V,S@FM/8L$F1H]"1Z<6QN<\]JBMM8H8
M;=[W.=JU89;D5?&VUL_(;QO3PU'CP.'V+O+)Y-IUBDQYGLT'QCV.RB"6P>]>
M1XM=?N74<^#V6['-J2:@*AMW&\.&W2?0C;&;#P\O1+BLM<.$O2^U7-G+G$1Q
M7:NK6ZM:J_1=11%Z%P0QXSWL$@[1.2R+2XF;3 5\JA'Q]CWGM.^[MY+"G5)"
M/W>?H,740@#Z'J8:'JTT'IP\%I'I<TDFIZ%J/N9I-(H!AL5]+AL70Q%#&5YK
MF:EJVAD*%G)VY+-J&P01U-8EU*!.HZ=/!EO$RVQ8*]?Y")BCDDS)57_*:R$.
MDPKS"7KN36.F<7@W+MIJNBH/X\^*^,[<**F\MA*:NJ#T+YM82A"5K58XP\;E
MSV 8CK)IU R#[V0Z>GIQ!SR^E:*%K'FTUH%5;MV[6A?:[XW%TZYR%Z1;]Q'C
MI]Q0L=9(! >HW)Y78ZLH 'UU/$47P6[2428+:XKY^PU2C2$25A5CE8F2<OH1
M9KAI"55%]=!Z^GIP%M\JLM_EG4=@%1>1MEX'&*N0BHXT9?.3IC[D[UD$,LKQ
MQQP/>E *UXN@="]( !'+GQ$RNBQ8 2=ZTWVS(&->TDEV]&N+PM""C'4LXRE0
M%%(U#")>C(3,B#JIJAT-8L/S?4<^$;J7[5OOJL):^3MM8VQ2JWZ]?'B6E,$O
M.L#)(*^O4D1E4APL+<U_CQIMF<6@D#(>A9#6ASR#O/I4W8^ I2[=JUWC]V]H
M69H2R22VX4D(4!!ZNT7]D<N7KQ7-,Z@P&:*-H" 6$DKGF*2>[KC]EN7)J"FN
ML+U$:E8/04#9)D4:2*.?0=2O(_7B43=>)P5K(9H\E]8/$4,AF<-0W)0CCBJ-
M/9JX\UY+6.Q8Z"$DC220UX4F'-M1]WUX8BCJ;BB3*2W2Z@2S\PRX?+96+;^)
MJU8+60F:/(T8E2883:6-Z8H(WAC(B@L9BP&=B-%$9&@XNMP'2T<<*(.:-I;@
M36J6*5<?)9BKI1AAQ<Z-7KL$)BI+7.BN)DZ0LB*NB1?F*Z'7@WAQ[R@9+*.3
M-SAYEVQV'C]Q<RM:'),B0>TH6;EJW#%;C *B1\:\A$%:70CI//3Z\^,Y\[FS
M.B:!I!I5">J,8^@<[ ]"(8:L4%&U:J68\+EF#U9,J\G3^T5UB5I9<4'U5)6Y
M (=0PX-A-75.5%:\M8SMDAM1CM19D%J9(XI*LJM;@QT/[E/(1+,TD?27FF[:
MJ@GRBC]-=.3'GRX)JVG0K(K^*$8&O6H,;T;^X*^U:-H6+N8MXS$5J,$,DENA
M;R]A((A:TT13 K$R$<@?X<4O>:Z1DM"#F$4KM6&LKVUPE"SLG8^W<+%CFN5\
M#3IXR66DQFG=8*R>YE>(MJR)*FH(T]3KP%(P4+\:K=BDE;'Q*#0-N.U%-.:/
M(.;"LB1PZ)(KLL$L;L@<B2&4E_RD:<4(N*<OSHA'>VV<3NK#6*TJPNT4G<CF
M1_U$9?HH.J^O\.!WZ]9H311=PV3%] 7&F?4L_8#Q+5ENQVSD<7TQS O0"E9I
M0"PZ#UG0$^I_'3A,UZQ6M*H&YMH9G\<X/;D G4FS=K8>L1^TX^.60$DUX$B=
MY&"]1,Z 2$ #\?4\$IF 1X#%91^0?CO8&#VK/N+%8&OA\KE]Q49;\F)EEIOE
M.N"2&4WQ$0; 4+U#7U/KP5 =+:TQ1#&M=)QR 794V8+'^,QK!C3B.M.<+K5#
M]/6&T(^\?<K%3S(X+%R\-T4%"A>:6S+FVD<&@2!AH!O1AC]K[)MVG7)S28BU
M6>(>Z3(6TQZPL=+0.,II]]YH=0KOJO\ #7B'&=N"XH<JD;)Q-.*,=Z[@W)MQ
M]M;:VUN_-U\'AL# E1,5;>O7EKY&22UUOW(1*\BJXYDZZ\CZ<"7#BZ2IW+J>
M6M>+?3(T-.HX!4U/=6Z9Y9)+NZ=PNA5>B9<@R3ZQC[0SHH[A;3GKKKP.MMML
MQS"236BGR[FRU:)B=R[AT?IZ2N3E?MJ#U:,7!Y$^J^G^KA_0J> P][%5EG.[
MFN)5[&:NNRFXXF>8222+8 *"9RFLLH<$*6]!RXL8P.%<<#15264,CPX5;0;-
MJ@5M[;G23H&?R?4CJFIL%&ZU('4RHH5"K#Z#EQ,Q-I6I5C;=C!I!-%WMY3-'
MV\LVY+B>Z>=7Z)4Z$D)ZDE6-$4&0R>K'F=>?%&SH4^$T;2B?*[KS5RMC;\6Z
MLQ%!D:\=2\JV946/(X\]A JC[8U>,ZZ?7UX62;@MWE5,6Y=Q0ZR1;LRTLD1Z
M-#:DZ#H?I]O5PL^M+@MWJ'D-QYZW81[>3O"N3&+-6K+V%O%&ZH_==M0\[=8!
M]?IP1P6[RJY6"/)"C[XWA23]F;=FZX>Y::[9)LS0U[4C.>U'CIHY 6KQ1 *V
MIUUX7";O*K@(EU:\**?>\@;AMI!MRQN;."?=4];&5JDMZS8$4 /_ !LJ%F98
M5GBY,2=#PN"W>57+((S@FMM6I1Q\\E-8DCC2IVHU61ZZ*BD!DZE<#1R-=3ZG
MAY'Z&X4*SQ#&TYDK^W8N+QE&29X[)GR!DJ5HXFLVIUG,$LB/'VIU,:=6G43Z
MCC/EF=+@X  '8H7#&.#:9U5KL.KE\%M"I6GO6[-PQRW&'NK\+HTSQO">I[);
M6-7T]=.7%.Q%00LT[:KTGPFW]I9S/>?,KF\'DMW>4,[MVO3VU!>O;AR55J<?
MC_'6+5"S5KV%7&F.%"\<R\F/X\&C(;EJ#Y%G9VKSIHTAAHIJ5./*X58V@,N,
MDO7E>"T(2;/4TTHG(65] IY:?QXBYH>,=BQ;D:R75.*X96>[8QTHEMW9H]60
M1F]>55/VZL.BRI+'7@&5QC- AH&\!VMA)/2J?8TV5I',QP7,E(+= )'W<E>8
MH8;A821#O$!XP-!KJ-.)#$ E$,>Y[R3F35,JA:R<Q2/]PRC*$9[4;79^E]%/
M4Q(D!U#'AT>Z%LC W$*E_<\A V@R65>,,Q1!D;J*"KD*?LF7FOTX2DR-L?=5
MKC<_F*^0P3_NV4,1W+M^T]1\A=>!UKYBE*'=#/\ >XZ?KZGBYEQPG1Z@-+I-
M)Z!ACUJX-KCL7L)\E-U;HQOG7R8^/WCO6-;V2Q&1BBJ[MSU>*JMW"8^98:T4
M602&G793J8T4 Z#C3O+ZWAGX5N7BW;)&USZ8@.)KLI7#"N"#N>Y5U>!48C.N
MQ(D^2_+*?IP^2-_0S=1FKUJV\<TGNXH5ZI80S7'7WC :1EN7TTXI9/?:>+*'
M"W,,KVG5&27-D#6@BM:.;B<*UR6:Y[,FZRN5WS3YL>G;BQ'EWR/CI^VL@EGW
M1FE,+-H!%*CV#K)'KH2H ZAP(SF$SK@Q58PM(J^0.H0=HT]."83NIH+3IWT0
M_P"6L]Y5W)\"MX3>7?(FZ/(5J'Y4^-9L/9W#G[F4L8[%3[,S8>K7E:5)(JMC
ML:LFI7J4-Z\;MTX-Y<_6^-\P(%65#:UQ':QZE&:.V=&2TOXODHO-B6BT44RI
M8LBK:D5JL,60OQ#E^1)94M=TJNO+GSXY_C.W"JR):LP"[9R3/T*.,BQF5NQ7
M^_&)6_<;PA6 K^5 +'+H'+^/%9<7&I5D,[@T&@JNFP]R;TH[ZVS(-PYI:5@Y
MC%VJLLMP0.\U*VC/.7G8"$JWKIZ\-L1K+Z1PX>ENDJJ$4,T4-&2L+*KW$,<3
MLT>H(!=)W;NL''J"3H>&4N,=P7W2V_ANN:I5Q'9%UD@O*;,A[Z-H"7+N3#''
M]630\/13TL>SB.-';D$Y?:^,W"^0Q.VL'C:<6'NQUI\Q-EIDNQ5D93>_:JKR
ME[N/<:@RCT?ESX72@722"0- [-5;V-J1[>QL30VWOU+F2CN6)C(6T:DXBQPG
M'H9$#%4 ]/4\N$C8HQ)G4*%AMOT9YLQA!')7Q%NO,URH95CR7OY':>"Q%+ %
M)[<CDC0Z$,=>$FFB,;]+,11"=G(Y? PY+&-/762CU(,:+,D=B]3D0Q)"&;K,
MW<CT//5E8\N&(J**H,<XTR!3:VA@<CEMD[DIYZ".M8RT$4^/AAUCD[5<!ZM<
MSN=&[0) U&IU/%?!;L)5S8&MVDI,6=K(<Y3]O>BQU#)"+'!I$DM/9N1GHL4+
M" D+*C_?UKH-#Q=$3"*-QQVJ#X&2RACJTIL5CO#Q)4V_>AKP99^J: 3VI/;=
M=>-Y%U[4$BD=00GGKSTX-9?2MP#6^^AKSE4$?:#G5\GQ(+.RYJ^JKDZW)2RG
M4=4JKH2ZGT5/Q!Y\$^N/V >^LSU1GVSJ^13L5M_J8-?MPSQ)U]N%'&C2NA17
M<@]6B:Z@ Z:\0?<.=W@ JY+=C"*$JXQ&+M4+D^.FR,G;OU6K335JS%HEZ@\>
MDJ-VRZZ :D:<^!'M8_$DU5K)"P "E%,W!M7#9EV-B:Q5ORUA5,T]:5T4IS$R
MV*NC$G3F #J.7 ;&</$&J,D>7BA0Q#AMF8B3NVY,S>I)$D-VS7Q$^/KL]8%6
MA-RR1(5G+<F 8:#GP?!,[' *+(VL:YU35"F2W#%BKA5_&^V)Z=E@U.5,[?NV
M;58@&%KC05U&/E$>@(/KZ\:4; \5*A \3/HZ@"M,#NG;,<Q_F3;F1PB69X.E
ML/>_?8U=/TX9)Z3*9:L<*-IU$\ASXK(WJMMOH-0]_O+5_C'>F\-@#N[-M5-X
M;*K66R28:M-%;LU97826&KQ3%HQ;EC4AT=6712-->*9MG6C8"<:DFB;F[,QO
M;>&*R'D_P%Y(W)-3G>2QNC8*FG[_ !MU@!8AVUCY8))YJM28$2U@HDC75HP5
MY<61V[),R0JY+A\>0!67W\Y^<IV*2^1=P1O$W:M&M-66&J5++:A>(486GL1#
M_NV4'7UXGE@JO6Y-P3;S7R(NVMHXFC5SN8&XS)=LY/,7*M:!I(YL>M:.M3FC
MK*[%+$0?1R1S)X@]H>*%+UR494!2''E/R9=AZIMWY[[DEB*FZ.G[V75^E(P.
MHA!Q#@MWE4OED?F2HC^1/(SS!7W7N3MQZ2#IR;!>O0 RE%4:]47VD:_EX)$@
M  TMP"I];E;V<,%\U=];OM=<!W3N"&-&+QK^\9#1&)T98W:R61')U*C0:\,Y
MX>*%HHB;>_>USB\"FGI19MK?.^,)N3;60CW9G7]MG\/;[3Y/(2]_VV3J.RD]
M]@ %.GIIHQX@&M^U"5G<ZY^V*!>H'R)\M8K.;!S^VL1@L=M2GMQYLEG\HV>D
MDW1G-PR#]:Y[A72Q5KV"Y B4Z 'C)?<.X[F:6T!HNG?=:XQ$  T"E1FO+?9>
M1SE&M&T&<R?N;[W\E9DAR&38=N=VCB-N)+8-B5(F 4GEH.+)#6(K,,#6/XS7
M.U;MBT5M^Y-D(L;9IW,K8<+6H7IEEL5?=6:DCH;B(\K.RE3IU>G+@"S^?*L;
M,YHV%>&W2_[+T]4G<_S=.GK[A[O7[33J[NNO<ZN?5^//CU7^3O\ (?H5MZCZ
MMKVZ*^\MK>%<=+D3Y_6.(R"#_$"^3$DND@0%!!M4]# D:J2->/-N>@GVBQX$
M@<E'XQ*NKYE_9Y9_^H9OQ*-,/=6_&Q,<U:CA<UE<M!UB:"C0EFZPP( >XY[:
MQCEZ>@X-%-4>/9T$>\%Y^X=@C]4D0=#Y0M/C*\5W8VX\<52=3%5IDV)'=@21
M]GW*Q',@$_AQ9P0A J;<NYL3O;#Q[?KWKJYZ5>W#C,C6=)Z\4?WO%8>2->W*
M).D=1Y!6/%;F:'BF2)9;\:V>:@$'X$2^#=A;BVI3\G[CS>*CQ%6KL_&81-9U
ML=_]YS@B/2B'0#2N.8]%T/IP=&1H\A]"RH;%P<XG<4<4JM6[.A3W,<;2==LV
M>N>K&^@!)0 C5@-"1Z_7C,"E;0M.(R1_B4I];*S"2![!5YE4K!8U7D C B./
MD-1Z'BZ' 'K6B(V$@-()W8*GW+(M=Z%0QPQ&S?:662/I7MUPO2D$3 \X2%!T
M'U/!%#L!6O#;T;4@J[QT*14Y)9-&2?I/1IU'0,-"$.ITU^HX!49X6T7Y+2J2
M.L_4ZNNO2 #S].3:?0?37A+.:T,)IM2DWCBYVW=A;4"61->2O5CE>=C7J0UY
MEDG>I 3TPV)0HZM!U'UX55(436V^$8V6>)^GK=^ZTW5H['22;U!+D<S]=> D
MK($/J00*JRRV$Q&<K@77R##&]5JE)3FZ5DFB&L,UZ/1O<J6&@'T/$XV!U05M
M7+F\)@!%:_ AGMN(H;:B6&P(^@0S.6Z0#H60-^19/73Z<6\%IPV(/$&IP"Y>
MVARL,M6^D;Q6"J2P$A8YVU 3N$?@0.?%E1O"RV-=Q":',[.E$<UFCLA:QFM8
MC$1,L%*Q)/WY! 975@U>.-"TS.OVZKR4G4GBJ7%HICBM,2\!NHYY(#W/F<72
M-?*8[)W5BKBW-E9V9)*UJNQ81JP=P6G4G[6//T'TX*@P&*7KK=R2V:R^0W#'
MC&%3-UL!9R=896]=F6AD\G4ECEB@JU4B*M7I0_:S%M&(&NG$7=X]:S7RR%[G
M &A.XJHS>VZ>V[\RT:-WM9C'4[5FS9E:9DKP%HG>:[)^MIV_M4,0&;0>O":X
MM-1FG8Y[CV@0%!KXDW>W,E@+6@UF-65"L,-"NG7&9*Y"]%RRWJS $CEQ/C.&
M>"L4Z)TL-CZ\LS5O<C_BH45I+%_MDM5HPS1AO:5Q"-9'.BG\>! 29B[>4*^N
ML]:KHY;6>RN(K##08?&QY:6TYE?W]FW'!U1Q!Q(!&(>I-3U?3TX/+],=1F@;
MYNNW+0<:A-%:LE?&V\G'#-$U6.?)6)9(X(X[!KQNL??Z/OZ  "/IH->*^,XY
MK&X#JYKGCL9F)_Y;WWAWPE/<B25\B(+%;MT)9JC=ZE*LZ 3-[HK][GT/]'%S
M7!S:DA'V<#HW"2NU-C.>9O-^\(\CC[F9_E'&I+2[L>V)$[[2@I)(*&2F(EF@
M$H!D!4]2ZCZ\1EIH-#BNL',0;8P'"M/>*!)O+OF7 ;YOO:\C_N*X7V5J[1R=
M6'V5CH[#-5L=DH"9:BZ'J]=3P,KK:X&\>=>FFY=_;(V=L-=^;CSN-Q&.R&'I
M..FT9JC966K'=[5".!WED+32=#HH)6/EZ<6LC:X5-*JR2X[9R(6"O&_GK=.^
M?*='*6;L5/;N2RK;?K8RE \,;"5B8,BP  EE(T"D<]#P[HV@$BE5%LVIU,%Z
M-KBLA:669LA'?K1R2+%56,Q2*T+=#:3-H&) Y@'BJAW(@8Y+-_R2IO8V3BI?
M1?WV*(= /2"D4G2-?RLVI)U^O!$7=Q1,==&(VK&*5HZ[JQ*Q=)'W>AT7D.6N
MK<Q].)JP]T]2-X[^/O;=NV+%ZM4R=(K%'7EKJ9K6@8I9>;1>I(_ZP.'P&:H)
M8,Q0=*M-R[?R62-&[6BEDIU-OX&M<R44G5%[FY"9(@I7J4Z?T_7@:4MUYC)1
MH9#JB:2W> 3Z$-W,+8BAKF**R'#RH\<=>;K>ROY#VPG68BXY'30CBHY]*TV,
M>(S5KLCL*JACYY4FJLC^\9"36D/9U((ZBRR])Y:_Z>'HAJ'<5\QI9HUQ"8VK
M"*Q5"&=NAV=I""=7Z?5N2_C].+XL :YU3' XX*F;'R]]II W3-W9#V49^DLS
M &3H!Z2&',GTXL)%"F);O"AP@S3Q]J:.=*O4"HD62/JY%CR8CK_AZ\!@@Y8I
M5&\)EX84,A5LXJ_*:]:Z19AF 4/CLD@Z$M*I +1,O)E'J>?#T.="E44S"X6L
M7?QUH5GA@KP:'HF'3*N015!-F&1=456UU/,Z'A4.XT2JW>% <QQ?:ZAW;[58
M!3)K]>V['2.33T?U7U'!E1O"JG!.54NJF&JOE[E!,A-:O6)*UF''PB98,=C6
M:7I@K33_ '&4S#64Z:,#KZ<-5N\+.#W,K4''H4ZG%6N[A@CKQMKB97@N9"JP
M$=>](-35AL#J1%Z/M;GS/$J$Y!9T\DA.13FV]7N1R/>M.W0:_;62;\L3E^B+
M5GT4$MI_2.*9\E3QG')5BQX:UOS)=.4LV<S36FL]:$2K1C+1G7HA.J",]1'6
M.1U//C+.:FQSB>W@$W^H)1D0$)&D1 4G1 =8M -3Z'3E^.G#Z7%N *UK<8+5
M&;BSV'W1N2WB<]E,+'FL3MF&W8HY"U1,E>IMRFLZRVH&[JJU>0QMTG70Z<$-
MDC(H'-KUA'RX ++.3DJ6<A;:@L@J"1V]S/:>Y->D!Z)+$EF4]R0:C3GQ.HIT
M+&G+:YC/>@_<-R2*O52MTHCSZ.J$?J'EKJ!Z^G&?<#'!#5&\54K9D5I<M-"T
ML,;"BTR1/'T1K$]@DJ&?10[:\^)-[HWT"NBKJZ$?!9:QML':.5@5=3]B!7Y^
MIT +=/V_C].)%:@(HJ2Q3L5XTF/;"J.X(V*CN]9_*JD@NP//0<)*HWA<$C83
MXK5@9Q=K62=26C6.Q'(JD+JP"D<N7%\ CXD9E%6AU5>P VLCOLADMX?.3.YG
M'?+#;^ K9/)U<3N':6W;^6Q^*S%3!29FS'L_ O#-)F<D!7KR5N\S=+:,VN@X
M]C\-67)K_P!GW-KV6)@YB.86T;&R0/F+V.=*':864>X4 K(*LCK5V!"V+&V@
MD\,R7$PK,)XQI^RH2ZI#>\0-II0+$61W[N"/$;OR4GD3*[;W!CLYE,3@MMRU
M(,J+6,QL"R4I_<J&CKY -^J;^@B?3UX] M/ GA5WC&QY0>1<OBM@V$NNRQI9
MVXVO<2T&HH30@NJ#4'%&V%A8/ XD9'6"%^P>4]X9O<]+;^>WEG-MX3(1XE<M
ME<Q8H3YW&R#;?NGR4.82&*K%BLW;(:*/0ZD=(/5P1XJ\+>'[3PM+SBQLX;V]
M?9L=I;&8AJ%V&4;$^KVT8*Z34TJ[NE;-SR:P9;"8</12H%.T/+7/R+8N[)??
M_P"&[?N5<P^Y99_D3XSI/FHZDU-+L%#;FX(TMSUY5#JUJ.QR8_F'IRX^>?$4
M/RUXX0-M6LYG.T1M(H6C1I<*9MQ-#D:8%>;<W=RYC71PQ2-GJ*.)[(QQKAMV
M8KSLO7)JE@56U[<78*=&I34#D01J-5_U<<FN.N'LVD><+KFLE(*%>W% ;DD5
MV*O8B[JI)'7D4.TL?4=>O4^NG"48:.C!&(5WX\I-G<YA;EBW4J3S92?'T,+W
M#)=M23UIXV9Y(I!+*!U=1Z1_9X6:OC[X7&?9FZ<3CL%D(*]5Z&2LW\;2NUL@
M)IOW"M.4GKP4B/L 73621NE/QX2*2]W1:W!A:F1L03)%DZ]VIBGKZBTTONFD
MALPM+ SQZK$>OJ!T+@:'A="H,KFRZ,:*=M#;$&WO;Y"Q8NWLW=J&O-)<G,T4
M51FZQ1:$\WE?74.!HOH>%UHX1!T1?]E17F<HYG(8S$08QG"G)7I)H(=2C:(5
MA$B(&.@UTY_3A="MMPX9@T1[C=JXJ##L^>L)!E(\5W6HT6_XQB9 &>O&"6DU
M7ERU(X70C'1AV)S5!/5V\%D7#4*2Y-C[:2:[6BELXGM#O12S++JTD]M!_P"C
MZ<)5NB:&D[@I]J"W;QYRR7+MA<?'#8M]J%%A[;D=NOT(=%0]!"CU_#A*A"4@
MJX+*8[+1Q,PQUP9YJCQNP,-]5CDBCBE3FZ]6K*H.@Y\)1 /'!IV:+[\B"K&T
M#.TEX3V);-1:[,>S!,HE03.I959>KT/X<.,QUJ5^00*$)+95X(NDK4L=+C[@
MSL(W_B3IIJ."]0&Y8U#TJ!17N2J]?'S*W^[ZA*>R$;F79?[3 _4>G =S)I<*
M945$S22#0^8H_P 71@JQ2LZS3N03UF<_>VFNH!.NGT_JX'XSJJC&N*HLKE$J
MWSWH)4G-935;O%HZW7H&9 IT4N#IKQ>:#,HW:AG)6;<V+NBQ/8G4B->J5W=5
M,DHT?[M44J.6O+UXN@+36A'G5%P\LB-$(UK'MR_55AGBZWK3=<8=A$"1 "Y
MT;_?CU!+2*!HIYCC:@(IF%EV<]),2/.$-7<??J+=O5)^XLT4DB210ZR1_:0M
M%=>4ED#[BWIH.*EM!S3D1YPF;X?R]S$;EK2036(Q-5C>U 7:.M-$P43/*C]$
M(+,3S34E@0>*)L--=ZOB^RZ4QLCNK/>*?*%W/X2Y%2?(&#+M%19VK7:$\H2*
MI(JE8T+J26G0%X>#+<BF80EP"#4Y+2&3P>SOD5@Y]W^.)JV#\I5ZEFUN[:LB
M00PY9XD'1)"C=J'KGZ=([$08S:_J$'BHYGK5#6N=W03U8K%UVAE:ZO5N4;E.
MU6EDBLT[L)BL8RVKLMBC-J.MCU#KC) UC/+EPDQ(&>!7>C3D%8&23LL6/0 _
M3U2'3E(">0/\>$FU-WCSJ1/'#&1%KT60 Q<L>;Z<U+'ETZ_ZN$A'$5.*H09X
MY=)YNW&78]76 JE5)#-_V-= 2>7/A'>5*.,3/#*[5J_8/Q\WOO2:R=O[BV]%
M9QN-@R-N/,S34XH9)JPNUXZDJ?:.KH <DA>H#4\-4':NICY)I@XC<3T*-YZW
MM3A3=6+R$;#.SQ4\&]6P1')E+3T*YMY&&:8(;-6&P"$E 90QTUUXPG ^LO)R
MU%!%[HSH.;<$I-CQ9N=Z42[:FCJ8^HBBTN;C6W.QA9H''Z A6HAU+\_0C@MU
M.$0,2IQR.>[3T)U8');MQDE$6,1C8+U*O#BX:=?+>YBM,T[S^_L]I0G>,<@!
M;F.7 -I\_BK#@,<%XP=Z?^5/<=N/W/\ FS][L]S]+O\ [;U]ON__ %/N<NK\
M.?'JM?\ 9U=G _0KH/W)T</X%M7Q/FL=BJ'R,K6YIX[N4^??R9CQD=>.9GF>
M"#:K6 98E*PJJ..;$ \<#S/^T0C_ .!#\8E76<R_L\L__4,WXE$F=AUH3%UC
ML3]QI6$L#3N9FE5B(Y!+Z/%U^HUTTX':0+2([G?$O/S\V?UR1%-?"69,MC[U
MN\\$=:>%G2>0-$8%D7K/2'9B.0] 3P5ZPA$BH:HRWD3>&8J3!\;)GJ^+JSPU
M2W=7W1&3D@?D^D4?VL" =>+(WAX)"OBI0]:TQ+&C["W59?(^[O6MY[<PV$J4
M6,E.WA(,?;MV/>R#11[:6)>IB#HW+B9- 3T%74K@<CAY\%]XO$LU V(9$@$B
M'N(QUZT(YF-/^\Y?Z.,H7 HMRTY+$(:#8OY5GKUVZ+PAQR!GMR.J5T5%_,>I
MT<EP.2@#A_6 2$)#RAL=SJ8-J"M]8ZC0W#A16O6+T#XJ"X%L3D$/:+-&1R&N
M@;GR&G&I!<"E*K8N@88P"BRH[RU:\=*5I+44*Q]#!E4E3J^C'D0$' :RI^XK
M.J7254NCM*58NS<DZE&HT;ZGGPD!'&9":;%3Y"C1S9Q=^+,*<CB<E/''AUA(
MD6O*I7W;RZ\QU<P?H.'5GJSLJ8HEAQ<BI$L8$:(P,O;.H()T8\AS+:\ [58H
M6;DA@L51U/7Z7Z$2*1HD:,*""2OYV)/->6G%T.9ZE4\=IO6I%I%,,<K(K+(%
MZ7)!_P!)XO")N?F5"B2K3D@>][6"%YX55II>VCM(#*L?4%.C.J_Z=. CF3TJ
MII.D=7P*D\C[CVFD%.1.WELA7:>U5$=A)88F4=4:RJP_5&HTZ -=>?%L/>)Z
M%7-BT=:SA(T.[-QQ5)X9L;5:]7ECJU>OV$F2*]X7+89@@JQ_6#30L."$,G7N
M/9<%O;DT^/CELW*T8M3AWZEM7 H4BK"&)*,@_*I^T<N%L1K3V1U)5^5%R#Q;
M;P$;6WS^8QF,H6J\:"*&G5C<6IH[$9)8?J)JKDZ<N+8>]Y%7+71Y52DVNFW0
MANV:Q:S%%/)2$3V;4<,+1GO22*X:!7.A4<]=>*+@8XH?!<K&7_;&NM:DAAN*
ML-#&F*K[=F22( S.82SO$5!.K?F(TX4?<'4H2GLJ)M6%;&=QD-B&\TMBA=:/
MLLTBW@@ET(A!TKCGKJV@7B061(S62T([W14L*FWL3'=G2ME9:RS1QQR&5*CP
MBO8H";41V!R+2^HCTYGA*KU<HVKF/NQ48&#UJ$258F!5@T4""-.EE 5AH/H.
M&]*$DEEB>8VUTA7?:AJ*UJT@]O##-,W5]H(BC:0 L= FI7AU*&>5\@:X=E9Z
MS69O;AR60R$M2"BF1F0B.O$MR6Y7E18U#S#12#77[M1JIY<);=M3H423'9/)
MC&5+\AOX+&3RV8=OW'EEH16Y(NQ)8A%B9F/2@&IT !Y#EPD:<\E:U*&Y,%6@
MLXF"# V,9DJ]C W,>>^]:S)J(K4;LP2:-%+:ZC1>)1X/%$@[20[<MG>"//C8
M^2QM3?6=@C%"E5RE?.7II/W'+3/U^\$M3[U@JB1CTOJ.K\."]BT+>X"-/DUN
M_$R;<VAB\3=6Q'G,S+EZ0ACD>#VD%%B"TX7M(Q9OM774\)'^L&OY*R ]WO(&
MFC1#'%K([%1V2BD,'#$,KJJZD 'D0>),[XZTA<D&N"H<Q<IS8RY!'+2L2VZ[
MU8H))VB[AL*(=(Y4^Y&!F7^&G#W&6*A*[U@+UF\:;3VS6\/^+X<GBZXL2X/#
M_O$4+&PEF>NLT<9L2G7K:-4',_33CFKV:2.;2T84"V.4DVUH8\JO)]"M-Q>(
M_&>ZZX>[B[5-$/<BLX;(6*=]; _)(KQN"%5]"!_JX%;=3:AAM6@^>K"VN8*4
M&9^,E:PMK]FWAD;443=(Q^Z*<=FW!TZ,'@RM<1V>V =!UZ@Z\^##=3U6>EMN
M'X]>15K=5&KAMPU?<0=,5N:.O<04QW(Q6FD?1T#G4:C77BZ*Y<6]O.J$N(C(
M\$;DM,%LS?>U=][;FW)M7.U=L0Y1/WA%@CO4.U8>17::>$.9(J\TJL4_M(#Q
M,S@BF]#^KN0ENW;$&V-RYK&O46"Y%D[7>[,#5H9ZMF1K=+(00%4Z8;$+A5T]
M -.++88A/ZLY5;Q?[L1?:S _J>@0CGS/JO&I4[%5)'H(KM5A1L3WL)9I"U[N
M:G(^2H%FTF6#7M7*,2'GV%(ZAZ D\-TJ&"H8X;5AIEFCZ2W4M5NI&!^TD."C
M,.7T/UX!H/*K?6#T(4SN,O9.>*CB\G#CK=;#^VS5R!B^3FK6=9!%&H :*58^
M2L#R)(X5 "AKF3B:>A?&V*UC%I6Q-!98<:EJ.>V9X^[9G:+EW;>O-Y)#SUYZ
M@\:L!- A^D9)M;ODS5C:<M/#U#D<O/8QTD5&*U#4>2&M<[L['63[56NVH)]3
MRX"GK194%=1WH_JXJ%+W[I'0AJWYZ6-AGC9%2PO1 IF6:5=>XH.O2-?7C+-
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M)C4FBM/D1EI\QY/N3W;/OLK3V_M6EE<H]*"A8S5N/!4ITR%JG7 @KV9(I!W
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M4M"R4FQ40DZ)%@@3[YX)BP60'7K7D1IP42=-56RY%LT,(!&]:.H)M3YCMLC
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MMVQ5.XMVI%6806JS7)&D<6T+%ULZZ$:,1IP.1V2=E%$KQ7]_)_+'[G^MW?\
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M:AMS'S[:GS$^7,5V*X:W[6>GJ:,,1W@I8%CRY\N7%'2E(S0,,4+=$0G0%1T
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M[,^4E6WB\;@*,U[85FECH<+7%2:1<=DT2Q%[?'V#J5[#R(#U2A]#S'$PV:#
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M/H?]'%1.)ZTU=J^RUEF"K)JRG5@>6@]/4_QX?9BGQVHKP4FA999%[KR)T L
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M)1'3%QHKO 4)[.^Z,-F.*<6-ST28T4&(8N6Y6*U^7Y=(]>0T_'@O8FFM1 ,
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MEDZ-3Z! P']AO7A=:'N8^&!3;50DK2()9)#K'IU)J3J >9U/J>$A5P5)2P_
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MIP!;$"8DFG9/P(B6$E@-1FFU=B@VWM^6C0]Q^XSF)K%HE U<Z ,9SIJI=0-
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MPBG;R:0.%<JKCE?''L:<N2R@FHTZ@ DGLP1I$ 3_ +Q60G[]!RX5%*2S]7Q
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M@*N5H#*T'F4; 7HJF[9;:VYA!',E*6&*A5KUNAZT2*:L,:JP83)S?UT',\(
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MWX+ZR!5!"W2"%$@T120/L;I'2A4](8@Z>G%KRX,-"<E1S20QL)!('73:MO\
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M>E_]&G!M!M 5=5W450=$6 $\M51 6_I( )U_CQ*@W!.I47;B;FB#J&HU5?\
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M6LUOD;)!#!+D*/\ B!?)&UCIYH^XU&7L[82:Q6^B3&(Z=7T^G'FOB#^T./\
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M9BGZY)NZ8G.@U!4G[W]-%T'"PV+4MQV S: OZ_DY*F.M2E5D:-5/0AT8GK4
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MKZ\/AOJ1T?&IV\<DL@<YI8&N&>VNZF[:CSRC,B?$RW-&K#KWA@(_IKJ^<RS
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M_*OT(/%4A^5C ^T/H"\NM)B]^@;9GCSD*?50QQ6\G-VD3HD)[C%"L*QNHZ=
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M9:DC6]P-'"PK6JDS+'!6DUYB1E.H)/+3AQF%4,T]MBZ?S/C(%Z#I6M]AEC+
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M*\U<]ALI=W7B(H@8X;V(>O7=E8*+D-ES( _Y1&(AIH/34<>6:6]"V[T-#<
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MI8C[ND]?4O5ZE#_HXEJ?M)4&L: " *IZZ]PE>HJ%9E]2O5TL?](/"U.WE/(
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M/D#'$KKO SQ'XRX 'T#@OUCCC6\B&&]TC0/2L09F'22:0Z$F>5UTU)4%C^8
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MNH).G5^!XDLRXS*SU)A8<!N%L9ND6)0REY6IT&GCLUYM&*UF*R*L3%0VK:R
M_7F>(>L%N V++=F3TJ$E$J&N+3OL;<82F;E>Q-[A9#(BS32)$[1R"- -%T!
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M&[P!P8RR.)*;)UD^FNO+ASECN3')>;_;N_W4=K]/]Q_S1>WIW5[7O?Y;Z?\
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MK*B9SFD48*%2D=.N"!(KM>;V_="/)(\D\76S=V4C5_N;7\W/B>&:'=%&\=L
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M2$,.*_MO[83!V9KUVS+E,Q<Z),E88DQ5K#Z'6C&3]J]?J/[('&BQT;6!KN\
MD' CH*FV)$6>>1GD9]22--00?7F3S/+EPYTR#2SO*0:7]D9JPQL?>,<Z>H<
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MN=OV/S+7')[7C_$S,WU+U-QU)>LZ\@5ZOZN%.R-]HY_$)EKAI:X&F[M!.>)
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MU9-VI;P6XLU7GV9;.+O8R[M_,66LU[%>6Q#8QV4?ML!%W#+T$\ASUY\-)0,
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M4H)=SZ5;V2BP4/=_]6@D1GD 8\^#HR2 3FN4GY<Z*X$],&FJ&/*FZ'Q?FO:
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M8@-HT9:1Z%(Q%R_3R:0W6EM59?=5A/R,LEN+G'"J'GU\M=?4^G$'  &0=\)
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MV[E,12.G35L1*)W%A^6K2:'3^'5Q197'!=26K2'<4UK\WB=751PPSQR5',#
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MV)XWP6PL]E:OCV:CEILG0V_MO)OO+,Y:1,WE.JY,RU;\$4*TJ6+IR%@-=)9
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M>RES!QO=>*%>9:QT]0ZB -.?!T3FM/:*LY?8QO> ]67C[QIM&E4MY:@,A?3
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M]PYRK-#!M[;"TY0:#SW9\[!C8[,O5T08VF;?4CL$^]@6#>H(XE>63'O<Z[
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M^ ?^T5/")JV3[33>W2-59[L#3+:T;7I7K,NI)"GG]-.(GV-<M<=3^;\VU''
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M%ES'CD&39@*8>A<Q&($_<L@99<F]>+VG[DS"(YB90U6W1HQ,%:RM<@:R+V]
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M:R0,T\.3EE\QV%3I]6D%*[#B<5EK+X#'97%6*-](E:TEI'R45919H62[&.>
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M'"HDFEF;I>>SYE:3W(LH,/>KVC-;]I/^X4F^V>M(JG1V^L9<\]/IP&[,]:K
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M\%Y <T4SS]XT48YX P N&H=-%W_S7/CE\@MN;[Q7RR^,OF:H\G^(-5^?OC?
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MN1PM2.!E[@F>:[%*$*D,H5HD+$_@.$,$-<98I>Y#LQ3I1K5ZDD-B&*9X<;<
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MA70WQC^<P*%<GNI+]][#8R"M")&:M#WN]&\!_P!TEF7EI-&IT;EZ\5/C>7'
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MA\W8WXVY;.YRQC/)<F%M+>K[<\EY'%O!=6S:6=;<L@B;7KDZ9MFMXVBE#0G
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M_3B9"6Q#&5/<Q]]Q]H2!9"&Y$J#V]%]06)'^CCC/:/\ \H7W^1]#UZ=['O\
MG^Q_6YOT"SLZI<RIB8E8#.19UTZF@3JDD1 "0695T .FO'8\D_W%:']0C_P
MO'_%@_\ N3F'[[D_PG+\OS^ZN2S#[8STK7B]!#610L* :\CT#4C\>#USP7S4
MLO3G6PGYXFC:/Z<^H&0,?H&7\.?$9.ZM7EUP+9X<=JT>)X;F)CDKND)L=-F:
M/I#NP,05="W/53Z\9S/G?(5TSY>-%Q=E0A^".NQZ% 5N99B[$$_QY_:>+^K-
M#J;%'KHJ%5T/+4_ASU^O KQVRIQGM*<UUX "TCOTQ2H>DZ\W0H&&I'Y2=>&9
M@3^9/H1TW[7/6/2L4_,1NG ;&_4E9VS=J1G)&K!<<_(\_P"/+C)\*_VD3?\
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M)K%SM5A;%K3<6@:&F",MP,P<.S3 XC(XJ&N6Q,<_5^YU8OPZ9XW!.OH?N)T
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M 7F/U?\ *[JZ1_\ C2NKHYZ?_>]KT_CI]./2/Y%_U7_PUT-3ZKJV\/X%Z,^
MZ52[0^3"7:PGA3Y^?))RY8!8SVML#GKH%_IXX+G$A9[1:95Y$/QB5=W/'&_V
M<VA>6AW](ILR!^XHEI'RCL_ QX'Q92Q]"..2EL_)Y'(M'9L0V;%[-9B24O(L
M94F2*M BJ?HK'3\>!1*[U:)ISU9>;RKC76L?"<X4^<DVK.^4RNX-K#/Q[?G3
M'KC\+<EAGDL6)ITEGKG42-9:9$9&.J$@-H.7!E6US"Y6>\,<O"!0OBO'V_,M
MBJU[*^5]S(MR""[+%CLA'T.\JJZQ!^T!THK::#TX56[QYUH .+ ^AH=NRO7O
M3$FV3B+6+@Q.;DN9;VE=JJ9.7+74RH:TA,CQ6:,L,T#.NJL8V4 '3B5'  T(
MW'9YTM+@[20:G91#M3PSL&BJR14=RQ/)(LRJV]=WQA670@DMEY.?VCEISTXE
M6^&'$%>L?&I<*35ITNU;J&OF3$JQ148>U6M9NC7@JR1'M9K-36G)'VRQS27Q
MU",#^UZGA?Y]M>/./C5\4<@!JUP/44LLQ2OPU\*J[GWI8BM926VMB;-Y^O8K
M^U+,Y2)+_1 ''VZ^A]>%6]^Z#S_DJS0^G=/F*A,]?<3MB[N2R4RV8+UZ]=%Z
MWGLMAX8W$(22W<FF3&M(6&O:52P//EP1-*YQT-J7TR&)\V:"TG!NTY=/5O\
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M&RB-0K Z#[E73H0 MW&ETU3IU!'/EQ2IXYYJ)DZMB[%'?[+HP*B15',H- 7
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M<'!"YWM.^<?3U3B9DXGB88G+!=]-$(_8E=10G1&?$)-,Z"EMACL6PO\ "^^
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M^.&Q/'V!HR9+=FZ*<UZQ3W%>V]6A,<5'<,;S4;%@]!U9PJE0\B,EFV=SR)W
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M'DCR5:N;GMY3R+OF_9W]CJ6(WO8L[LRT\N]</CT:''XS=>L^N5I4:SF&&,]
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MK'5GNB-8FBLR1@=IF9N_H.HE3Z +I_#ATN"-ZZT<@D$]V)SK%9JUXU<G0B2
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M3-&2.$'"RW>A;1ZI!J5.LFG+B'I5#B-)QV)ISJQC4QN6[D;!95?N1%BI'69
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M96:L\;61<%R:K T$!B! >-FZC_$#CB/#!_\ ^C\^ZK+_  95W/CC#V/>$?\
MB'.OV>!*'QGX]V_D<?;RF>QUZ_.\K5(;-BZXBL5G;J=A"O.)$/V])Y\N/2VS
M!H+=M3Z2O'YK)L\G%.9 ]"6^[_'"X'=\V(QM!SC[=FI/2N1](@]MD9%!B[WY
M8S2(T'5ZZ\N$Z8.;IVH>2P;"PR@XA:JV9MW;>W</#9IU<@;@[U>&U8E"JCP/
M&)[,,3:2!GD 7TY@:^G%:G;XK3N[3'/N*3*AGM/:PNW7EG<_=[@XR"-TY\RJ
M-'IKZ<#2]_R+HK7YD=90C)&LU29DB[/LV+@ ]1>4L>0T_'7BOK1+*ZQUJ ]2
MZL4JTK35"R=]I3&':01:2M757("F<?;KPD74HAH7:%O#9*>:%T6Y@[T:PS*O
M55NP $Q:1_:%.G4/Q)X'D^=4)3\D5G&"7N1R67(6<*Y34:$J-2I/X'3Z>O&C
M#W5RUQ\\/S2M*-RF(";2=@N= L:).7<ZZ.PT(7_R\6;%95?LL=>QT1P2O.SR
M%E#PB$@ :](T &@'/A%#S=X=2KU,=7*&&%EGKVJZM;F&@:CDD4A:<L9^Y-(_
M[1Y:_7A*K'RJ?6:*N)&TZF)T5=.1!]3KZ#3A4*2Y.YD?K*"-5U!YCGJ==?7A
M*B;,=2@92G6S<!Q\EJ2&O,\!MHL$;K9AAZSVRQ^XA6/UX2I "H8(+WC*QDV;
MWNXMN96[CDQ"QY"K6RE',RP!C0)LNO>ISC554#GKH.?#;$;MJCRGE&E9A=Q[
M4II0LXKR6 TM6-G5FQ,L&IYP::DK]IZN*9LPI1X/"36;@5<YDHF)25YY+"1"
MM$NL,FDB=L2 ,Q"D#BGK57-.X-J_BN,$49<E %D+.<:LA4!&U^U)BQ_J!(]=
M.#%G0#%&7EK 0;FP?QS,F;AK5KVP[V)3*0%9(,.M?+6&ELV9IQ'(6A4_[OI!
M4CZ\7P[47<1E[6C<4DSXVW#'CV_E*VNZ99\S:AQN?Q<*3RV:]&%M'R5,D/2K
M7BS$.%!T]>?%_H0OJYJKG$X2WC<#5]Q9QTB36[$;JR'N=UE57A@E/)'$BE>?
MH!SX6*C"!JHOU5BCD.C=) +1P#GV>CF(XF'*0EN?V\4S9#K6W!A7J4K(XXVJ
MT33(4>]&9W[@Z1U(#T<S]>7]/%"%N,^E1Z5%>S[A 8I8Q'%-T@MJ= !S'(@_
MCZ<+!##)6(A8']5A,&'2J@]1#>H)',CD.$K8<'>1<OVLS1RS1QQ]<3D&O(I9
M6  /<91ZCGIPO0B$&Y/%)9C:TG35F[DD)[8*+UKJ&Z$]54'TX6:2H#CU2-8G
M+2S,ZJKO$[+UGT[FHY(?J3Q9#W_(J;AI?'3I'O*) MVI>2+V\S1B9>]7;E&S
M!T"RP(?RQJO^O@@Y'J4K>W-%@?7_ )-ZZ?\ [SO73_\ !;73COOY)_U?] ND
MI_F^G\I\"]8_B7>CQ^*^9UIA5[M7YC_*FS4%F/K#7!'M"*'H;_N66.1]#SUU
MX\T\1L+O:)&:T_V*/QB5=CS&0,]FEJ*5/](IOQ*),?\ F>\R+7I2Q8X1M4E]
MW!6[ER2M7*O)2DD<]+P64'0VB@Z'@>6$F2,:L-#O0%PEA>3 &A[/%DKU8*<F
M=CC>U=EHBM+-!9AQX@<JQ-H)HDC=.ICU773A1V_#VU\B,?<"39[Z [<]Z"LM
M&1Y)T>5K;HP!5Y"=.M21U1Q)Z$ Z$C7@^#M.T;<UD7MRZ(")OV0K7WE#CLY3
M-6J6)Q%2S9R=B[#1IT*,36;%VU,RI!7JQZ]<I=V^T#5F/+Z\=#R=INIC;AM9
M,FC,N=]BT#>XT &TE9D<\T53JV9[DW<;X3\UO5FO7?$^_P 3U9"O;DVKE%EF
M56_4"1F+JU5.;#Z'EP>WPMXYK<ZN47K'"O9]5?AGT*RWOX<C<5._2,??25W1
MX+\Y9/=%VVGA'RS/1R*145KG8^4-=XV5G>46(T[M:96 "L-/MX'MO"OC22V9
MQ>57X(KE;/&WJ1$G,8(* 3:@>C\E<]K_ !U\]NF<D'A3R#AZTU&[1P4$VT\Q
M-3&1B"I[O)02H]N&.0+I&W5][_PXN_HCXO\ YLYA_!W_ !>55_7$)_Q@QZ/R
M4UK.S]_;$P>$FWCLO=.&@[-2G8R69P4V(HS9$0/I"LL\*.\K]!*@Z$Z<5<VY
M=SRPY)QKB.K=8:3Y1C[ZV+&2U=>Q0O;%HCMA%@P-J1J[>&1[671GBHLFX8>A
M.N$(['0.&.NG+EITZGCEM$5H[@L'RFEKB[?7(4Z$?ZLVUI$R36 T#*F6W;FI
MKR06HVD5RB]"GDI;4]/,^H^O%S71G-U$EQ14@=$@7MH^G4"VH.HUU].6IXSV
M/+W4IM5W%V +HW6Y/6G;C7F90>M5'U+@ $#^C7@H0$BM4_%&Y!.2WOA*&2JX
MN">3(3SR%;314;#TX$>)D7N2RI&@8,="->? TCC'L0LE]PCW*^7\A"FW=L87
M%RY')0SV+64L33M8:WHB013,S15Z:(2-$)U'TXU63=D&FP>A"UU=K>F%A:K+
M+7>$C7NJ[\ARB!^]/7GUCEK].![LF:,-&%'55L/>/4I7D'=[X&/ 4L#>%/<&
M7N6JD2&A[Y3C^A&M,T:1]SN2?[L,S*OUX#%O'3MR4\GY*(0YO'=^$Q?[1CK]
M2ZEC.VX\91:*#J@;(00K)+!,^I6'5=>9Y:\M>"&R: &@5 V[^E5R=RJD[1,<
MLF0CR%"2F8;UK'P]UXF,LD#*!-"$+%XF4^OT/+A<4[E3R\TN\!0EI3 >I"J]
MN$J\Z$,$/*20G\!KZ </Q3]JND= YL?$#JJT]G-,&C?6#MP120R2JB)/UZ!M
M&Z]>F/UUXK(#CJ. 5,;1@\G$XJ/^WV9I4[7:G@835"9'"+-'+%)'8E0]:Z)$
MAU#:_7B788-49UO^UR]_H5TLH$1;2N2P1=V]D\MD<N^/VI7QT$&:N0PS[A62
M;)!:K"M!)6?O.AJE S*Q75M1IIIPW&F^Y^_^0N0YG<SL)X1IU8)[^*=M5L%M
MW<U+W,L<@S23T;%F5[=).Y&DDL6/+&1H8.X[ C0<]>*9G\5NAPTN'E0L$+[B
M%LTCCQ'9UQVT1Q>JQU6C,M: ++J RQ Q_<-.DDG^UQ9;OC9V''#>K?5M':K4
MCH4&&G5K,[Q58X"VA<(-"WKH0W]G37@@R,^Q-51)+H^QJI$$T,$4BR,6AG)$
ML$WZR$:^@) TX=I)"BR?4VM**LEMT86>2K":\<4R1A->L2ZD#UT'3Z\24^/M
MI[ZBY+-TLI##5GKVHJUR.[  'T#@OTZ4G_46-(S"\XEZ04D3KU3ER/"J-ZJ9
M;<67B:J(?VGB<?LG&U\)@J$-&M0KF,6)UK227)HK$EIK.2GLAS8L2M*.IP%)
M'X\$Q=SH6PZU#[;O4..Q:)\5;9V_N/,[3SF\JFW\)1J;ABDA;$[I:;+YF>>1
M)4L2[=*2J\<=A0BR.W0@/(::<3+BUNK.@69;3N@N66^FH>ZE:Y=-$_[%2)$L
M?K3]V6Y8B[<HA9>A9':%PT4<1&L0'\.!)#Q.BJZFVJ"JO]D@MZ]4]YC$NDJU
M(JZF+IT8.SS*S,HUYA22?PXK8W0*#%$SBIIT+./F_8^SL1C,IY%S#9G(90/B
ML*!;M0PT'+S*,<T%:&+K+1MT\M-3]>)C @]*SI;8.!<3@!E1(W;F"S>_;V*V
MW>VUA\DV+LXU<A'3,;8VYBQD/W"2U)(X-E[@IZQL.2J2==>+N,=RSQ&RG=1'
MYY\#;4\>U]O;IQDEVC%9SJT&Q2S,,?52VKV*=J-48$O'%H.@\M.%QL<DSK%L
MK.-JTZ<*4SVU2<-AYKS!9.W#S[;%02T>@YG0* 6X+9'J%:J^T@$ATZJ+K%RL
M!#VE52Q+6#I$T:([.S\B0J@:_P =.(%:-RY]K&6!NKWD,>,-^2WY,G<R6%DD
MH3]_#V,O1>'V]D2V7KE5AG,92)8 &+ G4<-BN(O>)+*'$::5Z=J:6WJV)S%'
M,^.(\_B]GP]%[(8W-7)((,8M>!.Y+4@R2*ZU\I=.B*&;74\N%0C8FC>Z/8L[
M9'VF#DR=BF:R]XQU8Y \MVQDE698GGF:3ILI+&WY>@ :^O+@JUCBN6ZM ;[Z
MVVEURS5W4;[,WACL%9@FJXRWD+M*U%7:E9MA'NSLR"613._;"1"0$:_7D.*K
MHM@(:UF?2@0#5T1%0=JV*3:CKPW)O=UA[R!U2Q# NILHLI2-ND]T0E^G^KC(
MEB?*:C!9T]IZH>)75T4HLU;NKK3W'EE;1FCE,@/)2S.K:#0:Z$%M>-$ TI38
MN8(?4X;56XJA<RLE>I#]T$BLUF4MVTA(.K.VFO40/0?7BJ8.PH-JFQCWG=1-
MK'XK&8JKK0HQM/UPQ//(@[UTNIU:0GJ*QZ_E"Z'3Z\#T=N6M;P/HCSYD2WY?
M(YI5*UJ:&GLKQY'-:6#W55)K&T,9U5I(XT[UF6(:!6!ZE_JXD[2P:B58]SW8
M4Z$A-B81)2+&3VQ!:JH*@D7)6Y98;10Z2QQTHWAL1RCZ=7)?7UXICE#RX;A7
MWZ?"K^76-Q<R2<*G9CKB:856G,OX_P!R;[V5+C*=_;6VL%E8Z\V J3T[DF1P
MOMI&%E6R4"LUM9U4!1(05_#CS2?VB7D7-^8\JAY<)&V%Z^WU\4C6&4[=-/9K
M7*IIO7M]M[(+9_(^5<YO>;,@?S.SCGX?#!X7$KV0[6-5*9T%=R7VU/C??PFZ
M\+N:3>>#,>)R5'(3P0KEECNQ4R?TI%L5DB$LBGFP/3KP%XF\1\[YKR.;DT?+
M-++NWD9KXI.CBMI73HQTURJ*KK/#'LS\-^&_%W+O$;N?<5W++R&Z$?JX E,+
MP_AZ^(=(=2FH TK6BW*T].>S')+#^I8;NR".25$FA 4 )*'.J@J#Z<^.LY)%
M/]16L-PWAO@B;'G750#'93+)><^);RTNO$=W<VS]8?<3/R^ZRF2G3IK3IS5\
MNYL^\BP5LFT1@T%188H8S$-  3)T%V(7EZCC0X/2LCC="A92]DK)5<O9GN,H
M^]K=B)Y5C7F_9E#QR(G3KR.IX7!Z4 ;FLKFZ=N]4#6JYJRM5O-!4@/5&C6^X
MRN>>H/<)+$_PXDR/2ZM:X(J-U#JI[BJMLC6LU]*\=N3(/%*!>D<MVCZ*8QJ$
M8!ONY\6JSC="E82AF+U$VSDF,4+^U:&P09+-L ]701H*B^AT (/%3I=+B*5H
MGT"3MUI52HMEVI:4J37'DF266ZK"0\V(U92NOW( /3B#I20!3[)I\Q"DR.AU
M5R!/O(3WY7I8V?&PQ0=(GH+WJI59:TDA*&5V1U8#N. 2..-\,"GCCGM[^\A3
M_LR[5VWCUHC]E'A&VSI/SF6O^5MW::>]5!@G0&.'M1*TK")X8HEAB#2#59!T
M#370\QIZ\>@F/4XNK2I."\<XKG .& TCT))YO)SYW(1Q8&M>N1T<C)CLAE*Q
MA.-I=+CE*)")(IJK ?:%;777AVQD.!JH/+GM+2<"F'M^FE<FK[V#(FND%J21
M+#222>YZC)%(2.E ''H!].+4T?8Z5H:S?QD"T([%Z$2MB:2.LC=+J>V>AR#K
MKT#D/Q' TM=>"W[-VJ 'I*J)[^.KL4COU).[*C])D"ABHTZ3Z_F_'B#14TWH
ML$AU=RKK&>Q\C2*UVK&8T4J%DU (8<]=.8UY:<7<'I5O&Z% ESV,IQ2!F%R+
M,V:]'H@D1(Z=JTC?^T)"S!EK1NJA^6FI'%;K:KM6KWE%\NIFG)+:WCWQ]N:M
M-4>S.6E:3VY#1Z%B2S$$J ?X?3@AC=(IFL"=@=('5VKA1Q4JM(YKS$,.I49=
M%7[A]I;7TT/K_#B6.6U/DIEV-J9AE26M7;O0HL\TZQUH(M=9IK4SE5A ')?7
MJ/"0TU-0IN4>9XY<AD+%;VH:WV&DTZ$6:&)>A+"]#.LSS>H<<O3A*H8E1I6>
M,Z=&O\==/_-P]5?PAO7>,Q,C!DZR?KU$=/+T].?#%!W+=+FT-<%# $<Y9>0&
MH _#7ZZ_PX54/51<[AX-S8/(XBS--#=:%[./NQKUR5[U->[#<@1F0"Q$$^S0
MZ@^G"Z%?QNA0L'>_<8<3E5COF.W46)+&3B,5JS)2Z:T]@A]) \DL9)) UU&G
M$'LU>16P/UR##)"V[ \FX);"=73'643L3U2G[%T$3\BF@_@>*^#MJH\SIH55
M)#(T$(3J!+*P(.A(#!BI/X,!H?X<7TJ@F,T&M4S]W3W:7AOQ?'!6QUEX[>Z
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M8E74<U_LUM/_ %%-^)1(OH9!4A1[+49LV89Y;#,K5<?2E[O1%'?C&AKV*_\
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M*,[,"*ZJ->R=/KR'#4N#\HX4@V=?]Q9<MK%:R- =69S:GJP72',;@ELN:UJ
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M7^)]U[?W1C]N>7?(&(\58C:^T-Z>4-A8>S_]E4NW\\\$R0Y!(!)+1KL[%$8
MVB[BAB,#"*,TM'2&@BOO X[U8,<1DFQ\L?DEM#8WCCYW>6/&?EC84WEA:O\
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M 5I:X.C*IUY\^7]'&?=S&TP9B@S"[-7&0\';FD,B?N.W$BGDA,L%@O,U=(=
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MQ$ ,37$'1P;U1,K(=S'UB2:CG'RD53AH+AS4:\&Y4YCQ,I4?]Q7>\)$A8Y.
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MHE^31P*U)P(K!Z$:#VJ[<A&R\[]02P,$%     @ >H K6_Z@%G/+9   &'H
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M('I,?.=C(BI2,I+'M%3T=+14M#0,S%Q/&)B>,M'0LO&S/>5^QLO'2\\J("S
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M=RPXT'AR=&,F6&?I^3.2$J;"'-(LF3^!;#8VH="@4-FR+)1?Z,%>JTK0ZBV
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M1()N#K)^7V2$)>A+3#;T(K@ 7G,3\K(H"LOK9(G*KZQ?-,'/,9NH'$[C*?W
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M;$C*"UA\H);8UJ+W/%^_=H._T+\R.,A9P=K6_T_^SPG"7\+4OH"A*<!STT?
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M*2U2UA5",2'S)E>ETL0Y_4%-=?/D@0!;,Q1)KFK\ : (DP[6\R.7]D#4&6Q
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M [BQ9G_&^=78O>P3M$6',0U=O7=,*,?MQ"R$\HW#/AD7_8JDCPB7%.+]3O2
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M(&N(NLJP_WURZ';!^#!?4UEZ^A;R5]LC0YT _HL2Z&\]#!%P$1E-B',]]F2
MQ. E\X@ 9TYV_7'1I9B"+Y.!_+G&K'QER7<4"7MZ+*M N#@^AL!-!%16$@'#
M[C:M9>]Q%G@NT.1O(F"(QDY@14,G )HLK?4H20^QY8!CZ@IR:A>GE8'GS<RA
M/*JEY,6&C?N$KF+*4!Q_T.J(CG)IPIT9B-BY*KIFSN;W#15_#G+%!G.$AY;E
M[4A%R7Y?8#4%/ED+N,,K2WB3^GDYYTS!EI((F'Q(!&Q(HBM$IH6.H*N^#VLW
M>ZUA9Y.;S7*0!5L,](V'_9!?B?=]^I[O-55O:Q>Z>C,1U9?%X"7Y)3L5@1DT
M::K'V$2 E<)++%0SK-@]G9)G.\1XK9[SE>&/6?7W8]>!+L SWILYQ\<4A&CK
MQ#<"Y\"V<G*/9IM$4H(^J7G'-%/*QL3OOK0?L=8Y:['3^XDV$V8_AQ6$<^<@
MZ6:URJ?TEOT<#RS7]V($?.%F1("?_0K<#N>T<M4B\3W%6[SYUSF(G8WWI_+U
M5,=8CP*R#X#KMX.>'Y#T^R!)5K$"B,4L->.1XRR>Z^+^YJOU-RVL$(R?:6FU
MR]NHG[^G:329>*]$![:1P<HD5;C.WZU$U(]\NA6?]OZR*J-817WFNCPM"LKY
M"M$3!_4; GLYXCK-3X^ C+A,;4Q"A!*L8C8N6-/K>J?YY)$QIY92:@<1T-8_
M89>X^V?AM;2B."I90*.(_Y>!%F,22ML#*2$T*"AXR3X$GGDBP#ULV(8"T[3&
MKH<P#!F6G4NVDC, A03:<1O:# 8RZM@I&!3;0Z;,-1??R+%D$MC388LVH_I'
M>#V:B]1WGM=QKR,^^-.K$ &O*4]C,= I8U6<7CME$WD>@ AH)@ON "M.Y.&3
MV.86&O!3*+R]>OJ2$HPCEO562QF=E].3 YJ IV-()^2[85RB6H)VXK6MP1]K
M4]#5M,"I8XZ/2I\-]W> MZ"_4[>0^Y>/R%^I2+$:NBQ<)DC8NB;Z-M/47->/
MQ\!<BBJ*#Z%@:<CY\,+AL+-)O$_?2W=!XQ\34G'N>D^R/.[MY3.J\QP]AR:=
M5!BV0 ]D</L$E!814#!LFHH3,1]3(@]1A5Z%5 2DH((^1AYMGSTTZWE(,43:
M\F+R<&BB!'<M8GF0,ZG[42]T4THZK]I#?ZKHK$N5<Z)!=/^/9.Q%?HW["S<_
MNIL;#QI_0()^]PL9SZV6W&WM/B(#*'76 Z.( /9&N949B+M3MJ*XQ6V*'UD8
M/L\_CEU17'.A#1/Y#>U6RCN165H,R1*]]Z]W>7?C.R#(=MLIU&/LS<QBG$K^
ML+1DVOUP0KSP9<)!2Y6VN^".F;'5XS<NMI6**C@%F);YQCNOMHV76ZZ>]UK=
M7Y^,( )"36G.E:$]]!/0W41"PI,E)3H($= 1Q)V8LX1L%TAV::NLR7@UN]';
M\&:?(.5P]4W@[HX\<IJ4H!EUV0W=H$<^!L7E9.[(Q500KGY/!_/$N9Q @0LS
M_ZV9;\91W0"@V&<OD5X!LHCO-HO@W8:.8*1)(2?.53I0#]G;9Z>2'AO&%&&?
M'[($J.,X\R'(1=J<THVT;%!,8>0WIL^_1;R,)]WN:NE_N'^-](/B=M7%%P6]
M0EN(XPIJ70<^*CUW?[=>\RN#8F]$.*]W<@N^/!MW7#X/_Y*-#:AZZY>7/%7*
M-9)/22+7LJVMSI*4NX*L28/[@A<M:<A;>P<KYLL; ($/$C3Q9E_QX'$I'3$:
M)I6JD5UZ/ADO/J&OKYZ106"[3 <0Y-).\GJ/M3K"-_QTB9"ZSPQ:]&R OE%+
M;V\"7C:U[H/$::JVZ:YW"@Q.H4N3\^!^-HQ-X(/WU4)7&?/K.#B"'*N;.4+,
M1L/NX%9 +LI5X\]'*E[\1'Q85(C2U#SH.9^ZUL6I08=NRFL$+4/;:.0[PI1J
MW$E&'Z/Y*[,/=Y^)C:<Y_WXG_/P1=U;SBP$O7>_8V[,.<^ S>0()7T$#$"?X
M0R"'.JCF3^SZ8/:MI;!/=R.[+RFXWP+&A7N 9;(>EP[5;N624[MHRB]1"N3X
M]?IU@-T;#:,H3A6*V7,:F=I05MF&@-E+[B?3#>$_UX'DHQZ\5 2:O;-%T2]>
MO\_Q <@*O&,3O0SCAK:)EG1=BLUK.;'2.1)WQ',*7)#.,3Z:TY9>*.\O00PV
MX.^<EV/<JY156L.G2HYT%Q(I>/4@T]A&]15.0<,$.FH(.X&1W>2=Y*4T!:/
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M[[]?9,=(9M@[>PP>BU.8%"BY/<.!V-OF4#[V3#5+EJ=-[<8%Z^!*P/Y.+J7
MB-VCU _LZ:.$L8E[=7W/>UH=%<T.>Q3!R?]$6]ZC,[:;W60U'BM]W8NZRO!!
M'>+Y3S!14';DTF/,^$Y<OJW.C:0[CFR6Q9"EE[Z?,O=Y?E_,@[ZR#/W'IL>Z
M\6"<A\<]^]C.[9V42A*G@_9,N=^["DSOCR\NY^"_OK\,Y]N&YF)/6"K/ &?.
M=!V*BU=\4I@0GZP"4-.&*P-H7YN,_S]WZ=]OL/\%R*I#[99K<<?@Y6(%3JA
MBF>13/;@29\*+^-.2(>A[-QO+\V'N]DBZ-*_Y(:-=$^<5]"E>K;^+\K\OX:L
M9]A> _2L%T6FV<U3Y4=#KD=[LZKJBU(""1@<<'Y2!-P:.TT<XC+]IMG"I?>?
M(\=U\])'S*6"K"I17K/7'567'\S5OO=0FF(AC\ZSV& +F'([K0MP<<I0^RR8
MFF ^><I'(/W: C!-( +^ 2D\1#(7[X7 *KZ=%\+JI@04\+7,M5+K1_OMD= +
M7Z@#@HZ9]959_#EU49I5P7,6)_.=: 6*[#7C^)N"I/?:29*];441[4":32(
MKK,>ZSA&NM'[[8X_I51L5_?U#X >]O#?IN-CSRH*^[=Q$6@Q12)@:5 *FD@
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M[(SUC&LSP]AMM/^MI4PK.#Q%3TMUIG+6TOL9B>,9R.!2J^XPB]I!Y<-LU^A
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M?.75"[S9:!X.7#")&VPY&=J4,+?12$>GQ:VJ!3)]8> 1[]7UCN+E50PR"-%
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MNW507%^W-MAXX^XT@<8:=X?@FH;@[JX--!Y(@KN[!X=@P:&1)+@3+'CC[I!
M") PO_>;^N[<6S,U]ZV:FIJJJ6^=?W:MM<Y>^ZQS]EG/4V>=Y^7G+0"1NK*:
M,@ %%0"P^^< /)\!B!5];5T# 2@ = #@?Z@N  1R=AXV]@"[K_]H4)[7 !$
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MU5?K#K:ZLG 8.X]V;L0G!=<DYO:\<VQ8R\Q7@:5*.'-49\11E0(D(M$^490
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MI7SU/1RC.SJH'1+^6$FQ(ERF)A*:R*94N&?-#6!&K^X'=+E2-1TN %2P'V/
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M6Q[:G56;Z4#36!:\\]V.*KA2@0<P4YL_QA-)C(-OW26H<9M;R?="4ES4_?W
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M'':,*;D7F'[ADRJ&I"Z@4>67=#%68!#=;[XP/190QAQKLTY-BK% "?/RY$\
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M"> \:9C_8_9MFEH=&_[?00I4!KINF3_=$,@A=F77"3U%*:VLJ._&PMM0')S
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MG;2<8!P1:C-*5:;)^%:MCI*Z6[$.6M/#K=>:/^/2('?9WP6KC\AF'3.%E9\
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MJW:AAW**&/DU/#H^&:)TS&QU8KW\V78Z%)"'1UU\AYEG@Z^-X#NAL^?MI0L
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MJCM(U-6'788AEU-6N4:2?A>C0C@_YCWM=26EX&E&8XE5]/KS2L73ZTMIIS\
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M/&>SD4I;:[P*?>0\KZ*OK*$8LJ[>O'_)7<H6LXZ_GX/V7]A[RZ X@*=O<(%
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M?C(GG#1Z^'Y &)GY<@'1H9S595FF9N^P[.)6,7#DVWH 3N-2"8V1?3T2VE#
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MI<PA#)[;3>ZSQ7#JX5$]W\9[-9 Q\:]:%J[%BGQCUS(DK--S!N:4Y9XQ+9_
MM/A4P[+;.5Y!KKAZXY%>?W-;A'CK+?_9T_Q-Z;'S$B2Y$7\9C."6X&[Q]S1K
M(?(@/GS>H!/"0#<7*GO/^3OF3O,#BLG]52V,L<(_X=\YD&^8P;>6&S'*GRA"
MF(Z[99YEG#9:T]E":JU/)G=UC24JDUX%OO'G[WN#5$OQ,PKR*_@4*;LC["_@
MS:;2:Z]DXR9)>3D1"[#%^GXF!M=3ML FTQ"&.%A+>*ZS8K?LOO/+;*F?4)T1
M0GQUAD6>>'W9OE>N9V!J!Q. 1712/2S@->$Y$IG0HN4CD7'YM6)CQ,9'^-_T
M8.O]8F+>G$,G@;6HV-.NW(S<"QWSO=L,42+(.<<OZAUB+(:6:.-2U)+J^Q[.
M;$F&HV)$[23+L/"R!J'E=<R-/(B(->/Z7#AG3<**\V3"[EKM)C,R?ZXFMG,S
M(=P^T#N!%\1EIWF(+#<O]JG &%%<J%?9XFQ?-'HI*8"(*N/X8<W2%X@:_;2P
MH2Q\/"E\&=?..GX(>9,WN;PT-'9_Q?RBE;"*8^[5;B%L$"_5=J^,>G6.>_I-
MMI'WD$94/#JE\7>MW_@?;4O>V8!4PID;.C=*M6WVKD;AIQJW-<)IR0EYS8#&
M6NP%I&]BW]BX?[JS&]?P[ 6"NSD?WSC9KYS-CG>&WR!7LT*MV935=H!R$E];
MM];B5[P*P1XQ2;;/X_J5>U2C;+W^8KD+/AE^"09=V%_H/OOILJR\^@LH)CD2
M[\;(W4!FK5 %T#<FM3#O._%L/1DC1&;-.J%S!PD"O!UUE)93]CGL5E?PESAH
MLJ0L;_T&M7X##]F-4MCQG3.!U*L(U15C"';'SRP,QQR 4X!(8N-T>TU<5GS+
MCYV]-LZEJK\ S=2F&R5)/W!NL9U@\2.T_M\=P8HY)(BGN<[4Y$TRQGJ5AZO"
MNU6C5#BD&15*/XW)M_.[T>C FLEJ*X87MNAT9=?"O?M<_9!A4>$_XUH789_>
M2#!/G:KB(N'OZ'2F"7[_]4O#-B%-JY %F16*3'" HZ4L-V6!AYC9%:?4$QU_
ML2GC=0O+RP-,*]1S@&1K^]8N]SA=>*C"I]*;QX!ON=;ZJ]X&E= ,=IZ8[9X$
M+]G(,M=#6-:]1W;Y'9[&Q1Q?3#.N5K03.JD/:3/G1'&Z@P !'D_/>*1]8=6"
MB-D(@F?\27_G\^@A:=3SCNY!,67NM"OW5=_(8TC=#=E:7Q,,#FI8]%Z6L3JL
MI?/W%O!Z,,3M8Z"N1I'8S,B\=WC,C;,ZW*2C4MP(XYG7_LT>,TZD/3G[Y0/#
M=WQR%T$T;5DI)L[1S8?5O<\07A.H^6"R+,*D\@)*5$JW @QUB"S-H^"*1. =
M04R&M"!=LDV>NZXWU7%\&[) N"[%(&]SM5UTF</$H@.N]YMQ+]6]WZ:DBW;J
MJI([*E\H)&(=*F1>86DF)#!J!D4X?Z95;_&M&?5TG"$3Y+2J =DD@-HVH_H:
MO7J78WV,T91*5G8&@+[-'9ZN-TZEC#4=RP%,OG\(#ZNZY;C8O(WU-?^HOT,V
MRX+FT&5]&S4OSW:]MY+T C?AN]48+:='O1PWI8RI[1I&/KV)%E$J1OP%K/#J
MQPX%\$]NI/2 ']N])9M5T:0Q>T98-5#<9NPETK2\)1F66HT4VI&.M=$"JRFE
M9NTS87M.&B8']WHS)#XE;"D'3@P[7!EC&D9#CQ-D99.QYOF.,.RP$[Q$CAS]
MA$WA@FG>7[\*\8T *"JUJ!G5%MC^<A#8O*";7+'R=/;D'ENCSJ,=Q 1_BV3C
MP!T"UMOQSYD1]H_7S$XYK>18WHPZB^HC4:BQR&Q0QC4?+R88!;RBEQNF^60C
M*A4JRT/0%B:M:SP&!0.U)V-+.78NFP/=5%K/(WV5551^#9[:-GI[>KWJJRVY
M97O=!TFHUQY@JZH=(B*<(=1=B[!H#67Q0;$Y.?T+^"(CQ7K,='$[NI_Q]+F7
M\I?1_^U[PG]4VWJ-\I.E/>)3=$:1\>_(^.)RKVZ^>95@.E%/X+02@^'F24_E
MPTSTD2!VIJ@=!W\=+)_!V1';W'#G=4+D@3%Z5*FVXT2:,"]%]WO:7]I/091+
M#6U51=5T<#<U?YF- [-:QVGM:> 27>OQOT@H=TUN=;Z<>)4Z.,GL8D9364%C
M+M3,C<^O'*I-;T6 ^EDA5$-= Q\]13#I/$T@9((<HM!EGG';:IO/7C-8GO.U
MLIAJ^"MF;&Q<Q)<E3MHDW&G8=U9,4AZIN*5FF2!45INB3*E0%BG)'W8+$,*3
M)CXX%>MX@&(Q3#31FN#;G/_)#S_M/F\=[PVBR$04VR:-GM_*)8MU'/8@WC2>
ME(L]SJ5&5>HX;;F))VLTAXZJEKW@%:"QFR@=G<NU'+/)T69$Q!@+/T'K%6%P
M]\BW_O$H%WE);S1&:#]:_9BHWB@@/.A?/#=2K8 'Y-CB ZM?&LN6NW E8*LM
M PGN\D2+0^ZB)]0_$"KSFYS[CU05&?6\5'!2^V0Y_&5^YPW<-=$BLDF7QPEO
MNQB1.,>R.^/[^U($*Q'BU_4!12_5&XR=:5R:-T-?[,CF,^T"><7"OD/NO@I4
M+87;-V3S#>A-9E7D%QXNF8[F:U\M!K8?"EPN@4V;JP=&BK$I;/L.S"RWJL37
MWK!=R_9B2:<IRV"$Y@[&W"H'8;^P6&#@=@<QTHC$5[Z0!5?5B?T%5.D2N,XS
MV^DZ3+Z\USG=H%S8D.GW*G/PAUYR)IA7M1],M,F9<BL?M]B=5%96<BV'JKCP
MMH!V((8Q<T ?1@O(._G0K16D6)=,#SP? G2P-''> 6%+=\<TH#K?YZ%HEYWM
M=[7E]1&_IW%19B6=UW,5;[.H6(U2X'7Q&#ZPP^2TL,JTE'LPNJI%9F.G= <W
M8K;;TKGDC+^]U/4F3&Z(ON#^VKC#1V:03MM]2;M'08 NK_@%56G[Q=@7#G,A
M.&J;*/.<O=5(SY+(8DRA/,M4#=LGG+Q72K\^$A1EA6:6[JYA;#9CI3'>6"V>
MZK@%7""OT4/5W">"5?]XT&E%O@D=90Y%(M+NM?"*%SD8,YZ(N63Q$S5:FVUH
MVRWSS6$4.C,MS6+T.HYI) 'N]+DEP25\^1TY&2>RLZ:NCVM@SC'"#C6CAY$(
M0B"09 A+E%%PJRFGWX7VL'Z0B=91U!4+>" CG&K!?3S0OV/&F1V4G!D.0LF4
MNK5'0-QVL#H$)GM:B@Z:B]])QI0B/'S!&D9;>]ZET"NWRL,6T W"2[/6FC(-
M#+3+[9BV:[/HR:<_$NP=#QKG/L4?2_8?\3(L1#5[3[8HM8"*EXJ7H47CAUH[
MSW;Y'*C\1[^&^+U,@(JV!NY^:7K.7MN:7(GV2MF'RKT/DXXNQFX2/I45GA'4
MF<T;N(<?7@DG*<NX*^B#$O02'\/#U-=3-((JXMM+!?+&50T.3-FMF*-O.*V&
M'1>YP3MMYR<GM5S26K,F3N,J+B67NR 0/6G6?FUNQMVY*N^V-&0OVD0<;^#.
MOVU%\D/X24$<RWLG/N,J6N=E& 6GW&&[P_=W7IBIS&QM;,C(S 0RZS2TY:J7
M\W3N#;G@@4@XR^1*]*9M$:2(N;)\F=R\8LA3R!/2:;E76SA=@H!:JT!2(4 2
MY0%"Y7X?[B+1/7NU5K%-IEB+U60-DG\AN.+W^81E24WVDL?*#WN&R(/W6DF?
M@$_?D&*:>E3ZAUF)\[@CK'RIM7QTRU*M;* 5JH;OC7DI^!=+(ZO ,/&,^ _L
M$^(ONKGN?P'9OA'"E>6CTQGCNKQ"TZ:$&CMQ]3HD$M^)H^/%S/IV7K]RVHG-
M"/ANZ&MS=&;[R^?74N9&A#K62^I6,X2^5#_+I1&6,NUU:1?CU]ZZDJ"UL)4G
MD@ZJ"\O8.4IG=QK,JI5;XV^A/T*#<753.JQG\\L1?'M1]U2A%'D5^EH:3'!A
MUG5_.(;@W(GMMTC<I<AU>X!KJ!VNI.D=.O%:-8.NW\&IJ/&^NDO_RON531B%
M+FCR9F)N.#YG'=+TKARG5X3DM;J4M!JHJ>9:5ZOC9:/"5K<\=X;X=C+[389#
MX(0C#T+(^OI9#K[P1X.HU)QI1&B0[2K0(.$M!DX'>Z=42PH^@"1)Q_""UF/&
M=E9!.LAQ<42_<M]:>$:-,JM!4"S%.+-J/(SD_H%XX4B7 >[) M/*;>DZ6>[-
MN!AL%Q.KWOTP)]\SFRX@-19;K*VKTJO0I\+#%1F/N"!B931>/2T]G67T^M'Q
M:72"J('0Y)DT\S'I.SS^(TR.8/?@OY[67"59"I)1L,+048PNXJ,K0HR'W.(R
MJ--!YV($[XRE.Y'4FZZO\AW5+LA,P*PGI?_V2(+$&_\RR4O^(Q<@6;PFR&49
MZ*XE$:OIX.G5VP@PB1G+6-P]#]]_[R,5%2HC@*3XH5NEW(NOAF*2Q4U"DQMV
ML+C$?)8-?#Q?2&X<SZG*A*@0\;\K\8"+LL3\4I[,CB$"S9TT,P2%Q[;5S*^;
M85:#BBF0HL6"D4,*9U]];0N')D]8_07XF=_P[A35U7R0*_P.^9.=QM3;^@*\
M#TX./L1 +@!+X\MJX?P%Y #,X^3AX.C##*@</@*(BW]]*UAMG%D<GT?!O::\
M=1UA/CR $ 7MK6*^POK^#FV6CU*JF[9@K@.6ENO*F'6\L$SY2T-2<Q\&8JYE
M*VK;>G.<^<1F&*.SZ(ZRE7:-$N<CZQUY(R.?["2TXE$C>?X2XLH%31Y9R>?(
MUGI:_+P\=U-ER/, V^F:[G#-!RKAYUC'K1+TNWU95/WLZ/7-T(10Q6-GMG=8
MWM%V9?M4%RHT7VJ[]L*1.339C6B9$%M+BR?C-]:D'\GL>A9@OXI8H:9]\8F\
M>-PH3XBP[[^3_KAM1R[:,TQ8XE7V%.?+R'D@3)H9A4AO(7]B"=\1E]FKTE/I
ML-:.2G@I.GX\DA(^"QG#VNQOV18@^,F=FYQJM9['W\@)80ZA)4<2*_JDHSFI
M\055-#2SJK"%#X?K,FCN*W6R>[QI$S#>=,RPT:[FNA_6_U!&(3:N?"=L;X#0
M$.O)Z_(U%U!9W*JB)BNC+KEGNW'R;7AVJ1&W7VQZ%SLG&RWPZL#*.[RC0=1C
MU3RV#_U)V\-VP)#14STZ4ZR/'JFXI^L10KF9[6:CG58VED54DU2L-G?]A_CR
M1F9#D"7ZY]E&97EFK)^WUP3):8CT+H=AZE73H8% P(LNMPFY(YSO8J,-1&?.
M:-$ 8GKG*6F)R9Y]1_82?[,N2FE\K([O-+8P'2G./<,2VMO"%9P4P8P%%>X?
MEERL#9B4%[%/:^2;*;5DC#K.8LE\M"#^J*O3%I93"^)'J$;E7EW8QWXEE!9K
M;OV^@<4P8.WK?.M@<!^L*21G0=8(;%-"*S!_\SN>]AI3]$?-HTC@R.W6K:^
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M5$WM4FD?" 3!1_*GTC :!?:?3Y:Y]Q)JHH:MJHWQV_65OYL-D93BJ%.M<JG
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M"U89R\00*FN);KT!XE[3"P?J)J"XAN_A-VYLSF*/\(EO>M)\G$D!),12Y"'
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M"@5O/*\$3XT)G (?8FSR?U$(#*"@A:S@4&E@%IZHJUMV]])7=,OP4<Z0M+T
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M=/52VOQNQ=)$*>^/5!M,-?3^E7# >7T<CQGA43+C):<V[E^  BT^/C6S%*4
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M2Z>6ROS1>A Y*"?W,Q['A)63%Z]A!F*BIIJ(\/AM^>=ON-%)TB1\FVC*H(V
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MYFG93&@PK9]!SHH\SM41D=UK0D1:@\;\."(/>UX6B3!A:#X0Z#^[I\SWTF#
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M8CC_ .CU457/1R8B-+Z[2OT ONP_]?$;]$QJX^,?]/\ 4$L#!!0    ( 'J
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M #%+><9QYQ!K$D:PU*)05:*0Y'J"X;T+_ES_&/[^=-OYXZ[\KNA3#*-/9-?
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M &DCC7RB6$AC2;ID-(.CU=O-_D@ER#Z<*>=H]8ZS<>6,ZG_^VKAH2,M_C$M
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M ^ABXH8W142.4(&X:S>O7%"5N-SD,FMG?>[QU?'B"4XL) 'Y4E'<EP+B(&F
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M'VX.Z[5)010%W5 41>)14"-1&6,\ S\7!/:+I[ <TV0@P52WO[^*8)A%0P!
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MN(A!-I6N:\G3#5(R\5Q"Q7[#@/)>\[:"0S/[27 ' ZM% 8_C'!QH;Z]#E1Y
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MU;:WM0;*;^Q<^-TQK(D97OD!NT]XB6?#1#^[@JTG:&[,KAV$/8EW6OP=WQG
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M:]W;SI^PM(%ENKW^7KW6K$4JP_#2IY]S2#$RUD]$;Z-%AS?M]3)M_"[+&/
MSW<%7^I3PWL12RCP)" O26>R;_.>U[-9,!V_P@NV ;=X)SA^67I93'GE=\-\
M,; BRZS6SKX8QIPPY1N\RXSW< Y.J6,A \SMR9).-K($2FQ'X5Q4F-OY%\C"
M=X7HM]D?5#S)8]YXG'Y</%FQ)<F&<]HY<2)Y+) H+KOQ^2%R5'G&&]RU%=L=
M\I:"YLB+2.)M%1T1FZ&/Q(N ]SPW%I[MHDT:E(T%C,#,4BW2%=VC_Z+ "%RK
M@WP[KS0<(9EX"Y3S'-APR1H]IY_#%/8#OCPX*$KA@B7PBV6"0+2 EXJ_ZL^
M;< &<(+<+=:QF-;#7V!4X!PN!C+;(WAA@%^Z3$?(P:]#-J0Z+EHP(!ZKO\ 1
M#(<Z]K8+ K^"5H[40#K#C[%G>/1)DR<,R/W*P$G (2ZO+>(=LVWL:PFG+#DA
M'T5X'F!['A?LP)JZ#&M7 ?BE-5X4-#">&:Q!!K')Q^P%XKI%J6J\($ H!/33
ME*Y+>;$4VQT,_>0>/TW)M4D/!#E9P848(== EV)- \"I^6>G4FY.;RA<QC??
M@V^VI#2Q2/DSGK8,&E6'"SV\%2L!Y8,9H*5C"2-0. 0//>",*\0@%<E5^3M
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MG\=5G8:=Z,Q#A'<&T&(0XO@2+KSP25$)1IR_[DN-59]J*.O$UWYEY AAI.A
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MPTWY)?N>C"WR$['):$/;OD4LBT>RJ>#ARY?L2W.5!CEB5RC#.RC3M[YT\^L
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MY$:0=$+TV\"XAEX&I+5B H[]26:I4'U%EB 9D9VV#4HU&JN^GJW_M/8Z.V]
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M&JO*TVA'O!FX]A$AZ/J6,11J?])=F5ADT2*6P>_,3#"G43V&^T:;7&0":/'
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M<K@+HM*8CG)T;%D"? ",^0#<^S3H)@$3_K$%JO1;1 FT%0Y; E%'Y8JY656
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MV:UTA ;F0_5)VCP]W^W_?CV8N72<C> UIT$)[3IZ<G7GT5LH1G?6_@VQS5"
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MJY4HC96'D?3_8KS#:,Z#U%KM'C>-;E9O-WON;69//)II0X?4%6%WZ/(,#::
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M"VOPKCE[,J<D'V9G1HR2<_=W^G>7FXYB3\PBHC?+_7/"7Z9*>/82-$#N @Y
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MS,/L5WZ:I4QI7U9;$&/),1/1+$M#D, 2XDLBYXZO_+G\A(XKW'@0B\%U125
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MB&)3G?,MJ_ R.Z*9L1I[/_><)N)N1T"STUQ9F&(J122U44X?L&N#3SW,Z_#
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MUV/F=<VEAGLW5WFI!X@9GJ'J5>^YZDW+9J%*'EJF-G7G.)-5X(J*PL >C=<
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MEP=@&+0)+A!YQ+AP[I4<941V',U)FXS@JN"5D.D!>&62E.)JT(FU,2H* #H
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M->C*U<!B,2UFJT=IR$*@>["_*\D<8Q&MX+-&]\&/#*-M26)'J+MB-0SZ&;9
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M6*B<P.W3BSI\1=W7M?7B.RG^ZI#.M(5]F5?]U6GO;>]^H\W^\?BMWWW9;I2
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M=/69*5<PH1"A)(L^Z.!G[7>J$?(R8V1&^37SG&WGZYG!R%)QC 77/AJF:8&
M3#%'90816Z\_QH2WAO3=(D/O3PVB%'@Z(&^]B^7$E*@YL7"Z;A-:MRXIZ2MK
MQ' N/XP:&JQ=<4XS6GTI[($I<\9O[*<,Y\;^2-H"O_>]_^[TQ,_2*8FXJ73\
MD\XB9>YD&* SH&"('72^-V^Y>MG\_BH(E(3NIQS\65^ZN^Q<P3;\G'39(H59
MYG0FF7>Z8@<V;E^_C.*06T+B"R (21P1[L;ONDZ/BO5!WV6P./$.RS- 577-
M,1\?G1SYV@<+CS$RH2:V+ZEI-8(D*6 \TGV-*XX[1ZKKBF#I'J"IQ0:CSQ-B
MY!Y1P!]I7"ABY*/]SFGE=+:\O=O>W:UX[^P0OCL$Z>$MJ9X#XM49*FJ+"A6K
M@F6L>RF^Z[7W# FV9MII *]+WGV9^N\_?EBSH_O7 8!O#4?>)SX0B7DQ.O&<
M"L49Z2,%S FW5IJHHN0FM+D49\)#+?0L]$TJPE\!["Y/4\/;*(>HBOP3@"UJ
MCZA&(I2[ FAE&6!P#C.;(9!SIDAHK$1(W59OKZ=I6CL=,S6,X?"[L&R5QT#-
M$\MT3_3A1A.>ZXE/01:L>BCPECG)%LVWF2"SD_+AUJ'KY,#Y6\N8 $7.=Y39
MR-;^)N<I5 7C<31\,LA+CV+B;Q)/ ZRV*H1:,,$$I,!.VP&GTDB>#DRJ8&I@
M*\^0$"LQR, ?1I^@&XX9YQ)0MJ!AQE#UQPB'3ZJ^2."P:+(6BK+@:9S#@F8F
M8/7"DFVKREA?!.ZHK;^T@*0V":7J1,4 L_I=6(7)#S*RZ+^ERDU^C]"UUT@(
MJA<!20=1UF$3=9867%$(#-E+'KYV4=@ZE*M?VT# )O"<@VJ,T*3#&@9B![#5
MA-Q G/M1T^D,2E?;Q_"-/7 7JB=RR!?RB@HG4K2\M$]$%NBV80Q.:?)T1;.S
MU916\GZ'R"T#X%YHSI$07?K='<X\RFM]#P0]A(T(RVAR837(S:;?Q#0% VXJ
M[)+Y$/.FYA(!&LZ!&8.YRKE@:P/\X<8"]M:Q@"H6L+N.!=SO;;ISI^\AJV[>
M;] CJ]YZN;\!'O><&)ON)+A 'V7^?:HF9,2@F0L8^,-:W]65"&[E0;,RX6LO
M;*R&]$!0%JFM2]A%68)F)(,TCH-)3I?$_&6?9#$DCW(!PL(*!;D^S_25J&H1
MY!6&274K)J7GL;U'\]!KU(REO<<I1N9#/86=]K;[J2Q)?[C,/A(O?/XM\ =D
MCSG=WI(AK\^ UJBLEFI?A N6+PN;V0+]I5[@HJ_K;'YV!WN=)>^@,/)E;R ,
MM >P6UM;CV*W:N1V_&D29=/FYG%YS)>O).T,[<191F9&N*GCFO]S='1\]/KU
MHMOZI3V6O9C=X5%4J$WP+UI*DEYFP>3!7VW7V74-RERT,;>^].53V=;>3KN[
MLUIK[FQOOE*#S=[!5]RC]67Y^>\J"NFR)$FGLV*$TSW8;>_LK=B:=S??!MGF
M5F<M=)9\C]Z1L9@KND7=U:*HWO9!>VO%Q&QO9_/7,OFZ6[2^*JY^MO7KBE%.
M#]7]*[;FG;7,N9V+]%*I8J0ZG9538K9H2JNUYEYG\]> 1$[W#D7.0K?+T[M)
MIZ-23;]-=_NBK^KQ$=W^-PJK)[@EO3T29M/-[7G"S*#:K @ X;<D+$F&38:0
M=7&I5&+0"&S>:U[V\RB, ,_ .7<FJ%]UL74RU]O^;UP>66^CS4D/5:0)J,0F
M/<HK<YW&0S^(!F5<E(P#4V;(R:G!?9'NP1U*Z3_^($LGN;\Q2#,IT\W3:5\%
M2?[<H&P7DGZ!-K/2IYE3(#CCPA8%8#G>" UQ\[GP)F$6Q0!NRZ2S95*DF<XF
MKI I\@"X+MPD(X_X!\@#N$SI.)32#TNJ2BVQU'F=9Q(3N/B5\Q>P.G\C3[.S
MD<:VR:;J.1*^7,BS6GZAQGO+N,ITK+)XZMN=G=DXV0SY855#X+L3R50NV NR
MO>I"BB/*HEI'FM2GX!QZP)E3#*E3Z$ZF;MJ)V_[3:ZZDD6!!V^EBR/0ZO>XZ
MK^*.>81S=R41*+E(XXN9E'R=@N_/9N 713 8N8F.Q!%L4E(NV?F-S*&JCL?C
MX1GW_-,D3G6U@<9?5W7B,7E3G'+%Y3WIL*6;;"?S$X15HX9"<L2(6/NZ\ZW7
M*$ 0!E=[!/1-L^:,L4;B%Z<\X1_UW&';XA:)Y0!\U-E.<V?IS9ME@MZR45&A
M'>D"=PR!S6=0R/SI9JI_4]'<4I4378_V425(>WT;3&Z>)?&0%G,?>W^MNM6M
MZ]2MWO;45E( F#1(Y*F.ZU5J.IU;M_?F+&XH>)>C%-CBFB=5$!5U#:R9+*H3
MV6MNR;;G8KN9OFVYSMJ$JE7!N>F*,@P+_NA^DR8:X&JNIN<@!C;SQ2U(8"2Z
M,$#"!#@]5!.5:*S<1W>LCY8>#W./$1"KM&.@)X]4U?$];/9,0 E!GMHZW;HD
M;6FZH",E_9@M$5LB:+.T\3&; R3:/=T67O>=FU>[*8I*8%&$3*612V?HTK(F
MG >9(;R_SA"N,H3W'FF&\#=0I=[@V:ULI'Q^?9KJ''_6K:E=7\+%7MH*#IEO
M:N#$EO=A-"7S@VR[R8@LE:.8-0=FAV]JQ>./><E+9897SOH.6.2<]2T&:@.&
M<6P ^QD4%/Z938X/POZ)BCI^6:U<YR986UX-:ZLUI^QV=]\=#2.]'P>CH!J'
M;/":2,\9#RX F)H#S'P1!7Z6!@RH+##*C)CI21WCF6 O!%'&[7#9>P%7!/Q[
MVCM&/RKC@!Z.+0@('>#(K(MGSC-S6OHNJ$JGK1NGM"NRRYZSRSPS/6+;?^W\
MRW];)I' :1_*+*\:7H;4RYX$ ,[$XJU;#\Y /U$%U!0NJ0R@/Z5)"$>P_AQ;
M3?>;=!IY5L-]9B@-Y7EBH(6S<T!2*LSOZ01N5=12TQZ5&8-Q=D$MP*K3:!@\
M-&^D5>"/)W2(T_JZ91Y-G#=G8"%#'GA9BM@#O,*KRZ*B\5B%D9RZJ8UFMQI3
MN\5#%/XRHCM+"HJ_T['80/.-W$;),CB )ZJ7 %0N0CW4((G^UA:N290;\.7F
M3)F),<:AMG#^*I.!*;2</^G<V^GPW'9[;7IE%!L3!L1_0?_F\A=3H(AB11K*
M[IDQ@!P\R2W-4 UGGL5 ^H,K;=WQ3=FL^1TS6;ZJ 2-DUJ R^?.9&0RR%)V$
M:UM5O0@F7+4:RU\T(*@G@*#^"<>/Y"EI!6-&AQT8H@M;U"\URG -PT8S/H&>
MA)/!K+R:3L5^\/F'X#)12B.1>M_\8I%>YL7N'ARCWCXC[BET;?L6!\4\;P;M
M1 9D3#) SR3XE-<Q=I1 :,Z^"5\O=M#8=3/K]3](#_8/),DR_Q4OCTY] [/H
M=5Z\__#A%?_9??&\[7U@R.4$& 60F;.'B/G%,,Q9?V#_.:Z1&_ZK[OB&2Y[/
M6Q7:Z<:N_H+/D+XY+524!*7*O(V:QD%?F</#GFYT.[5O!=1TF@4#M(S>Z.W5
MAFW[KTK50/BR@BC6>,&,*6W4&*^PND*2<@P/A=Y!UI^NY<ZC7=^I45T]RY1=
MA1>!&']4CJ-0MR"E:: -F#:#-EX-@^?F.O[C?_^GM[W[8C)1B?T!=]2TO: U
M1VF3Z<14K[(Z>2&DKA^D/S6$ OROHX ;@TBGD#[02 H]*W00$; /S#"&AQ9"
MC)2X0ZBS9TI_0/LX9D ,[E=\ ?7/I ITMP2;]S4  [9V]#^J >055PRPNZV?
MP74ZZ-@!CBO_F0#S,*\TWC0+[@%]W/KBO'$P%84^ :PRV&.L@\;,5-97[=&N
M3].3-Z8O1NS65V1)D#G()+&1!;J[>IZDET,Z]>>@,KAG#9UUV@?\@YUV!Q)E
MI!PJ!X7,C!E5SVYU^=&M+4^>M-'DH#Z >?D,9I/?V[<O=5E% [S;@.X(4A0'
MLM,L"3B\RWJ$EY4)PA[HCB)A#(MSW3YM:Q=X,2IU6Q0@04'BH %X:N$I\@E'
MIR6&S;>3-Y4;X)FWT4_06PCXA8,!F4H2T?;F/\XJ<6!^JIOU*)0TE^/$#/YT
M2?.I7SWV<GBNET-4-5 5&?0<!($JL[!;USP%#C1CE#;=I_$2J5:FCZ6\ IE9
M>&ZH.V3/@!&X/IC 3TH.M:-/,=2MV@SU%8-' "-"&0],;I/$>#*@7\F/*T]4
MY;'A'="CV'[*:F; MND(Y(2(*B2P(CCGMI5Q,+#6&%]Y#.[D@,0XD@+>)_:[
M&&PXSP&UHE]I=$U'?1Y(1@D=:SD,!CH#3L2[(T&)5DHHZVNGQR->WXS3PT2H
MT>9UH.G(Z:EF8YX@!Y804LG1,$5K-CJ D#C1+]>F) T USXH!S?/2X=#-O(;
MYNSL+'16& "JX+'P+]*8V_*A(7H^CG)D*1'5)ZJBU,K\%-HFPYG;,0VJ; %/
MV(5T@H41JM.GDDV>E4@Q3DO<S(LJ%DOS""3)] P].Z*)XC<CK[$P[Y1\2&W^
MBUK,_A;S:^V6<))7(??MBZ4)&*"\=(2XX@;,Y_J"C1M'IF$?0^J&ZC+0@,_5
M RV]?CDN_@$?$ _L:?>*_$2^U!O5)M)1OC;&?XI^1K,]AX.^KEH0DI%<AM.?
M?HA^UO:Z;C'"RZI A]WV3.!'&3;>L]AY#1K(5&SPN^:S[J=[-5>!]0C!T=QT
M> ]7I6F6"E0DD8% L1-);=(_T36,%>A\) D76<I)%<080-1RUY2Y__9' + $
M.E^LIGF;.)^Z$$K4>K[<@SY9Y'ZWU=G=!=UU6[W]CC\L-#YT3G(V1OI%VW^I
M0KJBY\AFYDQKXE;2G8PQ_1+UB:0Y!*D6T3/$Z[$+].F>\"I0\#CX*^7FW@8#
M4O0PEHGSD:^BO,JH1YU"I$F0!I@I0VBYF*5<7Q!PEO-G@_S?]M[QQ? OU)G2
MPDG'OA;=I7(22Y/".-ZDH7)Z"6 KB?Y%J,O7(5FQ84F:,^9)6N1=*7GUO(BG
M3[??L-XOYA]UI7$IJ4(_8I;:/V]SDGK[3R0IZ:O2D?8?9SK2-Z?(Z?Z0W#_G
M>B68UWG)O$NSC';F?3MN_W$F]DCSX2EG/NCNPM'GX)8Z03[!=*6E(K:Y(S'M
MDY33X8$?Q9J%468/S:[O<2US%=2N>8D:NG%+H_4G>P41.2>3(.-&TW2GR CX
MD*E!,.YS[V[4C9%].F %" 8&XSPK-.:$BA0J^D<1C--L,L*E# 0XWX/RG\\V
M"(T8^)YL:[1_A2(V#LY@\.(ZAU/M]I<8,.+GFT6F)%3-JE[P"9%YH/33AP/.
M S/99D46G=MD@K=1:..!WDE$]LFI3A:P;E1^!=0_-\_]G>*H.ZEY],S<[J;H
M7@'GO0K3<90$TH!HZ(=T)^!:;-'OXT&D4S"#Y)R.B3[U>%TQ<L%(KQW%*7]*
MFR7_G= G9^E$_I[2SN$7]'?.*\4R6OXP+O53>1D/HQ!$0)M=)$'.GXYIDI_Y
M+[SYOR6MZG/;?P.5NN793+@^C,,+XQ&A3:.%L75)!Y"IF@L3)\FY#$Z%;MI'
M.HZ-O5N=GNFHF#WJ,J$AV:71CZ<>RFYCA)& B%X/WG0Z/J.W8X=,Y<>0S-K-
MF('G/P1QH-+/*<T209,$EF88@<[@?&)2<YW@9A;8HYRV@_V\TK<)QJZXGS^H
M),FG\051-S<'65H/@@?(%9ZX2%J@.SRNU:Z"9+)9J*,4;/0+?9]-%J ^5]=M
M?G)\W/R6>1 '2'.W^UHE#!W>).5NIN!.@L&T>BZ^UJ+ Y62(<$D K,:U#G;
MM<0)(?*GY6\Q)[LD_BQKV>/?("P63?0K6N+[Y7";99#L37XWNQ].#VS4_MG&
MUB;L+(5ZNMR?TXE-YVTLA#U])$;7K.W1K@_7QG1HM]W5JX[G_*&D*%C,"GVM
MVOY+(\*9.!2\6F4FD!HD&R6[O$K-)TTJY.*1HA;HC8,^>&X*'[ GP>)_'K\]
M/3I\ATRB[1=$F$$\);U($L+URYNWDY0!N692/#J$##_+N&K5I +3>_?V;(]
M,XZ^T7*;/9,7[&I)EZ,HEG+4/JD)\%-4S] A1%E*YZHOU*8=]A-BX&8X>B=2
MIEAWH/W 9B^QIO\!4M53OS5_L #P%@J %O(&4\F[EDP&RS8Y,B&&B*&)4 %)
M(A<OM'/;:EUJV8ZJ;A.*4CP4:"O63^TMD5P>N+8W]2NKKR#C8@-WDUN<C5ZG
MNVT+8Q'YI(M# J'1B99,A[A$-(@?1]P0G4M5+'&>480 <R19)9GZ85+&DRK]
MBMX@"5AXU9KL'^WZ?NK__%/T\]_M67M.CB>"SS7\_2>W^J=^NJ]L;7RQJ.;L
MDGF0R<UEH<F].0%P8Q"IHBP71!P'1*=[L->QZ?5@!-V#_>H#G;#Q-HVG?5I<
M.;8=&(G%'(X5:,T6)>!7 XUMAL($40NDK TS8EY#(_X3/35)$I] D3V&3NN_
MJBKW<Q_X:'90_6,]IK=I -1T<S%T&!2D+3\)QNIY55U$8B"3[L_(E:"%:_8I
M#A#FK*21T']W,2<]*O(T61=J^=W> :GNP3CE#"^:*3AZ[HV""X"Y(97<<GS.
MY=!=<6E?=K=;!_M=N#5,MS1X-F@$!]A,'O[4]M\/!6JCY8ZPO2]O\S>VMEH'
MG0-__-S'B[W&BXWBIBT>JWDA.YLCK@G_(9'5J-YS[4J($8-$0I3S&G'4*E/%
MXXD9T"<]Y5@E9U(:NM7:VMEJT^); I?&PDMOT6@:TA'H/3!(;X4:C!+>$@-*
MITEEAZRBU#<BC64L5N]5JT_UUA%A7^CCJ519TW]^*&VHU90WD)&<]"9: \I(
MVYD=H<]G-^3I<IFGSD4/X]BSRI2A)^<VB8E3 R<#C7TD)I?"$7L"3VJ.HJ8,
M'FC)CM=LZN3(<#U0S2O--PS?MC][]>KOYG>>OH_E!.TS&[W=67MT?!EUEZ5Q
M@2+-GK1&NR;G ?&135V?*/P9LZO6AAU-#';B* W7%/[0_(.DVYV68V1;0K&W
M-/4J* *XZLVQ5TK!*^TU."09<'>*W]UB=U0]Y]P><\T>=#=>Z15-Y70/KFZG
M\_VW=)-;C!+,Z[Y4@OR+&/=\Y+G_J" 3--YJ: ,0;,;NXD!FQJMV<C'$\;?.
M3NN'RYP@'0%._F_/>L^6/-EWUM?U=V@/2YBT\_2<.<P9\*Z7;.JRB$>0QK8Q
M?KX*BR;VZ?\F.NJ25OSU71VRL_Y&K[/=ZFWMMWH[.\]G^81IC=C[OKX:<-;E
M]H7:V]HD<V^W!O$],X_NW&E<P4G,<WNW/']C;][2]+_TW#56S!!XP%+_VKG-
M>^2.)[]SL-O>?<3S[^ZVNIW]=N^KE_#U5_T/P/[/WN_9U\$STIS?C6CV-J^9
M]L LN&7?.,WY1SKG&+=N]&+ZW2W-8V^O-WL=[FDNO=96=Z\]PUQNBYR_++GF
M2M+;I$WCQIO 3Y,4"VCTFM.ZP2$MT&J6V66/_9&WMJ O*5;77/!\4KW)X(9+
M[W_[&J]^^%%MQ_[V3GM[O2,N@>RTMO=[[660R=(%^IVSO8_PNM\:;U@VG2V#
M-?5ND_(6#*XI;_L!LJ9[W(Z]3J=]L-X15S5%C&Y_5@_[:M9D^FL]%5_MO:WB
M>C5:UT8N[ZV+!+E(\&!=)/@(B@3O.+QUS;MV[<Q^[=QK>;-NRL<5OGOJ8?67
MDDK(YZ0SB/:V6[XY0"? GD>?)%C-N1H_^L='FUU8[_1?>J  2E1A\I)<."N:
M!KIQ<4['9:K3-B7?(RT+!EHM:M5O^A$-IOO*OE)R4BH4[$&094") ;)%?^J?
M'%6Q=!<(CLN7.)8^4WS$D])I0M[<A]]G87H1#:(@V3PRE76F5D[&6 ?<'^WZ
M#)%[4G182CE&I+O9U%/.Z%KL@5Q0K^:_#:;X8-^Y)V-45"*?+8QR;E1IT3,6
MIFQQ$I:]41[N4[?-UZKK0B"FB8-"W*I#:(-^#8SV;-TC,J5G;Z3![+@,:I R
M'M</&&L:_9LD)ZS7V6KO(A]N8W=WWQ\6S]<$_VC7-X?@F60;.>H5!TR14+IM
ML+I1IP2^:P#=TP480!:UT\^","HY 9\'1,FH?SYN>R^G>F![?T9!Z,B:G3U'
MU,PO"T-O!6#4N-+"HK5+V73H]W;<<4Q&YQQTN#5JT:->'UI]>* H3;*[+2>O
M#I#ZZ:#,YU'L/"H21NI^PG!=FH#WB("E,) ,JT*#O-KV9_5$;A2&T"LB-.\K
M&+1H!O]V%_#J4%_DCPU[3UJ=#B-T]:N_GVMTL'0,".P41>E(EU*A0^1(3+35
M(YC[6D%YO.M[.?6$F)WL\FYGM^JX$S:4XX59[8T60[NMO8,]D%MW9ZNUL]5C
MN2X-:I2:(-]>*J 4MR;V@DH=Z+8Z6_MX<JNU33,!4>("R%9)GKI;L/MTS^:1
M9J->UX+7>0,M7[(;UK;[ R3!-XEW."$.P&?4LI4Y#L@_0NL 3TY@\M:MF@TI
M,6+F\7Q6,)K:96.VHW+?[=PI]G[N;>!+&:1JZ6**;+A->:B<MC WJ5_A!@=!
M+O4?8<K5']9@$=R7_D]YV?^Y1T=,_WG/_]B1?\C9:R'NF5(:8U-I]!E "0K;
M2_M0 Z,+98$$ZKMEBX'F%6^Q6R*%[42GKCN?(*-AP, V0/55F6#N> O*K(-"
M.*QVDP 8>!B9X@ >4:JPS>/F=(C;LM,:CY03@?61EFQZ6['<L]0:HQY-[")*
MI=Y4?F%J8Z1Q_*>)J<"2%YJ?V>YESIY<FMZQ-$30CR-TT\%$D'3-38[*X3 :
M1#AN*8WUQHSA2\<.Z50O;'>:<01N:UA&"W9;P^9%&4;5,<W?T+7<>;3K W "
MUQH:,M/H35(RQL5B,.^X;W:E_K1$U8&^3XI)3\,2O?NGCZ$K71VE@.@30VPI
MQTA,1&BMEW+[1&:)WMQ1D:VU/U,89ULZR&V989]K.GQ@*L&U]1^=PM7R3)+:
MAUJ2VN-<_5/G'?K04&4ZAOBM#/.YOBH1WZ9PD"__)I=<AX;YB-B;]PU+OS2+
M:-T<C+"P:]UMAX&(&59OL=EK=1E<:"-(DK3D6;*O##H#HX(KE(712%JW.V =
M?)O4JWXI7EO2;W(.VP+%3D0VEFK+PCWKQTM]8EI73X<SLWQ>*?1!+5;KC\T4
M [..(Q6_>*(FRKV;BG)Z->)"IA[89;_OCH^ZVYMOCS]N=@3HPOF@IWDQU,(@
MSX,I(&D85,9S?K7%.\:X>IK_2U,A;F!K/NXK)@$9Q-:@9PH.3VA7%MMZ/AB/
MHQS!!V3+-(&]DQ2![?7@JJY.-?DX#55<J<A5CTM,1/ .T6IRXPH Q>>ZI!N'
M3TJWFMB>F+P3!B;$_*MG5'7>0)DF(GRVX;!],^;1@A8X$?4X7G?E>[SK>R6]
MJH91#K+C[F]H?=&RJ Q:<V?+L7(XM3H'.Q;<1K,\CBM)8&S? BV(>2 LPT'4
MF;*7GZ4IW3$/ ;*2NRMS\P&^/'3MS0NT'TM/1"/+N0S/WG77^&%KB3XX"R8,
M08 NQ@#&S,*\ZL@!(]9C(RG7=E:2<*L58%BA3Y=@".E0@U'A_$.\T'B2'>.Z
M\ \'11ST^86'R8!QZ5O^>P28HU1[D?$L[D\9%[(VCQ;SEVT $\!JYTXC])8R
MLXV7S*='=(99&E> &H<__+,J5F^JR(D&0-)MC-#RCZ$ST#)EL$8_N+WUW8N*
M^@8"!: >FDCR.W33W?HN/'5>;%15: 5G62 \-U>9=FUD)(J!M<?W792GD%N$
MZM L<EY8_!N$%<$MUH!D#3R*9GR7@594@K8N#+7&'BIB%-P"!@_]5W,?,#SH
M0 4#_C7?;50Z4EAU5V)QJAF'$A3#>C_PO-DDG'U+N6=4RKE=[- "W,1SI>54
MKNSR0F ^#[B)EY8?17!.JA>+)C3 @:\K1T,MZS'2TVY5 P&800SX@6:W9K -
MM*X+27K09(?$O,&>C1.+1AC@^2%RD.9\;7GVT<G;"E2)@R5QD)SG$CC)!2?;
M8\"C38!:3WT!>6/I(/A+\-Z2H/$W3G\Y]8_HF,, 3HSV7>5BU%-UVWL[J\#F
MOW717TQ(WEHG)&/96YUU0O)\:5I-YEO(_-KIST]/R)Y*V(&4WW.EU6]HY#0'
M=KI$&K'>@. #;(R#&.(2Z@?9( UU_I$C:<QPW*L4XW .*S??%LO!I+7JF$L_
M.&O[,A4_PE*KSN7:HAA&V;CY6C!\%5O9?A'E))2U8$(2K 3[2<+E@ ^6.V"^
M1GX@/"S2BK(4)XT>-[3"330 @3RUCS >7UZI$Y(-R%8.>T$"8/0*:IWM>=CV
MWP(8U4R,)2UI+?H]'F^["%LQF]CESD)Y1B;7\K<X]$<30IL[VH<?GZXV>(<8
M20X0TG7]SU6QY?5?TRS+I%<P[E+XU3/6N_Y#$[#F:P99ZM$=[.X=5&<WBZAS
MO0G>LCW%XHNEV;7^)XU(M*;J;W0%UK$%>+R=[Y_[]2NM\S/INVB,#C/B60Z&
M<*T:9F,].M>?@^W^:E QV8-ZP9IW56[P&3U"N <)-[Y4EE76(\(MZ0%__;=/
M4A(4= /;M9-%B=^M5_@MU9NPYBEKGG)+/(4,V_SZ%^H+3$1[78?@4S:8814:
M;13<SV5<WYWUW7D(\IBA+1&)-:;(%R4S7'+P[#73S9+0>@ZO/P>XTP+IB_[(
MA>)3=RX?5H#?H2J"*,Z-:6K]R1(W0C4C+*Q2,-Y-G=F^L<M.-__A=]$;J?+,
M?K20WR<*?F9?H]NN@TN/=GVZ#YOI5Y2[/?GF9@6W.)DV2J!1<TP6:2Q9P3T"
MU2#0#@>'7W!SHCA&6ZQ81P%H]EE>!3#:WIO$ M5S.JL9LN"0;SJ( F-KU!*$
M&2>>YX,<!;A6_"S*=6VO#C!@-E>-5Z\)LX'?4Z7\-X4:^]W#=LL_H5']U\&@
M2+-U)/7QKH]8FL<LC1UV7(R>1S14D,53D],4^CJV*DS4/V(WX,:O[T^..!FK
M]\)_]\;?WMKL=KHZ.XLID'XEOD6BWXQ45K2-0+I#G,+3I@-DWJ3LHP\RHGQ,
MJ)F*)9\"#5JOEQ>/M'CC2M092V3\QF6@$RX"">'QEQ.5Y:;GD?W4DT\Y#WR"
M[ 'HMB8,=P.NCRO+>6O<M,/^2!9&[,"&X$2RR*TTW1L\3KQ(4ALSFQF!V8Q=
M9]NO!)MNHS2QW=,X8\M>_*MN>\8KH#V8&YVT4<F%TK';78O'&W*,!][Z&UE0
MC@!XK0*Z$"*X3HLRG#[FM3UU?KXPJ:UP>KS% 3$$1':JM,M6/9FSY:N$UJ,4
M1FLYPD&2*I3$X_/<\+JA0R/IT!./ %=)D7(=ZE[,R/J40!%X%(*:3DT,MW&<
M;>E1;TZ'>6 (L,PR+H+$A+&T>-$%-_*L5S7ZD<2S7.J/; LYIR6TR9D+@R*P
M67.<OH$<.*S%BJ#0M*HHG%(?M&ATNKE6A4+<HA6?\K*K(J%R$DJ6B\ZNO8F0
MX1+N*';4-?_T^ A"$$W)/XWH( HC7?7.V298ATE25B/2H;Q.,]+H.O1Z(^]<
MVE&<2_UK2?/?ZK28E.1$;C!?K@*W">&\J71^Z5CW33)Y,R8K4 L3EZ*0&3UU
M<@UU)Z^F4,]K>;R\S1I+EZ2;/D^LH-)6KIC]:DNH1[V^CW,Q+2+A/-!'Y:9P
M[J!@HN*&<ED$$9)HE*8, FV1-[GZF]C&!)_IGTJ#(:%@I+HRPBIX2,N, OP#
M:2RF29S9B$X%Z[7V=K<YY9:6AJ9)83!M^\>?)B87%NG&#N^T%9=;^YM\,YFG
M$/FK*CS<W>NVNML=,RKQX4DP93>M;5&]U=K=VZU^X)\.9DM&M^0?PO6WM[JM
MO8,MYY&/T7OW&9JTSG C-7.R.<SH-$C+SV@=WB"80!V@FXL^V=!>O]O;[=#4
MXYB-U:ANXQ)%\'/Z]_2N[[K[>]7/Z3)O.EM2'QV_/NA5/PX2#WL6,(<'O,N9
M2@93&;13^UW8'#A1!7&C"Y64RA^04(FXP>IWO1T[ES5SN*OU+;FSZ'63B5]'
M29"0E11[AR:+](W)NG0ER76TY">YDP^,3&Y%AA"+)T4QMQ:R.?D;.00R5==]
M!@%IB\,XO=2%3EKM$:W*O)&>\NCWG(K$I7";1?!)LI"01L#_HE'1K9Q!=1 N
M\Z$"%U/Y7#3#))V#1C44TB99%"63LLAM8TU:G715U=$5U'H>^+^W3]NL;T/;
M]D-T$,O029.T9CH08!J,&'$M(CUS8-3Q4"ED<"7JC$Z-G2E(G4Y1/!4-I40-
M@E++!78S,+O-M=\(VF$2:+6-9V!?_ ]%FF 6L8>DU@NT:DVMW4Q250-L(G;Z
MU_.U(^N$N9^DX1NFSRXG]_%6I_CE#-_M=88O9_AVUQF^*Y#AV[A-O9U[*MW_
MD)&!$$U(E3$2 +5U8^TJ?M!:S2UOX=5IIFX:2S/-Y6N7*RL)RB*U*1];.]]?
MV:E3/YE)\SX\6F_8^?4Y+U]H[<E',]/-Y$O=3O3WLM"Y+0ZOF1"#[B2;C.?W
M(RD,EUDPL5NVARTS#0GTQNRTMR=.<P1Y/W^XY.ZUKZI 2ZT=[<+>#LO?AFLO
M?4Z'![N)O9WOE[PS+-N;>S+3H.9;Z75>*YO_.3HZ/GK]>B$IWPXUW@L%?B!;
MX(-U5?!Z/]!/T_#+A&@F>K=W]EN(=9D;M\V; M=9?JOTN1I$R/Y,H;X8=N%O
MT5"M*?#J7=O:OR,27'$6B?PM7N5[XX?W7R'X!R^[]!M?T^F5=+J[<S\<\F'O
M^G))-(YOB4371'AK/')UZ/,5NG:42<$;<1(4JN4?)XPX^<W*YA.AS_^?E[W_
M_8/DE/=CG=\+I1X!VS#C2!UKHU44=SFB?N%6/A$Z[G5Z.[(SLX0\IX:EYK:;
M==K57+B/L.'CM9VJ)K6)."("4L>2;0RR>ZM#>(_(L?KD?*H[G?ORJ4H=X2WX
M ;7GL_N8/)]7NY#O@/%J3^?!]W,=H?>UC[?M)Z5=?XC:[;UL]WN-<?"6$=LV
MSHOG=Z*Z/A1JV]IM[>[<EB%U!:^[=P7UOHF-L]^1ZKE1_!!^"\TMCQL^%)KD
MS-<UZ[OU?7XG.;^\Y%^ \KM2G*_3WN_>EG&^@,K8SELM&CL=!$E8(S)_ Z"=
MXLFT.=8:^7,R&1ODSY6BQ;U.N[=F>+>^S;8PP?@SZ._58WR]]D'O03&^;S$"
M'R<A H"<(:)Y1Z[HRG9=@^2KMO 1DN[!WII-WC%UG@[(1%DM<=QK[>QM/20.
MN0)DUB@:7#U/3+?5V>L^+.ZV>H+Y(ZIJ)>\B4[[.8KN^7W!%Q/!M.PV7SB"?
MIC?Q@RT:MUD8(-0?IFMW8H.Q=@X>%F-]DKSS$,7T9^+@/E$#U-9/6U<9-RLE
MWO=[[>T'976O# T"PF*5*.U@JWW7CNTUOS.TUC!C5HKPMCOMK0?%XE;/?M%T
MN'8LWM3CLWW'YLQ#X9BU/-)Y6W][U+F2CL6M@[7=_+#(<,F.QZ=G/V]OW59L
M^N$6VMR3\):^39(B%F3GJO _9&A$O5),LI$@?E<D]S"LY0K)!*@TM\T)W_5Y
MN1O?_7!^MEJ2^+OMW?:MN; ?/E^[6S*;EW>SBC37:1_<EB/ZEOC:'2N =T60
M<T%METF<3T\+_ [ P+>5E?U8&.8=&2@?!)19]$" [J\4FUSK?W>N_ZV8&T;#
MH*\X,WLPPG;%J(\1]A\7>WNB:N!<NV3M_6MX_[B]P_+!'ZX$@MY9 T$S$'1O
M#01]S<;"UWG)//");Y[J'<-$WRN8B<:'5J%_;!HTG>BF3&LTDS6:28TW/PPT
MDX7D?OU3;T*;^#5DCC7$R==#G/@;WW4ZG></$A'Z23J6JO*&7[(TSXEY2P^K
ME;*_ONMU6_L'!ZV]WNU:8:M%6A:GE!=]A+X]/ZX46=V3V_)A\;&[LMP%0,>2
MVDH1VD:WM;.SU=KJ[3Q?!?YU5R3E0M:O'DUMM0ZZW5:WNWN[-+7F8-8K'A42
MX/OE?X/QY,7A*M)<I]/:9OU_S<666%0/)R2:"/.Z7Z,)XZA80>KJ$G'M]=;L
M[&[H[GTQ4AFO^$TRS(*\R,I!469*+('5HKP>\[6]-5];XJ;^$12:OMX&27"F
MQL3D5I"I[78.6MV#6U;\UUS-^LN"**;Q\S7A[6VU]GNW+$U7C+C(X)S0/DRE
M"BGXM%H$U>ONM7:V;UGY7W,R6UN43H.XB%:LE(A-S)W.UIIO+1/W($E*'45Z
MF2:A_R%3XZ@<K[.F7,+;(;);>>9VYU'-JEG>MYJ=3Y D]UK=_5ZKM[\:#K=[
M"7N^Y40;?^/XY9N/KPY_RLO)SQM=;#?]L5I)SMWMUAYI>-NWAJNQYH&U_3X>
M#M6@B"Z4L288#G"U2&ZWO7UKP.:KR-LJN4KT="W+X9YSW1X*)6Z0F-W>)7&[
M\M'4.Z+4/]+LW.:#!)/HVTHFGQY!;CY(KO@TT84:B7!!/O)?Q^GEFA[=%,QN
MK[6]UVWU=O:O*"RZFW* [L(J$_UAE(2*7Q\E2Y>NN3<.IGZ2TEF68S\LE5^D
M/O-SVOWVU<4%;C%!L]C@QONFT\2['9027&,3:2>65S_@7(4;S[B'XWOVP\_?
M,D9WJ[VS[.R#NN3_FLE=K^[IZ^EO)+;"M?Y7J&QLFG2)<:O[=/F9&JHL!]FJ
M($-29NY+T9D?H19.Y47++Z ^^J&:9&H0!5Q#$23A]=\>C%,BF\_\9)L6I,Q4
MWJ7)YB^'AQ_\UU$2).CQC?;S]';:@('RWZH@+VD*9JY]18R8=B+S S^,\D&9
MYS3B]>>1#KFTJ<P5_DS,RX?VY6/]PO8,5YM7+;E4KG;;14UW4YIU'3[<62X?
MOG81G%8L/;@6_6.:V9@L[$=5^'8/NWN7I'2-Q7&(9-E<=)C&Q%?@=1;AG(_2
MRYQI@8MPT[( ;?R6OJ7_1 7XQ$!("5R0!'^.-CAXW'P\ (4I2V$;ZA-(C'\1
MIV P_" QTS@8,YVBR_QWV]NFG^+S%LK]!R/BRACNNVYK9[=GOFS['T=13E-A
MLLV)%<JOFG/C26!<8&5TJU:-\B F$] >?$^_2Z#MJF0P;=\#47?;O?LZ^X=1
M^[GS &L_[\"4N;;=<NN*U&SAC]T4.@9\^K=G6\\:&W3/GK*OW#W!-UAR*2@7
M@;9NN1#T(;<B-S=Y^R;%SK=.UO6BY^;1+-C*Y14L=[]A-_CG2]Z+-R(>[WX?
M]A_6/IQ:=>6:6W%G)>X/C6+8P;-$EO;P?/V+HA(/AXEIF\VB:G_(U"1+PW+
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M\2[%LK>VW*=^,(_A*VSB3S_0CLSNS82>WV0HK4V!%OS1#^++8)K?>%OD6[T
M<X;U][KSP\3YM+Y^8_E=?D?^?R&]SB'-Z^E%LW3XS5-]=K=W^*N7?FW<O@J0
M]_$B]ZTA^6X@K&J0?(#=*Y.H\%/;&P;(=A8 CT]^DJE-!Q<$]6_#*,N+'^*
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MP[Y^C-[_E)?]GQ'MI?_P'$X'[D?R_9;\0[P2_KO^["]V//F7<!L]598'4Y=
M8=[+ JI%:0Y7IV1#2-JX)RKI3XF:9\_A1)VI1*M3GCPK9FW]6+A'WYK9/=KU
M@=D94IJGN(Q18_A%S:7266;Y2(-2A7<0>RH'?&.]N52O[PU)8,QGSLT3MLQZ
M#'O(H+,4VH50W</7ZEU?&$';/XQ+2/.QGX_2(F=BCC*B;;[KQ"'B6!65$XQ&
M8MZH%93$5[$:%"#[(!OX= &2@.:/XCI,@=Y?TG;Y_2"G]07P2\J5'L;E)_95
MTF72+[WJEM.KA"4K=Q5#E=%$H[0?T>QE-4^7(!_8A;LOST66X@JQZ\)X><%J
MM209T?6)U=J#\:@I_66  TZO5ZS=$N>V-=#8*1]'0S96@@EQC4]<!AY/_:U]
M7>*K3;8$3+1NHK*Z1.RYU]K;W?;8.9U#2?+#8"H\?#9$4]!J0)QX83_0#N.M
M Y(023$23[H:C(*$_2D/-EBG3[$"2WB0T],3NP*!8V^-P,$('-MK!([Y"!S+
MH?#:VQ:^B]2T"6E/C#4P1+#TL"PX3BKA6F(-[(%788LLB9+CN\C"P9<PN:)/
MAHD02QJXJ.TL[K)@/-DL)QBFV^E\7T<N\ <!JO6)3<($"GS.[N2@VX[L@!Z9
M;9<\+VF)7B+&7C(0](2$K/6 ]#UM!;],@RPD\Y[T7N:K%TIT/+'IM2_HC";%
M8_;+\ RJ,Y-1_6=:_9WAI-Z UM]7M+MXH6'?%T'<<C5'"?X-5#1A_3M@CY,V
M[,]@P"?0Q,'653:.M&YI1LIM8,XY&MDWGH%=?MX2C3=4!89!,'NDV&.& 2X1
MX;S6FOQJ34LEN;LE\*L ;1Z<J+AOS=04G)!^0K\[4^LTG:>DG,(O4)@3GAA3
MF QNP9<1OY?C4@*7B,15,(R0?T*_EL09<1-F*H_"4K6(4<3$>.A;]4EB=C"_
MQ4N7Q\%9VW^=EIGC4>4TE9B?L//)A>+\(7'^F+V -C[P\?1U;N-NQIBW+ P.
M6E81BH@8ZA0B!=9[H&,H]@7@K_P)-&QO(=-C'IF6<6A'J6OBW>VVD4(T$Q&%
MK&IC1/TN$3KVS<Z21L$%$BY4XH6T>6>)N"*BA*[E)!6'YR7^':J)8CI *D>0
M_\CB:DR7%(G$S9V#\E=M(!YX(9(CX7^([-'1$GE6+PW2IN6)IU-G7Y'^Q' U
MJH(9TL[EJ0GT0"B/JV(T6C=>/1;*R,HD'0XE_0D2F(_4N'H:4^9M\G"Z<JH8
MAH&.0K9N$J3WA/3>C:BMVBU.-!4'55QF$NX">2*QY[FSV>9EAI!I[6K<#Y)S
MGFU-\O6-M1:8/!2D;-'W*AAK@JL_(#EH1,]RHE..3Y62%L/3"?F2:-*3(U[[
M=1ZGJ^+FTO,TB(MY_9Z?Y/8\L+._%6$YR(CCD5"!#IWC<*W01$(KR4*DH9HH
M,O'!D1)'#KB?N@B8HW/V0(81G/P_8J?PI>?C%+YE(^=.WE=2CM$TP(@*9EOU
M0(_-*Q3QS?[RJ21",IM58[P:'!N3IB6<\:P@"[0-D<P9AE/]S!BA"B/)1> Q
M''[/:&IVSJ=OCYP<3I)=]$%^8R'-[Z@):!.PG%Q7++=WMWPCD0=E/QJ 62L!
MQ</P(I-Y=L*799*NZ)V1L9XK4UTQNCDC1OU;D**>*T778N1Q\LF;BY%FDYFU
M''G,Q/TZ)3Y.G(?!.HD)7G!JF<7K=-5+B0<$X460#"Q78/8HI0W$#=R,L,LT
M.V>55Z<NL2.)F.<X KL-%;,2)$<2'RFB030!.P?G[2N;;Q*GEUR6AXR7O!Q/
MC/2:Z+_!I71F=9.AA1')CAQ1V#=))&R]I<U#FY  A=YFLPG/) [L_T_7#\NL
M\M091U3F2#BI-B NN E^S!.IQ&%0<*4(9WD2/XX&* 2X9*O(_@;;0R;&,9ND
MGDQ,SZ0FH_))%DRMN(:)*X%P/K0T+28T47L2]&2K2J,786["RL:9ADP9F%J0
M.I(\PP0@,ZCF9Q+X/UIIG2:R5B-U:,EV_?DHJLI$S-:;65D]Y3/2\3C;1703
MU.?UE9<H[ %>41(EQ#/N/WTF;,2P:U&%:W'S:-?WGKB'-RR1G5KE3L,%CR@*
M75%B,98?P)H>D08XU,FLC:AC:Z_3\<_H.PR!6"+G3K)R9L<F,M151S:Q#91.
M7">?F\3J<"907)K0B]2GB1IH[F22);JMSMR7TXU!@<\YC3RA%] 0=@6\.-$2
M)V4V&)%Y[PTSE9MZ+]; #>/@XBXRX1E)&5_(QZ1HPPE FN/Z"CS:]?$5L"XA
MCF'0_X/B0B4*OG72?#Q]W9)Z*% R:_1D;@B];#!=B)N3OARG45ZPMZ?A6A3Z
M=](0_2%;C6>>(TLB8O-T!YB)6[FB_9FH.-.2F=X>77"]'2N H8XGU06K%L5*
MRB%9IM#?DIE)"@")BW18*(:;Y1MEIJ:D3H*SH_#D(,CZ=(,A7UAJ<':D,4UL
MN5R4I-D9D@!$<$0%[#CCY-3OKL_/N(L]*<U#O(WU&/%4;CCYLUQA2)N:5 GM
M="(\!2/E=)4&"SJRK)+&NZ"J5 _7W-C>R7O7W!J6&8?!K R6);B#5M[#FCN<
MQN&,]5J!GS[7VB^KJ69*XH)I@O@XVY?V]"IQ+0?H$J5>!U24-0-ZG";-5W@.
M4Q)7+%8_0"%?)X$]:N*&ZU ;)WR:1M/8>#\.1H'_@2T6?=*O2*1DT< ( H3Z
M.765OV1NE)"IR-ZY(,EU%@6;4K9V&)S#2 G'$O2XK"6H.<K\[OXFK4G-CB;Y
ML<R6JIB@F;AH93PQ\T*R"ON;N99V3G*#SF; 3SQ91*AHST)AM?-VA><<Q'EJ
M_'*<Q2M3X4''\/;1Z\S;JG(=FK-8?0&72$?LC;/3]_0;]-Y$-3#.2GP$)/<
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M K@YI:*R4@A[>%P[;A_O.*@:]:,-@*I1/YT[6'T' +49G&J=G=1:)Z<65@O
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M[_A#]Q-!J,:HF2=8L)0:<V]488LN[4V*<M,9-29_"J+0/%(=)"1]4JDE]ET
M$\(S8H0IT<4#$.)!&,=47:=/K@E$.J(&<9I1E-'C.DU-&X_ 2(VN<[I808!D
M:C (-<\CUOM#6PD L?I].%1H.12$:&CA]7)ROXE[=-"-344G,,9YAMQ%=]!
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M9@ O7.X@MVPA#7#V=-_#4#O:FR$:=#R$ XPQ&H,FC<_/7NI[?QO6COH^'0T
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MQQ32<(BA1)E[!;OKTENO11KG29>H"];^!,#(D]+G2EJF>2<5?^?X^)RWJC<
MP^R0>_%3$(%R&.*"P)\$2&1\#WQ]+Z*)+^O*LBC$?@FROJ%@3N$V63](_ .X
MKFSDQ@\(+MP\:Z?PQWLQ )5 ,;RO(:BR-;KWAW[0A15$FCW$R3?W05Y[*/ I
M/T_PPO3Z[M\YO("UC'&6;GG*,S@T\!0N+)DVU.&'M8)I>JY:$9F"'R0@ ./$
M(=3N@44&J!A$0+4@X83:26U,0^CE(2P(%(88+75CM]"-.[$'B#T@J<D4[_GW
M01HG  ;\"S8 7(M%,&P7N$<^<'QQ#Z;=$(6I8F/!O6086N J:T!K)Z#U /G
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M>63T+&"[#]3#O-2!8=I;-(3&O#F*%9FY:/!*.4;+4;[Q"1MM3@B '?YI:>(
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M  L9JGN?ACFIT?3*_O%R;+0<#X-(E;9PVWBV&+M=J=924 -3MX"0S%(K+W1
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M/:QYZ0IC_DG1U",M^\,\4&93W "<*^0*C0?R<JA=R@"O"@&/#;>AXED=J@T
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M.M2'*N9=CJ=9V]^#SC&71U0K$16Q6B#]E_0@LR9Y:M-57#P%F !8'-Y5KQ/
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MF"%4/?,KP@$2 V@$!O#68\DU#W9\S.[#4?-VOIX"U 1R++<_C]IW$]K7((E
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MO?:S@V(N"1SIB)$X3ZF*BPF,(-F=L<>\\57Z3;T"1PHHBAW0$KW!J<"U)Y[
MJYV:XLKV@MT#$F&U@HZJ1O*Q/F$WM':4U]A]#W<^/![&-;J?1_]C(]$?=T(M
MTIJY^EAQ9:DXVH,/AP5#0;3_+%+M@T:^[9OSHJT3'HAU#(.Y1@RSED28V^IY
MDZ9/&_6^/W-#GCV]Z\RX998T?=Z?Z;^<'BA0W$SG(.RX5Y\Y#<.V%D\L"#WA
MT__,_ 7-3X#V+W'<<NI9,(QQ:MDK"M8IP]Q'9]H=SG"T!P?8P/N&'26Q-\54
M5/ A&&Y42E2 ZAQ:]TT<>_6/;:[,B9N)+T1E4;BW@:9PF!%N:M%')ZE^]9R!
MK4N#N8(#4S+ER("+#8@'(CJQ?S7!#T"$!>]] &>3\)V-QK'<H>.*'>51P<Y?
M]/+BI.*Q. F+DW+'XJ1#9/R8+0L'B)>:[9:;X>/7%R856?88H(%Q@ H:FI@3
M1I\O\X]P!QE94%0,7CS+H<47Y2_^?;9+K.<F!UN$PAFF(1!(D(URV-<='*1U
MV%03'J#J8I)G\&^HGX6_RMN_N115"T#&L@Z8-4A$A?IYBOV]O#_=QJ7OS9FZ
MP.Y\-R?E&:N0>+-G&@4))9M4QY]G:KQ%':O-=$$A&#5*"B$K*FSMP*LHCH;'
M%A9=IP:@S0=+SA$'5CN->F!>8W+6'I4^"P?@X:>>IF I2=^269S79D$9!ITG
M*O=5(5=*)06J:\YD ^Q@2S9@!+IPY9E0@?Y.#1D/% YG=/K=4CK/ONOTIS#'
MX8)(?01_A@^S6)*,> NS4Y<2U%WRQGX=HAB#8 'PCLZ  AE<UN< 7"3O"&O-
MB5=S^;&?R9R1!+I%SNQ%[[@3P1II3-)8L)HG8< ]@7PT&E0FBI?S?4OEPZ_)
M."AAHQ-W0T=9V\*BSR&8S4IV/?&VF;%TOHC;]'RXJ6">GWV<8@9WGHXGILF2
M(/[@JC.VE"4[[5";'7)WU_'_#*Q=@-EK6 AALQ),V^L#9$F?IT1$5C7I#KMC
M@^B<X3-2@A*91VM)CZ[-G)YX;P\=XQZ_KY.8CYAGDWIE''7ORWIZG'Y7'\GN
M(*HCG\=N&UYH;\C3MHTH^&S$)ZHI*Y($F1;7WL=/_/M,QLUD4#P"/=6RZEQ%
M3E8 '22\BC%<)@XUR.;!G6=\V=^];G$"R5KHG$LQ-^TVR3F >?%WJI8+Q;)+
M. XG'FM&/S3&HWW32)Y+Q4GC>M-3=EVS.= UJS_P\ZR'V[_X]O4AFB@/F:DS
M&00I".+L=#9^_ +*V?EISMY2HV\3JR*H(1.:][T#XGUM]T$","1#38?J%F$J
M/<QJGSQIU? +H!<#?3\88^Y['%=LVF@\ J\>!6NG@K4")C%U*22GWP@KXX&3
ML5I)P8)Z\)SLCB2GC)MG1AVIP.(AF*W)+:?P[P\EQW[Q#[C^H!S$=(, H=\.
ML_,\GF307H_"O&_"G)TOS,4/),PUF^'#LW/0Q>@/.OCN0U?43*H&3!9L@$O2
M]8"H5*N&B'T@*Z"M.S6H+%R(ER05M77C$*O@H0<$+([RNP?R^V%<MXCBR9C:
M9 %"C.QUNQ:].IW6"&\QR9QPQ,=C:?B_O8J8_&W\+?B>ALH>M2%$@[\(UH@J
MKJYHD$]?SXBB02&7\'_%X>@?H:59W0'AVQ.NKFX/*RZT3^MSL5(01B%5]<,H
M7&G,W@N&3WB[3X\RTKMUVRU$1CKP81L4 [ -["4 %ZA4!R8351A5*$K:;%,U
MI_*^$GMVJ/,T^;-^\D.)4C#IGPLWSP\_:K]3%Y)S#U&]-E)$NBY*$_*/ -CF
MK+OKBS"0)6J_QW-(I8!#@H72 ZI=-1NM5LT6T^9#]:+&Y'/[)Q6X_;B'97#Q
MGCK%4_\IUF5]V)""SS']DGX[N_BA/"N%X'.,Y\S* 6?&EO7I:S9W<()D8Y(8
M1']EF>[ @!5/\QDRAI#HK2\JK'X+:'98>$*+*SA+QPI.K.#,'V8%9^0YIN&_
M%A^7=[XN0.CJS%G?.J_SP;FY8/)5+X[ *8<=N@?8(<,#HN^A]YVED!.;YEX&
MF!V^.T4_'#X>($Y([IF!]EYQ!I[Q(9_:Y &.X/_ULH1OC;$1<.Y,@0C/^Y/W
M)-J9<LTRJ(^%\4ILC^; Y$DHPR) %)QB2D])_"NV-428Y6M?SME4IIU.I]LC
M-:MFVY/WQ\?1PTAZ>GT ,\H:TA>-\8-?7& TX418P&L1H@"<>Z#B4!P9E$WL
M?TWQBG>0]+1M%WJ@]]M -N<8@].#FJ?>$:2I@QX3/'8^A#&Z8&;T^DMQGFB?
M?*Y<]-A=N7Q=NRA7SW^GN_/LYW5>^N]\HDOJ?!N-722U\=Y_;-[^+!D3.492
M1V:UD#/:Y\K2XN'M;/6AQJ/3A\)%]M]/KN4?]*2*#RPMZ(F[V)%K/+$II+ZK
M<N%N,Y\6&J6>BW1F</RGK^@SK[B$G:XVM_)JG<-TI(EZC,0R3OJB.*(^)18N
M5SH&9@/;\FE[TGK1WU^[6FLL#3ZMS@+_4ZW6JO7Z+!.@'?-&V'A9@(*GO'A_
M7VO=A^/J3"!7<\K,%X^-/3> KK49NE99EX^/O/*Y7,E*V>MR.1V!O',D+("X
M_-T?AKH5#W6KHC&HJ!+\#]3&OXH*. T5L\I']J'WVI93Z49[*%:JD[+8;$]>
MKMY:A<=;Y9><BY.ON8U5A!S,K.EORZ<]Q"'-TB95G$@(:6OX!W'W,&?,0/J/
MA9>N\ZF@003_.^^9F3\"U0P/$-5UD:/)8:2'T_Y+*-)_\H65*D:S-R^45"A^
M@M3A4#3_^TE^-[^HUE#23(ETY:&H?!+X/XS_?CK)TD.C)T670O]EJ3)[]L/]
M&56,^60^[X2=[(7/&]D03*5@#?^!R)\+)'\I#O(G4^E,?-0/D/V41_9O 1!2
MEFIL$A?7<M.R_NO^YFKPD,Y_JQ>6R/IB:\4OQ)Y+=JYD\^4YD\)0RK'>.++U
M$,%B6,33$2R/Q3P9>"+A54 Q%0,/II/I4G8I#P8>9%BZ_0O/*U!G%-,QG%<Y
M7=C$:07HCK-Y5AGHC!95&B97&E1[3)ZS#^U)I5LJ-#K-4[$1JZ$P8Z.%L1>*
M;.J!"7A?O&6<]1HNM+_F:+)Y'+8R!_GHN(*D9^.X;0K)8K:XE'F6[7U/Z18L
M<;E8;NERIK0FV0+$JS0C7C>:V@WP>\3G&^OTV]F/BUII@W[/' FB:SKIAG"(
MUF> Y1_<(C=&6<R2@,$9G]3.SMJQNYCF-&N#JX?S;X6Z68Q3<\XQM>RE[%2D
M_?1801>68Y#I0]6#(8@6J A+<9B*V7S\6C#CD9 K3>VWB#YL(*  IC.IQW9'
MNH2Z:QV%&#?$G)*;PN_TI/BNO9A2-C[=&#H8X2X4\0Y8E[Z+1[Q33@E#S/!"
M5\K$P3^'*7.1*1DLB7&8<LM#-BL+8M4CB&PJ%;F"'OP[(%&S]V 0U#E3\G>K
M]3N_1MK%Z5TOSGLKM 3BZDZTWHEED'VP[Q=0;@5AR\?AUZ?7M5D/A(3!4E:(
M@X2E=/QR5O%%Y& NB3F^541J\ZL2!":QC.=<UXQI$['_W!!_7YP]//U:%IG;
MQ%5WQ: Y)*%CR0I\P$@**MFT3[ L'+.(?"O(6QRQW%*V?)CR%H&*P2(7AUU>
M6MLP#Q"YK"\!-I)-^N4)D:J:81K7,HX2:_ I<49#?5 !-)5(G"[4CIL2Q-_5
MB[>+V_3H9OB\G3LO3/2<[P,:S_BJ/VP4-LH1AE<&Y3B"M.E"DM[BQZCZ=L\S
M4"V5X_!<-G>> >HJ/Q,8= /N/,ZN77X_KY0[E6X4JSM\1'"Y2D*\@87!=[]1
M/H]2#+=@9?;%K\UGX)D,\FH/62$RO8)^B2,DG<LF2^GE]L:<TXJJ83[D(04K
MC3@\L$PJF2JF-G-(T2L-0]D?2-0Y8KVW\?>]6LP2,]2#5.K+];QWLX-^[E5_
MN8\QGADVUW/5J)PVKAJM1FUQ:>'Q>*,7,;Z?DS?E]>:IHT4YX-")'CS/,(6,
MQ[,,.LNB]RSY^(M;<0S1WJFZJ:OJI)\:TW,M7)L7OQLWJ59W!]$9>XWT[V,V
MJ8[!+>B F^P!'XY&_9D;>O7[-Y"&H8VF="J.H'DZ62ROF\'::](%F3+I5!SV
M9CI9RJV;O0D0L[)'S)I0Z>>Y%N?(F29*KW>G/V^MVYWD&S@NB5>FDG[L[4W'
M\KS-S2<&Z9[([R>LN^:+0*F:D=\[ND*/O?#IZTD(-*>]"4/..?\5&#V6@NAD
MMK"!+/>I-P*IJ<BQ5)C/2,><P^=//^M-_>WJY[>'9<T.:W"S9RF4/IV-1_/#
M\F[YP'@W^$C#LVXZCNJ,8K)06.YMKE7"U!P17030,DS.V<(ZGL/";T_?'@M*
MZC[5C-*OLZ$XN;,%^EVZ!T>1CS]L>'7QH86WP=)Q!%++RY/2QZ!XQ%,+5BUQ
M6,[E;96<SPF13->=<PU#5<WD5ZW6GHQ^3WH7XQLS=QIC:CRNJO.UW:^XRIC"
MV5;!LA]+14JR5#[4$K U[-)T+*4HZ62YL(&JKWK8(O1:[_7Z9Z;\5KW<>-CJ
M6'*^SHGF%_C4[MDZMAI3H+U\YRF5&:1&+6D'T:O=.]4K>:8N%<,KT$P<506%
M9"F_O%UT+Q7HBC0,5*296#+YR4)^ U5]U$OJ6@:5CY.3FJBKFF4Z)EO%K%,^
M]C76<ZE[UBVS9LB&-BGO))C%5^KZ0/L@=:JL=7I?%A!Q!:&+(_293Y9*Z[K5
M!T'"8)F+P_"#8H4-E/6EED<FYEYXSZ,G?51IJO>/+]NX\(Z1B15\W$CW:QS!
MW^RQ#WZ3!Q>L8.*HO4ZGEKM&\00H"L$!"C<R@>J%JIG*?6V2>93:D_.W].M-
M7^V)HKA//?%[&)4(+^W96( O<M04/- >F654"Q2U;"R5S<5D/KL\'+A6(**J
M#8>RTVA7U7!."E&[3BG^1+]Y33\;?;T99TM\2/GQK,Z>G^2N+TZN6(#-N&)"
M+9O=NX1:3-$.;_OP'9$(&4*1!%Q$,*9+4Q1Z,G8A.1L&;N,]58905N&8A8Z^
M?GNXUL_J9Q>-Z^WZ9,A;[A;@T#U[$&2^B9VJG2@47D&KQQ$H+64/5*7'1MM@
MW1^'?9RFJG\#,6AO%="]J75?!M2<(;K!=NR+0C>4T9E2S9J&L=GRV)#B>G]1
MN:M=-*_.:G?W?-J!4/O^T&C]W$/MN5>+6>+.PQVKJ<@,OL 95=+GH[OVY/7V
MO7#U6NK==K=46C!3. /KHU^C"TP*TV-'*L$[N17UIHYHYA)NZI;H]P#*WI8;
M[9$LM26M;5$YN\5?&GQ,"2(WER_+K[]?U=1U@XJQ*9NP5O\21B*/V0E_RJJ-
M_2Y0-XWAOO\U.V H%]LB.9+WL'Q';L>6>5WJ15_DDC*;I<L,KQ%S_L@66$^@
M%=^HKVP0U:L2&S=UOR;DF]_4<@,OQUQQ_>6J6H#RGOF%=^2,>V2S7)X-9B#V
MLHIE#C0=6OH>5$6F]C*AK/-^A?R2=6;O</;^-A@]:.(P?2IEYG".Z#SNRY<?
M9S^^?'&>.LO8I:CKFID)I"@7@Y?+YL/I]3RQ6[ZNY<9YKAS^L_GTIZ^6_8KI
MZ4"^@T.),CP+_(>I7^$_'?WO&9J=+:)9TS)AL"7H05L+6+/B;W0NS/OO+_GG
M7_(<8FGN<U80G9DUA)>9?-C:%[_(V.*2+R5SY70R'5C]PJ@,_M\T+<MKT)(+
MQ../4:54' U?6\H.:!FH+O-A$P'!M,R6DJE")EG(!>4!?!SKV5E2H+\8$?JQ
M5Z*,=VJ=3QLD*RCN.+*6F50IF5\[;[G/M N^HV-I^RADDZ7,!KH7BK[8 QM'
M#DDW $>I=+O6T,*1IF>D)W=E<]J$+?T:E.E[+XI9LIN&(7M]E(RXP WSR)_+
MW-]E!%Q![T=S=F$\.OW=;,2SG,Q&RE_^=9 D#5;_T=(T\TA:2"?+(9#/YY)T
M28N%9Z=8> (#"74R(*I!;Y*&VM6&Y$HS +>MV6N)[].B:93>GW\9BI:ZRN]/
MX;I78A$5'><K.[L2%+JA TXX+N'E%4\TO*XH1$LES6'L<GKY'1TR$?G7\3 7
M'6:@EBI$RW!M[3"7))1G@Y].7IFK)F^BXK)8>\H,7U^>SJ/ 4,4) A.HMCRY
M9K3L^;[L,"D#2SU@'E_,XK-'N8)*B@7LO93,AC!ZC_4L*YQ6L,Z)I[^:/FI+
M)2RE.3 DJK1 _[AJYSWW[>7IN?+CZ25*KTT\]2Q!4#FR*A$8_'F2+G[.!(!2
M\5\'U+] F&%9VC6)H9[HBNQPH9.6L<@*>BV._.X1^6H+QQ>LZ&+IK]\X)M;?
M.(=XE:'<06-/W2>O--\[^%&M 0$P%FKEBBHD[ZF2,2$VKP-."ZJ8/D)WBKH)
M(T:I26P0.!9WU'$/,9%EL*7L:<A&+$OS[G+Q:/OR<;0]CK8O'$?;?_#1]MG@
MT?;.''*< \Q+H.D'T#+PN;")*XS%.,/>/0?BFROOY9!98V>*P&A<!\@;GL>,
M"8SFE"%/"+<2??/,;?KAU'OV7R_/^-88#X5W._0>#H@>5X+]1$]3_"NV%?EX
M$:\>''G/+S <>0\_4W;JVC_;IG@V56^GT]GV2,VJV?:D]O/GT.J2GS]>8'B:
M-:0O&N,'O[BL)YP($7E2N$(P[Y6WR[FL"X0=&92=[']-\907C')Z#OAJ08G@
MP>'Q3TN?_[!]&-Q>:0=5)%35_L^J7)7T,W=,U%Y/HC^$)[I$S[2#RE/NA]:P
M\FTR?LU+,1(],OO])SKV:^0I\X%T<V95NX& H"?5-1U,6F%,1%T@U$N7A$M+
M)4(VE0QZ_"ZVMW) *[:Q]/E5E[#3U>967NV204-.(QD?J>H'PTV=6FJQ=?HT
M>8@"<Z[W.W]F4KED)EM*9O+YO^(L_'5[->UIQ7M88[M7BUF2L;T2*4?B5"U,
M"W%V@/!C>R@V:Y.+3*X]Z4N7E^EQV7J-4C'Q%*P<%@^A]T46TZD%8/>UX4C1
MQH0(.ML!%3KC (;2!]/='Q2JZ]J0!86*)ZFTJ<V+[Q7CP6<HY_X= ^E7('V6
MD7Y>9"Z6Z<#99#ZU/*ZZSBSZG'_R58_Z<?05HE(GK*_/(^F#<K-\51Q<J-7.
M1C3_.I+N7;K0(SONGYTF9$31C67> 27X@8Y5#47%95(81WJ#2F$(%(*51<];
MWTT5#942C!,$7[.%JZO1J)_57Z4H8%!S[MFU[E9WQ<S>DF33TG<L>+-DC"AZ
M<0 @Y)+IM8?S[C<=EPE?',/G,LG\VOA:2P9#8+W3.<$!5\'2]_QR=?<F5WY4
M&E&0::)<??/+"D)))VY)T.9Z1!^N6B3@#*.)?BD.0(9LLI!;SK3'.I]53FZ)
MLHEE&#95V86-U&<M04F8";E@C4][:'(%-#0:5_5J<W)ZK[<G;Z9L56K%\64]
MBAT>T118.E)NOJ[9#;;A-$4C:H-8"LFH_WRHH#;AZ+A,-F-!*LXFB_D-(-;5
M793(ZD!4^Z2A.IA\S1X'[&,M<PZH%NM_]TEE_3JGII_KS4XKLW?>,=L79&==
M'$G(31*.-<F[_&; [78 D+C:$404ZGB&DJ1"7!4[DNDYM?ZQD7B9O,?:F%1(
M%D- R:U2WU]>*/(<^7B1L.<5L6%8V8MJM;\?WO@\"7^;17'>+^$.)'8TL2['
M 4"72Z;V%P]_5;$.3]PE AUQ_O:\3L-DJ1@E,#)?H%,+!=HS">@&BCP#!-J\
MKQMD5+_O:%'26+NYO;N>05%8O+I?DAU(]8B2'4<N)7>0@-%K$7:95,?AW&22
M^1"ACI6M<B]<DX.VQER0&TUUG$V_%/_(O\FE\]O'<CU*F&X#U[*]<MLGWJDK
MMX",$<4REMZ1 W6,5Z7F,EF,PR?))7/E#4R;\\;*ZYI.Z#?9P)WNN$7M"X.]
MYUR45:AG/<5:>NS@OVE+<GLH>B14>= JE>M6[6<_"D;<9N]9OC4H4V8W;I_N
M:#<6G<UD*U [H@C'D:)9PY8[5,(NEN9,*@Y7)!L%6LAK(P,UW?_,AW:V51GK
M\G<B?D'R*Z>&HJA>_\@U]\3Q=6Y8&1>_6ZZ:0\A(HDE_'<>0P#4")YN[6,,!
MZV52D1&R7?9?4.8*>2=V4D&<GFM>#GN78NLQ%873-WM3L>PN7$^;]OF6,+R'
MAA&9/);,0&8-U*)])=VR&R:6 8:!R'_1PS"5:?&: R)3>15E!=JRZ#5\3Y=V
M3[J6SMJAI6?+0!S_A6;DZ&K\NR9WSU/#C5Y#:Q9AP%8%*(_"IF[!<';YL7/Y
M<1QZ1&T2+R#:L8!C#PY]F1Z,YL#,.?+EGDP\M1]IG_5M$PMVS :K6/05;N,H
M(Q#['"43,6KOIB[28Y1541\W3#(T@L<3M.46U9O5QDVS-;E]_=D>FAX=6BX\
M:"^IT>C7P[82UO.5).N_YS:\8,(>=VW);^Q0HJFV=+P9F&*R7#I HVG;Q[)$
M^:2CN6CS#B633$6JU9]OD.5G] RE"8]8GA*5]&2S+:7:0\/5$9/NZ;E(OE_7
MKUO%/;:M&HZJH,H#-_)A[]<Y!Q=1CTSE?"9$UR31&*S,K2='ZV@5G17N^);I
MFVC>\CQ]DUT=LFME*,VI(0;3-J*+]@O5KAY+16S6KANG$_6]V9Y<U;N#VLUS
MNOX2!50S-DN%KA4!??F N7DXO[NY&1?0-J*BB!FO^S -CE7)NDR XW50T\E2
M.4KZ=+ZXUL.):\4T=;EC(;1.2YOC? P-CPR_7;\\W2E:^C8_V&.KPA5QSP8%
M4PL!1OEQ+[ U^2":^LG$"@&>+RZWJX\0X)LXZ"4*,1.K6YN+KWEGOHKT3AAI
M=F6&V'E-S($F-=17,A73NA79H'O6S..HP\=+2;ZQ&C=B=_<@*E-XGLMM'Y7^
M,&O_S.A,P!>J,GS-98>PSU"NR_(X(5D@HAJ,5ODXWPK+I5:/<<X%>EVJ"_^M
MY[I,ZT4KO)QO!N9"-)JO>JK1(;]"6&MX!G-TS=[")>W58J(?SR8QN#":/V)S
M<' R'G04)>DB#+F+=X<D*Q:.28Q"T!G!GUM<XD[^\TZPM8<NV9,^3V%9;-[?
MS(S7*9#'[U;W!ZFULJ/[@C/];]%F9Q>27["0,T:5D$LQQ*IT-;!>,DN7PJF]
M5-D%$B;BC16V, %G$@:JM)"C7.<0,>*RPWKF(9:=^IP-FDZY<*CKQB(A462F
M'$EF9C ZRV>U2L4PS%;C.:+,G$:4F9FE7+S+5%E=-!_[.Y"9)=9 -JRKNU6)
M6;;HL*FO</(25&L1C[P<S9BC&>.:,8$G]80?(9(@TK<#Q+I7(?B&WVZE,-95
M?][&"WN1%;;&&VO8(7JS-S,]V*.?%QD1"NED?_Z\4(N/.4<AAJ?#7(5]MGS%
M7.G,CEY>NN;ZKY^CG\\:.:=B&67-CF9?K"57HG0T:R,;U@$,'MP<:?WSZ!YQ
M!RN9>3,[R.63J6(F62H'^:UK*O[M-(=-,7XU-E&=L5U^=EY^U?/OYSU]$*>H
MIF(4U9DU]Q3Q_OM0?TM_D_9;5)>9.2NY!3L0U"7KSZUD6\Y.B,\ELS =*A/4
M1A*CF$:=$O7Q)D*M,/TIFSI.?\+I3\7C]*>/-OW)VR'F'9O$F&1J-E0NQ&RH
M1%4T!D)=T=[X$"BNI8ZSH'8Q"VI/1CVEVNETQA[U]*-6,BZ>+M46M.)'&O7D
MLMC'G>ETT/.;<H'SFR:IA_<?!46Z-N3C_*;XB5X-G-_T_"V?NB_GM98I?JSY
M36'<SWT?TK1N3?9Q$E/(U2YI#;LA)MPIM[KV*M/3/QT_T(NUH3K  A7J>;VR
M;CKOB*8*Z?1S)>.W4HH"$!S/-' _@EGE_D*H7S6?[H7Z7?-::-[6[BJMQLVY
M4*FV&H^-5J-VOX>QZ;U:S))*-,HJ;G,41Z^_J=Z>/DQ.7Y_;DYY1N[PRFV>_
M+J/@V\V9X;9X3-,T)Z0S>5GU5)+UN':CS"QKTC0Q=C 9:$F^ST?A:$'37+S]
M&^%JZA?2:*:"ZQ#IOBP&%@TJ8;VB^S!47U)_[W9(&RWMCM"-=V6%^,C1TJ+<
M#]\FWRO/I'NF2*4X[X?0*L"S,3B8+WNH;?=J,<%CNT*"ECO@KW I,"0-PW,Q
M9$GI]5>E<'696S97*,J!L_-V 4P!NY2-##I(]'&'EM'4?S[68O</"T"^F,I+
ME'T^#M2L^!''2[/R^FC+P@Q.L\SF?\P*ZT65O-SE?US6GY7M*NZ%<KR?&.,+
MR1M1?F,MVSY\I/'52;Q,>&-! XL=73Q >.?#,3-P\4#Q+3^3_/7D-EVOR?$Y
M8:L+[V(4\3T0W27$C2B\L?8S?U0P\:A8XIE\K)W-&P(5]]8U5[I=G<S.V_2(
MZ]4%N>F.*E7SI[B+V]99X+242J1C[H2);(]\FG31!+(0R[B.O;U!8R#A$I$K
MQ#&I<$.0X5Y)LZOCB03=H'2W:#/,RIO:>7N76Q.%3/+;OQYQD2<=6"7VMMK+
MW"F7!%,NHKC%,4.C6%H.&;.7\K8")9=)73Q#,TJE*.C>2Z3.,\K.=\4/AS*&
MVUA97\,P+"+-RE__4OO5>JJ.T]^BR-_<^RY8WGYJ^LNKK-#K#,,_@DP7):K=
MG;J.2VD64?+B@.K-'YKDK4/292(8QZR,=(A&^+6N/6?K;KC;\9,#,G252OEV
M<G$O]@>%^&Z_8-FK^QQ 635DB>AV&&>W8UL7$BVB^,4QXB*=BQ(/W&(G O_[
M C3]8FHM-/WYC'Y&1CHEXARKKM89O6F_QE?/%U$FOJQXJWB7LE,^]BXD&ML6
MXPAD'ZAWM)1Z2RZ(8ARV[@;B#]YVY@=5)_2[$R+9$V>:J@LR,B<!4+XS.Z^Y
MVFVN' 4)<4T7R5TQ*^!8A&R_$[990M*(<AAOS<9A"F04RBZ3T5BK,C9@RV6]
M.%]V1<45H3YD8SBB9@KL/+C8*O.S.!B_G=4:G>PN H> S@:5Z JL51!9#<BF
ML^K+T)06$#"B7,8[8WH/H4ECIN@R>8S#3,YL()1XY@8U<-*$,V815)$!VYV7
M+J\_92M6K98RKK9Q6?H !8,E,V!NT\K5RA$JE+>#(LD<_KE'%$W*2W'$N,/,
MA_KWHG]&.;<ENJ04A^^2#C$9=FTPSW*D:ON@P1,,XM/5/K9%D,L.VY.GB^+S
M#^-%?L]$">Z$=H*WASNSO&9W#5)&5!7Q@BJFDMG< 0XVW0#EEPE[O Y2*IDO
M1;$BYLOXU+ E'>RE,\+^UT.9JCB235'Q54I_%PWEL?M-O-*B6/*1_>WT=,G.
MFZ:_ ")!EZU1D&&.S;%N>G5CLKJ0%VYU0LUHR5,1XC,J497_4JWT0R5UW:SL
MI"J$+]$>*+_[,5D+21A-DY?CJ S)%-88I;0CGRX2.9>HYW+,".OKIB$#A#*U
M4"@KW2Z5(-.X%<?0WE]1)2B>L8@T52[MM[BNSEK:Z5.U4HW2XK()W\_>!OTS
M[@/1<$6VDZ#2Z8_C8,SG[C!'&U&%Q(J;'KLG<CS>=<K$R_%:^LE")K91K_.M
MT%0D3Q,4&\[PK-;NJI,+471\3-1RYZ/W<3_]D"U->OO1Z0W=O1A\MC@$C!-2
ML /1FT\2Q>8A150]\;:;II*%PAK^T(%2>9D&B'<X63I9S*XQG"PVW(W=QW4^
MHL\70O.R7.;\CNF'UL_'DO*M4K?V1,].(VHT;AYK]T=$C759I>!A%6JU\-[[
M2O>W)>L$0^2^$@U?=$ ]S[0GI%?+F.-J[O8]1IR-T $C7*@AVTTC/?D=T%8-
M@VR\JF_);;"4EI&NVFPJCCS#/@9Y0];T95/9&&OZ,@',7]?T,S+2*$\%LONX
M>OH^J)V]#0I19D4OS6LL=*O33LD?+N_C.E8!9Q%17.)HKSVF4E>1S\)\^8PP
M'GN)T(8W;KS)2A!DKX,YZ7UO-,Z?BK>JU8_O#HO1I93M_>R[2QE ^(B"&VNM
MTU[&Q<,*5'GM"^\CI-\_HNV=7:[)Z@Q??:Z;=O>SJ^1?^M_J5U'&JL:NN::=
MM'KCIG)3/3II:S**=\8,Y9 N(9(!FK3!6PA9JYFFWIM:]\7)"GW[<=:>U$\K
MV;PJWE9*F>TF;]-V]I8M5^C1]3H]CZS!G\W"@#7O- >YE*+1KK!T'&VSN7RR
M4(A2JKL')?31Z+HX#II-QV'1%Y+IT@;JYVMSQ-2#.')&.J9?0*NITUOC6SE5
MU%YV$#]I> 024#:2..H:I=/8?&-D2!,H78QJ NT!YT\=?B2>CV8,3_-\.<3(
MY)5YOC2'Y^^( O,";D7=',\R?>_BX>Q:><M\?XWB<*U_*_'5X62;,3*^(.GB
MVVZ;N1:1+]H5E(FCK"@?"1APGQJ!LYETC$%#[U3C.S+BH:IF;X;C_=%#Y/N?
MS6?=TK2W^LLNE'T U^O.!G8;3UA$R(B\'T=';#3>WY?00287(]NGYK#]/%9_
M^G%]VM2>GW^EMUPUZD3)]Y2]UV#I.&!5BLE,)DJ3_(ZK*T)1<(D=E8D%1269
M3\=1.1%\H=PZFT0/R3;/JV"-!TF9F-<O?G9N7XK7409?+"G&").,NG>PC(C?
M9SC '$?(K%30V404Z#@Z4&$>]/);ZE^0HHK[^)9HD]!#[!>W#R_WR=8NQ R1
M,0N(,WLS9J!K?!DS<WAZ6GTI&,]BK+C<,>3,1GQG0F=L3R?=9MXL4MHL@/K1
M%$HV%@@=JE%2!X:]%A.!EXE\'#Y%.IW,I=:%*0H>D.%(.=  _G_MMR6_TF50
MM7='#%.7N]2Q@C]45,G_"\\G;W$\T6QQ>U>Q0.YJ[UWLTKNC3EJMUR.0B0)-
MX=$.V4NI<F^<%<]?HMC^D=U<EH)R6@A1'4#/"?Z#N!L4)$L'I>"?P[03?MWN
M0454*K$4T62C 5S_O3N78P_.9ID^BK7PGIJCL?HUF;@44EN^;T_.AIWJ:>:T
MJ\BQ%B3/URH+O1^F:N8IF*30(7U954'):+TY\]X.R++>H)SXV;Y"K?.YS!Y'
M%B233(7PWB,4JAW/-<2Y9@//-188IF0V%UM+VPH=]6OJM5I[4DDULWKAY?ME
M-T8,^)7\*)L:F<_Y**J.T-^&5G+XCM7% ;\V7R!FYB^N]I =24.@L96+ _XI
MDT_F\ZO'A#@#1%5TQ[-=<H/EXO#.H]U@H8[V6#"Z3XM9<O/<6Z.10B"B*2K
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MLK37)Q*2X_);;#,.&<_"OSV)NB[2&]Z%HY=OLS$9'I/\U=6@5S]_'U=V,!J
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MUV_I2K0^ ?L;'YV8?O3T&GWDPZUCOI6^AH\,ICS1'8C4E'=F![,E.XL(W+K
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M+=3_T9O[5B<CT1/ <?-$V+KOV>NVQ"Q6&W-+)J9!$DL3WL) ?"5"AQ"56D9
M=,=9@O(%QTEEAI5"C52Q"WDKB) X5RL %=+GCA0>+G%":0D62H-?5M L$)V
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M'RI?%!%8DZ@G#_>?OMX1 $B!:JSP)<' FF!+5171,(0*]BII*N_V8T68G;'
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MH2=#9:TP)N+_9^]-FQ-7DC;0[_P*W;XS$=T1V,.^]'GOB6"U\8;;>/]"""1
MMI"P%C#\^EM959)*0A("!,9NO\M,VP:IEMPJ*_-Y-%*,;VVBE20U5,I"I6IZ
M I-(09Y1IXQ$),0A4&/ 8V4UL3N)1*M(?P8?DV5UQMDB1M] PR7(7.9**9(
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M(7X=DW1@I-]2Y[Q$1&-QL> 5\*TZ14.A,22:&%SC,=$B[O7 R2"H/45SI^_
M5X-]R4B"0S3$,8#=:7.K@R1X6)$(D.PO>!8Y82\RGI2]>*X&7-*S@F(37@ 9
ML7";Z>THAIO@G R7 AX1;A[)(VF\TA-QU0Y^QYA",QL)ILF7[@1#>0H[97&X
MP#6H)O5,0C=%0W6#M*C8@')C7,J"7!A=V&._^^ZP2*+87:0[L_)9KZ6?UO<
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MA[K> )8$'C]HR943@OHL'!H#WW\=:JJI"# .5?L-G:.&Z*P#"179'^WGHB_
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MH;-.?L?8UEA+_>\27XESAODV0I_6"*%0Z_EZ4KUZX?E&:1B3$<KLP A%LC?
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M:E)@^4VH=4FR7J G(OF8BE2[W-S5&@VWK"'J=K@A(*$'3P:7G\3Y&N3VE$]
MFD$#+Q4N#'VV9,EQ;;I3LF1.0$FIA/NE#WP2"-Z?8S_-EY=N*<P>+ N4[-95
MLV=4>JIIG*AHKVO(A(B:$G".=^&E17](=W'ZU"S/LAG^N3U<X])F2<3M0I^]
M$EU'.!%Y[IQ#.AC04P(TFCV86R=E[UG;=8+>[=$T=QQXIL[4NHN;5^DB57AH
MM76G!&7'ANJDW;HZ2=3:5[7&S177ZG3N&AW7A?'G._WN,%N[E\B43=>B" /\
MKL"B,"%[_)\P[#H_#F'A_<(?8U&Z.M6?1C6C=55: N'__?NQ_OC[]U&Z6"YE
M/#,\TL7^D?1^1(!R?G-H&!GIO:?)\ *' 8\]@-OAC@_4"SDN_801<D?+TPND
M2_%,;PGT3NV7,@WS-3=J+#,7VM-+E\JE-::7)91N6<_T?N& :\0#&A8X>G-L
MDO(CJ#7H2X;OOK$YW!O1X*$HP4)6JCC/J)-'=*6KEC5C"4_8@KN>%8PSK?W6
M2SF8@\S7.?K]58T?JT?@;@2IZ.U!0!=1,14SHV(YF4W[T3[AM4^0.,@E3>B<
MC\(J]"*[<!MBBB$-L[2D*XZR#N1S)!M -@'=!0*.9%%(2T#87*D*".3P.1JZ
M<U113\"7AZ(BXE,#N0J9BHHINN]'X*-.B*2;<$LHP<CZO#Z" &D$#T<AXP =
MTKB)C X"4!''O!LJ45"816M4('9"L0G=2Q'R![PVQXJ&0W%V\I;V*6CW. ,]
M!8U@C#9SI+O'*$%US$3$K=8P)%@$GN!BP<@T'D)(%!9)!KE0Q$,=F'#3 ^D6
MF9XS\3+-5.V5E+[ACR=H6@:'=?BMNNBZY41?@65#;R2OT9UP"*T=BH?02*":
MQ_?0Y(RQ3X@O1%@FGANJ]#(5XJ?OC,6'C;^EH/W742ROB_0B.FCWW;H):H"3
M!6H/S!.;V:+'!66(E=T^UT -/[1%<,@-@0B38W,IF2#G9O;A< [%[G5B]F1T
M,E#1X4D#>2'9!S1@4S;($Q5\5:[V19$T!J 3M::^X]M4]/A0EWQ-OP9G#<BY
M0,*"M!V'<7853AH73Y>#64_IN9R7/0@,1.<9^"H;'SR4C;I%BZG-&&X\?-#I
M9+'@URE* @=^@$Z2Z%$"6#HX.\L\.3=SR)XK1F(@TH0,2 "NX(5ZWMX+.@;;
M)0^.G/F(28I/<E:G#[)AZ'M8X,A!M@]F%7XT)_"?2QM="-CH&W'"S[&I6[W5
M#\W[X5/KY;E='OEN]3J[ZGWOAOL:!P%HKI L!WMMKU(E;&!%?)W1FW,-Y"Z0
M2;^V8$\K0TW$&Y_D2+[@C%=,\'B9 G;Z6>XG?)W>?3PA[S.59'1\I<]!<R,^
MHFG9#>>)-FAJHB<B[R@J[CP+$JZG"M=J<==72=S_!?DU- &HU2'N%=P@2:?@
M+(WS\@JM].%.9+7'R^CKU_;UC/TIY_56EK(RT229)OL*QUS+,7QN"S:&TAM3
MT\'=.9915]&:B=A.V4:2I 2189-%>L-"ZMMU$XOXP)31A!("=I>Z:J.]\KI!
MP5V1'U<@EZBHR+/JID;RK@;)_$".D?*3"BKS?1(:''-MYY8"/];J;R8%_? D
M-%:"UY#H,""X^--K;:5[?:P,%5%F] LK<0P[1B*#\5@R2*H)VK< IH?DQ/0/
M=[8;=B8=\F"70' C-4*7OANA<2-T_DLW0I>[B]OWR6NI-E*OP %]GN!VTY;E
M:G>A#T\?VI=WX\Z#=(@MR[GNHMK0RKGB_+ZC]SY#RS(:<;M7E0I"9?K0BJ<-
M/(:6Y2R*\NH/Y>?"13:5WKKU_@NW+)?0]MUWGMZOQH/[V\&!MBPWNHMZU>C)
MI4KV3HC+4GU R_+!A@F0KO([Z7.^J;Y;GX10E+R!I],3?B\C*1*2"5 /W3E#
MTE)YYQA)@FF>=H7!5;P4>+]I:*J,/VY3)$ D3=Z*3E+(S EP".I!_'S,-4E\
MFF2S7':(;3>,VJDX=EHF&  KT>=*#I+Z*I+8)$4_ R:O2'.E)-OA"I\3<$IP
M"K/PW;!S:>Q9:Q3WPZ1X%*=/)4B$!N3O_(L>?/-WB?#\74C=>!H=JW-S<_;0
M&S5;[]MJZ%YKQ8OIDO=V&1WPT6X9<^A*,RJ* ,<@[-J=LIF@^^6*.S\1^3'=
M17G<SC:%BV>MO75D\H&%X2NO'[_@17,^Y**YTET(\\LKZ8_\(K^-]G71?%&Y
MJB?0_W/5N]9%O75UTDER5XW;T+OFN-4JDXJL5D%D*+4HRL2HT)\_1EUXF9\(
M<+^ZRYMS%]N)VA\5Q,IS[87/;<IV,B&36Z(T^9SW_[LU+:2RC#<--0HW2RGO
M-*C0(C7X:A1N%C]DY9F;Z'(M:I9,QE?]+7:-BBO4VH*.)>YQIU.AXV9)3&)^
M;FZ+50B<K).GV2][2DW5UX;-_L#ANBL:H-V4E.5^HBE<B9]IP;_EXS/(Q^[H
MC#*9_WK)D5/':=)H>(%.E/'SU##$K0[$;CI*S(6OE[I2B[EE)7>K75TS\/?@
M]KBM(<\]E?IBY5W2NUW[L3";2]SBT%W</)R<U?N+U,5;F0$OUQW \JVH:L(G
M$%9?98VVZPS6$]YF8KBR+:7\[FL/@,)HI6BXJM4<[4?_ED4*[E(90Y\;:?L(
MW A'B(34-G+T=(X6NU]]/G\2?8OR!&:0\<A67"NPG13F5O,Q1*KY6\W*<#AR
M6(]BHI!QC\5 B:V'47YQ=ONB#MEBD1W;)_R&;>2B\-=9I\R&CBNWF5R,Q;?6
MR#C3"N7T83BN7%31*/UUHE'?A^/:4(X:M[=7=])8OC#R7\%Q195"R!W^=8ZK
ML9'CVE"P.N=5\:;ZJ,A]^0 <5V2Y.+BP>G>,/OCR/.#$5S4E&7Y/2FUQO< !
M,5UMZFO7B,&L!;#$65'N*K-4RA@]E/S];>S,5C$<'MV3\$AZ+I::WR_+IM;<
MJ=/>4AKE,T%Z?WZH:D(NNM>.74+W>@0-E>4XCAOIW)>5Y9V?6+WRV1*D^F5%
MJF>?R[[.?W_&,NI)-E2\XCBR9-<G1_LLXA7IGGR[HZ]7P*[JK^KMZ^U)53A<
M;^R-.<-$+)>*I;/JKQ"QW7CC+80Q(PQ2M4*M@-;GJWKCM60YCC-4^NO*<FK7
MQW"O?/XIG32+SP^MAC Z4&^\EGC%<7#)?B#[[EJWLP&,IQ>X(!ECC-.#.H!.
MK;Q/W@U?JE^NJ;35$7UQ7LX,[F<=_?J]N(:#WXX*=?,#MT= 8[G\R&=72NCV
MW+;[D(3JG@[2B^Q=O5S6TM?E]FA+-[R='.WC6.R1N#@.*!'.OY]#X(I;G'87
MRL*X-E]&YG/M);JOW)'=67%V=<M /HX31"E;WH,0?+QWVN[$NF@6SB^S<F<\
M>"P<LG?RH^HNYF.YX<B5OHBQ*._I8+G01^?-5V5<?TO[PW9]">_D+W%Q!.P1
MSH.?0^":6YS^%J-"Y4\M^WKYKO</UCOYRT L,7%V];WJMD*P#D]?M;LPIJ]O
MJCQK"RT'Q3,&GKYT#9W:SY_.1UKV/"6NP4.WHQ[%_%*/XJ4$^'=R2Q%,W0"0
M; ;2.Z@YD05/BO3][N)RI)3JE=1MYJ(0?1&^&PUWTVA8"&\T[$MOF4E#3C6S
M#JWWCAL-+UM7C9O*1>+ZIGW=N+EM?>/9?C T"E7KA--1B%O3)9TTH2./ UWW
M'-]'7D27",X^"IQ)F<F$0G\)&- 2/89X*-TF=Z8H(@WYE:MIHOC*(><$3?O?
M0(\?"?1H@1)8VR-;N4G/+CJL NI,68*W3UK$*#C:X"3HD1%!,I#<.!M.&2(X
M'< C@2P%F!@2UHM82%*"((\4]\@2*XZW0,-TSL4W 8B0FGADLQI 5G4.T 6
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MT+I 035Z[1(_$(OBX$-[".WL[0'^!7IR R[GYK?.XPG  [ R,DAH.3?^&5I
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MI6JP(,BLW:I7JB*.)[(Z%RU$H'3:RAJB?^6["_7M:9([OV\)TW(0=XE=8TR
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MLYND,9U[)VY>Q/X=O&/>I]Q?@ASM.Q3+>*DX(-T<%P+.K&DR%JYK/3T7VS?
MCJO]%BU+PUB8YES8-^]<BW\'GEY4G"ILEE%E&FZ]X](TVV$ EO,,2^;94E"&
M9\@9)CB=/1P[D^+8:>O8<61I??YZ+R[?1HHR*A_6L=.6U5H*//1T*9A6+G>>
M+E=",O53'GIZR;.<B- &CE+#AJSYAS %H*GD20JI>9R3/9K#Q!<3"BI2.X:D
MGWS[]5<PI27.3^\(JC-!/5#67%XUKY^O7Q[.W\N>K'+W"@(5=R2A)<TZ=\\R
MI=S)PEDF*4")\:(G3BQL?\;-[<[8)UCT41<LO_>NK-G#/>,8(4-F@7A YZFJ
M_]IKLP/>@543*5T<YE6HR+GBU#=!MW$8 JT@:$ZG-B-3F(XQ*C,$XY0,%E/O
M,E^N-\YN?G?L,H0DJ][&Z$V,2IK26"(SP8NC\M7 K)#8@TYN.7TBE;2CJ,0G
MZ-C2S>,U)3PPK?*Q4$F<V,NB9(K.T]6@1FY;D\A^[2QW&FYF$;A+J C!P9GI
MCO_5YK-?W\D?__T/_(<GO)$I2U"%<A13!)D&SNOP:T4&E"SHG.H$ZS[E1!DN
M":A>92R#=9IE?2,(7AD@6T>_FZU9?RW2E:; G4W?NG;OZ>]PL!__,7?(O+"+
M*7,)6U4BAME\42F%;Q9)E>5*]0@D[^>0F5<X&V36N>_-;[GS#W8P^0)D%B>]
M,W%+ O&;,Y+=_T%Q?-?%B:N$S%\LYJRG J\ENP?8.,SN*)8(*&H++&"SU5#R
MSW@5%O@$BM/SJ6>,8_W_^;7=&-BL=P?ZV\56?\V1K^<WG;8T'HO?,M%^6-$%
MJ;CDTX[4VH@=?Q)56VE;"R)AI=G\9C8ZO5[PY;=L%@3Y?J0HNJQ E&_(C,8/
MB"&KWXB/J?13XB!A"O+)?1<; $B0)OH_AZ5@X[9JA .#V:B4$-[GG&162?#B
M",@05!TY$/2E(,BN%/ODG[?!Q8VD?3\"7Y"%ZZH6,5#+$7P*O,M!A=S)IP!K
MM5RE[,:HUK:@ A(X/U&S0*IAKD$(4"[$BT_^=?@E((EY^":/BONM2CW-S,A#
MI?XS(P:!2UY@*KLJ3,!;L$H&+!Q"X#I(Q6WH0>'HD(W>2W"[ZJI2 VZ',GA1
MKNC2M?R8ONHJ3KKM],+YCQ /%,!92O$LCFZ0K:C&-D%VTT.^;G)&OL&)IU%\
MET4!_/ZY:=L4E#W#:W'R'%C!!%D-0-B"J"<D^X^&+Z PJHE&+!2CQ CUIEA
M60^4GB#S5D$CK'QPR&((KR0IP!C0!74*NX- L)0%0NB276UIJ"+)$C4X%/C
M)7P#)G 1Y]8;'?"&U<G25(%CF'8,%0K\E/6H)@QA5I.((5E4 ><WX"YTCD5#
ME!>V0-Q;V0^)YH!WJ:YP*@\.;Y6'Z@VNDA>UH2H@AP,GTT'<$&@#@/_-XXF:
MA(\[^:!NAAB<[+O1DP1Z#' I<!.!ND&:#>E9_!A\#>@VY%= ;>OXVX\\V-*Y
M9J>1PP(X8!M "R4/IP%M% N2WFH4E,^9OS-TI=E6".EK35 7"#\*'+6(SO\[
M!SXA@(6* [/2.^&V_?#VJ43U %;SM1P"T8$GI@D2SH@W>KZ@G<XXQ?O($X3W
M./WN?/ *C@-"WW \'!\S>EHJP,QC=\>1$;B</SBK3S@=<A<PF2$S #H$) +!
MO2Q+T]G4!UKA\XVY6!D+B,I1:Q].DBRB1\)C=8+MYJ&CP"+'V146WAY;>31=
MV%$0(AR %\GBW^8CCOY=REP'\E'F_7F2 4+#E'+XP9SQH+D?A&L_YC.8+"#H
MNF3)7J?H6(I@@8[9E3>?7,XY.9P&FFBK"4F<PBG CTVY#W$ZGX:>NYE/JL Z
M>:?(&8DRH !\R+WND]&&"<&]38"O,9NK,T43?J##A)V;@( A3V!&K)$\FB?,
MS8+VKG-\!\Q3WJ1EBT#S!EU!\G 31LY)&(2+,+[C)EAF]FI"\0CFY" 9\/]R
M]-'DG.6]R0Z"DS3%>1KI^-!%=T@P0$ ]67#RXU[8T;7K.2\[@HF5-]A.<\7?
MX;A(6_*B-#?0%D3M1X$P1*'IUSO$(=*/&M3LYBPR%8;<4)^##;&RK2'1&Z%)
MU=:39J\_) AP)QE!'8JX(Y1I>" Q@,@ '"BB! &P1FIQ_D<M?]+T(?((-D%A
M<<Y,64*Z,3L!F49QWC;-P3_YJ2B+P*Q$K(/$H5M;()MLZ;>U(A"$KI9/U$AO
MSJ7;84:8,]2GG'U2T*12?SUY%_7Y^\WE[6+P"4O>&P!>)0$ 7K._+G;;\OQV
MW+BO5_YM 'CEE !XK?Y:D%6!*=_=OY+V1=?1 ."U^^N5,GM:J.^EYTGY8'D@
M'FLJ;('U_KKV-IU>U6OG]8&-@6=-.]/"V0A\/(PSM[&,8OMKM20+Z_NK^Z?9
M>/?3CP?/R]G@>2G7!(Z$']3/+\_&M^O;R<[7Y(/72S%E&K#)/=E9/NLO[1*W
MVRG'8._E0K'WB*38>Z'+3P'!!PY3OWNOB.)'N=0;!B:>NB#XD-RC ^0>?1B8
M?'[!^\UG4.[DV"--V(C)'+YUB[V5G&ZG9P G"! I+O2#R1F03G'!J99Q%>BG
M&J([J "EJMX*8+,<T,C:-ES#.[";;46%#L"V%9^N'*(-OV86>*I<=7TU;)?/
MKB=I"CR9- 6>KLI-;JXK26H^*V7[AM-(>("O;E_SZ;RCLRL^@?GX?G=##:LK
M]:PS2E+QJ: =3YG,^'EUA[CM"!Y?&>'_M>X-CV41CP+\7R"N:H "H,IHF3$9
MA(GOG5W<%S98Z+9#9;P1-2O(=2[K*HR]#K&#^>_9 A\MW E33I1Q!!)L"H[R
M$9?B*/M-29^MK8X'WZEB*4_1E3Q5+O\(+<REJW^'5*[L,O&@CG%+\R[X&CI$
MV#F*"+=*S8T>9ZOZB'0UJ(TLD-(,X7IC1\:Q".Z+W?@"5J7<?F0>N-/3![O%
M85T .A'1MX$NFYA[S%V@-JENW1H;+6P# O%^Z*"D7YK<LARV7 +_OUDY[%%2
M<E#B>6DW1&R*74/JF@H8Z5^+M!LU5Q<='WF7N;N78KVT.G\??B'RCMJ:#8B>
M3D7T]I9_^\46R/AJBOW0?) .?,052\F@ Q+-+=E7 CY )?D"HJ/4G]CY&OYL
M_%XV/KW-]QA?H8?G$5*3G)UY=PIO,B&&0J ]EVTY?K)RY2VE+UJ0=BYW4%(*
MJL2/-Z[8^\%3C6K^'G?&CB)^M#,H8P5#A&Q1PI_]HM*43-'E+:TGA@IK^_DI
M=+.15:YMM,>11DTBB^:=Y6=JJ\9W1Q,_35G7 CNDJ>P6G(K6V*V-%JI0C3=:
M=DIJX6<3_^"!3V:7 8M/T&,FO7ZR)JL&0RHT$=(F9C1,W<Y0O37WOGB-4=+%
M:'4UG-U]7+[H9Y<";8-900=)D@3^/QC^-:GB^IX88R'A(E()B^I6BHG-5U(I
MI1^[//UMQ;.YH1FJI.&<JXB]\>75E1A%-X>@G#9:?1J2*Z6+)#GU$UVHQE>/
M)Q7K:7RSK7VO[5VKK:?P[UIWYB[CWN\#\&J<__5)D.0WH4<!D]3*T#MM*^I(
M$/6Y:@NVI$I?K_T&0N^B->1?-U/Z*6[2XHR"['<AE0A/%Q<UQ3?#T'DJ@=V0
MD&Y_'!#)DED:(@&GM;TIHG9/WX22TAC!LOY-3)'L4<3VO#^I*#U=X,9IK)0+
ME9W E*6G]ZP_%GCV*=_^]ZYSEW&!PTA>*'TQ^X3:=VZ"#T!TT7R]X*^[$M?+
MXO+V0/,1@@5SNBBG%>',EZKE1/D(QTJ<S.'D'/C(MMFK\[]I^IV^9HZ<;#?.
M,P@FYG11.*>542JP^[<RTEUL[^8V>T<WV'N<[)^]_),"\,D7)WM( ? I@U51
MONL^KBBM*AYU"D L.&]YNQ3*:NF@4@ V"L[M. 7 1U.GUXVWYJ)9&9+4ETP!
MB*>U[3,7R4("!/XCNG<_J,G\20+8A4RJ[2()P"=<;D^%F:2J-X]EZ4B2 .+%
MQ7;Y:64R38.AK), ,HV];Y\$X*,;M7LWX=K#YH0;?/TD@'B2VSY-#6BH[<VA
M?^=U^+]UW9^3!K '#?S5<P$V$NZ9Y0+X9/ASH\)?-2\51JK\6W(!XB7Y=CF$
M);*:KV9W17I(V0"9IB5FD0W@H^>KM^(9JZZ&S%5D0NN_)1L@EM:9[9,7JX52
M*9;84Y3%)Q?CF:$'9,4QZ6DJLP7^V;U=[M[7SVTH'ZR]%=,H+51Y57:;W="*
MOQD@WS_8AU>^34_M:^(6!C9.=$>\73.U_20W!&N9[?(KZ7R1*B:Z*SAXZOPK
ME#S9S\AO:"6SJIZN*E)[>5FESH^;;C?.;@BFYNUS*.E",;X@,7XOL]?[<<-G
MSQ#[8P4+S@JA6?7%<T3L!HF_+J>O@_+#Z]74OK6UD;!$"PD+]7 [$G)W+W@#
M D\:RHQJB%EAF#\4OLW<@B@G.^A<%U9AM>A#]!G$4^!@8X%KP:@Y4-1@JP*J
MS^O/P:JGU6BTYV_3.ZUMHU59\&R< <^F6O!L0P<\FR2.!(O;-D7I=-#_B28,
M?_)S%;8H\3"*'[!S_WL'M4G9U_P06^\$G+,68LKOA/MVGL?T!2[+_TSF*";C
MZKWL9;#C0FFNH6XW+O\^[U4!F63_=X!%#?X-Y-7-R"'+T-7^%6XHA>\E9OWY
M'1PT6.K?3"KD_'0Y?7BUKY8=PX$] >,9<+D:L1 T(">__2)V9%DE6%2ZZ"N[
M4?35L+1.*(>IA?;PVZ]JM>"_</C;5 )&HR-G(R6KR9"@"L1H#CL6X5W$/:IT
M10<*U&/U.IL3F0V+>()'>1SP SG4PPMW(7*1&N$B9+_D7V+)O^0T0A8EW$N-
M0YCX;HHEC 6A1I$$?/PO+Q&W^\(0L(\R/3FYEU6K0;SSP!N*IFO0^L?PU0X?
M0'MM_-;7-6$]XBVJ<X[B[F@UA..$6?.RJ Q&/R.GD-P>9Y.&3Z+L\: 8O44>
M<\=$<_Y5 @-+XHQNHG,9$PJ^/XEK]84;')ED9?:3=&QIV"@YH^TTG)WOE,NQ
MHLIQN#[A\O)\W5JLF^?=I5UDA$8A A9C3".=UY92*B2-+T0=-UL)"C#@ X?\
MY=O3>/%O["G_<1E<B?LFG3=Z]//HX8),O*\_?SXUGW[^I"H5TJ/OH-5](GZ<
M3$2>%X!6!+.DQ(^!*H$-8F'!$\M6+<,6KPNW&!2PT1LHB.#*<?M<5=!FPA!V
M1Y-6?UJC?6)K--P: JD0U+K :AR!^QXNO;Z>*&/>0)(&*0KPAJ&5YAJ64;P
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M98&I5N$MP0))T*2=0(GK$Z:01'A8:.84H2AM_2^F4"WG(%<V_JH6RD :8[6
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M'9"&0Q>WZRM#5O(5DLG3Q4\L*-F*D(+0&N.AX_#R:W-@VJ$HT#T,ACOJM3N
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M#2A((*-R\!7.'('X#G^$3U/%?^"+%K%9'T%_)/_Y08R!6ZZBCG?P'?0PMBO
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M)Y8H@A(S) G-S4]T@#BDS4L(:Q_= AB0ZN)EHI5ZVO/9&^W546A87Y:,4W'
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M1.Y_!92A.Q%Q@J$8:E"8C9&K4%_9CW2X%?Q5#=C.O%,!FH:."Z[ *F"_[YI
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M!A,"$H<=,HR_0N$,=(H^,9/HG)+>Z..#F@D (I%6^9Q3U!O$'5G<&M6='NP
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MM@H\C9D )B].%&*>TKQ+V#1_<Y>GTD(R%2+E_)Y5R26WK;$T6T@D/RYU5-Y
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MQ/'L+XZ_'AK%-D.6ZYV^AQ-1Y&]3$I,M#Y01F1_"K0!67H2P4X)NN)T^4"Q
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MNR*;(794L_ER=*[3"@^?[ XHA@::I"=08_+(EG5D5HGE@WI]:EKP>1=CX9Z
M$3)5[;^L1(6M\7?&$Z>GQYGTM_S)B=X.W*#73.NWP+S@F.8M8A5_Z+S-2%+
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MU)L6N(,T^7=H@5Y)_&I&3Z@,;3I..9FEY&?8 3P&LWB&L&F+ GL626U?(:*
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M*QX+\ _SIOGSX,<'N?+CYF/T8M$%%)8)N(Z5I[@60B!$'VP,"]M)IYDIO!=
M1T[.!SJ&7401_1+[">,KPV?X]9)C^\5%%>'VE2K!N$92>) .X*IF8[_Q#LC!
MT/$%[U%"0P[?>@[O[?JN+,VT),#$@,1#C!%U7P,;CU&;>P,@9LPBQ _UH5=T
M+A9UU@7^'Q1,(S4"5G\WS#8U.^;)ML3'^=P]0. !P_ZRS.U+('UUTQ+Z.^S.
M SD%/(["'Q*2-_@^E+,3F!\59X)=5GOL$6#UZ-!C86U3X:*FSV -T@0ATV"6
MGHFM<<TA]ABSW18\6E. *$+/#"W+!S;Z/@_HPQG"R9M.!=SXD1E"'1'+L7O
M9@$(;,QF,3%L1A'FCK!J>IJ"<M/6=*99BGR)B_F__\D6TA\!P]J*S! .D,'P
M62[S$7YF2Q_- -;CRTM_6Z48?DLC [FM!%LA6#WI)I;YI*&N Q^7"__Q3*VA
M:>DJ'U5*&V5H9@L$X:',6W;*.%//80:.+R1V'=VL5$@LHZB8'$\SO;4TMQXX
M(V/\0)'E [Z;!I/[@-(M0 80P_AIBJ;K"7R#BQ_@#D5O\V,7:HII$!L,"S!Z
MP26."E, FZ\48)E<K%0<@=LQ'!B3E X"9"1A1AD*()C3Q/B%$I,NAEO JQ*?
MB@#K8#1Z/95L+3^UDG@6HUGFI9OI,+$MV*-0SVMWE?L;VUV57TF[JYW%OQ?6
M.-:&.S2I(Q4VC-N*U0*.C:/E;9J0&)*#-$GG&JQFV\%)'2"^S0[HI'RN3$WH
M&]R\1O9*<E'AHV(>F=3G2K 0/$WDE_*Q,.:KL"I - .$(Z]  ^5"4<U#^3/R
MUS;3D%FC+#I6VJ#F<!6YV>;FO\JZ*$^ W5>Z8+"#DNM:(8!P9<C1)>^IXMW?
M#8Q@@/J#)JZ<.2IGZ-WXEB\@_&SYQ.2NI#;('UUQ528LVEN&ZS>F'I-"N$&M
M8MQL':;X<X_2?[?"O>-N-*Q;E;!NU7<LKEL;N8>+?^WV$OD0\6SO3>H\+'QP
M2)@1LSR/K&HZ59WC@!C[8YC#$%\+Q2E\M;-ZVIB%),*!A: $JJ=X/'< ((+A
M>.E'L%K L$#W'3DL& WS1*\F@N<I^MR?I+1I?!GUG;ID*BC+AM867$HXH_*>
M'T**+GC2#9D1PY:\VTA+)HN2XB>^F4C]N2BSWX.:3!MOP:&<?MJ*R_]3^H./
M%6K4U0=-@K@YV2;XV+##HRD<&W2;7R-PI2L&ETV.K^8+D81[V05^[E)':UHS
M/C/$U@DRP?/1>@&#Z;C9QL._9.C>H8T-BPG.KX6.3T^\<BW5C3S4\Y1>'E?P
M>K )L@",QH>.,F]"E8B'H3"!"\E*YXA(MB3MZP,;^0X<M'*X"4[SAB+V-P%S
M?GSY)D5VF)%29:Q$E;$3<F1V]>4>+O-OD!?\$*<%AL]0IT1%*K:FB7.1"<=_
MBL(7$X&.J!B19N!-X 1J- (O%2C(@7O*C@0'D '5] >Y"MKQ0R@R%/'M(0#>
M(@.?F42.I.C$:1HUX#_NBL>!<&/JK&4I]H-R*)-[$OTER/>&IO6 ;%L\G7LJ
M^>:*]6OX&TUZIU ,HQ@^6"#8+)#F(H>8/F?'I_ J%WUZP':G)9:?+C!]1/_Z
MHN8SZ'M.+P5\WW>) CXH'>9PT=,$5%. +;<T'=@]^9?.& ^6^7(:^\R$/:K^
M-\)SQ.,"&=P)#[I#^1:Y.X4Q<]E984S<XR[2/LT152PF4= &OE(!++C.#F\C
MV6.>",2'?7,9,WQU)&K@"'?JA+@#BNL)CZ..9XHC6/&K=\>'S3;1@FG9[V>N
MF.3\NTN\]CV-5M,&.A+"FZS:82;^1>M+6)$^(:@65#WOX4+_!FE%!TG#!%&[
MIBF'L]D+&A&VY^D1N5@8=Z7X#06*R"D$2CJ?QP+OYL%;G#>H:-@HEX:M&B!J
M@)=*_G6!0Y[G5G$S!=B5Q]3Z(@+;[K&^1DYX6*#;4=J.RR-4 (E./A0^0=E@
M0VH>BYP7; *;AW1)W'')+(4D<SA87(@3S[4G,2&Q$EY&U*##..\\0D@%0ULE
MB@WPO-UL2.I%)!T=3"AH%)Q/* \-WNL+IG=B*JTQ ?[[B(4E34"'CX[*2)Y6
M#%N1]D/0D0WRK!4O6R$$[F1J11@\LR.=BW.GW;OBB''MHP!"<GY</0P>-XQH
M(Z$0WY4)MXXF-IIG*_ U@!56%N*=%H+F8P 3%1* #'3MJ D9LS6DM' <$B\-
M6ZAGL#U@3E:\^.;WP^8AFK<H3CDNP*J;#B _F<.:+4R\@X[)QR^1G<CO#7++
M3B;2&<^8B4-&^V1L$B@5VS;;GO.5G(YL0B\\QG0&R4ML\YYTC6D<-=((;L""
M-<"XQ:?INH96)%&'1B[7'LGMB&X 4%A=YIA#(Z08O,GI'19?O.>%Q'M>^,)Z
MO;X*>[C\G3G =0*1\8"NW(1LZ2A6ID33>./V?\AXNW,#9^/IWD;C!=YG7),0
M>#9M^(JB8ZPX1M:T$@)R:2 >'553LNDX-46:4!B\1,6!;YMPCBD4@\ P6L;Z
M%'#,24*1A(2ZT0SS49DPFGD>BJ51*8X'&>6YZYZOKNVEKH=S"+)YRB$(ME$X
M7Z.987@-38K&&^; .RL\X>5*^ADSE-6A\6\>,3_3RW#4=#@:%*$\/\2!O:N(
MI$U,\>-9';'OIF'H6C]Z[ORM>+WA"3B>Z/I.F4C#">![SS<HI)ADL^$-R(41
MQ[=HVR#_X.) 38&]1F0->0\"3W7(NT#R-QSE%-CCJZE1WX$T9XNK:-_Z"85S
M+KRBW)51?X >^3/=;,'7%P G^;H5JZ4 J1PTGG1&>M" BW#$V#,=Z "H1'HW
ML$!?!RU''\FGBMXVC9:EJ5TF$JIN<$:XZ^5@A96. )[ ?0Z75.!T1[9&B9%G
MP#(#7[HX:_(G@,YA47A7JK3;E$>#)G[E>U,F5[Y<_WW!_0%TM15$@ZM7%=^C
MP-.!^5N1/H%W*9%7 >$;(J1[>7A\6!%ZWPG#C-*0@B+!<H#3P,(T)14\BRM-
M@ :DAOEJ#H\$T]'CT;J.PG%:MD6HF.?W]D%?PZ@.IBMQC5X?'<H[PL##M43;
MDGC[J!Y0!R/)[V#DZT=3U6Y[N+:_P7$ACFUN3LF$SY('R(J90&\0U0B"KKT@
M9*!-D$D4M:P4/T-<"J>.T^,R^6B".#HP; ?XH1\<+&?"HL)WG)-!C2Y?SN2"
MM>'S,2&5^/+)80A=D9E*9 B"L*8L[V%/ \,=E@2(S?Q,;W2^B/3NE+?>U,2"
MU9!-BRO54&,!:1HH4IZB!'SNLX8U %RR2*&91_R1E"3.;\!5PI[!IO#]IMTG
MYT5?N3>MZ:WR'1CY4OB67/K_QRUKOU!$PP"+BVJD-/D0.K'AI&I&=0ZI*4%W
M[.HZR(TNB3.A=) <"06T@QJ+;/JC!V)HWD%4CTTX"7(/<]"V"_KRZ9OYOS%]
M\^BO3=_<0\K98O8F<=)&0_CU@-][HC+" ]-^\@]Y42.R"84B>U+0B%6Q?JUK
M:&"Z*)2:@\*!#?%S8+,MQ@R)BTP=[6U1_46<_2CC*> T*D\D\V=R18P'&/)
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M>N,W,^0C2;Q*W$R9MV@2RD9.1*M@F041XTFGPA#2(T1&5E!HBFT;O:J6\_Z
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MYRK.'MECIOXD,FW]U_&4D$VTX&KN7NH[NJ(+!#>ETN\7LR2R@CP,7[R@)4G
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MI/#QU@;S*8#J>=DZVB[3*H*RL^O[(.E>6W!+.3FR>SYPX'ZQSJ8R/3ZG2H8
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MF,JMU:D\%=9;F=J5<B[6Q6,?H00TM2)1(3 58!\OP3"88&ZI[CE8=0<?KX<
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M[EQ=(?['#:O6N])_M_T99D=:7:+4]DNB5"[)FO!SJ]U["P*L64HI:-:;K.5
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M7R&%__5J0J;5;Q5'Q)[GGC1K9NO)[LD37(V-[?&3^&E^G_D.78OM)-LM,;N
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M\J_A^#Y\.%+\R)LXP^8&XE'-[0R];6*IA[CCLO8/CI&R0,:N<Z4?W3G#&:7
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MW*[,G=W#'^[VS%H\@_8T]X=Q^C]02P,$%     @ >H K6P!+3R1>%@  JX0
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MVS]\M GV:V<MP#"CU>K4&HWFU9?/I9V2^-[KU.KZ^]=FHW_QN53=V?E0NN<
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MKO!4#(R);5FA%Z=-AX+9S3%U1C+K*EGR<?,63T21OL[9A#+ES-*ULNEB<U7
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M+>.\?RR.[C[:/_Q0>FV(7$78O.^/7/3ZM;Y!VN?Q#ULLP^?#.Z'_F'C4PA2
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ML@S&[DP&XQ4#[Y**G(/76Y'S'%M^YWV&LW;CF^"IB_YEZ_3_ 5!+ P04
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MV]>_$JTV8HP8H".YZ[E7&\ZWC/>%PSDN+?/VM7@=6[RU_1=02P,$%     @
M>H K6[=I>M":!0  _QL  !4   !N,C4W-%]X,C@P97@R,RTQ,BYH=&WM66US
MVC@0_LX,_V&/F^LD,[S8)M VD,P0(&U:0FAP.]./PI9!C9 <R4["_?I;^85
M TV:R5TSO>1#;&1I]]G5LR^VVN_=T\%AL=!^W^_T\ KFK^V>N(/^8;N67O%I
M+7O</CKK?86Q^W70/R@%4D3[8%MA!"Z;4PU#>@WG<DY$.1THPY@J%I1P(2X=
MY>OF1$V9V >K=-@^/ANZJ_(J 9DSOMC_L<06)',U^YNF $J'K\1$AZUVS0A$
MY*.-.BN1#%%O"R)Z$U4(9U.$H=AT%K4@FS&1423G*;BCP_[-C$U8!$Z]:COM
MVM$32<[!_H0L3H/-($].W\'XO'M0$D[C]1Z]<>JVP^93R[*KW\)I"3H#]Z"T
M7>5#-S'7C4IQZG?@OL4Z8L&B!9[D4NW#.?7_P[U-39A([C_:CD@1H0.IT*=Q
M&%+E$4W73?2HB*AZ2JNZ9\-Q?^@6"V?'\.ES9W!R?-+OP:A_/CX;_FZV/F@'
MGXJ$R2 3/C5"K6J#B:<TY91&A/-831?%0E<*CR*2L>1QQ*30,!AT8485G2PP
M%H1&"!HB"=&,0AA/./,@8)R)*<@ -7CI(MNJULM@[U7M[.IDU[JY$N&;>_P%
M.T;.*^Y?QK+5E5>HQR\6<C&O5#*^:T2;>2[U9H)YA&,XAE(ARGB.[EM Q").
M_5S.MFEEZ/,+Z"I*+V"DY#?44D8W3131%R33!=<LFA4+1$ _" R,*PH]$E$#
MX4,L*-2M,CB6XZPAWZ9Q:0#1:#30+/=F[NL($=\ND0*.D<+HNLK'8@'9G,P)
MF#9B%Y0HH$@ ?PU%8PW%<OFJWX9,=J4*H4>O*)?A/-F_0>17OW/]/"1BB;?Z
M6_#Z?Q6BA&MY)T"9\'#OI2)F'F $*QI@B.'Z/*2RF+N-7":R\8P0VA!"(TFG
M3$>I( S0"$/"4&G)VG'%AIW523"4N@KU>KWBO&E8S68YO7_]=L]YF]];C3TG
MO[>=YIOLOK'7L.V5.7:2,);3FKOE8F%-U28X]3MP<C26_;JYFXB\5\B;;4(<
M[$GJN\7"#K8'/$T3'//+2D1MEJU?(NR9FO+("(MU$DJ&3<O82A[*6($@<UHV
M0<AC/ZF0.*:1"K%>%@3L5I!P*F?-)18$%C!3!/&)EB(O2SNXP*<!$QBK&*+C
M>!(27&G7+<OH1[;%/.-:Y2.$2LYC/D72^2;J#=#/U7'51'FL6,2H3A#W;[P9
M$=,DVN=,:UR^:_ :*T6:$(H%4Q 3"<ORDO)\"\$3P3\JUB_,?V:F/(+Y6!F0
MN[CY'OX.D&R&P@1TUH[=4UN61$JX<ENC#.O7:E0V?QO35AN8'O9)7.I8T9<,
M^TQ-N9]G'B9#D_V08S,2P36%&<'^6U&2II3;388)-0D5WSQN,US6LF0)"-=C
MIQT0IG@Z1#S,?<@=CNH5#17-V)RT2>;E,>77LO]9Y^X+FYZ9*6-49A*&V5H_
M*731C.&+IXW5RB>+]&TTQ%0QH2I[5T)*-"Q,()6!C''JG[:%[Z)?D)-T@:3C
M?AD^=<O0)8+X!#XT7;!/F]7GY[*'?:#<C-OM' WZT.T/!N-1IWLR?'=0LDK)
M[U&GU\M__[1MU\R/9F:J]5<+)E+Y5%5,9TQ"C1N6WYFOIFWW/!=_9:(=^X/<
M"Y$,2]GWVK;;RV=EHAM&\O=?#__%T'![OPY*3==@O.!7!'/1>^SR,"NMXL)_
MYX_QY"_VWMU/OQE1DF_#1YQX%V CU;3D[$F_M:Z[L@RC:HJM+Z;5W]"O3^HZ
M*AAV=LO*C6W8TG?X*D+5B_\>V/) UO&DZM?:GDT^K"6).LG96\Z9?GS@DAZD
MY __J%3@V%2X?1B1*6TAWLO8=-B($RJ5W">]DR^;CFV:X=UCFF0LB]]\+ UA
M9R6$[X):W9,1 D25"<1$_PK,FL&90KO/N)HYP$M/],S!WS]02P,$%     @
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MDD)/4:V!KQGT&>#4+S7SK3[[>&^^\?\+4$L#!!0    ( 'J *UN"!(/<C@4
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ME]$I@-V[26&Y^/:H[>C!G>; '1LJC]=0702Q;BN_?3!N:?U2J[$;*4*_R1Y
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M)Z4[*#)8B/.&6]621QKD$K_@-_N)1AF(!OUPQO^2AGYP\S=02P,$%     @
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M*RSOS.T0B0B3*$PB::HE,- +2!SCSC@QL?M0H#1!35(C\XJ*KM010Y;%UB,
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M+*M2\@V=?9[P7JQJ(?3KA_Q]A'YM\0]02P,$%     @ >H K6\C)JPOG(0
M4JH  !0   !N,C4W-%]X,C@P97@T+3,W+FAT;>T]:V_;1K;?!>@_S,W=%C)
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M5@IT8)3T9F90\A=YG55C<6JV0)ID2*?(V&"W0!TYOHZ6# *HL:D%**@E+%P
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M ;TNQ=X%A*XL$_G'@4%_0"Y6"6@A"1A9QBA_='0(RP"V"]O1N=&^*.G38&K
M?>G=">@G%L-]J M EF@CB J2+WY)"U4]^<N@X\7IBS>OQ,M7;]Z\/ST[.W_[
M\]_O'=VCSQ_?G[ZTG_]Y?G;QR]_O'1\=?7?ON@L.7(B;[D)0%2X^V)%!H000
MR]1N"%[$*H%G%V?VB95.JCE,_F#\D-Z]?W'VO/_GXW'[@4YP+66"@O&04E7A
M[?$/]/;)P^\<?S?GK$&-111D7+4<.07MUJ56&/;,6,I?DL^(LFU7J,R#X'?V
M#TIJP.+$IC?G+"& _T]T9M)#ID]X%_<O/N ?>&Z=10U;X7P]M^S-QY0'QWMA
MRD@>7 ]53NCU/F$5W9W<5S^YR35/CM[F:&O)"C=&B?OU#NN&0R===X@T(LWE
M[LB_^I''USQRYNLHR$$S*N=Z20Y)KXITGCNR9!.5!T5SJ@KC-,5X!+!^#&,#
M#MI@.PAYBC# X#Z@D%#Q1TH<'TLWS*=J7I!_)#0DPL61&^@.G;ZVEG!R32V!
M7F;?.I8'/#SZSJF#4A<VW;>1>-G2L\F&*O252AR*D&LMP!%T,D7]J@%F)K+/
M0L/(5Z2;N\ $F%,UJ<Q!SD0[I0GKI^HB=F]I5PTV'.QCX[D102?&PK3^\?8R
M&<DCER]-E*)A_49,/4Q2I4VJ=@IXH68Y'(_W8<+3Y!"<!Q!1G["H;OQM:>H+
M.5R./BN>&R)>,UO5^S8F^YMY 'V;O]>,QUI/:,\!?S%S_%I0^.(6^9=Q.%'\
MUZ@>UE)8RC4YGV*0-A0-;OFAEG+M?Z:D9*Z#0JLY,,"W!S?1/4LY[BYENJ.,
M*0H"2<:*,3&,0E% DM9C7V*G#ARV\8XKOS(<AHJWA+9.3;",/IRZ#+S6DHT#
MWV0K8[ ',_F:BPM]/NT8%,"+3#CF$+,B!RN-\]6]>XR7!HK;!'#6..N\]X[V
MF-0QY:UO^I9P$\<PPR@O(EMGTN>RDC;IWJ@;N@RB_9S0CW8AQ;U N4R5!+WA
MF$3*-\/7;TPN^Z1"G=RE0MVX5*B;@81LU%_E6##>\.;X'->'WQWLPUW&XC4Q
M."!YD_P4>79@2]"00[@DXM!OCLSQ&JG)-@RV?W(4" .LN-O,>:% U798>)]6
M*V=*E^%@G<EBCK,.!UAKW-B\"X.[9)D01E:GU:R?Y(4K6T<!&#=K\6F)+;N,
ME!1I8@GK+QDJ^*8X3N'7?U)R;W4S&VZ\)N4!O>R(MO!WU, V3*,&)1-U3E0$
MFCEY2"TQ/*' OF(0B)%1:RU,?)\-WX;"_ 8F@BIB7;J6"&AZA<.S.F*>HL09
MS% !Y;C9R,)2I._7T4J$*LN:"UBPVX,;#IZSBZ1J.*^>R01QB H@Z!4</(\Y
MN( KP%0JHY%3'6H9E-A' M4;)"";:8E5K8W Q9-G+SY02Y\_M43K1KL73%E,
MCW?!:3%A R!<]>%4+G2Z?K)3(_C?QX]^?/S4]?WA64@J 5J@<+$)-X4Z]!^9
M>P;4L9&!1R4',U D,,VJ!S^?_LDF\AU&_/\P@LP4#O,W'$24R$GZK/48[8<>
M5-E^AQVW!#M(V)BTD.9Q X($S4]L4-T*O\@@$&T1OT/LB%I#(+ZDY((,6B-@
MJB>F+!I\ZRW0\XF&K%9Z-X;MX=)H230*V[$T?]H8&J4D%R5U2E?C3@TIP?@=
M#^[0^V:A=Z'R8B8S_>\&CW.F26%Z'C3X(#8#*V8FO+.0Z0S^Z'J;%$1V/&,F
M(..?;>,&:M<D3T"K__/C-'<X<WV<02N2DC8:/3CX:$M0D"G!TJ55;Y67-SN4
ML*TGBB4 [PTEMR]EP 2QK.%@?X,&:0G,DRDF^+J:W 0=W3Y_"ET3U,!N22:^
M;RWH1D3+RC3V<K7/37,L"NVFDBRDA+48?-8N9RS>A]4$X8IQW_:QJ-TL+-@.
MI\D-!W-YI<)HE.EY!Y]:[^YC X:MT=Q@N$IN>UB$+?Y,I,"TG0S;H=EZD7UF
MO)&-B&SGS5-3<7&C_1WO,O&K+.*Y./XQ$B=')P^:=29I3EF^9R!QG.O"U5LO
M.0>-^H9)T.8*V\8N*/AJ#/?SO\[/Q87_U36=:+?_>6%I]&5@4IS:BG1802)-
M"0M,]U$M*TI]$"</:0\GC4FWC^4=,N1"3-"3:M#?>5M__I<X#1H+X>&/AX/S
M<W2FGJE4KCC?,FBP&NS73X"CO] S\0%6_BNK !_KB; M6SM'HA69$#T&F'-D
MA^3RI A:J1.--0Y-U6$LSK%33I:IV%1OFAX)L3E.\WC[.+J.WB^_=4;#P8Y#
M:B@SMCJ)(6+]HA,0TJ9VPD>YK#LL&(E/NX&GQ\/!!F9MO+EQN!-5K93*>.>F
M4JR"35 ET4>R P@>6'#SO5PLG\+'NJQ\'UL+G(\7 3G(TCK\A)S1@JG)@[0]
M8#?\@G@ M(0J: +3LYO2=V9!AS%F;IA<4)RDX8O4"P Q]L6@<J5 PH1D3",8
MR\KV@4!/HP5>N(X^3M='M\-!]SEPZ]H%5<085ST,"0H:_TC#+QV^G]J:M4T4
MV-C,R.&QF13+Y<)9R]Q.W&BLT[.S+M3I9 A(_( $- 6E=N"*5G8) 1;@.W6%
M[G]$A/,LYM "*ANNC4GKH0;*1>+M^!0+M6><6X);JN,8R X[!H98UW5R (V-
M#0:;ZV44!L:1ZS)M4&XD#\3CZ/%C^/_A8U-;*?JPA/+4@AJ2]E&96G[*3'9E
MFE3DFW2C+[4SF1R(A]&C1X_@_Q_[IX8W@6M_7*+I52"O%F_>O&Q R/SF4+E9
M[]*S5EUQG^BNY=F:O;XU#0>T4^3:%$3&'"OG1_"=-\VZ*,\/IC5)?93VTG]0
M-TV/ZIGE16ZVM0.S?)U./^XQPIHCLD"5? "_^^(V+,I<."UY)UM@@5P IZ-8
M()J:)I3C0B!41<IE&+XDUDSVF<O%*! P,$S4-X3OT&N#LKGJ@["SB4E1B$>F
ML3'6]!EL)V7><B*N830MC*FO*W%=(Q(5%OR=9X(+^M"M=SO0;I]TCP=WZ1XW
M+-WCVZ#4O>>.-^]D)A%9T9_)$US_&TOJ9;Y0E*7K'-1LH'T-\H]HYHHB>&1^
M=3/JX<"Y.FX'AW@E^P4[Y;KXT/UP8,VV*48Y3T%52,7Q(V-<UR S4CH1]6FI
MC9&';/YX?'S\T\GCD^.3=EDBU3$6QA?UM^/C\<,C/)S>-\ PZ@S><YDW!SM*
M$$SH8&J&/LJHY="F+TQ=F?W*Y1=@.]R#L,^ME:3#P1Z8WQ)MUY3E?>)N./AB
M"!^DM):"W&T-UYA*#:"=%X_Z,O3"H.3BTEB6<ZJ)IB:^G*<5BO?-U^SX2=<
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M#OMNNF.C45/7 FRF?LR@RDB=,AN])<KI:9 <TI^F [;)<( L;=JTKS#0A<D
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M_L'OT]'$-_3%[\'X9KAX:(95H0&#$0]A"'XKM'K&CA\-NO.FC0O:>.C 3[Q
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MH$=S4[3@.3@2$/G;NVYT;2IU:J" I%(*_QBW&R8M_:!H7TY,.4V&LOF)6^K
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M5HT,*/@5BOWV2^H#\]!S<]COS_H+_.SV;/@S*[!2GA>XA-VPF.\K:L%C!\7
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M8PAB7#W'>$#*@."?9-$U^2$B4.<##GD:4,,7_%:A_&OG1!+0JO$+CDP1UC:
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M_&EOT'*EB8:VSZIJTS,EVMWJ[Y<H.K5>6UMF>8VB(,2^Y[+M@97TM](!WK9
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M;4E(&N']@CWU1(&KH4YT]M,=T<%VQ0&J8+T9!XYW0L<7)=6\T)F^'5,"17Y
M%&MY8UL%Q:3<51@- I=I7Q"BZ2,_A0N=JDDW6:]N(5?,"8B9-O??ED!&=[@C
M7!(U 7;I&%IR-D"HM+D ]T,$+FT'#59XO0O?RB,%]>@64'(N0)RT!7GNT_O%
MCN@J'FTNI!LAN$^7L<KS <8V:'PW6G'/1<VR0W^V%U0VTW441G;@TM4D3F]K
M/WNK]:J!C:_"5[NE,<U+ M2YVI]7? T(<O B\/ZUSPVW,-!17-JI(UBJ,@)"
M89A_K^S$[0A,"CR ")D6H)0-HKO$9(;(D^?(MJWEQND8HA5X Y&N/9!I_.SP
ML+A=&6.%,!!IIXZ@H\H("(4VATSZN( N$ ]>D"SC 3LM49.[=[V>K0 GA_7@
MW4+EH3L"?KWL@BJBS=LC77.NT7?^IZKK\;9_M\ NPQ.(J#9?D/"UR/B9[K.]
M$/$(CMT:EOQ5%O)=:;ANX7T$BR#\^D+,>-FXP$T)!D*A;^C7$"'(/6Q?,-6/
M&+E;2E$/MZ!^U!Z<QEXH3(/T1?Q.8:&=&=2^(R@I\ #)/OM&]6]O#]BC'_R6
M_DWPI[U!T7.$ A>YZ:?VI$$)=#!Y?./@U5LN!2A=/]69H>TS!NA^(;(]/[QF
M;$3>T^ZE/$N]^_.KSY\_OSO_9+VV+KS0\7&X)HC^XW9\-;@;7U@W@]N[/ZR[
MV\'U;#"ZFTRO9];@^L(:#JX&UZ/QS/I+,KJU'?X_7FFOR) 11 YJY6HIF9Z:
MUEQGB=PU4UJUF@Q[:1 $"VVUX6J=L[;OOZJY,$7ABGN,%,4!J"D#=+(@]^=7
M$5D+Y-2.CK"T26!9>D%V*'%S?0E C@('J_ & JD+LHIET?-@EAY(4RXV*2[X
M.);,NS/2!:_)N4(:5(&6\X9<LS<C3]A_8K$!='_N16EN3L5LI<H#W.O9+U>=
M@;@JCW6OS_!1!@6(V/X,.?S>61$O>:\&)EUK*"EP!F+35T?LTLZHCC*(VBYA
M^S*(?1E$#5N6CI=!+"I,M/30?/Q,EW[FL9G.YYZ#I)6B)!TT;52*RR$6DVW<
M8K>-U1]NMO6*^3V"W*(5='L11DQ)- ;ESMG2FU+K(;H;LYE[U9VRA^=KPIS^
M0SOTPJ\!?@@1>6+L3X+'=43_C .V9>:7OX<<%ZVT+7Q:CU55TP% ;YK&P22[
M_)*5S^1=@Y$*:FCYY2$F!'^GG!5ZP@Y;WHN(;F'+T=Y2@HOY!P'5=C:_PL&"
MO==G-S+3>>SX@4$5M;[7E"F^XM42R *$C1'GM R#\@>XDDX= ZJ(D]9\D%E-
M27VBXS"BBX07+OD+)B0"),W.7-BW*[B48\BX8QI_S+E;E>$I=-"P*_!(J#?N
MG'6%[8!G*0I#2J1X_FS7ZX.F'<-#3#^$B+:<$6G>E"&RV78HLUD:/"%B+Y(G
MFIEW63!DY<?J&*85&81 SSP*:#$(;>?G&3\_^C@.6>=/ING23G?':0B:*/+L
M\V'D63J8A><6V@W'?MZ.MPT[TQ1L-HLHULQ$Y> 5!;CFV^H*XDTH*8H4.VAG
M3 @8+/9<F*V(TZ:CN21);L-H1*DA4 7,)#7L?BM];ENQ]+"$UM9VT+L/@XZH
M P(UN2QE8A)+LC%W8NW"--(%5U7@+4<072([]&+/SRQ:NQN67"18T/6,9]^6
M!Z.H]&W[.DZNQ+@"]:VM)9<>\MU=E2-*#S_Q%& @ZW3?=JW)$M(OI!M<=VH7
M_ 7Q?+]0V_=;W;==2DM=M )"P4-9[;+\0C?"OK\F"\^Q?;E !4U;/RVI2Q6B
M%A)MY4J<DHA![&-6?X+%V/'Y0W=&\WE1P*"DT_TG8\5=3#<D^$_:;AP.3YNA
MY%"3;WM_HND>2?D8 ]&L<+_0XNF?)0JQ@\TD8/=?R+VB9A[%>=/"2^S[^+OD
M^/_IW>'Q_VZ)K&1$RTN&M'PVIN6P02T[M.;QL#]EW  [QNME+DU3-9USOC+^
MF<F.OT'TW^L G;UC"BKA]43$ZRKY '-WQ&SZNV]87I9?RXXL]B'K[-U_6NQ;
M;0B LZWRAO#3Z2%[5^/!#'@BV!2U=(%#8>0Y; W#!'F+@.D2#EB@-(40A^$0
MS>D?J++2EG?V,Z(8DC^03<(Q^\H.1SH"_<_[ 3U)**CQV2'O*2&6';C6/":%
M*G!*"T>;4F,]<'*8IM,.5L0(8LTMNC>S-HPLBW._CSL?E%%GV;2O>$+T?K'>
M+V:(7ZQ2B.J65+HQ61#[<<FV@8#[C+:7-#?4CR8GNNY#<#4,8KW+4@<ZBA@[
M</.6G6]*LL4JA-?NC-,*A)&.N[K :B'.+43.FP5^>NNP.SFRB2%+_K%#+/G%
M_6@@@"?YXVC0MJ-.2<^Q@,A&EZ)R$OTZ@R7Z==:Z]ZV"2!,J:_>U'2'47X:P
M4'\9MNYWJR#4A,K:G6XUA$*P;3T[=K "6G%N-U96/<DOSAY '!Y'QL\1L2GA
M7F"3#=_+7>. K:54=LS)F 8,R&(F&OOH_6?#/29-\VZ6YR4^EU(:^09S$N['
M&$_G&2X'W,:NJ8KS@C.RL^Q[D9MBGG[*8@%ZB#LF+++W/7:FW3O'VI$5IA^U
M"/MJ&PZ+BR1U5H;Y6S3WD1-=([H3?Q[/Y_3G<#J_0_0T3BCH%QZK?8M8KJ0A
MBKXC%(QL0C:4V3CXAK8=A"'BGM&, ^@2DTNJ-%0 MG^+Z% L<>/-FCS2 Q-K
MFG3^&O($JUMRTA9O9MXB\.9T<6.Y'G=.BI1^3KD$I@\YET/2<1\$$O/.'0H!
MBMAO+12+@ $6I4*PW)T4K(=8#+R3D\C"LF-^6"^;BX.[(;+>*N:XF*<BH5].
M9&(])BSS#FS,=*@UE0WOM2-YV_@-U[MP)Z0#]XF;LILH6PNJM:W@SEX!Q'DY
MV:Q@6;84_40?#T%+AJ0"X()Y2@>V['1DB8^G*3YW\5RC]6KM<Y\=G3S;JAAL
M?97JYKDLJ,O9CLD5$J>C<H=8']O5^[!Z'U;OPS+.==+[L P!HO=A]3ZLWH?5
M^[!Z'U8[.\N]73\_&-,#&RNRI%(&,-?'> ]2 >EF.8 R/@Z5"(U<EN?)]6CZ
M96S=#?YA4BKGV$-#O[]EC[FL]IU;"H>SDL-H"F%3(++@2%=B"&-.>Y4@/HR.
M*RLZX[,Y;QD9K*,EYED9I7F?H/;:3HOE(1&Y[R$!&)3$.4]H45X<N(>>7$H%
MHB["Q=S<1_5!8^1)LT[X#,T,E,9.CN*=<5%Z(&'SUL]1JC,%*]+>[.E*.5$D
MB[\.',@.L12+>RVZ9WER+(""K_54FWPR.=8F_\J<:Y/?W ]\/R'/0W#NM;2Y
ML'7[?DNA0+$"J<U:D_:%;Z0%J0Y0F]Y)58Q&@PL))O2OK3M_5#0<B\DTS_MS
MB5@)2G^[JB;OD(8HH!*,1 $VL*$N/];]N1XK7L?QM"*W"@ZFEG=CNWB4. HF
M'_P@V9L5=^XRQJKL&7=^S1'.'X.7\/ J#O"BP)6P6/>F$4[983]ZD>TG5*1$
M"'"*7_X*6W<2E")^P&V)YHQ8VZ2QS$./R(KRYPXW5^@)^6<\,6PX("B;+?;"
MCFQ):)4T7]:<?HS'D*'0<K>?LQXVEL\^:)U9'O\DCRE;9SYJN?2KNB.OMJ*:
MSN=)\<K9$J'HU@N_A3N>)P'%?:5Z"W#4H)IBN?+*(R)>N=ZCRBC&W S4H 1@
M!4AU<1I_59#)-+[]\5>/[B2)LXQ7%^62$=+^!M2.*($:6#)"048&[<ZVU";9
MQ7F=KSP+RJGXU8;17M-!!20 X3*",NFR0@?21CJE6M<&0^\^MN3&>T/.\DG1
M#8BDDZX*A=5F)H GP!:X;NM?N#,4GU9![U3O+593Z)VV?\%U)'IG5= [,Z1.
M2<WH9=D"5TYMZ(WL<#D(7/:?\9]KCYZ"]]C>'1U@+)6'T!7%6/_AJ!S+=3NG
M03?7X,GV?+:UO\1D1FE*JM1Z*&141IO=O[E3#O)_E1SF!<!:F6WC#D&QS[74
M_ 6[O !@E5AL-':A"HC7.$+AC;V1NZJRK5X.5#FN%%S4&NK89%^TEYEL"IU?
M#I:JS((7^+H@_IT7AH]"JHPS%$4^B@O2,7M?"NURX[P<X"OP#>G !VWGFC0E
M0]6IKCC RT&]#,,0W!_U7#RN'T+TYYINXL=/;">O\"SH<RX'[^SK<#;^GZ_C
MZSMK_!O]7X/>!AWPEP-2< \&]M!TN[=/3]$MGK"U,;=U17 <7L5)>#?^RNV0
M>/HI^1T;V$'?I9I,_G*H#K@UZ* HH+3HOD321<\M6)&T"[$Q]XJK3GA,OKJJ
M"4)#[Z4.Z"WRB@N;MYTM0GFV2*%IKC!1?4F?8K?>+HM<@5V2=^N$=5+AW" _
MV &910L@T%R3;5*2-59AP#SK5 <P1ENENL SU"XE_IDB>[373%=,A'Q2"/U.
M1D<[9,H<%Q^&A(V[8&HD7!KDRL]06;2&"9KJ,2PRR8(8F&M*CH' 9!-R!$PM
MUU:]61-GR<I5X?F5';CR0GW"QKI"=F %QTHD@S*N_0'2!;X8+ CBNE-0OS/7
MLO6GN*6D"] +7NEI.TP<&*\+%#K$>XPR]J[P0)[ITWH)T%I<QX<,0"AILP8C
MWP[#Z3S9QTW)K;=81M=K)I+I?!> ,[)]GST(2^\9DX:2C=21 W<$[CJX-,Y?
M<T.P@Y#+:U-,PG#-;BJG/$)K.H\/!S#LQ7T[@JPB(W6[<$"#-EO:! VI5779
MR8SNF>+WVTR?XE+9PPUO$O(V-_:&E\]F[TZG?/D)?T-AA%Q6S?SY$3GTQSO,
M?C5=1V%$K;07+&*]A>QD:P28KB :I&'<.2YA*+S# X=.!H+81D^R*HB:FXYS
M(>W@ELN$A7NT#B.\0H35?Z&_ISO&,$Q945N^92-T!;LR[$!P9@*BFHN0V<LJ
MA!PW#I.Y>7H</]-=!(MD&=D16F#"HJ$#?U-7417PNP/WGU1@7#K-?V]"%[PG
MSUW;?K,?XPLP\PXTSQ(]S+%%/&,1,JPE>L3^YX':!_J;_P]02P,$%     @
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M3+ JX@V$G'8:4H"]WJ(GX9T86EA"_U +H5^X&"!"W,0IGM/_5.:E$D$OQ!"
M2LG12,$CR!":AB1,%''9TRR[13@N24+_H^4&_0>-=.%N4^7+ X?$GUWP0 6*
M??WA;]Z_N0*0V$N4(GR4X?@#S^B#(_;PZR182^ /?G?UB:6PZF_<^Q'$1Y8A
M&G[E1@8Q(5^?^1+G(8EY$7V='STQYQ]= E+X]AT96!00@:F9T)'U%-CO,=L4
M1,I;%^H>1Q/&%/*N0[\6]K OD J#((T-0F5OT55"C98G'LW2=!<D]WB;$1U]
M^F*N62,#.21+5P841R3 E-0H95$I[(D1_WL7D *39&\DA2#IFA<*J$-J#,1
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M)MD>8SK^+*?20G;LUCM[[DBVPGD>9VF07&/E'A11S'$1 2G(0=F G@P8EBB
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M6A?DBVU2%1",LL=I6GZK=5&01H@9P)'O@X*-<U'7,?T$FX6.<]J9X ND4RG
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MG&'P3KVV',Y%MMGB-"^O--Q6]QS.>?X9/V-6H%^?UTVRY+P6TC17A7)(X\R
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M>V%2VM]J#/T70S28@I^VT>LXCP"T6C/IY8Q8O1EEWWL#.Z%3YM6=>G%'VGP
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M3+R8;VUT8-K7]MNNV6U4%$=^ATE=/U+>?J6"\+Z='N;P"[&XCK;EK2]-<61
MK7'HC:;W58C"_T)#H%.^D44;<I)VTFR!\#K90=*MZ-T?M/Z=Q$6!T[M=495E
M5;RHJ<9<)I2'.=SE[S1+8%+%@^ +2X[EKR^#SA=!DE2 9VESW_0AKTEE$1RQ
M]:Z/9K?<'+3X?;@K0IX$I;JHG6M92M]23EUCMTT_%LMF9OJ@%Z:Q"H_WQE<P
MGOM*DR^3_R9W)/OSJ$(1\VWQ5,%[6^!I6?R,C?26";IDK!IHEX2B%)C400E-
M.)"=4<ZA;493B"(.V*[-J%(]XO+8,?;/T=%N<D?8J26&J'/'YGRS#6*RT6Z=
MLU)VO&MNA$.##7,6FF"(. KND)RM )O"W)2FT+:QY9V7O"9EB_*"1NVU,JBI
MA)W>[ZL%W+O%5RH)AE=:>!H>\>(MZ?I50B-<5)U[]T^C,"0[W"UL2A-<?G5P
MYT^J%V&GZ_@2:7MW!C='FQ7A4' $6LD=T4P7=6HBHB7;.(P6CTF\#HQC]1-^
MOGM<!.RT93VIUHG8EW@5A[&T7S)KN9HV_+G\="E>LX?KTNX1F'67?%>RWL,(
M[61#C".^JCC/\QT[@5L.%13^ZQ1<!@PS\"[3U-)@0H,1HFS5=ELI(?9RT'9'
M T%(^ZL59G6L09'K'F_+V\!R:WJ)*KX(I@*OHMA0'B3)%"!U-(/ *);'[^\H
MQ()VG>S*K"WS@?>A:J>U2HY99>' @%<:#4C,,L,49YL ; WO]>!;@L.RGAS]
M[P3S"D!I--NP*E;_Q?^N=%2=\AW)O.-\_*@O99"R'\4V&.X?V2%=WAAU['MO
M.4I':)\Q-DQP%1"1N />*@Y3>3!,M  IZ=]/=I1A6+X_Q]<963S<77TKZ#]8
M4Z@RD($[H[7='6T8[5)[Q,%:U3N=IN$=,NMJ>.E"CGFA1VJ"_KNR@>HD]&0D
MO-ZQJQ[*5>"'[(Z^GZ<@QT,G.G,HTI<QP8H[4DYVL27G:!- 2#H5]Y"LI1U4
M&F)+![4IU-A"E3';^397V2NOHTJQ\25?$D3X@EU-H4M(U1J.<TP3]$':J!+W
MSD5[C)+DKJR#NRU5SE#!E+SSB@_;Q.EJ/;5,2B[99>= EV!Z#3 <LX(IK-DS
M4M4<0P'3#A(0T4ON1GDE7V@*9%;*?M>Q= [I%[)DFF!8. JND!FFSS')TG+W
M$B@V=J,W&[8+7C8%2R_C/$PR=I6D75]@;\UC'SS694W_;&L*$J,/P"\>%PA2
ME)%X':?E"&B%<=/)L_R2X')&A]47\'\YKXWSH])*O05H%+=/.W7J+XK*AGPA
MJR)S+SGEES<$U3Z$SJT/WNG;WJ2Q?,I(\8#)ABUIZ>H?ZU7\W(RB!B^_^D24
M!T-!"Y!",6\F^(I)(B8*IGIOSX$;0]E=E;!30FD!]Z@DE81#(AT\(WUNCE<%
M]A@5H.M]]9K=#X*4XRK+,HB#NLA=$3 \D>.2]VDAN!,.O7,9?\-)])#55W8V
MM\]<9^2"X"CFQ8=TW=ID:T[/2ASF<N] Q3138*A[&'[Q_B\:^%IS9X@9?%5D
MKVJ39Z@QRM=B2K.('VZ&TM^*KZ3(-MI78NJ4#[+HMV&,=EW?.*S- 6X@8WTX
M;B.QS"I@==1NJR]L,8FS:%D$I-!MI5:!''ZOZF(@>'6OV: :=Y;'YVF8[%@I
M"'[2Y)[^5)[05*\M'V3)];SV1%>'D]PCS8 )1-.QRTYRX.ZVB)/M?;@C<<IJ
MER;M%%!=X;=J?4)IN3&*[G8XC'&DW=1@H^6=7Z.A#NG4J/+IN;KD<CW0\5;2
M:4(WY;:4>]E-7:7:\SXJB(I.Z@Q=XA#SFOKOWT+IICI[3Q>KZ_)RWG3--E\K
M^R.MBM..QP)\KX?1R'MOZB- "GU&1X5??1SG?&Z^;//5>2':YO,3[J1C92=)
M$!:[(%'<!J"1<]=7:&"V78-$R#L]3,@DQ3IJ23B5]FO,M!]C ;-*EA0-027L
MMM2,#G"_@HQ,TCMMK.!))T.]DZ5=)3K?Y71@G>>S\+==G,<\?3[?=_YEMY9G
M:\;/^MXX)^5K?G8VP)!R(G AO:J46?7%QWI+!90)2XEGIAE)O8I+=MJ [S)1
M)P^&=18@[1AF.=OG:!TZ()@.]D)E&.P(N%UO'@+KKS'7O\(;W0G8A!0KR7)6
MV[5;"QUMF8*G4;7UNW8[Y:M?Q1= '><U'S28X:@>@QQ'M,&S3(FW^!DK ;GF
M\WCG^U:D.ODQ^QJ0J-D#.*.CKDU97)+E6F&!([;[X)TTJS_EX]P-K4[_TMH1
MVNF>Y;UE.')0R/G9WI@_X&_;F.S_"*,[.S>[?S[&_<]90LTD<;&_#PIM/WGJ
M)SOO@-V\2J&W.>UCO3=5][X*AR5H"EOLT7,C^_MJN?=Q_N6:8%S/7KAJM_+G
MOMA6JWN-)VNSLH?^/ENLQM-A>V6BKU94%A$J=++\=;[9)C&.+JMU $FST<BY
MRQ@U,-M43R+DG48F9)*"H4RR79@YQM<_.%0W7/X;CM:8[U3(9T7S5T73,6JY
M#).6+G2#G$$%XF8H.\A"U0+Z.WIF F=H1L?+"7K[#LBJ,UN"F*=Y078LL-[Q
MMQ"'59S5[/73Z+C>B6F$/]QKJ52 5L74!JQZF\G)2[9</+$^>IZJXI12RN$B
MLPIB9XEY* *D3U/A$B;EN!R*4[1JPHRG6<\3] $^ML0:9J-M(2OW'EEOCX4P
M0>UVLY?%C2H2;*IYZMX=<$>9IS[.H'S*;&)U/U+G)LG!Q9/W>!/$*=^?U.PW
MD4UT>T7B?.#NYU4+;<DM#.\]F'_?Y9/J>QR07#NG_E(FDF!-_X*[-M2ETY*"
MBEP<TESP\/(*^_HX5IK.*X:-KWMCH09QPL$>MG M*--$'=4SQ.<AN#9JU7V/
M%6;1?^[R@A_)6>DNQ=0JP(M =G"E,T7E%VKUV$9RFULO7V:C SC"&P/[%,W.
MP\S?)<Y#$O/^SFHRJB?O;\9/ EL]V]<1!I,AFQ":;OX\H_]_HP.,4]=!B&<;
MMLIBY7Q7W!^C1-!J0K6R0/DD !3.*ZW7A,]#L^F1^G@B5SC=CKXB"[^PJY-P
M=+EC%R"5\]KEO;C\QT6==F,2QL*AE,E6'.Z_F^IB9UO=6!/>&7@8;N&^@QT_
MG4DS'[[+-$?;JM"W]QAWD01YWJ1R"W+/YB5J;_B\9)OG5;_F;Q6M=:(MI_6F
M#G&W=XIXBB%H6?TA3KP<BO<[$7Z%.84U..]NU0$I=?UU\ 9WU+V]0M%[X)V"
M5E^<H*X="N:TZH<@3G-6V ?GB_3J6T'[E5V</Y6#:DVE/@L]ET2T=J-+0J,2
MM!AI"_B%<5!R6(U5 EBL^!\(CJ[2(B[V#S3VYT%8_SSB9*&=-<^'#L>X;#B/
M:&,*3' ]#+_DGH=:#"6TI8 A=^=4Y1)O [8Y,MG?XS!;I_%_X:B#.Z\.KK.K
ML<O&WHH9WN&Q'N*C*1SW!<E:R'&> *[A'-4M]09+7VN[\F$OG_0MI^QR7D2F
M,WW7EC:4KMH>8A#>:LAQW#DDC/[WPOZ4-6ZWN[]HIN=_65^UJ:P^.="NZK.A
M>W69^U>+Y3DW^\LP>8Y9E:IZ!6K?V9JHG8RWTG2Z?\O>E5ZS,*M!7.BWAZWN
M_%CMU4>\CE.V,>IT$_A:I%%4UHQ1;P@?I>]PTGZ\6YWI>GME*%WS5." ]Y^?
M,&( W*4P!K8^9F"^P])_W\6GP<LL49< -"+.=Q,/P G96/4[F,&7!)2XH:"L
MY<(2]+-J)>*,EZK4EZ1UR(C.+F"MGSTY]]R0P!0)TA$"QA(1F1U5LE;//U]T
MJ\_EWZ\S4@9.K+P;:J01ITR;Y*#%Q(+" AR.3H$M[,P.2$KI6E'W9 ER9Q?7
M8L6>29M6"52:@NG$W:6_9M!MMJN6]<X72X#B92.- AO5XZ,2Q=^A,5,)*M6^
ME%,^\$4< ;-^<4<YZ65\&I0QHS-/IQ[?^GT45OH8?(LWNXV+25#MXW]7998&
M+]5IM:7JV2";L3N_3UN"Z?!FO7O,XR@.R'Y!RFIN'W'QE$7S])FZ@_$RX/?D
MLD24OA=!N!;35D _ZB.<-L\3O)Q>$SRB?>])Z F=$J[3;;101E!5A+!\"JKU
MSQ![$,MKE^70_8%Z"Z8L>^M!YW7<F.YO-BCY:1HZ!^1DEVD I*\&IIJ0 ]H=
MM4J[H291WBF;LUC-T[B(@X3]BW=PPU'/*$W7M8LL71G6,S*H05H!'0];J*Q3
MKWFBQ[+&SLGHU0%7;_.O=__+;^C3*[@CDPWPED,Z:2A%TJR1:M:^.@>K$:[5
M3K]P+M2,$LE_C_-=PK9.7]./V/S<M(1YNMT)>XM/]A0/B_#'?D62I?IC/0+*
MJ.ZT[@%<]G?030):]I\"6U@ X<MT)^\ERX5"GO5U%V@4>9=2V.5=A'K W0L)
MY9+>DW8K>*H5W?+\(91%_W:P<9&E=#"!":?U/0YQ_(RC.TPZ&W]58Y>11IP.
M&"<YV!M CK+@G9L'P1YR]@/)\ARM=FF4(U(I^N=LNSRM7%/KB7C:-"!?M^K\
M#H<K(J@A$SX&Y LNVE2^6^X33#2[S5(*"M/!;_=P&#LCR<ZVM"=;%BG_>86)
MXH5,,>229=,=[7)QO!4PC)T,?<CK/S"=/W[/M!#E\[RZ-MH[E2<O%XG5/,O:
M!\=>EE(_YT6L9)I>TU&6+%4/@30C>&HG3SY_"*FI#0KG]HJ5G/Z]ZY_^0INE
MS2L]46/5/?IWWH0M7/_]-^P/?+)ZGI;;7_E8Z$1O7OJDE]1@-:_JF(U3\A@P
M*>GI?!-'Y5021V=L0AC2KEF=\_DH[T_1CQX3 :BF>?Q7.ZK)'N_Q+Z<I']UG
M91.G77_9QF$5VU#7F)0?V!MMQ=5JD/T%80?X("P%L/0H27#T/;]Y^G<6RFO_
MO4;SD2!>5$"?](*/&M-'(?C]A/4I;ENT?:L8#Z/M&U[0=496."YVI'U%)\J6
MI4\"U8JGOZICCI@DCP'7L9[,Q?^[^EW)>_#1\XZ& :K5GN@E'[7W'8D!RIXY
MS_X?JR,&W*=X6LT"M''O]$Y.W^;W,H@#=;WE]TTR*]=/N\/4^^"A\SKF:4'B
M-(]#664[!\\#E9(<^MI.U%K[#WLY@_P#/53?ZA37XG[K\DTM%_'R;V*&5XG9
MXTL8\K0V@(+2 B*U"12V-E 2KUY^3Z)=?N$_7M(&VYSJ<+*@:X'B)?4Z$U_Q
MZ38#&"'\;GJH:7YK3F:R86]6UN-:E^N.*.(K7*AXXK_2Q[RT@8UMU92C$M/V
MH4![*B<NJPO3U+</ :E0<\PW4I?=NHR?XPBG49=YI_P2\N>^B'YF[&L\^6T-
MW8>^_+YDI*?"U$,EBJ)*%NUCG'CM):;DV=!*#[KM%XS$.JV30C4;9N\59RKJ
M/A1UGHH>]Z@K5ST9\4?W;G_O//X,-71E"+QW+=*+3<V%M\UJWN^J-93E-NE
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MZ&0;NG-2=(A(_]62D/[C5]H1%JN,;!9;=OM!1B[(?EMD_+8>V7C*3L4%V<:
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M98=/+/W+^=/>W^0PHEV4&_7N,L(6DQ8K.]Y,T'<;UT:ZU0]MELKPHMLXX-(
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MV_Y!HU1E3?O'Y+*G5>8)*%&O"MT;XPIFU8 0!CUUW(3C,R;1W,@_8TW+3%&
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MW/^@VQNQ,1NQ75WO775FYF[(LEQ'.R[+*ZFZY]PO'30)R9RF2#5(NJSSZR\
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M+'0:*B6^T7'YG? *IL0;/C&[M"+9NZ#3926G4S.!#(?!SC(RP["1C&Q%-E=
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M%)O$SY2=<&9)#4F .:+NA>Q? : I31.($/ GR?[9ZJ]L&C,2Z]\B9M.EDLG
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M( M*+;6B'#I1G;5Z\.=D&"_[F([&/DB:6U#KR QJ)=LO"E"M'R#M8$'UH=-
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MLUEI/* ]ZS]X'].85_PM3I7TA)EV%>F ?=!)@]J#_PGS0:L@!@+!WVSM+[5
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M[,H2-E38DUS ]LJ^MY>)<;4MU,BXH>2OE(3N5I,E">ELQ[QL8&)!W!74$QG
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M1Y4+])!"D21=8*"NK64PR%2KOG3#$2==;=,K]I,OK^I-N[(+MI,OUY@CWQW
M-OJV/*,NHU27VUK7%MN7UD.A(-X2#%Y:+!JT(NA"S'CY^9<0\R7$W$N(N;,D
MCA\UQ"QJC&7%!C1)//M6V%4)I3NRNB2;$F^6"'R:)G'BA![3,9W4CYIB>W&&
MLJ]A$Q\ 5;&][/<W$<U,0(.*)-)QL+T^.'2-!-198G>ADNA4&%&F5!DMT@B?
MH@?V,J-'0<N"5-Z]/\TL-FF"*D5AEO?5YYBSN/'?A[/Q_,1*+"T]K*)_>;G<
M#NF!!==-UVG 5,@3KX#SY%%*'DD8^T]D$C)H""!)SVP4.]SD>IS*;RH8,88?
M6P;26S$5C2&]M2TNW42AFX%^:V5,^P6^OM4"I+#7N/"BWY?7N+IXC4N5#^.3
M>'B?/@2^NRN-K XN*+M@;Z) [V_IV>C8[\Z^?64N=4D7[/V/J=25G./O8L_K
M[G!33Z?S^\3M -'%Q5=%F?PNOXEM'-O4E$YA.>^4P<M=YHZ7FS;UN/?[S2]
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M.$Q\A5VK8T@W"/X+CDI556&E8ZT3@Z<!\=JGQ%49.=:HW 9\9M3%,PH-M:Z
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M_= ;12$72O[EW>TWM<SU_:"B[^RT'29ZJ #0E^::0D;JY5G:P0XKW\,2+95
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M-S0Q,&MI;6<P,#0N:G!G4$L! A0#%     @ >H K6WD4P*SPU@  BO0  !(
M             ( !71$& &XR-3<T,3!K:6UG,# U+FIP9U!+ 0(4 Q0    (
M 'J *UMV;LDS/]H#  W-(@ 2              "  7WH!@!N,C4W-%]X,C@P
M+3$P:RYH=&U02P$"% ,4    " !Z@"M; $M/)%X6  "KA   %0
M    @ 'LP@H ;C(U-S1?>#(X,&5X,3 M,3$N:'1M4$L! A0#%     @ >H K
M6[_<@M[8 P  (A4  !0              ( !?=D* &XR-3<T7W@R.#!E>#(Q
M+3$N:'1M4$L! A0#%     @ >H K6TV[-+_& @  5@L  !0
M ( !A]T* &XR-3<T7W@R.#!E>#(S+3$N:'1M4$L! A0#%     @ >H K6QV7
M4I95!0  /AH  !4              ( !?^ * &XR-3<T7W@R.#!E>#(S+3$P
M+FAT;5!+ 0(4 Q0    ( 'J *UM!]02K7 4  +X=   5              "
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M"P!N,C4W-%]X,C@P97@R,RTS+FAT;5!+ 0(4 Q0    ( 'J *UM-16;(-@4
M !@3   4              "  2H."P!N,C4W-%]X,C@P97@R,RTT+FAT;5!+
M 0(4 Q0    ( 'J *UMI9V[#,P4  %@3   4              "  9(3"P!N
M,C4W-%]X,C@P97@R,RTU+FAT;5!+ 0(4 Q0    ( 'J *UNZ^?0^204  )P3
M   4              "  ?<8"P!N,C4W-%]X,C@P97@R,RTV+FAT;5!+ 0(4
M Q0    ( 'J *UO5IF/:; 4  $4?   4              "  7(>"P!N,C4W
M-%]X,C@P97@R,RTW+FAT;5!+ 0(4 Q0    ( 'J *UL@)GO$@P4  .H?   4
M              "  1 D"P!N,C4W-%]X,C@P97@R,RTX+FAT;5!+ 0(4 Q0
M   ( 'J *UN"!(/<C@4  ) @   4              "  <4I"P!N,C4W-%]X
M,C@P97@R,RTY+FAT;5!+ 0(4 Q0    ( 'J *ULV+B)2, <  "$>   4
M          "  84O"P!N,C4W-%]X,C@P97@S,2TQ+FAT;5!+ 0(4 Q0    (
M 'J *UL>UZ3!=0<  '<C   4              "  ><V"P!N,C4W-%]X,C@P
M97@S,2TR+FAT;5!+ 0(4 Q0    ( 'J *UN]OCWF!P0  +$.   4
M      "  8X^"P!N,C4W-%]X,C@P97@S,BTQ+FAT;5!+ 0(4 Q0    ( 'J
M*UN&IX@O)@0  +T0   4              "  <=""P!N,C4W-%]X,C@P97@S
M,BTR+FAT;5!+ 0(4 Q0    ( 'J *UO(R:L+YR$  %*J   4
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:+GAM;%!+!08     (0 A (0(  "=ZPP    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>n2574_x280-10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:currency="http://xbrl.sec.gov/currency/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:niobf="http://niocorp.com/20250630"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="niobf-20250630.xsd" xlink:type="simple"/>
    <context id="From2024-07-01to2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:CommonSharesWithoutParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:WarrantsEachExercisableFor1.11829212Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-09-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2025-09-11</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_RedeemableNoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_Entity0896800BCLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:Entity0896800BCLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:ElkCreekResourcesCorpECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_NioCorpTechnologiesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_NioCorpTechnologiesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">niobf:NioCorpTechnologiesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_YorkvilleConvertibleDebenturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleDebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleConvertibleDebenturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleDebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_April2024ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:April2024ConvertibleSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebenturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">niobf:YorkvilleConvertibleDebenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-17</startDate>
            <endDate>2024-07-19</endDate>
        </period>
    </context>
    <context id="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-17</startDate>
            <endDate>2024-07-19</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:YorkvilleConvertibleDebtFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-30</instant>
        </period>
    </context>
    <context id="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_ConvertibleDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:MonteCarloModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-11</startDate>
            <endDate>2024-04-12</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="From2024-04-132024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-04-13</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-12_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-12</instant>
        </period>
    </context>
    <context id="From2024-04-132024-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-13</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ClassBCommonStockECRCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">niobf:ClassBCommonStockECRCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_EarnoutMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">niobf:EarnoutMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-05</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:PurchaseAgreementSeriesBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-13</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-13_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-13</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="From2025-01-022025-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2025-01-02</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="From2025-04-022025-04-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2025-04-02</startDate>
            <endDate>2025-04-21</endDate>
        </period>
    </context>
    <context id="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-30</startDate>
            <endDate>2023-09-02</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-02_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-02</instant>
        </period>
    </context>
    <context id="From2023-09-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-06-022024-06-24_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-02</startDate>
            <endDate>2024-06-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-24_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-24</instant>
        </period>
    </context>
    <context id="From2024-06-012024-06-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:YorkvilleEquityFacilityFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">niobf:YorkvilleEquityFacilityFinancingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_GXIIPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_GXIIPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:GXIIPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PublicWarrants2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:PublicWarrants2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_LindGlobalAssetManagementThreeLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">niobf:LindGlobalAssetManagementThreeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-09-152024-09-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-09-15</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-17</instant>
        </period>
    </context>
    <context id="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:LindConsentWarrantIssuanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-15</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-05_custom_SeriesAPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-05</instant>
        </period>
    </context>
    <context id="AsOf2024-11-05_custom_SeriesBPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-05</instant>
        </period>
    </context>
    <context id="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-05</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-13_custom_SeriesAPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-13</instant>
        </period>
    </context>
    <context id="AsOf2024-11-13_custom_SeriesBPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-13</instant>
        </period>
    </context>
    <context id="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-13</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-13</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_SeriesAPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_SeriesBPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-13_custom_NovemberPrivateWarrantsliabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">niobf:NovemberPrivateWarrantsliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-13</instant>
        </period>
    </context>
    <context id="From2024-11-142025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">niobf:NovemberPrivateWarrantsliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">niobf:NovemberPrivateWarrantsliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-01-31_custom_SeriesAPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="AsOf2025-01-31_custom_SeriesBPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesAPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:SeriesBPublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice4.60Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice4.60Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice3.54Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.54Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice2.20Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice1.75Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice1.75Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice1.75OneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice1.75OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice3.25Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice3.25Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice1.98Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice1.98Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice11.50Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice11.50Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice2.31Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.31Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice2.05Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.05Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice2.07Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.07Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice2.07OneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.07OneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ExercisePrice2.60Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">niobf:ExercisePrice2.60Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_NoteWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-17</instant>
        </period>
    </context>
    <context id="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">niobf:BlackScholesValuationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-15</startDate>
            <endDate>2024-09-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_WarrantLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">niobf:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:NonRevolvingCreditFacilityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-11</instant>
        </period>
    </context>
    <context id="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">niobf:GeneralSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-02</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <instant>2024-10-30</instant>
        </period>
    </context>
    <context id="From2024-10-282024-10-30_us-gaap_BorrowingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:BorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-28</startDate>
            <endDate>2024-10-30</endDate>
        </period>
    </context>
    <context id="From2024-10-282024-10-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2024-10-28</startDate>
            <endDate>2024-10-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_FeasibilityStudyAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FeasibilityStudyAndEngineeringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_FieldManagementAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:FieldManagementAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_DrillingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:DrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_DrillingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:DrillingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_MetallurgicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_MetallurgicalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:MetallurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_GeologistsAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="niobf:CostCentreAxis">niobf:GeologistsAndFieldStaffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012024-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2018-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="AsOf2019-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_currency_CAD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_country_GB">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-07-18_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-18</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-26_us-gaap_WarrantMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-26</instant>
        </period>
    </context>
    <context id="From2025-07-012025-08-26_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-08-26</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_PurchasesofLandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:PurchasesofLandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-18</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_DoDAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">niobf:DoDAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-18</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512228</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <unit id="NUMBER">
        <measure>niobf:N</measure>
    </unit>
    <unit id="CADPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-07-01to2025-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-07-01to2025-06-30" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2024-07-01to2025-06-30" id="Fact000005">2025</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-07-01to2025-06-30" id="Fact000006">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="From2024-07-01to2025-06-30" id="Fact000007">0001512228</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0021">A1</dei:EntityIncorporationStateCountryCode>
    <dei:EntityPublicFloat
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="xdx2ixbrl0045"
      unitRef="USD">62900000</dei:EntityPublicFloat>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0106"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2023-07-012024-06-30" id="xdx2ixbrl0149">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="From2024-07-01to2025-06-30" id="xdx2ixbrl0151">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:InterestIncomeOperating
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForDeposits
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-07-01to2025-06-30"
      id="xdx2ixbrl0317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0324"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:ValueOfWarrantsIssued
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0357"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0383"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0415"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0420"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0459"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0464"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-07-01to2025-06-30"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0480"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0483"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0491"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0501"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0506"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0507"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NumberOfReportableSegments
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="xdx2ixbrl0527"
      unitRef="NUMBER">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="xdx2ixbrl0701"
      unitRef="USD">-17982000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="xdx2ixbrl0703"
      unitRef="USD">-11898000</us-gaap:NetIncomeLoss>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0777"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2025-06-30_custom_YorkvilleConvertibleDebenturesMember"
      id="xdx2ixbrl0786"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2025-06-30_custom_April2024ConvertibleSecurityMember"
      id="xdx2ixbrl0788"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0791"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2025-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      id="xdx2ixbrl0832"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0903"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl1162">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember"
      id="xdx2ixbrl1190">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="xdx2ixbrl1277"
      unitRef="USD">2881000</us-gaap:ShareBasedCompensation>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2025-06-30_custom_WarrantLiabilityMember"
      id="xdx2ixbrl1494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_DrillingMember"
      id="xdx2ixbrl1522"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="AsOf2025-06-30" id="xdx2ixbrl1532">P1Y7M6D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2024-07-01to2025-06-30"
      id="xdx2ixbrl1623"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="xdx2ixbrl1640"
      unitRef="USD">-139000</us-gaap:IncomeTaxExpenseBenefit>
    <niobf:DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1661"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl1675"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1676"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1739"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1740"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1744"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1745"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1749"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1750"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1753"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1754"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1758"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1760"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1763"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1769"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1770"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1774"
      unitRef="USD"
      xsi:nil="true"/>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1775"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1778"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl1779"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1782"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1783"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1787"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl1788"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1792"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl1796"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SubsequentEventDescription
      contextRef="From2025-07-012025-07-18_us-gaap_SubsequentEventMember"
      id="xdx2ixbrl1804">Maxim acted as sole placement agent for the July 2025 Offering. The Company intends to use the net proceeds from the July 2025 Offering for working capital and general corporate purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial operation.</us-gaap:SubsequentEventDescription>
    <dei:DocumentType contextRef="From2024-07-01to2025-06-30" id="Fact000015">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2024-07-01to2025-06-30" id="Fact000016">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-07-01to2025-06-30" id="Fact000017">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2024-07-01to2025-06-30" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-07-01to2025-06-30" id="Fact000019">001-41655</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-07-01to2025-06-30" id="Fact000020">NioCorp                                          Developments Ltd.</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-07-01to2025-06-30" id="Fact000022">98-1262185</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-07-01to2025-06-30" id="Fact000023">7000         South Yosemite Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-07-01to2025-06-30" id="Fact000024">Suite 115</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-07-01to2025-06-30" id="Fact000025">Centennial</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-07-01to2025-06-30" id="Fact000026">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-07-01to2025-06-30" id="Fact000027">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-07-01to2025-06-30" id="Fact000028">(720)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-07-01to2025-06-30" id="Fact000029">334-7066</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000030">Common     Shares, without par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000031">NB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-07-012025-06-30_custom_CommonSharesWithoutParValueMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member"
      id="Fact000033">Warrants,     each exercisable for 1.11829212      Common Shares</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member"
      id="Fact000034">NIOBW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-07-012025-06-30_custom_WarrantsEachExercisableFor1.11829212Member"
      id="Fact000035">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2024-07-01to2025-06-30" id="Fact000036">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2024-07-01to2025-06-30" id="Fact000037">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2024-07-01to2025-06-30" id="Fact000038">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-07-01to2025-06-30" id="Fact000039">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-07-01to2025-06-30" id="Fact000040">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-07-01to2025-06-30" id="Fact000041">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-07-01to2025-06-30" id="Fact000042">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2024-07-01to2025-06-30" id="Fact000043">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2024-07-01to2025-06-30" id="Fact000044">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-09-11"
      decimals="INF"
      id="Fact000046"
      unitRef="Shares">77757089</dei:EntityCommonStockSharesOutstanding>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000047">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cybersecurity
risk management is &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240701__20250630_zzvfcTvSgOPc"&gt;integrated&lt;/span&gt; into the Company&#x2019;s enterprise-wide risk management. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240701__20250630_zzBvnsiCi2g3"&gt;Our Board has overall oversight responsibility
for our risk management and management is responsible for identifying, considering, and assessing material risks to the Company.
Our Chief Financial Officer is responsible for assessing and managing cybersecurity risks&lt;/span&gt;; however, as a smaller reporting company,
we currently do not have a dedicated cybersecurity team. Our Chief Financial Officer reports to the Board regarding financial
and operating risks, including cybersecurity risks. Our Chief Financial Officer has experience in managing public companies and
assessing financial and operating risks.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_904_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240701__20250630_zY1yw6Uqqc27"&gt;Our
cybersecurity risk management is designed to provide a framework for assessing, identifying, and managing material risks from
cybersecurity threats and to respond to cybersecurity incidents, including material risks associated with the use of services
provided by &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240701__20250630_zaGSeNvtLRYe"&gt;third-party service providers&lt;/span&gt;. We rely on the cybersecurity protections of many of our third-party service providers.
Our primary third-party service providers utilize two-factor authentication as well as login and password protections with email
verifications.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;We
are in the process of evaluating our cybersecurity needs and developing appropriate measures to enhance our cybersecurity posture.
Our goal is to establish a cybersecurity framework that is commensurate with our size, complexity, and nature of our operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20240701__20250630_gIFCRMAORLTMA-EYWBMY_zwkZRvxSf94i"&gt;For
the year ended June 30, 2025, the Company had &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240701__20250630_zyBQEttKdXC6"&gt;no material cybersecurity incidents&lt;/span&gt; or threats that have materially affected or
were reasonably likely to materially affect our business strategy, results of operations or&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_C00_gIFCRMAORLTMA-EYWBMY_zFzSX3gs5OPk"&gt;
financial condition. Despite our efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances that we
have not experienced an undetected cybersecurity incident.&lt;/span&gt; As previously disclosed, on February 14, 2025, we became aware of
unauthorized third-party access to our information systems, including portions of its email systems, that resulted in misdirected
vendor payments. To date, the Cybersecurity Incident has not had a material impact on our business operations or financial
condition.&lt;/span&gt;&lt;/p&gt;

</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2024-07-01to2025-06-30" id="Fact000048">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000049">Our Board has overall oversight responsibility
for our risk management and management is responsible for identifying, considering, and assessing material risks to the Company.
Our Chief Financial Officer is responsible for assessing and managing cybersecurity risks</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="From2024-07-01to2025-06-30" id="Fact000050">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2024-07-01to2025-06-30" id="Fact000051">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000053">For
the year ended June 30, 2025, the Company had &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240701__20250630_zyBQEttKdXC6"&gt;no material cybersecurity incidents&lt;/span&gt; or threats that have materially affected or
were reasonably likely to materially affect our business strategy, results of operations or
financial condition. Despite our efforts, we cannot eliminate all risks from cybersecurity threats or provide assurances that we
have not experienced an undetected cybersecurity incident.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2024-07-01to2025-06-30" id="Fact000054">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorOpinionTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000056">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have audited the accompanying consolidated balance sheet of NioCorp Developments Ltd. and subsidiaries (the &#x201c;Company&#x201d;)
as of June 30, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, cash flows, and shareholders&#x2019;
equity and redeemable noncontrolling interest, for the each of the two years in the period ended June 30, 2025, the related notes
(collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in
all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and
its cash flows for each of the two years in the period ended June 30, 2025 in conformity with accounting principles generally
accepted in the United States of America.&lt;/span&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorLocation contextRef="From2024-07-01to2025-06-30" id="Fact000057">Denver, Colorado</dei:AuditorLocation>
    <dei:AuditorName contextRef="From2024-07-01to2025-06-30" id="Fact000058">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorFirmId contextRef="From2024-07-01to2025-06-30" id="Fact000059">34</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000067"
      unitRef="USD">25554000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000068"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000070"
      unitRef="USD">1183000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000071"
      unitRef="USD">916000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000073"
      unitRef="USD">26737000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000074"
      unitRef="USD">2928000</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssets
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000079"
      unitRef="USD">37000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000080"
      unitRef="USD">35000</us-gaap:DepositsAssets>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000082"
      unitRef="USD">3000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:LongTermInvestmentsAndReceivablesNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000083"
      unitRef="USD">4000</us-gaap:LongTermInvestmentsAndReceivablesNet>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000085"
      unitRef="USD">118000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000086"
      unitRef="USD">181000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000088"
      unitRef="USD">839000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000089"
      unitRef="USD">837000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000091"
      unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000092"
      unitRef="USD">16085000</us-gaap:CapitalizedCostsMineralInterestsInUnprovedProperties>
    <us-gaap:Assets
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000094"
      unitRef="USD">43819000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000095"
      unitRef="USD">20070000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000103"
      unitRef="USD">1795000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000104"
      unitRef="USD">1843000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000107"
      unitRef="USD">2365000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000110"
      unitRef="USD">7660000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000112"
      unitRef="USD">98000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000113"
      unitRef="USD">96000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000115"
      unitRef="USD">1893000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000116"
      unitRef="USD">11964000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000121"
      unitRef="USD">6852000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000122"
      unitRef="USD">1651000</us-gaap:OtherLiabilitiesNoncurrent>
    <niobf:EarnoutLiabilityAtFairValue
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000124"
      unitRef="USD">5880000</niobf:EarnoutLiabilityAtFairValue>
    <niobf:EarnoutLiabilityAtFairValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000125"
      unitRef="USD">3817000</niobf:EarnoutLiabilityAtFairValue>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000127"
      unitRef="USD">33000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000128"
      unitRef="USD">104000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000130"
      unitRef="USD">14658000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000131"
      unitRef="USD">17536000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000136"
      unitRef="USD">838000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000137"
      unitRef="USD">1534000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000145"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000147"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact000153"
      unitRef="Shares">58491196</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000155"
      unitRef="Shares">38062647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000142"
      unitRef="USD">208551000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000143"
      unitRef="USD">163823000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000157"
      unitRef="USD">-179317000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000158"
      unitRef="USD">-161912000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000160"
      unitRef="USD">-911000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000161"
      unitRef="USD">-911000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000163"
      unitRef="USD">28323000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000164"
      unitRef="USD">1000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000166"
      unitRef="USD">43819000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000167"
      unitRef="USD">20070000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000172"
      unitRef="USD">1944000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000173"
      unitRef="USD">3509000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000175"
      unitRef="USD">2237000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000176"
      unitRef="USD">3533000</us-gaap:ProfessionalFees>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000178"
      unitRef="USD">4135000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000179"
      unitRef="USD">2552000</us-gaap:ExplorationExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000181"
      unitRef="USD">3642000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000182"
      unitRef="USD">4163000</us-gaap:OtherGeneralExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000184"
      unitRef="USD">11958000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000185"
      unitRef="USD">13757000</us-gaap:OperatingExpenses>
    <niobf:ChangeInFairValueOfEarnoutSharesLiabilityValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000187"
      unitRef="USD">2063000</niobf:ChangeInFairValueOfEarnoutSharesLiabilityValue>
    <niobf:ChangeInFairValueOfEarnoutSharesLiabilityValue
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000188"
      unitRef="USD">-6704000</niobf:ChangeInFairValueOfEarnoutSharesLiabilityValue>
    <niobf:ChangeInFairValueOfWarrantLiabilityValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000190"
      unitRef="USD">4093000</niobf:ChangeInFairValueOfWarrantLiabilityValue>
    <niobf:ChangeInFairValueOfWarrantLiabilityValue
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000191"
      unitRef="USD">-1875000</niobf:ChangeInFairValueOfWarrantLiabilityValue>
    <niobf:ChangeInFairValueOfConvertibleNotesValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000193"
      unitRef="USD">40000</niobf:ChangeInFairValueOfConvertibleNotesValue>
    <niobf:ChangeInFairValueOfConvertibleNotesValue
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000194"
      unitRef="USD">2542000</niobf:ChangeInFairValueOfConvertibleNotesValue>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000196"
      unitRef="USD">48000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000197"
      unitRef="USD">4490000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000199"
      unitRef="USD">5000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000200"
      unitRef="USD">31000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:InterestIncomeOperating
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000202"
      unitRef="USD">94000</us-gaap:InterestIncomeOperating>
    <us-gaap:OtherIncome
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000205"
      unitRef="USD">122000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000206"
      unitRef="USD">147000</us-gaap:OtherIncome>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000208"
      unitRef="USD">-1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000209"
      unitRef="USD">-5000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000211"
      unitRef="USD">-17982000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000212"
      unitRef="USD">-12037000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000214"
      unitRef="USD">-0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000215"
      unitRef="USD">-139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000217"
      unitRef="USD">-17982000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000218"
      unitRef="USD">-11898000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000220"
      unitRef="USD">-577000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000221"
      unitRef="USD">-463000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000223"
      unitRef="USD">-17405000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:OciEquityMethodInvestmentBeforeTaxParent
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000224"
      unitRef="USD">-11435000</us-gaap:OciEquityMethodInvestmentBeforeTaxParent>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000226"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000228"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000230"
      unitRef="USDPShares">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000232"
      unitRef="USDPShares">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000234"
      unitRef="Shares">45072895</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000236"
      unitRef="Shares">45072895</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000238"
      unitRef="Shares">34320024</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000240"
      unitRef="Shares">34320024</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000245"
      unitRef="USD">-17982000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000246"
      unitRef="USD">-11898000</us-gaap:NetIncomeLoss>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000251"
      unitRef="USD">-2063000</niobf:ChangeInFairValueOfEarnoutShareLiability>
    <niobf:ChangeInFairValueOfEarnoutShareLiability
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000252"
      unitRef="USD">6704000</niobf:ChangeInFairValueOfEarnoutShareLiability>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000254"
      unitRef="USD">-4093000</niobf:ChangeInValuationOfWarrantLiabilities>
    <niobf:ChangeInValuationOfWarrantLiabilities
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000255"
      unitRef="USD">1875000</niobf:ChangeInValuationOfWarrantLiabilities>
    <niobf:ChangeInFairValueOfConvertibleNoteValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000257"
      unitRef="USD">-40000</niobf:ChangeInFairValueOfConvertibleNoteValue>
    <niobf:ChangeInFairValueOfConvertibleNoteValue
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000258"
      unitRef="USD">-2542000</niobf:ChangeInFairValueOfConvertibleNoteValue>
    <us-gaap:AccretionExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000260"
      unitRef="USD">43000</us-gaap:AccretionExpense>
    <us-gaap:AccretionExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000261"
      unitRef="USD">4490000</us-gaap:AccretionExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000263"
      unitRef="USD">789000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000264"
      unitRef="USD">2881000</us-gaap:ShareBasedCompensation>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000266"
      unitRef="USD">589000</niobf:FairValueOfCommitmentSharesIssued>
    <niobf:FairValueOfCommitmentSharesIssued
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">105000</niobf:FairValueOfCommitmentSharesIssued>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000269"
      unitRef="USD">144000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:Depreciation
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000272"
      unitRef="USD">3000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000273"
      unitRef="USD">2000</us-gaap:Depreciation>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000275"
      unitRef="USD">-1000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000276"
      unitRef="USD">-5000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000278"
      unitRef="USD">-6000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000279"
      unitRef="USD">20000</us-gaap:OperatingLeaseImpairmentLoss>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000281"
      unitRef="USD">122000</niobf:OtheroperatingGainsLosses>
    <niobf:OtheroperatingGainsLosses
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000282"
      unitRef="USD">148000</niobf:OtheroperatingGainsLosses>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000284"
      unitRef="USD">-10345000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000285"
      unitRef="USD">-10580000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000290"
      unitRef="USD">267000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000291"
      unitRef="USD">-469000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000293"
      unitRef="USD">-48000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">-1621000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000296"
      unitRef="USD">-10660000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000297"
      unitRef="USD">-11732000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000302"
      unitRef="USD">5000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsForDeposits
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000305"
      unitRef="USD">2000</us-gaap:PaymentsForDeposits>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000308"
      unitRef="USD">-7000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000314"
      unitRef="USD">45666000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000315"
      unitRef="USD">6185000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000318"
      unitRef="USD">6935000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000320"
      unitRef="USD">504000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000323"
      unitRef="USD">504000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000326"
      unitRef="USD">7223000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000327"
      unitRef="USD">1512000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000329"
      unitRef="USD">4234000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000330"
      unitRef="USD">205000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000332"
      unitRef="USD">34209000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000333"
      unitRef="USD">11403000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000335"
      unitRef="USD">23542000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000336"
      unitRef="USD">-329000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000338"
      unitRef="USD">2012000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000339"
      unitRef="USD">2341000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000341"
      unitRef="USD">25554000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000342"
      unitRef="USD">2012000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000347"
      unitRef="USD">4000</us-gaap:InterestPaidNet>
    <niobf:ConversionsOfDebtForCommonShares contextRef="From2024-07-01to2025-06-30" id="Fact000353">501</niobf:ConversionsOfDebtForCommonShares>
    <niobf:ConversionsOfDebtForCommonShares contextRef="From2023-07-012024-06-30" id="Fact000354">14,479</niobf:ConversionsOfDebtForCommonShares>
    <niobf:ValueOfWarrantsIssued contextRef="From2024-07-01to2025-06-30" id="Fact000356">2,262</niobf:ValueOfWarrantsIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000365"
      unitRef="Shares">31202131</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000359"
      unitRef="USD">140421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000360"
      unitRef="USD">-150477000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000361"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000362"
      unitRef="USD">-10967000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2023-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000363"
      unitRef="USD">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <niobf:StockIssuedDuringPeriodValueSharesEquityPlacement
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000373"
      unitRef="Shares">978432</niobf:StockIssuedDuringPeriodValueSharesEquityPlacement>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000367"
      unitRef="USD">2995000</niobf:StockIssuedDuringPeriodValueEquityPlacement>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000370"
      unitRef="USD">2995000</niobf:StockIssuedDuringPeriodValueEquityPlacement>
    <niobf:StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000381"
      unitRef="Shares">1358000</niobf:StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000375"
      unitRef="USD">3398000</niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000378"
      unitRef="USD">3398000</niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000389"
      unitRef="Shares">7800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <niobf:StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000397"
      unitRef="Shares">283692</niobf:StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000391"
      unitRef="USD">103000</niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000394"
      unitRef="USD">103000</niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000395"
      unitRef="USD">-103000</niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000405"
      unitRef="Shares">4232592</niobf:StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000399"
      unitRef="USD">14479000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000402"
      unitRef="USD">14479000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000407"
      unitRef="USD">148000</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueStockDividend
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000410"
      unitRef="USD">148000</us-gaap:StockIssuedDuringPeriodValueStockDividend>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000413"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000416"
      unitRef="USD">-204000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000419"
      unitRef="USD">2779000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000422"
      unitRef="USD">2779000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000426"
      unitRef="USD">-11435000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000428"
      unitRef="USD">-11435000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2023-07-012024-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000429"
      unitRef="USD">-463000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000437"
      unitRef="Shares">38062647</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000431"
      unitRef="USD">163823000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000432"
      unitRef="USD">-161912000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000433"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000434"
      unitRef="USD">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2024-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000435"
      unitRef="USD">1534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <niobf:StockIssuedDuringPeriodValueSharesEquityPlacement
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000445"
      unitRef="Shares">13321628</niobf:StockIssuedDuringPeriodValueSharesEquityPlacement>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000439"
      unitRef="USD">30059000</niobf:StockIssuedDuringPeriodValueEquityPlacement>
    <niobf:StockIssuedDuringPeriodValueEquityPlacement
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000442"
      unitRef="USD">30059000</niobf:StockIssuedDuringPeriodValueEquityPlacement>
    <niobf:StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000453"
      unitRef="Shares">5671742</niobf:StockIssuedDuringPeriodValueSharesYorkvilleEquityFacilityDraws>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000447"
      unitRef="USD">12941000</niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws>
    <niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000450"
      unitRef="USD">12941000</niobf:StockIssuedDuringPeriodValueYorkvilleEquityFacilityDraws>
    <niobf:StockIssuedDuringPeriodValueSharesStockWarrantsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000461"
      unitRef="Shares">828235</niobf:StockIssuedDuringPeriodValueSharesStockWarrantsExercised>
    <niobf:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000455"
      unitRef="USD">1809000</niobf:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <niobf:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000458"
      unitRef="USD">1809000</niobf:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000469"
      unitRef="Shares">512</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <niobf:StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000477"
      unitRef="Shares">348085</niobf:StockIssuedDuringPeriodValueSharesRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000471"
      unitRef="USD">119000</niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000474"
      unitRef="USD">119000</niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000475"
      unitRef="USD">-119000</niobf:StockIssuedDuringPeriodValueRedemptionsOfVestedShares>
    <niobf:StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000485"
      unitRef="Shares">258347</niobf:StockIssuedDuringPeriodValueSharesConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000479"
      unitRef="USD">501000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000482"
      unitRef="USD">501000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000487"
      unitRef="USD">2262000</niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants>
    <niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000490"
      unitRef="USD">2262000</niobf:StockIssuedDuringPeriodValueIssuanceOfLindConsentWarrants>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000493"
      unitRef="USD">482000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000496"
      unitRef="USD">482000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000499"
      unitRef="USD">-4234000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000502"
      unitRef="USD">-4234000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000505"
      unitRef="USD">789000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000508"
      unitRef="USD">789000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000512"
      unitRef="USD">-17405000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000514"
      unitRef="USD">-17405000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-07-012025-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000515"
      unitRef="USD">-577000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000523"
      unitRef="Shares">58491196</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000517"
      unitRef="USD">208551000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000518"
      unitRef="USD">-179317000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact000519"
      unitRef="USD">-911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000520"
      unitRef="USD">28323000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-06-30_custom_RedeemableNoncontrollingInterestMember"
      decimals="-3"
      id="Fact000521"
      unitRef="USD">838000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NatureOfOperations contextRef="From2024-07-01to2025-06-30" id="Fact000525">&lt;p id="xdx_80F_eus-gaap--NatureOfOperations_z31rqZBDihfd" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_825_zKgby0OEZ7Vg" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;DESCRIPTION
OF BUSINESS&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
Developments Ltd. (the &#x201c;Company&#x201d; or &#x201c;NioCorp&#x201d;) was incorporated on February 27, 1987, under the laws of
the Province of British Columbia and currently operates in &lt;span id="xdx_908_eus-gaap--NumberOfReportableSegments_dxL_uNUMBER_c20240701__20250630_zUiL9VuznpU" title="Number of reportable segments::XDX::1"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0527"&gt;one&lt;/span&gt;&lt;/span&gt; reportable operating segment consisting of exploration and development
of mineral deposits in the United States, specifically, the Elk Creek Niobium/Scandium/Titanium property (the &#x201c;Elk Creek
Project&#x201d;) located in southeastern Nebraska.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;On March 17, 2023 (the &#x201c;Closing Date&#x201d;),
the Company closed a series of transactions (the &#x201c;GXII Transaction&#x201d;), pursuant to the Business
Combination Agreement, dated September 25, 2022 (the &#x201c;Business Combination Agreement&#x201d;), among the Company, GX Acquisition Corp. II (&#x201c;GXII&#x201d;), and
Big Red Merger Sub Ltd (the &#x201c;Closing&#x201d;). At the Closing, the Company also closed convertible debt financings (the &#x201c;Yorkville
Convertible Debt Financing&#x201d;) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (together with
YA II PN, Ltd., &#x201c;Yorkville&#x201d;), and the standby equity purchase facility with Yorkville (the &#x201c;Yorkville Equity
Facility Financing&#x201d; and, together with the Yorkville Convertible Debt Financing, the &#x201c;Yorkville Financings&#x201d;)
became effective. The transactions contemplated by the Business Combination Agreement, including the GXII Transaction, the Yorkville
Financings and a 10-for-1 reverse stock split consummated in connection with the Closing, are referred to, collectively, as the
&#x201c;2023 Transactions.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to
construction and commercial operation. As further discussed in Note 4, these matters raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining
additional financing, and maintaining continued support from its shareholders and creditors.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:BasisOfAccounting contextRef="From2024-07-01to2025-06-30" id="Fact000529">&lt;p id="xdx_802_eus-gaap--BasisOfAccounting_z5XvER7iCjeg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82A_zWV72rtHBxva" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;BASIS
OF PREPARATION&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basis
                                         of Preparation and Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United
States of America (&#x201c;U.S. GAAP&#x201d;) and the rules and regulations of the U.S. Securities and Exchange Commission. The
consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries with all
significant intercompany transactions eliminated. Certain transactions include reference to Canadian dollars (&#x201c;C$&#x201d;)
where applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zGuk1eMn6nVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zqTB7GQb4nxg"&gt;These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 87%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jurisdiction
    of incorporation&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership
    at June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0896800
    BC Ltd. (&#x201c;0896800&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zcexJQlne0Xe" title="Jurisdiction of incorporation"&gt;British
    Columbia, Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_znYdXXHzlZTe" style="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z67aElvHa7u2" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp. (&#x201c;ECRC&#x201d;) &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zsaDnqiKPhAi" title="Jurisdiction of incorporation"&gt;Delaware,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zHKTM3jTQTR2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;80.42%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zMnPBX90Jxp8" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;79.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
    Technologies Limited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zAzzIeOpxC7b" title="Jurisdiction of incorporation"&gt;United
    Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zMpkBj4CXK3d" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zraq8mZZDNY1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_zsFFthMyjs42" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5in"&gt;&lt;span id="xdx_F13_zump1IRpSDG9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 and 4,282,116 Vested Shares
                                         and 3,391,596 and 3,391,596 Earnout Shares (each as defined below) held by third parties,
                                         and outstanding as of June 30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A7_zHuNeDHUudza" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Use
                                         of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date
of the consolidated financial statements, and the reported amounts of expenses during the reporting period. The Company regularly
evaluates estimates and assumptions related to the valuation of mineral properties, deferred income tax asset valuations, convertible
debt valuations, earnout valuation, derivative liabilities, warrant liabilities, and share-based compensation. The Company bases
its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable
under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results
experienced by the Company may differ materially and adversely from the Company&#x2019;s&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;












&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;estimates. To the extent there are material
differences between estimates and the actual results, future results of operations will be affected.&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccounting>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000531">&lt;p id="xdx_895_eus-gaap--ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_zGuk1eMn6nVe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B9_zqTB7GQb4nxg"&gt;These
consolidated financial statements include the accounts of the Company and the subsidiaries listed in the following table. All
intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 87%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Jurisdiction
    of incorporation&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership
    at June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0896800
    BC Ltd. (&#x201c;0896800&#x201d;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_zcexJQlne0Xe" title="Jurisdiction of incorporation"&gt;British
    Columbia, Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_znYdXXHzlZTe" style="font: 10pt Times New Roman, Times, Serif; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--Entity0896800BCLtdMember_z67aElvHa7u2" style="font: 10pt Times New Roman, Times, Serif; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Elk
    Creek Resources Corp. (&#x201c;ECRC&#x201d;) &lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zsaDnqiKPhAi" title="Jurisdiction of incorporation"&gt;Delaware,
    USA&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zHKTM3jTQTR2" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;80.42%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--ElkCreekResourcesCorpECRCMember_fKDEp_zMnPBX90Jxp8" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;79.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCECFF"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NioCorp
    Technologies Limited&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--IncorporationStateCountryName_c20240701__20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zAzzIeOpxC7b" title="Jurisdiction of incorporation"&gt;United
    Kingdom&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20250630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zMpkBj4CXK3d" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2025"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MinorityInterestOwnershipPercentageByParent_iI_pid_dp_uRatio_c20240630__srt--OwnershipAxis__custom--NioCorpTechnologiesLimitedMember_zraq8mZZDNY1" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Ownership at June 30, 2024"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_zsFFthMyjs42" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0.5in"&gt;&lt;span id="xdx_F13_zump1IRpSDG9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 and 4,282,116 Vested Shares
                                         and 3,391,596 and 3,391,596 Earnout Shares (each as defined below) held by third parties,
                                         and outstanding as of June 30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <niobf:IncorporationStateCountryName
      contextRef="From2024-07-012025-06-30_custom_Entity0896800BCLtdMember"
      id="Fact000533">British
    Columbia, Canada</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2025-06-30_custom_Entity0896800BCLtdMember"
      decimals="INF"
      id="Fact000535"
      unitRef="Ratio">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2024-06-30_custom_Entity0896800BCLtdMember"
      decimals="INF"
      id="Fact000537"
      unitRef="Ratio">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <niobf:IncorporationStateCountryName
      contextRef="From2024-07-012025-06-30_custom_ElkCreekResourcesCorpECRCMember"
      id="Fact000539">Delaware,
    USA</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2025-06-30_custom_ElkCreekResourcesCorpECRCMember"
      decimals="INF"
      id="Fact000541"
      unitRef="Ratio">0.8042</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2024-06-30_custom_ElkCreekResourcesCorpECRCMember"
      decimals="INF"
      id="Fact000543"
      unitRef="Ratio">0.797</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <niobf:IncorporationStateCountryName
      contextRef="From2024-07-012025-06-30_custom_NioCorpTechnologiesLimitedMember"
      id="Fact000545">United
    Kingdom</niobf:IncorporationStateCountryName>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2025-06-30_custom_NioCorpTechnologiesLimitedMember"
      decimals="INF"
      id="Fact000547"
      unitRef="Ratio">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="AsOf2024-06-30_custom_NioCorpTechnologiesLimitedMember"
      decimals="INF"
      id="Fact000549"
      unitRef="Ratio">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000559">&lt;p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zP1oUJg4dpU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_823_zN0w7EFaP3zb" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SIGNIFICANT
ACCOUNTING POLICIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zc8c0al9Ze3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_868_z3ZweeecMiT3" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
                                         Stage Issuer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#x201c;S-K 1300&#x201d;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#x2019;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#x2019;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_z9ppAztdFu9e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zwFw94J5Xv96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86E_zp7AyUpFwzql" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
                                         and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#x201c;U.S.&#x201d;) are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#x201c;CDIC&#x201d;) up
to C$100. At June 30, 2025, the Company had $24,711 and $22 in excess of the FDIC and CDIC insured limits, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zwTIkYd4GfJ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zVmA1NL8OM4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86E_z1sTjiimVs8g" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
                                         Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Functional
and reporting currency&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
included in the financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#x201c;the functional currency&#x201d;). The functional currency for all entities is
the U.S. Dollar except for NioCorp Technologies Limited, which is measured in British Pounds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency for these consolidated financial statements is U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
in foreign currency&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation
to reporting currency&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
gains and losses from the application of the U.S. dollar as the reporting currency, if any, are included as part of cumulative
currency translation adjustment, which is reported as a component of shareholders&#x2019; equity under accumulated other comprehensive
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_zzGc4b2EXj5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--MineralPropertiesPolicyTextBlock_z7h7egP2AxVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_864_z9oOUv8PHS8h" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
                                         Properties&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of common shares, no par value, of the Company (&#x201c;Common Shares&#x201d;) issued
as consideration. Properties acquired under option agreements, whereby payments are made at the sole discretion of the Company,
are capitalized as mineral property acquisition costs at such time as the payments are made. Exploration costs are expensed as
incurred. When it is determined that a mining deposit can be economically and legally extracted or produced based on established
proven and probable reserves under S-K 1300, and the Company&#x2019;s board of directors (the &#x201c;Board&#x201d;) has approved
the commencement of formal development activities, development costs related to such reserves and incurred after such board approval
will be considered for capitalization. The establishment of proven and probable reserves is based on&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;











&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;results of feasibility studies,
which indicate whether a property is economically feasible. Upon commencement of commercial production, capitalized costs will
be amortized over their estimated useful lives or units of production, whichever is a more reliable measure. Capitalized amounts
relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are written off.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#x2019;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was &lt;span id="xdx_904_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20250630_zBylhVoz8aX9" title="Impairment to mineral properties"&gt;&lt;span id="xdx_90B_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20240630_zbzLtOSaCkP" title="Impairment to mineral properties"&gt;no&lt;/span&gt;&lt;/span&gt; impairment recorded to mineral properties as of
June 30, 2025 or 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_zCiIZdKYt2Rl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zwVv4PIxVTJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_869_zmooaBqSCjB1" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long
                                         Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was &lt;span id="xdx_90D_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20240701__20250630_zFeFBsrmvcn5" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90E_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20230701__20240630_zHjdsI6AnJMk" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment recorded to long-lived assets as of June 30, 2025 or 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_859_zBvAVsfqkApk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zdOOBvw5BJ7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86C_zJ9OdHVnd3Wc" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &lt;i&gt;Leases&lt;/i&gt;, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#x201c;ROU&#x201d;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_z5skVgBbhusd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--ConvertibleDebtCarriedatFairValuePolicyTextBlock_z0JYCGUNEaFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_864_zCnFst6mSn9c" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
                                         Debt Carried at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
regard to the Company&#x2019;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in Note
8), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, &lt;i&gt;Derivatives and Hedging
&lt;/i&gt;(&#x201c;ASC 815&#x201d;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument to account
for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter using a
Monte Carlo simulation methodology which&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;












&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;incorporates multiple conversion scenarios. All changes in fair value subsequent to the
initial recording, excluding the impact of the change in fair value related to the Company&#x2019;s own credit risk, are recorded
as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#x2019;s own credit risk, if any, are recorded through other comprehensive
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_zAz6bkOdFVFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--WarrantsPolicyTextBlock_zh9de7G8fcsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86A_zzBqJ858BRCf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;We apply relevant accounting
guidance for warrants to purchase our Common Shares (&#x201c;Warrants&#x201d;) based on the nature of the relationship with the counterparty.
The Company has made an accounting policy election that the &#x201c;greater of&#x201d; Share-Price Input to the Black-Scholes Value
would not preclude equity classification. The Company has not had any historical transactions that include the &#x201c;greater of&#x201d;
Share-Price Input feature, and this is a new accounting policy election as of the current fiscal year. For Warrants issued to investors
or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC 480, &lt;i&gt;Distinguishing Liabilities
from Equity&lt;/i&gt;, and ASC 815, to assist in the determination of whether the Warrants should be classified as liabilities or equity.
The fair value of Warrants is estimated using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features
embedded in the Warrant. Inputs under both models include inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest
rate, the expected term, the volatility, and the dividend rate. Warrants that are determined to require liability classifications
are measured at fair value upon issuance and are subsequently remeasured to their then fair value at each subsequent reporting
period with changes in fair value recorded in current earnings. Warrants that are determined to require equity classifications
measured at fair value upon issuance and are not subsequently remeasured unless they are required to be reclassified.&lt;/p&gt;

&lt;p id="xdx_846_ecustom--EarnoutSharesPolicyTextBlock_zC8dRMo8Jo7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_865_zJVi2dEuUeTg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
                                         Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#x2019;s publicly traded Warrants,
the dividend rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective
and require significant judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_zwUAMTbliwgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zGR01jbEI8O5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86B_zmpv90UlaI9g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                         Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, receivables, equity securities, and accounts payable
and accrued liabilities. It is management&#x2019;s opinion that the Company is not exposed to significant interest, currency or
credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying value unless
otherwise noted.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_znAwGZnSUxfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zqWAzZAReQ88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;k)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_867_zbgAPKWIgidd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Concentration
                                         of Credit Risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Columbus, Ohio. As part
of its cash management process, the Company regularly monitors the relative credit standing of these institutions.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_z6xVAby1KLR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z0YgSoWoFSXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;l)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86D_zs7kZ0bx4kje" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Asset
                                         Retirement Obligation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20250630_znG4zUDnMSV4" title="Accrued Exploration Stage Obligations"&gt;48&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zD2FSDHEwQKg" title="Accrued Exploration Stage Obligations"&gt;48&lt;/span&gt; for estimated obligations as
of June 30, 2025 and June 30, 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zK2ADdgdL6y" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;














&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;

&lt;p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zPJ5O1LrTg49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;m)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_860_zbbirz5EKLSl" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, &lt;i&gt;&#x201c;Income Taxes &#x2013; Recognition.&#x201d;
&lt;/i&gt;Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#x201c;more likely than not&#x201d; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#x201c;Income Taxes &#x2013; Disclosure,&#x201d;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2025 and 2024, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_854_zvr8PDiV0zM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zb2890q1vRkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;n)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86D_z7Ncwdb9fCf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
                                         Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#x2019;s control and is reported in the mezzanine section between total liabilities
and shareholders&#x2019; deficit, as temporary equity in the Company&#x2019;s consolidated balance sheets. The Company&#x2019;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_z1Sw9JbIsHDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zMwRJISFnjl8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;o)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86C_zjipvAuSYPgf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
                                         and Diluted Per Share Disclosure&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 9), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWyAFxndIbw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8B8_zwlyT1end3Ah"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; background-color: white"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; background-color: white"&gt;For the year ended June 30,&lt;/td&gt;&lt;td style="background-color: white"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: justify; padding-left: 9pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_z4F4MXQKGrka" style="width: 10%; text-align: right" title="Net loss"&gt;(17,982&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zajpSponzKIc" style="width: 10%; text-align: right" title="Net loss"&gt;(11,898&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Adjust: Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20240701__20250630_zutq6Nkfe109" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"&gt;577&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zGc0Bl8WsSmh" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"&gt;458&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20250630_zkkxBtYRUH46" style="text-align: right" title="Net loss available to participating securities"&gt;(17,405&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zjlQucI0DBW3" style="text-align: right" title="Net loss available to participating securities"&gt;(11,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Net loss attributable to Vested Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20240701__20250630_zx6g14PGNxV4" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"&gt;1,102&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20230701__20240630_zJhpLAyk3YXc" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"&gt;967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20250630_zfcKqCWrkVkf" title="Net loss attributed to common shareholders - basic"&gt;&lt;span id="xdx_90A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20240701__20250630_zd5eiOeCJ9Ne" title="Net loss attributed to common shareholders - diluted"&gt;(16,303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zIPgAaR0Hkyi" title="Net loss attributed to common shareholders - basic"&gt;&lt;span id="xdx_900_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20230701__20240630_z1pwClWsysZi" title="Net loss attributed to common shareholders - diluted"&gt;(10,473&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zfo0ZGEwfa71" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zwkZKVhJ7xgd" title="Weighted average shares outstanding - diluted"&gt;45,072,895&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_z6kzP7KhBMEa" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zJeMmTyr4gFa" title="Weighted average shares outstanding - diluted"&gt;34,320,024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zXjqFfBFYpM1" title="Loss per Common Share outstanding - basic"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zrCFblI8gIGi" title="Loss per Common Share outstanding - diluted"&gt;(0.36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_zGSJbiYudYea" title="Loss per Common Share outstanding - basic"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zeZdYic62vO1" title="Loss per Common Share outstanding - diluted"&gt;(0.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zceKkRzdWzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following shares underlying options to purchase Common Shares (&#x201c;Options&#x201d;), Warrants, and outstanding convertible debt
were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation
for the periods indicated below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zfnV3917EYcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span id="xdx_8B2_zIFTJ9XdJ09f" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.6in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded potentially dilutive securities &lt;sup&gt;(1)(2)&lt;/sup&gt;:&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 66%; text-indent: 9pt"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20250630_fKDEpKDIp_zvHEtVOjsaJ6" style="width: 10%; text-align: right" title="Options"&gt;3,020,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zSVC9VR5dap3" style="width: 10%; text-align: right" title="Options"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: 9pt"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20250630_fKDEpKDIp_zfxzBVezte1f" style="text-align: right" title="Warrants"&gt;31,839,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_zO8ohOo3qU49" style="text-align: right" title="Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_d0_uShares_c20240701__20250630_fKDEpKDIp_zN7H7U4yxiug" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zIm3kG74jHG1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,849,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total potentially dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DilutiveSecurities_c20240701__20250630_fKDEpKDIp_zqI5JkNsZ54j" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities"&gt;34,859,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_z68NfvevSWJ4" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,908,061&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;














&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span id="xdx_F02_zcC7sWS9kIAl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 90%; padding-bottom: 4pt; text-align: justify"&gt;&lt;span id="xdx_F15_zdMfNW8gjA06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span id="xdx_F0E_zZPpBNjaaE8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;span id="xdx_F18_zw2zGyryrBC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zIQT9463Qr8f" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p id="xdx_853_zrm9h2CqCqpa" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zjNeX9w6d9k" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;p)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86C_zf3D18XBiwh7" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
                                         Based Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants Options to directors, officers, employees, and business advisors. Option terms and vesting conditions are at the
discretion of the Board. The Option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;)
on the day preceding the date of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of Options using the Black-Scholes option pricing model. The Company recognizes forfeitures as
they occur.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zOUEistcYy7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znH5E6LKdBDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;q)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86F_zYUklDvIs6re" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recent
                                         Accounting Standards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Recently
Adopted Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
fiscal year 2025, we adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07,&#160;&lt;i&gt;Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures&lt;/i&gt;. Management has evaluated the Company&#x2019;s operations and concluded it has&#160;one&#160;reportable
operating segment which will now require expanded disclosure. Adoption was made retroactively with segment disclosure included
for the fiscal years ended June 30, 2025 and 2024. This standard has not changed the processing, recording, or presentation of
financial data, other than providing additional disclosure regarding management oversight for the Company&#x2019;s single operating
segment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;br/&gt;
&lt;/span&gt;In December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;,
which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of
rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#x2019;s annual
periods beginning July 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively.
The Company is currently evaluating the ASU to determine its impact on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#x2019;s consolidated financial statements upon adoption.&#160;&lt;/span&gt;&lt;/p&gt;



</us-gaap:SignificantAccountingPoliciesTextBlock>
    <niobf:DevelopmentStageIssuerPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000561">&lt;p id="xdx_848_ecustom--DevelopmentStageIssuerPolicyTextBlock_zc8c0al9Ze3c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_868_z3ZweeecMiT3" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Development
                                         Stage Issuer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be a development stage issuer under Subpart 1300 of Regulation S-K of the United States Securities Act
of 1933, as amended (&#x201c;S-K 1300&#x201d;), and it devotes substantially all of its efforts to acquiring and exploring mining
interests that management believes should eventually provide sufficient net profits to sustain the Company&#x2019;s existence.
Until such interests are engaged in commercial production, the Company will continue to seek additional funding to support the
completion of its exploration and development activities. The Company&#x2019;s activities are subject to significant risks and
uncertainties, including its ability to secure sufficient funding to continue operations, to obtain proven and probable reserves,
to comply with industry regulations and obtain permits necessary for development of the Elk Creek Project, as well as environmental
risks and market conditions.&lt;/span&gt;&lt;/p&gt;

</niobf:DevelopmentStageIssuerPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000563">&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zwFw94J5Xv96" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86E_zp7AyUpFwzql" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
                                         and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents include cash on hand, cash in banks, investments in certificates of deposit with original maturities of 90
days or less, and money market funds. The Company maintains the majority of its cash balances with two financial institutions.
Accounts at banks in the United States (&#x201c;U.S.&#x201d;) are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;)
up to $250, while accounts at banks in Canada are insured by the Canada Deposit Insurance Corporation (&#x201c;CDIC&#x201d;) up
to C$100. At June 30, 2025, the Company had $24,711 and $22 in excess of the FDIC and CDIC insured limits, respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000565">&lt;p id="xdx_845_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zVmA1NL8OM4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86E_z1sTjiimVs8g" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
                                         Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Functional
and reporting currency&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
included in the financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic
environment in which the entity operates (&#x201c;the functional currency&#x201d;). The functional currency for all entities is
the U.S. Dollar except for NioCorp Technologies Limited, which is measured in British Pounds.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reporting currency for these consolidated financial statements is U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Transactions
in foreign currency&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
made in a currency other than the functional currency are remeasured to the functional currency at exchange rates at the dates
of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are remeasured to
the functional currency at the exchange rate at that date and non-monetary assets and liabilities are remeasured at historical
rates. Foreign currency translation gains and losses are included in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Translation
to reporting currency&lt;/i&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Translation
gains and losses from the application of the U.S. dollar as the reporting currency, if any, are included as part of cumulative
currency translation adjustment, which is reported as a component of shareholders&#x2019; equity under accumulated other comprehensive
loss.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <niobf:MineralPropertiesPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000567">&lt;p id="xdx_842_ecustom--MineralPropertiesPolicyTextBlock_z7h7egP2AxVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;d)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_864_z9oOUv8PHS8h" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
                                         Properties&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
property acquisition costs, including indirectly related acquisition costs, are capitalized when incurred. Acquisition costs include
cash consideration and the fair market value of common shares, no par value, of the Company (&#x201c;Common Shares&#x201d;) issued
as consideration. Properties acquired under option agreements, whereby payments are made at the sole discretion of the Company,
are capitalized as mineral property acquisition costs at such time as the payments are made. Exploration costs are expensed as
incurred. When it is determined that a mining deposit can be economically and legally extracted or produced based on established
proven and probable reserves under S-K 1300, and the Company&#x2019;s board of directors (the &#x201c;Board&#x201d;) has approved
the commencement of formal development activities, development costs related to such reserves and incurred after such board approval
will be considered for capitalization. The establishment of proven and probable reserves is based on&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;











&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;results of feasibility studies,
which indicate whether a property is economically feasible. Upon commencement of commercial production, capitalized costs will
be amortized over their estimated useful lives or units of production, whichever is a more reliable measure. Capitalized amounts
relating to a property that is abandoned or otherwise considered uneconomic for the foreseeable future are written off.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
recoverability of the carrying values of mineral properties is dependent upon economic reserves being discovered or developed
on the properties, permitting, financing, start-up, and commercial production from, or the sale/lease of, or other strategic transactions
related to these properties. Development and/or start-up of a project will depend on, among other things, management&#x2019;s ability
to raise sufficient capital for these purposes. We assess the carrying cost of our mineral properties for impairment whenever
information or circumstances indicate the potential for impairment. This would include events and circumstances such as our inability
to obtain all the necessary permits, changes in the legal status of our mineral properties, government actions, the results of
exploration activities and technical evaluations and changes in economic conditions, including the price of commodities or input
prices. Such evaluations compare estimated future net cash flows with our carrying costs and future obligations on an undiscounted
basis. If it is determined that the estimated future undiscounted cash flows are less than the carrying value of the property,
an impairment loss will be recorded. Where estimates of future net cash flows are not determinable and where other conditions
indicate the potential for impairment, management uses available market information and/or third-party valuation experts to assess
if the carrying value can be recovered and to estimate fair value. There was &lt;span id="xdx_904_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20250630_zBylhVoz8aX9" title="Impairment to mineral properties"&gt;&lt;span id="xdx_90B_eus-gaap--MineralPropertiesAccumulatedImpairment_iI_pn3n3_do_c20240630_zbzLtOSaCkP" title="Impairment to mineral properties"&gt;no&lt;/span&gt;&lt;/span&gt; impairment recorded to mineral properties as of
June 30, 2025 or 2024, respectively.&lt;/span&gt;&lt;/p&gt;

</niobf:MineralPropertiesPolicyTextBlock>
    <us-gaap:MineralPropertiesAccumulatedImpairment
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000576"
      unitRef="USD">0</us-gaap:MineralPropertiesAccumulatedImpairment>
    <us-gaap:MineralPropertiesAccumulatedImpairment
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000578"
      unitRef="USD">0</us-gaap:MineralPropertiesAccumulatedImpairment>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000580">&lt;p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zwVv4PIxVTJf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;e)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_869_zmooaBqSCjB1" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long
                                         Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-lived
assets, other than mineral properties, held and used by the Company are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability
of long-lived assets, the recoverability test is performed using undiscounted net cash flows related to the long-lived assets.
If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount
of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount
or fair value less costs to sell. There was &lt;span id="xdx_90D_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20240701__20250630_zFeFBsrmvcn5" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90E_eus-gaap--AssetImpairmentCharges_pn3n3_do_c20230701__20240630_zHjdsI6AnJMk" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment recorded to long-lived assets as of June 30, 2025 or 2024, respectively.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000582"
      unitRef="USD">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000584"
      unitRef="USD">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000586">&lt;p id="xdx_84E_eus-gaap--LesseeLeasesPolicyTextBlock_zdOOBvw5BJ7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;f)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86C_zJ9OdHVnd3Wc" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, &lt;i&gt;Leases&lt;/i&gt;, we determine if a contractual arrangement is, or contains,
a lease at the inception date. Right-of-use (&#x201c;ROU&#x201d;) assets and liabilities related to operating leases are separately
reported in the consolidated balance sheets. The Company currently has no finance leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at the lease commencement date based on the present value of the future lease payments
over the lease term. When the rate implicit to the lease cannot be readily determined, we utilize our incremental borrowing rate
in determining the present value of the future lease payments. The incremental borrowing rate is derived from information available
at the lease commencement date and represents the rate of interest that a lessee would have to pay to borrow an amount equal to
the lease payments on a collateralized basis over a similar term in a similar economic environment. Operating lease ROU assets
also include any cumulative prepaid or accrued rent when the lease payments are uneven throughout the lease term. The ROU assets
and lease liabilities may include options to extend or terminate the lease when it is reasonably certain that we will exercise
that option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
liabilities are increased by interest and reduced by payments each period, and the ROU asset is amortized over the lease term.
For operating leases, interest on the lease liability and the amortization of the ROU asset result in straight-line rent expense
over the lease term. Variable lease expenses are recorded when incurred.&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <niobf:ConvertibleDebtCarriedatFairValuePolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000588">&lt;p id="xdx_844_ecustom--ConvertibleDebtCarriedatFairValuePolicyTextBlock_z0JYCGUNEaFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;g)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_864_zCnFst6mSn9c" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
                                         Debt Carried at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;With
regard to the Company&#x2019;s debt related to the convertible promissory notes issued in April 2024 (as further discussed in Note
8), the Company has elected to account for these notes at fair value per the provisions of ASC Topic 815, &lt;i&gt;Derivatives and Hedging
&lt;/i&gt;(&#x201c;ASC 815&#x201d;). Under ASC 815-15-25, an election can be taken at the inception of a financial instrument to account
for the instrument at fair value. The notes were recorded at fair value at inception and assessed quarterly thereafter using a
Monte Carlo simulation methodology which&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;












&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;incorporates multiple conversion scenarios. All changes in fair value subsequent to the
initial recording, excluding the impact of the change in fair value related to the Company&#x2019;s own credit risk, are recorded
as a component of non-operating income/expense, within Change in fair value of convertible debt in the consolidated statements
of operations. Changes in fair value related to the Company&#x2019;s own credit risk, if any, are recorded through other comprehensive
loss.&lt;/span&gt;&lt;/p&gt;

</niobf:ConvertibleDebtCarriedatFairValuePolicyTextBlock>
    <niobf:WarrantsPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000597">&lt;p id="xdx_848_ecustom--WarrantsPolicyTextBlock_zh9de7G8fcsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;h)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86A_zzBqJ858BRCf" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;We apply relevant accounting
guidance for warrants to purchase our Common Shares (&#x201c;Warrants&#x201d;) based on the nature of the relationship with the counterparty.
The Company has made an accounting policy election that the &#x201c;greater of&#x201d; Share-Price Input to the Black-Scholes Value
would not preclude equity classification. The Company has not had any historical transactions that include the &#x201c;greater of&#x201d;
Share-Price Input feature, and this is a new accounting policy election as of the current fiscal year. For Warrants issued to investors
or lenders in exchange for cash or other financial assets, we follow guidance issued within ASC 480, &lt;i&gt;Distinguishing Liabilities
from Equity&lt;/i&gt;, and ASC 815, to assist in the determination of whether the Warrants should be classified as liabilities or equity.
The fair value of Warrants is estimated using Black Scholes modeling or Monte Carlo modeling, depending on the settlement features
embedded in the Warrant. Inputs under both models include inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest
rate, the expected term, the volatility, and the dividend rate. Warrants that are determined to require liability classifications
are measured at fair value upon issuance and are subsequently remeasured to their then fair value at each subsequent reporting
period with changes in fair value recorded in current earnings. Warrants that are determined to require equity classifications
measured at fair value upon issuance and are not subsequently remeasured unless they are required to be reclassified.&lt;/p&gt;

</niobf:WarrantsPolicyTextBlock>
    <niobf:EarnoutSharesPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000599">&lt;p id="xdx_846_ecustom--EarnoutSharesPolicyTextBlock_zC8dRMo8Jo7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_865_zJVi2dEuUeTg" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
                                         Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
Shares are classified as a liability due to failure to meet the equity classification criteria under ASC 815-40. The Earnout Shares
are measured at fair value upon issuance and subsequently remeasured at each reporting period using a Monte Carlo simulation methodology,
which includes inputs such as NioCorp&#x2019;s Common Share price, the risk-free interest rate, the expected term, the weighted
average of historical Common Share volatility and implied volatility underlying the Company&#x2019;s publicly traded Warrants,
the dividend rate, the conversion price, and the number of Earnout Shares outstanding. Assumptions used in the model are subjective
and require significant judgment.&lt;/span&gt;&lt;/p&gt;

</niobf:EarnoutSharesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-07-01to2025-06-30" id="Fact000601">&lt;p id="xdx_84D_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zGR01jbEI8O5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;j)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86B_zmpv90UlaI9g" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
                                         Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, receivables, equity securities, and accounts payable
and accrued liabilities. It is management&#x2019;s opinion that the Company is not exposed to significant interest, currency or
credit risks arising from its financial instruments. The fair values of these instruments approximate their carrying value unless
otherwise noted.&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2024-07-01to2025-06-30" id="Fact000603">&lt;p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zqWAzZAReQ88" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;k)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_867_zbgAPKWIgidd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Concentration
                                         of Credit Risk&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial instrument which potentially subjects the Company to credit risk is cash and cash equivalents, The Company holds investments
or maintains available cash primarily in two commercial banks located in Vancouver, British Columbia and Columbus, Ohio. As part
of its cash management process, the Company regularly monitors the relative credit standing of these institutions.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:AssetRetirementObligationsPolicy contextRef="From2024-07-01to2025-06-30" id="Fact000605">&lt;p id="xdx_84B_eus-gaap--AssetRetirementObligationsPolicy_z0YgSoWoFSXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;l)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86D_zs7kZ0bx4kje" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Asset
                                         Retirement Obligation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to various government laws and regulations relating to environmental disturbances caused by exploration and
evaluation activities. The estimated costs associated with environmental remediation obligations are accrued in the period in
which the liability is incurred if it is reasonably estimable or known. Until such time that a project life is established, the
Company records the corresponding cost as an exploration stage expense and has accrued $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20250630_znG4zUDnMSV4" title="Accrued Exploration Stage Obligations"&gt;48&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_pn3n3_c20240630_zD2FSDHEwQKg" title="Accrued Exploration Stage Obligations"&gt;48&lt;/span&gt; for estimated obligations as
of June 30, 2025 and June 30, 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
reclamation and environmental-related expenditures are difficult to estimate in many circumstances due to the early-stage nature
of the Elk Creek Project, the uncertainties associated with defining the nature and extent of environmental disturbance, the application
of laws and regulations by regulatory authorities and changes in reclamation or remediation technology. The Company periodically
reviews accrued liabilities for such reclamation and remediation costs as evidence indicating that the liabilities have potentially
changed becomes available. Changes in estimates are reflected in the consolidated statement of operations and comprehensive loss
in the period an estimate is revised.&lt;/span&gt;&lt;/p&gt;

</us-gaap:AssetRetirementObligationsPolicy>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000607"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000609"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000619">&lt;p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zPJ5O1LrTg49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;m)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_860_zbbirz5EKLSl" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25, &lt;i&gt;&#x201c;Income Taxes &#x2013; Recognition.&#x201d;
&lt;/i&gt;Under the approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between
the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded
against deferred tax assets if management does not believe the Company has met the &#x201c;more likely than not&#x201d; standard
imposed by ASC 740-10-25-5 to allow recognition of such an asset. ASC 740-10-50, &#x201c;Income Taxes &#x2013; Disclosure,&#x201d;
requires the Company to evaluate its income tax positions and recognize a liability for uncertain tax positions that are not more
likely than not to be sustained by tax authorities. As of June 30, 2025 and 2024, the Company believes it had no income tax uncertainties
that required recognition of a liability. If the Company were to determine that uncertain tax positions meet the criteria for
recognition, an estimated liability and related interest and penalties would be recognized as income tax expense.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <niobf:RedeemableNoncontrollingInterestPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000621">&lt;p id="xdx_841_ecustom--RedeemableNoncontrollingInterestPolicyTextBlock_zb2890q1vRkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;n)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86D_z7Ncwdb9fCf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
                                         Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redeemable
Noncontrolling Interest refers to non-controlling interest associated with the Vested Shares that are redeemable upon the occurrence
of an event that is not solely within the Company&#x2019;s control and is reported in the mezzanine section between total liabilities
and shareholders&#x2019; deficit, as temporary equity in the Company&#x2019;s consolidated balance sheets. The Company&#x2019;s non-controlling
interest is redeemable at fair value, and no adjustment to the earnings per share numerator is required because redemption at
fair value is not considered an economic distribution different from other common stockholders.&#160;&lt;/span&gt;&lt;/p&gt;

</niobf:RedeemableNoncontrollingInterestPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000623">&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zMwRJISFnjl8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;o)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86C_zjipvAuSYPgf" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
                                         and Diluted Per Share Disclosure&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
earnings (loss) per share represents net earnings (loss) attributable to common shareholders divided by the weighted average number
of Common Shares outstanding during the period. The Company considers Vested Shares and Released Earnout Shares (each as defined
in Note 9), to be participating securities, requiring the use of the two-class method. Diluted earnings (loss) per share represents
net earnings (loss) attributable to common shareholders divided by the weighted average number of Common Shares outstanding, inclusive
of the dilutive impact of all potentially dilutive securities outstanding during the period, as applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWyAFxndIbw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8B8_zwlyT1end3Ah"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; background-color: white"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; background-color: white"&gt;For the year ended June 30,&lt;/td&gt;&lt;td style="background-color: white"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: justify; padding-left: 9pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_z4F4MXQKGrka" style="width: 10%; text-align: right" title="Net loss"&gt;(17,982&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zajpSponzKIc" style="width: 10%; text-align: right" title="Net loss"&gt;(11,898&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Adjust: Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20240701__20250630_zutq6Nkfe109" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"&gt;577&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zGc0Bl8WsSmh" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"&gt;458&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20250630_zkkxBtYRUH46" style="text-align: right" title="Net loss available to participating securities"&gt;(17,405&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zjlQucI0DBW3" style="text-align: right" title="Net loss available to participating securities"&gt;(11,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Net loss attributable to Vested Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20240701__20250630_zx6g14PGNxV4" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"&gt;1,102&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20230701__20240630_zJhpLAyk3YXc" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"&gt;967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20250630_zfcKqCWrkVkf" title="Net loss attributed to common shareholders - basic"&gt;&lt;span id="xdx_90A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20240701__20250630_zd5eiOeCJ9Ne" title="Net loss attributed to common shareholders - diluted"&gt;(16,303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zIPgAaR0Hkyi" title="Net loss attributed to common shareholders - basic"&gt;&lt;span id="xdx_900_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20230701__20240630_z1pwClWsysZi" title="Net loss attributed to common shareholders - diluted"&gt;(10,473&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zfo0ZGEwfa71" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zwkZKVhJ7xgd" title="Weighted average shares outstanding - diluted"&gt;45,072,895&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_z6kzP7KhBMEa" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zJeMmTyr4gFa" title="Weighted average shares outstanding - diluted"&gt;34,320,024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zXjqFfBFYpM1" title="Loss per Common Share outstanding - basic"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zrCFblI8gIGi" title="Loss per Common Share outstanding - diluted"&gt;(0.36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_zGSJbiYudYea" title="Loss per Common Share outstanding - basic"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zeZdYic62vO1" title="Loss per Common Share outstanding - diluted"&gt;(0.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zceKkRzdWzhk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following shares underlying options to purchase Common Shares (&#x201c;Options&#x201d;), Warrants, and outstanding convertible debt
were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation
for the periods indicated below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zfnV3917EYcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span id="xdx_8B2_zIFTJ9XdJ09f" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.6in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded potentially dilutive securities &lt;sup&gt;(1)(2)&lt;/sup&gt;:&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 66%; text-indent: 9pt"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20250630_fKDEpKDIp_zvHEtVOjsaJ6" style="width: 10%; text-align: right" title="Options"&gt;3,020,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zSVC9VR5dap3" style="width: 10%; text-align: right" title="Options"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: 9pt"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20250630_fKDEpKDIp_zfxzBVezte1f" style="text-align: right" title="Warrants"&gt;31,839,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_zO8ohOo3qU49" style="text-align: right" title="Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_d0_uShares_c20240701__20250630_fKDEpKDIp_zN7H7U4yxiug" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zIm3kG74jHG1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,849,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total potentially dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DilutiveSecurities_c20240701__20250630_fKDEpKDIp_zqI5JkNsZ54j" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities"&gt;34,859,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_z68NfvevSWJ4" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,908,061&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;














&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span id="xdx_F02_zcC7sWS9kIAl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 90%; padding-bottom: 4pt; text-align: justify"&gt;&lt;span id="xdx_F15_zdMfNW8gjA06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span id="xdx_F0E_zZPpBNjaaE8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;span id="xdx_F18_zw2zGyryrBC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zIQT9463Qr8f" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000625">&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zWyAFxndIbw4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation
of loss per share. &lt;span id="xdx_8B8_zwlyT1end3Ah"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share
attributable to common shareholders:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%; margin-left: 0.5in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; background-color: white"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; background-color: white"&gt;For the year ended June 30,&lt;/td&gt;&lt;td style="background-color: white"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 74%; text-align: justify; padding-left: 9pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20240701__20250630_z4F4MXQKGrka" style="width: 10%; text-align: right" title="Net loss"&gt;(17,982&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_pn3n3_c20230701__20240630_zajpSponzKIc" style="width: 10%; text-align: right" title="Net loss"&gt;(11,898&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Adjust: Net loss attributable to noncontrolling interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20240701__20250630_zutq6Nkfe109" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"&gt;577&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230701__20240630_zGc0Bl8WsSmh" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: Net loss attributable to noncontrolling interest"&gt;458&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Net loss available to participating securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240701__20250630_zkkxBtYRUH46" style="text-align: right" title="Net loss available to participating securities"&gt;(17,405&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240630_zjlQucI0DBW3" style="text-align: right" title="Net loss available to participating securities"&gt;(11,440&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Net loss attributable to Vested Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20240701__20250630_zx6g14PGNxV4" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"&gt;1,102&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NetLossAttributableToVestedShares_pn3n3_uUSD_c20230701__20240630_zJhpLAyk3YXc" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to Vested Shares"&gt;967&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt; padding-left: 9pt"&gt;Net loss attributed to common shareholders - basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240701__20250630_zfcKqCWrkVkf" title="Net loss attributed to common shareholders - basic"&gt;&lt;span id="xdx_90A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20240701__20250630_zd5eiOeCJ9Ne" title="Net loss attributed to common shareholders - diluted"&gt;(16,303&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240630_zIPgAaR0Hkyi" title="Net loss attributed to common shareholders - basic"&gt;&lt;span id="xdx_900_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_pn3n3_c20230701__20240630_z1pwClWsysZi" title="Net loss attributed to common shareholders - diluted"&gt;(10,473&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Weighted average shares outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240701__20250630_zfo0ZGEwfa71" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240701__20250630_zwkZKVhJ7xgd" title="Weighted average shares outstanding - diluted"&gt;45,072,895&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240630_z6kzP7KhBMEa" title="Weighted average shares outstanding - basic"&gt;&lt;span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20230701__20240630_zJeMmTyr4gFa" title="Weighted average shares outstanding - diluted"&gt;34,320,024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-left: 9pt"&gt;Loss per Common Share outstanding &#x2013; basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240701__20250630_zXjqFfBFYpM1" title="Loss per Common Share outstanding - basic"&gt;&lt;span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20240701__20250630_zrCFblI8gIGi" title="Loss per Common Share outstanding - diluted"&gt;(0.36&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20230701__20240630_zGSJbiYudYea" title="Loss per Common Share outstanding - basic"&gt;&lt;span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20230701__20240630_zeZdYic62vO1" title="Loss per Common Share outstanding - diluted"&gt;(0.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000627"
      unitRef="USD">-17982000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000629"
      unitRef="USD">-11898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000631"
      unitRef="USD">577000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000633"
      unitRef="USD">458000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000635"
      unitRef="USD">-17405000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000637"
      unitRef="USD">-11440000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <niobf:NetLossAttributableToVestedShares
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000639"
      unitRef="USD">1102000</niobf:NetLossAttributableToVestedShares>
    <niobf:NetLossAttributableToVestedShares
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000641"
      unitRef="USD">967000</niobf:NetLossAttributableToVestedShares>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000643"
      unitRef="USD">-16303000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000645"
      unitRef="USD">-16303000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000647"
      unitRef="USD">-10473000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000649"
      unitRef="USD">-10473000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000651"
      unitRef="Shares">45072895</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000653"
      unitRef="Shares">45072895</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000655"
      unitRef="Shares">34320024</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000657"
      unitRef="Shares">34320024</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000659"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000661"
      unitRef="USDPShares">-0.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000663"
      unitRef="USDPShares">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000665"
      unitRef="USDPShares">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000667">&lt;p id="xdx_896_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zfnV3917EYcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span id="xdx_8B2_zIFTJ9XdJ09f" style="display: none; visibility: hidden"&gt;Schedule of excluded from the dilutive securities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.6in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Excluded potentially dilutive securities &lt;sup&gt;(1)(2)&lt;/sup&gt;:&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 66%; text-indent: 9pt"&gt;Options&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240701__20250630_fKDEpKDIp_zvHEtVOjsaJ6" style="width: 10%; text-align: right" title="Options"&gt;3,020,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20230701__20240630_fKDEpKDIp_zSVC9VR5dap3" style="width: 10%; text-align: right" title="Options"&gt;2,495,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: 9pt"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240701__20250630_fKDEpKDIp_zfxzBVezte1f" style="text-align: right" title="Warrants"&gt;31,839,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20230701__20240630_fKDEpKDIp_zO8ohOo3qU49" style="text-align: right" title="Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt"&gt;Convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_d0_uShares_c20240701__20250630_fKDEpKDIp_zN7H7U4yxiug" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20230701__20240630_fKDEpKDIp_zIm3kG74jHG1" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt"&gt;2,849,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total potentially dilutive securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DilutiveSecurities_c20240701__20250630_fKDEpKDIp_zqI5JkNsZ54j" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities"&gt;34,859,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DilutiveSecurities_c20230701__20240630_fKDEpKDIp_z68NfvevSWJ4" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total potentially dilutive securities"&gt;23,908,061&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;














&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span id="xdx_F02_zcC7sWS9kIAl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 90%; padding-bottom: 4pt; text-align: justify"&gt;&lt;span id="xdx_F15_zdMfNW8gjA06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 7%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"&gt;&lt;span id="xdx_F0E_zZPpBNjaaE8g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"&gt;&lt;span id="xdx_F18_zw2zGyryrBC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000669"
      unitRef="Shares">3020000</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000671"
      unitRef="Shares">2495500</us-gaap:IncrementalCommonSharesAttributableToWrittenPutOptions>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000673"
      unitRef="Shares">31839152</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000675"
      unitRef="Shares">18563561</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact000677"
      unitRef="Shares">-0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact000679"
      unitRef="Shares">2849000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000681"
      unitRef="USD">34859152000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000683"
      unitRef="USD">23908061000</us-gaap:DilutiveSecurities>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2024-07-01to2025-06-30" id="Fact000695">&lt;p id="xdx_848_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zjNeX9w6d9k" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;p)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86C_zf3D18XBiwh7" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
                                         Based Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company grants Options to directors, officers, employees, and business advisors. Option terms and vesting conditions are at the
discretion of the Board. The Option exercise price is equal to the closing market price on the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;)
on the day preceding the date of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates the fair value of Options using the Black-Scholes option pricing model. The Company recognizes forfeitures as
they occur.&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000697">&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znH5E6LKdBDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;q)&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_86F_zYUklDvIs6re" style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recent
                                         Accounting Standards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Recently
Adopted Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
fiscal year 2025, we adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07,&#160;&lt;i&gt;Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures&lt;/i&gt;. Management has evaluated the Company&#x2019;s operations and concluded it has&#160;one&#160;reportable
operating segment which will now require expanded disclosure. Adoption was made retroactively with segment disclosure included
for the fiscal years ended June 30, 2025 and 2024. This standard has not changed the processing, recording, or presentation of
financial data, other than providing additional disclosure regarding management oversight for the Company&#x2019;s single operating
segment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Issued
and Not Effective&lt;br/&gt;
&lt;/span&gt;In December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;,
which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of
rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company&#x2019;s annual
periods beginning July 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively.
The Company is currently evaluating the ASU to determine its impact on the Company&#x2019;s disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective
date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a
material impact on the Company&#x2019;s consolidated financial statements upon adoption.&#160;&lt;/span&gt;&lt;/p&gt;



</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000699">&lt;p id="xdx_80D_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zHYF9w32aZOg" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82C_zRkiL06WIOsl" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;GOING
CONCERN ISSUES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred a net loss of $&lt;span id="xdx_909_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20240701__20250630_ziNHsYhCtIN8" title="Net loss::XDX::-17982"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0701"&gt;17,405&lt;/span&gt;&lt;/span&gt; for the year ended June 30, 2025 (2024 - $&lt;span id="xdx_90A_eus-gaap--NetIncomeLoss_pn3n3_dxL_c20230701__20240630_zoc82Euk4hE6" title="Net loss::XDX::-11898"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0703"&gt;11,435&lt;/span&gt;&lt;/span&gt;) and had an accumulated deficit of $&lt;span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_di_c20250630_zww6tJrOqb0a" title="Accumulated Deficit"&gt;179,317&lt;/span&gt;
as of June 30, 2025. As a development stage issuer, the Company has not yet commenced its mining operations and accordingly does
not generate any revenue. The Company does not have sufficient cash on hand to fund planned operations as well as the construction necessary for mine development for the next twelve months. The Company is dependent on its ability to raise capital to fund future exploration and working capital
requirements. These conditions and events raise substantial doubt about
the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
response to these conditions and events, the Company plans to obtain additional financing. As discussed in Note 17, on July 18,
2025, the Company closed a public offering which resulted in net proceeds of approximately $&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfDebt_pn3n3_c20240701__20250630_z6GELYMfwbnb" title="Net proceeds from public offering"&gt;41,762&lt;/span&gt; after deducting placement agent
fees and discounts. Subject to the conditions discussed in Note 10a, NioCorp expects to have access to up to $&lt;span id="xdx_906_eus-gaap--ProceedsFromRepaymentsOfDebt_pn3n3_c20240701__20250630_zWFVgYIjZO9h" title="Net proceeds"&gt;46,917&lt;/span&gt; in net proceeds
from the Standby Equity Purchase Agreement, dated January 26, 2023 (the &#x201c;Yorkville Equity Facility Financing Agreement&#x201d;),
between the Company and YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;),
through April 1, 2026. In addition, the Company may pursue additional sources of financing, and while it has been successful in
doing so in the past, there can be no assurance it will be able to do so in the future. Other than the potential issuance of Common
Shares under the Yorkville Equity Facility Financing Agreement, the Company did not have any further funding commitments or arrangements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;












&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;for additional financing as of June 30, 2025. The Company&#x2019;s plans to obtain additional financing have not been finalized,
are subject to market conditions, and are not within the Company&#x2019;s control and therefore cannot be deemed probable. Further,
the Company will be required to raise additional funds for the construction and commencement of operations. As a result, the Company
has concluded that management&#x2019;s plans do not alleviate substantial doubt about the Company&#x2019;s ability to continue as
a going concern.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000705"
      unitRef="USD">-179317000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000707"
      unitRef="USD">41762000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000709"
      unitRef="USD">46917000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000718">&lt;p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z9mO3FdLZrOi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82A_zdyMNiQljlqh" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;LAND
AND BUILDINGS, NET&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zQQtDdjyGdN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B2_zoch6eAZCja4" style="display: none; visibility: hidden"&gt;Schedule of properties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 22%; padding-left: 0.125in"&gt;Land&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zRWGJDcz0Lq9" style="width: 10%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zYKalscBZKYe" style="width: 10%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zeIWh5zJTjog" style="width: 10%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zmeqIhtJr691" style="width: 10%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zETTNUimlLt5" style="width: 10%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zSKBeRBXnlcl" style="width: 10%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Buildings and other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_znnUAw00thW8" style="border-bottom: Black 1pt solid; text-align: right" title="Cost"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zlJdixZWBrd4" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIdiDMAiD3Z9" style="border-bottom: Black 1pt solid; text-align: right" title="Net"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zNDkoTkTGBd" style="border-bottom: Black 1pt solid; text-align: right" title="Cost"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z2df0C6C6pad" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zQ8GF7ZWIEdh" style="border-bottom: Black 1pt solid; text-align: right" title="Net"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Land and buildings, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630_zK92fVwSsPx7" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost"&gt;853&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630_z3UD99r1P9Oh" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation"&gt;14&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630_znztPujhuZCj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net"&gt;839&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zF6KM3lSmfX6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zshKFknmDq1a" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation"&gt;11&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zh6AQC3kMxsc" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net"&gt;837&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_ztvkqolwOdIl" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000720">&lt;p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zQQtDdjyGdN8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8B2_zoch6eAZCja4" style="display: none; visibility: hidden"&gt;Schedule of properties&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 22%; padding-left: 0.125in"&gt;Land&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zRWGJDcz0Lq9" style="width: 10%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zYKalscBZKYe" style="width: 10%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--LandMember_zeIWh5zJTjog" style="width: 10%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zmeqIhtJr691" style="width: 10%; text-align: right" title="Cost"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_d0_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zETTNUimlLt5" style="width: 10%; text-align: right" title="Accumulated depreciation"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--LandMember_zSKBeRBXnlcl" style="width: 10%; text-align: right" title="Net"&gt;807&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Buildings and other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_znnUAw00thW8" style="border-bottom: Black 1pt solid; text-align: right" title="Cost"&gt;46&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zlJdixZWBrd4" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zIdiDMAiD3Z9" style="border-bottom: Black 1pt solid; text-align: right" title="Net"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zNDkoTkTGBd" style="border-bottom: Black 1pt solid; text-align: right" title="Cost"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_z2df0C6C6pad" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630__srt--ProductOrServiceAxis__us-gaap--BuildingMember_zQ8GF7ZWIEdh" style="border-bottom: Black 1pt solid; text-align: right" title="Net"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Land and buildings, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20250630_zK92fVwSsPx7" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost"&gt;853&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20250630_z3UD99r1P9Oh" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation"&gt;14&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20250630_znztPujhuZCj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net"&gt;839&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentOther_iI_pn3n3_c20240630_zF6KM3lSmfX6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Cost"&gt;848&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20240630_zshKFknmDq1a" style="border-bottom: Black 2.5pt solid; text-align: right" title="Accumulated depreciation"&gt;11&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pn3n3_c20240630_zh6AQC3kMxsc" style="border-bottom: Black 2.5pt solid; text-align: right" title="Net"&gt;837&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2025-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000722"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000724"
      unitRef="USD">-0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000726"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2024-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000728"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000730"
      unitRef="USD">-0</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30_us-gaap_LandMember"
      decimals="-3"
      id="Fact000732"
      unitRef="USD">807000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2025-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000734"
      unitRef="USD">46000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000736"
      unitRef="USD">14000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000738"
      unitRef="USD">32000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000740"
      unitRef="USD">41000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000742"
      unitRef="USD">11000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30_us-gaap_BuildingMember"
      decimals="-3"
      id="Fact000744"
      unitRef="USD">30000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000746"
      unitRef="USD">853000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000748"
      unitRef="USD">14000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000750"
      unitRef="USD">839000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentOther
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000752"
      unitRef="USD">848000</us-gaap:PropertyPlantAndEquipmentOther>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000754"
      unitRef="USD">11000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000756"
      unitRef="USD">837000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:MineralIndustriesDisclosuresTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000758">&lt;p id="xdx_806_eus-gaap--MineralIndustriesDisclosuresTextBlock_zMhn8DA0T2L6" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82A_zciq2pEl0F35" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;MINERAL
PROPERTIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mineral
properties consist of original acquisition costs and purchased mineral rights related to the Elk Creek Project.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the land and mineral rights currently owned by the Company, the property interests of Elk Creek include seven prepaid
mineral exploration option-to-purchase agreements which include a pre-determined buyout for permanent ownership of the mineral
and/or surface rights. Terms of the agreements require no further significant payments, and the Company may terminate the leases,
negotiate lease extensions, or elect to purchase the mineral and/or surface rights any time. Agreements that allow for the purchase
of mineral rights contain provisions whereby the landowners would retain a 2% net smelter return.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended June 30, 2025, the Company completed negotiations with landowners in Nebraska and entered into contract amendments
which extended the option periods by approximately five years for option to purchase agreements (&#x201c;OTP&#x201d;) covering six
parcels of land for project construction and operation which the Company does not already own. The Company recorded an exploration
expense for $&lt;span id="xdx_904_ecustom--ExplorationExpenseForOTPExtensionPayments_pn3n3_uUSD_c20240701__20250630_zbLP80NxSF1c" title="Exploration expense for OTP extension payments"&gt;310&lt;/span&gt; paid for OTP extension payments made and will make periodic payments totaling $&lt;span id="xdx_904_ecustom--FutureOptionToPurchaseExtensionPaymentObligations_pn3n3_uUSD_c20240701__20250630_zIfWQXvUKYFk" title="Future Option to Purchase Extension Payment Obligations"&gt;93&lt;/span&gt; over the extension period.&lt;/span&gt;&lt;/p&gt;

</us-gaap:MineralIndustriesDisclosuresTextBlock>
    <niobf:ExplorationExpenseForOTPExtensionPayments
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000760"
      unitRef="USD">310000</niobf:ExplorationExpenseForOTPExtensionPayments>
    <niobf:FutureOptionToPurchaseExtensionPaymentObligations
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000762"
      unitRef="USD">93000</niobf:FutureOptionToPurchaseExtensionPaymentObligations>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000764">&lt;p id="xdx_809_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zAI8fVjLJmDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_824_zpn90gdHi14g" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ACCOUNTS
PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z0jnJnCG44Jh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8BE_z89LVvJqnj45" style="display: none; visibility: hidden"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; text-align: right; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250630_zNf6tlgv6vva" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240630_z3RwxcXCvoG8" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zLUTTOdkfLlc" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 49%; text-align: left; padding-left: 0.2in"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;692&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,417&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zugEg8xtDWVc" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zy4RuEKI3tSk" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zR7WW46OMhxd" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.2in"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_znXImEMCEGR7" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;1,795&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;1,843&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zLcsiORDuimf" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000766">&lt;p id="xdx_89B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z0jnJnCG44Jh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span id="xdx_8BE_z89LVvJqnj45" style="display: none; visibility: hidden"&gt;Schedule of account payable and accrued liabilities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; text-align: right; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20250630_zNf6tlgv6vva" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20240630_z3RwxcXCvoG8" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--AccountsPayableTradeCurrent_iI_pn3n3_zLUTTOdkfLlc" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 49%; text-align: left; padding-left: 0.2in"&gt;Accounts payable, trade&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;692&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,417&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pn3n3_zugEg8xtDWVc" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Trade payable accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,055&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_pn3n3_zy4RuEKI3tSk" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Environmental accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesFairValueDisclosure_iI_pn3n3_zR7WW46OMhxd" style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.2in"&gt;Loan origination fees payable to related party&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;28&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_pn3n3_znXImEMCEGR7" style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;1,795&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;1,843&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000768"
      unitRef="USD">692000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000769"
      unitRef="USD">1417000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000771"
      unitRef="USD">1055000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000772"
      unitRef="USD">350000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000774"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000775"
      unitRef="USD">48000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000778"
      unitRef="USD">28000</us-gaap:AccountsPayableAndAccruedLiabilitiesFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact000780"
      unitRef="USD">1795000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000781"
      unitRef="USD">1843000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000783">&lt;p id="xdx_800_eus-gaap--LongTermDebtTextBlock_zX3rUZT8pD59" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_825_zspCXbtTW0l7"&gt;CONVERTIBLE
DEBT&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_pn3n3_zNGRtBilwLCd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_8BE_z5k4S4bzws22" style="display: none"&gt;Schedule of convertible debt&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.2in; width: 49%"&gt;Yorkville convertible debentures&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zHfWyp91JNJg" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zMPkYj0bcnsc" style="width: 10%; text-align: right"&gt;571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.2in"&gt;April 2024 notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zGqxeyKolCB8" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zS1SGXYvTrd6" style="border-bottom: Black 1pt solid; text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630_z8e6tbzXlJ85" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630_zWouEHdpqit9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt"&gt;7,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Yorkville
Convertible Debentures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_980_eus-gaap--DebtInstrumentDescription_c20240701__20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_gBFDID-TLBFWD_zAy7XVAKng8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify" title="Convertible debt, description"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20250630__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zaCDDDZin4Kc" title="Aggregate principal amount"&gt;16,000&lt;/span&gt; aggregate principal&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;














&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_C06_gBFDID-TLBFWD_zRVIdLKxWPUl"&gt;
amount of unsecured convertible debentures (the &#x201c;Convertible Debentures&#x201d;) and (ii) Warrants exercisable for up to
&lt;span id="xdx_90D_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercise_pid_uShares_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zM6PDy84pDrk" title="Number of shares purchase"&gt;1,789,267&lt;/span&gt; Common Shares for cash or, if at any time there is no effective registration statement registering, or no current
prospectus available for, the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price
per Common Share of approximately $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z3bacnZscts" title="Number of shares purchase"&gt;8.9422&lt;/span&gt;, subject to adjustment to give effect to any stock dividend, stock split, reverse stock
split or similar transaction.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 19, 2024, the Company and Yorkville entered into a make-whole payment agreement under which Yorkville agreed to convert the
remaining outstanding principal and accrued interest of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_uUSD_c20240717__20240719__us-gaap--LongtermDebtTypeAxis__us-gaap--UnsecuredDebtMember_zr0N2VqeDCo9" title="Principal and accrued interest"&gt;554&lt;/span&gt; under the Convertible Debentures into Common Shares in exchange for
a $&lt;span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pn3n3_uUSD_c20240717__20240719__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_z1ZrYMb6nuX6" title="Principal and accrued interest"&gt;95&lt;/span&gt; make-whole payment. The Company recorded a gain on extinguishment of $&lt;span id="xdx_903_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_uUSD_c20240701__20250630__us-gaap--TypeOfArrangementAxis__custom--YorkvilleConvertibleDebtFinancingAgreementMember_zFeCZGM23xej" title="Principal and accrued interest"&gt;19&lt;/span&gt; as part of other gains in the condensed consolidated
statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Changes
in the Convertible Debentures are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ConvertibleDebtTableTextBlock_pn3n3_zD6ZVUqC1VQ8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BE_zkBS6SAU7BFb" style="display: none"&gt;&#160;Schedule of changes
in the convertible debentures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 67%"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zzJXZFnRUtt7" style="width: 10%; text-align: right" title="Balance at June 30, 2024"&gt;10,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zixJkcU1OtT8" style="text-align: right" title="Accretion expense"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt"&gt;Principal and accrued interest converted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zyXxmmDgr9f1" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted"&gt;(14,479&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zo4bGElTgiO2" style="text-align: right" title="Balance at June 30, 2024"&gt;571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; text-indent: -4.5pt; padding-left: 13.5pt"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4A4eTyUvxWa" style="text-align: right" title="Accretion expense"&gt;43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -4.5pt; padding-left: 13.5pt"&gt;Principal and interest converted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zW3rMxoUTXM5" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted"&gt;(614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z6flPImlVDK" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, December 31, 2024"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0832"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table discloses the components of interest expense associated with the Convertible Debentures:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_pn3n3_z9G1SDXr4CU1" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 2)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B7_zDo4TJHqzSpg" style="display: none"&gt;Schedule of  components of interest expense    with convertible debenture&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20240701__20250630_zf24biSHMNn1" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230701__20240630_zaF9W5nB7fog" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Component of Interest Expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCosts_z1X0V3sA5Mlj" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 54%; text-align: justify; padding-left: 9pt"&gt;Amortization of discount and issuance costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;42&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;4,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--ContractualInterest_zzFMSyEgqT45" style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Contractual interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--InterestAndDebtExpense_zBGZLdbINUjl" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;43&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;April
2024 Notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 12, 2024, the Company issued and sold to Yorkville and Lind Global Fund II LP (together with Yorkville, the &#x201c;April
2024 Purchasers&#x201d;), $8,000 aggregate principal amount of unsecured notes (the &#x201c;April 2024 Notes&#x201d;), pursuant to
a securities purchase agreement, dated April 11, 2024 (the &#x201c;April 2024 Purchase Agreement&#x201d;), between the Company and
each of the April 2024 Purchasers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also issued to the April 2024 Purchasers, in proportion to the aggregate principal amount of April 2024 Notes issued to
each April 2024 Purchaser, Warrants (the &#x201c;April 2024 Warrants&#x201d;) to purchase up to 615,385 Common Shares (the &#x201c;April
2024 Warrants Shares&#x201d;), which were equal to 25% of the aggregate principal amount of April 2024 Notes issued to the April
2024 Purchasers divided by the exercise price of $3.25, subject to any adjustment to give effect to any stock dividend, stock
split or recapitalization. The April 2024 Warrants expire on April 12, 2027.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the April 2024 Purchase Agreement, the April 2024 Purchasers advanced an aggregate of $6,935 to the Company in consideration
of the issuance by the Company to the April 2024 Purchasers of $8,000 aggregate principal amount of the April 2024 Notes and April
2024 Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the terms of the April 2024 Notes, subject to certain exceptions, on the first day of each calendar month, beginning on June 1,
2024 (excluding August 2024) (the &#x201c;Payment Date&#x201d;), the Company was required to repay a portion of the outstanding
balance of all of the April 2024 Notes, on a pro-rata basis, in an amount equal to the sum of (i) $1,400 of principal (or the
outstanding principal if less than such amount) in the aggregate among all of the outstanding Notes, plus (ii) 8.0% of the principal
amount being paid (the &#x201c;Payment Premium&#x201d;), and (iii) accrued and unpaid interest, if any, as of the Payment Date.
The Company was required to make payments on each Payment Date until the entire outstanding principal was repaid but did not have
an obligation to make a payment on a Payment Date if certain equity conditions were satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to certain limitations contained within the April 2024 Notes, holders of the April 2024 Notes were entitled to convert the principal
amount of, accrued and unpaid interest, if any, and any Payment Premium that has become due and payable on each April 2024 Note,
from time to time over their term, into a number of Common Shares equal to the quotient of the amount being converted divided
by a fixed conversion price of $2.75 per Common Share up to a maximum of 3,141,817 Common Shares (together with the April 2024
Warrant Shares, the &#x201c;April 2024 Underlying Shares&#x201d;). The terms of the April 2024 Notes restricted the conversion of
the April 2024 Notes by a holder if such a conversion would have caused such holder to exceed certain ownership thresholds in
the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Notes were the unsecured obligations of the Company and were originally scheduled to mature on December 31, 2024. The
April 2024 Notes incurred a simple interest rate obligation of 0.0% per annum (which would have increased to 18.0% per annum upon
the occurrence of an event of default).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Notes were also redeemable at the Company&#x2019;s option at any time and from time to time over their term at a redemption
price equal to the principal amount being redeemed, plus the Payment Premium, plus accrued and unpaid interest, if any, as of
the redemption date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Notes contained events of default customary for instruments of their type (with customer grace periods, as applicable)
and provided that, upon the occurrence of an event of default arising from certain events of bankruptcy or insolvency with respect
to the Company, all outstanding April 2024 Notes would become due and payable immediately without further action or notice. If
any other type of event of default occurred and continued, then any holder could have declared all of its April 2024 Notes to
be due and payable immediately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Purchase Agreement contained customary representations, warranties, conditions and indemnification obligations by each
party. The representations, warranties and covenants contained in the April 2024 Purchase Agreement were made only for purposes
of the April 2024 Purchase Agreement and as of specific dates, were solely for the benefit of the parties to such agreement and
are subject to certain important limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
April 2024 Purchase Agreement also contained certain covenants that, among other things, limited NioCorp&#x2019;s ability to use
the proceeds from the April 2024 Purchase Agreement to repay related party debt or to enter into any variable rate transaction
other than with Yorkville, subject to certain exceptions, and to distribute proceeds from the April 2024 Purchase Agreement to
subsidiaries other than ECRC and 0896800 B.C. Ltd. (together with ECRC, the &#x201c;Guarantors&#x201d;), upon the entry by the Guarantors
into a global guaranty agreement, dated as of April 11, 2024, among the Guarantors in favor of the April 2024 Purchasers (the &#x201c;Guaranty
Agreement&#x201d;). Pursuant to the Guaranty Agreement, the Guarantors guaranteed the full, prompt and unconditional payment when
due (whether at maturity, by acceleration or otherwise), and the performance of all liabilities, agreements and other obligations
of NioCorp to the April 2024 Purchasers contained in the April 2024 Notes, the April 2024 Warrants, and the April 2024 Purchase
Agreement, to the extent such liabilities, agreements, and obligations are payable in cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
upon the Company&#x2019;s analysis of the criteria contained in ASC 815, the Company determined that April 2024 Warrants met the
definition of a&#160;derivative liability, as any Warrant exercise that could cause the holder to exceed 19.9% ownership of NioCorp
Common Shares would require shareholder approval. As such, the April 2024 Warrants are recognized as Warrant liabilities on the
consolidated balance sheet and were measured at their inception date fair value and are subsequently remeasured at each reporting
period with changes being recorded as a non-operating gain or loss in the consolidated statement of operations and comprehensive
loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company elected to value the April 2024 Notes at fair value in accordance with ASC 815-15-25. The fair value of the April
2024 Notes was estimated using a Monte Carlo simulation pricing model and the April 2024 Notes were classified as Level 3
instruments. The Company incurred transaction costs totaling $&lt;span id="xdx_90E_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z3wBvJIVyKM" title="Transaction loss"&gt;474&lt;/span&gt; in connection with the issuance of the April 2024 Notes and
due to the fair value election noted above, these costs were expensed at closing. Components and initial valuations
associated with the April 2024 Notes were comprised of the following amounts:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;














&lt;div style="text-align: left; margin-bottom: 1pt"&gt;&lt;/div&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$902
    was recorded to Warrant liabilities, representing the initial fair value of the April 2024 Warrants based on the assumptions
    outlined below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zbDHipFh34ra" title="Fair value"&gt;10,315&lt;/span&gt; was recorded
    to the April 2024 Notes, representing the fair value based on the assumptions outlined below. The Company also recognized
    an opening transaction loss of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTlZFUlRJQkxFIERFQlQgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pn3n3_c20240401__20240430__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zNCbxaDNDpP8" title="Transaction loss"&gt;4,256&lt;/span&gt;, representing the difference between the fair value of the April 2024 Notes, including
    the fair value of the variable conversion features embedded therein, and cash received in the transaction.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table discloses the primary inputs for the Monte Carlo model used in valuing the April 2024 Notes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_ztDoIMw7tf11" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 3)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B2_zgRQhqKlvPDe" style="display: none"&gt;Schedule of primary inputs for the Monte Carlo model&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;April 12,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 55%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iE_pid_uUSDPShares_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIppadkki5u8" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znp1SpRQvOId" style="width: 12%; text-align: right" title="Closing common share price"&gt;3.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA5J2X6GyOm9" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zObltUbYfQDe" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Weighted average of the equity volatility and implied volatility of the 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z1M04SKpO8Sj" style="text-align: right" title="Equity volatility"&gt;80&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJ46VEBBxJV1" style="text-align: right" title="Equity volatility"&gt;66.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6PPiGHLGF8c" style="text-align: right" title="Risk-free rate"&gt;5.33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zxGN43jf9Gk4" style="text-align: right" title="Risk-free rate"&gt;5.26&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify"&gt;Implied discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwpvRc52YOE2" style="text-align: right" title="Implied discount rate"&gt;15.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA9ekh7Zmua7" style="text-align: right" title="Implied discount rate"&gt;15.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
September 4, 2024 and October 3, 2024, the Company entered into (i) consents and waivers (the &#x201c;2024 Yorkville Consents&#x201d;)
to the April 2024 Notes issued and sold to Yorkville pursuant to the April 2024 Purchase Agreement and (ii) consents and waivers
(together with the 2024 Yorkville Consents, the &#x201c;2024 Note Consents&#x201d;) to the April 2024 Notes issued and sold to Lind
II pursuant to the April 2024 Purchase Agreement. The 2024 Note Consents, among other things, extended and deferred certain monthly
payments and extended the maturity of the April 2024 Notes until January 31, 2025. On January 3, 2025, the Company entered into
a consent and waiver (the &#x201c;January Yorkville Consent&#x201d;) to the April 2024 Notes issued and sold to Yorkville pursuant
to the April 2024 Purchase Agreement. The January Yorkville Consent, among other things, deferred the due date for the amounts
that would otherwise have been due to Yorkville on January 1, 2025 to the maturity date and extended the maturity date to February
17, 2025, and prospectively waived any term of the April 2024 Notes that would otherwise be triggered upon a failure of the Company
to pay to Yorkville the remainder of the amount due on January 1, 2025. All remaining amounts due to Lind II ($176) and Yorkville
($1,000) under the April 2024 Notes were repaid on January 6, 2025, and February 7, 2025, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth a summary of the changes in the fair value of the April 2024 Notes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_pn3n3_zBtEDD9oljXi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 4)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BC_zgV4vA9u1aHf" style="display: none"&gt;&#160;Schedule of changes in the fair value of  April 2024 Note&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 45%; text-align: justify"&gt;Fair value, April 12, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240413__20240630_zteg0p1rgXqf" style="width: 12%; text-align: right" title="Fair value, April 12, 2024"&gt;10,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240413__20240630_zPSp9A4MHFK9" style="text-align: right" title="Principal payments"&gt;(1,512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ChangeInFairValue_c20240413__20240630_zlXYwaK7i5ng" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(1,714&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240701__20250630_zOBH3VzdRrU6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value, April 12, 2024"&gt;7,089&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240701__20250630_zhlBzptHc3q9" style="text-align: right" title="Principal payments"&gt;(7,129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangeInFairValue_c20240701__20250630_z9FPLejUwaBc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;40&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20240701__20250630_zXM39yVtExVl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, June 30, 2024"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0903"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table discloses the primary inputs for the Black-Scholes model used in valuing the April 2024 Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_z2E1MfvZJxBg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 5)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B0_zkcQeDw01o1a" style="display: none"&gt;Schedule of  Black-Scholes model used in April 2024 Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 39%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVwXQqnctCC6" style="width: 10%; text-align: right" title="Closing Common Share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVLIh4QzKVre" style="width: 10%; text-align: right" title="Closing Common Share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znZY2VpG4k8j" style="text-align: right" title="Term (years)"&gt;1.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z2WyWNSC4HH1" style="text-align: right" title="Term (years)"&gt;2.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJvm77hI83Rg" style="text-align: right" title="Expected volatility"&gt;82.22&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzulsrUdhQbl" style="text-align: right" title="Expected volatility"&gt;66.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhSO1cWiFxj2" style="text-align: right" title="Risk-free rate"&gt;3.78&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zalp8dXUKLV3" style="text-align: right" title="Risk-free rate"&gt;4.57&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth a summary of the changes in the fair value of the April 2024 Warrant liability:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zlZJY0yJbIZd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 6)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B5_zMtaaIWMP1F2" style="display: none"&gt;&#160;Schedule of changes in fair value of April 2024 Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 50%; text-align: justify"&gt;Fair value as of April 12, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0VrSHJRNjSj" style="width: 12%; text-align: right"&gt;902&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zktD7wgc3i07" style="border-bottom: Black 1pt solid; text-align: right"&gt;(604&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Fair value as of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZNBMGPqUfpk" style="text-align: right"&gt;298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhq95PR6iHj" style="border-bottom: Black 1pt solid; text-align: right"&gt;191&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqrYqwSOZr1" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;489&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LongTermDebtTextBlock>
    <niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000785">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock_pn3n3_zNGRtBilwLCd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_8BE_z5k4S4bzws22" style="display: none"&gt;Schedule of convertible debt&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.2in; width: 49%"&gt;Yorkville convertible debentures&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zHfWyp91JNJg" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleDebenturesMember_zMPkYj0bcnsc" style="width: 10%; text-align: right"&gt;571&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.2in"&gt;April 2024 notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zGqxeyKolCB8" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630__us-gaap--DebtInstrumentAxis__custom--April2024ConvertibleSecurityMember_zS1SGXYvTrd6" style="border-bottom: Black 1pt solid; text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total convertible debt&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConvertibleDebt_iI_pn3n3_c20250630_z8e6tbzXlJ85" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ConvertibleDebt_iI_pn3n3_c20240630_zWouEHdpqit9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total convertible debt"&gt;7,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:ScheduleOfChangesInLindIiiConvertibleSecurityTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleDebenturesMember"
      decimals="-3"
      id="Fact000787"
      unitRef="USD">571000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30_custom_April2024ConvertibleSecurityMember"
      decimals="-3"
      id="Fact000789"
      unitRef="USD">7089000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000793"
      unitRef="USD">7660000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebenturesMember"
      id="Fact000796">Pursuant
to the Yorkville Convertible Debt Financing Agreement, at the Closing, Yorkville advanced a total amount of $15,360 to NioCorp
in consideration of the issuance by NioCorp to Yorkville of (i) $16,000 aggregate principal
amount of unsecured convertible debentures (the &#x201c;Convertible Debentures&#x201d;) and (ii) Warrants exercisable for up to
1,789,267 Common Shares for cash or, if at any time there is no effective registration statement registering, or no current
prospectus available for, the resale of the underlying Common Shares, on a cashless basis, at the option of the holder, at a price
per Common Share of approximately $8.9422, subject to adjustment to give effect to any stock dividend, stock split, reverse stock
split or similar transaction.</us-gaap:DebtInstrumentDescription>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-06-30_us-gaap_UnsecuredDebtMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact000798"
      unitRef="USD">16000000</us-gaap:DebtInstrumentFaceAmount>
    <niobf:StockIssuedDuringPeriodSharesStockOptionsExercise
      contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      id="Fact000808"
      unitRef="Shares">1789267</niobf:StockIssuedDuringPeriodSharesStockOptionsExercise>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_us-gaap_WarrantMember_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="INF"
      id="Fact000810"
      unitRef="USDPShares">8.9422</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-07-172024-07-19_us-gaap_UnsecuredDebtMember"
      decimals="-3"
      id="Fact000812"
      unitRef="USD">554000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-07-172024-07-19_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact000814"
      unitRef="USD">95000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-07-012025-06-30_custom_YorkvilleConvertibleDebtFinancingAgreementMember"
      decimals="-3"
      id="Fact000816"
      unitRef="USD">19000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000818">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ConvertibleDebtTableTextBlock_pn3n3_zD6ZVUqC1VQ8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BE_zkBS6SAU7BFb" style="display: none"&gt;&#160;Schedule of changes
in the convertible debentures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="width: 67%"&gt;Balance, June 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zzJXZFnRUtt7" style="width: 10%; text-align: right" title="Balance at June 30, 2024"&gt;10,561&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zixJkcU1OtT8" style="text-align: right" title="Accretion expense"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 9pt"&gt;Principal and accrued interest converted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20230701__20240630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zyXxmmDgr9f1" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted"&gt;(14,479&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ConvertibleDebt_iS_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zo4bGElTgiO2" style="text-align: right" title="Balance at June 30, 2024"&gt;571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; text-indent: -4.5pt; padding-left: 13.5pt"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccretionExpenseIncludingAssetRetirementObligations_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z4A4eTyUvxWa" style="text-align: right" title="Accretion expense"&gt;43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: -4.5pt; padding-left: 13.5pt"&gt;Principal and interest converted&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PrincipalAndAccruedInterestConverted_pn3n3_uUSD_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_zW3rMxoUTXM5" style="border-bottom: Black 1pt solid; text-align: right" title="Principal and interest converted"&gt;(614&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConvertibleDebt_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__us-gaap--ConvertibleDebtSecuritiesMember_z6flPImlVDK" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, December 31, 2024"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0832"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="-3"
      id="Fact000820"
      unitRef="USD">10561000</us-gaap:ConvertibleDebt>
    <us-gaap:AccretionExpenseIncludingAssetRetirementObligations
      contextRef="From2023-07-012024-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="-3"
      id="Fact000822"
      unitRef="USD">4489000</us-gaap:AccretionExpenseIncludingAssetRetirementObligations>
    <niobf:PrincipalAndAccruedInterestConverted
      contextRef="From2023-07-012024-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="-3"
      id="Fact000824"
      unitRef="USD">-14479000</niobf:PrincipalAndAccruedInterestConverted>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="-3"
      id="Fact000826"
      unitRef="USD">571000</us-gaap:ConvertibleDebt>
    <us-gaap:AccretionExpenseIncludingAssetRetirementObligations
      contextRef="From2024-07-012025-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="-3"
      id="Fact000828"
      unitRef="USD">43000</us-gaap:AccretionExpenseIncludingAssetRetirementObligations>
    <niobf:PrincipalAndAccruedInterestConverted
      contextRef="From2024-07-012025-06-30_us-gaap_ConvertibleDebtSecuritiesMember"
      decimals="-3"
      id="Fact000830"
      unitRef="USD">-614000</niobf:PrincipalAndAccruedInterestConverted>
    <us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000834">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_pn3n3_z9G1SDXr4CU1" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 2)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B7_zDo4TJHqzSpg" style="display: none"&gt;Schedule of  components of interest expense    with convertible debenture&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20240701__20250630_zf24biSHMNn1" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230701__20240630_zaF9W5nB7fog" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Component of Interest Expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--AmortizationOfFinancingCosts_z1X0V3sA5Mlj" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 54%; text-align: justify; padding-left: 9pt"&gt;Amortization of discount and issuance costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;42&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;4,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--ContractualInterest_zzFMSyEgqT45" style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 9pt"&gt;Contractual interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--InterestAndDebtExpense_zBGZLdbINUjl" style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;43&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingExpenseByComponentTextBlock>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000836"
      unitRef="USD">42000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000837"
      unitRef="USD">4210000</us-gaap:AmortizationOfFinancingCosts>
    <niobf:ContractualInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000839"
      unitRef="USD">1000</niobf:ContractualInterest>
    <niobf:ContractualInterest
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000840"
      unitRef="USD">279000</niobf:ContractualInterest>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000842"
      unitRef="USD">43000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact000843"
      unitRef="USD">4489000</us-gaap:InterestAndDebtExpense>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2024-04-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact000853"
      unitRef="USD">474000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized
      contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact000863"
      unitRef="USD">10315000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-04-30_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact000865"
      unitRef="USD">4256000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000867">&lt;table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--ScheduleOfInterestRateDerivativesTableTextBlock_ztDoIMw7tf11" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 3)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B2_zgRQhqKlvPDe" style="display: none"&gt;Schedule of primary inputs for the Monte Carlo model&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;April 12,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 55%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iE_pid_uUSDPShares_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIppadkki5u8" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znp1SpRQvOId" style="width: 12%; text-align: right" title="Closing common share price"&gt;3.11&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA5J2X6GyOm9" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zObltUbYfQDe" title="Term (expiry)"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Weighted average of the equity volatility and implied volatility of the 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z1M04SKpO8Sj" style="text-align: right" title="Equity volatility"&gt;80&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJ46VEBBxJV1" style="text-align: right" title="Equity volatility"&gt;66.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6PPiGHLGF8c" style="text-align: right" title="Risk-free rate"&gt;5.33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zxGN43jf9Gk4" style="text-align: right" title="Risk-free rate"&gt;5.26&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify"&gt;Implied discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zwpvRc52YOE2" style="text-align: right" title="Implied discount rate"&gt;15.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ImpliedDiscountRate_pid_dp_uRatio_c20240411__20240412__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--MonteCarloModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zA9ekh7Zmua7" style="text-align: right" title="Implied discount rate"&gt;15.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000869"
      unitRef="USDPShares">1.73</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000871"
      unitRef="USDPShares">3.11</us-gaap:SharePrice>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      id="Fact000873">2024-12-31</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      id="Fact000875">2024-12-31</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000877"
      unitRef="Ratio">0.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000879"
      unitRef="Ratio">0.660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000881"
      unitRef="Ratio">0.0533</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000883"
      unitRef="Ratio">0.0526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ImpliedDiscountRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000885"
      unitRef="Ratio">0.150</niobf:ImpliedDiscountRate>
    <niobf:ImpliedDiscountRate
      contextRef="From2024-04-112024-04-12_us-gaap_MeasurementInputExercisePriceMember_us-gaap_MonteCarloModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000887"
      unitRef="Ratio">0.150</niobf:ImpliedDiscountRate>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000889">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_pn3n3_zBtEDD9oljXi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 4)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BC_zgV4vA9u1aHf" style="display: none"&gt;&#160;Schedule of changes in the fair value of  April 2024 Note&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 45%; text-align: justify"&gt;Fair value, April 12, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240413__20240630_zteg0p1rgXqf" style="width: 12%; text-align: right" title="Fair value, April 12, 2024"&gt;10,315&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240413__20240630_zPSp9A4MHFK9" style="text-align: right" title="Principal payments"&gt;(1,512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ChangeInFairValue_c20240413__20240630_zlXYwaK7i5ng" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(1,714&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FairValueHedgeAssetsAtFairValue_iS_c20240701__20250630_zOBH3VzdRrU6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value, April 12, 2024"&gt;7,089&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: left; text-indent: 9pt"&gt;Principal payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DebtInstrumentPeriodicPayment_iN_di_c20240701__20250630_zhlBzptHc3q9" style="text-align: right" title="Principal payments"&gt;(7,129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ChangeInFairValue_c20240701__20250630_z9FPLejUwaBc" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;40&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FairValueHedgeAssetsAtFairValue_iE_c20240701__20250630_zXM39yVtExVl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Balance, June 30, 2024"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0903"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="AsOf2024-04-12"
      decimals="-3"
      id="Fact000891"
      unitRef="USD">10315000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-04-132024-06-30"
      decimals="-3"
      id="Fact000893"
      unitRef="USD">1512000</us-gaap:DebtInstrumentPeriodicPayment>
    <niobf:ChangeInFairValue
      contextRef="From2024-04-132024-06-30"
      decimals="-3"
      id="Fact000895"
      unitRef="USD">-1714000</niobf:ChangeInFairValue>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000897"
      unitRef="USD">7089000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000899"
      unitRef="USD">7129000</us-gaap:DebtInstrumentPeriodicPayment>
    <niobf:ChangeInFairValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact000901"
      unitRef="USD">40000</niobf:ChangeInFairValue>
    <niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000905">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_ecustom--ShareholdersEquityAndShareBasedWarrantsTextBlock_z2E1MfvZJxBg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 5)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B0_zkcQeDw01o1a" style="display: none"&gt;Schedule of  Black-Scholes model used in April 2024 Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 39%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVwXQqnctCC6" style="width: 10%; text-align: right" title="Closing Common Share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zVLIh4QzKVre" style="width: 10%; text-align: right" title="Closing Common Share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_znZY2VpG4k8j" style="text-align: right" title="Term (years)"&gt;1.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z2WyWNSC4HH1" style="text-align: right" title="Term (years)"&gt;2.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJvm77hI83Rg" style="text-align: right" title="Expected volatility"&gt;82.22&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zzulsrUdhQbl" style="text-align: right" title="Expected volatility"&gt;66.34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhSO1cWiFxj2" style="text-align: right" title="Risk-free rate"&gt;3.78&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zalp8dXUKLV3" style="text-align: right" title="Risk-free rate"&gt;4.57&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:ShareholdersEquityAndShareBasedWarrantsTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000907"
      unitRef="USDPShares">2.33</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000909"
      unitRef="USDPShares">1.73</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      id="Fact000911">P1Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      id="Fact000913">P2Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000915"
      unitRef="Ratio">0.8222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000917"
      unitRef="Ratio">0.6634</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000919"
      unitRef="Ratio">0.0378</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000921"
      unitRef="Ratio">0.0457</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000931">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zlZJY0yJbIZd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CONVERTIBLE DEBT (Details 6)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B5_zMtaaIWMP1F2" style="display: none"&gt;&#160;Schedule of changes in fair value of April 2024 Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 50%; text-align: justify"&gt;Fair value as of April 12, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z0VrSHJRNjSj" style="width: 12%; text-align: right"&gt;902&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240413__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zktD7wgc3i07" style="border-bottom: Black 1pt solid; text-align: right"&gt;(604&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Fair value as of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZNBMGPqUfpk" style="text-align: right"&gt;298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zhq95PR6iHj" style="border-bottom: Black 1pt solid; text-align: right"&gt;191&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zqrYqwSOZr1" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;489&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-04-12_custom_EarnoutMember"
      decimals="-3"
      id="Fact000932"
      unitRef="USD">902000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-04-132024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000933"
      unitRef="USD">-604000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000934"
      unitRef="USD">298000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012025-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000935"
      unitRef="USD">191000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000936"
      unitRef="USD">489000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <niobf:DisclosureOfClassBCommonStockOfECRCTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000938">&lt;p id="xdx_803_ecustom--DisclosureOfClassBCommonStockOfECRCTextBlock_zpsT69BD9saf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_824_zTTqb5EHRhY9"&gt;CLASS
B COMMON STOCK OF ECRC&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Holders
of the Class B common stock of ECRC have the right to exchange such shares for Common Shares on a one-for-one basis, subject to
certain equitable adjustments, under certain conditions. All &lt;span style="color: #353535"&gt;&lt;span id="xdx_90A_eus-gaap--SharesIssued_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockECRCMember_zeqGQqKKeRl1" title="Common stock, shares, issued"&gt;&lt;span id="xdx_900_eus-gaap--SharesOutstanding_iI_pid_uShares_c20230630__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockECRCMember_ziJrYfy2vq83" title="Common stock, shares, outstanding"&gt;7,957,404&lt;/span&gt;&lt;/span&gt; shares of Class B common stock
of ECRC that were issued in connection with the Closing were issued and outstanding as of June 30, 2023. &lt;/span&gt;Of the issued
and outstanding shares of Class B common stock of ECRC, &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zmiPI88BrMGc" title="Earnout shares"&gt;4,565,808&lt;/span&gt; shares (the &#x201c;Vested Shares&#x201d;)&#x2009;were vested
as of the Closing Date and are exchangeable at any time, and from time to time, until the tenth anniversary of the Closing Date
(the &#x201c;Ten-Year Anniversary&#x201d;) and &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zo14V4C54JHa" title="Earnout shares"&gt;3,391,596&lt;/span&gt; shares (the &#x201c;Earnout Shares&#x201d;) are exchangeable until the Ten-Year
Anniversary, subject to certain vesting conditions. Under certain circumstances, and subject to certain exceptions, NioCorp may
instead settle all or a portion of any exchange pursuant to the terms of the Exchange Agreement, dated as of March 17, 2023, by and among NioCorp, ECRC, and GX Sponsor II LLC (the &#x201c;Sponsor&#x201d;) in cash, in lieu of Common Shares,
based on a volume-weighted average price of Common Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2024 and May 16, 2024, 243,692 Vested Shares and 40,000 Vested Shares, respectively, were exchanged for an equivalent
number of Common Shares, and on December 12, 2024 and December 20, 2024, 25,000 Vested Shares and 323,085 Vested Shares, respectively,
were exchanged for an equivalent number of Common Shares. These exchanges resulted in a change in the Company&#x2019;s ownership
interest in ECRC and were accounted for as an equity transaction in accordance with ASC 810-10-45-23, with no gain or loss recognized.
Accordingly, the carrying amount of the noncontrolling interest was adjusted to reflect the change in the Company&#x2019;s ownership
interest with a corresponding offset to equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Both
Vested Shares and Released Earnout Shares (as defined below) may be exchanged by the holders into Common Shares at any time. All
Vested Shares and Earnout Shares must be exchanged for Common Shares by the Ten-Year Anniversary except for Released Earnout Shares
that have been vested for a period of fewer than twenty-four months as of the Ten-Year Anniversary. Such Released Earnout Shares
will be forfeited if not exchanged for Common Shares by the date that is twenty-four months after the vesting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Vested
Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the exchange of Vested Shares are contingently redeemable at the option of the noncontrolling interest shareholders, the Company
classifies the carrying amount of the redeemable noncontrolling interest in the mezzanine section on the consolidated balance
sheet, which is presented above the equity section and below liabilities. Adjustments to the carrying value of the redeemable
noncontrolling interest associated with redemptions are recorded by reclassifying the proportionate amount of mezzanine equity
to permanent equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Earnout
Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfEarnOutShares_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zo6x7vKWDxlj" title="Description of earnout shares"&gt;The
Earnout Shares vest (the &#x201c;Released Earnout Shares&#x201d;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement. These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Earnout Shares were classified as a liability due to failure to meet the equity classification criteria under ASC 815-40, as Level
3 instruments under the fair value hierarchy and are considered a financial liability under ASC 480, Distinguishing Liabilities
from Equity. The Earnout Shares were measured at fair value on the Closing Date with subsequent changes in fair value recorded
in earnings. The Earnout Shares were valued utilizing a Monte Carlo simulation pricing model. The following table discloses the
primary inputs into the Monte Carlo models:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zImukLpr4Dj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8BF_zeToFecwANTk" style="display: none"&gt;Schedule of key valuation input&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 61%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zv8FWvKtsTTd" style="width: 10%; text-align: right" title="Closing common share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z5Ca5DGKWAdj" style="width: 10%; text-align: right" title="Closing common share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgSkDwnsuG48" style="width: 10%; text-align: right" title="Closing common share price"&gt;5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIBGhBtzP3hf" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zX2dmqp7K3l7" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7b3nvFHTal" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of the 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJSH0hW5Vdwi" title="Implied volatility of public warrants"&gt;75.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQ4UrZXQYY5f" title="Implied volatility of public warrants"&gt;65.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zvccAD58q9Gb" title="Implied volatility of public warrants"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6pZ9A1pxrW3" title="Risk-free rate"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zsGkAgKaGOhi" title="Risk-free rate"&gt;4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIg4xAqslFe4" title="Risk-free rate"&gt;3.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth a summary of the changes in the fair value of the Earnout Shares liability for the year ended June
30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z2QdcGsXG1Rb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BE_z3gTaXUN9u4h" style="display: none"&gt;&#160;Schedule of  fair value of the Earnout Shares liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 50%; text-align: justify"&gt;Fair value as of June 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3bKXXuUdipe" style="width: 12%; text-align: right" title="Fair value at beginning"&gt;10,521&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZaCmd22F7Cd" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(6,704&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Fair value as of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLWAzjKE8Wll" style="text-align: right" title="Fair value at beginning"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zV8E8YqOu4V5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;2,063&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zKDTEpC02DT9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Fair value at ending"&gt;5,880&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:DisclosureOfClassBCommonStockOfECRCTextBlock>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-06-30_custom_ClassBCommonStockECRCMember"
      decimals="INF"
      id="Fact000940"
      unitRef="Shares">7957404</us-gaap:SharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_ClassBCommonStockECRCMember"
      decimals="INF"
      id="Fact000942"
      unitRef="Shares">7957404</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-012025-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact000944"
      unitRef="Shares">4565808</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-012025-06-30_custom_EarnoutMember"
      decimals="INF"
      id="Fact000946"
      unitRef="Shares">3391596</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <niobf:DescriptionOfEarnOutShares
      contextRef="From2024-07-012025-06-30_custom_EarnoutMember"
      id="Fact000948">The
Earnout Shares vest (the &#x201c;Released Earnout Shares&#x201d;) in two equal tranches based upon achieving market share price
milestones of approximately $12.00 per Common Share and approximately $15.00 per Common Share, respectively, prior to the Ten-Year
Anniversary, or upon a change in control as defined in the underlying agreement. These shares will be forfeited if the market
share price milestones or an acceleration event is not reached prior to the Ten-Year Anniversary. At such time that the Earnout
Shares shall become vested, and therefore, become Released Earnout Shares, the shares will be transferred to the redeemable noncontrolling
interest in the mezzanine section of the Consolidated Balance Sheet.</niobf:DescriptionOfEarnOutShares>
    <niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000958">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_ecustom--ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock_zImukLpr4Dj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: white"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8BF_zeToFecwANTk" style="display: none"&gt;Schedule of key valuation input&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30,  &lt;br/&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 61%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zv8FWvKtsTTd" style="width: 10%; text-align: right" title="Closing common share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z5Ca5DGKWAdj" style="width: 10%; text-align: right" title="Closing common share price"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zgSkDwnsuG48" style="width: 10%; text-align: right" title="Closing common share price"&gt;5.03&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (expiry)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIBGhBtzP3hf" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zX2dmqp7K3l7" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2_dd_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zd7b3nvFHTal" title="Term (expiry)"&gt;March 17, 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of the 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zJSH0hW5Vdwi" title="Implied volatility of public warrants"&gt;75.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zQ4UrZXQYY5f" title="Implied volatility of public warrants"&gt;65.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zvccAD58q9Gb" title="Implied volatility of public warrants"&gt;33.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z6pZ9A1pxrW3" title="Risk-free rate"&gt;4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230701__20240630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zsGkAgKaGOhi" title="Risk-free rate"&gt;4.35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20220701__20230630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zIg4xAqslFe4" title="Risk-free rate"&gt;3.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:ScheduleOfPrimaryInputsIntoTheMonteCarloModelsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000960"
      unitRef="USDPShares">2.33</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000962"
      unitRef="USDPShares">1.73</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000964"
      unitRef="USDPShares">5.03</us-gaap:SharePrice>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact000966">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact000968">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      id="Fact000970">2033-03-17</niobf:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000972"
      unitRef="Ratio">0.750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000974"
      unitRef="Ratio">0.650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000976"
      unitRef="Ratio">0.335</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-07-012025-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000978"
      unitRef="Ratio">0.0404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000980"
      unitRef="Ratio">0.0435</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2022-07-012023-06-30_us-gaap_MeasurementInputExercisePriceMember_us-gaap_ValuationTechniqueOptionPricingModelMember_custom_EarnoutMember"
      decimals="INF"
      id="Fact000982"
      unitRef="Ratio">0.0383</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000984">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock_z2QdcGsXG1Rb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - CLASS B COMMON STOCK OF ECRC (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8BE_z3gTaXUN9u4h" style="display: none"&gt;&#160;Schedule of  fair value of the Earnout Shares liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 50%; text-align: justify"&gt;Fair value as of June 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_z3bKXXuUdipe" style="width: 12%; text-align: right" title="Fair value at beginning"&gt;10,521&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20230701__20240630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zZaCmd22F7Cd" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;(6,704&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Fair value as of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ServicingLiabilityAtFairValueAmount_iS_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zLWAzjKE8Wll" style="text-align: right" title="Fair value at beginning"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ServicingLiabilityAtFairValueAdditionsValue_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zV8E8YqOu4V5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;2,063&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ServicingLiabilityAtFairValueAmount_iE_pn3n3_c20240701__20250630__us-gaap--FinancialInstrumentAxis__custom--EarnoutMember_zKDTEpC02DT9" style="border-bottom: Black 2.5pt solid; text-align: right" title="Fair value at ending"&gt;5,880&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:ScheduleOfsummaryOfTheChangesInTheFairValueOfTheEarnoutShareLiabilityTableTextBlock>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2023-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000986"
      unitRef="USD">10521000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <niobf:ServicingLiabilityAtFairValueAdditionsValue
      contextRef="From2023-07-012024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000988"
      unitRef="USD">-6704000</niobf:ServicingLiabilityAtFairValueAdditionsValue>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2024-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000990"
      unitRef="USD">3817000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <niobf:ServicingLiabilityAtFairValueAdditionsValue
      contextRef="From2024-07-012025-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000992"
      unitRef="USD">2063000</niobf:ServicingLiabilityAtFairValueAdditionsValue>
    <us-gaap:ServicingLiabilityAtFairValueAmount
      contextRef="AsOf2025-06-30_custom_EarnoutMember"
      decimals="-3"
      id="Fact000994"
      unitRef="USD">5880000</us-gaap:ServicingLiabilityAtFairValueAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact000996">&lt;p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zILaMyMdXMU4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82B_zkeE3wk8hrE9"&gt;COMMON
SHARES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issuances&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fiscal
Year 2025 Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_983_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20241101__20241105_zoqYp4KVIdv9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify" title="Description of warrants"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 5, 2024, the Company closed an underwritten public offering (the &#x201c;November 2024 Registered Offering&#x201d;),
pursuant to the underwriting agreement, dated November 3, 2024 (the &#x201c;Underwriting Agreement&#x201d;), with Maxim Group
LLC (&#x201c;Maxim&#x201d;), as underwriter, which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#x201c;Series
A Public Warrants&#x201d;) to purchase up to an additional 1,672,090 Common Shares and 836,045 Warrants (the &#x201c;Series B
Public Warrants&#x201d; and, together with the Series A Public Warrants, the &#x201c;November 2024 Public Warrants&#x201d;) to
purchase up to an additional 836,045 Common Shares. Each Common Share was sold together with one Series A Public Warrant and
one-half of one Series B Public Warrant at a combined public offering price of $1.57. The gross proceeds from the November
2024 Registered Offering were $2,501 before deducting underwriting discounts and offering expenses. The November 2024 Public
Warrants were classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair
values of the Common Shares and the November 2024 Public Warrants on the date of issuance, with $943 allocated to the fair
value of the November 2024 Public Warrants and the balance of the proceeds of $1,558 allocated to Common Shares. The Company
incurred total transaction costs related to the November 2024 Registered Offering $1,226, which were treated as share
issuance costs at closing. The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are
exercisable immediately, and will expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07
per underlying Common Share, are exercisable beginning six months and one day from the date of issuance and will expire on
November 5, 2029. In addition, pursuant to the Underwriting Agreement, the Company granted Maxim a 45-day over-allotment
option to purchase (i) 238,853 additional Common Shares and (ii) 358,280 Option Warrants (as defined below) to purchase up to
an aggregate of 358,280 Common Shares. &#x201c;Option Warrant&#x201d; means one Series A Public Warrant combined with one-half
of one Series B Public Warrant. On November 4, 2024, Maxim partially exercised its over-allotment option to purchase&lt;span id="xdx_906_ecustom--DebtInstrumentIssuedPrincipalshars_c20241101__20241104__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesAMember_zPOftCEXUqIl"&gt;
79,734&lt;/span&gt; additional Series A Public Warrants and &lt;span id="xdx_908_ecustom--DebtInstrumentIssuedPrincipalshars_c20241101__20241104__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementSeriesBMember_za0Rmru8M2p7"&gt;39,867&lt;/span&gt;
additional Series B Public Warrants, which amounts are included in the amounts discussed above and were issued at closing of
the November 2024 Registered Offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table discloses the primary inputs for the Black-Scholes model used in valuing the November 2024 Public
Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zjABPV9bQ4mg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_zWeeoFmduHP2" style="display: none"&gt;Schedule of Black-Scholes model used in public warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;November 5, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;November 2024 Public Warrants:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series A&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series B&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 35%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zBwMFHnTn4K8" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zoffagcetK24" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zpK7A6WxWtri" title="Term (years)"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zpuiUMuYHYG7" title="Term (years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zTjDB5MmDIhk" title="Historic equity volatility"&gt;67.43&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zZEBZ0vBYNu2" title="Historic equity volatility"&gt;67.13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zdWGujIdLif9" title="Risk-free rate"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zyl3gVN7NXoa" title="Risk-free rate"&gt;4.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zp1wETlPCxF5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_98B_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20241101__20241113_z7UJcpV3rRR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
November 13, 2024, the Company closed a non-brokered private placement (the &#x201c;November 2024 Private Offering&#x201d;),
pursuant to binding subscription agreements with certain accredited investors as part of a non-brokered private placement of &lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20241101__20241113__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zTmdTlGXlD6j" title="Shares issue"&gt;2,199,602&lt;/span&gt;
units of the Company (the &#x201c;November 2024 Units&#x201d;). Each November 2024 Unit consisted of one Common Share, one
Warrant (a &#x201c;Series A Private Warrant&#x201d;) to purchase one Common Share, and one-half of one Warrant (each whole such
Warrant, a &#x201c;Series B Private Warrant&#x201d; and, together with the Series A Private Warrants, the &#x201c;November 2024
Private Warrants&#x201d;), with each Series B Private Warrant entitling the holder thereof to purchase one additional Common
Share. Each November 2024 Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company (the
&#x201c;Insider Investors&#x201d;) purchased November 2024 Units at a price of $1.7675 per November 2024 Unit, which price
includes $0.1975 per November 2024 Private Warrant and allowed such directors and officers to participate in the November
2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private Warrants have an exercise price of
$1.75 per underlying Common Share, are exercisable immediately, and will expire on November 13, 2026. The Series B Private
Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable beginning six months and one day from
the date of issuance and will expire on November 13, 2029. The Company recorded a non-cash expense of $34 and $110 to other
operating expenses and employee related costs, respectively, representing the excess of fair value of the November 2024 Units
over the purchase price paid by Insider Investors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
upon the Company&#x2019;s analysis of the criteria contained in ASC 815, the Company determined that the November 2024
Private Warrants met the definition of a derivative liability, as any Warrant exercise that could cause the holder to exceed
19.9% ownership of NioCorp Common Shares would require shareholder approval. As such, the November 2024 Private Warrants were
recognized as warrant liabilities on the consolidated balance sheet and were measured at their issuance date fair value of
$&lt;span id="xdx_905_eus-gaap--FairValueOptionChangesInFairValueGainLoss1_pn3n3_c20240701__20250630_zYhr0CjxDyb" title="Fair value of non operating gain/loss"&gt;1,928&lt;/span&gt;
and subsequently remeasured at each reporting period with changes being recorded as a non-operating gain or loss in
the consolidated statement of operations and comprehensive loss. The remaining proceeds of the November 2024 Private Offering
of $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdaOvSPTqX07" title="Remaining proceeds from private warrants"&gt;1,573&lt;/span&gt;
were allocated to Common Shares. The Company incurred total transaction costs related to the November 2024 Private
Offering of $&lt;span id="xdx_909_ecustom--RegisteredOffering_iI_pn3n3_c20241130_zuKlEOkD3Mp" title="Registered Offering"&gt;161&lt;/span&gt;,
of which $&lt;span id="xdx_90E_ecustom--PrivateOffering_iI_pn3n3_c20241130_zx99WNQVnrEd" title="Private Offering"&gt;60&lt;/span&gt;
was allocated to the November 2024 Private Warrants and was expensed at closing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables disclose the primary inputs for the Black-Scholes model used in valuing the November 2024 Private
Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zFjI4YyUrucg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_ztxowl6wpNnh" style="display: none"&gt;Schedule of Black-Scholes model used in Private warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;November 13, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;November 2024 Private Warrants:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series A Private&lt;/p&gt;
                                                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Series B Private Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 35%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z4s5mBECo834" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.49&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z36KZZtnDtQb" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.49&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zuirTne6rEEa" title="Term (years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z40LzAZPI1Sa" title="Term (years)"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zeBQfpiYG9U6" title="Historic equity volatility"&gt;67.26&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z5UfHhTX50H8" title="Historic equity volatility"&gt;67.52&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zvyh6atZ5Ek2" title="Risk-free rate"&gt;4.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zFfLVlhe2DF1" title="Risk-free rate"&gt;4.30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;November 2024 Private Warrants:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Series A Private Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Series B Private Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 35%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z5GQTy3h4J1k" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zNbYyKM4Cxzg" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zP0y9BLp3Rp4" title="Term (years)"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zANaPT946vLf" title="Term (years)"&gt;4.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zpYES54cGwCh" title="Historic equity volatility"&gt;86.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zwVEs7kpPGJ" title="Historic equity volatility"&gt;74.26&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z0QW52vdv1h6" title="Risk-free rate"&gt;3.88&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zfzanleeOQ79" title="Risk-free rate"&gt;3.77&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zhdErE0Nej5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The
following table sets forth a summary of the changes in the fair value of the November 2024 Private Warrants
liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_pn3n3_zgJQ0aYt8XEb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 3)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B9_zo6Yg9D0X9J4" style="display: none"&gt;Schedule of  changes in the fair value of  Private Warrants liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;November&#160;2024&#160;Private&#160;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Fair value at issuance (November 13, 2024)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_z9T2mvBFugIc" style="width: 15%; text-align: right" title="Beginning balance"&gt;1,929&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; text-indent: 9pt"&gt;Fair value of Warrants exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueOfWarrantsExercised_iN_pn3n3_di_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zNzQDvx8Cbl6" style="text-align: right" title="Fair value of Warrants exercised"&gt;(338&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zYu4P0N5b986" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;2,240&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zL0EmStf7uLi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;3,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_982_ecustom--CommonShareDescription_c20250102__20250131_zW6NyPukfRp8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify" title="Common share, description"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
January 31, 2025, the Company closed an underwritten registered direct offering (the &#x201c;January 2025 Offering&#x201d;), pursuant
to an underwriting agreement, dated January 29, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold
2,577,320 Common Shares, 2,577,320 Series A Warrants to purchase up to 2,577,320 Common Shares (the &#x201c;January 2025 Series
A Warrants&#x201d;) and 1,288,660 Series B Warrants to purchase up to an additional 1,288,660 Common Shares (the &#x201c;January
2025 Series B Warrants&#x201d; and, together with the January 2025 Series A Warrants, the &#x201c;January 2025 Warrants&#x201d;).
Each Common Share was sold together with one January 2025 Series A Warrant and one-half of one January 2025 Series B Warrant at
a combined public offering price of $1.94. The gross proceeds from the January 2025 Offering were approximately $5,000 before
deducting underwriting discounts and offering expenses. The January 2025 Warrants were classified as equity instruments, and accordingly,
the net proceeds were allocated based on the relative fair values of the Common Shares and the January 2025 Warrants on the date
of issuance, with $2,200 allocated to the fair value of the January 2025 Warrants and the balance of the proceeds of $2,800 allocated
to Common Shares. The Company incurred total transaction costs related to the January 2025 Offering of $799, which were treated
as share issuance costs at closing. The January 2025 Series A Warrants have an exercise price of $1.98 per underlying Common Share,
are exercisable immediately, and will expire on August 2, 2027. The January 2025 Series B Warrants have an exercise price of $2.05
per underlying Common Share, are exercisable immediately, and will expire on January 31, 2029.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following primary inputs were used in the Black-Scholes model for valuing the January 2025 Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_pn3n3_zxW275XyTNk7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 4)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span id="xdx_8BA_zR1scRy2NAkj" style="display: none"&gt;Schedule of Black-Scholes model for warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series A&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series B&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_ziqwvz8ifXng" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zF3dBkIGi8p" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zK3f3iIg1ugf" title="Term (years)"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_z0BPucdjJLQi" title="Term (years)"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zVxoQiJ3o6h1" title="Historic equity volatility"&gt;73.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zFYt7yuL6Myg" title="Historic equity volatility"&gt;73.36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_z0P6pIedNQqb" title="Risk-free rate"&gt;4.23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zez53Gsgpcjh" title="Risk-free rate"&gt;4.31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.3pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_989_ecustom--CommonShareDescription_c20250402__20250421_gBFCSD-TT_z6OMmw6PC0O1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify" title="Common share, description"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;On
April 21, 2025, the Company closed an underwritten public offering (the &#x201c;April 2025 Offering&#x201d;), pursuant to an underwriting
agreement, dated April 17, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold (i) 6,628,846 Common
Shares at a public offering price of $2.60 per Common Share and (ii) 1,063,462 pre-funded Warrants (the
&#x201c;April 2025 Pre-Funded Warrants&#x201d;) to purchase up to an additional 1,063,462 Common Shares at a public offering price
of $2.5999. The April 2025 Pre-Funded Warrants have an exercise price of $0.0001 per underlying Common Share, are exercisable
immediately, and do not have an expiration date. On April 17, 2025, Maxim partially exercised its over-allotment option to purchase
323,504 additional Common Shares at closing. The gross proceeds from the April 2025 Offering were&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span id="xdx_C08_gBFCSD-TT_z7hcYMPlT25e"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;
approximately $20,841 before deducting underwriting discounts and offering expenses. The April 2025 Pre-Funded Warrants were
classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair values of the Common
Shares and the April 2025 Pre-Funded Warrants on the date of issuance, with $2,765 allocated to the fair value of the April 2025
Pre-Funded Warrants (based on the value of the underlying Common Shares at closing) and the balance of the proceeds of $18,076
allocated to Common Shares. The Company incurred total transaction costs related to the April 2025 Offering of $2,102, which were
treated as share issuance costs at closing.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fiscal
Year 2024 Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 1, 2023, the Company closed a non-brokered private placement of
units of the Company (the &#x201c;September 2023 Units&#x201d;). A total of &lt;span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcnMzixEdHO7" title="Shares issue"&gt;250,000&lt;/span&gt; September 2023 Units were issued at a price
per September 2023 Unit of $&lt;span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zOXAxDpdMxdl" title="Price per unit"&gt;4.00&lt;/span&gt;, for total gross proceeds to the Company of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20230830__20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zN3hRBzc4Evd" title="Gross proceeds"&gt;1,000&lt;/span&gt;. Each September 2023 Unit consists of one
Common Share and one Warrant (&#x201c;September 2023 Warrant&#x201d;). Each September 2023 Warrant entitles the holder to acquire
one Common Share at a price of $&lt;span id="xdx_900_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20230902__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zi6PwD1M1g12" title="Shares price"&gt;4.60&lt;/span&gt; at any time prior to September 1, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
September 2023 Warrants were classified as an equity instrument and accordingly, the net proceeds of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930_z8SBiYPWUEtk"&gt;962&lt;/span&gt; were allocated based
on the relative fair values of the Common Shares and the September 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the September 2023 Warrants was $&lt;span id="xdx_909_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zxqBHTLMYjC6"&gt;254&lt;/span&gt; and the balance of the proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z63p12ovCXbi"&gt;708&lt;/span&gt; was allocated to the Common
Shares. The fair value of the September 2023 Warrants issued was computed using the Black Scholes pricing model using the following
assumptions: an expected life of &lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zTaxtwJfQoB1" title="Expected life"&gt;2.0&lt;/span&gt; years, a risk-free interest rate of &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrWoP0LjBpbf" title="Risk-free rate"&gt;4.85%&lt;/span&gt;, an expected volatility of &lt;span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zsWPARBBqCe5" title="Expected volatility"&gt;71.63%&lt;/span&gt;, and an expected
dividend rate of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230901__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zl5CQm3kSkV6" title="Expected dividend rate"&gt;0%&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 22, 2023, the Company closed a non-brokered private placement (the &#x201c;December 2023 Private Placement&#x201d;) of
&lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zX1ggqAg1NV7" title="Shares issue"&gt;413,432&lt;/span&gt; units of the Company (the &#x201c;December 2023 Units&#x201d;). Each December 2023 Unit consists of one Common Share and
one Warrant (&#x201c;December 2023 Warrant&#x201d;). Each December 2023 Warrant entitles the holder to acquire one Common Share
at a price of $&lt;span id="xdx_909_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zgixaxJwteWh" title="Shares price"&gt;3.54&lt;/span&gt; at any time until December 22, 2025. &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zMtLNVXWum32" title="Units issue and sold"&gt;274,587&lt;/span&gt; of the December 2023 Units were issued and sold to certain accredited
investors, who are not affiliated with the Company but with whom the Company had a pre-existing relationship, at a price of $&lt;span id="xdx_90F_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zhiAQd1sj7Wh" title="Shares price"&gt;3.08
&lt;/span&gt;per December 2023 Unit, and &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_uShares_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_z32sSJmDDfuc" title="Units issue and sold"&gt;138,845&lt;/span&gt; of the December 2023 Units were issued and sold to certain officers and directors of the Company
(the &#x201c;Insider Investors&#x201d;), at a price of $&lt;span id="xdx_90B_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20231231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zmNpsNmTa9Mb" title="Shares price"&gt;3.205&lt;/span&gt; per December 2023 Unit. The price per December 2023 Unit paid by the
Insider Investors included $0.125 per December 2023 Warrant underlying each December 2023 Unit purchased by the Insider Investors
which allowed the Insider Investors to participate in the December 2023 Private Placement in accordance with the rules of Nasdaq.
The Company received aggregate gross proceeds from the December 2023 Private Placement of approximately $&lt;span id="xdx_908_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__srt--CurrencyAxis__currency--CAD_zwVkOE7Lwlyh" title="Gross proceeds"&gt;1,290&lt;/span&gt;. The Company recorded
a non-cash expense of $&lt;span id="xdx_90D_eus-gaap--OtherCostAndExpenseOperating_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zT30JttLFDla" title="Other operating expenses"&gt;92&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--OperatingCostsAndExpenses_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zlrsXDk921lk" title="Employee related costs"&gt;10&lt;/span&gt; to other operating expense and employee related costs, respectively, representing the excess
of fair value of the December 2023 Units over the purchase price paid by Insider Investors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
December 2023 Warrants were classified as an equity instrument and accordingly, the estimated net proceeds of $1,241 were allocated
based on the relative fair values of the Common Shares and the December 2023 Warrants on the date of issuance. The amount allocated
to the fair value of the December 2023 Warrants was $&lt;span id="xdx_908_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zD6t4LldO1ke" title="Proceeds from equity"&gt;264&lt;/span&gt; and the balance of the proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2J60iSkglUa" title="Proceeds from equity"&gt;977&lt;/span&gt; was allocated to the Common Shares.
The fair value of the December 2023 Warrants issued was computed using the Black Scholes pricing model using the following assumptions:
an expected life of &lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpcB4YTFkPM6" title="Expected life::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;2.0&lt;/span&gt;&lt;/span&gt; years, a risk-free interest rate of &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zlHuOS8D7Huh" title="Risk-free rate"&gt;4.33%&lt;/span&gt;, an expected volatility of &lt;span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRV8tIpNHQg4" title="Expected volatility"&gt;54.8%&lt;/span&gt;, and an expected dividend rate
of &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zd1OEgMF963c" title="Expected dividend rate"&gt;0%&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 24, 2024, the Company closed a non-brokered private placement of units of
the Company (the &#x201c;June 2024 Units&#x201d;). A total of &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20240602__20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z6NWr6ZDZHze" title="Shares issue"&gt;315,000&lt;/span&gt; June 2024 Units were issued at a price per June 2024 Unit
of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNH8bFvFviml" title="Price per unit"&gt;1.91&lt;/span&gt;, for total gross proceeds to the Company of $&lt;span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_pn3n3_c20240602__20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcTtONtYf6el" title="Gross proceeds"&gt;602&lt;/span&gt;. Each June 2024 Unit consists of one Common Share and one Warrant (&#x201c;June
2024 Warrant&#x201d;). Each June 2024 Warrant entitles the holder to acquire one Common Share at a price of $&lt;span id="xdx_907_ecustom--SaleOfStockPricePerShare1_iI_pid_uUSDPShares_c20240624__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zz6ahyejhmwj" title="Shares price"&gt;2.20&lt;/span&gt; at any time prior
to June 24, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
June 2024 Warrants were classified as an equity instrument and accordingly, the net proceeds of $602 were allocated based on the
relative fair values of the Common Shares and the June 2024 Warrants on the date of issuance. The amount allocated to the fair
value of the June 2024 Warrants was $&lt;span id="xdx_90B_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z7xA8nTm5Wma" title="Proceeds from equity"&gt;161&lt;/span&gt; and the balance of the proceeds of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromOtherEquity_pn3n3_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztsJxj98WuKf" title="Proceeds from equity"&gt;441&lt;/span&gt; was allocated to Common Shares. The fair value
of the June 2024 Warrants issued was computed using the Black Scholes pricing model using the following assumptions: an expected
life of &lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zloz9QsTheUh" title="Expected life::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1190"&gt;2.0&lt;/span&gt;&lt;/span&gt; years, a risk-free interest rate of &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z0iRK4rJ8168" title="Risk-free rate"&gt;4.73%&lt;/span&gt;, an expected volatility of &lt;span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4VE0pTv5uZg" title="Expected volatility"&gt;73.92%&lt;/span&gt;, and an expected dividend rate of &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240601__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zRpIa9vIkxwh" title="Expected dividend rate"&gt;0%&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Yorkville
Equity Facility Financing Agreement Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2025, the Company has access to up to $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20250630__us-gaap--ShortTermDebtTypeAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zZjJ1nOuBIDc" title="Net proceeds"&gt;46,917&lt;/span&gt; in net proceeds from the Yorkville Equity Facility Financing Agreement.
The Yorkville Equity Facility Financing Agreement expires on &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20240701__20250630__us-gaap--ShortTermDebtTypeAxis__custom--YorkvilleEquityFacilityFinancingAgreementMember_zzPa7ixBjDG1" title="Expires date"&gt;April 1, 2026&lt;/span&gt;. The Company issued the following Common Shares under
the Yorkville Equity Facility Financing Agreement during the periods presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.7pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_pn3n3_zC1q0aJQbfSk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - COMMON SHARES (Details 5)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_8B7_zTkJ5AOPBgLi" style="display: none"&gt;Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For The Year  &lt;br/&gt;Ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 74%; text-align: justify"&gt;Common Shares issued&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--CommonStockSharesIssued1_pid_uShares_c20240701__20250630_zmIiFOnitAKi" style="width: 10%; text-align: right" title="Common shares issued"&gt;5,671,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CommonStockSharesIssued1_pid_uShares_c20230701__20240630_zIjUiwkfoof5" style="width: 10%; text-align: right" title="Common shares issued"&gt;1,358,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Gross funds received&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zLMDNYNZVIq5" style="text-align: right" title="Gross funds received"&gt;12,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230701__20240630_ztfSimaTqoz7" style="text-align: right" title="Gross funds received"&gt;3,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Market value of Common Shares issued&lt;br/&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssued1_c20240701__20250630_zqnd5BCHOKPj" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued"&gt;12,941&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssued1_c20230701__20240630_z74OWN2eV6E5" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued"&gt;3,398&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss on issuance&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240701__20250630_fKDEp_zi38DeaHmkSd" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance"&gt;589&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20230701__20240630_fKDEp_zPUTuQaIx7bh" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance"&gt;105&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0E_za1jIOPFlggi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 9pt"&gt;&lt;span id="xdx_F1F_zVuOpfGNvd5k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
                                         on issuance represents a non-cash amount equal to the difference between the proceeds
                                         received and the fair value of the Common Shares issued based on the Nasdaq closing price
                                         per Common Share on the issuance date and is recorded in other operating expenses in
                                         the condensed consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A0_zobZoM34NnW2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock
                                         Options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 19, 2024, the Company&#x2019;s shareholders voted to approve an amendment and restatement of its long-term incentive plan
(the &#x201c;2017 Amended Long-Term Incentive Plan&#x201d;) and the granting of incentive securities thereunder until January 19,
2027. Under the 2017 Amended Long-Term Incentive Plan, the Board may, in its discretion from time to time, grant Options and share
units (in the form of restricted share units and performance share units), plus dividend equivalents, to non-employee directors,
employees and certain other service providers (as described in the 2017 Amended Long-Term Incentive Plan) of the Company and affiliated
entities selected by the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to adjustment as described in the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares that may be reserved
for issuance to participants under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation
arrangements of the Company, may not exceed 10% of the issued and outstanding Common Shares from time to time, and the Common
Shares reserved for issuance upon settlement of share units will not exceed 5% of the issued and outstanding Common Shares from
time to time. The 2017 Amended Long-Term Incentive Plan limits the maximum number of Common Shares issued to insiders (as defined
under TSX rules for this purpose) within any 1-year period, or issuable to insiders at any time, in the aggregate, under all security-based
compensation arrangements (including the 2017 Amended Long-Term Incentive Plan) to 10% of the then issued and outstanding Common
Shares. The 2017 Amended Long-Term Incentive Plan also limits the aggregate number of Common Shares that may be reserved for issuance
to any one participant under the 2017 Amended Long-Term Incentive Plan, together with all other security-based compensation arrangements
of the Company, to 5% of the then issued and outstanding Common Shares (on a non-diluted basis). Subject to the adjustment provisions
of the 2017 Amended Long-Term Incentive Plan, the aggregate number of Common Shares actually issued or transferred by the Company
upon the exercise of Options will also be limited, as described in the 2017 Amended Long-Term Incentive Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board has power over the granting, amendment, administration, or settlement of any award.&lt;/span&gt;&lt;/p&gt;




















&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
transactions are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_pn3n3_zra9zMcF5HNh" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 6)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zqRO2c9yrHPf" style="display: none"&gt;Schedule of option&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number&#160;of&#160;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Aggregate Intrinsic Value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Remaining Contractual Life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 39%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zo5FW6VaGGV4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;1,541,500&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_z5aRZ0B4yIqc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;7.19&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_z7UbXA2DKgPg" style="text-align: right" title="Granted, in shares"&gt;1,625,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zq7dprEAdSfh" style="text-align: right" title="Granted, per share"&gt;2.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zcpRxLZtHLe3" style="text-align: right" title="Cancelled/expired, in shares"&gt;(7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zcua8iTgLMMi" style="text-align: right" title="Cancelled/expired, per share"&gt;3.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_ztAKExeJEcdj" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares"&gt;(663,200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zrSGke4oCfW2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share"&gt;5.88&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20250630_zvDjJdNSlaTc" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;2,495,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20240701__20250630_zDTBdK33q3N6" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;4.78&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20250630_zy0nRSWy2s9i" style="text-align: right" title="Granted, in shares"&gt;945,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zGNCkDvD8c12" style="text-align: right" title="Granted, per share"&gt;1.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20250630_zQGeplrrOW5l" style="text-align: right" title="Cancelled/expired, in shares"&gt;(512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zrSRhaFcDhab" style="text-align: right" title="Cancelled/expired, per share"&gt;1.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20250630_zYC8dMDLo6l8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares"&gt;(419,988&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zMk0H7ryc6M3" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share"&gt;9.44&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20250630_z1qx7VjdF3m6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;3,020,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20240701__20250630_zXM8lFwL92I" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;3.09&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20250630_zjwmjb5VjMmi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Aggregate intrinsic value"&gt;866&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630_zECCFukmRsF4" title="Weighted average remaining contractual life"&gt;3.5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2025,&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_uRatio_c20240701__20250630_zOh81uGwmVjb" title="Outstanding stock options vested"&gt; 99.8%&lt;/span&gt; of the outstanding Options were fully vested. The total intrinsic value of Options exercised during the
year ended June 30, 2025 &lt;span style="background-color: white"&gt;was nil, and as of June 30, 2025, &lt;/span&gt;there was $&lt;span id="xdx_90F_ecustom--UnrecognizedCompensationCosts_iI_pn3n3_c20250630_zsjCKtzAezfd" title="Unrecognized compensation costs"&gt;4&lt;/span&gt; of unrecognized
compensation costs related to unvested share-based compensation arrangements granted. The Company recognized share-based compensation
expense of $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensation_pn3n3_c20240701__20250630_zZYNEvzDISwc" title="Share based compensation expense"&gt;789&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensation_pn3n3_dxL_c20230701__20240630_zklICT3YfVJ1" title="Share based compensation expense::XDX::2881"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1277"&gt;2,779&lt;/span&gt;&lt;/span&gt; for the years ended June 30, 2025 and 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the weighted average information and assumptions used to determine Option costs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zzeVpWSx38yc" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 7)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: White; visibility: hidden"&gt;
    &lt;td style="display: none; padding-left: 5pt; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20240701__20250630_zr6u56GHJ8Ig" style="display: none; text-align: right; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20230701__20240630_zFf2bGLFP1C8" style="display: none; text-align: right; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt"&gt;&lt;span id="xdx_8B9_znuoL3SnEEvc" style="display: none"&gt;Schedule of  weighted average  and assumptions used to option costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_zBGQgMDOCHP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 5pt"&gt;Fair value per option granted during the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;0.84&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1.71&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_zYkx8Fz5RPLk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.44&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zEFumOScew94" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_zWvBAbR5Epja" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Expected stock price volatility (historical basis)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Expected option life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630_zbgAbYq8KEs5" style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230701__20240630_zJpZ9V8HBIi5" style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to January 1, 2024, the Company concluded that under ASU 718, &lt;i&gt;Compensation &#x2013; Stock Compensation (Topic 718)&lt;/i&gt;, Options
previously issued on December 31, 2021, May 30, 2022, and March 27, 2023, which included a C$ strike price (the &#x201c;CAD Options&#x201d;)
should remain equity-classified as management determined that the Options qualified for an exemption from liability classification
as the CAD Options were denominated in a currency in which a substantial portion of the Company&#x2019;s equity securities traded.
Effective January 1, 2024, the Company determined that due to historically decreasing trading volume on the TSX, this exemption
no longer applied and accordingly, these CAD Options were classified as a liability based on their fair values on that date. The
Company recorded a mark-to-market gain of $147 in other operating expenses related to these CAD Option liabilities for the year
ended June 30, 2024. The CAD Options expired at various dates during the year ended June 30, 2025, with no further gains or losses
recorded in other operating expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 28, 2024, the Board approved a modification to Options previously issued on March 27, 2023, with dual strike prices of $6.95
and C$9.52, under which the option to exercise in C$ was removed. No other terms or conditions were amended by the Board. Based
on this amendment, the Company re-classified these Options to equity on March 28, 2024, based on their fair value on that date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
transactions are summarized as follows. Weighted average exercise prices related to Canadian dollar denominated Warrants were
converted to U.S. dollars using end of period foreign currency exchange rates.&lt;/span&gt;&lt;/p&gt;



















&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zXuQE7ktV8p5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 8)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 3pt"&gt;&lt;span id="xdx_8BC_zs9ZXhkeybme" style="display: none"&gt;Schedule of Weighted average exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 59%; padding-bottom: 1pt; text-align: left; padding-left: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zUX6oVYEX5Ij" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance, Warrants"&gt;18,816,304&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zcGw2PVqxW6j" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;10.98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_zFwo2AhJUFP" style="text-align: right" title="Beginning balance, Warrants"&gt;1,593,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zwNyIPwG4fFj" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;3.33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_zDIy7pizdv4e" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants"&gt;(1,846,560&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_z4eGOlMMpZIa" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;8.67&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20250630_zEJ1tK2Ezljd" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20240701__20250630_zbSupISsCcpg" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;10.53&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20250630_ztbkMTkadHp7" style="text-align: right" title="Beginning balance, Warrants"&gt;13,553,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20250630_zWnCqbHapuc6" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;2.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20250630_zwJk9Mhe7C3i" style="text-align: right" title="Beginning balance, Warrants"&gt;(828,235&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20250630_zql4ZlYmrsZ4" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;1.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20250630_zCdUca7tTTc7" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants"&gt;(1,303,118&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20250630_zlHjkOpjYvtl" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;7.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20250630_zIyW2AzEkrwj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance, Warrants"&gt;29,985,922&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20240701__20250630_zYae6k9rdGej" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;7.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
June 30, 2025, the Company has outstanding exercisable Warrants, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXHd4VtQMRbi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 9)"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="display: none; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zdxmK0jNL4al" style="display: none"&gt;Schedule
of outstanding exercisable Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 5pt"&gt;Expiry Date&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zd0IIseyj82k" style="width: 18%; text-align: right" title="Number of share outstanding"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zFL0jlRwAgLl" style="width: 18%; text-align: right" title="Exercise price"&gt;4.60&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zyh0iohcDUw9" title="Expiry date"&gt;September 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zVGGTMFD7f5l" style="text-align: right" title="Number of share outstanding"&gt;413,432&lt;br/&gt;
&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_z8JIEsyEAb05" style="text-align: right"&gt;3.54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zc5mDRVkN54h" title="Expiry date"&gt;December 22, 2025&lt;/span&gt;&lt;br/&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_ztHLrjBYm4oh" style="text-align: right" title="Number of share outstanding"&gt;315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZSn1BkZxTe" style="text-align: right"&gt;2.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zvJmN7P2xkNe" title="Expiry date"&gt;June 24, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_z3XmybalTJr1" style="text-align: right" title="Number of share outstanding"&gt;1,117,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zjsy76CW6Wqe" style="text-align: right"&gt;1.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zs8QG8ZZoO56" title="Expiry date"&gt;November 5, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zr7pf8oErYi8" style="text-align: right" title="Number of share outstanding"&gt;1,992,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_z3syGfztzHT" style="text-align: right"&gt;1.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zwinatfKpBG2" title="Expiry date"&gt;November 13, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zzwRWNc2GOwg" style="text-align: right" title="Number of share outstanding"&gt;615,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zyAIT8J6VI26" style="text-align: right"&gt;3.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zEwwOexhFMvj" title="Expiry date"&gt;April 12, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_zypR2g71yvjd" style="text-align: right" title="Number of share outstanding"&gt;2,577,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ziEZfIN2d1R3" style="text-align: right"&gt;1.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ztlSJK2yX35d" title="Expiry date"&gt;August 2, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_fKDEp_zxtFEcbnmEJk" style="text-align: right" title="Number of share outstanding"&gt;15,666,626&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zArioAAX3led" style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zo5kJ0xeoZ54" title="Expiry date"&gt;March 17, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zO4CBiwWlLue" style="text-align: right" title="Number of share outstanding"&gt;2,816,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zwRG5lgseGJ8" style="text-align: right"&gt;2.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zrCEDZFZu0Ak" title="Expiry date"&gt;September 17, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_z1PzvW1Pp7xi" style="text-align: right" title="Number of share outstanding"&gt;1,288,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zZ0hhfGF2R86" style="text-align: right"&gt;2.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zIpDLmRqiWWi" title="Expiry date"&gt;January 31, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYCi8ZTEpbxg" style="text-align: right" title="Number of share outstanding"&gt;802,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zrClG3aAOJD" style="text-align: right"&gt;2.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYBjyllkmuij" title="Expiry date"&gt;November 5, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zJwsDpyLenOh" style="text-align: right" title="Number of share outstanding"&gt;1,067,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_ztkuA19O2YDg" style="text-align: right"&gt;2.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zIfQP5YVrlgl" title="Expiry date"&gt;November 13, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zHynswnRGWRl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share outstanding"&gt;1,063,462&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zEQauSMT7Hde" style="padding-bottom: 1pt; text-align: right"&gt;2.60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;No expiry&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630_zkrTCT5o5nuk" style="border-bottom: Black 2.5pt solid; text-align: right" title="Number of share outstanding"&gt;29,985,922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 6%; text-align: center"&gt;&lt;span id="xdx_F08_zntRSXlTmEJl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 94%; text-align: justify"&gt;&lt;span id="xdx_F10_zs4hJ7HULwAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    11,165,324 and 4,501,302 2023 Public Warrants and 2023 Private Warrants, respectively, as defined below. Each 2023 Public
    Warrant and 2023 Private Warrant is exercisable into 1.11829212 Common Shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A0_zxuVg6mqYfR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;In
connection with the Closing, pursuant to the Business Combination Agreement, the Company assumed GXII&#x2019;s obligations under
the agreement (the &#x201c;GXII Warrant Agreement&#x201d;) governing the GXII share purchase Warrants (the &#x201c;GXII Warrants&#x201d;)
and each GXII Warrant thereunder that was issued and outstanding immediately prior to the Closing Date was converted into one
Warrant to purchase 1.11829212 Common Shares (the &#x201c;NioCorp Assumed Warrants&#x201d;) pursuant to the GXII Warrant Agreement,
as amended by an Assignment, Assumption and Amendment Agreement, dated March 17, 2023, among the Company, GXII, Continental Stock
Transfer &amp;amp; Trust Company, as the existing warrant agent, and Computershare Inc. and its affiliate, Computershare Trust Company,
N.A, together as the successor warrant agent (the &#x201c;NioCorp Assumed Warrant Agreement&#x201d;). In connection with the Closing,
NioCorp issued (a)&#160;&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--GXIIPublicWarrantsMember_zCEP1bCoIsnc" title="Warrants traded prior to the closing"&gt;9,999,959&lt;/span&gt;&#160;public NioCorp Assumed Warrants (the &#x201c;2023 Public Warrants&#x201d;) in respect of
the GXII Warrants that were publicly traded prior to the Closing and (b)&#160;&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20240701__20250630__us-gaap--TransactionTypeAxis__custom--GXIIPrivateWarrantsMember_zecvBiZgVyL3" title="Warrants traded prior to the closing"&gt;5,666,667&lt;/span&gt;&#160;NioCorp Assumed Warrants (the &#x201c;2023
Private Warrants&#x201d;) to the Sponsor in respect of the GXII Warrants that it held prior to
the Closing, which NioCorp Assumed Warrants were subsequently distributed by the Sponsor to its members in connection with the
Closing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; color: #212529"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Each
NioCorp Assumed Warrant entitles the holder to the right to purchase 1.11829212 Common Shares at an exercise price of $11.50 per
1.11829212 Common Shares (subject to adjustments for stock splits, stock dividends, reorganizations, recapitalizations and the
like). No fractional shares will be issued upon exercise of any NioCorp Assumed Warrants, and fractional shares that would otherwise
be due to the exercising holder will be rounded down to the nearest whole Common Share. In no event will the Company be required
to net cash settle any NioCorp Assumed Warrant.&lt;/span&gt;&lt;/p&gt;

















&lt;div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"&gt;&lt;/div&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2023
Public Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may elect to redeem the 2023 Public Warrants subject to certain conditions, in whole and not in part, at a price of
$0.01 per 2023 Public Warrant if (i) 30 days&#x2019; prior written notice of redemption is provided to the holders, &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrants2023Member_zYaRw4xQUQ4b" title="Description of warrants"&gt;(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day
period ending on the third business day prior to the date on which the Company sends the notice of redemption to the Warrant
holders&lt;/span&gt; and (iii) there is an effective registration statement covering the Common Shares issuable upon exercise of
the 2023 Public Warrants, and a current prospectus relating thereto, available through the redemption date. Upon issuance of
a redemption notice by the Company, the Warrant holders will have until the redemption date to exercise for cash, or, at the
Company&#x2019;s election, on a cashless basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2023
Private Warrants &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
2023 Private Warrants: (i) will be exercisable either for cash or on a cashless basis at the holder&#x2019;s option and (ii)
will not be redeemable by the Company, in either case as long as the 2023 Private Warrants are held by the initial purchasers
or their permitted transferees. Any 2023 Private Warrants that are held by someone other than the initial purchasers or their
permitted transferees are treated as 2023 Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for the 2023 Private Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides
that because the 2023 Private Warrants do not meet the criteria for equity treatment thereunder, the 2023 Private Warrants must
be recorded as a liability. This liability is carried as a component of Warrant liabilities on the consolidated balance sheet
and is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted
to its current fair value, with the change in fair value recognized in the consolidated statement of operations and comprehensive
loss. The Company will reassess the classification at each balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
provided for in the &lt;span id="xdx_905_ecustom--ExchangeOfWarrantsDescription_c20240701__20250630_zIn4ATDZqcKe" title="Exchange of warrants, description"&gt;NioCorp Assumed Warrant Agreement, through June 30, 2025, a total of 1,165,365 2023 Private Warrants were
exchanged for 2023 Public Warrants. Upon exchange, the Company recorded an additional fair value expense of $26 and transferred
the fair value of the exchanged 2023 Public Warrants from warrant liabilities to equity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies the 2023 Private Warrants as Level 2 instruments under the fair value hierarchy and estimated the fair value
using a Black Scholes model with the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFk6Ox8K47Rd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 10)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B1_zaWJlw2aMbae" style="display: none"&gt;Schedule of Company classifies the 2023 Private Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%; text-align: justify"&gt;Stock price on valuation date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6oXgHKruWe6" style="width: 12%; text-align: right" title="Stock price on valuation date"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqekotrMP9Vi" style="width: 12%; text-align: right" title="Stock price on valuation date"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znCtEfbsXH08" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zF3USWMHviO5" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of the 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zokzvdR53Fk3" title="Implied volatility of public warrants"&gt;90.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9U5QvrJpznl" title="Implied volatility of public warrants"&gt;69.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znZARl9u7sBg" title="Risk free rate"&gt;3.70&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0eYdPxiw4Vg" title="Risk free rate"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgm51tujLyqh" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zg46M9I9XHcl" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected Warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlnRSv5Nal7c" title="Expected warrant life in years"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtYp_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zh9w0dnN8xu9" title="Expected warrant life in years"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
change in the 2023 Private Warrants liability is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_z0wgS9c7yeFj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 11)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BA_zyhMrnzpsjGb" style="display: none"&gt;Schedule of change in the 2023 Private Warrants liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Valuation at June 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zdA6r0J0esa4" style="width: 12%; text-align: right" title="Initial valuation, at begining"&gt;3,279&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu0bnuGHovO5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;(1,926&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Valuation at June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zEgWZiuvZZk4" style="text-align: right" title="Initial valuation, at begining"&gt;1,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exchange of 2023 Private Warrants for 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExchangeOfPrivateWarrantsForPublicWarrants_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqxGr8R6Ic6" style="text-align: right" title="Exchange of 2023 Private Warrants for 2023 Public Warrants"&gt;(482&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zZz1REyuZhG6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;1,661&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Valuation at June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zJRxXg73bqG3" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;2,532&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;

















&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Contingent
Consent Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p class="xdx_phnt_RGlzY2xvc3VyZSAtIENPTU1PTiBTSEFSRVMgKERldGFpbHMgTmFycmF0aXZlKQA_" id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationArrangementsDescription_c20240701__20250630__us-gaap--BusinessAcquisitionAxis__custom--LindGlobalAssetManagementThreeLLCMember_zT3rn8cfB36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify" title="Contingent consideration description"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#x201c;Lind Consent&#x201d;), between the Company and Lind Global Asset Management III, LLC (&#x201c;Lind III&#x201d;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#x201c;Contingent Consent Warrants&#x201d;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance. Further, the number of Contingent Consent Warrants issued would be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 17, 2024, the Company&#x2019;s Common Share price was below the threshold price set forth in the Lind Consent, and accordingly,
the Company issued &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20240915__20240917_zV7hAPsbKN5" title="Stock issued, shares"&gt;2,816,742&lt;/span&gt; Contingent Consent Warrants to Lind III. Each Contingent Consent Warrant is exercisable for one Common
Share at an exercise price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zchsq8WjatB4" title="Common share exercise price, per share"&gt;2.308&lt;/span&gt; and may be exercised at any time prior to their expiration on September 17, 2028. The number
of Contingent Consent Warrants issued was based on $&lt;span id="xdx_904_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_c20240915__20240917__us-gaap--TransactionTypeAxis__custom--LindConsentWarrantIssuanceMember_zo3BmPXABiDj"&gt;5,000&lt;/span&gt; divided by the five-day volume weighted average price of the Common
Shares on September 16, 2024. The Company valued the Contingent Consent Warrants at $2,262 based on a Black-Scholes valuation
with the following inputs:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zFUYIGd61og6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 12)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B2_ziBCaZUdluGd" style="display: none"&gt;Schedule of  Black-Scholes valuation
&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;September 17,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zqGe67wsIuDc" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;br/&gt;
&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zV77JykhDcch" title="Term (years)"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_z3nF9Ec9NROe" title="Historic equity volatility"&gt;67.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zo3NFj88A5Rb" title="Risk-free rate"&gt;3.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
change in the fair value of the Contingent Consent Warrants liability is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcdwdb4ubHde" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 13)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B2_zMGqK8zMF1m3" style="display: none"&gt;Schedule of change in fair value of Warrants liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify"&gt;Valuation at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zfJNBPrk2jef" style="width: 12%; text-align: right" title="Valuation, at begining"&gt;2,365&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: 0.6pt; padding-left: 0.125in"&gt;Fair value of Warrants issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zydUoDS605P6" style="text-align: right" title="Fair value of Warrants issued"&gt;(2,262&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Gain on issuance of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--GainOnIssuanceOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zCu0szBFtWX7" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on issuance of Warrants"&gt;(103&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Ending balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zD6HKT2NGPWl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation, at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1494"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized a gain of $&lt;span id="xdx_90B_ecustom--GainOnIssuanceOfWarrants_iN_pn3n3_di_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zlDiKqF7j3Sd" title="Gain on issuance of Warrants"&gt;103&lt;/span&gt; on the issuance of the Contingent Consent Warrants. This gain was recorded as a part of other
gains in the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees contextRef="From2024-11-012024-11-05" id="Fact000998">On
November 5, 2024, the Company closed an underwritten public offering (the &#x201c;November 2024 Registered Offering&#x201d;),
pursuant to the underwriting agreement, dated November 3, 2024 (the &#x201c;Underwriting Agreement&#x201d;), with Maxim Group
LLC (&#x201c;Maxim&#x201d;), as underwriter, which consisted of 1,592,356 Common Shares, 1,672,090 Warrants (the &#x201c;Series
A Public Warrants&#x201d;) to purchase up to an additional 1,672,090 Common Shares and 836,045 Warrants (the &#x201c;Series B
Public Warrants&#x201d; and, together with the Series A Public Warrants, the &#x201c;November 2024 Public Warrants&#x201d;) to
purchase up to an additional 836,045 Common Shares. Each Common Share was sold together with one Series A Public Warrant and
one-half of one Series B Public Warrant at a combined public offering price of $1.57. The gross proceeds from the November
2024 Registered Offering were $2,501 before deducting underwriting discounts and offering expenses. The November 2024 Public
Warrants were classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair
values of the Common Shares and the November 2024 Public Warrants on the date of issuance, with $943 allocated to the fair
value of the November 2024 Public Warrants and the balance of the proceeds of $1,558 allocated to Common Shares. The Company
incurred total transaction costs related to the November 2024 Registered Offering $1,226, which were treated as share
issuance costs at closing. The Series A Public Warrants have an exercise price of $1.75 per underlying Common Share, are
exercisable immediately, and will expire on November 5, 2026. The Series B Public Warrants have an exercise price of $2.07
per underlying Common Share, are exercisable beginning six months and one day from the date of issuance and will expire on
November 5, 2029. In addition, pursuant to the Underwriting Agreement, the Company granted Maxim a 45-day over-allotment
option to purchase (i) 238,853 additional Common Shares and (ii) 358,280 Option Warrants (as defined below) to purchase up to
an aggregate of 358,280 Common Shares. &#x201c;Option Warrant&#x201d; means one Series A Public Warrant combined with one-half
of one Series B Public Warrant. On November 4, 2024, Maxim partially exercised its over-allotment option to purchase
79,734 additional Series A Public Warrants and 39,867
additional Series B Public Warrants, which amounts are included in the amounts discussed above and were issued at closing of
the November 2024 Registered Offering.</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <niobf:DebtInstrumentIssuedPrincipalshars
      contextRef="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesAMember"
      decimals="INF"
      id="Fact000999"
      unitRef="Shares">79734</niobf:DebtInstrumentIssuedPrincipalshars>
    <niobf:DebtInstrumentIssuedPrincipalshars
      contextRef="From2024-11-012024-11-04_custom_PurchaseAgreementSeriesBMember"
      decimals="INF"
      id="Fact001000"
      unitRef="Shares">39867</niobf:DebtInstrumentIssuedPrincipalshars>
    <niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="From2024-07-012025-06-30_custom_PublicWarrantsMember"
      id="Fact001010">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zjABPV9bQ4mg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_zWeeoFmduHP2" style="display: none"&gt;Schedule of Black-Scholes model used in public warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;November 5, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;November 2024 Public Warrants:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series A&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series B&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                                                   &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 35%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zBwMFHnTn4K8" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zoffagcetK24" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zpK7A6WxWtri" title="Term (years)"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zpuiUMuYHYG7" title="Term (years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zTjDB5MmDIhk" title="Historic equity volatility"&gt;67.43&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zZEBZ0vBYNu2" title="Historic equity volatility"&gt;67.13&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zdWGujIdLif9" title="Risk-free rate"&gt;4.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241105__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zyl3gVN7NXoa" title="Risk-free rate"&gt;4.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-05_custom_SeriesAPublicWarrantsMember"
      decimals="INF"
      id="Fact001012"
      unitRef="USDPShares">1.455</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-05_custom_SeriesBPublicWarrantsMember"
      decimals="INF"
      id="Fact001014"
      unitRef="USDPShares">1.455</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember"
      id="Fact001016">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember"
      id="Fact001018">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember"
      decimals="INF"
      id="Fact001020"
      unitRef="Ratio">0.6743</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember"
      decimals="INF"
      id="Fact001022"
      unitRef="Ratio">0.6713</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-11-012024-11-05_custom_SeriesAPublicWarrantsMember"
      decimals="INF"
      id="Fact001024"
      unitRef="Ratio">0.0414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-11-012024-11-05_custom_SeriesBPublicWarrantsMember"
      decimals="INF"
      id="Fact001026"
      unitRef="Ratio">0.0420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees contextRef="From2024-11-012024-11-13" id="Fact001027">On
November 13, 2024, the Company closed a non-brokered private placement (the &#x201c;November 2024 Private Offering&#x201d;),
pursuant to binding subscription agreements with certain accredited investors as part of a non-brokered private placement of 2,199,602
units of the Company (the &#x201c;November 2024 Units&#x201d;). Each November 2024 Unit consisted of one Common Share, one
Warrant (a &#x201c;Series A Private Warrant&#x201d;) to purchase one Common Share, and one-half of one Warrant (each whole such
Warrant, a &#x201c;Series B Private Warrant&#x201d; and, together with the Series A Private Warrants, the &#x201c;November 2024
Private Warrants&#x201d;), with each Series B Private Warrant entitling the holder thereof to purchase one additional Common
Share. Each November 2024 Unit was issued and sold at a price of $1.57. The gross proceeds of the November 2024 Private
Offering were approximately $3,500 before deducting offering expenses. Certain directors and officers of the Company (the
&#x201c;Insider Investors&#x201d;) purchased November 2024 Units at a price of $1.7675 per November 2024 Unit, which price
includes $0.1975 per November 2024 Private Warrant and allowed such directors and officers to participate in the November
2024 Private Offering in accordance with the rules of the Nasdaq. The Series A Private Warrants have an exercise price of
$1.75 per underlying Common Share, are exercisable immediately, and will expire on November 13, 2026. The Series B Private
Warrants have an exercise price of $2.07 per underlying Common Share, are exercisable beginning six months and one day from
the date of issuance and will expire on November 13, 2029. The Company recorded a non-cash expense of $34 and $110 to other
operating expenses and employee related costs, respectively, representing the excess of fair value of the November 2024 Units
over the purchase price paid by Insider Investors.</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-11-012024-11-13_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001029"
      unitRef="Shares">2199602</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001031"
      unitRef="USD">1928000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001033"
      unitRef="USD">1573000</us-gaap:StockIssuedDuringPeriodValueOther>
    <niobf:RegisteredOffering
      contextRef="AsOf2024-11-30"
      decimals="-3"
      id="Fact001035"
      unitRef="USD">161000</niobf:RegisteredOffering>
    <niobf:PrivateOffering
      contextRef="AsOf2024-11-30"
      decimals="-3"
      id="Fact001037"
      unitRef="USD">60000</niobf:PrivateOffering>
    <niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="From2024-07-012025-06-30_custom_PrivateWarrantsMember"
      id="Fact001039">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PrivateWarrantsMember_zFjI4YyUrucg" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 1)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BB_ztxowl6wpNnh" style="display: none"&gt;Schedule of Black-Scholes model used in Private warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;November 13, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;November 2024 Private Warrants:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series A Private&lt;/p&gt;
                                                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Series B Private Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 35%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z4s5mBECo834" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.49&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z36KZZtnDtQb" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.49&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zuirTne6rEEa" title="Term (years)"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z40LzAZPI1Sa" title="Term (years)"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zeBQfpiYG9U6" title="Historic equity volatility"&gt;67.26&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_z5UfHhTX50H8" title="Historic equity volatility"&gt;67.52&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zvyh6atZ5Ek2" title="Risk-free rate"&gt;4.20&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20241101__20241113__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zFfLVlhe2DF1" title="Risk-free rate"&gt;4.30&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

















&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;November 2024 Private Warrants:&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Series A Private Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Series B Private Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 35%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z5GQTy3h4J1k" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zNbYyKM4Cxzg" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zP0y9BLp3Rp4" title="Term (years)"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zANaPT946vLf" title="Term (years)"&gt;4.38&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_zpYES54cGwCh" title="Historic equity volatility"&gt;86.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zwVEs7kpPGJ" title="Historic equity volatility"&gt;74.26&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPrivateWarrantsMember_z0QW52vdv1h6" title="Risk-free rate"&gt;3.88&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPrivateWarrantsMember_zfzanleeOQ79" title="Risk-free rate"&gt;3.77&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-13_custom_SeriesAPrivateWarrantsMember"
      decimals="INF"
      id="Fact001041"
      unitRef="USDPShares">1.49</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-11-13_custom_SeriesBPrivateWarrantsMember"
      decimals="INF"
      id="Fact001043"
      unitRef="USDPShares">1.49</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember"
      id="Fact001045">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember"
      id="Fact001047">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember"
      decimals="INF"
      id="Fact001049"
      unitRef="Ratio">0.6726</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember"
      decimals="INF"
      id="Fact001051"
      unitRef="Ratio">0.6752</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-11-012024-11-13_custom_SeriesAPrivateWarrantsMember"
      decimals="INF"
      id="Fact001053"
      unitRef="Ratio">0.0420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-11-012024-11-13_custom_SeriesBPrivateWarrantsMember"
      decimals="INF"
      id="Fact001055"
      unitRef="Ratio">0.0430</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharePrice
      contextRef="AsOf2025-06-30_custom_SeriesAPrivateWarrantsMember"
      decimals="INF"
      id="Fact001064"
      unitRef="USDPShares">2.33</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2025-06-30_custom_SeriesBPrivateWarrantsMember"
      decimals="INF"
      id="Fact001066"
      unitRef="USDPShares">2.33</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember"
      id="Fact001068">P1Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember"
      id="Fact001070">P4Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember"
      decimals="INF"
      id="Fact001072"
      unitRef="Ratio">0.8614</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember"
      decimals="INF"
      id="Fact001074"
      unitRef="Ratio">0.7426</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-07-012025-06-30_custom_SeriesAPrivateWarrantsMember"
      decimals="INF"
      id="Fact001076"
      unitRef="Ratio">0.0388</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-07-012025-06-30_custom_SeriesBPrivateWarrantsMember"
      decimals="INF"
      id="Fact001078"
      unitRef="Ratio">0.0377</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <niobf:ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001080">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_ecustom--ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock_pn3n3_zgJQ0aYt8XEb" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 3)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B9_zo6Yg9D0X9J4" style="display: none"&gt;Schedule of  changes in the fair value of  Private Warrants liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;November&#160;2024&#160;Private&#160;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Fair value at issuance (November 13, 2024)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ChangesInFairValueOfInitialValuation1_iS_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_z9T2mvBFugIc" style="width: 15%; text-align: right" title="Beginning balance"&gt;1,929&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; text-indent: 9pt"&gt;Fair value of Warrants exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FairValueOfWarrantsExercised_iN_pn3n3_di_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zNzQDvx8Cbl6" style="text-align: right" title="Fair value of Warrants exercised"&gt;(338&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCECFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: 9pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zYu4P0N5b986" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value"&gt;2,240&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Fair value as of June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20241114__20250630__us-gaap--SubsidiarySaleOfStockAxis__custom--NovemberPrivateWarrantsliabilitiesMember_zL0EmStf7uLi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;3,831&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:ScheduleOfChangesInTheFairValueOfPrivateWarrantsTableTextBlock>
    <niobf:ChangesInFairValueOfInitialValuation1
      contextRef="AsOf2024-11-13_custom_NovemberPrivateWarrantsliabilitiesMember"
      decimals="-3"
      id="Fact001082"
      unitRef="USD">1929000</niobf:ChangesInFairValueOfInitialValuation1>
    <niobf:FairValueOfWarrantsExercised
      contextRef="From2024-11-142025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember"
      decimals="-3"
      id="Fact001084"
      unitRef="USD">338000</niobf:FairValueOfWarrantsExercised>
    <niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs
      contextRef="From2024-11-142025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember"
      decimals="-3"
      id="Fact001086"
      unitRef="USD">2240000</niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs>
    <niobf:ChangesInFairValueOfInitialValuation1
      contextRef="AsOf2025-06-30_custom_NovemberPrivateWarrantsliabilitiesMember"
      decimals="-3"
      id="Fact001088"
      unitRef="USD">3831000</niobf:ChangesInFairValueOfInitialValuation1>
    <niobf:CommonShareDescription contextRef="From2025-01-022025-01-31" id="Fact001090">On
January 31, 2025, the Company closed an underwritten registered direct offering (the &#x201c;January 2025 Offering&#x201d;), pursuant
to an underwriting agreement, dated January 29, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold
2,577,320 Common Shares, 2,577,320 Series A Warrants to purchase up to 2,577,320 Common Shares (the &#x201c;January 2025 Series
A Warrants&#x201d;) and 1,288,660 Series B Warrants to purchase up to an additional 1,288,660 Common Shares (the &#x201c;January
2025 Series B Warrants&#x201d; and, together with the January 2025 Series A Warrants, the &#x201c;January 2025 Warrants&#x201d;).
Each Common Share was sold together with one January 2025 Series A Warrant and one-half of one January 2025 Series B Warrant at
a combined public offering price of $1.94. The gross proceeds from the January 2025 Offering were approximately $5,000 before
deducting underwriting discounts and offering expenses. The January 2025 Warrants were classified as equity instruments, and accordingly,
the net proceeds were allocated based on the relative fair values of the Common Shares and the January 2025 Warrants on the date
of issuance, with $2,200 allocated to the fair value of the January 2025 Warrants and the balance of the proceeds of $2,800 allocated
to Common Shares. The Company incurred total transaction costs related to the January 2025 Offering of $799, which were treated
as share issuance costs at closing. The January 2025 Series A Warrants have an exercise price of $1.98 per underlying Common Share,
are exercisable immediately, and will expire on August 2, 2027. The January 2025 Series B Warrants have an exercise price of $2.05
per underlying Common Share, are exercisable immediately, and will expire on January 31, 2029.</niobf:CommonShareDescription>
    <niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001092">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_ecustom--FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock_pn3n3_zxW275XyTNk7" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 4)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&lt;span id="xdx_8BA_zR1scRy2NAkj" style="display: none"&gt;Schedule of Black-Scholes model for warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series A&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Series B&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Public&lt;/p&gt;
                                              &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 35%"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_ziqwvz8ifXng" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zF3dBkIGi8p" style="width: 12%; text-align: right" title="Closing common share price"&gt;2.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Term (years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zK3f3iIg1ugf" title="Term (years)"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_z0BPucdjJLQi" title="Term (years)"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_zVxoQiJ3o6h1" title="Historic equity volatility"&gt;73.18&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zFYt7yuL6Myg" title="Historic equity volatility"&gt;73.36&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesAPublicWarrantsMember_z0P6pIedNQqb" title="Risk-free rate"&gt;4.23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250131__us-gaap--StatementEquityComponentsAxis__custom--SeriesBPublicWarrantsMember_zez53Gsgpcjh" title="Risk-free rate"&gt;4.31&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2025-01-31_custom_SeriesAPublicWarrantsMember"
      decimals="INF"
      id="Fact001094"
      unitRef="USDPShares">2.25</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2025-01-31_custom_SeriesBPublicWarrantsMember"
      decimals="INF"
      id="Fact001096"
      unitRef="USDPShares">2.25</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember"
      id="Fact001098">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember"
      id="Fact001100">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember"
      decimals="INF"
      id="Fact001102"
      unitRef="Ratio">0.7318</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember"
      decimals="INF"
      id="Fact001104"
      unitRef="Ratio">0.7336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-07-012025-01-31_custom_SeriesAPublicWarrantsMember"
      decimals="INF"
      id="Fact001106"
      unitRef="Ratio">0.0423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-07-012025-01-31_custom_SeriesBPublicWarrantsMember"
      decimals="INF"
      id="Fact001108"
      unitRef="Ratio">0.0431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <niobf:CommonShareDescription contextRef="From2025-04-022025-04-21" id="Fact001111">On
April 21, 2025, the Company closed an underwritten public offering (the &#x201c;April 2025 Offering&#x201d;), pursuant to an underwriting
agreement, dated April 17, 2025, with Maxim, as underwriter, pursuant to which the Company issued and sold (i) 6,628,846 Common
Shares at a public offering price of $2.60 per Common Share and (ii) 1,063,462 pre-funded Warrants (the
&#x201c;April 2025 Pre-Funded Warrants&#x201d;) to purchase up to an additional 1,063,462 Common Shares at a public offering price
of $2.5999. The April 2025 Pre-Funded Warrants have an exercise price of $0.0001 per underlying Common Share, are exercisable
immediately, and do not have an expiration date. On April 17, 2025, Maxim partially exercised its over-allotment option to purchase
323,504 additional Common Shares at closing. The gross proceeds from the April 2025 Offering were
approximately $20,841 before deducting underwriting discounts and offering expenses. The April 2025 Pre-Funded Warrants were
classified as equity instruments and accordingly, the net proceeds were allocated based on the relative fair values of the Common
Shares and the April 2025 Pre-Funded Warrants on the date of issuance, with $2,765 allocated to the fair value of the April 2025
Pre-Funded Warrants (based on the value of the underlying Common Shares at closing) and the balance of the proceeds of $18,076
allocated to Common Shares. The Company incurred total transaction costs related to the April 2025 Offering of $2,102, which were
treated as share issuance costs at closing.</niobf:CommonShareDescription>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001121"
      unitRef="Shares">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001123"
      unitRef="USDPShares">4.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2023-08-302023-09-02_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact001125"
      unitRef="USD">1000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-09-02_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001127"
      unitRef="USDPShares">4.60</niobf:SaleOfStockPricePerShare1>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-09-012023-09-30"
      decimals="-3"
      id="Fact001128"
      unitRef="USD">962000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001129"
      unitRef="USD">254000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2023-09-012023-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001130"
      unitRef="USD">708000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      id="Fact001132">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001134"
      unitRef="Ratio">0.0485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001136"
      unitRef="Ratio">0.7163</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-09-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001138"
      unitRef="Ratio">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001140"
      unitRef="Shares">413432</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001142"
      unitRef="USDPShares">3.54</niobf:SaleOfStockPricePerShare1>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001144"
      unitRef="Shares">274587</us-gaap:StockIssuedDuringPeriodSharesOther>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001146"
      unitRef="USDPShares">3.08</niobf:SaleOfStockPricePerShare1>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_srt_DirectorMember"
      decimals="INF"
      id="Fact001148"
      unitRef="Shares">138845</us-gaap:StockIssuedDuringPeriodSharesOther>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember_srt_DirectorMember"
      decimals="INF"
      id="Fact001150"
      unitRef="USDPShares">3.205</niobf:SaleOfStockPricePerShare1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember_currency_CAD"
      decimals="-3"
      id="Fact001152"
      unitRef="USD">1290000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact001154"
      unitRef="USD">92000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2024-07-012025-06-30_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact001156"
      unitRef="USD">10000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001158"
      unitRef="USD">264000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-07-012025-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001160"
      unitRef="USD">977000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001164"
      unitRef="Ratio">0.0433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
      contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001166"
      unitRef="Ratio">0.548</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-07-012025-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001168"
      unitRef="Ratio">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-06-022024-06-24_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001170"
      unitRef="Shares">315000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-06-24_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001172"
      unitRef="USDPShares">1.91</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-06-022024-06-24_us-gaap_PrivatePlacementMember"
      decimals="-3"
      id="Fact001174"
      unitRef="USD">602000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <niobf:SaleOfStockPricePerShare1
      contextRef="AsOf2024-06-24_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact001176"
      unitRef="USDPShares">2.20</niobf:SaleOfStockPricePerShare1>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact001186"
      unitRef="USD">161000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="From2024-06-012024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001188"
      unitRef="USD">441000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001192"
      unitRef="Ratio">0.0473</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001194"
      unitRef="Ratio">0.7392</niobf:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-06-012024-06-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001196"
      unitRef="Ratio">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember"
      decimals="-3"
      id="Fact001198"
      unitRef="USD">46917000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-07-012025-06-30_custom_YorkvilleEquityFacilityFinancingAgreementMember"
      id="Fact001200">2026-04-01</us-gaap:DebtInstrumentMaturityDate>
    <niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001202">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock_pn3n3_zC1q0aJQbfSk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in" summary="xdx: Disclosure - COMMON SHARES (Details 5)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_8B7_zTkJ5AOPBgLi" style="display: none"&gt;Schedule of issued Common Shares under the Yorkville Equity Facility Financing Agreement&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For The Year  &lt;br/&gt;Ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 74%; text-align: justify"&gt;Common Shares issued&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--CommonStockSharesIssued1_pid_uShares_c20240701__20250630_zmIiFOnitAKi" style="width: 10%; text-align: right" title="Common shares issued"&gt;5,671,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CommonStockSharesIssued1_pid_uShares_c20230701__20240630_zIjUiwkfoof5" style="width: 10%; text-align: right" title="Common shares issued"&gt;1,358,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-left: 0.125in"&gt;Gross funds received&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240701__20250630_zLMDNYNZVIq5" style="text-align: right" title="Gross funds received"&gt;12,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20230701__20240630_ztfSimaTqoz7" style="text-align: right" title="Gross funds received"&gt;3,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Market value of Common Shares issued&lt;br/&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssued1_c20240701__20250630_zqnd5BCHOKPj" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued"&gt;12,941&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssued1_c20230701__20240630_z74OWN2eV6E5" style="border-bottom: Black 1pt solid; text-align: right" title="Market value of Common Shares issued"&gt;3,398&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss on issuance&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20240701__20250630_fKDEp_zi38DeaHmkSd" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance"&gt;589&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NonmonetaryTransactionGainLossRecognizedOnTransfer_c20230701__20240630_fKDEp_zPUTuQaIx7bh" style="border-bottom: Black 2.5pt solid; text-align: right" title="(Gain)/Loss on Issuance"&gt;105&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0E_za1jIOPFlggi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 9pt"&gt;&lt;span id="xdx_F1F_zVuOpfGNvd5k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
                                         on issuance represents a non-cash amount equal to the difference between the proceeds
                                         received and the fair value of the Common Shares issued based on the Nasdaq closing price
                                         per Common Share on the issuance date and is recorded in other operating expenses in
                                         the condensed consolidated statement of operations and comprehensive loss.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</niobf:ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock>
    <niobf:CommonStockSharesIssued1
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001204"
      unitRef="Shares">5671742</niobf:CommonStockSharesIssued1>
    <niobf:CommonStockSharesIssued1
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001206"
      unitRef="Shares">1358000</niobf:CommonStockSharesIssued1>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001208"
      unitRef="USD">12352000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001210"
      unitRef="USD">3293000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:StockIssued1
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001212"
      unitRef="USD">12941000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001214"
      unitRef="USD">3398000</us-gaap:StockIssued1>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001216"
      unitRef="USD">589000</us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001218"
      unitRef="USD">105000</us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001229">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfStockOptionsRollForwardTableTextBlock_pn3n3_zra9zMcF5HNh" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 6)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zqRO2c9yrHPf" style="display: none"&gt;Schedule of option&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number&#160;of&#160;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Aggregate Intrinsic Value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Remaining Contractual Life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 39%; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20230701__20240630_zo5FW6VaGGV4" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;1,541,500&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20230701__20240630_z5aRZ0B4yIqc" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance"&gt;7.19&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20230701__20240630_z7UbXA2DKgPg" style="text-align: right" title="Granted, in shares"&gt;1,625,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zq7dprEAdSfh" style="text-align: right" title="Granted, per share"&gt;2.99&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20230701__20240630_zcpRxLZtHLe3" style="text-align: right" title="Cancelled/expired, in shares"&gt;(7,800&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zcua8iTgLMMi" style="text-align: right" title="Cancelled/expired, per share"&gt;3.95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20230701__20240630_ztAKExeJEcdj" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares"&gt;(663,200&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20230701__20240630_zrSGke4oCfW2" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share"&gt;5.88&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_uShares_c20240701__20250630_zvDjJdNSlaTc" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;2,495,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_uCADPShares_c20240701__20250630_zDTBdK33q3N6" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance"&gt;4.78&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_uShares_c20240701__20250630_zy0nRSWy2s9i" style="text-align: right" title="Granted, in shares"&gt;945,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zGNCkDvD8c12" style="text-align: right" title="Granted, per share"&gt;1.41&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_uShares_c20240701__20250630_zQGeplrrOW5l" style="text-align: right" title="Cancelled/expired, in shares"&gt;(512&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zrSRhaFcDhab" style="text-align: right" title="Cancelled/expired, per share"&gt;1.40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="background-color: White"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; background-color: White"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; background-color: White"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled/expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_uShares_c20240701__20250630_zYC8dMDLo6l8" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, in shares"&gt;(419,988&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_uCADPShares_c20240701__20250630_zMk0H7ryc6M3" style="border-bottom: Black 1pt solid; text-align: right" title="Cancelled/expired, per share"&gt;9.44&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_uShares_c20240701__20250630_z1qx7VjdF3m6" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;3,020,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_uCADPShares_c20240701__20250630_zXM8lFwL92I" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;3.09&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20250630_zjwmjb5VjMmi" style="border-bottom: Black 2.5pt solid; text-align: right" title="Aggregate intrinsic value"&gt;866&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240701__20250630_zECCFukmRsF4" title="Weighted average remaining contractual life"&gt;3.5&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001231"
      unitRef="Shares">1541500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001233"
      unitRef="CADPShares">7.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001235"
      unitRef="Shares">1625000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001237"
      unitRef="CADPShares">2.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001239"
      unitRef="Shares">7800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001241"
      unitRef="CADPShares">3.95</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001243"
      unitRef="Shares">663200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001245"
      unitRef="CADPShares">5.88</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001247"
      unitRef="Shares">2495500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001249"
      unitRef="CADPShares">4.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001251"
      unitRef="Shares">945000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001253"
      unitRef="CADPShares">1.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001255"
      unitRef="Shares">512</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001257"
      unitRef="CADPShares">1.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001259"
      unitRef="Shares">419988</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001261"
      unitRef="CADPShares">9.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001263"
      unitRef="Shares">3020000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001265"
      unitRef="CADPShares">3.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001267"
      unitRef="USD">866000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-07-01to2025-06-30" id="Fact001269">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001271"
      unitRef="Ratio">0.998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <niobf:UnrecognizedCompensationCosts
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001273"
      unitRef="USD">4000</niobf:UnrecognizedCompensationCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001275"
      unitRef="USD">789000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001279">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zzeVpWSx38yc" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 65%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 7)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: White; visibility: hidden"&gt;
    &lt;td style="display: none; padding-left: 5pt; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20240701__20250630_zr6u56GHJ8Ig" style="display: none; text-align: right; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20230701__20240630_zFf2bGLFP1C8" style="display: none; text-align: right; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt"&gt;&lt;span id="xdx_8B9_znuoL3SnEEvc" style="display: none"&gt;Schedule of  weighted average  and assumptions used to option costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_uUSDPShares_zBGQgMDOCHP3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 38%; text-align: left; padding-left: 5pt"&gt;Fair value per option granted during the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;0.84&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1.71&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uRatio_zYkx8Fz5RPLk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.44&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_zEFumOScew94" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_zWvBAbR5Epja" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Expected stock price volatility (historical basis)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5pt"&gt;Expected option life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630_zbgAbYq8KEs5" style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230701__20240630_zJpZ9V8HBIi5" style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001281"
      unitRef="USDPShares">0.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001282"
      unitRef="USDPShares">1.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001284"
      unitRef="Ratio">0.0444</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001285"
      unitRef="Ratio">0.0425</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001287"
      unitRef="Ratio">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001288"
      unitRef="Ratio">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001290"
      unitRef="Ratio">0.673</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001291"
      unitRef="Ratio">0.632</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2024-07-01to2025-06-30" id="Fact001292">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2023-07-012024-06-30" id="Fact001293">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001303">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zXuQE7ktV8p5" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 8)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 3pt"&gt;&lt;span id="xdx_8BC_zs9ZXhkeybme" style="display: none"&gt;Schedule of Weighted average exercise prices&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Weighted Average Exercise Price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 59%; padding-bottom: 1pt; text-align: left; padding-left: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20230701__20240630_zUX6oVYEX5Ij" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance, Warrants"&gt;18,816,304&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20230701__20240630_zcGw2PVqxW6j" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;10.98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20230701__20240630_zFwo2AhJUFP" style="text-align: right" title="Beginning balance, Warrants"&gt;1,593,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20230701__20240630_zwNyIPwG4fFj" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;3.33&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20230701__20240630_zDIy7pizdv4e" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants"&gt;(1,846,560&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20230701__20240630_z4eGOlMMpZIa" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;8.67&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_pid_uShares_c20240701__20250630_zEJ1tK2Ezljd" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants"&gt;18,563,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iS_pid_uUSDPShares_c20240701__20250630_zbSupISsCcpg" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;10.53&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClassOfWarrantOrRightGranted_pid_uShares_c20240701__20250630_ztbkMTkadHp7" style="text-align: right" title="Beginning balance, Warrants"&gt;13,553,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClassOfWarrantOrRightExercisePriceGranted_pid_uUSDPShares_c20240701__20250630_zWnCqbHapuc6" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;2.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ClassOfWarrantOrRightExercised_pid_uShares_c20240701__20250630_zwJk9Mhe7C3i" style="text-align: right" title="Beginning balance, Warrants"&gt;(828,235&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePriceExercised_pid_uShares_c20240701__20250630_zql4ZlYmrsZ4" style="text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;1.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.145in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ClassOfWarrantOrRightExpired_pid_uShares_c20240701__20250630_zCdUca7tTTc7" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance, Warrants"&gt;(1,303,118&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePriceExpired_pid_uUSDPShares_c20240701__20250630_zlHjkOpjYvtl" style="border-bottom: Black 1pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;7.72&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left; padding-left: 3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance, June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_pid_uShares_c20240701__20250630_zIyW2AzEkrwj" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance, Warrants"&gt;29,985,922&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iE_pid_uUSDPShares_c20240701__20250630_zYae6k9rdGej" style="border-bottom: Black 2.5pt solid; text-align: right" title="Beginning balance at Weighted Average Exercise Price"&gt;7.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001305"
      unitRef="Shares">18816304</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact001307"
      unitRef="USDPShares">10.98</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <niobf:ClassOfWarrantOrRightGranted
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001309"
      unitRef="Shares">1593817</niobf:ClassOfWarrantOrRightGranted>
    <niobf:ClassOfWarrantOrRightExercisePriceGranted
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001311"
      unitRef="USDPShares">3.33</niobf:ClassOfWarrantOrRightExercisePriceGranted>
    <niobf:ClassOfWarrantOrRightExpired
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001313"
      unitRef="Shares">-1846560</niobf:ClassOfWarrantOrRightExpired>
    <niobf:ClassOfWarrantOrRightExercisePriceExpired
      contextRef="From2023-07-012024-06-30"
      decimals="INF"
      id="Fact001315"
      unitRef="USDPShares">8.67</niobf:ClassOfWarrantOrRightExercisePriceExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001317"
      unitRef="Shares">18563561</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001319"
      unitRef="USDPShares">10.53</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <niobf:ClassOfWarrantOrRightGranted
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001321"
      unitRef="Shares">13553714</niobf:ClassOfWarrantOrRightGranted>
    <niobf:ClassOfWarrantOrRightExercisePriceGranted
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001323"
      unitRef="USDPShares">2.05</niobf:ClassOfWarrantOrRightExercisePriceGranted>
    <niobf:ClassOfWarrantOrRightExercised
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001325"
      unitRef="Shares">-828235</niobf:ClassOfWarrantOrRightExercised>
    <niobf:ClassOfWarrantOrRightExercisePriceExercised
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001327"
      unitRef="Shares">1.78</niobf:ClassOfWarrantOrRightExercisePriceExercised>
    <niobf:ClassOfWarrantOrRightExpired
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001329"
      unitRef="Shares">-1303118</niobf:ClassOfWarrantOrRightExpired>
    <niobf:ClassOfWarrantOrRightExercisePriceExpired
      contextRef="From2024-07-01to2025-06-30"
      decimals="INF"
      id="Fact001331"
      unitRef="USDPShares">7.72</niobf:ClassOfWarrantOrRightExercisePriceExpired>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001333"
      unitRef="Shares">29985922</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001335"
      unitRef="USDPShares">7.06</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001337">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--ScheduleOfOutstandingExercisableWarrantsTableTextBlock_zXHd4VtQMRbi" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 9)"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td colspan="2" style="display: none; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zdxmK0jNL4al" style="display: none"&gt;Schedule
of outstanding exercisable Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Number&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 5pt"&gt;Expiry Date&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zd0IIseyj82k" style="width: 18%; text-align: right" title="Number of share outstanding"&gt;250,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zFL0jlRwAgLl" style="width: 18%; text-align: right" title="Exercise price"&gt;4.60&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice4.60Member_zyh0iohcDUw9" title="Expiry date"&gt;September 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zVGGTMFD7f5l" style="text-align: right" title="Number of share outstanding"&gt;413,432&lt;br/&gt;
&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_z8JIEsyEAb05" style="text-align: right"&gt;3.54&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.54Member_zc5mDRVkN54h" title="Expiry date"&gt;December 22, 2025&lt;/span&gt;&lt;br/&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_ztHLrjBYm4oh" style="text-align: right" title="Number of share outstanding"&gt;315,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zmZSn1BkZxTe" style="text-align: right"&gt;2.20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.20Member_zvJmN7P2xkNe" title="Expiry date"&gt;June 24, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_z3XmybalTJr1" style="text-align: right" title="Number of share outstanding"&gt;1,117,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zjsy76CW6Wqe" style="text-align: right"&gt;1.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75Member_zs8QG8ZZoO56" title="Expiry date"&gt;November 5, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zr7pf8oErYi8" style="text-align: right" title="Number of share outstanding"&gt;1,992,214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_z3syGfztzHT" style="text-align: right"&gt;1.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.75OneMember_zwinatfKpBG2" title="Expiry date"&gt;November 13, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zzwRWNc2GOwg" style="text-align: right" title="Number of share outstanding"&gt;615,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zyAIT8J6VI26" style="text-align: right"&gt;3.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice3.25Member_zEwwOexhFMvj" title="Expiry date"&gt;April 12, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_zypR2g71yvjd" style="text-align: right" title="Number of share outstanding"&gt;2,577,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ziEZfIN2d1R3" style="text-align: right"&gt;1.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice1.98Member_ztlSJK2yX35d" title="Expiry date"&gt;August 2, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_fKDEp_zxtFEcbnmEJk" style="text-align: right" title="Number of share outstanding"&gt;15,666,626&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: left"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zArioAAX3led" style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice11.50Member_zo5kJ0xeoZ54" title="Expiry date"&gt;March 17, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zO4CBiwWlLue" style="text-align: right" title="Number of share outstanding"&gt;2,816,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zwRG5lgseGJ8" style="text-align: right"&gt;2.31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.31Member_zrCEDZFZu0Ak" title="Expiry date"&gt;September 17, 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_z1PzvW1Pp7xi" style="text-align: right" title="Number of share outstanding"&gt;1,288,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zZ0hhfGF2R86" style="text-align: right"&gt;2.05&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.05Member_zIpDLmRqiWWi" title="Expiry date"&gt;January 31, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYCi8ZTEpbxg" style="text-align: right" title="Number of share outstanding"&gt;802,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zrClG3aAOJD" style="text-align: right"&gt;2.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07Member_zYBjyllkmuij" title="Expiry date"&gt;November 5, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zJwsDpyLenOh" style="text-align: right" title="Number of share outstanding"&gt;1,067,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_ztkuA19O2YDg" style="text-align: right"&gt;2.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.07OneMember_zIfQP5YVrlgl" title="Expiry date"&gt;November 13, 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zHynswnRGWRl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of share outstanding"&gt;1,063,462&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20250630__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePrice2.60Member_zEQauSMT7Hde" style="padding-bottom: 1pt; text-align: right"&gt;2.60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;No expiry&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_uShares_c20250630_zkrTCT5o5nuk" style="border-bottom: Black 2.5pt solid; text-align: right" title="Number of share outstanding"&gt;29,985,922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 6%; text-align: center"&gt;&lt;span id="xdx_F08_zntRSXlTmEJl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 94%; text-align: justify"&gt;&lt;span id="xdx_F10_zs4hJ7HULwAd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    11,165,324 and 4,501,302 2023 Public Warrants and 2023 Private Warrants, respectively, as defined below. Each 2023 Public
    Warrant and 2023 Private Warrant is exercisable into 1.11829212 Common Shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</niobf:ScheduleOfOutstandingExercisableWarrantsTableTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice4.60Member"
      decimals="INF"
      id="Fact001339"
      unitRef="Shares">250000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice4.60Member"
      decimals="INF"
      id="Fact001341"
      unitRef="CADPShares">4.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice4.60Member"
      id="Fact001343">2025-09-01</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice3.54Member"
      decimals="INF"
      id="Fact001345"
      unitRef="Shares">413432</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice3.54Member"
      decimals="INF"
      id="Fact001346"
      unitRef="CADPShares">3.54</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice3.54Member"
      id="Fact001348">2025-12-22</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.20Member"
      decimals="INF"
      id="Fact001350"
      unitRef="Shares">315000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.20Member"
      decimals="INF"
      id="Fact001351"
      unitRef="CADPShares">2.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.20Member"
      id="Fact001353">2026-06-24</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.75Member"
      decimals="INF"
      id="Fact001355"
      unitRef="Shares">1117090</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.75Member"
      decimals="INF"
      id="Fact001356"
      unitRef="CADPShares">1.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.75Member"
      id="Fact001358">2026-11-05</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.75OneMember"
      decimals="INF"
      id="Fact001360"
      unitRef="Shares">1992214</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.75OneMember"
      decimals="INF"
      id="Fact001361"
      unitRef="CADPShares">1.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.75OneMember"
      id="Fact001363">2026-11-13</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice3.25Member"
      decimals="INF"
      id="Fact001365"
      unitRef="Shares">615385</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice3.25Member"
      decimals="INF"
      id="Fact001366"
      unitRef="CADPShares">3.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice3.25Member"
      id="Fact001368">2027-04-12</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.98Member"
      decimals="INF"
      id="Fact001370"
      unitRef="Shares">2577320</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.98Member"
      decimals="INF"
      id="Fact001371"
      unitRef="CADPShares">1.98</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice1.98Member"
      id="Fact001373">2027-08-02</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      id="Fact001375"
      unitRef="Shares">15666626</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice11.50Member"
      decimals="INF"
      id="Fact001376"
      unitRef="CADPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice11.50Member"
      id="Fact001378">2028-03-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.31Member"
      decimals="INF"
      id="Fact001380"
      unitRef="Shares">2816742</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.31Member"
      decimals="INF"
      id="Fact001381"
      unitRef="CADPShares">2.31</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.31Member"
      id="Fact001383">2028-09-17</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.05Member"
      decimals="INF"
      id="Fact001385"
      unitRef="Shares">1288660</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.05Member"
      decimals="INF"
      id="Fact001386"
      unitRef="CADPShares">2.05</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.05Member"
      id="Fact001388">2029-01-31</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.07Member"
      decimals="INF"
      id="Fact001390"
      unitRef="Shares">802045</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.07Member"
      decimals="INF"
      id="Fact001391"
      unitRef="CADPShares">2.07</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.07Member"
      id="Fact001393">2029-11-05</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.07OneMember"
      decimals="INF"
      id="Fact001395"
      unitRef="Shares">1067946</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.07OneMember"
      decimals="INF"
      id="Fact001396"
      unitRef="CADPShares">2.07</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.07OneMember"
      id="Fact001398">2029-11-13</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.60Member"
      decimals="INF"
      id="Fact001400"
      unitRef="Shares">1063462</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-06-30_custom_ExercisePrice2.60Member"
      decimals="INF"
      id="Fact001401"
      unitRef="CADPShares">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001403"
      unitRef="Shares">29985922</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-012025-06-30_custom_GXIIPublicWarrantsMember"
      decimals="INF"
      id="Fact001406"
      unitRef="Shares">9999959</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-012025-06-30_custom_GXIIPrivateWarrantsMember"
      decimals="INF"
      id="Fact001408"
      unitRef="Shares">5666667</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2024-07-012025-06-30_custom_PublicWarrants2023Member"
      id="Fact001418">(ii)
the last reported sale price of the Common Shares equals or exceeds approximately $16.10 per share (as adjusted for stock
splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day
period ending on the third business day prior to the date on which the Company sends the notice of redemption to the Warrant
holders</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <niobf:ExchangeOfWarrantsDescription contextRef="From2024-07-01to2025-06-30" id="Fact001420">NioCorp Assumed Warrant Agreement, through June 30, 2025, a total of 1,165,365 2023 Private Warrants were
exchanged for 2023 Public Warrants. Upon exchange, the Company recorded an additional fair value expense of $26 and transferred
the fair value of the exchanged 2023 Public Warrants from warrant liabilities to equity.</niobf:ExchangeOfWarrantsDescription>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001422">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zFk6Ox8K47Rd" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 10)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B1_zaWJlw2aMbae" style="display: none"&gt;Schedule of Company classifies the 2023 Private Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 25%; text-align: justify"&gt;Stock price on valuation date&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z6oXgHKruWe6" style="width: 12%; text-align: right" title="Stock price on valuation date"&gt;2.33&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zqekotrMP9Vi" style="width: 12%; text-align: right" title="Stock price on valuation date"&gt;1.73&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Strike price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znCtEfbsXH08" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zF3USWMHviO5" style="text-align: right" title="Strike price"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Implied volatility of the 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zokzvdR53Fk3" title="Implied volatility of public warrants"&gt;90.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9U5QvrJpznl" title="Implied volatility of public warrants"&gt;69.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znZARl9u7sBg" title="Risk free rate"&gt;3.70&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z0eYdPxiw4Vg" title="Risk free rate"&gt;4.45&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgm51tujLyqh" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uRatio_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zg46M9I9XHcl" title="Dividend yield"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Expected Warrant life in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240701__20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlnRSv5Nal7c" title="Expected warrant life in years"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtYp_c20230701__20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zh9w0dnN8xu9" title="Expected warrant life in years"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001424"
      unitRef="USDPShares">2.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001426"
      unitRef="USDPShares">1.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001428"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001430"
      unitRef="USDPShares">11.50</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001432"
      unitRef="Ratio">0.900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001434"
      unitRef="Ratio">0.690</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001436"
      unitRef="Ratio">0.0370</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001438"
      unitRef="Ratio">0.0445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001440"
      unitRef="Ratio">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="INF"
      id="Fact001442"
      unitRef="Ratio">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-07-012025-06-30_us-gaap_FairValueInputsLevel2Member"
      id="Fact001444">P2Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-07-012024-06-30_us-gaap_FairValueInputsLevel2Member"
      id="Fact001446">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <niobf:ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001448">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock_z0wgS9c7yeFj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 11)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8BA_zyhMrnzpsjGb" style="display: none"&gt;Schedule of change in the 2023 Private Warrants liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Valuation at June 30, 2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zdA6r0J0esa4" style="width: 12%; text-align: right" title="Initial valuation, at begining"&gt;3,279&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20230701__20240630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zu0bnuGHovO5" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;(1,926&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Valuation at June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zEgWZiuvZZk4" style="text-align: right" title="Initial valuation, at begining"&gt;1,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;Exchange of 2023 Private Warrants for 2023 Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExchangeOfPrivateWarrantsForPublicWarrants_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zqxGr8R6Ic6" style="text-align: right" title="Exchange of 2023 Private Warrants for 2023 Public Warrants"&gt;(482&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Change in valuation&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zZz1REyuZhG6" style="border-bottom: Black 1pt solid; text-align: right" title="Change in valuation"&gt;1,661&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Valuation at June 30, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_ecustom--ChangesInFairValueOfInitialValuation1_iE_pn3n3_c20240701__20250630__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--NoteWarrantMember_zJRxXg73bqG3" style="border-bottom: Black 2.5pt solid; text-align: right" title="Ending balance"&gt;2,532&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:ScheduleOfChangesInTheFairValueOfThe2023PrivateWarrantsLiabilityTableTextBlock>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2023-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001450"
      unitRef="USD">3279000</niobf:ChangesInFairValueOfInitialValuation>
    <niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs
      contextRef="From2023-07-012024-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001452"
      unitRef="USD">-1926000</niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2024-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001454"
      unitRef="USD">1353000</niobf:ChangesInFairValueOfInitialValuation>
    <niobf:ExchangeOfPrivateWarrantsForPublicWarrants
      contextRef="From2024-07-012025-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001456"
      unitRef="USD">-482000</niobf:ExchangeOfPrivateWarrantsForPublicWarrants>
    <niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs
      contextRef="From2024-07-012025-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001458"
      unitRef="USD">1661000</niobf:ServicingAssetsAtFairValueChangesInFairValueResultingFromChangesInValuationInputs>
    <niobf:ChangesInFairValueOfInitialValuation1
      contextRef="AsOf2025-06-30_us-gaap_NoteWarrantMember"
      decimals="-3"
      id="Fact001460"
      unitRef="USD">2532000</niobf:ChangesInFairValueOfInitialValuation1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription
      contextRef="From2024-07-012025-06-30_custom_LindGlobalAssetManagementThreeLLCMember"
      id="Fact001469">As
consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the
&#x201c;Lind Consent&#x201d;), between the Company and Lind Global Asset Management III, LLC (&#x201c;Lind III&#x201d;), Lind III
received, amongst other things, the right to receive additional Warrants (the &#x201c;Contingent Consent Warrants&#x201d;) if on
September 17, 2024, the closing trading price of the Common Shares on the Toronto Stock Exchange or such other stock exchange
on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants
to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate
as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date
of issuance. Further, the number of Contingent Consent Warrants issued would be proportionately adjusted based on the percentage
of Warrants currently held by Lind III that are exercised, if any, prior to the issuance of any Contingent Consent Warrants.</us-gaap:BusinessCombinationContingentConsiderationArrangementsDescription>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-152024-09-17"
      decimals="INF"
      id="Fact001471"
      unitRef="Shares">2816742</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-17_custom_LindConsentWarrantIssuanceMember"
      decimals="INF"
      id="Fact001473"
      unitRef="USDPShares">2.308</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2024-09-152024-09-17_custom_LindConsentWarrantIssuanceMember"
      decimals="-3"
      id="Fact001474"
      unitRef="USD">5000000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001476">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zFUYIGd61og6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 12)"&gt;
&lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: justify"&gt;&lt;span id="xdx_8B2_ziBCaZUdluGd" style="display: none"&gt;Schedule of  Black-Scholes valuation
&lt;/span&gt;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Key Valuation Input&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;September 17,  &lt;br/&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify"&gt;Closing Common Share price&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zqGe67wsIuDc" style="width: 12%; text-align: right" title="Closing common share price"&gt;1.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Term (years)&lt;br/&gt;
&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zV77JykhDcch" title="Term (years)"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Historic equity volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_z3nF9Ec9NROe" title="Historic equity volatility"&gt;67.14&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uRatio_c20240915__20240917__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ValuationTechniqueAxis__custom--BlackScholesValuationMember_zo3NFj88A5Rb" title="Risk-free rate"&gt;3.44&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember"
      decimals="INF"
      id="Fact001478"
      unitRef="USDPShares">1.74</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember"
      id="Fact001480">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember"
      decimals="INF"
      id="Fact001482"
      unitRef="Ratio">0.6714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-09-152024-09-17_us-gaap_MeasurementInputExercisePriceMember_custom_BlackScholesValuationMember"
      decimals="INF"
      id="Fact001484"
      unitRef="Ratio">0.0344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001486">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock_zcdwdb4ubHde" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMON SHARES (Details 13)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B2_zMGqK8zMF1m3" style="display: none"&gt;Schedule of change in fair value of Warrants liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify"&gt;Valuation at June 30, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--ChangesInFairValueOfInitialValuation_iS_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zfJNBPrk2jef" style="width: 12%; text-align: right" title="Valuation, at begining"&gt;2,365&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: 0.6pt; padding-left: 0.125in"&gt;Fair value of Warrants issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FairValueAdjustmentOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zydUoDS605P6" style="text-align: right" title="Fair value of Warrants issued"&gt;(2,262&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in"&gt;Gain on issuance of Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--GainOnIssuanceOfWarrants_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zCu0szBFtWX7" style="border-bottom: Black 1pt solid; text-align: right" title="Gain on issuance of Warrants"&gt;(103&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Ending balance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--ChangesInFairValueOfInitialValuation_iE_pn3n3_c20240701__20250630__us-gaap--StatementEquityComponentsAxis__custom--WarrantLiabilityMember_zD6HKT2NGPWl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation, at ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1494"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</niobf:ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock>
    <niobf:ChangesInFairValueOfInitialValuation
      contextRef="AsOf2024-06-30_custom_WarrantLiabilityMember"
      decimals="-3"
      id="Fact001488"
      unitRef="USD">2365000</niobf:ChangesInFairValueOfInitialValuation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012025-06-30_custom_WarrantLiabilityMember"
      decimals="-3"
      id="Fact001490"
      unitRef="USD">-2262000</us-gaap:FairValueAdjustmentOfWarrants>
    <niobf:GainOnIssuanceOfWarrants
      contextRef="From2024-07-012025-06-30_custom_WarrantLiabilityMember"
      decimals="-3"
      id="Fact001492"
      unitRef="USD">-103000</niobf:GainOnIssuanceOfWarrants>
    <niobf:GainOnIssuanceOfWarrants
      contextRef="From2024-07-012025-06-30_custom_WarrantLiabilityMember"
      decimals="-3"
      id="Fact001496"
      unitRef="USD">-103000</niobf:GainOnIssuanceOfWarrants>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001498">&lt;p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zPJ2FHL92nq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_821_zgIbbwJJuj9f"&gt;RELATED
PARTY TRANSACTIONS AND BALANCES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 11, 2024, the Company and Mark Smith, Chief Executive Officer, President, and Executive Chairman of NioCorp, entered
into a loan agreement (the &#x201c;Smith Loan Agreement&#x201d;), which provided for a $&lt;span id="xdx_90B_eus-gaap--LongTermLineOfCredit_iI_c20240911__us-gaap--TypeOfArrangementAxis__custom--NonRevolvingCreditFacilityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zLYbG582apqi"&gt;2,000&lt;/span&gt; non-revolving, multi-draw credit facility
(the &#x201c;Smith Loan&#x201d;). The Smith Loan had an interest rate of &lt;span id="xdx_90B_eus-gaap--RelatedPartyTransactionRate_pid_dp_uRatio_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zzY88hw4WA8b"&gt;10%&lt;/span&gt; per annum, calculated monthly in arrears, through the
date of repayment of the Smith Loan. The Company could pre-pay the Smith Loan at any time without notice and without penalty,
but any amount of principal or interest repaid by the Company prior to the earlier of the date of expiration of the Smith Loan
Agreement, on June 30, 2025, and the occurrence of an event of default under the Smith Loan Agreement was subject to an early
payment fee of &lt;span id="xdx_908_ecustom--LineOfCreditFacilityEstablishmentFee_pid_dp_uRatio_c20240902__20240911__us-gaap--TypeOfArrangementAxis__custom--GeneralSecurityAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--ChiefExecutiveOfficerMember_zgbo0BEb6dRh"&gt;2.5%&lt;/span&gt; of the value of any such payment. The Smith Loan was secured by all of the Company&#x2019;s assets pursuant
to a general security agreement between the Company and Mr. Smith dated September 11, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Through
October 30, 2024, the Company borrowed a total of $&lt;span id="xdx_908_eus-gaap--OtherBorrowings_iI_c20241030_zA7nxAOPk56i"&gt;504&lt;/span&gt; under the Smith Loan and subsequently the Company repaid $508, representing
the balance of interest and principal outstanding under the Smith Loan, together with $&lt;span id="xdx_90C_eus-gaap--LoanProcessingFee_c20241028__20241030__us-gaap--FairValueByLiabilityClassAxis__us-gaap--BorrowingsMember_zoY7mEff535b" title="Loan Origination fees"&gt;41&lt;/span&gt; related to loan origination fees payable.
As of June 30, 2025, there were &lt;span id="xdx_902_eus-gaap--InterestBearingLiabilitiesAverageAmountOutstanding_do_c20241028__20241030_zkXMFLfYLIS6"&gt;no&lt;/span&gt; amounts outstanding under the Smith Loan.&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:LongTermLineOfCredit
      contextRef="AsOf2024-09-11_custom_NonRevolvingCreditFacilityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact001499"
      unitRef="USD">2000</us-gaap:LongTermLineOfCredit>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact001500"
      unitRef="Ratio">0.10</us-gaap:RelatedPartyTransactionRate>
    <niobf:LineOfCreditFacilityEstablishmentFee
      contextRef="From2024-09-022024-09-11_custom_GeneralSecurityAgreementMember_srt_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact001501"
      unitRef="Ratio">0.025</niobf:LineOfCreditFacilityEstablishmentFee>
    <us-gaap:OtherBorrowings
      contextRef="AsOf2024-10-30"
      decimals="0"
      id="Fact001502"
      unitRef="USD">504</us-gaap:OtherBorrowings>
    <us-gaap:LoanProcessingFee
      contextRef="From2024-10-282024-10-30_us-gaap_BorrowingsMember"
      decimals="0"
      id="Fact001504"
      unitRef="USD">41</us-gaap:LoanProcessingFee>
    <us-gaap:InterestBearingLiabilitiesAverageAmountOutstanding
      contextRef="From2024-10-282024-10-30"
      decimals="0"
      id="Fact001505"
      unitRef="USD">0</us-gaap:InterestBearingLiabilitiesAverageAmountOutstanding>
    <niobf:ExplorationExpendituresDisclosuresTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001514">&lt;p id="xdx_808_ecustom--ExplorationExpendituresDisclosuresTextBlock_zXIYJ1SicAK5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_821_zzZjGz7dmPCc"&gt;EXPLORATION
EXPENDITURES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p id="xdx_89B_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zX9TSKCbmkQ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zvupSjrUFyr7" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left; padding-left: 0.25in"&gt;Feasibility study and engineering&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDpWpOYxdWYa" style="width: 10%; text-align: right"&gt;1,112&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zXQAjsGpRnck" style="width: 10%; text-align: right"&gt;353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Field management and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_z5RYCZFNd7B3" style="text-align: right"&gt;900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zBo3QRoaGHrk" style="text-align: right"&gt;503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Drilling&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--DrillingMember_z8Fz75bOQNc4" style="text-align: right"&gt;1,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--DrillingMember_zGXhEJ9phMh1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Metallurgical&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--MetallurgicalMember_z1xqNRpM3yB9" style="text-align: right"&gt;214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zuGpdFF7VYai" style="text-align: right"&gt;1,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Geologists and field staff&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z2Rw7VSemRwi" style="border-bottom: Black 1pt solid; text-align: right"&gt;453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z6NoXbEcfhRf" style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630_z6Z8yyA8jQ85" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;4,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_zQC1S18XGML7" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;2,552&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A7_znF8oZDbQW81" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

</niobf:ExplorationExpendituresDisclosuresTextBlock>
    <niobf:ScheduleOfExplorationExpendituresTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001516">&lt;p id="xdx_89B_ecustom--ScheduleOfExplorationExpendituresTableTextBlock_zX9TSKCbmkQ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zvupSjrUFyr7" style="display: none; visibility: hidden"&gt;Schedule of exploration expenditures&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left; padding-left: 0.25in"&gt;Feasibility study and engineering&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zDpWpOYxdWYa" style="width: 10%; text-align: right"&gt;1,112&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FeasibilityStudyAndEngineeringMember_zXQAjsGpRnck" style="width: 10%; text-align: right"&gt;353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Field management and other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_z5RYCZFNd7B3" style="text-align: right"&gt;900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--FieldManagementAndOtherMember_zBo3QRoaGHrk" style="text-align: right"&gt;503&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Drilling&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--DrillingMember_z8Fz75bOQNc4" style="text-align: right"&gt;1,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--DrillingMember_zGXhEJ9phMh1" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Metallurgical&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--MetallurgicalMember_z1xqNRpM3yB9" style="text-align: right"&gt;214&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--MetallurgicalMember_zuGpdFF7VYai" style="text-align: right"&gt;1,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Geologists and field staff&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z2Rw7VSemRwi" style="border-bottom: Black 1pt solid; text-align: right"&gt;453&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630__custom--CostCentreAxis__custom--GeologistsAndFieldStaffMember_z6NoXbEcfhRf" style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ExplorationExpense_pn3n3_c20240701__20250630_z6Z8yyA8jQ85" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;4,135&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ExplorationExpense_pn3n3_c20230701__20240630_zQC1S18XGML7" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;2,552&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</niobf:ScheduleOfExplorationExpendituresTableTextBlock>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012025-06-30_custom_FeasibilityStudyAndEngineeringMember"
      decimals="-3"
      id="Fact001517"
      unitRef="USD">1112000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_FeasibilityStudyAndEngineeringMember"
      decimals="-3"
      id="Fact001518"
      unitRef="USD">353000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012025-06-30_custom_FieldManagementAndOtherMember"
      decimals="-3"
      id="Fact001519"
      unitRef="USD">900000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_FieldManagementAndOtherMember"
      decimals="-3"
      id="Fact001520"
      unitRef="USD">503000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012025-06-30_custom_DrillingMember"
      decimals="-3"
      id="Fact001521"
      unitRef="USD">1456000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012025-06-30_custom_MetallurgicalMember"
      decimals="-3"
      id="Fact001523"
      unitRef="USD">214000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_MetallurgicalMember"
      decimals="-3"
      id="Fact001524"
      unitRef="USD">1678000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-012025-06-30_custom_GeologistsAndFieldStaffMember"
      decimals="-3"
      id="Fact001525"
      unitRef="USD">453000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30_custom_GeologistsAndFieldStaffMember"
      decimals="-3"
      id="Fact001526"
      unitRef="USD">18000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001527"
      unitRef="USD">4135000</us-gaap:ExplorationExpense>
    <us-gaap:ExplorationExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001528"
      unitRef="USD">2552000</us-gaap:ExplorationExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001530">&lt;p id="xdx_80F_eus-gaap--LesseeOperatingLeasesTextBlock_zv9Lk049ROtf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_820_zvmCaQTA8wGl"&gt;LEASES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2025 and 2024, the Company had one corporate office lease with a remaining lease term of &lt;span id="xdx_908_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dxL_c20250630_zznh92DLdroj" title="Remaining lease term::XDX::P1Y7M6D"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1532"&gt;1.6&lt;/span&gt;&lt;/span&gt; years as of June 30,
2025. During the year ended June 30, 2025 and 2024, operating cash flows included cash payments of $&lt;span id="xdx_902_eus-gaap--OperatingLeasePayments_pn3n3_c20240701__20250630_z6lXWIl8LRWf" title="Cash payment"&gt;96&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--OperatingLeasePayments_pn3n3_c20230701__20240630_zBoGch2L0Pe6" title="Cash payment"&gt;71&lt;/span&gt;, respectively related
to the measurement of lease liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zExnnFSqKCr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zXg6SXALdpah"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; padding-left: 0.25in; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240701__20250630_zPGWeoLTBkT5" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230701__20240630_zewXOxszxypd" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--FixedRentExpense_pn3n3_zHftaIQeq4I9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left; padding-left: 0.25in"&gt;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;94&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--VariableLeaseCost_pn3n3_zQBosEWhT6Fh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_pn3n3_z3K5NHD26yt9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Short term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--SubleaseIncome_iN_pn3n3_di_zLvRh6GJA36j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Sublease income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(41&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(32&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_z2a6AOMPC4wf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Net lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zma3iv7OKjbk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmzjjIoA1uQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zXhhM714HkE8"&gt;The
maturity of lease liabilities is as follows at June 30, 2025:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 1in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250630_zjZPCCujtBoe" style="border-bottom: Black 1pt solid; text-align: center"&gt;Fiscal Year Lease Maturities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zZGeTJaETxR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 0.125in"&gt;2026&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_zZQruMfEojNe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;2027&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zKDlzTqqRZ6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0in"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zTNC2qafKZ8l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less amount of payments representing interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(17&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zlaWoBnsjcab" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0in"&gt;Present value of lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;131&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zSp5xIOfexG7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less current portion of operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(98&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_zlkSIvHbAlQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0in"&gt;Noncurrent operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zkSCnuO7cMXk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001534"
      unitRef="USD">96000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001536"
      unitRef="USD">71000</us-gaap:OperatingLeasePayments>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001538">&lt;p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zExnnFSqKCr9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BD_zXg6SXALdpah"&gt;The
Company incurred lease costs as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; padding-left: 0.25in; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_492_20240701__20250630_zPGWeoLTBkT5" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230701__20240630_zewXOxszxypd" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--FixedRentExpense_pn3n3_zHftaIQeq4I9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 34%; text-align: left; padding-left: 0.25in"&gt;Fixed rent expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;94&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;90&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--VariableLeaseCost_pn3n3_zQBosEWhT6Fh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Variable rent expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_pn3n3_z3K5NHD26yt9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Short term lease cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--SubleaseIncome_iN_pn3n3_di_zLvRh6GJA36j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Sublease income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(41&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(32&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LeaseCost_pn3n3_z2a6AOMPC4wf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Net lease cost &#x2013; other operating expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;81&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <niobf:FixedRentExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001540"
      unitRef="USD">94000</niobf:FixedRentExpense>
    <niobf:FixedRentExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001541"
      unitRef="USD">90000</niobf:FixedRentExpense>
    <us-gaap:VariableLeaseCost
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001543"
      unitRef="USD">13000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001544"
      unitRef="USD">14000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001546"
      unitRef="USD">10000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001547"
      unitRef="USD">9000</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001549"
      unitRef="USD">41000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001550"
      unitRef="USD">32000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001552"
      unitRef="USD">76000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001553"
      unitRef="USD">81000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001555">&lt;p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zmzjjIoA1uQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_zXhhM714HkE8"&gt;The
maturity of lease liabilities is as follows at June 30, 2025:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%; margin-left: 1in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250630_zjZPCCujtBoe" style="border-bottom: Black 1pt solid; text-align: center"&gt;Fiscal Year Lease Maturities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_maLOLLPzI5d_zZGeTJaETxR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; padding-left: 0.125in"&gt;2026&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_maLOLLPzI5d_zZQruMfEojNe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;2027&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;50&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--TotalLeasePayments_iI_pn3n3_mtLOLLPzI5d_zKDlzTqqRZ6d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0in"&gt;Total lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--LessAmountOfPaymentsRepresentingInterest_iNI_pn3n3_di_zTNC2qafKZ8l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less amount of payments representing interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(17&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_pn3n3_zlaWoBnsjcab" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0in"&gt;Present value of lease payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;131&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--LessCurrentPortionOfOperatingLeaseLiability_iNI_pn3n3_di_zSp5xIOfexG7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Less current portion of operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(98&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--OperatingLeasesLiabilityNoncurrent_iI_pn3n3_zlkSIvHbAlQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0in"&gt;Noncurrent operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001557"
      unitRef="USD">98000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001559"
      unitRef="USD">50000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <niobf:TotalLeasePayments
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001561"
      unitRef="USD">148000</niobf:TotalLeasePayments>
    <niobf:LessAmountOfPaymentsRepresentingInterest
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001563"
      unitRef="USD">17000</niobf:LessAmountOfPaymentsRepresentingInterest>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001565"
      unitRef="USD">131000</us-gaap:OperatingLeaseLiability>
    <niobf:LessCurrentPortionOfOperatingLeaseLiability
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001567"
      unitRef="USD">98000</niobf:LessCurrentPortionOfOperatingLeaseLiability>
    <niobf:OperatingLeasesLiabilityNoncurrent
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001569"
      unitRef="USD">33000</niobf:OperatingLeasesLiabilityNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001571">&lt;p id="xdx_80A_eus-gaap--IncomeTaxDisclosureTextBlock_zJFN0X4ylJ5b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_822_z7kxkFvJFG4g"&gt;INCOME
TAXES&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zckpTasrHiFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zpkvrK11UNG7"&gt;Domestic
and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; padding-left: 0.125in"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zaOhNaXNsYC6" style="width: 10%; text-align: right" title="Total"&gt;(13,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zmNtALZ3bC8c" style="width: 10%; text-align: right" title="Total"&gt;(8,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zZUh6jHB9YUa" style="text-align: right" title="Total"&gt;(4,818&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zhf8OrpcQsKl" style="text-align: right" title="Total"&gt;(3,679&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;United Kingdom&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zusJMQG2Neha" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z5KneQklMtp1" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(39&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630_zl10EWO39HOa" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total"&gt;(17,982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630_zBsN06zrz9ne" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total"&gt;(12,037&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A8_zuNlDp2zO4Zk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;















&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs0kZpMl1m02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zurgVWVYgAvd" style="display: none; visibility: hidden"&gt;The following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; text-align: right; padding-left: 5pt; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240701__20250630_zidKaOJrl8Of" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230701__20240630_z68QjPkVMzH3" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_pn3n3_zx3izuI5Rcf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 5pt"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;(17,982&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;(12,037&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_uUSD_zwDoic6nmFV8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Income tax benefit at Canadian federal rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,697&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,806&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_uUSD_zvP0cakAhIZ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Income tax benefit at Canadian provincial rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,158&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,444&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--WarrantLiability_pn3n3_zCJxMaapPwZk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(506&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--EarnoutSharesLiability_pn3n3_z92zcxpmYaRi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Earnout shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,810&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_z2ZCuN46k7G5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;747&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_pn3n3_zOwlLdLRAK1b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Foreign rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--AssetRetirementObligationAccretionExpense_pn3n3_zfyClHvGmsh6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_pn3n3_zwfH6057hQP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Change in estimates related to prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1623"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--PaymentsOfStockIssuanceCost_pn3n3_zEdnnPmkiJha" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Stock issuance costs in equity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,143&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(55&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ConvertibleNoteValuation_iN_pn3n3_di_zNv4wMsU3fO2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Convertible note valuation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(137&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_zvwKqSBKbIv9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_zjCO45iqQXyc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,978&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,718&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_d0_c20240701__20250630_zIzZEyXYrxol" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zQQqTjLajXF1" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit::XDX::-139"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1640"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zP2YbN9YTIL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
tax benefit for the year ended June 30, 2024, was derived solely from our U.S. operations. The Company acquired a federal income tax payable of $&lt;span id="xdx_90B_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pn3n3_uUSD_c20230701__20240630_zWWWo1gTG0Zh"&gt;443&lt;/span&gt; in connection with the GXII Transaction. As a result of a post-transaction loss at ECRC, a partial release of the valuation allowance attributed to the reduction of the acquired federal income tax payable of $139 was recorded as an income tax benefit in the consolidated statement of operations and comprehensive loss for the year ended June 30, 2024. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z7CUHDhhOpI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zgyFopWNwKe6"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; text-align: right; padding-left: 5.4pt; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250630_zN8lA9GyijW4" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240630_zuYT51idjSr9" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzakr_zyQh7jWlY2v1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 0.25in"&gt;Net operating losses available for future periods&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;16,125&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;14,177&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zlKDJJv2arNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Mineral interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z0DV4YMNxnWc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Startup and organizational costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,842&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zJ7Q8LQevTic" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Research and development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zSHr7KpUMOH9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Share issuance/financing costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

    &lt;tr id="xdx_406_ecustom--DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_iI_pn3n3_maDTAGzakr_zp1IvHCSliy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Canadian restricted interest and financing carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1661"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;




&lt;tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zRloSVdyfijb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Capital losses available for future periods&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzakr_zJpu2BYmt9N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_mtDTAGzakr_maDTALNz97R_zLdETNgphVsk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTALNz97R_zIkydzzEBbQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(32,159&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(28,181&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNz97R_zBeLq83o7uj9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1676"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_zHiBXJPKVbYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--SummaryOfValuationAllowanceTextBlock_zGOanMTlNbRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zou3u5NwneBd"&gt;Changes
in the valuation allowance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Valuation allowance, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20240701__20250630_zOyRK6RmI4zk" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(28,181&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20230701__20240630_z1g50xPtM5e4" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(25,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Current year additions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20240701__20250630_zJzdRfZwDu9e" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions"&gt;(3,978&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_zAdcqG6EKmY3" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions"&gt;(2,718&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20240701__20250630_zAOd9WUQqNvl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(32,159&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20230701__20240630_zNRPWvKWj53f" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(28,181&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_zd9zz0TbUv3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company establishes a valuation allowance against future income tax assets if, based on available information, it is more likely
than not that all of the assets will not be realized. The valuation allowance of $&lt;span id="xdx_90F_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pn3n3_uUSD_c20250630_zs5lRSZwwgtf" title="Valuation allowance"&gt;32,159&lt;/span&gt; at June 30, 2025, relates mainly to net
operating loss carryforwards in Canada and mineral interests due to deferred exploration expenditures in the United States, where
the utilization of such attributes is not more likely than not.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;















&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;The Company has the following cumulative
net operating losses for Canadian and U.S. Federal income tax purposes. Canadian tax loss carryforwards will generally expire between
2028 and 2045. U.S. tax losses incurred through June 30, 2018, totaled $&lt;span id="xdx_905_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_uUSD_c20180630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zYBraYVX1Xb7" title="Tax losses incurred"&gt;981&lt;/span&gt; and will generally expire between 2031 and 2038. As
a result of the Tax Cuts and Jobs Act of 2017, U.S. tax losses incurred for our tax years ending on and after June 30, 2019, totaling
$&lt;span id="xdx_90B_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pn3n3_uUSD_c20190630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zDaLhmgGiENg" title="Tax losses incurred"&gt;5,645&lt;/span&gt;, have no expiration.&lt;/p&gt;




&lt;p id="xdx_89F_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zv2LGAJKYGFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_za9L87PEP262" style="display: none; visibility: hidden"&gt;Schedule of cumulative net operating losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 3pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 3pt"&gt;Jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 24%; padding-left: 0.125in"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--CA_zk6uhfxZdTS2" style="width: 10%; text-align: right" title="Total"&gt;53,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--CA_zPSxwRqTJFi6" style="width: 10%; text-align: right" title="Total"&gt;47,623&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--US_zATr1iAW8bi2" style="text-align: right" title="Total"&gt;6,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--US_zXhWEqe32mAg" style="text-align: right" title="Total"&gt;4,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;United Kingdom&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--GB_z7scLv8mA3ig" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;112&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--GB_zeOeeNPWj2rd" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 3pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630_zHw7g5ZprTab" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total"&gt;59,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zYVKId8oc0D1" style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: right" title="Total"&gt;52,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zql5hxzXrpOg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company has a Canadian capital loss carryforward of $&lt;span id="xdx_906_ecustom--CapitalLossCaryforward_iI_pn3n3_c20250630__srt--CurrencyAxis__currency--CAD_ziCF7dAU8hN5" title="Capital loss carryforward"&gt;3,378&lt;/span&gt; as of June 30, 2025, which has no expiration date and
can be used to offset future capital gains, and U.S. state net operating loss carryforwards of $&lt;span id="xdx_90B_ecustom--CapitalLossCaryforward_iI_pn3n3_c20250630__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zQhrk4qe5Xac" title="Net operating loss carryforwards"&gt;8,742&lt;/span&gt; as of June 30, 2025 which
generally expire between 2031 and 2045.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
June 30, 2025 and 2024, we had no undistributed earnings of foreign subsidiaries that would be subject to income tax upon distribution
to Canada from a foreign subsidiary. As such, as of June 30, 2025 and 2024, we did not provide for deferred taxes on any such
earnings of our foreign subsidiaries.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had no unrecognized tax benefits as of June 30, 2025 or 2024. The Company has not recognized any interest or penalties in the fiscal
years presented in these consolidated financial statements. The Company is subject to income tax in the U.S. federal jurisdiction,
the United Kingdom, and Canada. Certain years remain subject to examination but there are currently no ongoing exams in any taxing
jurisdictions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 4, 2025, the One Big Beautiful Bill Act (&#x201c;OBBBA&#x201d;) was enacted in the U.S., which includes a broad range of tax
reform provisions affecting businesses. The OBBBA includes numerous changes to existing tax law including extending or making
permanent certain business and international tax measures initially established under the 2017 Tax Cuts and Jobs Act, which were
set to expire. The OBBBA contains several changes to corporate taxation including modifications to capitalization of research
and development expenses, modifications to deductions for interest expense, and accelerated depreciation on certain asset additions.
As the legislation was signed into law after June 30, 2025, our operating results for the year ended June 30, 2025, do not include
any adjustments related to the OBBBA, and the Company does not expect a material impact to our financial statements due to the
enactment of the OBBBA.&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001573">&lt;p id="xdx_898_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zckpTasrHiFd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zpkvrK11UNG7"&gt;Domestic
and foreign components of loss before income taxes for the years ended June 30, 2025 and 2024 are as follows:&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; padding-left: 0.125in"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--CA_zaOhNaXNsYC6" style="width: 10%; text-align: right" title="Total"&gt;(13,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--CA_zmNtALZ3bC8c" style="width: 10%; text-align: right" title="Total"&gt;(8,319&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--US_zZUh6jHB9YUa" style="text-align: right" title="Total"&gt;(4,818&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--US_zhf8OrpcQsKl" style="text-align: right" title="Total"&gt;(3,679&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;United Kingdom&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630__srt--StatementGeographicalAxis__country--GB_zusJMQG2Neha" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(75&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630__srt--StatementGeographicalAxis__country--GB_z5KneQklMtp1" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;(39&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20240701__20250630_zl10EWO39HOa" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total"&gt;(17,982&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pn3n3_c20230701__20240630_zBsN06zrz9ne" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total"&gt;(12,037&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_country_CA"
      decimals="-3"
      id="Fact001575"
      unitRef="USD">-13089000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_country_CA"
      decimals="-3"
      id="Fact001577"
      unitRef="USD">-8319000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_country_US"
      decimals="-3"
      id="Fact001579"
      unitRef="USD">-4818000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_country_US"
      decimals="-3"
      id="Fact001581"
      unitRef="USD">-3679000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-012025-06-30_country_GB"
      decimals="-3"
      id="Fact001583"
      unitRef="USD">-75000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012024-06-30_country_GB"
      decimals="-3"
      id="Fact001585"
      unitRef="USD">-39000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001587"
      unitRef="USD">-17982000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001589"
      unitRef="USD">-12037000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001597">&lt;p id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zs0kZpMl1m02" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The&lt;/span&gt; &lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zurgVWVYgAvd" style="display: none; visibility: hidden"&gt;The following table is a reconciliation of income taxes at statutory rates:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; text-align: right; padding-left: 5pt; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20240701__20250630_zidKaOJrl8Of" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230701__20240630_z68QjPkVMzH3" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax_pn3n3_zx3izuI5Rcf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 5pt"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;(17,982&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;(12,037&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_iN_pn3n3_di_uUSD_zwDoic6nmFV8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Income tax benefit at Canadian federal rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,697&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,806&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_pn3n3_uUSD_zvP0cakAhIZ" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Income tax benefit at Canadian provincial rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,158&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,444&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--WarrantLiability_pn3n3_zCJxMaapPwZk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(506&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--EarnoutSharesLiability_pn3n3_z92zcxpmYaRi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Earnout shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,810&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_pn3n3_z2ZCuN46k7G5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;747&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationForeignIncomeTaxRateDifferential_pn3n3_zOwlLdLRAK1b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Foreign rate differential&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--AssetRetirementObligationAccretionExpense_pn3n3_zfyClHvGmsh6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Accretion expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationPriorYearIncomeTaxes_pn3n3_zwfH6057hQP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Change in estimates related to prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1623"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--PaymentsOfStockIssuanceCost_pn3n3_zEdnnPmkiJha" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Stock issuance costs in equity&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,143&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(55&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--ConvertibleNoteValuation_iN_pn3n3_di_zNv4wMsU3fO2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Convertible note valuation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(137&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--IncomeTaxReconciliationOtherAdjustments_pn3n3_zvwKqSBKbIv9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_pn3n3_zjCO45iqQXyc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.2in"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,978&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,718&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5pt"&gt;Income tax benefit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_d0_c20240701__20250630_zIzZEyXYrxol" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_pn3n3_dxL_c20230701__20240630_zQQqTjLajXF1" style="border-bottom: Black 2.5pt solid; text-align: right" title="Income tax benefit::XDX::-139"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1640"&gt;139&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001599"
      unitRef="USD">-17982000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001600"
      unitRef="USD">-12037000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001602"
      unitRef="USD">2697000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001603"
      unitRef="USD">1806000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001605"
      unitRef="USD">-2158000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001606"
      unitRef="USD">-1444000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <niobf:WarrantLiability
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001608"
      unitRef="USD">1105000</niobf:WarrantLiability>
    <niobf:WarrantLiability
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001609"
      unitRef="USD">-506000</niobf:WarrantLiability>
    <niobf:EarnoutSharesLiability
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001611"
      unitRef="USD">557000</niobf:EarnoutSharesLiability>
    <niobf:EarnoutSharesLiability
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001612"
      unitRef="USD">-1810000</niobf:EarnoutSharesLiability>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001614"
      unitRef="USD">239000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001615"
      unitRef="USD">747000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001617"
      unitRef="USD">102000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001618"
      unitRef="USD">62000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001620"
      unitRef="USD">11000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001621"
      unitRef="USD">1138000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001624"
      unitRef="USD">160000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <niobf:PaymentsOfStockIssuanceCost
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001626"
      unitRef="USD">-1143000</niobf:PaymentsOfStockIssuanceCost>
    <niobf:PaymentsOfStockIssuanceCost
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001627"
      unitRef="USD">-55000</niobf:PaymentsOfStockIssuanceCost>
    <niobf:ConvertibleNoteValuation
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001629"
      unitRef="USD">137000</niobf:ConvertibleNoteValuation>
    <niobf:ConvertibleNoteValuation
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001630"
      unitRef="USD">-607000</niobf:ConvertibleNoteValuation>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001632"
      unitRef="USD">143000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001633"
      unitRef="USD">50000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001635"
      unitRef="USD">3978000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001636"
      unitRef="USD">2718000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001638"
      unitRef="USD">-0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001641"
      unitRef="USD">443000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001643">&lt;p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z7CUHDhhOpI9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B4_zgyFopWNwKe6"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes. The significant components of deferred taxes are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom; visibility: hidden"&gt;
    &lt;td style="display: none; text-align: right; padding-left: 5.4pt; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_491_20250630_zN8lA9GyijW4" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240630_zuYT51idjSr9" style="display: none; text-align: center; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;td style="display: none; visibility: hidden"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzakr_zyQh7jWlY2v1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 44%; text-align: left; padding-left: 0.25in"&gt;Net operating losses available for future periods&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;16,125&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;14,177&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsMineralInterest_iI_pn3n3_maDTAGzakr_zlKDJJv2arNh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Mineral interests&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--DeferredTaxAssetsStartupAndOorganizationalCosts_iI_pn3n3_maDTAGzakr_z0DV4YMNxnWc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Startup and organizational costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,842&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--DeferredTaxAssetsResearchAndDevelopmentCosts_iI_pn3n3_maDTAGzakr_zJ7Q8LQevTic" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Research and development costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,419&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredTaxAssetsShareIssuanceCosts_iI_pn3n3_maDTAGzakr_zSHr7KpUMOH9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Share issuance/financing costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

    &lt;tr id="xdx_406_ecustom--DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward_iI_pn3n3_maDTAGzakr_zp1IvHCSliy8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.25in"&gt;Canadian restricted interest and financing carryforward&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1661"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;




&lt;tr id="xdx_40C_ecustom--CapitalLossesAvailableForFuturePeriods_iI_pn3n3_maDTAGzakr_zRloSVdyfijb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.25in"&gt;Capital losses available for future periods&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzakr_zJpu2BYmt9N7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 0.25in"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;41&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;69&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_iI_pn3n3_mtDTAGzakr_maDTALNz97R_zLdETNgphVsk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,159&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTALNz97R_zIkydzzEBbQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.25in"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(32,159&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(28,181&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNz97R_zBeLq83o7uj9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1676"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001645"
      unitRef="USD">16125000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001646"
      unitRef="USD">14177000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <niobf:DeferredTaxAssetsMineralInterest
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001648"
      unitRef="USD">10438000</niobf:DeferredTaxAssetsMineralInterest>
    <niobf:DeferredTaxAssetsMineralInterest
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001649"
      unitRef="USD">9438000</niobf:DeferredTaxAssetsMineralInterest>
    <niobf:DeferredTaxAssetsStartupAndOorganizationalCosts
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001651"
      unitRef="USD">1842000</niobf:DeferredTaxAssetsStartupAndOorganizationalCosts>
    <niobf:DeferredTaxAssetsStartupAndOorganizationalCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001652"
      unitRef="USD">1987000</niobf:DeferredTaxAssetsStartupAndOorganizationalCosts>
    <niobf:DeferredTaxAssetsResearchAndDevelopmentCosts
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001654"
      unitRef="USD">1295000</niobf:DeferredTaxAssetsResearchAndDevelopmentCosts>
    <niobf:DeferredTaxAssetsResearchAndDevelopmentCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001655"
      unitRef="USD">1419000</niobf:DeferredTaxAssetsResearchAndDevelopmentCosts>
    <niobf:DeferredTaxAssetsShareIssuanceCosts
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001657"
      unitRef="USD">1357000</niobf:DeferredTaxAssetsShareIssuanceCosts>
    <niobf:DeferredTaxAssetsShareIssuanceCosts
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001658"
      unitRef="USD">635000</niobf:DeferredTaxAssetsShareIssuanceCosts>
    <niobf:DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001660"
      unitRef="USD">605000</niobf:DeferredTaxAssetsRestrictedInterestAndFinancingCarryforward>
    <niobf:CapitalLossesAvailableForFuturePeriods
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001663"
      unitRef="USD">456000</niobf:CapitalLossesAvailableForFuturePeriods>
    <niobf:CapitalLossesAvailableForFuturePeriods
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001664"
      unitRef="USD">456000</niobf:CapitalLossesAvailableForFuturePeriods>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001666"
      unitRef="USD">41000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001667"
      unitRef="USD">69000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001669"
      unitRef="USD">32159000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001670"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001672"
      unitRef="USD">32159000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001673"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:SummaryOfValuationAllowanceTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001678">&lt;p id="xdx_891_eus-gaap--SummaryOfValuationAllowanceTextBlock_zGOanMTlNbRl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zou3u5NwneBd"&gt;Changes
in the valuation allowance are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;For the year ended June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 44%; text-align: left"&gt;Valuation allowance, beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20240701__20250630_zOyRK6RmI4zk" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(28,181&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DeferredTaxAssetsNet_iNS_pn3n3_di_c20230701__20240630_z1g50xPtM5e4" style="width: 10%; text-align: right" title="Valuation allowance, beginning of year"&gt;(25,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Current year additions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20240701__20250630_zJzdRfZwDu9e" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions"&gt;(3,978&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxAssetsValuationAllowanceAdditions_iN_pn3n3_di_c20230701__20240630_zAdcqG6EKmY3" style="border-bottom: Black 1pt solid; text-align: right" title="Current year additions"&gt;(2,718&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Valuation allowance, end of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20240701__20250630_zAOd9WUQqNvl" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(32,159&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DeferredTaxAssetsNet_iNE_pn3n3_di_c20230701__20240630_zNRPWvKWj53f" style="border-bottom: Black 2.5pt solid; text-align: right" title="Valuation allowance, end of year"&gt;(28,181&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001680"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact001682"
      unitRef="USD">25463000</us-gaap:DeferredTaxAssetsNet>
    <niobf:DeferredTaxAssetsValuationAllowanceAdditions
      contextRef="From2024-07-01to2025-06-30"
      decimals="-3"
      id="Fact001684"
      unitRef="USD">3978000</niobf:DeferredTaxAssetsValuationAllowanceAdditions>
    <niobf:DeferredTaxAssetsValuationAllowanceAdditions
      contextRef="From2023-07-012024-06-30"
      decimals="-3"
      id="Fact001686"
      unitRef="USD">2718000</niobf:DeferredTaxAssetsValuationAllowanceAdditions>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001688"
      unitRef="USD">32159000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001690"
      unitRef="USD">28181000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001692"
      unitRef="USD">32159000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards
      contextRef="AsOf2018-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact001700"
      unitRef="USD">981000</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards
      contextRef="AsOf2019-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact001702"
      unitRef="USD">5645000</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001704">&lt;p id="xdx_89F_eus-gaap--SummaryOfOperatingLossCarryforwardsTextBlock_zv2LGAJKYGFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_za9L87PEP262" style="display: none; visibility: hidden"&gt;Schedule of cumulative net operating losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 3pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-left: 3pt"&gt;Jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 24%; padding-left: 0.125in"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--CA_zk6uhfxZdTS2" style="width: 10%; text-align: right" title="Total"&gt;53,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--CA_zPSxwRqTJFi6" style="width: 10%; text-align: right" title="Total"&gt;47,623&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--US_zATr1iAW8bi2" style="text-align: right" title="Total"&gt;6,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--US_zXhWEqe32mAg" style="text-align: right" title="Total"&gt;4,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;United Kingdom&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630__srt--StatementGeographicalAxis__country--GB_z7scLv8mA3ig" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;112&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630__srt--StatementGeographicalAxis__country--GB_zeOeeNPWj2rd" style="border-bottom: Black 1pt solid; text-align: right" title="Total"&gt;39&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 3pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20250630_zHw7g5ZprTab" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total"&gt;59,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLossCarryforwards_iI_pn3n3_c20240630_zYVKId8oc0D1" style="border-bottom: Black 2.5pt solid; padding-bottom: 1pt; text-align: right" title="Total"&gt;52,567&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-06-30_country_CA"
      decimals="-3"
      id="Fact001706"
      unitRef="USD">53194000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30_country_CA"
      decimals="-3"
      id="Fact001708"
      unitRef="USD">47623000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-06-30_country_US"
      decimals="-3"
      id="Fact001710"
      unitRef="USD">6627000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30_country_US"
      decimals="-3"
      id="Fact001712"
      unitRef="USD">4905000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-06-30_country_GB"
      decimals="-3"
      id="Fact001714"
      unitRef="USD">112000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30_country_GB"
      decimals="-3"
      id="Fact001716"
      unitRef="USD">39000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001718"
      unitRef="USD">59933000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001720"
      unitRef="USD">52567000</us-gaap:OperatingLossCarryforwards>
    <niobf:CapitalLossCaryforward
      contextRef="AsOf2025-06-30_currency_CAD"
      decimals="-3"
      id="Fact001722"
      unitRef="USD">3378000</niobf:CapitalLossCaryforward>
    <niobf:CapitalLossCaryforward
      contextRef="AsOf2025-06-30_us-gaap_DomesticCountryMember"
      decimals="-3"
      id="Fact001724"
      unitRef="USD">8742000</niobf:CapitalLossCaryforward>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001726">&lt;p id="xdx_80B_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zzzplemwOC37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;15.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_826_zhBGYmXjvBT9"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span&gt;&lt;span&gt;Fair
Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures the fair value of financial assets and liabilities based on U.S. GAAP guidance which defines fair value, establishes
a framework for measuring fair value, and expands disclosures about fair value measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies financial assets and liabilities as held-for-trading, available-for-sale, held-to-maturity, loans and receivables,
or other financial liabilities depending on their nature. Financial assets and financial liabilities are recognized at fair value
on their initial recognition.&lt;span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
assets and liabilities classified as held-for-trading are measured at fair value, with gains and losses recognized in net income.
Financial assets classified as held-to-maturity, loans and receivables, and financial liabilities other than those classified
as held-for-trading are measured at amortized cost, using the effective interest method of amortization. Financial assets classified
as available-for-sale, including investments in equity securities, are measured at fair value, with unrealized gains and losses
being recognized in income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments including receivables, accounts payable and accrued liabilities, and related party loans are carried at amortized
cost, which management believes approximates fair value due to the short-term nature of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables present information about the assets and liabilities that are measured at fair value on a recurring basis as
of June 30, 2025, and 2024, respectively, and indicate the fair value hierarchy of the valuation techniques the&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;















&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Company utilized
to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active
markets for identical instruments. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted
prices, interest rates, and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the financial
instrument and include situations where there is little, if any, market activity for the instrument.&lt;/span&gt;&lt;/p&gt;



&lt;p id="xdx_89E_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zkm0AZ72Wp0a" style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zL3QqlX7ONIh" style="display: none; visibility: hidden"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 48%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630_z6mIN1EWqmQa" style="width: 10%; text-align: right" title="Cash and cash equivalents"&gt;25,554&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsaCEdpTEjp1" style="width: 10%; text-align: right"&gt;25,554&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZDR8Sk0mZQ" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLghj8V3Bfna" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630_zLzNssnTQApk" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKreZNu3ZKC2" style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zubMPzpYQb77" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpyNxUhpo7i5" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630_ziVisi7fFnKb" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Assets"&gt;25,557&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvAigtjc9I83" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;25,557&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8eRQMAA8YPh" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1749"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCEpplm4a34h" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1750"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zV94tD9akeCb" style="text-align: right" title="Earnout Shares liability"&gt;5,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcKELJSdao4i" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWAkDZGJHWae" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4VRaHm5Qtxk" style="text-align: right"&gt;5,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630_zSK4M2AspqKh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;6,852&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHb62pLcaZEf" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1w8tlKZxfy4" style="border-bottom: Black 1pt solid; text-align: right"&gt;6,852&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z024lwG5fGel" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zHWx22eO4NRe" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Liabilities"&gt;12,732&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhR3Vs3vI85c" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1763"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgro6MDL5Kx6" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;6,852&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuIygyQ43me9" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;5,880&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 48%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630_z0erBTk3XG0l" style="width: 10%; text-align: right" title="Cash and cash equivalents"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyq88zENMvXk" style="width: 10%; text-align: right"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zX0voHd7R405" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrlcDnRt3Nak" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630_zU9m5yLbd0g7" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHKFXeuLB164" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9fdwIVI7mWj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1774"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjzGmyfXylgh" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1775"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630_zegq5dSkYIt6" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpUVAXDALwEd" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z17y5tejqWmb" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1778"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCxLR7QMzobh" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_iIP3us-gaap--AssetsFairValueDisclosure_pn3n3_c20240630_zwANORIDx3hk" style="text-align: right" title="April 2024 notes"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4mbqnjCKIYb" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9oC2C8Mx7Qj" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1783"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zi4fNOdDNtR1" style="text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zxywbEgGaDUl" style="text-align: right" title="Earnout Shares liability"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6eGOd2iVj0d" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjSYPtYwgb31" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYkSQnVEP7Lc" style="text-align: right"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630_zmbj6UEHzZi2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;4,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdQBpQoPOhkk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1792"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNJEi1Plqqh9" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkV1QiBPMW1g" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zsZt5ooqQSmc" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;14,922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQkW61lbASyb" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgXxIQyksy0b" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zM5MdBbgAZZg" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;13,271&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zDO6FIHXgOi8" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001735">&lt;p id="xdx_89E_eus-gaap--FairValueByBalanceSheetGroupingTextBlock_zkm0AZ72Wp0a" style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B9_zL3QqlX7ONIh" style="display: none; visibility: hidden"&gt;Schedule of fair values determined by level 3 inputs are unobservable data&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 48%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630_z6mIN1EWqmQa" style="width: 10%; text-align: right" title="Cash and cash equivalents"&gt;25,554&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zsaCEdpTEjp1" style="width: 10%; text-align: right"&gt;25,554&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zZDR8Sk0mZQ" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zLghj8V3Bfna" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630_zLzNssnTQApk" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKreZNu3ZKC2" style="border-bottom: Black 1pt solid; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zubMPzpYQb77" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpyNxUhpo7i5" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630_ziVisi7fFnKb" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Assets"&gt;25,557&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zvAigtjc9I83" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;25,557&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z8eRQMAA8YPh" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1749"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCEpplm4a34h" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1750"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zV94tD9akeCb" style="text-align: right" title="Earnout Shares liability"&gt;5,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcKELJSdao4i" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zWAkDZGJHWae" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z4VRaHm5Qtxk" style="text-align: right"&gt;5,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630_zSK4M2AspqKh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;6,852&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHb62pLcaZEf" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z1w8tlKZxfy4" style="border-bottom: Black 1pt solid; text-align: right"&gt;6,852&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z024lwG5fGel" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1760"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630_zHWx22eO4NRe" style="border-bottom: Black 2.5pt solid; text-align: right" title="Total Liabilities"&gt;12,732&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zhR3Vs3vI85c" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1763"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgro6MDL5Kx6" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;6,852&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20250630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zuIygyQ43me9" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;5,880&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="text-align: center"&gt;As of June 30, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 48%; text-align: left; padding-left: 0.125in"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630_z0erBTk3XG0l" style="width: 10%; text-align: right" title="Cash and cash equivalents"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zyq88zENMvXk" style="width: 10%; text-align: right"&gt;2,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zX0voHd7R405" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrlcDnRt3Nak" style="width: 10%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Investment in equity securities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630_zU9m5yLbd0g7" style="border-bottom: Black 1pt solid; text-align: right" title="Investment in equity securities"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zHKFXeuLB164" style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9fdwIVI7mWj" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1774"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AvailableForSaleSecuritiesEquitySecuritiesOther_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zjzGmyfXylgh" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1775"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630_zegq5dSkYIt6" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zpUVAXDALwEd" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;2,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z17y5tejqWmb" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1778"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCxLR7QMzobh" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in"&gt;April 2024 notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--NotesPayable_iIP3us-gaap--AssetsFairValueDisclosure_pn3n3_c20240630_zwANORIDx3hk" style="text-align: right" title="April 2024 notes"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z4mbqnjCKIYb" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9oC2C8Mx7Qj" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1783"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NotesPayable_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zi4fNOdDNtR1" style="text-align: right"&gt;7,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in"&gt;Earnout Shares liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zxywbEgGaDUl" style="text-align: right" title="Earnout Shares liability"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6eGOd2iVj0d" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zjSYPtYwgb31" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OtherLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zYkSQnVEP7Lc" style="text-align: right"&gt;3,817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 0.125in"&gt;Warrant liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630_zmbj6UEHzZi2" style="border-bottom: Black 1pt solid; text-align: right" title="Warrant liabilities"&gt;4,016&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zdQBpQoPOhkk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1792"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNJEi1Plqqh9" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zkV1QiBPMW1g" style="border-bottom: Black 1pt solid; text-align: right"&gt;2,365&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630_zsZt5ooqQSmc" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;14,922&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQkW61lbASyb" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zgXxIQyksy0b" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FinancialLiabilitiesFairValueDisclosure_iI_pn3n3_c20240630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zM5MdBbgAZZg" style="border-bottom: Black 2.5pt solid; text-align: right"&gt;13,271&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001737"
      unitRef="USD">25554000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001738"
      unitRef="USD">25554000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001742"
      unitRef="USD">3000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001743"
      unitRef="USD">3000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001747"
      unitRef="USD">25557000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001748"
      unitRef="USD">25557000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001752"
      unitRef="USD">5880000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001755"
      unitRef="USD">5880000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001757"
      unitRef="USD">6852000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001759"
      unitRef="USD">6852000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30"
      decimals="-3"
      id="Fact001762"
      unitRef="USD">12732000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001764"
      unitRef="USD">6852000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2025-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001765"
      unitRef="USD">5880000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001767"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001768"
      unitRef="USD">2012000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001772"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <niobf:AvailableForSaleSecuritiesEquitySecuritiesOther
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001773"
      unitRef="USD">4000</niobf:AvailableForSaleSecuritiesEquitySecuritiesOther>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001776"
      unitRef="USD">2016000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel1Member"
      decimals="-3"
      id="Fact001777"
      unitRef="USD">2016000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001781"
      unitRef="USD">7089000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001784"
      unitRef="USD">7089000</us-gaap:NotesPayable>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001786"
      unitRef="USD">3817000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:OtherLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001789"
      unitRef="USD">3817000</us-gaap:OtherLiabilitiesFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001791"
      unitRef="USD">4016000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001793"
      unitRef="USD">1651000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001794"
      unitRef="USD">2365000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact001795"
      unitRef="USD">14922000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="-3"
      id="Fact001797"
      unitRef="USD">1651000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="-3"
      id="Fact001798"
      unitRef="USD">13271000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001800">&lt;p id="xdx_80F_eus-gaap--SegmentReportingDisclosureTextBlock_zSwSSJGcaVTk" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_820_zXNMrwBcN7z1"&gt;SEGMENT
INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has&#160;one&#160;reportable segment: the United States. The United States segment conducts exploration, development,
and care and maintenance activities at the Elk Creek Project. This segment holds substantially all of the Company&#x2019;s non-current assets and does not presently report any revenues from operations.
Through this segment, the Company seeks to position the Elk Creek Project as a development opportunity in the strategic minerals
sector. The Company&#x2019;s chief operating decision maker is the Chief Executive Officer (&#x201c;CODM&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
information and annual operating plans and forecasts are prepared and reviewed by the CODM at a consolidated level. The CODM
assesses performance for the single operating segment and decides how to better allocate resources based on total operating
expenses, net loss, changes in cash and cash equivalents, and cash and cash-equivalent balances that are reported on the
Consolidated Statement of Operations and Consolidated Statement of Cash Flows. The Company&#x2019;s objective in making
resource allocation decisions is to optimize the Company&#x2019;s ability to develop and operate the Elk Creek Project. In
addition, the CODM reviews the segment&#x2019;s assets based on total assets reported on the consolidated balance sheet, and
the accounting policies of our single operating segment are the same as those described in the Summary of Significant
Accounting Policies herein. For additional reportable single operating segment level financial information, see the
Consolidated Financial Statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001802">&lt;p id="xdx_809_eus-gaap--SubsequentEventsTextBlock_zd9d4dEfE1T6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;span id="xdx_82B_z3cj66coW1fl"&gt;SUBSEQUENT
EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The
July 2025 Offering &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--SubsequentEventDescription_dxL_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTWVuOwpA7Ri" title="Subsequent event description::XDX::Maxim%20acted%20as%20sole%20placement%20agent%20for%20the%20July%202025%20Offering.%20The%20Company%20intends%20to%20use%20the%20net%20proceeds%20from%20the%20July%202025%20Offering%20for%20working%20capital%20and%20general%20corporate%20purposes%2C%20including%20to%20advance%20its%20efforts%20to%20launch%20construction%20of%20the%20Elk%20Creek%20Project%20and%20move%20it%20to%20commercial%20operation."&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1804"&gt;On
July 18, 2025, the Company closed a public offering (the &#x201c;July 2025 Offering&#x201d;), pursuant to which the Company issued
and sold 13,850,000 Common Shares at a public offering price of $3.25 per Common Share, for net proceeds of approximately $41,762
after deducting placement agent fees discounts and prior to other offering expenses.&lt;/span&gt;&lt;/span&gt; Maxim&lt;/span&gt;&lt;/p&gt;



















&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;acted as sole placement agent for the
July 2025 Offering. The Company intends to use the net proceeds from the July 2025 Offering for working capital and general corporate
purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial operation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
Common Share Issuances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;During the period from July 1, 2025 through September 11, 2025, the Company issued &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20250826__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJRjaNoboB08" title="Issuance of shares"&gt;5,000,312&lt;/span&gt; Common Shares through the exercise
of Warrants and Options by their holders and received cash totaling approximately $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn3n3_uUSD_c20250701__20250826__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdKgm3eWted7" title="Cash received"&gt;10,401&lt;/span&gt;. In addition, &lt;span id="xdx_906_ecustom--ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_pid_uShares_c20250701__20250826__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zImuPP2CRRl8" title="Exchnage for shares"&gt;415,581&lt;/span&gt; Vested Shares were exchanged
for an equivalent number of Common Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Purchases
of Land &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 1, 2025, ECRC closed on its option to purchase three parcels of land in Johnson County, Nebraska (the &#x201c;Property&#x201d;),
pursuant to the terms of the Option to Purchase, dated as of December 4, 2009, as amended, and the Option to Purchase, dated December
4, 2014, as amended, each between Roger and Nancy Woltemath (the &#x201c;Owners&#x201d;) and ECRC (together, the &#x201c;Option Agreements&#x201d;).
Pursuant to the terms of the Option Agreements, the Owners sold, transferred, conveyed and assigned to ECRC all of their rights,
privileges, title and interest in and to the surface rights with respect to one of the parcels (consisting of the property known
as Woltemath80S) and to the surface rights and associated mineral rights with respect to the other two parcels (consisting of
approximately 1.66 acres of the property known as Woltemath002).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Option Agreements provided for a purchase price calculated based on the appraised value per acre of the parcels of land. The aggregate
purchase price was approximately $&lt;span id="xdx_906_eus-gaap--PaymentsToAcquireLand_pn3n3_uUSD_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--PurchasesofLandMember_z0cIGTyQVEac" title="Agregate purchase price"&gt;2,700&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;DoD
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0; margin-left: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 4, 2025, ECRC entered into a Project Sub-Agreement (the &#x201c;DoD Agreement&#x201d;) with Advanced Technology International
(&#x201c;ATI&#x201d;), an entity acting on behalf of the Defense Industrial Base Consortium under the authority of the U.S. Department
of Defense (&#x201c;DoD&#x201d;). Subject to the terms and conditions of the DoD Agreement, ECRC is entitled to receive up to an
aggregate of approximately $&lt;span id="xdx_90D_eus-gaap--ProceedsFromCustomersForProgressPayments_pn3n3_dm_c20250701__20250718__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TransactionTypeAxis__custom--DoDAgreementMember_zFB10Q4DDlc7" title="Reimbursement Payments"&gt;10.0&lt;/span&gt; million of reimbursement payments from the DoD upon the achievement of certain project milestones
related to feasibility study-level engineering and additional reserve drilling, as well as preparing updated cost estimates, for
the Elk Creek Project.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-08-26_us-gaap_WarrantMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001814"
      unitRef="Shares">5000312</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2025-07-012025-08-26_us-gaap_SubsequentEventMember"
      decimals="-3"
      id="Fact001816"
      unitRef="USD">10401000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <niobf:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="From2025-07-012025-08-26_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001818"
      unitRef="Shares">415581</niobf:ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:PaymentsToAcquireLand
      contextRef="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_PurchasesofLandMember"
      decimals="-3"
      id="Fact001820"
      unitRef="USD">2700000</us-gaap:PaymentsToAcquireLand>
    <us-gaap:ProceedsFromCustomersForProgressPayments
      contextRef="From2025-07-012025-07-18_us-gaap_SubsequentEventMember_custom_DoDAgreementMember"
      decimals="-3"
      id="Fact001822"
      unitRef="USD">10000000.0</us-gaap:ProceedsFromCustomersForProgressPayments>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2025-04-012025-06-30" id="Fact001823">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2025-04-012025-06-30" id="Fact001824">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2025-04-012025-06-30" id="Fact001825">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2025-04-012025-06-30" id="Fact001826">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2024-07-01to2025-06-30" id="Fact001827">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001829">

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90F_eecd--AwardTmgMethodTextBlock_c20240701__20250630_zUCn0D2oxEt" title="Award Timing Method"&gt;Under
our policies and practices, the approval of Options (including any Option grants to our named executive officers and
directors) is typically provided at a Board or Compensation Committee meeting or via unanimous written action on the part of the  Board or Compensation
Committee, but such grants are not generally made on any kind of predetermined, regular schedule. Instead, as noted above, our
award recipients (including the named executive officers and directors) generally receive annual grants of fully-vested and exercisable
Options at various times each year, including as recommended by the CEO to the Board or Compensation Committee.&lt;/span&gt;  Board or Compensation Committee
meetings or written actions to approve such grants are scheduled on an ad hoc, as-needed basis, generally prompted by a determination
by the Board or Compensation Committee that such grants should be made (or a request by management or the Board that such grants be made).
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_900_eecd--AwardTmgPredtrmndFlag_dbT_c20240701__20250630_zqSmXRRTVSi" title="Award Timing Predetermined"&gt;These grants are then made effective at the meeting at which the grants are so approved.&lt;/span&gt; The  Board or Compensation Committee typically
fixes the grant schedule for such awards when they are approved at such meetings or through written action. Generally, award values
to be utilized for such awards are determined shortly before or as of the grant date based upon the closing share price on the
business day preceding the grant. These values and other information are then used in determining the number of Options to be
awarded to recipients, but values are not modified to reflect any subsequent increase or decrease in value of our stock between
the end of the preceding business day and the effective date of the grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
equity grant approach is used by the Board or Compensation Committee in order to best help ensure the grants are made only during an open
window, and after the release of the Company&#x2019;s &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_903_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20240701__20250630_zbGP1hraM7O9" title="Award Timing MNPI Considered"&gt;material non-public information&lt;/span&gt; regarding its most recently-completed fiscal
year. Including for grants made during fiscal year 2025, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90B_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20240701__20250630_z312nmHTEpF7" title="Award Timing, How MNPI Considered"&gt;we do not time the disclosure of material non-public information for
purposes of affecting the value of executive compensation, and we do not make any grants while in the possession of material non-public
information.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
fiscal year 2025, we did not grant Options (or similar awards) to any of our named executive officers during the period beginning
four business days before and ending one business day after the filing of any Company periodic report on Form 10-Q or Form 10-K,
or the filing or furnishing of any Company Form 8-K, that disclosed any material non-public information.&lt;/span&gt;&lt;/p&gt;

</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001831">Under
our policies and practices, the approval of Options (including any Option grants to our named executive officers and
directors) is typically provided at a Board or Compensation Committee meeting or via unanimous written action on the part of the  Board or Compensation
Committee, but such grants are not generally made on any kind of predetermined, regular schedule. Instead, as noted above, our
award recipients (including the named executive officers and directors) generally receive annual grants of fully-vested and exercisable
Options at various times each year, including as recommended by the CEO to the Board or Compensation Committee.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="From2024-07-01to2025-06-30" id="Fact001833">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="From2024-07-01to2025-06-30" id="Fact001835">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="From2024-07-01to2025-06-30" id="Fact001837">we do not time the disclosure of material non-public information for
purposes of affecting the value of executive compensation, and we do not make any grants while in the possession of material non-public
information.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000539"
          xlink:label="Fact000539"
          xlink:type="locator"/>
        <link:footnote id="Footnote000550" xlink:label="Footnote000550" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
                                         100% of Class A common stock owned by 0896800, and 3,934,031 and 4,282,116 Vested Shares
                                         and 3,391,596 and 3,391,596 Earnout Shares (each as defined below) held by third parties,
                                         and outstanding as of June 30, 2025 and 2024, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000539"
          xlink:to="Footnote000550"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000541"
          xlink:label="Fact000541"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000541"
          xlink:to="Footnote000550"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000543"
          xlink:label="Fact000543"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000543"
          xlink:to="Footnote000550"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000669"
          xlink:label="Fact000669"
          xlink:type="locator"/>
        <link:footnote id="Footnote000692" xlink:label="Footnote000692" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as
    of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations
    as required if the securities were dilutive.</link:footnote>
        <link:footnote id="Footnote000693" xlink:label="Footnote000693" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Earnout
    Shares (as defined below) are excluded as the vesting terms were not met as of the end of the reporting period.&#160;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000669"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000669"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000671"
          xlink:label="Fact000671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000671"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000671"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000673"
          xlink:label="Fact000673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000673"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000673"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000675"
          xlink:label="Fact000675"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000675"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000675"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000677"
          xlink:label="Fact000677"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000677"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000677"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000679"
          xlink:label="Fact000679"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000679"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000679"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000681"
          xlink:label="Fact000681"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000681"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000681"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000683"
          xlink:label="Fact000683"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000683"
          xlink:to="Footnote000693"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000683"
          xlink:to="Footnote000692"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001216"
          xlink:label="Fact001216"
          xlink:type="locator"/>
        <link:footnote id="Footnote001219" xlink:label="Footnote001219" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Loss
                                         on issuance represents a non-cash amount equal to the difference between the proceeds
                                         received and the fair value of the Common Shares issued based on the Nasdaq closing price
                                         per Common Share on the issuance date and is recorded in other operating expenses in
                                         the condensed consolidated statement of operations and comprehensive loss.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001216"
          xlink:to="Footnote001219"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001218"
          xlink:label="Fact001218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001218"
          xlink:to="Footnote001219"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001375"
          xlink:label="Fact001375"
          xlink:type="locator"/>
        <link:footnote id="Footnote001404" xlink:label="Footnote001404" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    11,165,324 and 4,501,302 2023 Public Warrants and 2023 Private Warrants, respectively, as defined below. Each 2023 Public
    Warrant and 2023 Private Warrant is exercisable into 1.11829212 Common Shares.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001375"
          xlink:to="Footnote001404"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
